<SEC-DOCUMENT>0001558370-22-004868.txt : 20220331
<SEC-HEADER>0001558370-22-004868.hdr.sgml : 20220331
<ACCEPTANCE-DATETIME>20220331140800
ACCESSION NUMBER:		0001558370-22-004868
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		138
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220331
DATE AS OF CHANGE:		20220331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Centogene N.V.
		CENTRAL INDEX KEY:			0001757097
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39124
		FILM NUMBER:		22791305

	BUSINESS ADDRESS:	
		STREET 1:		AM STRANDE 7
		CITY:			ROSTOCK
		STATE:			2M
		ZIP:			18055
		BUSINESS PHONE:		49 30 2130 00325

	MAIL ADDRESS:	
		STREET 1:		AM STRANDE 7
		CITY:			ROSTOCK
		STATE:			2M
		ZIP:			18055

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Centogene B.V.
		DATE OF NAME CHANGE:	20181025
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>cntg-20211231x20f.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.8042.36810 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 3/31/2022 3:12:03 PM -->
      <!-- iXBRL Library version: 1.0.8042.36816 -->
      <!-- iXBRL Service Job ID: 08663a31-c35e-443a-a15b-a37a4591fb57 -->

  <html xmlns:cntg="http://centogene.com/20211231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" sign="-" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_dOEUqG-P8E-R6_hbBKJEgw">2.06</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" sign="-" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_QF0Wcquba0SW1kQUPxLwJw">1.02</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" sign="-" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_pREXZ8GJmkKRhYIIX6tiPQ">1.27</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityCentralIndexKey" id="Tc_3IhO1dtYV0ym0PhbtlF9zA_2_1">0001757097</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:CurrentFiscalYearEndDate" id="Tc_Ep04vdF78Ey2wukykCq3bA_3_1">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentFiscalYearFocus" id="Tc_PE2_MQC7uEKf3MnvkXA-IA_4_1">2021</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentFiscalPeriodFocus" id="Tc_q6sIDP0YpE2lArUW8PG9LA_5_1">FY</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:AmendmentFlag" id="Tc_lseNrnVwN0K_qa-SRrYIOA_6_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityExTransitionPeriod" id="Tc_6Uj5Qb7n-0CTPEolQRQtSg_7_1">false</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_3_31_2020_To_3_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_7cIHbJ3WAEqZLmNWl9i16Q" decimals="4" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_jSIetAVFSUy9rOmGdWl3DQ">0.3333</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_3_31_2021_To_3_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9paPg1JNikGwlMsq-h96ag" decimals="4" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_fRre5vnXW0GOsU14ZJw1hA">0.3333</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_3_31_2022_To_3_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2MIM2SZhH0CgyvooSRXAiA" decimals="4" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_qjf0jjHjLE63EWQQBJvIIg">0.3333</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_contract_NQVYhN94Wkqxz3djLmP5NQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q" decimals="INF" name="cntg:NumberOfTimesLeaseContractCanBeExtended" id="Hidden_iUFcya4OnkmTbsk8Tv6XcQ">2</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_utNz0u9_5EyF6tB0tPCjrA" name="cntg:ReceivablesPaymentTerms" id="Hidden_01i51NYs8kukTb1nNEXfkg">P30D</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityThreeMember_MUCauPDoGEOo0vEXc8Cj9g" decimals="-3" name="cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity" id="Hidden_SQJSZp5xzU-f4eqciOHicg">500000</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EbcQzhDBV02EnqEK26rE4A" decimals="4" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_Di3UQRQ2MUWSk55FplrgzQ">0.3333</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Rnqc_kluz0ua1KLQBeraOg" decimals="4" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_lq4xIkppPkuJR_e8mjx1ZA">0.3333</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tp1a3EJuEEC8q9t8edUj6Q" decimals="4" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_EQTkAO2Ni02-Mndxnfpk_A">0.3333</ix:nonFraction><ix:nonNumeric contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw" name="cntg:ThresholdTradingDays" id="Hidden_2x0a_zAG40CpBOwHDJxpzQ">P20D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Hidden_j7I3SlyuWU6KYGVcxzrMkg">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Hidden_YStt1HXTrUSZGYMRD2aLHg">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Hidden_YVS6AVoIeUKeeejiDsF3JA">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Hidden_AdWcPoKHd0iDW7odOEhQgg">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Hidden_HW0l6QwPxEehXDxtNMXdTA">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Hidden_y1wywXdbVUOTeWK6mrdN-A">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Hidden_YZDLiCDl6EqhXBUv-LZuNw">P10Y</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cntg-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_12_18_2020_To_12_18_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_PW37pFbf_ECSJNc8ERvHPg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-18</xbrli:startDate><xbrli:endDate>2020-12-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_CV9SX4hApkWmqEt_60wM4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_30_2021_To_6_30_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_nqnnCqAqhkms8MmscboYow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-30</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IJi6tizcMkqoRBY2BmqqJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:SoftwarePatentsAndTrademarksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_H6sJ9CbA3Uqak-twBHs28g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:SoftwarePatentsAndTrademarksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_QclbJBn7ZU-bkYebSJREIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_CoronaTestPortalMember_LjhxO9L-BkaT6QFPOJAsSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:CoronaTestPortalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_Nljnlu_Jg0W2A_crlX3lqA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_t0eueDKCHEKgNoS0LdjhcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Vx47RrdIq0GQ-Ki9-H37zA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_4T1vNzsxNkCbKq5j-Bd34w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_hl6aZ99S1EmWbvQH7J5vNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_ZLDQszdhKEWtIgEyyR7CjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_h1P9Uyda7EyoO2LPxzrHJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_IfrsIPOMember_d-_7q8doLUSyk01ZAKC7zA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_-kfNLSIGS0CnDBcj9PVDWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:SupervisoryBoardActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_BvghgdBxEEK2gQ296xhPFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CorporateStrategyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingSuppliesPurchasesMember_PMe3DYqonU-W4y4ejGN9NQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CovidTestingSuppliesPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_OO2fJYJiZ0i04iwTzazmNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:SupervisoryBoardActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_aVpyI5X7v02azktZKILDIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:RelatedPartyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerCeoAndMajorShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_UKYRDn2W90unJoMzUYsVTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CorporateStrategyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_cu0LEFW0kkCkn6XxXp6-EA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:SupervisoryBoardActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_hqH7Ao9bKk-C9CGDc25eug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CorporateStrategyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_JO38uhlHsEqj0m4RCxwbMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_qUqCYL8yF0CdfM0hT5d4hw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_GV4YMZdmTU6rHuLJZRyL-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_hqryZrQyo0u9vk198ZL9tw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_-gQEIJhhKESSr-jRSWvRtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_u8KGLF7B5U-cOI8U7qgNTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_vHwIWQCj6UO2OcggKwqNGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_NqWV89gKk0OodA4cK3KhyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_PjLMlUODRk2FbEMI9yrkqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_cHFYMEOjEEeAbEoJwPK02w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_hqCpXOTPc0ife4tCRqxAhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AED</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_zoJoP5b4TE-XfyAcw6W03g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_mqnnjQQULE6jGbqjlZnJgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_cloQKLoTo0WfQp8u9x2sCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AED</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_DH-VjAVOi0q0q4n9FC79TA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_gr8iddTpHUKdwj10hqL1EA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_Y0wjUE1Kn0Cww5TD7WEkoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_yU8ydiLypEye2GvazPiV4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_y0Lzs-KudUaAjZAL7q9mYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_WHyj8PIaVEykw5TtSMGt3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_-k8208qQ10SHd_-JTl8E2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_r79EEaTrbE2YzRa5xIlIIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_cMFBX5CjWEKs38l_X26NEw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_aKCHQwKnTkW-WicxuBEYgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_7LGAWQ8N8EWHfyuzxK-yzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_jzVLa-F6DkiRRjGQ1jjAxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_8GUO8-vudkOK8pX-AcOLCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_C-SoSBT-jUu6aB0HnuOW3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_-5Y_ZC3Cy06jqSRg2rkNWg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_tsk8qBlLdUKKx-fMOsu2-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_Q4DmiPOJc06nX5FPcvcI3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingServicesMember_ybA9VqNfoU6JvMqlmNzzdg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CovidTestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_3QEbeOJ5BkaO7w7EMQ7ebw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_npNxfNEcOEiHMRcMz1OMNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_PCFksdHhDEW2XtLHDI7Jvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hY1buzymRUmo804bWIJEcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_-Trx4lnT9EqhKeaem--7cw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_0EhnM-nI9U60TimMN9cS6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_t5U2pU1llkyqTaF2VHf4kQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_r9aWl2b-v0OSqz3If8MAOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_D52k1rmdSkSQ8eJxUeQTMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_5om3Tuoy6U67GcuWFQxn_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_8iKdtQU-_Eu7d8Hvzi8aSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sey9N6DwsECg7Y8DnOwQ7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_DOZiypy0h0yBjpMQ3UPvww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_st_41JliCE2l_ojbTOAjxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_Bo1twD2K6U6g1a4dtlQlRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_clx9prwtLE2o24g-cVlXXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_rP9H_6ZxBUiMxdA5czmkLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3ijtgqtaKE687iwfHUfycw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hWWVNS2x5kyprvvsloH-qg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HT11Yq7HqEiuy71IFa5GQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_UQLS1jqBcUaiRdVG9-LbFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_mMrEFk5yCEeTQec-FbsYew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mdFt7GHH9kCbATPAUndvBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_9xKbq0HvrE23nctfL9kqJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_uhttJnikwUygDyIGsX0K2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_cOG0cWgzz0yXAS58I-gQ_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_khmhDdbQsUmgB98c9HcKgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Ybu5gGcGb0CLhwhCRJoJzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3R-RJj8W30CmqBQ9_P-L6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_wr28CgnaFUihv57zlIv9nw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_HinXUd8jiU-OqKDtmHiBBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_gQTQ8dl_nkqEQsnhaCYVXg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_6jOQBXEji0iws7Kj-GYZLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Ys662UuLNkyBTJCZFPfCxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ythndJ_8XEOkXQ82UmIkkQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_pCwwsigl0U2m5E7-eDM8uA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PF_KqP6LSESi2HEzjtBOPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HrC70U1Yj0u0D_A7_q4GXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_hrmD1qRunUmmMLok8OgVQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Pq1dqziFrECoxJA6IUPO0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_g9Q4KqtnV0uSsn7ARpe8uA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_RO2fs0emCUu9jR98AuIlGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_q9a-MHMvKUK5U_xsAmy2MQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_i4C0ubETiUCzWqGtU1jx2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_6zdpYcOa-ESFJJRwZE-Oag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_l03HHyyeUEi1A6xEJ5Edmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_R_eEBY9qmE-NM3Tvk2KDqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_5aArgCY3JUK83G5Z3yyuaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_zy3jWFs1Ikq8JSLXUCeHJQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ZXy9HwJvXUaEjtHUhuk8ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_W3F58Jfx80ii3Fx2Pkj0bg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_iS_M28fhFE6M9oKHCruHBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_HkDJI80zTkuUmk--Ej4yXw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_jPRbVhHuNkuHoAHPHl0FHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_HHPssicdQUqnZ5X69XqpQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_dIyWF4ygA0iQzM7wM628QQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_OiigMHAcVkuVDMVMzBsepg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_4JRA7asUB0ioKSQ0gqeV8A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_oREizo1DqkCFGwT7ENil_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_c1SgMStWuEuH_usbmcBK0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_j0CQFn_gS0GfVtrcdtpKYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_n86T_jTggkKRt30kBqsVZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mVhL40cYQEePQ61JZHkZ5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ROnDIAnWzk-FwbKaqoEgXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_80vPPmzZsEK-rHwOiITf5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Z8iyfz_ZhEyQVS1VVRoDQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember__5AEW953l0KC20ixoMs7ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_zA1NYJLwcUaXbGpQUDVDuQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_gNfrmr6fLUixQ62x_Fwrew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_AZFndmgY0UCwCIG8wtdz9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_km5pa8EmQ0OS81LK01_wkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_9Ui5l_nU70uEou7uc-87Jw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RI1XvAcXBkW1sMvmWPyezA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_azRhFhatK0S_v248GkC16A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YTUjyWxrfkmjjtjGT1KC5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_n9XhJgrCrEySPhrU20QprQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RZW3v4iO4kG8NHVW3fjBIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SA</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_wJkGwu7MkUC7XJrNmADbTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hgIa0VboT0mS4D8xJQpCCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_DO-kg8eAVE-lWMef-KoDVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Gn5qMK_C4UePkU4n8Ymluw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_FeVjB1MUOEeh9_f7uvi5AA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ZnrF_dp5Y0KfdoqcK2Js3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_7PcrTsViCkCTYuQCigBbTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Oy3dJv22rkSAReGZRjnSUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_tB9oEnXM7EW6ytrbi0USWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_MTbFAzD3FUiK7SEe_WS1Jg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_OeyM4bZnmk-KdBoTF1lVhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_N_D2fMybOEioJzSGBTNgVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_D-7kMsmp8Uer11pu6XnQCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_fKiyneNNIEaYn8UkC13EtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_OP1UzlIcX0OmY9sJACaIww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_1IGbd19w8k2QJL4QJn5QLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_Uoe9zKqJoESD7LidLdm1YA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_tYw_3cgR1Ueq-Gbz16oQHg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_v3fS0Y4zQ0uHtd_W4YK3ng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_WqUWe927Nk6uSgbaCxFjkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentosafeB.v.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_fxCJFiGsDU2tRIrSA3JTfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneUsLlcBurlingtonUsaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_SSqn3JwlZEKIYquVSRVj4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneSwitzerlandAgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_1RkheOIhVU2eH6psyo77cw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneIndiaPvt.LtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_gdQ7ArXwUU29FpifO1d2Tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_6ilmlbgLQUaozewCaC7r6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneFzLlcUnitedArabEmiratesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_jno_GFKBDk6OafQHIJLx7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneD.o.oBelgradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_9ANqzl7ZTUajud4xjfwt1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentosafeB.v.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_UnWKT0VVDEW_wX3NeqiDeA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneUsLlcBurlingtonUsaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_99jSw-B3lEmA9RjJZquI8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneSwitzerlandAgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_tcRN6jVWa0CvEfR4vmQr5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneIndiaPvt.LtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_nM4VKfdToUCleIioxMHAVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_aJjp5Hfn9ECKKXqBeqaLXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneFzLlcUnitedArabEmiratesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_LsRE2steYEuxjfr5k30J1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneD.o.oBelgradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_gykS6db5-UCUac4tLpVtSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_cybCz_DIdUCl_xWyu3Pv8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_I8JCso4MK0qgaLEwIyMTbg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_lEC-E1pPPkKKZSA0ZSkDSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_edmJJe7tlEedyQZh-3w6bA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_fuZVkW08oEaKwXZ7YfUYkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_I6xfcf-C2UWRvm-kxsFGQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_kpzFl95A4Eihik8AD-vh0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_imxgf1UU7EmYdPJ5WDOOCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_bR_4j4cSckicZd6QmHkZiw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_pqgYMySFy0mCl4qrOYa00Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_pDjbDgn5b0qPOlPHWmNdPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_yS6hjJywgUWf5TfLOUo9lQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_-qbWr3ldhUuv7EtvkZChEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_2vB3kEQ9kke7ig8iaxIHWg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_-cmNgE1L_UWx4FtHzGHuYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jxm_mplIxEmZEcgIhg-8iQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_eqR6NyQJOkW920BqJk1jTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_PrcgwTEj0kWm_mcSL5ht7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_H9IaZfpHHEeg-x_U6Loa3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_YVVpLHmHuUCyVsz8RIAg9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rBalwrMaEkicgxSJdYTFzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_9xS0NR0lGEmdKJ-O-1K3zQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_KLZzrB9iaka5B8A46KUKYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_bOr7Q08nUkCJL9UFD5xgEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_MPE_bAH260S1MVcfmAfdbg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_FJL5PQArUkCuYTb_22g-4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_MbQzBIokME2nAKgB5upFAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneIndiaPvt.LtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_XwVB5e8oEUO5d47G1QgffA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_bm2QM3qwUEqolDwi7dS3oQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PGxsbLEs7UOMIWZf7Z03Zg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:PharmaceuticalPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_vD7DKV3Hb0uFeh-tXovtcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_-u-gDw9Kw02XQH5X4XgSEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_sgzRGPjWTEKksOKAeqNcwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:PharmaceuticalPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember__CSueLWvfkaKMbg97rwstw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_6_24_2021_To_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_Lggp4PkrtEW3C7ZFnD1fIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-24</xbrli:startDate><xbrli:endDate>2021-06-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_scfLHvbOHEyhfw0eoqJLjQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrJonathanGSheldonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_NfDBPr_PCU-WeXMIEGto4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_ui7vsg5w4EG0lJsC-MuuLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Cm6rxbg5V02howDd6-HKiA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_uNK3cJ2KukGhjB1H809MEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_I_CkDW4jyE2fLJmcucRgFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_kVJa9lQw5EeR7IQzDBa0jg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChiefInformationOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_WYFrUDbkkUihIyr9HpBc4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_e7pwRt_d5Ey8miVUeDmHnQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_EZ4EQKl6u0y4U2G9Chnqbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedAwardsSubjectToTimeVestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_pLa-1tNWhkaifjyG5-55CA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_ECxfpRaeB0icCiSqRrYWNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrJonathanGSheldonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_cKZBZTR-hUKsYvIbDIFtyw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VP9HWW5A2E-7VpFzEFjsVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dLhT7Cmve0CdytDI3taX5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_10_15_2020_To_10_15_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_V6gW_1JbeU2rr1ZWiZ89Tw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-15</xbrli:startDate><xbrli:endDate>2020-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DtkVOppjHkWA1R9t0aDNNw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WUAkQyT5QUKI_CA2QFIqng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RzmMZK-ny0O74pah0YcM8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EYVETEm8qkGi1WMdtZbI0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChiefInformationOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_LCJaveMDmkGVp9ON5ZIyPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:PeerSchatzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MiguelCoegoRiosMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_AnpIXYXhBkuyC6Ni6BiUGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MiguelCoegoRiosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VestingInFourTranchesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-07</xbrli:startDate><xbrli:endDate>2022-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_yqUJXsPgDUScDg3m6hyHWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_1_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_9zMVFYEdmk-gHU2SpZ4EMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_mRyO_XlQBEWt7q8iQ7G_8A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_XrpCDWtFQUmPxSAiXPTXUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_vd39B4F3FUO_Erq6z5AVPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_iozvi2N5fUy5-JmDwCHMOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_FuwgOdOK2EGp4zWT_laRCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_rIlXfTTwmU-ysaRC7xDcSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_XfZVUuusyE6sKx1xn01SHw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_pbC3EeTlG02DpVQruwf4Tw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_4eI5LpLv_0eo4uPM2ev0NQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_B6gQoQkzLU6SHuMVF2-iZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_3v-ci-9RIE-ahgs5Q3wFMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_xTVVLa1l40W4cNlLaMYVqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1ld6bOFbL0-jZ3xi0wJJeg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_zZC6MbCQ0E-4cbWihISE2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_CUAJUdk83Um44_JFEP8vXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZZvNtzkppE2H6789cVRd6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_bVwoyln2AUi08pK8bb-Xcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_exG11_HvBUqZzNaMA2BROg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_PUdDMYJxs0uelX1OleXC9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_9Pk-XO-w6kazSFU2ZKTLMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZXCGb0Im-UKu347o-AvPMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_HgkA9kih00i_kzO7PaqJPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_091uV2Fq_0qIxxVqOPG-zw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_QZfp6KzOOkKZiy-H5CT4mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_iTqtnBHt_kCG66_LrnRX5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_5wg1Zs52TkaxKu1Aw0P4Pw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_9xKYcirppUaOjw1XbQSfdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_LIP-LQLQ8UqI_DwDXlei1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_goSBvtoOwUimSgVTIL8xDA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_loohpHzHaEaNrs2gcMBUCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_N4HdUneZ4E-AHlGZSokgjg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_6QowRtO2bEKJIQeTYviHqA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_Nt_CcI-0j0aio14DEtDbsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_tZJnFmxuvESALxdrRN7PBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_IY8Y75xLuUqO-v68GXjtQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_gGgYwThhA0yTgQ_UqSHevA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_wO1nyt_hYEmFefkfmJrSBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_vQpey-VclkGOtoNQ0QvVjg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_TenVHCDHtEWBdBEcmQJ5Ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_alWkS9-7z0m53IksGJp1Wg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_zxwIfxJDvUW4PlzvkDXuFg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_F94moY9-wE6MiLBgNhWeLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_OLnDAxQ4XESWJVC9_RdH_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_w4OmoUQNEkmOiPw-yYz1gg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_RgosDLxdDkaOOiIDh22DcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:BankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_eqHyAFkkLECwnDL6Bn6VjQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_NANDNBjf2EaG0Ib3x2YeUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentMunicipalLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cArnp-3_30mf8DvP_LdFug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_mWZOLj7bwU68ESmKMOpaew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_d-rj6ZvYbkKxosbQKnX2KQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_s1T9fhanpEauW0zp7hr-Dg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_OrZxBSCrjECX-zhxs899wA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:FinancingActivitiesMunicipalLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_DtG1lO2ItU27MlS9ffm2uw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_0I3YNkAwCUaxTut_BdZ8UA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BL1i3OTWXkiZ1SLLgFTjaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_9Fb3pxnGaUSRHrSKjMx4ew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_uYV506SBMkuvBE_EZMSfgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_tFtzIuvOnk6eFcAYgKYnZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_cquxSQFt7EuMikBUJNV8XQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_-D-lKyd0xUG2GJXr65MPdg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5eaVP-7_1UKBsld_2DURNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_6ZxMHT3Ak06Btt3uetZikw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_Fj9Rp4R76k2ZiXVlDvyuMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_4KIQ2EJM10KtGQbtSjZSUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_mCcyce8TbkO8Vgcxe5L8zw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_uGud5JzQG02kaS3Mgza75Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_nHe0IepNs0m-_JVwFYjKRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_t3uvbKfeMUqBA08LcKFV-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Z8byyXazL0CZp8NK1au0EA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Zn-0UMVx3E2y3vqaDMW_5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VBSTmHETgUeIl7NqPr5fzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_PJiIvVIxGUC41eoN-l986A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_smkCz2ptokGCqin3TdKpUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_3NmcgXK8lEOsvBWBRUv4vA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_pMqKy82tCkCyUZNqkklFgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_BYnxal9n_UyhTA2Zunv0qg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_SRmpcImuLkKr7Mhauf75CA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_DVwpaAKq20WetXOFxByNKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_t6wM7AhQ-EmoLvKXt9OZvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_dYyKiaYqrE-5cSLRxZqoFg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_b6v3zHDw4ki2KCugNSJoWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_KXY4hB06pEyeR-sh2ouA0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_-0qkA_V1Hk2dqGzpyUy7Dg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_kHvSJAIc5Uy3c7q4gg9Klg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_7xeJVhJvYUmbsnvDHQ8d3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_52eSLkL1IEKzP0P0QbaXNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_zDoz25BuFEmJyAnqcxNW5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_vYQneCL0Uki_zA6xML9L3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_6nXywAwdyk2CprWek0Ldig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_xGvnCbYIxkKMBxggavLiYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_abKhok6QA0qwwg9SxU0qaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentMunicipalLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_cNSOgL4hV0ag41MiwnIxFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:FinancingActivitiesMunicipalLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_KqENbDNqJkWj590bxS6xEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_h8KVGyeyBUaFAxgh3PnrpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_FHvvZ20F_UCAedsf03EZGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SellingShareholdersMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_XLF3uUzrWEa3kZA0wFlJcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SellingShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorPurchasesOfAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_VdrlZSWEREarVoh3zIZywA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorPurchasesOfAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_LRKY6gLhMEChXFAJqFrQYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_3znQxHgm3kWUN47RhL_tkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_8do-YyNisUSwYP5bueDYNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersAndDatabasesMember_z7T7AVbVWEqN5q7cJhF12Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersAndDatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_mgdgQ6ZdVEWu7MZBFuxPcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_a3Yg9ypl1k2iDGuR8xuRyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_3g8HtBjL_kykX8R0GC1k4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ClpwBom6cUqWd-ufPXZ0UQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_LzHf5lcGX0618OATPQ19RA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_UUEtJvvNV0G4AhFLi2cvzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_SpNNQ_JBZUOkx3nQnjLf9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_3oFLP2tExkCs_4EjAnnqvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherOfficeAndLaboratoriesMember_OVbtCKe6kk-CtIPs5TAqeA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherOfficeAndLaboratoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_TE1FCKSJ10Wnq3AFudeGVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:SecuredBankLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_KNPG7ftQ40y3-jayGIuG_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:SecuredBankLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_M_ofTAJmRkyW0qYhKuCWYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_8WV5gyv1i0GftN0I4C3eiQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeAndOtherReceivablesDueWithInTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_z1xLnpmvrEaXgiuUBqzwfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeAndOtherReceivablesDueWithInTwoMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_vfEsDhfpBk2COGW2LU7q1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nrmK-W5eVkeDWBDFsK1gbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_1I2zB8P7-EGuayPURgq3Xg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_gmTaq6Yn1ECvIEhMtnPX0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_c3WvXYkgjU2w62UITw_QoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_iBTWkttdV062pZ701mLkyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_jAebtKB3PUWEhq3JPxUl8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_YGwYj8iWBkW5FDEsRlrh0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_v7Uhyrox_UqVpbuf1EAC0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_9o0XhkZxGky0b7QNSp7Ieg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_q-OwjmoAGkCq9QP-5ONw2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_VNENwsckGUiWfp5ITIZVqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_-KBY6U1X6EOR-VWQfNcPHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_Z_smm4P60EyfOSuzKxAlhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_AWSNyH90oEO0mlR_BPIyQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_kqTayYwJoEGJgu7xk2O20Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_iNZqJbVbKki0oB6o29DKAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember_8g_ZitjpWU2j9Bs86BqZrw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_XEJ63VPP90SKEPNBmiOU_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_Nr5CKDFzgEmOhALcEcaUKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_nBhxP_A8lkWu92Je-mOYBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_mTPqfJbCUUm--tsL4sV-ig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_qMKixKGV5UWRZqRsEsGsdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_quezt-h_1EWrq43Pa0YWsg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_im24XRyLI0GqUcsxo8IrZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_VIL6RPyEFkOt1QnphczzYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nnGZ6V0R5Ui7TR-RGngNEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_AHlMhGU4RUO4AYFCEWNB4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_aSbUFoGlt0-vDtnrIjva9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_YBYcui1xWESYnTn6QF0bXw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_CeCE8jbz0EGNqIacDltO2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_53uzl0nKCEWKL9P-aqzedw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_6HnJiRc8uEOIwyqFZl2paw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_h3ZfOluujEiPQeT9NlQKMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_IGCBy0alu02k3K8HN8HMVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_bV11S-JGL0-qYfeSG-mqaQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_YEwbUrATUE6gX9KIiJ2XJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_alAn4anr30uPH3nv6D0QTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_MAiDhc93mEuXQd1PbNze4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_7zHmJCcCi0iHo0JtjolMqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_Gg9_HCfVqkyGfAYx_drdzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember__GLD_N50Q0qJTvDIg66vCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_sDI8Zd37_kGSZzcJnjDK3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_oDDkh1PJbE2F8ijvw05Pvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_Q0uVwOjO7ECfq8SqO9fgPg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_2zZ4FqgNmU6u242fuMe22Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_2o28VsnJ302Wcsmk8ET49g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_3_Qlw4YfQ0qJvktlFzldsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_lKSmRPULxECSr0eRnZJv2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_2eYckct7zEO-8jBTYOIllw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_3jNAkLwyqECFEAQq580h_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_gS9HG6od70ei9gUMi0zxBw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DpbCs0wmDU6o6dQo732WVg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ManagementBoardAndEmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_aEEdjxkwJUmQ8BYGV087NQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dHEoTjnDeE6r34FsHbGMEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Pv_4vLW3B0ydriIBKiHLXw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ManagementBoardAndEmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_Y0FLGBLSsUOi8XOAx5OviQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017And2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_J6cKOx758Uan9G_GzTxF7Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2017CashSettledMember_ddZeCSMPQkigLGIMskIdRw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:VirtualShareOptionProgram2017CashSettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_QBlrGqBAdESpyQFY-rXeBw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:VirtualShareOptionProgram2016CashSettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017And2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_StockOptionPlan2016Member_GI6mBJf-uEaspTZUbL_7cg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:StockOptionPlan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_7_2021_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_kqeqzG7A9E-5ZgMWESZGzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">cntg:PartneringLaboratoryPhysicianProfDrPeterBauerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_S0MC9TMobkCnNHOB62yknw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_X97kRl32r0SL4FxM_6oahw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_OD742rXyRkCCIa1akqAdkw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_yKg2jE127UGpUbOS8qY3Tw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_F1HqNUC0w0yF40_NYU5-pA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_OJOdfR7_SU-Nboe2Mk7i5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_B3S0Y9EU7EC4i2truDPkCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_d0QbT8X_7EC8vnyFCWMmUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_ZdfnsggUIk2dILdWP3oszw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_-iDqdbmCPEajuOsNr85IOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_k6D4DSCZeEKWLGaxOgVzTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_D3EKD6FKfkq_ZzWKmtMzhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_qttKShlhOUaMLtKd7DFFOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_A_FsM08yS06J9681vM0x0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_s8pyC--PfU2a1cGfakOyRA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_WefR96CjT0i-wI_gc8Tt-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_ep_o1_bT5EeKC78nBN7dbg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_zkuIRUT7fkmPld_mOMD4eA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_1IhyUssZbUOMIOgGzDA_QQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Dsbd-0Y1U0K6IobP1taD7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_ASav9p4dxEO3JQhjgj2p-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_uWLOxsW1eEmoFw2X5N9jYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_FDERhT7zokOtLHTy2PLLsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_gFxC2tLdrUODGcKQ8Sm_rg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6yWOMiPRDECERNx2-xKf8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017And2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_u7fv_dcK-kmlAC640STiRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Ws6ILO8IfUWKpcaFtKnMBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember__QDyppugek-Sh2NBifnpow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_Wsje2nrQu02pAKwNiLBXBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_yBvnu7QHa0K2BszKcg5KZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember__luwaUE-_Ei_x9Oj9E5zMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_Iz_MtPVKxkKthZpts8RjoA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsDepreciationAndAmortizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_f4ic3iZXSU6dqSWwhtj5RA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsDepreciationAndAmortizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_yMvM3I89g0uOJQ1FgVa7uw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsDepreciationAndAmortizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_eDNvK1TmeEG14kTMUgQaLg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_G9S6WR6LUkWpOgDW2ba0hg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_QzlZ2gHa9UmZqgp-gMT1xA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_BcIW7LDHy0CnsUV9Pv217w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:MeasurementOfServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_6cqIyIHrEkyiYD7ANN1bDg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_PzgOubk0sUiPtObl6v_YAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_J4CTxkjWd0i7eimj-78dVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_3fVvStyvDkODlS0OB9wu2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:MeasurementOfServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_9Epnx9NGxUyO_NrCcxyv3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_EftQ82OO8kC-o269ZjHJoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_-qIGtGSHJkaH45QX4EJ-vQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:GovernmentGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_6JeY3hzvoUmiYLFCkMlKPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_k0i-lMHYs0mveCZGWLchMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_nSTQU73o0Ei4uWEp9Ik9Ww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:GovernmentGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_TVcAOmx4hE6T2TjYZkvryA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2MOgA84ZvUenL2B0HVv5GA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_GU9QgCbQgECYTx4q1I_gFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_jyXlykJnhUCcrgqw5ohJ0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_897mirp3Ske02sLLpjt71A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-tikKSwR3UCPoT5YzJiKAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_PAP0ZlgjQEKQn4Hcd138ig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_7QvO56SloEm_LGEAxTptVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_vbrOgTDfJ0e6FyvtY_qOlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_OdjXVnK2IkSMmsnB2jcPFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_mmip9BVluE-UTcolIDlfkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_1MoZEasurUyfu0ObaxOLFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_T7-iENiVYUyPsm2u4I6Pqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_ZMDElsu6kkCNvAhR--AP0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_ifrs-full_TypesOfInterestRatesAxis_cntg_FloorRateMember_xBPN5MEG9E6vID66HBPpOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">cntg:FloorRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_UJLB8dmYAkWtWhi5WI1mgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_ad_D9-9ZjU6KAfCtl8pHWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:RelatedPartyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerCeoAndMajorShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VMdLXHYHe0mBFblmw8jl9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MkH40joHJkuDjye7-7vt4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_1oxG-ulhZkewdx8UmyncDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_fYFW5_Lv4Eu7pT63KH2LHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_yaEih7N5-0KOOF5zjhU-TA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_PpfrBDRiYE6X2aaNart3Kw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_mfxVmFR_xEyQeUhCH23gEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_OSY64BhwkUypKBgHktTxdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_06MXARpagUinzCDOWZ3Lzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_COIkXqsq3EuSXQ8ccGnOYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jB3v8yGjV0Wzi4l46Yp0Ww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_a9m-Txeoa0yrNuKt2KsrgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_5Ul6LbHt3Uml3dMdzr_SfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_JJuBkPLnakebKDZ6svlPTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_8tdZRFUyHUy1cqWB5uPVCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_dcozlUxUTEm0gw3SLkH3-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5hTATt8HAUSJCLPDnOCGvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_78Nr_Jks_0OKR7JkB9K_fQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_JX-s2F9e10SlNE7SMW4K0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_oIZwdOmoREqE4B_LSTBrPg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_h73Wub4Up0GkkBugURy3GA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GA3_hAw990K3e4HpR8KZlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_jzWpq6P7GkC8v17Iacya0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_lo0H8n9Nq0O6cFGGChm3OA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusRecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_Gr0aLoEJnkKrHhlW3a8QGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsusRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusDerecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_vmSzJlkTlU2f0ogmnllTIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsusDerecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_5_2021_To_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Wnp1O-SE3EaWTFbyh8ZNrw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-05</xbrli:startDate><xbrli:endDate>2021-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_5BgL8gvkB06Ow57f8rxdoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ViceChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RRXiYNlkWkq3h07ypEAPTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ViceChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfCompensationCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_serqoK5ea0CVflGxqcVFGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChairmanOfCompensationCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfAuditCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Tb9WXS3-AUy4C6w9hUDAdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChairmanOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_vuU72Kbpq0W86SjCUL5Wog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_VmnidKUOw0WoRlLrj829EQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_x92x8S-RsEqIAad9QHOnPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ha2hcVFm9USAnZurtaYg4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OfficesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_s-Pt6IBZJU6njzi-YxbBHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OfficesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_9C85cYkhmEagnhCDbgR3AQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_aP3WLzf6M0CLLqABTJdjzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_TgPeSvqouUGI0WVPV6Fpag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_5Ec6abUhxEqrvssO3I3V1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_h_nPcgoxBEe8fAs9VKUdBw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_Lv3jrzK6k02RPZdSdWq4Rw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_sqSmjjzLIUyAz8bHBnf8gw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_pxx5jMplQ023eMujrnK7Mg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_HQ7jbEAacECvHaRSqE6IBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ryAYBZr5MkGcAGRJi9dXVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_K_VUIvDBuUOw0I-5hs6miw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_VE4Zb24yM0-210qngfcykg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorPurchasesOfAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneAndThreeMember_1pwVmq3z50WQKX7nCXD94A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsOneAndThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_llexk3x_AUmw6uyZBIrKZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_eAQrHbDIbE2JWeOzUkgTzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_EWLOPAf3s06Yaf102xYwkw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_yHGXCfJRZUmQPTopPKil4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_LRSLwc9jLEWT_6ss8x1zQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_hvAwpduUMkS_--hMwyClRw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_Chzm4i2edE6J2DMBM3190g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_s1PTQMK510ykabqlfipOvQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndMachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_nN1e1Q0e8kGM1jF00oCH2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_utNz0u9_5EyF6tB0tPCjrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_fT4qcBDw9EGETB6DVY3dyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_4MGHm-fiQ0S-NkUoqSHdJQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_gE_fMmwbY0-dkhMzL5yzoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Jxfmi8_7z0KhYrUFcANEng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_HpZLjBEdXU2I8BB2YamhLg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_LUjbd8sTrEGlOUAQswnsuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:VirtualShareOptionProgram2016CashSettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_mLSkDz_SwkeNhCK3FKDtYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_oC-Mfx2jaUiilWSjgsPQBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_TvyCsMUqekaRcguge2kBDA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_UZb9Ik94skWa-HFbTuSMPg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_q1nYC9yqtEWW20MzQIkwFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ManagementMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_f5-2plb0q0-wYgUIlGZSEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VestingInFourTranchesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-07</xbrli:startDate><xbrli:endDate>2022-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_64L26hAwIkSVEZySJMUuIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_E6OgGNIl3kmP-TkRKZ6LGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6BAEvdBRvEWAG0lUbPv9tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GI6jpuFNvkutlq0qWaVoUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_w5uFjzeAFkaVyynChFMU0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_25_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_sgqoRzpr6kyNzDY9rq2YQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_1v4SxiTooEOxh0OPstkkmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WQu1wOdXfU6jJWFMBs7BmA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tFCvLv4fB0W8h2vSoBrRIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_25_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_oVuQnUbma0GfMOyRtTtgqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:PeerSchatzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:PharmaceuticalPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l3DMVfcSck6NtIEREMfo0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_GTBMEUx2bE2fzTJ4qOUR-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_GQnaSesZO02Ad6SmW22DGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_mQOuHcBww0qhWOVQnUs6Sg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndMachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBostonMember_uzMhEfk4nEWX7K-ikyO7JQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesInBostonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBerlinMember_PZ93SKoOakme1tsNGTWckg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesInBerlinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_7_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_5mtjV-dSjU23MM1xhgok7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_T02QWHkiiU6Rq5vnTMYTIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_cIYko65EgkiZ7oKBWF8NyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_PsYZ_Pee1keOQx_1jfic9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:BankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_pxPW_PzRlkKEtKb4tqL2Uw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_jBSfbMY2lki0j7PbxL_v1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:BankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_5NYYA4fPLkOwhQf6kwQBhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_lnY-Exnu_Ei1u4vGqsRWWg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_x2UJf7_pxkOnSeiJ7yIVHQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rZ2pIjWt-0-tbNOWGJRkUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_LiVI1zychE6WlZz_18uRbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2020_jjcjEUhSo06U9XQl7FB8sw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_AWKL1ObmqUyfc9ddDXBLhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_E0hk7XwMHkiMLSQWwvqDyw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-07</xbrli:startDate><xbrli:endDate>2022-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VugOHEd-30i25LugBEmvOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_6lvAjzC9w0a-ExtvrVissA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:PeerSchatzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-18</xbrli:startDate><xbrli:endDate>2020-12-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_P4QuY9PyE0m3yFf7W6apMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-18</xbrli:startDate><xbrli:endDate>2020-12-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_FG-eKZsRE0Of78EHPSAZ_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_31_2022_To_3_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2MIM2SZhH0CgyvooSRXAiA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_31_2021_To_3_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9paPg1JNikGwlMsq-h96ag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_SC_KXEUc3E6xppndc2mfrg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedPaymentArrangementTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-18</xbrli:startDate><xbrli:endDate>2020-12-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GosQtpqEsUy9vxX2amQi1g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedPaymentArrangementTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-18</xbrli:startDate><xbrli:endDate>2020-12-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Rnqc_kluz0ua1KLQBeraOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:IfrsShareBasedPaymentArrangementTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tp1a3EJuEEC8q9t8edUj6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:IfrsShareBasedPaymentArrangementTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EbcQzhDBV02EnqEK26rE4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:IfrsShareBasedPaymentArrangementTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-11</xbrli:startDate><xbrli:endDate>2020-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_31_2020_To_3_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_7cIHbJ3WAEqZLmNWl9i16Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-31</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:OptionsGrantedTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_31_2019_To_3_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_3U_fG7sutUSP4d2rpl_g0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityTwoMember_z-vR9ah280KWInpHt2Pf-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityThreeMember_MUCauPDoGEOo0vEXc8Cj9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_InfrequentItemsAxis_cntg_Covid19Member_jq7vmuWOsU2bxZzrIIp5CA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:InfrequentItemsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_InfrequentItemsAxis_cntg_Covid19Member_4cfu7k0uNkCbmNqwluM_rg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:InfrequentItemsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredBankLoansWithMaturityPeriod2017To25ThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_B-4Za9jSeEuOpXOxxvEANg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredBankLoansWithMaturityPeriod2017To25ThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_tH9SKU_4CEueGcGPE4KKrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Bvjg5Ricb0CsHHRkM2oKiw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrModigAndMrSheldonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:Mr.KimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_5GYsZrZiqEGPJtHs8Ny2fw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_xEzYX8OnjUOMl3IAx5vk2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MYgrX_n3jkaDz1IqXgfPzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_o6x3iNUNZEKJCglE3V0-6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_nUy4aXz07EqtEkGVtRBxvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_zf-wHnQpt06jb4tX_HSi1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">cntg:UniversitairMedischCentrumUtrechtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_8_2018_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_0CIYtds9E0mzIEud1TfR8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">cntg:UniversitairMedischCentrumUtrechtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_D3CrI-gxmka4zS7T_IluDA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:BorrowingsByNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_EVd8k1wgy0qJRv3QcJNjwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_M1EU4d6N9kCphLDz7bVjpw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_5QwdsOAvnkeo5LIcezl3Dw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:BorrowingsByNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_l-qjFsXgx02dSZIZxayWmA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_ByAFGvd16EGpT4q2K6NblA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:LpcGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:LpcGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_laKnVzYd2k-Sn9PzEQVwzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:LpcGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_WmW2dmc1-kKD6NAJoNXQBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xN3cXJlN6kKKfXv-f-akRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_cV4yyZGsZUiiKrDyDu6AAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_hG3SF9wOgkiDoa6rqpCHSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xItn-kSCNkSjgL0_YwgUQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_McmJjgE_k0alVLPoqAURaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_SvSryWkeDES4Mz3BiNpI4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_RostockHeadquartersBuildingMember_qSoBB62nPUyoN1idod-5Jg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_BerlinOfficesMember_1-SX3GoaW06QetWW2MQe4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:BerlinOfficesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_YXoCaUO5F0KnHQTBrV0F9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingAndBerlinOfficesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_wBoe6UcpT0q8rlfoh6cZ6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_QxSd-SnvrUqPZtQeLpmFXg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:IfrsCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:IfrsCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:IfrsCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001757097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ"><xbrli:measure>cntg:installment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w"><xbrli:measure>cntg:Options</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_contract_NQVYhN94Wkqxz3djLmP5NQ"><xbrli:measure>cntg:contract</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw"><xbrli:measure>cntg:tranche</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA"><xbrli:measure>cntg:Y</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:AED</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Divide_CHF_EUR_09Qkxn-hrkG46Zlsshurbw"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_RSD_EUR_oVrkuRnZ4UOXTq9NNZ3SYA"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:RSD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_item_-qWnVJTSfkeBJ1EtMUURPA"><xbrli:measure>cntg:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg"><xbrli:measure>cntg:EquityInstruments</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_D_v74mkiZpokKNiaOyAGgw5A"><xbrli:measure>cntg:D</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_segment_fj3IE5HhAk64wBBglbJJCQ"><xbrli:measure>cntg:segment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng"><xbrli:measure>cntg:customer</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:10.35pt;"><a id="_f1ff3c5b_4581_4690_a3b8_7c1e1ba3aed8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-indent:36pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:8pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentType" id="Narr_9_lIaYasPUarSdrwrgCkxg"><b style="font-weight:bold;">20-F</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">(Mark One)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentRegistrationStatement" id="Narr_H8Us_eAEZUeDH8Ueh2CVhg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><b style="font-size:9pt;font-weight:bold;">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES</b><span style="font-size:9pt;"><br /></span><b style="font-size:9pt;font-weight:bold;">EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentAnnualReport" id="Narr_vBRI8l0zrUmVxK-sJLkndg"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><b style="font-size:9pt;font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE </b><span style="font-size:9pt;"><br /></span><b style="font-size:9pt;font-weight:bold;">ACT OF 1934</b><span style="font-size:9pt;"><br /></span><b style="font-size:9pt;font-weight:bold;">For the fiscal year ended </b><ix:nonNumeric format="ixt:datemonthdayyearen" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentPeriodEndDate" id="Narr_zvmA6xG5M0OyrB4tkC6gGg"><b style="font-size:9pt;font-weight:bold;">December 31, 2021</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 6pt 18pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentTransitionReport" id="Narr_t9BqYFbWFUSjz_sgmj0EdQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><b style="font-size:9pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE</b><span style="font-size:9pt;"><br /></span><b style="font-size:9pt;font-weight:bold;">ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 10pt 18pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentShellCompanyReport" id="Narr_nlub3AE-90GBLPXPkbW_Ig"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><b style="font-size:9pt;font-weight:bold;">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES </b><span style="font-size:9pt;"><br /></span><b style="font-size:9pt;font-weight:bold;">EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 10pt 18pt;"><b style="font-weight:bold;">Date of event requiring this shell company report:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:9.35pt;text-indent:-9.35pt;margin:0pt 0pt 12pt 45.35pt;"><b style="font-weight:bold;">For the transition period from </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><b style="font-weight:bold;white-space:pre-wrap;">  to</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><span style="font-size:9pt;">Commission file number: </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityFileNumber" id="Narr_kZl7UOUqk0S96zZQFiPejQ"><b style="font-size:9pt;font-weight:bold;">001-39124</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityRegistrantName" id="Narr_fn2ppT7icE-ncuuMp4Yi2g"><b style="font-weight:bold;">Centogene N.V.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(Exact name of Registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">The </b><ix:nonNumeric format="ixt-sec:edgarprovcountryen" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityIncorporationStateCountryCode" id="Narr_r4wl0NRYhUidn-3j_O6AJA"><b style="font-weight:bold;">Netherlands</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 10pt 0pt;">(Jurisdiction of incorporation or organization)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityAddressAddressLine1" id="Narr_pQCO7-ufhEKUNZCYUmCYWg"><b style="font-weight:bold;">Am Strande 7</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityAddressPostalZipCode" id="Narr_yZvd_WN7c0qkSVCBlbZBlw"><b style="font-weight:bold;">18055</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityAddressCityOrTown" id="Narr_ubJcj0ICJUy6qEPNq0UN5w"><b style="font-weight:bold;">Rostock</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric format="ixt-sec:countrynameen" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityAddressCountry" id="Narr_lLh2ULlHRkW5vjufhzEQmw"><b style="font-weight:bold;">Germany</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">(+49) 381 80113 500</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> (Address of principal executive offices)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA" name="dei:ContactPersonnelName" id="Narr_MLdh2XuKzEmqrkwigOHW0g"><b style="font-size:8pt;font-weight:bold;">Kim Stratton</b></ix:nonNumeric><b style="font-size:8pt;font-weight:bold;">,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Chief Executive Officer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:8pt;font-weight:bold;">Tel: (</b><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA" name="dei:CityAreaCode" id="Narr_miLSBApWLUGb5AR4Jwu7ow"><b style="font-size:8pt;font-weight:bold;">+49</b></ix:nonNumeric><b style="font-size:8pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA" name="dei:LocalPhoneNumber" id="Narr_wNnw4I8qjUe1zglFPqMmHA"><b style="font-size:8pt;font-weight:bold;">381 80113 500</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:8pt;font-weight:bold;">Email: </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA" name="dei:ContactPersonnelEmailAddress" id="Narr_5Hfmwps2TkW7IqPs3TO7Mw"><b style="font-size:8pt;font-weight:bold;">kim.stratton@centogene.com</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA" name="dei:EntityAddressAddressLine1" id="Narr_JwN3E0ahkUShR515qO2how"><b style="font-size:8pt;font-weight:bold;">Am Strande 7</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA" name="dei:EntityAddressPostalZipCode" id="Narr_XDZRA_v7a0KotkdQ74akQA"><b style="font-size:8pt;font-weight:bold;">18055</b></ix:nonNumeric><b style="font-size:8pt;font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA" name="dei:EntityAddressCityOrTown" id="Narr_Ix4HujJ9AUO7Hr8JBPZJiQ"><b style="font-size:8pt;font-weight:bold;">Rostock</b></ix:nonNumeric><b style="font-size:8pt;font-weight:bold;">, Germany</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">Securities registered or to be registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_78f80cba_e267_4d03_854d_abe4d6b6bc73"></a><a id="Tc_4NMAEVtGt02F68BtIsJz8Q_1_0"></a><a id="Tc_ty5oWIE9NUCqUCG2S9PPrQ_1_2"></a><a id="Tc_-mhk0FN1mkaApmSJbPrtHw_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;">&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;">&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:Security12bTitle" id="Tc_vkPMRKnvk0ae-4do2q6n-Q_2_0"><span style="font-size:9pt;">Common shares, par value &#8364;0.12 per share</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:TradingSymbol" id="Tc_XRVJ3GkJiE-jJ6zjYd3PAg_2_2"><span style="font-size:9pt;">CNTG</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:SecurityExchangeName" id="Tc_1n0eD5eTGEGJBVlmg6BQIw_2_4"><span style="font-size:9pt;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Securities registered or to be registered pursuant to Section 12(g) of the Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">None</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">None</b></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 10pt 0pt;">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">The number of outstanding common shares as of December 31, 2021 was:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><a id="_51e29301_4491_42fd_831d_49e72536b4b1"></a><a id="Tc_bUMA-Un9kkuCJ84oHvC9Jw_1_0"></a><a id="Tc_-73oPfqnWkS0Wp25a57wxg_1_2"></a><a id="Tc_hz0-TFLqkkutuKqFgly00A_2_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:48.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:48.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:top;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:48.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of Shares Outstanding as of December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:48.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;">Common shares, par value of &#8364;0.12 per share</p></td><td style="vertical-align:top;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.98%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="Tc_0If1Fkls4Ey6AUfUr0BRXQ_2_2">22,567,971</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-size:9pt;">Yes </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span><span style="font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityWellKnownSeasonedIssuer" id="Narr_du3e5d31j0eHKxw104Ud7g"><span style="font-size:9pt;">No</span></ix:nonNumeric><span style="font-size:9pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-size:9pt;">Yes </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span><span style="font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityVoluntaryFilers" id="Narr_ICyBWLZWnU26aCbVjhCJtg"><span style="font-size:9pt;">No</span></ix:nonNumeric><span style="font-size:9pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt 0pt 10pt 0pt;"><span style="font-size:9pt;">Note</span>&#8212;<span style="font-size:9pt;">Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityCurrentReportingStatus" id="Narr_TOSrNSW_lE2WPqTZmdYDdQ"><span style="font-size:9pt;">Yes</span></ix:nonNumeric><span style="font-size:9pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span><span style="font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size:9pt;">No </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityInteractiveDataCurrent" id="Narr_Di8pKKW05EebT0UZZilgAQ"><span style="font-size:9pt;">Yes</span></ix:nonNumeric><span style="font-size:9pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span><span style="font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size:9pt;">No </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr><td style="vertical-align:bottom;width:25.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Large Accelerated Filer <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:18.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:EntityFilerCategory" id="Narr_4F6oG0HDAkSqtCMbXMCXww"><span style="font-size:9pt;">Accelerated Filer</span></ix:nonNumeric><span style="font-size:9pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9746;</span></p></td><td style="vertical-align:bottom;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:22.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-accelerated Filer <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:29.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;">Emerging growth company </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_3Qv_dFFMWEObBXBrujsikg"><span style="font-family:'Segoe UI Emoji';font-size:9pt;">&#9746;</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 27.35pt;"><span style="color:#221e1f;font-size:9pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt 0pt 8pt 27.35pt;"><span style="color:#221e1f;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-size:9pt;">Yes </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span><span style="font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size:9pt;">No </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="Narr_UXc6G-Qhzk-WDXctWO_zGQ"><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt 0pt 8pt 27.35pt;"><span style="color:#221e1f;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt 0pt 8pt 27.35pt;"><span style="color:#221e1f;">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 36pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span>U.S. GAAP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 36pt;"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9746;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:DocumentAccountingStandard" id="Narr_i4QHXF2ySUGRWBXclg-Qug"><span style="font-size:9pt;">International Financial Reporting Standards</span></ix:nonNumeric><span style="font-size:9pt;"> as issued by the International Accounting Standards Board</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 36pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span><span style="font-family:'Segoe UI Symbol';">&#160;</span>Other</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> Item 17&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span> Item 18</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-size:9pt;">Yes </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="Narr_7qjwL9hexUy-J7Lgr8jvdg"><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></ix:nonNumeric><span style="font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-size:9pt;">No </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-indent:36pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_0e497497_67c4_488d_8c1c_88f77797bd69"></a><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">TABLE OF CONTENTS</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:80.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;border-bottom:1px solid #000000;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">Page</b></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:95.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1.5pt 0pt;"><a href="#PARTONE_237102"><span style="font-style:normal;font-weight:normal;">PART ONE</span></a></p></td><td style="vertical-align:top;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1.5pt 0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item1IdentityofDirectorsSeniorManagement"><span style="font-style:normal;font-weight:normal;">Item&#160;1.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1IdentityofDirectorsSeniorManagement"><span style="font-style:normal;font-weight:normal;">Identity of Directors, Senior Management and Advisers</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item2OfferStatisticsandExpectedTimetable"><span style="font-style:normal;font-weight:normal;">Item&#160;2.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item2OfferStatisticsandExpectedTimetable"><span style="font-style:normal;font-weight:normal;">Offer Statistics and Expected Timetable</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item3KeyInformation_397487"><span style="font-style:normal;font-weight:normal;">Item&#160;3.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item3KeyInformation_397487"><span style="font-style:normal;font-weight:normal;">Key Information</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item4InformationontheCompany_409827"><span style="font-style:normal;font-weight:normal;">Item&#160;4.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item4InformationontheCompany_409827"><span style="font-style:normal;font-weight:normal;">Information on the Company</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">55</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item4AUnresolvedStaffComments_100896"><span style="font-style:normal;font-weight:normal;">Item&#160;4A.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item4AUnresolvedStaffComments_100896"><span style="font-style:normal;font-weight:normal;">Unresolved Staff Comments</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">94</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item5OperatingandFinancialReviewandProsp"><span style="font-style:normal;font-weight:normal;">Item&#160;5.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item5OperatingandFinancialReviewandProsp"><span style="font-style:normal;font-weight:normal;">Operating and Financial Review and Prospects</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">94</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item6DirectorsSeniorManagementandEmploye"><span style="font-style:normal;font-weight:normal;">Item&#160;6.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item6DirectorsSeniorManagementandEmploye"><span style="font-style:normal;font-weight:normal;">Directors, Senior Management and Employees</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">113</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item7MajorShareholdersandRelatedPartyTra"><span style="font-style:normal;font-weight:normal;">Item&#160;7.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item7MajorShareholdersandRelatedPartyTra"><span style="font-style:normal;font-weight:normal;">Major Shareholders and Related Party Transactions</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">127</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item8FinancialInformation_194908"><span style="font-style:normal;font-weight:normal;">Item&#160;8.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item8FinancialInformation_194908"><span style="font-style:normal;font-weight:normal;">Financial Information</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">130</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item9TheOfferandListing_971973"><span style="font-style:normal;font-weight:normal;">Item&#160;9.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item9TheOfferandListing_971973"><span style="font-style:normal;font-weight:normal;">The Offer and Listing</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">131</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item10AdditionalInformation_632065"><span style="font-style:normal;font-weight:normal;">Item&#160;10.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item10AdditionalInformation_632065"><span style="font-style:normal;font-weight:normal;">Additional Information</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">131</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item11QuantitativeandQualitativeDisclosu"><span style="font-style:normal;font-weight:normal;">Item&#160;11.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item11QuantitativeandQualitativeDisclosu"><span style="font-style:normal;font-weight:normal;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">150</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item12DescriptionofSecuritiesOtherThanEq"><span style="font-style:normal;font-weight:normal;">Item&#160;12.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item12DescriptionofSecuritiesOtherThanEq"><span style="font-style:normal;font-weight:normal;">Description of Securities Other Than Equity Securities</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">152</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:95.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1.5pt 0pt;"><a href="#PARTTWO_300980"><span style="font-style:normal;font-weight:normal;">PART TWO</span></a></p></td><td style="vertical-align:top;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1.5pt 0pt;">153</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item13DefaultsDividendArrearagesandDelin"><span style="font-style:normal;font-weight:normal;">Item&#160;13.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item13DefaultsDividendArrearagesandDelin"><span style="font-style:normal;font-weight:normal;">Defaults, Dividend Arrearages and Delinquencies</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">153</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item14MaterialModificationstotheRightsOf"><span style="font-style:normal;font-weight:normal;">Item&#160;14.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item14MaterialModificationstotheRightsOf"><span style="font-style:normal;font-weight:normal;">Material Modifications to the Rights Of Security Holders and Use Of Proceeds</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">153</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item15ControlsandProcedures_352699"><span style="font-style:normal;font-weight:normal;">Item&#160;15.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item15ControlsandProcedures_352699"><span style="font-style:normal;font-weight:normal;">Controls and Procedures</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">153</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16Reserved_598589"><span style="font-style:normal;font-weight:normal;">Item&#160;16.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16Reserved_598589"><span style="font-style:normal;font-weight:normal;">[Reserved]</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">155</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16AAuditCommitteeFinancialExpert_983"><span style="font-style:normal;font-weight:normal;">Item&#160;16A.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16AAuditCommitteeFinancialExpert_983"><span style="font-style:normal;font-weight:normal;">Audit Committee Financial Expert</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">155</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16BCodeofEthics_42095"><span style="font-style:normal;font-weight:normal;">Item&#160;16B.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16BCodeofEthics_42095"><span style="font-style:normal;font-weight:normal;">Code of Ethics</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">155</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16CPrincipalAccountantFeesandService"><span style="font-style:normal;font-weight:normal;">Item&#160;16C.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16CPrincipalAccountantFeesandService"><span style="font-style:normal;font-weight:normal;">Principal Accountant Fees and Services</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">155</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16DExemptionsfromtheListingStandards"><span style="font-style:normal;font-weight:normal;">Item&#160;16D.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16DExemptionsfromtheListingStandards"><span style="font-style:normal;font-weight:normal;">Exemptions from the Listing Standards for Audit Committees</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">156</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16EPurchasesofEquitySecuritiesbytheI"><span style="font-style:normal;font-weight:normal;">Item&#160;16E.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16EPurchasesofEquitySecuritiesbytheI"><span style="font-style:normal;font-weight:normal;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">156</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16FChangeinRegistrantsCertifyingAcco"><span style="font-style:normal;font-weight:normal;">Item&#160;16F.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16FChangeinRegistrantsCertifyingAcco"><span style="font-style:normal;font-weight:normal;">Change in Registrant&#8217;s Certifying Accountant</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">156</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16GCorporateGovernance_223061"><span style="font-style:normal;font-weight:normal;">Item&#160;16G.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16GCorporateGovernance_223061"><span style="font-style:normal;font-weight:normal;">Corporate Governance</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">156</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item16HMineSafetyDisclosure_410828"><span style="font-style:normal;font-weight:normal;">Item&#160;16H.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16HMineSafetyDisclosure_410828"><span style="font-style:normal;font-weight:normal;">Mine Safety Disclosure</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">157</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#MiscellaneousDisclosureunderIranThreatRe"><span style="font-style:normal;font-weight:normal;">Miscellaneous</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#MiscellaneousDisclosureunderIranThreatRe"><span style="font-style:normal;font-weight:normal;">Disclosure under Iran Threat Reduction and Syria Human Rights Act of 2012&#160;(ITRA)</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">157</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:95.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1.5pt 0pt;"><a href="#PARTTHREE_737517"><span style="font-style:normal;font-weight:normal;">PART THREE</span></a></p></td><td style="vertical-align:top;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1.5pt 0pt;">158</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item17FinancialStatements_723098"><span style="font-style:normal;font-weight:normal;">Item&#160;17.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item17FinancialStatements_723098"><span style="font-style:normal;font-weight:normal;">Financial Statements</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">158</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item18FinancialStatements_676801"><span style="font-style:normal;font-weight:normal;">Item&#160;18.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item18FinancialStatements_676801"><span style="font-style:normal;font-weight:normal;">Financial Statements</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">158</p></td></tr><tr><td style="vertical-align:top;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 10pt;"><a href="#Item19Exhibits_577974"><span style="font-style:normal;font-weight:normal;">Item&#160;19.</span></a></p></td><td style="vertical-align:top;width:80.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item19Exhibits_577974"><span style="font-style:normal;font-weight:normal;">Exhibits</span></a></p></td><td style="vertical-align:bottom;width:4.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">158</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">i</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_8ae6dfec_d628_4a6e_933f_20b8c5e8482b"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CERTAIN DEFINITIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Except otherwise indicated and except where the context otherwise requires, references in this Annual Report on Form&#160;20-F to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:49.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;Centogene&#8221;, the &#8220;Company&#8221;, the &#8220;Group&#8221;, &#8220;we&#8221;, &#8220;our&#8221;, &#8220;ours&#8221;, &#8220;us&#8221; or similar terms</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:48.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to Centogene&#160;N.V. or Centogene&#160;N.V. together with its subsidiaries, as the context may require;</p></td></tr><tr><td style="vertical-align:top;width:49.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;Exchange Act&#8221;</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to the United States Securities Exchange Act of 1934, as amended;</p></td></tr><tr><td style="vertical-align:top;width:49.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;FDA&#8221;</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to the United States Food and Drug Administration;</p></td></tr><tr><td style="vertical-align:top;width:49.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;IASB&#8221;</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to International Accounting Standards Board;</p></td></tr><tr><td style="vertical-align:top;width:49.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;IFRS&#8221;</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to International Financial Reporting Standards;</p></td></tr><tr><td style="vertical-align:top;width:49.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;SEC&#8221;</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to the United States Securities and Exchange Commission;</p></td></tr><tr><td style="vertical-align:top;width:49.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;Securities Act&#8221;</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to the Securities Act of 1933, as amended;</p></td></tr><tr><td style="vertical-align:top;width:49.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;&#8364;&#8221;, &#8220;EUR&#8221; and &#8220;euro&#8221;</p></td><td style="vertical-align:top;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to the European currency euro; and</p></td></tr><tr><td style="vertical-align:top;width:49.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">&#8220;$,&#8221; &#8220;USD,&#8221; &#8220;US$&#8221; and &#8220;U.S. dollar&#8221;</p></td><td style="vertical-align:top;width:2.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">are to the United States dollar.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_aee01112_8ae6_4a6b_96e6_8e1636436709"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PRESENTATION OF FINANCIAL INFORMATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We report under International Financial Reporting Standards (&#8220;IFRS&#8221;), as issued by the International Accounting Standards Board (the &#8220;IASB&#8221;). We present our consolidated financial statements in accordance with IFRS. We have made rounding adjustments to some of the figures included in this Annual Report. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation of the figures that preceded them.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our financial statements included in this Annual Report are presented in euro and, unless otherwise specified, all monetary amounts are in euro. All references in this Annual Report to &#8220;$&#8221;, &#8220;U.S. dollars&#8221; and &#8220;dollars&#8221; means U.S. dollars and all references to &#8220;&#8364;&#8221;, &#8220;EUR&#8221; and &#8220;euro&#8221; mean euro, unless otherwise noted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In this Annual Report, unless otherwise indicated, some euro amounts as of December 31, 2021 have been translated into U.S. dollars at the rate of $1.1326 to &#8364;1.00, the official exchange rate quoted by the European Central Bank. For information related to our initial public offering, which closed on November&#160;8, 2019, some euro amounts have been translated into U.S. dollars at the rate of $1.1129 to &#8364;1.00, the official exchange rate quoted as of October&#160;17, 2019 by the U.S. Federal Reserve Bank. For information related to the follow-on equity offering, which closed on July 24, 2020, some euro amounts have been translated into U.S. dollars at the rate of $1.1340 to &#8364;1.00. For information on the exchange rate used for the Group&#8217;s consolidated financial statements as of December&#160;31, 2021 and 2020 and for the three years ended December&#160;31, 2021, 2020 and 2019, included in this Annual Report, please see &#8220;Note&#160;5(a)&#8212;Foreign currency and currency translations&#8221; to such financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We have historically conducted our business through Centogene AG (which is now known as Centogene GmbH), and therefore our historical financial statements present the results of operations and financial condition of Centogene AG and its controlled subsidiaries. In connection with our initial public offering, Centogene&#160;AG was acquired by Centogene&#160;B.V., which subsequently converted into Centogene&#160;N.V., on November&#160;7, 2019, as part of our corporate reorganization in connection with our initial public offering, and the historical consolidated financial statements of Centogene AG included in this Annual Report became the historical consolidated financial statements of Centogene&#160;N.V. On March&#160;5, 2020, the Company resolved that Centogene AG shall be converted into a German limited liability company and renamed Centogene&#160;GmbH. Such conversion became effective upon the registration in the German commercial register on June 29, 2020, and was therefore completed in the financial year ending December&#160;31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e5c2b885_2871_4664_858b_78fe4700c414"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">USE OF TRADEMARKS, TRADE NAMES AND SERVICE MARKS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">CENTOGENE&#8482; is our main trademark. The trademarks, trade names and service marks appearing in this Annual Report are property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report are referred to without the symbols <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup> and &#8482;, but such references should not be construed as any indication that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_a2eac3f3_a365_43ae_9072_d28d9840cf5d"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FORWARD LOOKING STATEMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This Annual Report contains statements that constitute forward-looking statements. All statements other than present and historical facts and conditions contained in this Annual Report, including statements regarding our future results of operations and financial position, business strategy, plans and our objectives for future operations, are forward-looking statements. When used in this Annual Report, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;is designed to,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;objective,&#8221; &#8220;should,&#8221; or the negative of these and similar expressions identify forward-looking statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Forward-looking statements are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified under &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8221; in this Annual Report. These risks and uncertainties include factors relating to:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to generate cash from operations and attract financing;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our strategic restructuring initiative and the related restructuring cost;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to effectively manage our future growth and to execute our business strategy;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to generate sufficient revenue from our relationships with our pharmaceutical partners and clients, and to otherwise maintain our current relationships, or enter into new relationships, with pharmaceutical partners and clients;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the effects of the COVID-19 pandemic on our business and results of operations;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">economic, political or social conditions and the effects of these conditions on our pharmaceutical partners<span style="font-family:'Symbol';">&#8217;</span> and diagnostics clients<span style="font-family:'Symbol';">&#8217;</span> businesses and levels of business activity;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our expectations for our products and solutions achieving commercial market acceptance, and our ability to keep pace with the rapidly evolving industry in which we operate;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our assumptions regarding market size in the rare disease industry and our growth potential;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our pharmaceutical partners<span style="font-family:'Symbol';">&#8217;</span> and clients<span style="font-family:'Symbol';">&#8217;</span> need for rare disease information products and solutions and any perceived advantage of our products over those of our competitors;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to manage our international expansion, including our exposure to new and complex business, regulatory, political, operational, financial, and economic risks, and numerous and conflicting legal and regulatory requirements;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our continued reliance on our senior management team and other qualified personnel and our ability to retain such personnel;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to obtain, maintain, protect and enforce sufficient patent and other intellectual property protection for any products or solutions we develop and for our technology;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the ongoing protection of our trade secrets, know-how, and other confidential and proprietary information;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to remediate our material weaknesses in internal control over financial reporting;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">general economic, political, demographic and business conditions in North America, the Middle East, Europe and other regions in which we operate;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">changes in government and industry regulation and tax matters;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">other factors that may affect our financial condition, liquidity and results of operations; and</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">other risk factors discussed under <span style="font-family:'Symbol';">&#8220;</span>Item<span style="font-family:'Symbol';">&#160;</span>3. Key Information<span style="font-family:'Symbol';">&#8212;</span>D. Risk Factors.<span style="font-family:'Symbol';">&#8221;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">You should refer to the section of this Annual Report titled &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8221; for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this Annual Report will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_2f02dbf9_df8f_4d00_870e_3f80ef310c3a"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ENFORCEMENT OF JUDGMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are organized and existing under the laws of the Netherlands, and, as such, under Dutch private international law rules the rights of our shareholders and the civil liability of our directors and executive officers are governed in certain respects by the laws of the Netherlands. The ability of our shareholders in certain countries other than the Netherlands to bring actions against us, our directors and executive officers may be limited under applicable law. In addition, substantially all of our assets are located outside the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As a result, it may not be possible for investors to effect service of process within the United States upon us or our directors and executive officers or to enforce against them or us in U.S. courts, including judgments predicated upon the civil liability provisions of the federal securities laws of the United States. In addition, it is not clear whether a Dutch court would impose civil liability on us or any of our directors and executive officers in an original action based solely upon the federal securities laws of the United States brought in a court of competent jurisdiction in the Netherlands. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of the date of this Annual Report, the United States and the Netherlands do not have a treaty providing for the reciprocal recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters. With respect to choice of court agreements in civil or commercial matters, it is noted that the Hague Convention on Choice of Court Agreements entered into force for the Netherlands, but has not entered into force for the United States. Accordingly, a judgment rendered by a court in the United States, whether or not predicated solely upon U.S. securities laws, would not automatically be recognized and enforced by the competent Dutch courts. However, if a person has obtained a judgment rendered by a court in the United States that is enforceable under the laws of the United States and files a claim with the competent Dutch court, the Dutch court will in principle give binding effect to a foreign judgment if (i) the jurisdiction of the foreign court was based on a ground of jurisdiction that is generally acceptable according to international standards, (ii) the judgment by the foreign court was rendered in legal proceedings that comply with the Dutch standards of proper administration of justice including sufficient safeguards (<i style="font-style:italic;">behoorlijke rechtspleging</i>), (iii) binding effect of such foreign judgment is not contrary to Dutch public order (<i style="font-style:italic;">openbare orde</i>) and (iv) the judgment by the foreign court is not incompatible with a decision rendered between the same parties by a Dutch court, or with a previous decision rendered between the same parties by a foreign court in a dispute that concerns the same subject and is based on the same cause, provided that the previous decision qualifies for recognition in the Netherlands. Even if such a foreign judgment is given binding effect, a claim based thereon may, however, still be rejected if the foreign judgment is not or no longer formally enforceable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on the lack of a treaty as described above, U.S. investors may not be able to enforce against us or our directors, representatives or certain experts named herein who are residents of the Netherlands or countries other than the United States any judgments obtained in U.S. courts in civil and commercial matters, including judgments under the U.S. federal securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The United States and Germany currently do not have a treaty providing for the reciprocal recognition and enforcement of judgments, in civil and commercial matters. Consequently, a final judgment for payment or declaratory judgments given by a court in the United States, whether or not predicated solely upon U.S. securities laws, would not automatically be recognized or enforceable in Germany. German courts may deny the recognition and enforcement of a judgment rendered by a U.S. court if they consider the U.S. court not to be competent or the decision to be in violation of German public policy principles. For example, judgments awarding punitive damages are generally not enforceable in Germany. A German court may reduce the amount of damages granted by a U.S. court and recognize damages only to the extent that they are necessary to compensate actual losses or damages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition, actions brought in a German court against us, our management board and supervisory board and the experts named herein to enforce liabilities based on U.S. federal securities laws may be subject to certain restrictions. In particular, German courts generally do not award punitive damages. Litigation in Germany is also subject to rules of procedure that differ from the U.S. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">rules, including with respect to the taking and admissibility of evidence, the conduct of the proceedings and the allocation of costs. German procedural law does not provide for pre-trial discovery of documents, nor does Germany support pre-trial discovery of documents under the 1970 Hague Evidence Convention. Proceedings in Germany would have to be conducted in the German language and all documents submitted to the court would, in principle, have to be translated into German. For these reasons, it may be difficult for a U.S. investor to bring an original action in a German court predicated upon the civil liability provisions of the U.S. federal securities laws against us, our management board and supervisory board and the experts named in this Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_d63d30e9_bd83_4257_a447_6dfb6c834a17"></a><a id="PARTONE_237102"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PART ONE</b></p><a id="Item1IdentityofDirectorsSeniorManagement"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">1.  Identity of Directors, Senior Management and Advisers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_732d31c6_6087_4fee_b727_12b9d74d08f3"></a><a id="Item2OfferStatisticsandExpectedTimetable"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">2.  Offer Statistics and Expected Timetable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_64fcad15_037e_416f_8c20_eff2f32a0d4f"></a><a id="_Hlk99546463"></a><a id="Item3KeyInformation_397487"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">3.  Key Information</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Selected Financial Data</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following selected consolidated statements of financial position as of December&#160;31, 2021 and 2020, and the consolidated statements of comprehensive loss for the years ended December&#160;31, 2021, 2020 and 2019 are derived from the consolidated financial statements appearing elsewhere in this Annual Report, which have been audited by Ernst&#160;&amp; Young&#160;GmbH Wirtschaftspr&#252;fungsgesellschaft (&#8220;Ernst&#160;&amp; Young&#8221;). <span style="background:#ffffff;">The </span>selected consolidated statements of financial position as of<span style="background:#ffffff;"> December&#160;31, 2019 and December&#160;31, 2018 and the selected </span>consolidated statements of comprehensive loss for the years ended December&#160;31, 2018 and December&#160;31, 2017 are<span style="background:#ffffff;"> derived from audited consolidated financial statements not included in this Annual Report. As an emerging growth company, the presentation of selected historic financial data is limited to periods for which audited financial statements have been presented in connection with our first registration statement</span>, filed on Form&#160;F-1 (File No.&#160;333-234177), <span style="background:#ffffff;">that became effective under the Securities Act.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial information presented in the consolidated financial statements of Centogene&#160;N.V. for periods prior to the completion of our corporate reorganization is that of Centogene AG (which is now known as Centogene GmbH), our wholly-owned subsidiary. The consolidated financial statements of Centogene&#160;N.V. are a continuation of the historical consolidated financial statements of Centogene AG.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The information presented below is qualified by the more detailed historical consolidated financial statements set forth in this Annual Report, and should be read in conjunction with those consolidated financial statements, the notes thereto and the discussion under &#8220;Item&#160;5. Operating and Financial Review and Prospects&#8221; included elsewhere in this Annual Report.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We maintain our books and records in euros, and we prepare our financial statements under IFRS as issued by the IASB.<span style="color:#0000ff;font-style:italic;font-weight:bold;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Years&#160;Ended&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2017</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="11" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands, except number of shares)</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Consolidated statement of comprehensive loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 189,923</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 128,381</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 48,780</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 40,478</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 31,689</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 161,765</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 83,437</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 26,005</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 19,941</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14,939</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Gross profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 28,158</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 44,944</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,775</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 20,537</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 16,750</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 19,297</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14,935</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,590</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,300</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,396</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 46,739</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 40,160</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 23,160</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 18,610</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,498</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,860</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,026</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,254</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,474</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,897</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Impairment of financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,140</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,738</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 752</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 792</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 367</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other operating income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,936</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,394</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,781</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,306</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,043</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 86</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 182</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,284</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 273</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 90</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Real estate transfer tax expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,200</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (46,028)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (19,703)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (18,684)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (10,606)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (4,455)</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest and similar income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 33</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest and similar expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 851</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,029</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,075</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,021</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finance costs, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (848)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,394)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2,013)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,042)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,007)</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Loss before taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (46,876)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (21,097)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (20,697)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (11,648)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (5,462)</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax (benefits)/expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (24)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 281</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 158</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (310)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Loss for the year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (46,852)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (21,378)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (20,855)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (11,338)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (5,476)</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 543</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (48)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive loss for the period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><b style="font-weight:bold;">(46,309)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (21,426)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (20,839)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (11,346)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (5,466)</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Loss per share&#8212;Basic and diluted (in EUR) (2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2.06)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1.02)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1.27)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (0.80)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (0.45)</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of outstanding shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 22,437,301</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 20,909,673</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16,409,285</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14,112,841</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 12,065,714</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Restated for 2020 to reflect the impact of the reclassification of certain costs from cost of goods sold to general administrative expenses and selling expenses. (See note<span style="color:#0000ff;"> </span>2.4 to our consolidated financial statements as of December 31, 2021 and 2020 and for the three years ended December 31, 2021, 2020 and 2019 included elsewehere in this Annual Report).</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic and diluted loss per share is calculated by dividing loss for the year attributable to our equity holders by the weighted average number of shares outstanding during the same period, adjusted for the effect of the corporate reorganization and is represented in euros per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:52.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2017</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="11" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:44.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:52.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Consolidated statement of financial position:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 17,818</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 48,156</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 41,095</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,222</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,157</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 90,694</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 150,130</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 117,510</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 76,674</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 55,486</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 39,496</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 57,118</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 29,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 24,283</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 23,808</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total non&#8209;current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 23,695</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 27,235</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 29,588</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,867</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 15,324</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 27,503</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 65,777</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 58,922</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 26,524</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16,354</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Capitalization and Indebtedness</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 36pt;">Not applicable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Reason for the Offer and Use of Proceeds</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 36pt;">Not applicable</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Risk Factors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Summary Risk Factors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">In the course of conducting our business operations, we are exposed to a variety of risks, some of which are inherent in our industry and others of which are more specific to our own businesses. The discussion below addresses the material factors, of which we are currently aware, that could affect our businesses, results of operations and financial condition and make an investment in the Company speculative or risky.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Some of these risks include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our strategic restructuring initiative may not achieve intended benefits and the related&#160;restructuring&#160;cost&#160;could have a material adverse effect on our business and results of operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may fail to maintain, enter into or generate sufficient revenue from relationships with our clients or pharmaceutical partners to achieve and maintain profitability.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The COVID-19 pandemic as well as potential future pandemics and measures taken in response thereto.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Difficulty in successfully identifying patients for our pharmaceutical partners due to relatively small patient populations for rare diseases.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure to generate sufficient volumes of data from our diagnostic tests for inclusion in our data repository.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Supply chain challenges, including limited supply of critical equipment, consumables or services.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Many </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">events beyond our control, including geopolitical events, may adversely affect&#160;our business</span><span style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We derive a large proportion of our revenues and equipment from agreements with a limited number of pharmaceutical partners and suppliers, respectively.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Volatile, negative or uncertain economic, political or social conditions and the effects of these conditions on our pharmaceutical partners&#8217; and diagnostics clients&#8217; businesses and levels of business activity.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Restrictions or delays in the receipt of patient samples to our laboratories for diagnostic testing.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Substantial product liability or professional liability claims that could exceed our resources.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Interruption of access or damage to our highly specialized laboratory facilities, storage facilities or equipment.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Challenges to patient consent validity could impede our rare disease information development efforts.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure in our information technology systems.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Inability to attract and retain new talent, including members of our senior management team.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">New and complex business, regulatory, political, operational, financial, and economic risks as a result of international business expansion.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unanticipated difficulties involved in the Implementation of partnership agreements with our pharmaceutical partners.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure to achieve or maintain sales of our products and solutions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure to manage our future growth effectively, which could make it difficult to execute our business strategy.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Inability to successfully commercialize new products or solutions on a timely basis or at all.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure to expand our direct sales and marketing force to adequately address our pharmaceutical partners&#8217; and clients&#8217; needs.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The knowledge and interpretation based solutions we provide to our pharmaceutical partners may not achieve significant commercial market acceptance.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure to keep pace with the rapidly evolving industry in which we operate.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may fail to successfully respond to increasing demand for our products and solutions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure to obtain favorable pricing for our products and to meet our profitability expectations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ethical, legal and social concerns related to the use of genomic information could reduce demand for our genetic rare disease knowledge and interpretation based products and solutions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our resource allocation decisions may lead us to focus on research and development programs that are not commercially viable, and as a result we may be unable to recover the costs incurred under these efforts.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Failure to compete successfully with competitors, including new entrants in the market.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If our pharmaceutical partners experience any of a number of possible unforeseen events in connection with their clinical trials, our ability to commercialize future solutions or improvements to existing solutions could be delayed or prevented.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our employees, principal investigators, consultants, and commercial partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, insider trading, misappropriation of trade secrets and wrongful use or disclosure of confidential information.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may lose the support of key thought leaders and fail to establish our products and solutions as a standard of care for patients with rare, metabolic, and neurodegenerative diseases.</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Security breaches, loss of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are subject to significant foreign currency exchange controls in certain countries in which we operate.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may acquire assets or other businesses that could negatively affect our operating results, dilute our shareholders&#8217; ownership or increase our debt.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Regulatory risks including as a result of conflicting requirements, regulatory changes</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">in the way that the FDA and the European Union regulate laboratory developed tests, non-compliance with FDA and EMA regulatory requirements and with evolving European and other data privacy laws, violations of worldwide anti bribery laws, transactions involving Iran or other sanctioned countries, and our inability to obtain timely regulatory approvals or adhere to regulations regarding our products and solutions.  </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may fail to achieve coverage or adequate reimbursement for our products and solutions by commercial third party payors or government payors.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Inability to obtain and maintain patent and other intellectual property protection for any products or solutions we develop and for our technology, allowing our competitors to develop and commercialize products and solutions similar or identical to ours.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Additional intellectual property risks, including our inability to protect the confidentiality of our trade secrets, know how, and other confidential and proprietary information, the unenforceability of our patents and intellectual property rights, third party claims of intellectual property infringement</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">or commercial rights to inventions we develop, non-compliance with patent agency requirement and dependence on licenses granted to us by others. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have a history of losses and we may incur losses in the future. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may need to raise additional capital to fund, develop and expand our operations. Raising additional capital may cause dilution to our shareholders, restrict our operations or require us to relinquish rights to our technologies or drug candidates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be required to refund grants and subsidies, and may fail to meet covenants under loan facilities</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have identified two material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future that may cause us to fail to meet our reporting obligations or result in material misstatements of our financial statements. If we fail to remediate our material weaknesses or establish and maintain an effective system of internal control over financial reporting, we may not be able to report our financial results accurately or to prevent fraud, and such failure could cause investors to lose confidence in our reported financial and other public information and have a negative effect on the trading price of our common shares.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our results of operations could be materially adversely affected by fluctuations in foreign currency exchange rates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Risks relating to our common shares, including fluctuations in our share price, risk of dilution upon future issuances, multi-jurisdictional tax consequences, impacts of our Dutch public company status (including differing shareholder rights), risks resulting from our emerging growth company and foreign private issuer status, our non-payment of dividends and our broad discretion in the use of our cash on hand.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additional factors discussed below could affect our business, prospects, financial condition and results of operations. You should carefully consider the following risks and uncertainties and all of the other information in this Annual Report before making any investment decision. Our business, financial condition or results of operations could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our common shares could decline and you could lose all or part of your investment. The risks described below are those that we currently believe may materially affect us. We may face additional risks and uncertainties not currently known to us or that we currently deem to be immaterial.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Certain Factors Relating to Our Business and Strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Our strategic restructuring initiative may not achieve intended benefits and the related&#160;restructuring&#160;cost&#160;could have a material adverse effect on our business and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:22.5pt;margin:0pt;"><span style="font-family:'Georgia';">I</span><span style="font-size:10pt;">n November 2021, our Management Board and Supervisory Board approved a restructuring plan to further reduce operating costs and improve profitability. We estimate total restructuring charges, which consist of personnel costs and one-time severance charges, will be approximately &#8364; 640 thousand during 2021 and 2022. We anticipate this initiative will generate approximately &#8364; 6,2 million in annual net savings starting in 2022, plus additional planned savings in operating expenditure which will be allocated to support growth related initiatives. In addition, </span><span style="font-size:10pt;">on February 1, 2022, we announced the resignation of Dr. Andrin Oswald as CEO due to prolonged medical leave of absence and the appointment of Kim Stratton as CEO.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:35.45pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">There is also a risk that our restructuring plan will not capture all of the intended benefits or may not result in the expected cost savings. Further, the restructuring may yield unintended consequences such as attrition beyond our targeted workforce reduction. The Company&#8217;s success is dependent on the skills of our key personnel. Our restructuring plan involving workforce reduction may lead to an unintended loss of experienced employees or know-how. The loss of any member of our key personnel and actual or threatened work slowdowns or stoppages could lead to operational delays or cost increases. If these incidents occur or if we are unable to attract, retain and maintain productive relations with our employees and key professionals, our operating results and financial condition may be adversely affected. There is also a risk that our restructuring plan will not capture all of the intended benefits or may not result in the expected cost savings. Further, the restructuring may yield unintended consequences such as attrition beyond our targeted workforce reduction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">We may fail to generate sufficient revenue from our relationships with our clients or pharmaceutical partners to achieve and maintain profitability.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We believe our commercial success is dependent upon our ability to successfully market and sell our products and solutions to clients and pharmaceutical partners, to continue to sell our suite of diagnostic tests, to continue to expand our current relationships and to develop new relationships with pharmaceutical partners. The demand for our existing services may decrease or may not continue at historical rates for a number of reasons, including, among others, the development by competitors of new products or solutions that we are not able to commercialize, and increased competition from companies that offer similar products and solutions. In addition to reducing our revenue, if our pharmaceutical partners or clients decide to decrease or discontinue their partnerships or relationships with us, and their use of our knowledge and interpretation-based solutions, this may reduce our access to research and patient data that facilitates the incorporation of newly developed information about rare diseases into our data repository. Our business model and strategy depend on the continued input of new data into our repository, and any such reduction in access to research and patient data could affect our ability to offer the same quality and scope of solutions to our pharmaceutical partners and other clients, which could adversely affect or business, prospects, financial condition and results of operations. We are currently not profitable. Even if we succeed in increasing adoption of our existing solutions by pharmaceutical partners or tests by our clients or pharmaceutical partners, we may fail to generate sufficient revenue to achieve and maintain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">The COVID-19 pandemic could adversely impact our business and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In December 2019, the COVID-19 virus, commonly known as &#8220;coronavirus&#8221;, surfaced in Wuhan, China. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The COVID-19 disease has spread from China to many other countries including the U.S., the UK and the EU, with the number of reported cases and related deaths increasing daily and, in many countries, at a very rapid pace.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Many governments, including in the United States and Germany, have imposed increasingly stringent restrictions to seek to mitigate, or slow down, the spread of COVID-19, including restrictions on international and local travel, public gatherings and participation in business meetings, as well as closures of workplaces, schools, and other sites, and are requesting &#8220;social distancing.&#8221; In addition to those government measures, we have also taken a series of actions aimed at safeguarding the Company&#8217;s employees and business associates, including implementing a work-from-home policy and regular weekly tests for employees except for those related to our laboratory operations which were active from the third quarter of 2020 to the third quarter of 2021. The duration of such measures is highly uncertain, but could be prolonged, and even stricter measures may be put in place.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The COVID-19 pandemic has caused financial markets globally to experience material declines and very elevated volatility, which had an adverse impact on GDP and broader economic conditions, including in Germany and the United States. There is no assurance that the responses from central banks (which include reductions in interest rates and liquidity support) and financial support and fiscal spending by certain governments will be sufficient to support the U.S. or other economies or that financial markets will return to normal. The ongoing effects of the COVID-19 pandemic on global economies and financial markets could trigger a recession or slowdown.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">While vaccines have been widely rolled out in Europe and other parts of the world, leading to a relaxation of testing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">requirements in several countries during 2021, as newer, more severe variants of the COVID-19 virus emerge, there remains uncertainty about the continued protection (and duration of protection) offered by such vaccines. How and when this would affect the potential prolongation of the need for testing on a broader scale remains uncertain.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:35.45pt;margin:0pt;">There is significant uncertainty relating to the potential effect of the COVID-19 virus on our business. Any of the factors above could result in significant volatility in, and have a material adverse effect on, our business, financial condition, rating and results </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">of operations. In particular, they could result in increased costs of execution with regards to operational plans. In addition, COVID-19 may disrupt our supply chain, particularly as it relates to the United States (from where a significant proportion of our sequencing products are sourced) as well other countries in which we operate and from where we receive tests, and otherwise adversely affect international trade and business activities. The COVID-19 pandemic may also result in the loss of our significant client relationships. The magnitude of the impact on us will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including, among other things, the duration and spread of the outbreak, its severity and strain mutations, counter-measures and the development and availability of effective treatments and vaccines. The effects of COVID-19 on us, and on the environment in which we operate, has resulted, and may continue to result, in significant volatility of the trading price of our common shares. Although we are taking a number of measures aimed at minimizing disruptions to our business and operations, and while the provision of testing for the COVID-19 virus is anticipated to generate additional revenues for us in the first half of 2022, the full extent to which the global COVID-19 pandemic may impact our business will depend on future developments, which are highly uncertain and cannot be predicted, such as the duration of the pandemic, the availability of vaccines, the probability of the occurrence of further outbreaks and the ultimate impact on the financial markets and the global economy, and could result in an unforeseen negative impact on our business and our future results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To the extent the COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described under &#8220;&#8212;We may face restrictions or delays in the receipt of patient samples to our laboratories for diagnostic testing&#8221; and &#8220;&#8212;We may be adversely affected by volatile, negative or uncertain economic, political or social conditions and the effects of these conditions on our pharmaceutical partners&#8217; and diagnostics clients&#8217; businesses and levels of business activity.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:14pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;background:#ffffff;">In response to the&#160;COVID-19&#160;pandemic, we ramped up our molecular testing for the diagnosis of&#160;COVID-19. The demand for such tests has shrunk, and we may be unable to recoup the significant expenses incurred and investments made in testing capabilities.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In response to the COVID-19 pandemic, we took a series of measures aimed at minimizing the disruptions to our business and operations, including by adding COVID-19 molecular testing to our product mix. To support the rapid rollout of our COVID-19 testing offering, we have incurred significant expenses and made significant investments, including the acquisition of laboratory facilities, walk-in testing facilities, and mobile test centers, as well as related equipment and inventory. Our COVID-19 testing business grew significantly since the second quarter of 2020 and, as a result, we started managing and reporting it as a separate reportable business segment in the third quarter of 2020. Total investments in COVID-19 testing as of December 31, 2021 amounted to &#8364;2,834 thousand, of which &#8364;2,480 thousand are COVID-19 related mobile test laboratories and equipment. An amount of &#8364;354 thousand is included in intangible assets and relates to the development of CENTOGENE&#8217;s Corona Test Portal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">While the&#160;</span>COVID-19&#160;pandemic has created an opportunity for our business and helped us offset the pandemic-related slowdown in our Diagnostics and Pharmaceutical businesses, we noticed a decrease in COVID-19 test order intakes during the third quarter of 2021, specifically in Germany, which led to management review of and resolution on options to discontinue lease contracts at unprofitable COVID-19 testing sites as well as reaching the decision to close a laboratory in Hamburg. Similarly, we have significantly ramped down COVID-19 related inventory levels to align with the needs of the remaining test sites and laboratories. Due to the impact of these changes during the COVID-19 pandemic, particularly developments in vaccination campaigns with increasing vaccination numbers and relaxation of testing regulations by several countries, we reassessed certain related accounting judgments and estimates. As a result, in line with our accounting policies for long-lived assets, management reviewed the estimated useful lives of long-lived assets utilized in the COVID-19 test offerings given changes in circumstances and management&#8217;s expectations. Management considered how the underlying assets are currently deployed, including whether the assets are utilized in leased facilities or service agreements which management is unlikely to renew, and potential alternative uses of the assets within the COVID-19 business or within the diagnostics and pharmaceutical businesses. Consequently, we prospectively adjusted the estimated useful lives of our long-lived assets which include property, plant and equipment, right-of-use assets and intangible assets which had an aggregate carrying amount of &#8364; 8,549 thousand to a remaining estimated useful life of eight months, with effect at the beginning of the third quarter of 2021. This prospective change in estimate resulted in accelerated depreciation expense of &#8364;4,138 thousand during the year ended December 31, 2021. Additionally, following the closure of the Hamburg lab, we recognized an accelerated depreciation of right-of-use assets in an amount of &#8364; 746 thousand for the year ended December 31, 2021.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We presently expect our COVID-19 testing business to continue contributing to our revenue in 2022. However, the demand for our COVID-19 tests may not be sustainable and the recent increase in our revenues from COVID-19 testing may not be indicative of future revenues.&#160;Such demand, and the revenues of our COVID-19 testing segment, may shrink rapidly in the future, for instance:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">as the pandemic abates or infection rates decline;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">as governmental and health authorities relax rules on mandatory COVID-19 testing;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">as vaccinations become more widely administered; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if other tests become more accepted or produce results more quickly, more accurately or at lower cost;</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><span style="font-size:10pt;">in each case in particular in the regions where we offer our COVID-19 testing services. As a result, we may be unable to recoup the significant expenses we incurred in connection with our COVID-19 testing business. In addition, while we are depreciating all of the investments made in our COVID-19 testing business on an accelerated timetable, we may be required to write-down some or all of our investments in, and working capital related to, our COVID-19 testing business. Any of the foregoing developments and events could have a material adverse effect on our business, results of operations and financial position</span><span style="font-family:'Calibri','Helvetica','sans-serif';">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-bottom:12pt;margin:0pt;">Many events beyond our control, including geopolitical events, may adversely affect&#160;our business<i style="font-family:'Arial','Helvetica','sans-serif';font-weight:normal;background:#ffffff;"> </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Many events beyond our control can adversely affect the healthcare industry, with a corresponding negative impact on our business and results of operations. Our operations and those of our third-party suppliers and collaborators could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes or other extreme weather conditions, medical epidemics, labor disputes, war or other business interruptions. Although we have limited business interruption insurance policies in place, any interruption could come with high costs for us, as salaries and loan payments would usually continue. Moreover, any interruption could seriously harm our ability to timely proceed with our diagnostics, pharmaceutical collaborations and research activities. Moreover, at the end of 2021 and into 2022, international tensions escalated when Russia amassed large numbers of military ground forces and support personnel on the Ukraine-Russia border and, in February 2022, Russia invaded Ukraine. In response, the North Atlantic Treaty Organization, or NATO has deployed additional military forces to Eastern Europe, including Lithuania, and the Biden administration along with many European countries announced certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and other countries have created global security concerns that could result in a regional conflict and otherwise have a lasting impact on regional and global economies, any or all of which could disrupt our supply chain, adversely affect our ability to conduct ongoing and future Diagnostics activities, Pharmaceutical collaborations, and research programs which could adversely impact our business and results of operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to maintain our current relationships with pharmaceutical companies, or enter into new relationships on a similar scale.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our success in the future depends in part on our ability to maintain relationships and to enter into new relationships with pharmaceutical partners. Partnerships are complex and time-consuming to negotiate and document. Whether we reach a definitive agreement for a partnership will depend on a number of factors, including, among other things, upon our partners&#8217; assessment of our industry knowledge, data repository, logistical resources and expertise, the terms and conditions of the proposed partnership, and our partners&#8217; evaluation of the potential value added from our rare disease knowledge and insights. If we are unable to do so, we may have to curtail our research on a particular rare disease or increase our expenditures and undertake research and development activities at our own expense. Further, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future partners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our ability to maintain our current relationships with our pharmaceutical partners, or enter into new relationships, can be difficult due to several factors, including that:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our products and solutions are focused towards facilitating the development of rare disease treatments which limits our market to pharmaceutical partners active in the rare disease space;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">orphan drug development is complex, expensive and time-consuming due to limited identified patient populations and limited industry knowledge of rare diseases;</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our pharmaceutical partners may decide to decrease or discontinue their use of our rare disease information platform due to circumstances outside of our control, including changes in their research and development plans, whether they can obtain positive data or regulatory approval in clinical trials or successfully commercialize a treatment, changes in the regulatory environment, or utilization of internal testing resources or genetic or other tests performed by other parties, among others;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">internal and external constraints may be placed on potential pharmaceutical partners that can limit the number and type of relationships with companies like us they can consider and consummate; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our pharmaceutical partners may be dissatisfied with our products or solutions or that we may fail to deliver expected benefits from our products or solutions.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additionally, some of our pharmaceutical partners have contracted with us to provide testing for large numbers of samples or to focus our research on a particular rare disease, which could restrict our ability to perform tests for other clients or pharmaceutical partners or limit our ability to expand our data repository outside of a specified patient population or rare disease. If we fail to maintain our current relationships with our pharmaceutical partners, or enter into new partnerships, our business could suffer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Because the identified patient populations for rare diseases are relatively small, it may be difficult to successfully identify patients for our pharmaceutical partners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our inability to identify a sufficient number of patients for our partners&#8217; clinical trials could result in significant delays and could require our partners to abandon one or more clinical trials altogether. Enrollment delays in our partners&#8217; clinical trials may result in increased development costs for our partners&#8217; drug candidates, which would cause the value of the solutions which we offer to our pharmaceutical partners to decline. If we are unable to identify patients with a specified driver of disease or applicable genomic alteration, this could compromise our ability to add value to our partners&#8217; clinical trials by accelerating clinical development and regulatory timelines. In addition, our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with our partners&#8217; existing treatments or drug candidates, are based on our internal estimates derived from data in our repository. These estimates may prove to be incorrect, and new studies may reduce the estimated incidence or prevalence of these diseases. The number of patients in the United States, European Union and elsewhere may turn out to be lower than expected, may not be otherwise amenable to treatment with our partners&#8217; drug candidates or patients may be difficult to identify and access, all of which would adversely affect our business, prospects and ability to achieve or sustain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to generate sufficient volumes of data from our diagnostic tests for inclusion in our data repository.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our business model assumes that we will be able to continue to generate significant diagnostic test volume in order to maintain the generation of data that feeds into our data repository, which is necessary for the development of new products and solutions for our pharmaceutical partners and clients. We may not succeed in continuing to drive clinical adoption of our tests to achieve sufficient volumes. Inasmuch as detailed genetic or other data from our tests have only recently become available at relatively affordable prices, the pace and degree of clinical acceptance of the utility of such testing is uncertain. Specifically, it is uncertain how much genetic or other data will be accepted as necessary or useful, as well as how detailed that data should be, particularly since medical practitioners may have become accustomed to genetic or other testing that is specific to one or a few genes. To generate demand for our tests, we will need to continue to make our diagnostics clients, as well as physicians and key opinion leaders, aware of the benefits of our tests, including the price, the breadth of our testing options, and the benefits of having additional genetic or other data available from which to make treatment decisions. In addition, physicians in other areas of medicine may not adopt genetic or other testing for certain rare diseases as readily as it has been adopted for some more well-known rare diseases and our efforts to sell our tests to physicians outside of a set number of rare diseases may not be successful. A lack of or delay in increased clinical acceptance of our diagnostic tests would negatively impact sales and market acceptance of our tests and limit our ability to expand on the scope and quality of knowledge and interpretation-based solutions offered to our pharmaceutical partners, which could in turn impact our revenue growth and potential profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, genetic or other testing is still relatively expensive and many potential pharmaceutical partners and clients may be sensitive to pricing concerns. Potential pharmaceutical partners or clients may not adopt our tests if adequate reimbursement is unavailable, or if we are not able to maintain low prices in the future relative to our competitors. If we are not able to generate demand for our tests at sufficient volume, or if it takes significantly more time to generate this demand than we anticipate, our business, prospects, financial condition and results of operations could be materially harmed.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We derive a large proportion of our revenues from agreements with a limited number of pharmaceutical partners and clients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have historically earned a large proportion of our revenue from a limited number of pharmaceutical partners and diagnostic testing clients. In the years ended December&#160;31, 2021 and 2020, our top five pharmaceutical partners, in the aggregate, accounted for 6.9% (30.2% excluding COVID-19 revenues) and 12.6% (41.4% excluding COVID-19 revenues) of our revenues, respectively. The loss of, or material reduction in, revenues from any one of our major pharmaceutical partners or clients could materially reduce our total revenues, harm our reputation in the industry and/or reduce our ability to accurately predict our revenue, net income and cash flow. The loss of, or material reduction, in revenue from any one of our major pharmaceutical partners or clients could also adversely affect our gross profit and utilization as we seek to redeploy resources previously dedicated to that partner. We cannot assure you that revenue from our major pharmaceutical partners or clients will not be significantly reduced in the future. We also may not be able to maintain our relationships with our major pharmaceutical partners or clients on existing or on continued favorable terms and our major pharmaceutical partners or clients may not renew their agreements with us, in which case our business, financial condition and results of operations would be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In particular, during the year ended December&#160;31, 2021, our collaboration with Takeda Pharmaceutical Company Limited, represented 5.1% (22.2% excluding COVID-19 revenues) of our total revenues (2020: 8.6% (28.2% excluding COVID-19 revenues)). We expect that our collaboration with Takeda will continue to account for a material portion of our revenue in 2022. The revenue attributable to Takeda may fluctuate in the future, which could have an adverse effect on our financial condition and results of operations. In addition, changes in the terms of our agreements with Takeda, or a modification or termination of our relationship with Takeda, could result in delays in the receipt of revenue by us, or a temporary or permanent loss of revenue to us. In addition, certain pharmaceutical companies, including those with which we currently have agreements, may choose not to do business with us or may seek out other partners for genetic rare disease information due to our strategic collaboration with Takeda, particularly if they are actual or potential competitors with Takeda. If we are unable to continue to grow our business with other pharmaceutical companies, our business and results of operations would be adversely affected. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our client concentration may also subject us to perceived or actual leverage that our pharmaceutical partners or clients may have, given their relative size and importance to us. If our pharmaceutical partners or clients seek to negotiate their agreements on terms less favorable to us and we accept such unfavorable terms, this may have a material adverse effect on our business, financial condition and results of operations. Accordingly, unless and until we diversify and expand our client base, our future success will significantly depend upon the timing and volume of business from our largest pharmaceutical partners and clients and the financial and operational success of these pharmaceutical partners and clients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may be adversely affected by volatile, negative or uncertain economic, political or social conditions and the effects of these conditions on our pharmaceutical partners&#8217; and diagnostics clients&#8217; businesses and levels of business activity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Global economic conditions affect our pharmaceutical partners&#8217; and diagnostic clients&#8217; businesses and the markets they serve, and volatile, negative or uncertain economic conditions may have an adverse effect on our revenue growth and profitability. Volatile, negative or uncertain economic conditions in our significant markets, in particular in our North America, Middle East or European regions, where we generated 10.3%, 8.7% and 79.3%, respectively, of our total revenues for the year ended December&#160;31, 2021, could undermine business confidence, both in those markets and other markets, and cause our pharmaceutical partners or clients to reduce or defer their spending on new technologies or initiatives or terminate existing contracts, which would negatively affect our business. Growth in the markets we serve could be at a slow rate, or could stagnate, for an extended period of time. Differing economic conditions and patterns of economic growth and contraction in the geographical regions in which we operate and the industries we serve may affect demand for our products and solutions. Weakening in these markets as a result of high government deficits, credit downgrades or otherwise could have a material adverse effect on our results of operations. Ongoing economic volatility and uncertainty affects our business in a number of other ways, including making it more difficult to accurately forecast partner demand beyond the short term and effectively build our revenue and resource plans, particularly given the iterative nature of the negotiation of new contracts with our pharmaceutical partners. This could result, for example, in us not having the level of appropriate personnel where they are needed, and could have a significant negative impact on our results of operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Moreover, acts of terrorist violence, political unrest, armed regional and international hostilities and international responses to these hostilities, natural disasters, global health risks or pandemics or the threat of or perceived potential for these events could have a negative impact on us. These events could adversely affect our pharmaceutical partners&#8217; levels of business activity and precipitate sudden significant changes in regional and global economic conditions and cycles. These events also pose significant risks to our people and to physical facilities and operations around the world, whether the facilities are ours or those of our distributors, pharmaceutical partners or physicians that utilize our diagnostic testing services. By disrupting communications and travel and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">increasing the difficulty of obtaining and retaining highly skilled and qualified personnel, these events could make it difficult or impossible for us to deliver products and solutions to our clients and pharmaceutical partners. Extended disruptions of electricity, other public utilities or network services at our facilities, as well as system failures at, or security breaches in, our facilities or systems, could also adversely affect our ability to serve our clients and pharmaceutical partners. We might be unable to protect our people, facilities and systems against all such occurrences. We generally do not have insurance for losses and interruptions caused by terrorist attacks, conflicts and wars. If these disruptions prevent us from effectively serving our clients and pharmaceutical partners, our results of operations could be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may face restrictions or delays in the receipt of patient samples to our laboratories for diagnostic testing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our business depends on our ability to quickly and reliably receive samples from physicians. Our CentoCard product is typically sent from locations worldwide to our laboratory in Rostock, Germany as well as our Cambridge, Massachusetts facility. Disruptions in delivery, whether due to factors beyond our control such as natural disasters, terrorist threats, political instability, governmental policies, failures by physicians to properly label or package the samples, failure by postage services, labor disruptions, bad weather or other factors could adversely affect the receipt by us of samples or specimen integrity and could impact our ability to process samples in a timely manner and to provide our services to our clients and pharmaceutical partners. In particular, there is a general trend in certain countries, for example in China and certain countries in South America, where policies have been introduced that restrict the processing of genetic or other testing outside the country in which the patient is located. This could disrupt the transportation of samples to our testing facilities in Germany and the United States from such countries, and could adversely impact our current business operations or prevent us from expanding into certain new regions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, the majority of our samples are delivered to us via regular postal services worldwide. If such services are disrupted, or if we are unable to continue to obtain expedited delivery services or specialized delivery services for certain products, such as our prenatal algorithmic test, on commercially reasonable terms, our operating results may be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may become subject to substantial product liability or professional liability claims that could exceed our resources.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The marketing, sale and use of our products and solutions could lead to the filing of product liability claims if someone were to allege that our products and solutions identified inaccurate or incomplete information regarding the diagnostic information of the rare disease indication analyzed, reported inaccurate or incomplete information concerning the available treatments for a certain type of rare disease or otherwise failed to perform as designed. For example, we have been subject to a claim from a client that our prenatal diagnostic test conducted at their request failed to identify a specific mutation present in a patient.  See &#8220;Item&#160;4. Information On The Company&#8212;B. Business Overview&#8212;Legal Proceedings&#8221; and &#8220;Item&#160;8. Financial Information&#8212;A. Consolidated Statements and Other Financial Information&#8212;Legal Proceedings.&#8221; We may also be subject to liability for errors in, a misunderstanding of, or inappropriate reliance upon, the information we provide in the ordinary course of our business activities. A product liability or professional liability claim could result in substantial damages and be costly and time-consuming for us to defend.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our service and professional liability insurance may not fully protect us from the financial impact of defending against product liability or professional liability claims. Any product liability or professional liability claim brought against us, with or without merit, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any product liability lawsuit could damage our reputation or cause current clients or pharmaceutical partners to terminate existing agreements and potential clients or pharmaceutical partners to seek other partners, any of which could impact our results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If the validity of a consent from a patient was challenged, we could be forced to stop using certain of our data resources, which would impede our rare disease information development efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We provide diagnostic testing services to patients of our pharmaceutical partners and diagnostics clients worldwide. We also provide products and solutions, including biomarker development and testing, to our pharmaceutical partners. Such products and solutions involve the aggregation of data obtained from patients in our existing data repository and data obtained from new tests conducted both on patients whose samples remain in our biobank or new patients from whom we collect samples.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To a large extent, we also rely upon our pharmaceutical partners, our clients and, in some cases, third-party laboratories to collect the subject&#8217;s informed consent and comply with applicable local laws and international regulations. Although we maintain policies and procedures designed to monitor the collection of consents by both ourselves and such third parties, we or third parties may not obtain the required consents in a timely manner, or at all. In addition, consents that we have obtained or will obtain may not meet the existing or future standards required by relevant governmental authorities.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The collection of data and samples in many different countries results in complex legal questions regarding the adequacy of consent and the status of genetic material under a large number of different legal systems. In some jurisdictions, samples that contain a person&#8217;s DNA might irrevocably qualify as personal data, as in theory such samples can never be completely anonymized. Legitimate interests of the donor might cause a &#8220;revival&#8221; of his or her personal rights in the future and limit our rights of utilization. The subject&#8217;s consent obtained in any particular country could be withdrawn or challenged in the future, and those consents could prove invalid, unlawful, or otherwise inadequate for our purposes. Furthermore, we may face disputes with patients should their data be used in a manner which they did not expect or if the consent was recorded incorrectly or obtained fraudulently. Any findings against us, or our pharmaceutical partners, clients or distributors, could deny us access to or force us to stop using certain of our clinical data or samples, which would impede our genetic or other information solution development efforts. We could become involved in legal challenges, which could consume our management and financial resources.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If access to our highly specialized laboratory facilities, storage facilities or equipment is interrupted or damaged, our business could be negatively impacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our diagnostic testing products and pharmaceutical solutions are rendered at our laboratory facilities. We currently run the majority of our core diagnostic testing at our laboratory in Rostock, Germany, and we also commenced operations at our laboratory in Cambridge, Massachusetts in August 2018. If one or more of our laboratories, and particularly our facility in Rostock, become inoperable or some or all of our key equipment ceases to function even for a short period of time, we may be unable to perform our genetic or other tests or develop solutions in a timely manner or at all, which may result in the loss of clients and pharmaceutical partners or harm to our reputation, and we may be unable to regain those clients and pharmaceutical partners or repair our reputation in the future. Our facilities and equipment could be harmed or rendered inoperable by natural or man-made disasters, including war, fire, earthquake, flood, power loss, communications or internet failure or interruption, or terrorism, which may render it difficult or impossible for us to operate our genetic rare disease information platform for some period of time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In particular, the biomaterials that are stored in our biobank are located in our Rostock facility. Should the biomaterials that we store there be damaged or destroyed, we would lose part or all of our existing biomaterials and as a result we would not be able to retest this material for future research and development uses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Furthermore, our facilities and the equipment we use to perform our research and development work could be unavailable or costly and time-consuming to repair or replace. It would be difficult, time-consuming, and expensive to rebuild any of our facilities or license or transfer our proprietary technology to a third party, particularly in light of the licensure and accreditation requirements and specific equipment needed for laboratories like ours. Even in the unlikely event we are able to find a third party with such qualifications to enable us to perform our genetic or other tests or develop our solutions, we may be unable to negotiate commercially reasonable terms with such third parties. Any interruption of our laboratory operations could harm relationships with our clients and pharmaceutical partners or regulatory authorities, which could adversely affect our ability to generate revenue or maintain compliance with regulatory standards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">While we carry insurance for damage to our property and laboratory and the disruption of our business, such insurance may not cover all of the risks associated with damage to our property or laboratory or disruption to our business, may not provide coverage in amounts sufficient to cover our potential losses, may be challenged by insurers underwriting the coverage, and may not continue to be available to us on acceptable terms, if at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We depend upon our information technology systems, and any failure of these systems could harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We depend on information technology and telecommunications systems for significant elements of our operations, including our BioDatabank, our CentoPortal client-facing platform, our COVID-19 Test Portal, our laboratory information management system, our third-party datacenter solutions, our broadband connections and our client relationship management system. We have installed a number of enterprise software systems that affect a broad range of business processes and functional areas, including, for example, systems handling human resources, financial controls and reporting, contract management and other infrastructure operations. These information technology systems support a variety of functions, including laboratory operations, test validation, sample tracking, quality control, customer service support, billing and reimbursement, research and development activities, scientific and medical curation, and general administrative activities. In addition, our system is backed up by two offsite data centers that offer a disaster recovery system for our database in separate locations near Frankfurt. Any technical problems that may arise in connection with third-party data center hosting facilities could result in interruptions in our service.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our information technology systems are vulnerable to damage from a variety of sources, including network failures, malicious human acts, and natural disasters. Our business will also be harmed if our laboratory partners and potential laboratory partners believe our service is unreliable. Moreover, despite network security and back-up measures, some of our servers are potentially vulnerable to physical or electronic break-ins, malicious computer software (malware), and similar disruptive problems. Failures or significant downtime of our information technology systems, or those used by our third-party service providers, could prevent us from conducting our comprehensive genomic analyses, preparing and providing reports and data to partners and physicians, billing payors, processing reimbursement appeals, handling patient or physician inquiries, conducting research and development activities, and managing the administrative aspects of our business. Additionally, to the extent that any disruption or security breach results in a loss or damage to our data or applications, or inappropriate disclosure of confidential or proprietary information, we may incur significant liability. Any disruption or loss of information technology or telecommunications systems on which critical aspects of our operations depend could have an adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We rely on a limited number of suppliers, or, in some cases, a sole supplier, for some of our laboratory equipment and may not be able to find replacements or immediately transition to alternative suppliers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe that there are only a few equipment manufacturers that are currently capable of supplying and servicing the sequencing equipment necessary for our laboratory operations. For example, we rely on a key supplier, Illumina, for certain sequencing equipment used for our processes. We may not be able to obtain acceptable substitute equipment from another supplier on the same basis or at all. Even if we are able to obtain acceptable substitutes from replacement suppliers, their use could require us to significantly alter our laboratory operations. An interruption in our laboratory operations could occur if we encounter delays or difficulties in securing or maintaining the proper function of this laboratory equipment. Any such interruption could negatively impact research and development and launches of new products or solutions, and significantly affect our business, financial condition, results of operations, and reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">The loss or transition of any member of our senior management team, or our inability to attract and retain new talent, could adversely affect our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our success depends on the skills, experience, and performance of key members of our senior management team. The individual and collective efforts of these employees will be important as we continue to develop our BioDatabank and additional products and solutions, and as we expand our commercial activities. The loss or incapacity of existing members of our senior management team could adversely affect our operations if we experience difficulties in hiring qualified successors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The complexity inherent in integrating a new key member of the senior management team with existing senior management may limit the effectiveness of any such successor or otherwise adversely affect our business. Leadership transitions can be inherently difficult to manage and may cause uncertainty or a disruption to our business or may increase the likelihood of turnover of other key officers and employees. Specifically, a leadership transition in the commercial team may cause uncertainty about or a disruption to our commercial organization, which may impact our ability to achieve sales and revenue targets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our research and development programs and laboratory operations depend on our ability to attract and retain highly skilled scientists and technicians. We may not be able to attract or retain qualified scientists and technicians in the future due to the intense competition for qualified personnel among life science businesses globally. We also face competition from universities and public and private research institutions in recruiting and retaining highly qualified scientific personnel. We may have difficulties locating, recruiting, or retaining qualified sales people. Recruitment and retention difficulties can limit our ability to support our research and development and sales programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">International expansion of our business exposes us to new and complex business, regulatory, political, operational, financial, and economic risks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our business strategy incorporates plans for significant expansion in the countries in which we currently operate and internationally. Doing business internationally involves a number of risks, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">multiple, conflicting, and changing laws and regulations such as data protection laws, privacy regulations, tax laws, export and import restrictions, employment laws, regulatory requirements (including requirements related to patient consent, testing of genetic material and reporting the results of such testing) and other governmental approvals, permits, and licenses, or government delays in issuing such approvals, permits, and licenses;</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">failure to obtain regulatory approvals for the manufacture and sale of our products and use of our products and solutions in various countries;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">transition and management of our former distribution relationships in various countries;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">potentially relevant third-party intellectual property rights;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">difficulties in staffing and managing foreign operations;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">complexities and difficulties in obtaining, maintaining, protecting and enforcing our intellectual property rights;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">logistics and regulations associated with preparing, shipping, importing and exporting tissue and blood samples, including infrastructure conditions, transportation delays, and customs;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">limits in our ability to penetrate new geographical regions due to competition;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">logistical issues or increases in costs of transporting tests and samples since our diagnostic tests are conducted primarily in Germany;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">financial risks, such as the impact of local and regional financial crises on demand and payment for our products and solutions, and exposure to foreign currency exchange rate fluctuations;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">risks associated with operations in countries which have experienced, or are currently experiencing, high rates of inflation which increase our costs, inhibit economic growth and could lead to reduced demand for our products and solutions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">natural disasters, political, and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts, curtailment of trade, and other business restrictions; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">regulatory and compliance risks that relate to maintaining accurate information and control over sales and distribution activities that may fall within the purview of the United States Foreign Corrupt Practices Act (the <span style="font-family:'Symbol';">&#8220;</span>FCPA<span style="font-family:'Symbol';">&#8221;</span>) or comparable foreign regulations, including its books and records provisions, or its anti-bribery provisions.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Any of these factors could significantly harm our future international expansion and operations and, consequently, our revenue and results of operations. The difference in regulations under the laws of the countries in which we may expand and the laws of the countries in which we currently operate may be significant and, in order to comply with such new laws, we may have to implement global changes to our products and solutions or business practices. Such changes may result in additional expense to us and either reduce or delay development of our products and solutions, commercialization of our biomarkers and other solutions or expansion of our data repository and biobank. In addition, any failure to comply with applicable legal and regulatory obligations could affect us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties and restrictions on certain business activities. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our activities in these countries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Failure to manage these and other risks may have a material adverse effect on our operations in any particular country and on our business as a whole.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Implementation of partnership agreements with our pharmaceutical partners may result in material unanticipated problems, expenses, liabilities, competitive responses, loss of client relationships and diversion of management&#8217;s attention.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The negotiation of our existing partnership agreements, as well as any new partnership agreements that we enter into, take up significant management time and resources. Moreover, in part due to the complex nature of our partnership agreements, which typically provide for research and development collaboration as well as utilization of our patient screening processes, we may need to expend capital and dedicate manpower to meeting the requirements of our pharmaceutical partners. Any partnership agreements that we enter into in the future may contain restrictions on our ability to enter into potential collaborations with other third parties, or to otherwise provide products and solutions in connection with a particular rare disease indication. As a result of these and other factors, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">our partnership agreements may result in material unanticipated problems, expenses, liabilities, competitive responses, loss of client relationships and diversion of management&#8217;s attention.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Many of these factors will be outside of our control, and any one of them could result in increased costs, decreases in the amount of expected revenues and diversion of management&#8217;s time and energy, which could materially impact our business, financial condition and results of operations. As a result, we cannot assure you that our relationship with any pharmaceutical partner will result in the realization of the anticipated benefits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If our products and solutions do not perform as expected, we may fail to achieve or maintain sales of our products and solutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our success depends on the market&#8217;s confidence that we can provide accurate diagnostic testing products and reliable, high-quality rare disease information solutions. Our partnerships with our pharmaceutical partners and clients are typically designed to provide results in respect of a particular rare disease, and our preliminary assessments or knowledge about such disease may necessarily be limited by the amount of information currently available. As a result, the work we undertake on behalf of our pharmaceutical partners and clients may not yield the results that our pharmaceutical partners and clients expect or anticipate. We believe that our pharmaceutical partners and clients are likely to be particularly sensitive to solution and testing service defects and errors, including if our products or services fail to detect genomic or other alterations with high accuracy from clinical specimens or if we fail to accurately develop a biomarker.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Moreover, we may fail to maintain the accuracy and reproducibility we have demonstrated to date with our genetic or other testing services, particularly for clinical samples, as our test volume increases. The sequencing process yields that we achieve depend on the design and operation of our sequencing process, which uses a number of complex and sophisticated biochemical, informatics, optical, and mechanical processes, many of which are highly sensitive to external factors. An operational or technological failure in one of these complex processes or fluctuations in external variables may result in sequencing processing yields that are lower than we anticipate or that vary between sequencing runs. In addition, we are regularly evaluating and refining our sequencing process. These refinements may initially result in unanticipated issues that further reduce our sequencing process yields or increase the variability of our sequencing process yields. Errors, including if our products or solutions fail to detect genomic variants with high accuracy, or mistakes, including if we fail to or incompletely or incorrectly identify the significance of gene variants, could have a significant adverse impact on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Hundreds of genes can be implicated in some disorders, and overlapping networks of genes and symptoms can be implicated in multiple conditions. As a result, a substantial amount of judgment is required in order to interpret testing results for an individual patient and to develop an appropriate patient report. As a result, we may make errors in our interpretation of testing results, which could impair the results of our tests and adversely impact the quality of our overall knowledge base. The failure of our products or solutions to perform as expected would significantly impair our operating results and our reputation. We may also be subject to legal claims arising from, or loss of business as a result of, any defects or errors in our products and solutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to manage our future growth effectively, which could make it difficult to execute our business strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We anticipate growth in our business operations. This future growth could create strain on our organizational, administrative and operational infrastructure, including laboratory operations, quality control, customer service, and sales force management. We may fail to maintain the quality or expected turnaround times of our products and services, or satisfy customer demand as it grows. Our ability to manage our growth properly will require us to continue to improve our operational, financial and management controls, as well as our reporting systems and procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We plan to expand our laboratory and technical operations as our business grows. However, any expansion strategies and any future growth could create strain on our organizational, administrative and operational infrastructure, including laboratory operations, quality control, customer service and sales force management. We may not be able to maintain the quality or expected turnaround times of our testing services or satisfy client demand as our business grows. Our ability to manage our growth properly will require us to continue to improve our operational, financial, and managerial controls, as well as our reporting systems and procedures, and to obtain appropriate regulatory approvals and meet regulatory standards applicable for the operation of our business.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">The development of new products and solutions is a complex process, and we may be unable to successfully commercialize new products or solutions on a timely basis or at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">New diagnostic test products and our interpretation-based solutions, including our biomarkers, take time to develop and commercialize. We may fail to develop and commercialize new diagnostic tests or solutions on a timely basis. Moreover, there can be no assurance that our products or solutions will be capable of meeting the needs of our clients and pharmaceutical partners, or that we will be able to commercialize them at all. Before we can commercialize any new products or solutions, we need to expend significant funds in order to:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">conduct substantial research and development, including epidemiology and validation studies and potentially patient scope analyses;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">further develop our laboratory processes or equipment;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">allocate laboratory space for new solutions or further scale our infrastructure to accommodate research and development or new equipment;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">in the case of products or solutions for which we are seeking regulatory or marketing approval, such as biomarkers, pursue such regulatory approval.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The development of new products and solutions involves risk, and development efforts may fail for many reasons, including the failure of any product or solution to perform as expected, a lack of validation or reference data, failure to demonstrate utility of a test or solution, or, in the case of solutions for which we are seeking or have received the Food and Drug Administration (&#8220;FDA&#8221;), European Commission and European Medicines Agency (&#8220;EMA&#8221;), German Federal Institute for Medicinal Products and Medical Devices (<i style="font-style:italic;">Bundesinstitut f&#252;r Arzneimittel und Medizinprodukte</i>), or comparable authorities&#8217; or agencies&#8217; approval, the inability to obtain such approval or the loss of such approval. In particular, our biomarker development and patent processes are subject to review by regulatory agencies and governing bodies. We cannot predict whether or when we will successfully complete development of each biomarker and if we will receive patent protection on any biomarkers that we develop.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As we develop new products and solutions, we will have to make significant investments in development, marketing, and selling resources. Any failure to develop or deliver adequate products or solutions to our clients and pharmaceutical partners on a timely basis or at all could significantly affect our business, financial condition, results of operations, and reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We have limited experience in marketing and selling our products and solutions and we may fail to expand our direct sales and marketing force to adequately address our pharmaceutical partners&#8217; and clients&#8217; needs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have limited experience in marketing and selling our products and solutions to pharmaceutical partners, and currently rely on a small sales force to sell our products and solutions. We may not be able to market, sell, or distribute our existing products and solutions or other services we may develop effectively enough to support our planned growth.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our future sales and further business growth will depend in large part on our ability to develop, and expand, our sales force and to increase the scope of our marketing efforts, particularly in the United States. Our target market of pharmaceutical partners and clients is a diverse market with particular, individualized needs. As a result, we believe it is necessary to develop a sales force that includes sales representatives with specific rare disease technical backgrounds. We will also need to attract and develop marketing personnel with industry expertise. Competition for such employees is intense. We may not be able to attract and retain personnel or be able to build an efficient and effective sales and marketing force, which could negatively impact sales and market acceptance of our products or solutions and limit our revenue growth and potential profitability. Our expected future growth will impose significant added responsibilities on members of management, including the need to identify, recruit, maintain, and integrate additional employees. Our future financial performance will depend in part on our ability to manage this potential future growth effectively, without compromising quality.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If we believe a significant market opportunity for our products or solutions exists in a particular jurisdiction in which we do not have direct access through one of our existing offices, from time to time we may enlist distribution partners and local laboratories to assist with sales, distribution, and client support. We may not be successful in finding, attracting, and retaining distribution partners or laboratories, or we may not be able to enter into such arrangements on favorable terms. Sales practices utilized by our distribution partners that are locally acceptable may not comply with sales practices standards required under German, Dutch, United States or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">other laws that apply to us, which could create additional compliance risk. If these additional sales and marketing efforts are not successful, we may not achieve significant market acceptance for our solutions in these markets, which could harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">The knowledge and interpretation-based solutions we provide to our pharmaceutical partners may not achieve significant commercial market acceptance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our knowledge and interpretation-based solutions may not gain significant acceptance in the orphan drug development market and, therefore, may not generate substantial revenue or profits for us. Our ability to achieve increased commercial market acceptance for our existing knowledge and interpretation-based solutions will depend on several factors, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to convince the medical and pharmaceutical community of the clinical utility of our solutions and their potential advantages over existing and new solutions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the willingness of our pharmaceutical partners, as well as their physicians and patients, to utilize our solutions; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the agreement by commercial third-party payors and government payors to reimburse any treatments provided by our pharmaceutical partners, the scope and amount of which will affect a partners<span style="font-family:'Symbol';">&#8217;</span> willingness or ability to pay for our solutions and will influence physicians<span style="font-family:'Symbol';">&#8217;</span> decisions to recommend our solutions.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe that the successful completion of clinical trials by partners that use our solutions, publication of scientific and medical results based on the information gained from our repository in peer-reviewed journals, and presentations at leading conferences are critical to the broad adoption of our solutions. Publication in leading medical journals is subject to a peer-review process, and peer reviewers may not consider the results of studies involving our solutions sufficiently novel or worthy of publication.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The failure to be listed in physician guidelines or the failure of our solutions to produce favorable results for our partners or to be published in peer-reviewed journals could limit the adoption of our solutions. Failure to achieve widespread market acceptance of our solutions would materially harm our business, financial condition, and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Failure to keep pace with the rapidly evolving industry in which we operate could make us obsolete.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our business relies on commercial activities in the rare disease genetic or other testing and diagnosis field. In recent years, there have been numerous advances in methods used to analyze very large amounts of genomic information and the role of genetics and gene variants in rare diseases and treatments, including through the development of biomarkers. Our industry has and will continue to be characterized by rapid technological change, increasingly larger amounts of data, frequent new testing service introductions and evolving industry standards. Our future success will also depend on our ability to keep pace with the evolving needs of our clients and pharmaceutical partners on a timely and cost-effective basis and to pursue new market opportunities that develop as a result of technological and scientific advances. Our current products and solutions could become obsolete unless we continually update our offerings to reflect new scientific knowledge about genes and genetic variations and their role in rare diseases and treatments. If we fail to anticipate or respond adequately to technological developments, demand for our products and solutions will not grow and may decline, and our business, revenue, financial condition and operating results could suffer materially.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Moreover, many companies in this market are offering, or may soon offer, products and solutions that compete with our products and solutions, in some cases at a lower cost than ours. We cannot assure you that research and discoveries by other companies will not render our existing or potential products and solutions uneconomical or result in tests superior to our existing tests and those we may develop. We also cannot assure you that any of our existing products and solutions, or those that we develop in the future, will be preferred by our clients, pharmaceutical partners, physicians or other payors to any existing or newly developed technologies or tests. If we fail to maintain competitive test products, our business, prospects, financial condition and results of operations could be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to successfully respond to increasing demand for our products and solutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As our sales volume grows, we will need to continue to increase our infrastructure for sample intake, customer service, billing and general process improvements, expand our internal quality assurance program, and extend our platform to support comprehensive genomic and other analyses at a larger scale within expected turnaround times. We will need additional certified laboratory scientists and other scientific and technical personnel to process higher volumes of our products and solutions. Portions of our process cannot be fully automated and will require additional personnel to scale. We will also need to purchase additional </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">equipment, some of which can take a long time to procure, set up, and validate, and increase our software and computing capacity to meet increased demand.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We may fail to successfully implement any of these increases in scale, expansion of personnel, equipment, software and computing capacities, or process enhancements and we may have inadequate space in our laboratory facilities to accommodate such required expansion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As additional products and solutions are commercialized, we will need to incorporate new equipment, implement new technology systems and laboratory processes, and hire new personnel with different qualifications. Failure to manage this growth or transition could result in turnaround time delays, higher product costs, declining product quality, deteriorating customer service, and slower responses to competitive challenges. A failure in any one of these areas could make it difficult or impossible for us to meet market expectations for our products and solutions, and could damage our reputation and the prospects for our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to obtain favorable pricing for our products and solutions and to meet our profitability expectations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If we are not able to obtain favorable pricing for our products and solutions to enable us to meet our profitability expectations, our revenues and profitability could materially suffer. The rates we are able to charge for our products and solutions are affected by a number of factors, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">general economic and political conditions in the countries in which we operate;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the competitive environment in our industry, as described below;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our clients<span style="font-family:'Symbol';">&#8217;</span> and pharmaceutical partners<span style="font-family:'Symbol';">&#8217;</span> cost sensitivities;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to accurately estimate, attain and sustain revenues and royalties, margins and cash flows over the full partnership period for our solutions, which includes our ability to estimate the impact of inflation and foreign exchange on our margins over long-term contracts; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">procurement practices of our pharmaceutical partners and clients and their use of third-party advisors.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The competitive environment in our industry affects our ability to obtain favorable pricing in a number of ways, all of which could have a material negative impact on our results of operations. The less we are able to clearly convey the value of our products and solutions or differentiate our products and solutions, the more risk we have that they will be seen as commodities, with price being the driving factor in selecting us as a partner. Competitors may be willing, at times, to price contracts or products lower than we do in an effort to enter the market or increase market share. Further, if competitors develop and implement methodologies that yield greater efficiency or efficacy, they may be able to offer products and solutions similar to ours at lower prices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Ethical, legal and social concerns related to the use of genomic or other diagnostic information could reduce demand for our rare disease knowledge and interpretation-based products and solutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Genomic testing, like that conducted for our pharmaceutical partners and clients using our genetic rare disease information platform, has raised ethical, legal and social issues regarding privacy and the appropriate uses of the resulting information. Governmental authorities could, for social or other purposes, limit or regulate the use of genomic information or genomic testing or prohibit testing for genetic predisposition to certain conditions, particularly for those that have no known cure. Similarly, these concerns may lead patients to refuse to use genomic tests even if permissible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Ethical and social concerns may also influence United States and foreign patent offices and courts with regard to patent protection for technology relevant to our business. These and other ethical, legal and social concerns may limit market acceptance of our products and solutions or reduce the potential markets for products and solutions enabled by our genetic rare disease information platform, either of which could have an adverse effect on our business, financial condition, or results of operations.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We have limited resources to be expended on research and development programs. Our resource allocation decisions may lead us to focus on research and development programs that are not commercially viable, and as a result we may be unable to recover the costs incurred under these efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Because we have limited financial and managerial resources, we focus on research and development programs that we identify for rare diseases in collaboration with our pharmaceutical partners, or based on our assessment of the market needs. As a result, we may forego or delay pursuit of opportunities with other orphan drug candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial drugs or profitable market opportunities. Our spending on current and future research and development programs for specific diseases may not yield any relevant results that are helpful to our existing programs or assist in the creation of any commercially viable drugs. If we do not accurately evaluate the commercial potential or target market for a particular drug candidate, we may relinquish valuable rights to that drug candidate through collaboration, licensing or other royalty arrangements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we fail to compete successfully with our competitors, including new entrants in the market, we may be unable to increase or sustain our revenue or achieve and sustain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">While personalized genomic diagnostics is a relatively new area of science, we face competition from companies that offer tests or have conducted research to profile genes and gene expression in various rare diseases. Our principal competition comes from diagnostic companies that offer diagnostic tests that capture genetic, phenotypic and epidemiological data, as well as laboratories and academic research centers. Many hospitals and academic medical centers may also seek to perform the type of genetic or other testing and knowledge and interpretation-based solutions we offer at their own facilities or using their own research capabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Some of our present and potential competitors may have substantially greater financial, marketing, technical or manufacturing resources than we do. Our competitors may also be able to respond more quickly to new technologies or processes and changes in client demands. They may also be able to devote greater resources towards the development, promotion and sale of their products or solutions for pharmaceutical partners than we can. As competition in our market increases, we may also be subject to increased litigation risk, including in connection with patents as well as our marketing practices and other promotional activities. In addition, our current and potential competitors may make strategic acquisitions or establish cooperative relationships among themselves or with third parties that increase their ability to address the needs of our physicians or partners. If we fail to compete successfully against current or future competitors, our business will be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Because our genetic or other testing and knowledge and interpretation-based solutions and products have limited patent protection, new and existing companies worldwide could seek to develop genetic or other tests or similar products and solutions that compete with ours. These competitors could have technological, financial, and market access advantages that are not currently available to us and they could develop and commercialize competing products and solutions faster than we are able to do so. Increased competition, including price competition, could have a material adverse impact on our net revenues and profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If our pharmaceutical partners experience any of a number of possible unforeseen events in connection with their clinical trials, our ability to commercialize future solutions or improvements to existing solutions could be delayed or prevented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our pharmaceutical partners may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent their ability to continue or conduct further clinical trials or obtain regulatory approval of or commercialize future orphan drugs. Unforeseen events that could delay or prevent our pharmaceutical partners&#8217; ability to conduct or support clinical trials, obtain regulatory approval of or commercialize future orphan drugs include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory authorities or ethical review boards, including IRBs, may not authorize the commencement of a clinical trial or may not accept clinical trial protocols;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">clinical trials may produce negative or inconclusive results, and our pharmaceutical partners may decide, or regulatory authorities may require them to, to abandon development programs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the number of patients, or amount of data, required for clinical trials may be larger than we or our pharmaceutical partners anticipate, or patient enrollment in clinical trials may be slower than we or our pharmaceutical partners anticipate or patients may drop out of these clinical trials at a higher rate than we or our pharmaceutical partners anticipate;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">failure to conduct our clinical trials in accordance with applicable regulatory requirements of the FDA and of the regulatory authorities responsible for authorization or oversight of the conduct of clinical trials in other countries;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">inability to develop companion diagnostic tests for a particular rare disease or to add companion diagnostic claims to existing tests, and/or obtain regulatory approval to market any such test on a timely basis or at all;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">clinical trials of our pharmaceutical partners for which we are developing companion diagnostic tests may suggest or demonstrate that our partners&#8217; treatments are not as efficacious and/or as safe as other similar treatments or that our companion diagnostic test is not essential to determine which patients would benefit from these treatments; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">mergers and acquisitions could have an impact on the priorities of our pharmaceutical partners; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our pharmaceutical partners may decide, or regulatory authorities or institutional review boards may require them, to suspend or terminate clinical research for various reasons, including cost, adequate end market size, available data or noncompliance with regulatory requirements.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If our pharmaceutical partners choose not to conduct clinical trials for treatments in the rare disease space due to the above factors or otherwise, they may have less need of our products and solutions and may therefore choose not to partner with us. Our ability to continually expand our existing data repository depends on our ability to maintain partnerships with our pharmaceutical clients. Should our partners delay or cancel their ongoing existing trials or choose not to begin new trials for treatments in the disease areas relevant to us, our ability to commercialize future solutions or improvements to existing solutions could be delayed or prevented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our employees, principal investigators, consultants, and commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are exposed to the risk of fraud or other misconduct by our employees, principal investigators, consultants, and commercial partners, including our distributors in our diagnostics business and pharmaceutical partners in our pharmaceutical business. Misconduct by these parties could include intentional failures to comply with the regulations of applicable regulatory authorities (including the FDA and the European Commission and EMA), comply with healthcare fraud and abuse laws and regulations, report financial information or data accurately, or disclose unauthorized activities to us. In particular, sales, marketing, and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, bribery, kickbacks, self-dealing, and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, client incentive programs, and other business arrangements. Such misconduct could also involve the improper use of information obtained in the course of clinical studies, which could result in regulatory sanctions and cause serious harm to our reputation. We currently have an insider trading policy as well as a code of conduct applicable to all of our employees and conduct a background check before entering into any new contracts with third party distributors, but it is not always possible to identify and deter employee or third party misconduct, and our insider trading policy and code of conduct, due diligence and the other precautions we take to detect and prevent such misconduct may not be effective in controlling unknown or unmanaged risks or losses, or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could result in the imposition of significant fines or other sanctions, which could have a significant impact on our business. Whether or not we are successful in defending against such actions or investigations, we could incur substantial costs, including legal fees, and divert the attention of management in defending ourselves against any of these actions or investigations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may lose the support of key thought leaders and fail to establish our products and solutions as a standard of care for patients with rare diseases, which may limit our revenue growth and ability to achieve future profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have established relationships with leading rare disease thought leaders at premier institutions and rare disease networks. If we suffer harm to our reputation, whether due to actions outside of our control or otherwise, our relationships with these persons may suffer which could adversely impact our business, including our key pharmaceutical partnerships and diagnostic client relationships. Moreover, if these key thought leaders determine that our BioDatabank, our existing products or solutions or other new products or solutions that we develop are not useful to our partners&#8217; development of treatments for rare diseases, that alternative technologies are more effective, or if they elect to use internally developed products or solutions, we could encounter significant difficulty validating our testing platform, driving adoption, or establishing our genetic knowledge and interpretation-based solutions and tests as a standard of care, which would limit our revenue growth and our ability to achieve profitability.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Security breaches, loss of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.<span style="font-style:normal;font-weight:normal;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the ordinary course of our business, we collect and store sensitive data, including legally protected health information, personally identifiable information, intellectual property, and proprietary business information owned or controlled by us or physicians, pharmaceutical partners and other clients. We manage and maintain our applications and data utilizing a combination of on-site systems, managed data center systems, and cloud-based data center systems. We also communicate, and facilitate the exchange of, sensitive patient data to and between ourselves and physicians of the patients for whom we conduct diagnostic tests through an online client-facing portal, CentoPortal. These applications and related data encompass a wide variety of business-critical information including legally protected health information, personally identifiable information, research and development information, commercial information, and business and financial information. We face a number of key risks related to the protection of this information, including: unauthorized access risk; inappropriate or unauthorized disclosure risk; inappropriate modification risk; and the risk of our being unable to adequately monitor our controls.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The secure processing, storage, maintenance, and transmission of this critical information is vital to our operations and business strategy. Our information technology and infrastructure, and that of our third-party disaster recovery back-up providers, may be vulnerable to attacks by hackers or malicious software or breached due to personnel error, unauthorized access, malfeasance, or other disruptions. Any such breach or interruption could compromise the security or integrity of our networks, and the information stored there could be accessed by unauthorized parties, publicly or incorrectly disclosed, corrupted, lost, or stolen. Any such access, disclosure, corruption, other loss, or theft of information could result in governmental investigations, class action legal claims or proceedings, liability under laws that protect the privacy of personal information, such as but not limited to the Health Insurance Portability and Accountability Act (&#8220;HIPAA&#8221;), the General Data Protection Regulation (EU 2016/679) (&#8220;GDPR&#8221;) and regulatory penalties. Although we have implemented security measures and a formal, dedicated enterprise security program to prevent unauthorized access to patient data, applications such as our online client-facing portals are currently accessible through public web portals and may, in the future, be accessible through dedicated mobile applications, and there is no guarantee we can absolutely protect our online portals or our mobile applications from breach. Unauthorized access to, or loss or dissemination of, the data embedded in or transferred via these applications could also disrupt our operations, including our ability to conduct our analyses, provide test results, bill our pharmaceutical or other partners, provide client assistance solutions, conduct research and development activities, collect, process, and prepare company financial information, provide information about our products and solutions and other pharmaceutical partner and physician education and outreach efforts through our website, manage the administrative aspects of our business, and damage our reputation, any of which could adversely affect our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are a &#8220;covered entity&#8221; as defined under HIPAA, and the United States Office of Civil Rights may impose penalties on a covered entity for a failure to comply with a requirement of HIPAA. Penalties will vary significantly depending on factors such as the date of the violation, whether the covered entity knew or should have known of the failure to comply, or whether the covered entity&#8217;s failure to comply was due to willful neglect. A person who knowingly obtains or discloses individually identifiable health information in violation of HIPAA may face a criminal penalty of up to $50,000 and imprisonment up to one year. The criminal penalties increase to $100,000 and up to five years&#8217; imprisonment if the wrongful conduct involves false pretenses, and to $250,000 and up to 10&#160;years&#8217; imprisonment if the wrongful conduct involves the intent to sell, transfer, or use identifiable health information for commercial advantage, personal gain, or malicious harm. The United States Department of Justice (the &#8220;DOJ&#8221;) is responsible for criminal prosecutions under HIPAA. Furthermore, in the event of a breach as defined by HIPAA, the covered entity has specific reporting requirements under HIPAA regulations. In the event of a significant breach, the reporting requirements could include notification to the general public.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, the interpretation and application of consumer, health-related, and data protection laws in the United States, Europe, and elsewhere are often uncertain, contradictory, and in flux. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our practices. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business. In addition, these privacy regulations may differ from country to country, and may vary based on whether testing is performed in the United States or in the local country. Our operations or business practices may not comply with these regulations in each country, and complying with these various laws could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We are subject to significant foreign currency exchange controls in certain countries in which we operate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We are in some countries, and could become elsewhere, subject to strict restrictions on the movement of cash and the exchange of foreign currencies, which limits our ability to use this cash across our global operations. We also face risks related to the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">collection of payments due to us from our major pharmaceutical partners or clients that are located in certain geographical regions with foreign currency or international monetary controls. This risk could increase as we continue our geographic expansion. In particular, for the years ended December&#160;31, 2021 and 2020 we derived 8.7% and 9.8%, respectively, of our total revenues from our Middle East region. Certain Middle East economies have adopted or been subject to international restrictions on the ability to transfer funds out of the country and convert local currencies into euros. This may increase our costs and limit our ability to convert local currency into euros and transfer funds out of certain countries. Any shortages or restrictions may impede our ability to convert these currencies into euros and to transfer funds, including for the payment of dividends or interest or principal on our outstanding debt. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may acquire assets or other businesses that could negatively affect our operating results, dilute our shareholders&#8217; ownership or increase our debt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to organic growth, we may pursue growth through the acquisition of assets or other businesses that may enable us to enhance our technologies and capabilities, expand our geographic market, add experienced management personnel or add new or improve our existing products and solutions. We also may pursue strategic alliances and joint ventures that leverage our technical platform and industry knowledge to expand our products and solutions. Negotiating these transactions and the formation of strategic alliances or joint ventures can be time-consuming and expensive, and may be subject to third-party approvals as well as approvals from governmental authorities, which are beyond our control. In addition, some third parties may choose not to enter into partnership or collaboration agreements with us because of our existing relationships with other pharmaceutical partners. Consequently, we may not be able to complete any contemplated transactions on favorable terms or at all, and we can make no assurance that such transactions, once undertaken and announced, will close.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">An acquisition or investment may result in unforeseen operating difficulties and expenditures, including in integrating businesses, products and solutions, personnel, operations, and financial, accounting and other controls and systems, and retaining key employees, with the assumption of unknown liabilities or known liabilities that prove greater than anticipated, and in retaining the clients of any acquired business. Any such difficulties could disrupt our ongoing operations or require management resources that we would otherwise focus on developing our existing business. Future acquisitions could result in the use of our available cash and marketable securities, potentially dilutive issuances of equity securities, the incurrence of debt, contingent liabilities, or impairment expenses related to goodwill, and impairment or amortization expenses related to other intangible assets, which could harm our financial condition. As a result, we may not realize the anticipated benefits of any acquisition, technology license, strategic alliance, or joint venture. These challenges related to acquisitions or investments could adversely affect our business, results of operations, and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Certain Factors Relating to Our Industry</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Regulatory Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our global operations expose us to numerous and sometimes conflicting legal and regulatory requirements, and violation of these requirements could harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are subject to numerous, and sometimes conflicting, legal regimes in the countries in which we operate, including on matters as diverse as health and safety standards, marketing and promotional activities, anticorruption, import/export controls, content requirements, trade restrictions, tariffs, taxation, sanctions, immigration, internal and disclosure control obligations, securities regulation, anti-<span style="white-space:pre-wrap;">competition, data privacy and labor relations. This includes in emerging markets where legal systems may be less developed or familiar to us.  We strive to abide by and maintain compliance with these laws and regulations. Compliance with diverse legal requirements is costly, time-consuming and requires significant resources. Violations of one or more of these regulations in the conduct of our business could result in significant fines, criminal sanctions against us or our supervisory board or officers, prohibitions on doing business and damage to our reputation. Violations of these regulations in connection with the performance of our obligations to our clients or pharmaceutical partners also could result in liability for significant monetary damages, fines and/or criminal prosecution, unfavorable publicity and other reputational damage, restrictions on our ability to process information and allegations by our clients or pharmaceutical partners that we have not performed our contractual obligations. Due to the varying degrees of development of the legal systems of the countries in which we operate, local laws might be insufficient to protect our rights.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The United Kingdom withdrew from the European Union (&#8220;Brexit&#8221;) and ratified an agreement on the future trading relationship between the parties (the &#8220;UK-EU Trade and Cooperation Agreement&#8221; or &#8220;TCA&#8221;). The TCA is subject to formal approval by the European Parliament and the Council of the European Union before it comes into effect and has been applied provisionally since January 1, 2021. Because the agreement merely sets forth a framework in many respects and will require complex additional </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">bilateral negotiations between the United Kingdom and the European Union as both parties continue to work on the rules for implementation, significant uncertainty remains about how the precise terms of the relationship between the parties will differ from the terms before withdrawal. The Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) was appointed as the United Kingdom&#8217;s standalone medicines and medical devices regulator (responsible for designating Review Bodies), effective January 1, 2021, and new legislation has been introduced in the United Kingdom, the provisions of which remain to be clarified. Further MHRA guidance is anticipated in the coming months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our international operations could be affected by changes in laws, trade regulations, labor and employment regulations, and procedures and actions affecting approval, products and solutions, pricing, reimbursement and marketing of our products and solutions, as well as by inter-governmental disputes. Any of these changes could adversely affect our business. The imposition of new laws or regulations, including potential trade barriers, may increase our operating costs, impose restrictions on our operations or require us to spend additional funds to gain compliance with the new rules, if possible, which could have an adverse impact on our financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Current and future legislation, in particular legislation related to orphan drugs, may impact overall investment and activity in the rare disease space or our ability to obtain regulatory approvals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the United States, the European Union, its member states and some other foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system. These changes could affect our ability to sell profitably any products for which we require approvals. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access to healthcare.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Specifically, regulatory authorities in some jurisdictions, including the United States and the European Union, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 individuals annually in the United States, or a patient population of greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the United States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Similarly, in the European Union, the European Commission grants orphan drug designation after receiving the opinion of the EMA&#8217;s Committee for Orphan Medicinal Products on an orphan drug designation application. Orphan drug designation is intended to promote the development of drugs that are intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions affecting not more than five in 10,000 persons in the European Union and for which no satisfactory method of diagnosis, prevention, or treatment has been authorized (or the product would be a significant benefit to those affected). In addition, designation is granted for drugs intended for the diagnosis, prevention, or treatment of a life-threatening, seriously debilitating or serious and chronic condition and when, without incentives, it is unlikely that sales of the drug in the European Union would be sufficient to justify the necessary investment in developing the drug. In the European Union, orphan drug designation entitles a party to financial incentives, such as reduction of fees or fee waivers, and a ten-year market exclusivity once the drug is on the market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These legislative initiatives have led to an increase in investment and activity in the rare disease drug development space. If these and other legislative initiatives were to change to become less favorable to orphan drug developers and researchers, it could harm our business, results of operations and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to comply with the complex federal, state, local and foreign laws and regulations that apply to our business and become subject to severe financial and other consequences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our laboratory in the United States is subject to the Clinical Laboratory Improvement Amendments of 1998 (&#8220;CLIA&#8221;), a United States federal law that regulates all clinical diagnostic laboratories that perform testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention, or treatment of disease. CLIA regulations mandate specific standards in the areas of personnel qualifications, administration, participation in proficiency testing, patient test management, quality control, quality assurance, and inspections. Our laboratory facilities located in Rostock, Germany and Cambridge, Massachusetts, United States each have a current certificate of accreditation under CLIA to conduct all genetic and biochemical analyses offered through our accreditation by the College of American Pathologists (&#8220;CAP&#8221;). To renew the CLIA certificates, we are subject to survey </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">and inspection every two years. Moreover, CLIA inspectors may make unannounced inspections of our clinical laboratories at any time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Any sanction imposed under CLIA, its implementing regulations, or state or foreign laws or regulations governing licensure, or our failure to renew a CLIA certificate, a state or foreign license, or accreditation, could have a material adverse effect on our business. Most CLIA deficiencies are not classified as &#8220;condition-level&#8221; deficiencies, and there are no adverse effects upon the laboratory operations as long as the deficiencies are corrected. Remediation of these deficiencies are routine matters, with corrections occurring within several hours or weeks. More serious CLIA deficiencies could rise to the level of &#8220;condition-level&#8221; deficiencies, and CMS has the authority to impose a wide range of sanctions, including revocation of the CLIA certification along with a bar on the ownership or operation of a CLIA certified laboratory by any owners or operators of the deficient laboratory. There is an administrative hearing procedure that can be pursued by the laboratory in the event of imposition of such sanctions, during which the sanctions are stayed, but the process can take a number of years to complete. If we were to lose our CLIA certification or CAP accreditation, we would not be able to operate our clinical laboratories and perform our genetic or other tests, which would result in material harm to our business and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are also required to maintain a license for our Cambridge laboratory facility to perform testing in Massachusetts. Massachusetts laws establish standards for day-to-day operation of our clinical laboratory, including the training and skills required of personnel and quality control over and above that required by CLIA. We are also licensed to perform testing in our Cambridge laboratory facility by the states of California, Pennsylvania and Maryland. We are in the process of obtaining a New York State license to perform testing and deliver the related test report for specimens originating from New York.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For samples tested in the U.S., we are also subject to HIPAA, under which the Department of Health and Human Services established comprehensive federal standards with respect to the privacy and security of protected health information and requirements for the use of certain standardized electronic transactions; certain of our services, including our online client-facing portals for reporting and research, are subject to these standards and requirements. Amendments to HIPAA under the Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH Act&#8221;), and related regulatory amendments, which strengthen and expand HIPAA privacy and security standards, increase penalties for violators, extend enforcement authority to state attorneys general, and impose requirements for breach notification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We furnish to pharmaceutical partners genomic information that has been de-identified in accordance with HIPAA or anonymized in accordance with GDPR and relevant international health information privacy regulations. The laws of certain states and countries may require specific consent from the individual either to retain or utilize certain genetic or other information for research or other purposes even if such information has been de-identified, or may require that we obtain a waiver of such consent from an ethical or privacy review board. Even where we furnish to pharmaceutical partners and academic researchers genomic information that has been de-identified or anonymized in accordance with applicable laws and regulations, pharmaceutical partners or academic researchers may use technology or other methods to link that de-identified or anonymized genomic information to the patient from whom it was obtained in contravention of one or more applicable laws and regulations. Similarly, as we expand our decision support applications and offerings, we may encounter greater regulatory risk, such as compliance with HIPAA, GDPR and other regulations governing the use of protected health information and the promotion of FDA approved drugs. A finding that we have failed to comply with any such laws and any remedial activities required to ensure compliance with such laws could cause us to incur substantial costs, to be subject to unfavorable publicity or public opinion, to change our business practices, or to limit the retention or use of genetic or other information in a manner that, individually or collectively, could be adverse to our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the European Union, various regulations apply to genetic or other testing and the use of genomic information. In Germany, the Genetic Diagnosis Act (<i style="font-style:italic;">Gendiagnostikgesetz</i>) (the &#8220;GenDG&#8221;) and guidelines and written opinions on novel genetic screenings developed by the Commission on Genetic Testing, an interdisciplinary independent commission established in 2009 in accordance with the GenDG, apply to such testing. The GenDG prohibits us from communicating results of genetic or other tests directly to a patient located within Germany. Instead, the results may only be provided to a physician who is a qualified genetic counsellor under applicable rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition to CLIA, GDPR, HIPAA and the GenDG, our operations are subject to other extensive federal, state, local, and foreign laws and regulations, all of which are subject to change. Our failure to comply with any such laws and regulations could lead to civil or criminal penalties, exclusion from participation in government healthcare programs, or prohibitions or restrictions on our ability to conduct commercial activities. We believe that we are in material compliance with all statutory and regulatory requirements, but there is a risk that one or more government agencies could take a contrary position. These laws and regulations are complex and are subject to interpretation by the courts and by government agencies. If one or more such agencies allege that we may be in violation </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">of any of these requirements, regardless of the outcome, it could damage our reputation and adversely affect important business relationships with third parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to comply with evolving European and other privacy laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On May&#160;25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April&#160;27, 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (the &#8220;GDPR&#8221;) went into effect. The GDPR imposes a broad range of strict requirements on companies subject to the GDPR, such as us, including requirements relating to having legal bases for processing personal data relating to identifiable individuals and transferring such information outside the European Economic Area (the &#8220;EEA&#8221;), including to the United States, providing details to those individuals regarding the processing of their personal data, keeping personal data secure, having data processing agreements with third parties who process personal data as processor, responding to individuals&#8217; requests to exercise their rights in respect of their personal data, reporting security breaches involving personal data to the competent national data protection authority and affected individuals, appointing data protection officers, conducting data protection impact assessments, and record-keeping. The GDPR increases substantially the penalties to which we could be subject in the event of any non-compliance, including fines of up to the higher of 10,000,000&#160;Euros and 2% of our total worldwide annual turnover for the preceding financial year for certain comparatively minor offenses, or up to the higher of 20,000,000&#160;Euros and 4% of our total worldwide annual turnover for the preceding financial year for more serious offenses. Given the new law, we face uncertainty as to the exact interpretation of the new requirements and we may be unsuccessful in implementing all measures required by data protection authorities or courts in interpretation of the new law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In particular, national laws of member states of the European Union are still in the process of being adapted to the requirements under the GDPR, thereby implementing national laws which may partially deviate from the GDPR and impose different obligations from country to country, so that we do not expect to operate in a uniform legal landscape in the European Union. Also, in the field of handling genetic and health data, the GDPR specifically allows national laws to impose additional and more specific requirements or restrictions, and European laws have historically differed quite substantially in this field, leading to additional uncertainty. Following Brexit, we are also required to comply with GDPR as implemented in the United Kingdom, including through the Data Protection Act 2018.<span style="font-style:italic;font-weight:bold;"> </span>The relationship between the United Kingdom and the European Union in relation to certain aspects of data protection law remains unclear, including the treatment of data transfers between European Union member states and the United Kingdom.<span style="font-style:italic;font-weight:bold;"> </span>These changes may lead to additional compliance costs and could increase our overall risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We must also ensure that we maintain adequate safeguards to enable the transfer of personal data outside of the EEA, in particular to the United States, in compliance with European data protection laws. In this regard, the July 2020 ruling by the Court of Justice of the EU (the &#8220;CJEU&#8221;) in the case referred to as Schrems II is significant. The CJEU held that businesses can use European Commission endorsed standard contractual clauses (&#8220;SCCs&#8221;), which are widely relied on, for data transfers to jurisdictions outside of the EEA. However, it emphasized the need for due diligence by businesses if they wish to use SCCs, and called into question whether businesses can use SCCs to facilitate data transfers to certain jurisdictions with invasive surveillance regimes in a way which complies with the GDPR. This is also true for the new set of SCCs adopted by the European Commission in 2021. The CJEU also invalidated the EU-US Privacy Shield for transferring personal data from the EEA to the US. The new set of SCCs may require businesses to transition existing agreements that rely on the outdated SCCs to the current SCCs. Such a transition exercise is likely to prove both costly and time consuming. We expect that we will continue to face uncertainty as to whether our efforts to comply with our obligations under European privacy laws will be sufficient. If we are investigated by a European data protection authority, we may face fines and other penalties. Any such investigation or charges by European data protection authorities could have a negative effect on our existing business and on our ability to attract and retain new clients or pharmaceutical partners. We may also experience hesitancy, reluctance, or refusal by European or multinational clients or pharmaceutical partners to continue to use our products and solutions due to the potential risk exposure as a result of the current (and, in particular, future) data protection obligations imposed on them by certain data protection authorities in interpretation of current law, including the GDPR. Such clients or pharmaceutical partners may also view any alternative approaches to compliance as being too costly, too burdensome, too legally uncertain, or otherwise objectionable and therefore decide not to do business with us. Any of the foregoing could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We could be adversely affected by violations of worldwide anti-bribery laws, including the U.S. Foreign Corrupt Practices Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We are subject to a variety of anti-bribery and anti-corruption laws in the jurisdictions in which we operate. In particular, we are subject to Germany&#8217;s Anti-Bribery Act of 2015 (<i style="font-style:italic;">Gesetz zur Bek&#228;mpfung der Korruption im Gesundheitswesen</i>), which implements EU anti-corruption laws and the European legislation and the Criminal Law Convention on Corruption of the Council of Europe into German law, and the FCPA, which prohibits companies and their intermediaries from making payments in violation of law to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">non-United States government officials for the purpose of obtaining or retaining business or securing any other improper advantage. We are also subject to similar anti-bribery laws in the jurisdictions in which we operate, including the United Kingdom&#8217;s Bribery Act of 2010, which prohibits commercial bribery and makes it a crime for companies to fail to prevent bribery.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We use third-party collaborators, strategic partners, law firms and other representatives for patent registration and other purposes in a variety of countries, including those that are known to present a high corruption risk. We also use third-party distributors worldwide as part of our diagnostics business. Our reliance on third parties to sell our products and solutions internationally demands a high degree of vigilance because we can be held liable for the corrupt or other illegal activities of these third-party collaborators, or their or our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. In addition, although we have implemented policies and procedures to ensure compliance with anti-corruption and related laws and maintain a code of conduct, there can be no assurance that all of our employees, representatives, contractors, partners, or agents will comply with these laws at all times. Other United States companies in the medical device and pharmaceutical fields have faced criminal penalties under the FCPA for allowing their agents to deviate from appropriate practices in doing business with these individuals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These laws are complex and far-reaching in nature, and, as a result, we cannot assure you that we would not be required in the future to alter one or more of our practices to be in compliance with these laws, any changes in these laws, or the interpretation thereof. Non-compliance with these and other relevant laws could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and debarment from contracting with certain governments or other persons, the loss of export privileges, reputational harm, adverse media coverage, and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, results of operations, and financial condition could be materially harmed. In addition, responding to any action will likely result in a materially significant diversion of management&#8217;s attention and resources and significant defense costs and other professional fees. Enforcement actions and sanctions could further harm our business, results of operations, and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Transactions involving Iran or other countries or parties that are targets of U.S. or other economic sanctions could expose us to certain risks and may lead some potential customers and investors to avoid doing business with us or investing in our securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">U.S. law generally prohibits U.S. persons, and in some cases non-U.S. entities owned or controlled by U.S. persons, from doing business with countries, territories, individuals and entities that are the target of sanctions administered by the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, including Iran. Other countries also maintain certain economic sanctions targeting certain counties, territories and parties. The United States has also implemented certain sanctions targeting non-U.S. persons for activities conducted outside the United States &#8220;secondary sanctions&#8221; that involve specific sanctions targets or certain activities, including, among other things, certain transactions related to Iran. Further, certain countries maintain and enforce export controls regulating trade in items that originate in, incorporate content from, or are produced on the basis of technology developed in such country &#8220;export controls.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Centogene GmbH, which is not a U.S. person and is not owned or controlled by U.S. persons provided diagnostic tests to a pathology and genetic center in Iran during the year ended December 31, 2021 through which it provides diagnostic tests to patients in Iran. To our knowledge, neither we nor our customer have entered into any arrangements with or sold any products to persons included on the Specially Designated Nationals and Blocked Persons List maintained by the U.S. Department of the Treasury&#8217;s Office of Foreign Asset Control. During the years ended December&#160;31, 2021, 2020 and 2019, revenues from Iran amounted to &#8364;1 thousand, &#8364;13&#160;thousand and &#8364;1 thousand, respectively. Our net assets receivable from or attributable to our contacts in Iran as of December&#160;31, 2021, 2020 and 2019 amounted to zero, &#8364;&#160;1&#160;thousand and &#8364;1 thousand, respectively. In December 2021, Centogene GmbH assigned claims against its Iranian distributor in an aggregate amount of &#8364;1.4 million to Germela Consulting GmbH, which has since filed a lawsuit against DeNa Lab in Berlin, Germany. We had no liabilities due from or attributable to our contacts in Iran for these periods. Centogene believes that its business with Iranian parties is conducted in compliance with all applicable sanctions and export controls and that such activities, which involve providing genetic or other testing services to patients, are not sanctionable under U.S. secondary sanctions targeting Iran. However, U.S. sanctions are subject to change and if we were then determined to have engaged in activities targeted by certain U.S. sanctions, we could be exposed to the possible imposition of sanctions on us. We may also face reputational damage due to our sales to Iran. The above circumstances could have an adverse effect on our business or results of operations.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may fail to adhere to regulations of promotional claims and activities regarding our products and solutions. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Once a patient has been identified and diagnosed through our diagnostics testing, we provide each patient&#8217;s physician with a diagnostic report. If a positive diagnosis is confirmed, we provide the physician with information on relevant treatment options, although the physician is responsible for ultimately making clinically relevant decisions for the treatment of his or her patient.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the United States, the FDA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription drugs and devices. In particular, a device may not be promoted for uses or indications beyond those contained in the device&#8217;s approved labeling, or &#8220;off-label&#8221; uses. Similar laws and regulations exist in other jurisdictions where we promote our products. If the FDA determines that we have promoted our products for off-label use, it could request that we modify those promotional materials or take regulatory or enforcement actions, including the issuance of an untitled letter, warning letter, injunction, seizure, civil fine and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities may take action if they consider our promotional or training materials to constitute promotion of an unapproved use. If not successfully defended, enforcement actions related to off-label promotion could result in significant fines or penalties. The U.S. government has levied large civil and criminal fines against companies for alleged improper promotion and has entered into corporate integrity agreements and deferred prosecution agreements with companies that engaged in off-label promotion. The FDA has also requested that such companies enter into consent decrees and has taken other enforcement action. If the DOJ or FDA determines that we have engaged in off-label promotion in our test reports, we may be subject to civil or criminal fines. Although our policy is to refrain from statements that could be considered off-label promotion of third parties, the regulatory standards regarding off-label promotion are ambiguous, and the FDA or another regulatory agency could conclude that we have engaged in off-label promotion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to promoting our devices in a manner consistent with their approved indications, we must have adequate substantiation for the claims we make for our products or solutions. If any of our claims are determined to be false, misleading or deceptive, our products or solutions could be considered to be misbranded under the Federal Food, Drug, and Cosmetic Act (the &#8220;FDC Act&#8221;) or to violate the Federal Trade Commission Act. We could also face lawsuits from our competitors under the Lanham Act, alleging that our marketing materials are false or misleading. Such lawsuits, whether with or without merit, are typically time-consuming, costly to defend, and could harm our reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Federal and state legislation regulate interactions between medical device manufacturers and healthcare professionals. We are subject to federal and state laws targeting fraud and abuse in healthcare, including anti-kickback laws, false claims laws, and other laws constraining or otherwise related to financial arrangements manufacturers may enter into with healthcare professionals. For example, the Physician Payments Sunshine Act requires device manufacturers to report and disclose payments or other transfers of value made to physicians and teaching hospitals. Violations of these laws can result in criminal or civil sanctions, including fines, imprisonment, and exclusion from government reimbursement programs, all of which could materially harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, incentives exist under applicable laws that encourage competitors, employees, and physicians to report violations of law governing promotional activities for pharmaceutical products and solutions. These incentives could lead to so-called whistleblower lawsuits as part of which such persons seek to collect a portion of monies allegedly overbilled to government agencies due to, for example, promotion of pharmaceutical products and solutions beyond labeled claims. These incentives could also lead to lawsuits that claim we have mischaracterized a competitor&#8217;s service in the marketplace and, as a result, we could be sued for alleged damages to our competitors. Such lawsuits, whether with or without merit, are typically time-consuming and costly to defend. Such lawsuits may also result in related shareholder lawsuits, which may also be costly to defend.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Changes in the way that the FDA and the European Union regulate laboratory developed tests, manufactured, validated, and performed by laboratories like ours could result in additional expense in offering our current and any future products and solutions or even possibly delay or suspend development, manufacture, or commercialization of such products and solutions. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The FDA does not currently regulate most laboratory developed tests (&#8220;LDTs&#8221;). We believe that the tests we currently offer meet the definition of LDTs, as they have been designed, developed and validated for use in a single CLIA-certified laboratory. If our tests are qualified as LDTs, they are currently not subject to FDA regulation as medical devices. Since the early 1990s, the FDA has taken the position that, although LDTs are medical devices, it would exercise enforcement discretion by not requiring compliance with the FDC Act, or its regulations for LDTs. That remains the guidance of the FDA today. However, the FDA has taken certain actions in the past that, if renewed by the FDA, could result in a new regulatory approach for LDTs. In October 2014, the FDA published two draft guidance documents that, if finalized, would implement a regulatory approach for most LDTs. The draft guidance documents proposed to impose a risk-based, phased-in approach for LDTs similar to the existing framework for in vitro diagnostic devices. In January 2017, the FDA released a discussion paper synthesizing public comments on the 2014 draft guidance documents and outlining </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">an updated possible approach to regulation of LDTs. Although the discussion paper has no legal status and does not represent a final version of the LDT draft guidance documents, it proposes a risk-based framework that would require most LDTs to comply with most of the FDA&#8217;s regulatory requirements for medical devices. In March 2017, a discussion draft of the Diagnostic Accuracy and Innovation Act (&#8220;DAIA&#8221;) was circulated, which, if enacted, would implement a regulatory scheme for all diagnostic tests, including both in vitro diagnostic devices and LDTs. Under DAIA, CMS would have jurisdiction over laboratory operations under an amended CLIA, and the FDA would regulate the design, development and validation of diagnostic tests under an amended FDC Act. We cannot predict whether this bill or any other any other legislative proposal will be enacted into law or the impact such new legal requirements would have on our business. We also cannot predict whether the FDA will take action to regulate LDTs or what approach the FDA will seek to take.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, in November 2013, the FDA finalized guidance regarding the sale and use of products labeled for research or investigational use only. Among other things, the guidance states that the FDA continues to be concerned about distribution of research- or investigational-use only products intended for clinical diagnostic use. The guidance states that the FDA will assess whether a manufacturer of such research- or investigational-use only products intends that its products be used for clinical diagnostic purposes by examining the totality of circumstances, including advertising, instructions for clinical interpretation, presentations that describe clinical use, and specialized technical support such as assistance performing clinical validation, surrounding the distribution of the product in question. The FDA has advised that if evidence demonstrates that a product is inappropriately labeled for research- or investigational-use only, the device could be deemed misbranded and adulterated within the meaning of the FDC Act. If the FDA were to undertake enforcement actions, some of our suppliers may cease selling research-use only (&#8220;RUO&#8221;) products to us, and any failure to obtain an acceptable substitute could significantly and adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the European Union LDTs are similarly exempt from the regulations that govern medical devices and in-vitro diagnostics (&#8220;IVDs&#8221;) under certain conditions. The European Union and German legislation on in-vitro diagnostic medical devices (&#8220;IVD-MDD&#8221;) applies. According to the recitals of the Council Directive 98/79/EC on IVD-MDD, reagents which are produced within &#8220;health-institution laboratories&#8221; for use in that environment and which are not subject to commercial transactions are not covered by the Directive. However, the legal framework for applying the exemption clauses for LDTs is not entirely clear as the IVD-MDD lacks an explicit definition and there is no related case law. On May&#160;26, 2022, when the new Regulation (EU) 2017/746 of the European Parliament and of the Council of 5&#160;April 2017 on in-vitro diagnostic medical devices (&#8220;IVD-MDR&#8221;) becomes applicable, the general safety and performance requirements set out in Annex&#160;I of the IVD-MDR are applicable also to devices manufactured and used only within health institutions. Overall the exemptions for LDTs will be narrowed, as even in relation to LDTs, health institutions&#8212;among others&#8212;have to provide information upon request on the use of such devices to their competent authority and each health institution will have to draw up a declaration which it will make publicly available. If these conditions are not met and/or diagnostic tests are manufactured and used only within health institutions but &#8220;on an industrial scale&#8221;, such tests will qualify as IVDs with the full applicability of the IVD-MDR. If we were not able to qualify for an exemption, we would be subject to regulation in the European Union. We also cannot predict whether the EU will amend or implement new laws which may impact our current operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">For tests that are subject to FDA or EU regulation, we may not be able to obtain timely approvals for our tests or for modifications to our tests, which could delay or prevent us from commercializing our tests and harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The diagnostic tests we currently offer might meet the definition of LDTs, as they have been designed, developed and validated for use in a single CLIA-certified laboratory. If our tests are LDTs, they are currently not subject to FDA or EU regulation as an in-vitro-diagnostic. In May 2022 when the new IVD Regulation&#160;2017/746/EU comes into force in the European Union, a qualification of our diagnostic tests as IVD-MDs becomes more likely as the manufacture of diagnostic tests &#8220;on an industrial scale&#8221; will not qualify as LDTs. If the FDA or EU takes action to finalize and implement a regulatory system for LDTs, or if legislation is enacted that subjects LDTs to FDA regulation, we would need to comply with the FDA regulatory requirements for our LDTs. If the FDA takes action to regulate LDTs as devices, we believe that our LDTs would likely be regulated as Class&#160;II devices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the EU, genetic or other tests on humans and prenatal tests for genetically caused disorders are regulated as Class&#160;C devices under the IVD Regulation. If our LDTs are subject to the IVD Regulation, our tests that qualify as Class&#160;C devices will be subject to conformity assessments performed by a notified body.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If services that are currently marketed as LDTs become subject to FDA requirements for in-vitro-diagnostics or are qualified as being subject to the European Union regulations on in vitro diagnostic medical devices, including requirements for premarket clearance or approval, we may not be able to obtain such clearance or approvals on a timely basis, or at all. Our business could be negatively impacted if we are required to stop selling genetic rare disease knowledge and interpretation-based products and solutions pending their clearance or approval, or the launch of any new products and solutions that we develop could be delayed. Likewise, for </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">tests that are regulated as medical devices, we may not be able to obtain clearance or approval of new devices or modifications to marketed devices on a timely basis, or at all, which could delay or prevent us from commercializing our tests and harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Class&#160;II medical devices must obtain FDA clearance of a premarket notification, or 510(k), prior to marketing, unless the FDA has exempted the device from this requirement. Under the 510(k) process, we must demonstrate that our test is substantially equivalent in technological characteristics and intended use to a legally marketed predicate device. The FDA&#8217;s review and clearance of a 510(k) usually takes from four to twelve months, but it can take longer. Any modifications to an FDA-cleared device that could significantly affect its safety or effectiveness or that would constitute a major change in its intended use would require a new 510(k) clearance or, if the modified device is not substantially equivalent, possibly a de novo classification request or a premarket approval application (&#8220;PMA&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If we are unable to identify an appropriate predicate that is substantially equivalent to our device, we would be required to submit a PMA application or a de novo reclassification request, because devices that have not been classified are automatically categorized as Class&#160;III. Under the de novo process, we may request that the FDA classify a new low or moderate risk device that lacks an appropriate predicate as a Class&#160;I or Class&#160;II device. The de novo process typically requires the development of clinical data and usually takes between six to twelve months from the time of submission of the de novo application, but it can take longer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">For tests that are subject to FDA or EU regulation, if we do not comply with FDA or EMA regulatory requirements, we may be subject to enforcement action, with severe consequences for our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">After approval, devices subject to FDA or EMA regulation are required to comply with post-market requirements. Among the requirements, we and our suppliers must comply with the FDA&#8217;s Quality System Regulations (&#8220;QSRs&#8221;), which set forth requirements for the design and manufacture of devices, including the methods and documentation for the design, control testing, quality assurance, labeling, packaging, storage, and shipping of our devices. Our limited experience in complying with these requirements may lead to operational challenges as we increase the scale of our QSR-compliant operations in the United States and develop and refine our policies and procedures for evaluating and mitigating issues we encounter with our processes. Further, if there are any modifications made to the manufacturing of our PMA-approved marketed solutions, a PMA supplement may be required to be submitted to, and approved by, the FDA before the modified device may be marketed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other post-market requirements include the reporting of adverse events and malfunctions of which we become aware within the prescribed time frame to the FDA, post-approval studies, establishment registration and device listing, and restrictions on advertising and promotion. We may fail to meet these requirements, which could subject our business to further regulatory risks and costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The FDA enforces the post-market requirements of the FDC Act through announced and unannounced inspections. Failure to comply with applicable regulatory requirements could require us to expend time and resources to respond to the FDA&#8217;s observations and to implement corrective and preventive actions, as appropriate. If we cannot resolve such issues to the satisfaction of the FDA, we may be subject to enforcement actions, including untitled or warning letters, fines, injunctions, or civil or criminal penalties. In addition, we could be subject to a recall or seizure of current or future solutions, operating restrictions, a partial suspension, or a total shutdown of service. Any such enforcement action would have a material adverse effect on our business, financial condition, and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">In the future, we may fail to achieve coverage or adequate reimbursement for our products and solutions by commercial third-party payors or government payors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As we expand our operations globally, and in particular to the United States, sales of our existing and any future products and solutions we develop, in particular our diagnostic testing services, in the future may depend upon the availability of adequate reimbursement from third-party payors. These third-party payors include government healthcare programs and/or statutory health insurance schemes in various markets, such as Medicare and Medicaid in the United States and statutory health funds in Germany (the &#8220;GKV&#8221;), managed care providers, accountable care organizations, private health insurers, and other organizations. We believe that obtaining a positive Medicare Local Coverage Determination, or National Coverage Determination and a favorable Medicare reimbursement rate, and obtaining the agreement of established commercial third-party payors to provide coverage and adequate payment, for each of our existing diagnostic testing services, and any future products and solutions we develop, will be an important element in achieving material commercial success in the United States. Physicians may not order our products and solutions unless commercial third-party payors and government payors authorize coverage and pay for all, or a substantial portion, of the rates established for our products and solutions.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Commercial third-party payors and government payors internationally increasingly attempt to contain healthcare costs by lowering reimbursement rates, limiting coverage of diagnostic test services, and creating conditions of reimbursement, such as requiring participation in clinical evidence development involving research studies and the collection of physician decision impact and patient outcomes data. As a result of these cost-containment trends, commercial third-party payors and government payors that currently provide, or in the future may provide, reimbursement for one or more of our services may propose and/or actually reduce, suspend, revoke, or discontinue payments or coverage at any time. Payors may also create conditions for coverage or may contract with third-party vendors to manage laboratory benefits, in both cases creating administrative hurdles for ordering physicians and patients that may make our products and solutions more difficult to sell. The percentage of submitted claims that are ultimately paid, the length of time to receive payment on claims, and the average reimbursement of those paid claims is likely to vary from period to period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">There is significant uncertainty surrounding whether the use of diagnostic tests that incorporate new technology will be eligible for coverage by commercial third-party payors and government payors or, if eligible for coverage, what the reimbursement rates will be for these services. In Germany, the majority of patients are insured via the GKV. The benefit catalogue defining which services in medical care are reimbursed by the GKV is specified by the directives of the Federal Joint Committee as the highest decision-making body of the joint self-government of physicians, dentists, hospitals and health insurance funds in Germany. The fact that a diagnostic test has been approved for reimbursement in the past, has received approval from the FDA or has been certified by a notified body, or has obtained coverage for any particular rare disease indication or in any particular jurisdiction, does not guarantee that such diagnostic service will remain covered and/or reimbursed or that similar or additional diagnostic tests and/or related rare disease types will be covered and/or reimbursed in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As a result, if adequate third-party coverage and reimbursement are unavailable, we may not be able to maintain volume and price levels sufficient to realize an appropriate return on investment in our diagnostic testing services or to advance our research and development solutions for our pharmaceutical partners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We cannot predict what future healthcare initiatives will be introduced or implemented in the jurisdictions in which we operate, or how any future legislation or regulation may affect us. Any taxes imposed by legislation, as well as changes to the reimbursement amounts paid by payors for our existing and future products and solutions, could have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Intellectual Property Risks Related to Our Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we are unable to obtain and maintain patent and other intellectual property protection for any products or solutions we develop and for our technology, or if the scope of intellectual property protection obtained is not sufficient, our competitors could develop and commercialize products and solutions similar or identical to ours, and our ability to successfully commercialize any products or solutions we may develop may be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our success depends in large part on our ability to obtain and maintain patent and other intellectual property protection in the United States and other countries for our biomarkers and other products and solutions. Patent law relating to the scope of claims in the fields in which we operate is complex and uncertain, so we cannot make any assurances that we will be able to obtain or maintain patent or other intellectual property rights, or that the patent and other intellectual property rights we may obtain will be valuable, provide an effective barrier to competitors or otherwise provide competitive advantages. In particular, our Lyso-Gb3 biomarker, which we use to support the diagnosis of Fabry disease, is not protected by any patents or included in any pending patent applications, and its successful commercialization by one of our competitors or by other third parties, which, in all probability, we would not be able to prevent, could materially harm our business or results of operations. Moreover, patent applications that we have made in the past have been subject to comment and revision by the relevant patent offices, which have resulted in our withdrawal of certain patent applications. If we are unable to obtain or maintain patent or other intellectual property protection with respect to our proprietary products and solutions, our business, financial condition, results of operations, and prospects could be materially harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The scope of patent protection is uncertain. Changes in either the patent laws or their interpretation in the United States and other countries may diminish our ability to protect our inventions, obtain, maintain, and enforce our intellectual property rights and, more generally, could affect the value of our intellectual property or narrow the scope of our patents. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The patent prosecution process is expensive, time-consuming, and complex, and we may not be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output in time to obtain patent protection. Parties who have access to confidential or patentable aspects of our research and development output, such as our management and employees, advisors, and other third parties, and who are party to non-disclosure and confidentiality agreements with us, may breach such agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection, or might themselves file respective IP rights. In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&#160;months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The patent position of companies in our industry generally is unsettled, involves complex legal and factual questions, and has been the subject of much litigation in recent years. As a result, the issuance, scope, validity, enforceability, and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued that protect our products or solutions or which effectively prevent others from commercializing competitive products and solutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Moreover, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Even if patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise provide us with any competitive advantage. Any patents that we hold may be challenged, narrowed, circumvented, or invalidated by third parties. In particular, for more information regarding U.S. patent law decisions that negatively impact the patentability of biomarkers, diagnostic products and diagnostic methods, and the validity of granted U.S. patents covering such subject matter, see &#8220;&#8212;Developments in patent law could have a negative impact on our business&#8221; below. Consequently, we do not know whether any of our biomarkers or other products and solutions will be protectable or remain protected by valid and enforceable patents. Our competitors or other third parties may be able to circumvent our patents by developing similar or alternative products and solutions in a non-infringing manner. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we are unable to protect the confidentiality of our trade secrets, know-how, and other confidential and proprietary information, our business and competitive position would be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In addition to seeking patent protection for our products and solutions, we also rely upon trade secret protection and non-disclosure agreements and invention assignment agreements with our management and employees, consultants and other third parties to protect our unpatented know-how, technology, and other confidential or proprietary information. For example, significant elements of our proprietary platform and some of our tests, including aspects of sample preparation, computational-biological algorithms, and related processes and software, are based on unpatented trade secrets and know-how that to our knowledge are not publicly disclosed. In addition to contractual measures, we try to protect the confidential nature of our proprietary information using physical and technological security measures. Such measures may not provide adequate protection for our proprietary information; for example, in the case of misappropriation of intellectual rights by a member of management, an employee, consultant, or other third party with authorized access. We also cannot rule out the possibility that third parties specifically try to obtain our know-how, trade secrets or other confidential and proprietary information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#0000ff;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Trade secrets and know-how can be difficult to protect. We cannot guarantee that we have entered into applicable non-disclosure agreements and invention assignment agreements with our management and employees, consultants and other third parties who have had access to our trade secrets or other proprietary information. Our security and contractual measures may not prevent a member of management, an employee, consultant, or other third party from misappropriating our trade secrets and providing them to a competitor, other third parties or to the public, and any recourse we take against such misconduct, including litigation, may not provide an adequate remedy to protect our interests fully. Enforcing a claim that a party illegally disclosed or misappropriated intellectual property can be difficult, expensive, and time-consuming, and the outcome is unpredictable. Due to variation in the degree of protection afforded to intellectual property of this nature under the laws and regulations applicable to different international markets where our services are sold, our ability to pursue and obtain an adequate remedy may depend significantly on the jurisdiction in which the misconduct takes place and our ability to enforce a favorable judgment against the offending party in a jurisdiction in which such party has substantial assets. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information were independently developed by a competitor, our competitive position could be harmed.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk66547348"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Patents covering our products or solutions could be found invalid or unenforceable if challenged</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The issuance of a patent is not conclusive as to its inventorship, scope, validity, or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. Others have filed, and in the future are likely to file, patent applications or related intellectual property rights that are similar or identical to ours. To determine the priority of inventions, demonstrate that we did not derive our invention from another individual or entity, or defend third-party challenges or reservations of the granting authorities to the validity or enforceability of our patent rights, we may have to participate in opposition, derivation, revocation, reexamination, entitlement, post-grant and <i style="font-style:italic;">inter partes</i> review, or interference proceedings at the U.S. Patent and Trademark Office (the &#8220;USPTO&#8221;) or similar offices or respective courts in Europe or other jurisdictions. For example, we are aware of an opposition proceeding filed at the European Patent Office (&#8220;EPO&#8221;) by Sanofi against EP Patent No.&#160;2&#160;718&#160;725 B1 (the &#8220;725 Patent&#8221;), a European patent that we own relating to our biomarker for Gaucher disease. The EPO opposition proceeding challenges the patentability of the &#8216;725 Patent in its entirety. The EPO rejected the opposition in the first instance in the hearing held on February&#160;4, 2020. Sanofi filed an appeal against the opposition decision to the Board of Appeal at the EPO and the &#8216;725 Patent may still be revoked or maintained in amended form, in whole or in part, if the Board of Appeal does not uphold the opposition decision. Revoking the &#8216;725 Patent may limit our ability to stop others from using or commercializing similar or identical products and solutions to ours, or limit the duration of the patent protection of our products and solutions. We are also aware of an opposition proceeding filed at the European Patent Office (&#8220;EPO&#8221;) by Sanofi against EP Patent No.&#160;3 318 881 B1 (the &#8220;881 Patent&#8221;) on April 15, 2021, another European patent that we own relating to our biomarker for Gaucher disease. The EPO opposition proceeding challenges the patentability of the &#8216;881 Patent in its entirety. Oral proceedings concerning the European patent will take place before the opposition division of the EPO on May 04, 2022. The &#39;881 Patent may be revoked or maintained in amended form, in whole or in part, which could materially harm our business. Should the &#39;881 Patent be revoked or maintained in amended form, we would have the right to appeal against the decision of the Opposition Division. However, the outcome of the appeal is unclear. Revoking the &#8216;881 Patent may limit our ability to stop others from using or commercializing similar or identical products and solutions to ours, or limit the duration of the patent protection of our products and solutions. See &#8220;Item&#160;4. Information On The Company&#8212;B. Business Overview&#8212;Legal Proceedings&#8221; and &#8220;Item&#160;8. Financial Information&#8212;A. Consolidated Statements and Other Financial Information&#8212;Legal Proceedings.&#8221; Sanofi or other third parties may file future oppositions or other challenges, in Europe or other jurisdictions, against other patents that we own and may also challenge or attack the validity of the national parts of the &#8216;725 Patent and/or the &#39;881 Patent before national patent courts in parallel or after the proceedings before the EPO. An adverse determination in any such proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our products or solutions and compete directly with us, without payment to us. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">It is expected that actions will also be possible before the new European Unified Patent Court from the second half of 2022. If we do not actively exclude our existing (European patent applications as well as granted) European patents from this system (&#8220;opt-out&#8221;), they will become part of this new court system and it will be possible for third parties to challenge these patents before the courts of the Unified Patent Court system, with the consequence that these patents can then be restricted or revoked for the territory of all EU Member States participating in the Unitary Patent Court system (at the time of February 2022, these are Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Slovenia, Sweden; other countries may be added in the future, in particular Cyprus, Czech Republic, Greece, Hungary, Ireland, Romania and Slovakia) for which the European patent has effect. The same applies for future European patents and patent applications that are not opted out of the Unified Patent Court system, which is possible for a period of seven years after the date of entry into force of the Agreement on a Unified Patent Court unless an action has already been brought before the Unified Patent Court system in respect of the European patent or patent application. For future European patent applications it also has to be decided whether a request for unitary effect is submitted with the consequence that the patent if grantable will be granted as Unitary Patent and can therefore be challenged before the Unified Patent Court and be restricted or revoked for the territory of all EU Member States participating in the Unitary Patent Court system. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Moreover, we may have to participate in interference proceedings declared by the USPTO to determine priority of invention or in post-grant challenge proceedings, such as oppositions in a foreign patent office or nullity or entitlement proceedings, that challenge priority of invention or other features of patentability. Such challenges may result in loss of patent rights, loss of exclusivity, or in patents being cancelled, narrowed, amended, invalidated, revoked or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical products and solutions, or limit the duration of the patent protection of our products and solutions. Such proceedings could also result in substantial costs in legal fees and require significant time from our management and employees, even if the eventual outcome is favorable to us. In the event of entitlement proceedings, purported co-inventors may bring claims for ownership, co-ownership, compensation and/or damages. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common shares. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, if we initiate legal proceedings against a third party to enforce a patent covering our products or solutions, the defendant could counterclaim that such patent is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. In other jurisdictions, defendants have and/or may have comparable grounds for defending against such claims, especially with regard to claims that a patent is invalid. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art of which we and the patent examiner were unaware during prosecution or that a court or office dealing with the invalidity will judge prior art known to us to be detrimental to novelty in a manner deviating from our opinion and/or the opinion of the granting authority, or will consider the invention to be obvious and thus not protectable on the basis of such prior art. Such challenges could result in the revocation of, cancellation of, or amendment to our patents in such a way that they no longer sufficiently cover our products and solutions. If a third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our products or solutions. Such a loss of patent protection would materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Litigation or other proceedings or third-party claims of intellectual property infringement could require us to spend significant time and money and could prevent us from selling our products and solutions or impact our share price. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our commercial success depends upon our ability to develop and commercialize products and solutions and use our proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property and proprietary rights of third parties. We could become party to, or threatened with, adversarial proceedings or litigation regarding intellectual property rights with respect to our technology and any products or solutions we may develop, including interference proceedings, post-grant review, <i style="font-style:italic;">inter partes</i> review, and derivation proceedings before the USPTO and similar proceedings in foreign jurisdictions, such as oppositions before the EPO or nullity or entitlement proceedings. Third parties may assert infringement and other claims against us based on existing patents or patents that may be granted in the future, regardless of their merit, and we may assert infringement and other claims against third parties. As we continue to commercialize our genetic rare disease information solutions (including our biomarkers), launch new solutions and enter new markets, we expect that competitors will claim that our products or solutions infringe or otherwise violate their intellectual property rights, including as part of business strategies designed to impede our successful commercialization and entry into new markets. Third parties may have obtained, and may in the future obtain, patents under which such third parties may claim that the use of our technologies constitutes patent infringement. Third parties have in the past asserted and may in the future assert that we are employing their proprietary technology without authorization, and we occasionally receive letters from third parties inviting us to take licenses under, or alleging that we infringe, their patents. Depending upon the circumstances, we may elect to remove a particular biomarker from one of our products or solutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Even if we believe that third-party intellectual property claims are without merit, there is no assurance that a court would find in our favor on questions of infringement, validity, enforceability, or priority. A court of competent jurisdiction could hold that these third-party patents are valid, enforceable, and infringed, which could materially and adversely affect our ability to commercialize any products or solutions we may develop or have developed. In order to successfully challenge the validity of any such U.S. patent in federal court or in courts in other jurisdictions, we would need to overcome a presumption of validity. As this burden is a high one, requiring us to present clear and convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. The same applies to other jurisdictions. Even if we were to find prior art that could justify the invalidation of the intellectual property right under which we are attacked, because of the bifurcated system dealing with infringement and validity before different courts in some jurisdictions (e.g. Germany), we may first be injuncted for infringement of the intellectual property right, which may be corrected only after subsequent invalidation of the intellectual property right. If we are found to infringe a third party&#8217;s intellectual property rights, and we are unsuccessful in demonstrating that such patents are invalid or unenforceable, we could be required to obtain a license from such third party to continue commercializing our products or solutions. However, we may not be able to obtain any required license on commercially reasonable terms, or at all and therefore may be unable to develop, sell or otherwise commercialize our products or solutions. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing, royalty and other payments. Furthermore, parties making claims against us may be able to obtain injunctive or other relief, which could block our ability to develop, commercialize, and sell our products and solutions, and could result in the award of substantial damages against us. In the event of a successful claim of infringement, misappropriation or other intellectual property violation against us, we may be required to render account for and pay damages and attorneys&#8217; fees, recall or destroy stocks and obtain one or more licenses from third parties, or be prohibited from developing, commercializing and selling certain products or solutions. In addition, we could be found liable for significant monetary </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">damages, including treble damages and attorneys&#8217; fees, if we are found to have willfully infringed a patent or other intellectual property right.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The new European Unified Patent Court system, which is expected to start at late 2022, will allow the patent owner to obtain injunctive relief with unitary effect, i.e. within the territories of the EU Member States participating in the Agreement on a Unified Patent Court including e.g. claims for damages, compensation, recall, destruction and information with regard to its Unitary Patents. For European patents not taken out of the Unified Patent Court system by &#8220;opt-out&#8221;, decisions of the courts of the Unified Patent Court system cover the territory of the EU Member States participating in the Agreement on a Unified Patent Court for which the European patent has effect. This may result in the loss of significant market opportunities and substantial adverse effects of a judgement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our shares. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. We also could incur substantial costs and divert the attention of our management and other employees in participating in litigation or proceedings of this nature, and an adverse ruling or perception of an adverse ruling in could have a material adverse impact on our cash position and share price. Any of the foregoing could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Obtaining and maintaining a patent portfolio entails significant expense and resources. Part of the expense includes periodic maintenance fees, renewal fees, annuity fees and various other governmental fees associated with patents and patent applications due in several stages over the lifetime of patents and patent applications. The USPTO and various non-U.S. government agencies require compliance with several procedural, documentary, fee payment, and other similar provisions during the patent application process. We may or may not choose to pursue or maintain protection for particular inventions. In addition, there are situations in which failure to make certain payments or noncompliance with certain requirements in the patent process can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. If we choose to forego patent protection or allow a patent application or patent or other intellectual property right to lapse purposefully or inadvertently, our competitive position could suffer. In such an event, potential competitors might be able to enter the market with similar or identical products and solutions. If we fail to obtain, maintain, protect or enforce our intellectual property rights successfully, our competitive position could suffer. Any of the foregoing could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our rights to develop and commercialize our technology, products and solutions may in the future be subject, in part, to the terms and conditions of licenses granted to us by others. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In connection with the development of new products and solutions we may license intellectual property from third parties in the future, or may deem it necessary to do so in order to commercialize our products or solutions. We may be unable to obtain these licenses at a reasonable cost, or at all. We could, therefore, incur substantial costs related to royalty payments or other payments for licenses obtained from third parties. We may also be unable to obtain exclusive rights to use such intellectual property or technology in all relevant fields of use and in all territories in which we may wish to develop or commercialize our products and solutions in the future and, as a result, we may not be able to prevent competitors from developing and commercializing competitive products or solutions. Moreover, we could encounter delays in introducing new products or solutions while we attempt to develop alternative products and solutions, and the defense of any lawsuit or failure to obtain any of these licenses on favorable terms could prevent us from commercializing our products and solutions, which would materially affect our ability to grow.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our licensors might conclude that we have materially breached our license agreements and might therefore terminate the license agreements, thereby removing our ability to develop and commercialize products and solutions covered by such agreements. License agreements could also be time-limited or terminated when possible. If these in-licenses are terminated, or if the underlying patents fail to provide the intended exclusivity, competitors might have the freedom to market competing products and solutions identical or similar to ours. Disputes may arise regarding intellectual property subject to a licensing agreement, including:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the scope of rights granted under the license agreement and other interpretation-related issues; as well as the effectiveness of the license agreement in general;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the extent to which our products and solutions infringe on intellectual property of the licensor that is not subject to the licensing agreement;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the sublicensing of patent and other rights under our collaborative development relationships;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our diligence obligations under the license agreement and what activities satisfy those diligence obligations;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">which royalties payments are owed;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our partners, including the question of bearing the costs; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the priority of invention of patented technology.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, agreements under which we license intellectual property or technology from third parties could be complex and turn out to be invalid in whole or in part. Certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement. Moreover, if disputes over intellectual property or technology that we have licensed prevent or impair our ability to maintain other licensing arrangements on commercially acceptable terms, defending our position could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">With regard to the expected start of the Unified Patent Court in the late second half of 2022, it should be noted that this is a completely new court system, whose procedural and adjudicative methods as well as the mutual effects between the national European patent jurisdictions and the jurisdiction of the new system are practically impossible to assess at present. This creates an uncertainty that may harm our business, prospects, financial condition and results of operations because decisions may be issued and case law may develop that is disadvantageous for us. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Developments in patent law could have a negative impact on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Changes in either the patent laws or interpretation of patent laws could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. From time to time, the United States Supreme Court (the &#8220;Supreme Court&#8221;), other federal courts, the U.S. Congress, the USPTO, or other foreign patent offices, courts or legislators may change the standards of patentability and any such changes could have a negative impact on our business. Assuming that other requirements for patentability are met, prior to March 2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file&#160;a patent application was entitled to the patent. After March 2013, under the Leahy-Smith America Invents Act (the &#8220;America Invents Act&#8221;), enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file&#160;a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. The America Invents Act also includes a number of significant changes that affect the way patent applications will be prosecuted and also may affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO-administered post-grant proceedings, including post-grant review, <i style="font-style:italic;">inter partes</i> review, and derivation proceedings. However, the America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, the patent positions of companies in our industry are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. For example, diagnostic method claims and &#8220;gene patents&#8221; were considered in two landmark Supreme Court cases, <i style="font-style:italic;">Mayo Collaborative v. Prometheus Laboratories</i> (&#8220;Prometheus&#8221;), and <i style="font-style:italic;">Association for Molecular Pathology v. Myriad Genetics</i> (&#8220;Myriad&#8221;). In Prometheus, a case involving patent claims over a medical testing method directed to optimizing the amount of drug administered to a specific patient, Prometheus&#8217; claims failed to incorporate sufficient inventive content above and beyond merely describing underlying natural correlations to allow the claimed processes to qualify as patent-eligible processes that apply natural laws. In Myriad, a case brought by multiple plaintiffs challenging the validity of patent claims held by Myriad Genetics,&#160;Inc. relating to the breast cancer susceptibility genes BRCA1 and BRCA2, the court held that isolated genomic DNA that exists in nature, such as the DNA constituting the BRCA1 and BRCA2 genes, is not patentable subject matter, but that cDNA, which is an artificial construct created from RNA transcripts of genes, may be patent eligible. The Federal Circuit has begun to apply the holdings in Prometheus and Myriad. In 2015, the Federal Circuit, in <i style="font-style:italic;">Ariosa v. Sequenom</i>, applying Prometheus, found claims to a prenatal diagnostic method that relied on a natural product to be patent ineligible, and clarified that the absence of preemption of a natural phenomenon was not sufficient to demonstrate patent eligibility.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In response to the Supreme Court decisions in Prometheus, Myriad, and <i style="font-style:italic;">Alice Corporation Pty.&#160;Ltd. v. CLS Bank International</i> (&#8220;Alice Corp.&#8221;), and others, the USPTO has updated the Manual of Patent Examination Procedure to provide guidance to USPTO personnel in determining the eligibility of patent claims reciting judicially recognized exceptions to patentable subject matter, including laws of nature, natural phenomena, or abstract ideas, for patent eligibility. The USPTO guidance indicates that claims reciting a judicial exception to patent-eligible subject matter must amount to significantly more than the judicial exception itself in order to be patent-eligible subject matter. We cannot assure you that our efforts to seek patent protection for our products and solutions will not be negatively impacted by this interim guidance issued by the USPTO, the decisions described above, rulings in other cases, or changes in guidance or procedures issued by the USPTO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We cannot fully predict what impact the Supreme Court&#8217;s decisions in Prometheus, Myriad, Alice Corp., and other decisions may have on our ability or the ability of companies or other entities to obtain or enforce patents relating to DNA, genes, or genomic-related discoveries in the future. Despite the USPTO&#8217;s interim guidance and Federal Circuit cases described above, the contours of when claims reciting laws of nature, natural phenomena, or abstract ideas may meet the patent eligibility requirements are not clear and may take years to develop via interpretation at the USPTO and in the courts. There are many previously issued patents claiming nucleic acids and diagnostic methods based on natural correlations that issued before the recent Supreme Court decisions discussed, and although many of these patents may be invalid under the standards set forth in the Supreme Court&#8217;s recent decisions, until successfully challenged, these patents are presumed valid and enforceable, and certain third parties could allege that we infringe, or request that we obtain a license to, these patents. Whether based on patents issued prior to or after these Supreme Court decisions, we might have to defend ourselves against claims of patent infringement, or choose to license rights, if available, under patents claiming such methods. In particular, although the Supreme Court has held in Myriad that isolated genomic DNA is not patent-eligible subject matter, certain third parties could allege that activities that we may undertake infringe other classes of gene-related patent claims, and we could have to defend ourselves against these claims by asserting non-infringement and/or invalidity positions, or pay to obtain a license to these claims. In any of the foregoing or in other situations involving third-party intellectual property rights, if we are unsuccessful in defending against claims of patent infringement, we could be forced to pay damages or be subjected to an injunction that would prevent us from utilizing the patented subject matter in question if we are unable to obtain a license on reasonable terms or at all. Such outcomes could materially affect our ability to offer our products and solutions and have a material adverse impact on our business. Even if we are able to obtain a license or successfully defend against claims of patent infringement, the cost and distraction associated with the defense or settlement of these claims could have a material adverse impact on our business. Any of the foregoing could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may not be able to enforce our intellectual property rights throughout the world.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. Accordingly, we may face an increased risk in these jurisdictions that unauthorized parties may attempt to copy or otherwise obtain or use our patented technology, trademarks, formulations or other intellectual property. The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of Germany or the United States. Specifically, the legal systems of some countries, particularly developing countries, do not favor the enforcement of patents and other intellectual property protection, especially those relating to biotechnology. This could make it difficult for us to stop the infringement of our patents or other intellectual property rights and to prevent third parties from selling or importing products made using our inventions in and to the United States, Germany or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent or other protection to develop their own products and, further, may export otherwise infringing products to territories </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">where we have patent protection but enforcement is not as strong as that in Germany or the United States. These products may compete with our products and solutions, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. In addition, the use of our patents and/or other intellectual property rights may be permitted in individual cases because, for example, prior use rights or other privileges exist, such as e.g. use of the patents for experimental or research purposes. Additionally, many countries have compulsory licensing laws under which a patent owner must grant licenses to third parties or limit the enforceability of patents against third parties, including government agencies or government contractors. In these countries, patents may provide limited or no benefit. Patent protection must ultimately be sought on a country-by-country basis, which is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain countries, and we will not have the benefit of patent protection in such countries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Monitoring infringement and misappropriation of intellectual property can be difficult and expensive, and we may not be able to detect every instance of infringement or misappropriation of our proprietary rights. Even if we do detect infringement or misappropriation of our proprietary rights, proceedings to enforce our intellectual property rights could result in substantial costs, divert the efforts and attention of our employees and management from other aspects of our business, put our patents at risk of being invalidated or construed narrowly or provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop. In addition, changes in the law and legal decisions by courts in Germany, the United States and other jurisdictions, in particular, the newly formed European Unified Patent Court, may affect our ability to obtain adequate protection for our products and solutions and to enforce our intellectual property rights. Any of the foregoing could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Third parties may assert ownership or commercial rights to inventions we develop.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Third parties may in the future make claims challenging the inventorship or ownership of our intellectual property. For example, we rely on certain third parties to provide us with biological materials that we use to conduct our genomic analyses. We have written agreements with collaborators that provide for the ownership of intellectual property arising from our collaborations. These agreements provide that we must negotiate certain commercial rights with collaborators with respect to joint inventions or inventions made by our collaborators that arise from the results of the collaboration. In some instances, there may not be adequate written provisions to address clearly the resolution of intellectual property rights that may arise from a collaboration. If we cannot successfully negotiate sufficient ownership and commercial rights to the inventions that result from our use of a third-party collaborator&#8217;s materials where required, or if disputes otherwise arise with respect to the intellectual property developed with the use of a collaborator&#8217;s samples, we may be limited in our ability to capitalize on the market potential of these inventions. In addition, we may face claims that our agreements with our management, employees, contractors, or consultants obligating them to assign intellectual property to us are ineffective, or in conflict with prior or competing contractual obligations of assignment, which could result in ownership disputes regarding intellectual property we have developed or will develop and interfere with our ability to capture the commercial value of such inventions. We cannot exclude the possibility that third parties may claim to have made contributions to our inventions and accordingly claim co-inventor shares in inventions that we believe were made without the participation of third parties. Litigation may be necessary to resolve an ownership dispute, and if we are not successful, we may be precluded from using certain intellectual property, or may lose our exclusive rights in that intellectual property and may even face damages and/or compensation claims of the third party for our use of the intellectual property. Any of the foregoing could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Most of our employees and inventions are subject to German law. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Most of our personnel, including our directors, work in Germany and are subject to German employment law. Inventions which may be the subject of a patent or of protection as a utility model and which are or were made by personnel working in Germany (except for legal representatives of our respective legal entities, for example managing directors) are subject to the provisions of the German Act on Employees&#8217; Inventions (<i style="font-style:italic;">Gesetz &#252;ber Arbeitnehmererfindungen</i>) (the &#8220;German Inventions Act&#8221;), which regulates the ownership of, and compensation for, inventions made by employees. We face the risk that disputes may occur between us and our current or past employees pertaining to the sufficiency of compensation paid by us, allocation of rights to inventions under this Act or alleged non-adherence to the provisions of this Act, any of which may be costly to resolve and take up our management&#8217;s time and efforts whether we prevail or fail in such dispute. In addition, under the German Inventions Act, certain employees retain rights to patents and/or utility models they invented or co-invented and disclosed to us prior to October&#160;1, 2009. If we do not manage to have the respective third-party interests transferred to us or are unable to obtain an exclusive license to any such third-party co-owners&#8217; or owners&#8217; interest in such patents and/or utility models, such co-owners or owners may be able to transfer or license their rights to other </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">third parties, including our competitors. In addition, we may need the cooperation of any such co-owners or owners to enforce any such patents and/or utility models against third parties, or to conclude license agreements regarding such patents and/or utility models with third parties, and such cooperation may not be provided to us. While we believe that all of our current and past German employee inventors have subsequently assigned to us their interest in inventions, patents and/or utility models they invented or co-invented, there can be no assurance that all such assignments are fully effective, which can lead to unexpected costs or economic disadvantages. Even if we lawfully own all inventions created by our employees who are subject to the German Inventions Act, we are required under German law to reasonably compensate such employees for the use of the inventions and intellectual property rights related thereto. If we are required to pay compensation or face other disputes under the German Inventions Act, our results of operations could be adversely affected. Legal representatives of legal entities, for example managing directors, whose contractual relationships with the respective entity are subject to German law and that are not subject to the German Inventions Act as well as consultants must assign and transfer their interest in inventions, patents and/or utility models they invent or co-invent to us in order for us to have any rights to such inventions, patents and/or utility models. While we believe that all assignments have been made, there can be no assurance that all such assignments are fully effective, which may harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If any of our current or past employees, legal representatives of our legal entities or consultants obtain or retain ownership or co-ownership of any inventions or related intellectual property rights that we believe we own, we may lose valuable intellectual property rights and be required to acquire the respective third-party interests or to obtain and maintain licenses from such employees or legal representatives of legal entities or consultants to such inventions or intellectual property rights, which may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to acquire the respective third-party interests or to obtain and maintain a license to any such employee&#8217;s, legal representative&#8217;s of legal entities or consultant&#8217;s interest in such inventions or intellectual property rights, we may need to cease the development, manufacture, and commercialization of one or more of the products or solutions we may develop or may have developed. In addition, any loss of exclusivity of our intellectual property rights could limit our ability to stop others from using or commercializing similar or identical products and solutions. We may also face entitlement, compensation and/or damages claims from our current or past employees, legal representatives of our legal entities or consultants owning or co-owning any inventions or related intellectual property rights that we believe we own. Any of the foregoing events could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Many of our employees (including our management) and consultants are currently or were previously employed at universities or other diagnostic or biopharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these individuals have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a current or former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees and/or consultants. Such claims could materially harm our business, prospects, financial condition and result of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, while it is our policy to require our employees (including our management)<span style="font-style:italic;font-weight:bold;"> </span>and consultants who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Intellectual property rights do not necessarily address all potential threats.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">others may be able to make products or solutions that are similar to any products or solutions we develop or commercialize or utilize similar technology but that are not covered by the claims of our patents or patents that we might own or license in the future;</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">we might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own or may own or license in the future, and this may result for example in possible rights to use the invention for the one who first made the invention; and in the invalidity of our patents;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">we might not have been the first to file patent applications covering certain of our inventions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">it is possible that our pending patent applications or those that we may own or license in the future will not lead to issued patents;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our issued patents may be held invalid or unenforceable, including as a result of legal challenges by our competitors;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our customers or competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products or solutions for sale in our major commercial markets;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">we may not develop additional proprietary technologies that are patentable;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the patents of others may harm our business; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">we may choose not to file<span style="font-family:'Symbol';">&#160;</span>a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file<span style="font-family:'Symbol';">&#160;</span>a patent covering such intellectual property.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Should any of these events occur, they could materially harm our business, prospects, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks Relating to Our Financial Condition and Capital Requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We have a history of losses and we may incur losses in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have historically incurred losses, including total comprehensive losses of &#8364;46,309&#160;thousand, &#8364;21,426&#160;thousand and &#8364;20,839&#160;thousand in the years ended December&#160;31, 2021, 2020 and 2019, respectively. We expect our losses to continue as a result of ongoing research and development expenses and increased selling and marketing costs. These losses have had, and will continue to have, an adverse effect on our working capital, total assets, and shareholders&#8217; equity. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our inability to achieve and then maintain profitability would negatively affect our business, financial condition, results of operations, and cash flows. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Failure to meet covenants under any loan facility may limit our liquidity and could result in the lenders accelerating amounts we owe to them under the facility.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We may enter into new debt facilities in the future. The breach of any covenants under these new facilities, if not remedied or waived in time, could result in a default on our obligations and/or cause the acceleration of our outstanding debt by our lenders, which could have a material adverse impact on our business, financial condition, results of operations, cash flows, and the trading price of our securities. If we are not able to repay the loans, this may lead to the commencement of foreclosure or other enforcement actions against any of our assets securing such debt. Even if the bank would waive a covenant breach, we may be subject to an increase of interest rates or margins, respectively, as well as the payment of a waiver fine. Furthermore, the covenants as well as the breach of the covenants may impose restrictions on the way we can operate and may limit our ability to finance our future operations and capital needs and our ability to pursue business activities that may be in our interests.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may need to raise additional capital to fund our existing operations, develop our genetic information platform, commercialize new products and solutions and expand our operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If our available cash balances and anticipated cash flow from operations are insufficient to satisfy our liquidity requirements, including because of lower demand for our products or solutions as a result of other risks described herein, we may seek to sell common or preferred equity or convertible debt securities, enter into another credit facility or another form of third-party funding, or seek other debt financing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our ongoing efforts to expand our business will require substantial cash resources. We may consider raising additional capital in the future to expand our business, to pursue strategic investments, to take advantage of financing opportunities, or for other reasons, including to:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">increase our sales and marketing efforts to drive market adoption of our products and solutions and address competitive developments;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">fund development and marketing efforts of any future products and solutions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">further expand our laboratory operations;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">expand our technologies into other types of diseases;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">obtain, maintain, protect and enforce existing or new intellectual property rights;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">acquire, license or invest in technologies, including information technologies;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">acquire or invest in complementary businesses or assets; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">finance capital expenditures and general and administrative expenses.</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our present and future funding requirements will depend on many factors, including:</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our ability to achieve revenue growth;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the cost of expanding our laboratory operations and offerings, including our sales and marketing efforts;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our rate of progress in, and cost of the sales and marketing activities associated with, establishing adoption of our products and solutions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">our rate of progress in, and cost of research and development activities associated with, products and solutions in research and early development;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the effect of competing technological and market developments;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">costs related to international expansion; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the potential cost of and delays in research and development as a result of any regulatory oversight applicable to our products and solutions.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If we raise funds by issuing debt securities, those debt securities would have rights, preferences, and privileges senior to those of holders of our common shares. The terms of debt securities issued or borrowings pursuant to a credit or similar agreement could impose significant restrictions on our operations. Such financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring debt, making capital expenditures or declaring dividends. If additional funds are raised by issuing equity securities, existing shareholders may suffer significant dilution. If we raise funds through collaborations and licensing arrangements, we might be required to relinquish significant rights to our platform technologies or solutions, or grant licenses on terms that are not favorable to us.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additional equity or debt financing might not be available on reasonable terms or at all. Because of our potential long-term capital requirements, we may access the public or private equity or debt markets whenever conditions are favorable, even if we do not have an immediate need for additional capital at that time. If we cannot secure additional funding when needed, we may have to delay, reduce the scope of, or eliminate one or more research and development programs or sales and marketing initiatives. In addition, we may have to work with a partner on one or more of our development programs, which could lower the economic value of those programs to us. Lastly, if we are unable to obtain the requisite amount of financing needed to fund our planned operations, it could have a material adverse effect on our business and financial position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may be required to refund grants and subsidies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have received various grants and subsidies to fund our research and development programs from various funding organizations. However, the Company continues to engage in efforts to secure further grants and subsidies for the next development steps of its product candidates. Some of these grants and subsidies provide for certain requirements in respect of the utilization of proceeds generated as a result of the publicly sponsored projects. For example, we received grants from the European Regional Development Fund in order to fund our Rostock facility, which grants are limited in purpose to development and innovation in the state of Mecklenburg-Western Pomerania, Germany. Other grants which we obtain may impose restrictions on our operations, and if we are in noncompliance with the restrictions and conditions of any grant or subsidy program, a partly or complete repayment cannot be excluded. This may also apply to grants and subsidies we may apply for in the future. If we are required to refund grants or subsidies, this could have a material adverse effect on our liquidity and cash flow position and may negatively affect our business, prospects and financial conditions. In the year ended December&#160;31, 2021, we have received a total of &#8364;168&#160;thousand in grants for our activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We incur significant costs as a result of operating as a public company and our management needs to devote substantial time to public company compliance programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As a public company, we incur significant legal, accounting, and other expenses due to our compliance with regulations and disclosure obligations applicable to us, including compliance with the Sarbanes-Oxley Act, as well as rules implemented by the SEC, and the Nasdaq Global Market (&#8220;Nasdaq&#8221;). The SEC and other regulatory authorities have continued to adopt new rules and regulations and make additional changes to existing regulations that require our compliance. In July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) was enacted. There are significant corporate governance- and executive compensation-related provisions in the Dodd-Frank Act that have required the SEC to adopt additional rules and regulations in these areas. Shareholder activism, the current political environment, and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact, in ways we cannot currently anticipate, and the manner in which we operate our business. Our management and other personnel will need to devote a substantial amount of time to these compliance programs and the monitoring of public company reporting obligations, and as a result of the new corporate governance- and executive compensation-related rules, regulations, and guidelines prompted by the Dodd-Frank Act, and further regulations and disclosure obligations expected in the future, we will likely need to devote additional time and costs to comply with such rules and regulations. These rules and regulations will cause us to incur significant legal and financial compliance costs and will make certain activities more time-consuming and costly.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To comply with the requirements of being a public company, we may need to undertake various actions, including implementing new internal controls and procedures and hiring new accounting or internal audit staff. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that information required to be disclosed in reports under the Exchange Act is accumulated and communicated to our principal executive and financial officers. Our current controls and any new controls that we develop may become inadequate, and additional material weaknesses in our internal control over financial reporting may be discovered in the future. Any failure to develop or maintain effective controls could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting, which we may be required to include in the periodic reports we file with the SEC under Section&#160;404 of the Sarbanes-Oxley Act, and could harm our operating results, cause us to fail to meet our reporting obligations, or result in a restatement of our prior period financial statements. For example, we identified an error in our statement of comprehensive income for the year ended December 31, 2020 which we have corrected and restated in this filing. In the event that we are not able to demonstrate compliance with the Sarbanes-Oxley Act, that our internal control over financial reporting is perceived as inadequate, or that we are unable to produce timely or accurate financial statements, investors may lose confidence in our operating results, and the price of our common shares could decline.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are required to comply with certain of the SEC rules that implement Section&#160;404 of the Sarbanes-Oxley Act, which requires management to certify financial and other information in our annual reports and provide an annual management report on the effectiveness of our internal control over financial reporting, commencing with this, our second annual report. This assessment includes the disclosure of any material weaknesses in our internal control over financial reporting identified by our management or our independent registered public accounting firm. During the evaluation and testing process, if we identify one or more material weaknesses in our internal control over financial reporting or if we are unable to complete our evaluation, testing, and any required remediation in a timely fashion, we will be unable to assert that our internal control over financial reporting is effective. For further details, see &#8220;Item 15 &#8211; Controls and Procedures&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our independent registered public accounting firm will not be required to formally attest to the effectiveness of our internal control over financial reporting until the first annual report required to be filed with the SEC following the date we are no longer an &#8220;emerging growth company&#8221; as defined in the JOBS Act. We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal controls in the future. If we are unable to assert that our internal control over financial reporting is effective, or if our independent registered public accounting firm is unable to express an opinion on the effectiveness of our internal control over financial reporting, we could lose investor confidence in the accuracy and completeness of our financial reports, which could have a material adverse effect on the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we fail to implement effective internal controls over financial reporting, such failure could result in material misstatements in our financial statements, cause investors to lose confidence in our reported financial and other public information and have a negative effect on the trading price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. Section&#160;404 of the Sarbanes-Oxley Act of 2002 requires management of public companies to develop and implement internal controls over financial reporting and evaluate the effectiveness thereof. If we fail to design and operate effective internal controls or remediate our existing material weaknesses, it could result in material misstatements in our financial statements, impair our ability to raise revenue, result in the loss of investor confidence in the reliability of our financial statements and subject us to regulatory scrutiny and sanctions, which in turn could harm the market value of our common shares.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We will be required to disclose changes made in our internal controls and procedures and our management will be required to assess the effectiveness of these controls annually. However, for as long as we are an &#8220;emerging growth company&#8221; under the JOBS Act, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section&#160;404. We could be an &#8220;emerging growth company&#8221; for up to five years after our initial public offering. An independent assessment of the effectiveness of our internal controls could detect problems that our management&#8217;s assessment might not. Undetected material weaknesses in our internal controls could lead to financial statement restatements and require us to incur the expense of remediation.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We have identified two material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future that may cause us to fail to meet our reporting obligations or result in material misstatements of our financial statements. If we fail to remediate our material weaknesses or if we fail to establish and maintain an effective system of internal control over financial reporting, we may not be able to report our financial results accurately or to prevent fraud.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. Section&#160;404 of the Sarbanes-Oxley Act of 2002 requires management of public companies to develop and implement internal controls over financial reporting and evaluate the effectiveness thereof. A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis.</p><a id="_Hlk99569940"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In connection with the preparation of our unaudited interim condensed consolidated financial statements as of and for the nine month period ended September&#160;30, 2018, we identified a material weakness in our internal controls as of December&#160;31, 2017, related to the lack of effectively designed review controls over judgmental and complex areas of the financial statement close process and a lack of effectively designed routine financial statement close process controls. The material weakness was not fully remediated as of December&#160;31, 2021 and now relates to a lack of effectively designed review and monitoring financial statement close process controls, including the ability of our business to timely and appropriately communicate unexpected or new transactions to the finance function and the lack of timely and appropriate assessment of the related accounting implications of these transactions; and a lack of an effectively designed and complete general IT controls framework (including system interfaces).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In response to such material weaknesses, management hired additional senior accounting and financial professionals with the experience and knowledge necessary to supervise the financial statement closing process and review the accounting records and necessary adjustments. An additional experienced professional was also engaged to begin establishing and implementing relevant internal control procedures to address the material weaknesses identified. At the end of 2021, we completed an optimization of our accounting system and we commenced automation of certain control activities and report functionality. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Further improvement of the internal control environment of our key accounting processes was limited during 2021 due to the COVID-19 pandemic which resulted in an increase in business activities that required our focus. During 2021, we performed risk assessments to identify relevant financial risks, significant business processes and are designing and implementing a formalized SOX based framework for internal control. We designed and formalized policies and procedures to ensure routine transactions and complex areas of the financial statement close process are sufficiently analyzed and assessed against the requirements of IFRS and our corporate governance standards. In the year ending December&#160;31, 2022, we intend to finalize the design and implementation of our internal control framework. Although we are working to remediate the material weaknesses as quickly and efficiently as possible, we cannot reliably estimate the duration that will be required to effectively remediate the material weaknesses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If we are unable to successfully remediate our identified material weaknesses, if we discover additional material weaknesses or if we otherwise are unable to report our financial statements accurately or in a timely manner, we would be required to continue disclosing such material weaknesses in future filings with the SEC, which could adversely affect our business, investor confidence in our company and the market price of our common shares and could subject us to litigation or regulatory enforcement actions. As a result, shareholders could lose confidence in our financial and other public reporting, which would harm our business and the market value of our common shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Raising additional capital may cause dilution to our shareholders, restrict our operations or require us to relinquish rights to our technologies or drug candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors on January 31, 2022, we received &#8364; 15.0 million as consideration for the issuance by us of an aggregate of 4,479,088 common shares at a price per share of USD 3.73 and warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To the extent that we choose or need to raise additional capital through the sale of common shares or securities convertible or exchangeable into common shares, the ownership interest of our shareholders may be further diluted, and the terms of any such securities may include liquidation or other preferences that materially adversely affect the rights of our common shareholders.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">45</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, the Company and certain of its subsidiaries entered into a debt financing agreement in the total amount of up to USD 45.0 million on January 31, 2022 (the &#8220;Loan Facility&#8221;). The Loan Facility contains customary affirmative covenants, negative covenants and events of default, including covenants and restrictions that, among other things, require the Company to satisfy a financial covenant, restrict the Company&#8217;s ability to transfer cash to its subsidiaries and, in certain circumstances, restrict the Company&#8217;s ability to incur liens, incur additional indebtedness, engage in mergers and acquisitions, make distributions or make asset sales without the prior written consent of the lenders thereunder. Additional debt financing, if available, would further increase our fixed payment obligations and may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If we raise funds through additional collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our intellectual property, future revenue streams, research programs or drug candidates or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our drug development or future commercialization efforts or grant rights to develop and market drug candidates that we would otherwise prefer to develop and market ourselves.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our results of operations could be materially adversely affected by fluctuations in foreign currency exchange rates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Although we report our results of operations in euro, not all of our net revenues are denominated in the euro. Unfavorable fluctuations in foreign currency exchange rates could have a material adverse effect on our results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Because our consolidated financial statements are presented in euro, we must translate revenues, expenses and income, as well as assets and liabilities, into euros at exchange rates in effect during or at the end of each reporting period. Therefore, changes in the value of the euro against other currencies will affect our net revenues, operating income and the value of balance-sheet items originally denominated in other currencies. These changes cause our growth in consolidated earnings stated in euro to be higher or lower than our growth in local currency when compared against other periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As we continue to leverage our global delivery model, more of our expenses are incurred in currencies other than those in which we bill for the related services. An increase in the value of certain currencies against the euro could increase costs for delivery of services at off-shore sites by increasing labor and other costs that are denominated in local currency. There can be no assurance that our contractual provisions will offset their impact, or that our currency hedging activities, which are designed to partially offset this impact, will be successful. In addition, our currency hedging activities are themselves subject to risk. These include risks related to counterparty performance under hedging contracts and risks related to currency fluctuations. We also face risks that extreme economic conditions, political instability or hostilities or disasters of the type described below could impact our underlying exposures, perhaps eliminating them. Such an event could lead to losses being recognized on the currency hedges then in place, not offset by anticipated changes in the underlying hedge exposure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Certain Factors Relating to Our Common Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Sales of substantial amounts of our common shares in the public market, or the perception that these sales may occur, could cause the market price of our common shares to decline.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sales of substantial amounts of our common shares in the public market, or the perception that these sales may occur, could cause a decline in the market price of our common shares. This could also impair our ability to raise additional capital through the sale of our equity securities. Under our articles of association, we are authorized to issue up to 79,000,000 common shares, of which 22,567,971 common shares were outstanding as of December&#160;31, 2021. If our existing shareholders sell substantial amounts of common shares in the public market, or the market perceives that such sales may occur, the market price of our common shares and our ability to raise capital through an issue of equity securities in the future could be adversely affected. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Moreover, we have entered into a registration rights agreement entitling certain of our existing shareholders to rights, subject to conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other shareholders. In addition, we have registered on a Form&#160;S-8 registration statement all common shares that we may issue under our new long term equity incentive plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As a result, these shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. If these additional shares are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common shares could decline.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">46</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We have broad discretion in the use of our cash on hand and may invest or spend it in ways with which you do not agree and in ways that may not yield a return on your investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2021, we had &#8364;17.8&#160;million in cash and cash equivalents. Our management will have broad discretion in the use of such cash and could spend it in ways that do not improve our results of operations or enhance the value of our common shares. You will not have the opportunity to influence our decisions on how to use our cash on hand. The failure by our management to apply these funds effectively could result in financial losses that could harm our business, cause the price of our common shares to decline and delay the development of our product candidates. Pending its use, we may invest our cash on hand in a manner that does not produce income or that loses value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We are an &#8220;emerging growth company&#8221; and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common shares less attractive to investors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and we are taking advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies.&#8221; For example, for as long as we are an &#8220;emerging growth company&#8221; under the recently enacted JOBS Act, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section&#160;404 of the Sarbanes-Oxley Act. We could be an emerging growth company for up to five years. We cannot predict if investors will find our common shares less attractive because we will rely on these exemptions. If some investors find our common shares less attractive as a result, there may be a less active trading market for our common shares and our share price may be more volatile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, Section&#160;107 of the JOBS Act provides that an emerging growth company can use the extended transition period provided in Section&#160;7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. Given that we currently report and expect to continue to report under IFRS as issued by the IASB, we have irrevocably elected not to avail ourselves of this extended transition period and, as a result, we will adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required by the IASB. Since IFRS makes no distinction between public and private companies for purposes of compliance with new or revised accounting standards, the requirements for our compliance as a private company and as a public company are the same.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We are a foreign private issuer and, as a result, we are not subject to U.S. proxy rules and are subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We report under the Exchange Act as a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including (i)&#160;the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act, (ii)&#160;the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time and (iii)&#160;the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form&#160;10-Q containing unaudited financial and other specified information, or current reports on Form&#160;8-K, upon the occurrence of specified significant events. In addition, foreign private issuers are not required to file their annual report on Form&#160;20-F until four months after the end of each fiscal year, while U.S. domestic issuers that are accelerated filers are required to file their annual report on Form&#160;10-K within 75&#160;days after the end of each fiscal year. Foreign private issuers are also exempt from the Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information. As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may lose our foreign private issuer status, which would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We are a foreign private issuer and therefore we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. If in the future we are not a foreign private issuer as of the last day of the second fiscal quarter in any fiscal year, we would be required to comply with all of the periodic disclosure, current reporting requirements and proxy solicitation rules of the Exchange Act applicable to U.S. domestic issuers. In order to maintain our current status as a foreign private issuer, either (a)&#160;a majority of our common shares must be either directly or indirectly owned of record by non-residents of the United States or (b)(i) a majority of our managing directors, supervisory board members and executive officers may not be United States citizens or residents, (ii)&#160;more than 50% of our assets cannot be located in the United States and (iii)&#160;our business must be administered principally outside the United States. If we were to lose this status, we would be </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">47</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required to make changes in our corporate governance practices in accordance with various SEC and stock exchange rules. The regulatory and compliance costs to us if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be significantly higher than the costs we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs and would make some activities highly time consuming and costly. These rules and regulations could also make it more difficult for us to attract and retain qualified directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">As a foreign private issuer and as permitted by the listing requirements of Nasdaq, we follow certain home country governance practices rather than the corporate governance requirements of Nasdaq.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are a foreign private issuer. As a result, in accordance with the listing requirements of Nasdaq, we are relying on home country governance requirements and certain exemptions thereunder rather than relying on the corporate governance requirements of Nasdaq. In accordance with Dutch law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. To this extent, our practice will vary from the requirement of Nasdaq Listing Rule&#160;5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting shares. Although we must provide shareholders with an agenda and other relevant documents for the general meeting of shareholders, Dutch law does not have a regulatory regime for the solicitation of proxies and the solicitation of proxies is not a generally accepted business practice in the Netherlands, thus our practice varies from the requirement of Nasdaq Listing Rule&#160;5620(b). As permitted by the listing requirements of Nasdaq, we have also opted out of the requirements of (i) Nasdaq Listing Rule&#160;5605(d), which requires, among other things, an issuer to have a compensation committee that consists entirely of independent directors and makes determinations regarding the independence of any compensation consultants, (ii) Nasdaq Listing Rule&#160;5605(e), which requires independent director oversight of director nominations, and (iii) Nasdaq Listing Rule&#160;5605(b), which requires an issuer to have a majority of independent directors on its board. In addition, we have opted out of shareholder approval requirements, as included in the Nasdaq Listing Rules, for the issuance of securities in connection with certain events such as the acquisition of shares or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of the Company and certain private placements. To this extent, our practice varies from the requirements of Nasdaq Rule&#160;5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events. Accordingly, you may not have the same protections afforded to shareholders of companies that are subject to these Nasdaq rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Insiders continue to have substantial control over us and could limit your ability to influence the outcome of key transactions, including a change of control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our principal shareholders, including certain of our managing directors, supervisory board members and executive officers and entities affiliated with them, in the aggregate, continue to beneficially own approximately 51.2% of outstanding common shares as at December 31, 2021 and 59.3% of outstanding common shares after the year-end financing. For further information, please refer to note 29 to our consolidated financial statements as of and for the year ended December 31, 2021. As a result, these shareholders, if acting together, are able to influence or control matters requiring approval by our general meeting of shareholders, including the election of managing directors and supervisory board members, changes to our articles of association and the approval of mergers or other extraordinary transactions. They may also have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. The concentration of ownership may have the effect of delaying, preventing or deterring a change of control of our company, could deprive our shareholders of an opportunity to receive a premium for their common shares as part of a sale of our company and might ultimately affect the market price of our common shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We do not anticipate paying any cash dividends in the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We currently intend to retain our future earnings, if any, for the foreseeable future, to repay indebtedness and to fund the development and growth of our business. We do not intend to pay any dividends to holders of our common shares. As a result, capital appreciation in the price of our common shares, if any, will be your only source of gain on an investment in our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we do pay dividends, we may need to withhold tax on such dividends payable to holders of our shares in both Germany and the Netherlands.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We do not intend to pay any dividends to holders of our common shares. However, if we do pay dividends, we may need to withhold tax on such dividends both in Germany and the Netherlands. As an entity incorporated under Dutch law, any dividends </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">48</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">distributed by us are subject to Dutch dividend withholding tax on the basis of Dutch domestic law. However, on the basis of the 2012 Convention between the Federal Republic of Germany and the Kingdom of the Netherlands for the avoidance of double taxation with respect to taxes on income (the &#8220;double tax treaty between Germany and the Netherlands&#8221;), the Netherlands will be restricted in imposing these taxes if we continue to be a tax resident of Germany and our place of effective management is located in Germany. See &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8212;We may become taxable in a jurisdiction other than Germany and this may increase the aggregate tax burden on us.&#8221; However, Dutch dividend withholding tax is still required to be withheld from dividends if and when paid to Dutch resident holders of our common shares (and non-Dutch resident holders of our common shares that have a permanent establishment in the Netherlands to which their shareholding is attributable). As a result, upon a payment of dividends, we will be required to identify our shareholders in order to assess whether there are Dutch residents (or non-Dutch residents with a permanent establishment in the Netherlands to which the common shares are attributable) in respect of which Dutch dividend tax has to be withheld. Such identification may not always be possible in practice. If the identity of our shareholders cannot be determined, withholding of both German and Dutch dividend tax may occur upon a payment of dividends.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Furthermore, the withholding tax restriction referred to above is subject to the applicability of the Multilateral Convention to Implement Tax Treaty Related Measures to Prevent Base Erosion and Profit Shifting (the &#8220;MLI&#8221;) While Germany has enacted the MLI with effect as of April 1 2021, it has, so far, refrained from initiating a notification procedure vis-&#224;-vis the Netherlands as necessary under the rules of the MLI to set into force the rules of the MLI, and neither has the Netherlands notified the applicability of the MLI towards Germany. Only if Germany decides to change its reservation with respect to the tie-breaker provision (the &quot;MLI Tie-Breaker Reservation&quot;) included in Article 4(3) of the 2012 Convention between the Federal Republic of Germany and the Kingdom of the Netherlands for the avoidance of double taxation with respect to taxes on income, and only if the applicability of the MLI has been mutually notified by Germany and the Netherlands, we may no longer be entitled anymore to any benefits of the double tax treaty between Germany and the Netherlands, including the withholding tax restriction, provided that Germany and the Netherlands do not reach an agreement on our tax residency for purposes of the double tax treaty between Germany and the Netherlands, except to the extent and in such manner as may be agreed upon by the authorities. As a result, any dividends distributed by us may be subject to withholding tax both in Germany and the Netherlands.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, a proposed law is currently pending before the Dutch parliament, namely the Emergency act conditional exit dividend tax (Spoedwet conditionele eindafrekening dividendbelasting) which would, if enacted, impose a dividend withholding (exit) tax on certain deemed distributions if we cease to be a Dutch tax resident and become a tax resident of a jurisdiction that is not a member of the EU or the EEA, when such jurisdiction does not satisfy certain conditions. In some cases, we would have a right to recover the amount of tax from our shareholders when such shareholder is not entitled to an exemption. If enacted in the form in which it is presently pending before the Dutch parliament, the proposed law will have retroactive effect to December 8, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may become taxable in a jurisdiction other than Germany and this may increase the aggregate tax burden on us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Since our incorporation we have had, on a continuous basis, our place of &#8220;effective management&#8221; in Germany. Therefore, we believe that we qualify as a tax resident of Germany on the basis of German domestic law. As an entity incorporated under Dutch law, however, we also qualify as a tax resident of the Netherlands on the basis of Dutch domestic law. However, based on our current management structure and the current tax laws of Germany and the Netherlands, as well as applicable income tax treaties, and current interpretations thereof, we believe that we are tax resident solely in Germany for the purposes of the double tax treaty between Germany and the Netherlands due to the &#8220;effective management&#8221; tie-breaker. The test of &#8220;effective management&#8221; is largely a question of fact and degree based on all the circumstances, rather than a question of law. Nevertheless, the relevant case law and OECD guidance suggest that the Company is likely to be regarded as having become a German tax resident from incorporation and remaining so if, as the Company intends, (i)&#160;most meetings of its management board are held in Germany (and none are held in the Netherlands) with a majority of directors present in Germany for those meetings; (ii)&#160;at those meetings there are full discussions of, and decisions are made regarding, the key strategic issues affecting the Company and its subsidiaries; (iii)&#160;those meetings are properly minuted; (iv)&#160;at least some of the directors of the Company, together with supporting staff, are based in Germany; and (v)&#160;the Company has permanent staffed office premises in Germany. We may, however, become subject to limited income tax liability in other countries with regard to the income generated in the respective other country, for example, due to the existence of a permanent establishment or a permanent representative in such other country. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The applicable tax laws, tax treaties or interpretations thereof may change. Furthermore, whether we have our place of effective management in Germany and are as such tax resident in Germany is largely a question of fact and degree based on all the circumstances, rather than only a question of law, which facts and degree may also change. Changes to applicable tax laws, tax treaties or interpretations thereof and changes to applicable facts and circumstances (for example, a change of board members or the place where board meetings take place), or changes in the applicable tax treaties, including a potential future change to the MLI tie-breaker </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">49</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">reservation, may result in us also becoming a tax resident of the Netherlands or another jurisdiction (other than Germany), potentially also triggering an exit liability in Germany. As a consequence, our overall effective income tax rate and income tax expense could materially increase, which could have a material adverse effect on our business, results of operations, financial condition and prospects, which could cause our share price and trading volume to decline. However, if there is a double tax treaty between Germany and the respective other country, the double taxation of income may be reduced or avoided entirely.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Shareholders may not be able to exercise preemptive rights and, as a result, may experience substantial dilution upon future issuances of common shares</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the event of an issuance of common shares, subject to certain exceptions, each shareholder will have a pro rata preemptive right in proportion to the aggregate nominal value of the common shares held by such holder. These preemptive rights may be restricted or excluded by a resolution of the general meeting of shareholders or by another corporate body designated by the general meeting of shareholders. Our management board is authorized, until June 24, 2026, to issue shares or grant rights to subscribe for shares up to our authorized share capital from time to time and to limit or exclude preemptive rights in connection therewith. This could cause existing shareholders to experience substantial dilution of their interest in us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If equity and industry research analysts publish negative evaluations of or downgrade our common shares, the price of our common shares could decline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The trading market for our common shares relies in part on the research and reports that equity and industry research analysts publish about us or our business. We do not control these analysts. If one or more of the analysts covering our business downgrade their evaluations of our common shares, the price of our common shares could decline. If one or more of these analysts cease to cover our common shares, we could lose visibility in the market for our common shares, which in turn could cause our common shares price to decline.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our ability to use our net operating loss carryforwards and other tax attributes may be limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our ability to utilize our net operating losses (&#8220;NOLs&#8221;) is currently limited, and may be limited further, under Section&#160;8c of the German Corporation Income Tax Act (<i style="font-style:italic;">K&#246;rperschaftsteuergesetz,</i> the &#8220;KStG&#8221;) and Section&#160;10a of the German Trade Tax Act (<i style="font-style:italic;">Gewerbesteuergesetz</i>, the &#8220;GewStG&#8221;). These limitations apply if a qualified ownership change, as defined by Section&#160;8c KStG, occurs and no exemption is applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under current tax laws, tax loss carryforwards can generally be used for an unlimited period of time but any change of control in the Company &#8211; including as a result of a capital increase &#8211; could result in the expiry of such tax loss carryforwards and of any current year losses if, subject to further prerequisites, more than 50% of the subscribed capital or voting rights of the Company will be, directly or indirectly, transferred to an acquirer (including parties related to the acquirer constituting a group of acquirers with aligned interests) within five years or a comparable acquisition occurs. However, tax loss carryforwards and unused current losses taxable in Germany will not expire to the extent that they are covered by built in gains taxable in Germany at the time of such acquisition (Stille-Reserven-Klausel, the &#8220;Hidden-Reserves Clause&#8221;). Pursuant to the Hidden Reserves-Clause, any share transfer that would otherwise be subject to the loss forfeiture rule above does not result upon application in forfeiture of tax loss carryforwards and interest carryforwards resulting from current business operations of the Company, if the current business operations of the Company remained the same (i) from the time of its establishment; or (ii) during the last three business years prior to the share transfer and such business operations are maintained after the transfer (fortf&#252;hrungsgebundener Verlustvortrag). The determination of whether the business operations have been maintained is assessed on the basis of qualitative factors, such as the produced goods and services, target markets, customer and supplier bases, etc. However, the tax loss carryforwards will be forfeited in any circumstance if, after the share transfer, the business operations of the Company become dormant, are modified or substantially restructured, the Company becomes a partner in an operating partnership (Mitunternehmerschaft), the Company becomes a fiscal unity parent, or assets are transferred from the Company and recognized at a value lower than the fair market value. This requirement is monitored until the retained tax loss carryforwards have been fully utilized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">According to another appeal filed by the fiscal court of Hamburg dated August&#160;29, 2017, Section&#160;8c, paragraph&#160;1, sentence 1 KStG is not in line with the German constitution. The appeal is still pending. It is unclear when the Federal Constitutional Court will decide this case. According to statements in German legal literature, there are good reasons to believe that the Federal Constitutional Court may come to the conclusion that Section&#160;8, paragraph&#160;1, sentence 1 KStG is not in line with the German constitution.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">50</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2021, we estimate unrecognized NOL carryforwards for German tax purposes of &#8364;75.3 million available which have not yet been assessed. However, we have not recognized a deferred tax asset for tax losses carried forward in our consolidated financial statements, see &#8220;Item 18. Financial Statements&#8212;Notes to the consolidated financial statements as of December 31, 2021 and 2020 and for the three years ended December 31, 2021, 2020 and 2019&#8221;. Future changes in share ownership may also trigger an ownership change and, consequently, a Section&#160;8c KStG or a Section&#160;10a GewStG limitation. Any limitation may result in the expiration of a portion or the complete tax operating loss carryforwards before they can be utilized. As a result, if we earn net taxable income, our ability to use our pre-change net operating loss carryforwards to reduce German income tax may be subject to limitations, which could potentially result in increased future cash tax liability to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Although we do not believe that we were a &#8220;passive foreign investment company,&#8221; or a PFIC, for U.S. federal income tax purposes for 2021, we may be a PFIC for 2022 or one or more future taxable years. If we are a PFIC for any taxable year, U.S. shareholders may be subject to adverse U.S. federal income tax consequences. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Under the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), we will be a PFIC for any taxable year in which, after the application of certain look-through rules with respect to our subsidiaries, either (i)&#160;75% or more of our gross income consists of passive income or (ii)&#160;50% or more of the average value of our assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, passive income. Passive income includes, among other things, dividends, interest, certain non-active rents and royalties, and investment gains. For these purposes cash is generally a passive asset. Goodwill is generally an active asset to the extent associated with business activities that produce active income. Based on our current operations and composition of our income and assets, and certain estimates as to the value of our assets, we do not believe that we were a PFIC for our 2021 taxable year. However, there can be no assurance that the Internal Revenue Service (the &#8220;IRS&#8221;) will agree with our conclusion. In addition, whether we will be a PFIC in 2022 or any future taxable year is uncertain because, among other things, (i)&#160;we currently own, and expect to continue to own, a substantial amount of passive assets, including cash, (ii)&#160;the value of our assets that generate non-passive income for PFIC purposes, including our intangible assets, is uncertain and may vary substantially over time (and may be determined, in large part, by reference to our market capitalization, which has been, and may continue to be, volatile) and (iii)&#160;the composition of our income may vary substantially over time. Accordingly, there can be no assurance that we will not be a PFIC for any taxable year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If we are a PFIC for any taxable year during which a U.S. investor holds our common shares, we will continue to be treated as a PFIC with respect to that U.S. investor for all succeeding years during which the U.S. investor holds our common shares, even if we cease to meet the threshold requirements for PFIC status, unless certain exceptions apply. Such a U.S. investor may be subject to adverse U.S. federal income tax consequences, including (i)&#160;the treatment of all or a portion of any gain on disposition as ordinary income, (ii)&#160;the application of an additional tax effectively representing deferred interest charge on such gain and the receipt of certain dividends and (iii)&#160;compliance with certain reporting requirements. We do not intend to provide the information that would enable investors to make a qualified electing fund election (a &#8220;QEF Election&#8221;) that could mitigate the adverse U.S. federal income tax consequences should we be classified as a PFIC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For further discussion, see &#8220;Item&#160;8. Financial Information&#8212;E. Taxation&#8212;Material U.S. Federal Income Tax Considerations for U.S. Holders.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">If a U.S. person is treated as owning 10% or more of our stock by vote or value, such person may be subject to adverse U.S. federal income tax consequences.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If a U.S. person is treated as owning (directly, indirectly or constrictively) 10% or more of our stock by value or voting power, such person generally will be treated as a &#8220;United States shareholder&#8221; with respect to each &#8220;controlled foreign corporation&#8221; (a &#8220;CFC&#8221;) in our group. A CFC is a non-U.S. corporation more than 50% of the stock (by voting power or value) of which is owned (directly, indirectly or constructively) by &#8220;United States shareholders.&#8221; We have not determined whether we are a CFC. However, even if we are not a CFC, under certain ownership attribution rules our non-U.S. subsidiaries could be treated as owned by our U.S. subsidiary and thus may be treated as CFCs. A United States shareholder of a CFC may be subject to additional U.S. federal income tax liabilities and reporting requirements. We do not intend to furnish to any information that may be necessary for United States shareholders, if any, to comply with the CFC rules. U.S. investors that may be treated for purposes of the CFC rules as owning 10% of our stock by voting power or value should consult their tax advisers regarding the potential application of these rules in their particular circumstances.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">51</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We are a Dutch public company. The rights of our shareholders are different from the rights of shareholders in companies governed by the laws of U.S. jurisdictions and may not protect investors in a similar fashion afforded by incorporation in a U.S. jurisdiction. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are a Dutch public company (<i style="font-style:italic;">naamloze vennootschap</i>) organized under the laws of the Netherlands. Our corporate affairs are governed by our articles of association and by the laws governing companies incorporated in the Netherlands. However, there can be no assurance that Dutch law will not change in the future or that it will serve to protect investors in a similar fashion afforded under corporate law principles in the United States, which could adversely affect the rights of investors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The rights of shareholders and the responsibilities of managing directors and supervisory board members may be different from the rights and obligations of shareholders and board members in companies governed by the laws of U.S. jurisdictions. In the performance of their duties, our managing directors and supervisory board members are required by Dutch law to consider the interests of our company, its shareholders, its employees and other stakeholders, in all cases with due observation of the principles of reasonableness and fairness. It is possible that some of these parties will have interests that are different from, or in addition to, your interests as a shareholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Provisions of our articles of association or Dutch corporate law might deter acquisition bids for us that might be considered favorable and prevent, delay or frustrate any attempt to replace or remove the members of our management board or supervisory board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under Dutch law, various protective measures are possible and permissible within the boundaries set by Dutch law and Dutch case law. In this respect, certain provisions of our articles of association may make it more difficult for a third party to acquire control of us or effect a change in our management board and supervisory board. These include:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a provision that our managing directors and supervisory board members are appointed on the basis of a binding nomination prepared by our supervisory board which can only be overruled by a two-thirds majority of votes cast representing more than 50% of our issued share capital;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a provision that our managing directors and supervisory board members may only be dismissed by the general meeting of shareholders by a two-thirds majority of votes cast representing more than 50% of our issued share capital (unless the dismissal is proposed by the supervisory board in which case a simple majority of the votes would be sufficient); and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a requirement that certain matters, including an amendment of our articles of association, may only be brought to our shareholders for a vote upon a proposal by our management board with the approval of our supervisory board.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Furthermore, in accordance with the Dutch Corporate Governance Code, or DCGC, shareholders who have the right to put an item on the agenda for our general meeting or to request the convening of a general meeting shall not exercise such rights until after they have consulted our management board. If exercising such rights may result in a change in our strategy (for example, through the dismissal of one or more of our managing directors or supervisory directors), our management board must be given the opportunity to invoke a reasonable period of up to 180 days to respond to the shareholders&#8217; intentions. If invoked, our management board must use such response period for further deliberation and constructive consultation, in any event with the shareholder(s) concerned and exploring alternatives. At the end of the response time, our management board, supervised by our supervisory board, shall report on this consultation and the exploration of alternatives to our general meeting. The response period may be invoked only once for any given general meeting and shall not apply (i) in respect of a matter for which a response period has been previously invoked or (ii) if a shareholder holds at least 75% of our issued share capital as a consequence of a successful public bid.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Moreover, our management board, with the approval of our supervisory board, can invoke a cooling-off period of up to 250 days when shareholders, using their right to have items added to the agenda for a general meeting or their right to request a general meeting, propose an agenda item for our general meeting to dismiss, suspend or appoint one or more managing directors or supervisory directors (or to amend any provision in our articles of association dealing with those matters) or when a public offer for our company is made or announced without our support, provided, in each case, that our management board believes that such proposal or offer materially conflicts with the interests of our company and its business. During a cooling-off period, our general meeting cannot dismiss, suspend or appoint managing directors and supervisory directors (or amend the provisions in our articles of association dealing with those matters) except at the proposal of our management board. During a cooling-off period, our management board must gather all relevant information necessary for a careful decision-making process and at least consult with shareholders representing 3% or more of our issued share capital at the time the cooling-off period was invoked, as well as with our Dutch works </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">52</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">council (if we or, under certain circumstances, any of our subsidiaries would have one). Formal statements expressed by these stakeholders during such consultations must be published on our website to the extent these stakeholders have approved that publication. Ultimately, one week following the last day of the cooling-off period, our management board must publish a report in respect of its policy and conduct of affairs during the cooling-off period on our website. This report must remain available for inspection by shareholders and others with meeting rights under Dutch law at our office and must be tabled for discussion at the next general meeting. Shareholders representing at least 3% of our issued share capital may request the Enterprise Chamber of the Amsterdam Court of Appeal, or the Enterprise Chamber (Ondernemingskamer), for early termination of the cooling-off period. The Enterprise Chamber must rule in favor of the request if the shareholders can demonstrate that:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our management board, in light of the circumstances at hand when the cooling-off period was invoked, could not reasonably have concluded that the relevant proposal or hostile offer constituted a material conflict with the interests of our company and its business;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our management board cannot reasonably believe that a continuation of the cooling-off period would contribute to careful policy-making; or</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">other defensive measures, having the same purpose, nature and scope as the cooling-off period, have been activated during the cooling-off period and have not since been terminated or suspended within a reasonable period at the relevant shareholders&#8217; request (i.e., no &#8216;stacking&#8217; of defensive measures).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We are not obligated to, and do not, comply with all best practice provisions of the Dutch Corporate Governance Code. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As a Dutch public company, we are subject to the DCGC. The DCGC contains both principles and best practice provisions that regulate relations between the management board, the supervisory board and the shareholders. The DCGC is based on a &#8220;comply or explain&#8221; principle. Accordingly, companies are required to disclose in their annual reports, filed in the Netherlands, whether they comply with the provisions of the DCGC. If they do not comply with those provisions (for example, because of a conflicting Nasdaq requirement), the company is required to give the reasons for such non-compliance. The DCGC applies to Dutch companies listed on a government-recognized stock exchange, whether in the Netherlands or elsewhere, including Nasdaq. We do not comply with all best practice provisions of the DCGC. This may affect your rights as a shareholder and you may not have the same level of protection as a shareholder in a Dutch company that fully complies with the DCGC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our share price might fluctuate, as a result of which you could lose a significant part of your investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The market price of our common shares may fluctuate significantly in response to numerous factors, many of which are beyond our control, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">financial analysts ceasing to cover our common shares or changes in financial estimates by analysts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">actual or anticipated variations in our operating results;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in financial estimates by financial analysts, or any failure by us to meet or exceed any of these estimates, or changes in the recommendations of any financial analysts that elect to follow our common shares or the shares of our competitors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">announcements by us or our competitors of significant contracts or acquisitions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">future sales of our shares; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">investor perceptions of us and the industries in which we operate.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">53</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">In addition, the stock market in general has experienced substantial price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of particular companies affected. These broad market and industry factors may materially harm the market price of our common shares, regardless of our operating performance. In the past, following periods of volatility in the market price of certain companies&#8217; securities, securities class action litigation has been instituted against these companies. This litigation, if instituted against us, could adversely affect our financial condition or results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Claims of U.S. civil liabilities may not be enforceable against us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are organized and existing under the laws of the Netherlands, and, as such, under Dutch private international law rules the rights of our shareholders and the civil liability of our directors and executive officers are governed in certain respects by the laws of the Netherlands. The ability of our shareholders in certain countries other than the Netherlands to bring actions against us, our directors and executive officers may be limited under applicable law. In addition, substantially all of our assets are located outside the United States. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As a result, it may not be possible for investors to effect service of process within the United States upon us or our directors and executive officers or to enforce against them or us in U.S. courts, including judgments predicated upon the civil liability provisions of the federal securities laws of the United States. In addition, it is not clear whether a Dutch court would impose civil liability on us or any of our directors and executive officers in an original action based solely upon the federal securities laws of the United States brought in a court of competent jurisdiction in the Netherlands. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of the date of this Annual Report, the United States and the Netherlands do not have a treaty providing for the reciprocal recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters. With respect to choice of court agreements in civil or commercial matters, it is noted that the Hague Convention on Choice of Court Agreements entered into force for the Netherlands, but has not entered into force for the United States. Accordingly, a judgment rendered by a court in the United States, whether or not predicated solely upon U.S. securities laws, would not automatically be recognized and enforced by the competent Dutch courts. However, if a person has obtained a judgment rendered by a court in the United States that is enforceable under the laws of the United States and files a claim with the competent Dutch court, the Dutch court will in principle give binding effect to a foreign judgment if (i) the jurisdiction of the foreign court was based on a ground of jurisdiction that is generally acceptable according to international standards, (ii) the judgment by the foreign court was rendered in legal proceedings that comply with the Dutch standards of proper administration of justice including sufficient safeguards (<i style="font-style:italic;">behoorlijke rechtspleging</i>), (iii) binding effect of such foreign judgment is not contrary to Dutch public order (<i style="font-style:italic;">openbare orde</i>) and (iv) the judgment by the foreign court is not incompatible with a decision rendered between the same parties by a Dutch court, or with a previous decision rendered between the same parties by a foreign court in a dispute that concerns the same subject and is based on the same cause, provided that the previous decision qualifies for recognition in the Netherlands. Even if such a foreign judgment is given binding effect, a claim based thereon may, however, still be rejected if the foreign judgment is not or no longer formally enforceable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on the lack of a treaty as described above, U.S. investors may not be able to enforce against us or our directors, representatives or certain experts named herein who are residents of the Netherlands or countries other than the United States any judgments obtained in U.S. courts in civil and commercial matters, including judgments under the U.S. federal securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The United States and Germany currently do not have a treaty providing for the reciprocal recognition and enforcement of judgments, in civil and commercial matters. Consequently, a final judgment for payment or declaratory judgments given by a court in the United States, whether or not predicated solely upon U.S. securities laws, would not automatically be recognized or enforceable in Germany. German courts may deny the recognition and enforcement of a judgment rendered by a U.S. court if they consider the U.S. court not to be competent or the decision to be in violation of German public policy principles. For example, judgments awarding punitive damages are generally not enforceable in Germany. A German court may reduce the amount of damages granted by a U.S. court and recognize damages only to the extent that they are necessary to compensate actual losses or damages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition, actions brought in a German court against us, our managing directors, our supervisory board members, our senior management and the experts named herein to enforce liabilities based on U.S. federal securities laws may be subject to certain restrictions. In particular, German courts generally do not award punitive damages. Litigation in Germany is also subject to rules of procedure that differ from the U.S. rules, including with respect to the taking and admissibility of evidence, the conduct of the proceedings and the allocation of costs. German procedural law does not provide for pre-trial discovery of documents, nor does Germany support pre-trial discovery of documents under the 1970 Hague Evidence Convention. Proceedings in Germany would have to be conducted in the German language and all documents submitted to the court would, in principle, have to be translated into German. For these reasons, it may be difficult for a U.S. investor to bring an original action in a German court predicated upon the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">54</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">civil liability provisions of the U.S. federal securities laws against us, our managing directors, our supervisory board members, our senior management and the experts named in this Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Based on the foregoing, there can be no assurance that U.S. investors will be able to enforce against us or management board members, supervisory board members and executive officers or certain experts named herein who are residents of or possessing assets in the Netherlands, Germany, or other countries other than the United States any judgments obtained in U.S. courts in civil and commercial matters, including judgments under the U.S. federal securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_7049bd21_938c_4129_b202_8ed5ee1557ab"></a><a id="_Hlk95844304"></a><a id="Item4InformationontheCompany_409827"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">4.  Information on the Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>History and Development of the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Centogene was founded by our former CEO, Prof. Arndt Rolfs, in 2006 in Rostock, Germany. In connection with our initial public offering, which closed on November&#160;12, 2019, we executed a corporate reorganization whereby Centogene&#160;B.V., which was incorporated on October&#160;11, 2018, was converted into Centogene&#160;N.V. and Centogene&#160;N.V. became the holding company for Centogene AG, which remains our principal operating subsidiary. Centogene&#160;N.V. is a Dutch public company (<i style="font-style:italic;">naamloze vennootschap</i>) organized under the laws of the Netherlands and our legal and commercial name is Centogene&#160;N.V. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In July&#160;2020, we completed a follow-on public offering of 3,500,000 common shares of the Company (the &#8220;Follow-on Equity Offering&#8221;), consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of $14.00 per common share (i.e., &#8364;12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, to the Company were &#8364;22 million. On March&#160;5, 2020, the Company resolved that Centogene AG shall be converted into a German limited liability company and renamed Centogene&#160;GmbH. Such conversion became effective upon the registration in the German commercial register on June 29, 2020, and was therefore completed in the financial year ending December&#160;31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our principal executive offices are located at Am Strande 7, 18055 Rostock, Germany and our additional offices are in Berlin (Germany), Cambridge (Massachusetts, United States), Vienna (Austria), Dubai (United Arab Emirates), Delhi (India) and Zug (Switzerland). Since November&#160;7, 2019, our common shares have traded on Nasdaq under the symbol &#8220;CNTG.&#8221; Our agent for service of process in the United States is Cogency Global, located at 10 East 40<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>&#160;Street, 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>&#160;Floor, New York, NY 10016. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are an emerging growth company and as such, we are eligible to, and intend to, take advantage, for up to five years, of certain exemptions from various reporting requirements applicable to other public companies that are not Emerging Growth Companies, such as not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We will remain an emerging growth company until the earliest of: (i)&#160;the last day of our fiscal year during which we have total annual gross revenues of at least $1.07&#160;billion; (ii)&#160;the last day of our fiscal year following the fifth anniversary of the closing of our initial public offering; (iii)&#160;the date on which we have, during the previous three-year period, issued more than $1.0&#160;billion in non-convertible debt; (iv)&#160;the date on which we are deemed to be a Large Accelerated Filer under the Exchange Act, with at least $700&#160;million of equity securities held by non-affiliates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our capital expenditures for 2021, 2020 and 2019 amounted to &#8364;5,702 thousand, &#8364;16,547&#160;thousand and &#8364;7,576&#160;thousand, respectively. These expenditures were primarily for property, plant and equipment and intangible assets. For further details see Item 4B below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The SEC maintains an Internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that website is&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">www.sec.gov</span>. Our website can be found at&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">www.centogene.com</span>. The information on our website is not incorporated by reference into this Annual Report, and you should not consider information contained on our website or any websites mentioned in this Annual Report to be part of this Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Business Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We are a strong partner for patients, physicians, and biopharma companies, from diagnostics to discovery, clinical development, market access &amp; expansion in rare, metabolic, and neurodegenerative diseases. We are a commercial-stage company that transforms real-world clinical and multi-omics data into superior insights to the diagnosis, drug discovery and treatment of rare </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">55</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">disease patients. We are developing a global proprietary rare disease platform based on our real-world data and biological repository representing approximately 650,000 individuals from over 120 different countries as of December&#160;31, 2021. Our platform includes epidemiologic, phenotypic and genetic and multi-omics data that reflects a global population, and also a biobank of these patients&#8217; biological samples. We believe this represents the only platform that comprehensively analyzes multi-level data to improve the understanding of rare, metabolic, and neurodegenerative hereditary diseases, which can aid in the identification of patients and improve our pharmaceutical partners&#8217; ability to bring orphan drugs to the market. As of December&#160;31, 2021, we collaborated with 33 pharmaceutical partners on projects targeting over 46 different rare diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A rare disease, by definition in the United States, is a disease that affects 200,000 or fewer people. However, with over 7,000 currently identified rare diseases, they in aggregate affect more than 350&#160;million people globally. Rare diseases can be severe and often take years to diagnosis. On average it takes six to eight years for a patient with a rare disease to be diagnosed. This underscores the significant unmet need for high-quality genetic or other information in the rare disease space for the early identification and effective treatment of patients. Despite legislative initiatives and continued investment in rare disease drug development, significant unmet need still exists. Of the 7,000 identified rare diseases, it is estimated that 80%, or 5,600, have a genetic origin and, of these rare hereditary diseases, less than 5%, have an FDA approved treatment. The introduction of new treatments and development of cost-effective drugs are constrained by a number of factors including: a lack of high-quality information regarding the clinical heterogeneity of medical symptoms, lack of comprehensive and curated medical data, difficulties in the early identification of patients, lack of biomarkers and difficulties in understanding market size and epidemiology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Our business is comprised of  solutions for both physicians and their patients, as well as biopharma/ pharmaceutical companies. Our diagnostics solution typically starts with specialist physicians requesting diagnostic information to identify or confirm a rare disease by sending us their patients&#8217; blood samples on our proprietary dried blood spot collection kit that bears the CE Mark&#160;-&#160;the CentoCard. With highly advanced technology, our BioDatabank and our team of medical experts, we then deliver reports back to the physicians that contain what we believe is critical information containing genetic, proteomic, metabolomic information, or some combination, depending on what is most salient for each case. We also input this data to our Centogene BioDatabank.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For our pharmaceutical partners, we are able to provide various valuable information using our platform. For instance, with the access to the data in our repository and biomaterials in our biobank, we have successfully developed biomarkers by applying highly sophisticated tools, including mass spectrometry technologies, together with artificial intelligence capabilities in an efficient and cost effective manner. Biomarkers are important in orphan drug development as well as post commercialization monitoring, by demonstrating the efficacy of existing and new drugs, performing longitudinal monitoring and informing necessary titration for individual rare disease patients. Newly identified biomarkers may also have the potential to become validated disease modifiers, opening up opportunities for new therapeutic approaches. As of December&#160;31, 2021, we have developed 11 biomarkers covering 10 diseases. We have also commercialized many biomarkers as laboratory developed tests for AADC deficiency, Fabry disease, Gaucher disease, Niemann-Pick Type&#160;A/B and Niemann-Pick Type&#160;C diseases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In December 2018, the FDA issued a statement that supports the use of real-world evidence to accelerate drug development and to monitor the safety of drugs after they have been commercialized. Moreover, in February 2019, the FDA also issued a revised draft guidance for drug discovery in rare diseases, including a discussion of the benefits of using biomarkers as surrogate endpoints (the outcomes of which can be measured against therapy effectiveness in clinical trials). We believe that this guidance from FDA, acknowledging the benefits of the use of both real-world evidence and biomarkers, further validates the value of our global proprietary rare disease platform and our biomarkers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We historically have offered solutions to our pharmaceutical parties and clients through two business segments. In addition, the COVID-19 pandemic, which began in December 2019, resulted in our recognizing, as of the beginning of Q3 2020, a separate reportable segment comprising our COVID-19 diagnostics business. Our historical business segments &#8211; pharmaceutical and diagnostics &#8211; remain our core business segments. Our pharmaceutical segment provides a variety of products and services to our pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological and patient population sizing insights, biomarker discovery and patient monitoring and follow-up. Our information platforms, our access to rare diseases patients and their biomaterials and our ability to develop proprietary technologies including biomarkers enable us to provide services to our pharmaceutical partners in all phases of the drug development process as well as post-commercialization. Revenues in our pharmaceutical segment are generated primarily from collaboration agreements with our pharmaceutical partners, which are structured on a fee per analysis basis, milestone basis, fixed fee basis, royalty basis or a combination of these. For the year ended December&#160;31, 2021, &#8364;15,641&#160;thousand, or 8.2%, of our total revenues were derived from our pharmaceutical segment. For the year ended December&#160;31, 2020, &#8364;16,951 thousand, or 13.2%, of our total revenues were derived from our pharmaceutical segment. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">56</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our diagnostics segment provides targeted genetic sequencing and diagnostics services to patients through our distribution partners and clients, who are typically physicians, labs or hospitals. Since our inception in 2006, we have been spearheading advanced diagnostic solutions using advanced technologies and techniques applied across multiple analysis. As of December&#160;31, 2021, we believe we offer the broadest diagnostic testing portfolio for rare diseases, covering over 19,000 genes using over 10,000 different tests.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revenues from our diagnostics segment are typically generated by set fees per diagnostic test or per bundle of diagnostic tests under contracts with our clients. For the year ended December&#160;31, 2021, &#8364;27,900&#160;thousand, or 14.7%, of our total revenues were derived from our diagnostics segment. For the year ended December&#160;31, 2020, &#8364;22,108&#160;thousand, or 17.2%, of our total revenues were derived from our diagnostics segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We continuously work on expanding our medical and genetic knowledge of rare genetic diseases. We work with renowned international scientific and academic institutions on a variety of groundbreaking research projects involving a significant number of rare genetic disease patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The test requests that we receive from our customers in our pharmaceutical segment, our diagnostics segment, as well as from research projects yield a rich collection of genetic and biochemical data which are used to map out phenotype-genotype correlations and continuously enrich and improve the quality of our database.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year ended December&#160;31, 2021, we received over 120,800 test requests in total for both our pharmaceutical and diagnostics segments, as well as for our internal research projects, bringing the total number of test requests received in the period from January&#160;1, 2016 to December&#160;31, 2021 to approximately 639,500. Compared to the total number of patients in our repository as of December&#160;31, 2021, this shows that approximately 86% of our data and biomaterials came from the last five years, which is an important factor when it comes to recruiting patients for clinical trials and clinical studies, considering the short average life expectancy of rare disease patients. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revenues generated through the COVID-19 segment for the year ended December 31, 2021 represented 77.1% of our total revenues. To support its test offerings, we acquired laboratory facilities and equipment, developed a Corona Test Portal and leased laboratory space at several locations in Germany. Total investments in COVID-19 testing during the year ended December 31, 2021 amounted to &#8364;2.8 million, of which &#8364;2.4 million, are included in property, plant and equipment. An amount of &#8364;0.4 million is included in intangible assets and relates to the development of the Corona Test Portal. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The graphic below shows the cumulative test requests for the diagnostics, pharmaceutical and COVID-19 segments, as well as test requests received for our internal research projects during the period from January&#160;1, 2016 to December&#160;31, 2021. The testing </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">57</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:236.16pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">expenses relating to requests received for our internal research projects were included in Corporate as they did not generate any revenue and cannot be allocated to either of our three business segments. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f004.jpg" alt="Graphic" style="display:inline-block;height:236.16pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:356.77pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the fraction of the pharmaceutical, diagnostics and corporate tests, for which we have optional research consent from the patients in our BioDatabank, we are able to retest their biomaterials in our biobank.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The graphic below shows the cumulative 233,500 test requests received from our diagnostics segment in the period from January&#160;1, 2016 to December&#160;31, 2021, split by different type of analysis. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f005.jpg" alt="Graphic" style="display:inline-block;height:189.91pt;left:0%;padding-bottom:0.6pt;position:relative;top:0pt;width:369.57pt;" /></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">&#8220;Standard genetic&#8221; testing includes our single gene, CNV and mutation quantification products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">From our inception in 2006, Centogene has been focused on changing the way patients with rare diseases are treated. Our laboratory at our headquarters in Rostock, Germany, as well as our Cambridge, Massachusetts facility, are equipped with the most advanced technologies from thirteen different diagnostic platforms and, as of December&#160;31, 2021, together employ approximately 808 highly qualified personnel (including consultants) from over 55 nationalities. In addition to our laboratories, we have sales and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">58</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">administrative offices located in Berlin (Germany), Cambridge (Massachusetts, United States), Vienna (Austria), Dubai (United Arab Emirates), Delhi (India) and Zug (Switzerland), allowing us to further expand our international footprint.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our strategic objective is to be an essential partner for patients, physicians, and biopharma companies, from diagnostics to discovery, clinical development, market access &amp; expansion in rare, metabolic and neurodegenerative diseases. We aim to improve the diagnosis and treatment of rare, metabolic, and neurodegenerative diseases by transforming real-world clinical and genetic and multi-omics data into actionable information for patients, physicians, and pharmaceutical companies, and unlocking critical knowledge that will guide and accelerate orphan drug development. To achieve this objective, our strategy is to:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Transform the rare disease landscape by applying precision medicine more comprehensively.  </b>Rare diseases affect patients of all ages and ethnicities, across the world. We are focused on creating broader awareness of the challenges these patients and their families face, including the lack of accurate and up-to-date diagnostic solutions and the lack of effective therapies. We leverage our global network to access patient populations of varying ethnicities and continue to expand our existing data repository, which we believe is the world&#8217;s largest repository for rare hereditary diseases. We believe this central source of knowledge will allow us to apply precision medicine more comprehensively, which will enable more accurate diagnosis as well as support the more efficient discovery and development of effective new treatment solutions for rare hereditary disease patients.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Further our leadership position in rare diseases and continue to build upon our data BioDatabank, which we believe is the world&#8217;s largest, and most comprehensive repository for rare disease patient data.</b> Since our Company&#8217;s founding in 2006, we have been focused on collecting clinical, phenotypic and genomic data for patients with rare hereditary diseases. We plan to continue growing this repository of information and biological samples through the identification of additional patients by expanding our clinical network, which will facilitate more effective new drug development. This synergistic model will allow us to maintain our competitive advantage of having what we believe is the world&#8217;s largest curated data and sample repository for rare hereditary diseases.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Accelerate the discovery and development of orphan drugs for new and existing pharmaceutical partners.</b> We are focused on leveraging our vast knowledge-base to support drug development for the rare disease industry in various ways. We intend to continue expanding the scope of these collaborations as well as our network of partners, and in particular commencing our collaboration at an earlier stage of the drug development by our partners. Our services span the full spectrum of diagnostics, drug discovery and development, including <i style="font-style:italic;">in vitro</i> molecular screening (or target discovery), clinical development, incl. epidemiological studies, biomarker development as well as patient recruitment and identification, and to market access &amp; expansion. We believe this offering supports the speed and efficiency of our pharmaceutical partners&#8217; drug development efforts and accelerate bringing new diagnostic and treatment solutions to rare hereditary disease patients. In the most attractive areas, we may establish and pursue our own discovery programs or co-invest into partnered programs. This includes the building up of our Disease Avatars.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Evolve our business to share in more of the value we provide to our pharmaceutical partners.  </b><span style="white-space:pre-wrap;">Our database is also valuable beyond drug discovery,  as the biomarkers can be relevant for patient stratification and monitoring. Our database has multiple additional applications such as patient identification for therapeutic trials and treatment. For example, by identifying patients with a specific characteristic that are eligible for a clinical trial, we can reduce the time of clinical trial patient enrollment for our pharmaceutical partners. Reducing this enrollment time is often critically important in rare disease as the small number of patients of each disease can cause long enrollment periods. </span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Rare Disease Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Rare Diseases Act of 2002 defines a rare disease as having a prevalence of fewer than 200,000 affected individuals in the United States. In the European Union, orphan drug designation is intended to promote the development of drugs for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions affecting not more than one in 2,000 persons in the European Union and for which no satisfactory method of diagnosis, prevention, or treatment has been authorized (or the product would be a significant benefit to those affected).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">59</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The National Institutes of Health lists more than 7,000 disorders that qualify as rare diseases.  A wide range of conditions qualify as rare diseases and include, but are not limited to:</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Lysosomal storage disorders such as Gaucher disease, Fabry disease, Pompe disease, the mucopolysaccharidosis disorders, Farber disease, Niemann-Pick disease and Metachromatic leukodystrophy;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Neurologic and neuromuscular disorders such as Huntington<span style="font-family:'Symbol';">&#8217;</span>s disease, Spinal Muscular Atrophy, Duchenne Muscular Dystrophy and Neuronal ceroid-lipofuscinosis type<span style="font-family:'Symbol';">&#160;</span>2; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Non-malignant hematological disorders such as paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, hemophilia and hemoglobinopathies such as sickle cell disease and <span style="font-family:'Symbol';">&#946;-</span>thalassemia.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">According to research published in the European Journal of Human Genetics in September 2019, a conservative, evidence-based estimate for the population prevalence of rare diseases is 3.5-5.9%, which equates to 263 to 446&#160;million people affected globally at any point in time. According to the International Rare Diseases Research Consortium, there were over 800 new rare diseases identified between 2010 and 2019. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cause of Rare Diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">While there are many causes of rare diseases, approximately 5,600 are due to genetic mutations which are hereditary and passed from one generation to the next. Genes direct the production of proteins, make up body structures like organs and tissue, as well as control chemical reactions and carry signals between cells. If a cell&#8217;s DNA is mutated, a dysfunctional protein may be produced, which can lead to a disease. Therefore, one way in which rare diseases can be diagnosed is by identifying the specific mutations in a patient&#8217;s DNA, even without the manifestation of physical symptoms. To date, there are estimated to be approximately 4,700 rare genetic diseases that can be diagnosed by diagnostic sequencing tools. Despite these advancements in science and availability of next-generation sequencing (&#8220;NGS&#8221;) technologies, rare diseases are complex and an underlying genetic cause for approximately 1,400 rare diseases is still unknown. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, new genetic mutations associated with identified rare diseases are discovered every year, and as a result, rare genetic diseases that can be diagnosed need to be continuously updated with the new information, otherwise the diagnosis provided becomes inaccurate over time. Furthermore, capabilities to deeply characterize patients with rare genetic variants including RNA (transcriptomic) analysis, peptide and protein (proteomic) analysis, and functional assays and metabolite (metabolomic) analysis help significantly to delineate mechanisms of disease and thereby characterize molecular markers of disease beyond the &#8220;naked&#8221; disease causing variants which is captured through DNA sequencing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Manifestation and Diagnosis of Rare Diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Because of phenotypic heterogeneity, rare disease manifestations vary in onset and severity and many rare diseases exhibit&#160;a number of variations or sub-types. Almost 70% of the rare genetic diseases are pediatric onset, which means symptoms may be observed at birth or in childhood, as is usually the case with Spinal Muscular Atrophy, neurofibromatosis and chondrodysplasia. The remaining rare genetic diseases manifest symptoms during adulthood. Given the delayed onset and large variance in the symptoms that can manifest, the vast majority of these patients are misdiagnosed, years after the onset of symptoms the true molecular etiology is often not yet identified.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Given the multifaceted genetic and phenotypical nature of rare diseases, diagnosis is complex and requires specialist knowledge. It is often difficult for rare disease patients to find healthcare professionals with adequate experience. If diagnosis, treatment and management are not led by specialists, it may result in an incorrect diagnosis and inappropriate treatment, which can result in poorer patient outcomes. In addition, comprehensive phenotypical information on rare diseases is not always captured, and as a result, symptoms are often misinterpreted and patients are often not properly diagnosed, in particular when patients with such symptoms present to physicians who have never encountered rare diseases before. Even though genetic testing is the current accepted standard for making a diagnosis, these tests are not readily available to general practitioners on a global scale. Furthermore, there are still knowledge barriers that prevent the full interpretation of data obtained from such tests.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Delay to diagnosis is commonly experienced by patients and is due to poor awareness of rare diseases by health professionals, limited availability of molecular testing, and the small number of patients affected. This delay in diagnosis can be significant for many patients and may lead to irreversible progression of the patient&#8217;s condition, in particular when children are </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">60</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">suffering from rare diseases. For example, in the United Kingdom and the United States, the average time to obtain a correct diagnosis for rare diseases was found to be five to seven years, and in this time there were two to three incorrect diagnoses for a given condition. Pediatric rare disease patients can experience an even more significant delay in diagnosis. Across both pediatric and adult patient populations, approximately 90% of rare disease patients are typically undiagnosed. For example, the National Institutes of Health estimate that there are approximately 50,000 Fabry disease patients in the United States, whereas only 4,000 to 5,000 are currently diagnosed. As a result of incorrect and delayed diagnosis, unnecessary tests and treatments are often carried out and in some cases treatment windows are missed entirely.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Regulatory Environment and Current Market</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The COVID-19 pandemic, which began in December 2019 in China and has spread worldwide, has caused many governments to implement measures to slow the spread of the outbreak through quarantines, travel restrictions, heightened border scrutiny and other measures. We have taken a series of actions aimed at safeguarding our employees and business associates, including implementing a work-from-home policy for employees except for those related to our laboratory operations. These disruptions could result in increased costs of execution of operational plans or may negatively impact our business due to its negative impact on the global economy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For more information on the impact of the COVID-19 outbreak on our business and financial results, please see &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8212;The COVID-19 pandemic could adversely impact our business and results of operations.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Orphan drug legislation in the United States has made significant improvements in encouraging the development of new drugs to treat rare diseases. Since the passage of the Orphan Drug Act and subsequent amendments to the orphan drug regulations, the FDA has granted over 5,000 orphan drug designations. Moreover, the FDA&#8217;s Center for Drug Evaluation and Research (&#8220;CDER&#8221;) approved 50 novel drugs in 2021, among which 52% were approved for treatment of orphan diseases, down from 58% in the previous year. During the year ended December&#160;31, 2021, CDER has approved more than twice as many orphan drugs than in the previous 10&#160;years, with a total of 221 novel orphan drugs approved from 2012 to 2021, as compared to 79 approvals for the period from 2003 to 2012. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the United States, orphan drug designation allows the drug sponsor to benefit from incentives for the development of these products up to marketing approval. The measures apply to all stages of drug development and include tax credits on clinical research, waiver of certain application fees and marketing exclusivity for seven years. In addition, more than $400&#160;million was provided by the FDA&#8217;s Orphan Products Clinical Trials Grants Program over the last three decades and led to the approval of more than 60 different drugs for rare diseases. In the European Union, financial incentives including fee reductions or waivers are available and market exclusivity is granted for ten years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Due to these legislative initiatives, there has been an increase in investment and activity in the rare disease drug development space. According to a new report from Global Genes, a leading rare disease advocacy organization, investment in rare diseases is gaining momentum. In 2021, drug developers invested a total of US$22.9 billion for research on rare disorders, an increase of 28% compared to 2020. It is estimated  that Orphan invoice spending has been increasing at a rate of over 14% for the last five years, and faster than other specialty or traditional drugs for the past four years. These investments are expected to lead to the approval of new rare disease drugs, which, according to market research, are expected to grow at a CAGR of 11.2% from 2019 to 2024 to $217&#160;billion, capturing approximately 18% of worldwide prescription sales.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Key Challenges in Rare Disease Drug Development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Despite the legislative initiatives to encourage orphan drug development and the consequent increase in investment and activity in the rare disease drug development space, significant unmet needs still exist. Of the 5,600 rare hereditary diseases, very few rare hereditary diseases have an FDA approved treatment. The limited number of treatments available for rare diseases is the greatest challenge for patient care and is based on the lack of research on rare diseases and barriers in developing and commercializing treatments.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">61</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe the following summarizes the key challenges clinicians and the pharmaceutical industry are facing today:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Lack of high-quality medical data as a result of:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Lack of phenotypic understanding.  </i>For many diseases, the symptoms are non-specific and often do not fit the typical picture of the disease. Due to their phenotypic heterogeneity, rare diseases have highly diverse clinical manifestations and unpredictable progression rates. These factors make it difficult for physicians to make an accurate diagnosis and determine an optimal treatment strategy.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Lack of comprehensive and curated information.  </i>A full understanding of the causes of a rare disease requires proteomic, metabolomic and genomic information at a genetic level, as well as detailed clinical information. Moreover, thorough medical validation processes must be conducted to ensure the quality of this information. While there are a few, limited rare disease databases available to the market, such as parts of ClinVar and HGMD, they are not specifically set up to service the rare disease industry and, due to their nature, lack medical curation. Consequently, this limits the accuracy and utility of that data for clinical diagnoses and decision-making.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Lack of ethnically diverse datasets.  </i>The majority of existing rare disease datasets only capture individuals in developed regions of the world, where healthcare expenditure is disproportionately higher. This disparity yields population datasets that are specific to such regions and does not capture the full ethnic and hereditary nature that may be present in various rare diseases. For example, as published in <i style="font-style:italic;">Nature</i>, despite the fact that unique genetic mutations are present across many different ethnicities, 87% of all genetic datasets are of European descent.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Difficulties in the early identification of patients.</span><span style="white-space:pre-wrap;">  Identifying rare disease patients is difficult given the small patient population for each rare disease. In addition, the population for each of the rare diseases is typically also scattered and diverse, which makes it more difficult to gain access to patients and collect sufficient real-world data to perform meaningful analyses to obtain a better understanding of the rare diseases. The lack of sufficient understanding of the clinical manifestations of rare disease makes it even more challenging to derive accurate diagnoses. The ability to access relevant patients with a particular rare disease and to access appropriate expertise, a network and dataset via the biobank, improves the accuracy of disease identification and facilitates the development of new treatments and diagnostic procedures.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Lack of biomarkers.</span><span style="white-space:pre-wrap;">  The small patient populations, phenotypic heterogeneity, homogenous datasets and lack of curated information for rare diseases all impede biomarker discovery. Without an identified biomarker, the ability to diagnose and ultimately treat a patient in a timely manner is diminished. Delayed diagnoses and limited knowledge of available treatments can lead to incorrect patient management, further disease progression and/or invasive or detrimental treatments. For example, patients suffering from Gaucher disease and Cystic Fibrosis can have average life expectancies of only eleven years and one year, respectively, if no treatments are available, leaving limited time for effective treatment if not diagnosed early. In addition, the lack of an identified biomarker can create hurdles in obtaining drug approval as biomarkers can be beneficial in clinical development, specifically in monitoring how effectively a patient is treated by a drug.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Difficulties in orphan drug development and commercialization as a result of:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Clinical Trial Recruitment.  </i>Relevant patient populations are typically spread across large geographical regions, making adequate patient recruitment for clinical trials particularly difficult, which can delay development.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Trial Design and Dose Selection.  </i>Small patient populations do not allow for multiple parallel studies in the same indication. This also applies to dosages, where the number of dose levels studied may be limited by the practical considerations of running a trial. As a result of these limitations, careful thought must be given to study design in order to optimize clinical trial success.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Patient Management.  </i>In an orphan drug trial, clinical management of individual patients can be difficult. Understanding the burden of disease and managing the patient and family experience within a study is key. Because of the progressive nature of many rare diseases, it is crucial to enroll patients at a time where treatment has the highest potential to be effective.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">62</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Eligibility Criteria.  </i>Eligibility criteria influences the type of patient eligible to participate in a clinical study. Consequently, this dynamic interferes with the establishment of a database that captures clinical efficacy and safety data which can be extrapolated to a larger network of patients with the same disorder.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Understanding the End Market.  </i>Obtaining accurate epidemiological data is crucial for pharmaceutical companies to appropriately size the ultimate end market for a given drug in development. Given the small patient populations, it can be a challenge for pharmaceutical companies to recover the costs of rare disease drug development. As a result, this may impede initial investment in rare disease therapies.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Market Traction.  </i>Once a rare disease drug is commercialized, the limited number of identified patients and challenges associated with diagnosis make it difficult for physicians and pharmaceutical companies to find individuals who would benefit from an approved therapy. In order to more successfully market a commercial drug, improved datasets are needed to aid in patient identification.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Vision</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have an integrated approach with a detailed, global understanding of the genetic basis and the clinical phenotype of rare hereditary diseases, which we believe will unlock the ability to target rare, metabolic, and neurodegenerative diseases and provide critical knowledge that will guide drug development and monitoring, and ultimately improve patient care. We perform analysis on the patients&#8217; data that we receive from our pharmaceutical and diagnostics businesses as well as from our research projects using a multi-omics approach, which combines genomics, proteomics, metabolomics and phenomics. The combination of multi-omics provides deep insights in the pathogenesis of rare hereditary diseases. The value in such a holistic diagnostics process has resulted in a shift from data generation to interpretation-based diagnostics, whereby the development and use of biomarkers and tests is the central element to bring rationality to treatment decisions for rare disease patients. High-quality, standardized clinical information supporting medical interpretation is a crucial element of the diagnostic process and leads to greater knowledge of the causes and symptoms of rare diseases. We believe a combination of worldwide data and detailed access to phenotype, genotype, transcriptomics, proteomics and metabolomics data will aid in the development of new treatments and reduce the costs associated with orphan drug development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Platform&#8212;An Integrated, Knowledge-Based System</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To deliver on this vision, we have developed a global real-world data based proprietary platform that we believe will improve methods for identifying and monitoring rare diseases and provide solutions that accelerate the development of orphan drugs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">At the core of our platform is our BioDatabank, allowing us to assemble an extensive knowledge base in rare hereditary diseases. We collect this detailed level of data in our repository through our easy-to-use CentoCard, a CE-Marked dried blood spot collection kit, captures blood samples of potential rare disease patients with a low cost of distribution, accompanied by the patients&#8217; medical histories and completed consent forms from the physicians. The data is then validated by professionals using a systematic and scientific approach creating what we believe to be the world&#8217;s largest curated database for rare disease variants. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">This systematic and thorough process results in information-based offerings that are beneficial for our pharmaceutical partners. This includes the ability to derive diagnostic solutions to accurately identify rare disease patients and the ability to identify new biomarkers, which help streamline and accelerate the path to approval for new drugs. As we facilitate the development of new drugs and the identification of more patients, an increasing number of patients are involved in clinical trials, which leads to even more </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">63</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:251.33pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">diagnostic information being added to our repository. This synergistic model allows us to continuously enhance our own expertise and support pharmaceutical knowledge in the rare disease field. A graphical description of our platform is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f007.jpg" alt="Graphic" style="display:inline-block;height:251.33pt;width:525pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">The Strengths of Our Platform</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our platform is intended to streamline and accelerate the development of treatments for rare, metabolic, and neurodegenerative diseases, and aids in the understanding of how to identify new rare disease patients and how to recognize and quantify market opportunities in patient populations. We believe we offer the following solutions for the industry:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Extensive repository to identify rare disease patients:  </b>Our BioDatabank includes epidemiologic, phenotypic and genetic data that reflects a global population, and also a biobank of these patients&#8217; blood samples. This capability has been facilitated by our development of the CentoCard, a convenient logistical solution. CentoCard is CE-Marked and easily stored, allowing for massive amounts of data aggregation from around the world. Additionally, where we have optional research consent from the patients in our BioDatabank, we have the ability to retest their biomaterials in our biobank. We are able to provide information about available treatment options to the physicians in our medical reports, therefore adding to the physician&#8217;s decision-making tools in determining treatment for the patients. We believe this solution reflects the largest repository of rare disease patient data, thereby allowing us to assemble a knowledge base from which to derive accurate diagnoses and epidemiological information. We have relationships with a global network of specialists at rare disease &#8220;centers of excellence&#8221;, with these relationships and the logistical advantages of our CentoCard product, we are able to continuously grow our repository from the collection of new patient samples and related patient data.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Ethnically diverse datasets:  </b>Our BioDatabank has the advantage of holding samples from a broad range of ethnicities. Our repository covers a substantial majority of ethnicities, as we have performed diagnostic tests for patients in over 120 countries. Without the ability to recognize ethnicity-specific patterns, the interpretation of genetic variants in patients is difficult and a patient&#8217;s physician may fail to find an accurate diagnosis. The mutation frequency distribution within one ethnicity can vary significantly from that of other ethnic groups within the same rare disease population. For example, a mutation in the Caucasian population might have a significant functional impact and cause a disease, but the exact same mutation in the Mongolian population might be without any functional consequence. Also, studies have shown that of the more than 1,893 Cystic Fibrosis mutations identified, patients of different ethnicities were subject to different types of genetic mutations. With access to data from a more diverse patient population, we are able to improve the interpretation of genetic variants, whether benign or causative. </p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">64</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:229.5pt;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:35.45pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Curated information in our unique BioDatabank:  </b><span style="font-family:'Calibri','Helvetica','sans-serif';white-space:pre-wrap;">We have built a truly differentiated BioDatabank of multi-modal data, including sociodemographic, clinical, multi-omics data as well as biomaterial of over 650,000 individuals.  As of December 31, 2021, </span>our BioDatabank included approximately 650,000 individuals and more than 400,000 of dried blood spots cards stored in our own physical biobank which enables retrospective analysis for research consented samples. Whole Exome Sequencing data and Whole Genome Sequencing data is available for approximately 84,000 and 14,000 individuals, respectively. Equally notable is our network of approximately 29,000 active physicians with whom we have been in contact in the last five years.<span style="font-family:'Calibri','Helvetica','sans-serif';"> </span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:21.25pt;text-indent:-21.25pt;margin:0pt 0pt 0pt 35.45pt;"><span style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:35.45pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">Geographic diversity:</b> Our BioDatabank includes individuals representing over 120 different countries. It is observed that the largest share of data within our BioDatabank relates to Europe followed by the Middle East. In Europe, Germany and Italy are the top contributors. Germany, being the country we have our origin, registers a high count of individuals. In the Middle East, Saudi Arabia and Iran contribute a large inflow of patients. Many cases of genetic rare diseases are observed in these regions and we have established a strong network of physicians.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 72pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt 0pt 0pt 36pt;"><img src="cntg-20211231x20f008.jpg" alt="Map&#10;&#10;Description automatically generated" style="display:inline-block;height:228.85pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:432.53pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 72pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">CentoMD:  </b>CentoMD is a subset of Centogene&#8217;s BioDatabank that contains among others genetic, demographic and phenotypic data on patients with issued clinical reports. CentoMD was designed to filter data for gene specific variants or variants associated to certain phenotypes. More recently, we have focused on the BioDatabank as a whole to leverage its complete data modalities for patients and customers.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Data Creation:  </b>Our team of scientists collects, annotates and reviews the phenotypic, genetic and other clinically relevant data of patient samples to ensure the highest medical validity of each sample. We also employ Human Phenotype Ontology (&#8220;HPO&#8221;) coding to accurately track and standardize sample phenotype and genotype data. The data curation is performed by our professional scientists with strong backgrounds in human genetics. Our methodological approach to information curation ensures we provide highly accurate data relevant to clinical diagnoses and decision-making. In this way, our Centogene BioDatabank brings rationality to the interpretation of global genetic data.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">65</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:207pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f009.jpg" alt="Graphic" style="display:inline-block;height:183.5pt;width:468pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Therapeutic areas and disease focus</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our broad expertise in rare diseases genetics is reflected in its<span style="font-family:'Calibri','Helvetica','sans-serif';"> BioDatabank </span>share of rare disease cohorts. The <span style="font-family:'Calibri','Helvetica','sans-serif';">BioDatabank </span>host comprehensive clinical, genetic and other omics data for more than 300 disease cohorts with at least 20 molecular genetic diagnosed individuals. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our data from genetically diagnosed patients encompasses the whole spectrum of diseases, with a focus on metabolic and neurological disorders. In total, more than 12 therapeutic indications are covered, including dysmorphology, bone, skin, immunological, tumoral, gastrointestinal, hematological, and cardiovascular disorders, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f010.jpg" alt="Graphic" style="display:inline-block;height:206.9pt;left:0%;padding-bottom:0.1pt;position:relative;top:0pt;width:468pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition to powering our diagnostic capabilities, the <span style="font-family:'Calibri','Helvetica','sans-serif';">BioDatabank</span>&#8217;s depth and richness of information has allowed us to uncover and describe new gene-disease associations. The BioDatabank also powers our R&amp;D efforts to explore and validate candidate biomarkers and potential new therapies for some of the diseases on which we are experts. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 56.7pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We are prioritizing rare metabolic and neurological disorders, with a focus on Gaucher, Niemann-Pick type C, and genetic Parkinson&#8217;s disease. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 56.7pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">66</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As an initial step to achieve this goal for these &#8216;top 3 diseases&#8217;, we aim to enrich and integrate all omics data within these three cohorts, creating so called Disease Avatars. The Disease Avatars reflect diverse datasets from 100-500 patients as well as 10-20 patient-derived cell lines, generating a model representation of the disease phenotype of pathway.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 56.7pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Avatars will enable a rapid R&amp;D cycle by generating data-driven insights and developing a better understanding of disease biology. The multimodal data within the Avatars by generating data-driven insights and hypotheses and validating them via patient-derived cell models aim to recapitulate the human disease in silico and in a dish, allowing us to better understand disease pathophysiology and to identify and test drug candidates in these models. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 56.7pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">They will aid in solving unmet medical needs for the patients and their families, allowing better diagnostics, uncover the biological factors that determine diverse disease outcomes (disease modifiers), discover/validate useful disease biomarkers, and mine candidate drug targets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Data Governance</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6.5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In 2021 Centogene introduced a new data governance roadmap that defines the major workstreams to further improve our use of sensitive data in an environment with ever growing regulatory and business demands. In this context, we understand data governance as the critical success factor to protect our patients&#8217; privacy according to the highest legal and ethical standards, but also to enable a maximum flexible use of data to reveal innovative insights making the crucial difference for our patients and medical research partners. Thus, data governance plays a central role in our data strategy by offering transparency on our data and its underlying policies and defining a framework ensuring that data users can access high quality data in an efficient, trustworthy and secure manner. We constantly improve and align our activities to satisfy the evolving requirements of internal and external audits and aim to build with future scaling in mind. In this context, the increased understanding of the availability, interpretation and visibility of optional research consent was an important data governance initiative we executed in 2021. It offered us a clear view of the amount of data available for different use cases and gave important indications regarding our way forward with the data governance setup.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Core Business Commercialization Strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are committed to improving the lives of rare disease patients by improving methods for identifying and monitoring rare diseases and providing solutions that accelerate the development of orphan drugs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our solutions from our core businesses are offered to our clients via two channels: </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Pharmaceutical:  </b>Our BioDatabank, clinical network, and CAP/CLIA diagnostic capabilities enable partnership offerings to our pharmaceutical partners across all phases of the drug discovery and development process as well as post-commercialization. </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Research and drug development partnerships: portfolio prioritization, drug target and biomarker discovery, disease models and translational science</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Clinical development partnerships: real world data sets, study design and site feasibility, patient recruitment and centralized lab support</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Market access and expansion: product launch strategy &amp; pricing, market access and label expansion, and diagnostic solutions</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 56.7pt;">Revenues from our pharmaceutical segment are generated primarily from partnership agreements with our pharmaceutical partners, which can be structured on a fee per analysis basis, milestone basis, fixed fee basis, royalty basis or a combination of these. For the year ending December&#160;31, 2021, &#8364;15.6&#160;million, or 8.2%, of our total revenues were derived from our pharmaceutical segment. For the year ended December&#160;31, 2020, &#8364;17.0&#160;million, or 13.2%, of our total revenues were derived from our pharmaceutical segment. </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Diagnostics:  </b>Our diagnostics segment provides targeted genetic sequencing and diagnostics services to patients through our distribution partners or our clients, who are typically physicians, labs or hospitals. As of December&#160;31, 2021, we believe we offer the broadest diagnostic testing portfolio for rare diseases, covering over 19,000 genes using over 10,000 different tests. Revenues from our diagnostics segment are typically generated by set fees per diagnostic test or per </p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">67</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:231.04pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 54pt;">bundle of diagnostic tests under contracts with our clients. In turn, the data collected from our diagnostics services allow us to continue to grow our repository and our BioDatabank. For the year ended December&#160;31, 2021, &#8364;27.9 million, or 14.7%, of our total revenues were derived from our diagnostics segment. For the year ended December&#160;31, 2020, &#8364;22.1&#160;million, or 17.2%, of our total revenues were derived from our diagnostics segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Pharmaceutical Solutions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are committed to accelerating the orphan drug development process for our pharmaceutical partners. As of December&#160;<span style="white-space:pre-wrap;">31, 2021, we collaborated with 33 pharmaceutical partners. In 2021, we entered into 18 new collaborations and completed 39 collaborations, resulting in a total of 45 active collaborations. Over 46 different rare diseases are covered by our current and historic collaborations.  We provide information solutions and diagnostic services to our pharmaceutical partners in all phases of drug development and treatment, including discovery, preclinical development and clinical development, as well as post-market care. The below chart demonstrates the scope of our pharmaceutical services to each stage of the drug development process:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f011.jpg" alt="Graphic" style="display:inline-block;height:230.54pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:484.41pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In Vitro Molecular Screening</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A full understanding of a given rare disease and the ability to identify and target the right molecules is essential for drug development. With access to our biological samples, we are able to aid <i style="font-style:italic;">in vitro</i> molecular screening efforts which can accelerate drug discovery efforts. Combined with access to our biobank and our data repository, our pharmaceutical partners are able to gain novel insights into the natural history of rare diseases, the broad spectrum of the different clinical symptoms as well as the genotype-phenotype correlation. Moreover, in situations where several genes can cause the same clinical symptoms and therefore, potentially cloud an accurate diagnosis, we believe we are able to identify additional genes that aid in the accurate diagnosis with the knowledge gathered in our database.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Epidemiological Studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The ability of pharmaceutical companies to identify patients early and to optimize their clinical trials is key to the development of treatments for rare diseases. We offer epidemiological studies that will provide our partners with important study design and site feasibility data as well as identify the right patients for future clinical studies. Epidemiological studies can target a specific country or region of interest thereby enabling a better understanding of market potential.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Through partnership, our pharma partners are able to specify the rare disease of interest as focus for an interventional clinical trial, and we identify the available epidemiological data and enhance the data with genetic and phenotypic information from our BioDatabank. From there, our pharmaceutical partners are able to better understand and define specific conditions or eligibility criteria that patients must meet for a clinical study.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">68</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:159.04pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We then perform a patient selection and identification program. We start by identifying existing patients in our BioDatabank who fit the defined criteria. If a patient sample is included in our sample repository but not yet tested to the level required for the trial, we run a diagnostics test to confirm if the patient meets the study criteria. If we need to find a larger cohort of patients than is currently included in our database or in our sample repository, we leverage our global network of partners, key opinion leaders, clinical labs and specialist physicians to help identify new patients who are at risk of developing, or have developed, the particular disease, in line with our pharmaceutical partners&#8217; defined patient cohort criteria. As a result, we are able to help our pharmaceutical partners optimize their clinical trials by more effectively selecting relevant patient groups and by leveraging our detailed understanding of the epidemiological data of the specific disease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Metabolic Biomarker Development </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Biomarkers are key tools employed across the continuum of rare disease drug development. Namely, they are utilized to support diagnosis, serve as a companion diagnostic to demonstrate treatment efficacy, as well as  monitor disease progression. Furthermore, biomarkers enable more efficient and economical patient diagnosis than genetic testing and allow mass screening programs for large patient cohorts. Biomarkers can also be relevant for precision medicine or for stratification.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the development of a high-quality biomarker for a given rare disease, both heterogenous and homogeneous cohorts of patients with known phenotypic and genotypic aspects are needed to identify/validate the sensitivity and specificity of a biomarker for a given disease. We believe our BioDatabank contains the largest curated mutation database for rare diseases as well as a vast source of healthy control individuals against whom we are able to identify the characteristics of unique biomarkers. Therefore, we believe we are ideally positioned to lead the market in rare disease biomarker development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2021, eleven biomarker assays have been completed covering ten rare diseases, including AADC deficiency, Cystic Fibrosis, Fabry disease, Faber disease, Gaucher disease, Hereditary Angioedema Disease (&#8220;HAE&#8221;), Niemann-Pick Type&#160;A/B and Niemann-Pick Type&#160;C diseases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">With proprietary biomarkers, we can also qualitatively measure a patient&#8217;s response to approved drugs and to drugs in clinical trials, and using this data helps to determine the optimum treatment dosage for each patient. This not only helps to accelerate the development of orphan drugs by demonstrating the efficacy of the drugs in clinical trials, but also allows patients, physicians and reimbursement agencies to better understand the impact of the drugs. The below graphs demonstrate how Lyso-Gb1, our first commercialized biomarker, can be used for patient screening and monitoring in the context of Gaucher disease:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><img src="cntg-20211231x20f012.jpg" alt="Graphic" style="display:inline-block;height:158.64pt;left:0%;padding-bottom:0.4pt;position:relative;top:0pt;width:514.2pt;" /></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 8pt 0pt;">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on a combination of our biomarker and a genetic confirmatory test</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">(Rolfs et. al., 2013.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The left graph demonstrates the sensitivity and specificity of our Lyso-Gb1 biomarker for Gaucher disease. According to a 2017 study, patients who are not suffering from Gaucher disease present with a Lyso-Gb1 level of less than 12 nanograms per ml, whereas patients with Gaucher disease display elevated levels of Lyso-Gb1. Based on the definition of the cut-off of 12ng/ml Lyso-Gb1, we can demonstrate a 100% sensitivity and close to 100% specificity, which means our Lyso-Gb1 biomarker, when combined with a confirmatory genetic test, can provide 100% accuracy in identifying patients suffering from Gaucher disease, and also those who are not suffering from the disease.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">69</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The right graph demonstrates how our Lyso-Gb1 biomarker can also be used to titrate the proper enzyme replacement therapy dosage in each individual patient. An increase of the Lyso-Gb1 level signals that the dosage of the enzyme replacement therapy needs to be adjusted. After adjustment, Lyso-Gb1 levels decreased to an almost normal level. This is valuable for demonstrating drug efficacy to relevant authorities for approval, and also for demonstrating to reimbursement agencies that individualized treatment and dosage may be required for the patient.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Genetic Screening of High Risk Populations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Once a treatment is available for a rare disease, early identification of patients is critical so that patients can be treated before they have reached the stage of irreversible progression. We are able to support our pharmaceutical partners in market access and label expansion through patient identification efforts by leveraging our knowledge and performing genetic and biochemical screening on large groups of patients with the risk profile of a given rare disease. Most often, we do this by using our biomarkers, which is economically efficient. If a positive diagnosis is concluded, we provide physicians with information on relevant treatment options, which helps physicians make clinically relevant decisions for the treatment of their patients. For negative diagnoses, no further confirmatory genetic or other testing is necessary. We provide each patient&#8217;s physician with a diagnostic report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Research and Development Validation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on our extensive expertise in rare diseases and our access to detailed genetic data, our pharmaceutical partners can approach us for guidance during their drug development endeavors. More specifically, our pharmaceutical partners can ask us to review their clinical trial design, evaluate clinical data from an ongoing or recently completed clinical trial and validate related biomarkers. All of these services are aimed at optimizing their clinical development efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Key Partnerships</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Shire/Takeda </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In January 2015, we entered into an agreement with Shire, now a subsidiary of Takeda Pharmaceutical Company Limited, to provide certain diagnostic testing capabilities to Shire and its affiliates in order to enhance early diagnosis of patients suffering from lysosomal storage and other rare diseases, including Fabry disease, Gaucher disease and Hunter syndrome. Our unique expertise and repository of data contributes to Shire&#8217;s mission to shorten the time it takes for rare disease patients to get diagnosed. In connection with this agreement, we receive a fixed annual fee plus additional service-based payments related to regulatory and diagnostic sequencing activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, in 2018, we entered into a new research agreement with Shire relating to their ongoing drug development efforts in HAE. As part of this agreement, we are conducting an extensive epidemiological study leveraging our data repository and network of physicians at centers of excellence to gain unique insights into HAE and to support Shire&#8217;s ongoing clinical development efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In July 2019, we entered into a collaborative research agreement with Shire related to HAE Kininogen assay mass spectrometry testing and screening. Both parties obtained the limited right to use each other&#8217;s data and intellectual property related to such testing and screening for the sole purpose of performing research under the agreement. This study was finalized  in December 2021.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2021, we entered into a collaboration with GWT (a German company contracted by Takeda) to provide laboratory testing services for a study on thrombocytopenic patients that potentially suffer from Gaucher disease (PRAGMATIC Diagnose study).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In December 2021, we extended our Global Master Service Agreement with Takeda to March 2023. This continuous partnership allows us to continue diagnosing and connecting rare disease patients globally.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Evotec International&#160;GmbH (&#8220;Evotec&#8221;)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In July 2018, we entered into an agreement with Evotec to support and jointly expedite their identification of new small molecule treatments in the field of glucocerebrosidase deficiency (&#8220;Gaucher Disease&#8221;). Evotec identifies active pharmaceutical ingredients based on the induced pluripotent stem cells (&#8220;iPSC&#8221;) that are generated from fibroblasts we obtain from skin biopsies of patients. We believe our collaboration will aid in the acceleration of drug development through the adoption and application of more </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">70</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">accurate cellular models of the target disease and specific biomarkers to monitor such diseases. Our collaboration combines Evotec&#8217;s cellular compound screening  platform and drug discovery capabilities with our medical and genetic insights to develop a high throughput platform to test innovative small molecules in Gaucher Disease. In connection with this agreement, we received an initial payment in 2018 and milestone payments as well as further royalty fees on net sales of products developed from this collaboration in 2018 and 2019</span>. In July 2020, we expanded our agreement with Evotec into an extensive collaboration for the discovery of both targets and therapies for Gaucher Disease (&#8220;GD&#8221;). The use of patient-derived, tissue-specific disease models, which have been created using our iPSC platform, allows for proof of concept evaluations in GD. The collaboration combines Evotec&#8217;s expertise in high throughput screening and compound generation along with our genomic and metabolomic platforms to discover novel therapies for the treatment of GD patients. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Denali Therapeutics (&#8220;Denali&#8221;)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In September 2018, we entered into a strategic collaboration with Denali for the global identification and recruitment of LRRK2 positive Parkinson&#8217;s disease patients. We will utilize our CentoCard and extensive network with centers of excellence to conduct a targeted global recruitment campaign focused on the early identification and characterization of LRRK2 positive Parkinson&#8217;s patients for the recruitment into Denali&#8217;s clinical trials. Given that we believe Denali&#8217;s study is the lead clinical investigation of LRRK2 inhibitors for the treatment of Parkinson&#8217;s disease, there is no large global existing cohort of identified patients with the LRRK2 mutation in the early phase of the disease. We aim to overcome those challenges and accelerate the enrollment of further patients into this clinical study and consequently facilitate Denali&#8217;s drug development process. In connection with this collaboration, we receive ongoing payments for patient enrollments and are eligible for success-based and commercial milestones and reimbursement of selected costs. In May 2021, we extended our partnership with Denali to recruit and test an additional 2,500 patients for the study of Parkinson&#39;s disease genetics in order to diagnose patients earlier and accelerate personalized Parkinson&#8217;s treatments<span style="color:#ff0000;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pfizer&#160;Inc. (&#8220;Pfizer&#8221;)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2019, we entered into a strategic collaboration with Pfizer, pursuant to a global master scientific services agreement (&#8220;MSSA&#8221;). In addition to the MSSA, we entered into a statement of work (&#8220;SOW&#8221;) in November 2019 to provide testing and analysis services to Pfizer for patients in the United States or Puerto Rico with transthyretin amyloid cardiomyopathy (&#8220;ATTR-CM&#8221;), patients suspected of having ATTR-CM, or individuals with a confirmed family history of hereditary ATTR-CM.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In October 2019, we entered into a data access and collaboration agreement (&#8220;DACA&#8221;) with Pfizer, pursuant to which we granted Pfizer access to our data repository, which may be used in the discovery and validation of novel genetic and biochemical targets for the potential development of new therapies for rare diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Diagnostic Solutions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Overview and Product Offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our diagnostic solutions segment provides diagnostic testing services to patients exclusively through our network of distribution partners and our diagnostics clients, who are typically physicians, laboratories, universities, or hospital facilities. Our diagnostic segment serves over 100 countries due in part to our CentoCard solution enabling an efficient and simple transfer of the sample from the point of care to the lab. Additionally, our online platform, CentoPortal, allows our clients to quickly and easily place orders and obtain information related to their patients&#8217; test results and benefit from advancements in rare disease research, which we update on a regular basis. We provide a high-quality, end-to-end clinical diagnostics solution, which includes pretest clinical counseling performed by our medical experts whenever necessary, sample preparation, sequencing using NGS technology, medical interpretation using our manual and automated bioinformatics pipelines, and medical reporting by our specialists.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Of the more than 5,600 identified rare hereditary diseases, in many cases not only is there no treatment available, but even the natural course of the disease and the relevant tests to diagnose the disease are unknown or underdeveloped. In order to further improve the understanding of rare hereditary diseases and to provide a better and earlier diagnosis for rare disease patients, we continuously develop new testing products to provide the most effective diagnosis products to our physician clients, leveraging insights from our platform and our deep medical expertise.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In 2021, we launched NEW CentoXome&#174; our enhanced sequencing solution with outstanding clinical coverage and clinical diagnostic power in a single test. It provides highly uniform coverage of the entire exome and mitochondrial genome, and nearly </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">71</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:250.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">complete coverage of all known disease-causing regions throughout the genome in a single test. The improved test design includes the most up-to-date scientific knowledge and unique insights based on our rare disease-centric BioDatabank.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to traditional genetic or other testing, we have continued developing innovative diagnostic tests to provide patients with faster, more reliable, and more complete solutions. For example, we have developed an integrated multiomic panel, CentoMetabolic MOx - a product covering more than 180 metabolic disorders, which integrates genetic and biochemical testing, including enzyme assays as well as biomarkers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> As of December&#160;31, 2021, we offered a comprehensive testing portfolio of over 10,000 genetic sequencing tests covering more than 19,000 genes, from single gene to WGS-based products. We also offered differentiated comprehensive testing solutions including Multiomic Solutions, CNV Analysis, Biochemical testing, Reproductive Health and Prenatal Testing, among others. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In 2022, we announced the global release of CentoCloud, a SaaS platform enabling decentralized analysis, interpretation, and reporting of genomic variants linked to rare diseases.  Additionally, the CentoCloud solution will be able to utilize the power of proprietary reagent kits we are developing in collaboration with Twist Bioscience for rare disease diagnostics. The CentoCloud SaaS platform provides rapid and reliable medical reports, which can be challenging for sequencing laboratories due to bioinformatics resource as well as medical expertise limitations. Based on the decentralization of genetic testing and our rare disease-centric BioDatabank and Artificial Intelligence (AI)-based clinical interpretation, CentoCloud will enable access to high quality medical reporting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f014.jpg" alt="Graphic" style="display:inline-block;height:249.85pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:410.5pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Overview of the Diagnostic Process</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our diagnostics processes are designed with the aim of providing the highest-quality diagnosis within the shortest turnaround time. We currently perform a majority of the diagnostic services for our diagnostics and pharmaceutical businesses in our clinical laboratory located in Rostock, Germany, which is certified under CLIA and accredited by the CAP. Additionally, we perform certain of these services in our Cambridge, Massachusetts facility, which is also certified under CLIA, accredited by the CAP and permitted by the Massachusetts State Clinical Laboratory Program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We strive to provide the best quality of diagnostics testing, not only by following the strictest quality criteria complying with CAP, and CLIA certifications and adhering to ISO&#160;15189 standards supported by our multidiscipline quality management system (&#8220;QMS&#8221;), but also by following applicable and market standard Good Laboratory Practice (&#8220;GLP&#8221;) and Good Manufacturing Practice Regulations (&#8220;GMP&#8221;) guidelines. Our processes are highly efficient and have been designed to deliver our medical report back to the physician within 30&#160;days from receipt of the sample, even for our most complex tests.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">72</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:214.51pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our diagnostics process is defined by our five-step process:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f015.jpg" alt="Graphic" style="display:inline-block;height:213.96pt;left:0%;padding-bottom:0.55pt;position:relative;top:0pt;width:517.99pt;" /></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Medical Quality and Counseling:  </b>Rare disease specialists review the patient&#8217;s clinical records and confirm that the physician has requested the appropriate genetic test with regard to the patient&#8217;s individual circumstances and medical history. In all cases, the physician is required to provide us with a completed patient consent form, which our staff review for adequacy prior to the performance of any diagnostic services.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Logistics:  </b>We use the CentoCard collection method for obtaining the majority of our samples. This standardized procedure allows us to extract high-quality biological material from dried blood spots on the CentoCard, including DNA (for molecular diagnostics), protein (for enzymatic and biomarker assays) and metabolites (for biomarker assays).</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Clinical Data Management:  </b>Physicians are able to order our diagnostic tests for a particular patient either online through our CentoPortal platform or by email or mail.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Diagnostics:  </b>Once a patient sample is received, we prepare the biological material for testing by taking an extract of the DNA from the relevant sample. Depending on the test requested by the physician, we would then proceed to run any number of our diagnostic services listed above.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Once produced, the data is entered into a sophisticated series of our proprietary computational algorithms designed to detect and identify known pathogenic variants. The sequenced data is analyzed using our fully validated and automated bioinformatics pipeline and annotated with information from our BioDatabank. Our BioDatabank is key to the diagnostics process as it is used as the basis of comparison with the patient&#8217;s sequenced data. This analyzed genetic information together with the patient&#8217;s medical history and clinical data is then interpreted by our medical experts, a team of trained human geneticists and doctors. All identified mutations along with their annotations will undergo a manual validation against the medical history of the patient in order to ensure accuracy.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Additionally, our bioinformatics pipelines provide a highly automated approach to analysis of variant classification, CNV identification and other genetic data. To augment our bioinformatics pipelines, we have developed a database to store all variant information, which is part of our BioDatabank, and is the basis for our evaluation and interpretation of genetic data. We have developed an in-house variant prioritization and classification system, named CentoPrio, to enhance our interpretation capabilities. CentoPrio takes advantage of the vast amount of genotypic and phenotypic data stored in our databases. Through the use of proprietary algorithms and machine learning algorithms (artificial intelligence), we combine this data with current medical knowledge to prioritize particular variants that have been identified in previously closed patient cases.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">73</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:189.09pt;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Reporting:  </b>Our test reports deliver clinically relevant information in a manner that seamlessly integrates into physician practices. A standard report contains a summary of the test result, provides our analysis, recommendations and detailed description of the patient&#8217;s relevant genomic alterations and a full data record for consolidation with the patient&#8217;s medical records. The report also identifies noteworthy absences of genomic alterations and summaries of, and references to, supporting data from peer-reviewed publications. If requested by the physician, we also provide information on variants in genes not associated with the patient&#8217;s disease or symptoms but that nonetheless contain medically actionable information (such as incidental or secondary findings).</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">All of our medical reports are written by professional medical experts facilitated by our automated report writing technology and are reviewed and approved by our Chief Medical Officer before distribution. Physicians obtain one report per patient diagnosis while our pharmaceutical partners obtain genomic information that has been provided with express patient consent and de-identified in accordance with HIPAA and other relevant health information privacy procedures. All reports are easily accessible through our online platform, CentoPortal.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Solutions for Providing High-Quality Data </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">CentoCard</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our sample collection method is a CE-Marked dried blood spot collection kit, the CentoCard (as shown below), which is translated into more than 30 languages and registered in more than 50 countries. The CentoCard is sent to physicians as part of a five-component kit: (1)&#160;the CentoCard, (2)&#160;a genetic or other testing informed consent form, (3)&#160;an instruction leaflet, (4)&#160;a self-addressed return envelope and (5)&#160;a plastic sleeve for the used CentoCard to be sealed in once the sample is obtained. In order to obtain the sample, a small amount of blood is drawn from a patient by his or her physician and placed on designated spots on the CentoCard. This sample is then left to dry for approximately two hours, during which time the sample stabilizes. Each CentoCard produced has a unique barcode that allows for the card to be traced at all times. It is delivered to our laboratory in Rostock, Germany, along with a signed consent form, from anywhere in the world via regular post. Samples collected on CentoCard are considered non-biohazardous materials, which allows them to be mailed across many borders without the need for certain customs declarations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We use the CentoCard collection method to obtain the majority of our samples. This standardized procedure allows us to extract high-quality biological material and perform most of our diagnostic tests from a portion of a single dried blood spot on the CentoCard. Using the CentoCard, we are able to provide a solution where necessary molecular and biochemical tests can be run simultaneously using the same patient sample. Given that the biomaterial stabilizes on the CentoCard, we are able to retest the existing patient samples multiple times for more than 10&#160;years from initial sample collection.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f016.jpg" alt="Graphic" style="display:inline-block;height:189.09pt;width:369.5pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">CentoPortal</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">After a physician creates an online account on CentoPortal by following a few easy steps, the physician can order a test product of his or her choosing, provide and sign a patient consent online, provide an overview of the patient&#8217;s medical history, track </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">74</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">the samples and progress of the diagnostic test and download the final medical report once the process is complete. Access to the CentoPortal requires secured authentication. This helps prevent unauthorized access, unauthorized use or loss of patient data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Biobank</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have established a high quality biorepository for use in our research and development collaborations with our pharmaceutical partners. Our biobank provides a large diversity of positive test cases in the field of inherited rare diseases and comprises original patient materials characterized through our genetic and/or biochemical diagnostics and with associated clinical information. The biobank operates under robust quality standards and is the first CAP accredited repository outside the United States. It is also compliant with the new ISO20387 standard and comprises materials from patients who have consented to the use of such materials in research. All of our samples have gone through our rigorous process of documentation, analysis and data evaluation by our in-house experts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Metabolic Biomarker Development Process</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">So long as an adequate patient cohort exists for any of the 7,000 identified rare diseases, of which approximately 80% have a genetic origin, we believe unique biomarkers can be established. However, the prerequisite is for up- or down-regulated metabolites to be present in the sample medium (e.g. blood) of pathologic or control cases. We may either develop a biomarker on our own, in which case we choose the rare disease to be analyzed using a biomarker, or we may develop a biomarker at the request of a pharmaceutical company, in which case we typically adapt a biomarker for a specific rare disease identified by the pharmaceutical company. In both cases, we own the rights to the biomarker or biomarker test, but in circumstances where a pharmaceutical company is funding the biomarker development process, we may agree to parameters for use of the biomarker going forward. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The first step to the biomarker development process is the identification of patients suffering from a particular disease compared to a respective control group of healthy individuals. To perform this, our repository, which we refer to as the data lake, is browsed for samples to perform patient stratification. Patients with a phenotype and/or genotype known to be an indicator of the particular rare disease for which we plan to develop the biomarker are compared with a large cohort of healthy control individuals. We can conduct this process with a disease cohort of as few as ten patients in the case of metabolic diseases, although it is our experience that a higher number of patients (i.e.,&#160;approximately 40)&#160;could result in a more specific biomarker target validation. The samples included in the analysis (patients and controls) must be of the same type (e.g.,&#160;dried blood spots, plasma, tissue) and contain the same anticoagulant. The control samples must be matched to the pathological samples by sample age, patient age, gender, origin, and storage condition. Information on ongoing treatments is important since it has an effect on the patient&#8217;s metabolic profile. In addition, Our clinical study department is involved with the identification and recruitment of patients when there is a lack of patients identified in our repository.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The extraction of metabolites from a sample is performed in a highly standardized manner as the results of the biomarker discovery depend on the stability of the samples and the uniformity of the extraction process. We then analyze the samples using an untargeted high resolution hybrid mass spectrometer to obtain a full metabolic profile The resulting differences found between the patient cohort profiles and the control cohort profiles are identified using statistical and mathematical algorithms as well as methods based on artificial intelligence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Machine Learning algorithms and statistical methods helps us to identify correlations between different data in an efficient and more accurate manner, and to discover patterns that would not be discovered manually. Machine Learning also allows us to perform fully automated pattern recognition on multidimensional data (e.g.,&#160;retention time, collision cross section, monoisotopic ion mass, fragmentation pattern) obtained from mass spectrometry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2020, we built an integrated biomarker development platform that substantially simplifies and accelerates the search and confirmation of metabolomic biomarkers. The platform allows us to align arbitrary numbers of mass spectrometry measurements. As of December 31, 2021, the metabolic profiles of 12 000 individuals are available in one aligned dataset within our CentoMetabolome data base. On this dataset, we can perform virtual experiments qualitatively for biomarker development. Since no further biomaterial is consumed after the one-time initial measurement, an unlimited number of experiments can be performed. The functionality is integrated in a user-friendly platform and therefore accessible to biological experts without knowledge about machine learning. The platform supports the search for biomarker candidates as well as screening of patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The mass spectrometry peaks (signals) identified by the platform are then investigated with other mass spectrometric techniques (fragmentation and targeted mass spectrometry) to identify the metabolites underlying the signal (so-called structural </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">75</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">elucidation). Subsequently, using estimate on the structural identity of the biomarker candidate, a pure synthesized standard is measured to confirm the structural assignment and inspected to determine if the biomarker candidate is present in the metabolic pathway that is affected by the disease (biological interpretation).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Proof of concept for the biomarker assay is performed on anonymized samples using targeted mass spectrometry, in which the identified biomarker candidates are quantified. This part of the process (assay development) could be completed in three-months per biomarker project. We can then use the biomarkers to develop standardized tests for other services such as our patient screening processes followed by validation tests.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Validation Tests</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As more patients are enrolled to the clinical trials, we are also able to perform further validation tests for the biomarker so that it could be used for longitudinal monitoring. Validation is a three to six month process during which the biomarker and its characteristics are assessed, which helps to determine the range of conditions under which the biomarker will give reproducible and accurate data. Approximately 50 to 100 patients in a disease cohort are needed to complete the validation process and approximately 8,000 to 10,000 different measurements are needed to comply with all CAP/CLIA/ISO requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are dedicated to scientific research and development in order to continuously improve the industry&#8217;s understanding of epidemiology and its analysis of clinical heterogeneity as an aid to the diagnosis of rare diseases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In addition, we also undertake scientific research and clinical studies, both independently and together with our pharmaceutical partners, with the aim of positively contributing to the global understanding of rare diseases, as well as to improve the accuracy of diagnosis and to support the development of effective treatments for rare diseases. Our large BioDatabank with over 400,000 rare disease biosamples and over 31 million unique variants is key to our research and development. Clinical data captured combined with whole genome sequencing, transcriptomics and metabolomics allows unique insights into rare disease pathologies. It enables our research in rare disease genomics, biomarker development and serves as a starting point for drug discovery. Cellular disease models serve as a starting point for testing hypotheses of pathological mechanisms.  For this, patient derived IPS cells are differentiated towards mature cellular phenotypes. Disease causing mutations in those cells enable the establishment of cellular disease models and when comparing to healthy cells allows target and drug discovery with the aim of reverting a pathological phenotype towards a healthy phenotype.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We published over 50 scientific papers in 2021 which made significant scientific impact as represented by the impact factor (+33% as compared with 2020). The highlights from our publications include: Centogene led work to delineate 6 novel rare disease genes using an in-silico approach in our BioDatabank (Bertoli-Avela et al., 2021; PMID: 33875846), co-authorship in the discovery of a novel gene for birth defects published in the prestigious New England Journal of Medicine (PMID: 34587386), and Centogene led work characterizing a novel disease gene leading to a cystic fibrosis-like disease using our multiOMIC platform integrating genomics, transcriptomics, and metabolomics (PMID: 34952832).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our major on-going clinical studies, other than those related to biomarker development, are as follows as of December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Global Study on Colon- and Pancreas-Carcinoma (PICOP-Global)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2019, we announced the initiation of a 24 month global proof of concept study focusing on the identification of tumor specific neoantigens, which we anticipate will be used by our partners as the basis for developing a personalized, immune-based therapy to trigger patients&#8217; own immune responses against tumors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">This ongoing study for patients with colon or pancreas carcinoma gained momentum after the complete lockdown during the pandemic was lifted. In 2021, 50 additional patients were recruited. In total, 254 individuals have contributed tumor material and reference samples to establish our neoepitope pipeline. All study sites, i.e. Rostock, Greifswald, and Lahore, Pakistan contributed similar numbers and sample qualities. Furthermore, the analysis of DNA (tumor specific variants) and RNA (expression of potential neoepitopes) is fully deployed, and samples can be processed and analyzed within two weeks from samples entering into our &#8220;neoepitope candidate list&#8221;. Intensive research and development were carried out on optimizing peptide mass spectrometry in order to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">76</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">directly confirm predicted neoepitopes in tumor samples. Furthermore, in collaboration with our industry partner, we established tools to qualify and quantify neoepitope-specific T-cell responses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Induced pluripotent stem cells (iPSC) program</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Since early 2019, we have independently conducted an iPSC program (the &#8220;iPSC Program&#8221;) with the aim of supporting orphan drug development in a more cost effective and efficient manner, in particular for the development of orphan drugs related to rare neurodegenerative, metabolic, and cardiovascular diseases. Human iPSCs, first reported in 2007, are reprogrammed from somatic cells and are self renewal cells that can produce different types of cells. In the drug discovery process for rare diseases, iPSC technology is particularly important in providing information on the clinical spectrum of such diseases by generating disease specific cells which can be used to evaluate novel therapeutics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2021, we had collected approximately 1,600 skin biopsies from patients with rare diseases from around the world. As part of our iPSC Program, we are currently in the process of reprogramming these biopsies into iPSC for a number of metabolic rare diseases and differentiating the cells into a number of disease-relevant cell types (macrophages, liver, microglia and neurons). We currently establish patient-derived macrophage disease models in GBA-1 Parkinson&#8217;s Disease, Gaucher and Niemann Pick Type C. Once completed, the iPSC Program will further support orthogonal target validation as well as further biomarker discovery that we undertake.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Rostock International Parkinson&#8217;s Disease Study (ROPAD)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">By end of 2020, the ROPAD Study, which was initiated in May 2019 to investigate the genetic factors in Parkinson&#8217;s disease, achieved its goal of recruiting and genetically characterizing more than 10,000 subjects with Parkinson&#8217;s Disease (PD). In total, more than 300 LRRK2-PARK patients and almost 1,200 GBA-PARK were genetically identified among other rarer forms of genetic PD, such as PRKN, SNCA, PINK1, and others. In March 2021, we started to prepare an extension of the concept (&#8220;ROPAD2&#8221;), where,  more than 2,500 PD patients were to be enrolled until March 2022 according to a partnership contract with Denali Therapeutics. By the end of 2021, the recruitment exceeded 400 subjects per month and more than 1,200 participants were analyzed. In parallel, we prepared for extension of the protocol beyond 2,500 PD patients throughout 2022 and 2023.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Progranulin Study in Frontotemporal Dementia (EFRONT)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We succeeded in entering a larger patient finding program with Alector in May 2021. Study goals are the identification of GRN positive patients with fronto-temporal dementia potentially eligible to be included in the Alector phase 2/3 clinical study. Unfortunately, the study initiation and patient recruitment was significantly delayed due to the COVID-19 pandemic. However, the project has resumed and as of December 2021, 22 study sites have been opened and 82 patients been included and genetically screened for GRN mutations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Epidemiological Analysis for Hereditary Angioedema Disease (EHA)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2021, the EHA study recruitment efforts increased from 1,100 at the end of 2020 to 2,060 study subjects at the end of 2021. The recruitment took place at 55 study sites and an extension phase to include an additional 1,200 individuals in 2022 has been agreed upon with Takeda.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The related biomarker study HAEKA, focusing on the collection of high-frequency samples from patients suffering from HAE attacks, was mutually terminated in December 2021 after 59 patients with more than 180 attack samples were recruited and processed on our mass spectrometric platform for metabolomics. Moving forward, our focus is primarily on the biomarker validation. A final report on the HAEKA study was shared with Takeda at the end of December 2021. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> European Alpha-Mannosidosis Patient Epidemiological Program (EUMAP)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Recruitment for the EUMAP study, sponsored by Chiesi, where samples from individuals suspected to have alpha mannosidosis is progressing steadily. Although the initial target to recruit 1,000 patients by September 2020 was not met due to the delays caused by the COVID-19 pandemic, we added nearly 250 patients in 2021. The total number of recruited patients at the end of 2021 was 677. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">77</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Hereditary Transthyretin-Related Amyloidosis Study (TRAMoniTTR)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Following the success of the TRAM2 study, where approximately 5,000 individuals were screened for TTR mutations resulting in the identification of almost 60 individuals with this rare neurodegenerative disease, a longitudinal study focusing on TTR-positive individuals was designed and initiated with the support of our pharma partner Alnylam. In 2021, 1,449 subjects have been screened in 49 German centers. To date, 23 individuals with TTR mutations have been recruited for follow-up visits and the samples are used for  comprehensive multiOMIC characterization to define and validate TTR-specific biomarkers using transcriptomics and metabolomics.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our major ongoing collaborative drug discovery efforts making use of our unique insight into disease mechanisms are as follows as of December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Target discovery in Niemann Pick Disease of the type C applying artificial intelligence</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are collaborating with Insilico Medicine to identify novel therapeutic targets for Niemann Pick Disease type C. We will leverage our BioDatabank with multiomic patient data and NPC cell lines (for transcriptomic data and validation of identified candidates), using Insilico Medicince&#8217;s comprehensive novel target discovery AI platform for the identification of differential metabolites, pathways, and genetic modifiers. Both companies will analyze identified targets before pursuing validation in our cellular models and initiation of novel drug discovery efforts in a disease with very limited treatment options for patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Drug discovery in Gaucher Disease </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">In January 2022, we entered the third year of a collaborative effort with Evotec to discover novel small molecule drug candidates to target the unmet medical needs in Gaucher disease. The combination of our unique understanding of genetics, transcriptomics, metabolomics and IPS derived cellular disease models in Gaucher disease, and Evotec&#8217;s outstanding drug discovery capabilities make this a promising collaboration to discover drug candidates to glucocerebrosidase (GBA-1), a gene described as causative in Gaucher disease. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sales and Marketing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2021, we had a sales force of approximately 70 employees and consultants in our diagnostics segment. Our sales team members are all trained in key account management and/or genetic diagnostics and are able to discuss the different diagnostic and workflow needs of doctors, physicians, and genetic counselors. With our global footprint, we support rare disease patients around the world. Through a 3-zone and 5-region structure, we ensure patient and physician centricity. North America (NAMER) and Latin America (LATAM) are part of the West-Zone, Europe, and the Middle East &amp; Africa (EMEA) are part of the Central-Zone, and Asia Pacific (APAC) is part of the East-Zone. Each of the geographical regions is led by a Regional General Manager supervising a team of sales and clinical liaisons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2022, we will continue to expand our direct footprint and our distribution network to further increase the sample volumes in targeted geographic areas.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Information Technology Platforms</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our IT infrastructure platform is based on state-of-the-art standardized components. We run our systems according to the following hybrid production model in an effort to optimize cost and service levels:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Systems that require a short distance-to-lab infrastructure are run in-house in separate, protected server rooms;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Tailored systems with special requirements and heightened security use outsourced infrastructure as a service provided by Datagroup AG, which is GDPR-compliant. These services are provided by two datacenters in Frankfurt and our lab in Rostock, which are connected by two independent and encrypted 10GB landlines; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Highly standardized, high volume requirements use cloud services provided by Amazon Web Services and Microsoft.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">78</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All services are based on virtualized server systems with central storage components accompanied by backup and restore services, centrally managed network services, firewall systems, internet, databases and workplace services. System monitoring and events are implemented for all relevant systems with a central monitoring solution and central network scanner controls. Centrally managed user accounts are handled in the directory system.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Information security is highly valued and the principles of confidentiality, integrity and availability of information are a part of our core values. Information is protected by a variety of controls and procedures, including firewalls, password protections, data encryption (in storage and in transit) and malware protection tools. All internet-facing applications are regularly security tested. All personal data processing services are evaluated by our data protection officer and information security officer and documented in accordance with GDPR. Additionally, our data services are certified across a variety of industry security standards, including ISO&#160;9001 (which aims to ensure we consistently provide services and products that meet customer and regulatory security expectations) and ISO&#160;27001 (which standards ensure the data in our database are secured).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our workflows and processes are supported by various specialized applications. For example, via our user-friendly online portal &#8220;CentoPortal,&#8221; analyses ranging from individual diagnostic requests to requests for pharmaceutical projects with high throughput testing can be ordered. Physicians can view the status of the samples they submitted and download a complete medical report. Upon receiving samples, we digitize all information to support a fully digital internal workflow. This starts with a web application for sample entries, where information is transferred automatically by interfaces to our laboratory information system. This information forms the basis of our medical reports, which are made available to doctors for download. Data is shared between CentoPortal and our laboratory information systems through a fully automated interface.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Artificial Intelligence</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Since 2018, we have been using artificial intelligence to further automate our processes, obtain new insights about rare diseases from mass data sets and generate new knowledge-driven business models. For example, we use artificial intelligence to enhance our biomarker discovery process. This allows us to shorten data analysis time from weeks to minutes and to identify multiple biomarkers or additional biomarker patterns in our multi-omicsdatasets. We also use artificial intelligence to automate our curation process and the identification of genetic and/or metabolic modifiers. We currently have ten employees dedicated to this artificial intelligence effort.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe that our data repository provides us with a competitive advantage for driving the development of new and effective artificial intelligence tools, as the foundation of any successful artificial intelligence program is high quality data in a volume that can effectively generate results. The higher quality the data and the more data that are available, the better chance we have of building machine learning models with high predictive power and accuracy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2021, we deployed the following artificial intelligence programs:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Intelligent Character Recognition</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Intelligent character recognition (&#8220;ICR&#8221;) at the sample entry stage enables us to fully digitize all information contained in sample order paperwork. Even on handwritten texts, our ICR technology achieves significant performance. This allows us to obtain accurate patient information at the initial stage of the diagnostics process and reduces the likelihood of human error.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Clinical Information Extraction</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We extract clinical information from diagnostic reports, using natural language processing methods. Text recognition analyses PDF medical reports and detects clinical status, family history, HPO terms, age, and other data. The data is subsequently applied to enrich cases in our BioDatabank.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Anomaly Detection in NGS data</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We implemented an AI function that identifies lab contaminations at the sample or library preparation stages. This provides corrective measures and counter measures for future applications. The algorithm is programmed to recognize &#8220;normal&#8221; data and alerts its users when an anomaly is detected. Information regarding the anomaly is provided by the algorithm detailing its top-k indicators and comparisons are made to similar anomalies detected in the past along with the respective reported results and subsequent actions taken.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">79</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Variant Prioritization</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have deployed a new variant prioritization tool based on our in-house artificial intelligence capability. This tool identifies the most likely disease-causing genes based on our repository, in order to further accelerate our and our partners&#8217; diagnostics processes, and is in particular aimed to enhance the diagnostics process for whole exome and clinical exome sequencings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">With our clinical exome panel, which covers over 19,000 genes with known associated clinical phenotypes and covers over 3,700 diseases, the result of the sequencing process usually discovers between 70,000 and 150,000 variants per individual. However, the majority of these variants are benign or unrelated to the observed disease phenotype of the patient. With our huge data repository built up from the last 12&#160;years, and a curated database with standardized HPO terms, our tool is able to rank the variants from most to least relevant. Based on such &#8220;ranked&#8221; variants, we can then compare the HPO terms of a new patient with the results of prior, anonymized patients included in our repository with variants in the same gene. This allows us to provide a diagnosis in a more rapid, comprehensive and accurate manner, especially for patients with very rare or as yet undescribed diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Variant Classification</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2015, American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published a joint consensus recommendation for interpretation of genetic variants. ACMG&#8217;s recommended standards classify genetic variants, based on 28 criteria, into five categories: pathogenic, likely pathogenic, variant of uncertain significance (VUS), likely benign and benign. We have implemented a semi-automated variant classification tool that classifies variants detected in a sample based on ACMG&#8217;s recommended standards. Our tool will significantly reduce the time taken to interpret the clinical significance of genetic variants and increase the quality such interpretation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">AI-based Artifact Detection Tool</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Artifacts discovery via current diagnostic workflow such as visual infection and sanger sequencing for WGS cases requires a lot of manual work. This method of discovery is inefficient, error prone and risks important variants being missed in the discovery process. By applying our artifact prediction model, we can improve the reliability of the data by distinguishing true variant cells from sequencing errors in WGS samples, and prioritize true variants in the evaluation processes which results in a reduction of analysis effort and increases the diagnostic efficiency. Subsequently, a report is provided to our medical experts for the interpretation of variant sequencing quality which categorizes the results into one of three classes: &#8220;likely artifact&#8221;, &#8220;likely true&#8221;, and &#8220;unknown&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Artifact detection is a tool used for the classification of small sequence variants (SNPs, InDels) into likely artifacts, unknown, or likely variant. It enables the automated detection of artifacts in VCF-files using machine learning algorithms. The model is based on gradient boosting classification, which uses an ensemble of so-called weak learners to create a strong learner, yielding reliable classification results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Automated Curation Report</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our curators are responsible for the collection, association, update and review of genetic and phenotypic data of cases analyzed at Centogene to assure the highest level of data quality. The automated curation process supports our curation process with a set of rules encoding the expert knowledge and classifying newly incoming cases as well as reclassifying the old ones if new genomic insights result from research.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Biomarker Discovery &amp; Support of Metabolomic Processes</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We built a proprietary, AI-powered biomarker platform called CentoMetabolome. This internally developed platform has the potential to revolutionize the detection of new biomarkers by accelerating components of biomarker development that previously required months to complete to a few days. This includes supporting full metabolome screening, identifying biomarker candidates, and establishing a better understanding of drug efficacy. The integration of the artificial intelligence-based methods into a user-friendly platform enables the medical experts to perform high-quality and high-performance biomarker experiments, with integrated quality control checks. Further support is given for structural identification through a database that links mass-spec peaks with previously identified metabolites, and by methods that automatically identify previously unknown peaks. In addition, we have been awarded the Health-i Award for the development of this platform, which recognizes companies that are transforming healthcare domestically and internationally. The Health-i Award winners were selected by industry and research experts for initiatives that are aimed at transforming the next era of healthcare through innovation.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">80</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Multi-Omics Analysis</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We piloted a multi-omics platform for genomics and metabolomics integration and visualization, which consists of a comprehensive multi-omics map of genes, mutations, metabolic reactions, enzymes, and regulatory elements of the lysosomal storage diseases. The map allows for the overlay of our genomic, metabolomics and, phenomic data, the performance of perturbation experiments of expression parameters for phenotype prediction and the analysis of fold change data. This platform is capable of being extended to transcriptomics and proteomics. The platform provides a unique, innovative model for understanding system biology and allows for the selection of targets for drug discovery. In particular, it allows for the investigation of lysosomes and the associated pathways in the cause of disease. Furthermore, inbuilt applications within the platform allow correlations between genomic and metabolomic data, and extraction of pathways and differential metabolites to further enable biological understanding of diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Knowledge Graph for Disease Understanding</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A knowledge graph is a framework built to integrate and map patient relevant datasets along with complementary types of data in a meaningful way. We have built a knowledge graph that merges our data with millions of datapoints on genes, protein-protein interaction networks, and metabolites. At the same time, Machine learning and AI applications are activated to identify any previously unknown patterns while making novel target predictions. The graph is used as a data-structure underlying various analyses within our disease projects, such as disease exploration, RNA-Seq dual experiment visualization, and identification of novel target genes. It is expected that the data and knowledge captured in CentoGraph will keep expanding and evolving with time and with every new Centogene designed experiment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Genome-wide association studies (GWAS) pipeline </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We have developed a genome-wide association studies (GWAS) pipeline to identify genetic modifiers. This pipeline includes different statistical tests, both at the variant and at the gene level. The implementation allows for variant filtering based on different quality criteria, as well as specific genetic principles. In addition, different gene collapsing models are defined based on variant properties such as minor allele frequency (MAF) and the predicted variant effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Big Data</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Many rare diseases share phenotypic and genetic traits which interests Biopharma companies involved in drug development and commercialization. Patients, diagnostics, genetic, transcriptomic, proteomic, metabolic and phenotypic information extractable from patient samples are stored in different data formats with different applications and workflows. To optimize the infrastructure for cross-departmental data evaluation, we developed the BigData platform as a way forward to provide a low-cost scale solution for data storage and processing. It enables users to perform analytics and data science through a flexible, scalable and cloud based platform across patient biomarker and bioinformatics data. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Big Data solution is an analytical and reporting platform which changes traditional cross-departmental (silos) into a highly scalable, available system for data storage and analytics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 36pt;"><span style="font-style:italic;font-weight:bold;">Healthcare Reimbursement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Reimbursement of genetic or other testing differs markedly among countries and evolves rapidly based on advancements in technologies and cost. It is a challenge for insurers or public payers to decide when to reimburse for genetic or other tests that are offered by healthcare providers. One of the reasons this is difficult is that often there are alternative treatments with differing results, which insurers may not be able to easily evaluate</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Depending on the billing arrangement and applicable law, we may be reimbursed for genetic or other testing services by third-party payors that provide coverage to the patient, such as an insurance company or managed care organization, or by physicians or other authorized parties (such as hospitals or independent laboratories) that order our tests or refer tests to us. In the years ended December&#160;31, 2021 and 2020, we derived between 1% and 2% of our total revenue from United States third-party payers that includes managed care organizations and other healthcare providers. In the years ended December&#160;31, 2021 and 2020, we derived less than 1% of our total revenue from EU insurance companies and managed care organizations based in the European Union</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We have strategically determined to focus on countries around the globe where the prevalence of rare hereditary diseases is high or the availability of national genetic or other testing and interpretation is to some extent limited and therefore the complete </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">81</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">reimbursement or partial payment by the government for our services is more likely. Therefore, the major markets for our diagnostics business currently include the Middle East, Western Europe, parts of Eastern Europe, Latin America, North America, South Asia and parts of South-East Asia. In most of our markets, our diagnostics tests are billable directly to the party submitting the request for a test to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Data Management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Data is the basis for all of our diagnostic and research processes. We are generating approximately up to 25TB of new data in the lab every month. The data is stored in our own infrastructure as well as in a certified third party data center and with Amazon Web Services. The software solutions supporting these processes are based on modern database architecture, and all of our critical systems are fully redundant and backed up in real-time to these facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Further, we implement our big data concept based on architecture. Because we store a vast amount of raw data in our repository, we are able to aggregate data to gain new insights. Data gathering and variant curation are procedures developed and implemented in a web-based software (developed and maintained by Centogene&#160;N.V.) that is compliant with the HUGO Gene Nomenclature Committee (the &#8220;HGNC&#8221;), the Human Genome Variant Society (the &#8220;HGVS&#8221;) and HPO nomenclatures. The software integrates in-house sample management systems and analysis platforms with external databases, utilizes a combination of computer-based tools and manual review in order to assure the accuracy, efficiency and quality of curation process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Quality Management System</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have developed and maintained a QMS that integrates the compliance of our processes with various medical device regulations, clinical trial requirements and clinical laboratory requirements. Our QMS is supported by standard operating procedures, educational and staff training plans, internal and external proficiency and competency programs, internal and external auditing, quality improvement indicators and pre-post analytical quality controls, including equipment maintenance, negative and positive controls, change management, employees and customer health and safety and document control programs. Our QMS integrates the compliance of our processes with the following requirements:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">42 CFR &#167;493</b><span style="display:inline-block;width:22pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Clinical Laboratory Improvement Amendments of 1988 (CLIA)</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">21 CFR &#167;820</b><span style="display:inline-block;width:22pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">FDA Quality System Regulation</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">21 CFR &#167;812</b><span style="display:inline-block;width:22pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Investigational Device Exemptions</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">ISO 15189</b><span style="display:inline-block;width:31.74pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Medical laboratories &#8211; Particular requirements for Quality and Competence</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">ISO 13485</b><span style="display:inline-block;width:31.74pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Medical Devices &#8211; Quality Systems &#8211; Requirements for Regulatory Purposes</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">EU 2017/746</b><span style="display:inline-block;width:23.25pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">European Union In Vitro Diagnostic Regulation</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">ISO 14971</b><span style="display:inline-block;width:31.74pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Medical Devices &#8211; Application of Risk Management to Medical Devices</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">21 CFR &#167;803</b><span style="display:inline-block;width:22pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">FDA Medical Device Reporting</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">21 CFR &#167;806</b><span style="display:inline-block;width:22pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">FDA Reports of Medical Device Corrections and Removals</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">MEDDEV 2.12-1</b><span style="display:inline-block;width:6.5pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Guidelines on a Medical Devices Vigilance System</i><span style="display:inline-block;width:32.56pt;"></span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:bold;">NCCLS GP26-A3</b><span style="display:inline-block;width:3.75pt;"></span><span style="display:inline-block;width:36pt;"></span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Application of a Quality Management System Model for Laboratory Services</i></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe our QMS was built to withstand the rigorous review and auditing of medical device regulations, clinical trial requirements and clinical laboratory requirements to ensure our patients and clients receive the highest quality level of care and service.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">82</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Client data protection is of high importance to us, as we provide solutions to our clients in more than 120 different countries with varying requirements. We protect our clients and employees through an informed consent process, which goes through a rigorous legal review with in-country specialists and our internal HIPAA and GDPR compliance policies. We continuously monitor all electronically archived and incoming data through these channels.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Data Acquisition and Curation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Curation is the process of collection, association, updating and review of epidemiologic, phenotypic and genetic data of patients analyzed by us into a structured and standardized format. It uses a combination of computer-based tools and manual review in order to assure the accuracy, efficiency and quality of the curation process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Data acquisition.</i><span style="white-space:pre-wrap;">  Data gathering and variant curation procedures are developed and implemented in a web-based software which is compliant with the HGNC, HGVS and HPO nomenclatures allowing collection of variants detected in nuclear coding, nuclear non-coding and mitochondrial genes. The software integrates in-house sample management systems and analysis platforms with external databases providing the curator with a comprehensive and straightforward overview of the evidences regarding genotype-phenotype correlation available both in-house and external.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The data is gathered by a combination of manual submission and data importation following an individual-oriented model where characteristics belonging to a particular individual (including patient information, clinical data, methodology and detected genetic variants) are stored and associated together.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our uniform classification of variants is an important step in improving our understanding of disease pathogenicity. There are approximately 3&#160;<span style="white-space:pre-wrap;">billion base pairs in an individual genome, which translates to approximately 200 gigabytes of data that can be obtained from a single sequencing process. The classification of variants which we record in our BioDatabank follows the American College of Medical Genetics and Genomics guidelines for variant classification, differentiated into five categories: pathogenic, likely pathogenic, uncertain clinical significance, likely benign or benign. If a diagnostic test is finalized without assigned clinical significance we still include the data under an  &#8220;unclassified&#8221; quality status. This information can then be used as comparative data for future diagnostic tests. This systematic classification of variants is based on a highly qualified and standardized curation process, which allows us to provide our clients with high-quality clinical interpretations of newly identified variants, and also ensures that changes in variant classification will be communicated and reflected in our clinical interpretations in a timely manner.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As industry knowledge on variant frequencies increases, we reevaluate the variant classifications contained in our database on a regular basis to ensure our system incorporates the most up-to-date information. Additionally, given the number of rare diseases that have yet to be fully diagnosed and the speed of advancements in the rare disease industry, we regularly revisit &#8220;uncertain&#8221; patient data to reassess prior clinical interpretations against this new industry knowledge.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Database curators.</i><span style="white-space:pre-wrap;">  Our curators are scientists with strong backgrounds in human genetics. They continuously undergo extensive training to ensure curation consistency and standardization. They assure that data is properly associated and interpreted and that there are no inconsistencies or discrepancies against detected in-house observations and from external sources. They close the curation process by manual approval that reviewed and curated data comply with standard in-house procedures.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Curation workflow.</i><span style="white-space:pre-wrap;">  To provide high-quality data, our curation process is divided in three phases: variant-wise, individual-wise and warnings-wise procedures.</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Curation by variant.  </i>To begin the curation process, the variant-linked information is reviewed. This includes approval of variant nomenclature, terminology, accuracy, consistency and record completeness.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Curation by individual.  </i>In order to start curation on a patient-by-patient basis, all variants detected in an individual must be approved. This process aims to assure that the data belonging to an individual follows the guidelines for clinical reporting closely and that all associated data is in agreement with our established guidelines and applicable industry standards. The following factors are considered critical for the clinical statement: variant clinical significance, patient genotype, inheritance pattern of the disorder, the sex of the patient and the phenotypic description, when available.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><i style="font-style:italic;white-space:pre-wrap;">Curation by warning.  </i>The database generates warnings at different levels (variant, individual, gene database levels) to detect errors, invalid terms and nomenclatures and inconsistencies. These warnings are triggered by additional evidence </p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">83</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 54pt;">obtained internally, such as medical reports, or detected externally, such as articles, publications and external databases. Each warning is then manually documented and resolved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Intellectual Property </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our success depends in part on our ability to obtain and maintain proprietary protection for our genetic rare disease information platform, proprietary biomarkers, products and solutions and other know-how related to our business, defend and enforce our intellectual property rights, in particular, our patent rights, preserve the confidentiality of our trade secrets, and operate without infringing valid and enforceable intellectual property rights of others. We seek to protect our proprietary position by, among other things, filing EU, U.S. and certain foreign patent applications related to our biomarkers, where patent protection is available. Our policy is to seek patent protection and trademark registration for commercially valuable assets we develop, as appropriate, and maintain as trade secrets other aspects of our genetic rare disease information platform, processes and know-how. We also rely on proprietary technologies, methods and processes, product designs and branding that we have developed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding these efforts, we cannot be sure that patents will be granted with respect to any patent applications we have filed or may file in the future, and we cannot be sure that any issued patents will not be challenged, invalidated, or circumvented or that such patents will be commercially useful in protecting our technology. Moreover, trade secrets can be difficult to protect. While we have confidence in the measures we take to protect and preserve our trade secrets, such measures can be breached, and we may not have adequate remedies for any such breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. For more information regarding the risks related to our intellectual property, please see &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8212;Intellectual Property Risks Related to Our Business.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Patents </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Each patent family in our patent portfolio typically includes one or more priority-forming patent applications on the basis of which an international patent application (an application filed under the Patent Cooperation Treaty (&#8220;PCT&#8221;)) is filed, after which national and regional patent applications are prosecuted in various jurisdictions. As of December&#160;31, 2021, our patent portfolio was as follows:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">With regard to our biomarker for Gaucher disease, we own two issued U.S. patents, one pending U.S. non-provisional patent application, issued patents in Australia, China, Europe, Israel, Japan and Russia, and five pending patent applications in the following foreign jurisdictions: Brazil, Canada, Europe, Hong Kong, and Russia. The two issued European patents have been validated in one or more contracting states of the European Patent Convention. These issued patents, and any patents granted from such applications, are expected to expire in 2032, without taking potential patent term extensions or adjustments into account.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">With regard to our biomarker for Niemann-Pick disease, we own two issued U.S. patents, two pending U.S. non-provisional patent applications, issued patents in Australia, Brazil, Europe, Israel, Japan and Mexico, and pending patent applications in the following foreign jurisdictions: Australia, Canada, and Japan. The one issued European patent has been validated in one or more contracting states of the European Patent Convention. These issued patents, and any patents granted from such applications, are expected to expire between 2032 and 2034, without taking potential patent term extensions or adjustments into account.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">With regard to our biomarker for Cystic Fibrosis, we own one pending U.S. non-provisional patent application and seven pending patent applications in the following foreign jurisdictions: Australia, Brazil, Canada, Europe, Israel, Hong Kong and India. Any patents granted from such applications are expected to expire in 2037, without taking potential patent term extensions or adjustments into account.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The term of individual patents depends upon the legal term for patents in the countries in which they are granted. In most countries, including the United States, the patent term is 20&#160;years from the earliest claimed filing date of a non-provisional patent application in the applicable country. In the United States, a patent&#8217;s term may, in certain cases, be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over a commonly owned patent or a patent naming a common inventor and having an earlier expiration date.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">84</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have entered into agreements with the University of Rostock and a related scientific institute pursuant to which such parties have fully transferred to us interests that they had co-owned with us with respect to patents and patent applications relating to our biomarkers for Gaucher disease, metachromatic leukodystrophy and Niemann-Pick disease or to the treatment of cancer or lysosomal storage disorders. Pursuant to the terms of these agreements, we were required to pay a total of &#8364;150,000 in upfront transfer fees and are obligated to pay royalties below 1% on net sales generated by the applicable patents in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Trade Secrets and Trademarks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to patent protection, we also rely on trade secrets, know-how, continuing technological innovation, and confidential information to develop and maintain our proprietary position and protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection, including, our genetic rare disease information platform. We seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and commercial partners. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our proprietary technology by third parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our brand is very important to us, as it is a symbol of our reputation and representative of the goodwill we seek to generate with our customers. Consequently, we have invested significant resources in the protection of our trademarks. We seek trademark protection in the United States and in foreign jurisdictions where available and when appropriate. We own registered trademarks for both &#8220;Centogene&#8221; and &#8220;CentoMD&#8221; in Europe, the United States and other jurisdictions, including Canada and Japan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Regulation </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our diagnostics and pharmaceutical businesses are highly regulated due to our operation of clinical laboratories in Rostock, Germany and Cambridge, Massachusetts and because of our provision of diagnostic services and our development of proprietary biomarkers. In addition, we are subject to a variety of regulations and industry standards worldwide governing, among other things, data privacy, distribution of our products and patents and trademark licensing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The key U.S. and European regulations that are applicable to our business are discussed in more detail below. Whether or not we obtain FDA clearance or approval or a CE Mark for a product, we must obtain the requisite approvals from regulatory authorities in foreign countries prior to the use of a diagnostic or other product in those countries. The requirements and processes governing patient consents, product registration and pricing vary from country to country.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">United States Regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our business is subject to and impacted by extensive and frequently changing laws and regulations in the United States at both the federal and state levels. These laws and regulations include regulations particular to our business and laws and regulations relating to conducting business generally. We also are subject to inspections and audits by governmental agencies. Set forth below are highlights of the key United States regulatory schemes applicable to our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">CLIA and State Regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Because we operate clinical laboratories, we are required to hold certain United States federal and state licenses and certifications to conduct our business. We are subject to CLIA regulations in the United States, which establish quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results regardless of where the test is performed. Our laboratories in Rostock, Germany and Cambridge, Massachusetts are CLIA-certified and accredited by CAP, as well as CAP ISO&#160;15189 accredited. In addition, we are required to meet certain laboratory licensing requirements for states with regulations beyond CLIA. For more information on state licensing requirements, see &#8220;&#8212;Regulation&#8212;United States Regulation&#8212;State Laboratory Testing.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Under CLIA, a laboratory is any facility that performs laboratory testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention or treatment of disease, or the impairment of, or assessment of health. CLIA also requires that we hold a certificate applicable to the type of work we perform and comply with certain standards. CLIA further regulates virtually all clinical laboratories by requiring that they be certified by the federal government and comply with various operational, personnel, facilities administration quality and proficiency requirements intended to ensure that their clinical laboratory testing services are accurate, reliable and timely. Laboratories must register and list their tests with the Centers for Medicare&#160;&amp; </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">85</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Medicaid Services, or CMS, the agency that oversees CLIA. CLIA compliance and certification is also a prerequisite to be eligible to bill for services provided to governmental payor program beneficiaries and for many private payors. CLIA is user-fee funded. Therefore, all costs of administering the program must be covered by the regulated facilities, including certification and survey costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are subject to survey and inspection every two years to assess compliance with program standards, and may be subject to additional unannounced inspections. Laboratories performing high-complexity testing are required to meet more stringent requirements than laboratories performing less complex tests. In addition, a laboratory like ours that is certified as &#8220;high-complexity&#8221; under CLIA may develop, manufacture, validate and use proprietary tests referred to as LDTs. While laboratories that offer LDTs are subject to the FDC Act, in addition to CLIA, the FDA has generally exercised enforcement discretion towards these tests. In compliance with CLIA requirements to establish performance specifications, including accuracy, precision, specificity, sensitivity and a reference range for any LDT used in clinical testing, our LDTs have undergone full analytical validation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to CLIA requirements, we elect to participate in the accreditation program of CAP. CMS has deemed CAP standards to be equally or more stringent than CLIA regulations and has approved CAP as a recognized accrediting organization. Inspection by CAP is performed in lieu of CMS for accredited laboratories. Because we are accredited by the CAP Laboratory Accreditation Program, we are deemed to also comply with CLIA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">State Laboratory Testing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">CLIA also provides that a state may adopt laboratory regulations that are more stringent than those under federal law, and a number of states have implemented their own more stringent laboratory regulatory schemes. State laws may require that laboratory personnel meet certain qualifications, specify certain quality controls, or prescribe record maintenance requirements. Our clinical operations at our Cambridge laboratory are required to meet certain state laboratory licensing and other requirements, which in some areas are more stringent than CLIA requirements. Our Cambridge, Massachusetts lab is also subject to Massachusetts Department of Public Health clinical laboratory permitting requirements. In October 2018, we received our CLIA permit to perform high complexity genetic testing in our Cambridge, Massachusetts lab. Our Massachusetts Department of Public Health clinical laboratory permit application was reviewed and the lab was inspected. It passed accreditation with no deficiencies and was issued a Massachusetts license for high complexity testing in November 2018. We have been permitted to begin testing in November 2018. Two states, New York and Washington, are CLIA-exempt, however, and as such have their own regulatory requirements to which we may be subject. CMS deemed both New York and Washington as CLIA-exempt because their licensing and supervisory programs are more stringent than that run by CMS and the CDC. New York requires clinical laboratories that accept specimens from New York residents to have both a CLIA and New York Clinical Laboratory Evaluation Program (&#8220;CLEP&#8221;) permit. CLEP approval can take up to a year, and can be costly and time-consuming. Washington State does not require clinical laboratories to have a CLIA permit, but does require the clinical laboratory to apply for a Washington State lab permit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Several states in the United States require the licensure of out-of-state laboratories that accept specimens from those states. For example, New York requires a laboratory to hold a permit which is issued after an on-site inspection and approval of testing methodology, and has various requirements over and above CLIA and CAP, including those for personnel qualifications, proficiency testing and physical facility, equipment and quality control standards. Each of our CLIA laboratory locations, including our site in Massachusetts, holds the appropriate licensure for the activities performed at that location. CLEP permit requires LDTs that are offered to New York State patients must be submitted for approval before they can be marketed or offered in New York. The Company is in the process of obtaining the requisite approvals for its LDTs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">From time to time, other states, such as California, Rhode Island, Maryland, New York and Pennsylvania, may require out-of-state laboratories to obtain licensure in order to accept specimens from the state, even though the laboratory is not located in such state. If we identify any other state with such requirements, or if we are contacted by any other state advising us of such requirements, we intend to follow instructions from the state regulators as to how we should comply with such requirements. We are currently licensed in Florida, Pennsylvania, Maryland, Rhode Island and California and are in the process of obtaining a New York State license.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Many states have also implemented genetic or other testing and privacy laws imposing specific patient consent requirements and protecting test results. In some cases, we are prohibited from conducting certain tests without a certification of patient consent by the physician ordering the test. Requirements of these laws and penalties for violations vary widely. We review our obligations regarding genetic or other testing and consent periodically. If we identify states with such requirements, or if we are contacted by any other state advising us of such requirements, we intend to follow instructions from the state regulators as to how we should comply with such requirements.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">86</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">FDA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the United States, medical devices are subject to extensive regulation by the FDA, under the FDC Act, and its implementing regulations, and other federal and state statutes and regulations. The laws and regulations govern, among other things, medical device development, testing, labeling, storage, premarket clearance or approval, advertising and promotion and product sales and distribution. To be commercially distributed in the United States, medical devices must receive from the FDA prior to marketing, unless subject to an exemption, either approval of a PMA (for most Class&#160;III devices), clearance of a 510(k) premarket notification or classification pursuant to a de novo submission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">IVDs are types of medical devices that can be used in the diagnosis or detection of diseases, conditions or infections, including, without limitation, the presence of certain chemicals, genetic information or other biomarkers. Predictive, prognostic and screening tests, such as carrier screening tests, can also be IVDs. A subset of IVDs is known as analyte-specific reagents (&#8220;ASRs&#8221;). ASRs consist of single reagents, and are intended for use in a diagnostic application for the identification and quantification of an individual chemical substance in biological specimens. ASRs are medical devices, but most are exempt from 510(k) review. As medical devices, ASRs have to comply with some QSR provisions and other device requirements, such as establishment registration, device listing and medical device reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The FDC Act classifies medical devices into one of three categories based on the risks associated with the device and the level of control necessary to provide reasonable assurance of safety and effectiveness. Class&#160;I devices are deemed to be low risk and are subject to the fewest regulatory controls. Many Class&#160;I devices are exempt from FDA premarket review requirements. Class&#160;II devices, including some software products to the extent that they qualify as a device, are deemed to be moderate risk, and generally require clearance through the premarket notification, or 510(k) clearance, process in order to be commercially distributed. Class&#160;III devices are generally the highest risk devices and are subject to the highest level of regulatory control to provide reasonable assurance of the device&#8217;s safety and effectiveness. Class&#160;III devices typically require approval of a PMA by the FDA before they are marketed. A clinical study is almost always required to support a PMA application and is sometimes required for 510(k) clearance. All clinical studies of investigational devices must be conducted in compliance with any applicable FDA and Institutional Review Board requirements. Devices that are exempt from FDA premarket review requirements must nonetheless comply with general post-market controls as described below, unless the FDA has chosen to exercise enforcement discretion and not regulate them.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">510(k) clearance pathway.</i><span style="white-space:pre-wrap;">  To obtain 510(k) clearance, a manufacturer must submit a premarket notification demonstrating to the FDA&#8217;s satisfaction that the proposed device is substantially equivalent to a previously 510(k)-cleared device or a device that was in commercial distribution before May&#160;28, 1976 for which the FDA has not yet called for submission of PMA applications. The previously cleared device is known as a predicate. The FDA&#8217;s 510(k) clearance pathway usually takes from three to 12&#160;months, but it can take longer, particularly for a novel type of product.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">PMA pathway.</i><span style="white-space:pre-wrap;">  The PMA pathway requires proof of the safety and effectiveness of the device to the FDA&#8217;s satisfaction. The PMA pathway is costly, lengthy and uncertain. A PMA application must provide extensive preclinical and clinical trial data as well as information about the device and its components regarding, among other things, device design, manufacturing and labeling. As part of its PMA review process, the FDA will typically inspect the manufacturer&#8217;s facilities for compliance with QSR requirements, which impose elaborate testing, control, documentation and other quality assurance procedures. The PMA review process typically takes one to three years but can take longer.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">De novo pathway.</i><span style="white-space:pre-wrap;">  If no predicate device can be identified, the product is automatically classified as Class&#160;III, requiring a PMA application. However, the FDA can reclassify, or use &#8220;de novo classification,&#8221; for a device for which there was no predicate device if the device is low or moderate risk. The FDA will identify &#8220;special controls&#8221; that the manufacturer must implement, which often include labeling and other restrictions. Subsequent applicants can rely on the de novo product as a predicate for a 510(k) clearance. The de novo route is less burdensome than the PMA process. A device company can ask the FDA at the outset if the de novo route is available and submit the application as one requesting de novo classification. The de novo route has been used for many IVD products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Post-market general controls.</i><span style="white-space:pre-wrap;">  After a device, including a device exempt from FDA premarket review, is placed on the market, numerous regulatory requirements apply. These include the QSR, labeling regulations, registration and listing, the Medical Device Reporting regulation (which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur) and the Reports of Corrections and Removals regulation (which requires manufacturers to report recalls and field actions to the FDA if initiated to reduce a risk to health posed by the device or to remedy a violation of the FDC Act).</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">87</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The FDA enforces these requirements by inspection and market surveillance. If the FDA finds a violation, it can institute a wide variety of enforcement actions, ranging from an untitled or public warning letter to more severe sanctions such as fines, injunctions and civil penalties; recall or seizure of products; operating restrictions and partial suspension or total shutdown of production; refusing requests for 510(k) clearance or PMA approval of new products; withdrawing 510(k) clearance or PMAs already granted; and criminal prosecution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Research use only.</i><span style="white-space:pre-wrap;">  Research use only (&#8220;RUO&#8221;) products belong to a separate regulatory classification under a long-standing FDA regulation. RUO products are not regulated as medical devices and are therefore not subject to the regulatory requirements discussed above. The products must bear the statement: &#8220;For Research Use Only. Not for Use in Diagnostic Procedures.&#8221; RUO products cannot make any claims related to safety, effectiveness or diagnostic utility, and they cannot be intended for human clinical diagnostic use. A product labeled RUO but intended to be used diagnostically may be viewed by the FDA as adulterated and misbranded under the FDC Act and is subject to FDA enforcement activities, including requiring the supplier to seek clearance or approval for the products. Our LDT uses instruments and reagents labeled as RUO in our laboratories.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Laboratory-developed tests.</i><span style="white-space:pre-wrap;">  LDTs have generally been considered to be tests that are designed, developed, validated and used within a single laboratory. The FDA takes the position that it has the authority to regulate such tests as medical devices under the FDC Act. The FDA has historically exercised enforcement discretion and has not required clearance or approval of LDTs prior to marketing. In addition, New York CLEP separately approves certain LDTs offered to New York State patients. The Company is in the process of obtaining the requisite approvals for its LDTs in New York.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On October&#160;3, 2014, the FDA issued two draft guidance documents regarding oversight of LDTs. These draft guidance documents proposed more active review of LDTs. The draft guidance has been the subject of considerable controversy, and in November 2016, the FDA announced that it would not be finalizing the 2014 draft guidance documents. On January&#160;13, 2017, the FDA issued a discussion paper which laid out elements of a possible revised future LDT regulatory framework, but did not establish any regulatory requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The FDA&#8217;s efforts to regulate LDTs have prompted the drafting of legislation governing diagnostic products and services that sought to substantially revamp the regulation of both LDTs and IVDs. Congress may still act to provide further direction to the FDA on the regulation of LDTs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe that the majority of the tests we currently offer meet the definition of LDTs, as they have been designed, developed and validated for use in a single CLIA-certified laboratory. If our tests are LDTs, they are currently not subject to FDA regulation as IVDs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">HIPAA and HITECH</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under the administrative simplification provisions of HIPAA, as amended by the HITECH Act, the United States Department of Health and Human Services issued regulations that establish uniform standards governing the conduct of certain electronic healthcare transactions and protecting the privacy and security of protected health information used or disclosed by healthcare providers and other covered entities. Three principal regulations with which we are required to comply have been issued in final form under HIPAA: privacy regulations, security regulations and standards for electronic transactions, which establish standards for common healthcare transactions. The privacy and security regulations were extensively amended in 2013 to incorporate requirements from the HITECH Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The privacy regulations cover the use and disclosure of protected health information by healthcare providers and other covered entities. They also set forth certain rights that an individual has with respect to his or her protected health information maintained by a healthcare provider, including the right to access or amend certain records containing protected health information, or to request restrictions on the use or disclosure of protected health information. The security regulations establish requirements for safeguarding the confidentiality, integrity and availability of protected health information that is electronically transmitted or electronically stored. The HITECH Act, among other things, established certain protected health information security breach notification requirements. A covered entity must notify affected individual(s) and the United States Department of Health and Human Services when there is a breach of unsecured protected health information. The HITECH Act also strengthened the civil and criminal penalties that may be imposed against covered entities, business associates, and individuals, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, other federal and state laws may govern the privacy and security of health and other information in certain circumstances, many of which differ from each other in significant ways and may not be </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">88</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">preempted by HIPAA, thus complicating compliance efforts. The HIPAA privacy and security regulations establish a uniform federal &#8220;floor&#8221; that healthcare providers must meet and do not supersede state laws that are more stringent or provide individuals with greater rights with respect to the privacy or security of, and access to, their records containing protected health information. Massachusetts, for example, has a state law that protects the privacy and security of personal information of Massachusetts residents that is more prescriptive than HIPAA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These laws contain significant fines and other penalties for wrongful use or disclosure of protected health information. Additionally, to the extent that we submit electronic healthcare claims and payment transactions that do not comply with the electronic data transmission standards established under HIPAA and the HITECH Act, payments to us may be delayed or denied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">United States Federal and State Fraud and Abuse Laws</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the United States, there are various fraud and abuse laws with which we must comply and we are potentially subject to regulation by various federal, state and local authorities, including CMS, other divisions of the U.S. Department of Health and Human Services (e.g.,&#160;the Office of Inspector General), the DOJ and individual U.S. Attorney offices within the DOJ, and state and local governments. We also may be subject to foreign fraud and abuse laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the United States, the federal Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration to induce or in return for patient referrals for, or purchasing, leasing, ordering or arranging for the purchase, lease or order of, any healthcare item or service reimbursable under a governmental payor program. Courts have stated that a financial arrangement may violate the Anti-Kickback Statute if any one purpose of the arrangement is to encourage patient referrals or other federal healthcare program business, regardless of whether there are other legitimate purposes for the arrangement. Violations may result in imprisonment, criminal fines, civil money penalties and exclusion from participation in federal healthcare programs. Many states also have anti-kickback statutes, some of which may apply to items or services reimbursed by any third-party payor, including commercial insurers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to the administrative simplification regulations discussed above, HIPAA also created two new federal crimes: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from governmental payor programs such as the Medicare and Medicaid programs. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact, or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from governmental payor programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Finally, another development affecting the healthcare industry is the increased enforcement of the federal False Claims Act and, in particular, actions brought pursuant to the False Claims Act&#8217;s &#8220;whistleblower&#8221; or <i style="font-style:italic;">qui tam</i> provisions. The False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment by a federal governmental payor program. The <i style="font-style:italic;">qui tam</i> provisions of the False Claims Act allow a private individual to bring actions on behalf of the federal government alleging that the defendant has defrauded the federal government by submitting a false claim to the federal government and permit such individuals to share in any amounts paid by the entity to the government in fines or settlement. When an entity is determined to have violated the False Claims Act, it may be required to pay up to three times the actual damages sustained by the government, plus civil penalties ranging from $11,181 to $22,363 for each false claim. These civil penalties are also adjusted for inflation periodically.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, various states have enacted false claim laws analogous to the federal False Claims Act, although many of these state laws apply where a claim is submitted to any third-party payor and not merely a governmental payor program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Physician Referral Prohibitions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Under a United States federal law directed at &#8220;self-referral,&#8221; commonly known as the &#8220;Stark Law,&#8221; there are prohibitions, with certain exceptions, on referrals for certain designated health services, including laboratory services, that are covered by the Medicare and Medicaid programs by physicians who personally, or through a family member, have an investment or ownership interest in, or a compensation arrangement with, an entity performing the tests. The prohibition also extends to payment for any testing referred in violation of the Stark Law. A person who engages in a scheme to circumvent the Stark Law&#8217;s referral prohibition may be fined up to $100,000 for each such arrangement or scheme. In addition, any person who presents or causes to be presented a claim to the Medicare or Medicaid programs in violation of the Stark Law is subject to civil monetary penalties of up to $15,000 per bill </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">89</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">submission, an assessment of up to three times the amount claimed and possible exclusion from participation in federal governmental payor programs. Bills submitted in violation of the Stark Law may not be paid by Medicare or Medicaid, and any person collecting any amounts with respect to any such prohibited bill is obligated to refund such amounts. Many states have comparable laws that are not limited to Medicare and Medicaid referrals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Corporate Practice of Medicine</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Approximately 30 states in the United States have enacted laws prohibiting business corporations, such as us, from practicing medicine and employing or engaging physicians to practice medicine, generally referred to as the prohibition against the corporate practice of medicine. These laws are designed to prevent interference in the medical decision-making process by anyone who is not a licensed physician. For example, California&#8217;s Medical Board has indicated that determining what diagnostic tests are appropriate for a particular condition and taking responsibility for the ultimate overall care of the patient, including providing treatment options available to the patient, would constitute the unlicensed practice of medicine if performed by an unlicensed person. Violation of these corporate practice of medicine laws may result in civil or criminal fines, as well as sanctions imposed against us and/or the professional through licensure proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other United States Regulatory Requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our laboratories are subject to United States federal, state and local regulations relating to the handling and disposal of regulated medical waste, hazardous waste and biohazardous waste, including chemical, biological agents and compounds, blood samples and other human tissue. Typically, we use outside vendors who are contractually obligated to comply with applicable laws and regulations to dispose of such waste. These vendors are licensed or otherwise qualified to handle and dispose of such waste.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The U.S. Occupational Safety and Health Administration has established extensive requirements relating to workplace safety for healthcare employers, including requirements to develop and implement programs to protect workers from exposure to blood-borne pathogens by preventing or minimizing any exposure through needle stick or similar penetrating injuries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The U.S. federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to annually report to CMS information related to payments or other transfers of value made to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">European Regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">European sales of medical and diagnostic devices are subject to European regulations. The time required to obtain clearance or approval by a foreign country may be longer or shorter than that required for FDA clearance or approval, and the requirements may be different. Set forth below are highlights of the key European regulatory schemes applicable to our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">European Conformity Marking (&#8220;CE Mark&#8221;) and Certifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The primary regulatory body in Europe is the European Commission, which has adopted numerous directives and has promulgated standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical and diagnostic devices. Devices that comply with the requirements of a relevant directive will be entitled to bear the CE Mark indicating that the device conforms to the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout the member states of the European Union, and other countries that comply with or mirror these directives. The method of assessing conformity varies depending on the type and class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a notified body, an independent and neutral institution appointed by a country to conduct the conformity assessment. This third-party assessment may consist of an audit of the manufacturer&#8217;s quality system, review of technical documentation and specific testing of the manufacturer&#8217;s device. Such an assessment may be required in order for a manufacturer to commercially distribute the product throughout these countries. ISO&#160;13485 certification is a voluntary standard. Quality systems that implement relevant harmonized standards establish the presumption of conformity with the essential requirements for a CE Mark. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We currently have 3 Invitro Diagnostic Medical Devices, the CentoCard, CentoSwab and CentoNIPT, which must be in compliance with Directive IVD 98/79/EG and Regulation (EU) 2017/746 (which will enter into force on May 26, 2022), to affix the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">90</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">CE Mark. The EU MDR Medical Device Regulation (MDR) is applicable for all our Medical Devices to affix the CE Mark. We use EN ISO 13485:2016 as the Quality Management Standard for Medical Devices and Invitro Diagnostic Medical Devices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Laboratory-Developed Tests</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">As currently a majority of our diagnostic testing is run at our laboratory in Rostock, Germany, the European Union and German legislation on <i style="font-style:italic;">in vitro</i> diagnostic medical devices applies. According to the recitals of the IVD-MDD, reagents which are produced within &#8220;health-institution laboratories&#8221; for use in that environment and which are not subject to commercial transactions are not covered by the Directive. However, the legal framework for applying the exemption clauses for LDTs is not entirely clear as the IVD-MDD lacks an explicit definition and there is no related case law. As of May 2022, when the new IVD-MDR becomes applicable, the general safety and performance requirements set out in Annex&#160;I IVD-MDR are applicable also to devices manufactured and used only within health institutions. Overall the exemptions for LDTs will be narrowed, as even health institutions that use LDTs, among other institutions, will have to provide information upon request on the use of such devices to their relevant authorities and the particular health institution will have to draw up a declaration which it is required to make publicly available. If those conditions are not met and/or diagnostic tests are manufactured and used only within health institutions but not &#8220;on an industrial scale&#8221;, such tests will qualify as IVDs with the IVD-MDR, generally applying with full applicability. However, with Regulation (EU) 2022/112 of January 25, 2022, new transitional periods for certain IVDs and a deferred application of conditions for in-house-devices have been introduced. Additionally, U.S. regulation applies to our laboratory-developed tests (see &#8220;Regulation&#8212;Regulation States Regulation&#8212;Laboratory-developed tests&#8221; for more information).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">General Data Protection Regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In May 2016, the European Union formally adopted the GDPR, which applied to all EU member states as of May&#160;25, 2018 and replaced the EU Data Protection Directive. The GDPR imposes strict requirements on controllers and processors of personal data, including special protections for &#8220;sensitive information,&#8221; which includes health and genetic information of data subjects residing in the European Union. The GDPR grants individuals the opportunity to object to the processing of their personal information, allows them to request deletion of personal information in certain circumstances, and provides an individual with an express right to seek legal remedies in the event the individual believes his or her rights have been violated. Further, the GDPR imposes strict rules on the transfer of personal data out of the European Union to the United States or other regions that have not been deemed to offer &#8220;adequate&#8221; privacy protections. It has increased our responsibility and liability in relation to personal data that we process and we may be required to put in place additional mechanisms ensuring compliance with the new EU data protection rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The GDPR is a complex law and the regulatory guidance is still evolving, including with respect to how the GDPR should be applied in the context of transactions from which we may gain access to personal data. Furthermore, many of the countries within the European Union are still in the process of drafting supplementary data protection legislation in key fields where the GDPR allows for national variation, including the fields of clinical study and other health-related information. There is still significant uncertainty related to the manner in which data protection authorities will seek to enforce compliance with GDPR in the medical and research fields. For example, it is not yet clear if such authorities will conduct random audits of companies subject to the GDPR or will only respond to complaints filed by individuals who claim their rights have been violated. Enforcement actions to date in other industries has resulted in significant fines and other penalties. Failure to comply with the requirements of the GDPR and the related national data protection laws of EU member states, which may deviate slightly from the GDPR, may result in material fines.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">European Fraud and Abuse Laws</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In Europe, various countries have adopted anti-bribery laws providing for severe consequences, in the form of criminal penalties and/or significant fines, for individuals and/or companies committing a bribery offense. Violations of these anti-bribery laws, or allegations of such violations, could have a negative impact on our business, results of operations and reputation. For instance, in the United Kingdom, under the Bribery Act 2010, which went into effect in July 2011, a bribery occurs when a person offers, gives or promises to give a financial or other advantage to induce or reward another individual to improperly perform certain functions or activities, including any function of a public nature. Bribery of foreign public officials also falls within the scope of the Bribery Act 2010. Under the new regime, an individual found in violation of the Bribery Act 2010 faces imprisonment of up to 10&#160;years. In addition, the individual can be subject to an unlimited fine, as can commercial organizations for failure to prevent bribery.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In Germany, interactions between pharmaceutical and medical device companies and physicians, other healthcare professionals and healthcare organizations are subject to the general criminal law regime covering anti-bribery in the public and private sectors, respectively, as well as to more recently enacted specific provisions in the German Criminal Code (Strafgesetzbuch &#8211; </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">91</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">StGB) covering anti-bribery in the healthcare sector in connection with the prescription and procurement of medicinal products and medical devices and the allocation of patients or material for diagnostic purposes. Obligations to report payments to healthcare professionals or healthcare organizations are currently limited to members of certain industry associations. Marketplace activities and medical claims are regulated by the Healthcare Advertising Act (Heilmittelwerbegesetz &#8211; HWG) and the Act against Unfair Competition (Gesetz gegen unlauteren Wettbewerb &#8211; UWG) allowing competitors, among others, to seek interim injunctions in ex-parte proceedings, and by consumer protection laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Violations of these laws may subject us to criminal, civil and administrative sanctions including monetary penalties, damages, fines, injunctions, disgorgement, individual imprisonment and exclusion from participation in government funded healthcare programs, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these laws, reputational harm, and we may be required to curtail or restructure our operations. Moreover, we expect that there will continue to be federal, and state and foreign laws and regulations, proposed and implemented, that could impact our future operations and business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Competition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe, for our core business, that we are the company offering the most comprehensive services to both diagnostics and pharmaceutical partners in the rare disease field, with highly curated data combining genetic, epidemiological and phenotypical information and proprietary biomarkers. Our principal competitors are existing mainstream diagnostics companies or companies specializing in certain rare diseases as well as cloud-based bioinformatic companies and entities that offer open source uncurated genetic databases. However, these companies do not offer curated information or as broad of a testing portfolio for rare diseases in as many geographical regions as we do. For example, we have found that the genetic mutation causing the same rare diseases and the phenotypical patterns may vary depending on the ethnicity of the patients, which we have identified based on our global data sets. Such unique insights may not be available to other companies that do not have the same global scope of patient data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our principal competitors in our diagnostics segment include mainstream diagnostic testing companies as well as labs or hospital conglomerates which offer the same services. In our pharmaceutical segment, our competitors include diagnostic testing companies and large pharmaceuticals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">With the continuous development in the NGS technology, the cost of genetic sequencing is anticipated to decrease and there may be companies intending to compete with us by performing massive sequencing at lower prices in order to obtain the relevant data to construct a similar database and repository. However, given the current limitations in the rare diseases fields, as well as the required quantity and quality of the data in order to make any relevant analysis, we believe our BioDatabank is the leading rare-disease centric BioDatabank, due to its focus, data quantity and data diversity (ethnic, geographic, etc).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Legal Proceedings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For more information, see &#8220;Item&#160;8. Financial Information&#8212;A. Consolidated Statements and Other Financial Information&#8212;Legal Proceedings.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Organizational Structure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our parent company is Centogene&#160;N.V. (the &#8220;Company&#8221;). Centogene&#160;B.V. was incorporated on October&#160;11, 2018. In connection with our initial public offering which closed on November&#160;12, 2019, we executed a corporate reorganization whereby Centogene&#160;B.V. was converted into Centogene&#160;N.V., and Centogene&#160;N.V. became the holding company for Centogene AG (now Centogene GmbH).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">92</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our major subsidiaries are listed below. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Country&#160;in&#160;which&#160;primary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity&#160;interest&#160;(%)</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">activities&#160;are&#160;pursued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec&#160;31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec&#160;31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene GmbH <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene FZ-LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Arab Emirates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene US, LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USA</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene GmbH</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Austria</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 90</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 90</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene India Pvt. Ltd.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">India</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene Switzerland AG</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Switzerland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CentoSafe B.V.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Netherlands</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene d.o.o. Belgrade</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Serbia</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Bauer Laboratoriums GmbH<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Centogene IP GmbH and Centogene Shared Service GmbH were merged with Centogene GmbH on January 1, 2021.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The Group acquired the remaining 49% of Centogene India Pvt. Ltd. in 2020.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Centogene does not own any shares in Dr. Bauer Laboratoriums GmbH. However, Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns from, and the ability to use power to affect returns of, Dr. Bauer Laboratoriums GmbH.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Property, Plants and Equipment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our headquarters are located in Rostock, Germany, where we occupy approximately 8,500 square meters of office and laboratory space that was originally constructed by us. In July 2019, Centogene AG (now Centogene GmbH) entered into a sale and leaseback transaction, pursuant to which we sold our Rostock headquarters building to a third party for &#8364;24,000&#160;thousand. We then leased the building from the third party for a period of 12&#160;years at a fixed rate per month with the option to extend twice. In addition, a bank guarantee of &#8364;3,000&#160;thousand (which we have secured by cash deposit of &#8364; 1,500&#160;thousand) is required to be maintained during the lease period. In February 2020, we entered into another lease contract for the further expansion of our Rostock headquarters. The additional lease contract covers a total area of approximately 2,850 square meters of offices, staff facilities and storage spaces, and will commence during the first quarter of 2023, when the building is expected to be completed by the lessor. The lease is charged at a fixed rate and covers a fixed period of eight years, with the option to extend twice. The lease cannot be terminated during the fixed eight-year period, but we are permitted to sub-lease to a third party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In September 2018, we also opened an office and laboratory facility in Cambridge, Massachusetts. We rented the premises with a two-year lease covering approximately 168 square meters. In June 2019, we rented additional premises of approximately 194 square meters. The contract provides for, and we have exercised, an option to extend for a period of two years after the current term ended on June&#160;30, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Both laboratories in Rostock, Germany and in Cambridge, Massachusetts, are equipped with the most advanced technologies for clinical diagnostics, clinical studies and research and development. We strive to follow the strictest quality criteria at all times and both laboratories are certified by the Centers for Medicare and Medicaid Services and accredited by the College of American Pathologists. To further enhance flexibility in capital management, we may purchase some of the leased laboratory equipment. These leases usually cover a period of two to four years, and our obligations under these leases are secured by the lessor&#8217;s title to the leased assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In March 2020, we announced the commencement of testing for COVID-19. In order to increase the testing capacity, we acquired the laboratory facilities and equipment of a former cancer immunotherapy company and leased their former laboratory space in Hamburg, Germany. The lease is charged at a fixed rate and covers a fixed period of five years, with an option to extend. We do not have the right to terminate the lease during the fixed five-year period, but we are permitted to sub-lease to a third party. To facilitate the increased demand in testing for COVID-19 in Germany, we opened a COVID-19 test center at Germany&#8217;s largest airport in Frankfurt am Main and an additional COVID-19 testing laboratory based in Industriepark H&#246;chst in Frankfurt am Main, Germany. In addition, we entered into short term lease agreements and operated COVID-19 test centers at the airports in Hamburg, D&#252;sseldorf and Berlin as well as in city centers in Frankfurt am Main, Wiesbaden and Berlin. In October 2021, we reassessed our long-term plans of providing COVID-19 testing due to changes in the COVID-19 pandemic, particularly developments in vaccination campaigns with increasing vaccination numbers and relaxation of testing regulations by several countries. As a result, we closed our Hamburg laboratory and exited service agreements and test center leases that were not profitable.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">93</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to our laboratories, we have sales and administrative offices located in Berlin (Germany), Cambridge (Massachusetts, United States), Vienna (Austria), Dubai (United Arab Emirates), Delhi (India) and Zug (Switzerland), allowing us to further expand our international footprint. Considering the continuous expansion of our business, we relocated our office to Berlin, Germany in October 2019. The new office covers an area of approximately 1,770 square meters and was leased for a period of 12&#160;years without an extension option. Until the end of the lease period for our Berlin, Germany office, we must provide a bank guarantee of &#8364;257&#160;thousand (which we collateralized with a cash deposit of &#8364;128&#160;thousand).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of December&#160;31, 2021, we employed approximately 808 highly qualified personnel (including consultants) from over 55 nationalities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_2ef8855b_1e89_41dc_b983_79ad52525f17"></a><a id="Item4AUnresolvedStaffComments_100896"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">4A.  Unresolved Staff Comments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">None</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_240947dd_0aab_44a8_b798_c110e27be4e8"></a><a id="Item5OperatingandFinancialReviewandProsp"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">5.  Operating and Financial Review and Prospects</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Operating Results</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">The following discussion of our financial condition and results of operations should be read in conjunction with Centogene&#8217;s audited consolidated financial statements as of December&#160;31, 2021 and 2020 and for the years ended December&#160;31, 2021, 2020 and 2019 and the notes thereto, included elsewhere in this Annual Report as well as the information presented under &#8220;Item&#160;3&#8212;A. Selected Financial Data.&#8221; Financial information presented in the consolidated financial statements for periods prior to the completion of our corporate reorganization in November 2019 is that of Centogene AG (which is now known as Centogene GmbH), our wholly-owned subsidiary. The consolidated financial statements of Centogene&#160;N.V. are a continuation of the historical consolidated financial statements of Centogene AG. Centogene AG was acquired by Centogene&#160;B.V., which subsequently converted into Centogene&#160;N.V., on November&#160;7, 2019 as part of our corporate reorganization. Centogene&#160;B.V. had no assets, liabilities or contingent liabilities until the completion of our corporate reorganization. Following the corporate reorganization, Centogene&#160;</i><i style="font-style:italic;white-space:pre-wrap;">N.V. became the holding company of Centogene AG and the historical consolidated financial statements of Centogene AG (now Centogene GmbH) as of and for the year ended 2018  included in this Annual Report became the historical consolidated financial statements of Centogene&#160;N.V. On March 5, 2020, we resolved that Centogene AG shall be converted into a German limited liability company and renamed Centogene GmbH. Such conversion became effective upon the registration in the German commercial register on June 29, 2020, and was therefore completed in the financial year ending December 31, 2020.The following discussion is based on our financial information prepared in accordance with IFRS as issued by the IASB, which may differ in material respects from generally accepted accounting principles in the United States and other jurisdictions. The following discussion includes forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those described under &#8220;Item&#160;3&#8212;D. Risk Factors&#8221; and elsewhere in this Annual Report.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#0000ff;font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are a commercial-stage company with our core businesses focused on rare diseases that transforms real-world clinical and genetic or other data into actionable information for patients, physicians and pharmaceutical companies. Our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. We have developed a BioDatabank of multi-modal data: Sociodemographic, clinical, multi-omics data as well as biomaterial included from over 650,000 individuals. As of December 31, 2021, more than 400,000 dried blood spots cards are stored in our own physical biobank which enables retrospective analysis for research consented samples. For approximately 84,000 individuals Whole Exome Sequencing data and for 14,000 individuals Whole Genome Sequencing data is available. Equally notable is our network of approximately 29,000 active physicians we have been in contact with in the last five years. We believe this represents the only platform that comprehensively analyzes multi-level data to improve the understanding of rare hereditary diseases, which can aid in the identification of patients and improve our pharmaceutical partners&#8217; ability to bring orphan drugs to the market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">We also leveraged our diagnostics expertise and entrepreneurial capabilities, to rapidly contribute to the worldwide COVID-19 response.  We developed and commenced testing for COVID-19 in mid-2020, </span>offering comprehensive and high quality COVID-19 testing solutions<span style="white-space:pre-wrap;">, mostly in Germany, our home country.  This includes our COVID-19 tests, which received Emergency Use Authorizations (&#8220;EUA&#8221;) from the FDA in July 2020; our CentoKit-19, a fully validated sample collection kit which can either be used </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">94</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">by healthcare professionals or self-administered by individuals; and our Corona Test Portal, a secure digital platform allowing seamless registration and result notification. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have identified three reportable segments:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-style:italic;font-weight:bold;white-space:pre-wrap;">Pharmaceutical.  </span>Our pharmaceutical solutions provide a variety of services to our pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. Our information platforms, access to rare disease patients and their biomaterials, and ability to develop proprietary technologies and biomarkers enable us to provide services to our pharmaceutical partners in all phases of the drug development process as well as post-commercialization. Revenues from our pharmaceutical segment are generated primarily from collaboration agreements with our pharmaceutical partners. As of December&#160;31, 2021, we collaborated with 33 pharmaceutical partners. In addition, we have developed 11 biomarkers covering 10 diseases. Since early 2020, we started to pursue a metabolomics approach for establishing a biomarker discovery pipeline for rare hereditary disease. Our new approach will include a tandem mass spectrometry methodology and artificial intelligence and, combined with the large volume of datasets in our global rare disease platform, has proven successful in the identification of new biomarkers. The new biomarker candidates are identified and then further validated and optimized in epidemiological clinical trials. </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-style:italic;font-weight:bold;white-space:pre-wrap;">Diagnostics.  </span>Our diagnostics segment provides targeted genetic sequencing and diagnostics services to our clients worldwide, who are typically physicians, laboratories or hospitals, either directly or through distributors. As of December&#160;31, 2021, we believe we offer the broadest diagnostic testing portfolio for rare diseases, covering over 19,000 genes using over 10,000 different tests. In turn, the data collected from our diagnostics services and biomaterials allow us to continue to grow our BioDatabank. </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 testing.</span><span style="white-space:pre-wrap;">  While not a core business, due to its growth and financial significance in relation to our total activities, our COVID-19 testing business has been managed and reported as a separate segment since the third quarter of 2020. We started offering COVID-19 testing in March 2020. Our initial COVID-19 test was a molecular diagnostic test performed for the in vitro qualitative detection of RNA from the SARS-CoV-2 in oropharyngeal samples from presymptomatic probands according to the recommended testing by public health authority guidelines. It has also been validated in our CAP/CLIA/ISO certified analytical laboratory and has received EUA from the FDA for use by authorized laboratories. The majority of these tests were performed in airport locations at the Frankfurt, Hamburg, Dusseldorf, and Berlin airports. Furthermore, tests are offered through collaborations with the state government and other companies. We plan to phase out this segment by the end of March 31, 2022.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our business has continuously seen notable expansion in recent years. In the year ended December&#160;31, 2021, we received over 2,451.3 thousand test requests, of which 2,330.5 thousand account for COVID-19 tests compared to the previous year where 1,510.5 thousand test requests were received, of which 1,395.4 thousand accounted for COVID-19. Excluding the COVID-19 tests, we received 120.8 thousand test requests in 2021, representing an approximate 5% increase as compared to approximately 115.1 thousand test requests received during the year ended December&#160;31, 2020, and an approximate 10% decrease as compared to 133.8 thousand test requests received during the year ended December&#160;31, 2019. The decrease in test requests received in the year ended December&#160;31, 2020 compared to the year ended December&#160;31, 2019 was approximately 14%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our revenue for the year ended December&#160;31, 2021 was &#8364;189,923&#160;thousand, an increase of &#8364;61,542&#160;thousand, or 47.9%, from &#8364;128,381&#160;thousand for the year ended December&#160;31, 2020. Our revenue for the year ended December&#160;31, 2020 was &#8364;128,381&#160;thousand, an increase of &#8364;79,601&#160;thousand, or 163%, from &#8364;48,780&#160;thousand for the year ended December&#160;<span style="white-space:pre-wrap;">31, 2019.  Our pharmaceutical, diagnostics and COVID-19 segments contributed 8.2%, 14.7% and 77.1%, respectively, of our total revenues for the year ended December&#160;31, 2021, as compared to 13.2%, 17.2%, and 69.6% respectively, of our total revenues for the year ended December&#160;31, 2020 and 44.1%, 55.9%, and nil respectively, of our total revenues for the year ended December&#160;31, 2019. Test requests received by our pharmaceutical and diagnostics segments for the year ended December&#160;31, 2021 were approximately 55.4 thousand and 57.1 thousand, respectively, representing a decrease of approximately 18.3% and 36.3%, respectively, as compared to approximately 67.8 thousand and 41.9 thousand test requests, respectively, received for the year ended December&#160;31, 2020. Test requests received by our pharmaceutical and diagnostics segments for the year ended December&#160;31, 2020 represented decreases of approximately 4.0% and 18.8%, respectively, as compared to approximately 70.6 thousand and 51.6 thousand test requests, respectively, received for the year ended December&#160;31, 2019. </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">95</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Since the inception of our business, our research and development has been substantially devoted to our biomarkers and interpretation solutions. For the year ended December&#160;31, 2021, we incurred research and development expenses of &#8364;19,297&#160;thousand, an increase of &#8364;4,362&#160;thousand, or 29.2%, from &#8364;14,935 thousand for the year ended December&#160;31, 2020. Our research and development expenses for the year ended December&#160;31, 2020 increased by &#8364;5,345&#160;thousand, or 55.7%, from &#8364;9,590&#160;thousand for the year ended December&#160;31, 2019. During the years ended December&#160;31, 2021, 2020 and 2019, we received test requests of approximately 8,300, 5,400, and 11,600, respectively, for our internal research and development projects. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our loss before taxes for the year ended December&#160;31, 2021 was &#8364;46,876&#160;thousand, an increase of &#8364;25,779&#160;thousand, or 122.2%, from &#8364;21,097 thousand for the year ended December&#160;31, 2020. Our loss before taxes for the year ended December&#160;31, 2020 increased by &#8364;400&#160;thousand, or 1.9%, from &#8364;20,697&#160;thousand for the year ended December&#160;31, 2019. Our loss before taxes for the year ended December 31, 2021 included an impairment of &#8364;1,067 thousand related to certain identified biomarkers as part of the Company&#8217;s restructuring initiative which began in Q4 2021 and accelerated depreciation of COVID-19 related long lived assets of &#8364;4,884 thousand which relates to the closure of the Hamburg laboratory and equipment utilized for service agreements and test sites that are not profitable. Our loss before taxes for the year ended December 31, 2020 included an impairment of &#8364;4,700 thousand related to certain identified biomarkers as part of the Company&#8217;s strategy reassessment which began in Q4 2020. Our loss before taxes for the year ended December&#160;31, 2019 included real estate transfer taxes of &#8364;1,200&#160;thousand related to the sale and leaseback transaction for our Rostock headquarter building and initial public offering expenses of &#8364;1,092&#160;thousand. Our loss before taxes for the year ended December&#160;31, 2021 also included share-based compensation expenses of &#8364;8,035&#160;thousand, as compared to &#8364;5,648&#160;thousand for the year ended December&#160;31, 2020, and &#8364;6,418&#160;thousand for the year ended December&#160;31, 2019. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Important Developments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Going Concern </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:35.45pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">As an early commercial-stage company, we are still in progress towards reaching break-even on our diagnostic and pharma businesses. We are subject to a number of risks similar to those of other development and early commercial stage companies. These risks include, among other things, the failure to enter into and successfully execute further collaborations with pharmaceutical partners, the failure to generate revenue from our development portfolio and risks associated with research, development, testing and obtaining related regulatory approvals in relation to our product candidates. Our ongoing success and ultimately the attainment of profitable operations depends on future uncertain events which include, among other things, obtaining adequate financing to promote our commercial and development activities until we can generate sufficient revenues to support our operating cash requirements. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:35.45pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">We have incurred operating losses since inception. For the year ended December 31, 2021 we incurred a net loss of &#8364; 46.3 million (of which &#8364;46.0 million are related to loss from operations, resulting in an operating cash outflow of &#8364; 21.7 million). As of December 31, 2021, we had generated an accumulated deficit of &#8364; 109.3 million, and had an equity position of &#8364; 27.5 million. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">However, our cash and cash equivalents will be sufficient to fund our planned operating cash requirements for at least the next twelve months from the date of issuance of these financial statements. <span style="white-space:pre-wrap;">As of December 31, 2021 we had cash and cash equivalents of &#8364; 17.8 million with relatively low short term debt obligations of &#8364; 3.8 million and no financial covenants. In addition,  we entered into the Loan Facility on January 21, 2022. Under the terms of the Loan Facility, we drew down USD 25.0 million on January 31, 2022 and will have access to a second tranche of USD 20.0 million upon achievement, prior to July 31, 2023, of product revenue from our diagnostics and pharmaceutical services segments of at least USD 50.0 million calculated on a trailing twelve month basis as of the last day of any fiscal month. The Loan Facility also includes covenants such that the Group is required to maintain product revenue of at least &#8364; 30.0 million as of the last day of each fiscal quarter and on a trailing twelve month basis prior to obtaining the second tranche &#8364; 40.0 million on or after obtaining the second tranche. Both tranches mature on January 29, 2027 with amortized repayments commencing March 1, 2025. The loans extended under the Loan Facility bear monthly interest payments at an interest rate of 7.93% per annum plus the 1-month CME Term SOFR reference rate as published by the CME Group Benchmark Administration Limited (subject to a floor of 0.07%). In addition, pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors and dated January 31, 2022, we also received &#8364; 15.0 million in exchange for the issuance of an aggregate of 4,479,088 common shares at a price per share of USD 3.73 and warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">96</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Effect of COVID-19 Pandemic</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The COVID-19 pandemic has spread worldwide and continues to cause many governments to maintain measures, such as quarantines, travel restrictions, closures of borders, and mandatory maintenance of physical distance between individuals to slow the spread of the outbreak. Since the second quarter of 2020, the COVID-19 pandemic resulted in a slowdown in our diagnostics and pharmaceutical businesses. As part of our initiative to assist local, national and international authorities, as well as other partners in their efforts to facilitate the earliest possible diagnosis of COVID-19 and thereby contribute to allowing society to return to a &#8220;new&#8221; normal, we commenced testing for COVID-19 in March 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">During the year ended December 31, 2021, we continued the COVID-19 testing activities that started in 2020 with a leading role in providing testing services at airports in Germany. Furthermore, new variants of the virus emerged since mid-December 2020 and in 2021 which prompted large-scale vaccination campaigns across many countries in Europe. As a result, the vaccinated number of individuals increased across many countries in Europe which led to relaxation of testing regulations in many countries during the year. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Total investments in COVID-19 testing as at December 31, 2021 amounted to &#8364;2,834 thousand, of which &#8364;2,480 thousand are COVID-19 related mobile test laboratories and equipment. An amount of &#8364;354 thousand is included in intangible assets and relates to the development of our Corona Test Portal. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">While total gross margin for our Diagnostics and Pharmaceutical segments combined increased by &#8364;9,117 thousand or 19.5 percentage points in the year ended December 31, 2021 as compared to the previous year ended December 31, 2020, gross margin for our COVID-19 segment for the year ended December 31, 2021 was &#8364;13,352 thousand representing a decrease of &#8364;25,407 thousand or of 34 percentage points as compared to &#8364;38,759 thousand. The decrease in gross margin within the COVID-19 segment is primarily due to business to government contract structure changes, costs relating to the set-up of the COVID-19  business unit, committed fixed overhead costs and reduction of COVID-19 test order intakes within the second half of 2021 which resulted in accelerated depreciation and amortization of COVID-19 related assets.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">At the end of the third quarter of 2021, management updated its long term outlook for the COVID-19 testing business, which led to management&#8217;s decision to initiate a wind down process in which lease contracts at unprofitable COVID-19 testing sites would not be renewed and a laboratory in Hamburg would be closed. Similarly, we have significantly ramped down COVID-19 related inventory levels to align with the needs of the remaining test sites and laboratories. Due to the impact of these changes during the COVID-19 pandemic, particularly developments in vaccination campaigns with increasing vaccination numbers and relaxation of testing regulations by several countries, we have reassessed certain related accounting judgments and estimates. As a result, in line with our accounting policies for long-lived assets, management reviewed the estimated useful lives of long-lived assets utilized in the COVID-19 test offerings given changes in circumstances and management&#8217;s expectations. Management considered how the underlying assets are currently deployed, including whether the assets are utilized in leased facilities or service agreements which management is unlikely to renew, and potential alternative uses of the assets within the COVID-19 business or within the diagnostics and pharmaceutical businesses. Consequently, we prospectively adjusted the estimated useful lives of our long-lived assets which include property, plant and equipment, right-of-use assets and intangible assets to a remaining estimated useful life of 8 months, with effect at the beginning of the third quarter 2021. This prospective change in estimate resulted in accelerated depreciation expense of &#8364;4,138 thousand for the year ended December 31, 2021. Additionally, we recognized an accelerated depreciation of right-of-use assets in an amount of &#8364; 746 thousand for the closure of the Hamburg laboratory during the year ended December, 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Although we are taking a number of measures aimed at minimizing disruptions to our business and operations, and while the provision of testing for the COVID-19 virus generates additional revenues for us, the full extent to which the global COVID-19 pandemic may impact our business will depend on future developments, which are highly uncertain and cannot be predicted, such as the duration of the pandemic, its severity and strain mutations, the availability of vaccines, the probability of the occurrence of further outbreaks and the ultimate impact on the financial markets and the global economy, and could result in an unforeseen negative impact on our business and our future results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Research and Development </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Despite the disruption from the COVID-19 pandemic, we continued to expand our medical and genetic knowledge of rare genetic diseases, with the vision of shortening the diagnostics odyssey of rare disease patients and accelerating the development of new orphan drugs.&#160; In particular, we focused on the following collaborations during the year:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Collaboration with Evotec SE (&#8220;Evotec&#8221;) in the research, discovery and</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> development of medical solutions for rare diseases related to the protein target glucocerebrosidase (&#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">GBA</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;), a well-known enzyme deficiency linked to Gaucher disease. &#160;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">97</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">This collaboration combines our global proprietary rare disease platform and biomarker expertise, with a jointly developed &#160;induced pluripotent stem cell (&#8220;iPSC&#8221;) platform, drug discovery and development capabilities of Evotec.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Collaboration with PTC Therapeutic, Inc (&#8220;PTC&#8221;) to expand our existing partnership to several new regions including many countries in Europe, the Middle East, and Latin America to provide genetic testing and 3-O-Methyldopa (3-OMD) biomarker analytics to help identify patients with Aromatic L-amino Acid Decarboxylase (AADC) deficiency.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><span style="font-family:'Times New Roman';">&#9679;</span>&#160;&#160;&#160;&#160;&#160;&#160;Collaboration with Alnylam Pharmaceuticals (&#8220;Alnylam&#8221;) to expand its existing epidemiology and biomarker work through the initiation of a new clinical program (TRAMoniTTR) focused on Hereditary Transthyretin Amyloidosis (hATTR). Through the newly executed agreement, the Company will provide specific analyses regarding anonymized TTR patient populations with a focus on long-term longitudinal data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Follow-on Equity Offering</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In July&#160;2020, we completed a follow-on public offering of 3,500,000 common shares of the Company (the &#8220;Follow-on Equity Offering&#8221;), consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of $14.00 per common share (i.e., &#8364;12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, to the Company were &#8364;22 million. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Leadership transition</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">On December 20, 2021, we announced the appointment of Kim Stratton as the interim CEO while Dr. Andrin Oswald, M.D, our then CEO took a temporary medical leave of absence. Subsequently, on February 1, 2022, we announced the resignation of Dr. Andrin Oswald as CEO due to prolonged medical leave of absence and effective immediately, Kim Stratton was appointed as the new CEO on the same date with immediate effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">On February 8, 2022, we announced the resignation&#160;of Ren&#233; Just as CFO effective March 31, 2022, followed by the appointment of Miguel Coego Rios as Executive Vice President of Finance &amp; Legal and interim CFO (&#8220;Interim CFO&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Financial Operations Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Revenue </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Our revenue is principally derived from the provision of pharmaceutical solutions and diagnostic tests enabled by our knowledge and interpretation-based platform, as well as from our COVID-19 testing solution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Besides the impact of our COVID-19 testing solution related revenue, we expect our revenue to increase over time as we continue to expand our commercial efforts internationally with a focus on further growth in our pharmaceutical segment. We expect revenue from our diagnostics segment to grow in absolute terms but decrease as a proportion of total revenue if there is growth in our pharmaceutical segment. The development of the COVID-19 testing revenues will strongly depend on the further development of the COVID-19 pandemic. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Changes in revenue mix between our pharmaceutical, diagnostics and COVID-19 segments can impact our results period over period. We typically incur lower costs for the provision of solutions in our pharmaceutical segment and therefore generate higher returns from our pharmaceutical segment contracts than from our diagnostics and COVID-19 segment contracts. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Pharmaceutical segment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">We generate revenue in our pharmaceutical segment from the solutions we provide to our pharmaceutical partners to accelerate their development of treatments for rare hereditary diseases. Our data-driven studies are not only able to provide valuable information for drug target discovery, but also allow a better and more targeted design of clinical trials afterwards. Our biomarkers can be used not only in effective identification of rare disease patients, but also used to demonstrate the efficacy of the drugs, perform longitudinal monitoring and titrate the dosage needed of individual rare disease patients. Our partnership agreements are structured on a fee per analysis basis, milestone basis, fixed fee basis, royalty basis or a combination of these. We recognize our revenue from the rendering of solutions to our pharmaceutical partners as such service is performed, or upon the achievement of certain milestones if applicable to the partnership agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended December&#160;31, 2021, we entered into 18 new collaborations and successfully completed 39 collaborations resulting in a total of 45 active collaborations. Over 46 disorders are covered by our current and historic collaborations. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">98</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:216pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">During the year ended December&#160;31, 2020, we entered into 16 new collaborations, and successfully completed 26 collaborations resulting in a total of 66 active collaborations, covering 49 disorders. During the year ended December 31, 2019, we entered into 10 new collaborations with 9 new pharmaceutical partners, and 18 new collaborations with existing pharmaceutical partners, resulting in a total of 76 active collaborations, covering 46 disorders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f018.jpg" alt="Graphic" style="display:inline-block;height:216pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:213pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The timing of entry into new contracts with our pharmaceutical partners can be difficult to predict. Accordingly, we can experience different revenue patterns quarter-to-quarter and year-over-year due to the satisfaction of performance obligations involving significant upfront and milestone fees due from our pharmaceutical partners. We recognize revenue for upfront fees at a point in time when the right to use the intellectual property is transferred to the customer, while revenue for milestone payments is recognized over time using an input method based on the work rendered by us, or at a point in time when the applicable provisions for over-time recognition are not present (e.g.,&#160;the sale of CentoCards). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2021 we entered into collaboration agreements with certain pharmaceutical partners, which resulted in upfront fees payable to us of over &#8364;455&#160;thousand for set up fees, will be recognized over time and during the partnership period. During the year ended December 31, 2020 we did not enter into collaboration agreements with pharmaceutical partners that included upfront fees. During the year ended December&#160;31, 2019, we entered into collaboration agreements with certain pharmaceutical partners, of which upfront fees of &#8364;1,930&#160;thousand, representing the transaction prices allocated to the one-off transfer of our intellectual property, were received and recognized as revenues. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">99</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:213.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Diagnostics segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">We generate revenue in our diagnostics segment primarily from genetic sequencing and diagnostics services, such as WES and WGS. The test requests received by our diagnostics segment for the years ended December&#160;31, 2021, 2020 and 2019 were split amongst our primary testing products as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"> <img src="cntg-20211231x20f019.jpg" alt="Graphic" style="display:inline-block;height:213.5pt;width:244.71pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">We provide these services in over 120 countries either through third party distributors or directly to our diagnostics clients, who are typically physicians, labs or hospital facilities. Revenues are based on a negotiated price per test or on the basis of agreements to provide certain testing volumes over defined periods. Revenue from the rendering of clinical diagnostic services (sequencing, interpretation and reporting) is recognized over time by reference to the percentage of completion of the service on the reporting date, assessed on the basis of the work rendered. We strategically focus on countries around the globe where the prevalence of rare hereditary diseases is high or the availability of national genetic testing and interpretation is to some extent limited and therefore the complete reimbursement or partial payment by the government for our services is more likely. The major markets for our diagnostics business currently include the Middle East and North Africa region, Scandinavia, parts of Central and Eastern Europe, Latin America, North America and parts of Asia. In most of our markets, our diagnostics tests are billable directly to the party submitting the request for a test to us. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">COVID-19 segment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Starting from the Mecklenburg-Western Pomerania region of Germany, where we initially focused on employees and essential workers in Rostock, our COVID-19 testing solution was further expanded to nursing homes as well as to high school students in Germany, and has been available to the rest of the world since May&#160;<span style="white-space:pre-wrap;">2020.  Some of our tests are offered free of charge by the Company, while others are offered in collaboration with state governments and other partners.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 8pt 0pt;"><span style="background:#ffffff;">While the&#160;</span>COVID-19&#160;pandemic has created an opportunity for our business, we noticed a decrease in COVID-19 test order intakes during the third quarter of 2021, specifically in Germany, which led to management reviewing the likelihood of not renewing lease contracts at unprofitable COVID-19 testing sites as well as reaching the decision to close a laboratory in Hamburg. Similarly, we have significantly ramped down COVID-19 related inventory levels to align with the needs of the remaining test sites and laboratories.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">We presently expect our COVID-19 testing business to continue contributing to our revenue in 2022 albeit at a significantly lower level than in the previous year. We expect demand for our COVID-19 tests to further decline as vaccination rates rise, mandatory testing requirements are phased out and the closure of unprofitable COVID-19 testing sites. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Cost of Sales and Operating Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Our cost of sales and our operating expenses support all of the products and services that we provide to our customers and, as a result, are presented in an aggregate total for the business segments. We allocate certain overhead expenses, such as maintenance and depreciation to cost of sales and operating expense categories based on headcount and facility usage. As a result, overhead expense allocation is reflected in cost of sales and each operating expense category.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">100</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Cost of Sales</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Cost of sales consists of cost of consumables, supplies and other direct costs such as personnel expenses, depreciation of laboratory equipment, amortization of biomarkers, repair and maintenance costs, shipping costs, rent of COVID-19 testing facilities, other directly related COVID-19 testing costs, as well as certain allocated overhead expenses. The share-based compensation expenses included in cost of sales for the year ended December&#160;31, 2019 amounted to &#8364;1,153&#160;thousand, mainly related to options granted to an employee. In 2021 and 2020, all share-based compensation expenses have been included in the general &amp; administrative expenses.<span style="font-style:italic;font-weight:bold;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">We expect these costs in absolute terms will increase as we grow our revenue but decrease as a percentage of revenue over time as our pharmaceutical segment revenue increases and as we continue to implement operational efficiencies. During the year ended December&#160;31, 2021, our cost of sales represented 85.2% of our total revenue, as compared to 65.0% for the year ended December&#160;31, 2020, and 53.3% for the year ended December&#160;<span style="white-space:pre-wrap;">31, 2019. The increased share in 2021 was mainly due to changes in the business to government contract structures, costs relating to the set-up of the COVID-19  business unit, committed fixed overhead costs and coupled with the slowdown in the COVID-19 segment within the second half of 2021. Furthermore, cost of sales included an impairment of &#8364;1,067 thousand related to </span>certain identified biomarkers as part of the Company&#8217;s restructuring initiative which began in Q4 2021 and accelerated depreciation of COVID-19 related long lived assets of &#8364;4,884 thousand which relates to the closure of the Hamburg laboratory and equipment utilized for service agreements and test sites that are not profitable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Research and Development Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Our research and development (&#8220;R&amp;D&#8221;) expenses consist primarily of costs incurred for the research and development of new products and solutions, in particular our biomarkers, and the development of our IT driven and interpretation-based solutions. In the three fiscal years ended December&#160;31, 2021, we spent &#8364;56,822&#160;thousand on research and development, of which &#8364;13,000&#160;thousand was capitalized as intangible assets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Expenses for research activities are recognized through profit or loss in the period in which they are incurred, unless they reach the development stage and prove to be technically and commercially feasible, upon which the expenses are capitalized. With respect to biomarkers, expenses are capitalized when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, expenses are capitalized upon the completion of our internal validation test. Before such dates, any development costs are recognized in profit or loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Research and development which we conduct pursuant to our pharmaceutical partnership agreements is typically limited to a specific rare disease. As a result, our research and development expenses may vary substantially from period to period based on the timing of our research and development activities or our pharmaceutical partners, including due to the entry into, renegotiation of or termination of our partnership agreements. Our research and development expenses may also be impacted by changes in regulatory requirements and healthcare policies globally, particularly in respect of the validation and patent application processes that we conduct for our biomarkers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">During the year ended December&#160;31, 2021, our research and development expenses represented 10.2% of our total revenue, as compared to 11.6% for the year ended December&#160;31, 2020, and 19.7% for the year ended December&#160;31, 2019. The decrease mainly related to the COVID-19 business, which generated additional revenue and where research and development expenses were negligible. We continue to innovate our information platform, develop additional products and solutions and expand our data management resources. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">General Administrative Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Our general administrative expenses include costs for our personnel, premises, IT operations, accounting and finance, legal and human resources functions. These expenses consist principally of salaries, bonuses, employee benefits, travel, and share-based compensation, as well as professional services fees such as consulting, audit, tax and legal fees and general corporate costs, insurance costs and allocated overhead expenses. We account for all general administrative expenses as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">During the year ended December&#160;31, 2021, our general administrative expenses represented 24.6% of our total revenue, as compared to 31.3% for the year ended December&#160;31, 2020, and 47.5% for the year ended December&#160;31, 2019. The decrease was mainly related to the COVID-19 business, where general administrative expenses as a percentage of revenues are comparably low. The share-based compensation expenses included in general administrative expenses for the years ended December&#160;31, 2021, 2020 and 2019 amounted to &#8364;8,035&#160;thousand, &#8364;5,658&#160;thousand and &#8364;5,265&#160;thousand, respectively. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">101</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Selling Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Our selling expenses consist of costs from our sales organization, which includes our direct sales force and sales management, client services, distributor relations, marketing and business development personnel. These expenses primarily include salaries, commissions, bonuses, employee benefits and travel, as well as marketing and educational activities and allocated overhead expenses. We expense all selling expenses as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">During the year ended December&#160;31, 2021, selling expenses accounted for 5.2% of our total revenue, as compared to 6.3% for the year ended December&#160;31, 2020, and 19.0% for the year ended December&#160;31, 2019. The decrease was mainly related to the COVID-19 business, where selling expenses as a percentage of revenues are comparably low. We expect that our selling expenses will continue to grow as we continue to increase our business footprint and expand our business development efforts in our pharmaceutical segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Other Operating Income / (Expenses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Other operating income and expenses primarily includes government grants, gain on disposal of property, plant and equipment and exchange rate gains or losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Government grants contain performance-based grants to subsidize research, development and innovation in the state of Mecklenburg-Western Pomerania from funds granted by the European Regional Development Fund (&#8220;R&amp;D Grants&#8221;). Furthermore, government grants contain investment grants related to the construction of our headquarters in Rostock, Germany in prior years and purchase of equipment for laboratory automization (&#8220;Investment Grants&#8221;). R&amp;D Grants that compensate our research and development expenses are recognized directly in profit or loss, while R&amp;D Investment Grants are initially recognized as deferred income and subsequently released to profit or loss on a systematic basis over the useful life of the related asset. We received different government grants in the state of Mecklenburg-Western Pomerania from funds granted by the European Regional Development Fund to subsidize our research, development and innovation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">During the year ended December&#160;31, 2021, we received R&amp;D Grants of &#8364;168&#160;thousand, as compared to &#8364;764&#160;thousand and &#8364;1,463&#160;thousand for the year ended December 31, 2020 and December 31, 2019, respectively. Furthermore, we received Investment Grants of &#8364;792&#160;thousand in the year ended December&#160;31, 2019. The government grant that we receive, can fluctuate from period to period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 8pt 0pt;">Results of Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt;">Year Ended December&#160;31, 2021 Compared to Year Ended December&#160;31, 2020</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt;"><span style="font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Years Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">Consolidated statement of comprehensive loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Revenue</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 189,923</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 128,381</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Cost of sales</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 161,765</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 83,437</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">Gross profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> 28,158</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> 44,944</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Research and development expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 19,297</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 14,935</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">General administrative expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 46,739</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 40,160</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Selling expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 9,860</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 8,026</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Impairment of financial assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 1,140</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 3,738</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Other operating income</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 2,936</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 2,394</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Other operating expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 86</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 182</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (46,028)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (19,703)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Interest and similar income</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 6</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Interest and similar expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 851</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 1,400</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Finance costs, net</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> (848)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> (1,394)</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">Loss before taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (46,876)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (21,097)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Income tax expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> (24)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 281</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">Loss for the year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (46,852)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (21,378)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">Other comprehensive income/(loss)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> 543</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="font-size:8.5pt;white-space:pre-wrap;"> (48)</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">Total comprehensive loss for the year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:8.5pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (46,309)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;white-space:pre-wrap;"> (21,426)</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 8pt 0pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Restated for 2020 to reflect the impact of the reclassification of certain costs from cost of goods sold to general administrative expenses and selling expenses. (See note 2.4 to our consolidated financial statements as of December 31, 2021 and 2020 and for the three years ended December 31, 2021, 2020 and 2019 included elsewhere in this Annual Report).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">102</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:187.53pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revenue increased by &#8364;61,542&#160;thousand, or 47.9%, to &#8364;189,923&#160;thousand for the year ended December&#160;31, 2021 from &#8364;128,381&#160;thousand for the year ended December&#160;31, 2020, mainly driven by revenue from our COVID-19 testing business, and a recovery of our Core businesses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The breakdown of our revenue by segment was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Years&#160;Ended&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Revenue by segment:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmaceutical</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 15,641</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16,951</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diagnostics</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 27,900</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 22,108</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">COVID-19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 146,382</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 89,322</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 189,923</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 128,381</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pharmaceutical segment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revenues from our pharmaceutical segment were &#8364;15,641&#160;thousand for the year ended December&#160;31, 2021, a decrease of &#8364;1,310&#160;thousand, or 8%, from &#8364;16,951&#160;thousand for the year ended December&#160;31, 2020. This decrease was primarily due to the impact of the COVID-19 pandemic, which slowed down or delayed the clinical studies of our pharmaceutical partners. We collaborated with 33 pharmaceutical partners, as of December 31, 2021 and December&#160;31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December&#160;31, 2021, we entered into 18 new collaborations and successfully completed 39 collaborations resulting in a total of 45 active collaborations in December 31, 2021 compared to 66 active collaborations as of December&#160;31, 2020. Revenues from our new collaborations totalled &#8364;2,323&#160;thousand for the year ended December&#160;31, 2021 with upfront payments of &#8364;455 thousand related to setup fees. During the year ended December&#160;31, 2020, we entered into 16 new collaborations and completed 26 collaborations, decreasing the total number of active/completed collaborations to 66, from 76 active collaborations as of December&#160;31, 2019. Revenues from our new collaborations totalled &#8364;968&#160;thousand for the year ended December&#160;31, 2020, which amount did not include any upfront fees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have been successful in entering into collaborations with pharmaceutical partners in the early stages of drug development, which puts us in a position to provide more support to the development process and increases our potential to secure further collaborations for the same drugs, such as biomarker developments. The graphic below shows our revenues for the year ended December&#160;31, 2021 and 2020 resulting from our collaborations with our pharmaceutical partners split between the drug development stages. For further details on each of our drug development stages, please see &#8220;Item&#160;4. Information on the Company&#8212;B.&#160;Business Overview&#8212;Pharmaceutical Solutions.&#8221; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="cntg-20211231x20f021.jpg" alt="Graphic" style="display:inline-block;height:186.98pt;left:0%;padding-bottom:0.55pt;position:relative;top:0pt;width:331.98pt;" /></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">103</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:213pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December&#160;31, 2021, revenues from one pharmaceutical partner represented 5.1% of our total revenues, as compared to 8.6% for the year ended December&#160;31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Diagnostics segment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revenues from our diagnostics segment were &#8364;27,900&#160;thousand for the year ended December&#160;31, 2021, an increase of &#8364;5,792&#160;thousand, or 26%, from &#8364;22,108&#160;thousand for the year ended December&#160;31, 2020. We received approximately 57,100 test requests in our diagnostics segment during the year ended December&#160;31, 2021, representing an increase of approximately 36.3% as compared to approximately 41,900 test requests received for the year ended December&#160;31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the years ended December&#160;31, 2021 and 2020, our total diagnostic segment revenues were split amongst our primary testing products as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"> <img src="cntg-20211231x20f022.jpg" alt="Graphic" style="display:inline-block;height:213pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:214.47pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The increase in revenues was primarily related to an increase in order intakes for panel testing, WES and WGS during the year ended December 31, 2021. Total revenues from panel testing, WES and WGS for the year ended December&#160;31, 2021 amounted to &#8364;19,921&#160;thousand, representing an increase of 25.1% as compared to &#8364;15,918 thousand for the year ended December&#160;31, 2020. The total number of panel testing, WES and WGS order intakes received in the diagnostics segment for the year ended December&#160;31, 2021 was approximately 27,962, representing an increase of 42.0% as compared to approximately 19,692 test requests received for the year ended December&#160;31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">COVID-19 testing segment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revenues generated from the testing for COVID-19 and sales of CentoSwab for the year ended December 31, 2021 amounted to &#8364;146,382&#160;<span style="white-space:pre-wrap;">thousand with approximately 2.3 million test requests received.  During the year ended December 31, 2021, revenues from one COVID-19 testing partner represented 9.4% of our total revenues.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">104</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Revenue by geographical region</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The breakdown of our revenue from all our segments, in the aggregate, by geographical region was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Years&#160;Ended&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Revenue by geographical region:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 150,584</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 94,068</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">of which: Germany</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 141,133</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 81,065</i></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">of which: Netherlands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 3,622</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 6,575</i></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16,432</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 12,624</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 19,496</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 19,265</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">of which: United States</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 19,309</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> 19,059</i></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,593</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,888</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 818</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 536</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 189,923</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 128,381</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In cases where our pharmaceutical partners are developing a new rare disease treatment, we generally anticipate that the final approved treatment will be made available globally. As a result, we allocate the revenues of our pharmaceutical segment by geographical region by reference to the location where each pharmaceutical partner mainly operates, which is based on the region from which most of their revenues are generated. The allocation of revenues in our diagnostics and COVID-19 segments is based on the location of each customer. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our North America region contributed &#8364;19,496&#160;thousand to revenue for the year ended December&#160;31, 2021, an increase of &#8364; 231 thousand to &#8364;19,265&#160;thousand for the year ended December&#160;31, 2020. Revenues from the North America region represented 10.3% of our total revenues for the year ended December&#160;31, 2021 as compared to 15.0% for the year ended December&#160;31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our Middle East region contributed &#8364;16,432&#160;thousand to revenue for the year ended December&#160;31, 2021, an increase of &#8364;3,808&#160;thousand, or 30%, from &#8364;12,624&#160;thousand for the year ended December&#160;31, 2020. This revenue increase was primarily attributable to the increase in sales of panel testing, WES and WGS tests. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our Europe region contributed &#8364;150,584&#160;thousand to revenue for the year ended December&#160;31, 2021, an increase of &#8364;56,516&#160;thousand, or 60%, from &#8364;94,068&#160;thousand for the year ended December&#160;31, 2020. This increase was mainly driven by revenues from our COVID-19 testing during the year, as over 96.6% of such revenues were generated in Germany. Revenues from the Europe region represented 79.3% of our total revenues for the year ended December 31, 2021 as compared to 73.3% for the year ended December 31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Cost of Sales </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cost of sales increased by &#8364;78,328&#160;thousand, or 94%, to &#8364;161,765&#160;thousand for the year ended December&#160;31, 2021, from &#8364;83,437&#160;thousand for the year ended December&#160;31, 2020. Cost of sales for the year ended December&#160;31, 2021 represented 85.2% total revenue, an increase of 20.2 percentage points as compared to 65.0% for the year ended December&#160;31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cost of sales incurred by our pharmaceutical and diagnostics segments for the year ended December&#160;31, 2021 represented 74.0% and 62.2% of revenues from the respective segments, a decrease of 14.3&#160;percentage points and 21.9&#160;percentage points, respectively, as compared to 88.3% and 84.1%, respectively, for the year ended December&#160;31, 2020. The 14.3 percentage point decrease for our pharmaceutical segment was mainly due to an impairment of &#8364;4,700 thousand related to the capitalized biomarkers included in cost of sales for the year ended December&#160;31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">Cost of sales incurred by our COVID-19 business for the year ended December 31, 2021 represented 90.9% of the related revenues as compared to 57.2% for the year ended December 31, 2020. The increase in the cost of sales to revenue percentage was primarily due to changes in the business to government contract structures, costs relating to the set-up of the COVID-19  business unit, committed fixed overhead costs coupled with the downturn of COVID-19 testing in the second half of the year which led to accelerated depreciation and amortization expenses of COVID-19 related assets, as well as costs related to the shutdown of our </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">105</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Hamburg lab and unprofitable testing sites. Moving forward, we have restructured our COVID-19 related operations and consolidated our testing efforts to minimize expenses and improve cost efficiency within the segment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Gross Profit</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The recovery of our core business segments (Diagnostics and Pharmaceutical segments combined) generated total gross margin of &#8364; 14,615 thousand or 34% of revenues which represents an increase of &#8364;9,117 thousand or 19.5 percentage points in the year ended December 31, 2021 as compared to &#8364;5,498 thousand or 14% of revenues in the previous year ended December 31, 2020. However, gross margin for our COVID-19 segment for the year ended December 31, 2021 was &#8364;13,352 thousand or 9% of revenues representing a decrease of &#8364;25,407 thousand or of 34 percentage points as compared to &#8364;38,759 thousand or 43% of revenues in the year ended December 31, 2020. This reduction was primarily due to the decision to shift COVID-19 testing to subcontractors. As a result, our total gross profit decreased by &#8364;16,786 thousand, to &#8364;28,158 thousand for the year ended December&#160;31, 2021, from &#8364;44,944 thousand for the year ended December 31, 2020 driven by the factors described above. Gross profit margin decreased by 20 percentage points from 35% of revenues in 2020 to 15% of revenues in 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Research and Development Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below gives a breakdown of our research and development expenses for the years ended December&#160;31, 2021 and 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:29.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Years&#160;Ended&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:29.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:29.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Wages and salaries and social security expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,021</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,585</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Laboratory supplies and consumable costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 301</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,719</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">IT development costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,422</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,208</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation and amortization expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,900</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,971</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,653</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 452</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total research and development expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,297</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,935</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Research and development expenses increased by &#8364;4,362&#160;thousand, or 29.2%, to &#8364;19,297 thousand for the year ended December&#160;31, 2021, from &#8364;14,935&#160;thousand for the year ended December&#160;31, 2020. This mainly represents personnel costs, IT-related expenses incurred in our research that do not qualify for capitalization, increased depreciation and amortization and other costs such as consumables, patent applications, legal costs and external consultant costs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">General Administrative Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below gives a breakdown of our general administrative expenses for the years ended December&#160;31, 2021 and 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:32.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Years&#160;Ended&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:32.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:32.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Wages and salaries, social security and termination expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 13,664</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,657</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share&#8209;based payment expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,035</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,658</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Legal, audit and consulting expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,048</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,975</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Travelling, corporate communication and event expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,386</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,895</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">IT operational costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,513</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,404</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Insurance premiums</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,432</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,003</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recruitment expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,062</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,273</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation and amortization expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,949</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,777</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,650</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,518</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total general administrative expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 46,739</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 40,160</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Restated for 2020 to reflect the impact of the reclassification of certain costs from cost of goods sold to general administrative expenses and selling expenses. (See note 2.4 to our consolidated financial statements as of December 31, 2021 and 2020 and for the three years ended December 31, 2021, 2020 and 2019 included elsewhere in this Annual Report).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">106</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">General administrative expenses increased by &#8364;6,579&#160;<span style="white-space:pre-wrap;">thousand, or  16.4%, to &#8364;46,739&#160;thousand for the year ended December&#160;31, 2021, from &#8364;40,160&#160;thousand for the year ended December&#160;31, 2020, principally due to an increase in personnel costs, costs related to being a publicly listed company and operating expenses as a result of the expansion of the business. The increase in costs relating to being a publicly listed company relates to costs such as additional legal, accounting, corporate governance and investor relations expenses, partially offset by a slight decrease in directors&#8217; and officers&#8217; insurance premiums. In addition, the increase is also the result of additional investments in IT support and data center costs. The general administrative expenses included share-based compensation expenses of &#8364;8,035&#160;thousand for the year ended December&#160;31, 2021, an increase of &#8364;2,377&#160;thousand as compared to &#8364;5,658&#160;thousand for the year ended December&#160;31, 2020.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Selling Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Selling expenses increased by &#8364;1,834&#160;thousand, or 22.9%, to &#8364;9,860&#160;<span style="white-space:pre-wrap;">thousand for the year ended December 31, 2021, from  &#8364;8,026&#160;thousand for the year ended December&#160;31, 2020, were principally due to an increase in personnel expenses, online service expenses as well as travel expenses due to the easing of travel restrictions from the COVID-19 pandemic.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Impairment of financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Impairment expenses for financial assets for the year ended December 31, 2021, were &#8364;1,140 thousand, representing a decrease of &#8364;2,598 thousand from &#8364;3,738 thousand for the year ended December 31, 2020. These impairment losses related to the re-assessment of the receivables and contract assets arising from contracts with customers, partly due to the effect of the COVID-19 pandemic.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Other Operating Income / (Expenses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Other operating income increased by &#8364;542&#160;thousand, or 22.6%, to &#8364;2,936&#160;thousand for the year ended December&#160;31, 2021, from &#8364;2,394&#160;thousand for the year ended December&#160;31, 2020, principally due to an increase in recognition of grant income, as well as a gain of &#8364;387&#160;thousand from the forgiveness of a bank loan granted under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Other operating expenses increased by &#8364;96&#160;thousand, or 52.7%, to &#8364;86&#160;thousand for the year ended December&#160;31, 2021, from &#8364;182&#160;thousand for the year ended December&#160;31, 2020, principally due to foreign exchange differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Interest and Similar Income / (Expenses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Interest and similar income decreased by &#8364;3&#160;thousand to &#8364;3&#160;thousand for the year ended December&#160;31, 2021, from &#8364;6&#160;thousand for the year ended December&#160;31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Interest and similar expenses decreased by &#8364;549&#160;thousand, or 39.2%, to &#8364;851&#160;thousand for the year ended December&#160;31, 2021, from &#8364;1,400&#160;thousand for the year ended December&#160;31, 2020, principally due to the unwinding of discount on lease liabilities and foreign currency losses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Loss Before Taxes for the Year</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">As a result of the factors described above, our loss before taxes for the year ended December&#160;31, 2021 was &#8364;46,876&#160;thousand, an increase of &#8364;25,779&#160;thousand, or 122.2%, from &#8364;21,097 thousand for the year ended December&#160;31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Segment Adjusted EBITDA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our Segment Adjusted EBITDA was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Years&#160;Ended&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Segment Adjusted EBITDA:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmaceutical</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,843</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,194</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diagnostics</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,024</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2,408)</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">COVID-19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 20,678</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 37,215</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 29,545</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 41,001</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">107</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Adjusted EBITDA from our pharmaceutical segment was &#8364;4,843&#160;thousand for the year ended December&#160;31, 2021, a decrease of &#8364;1,351&#160;thousand, or 22%, from &#8364;6,194&#160;thousand for the year ended December&#160;31, 2020. This decrease was primarily attributable to the decrease in revenues from the pharmaceutical segment, as well as the increase in cost of sales including an impairment of &#8364;1,067 thousand and the continuous expansion of our business development team.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Adjusted EBITDA from our diagnostics segment was &#8364;4,024&#160;thousand for the year ended December&#160;31, 2021, an increase of &#8364;6,432 thousand, or 267%, from negative &#8364; 2,408&#160;thousand for the year ended December&#160;31, 2020. This increase was primarily attributable to an increase in revenues during the year and decreased credit loss allowances for trade receivables and contract assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Adjusted EBITDA from our COVID-19 segment was &#8364;20,678&#160;thousand for the year ended December&#160;31, 2021, a decrease of &#8364;16,537 thousand, or 44%, from &#8364; 37,215&#160;thousand for the year ended December&#160;<span style="white-space:pre-wrap;">31, 2020. This decrease was primarily attributable to changes in the business to government contract structures, costs relating to the set-up of the COVID-19  business unit, committed fixed overhead costs coupled with the downturn of COVID-19 testing in the second half of the year.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For further information about how we calculate Adjusted EBITDA, how it is used and our reconciliation of segment Adjusted EBITDA to the most comparable IFRS measure of the Group, see &#8220;Note 7 &#8212; Segment information and revenue from contracts with customers&#8221; of our consolidated financial statements as of and for the year ended December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the discussion of our results of operations for the year ended December&#160;31, 2019 compared to year ended December&#160;31, 2020, see &#8220;Financial Operations Overview &#8212;Year Ended December&#160;31, 2019 Compared to Year Ended 31, 2020&#8221; included in our annual report for the year ended December 31, 2020 on Form 20-F (File No.&#160;001-39124) filed with the SEC on April&#160;15, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Quarterly Data</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth certain unaudited financial data for each fiscal quarter for the periods indicated. The unaudited quarterly information includes all normal recurring adjustments that we consider necessary for a fair statement of the information shown. This information should be read in conjunction with the audited consolidated financial statements and related notes thereto appearing elsewhere in this Annual Report. Our quarterly results are not necessarily indicative of future operating results.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0563c1;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.22%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:30.34%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0563c1;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.82%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">First Quarter</p></td><td style="vertical-align:bottom;width:0.96%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.84%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Second Quarter</p></td><td style="vertical-align:bottom;width:0.8%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.12%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Third Quarter</p></td><td style="vertical-align:bottom;width:1.66%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.79%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Fourth Quarter</p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.2%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">First Quarter</p></td><td style="vertical-align:bottom;width:1.2%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.79%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Second Quarter</p></td><td style="vertical-align:bottom;width:1.2%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.98%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Third Quarter</p></td><td style="vertical-align:bottom;width:1.26%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.68%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Fourth Quarter</p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0563c1;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;width:63.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">(unaudited, In EUR thousands)</p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 64,960</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 51,871</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 30,196</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 42,896</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12,105</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,719</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 36,305</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 70,252</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cost of sales <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50,755</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 42,533</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 34,951</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 33,526</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,018</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6,443</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 24,901</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 45,075</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross profit </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,205</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,338</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (4,755)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,370</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,087</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,276</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,404</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 25,177</b></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,335</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,053</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,821</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,088</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,691</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,119</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,796</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,329</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General administrative expenses <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12,595</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,540</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,051</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,553</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,898</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,801</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,501</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,960</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Selling expenses <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,142</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,123</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,228</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,367</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,326</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,724</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,330</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,646</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Impairment of financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 95</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 580</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 502</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (37)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,174</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,147</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 917</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other operating income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 366</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,276</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,011</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 283</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 945</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 801</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 679</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (31)</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 34</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> -</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 101</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 37</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 53</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;background:#cceeff;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (9)</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (4,630)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (7,684)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (21,346)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (12,368)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (8,158)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (10,104)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (4,744)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,303</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 8pt 0pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except for the fourth quarter in 2021, Cost of sales, general administrative expenses and selling expenses have been restated to reflect the impact of the reclassification of advertising expenses, credit card fees and other selling expenses from cost of sales to general administrative expenses and selling expenses. (See note 2.4 to our consolidated financial statements as of December 31, 2021 and 2020 and for the three years ended December 31, 2021, 2020 and 2019 included elsewhere in this Annual Report).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Liquidity and Capital Resources</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our cash requirements are principally for working capital and capital expenditures of all our businesses, including expansions and improvements to our laboratory facilities, technology infrastructure and research and development activities. In fiscal year 2022 and beyond, we anticipate that our capital expenditures in our rare disease business will increase from prior periods as we continue to increase our research and development efforts. Historically, our main source of liquidity has been our secured loans, municipal loans </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">108</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">and government funding of research programs, and proceeds from our initial public offering. In July 2020, we completed the Follow-on Equity Offering and received net offering proceeds, after deducting underwriting discounts and commissions, of &#8364;22 million. In January 2022, we secured a debt financing agreement (&#8220;Loan Facility&#8221;) in the total amount of USD 45.0 million (&#8364;40.2 million) and additional &#8364;15 million through issuance of common shares and warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our financial condition and liquidity are and will continue to be influenced by a variety of factors, including our ability to continue to generate cash flows from our operations, our capital expenditure requirements, and the impact of the COVID-19 pandemic on financial markets and the global economy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our known material liquidity needs for periods beyond the next twelve months are described below in &#8220;&#8212;F. Tabular Disclosure of Contractual Obligations.&#8221; We believe cash generated from our operations, cash and cash equivalents per year-end, financial instruments, government funding of research programs together with the Loan Facility and capital injection obtained in 2022 will be sufficient to fund our operations for at least 12 months from the date of issuance of these financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Contractual Obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below presents the residual contractual terms of the financial liabilities as of December 31, 2021, including estimated interest payments. The figures are undiscounted gross amounts, including estimated interest payments and interest on undrawn loan funds, but without showing the impact of offsetting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Between&#160;1&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Between&#160;3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">contractual&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Less&#160;than&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">and&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;and&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">More&#160;than</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">cash&#160;flows</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">1&#160;year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3&#160;years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">5&#160;years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;5&#160;years</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,310</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,310</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 505</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 505</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 22,050</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,119</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,423</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,615</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,893</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short term and low value leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 93</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 44</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables and purchase obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11,252</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11,252</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 37,210</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,230</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,472</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,615</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,893</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Lease liabilities include leases related to lease contracts for land and buildings, offices as well as various items motor vehicles and other equipment which are accounted for according to IFRS 16, and measured at the present value of lease payments over the lease term at the commencement date of the leases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Lease liabilities also include contractual cash flows in relation to the expansion of the Rostock headquarters and leasing of our Frankfurt laboratory, our Airport Berlin, Airport D&#252;sseldorf and Airport Frankfurt testing centers that are not accounted for yet. The future lease payments and utilities for these non-cancellable lease contracts are &#8364;107 thousand within one year, &#8364;2,370 thousand within five years and &#8364;4,219 thousand thereafter (December 31, 2020: &#8364;283 thousand within one year, &#8364;1,686 thousand within five years and &#8364;4,855 thousand thereafter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the Securities and Exchange Commission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Material Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Private Placement of Common Shares and Warrants</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On January 31, 2022, we entered into a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) with the purchasers named therein (the &#8220;Investors&#8221;) and a Warrant Agreement (the &#8220;Warrant Agreement&#8221;) with the Investors. Pursuant to the Securities Purchase Agreement and the Warrant Agreement, we agreed to sell to the Investors (i) an aggregate of 4,479,088 common shares at a price per share of USD 3.73, and (ii) warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72 (the &#8220;Warrants&#8221;), for aggregate gross proceeds of &#8364;15.0 million. The Warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">109</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Securities Purchase Agreement and the Warrant Agreement contain customary representations and warranties from the Company and the Investors and customary closing conditions. The closing of the Private Placement occurred on January 31, 2022 (the &#8220;Closing Date&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company also agreed pursuant to the Securities Purchase Agreement and the Warrant Agreement, among other things, to indemnify the Investors from certain liabilities arising out of or based in whole or in part on the inaccuracy of the representations and warranties of the Company contained in those respective agreements or the failure of the Company to perform its obligations thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Each of the Investors is a party to the Company&#8217;s existing Registration Rights Agreement, dated November 12, 2019 (as amended, the &#8220;Registration Rights Agreement&#8221;) (one Investor having executed a joinder thereto prior to the Closing Date). Pursuant to the Registration Rights Agreement, we have agreed under certain circumstances to file a registration statement to register the resale of the securities held by such Investors, subject to certain exceptions, as well as to cooperate in certain public offerings of such securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Loan and Security Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">On January 31, 2022 (the &#8220;Closing Date&#8221;), the Company, Centogene GmbH, CentoSafe B.V. and Centogene US, LLC (together, the &#8220;Borrowers&#8221;), entered into the Loan Facility with Oxford Finance LLC (&#8220;Oxford&#8221;) and the other financial institutions or entities from time to time parties to the Loan Facility (collectively, referred to as &#8220;Lenders&#8221;) and Oxford, in its capacity as collateral agent for itself and  the Lenders (in such capacity, &#8220;Agent&#8221;). Under the Loan Facility, the Lenders agreed to make available to the Borrowers certain term loans in an aggregate principal amount of up to $45.0 million, subject to funding in two tranches as follows: (a) on the Closing Date, a loan in the aggregate principal amount of $25.0 million (the &#8220;Term A Loan&#8221;) and (b) on and after the Term B Milestone (as defined below) until the earlier of 60 days thereafter and July 31, 2023, a loan in the aggregate principal amount of USD 20.0 million (the &#8220;Term B Loan&#8221; and collectively with the Term A Loan, the &#8220;Term Loans&#8221;). The obligations of the Lenders to fund the Term B Loan are subject to our achievement of product revenues from our diagnostics and pharmaceutical services segments of at least USD 50.0 million calculated on a trailing twelve month basis as of the last day of any fiscal month (such achievement, the &#8220;Term B Milestone&#8221;). As security for the Borrowers&#8217; obligations under the Loan Facility, the Borrowers granted the Lenders a first priority security interest on the Borrowers&#8217; assets. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The maturity date of the Term Loans is January 29, 2027, with amortized payments commencing March 1, 2025 in 24 equal monthly payments. The Term Loans bear an interest rate of 7.93% per annum plus the 1-month CME Term SOFR reference rate as published by the CME Group Benchmark Administration Limited (subject to a floor of 0.07%), based on a year consisting of 360 days.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">At any time following the Closing Date, the Borrowers may prepay an amount of not less than all of the then outstanding principal balance and all accrued and unpaid interest on the Term Loans, subject to at least fifteen days&#8217; prior written notice to the Agent and the payment of a prepayment fee equal to (x) if made on or prior to the first anniversary of the Closing Date, 3.0% of the principal amount being prepaid, (y) if made after the first anniversary of the Closing Date but on or prior to the second anniversary of the Closing Date, 2.0% of the principal amount being prepaid and (z) otherwise, 1.0%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Loan Facility contains customary affirmative covenants, negative covenants and events of default, including covenants and restrictions that, among other things, require the Borrowers to satisfy a financial covenant, restrict Borrowers&#8217; ability to transfer cash to their subsidiaries, and in certain circumstances restrict the ability of the Borrowers to incur liens, incur additional indebtedness, engage in mergers and acquisitions, make distributions or make asset sales without the prior written consent of Lenders. A failure to comply with these covenants could permit the Lenders to declare the Borrowers&#8217; obligations under the Loan Facility, together with accrued interest and fees, to be immediately due and payable, plus any applicable additional amounts relating to a prepayment or termination, as described above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">110</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Comparative Cash Flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Comparison of the Years Ended December&#160;31, 2021 and 2020</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table sets forth our cash flows for the periods indicated:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;Years&#160;Ended&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Consolidated statement of cash flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash flow (used in)/ from operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (21,739)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,462</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash flow (used in) investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (5,360)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (16,151)</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash flow (used in)/ from financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (3,203)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14,842</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net (decrease)/ increase in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (30,302)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,153</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash and cash equivalents at the beginning of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 48,156</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 41,095</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of movements in exchange rates on cash held</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (36)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (92)</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 17,818</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 48,156</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Operating Activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our cash flow used in, or from, operating activities primarily relates to changes in the components of our working capital, including cash received from our COVID-19 business, pharmaceutical partners and diagnostics clients, and payments made to our suppliers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year ended December&#160;31, 2021, cash flow used in operating activities was &#8364;21,652&#160;thousand, an increase of &#8364;30,114&#160;thousand as compared to cash generated from operating activities of &#8364;8,462&#160;thousand for the year ended December&#160;<span style="white-space:pre-wrap;">31, 2020. This change was mainly driven by the COVID-19 business segment where business to government contract structures were amended resulting in higher subcontracting costs for each testing site, costs relating to the set-up of the COVID-19  business unit, committed fixed overhead costs coupled with the downturn of COVID-19 testing in the second half of the year.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Investing Activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our cash flow used in, or from, investing activities consists of investments in intangible assets, plant, property and equipment, grants received for investments in property, plant and equipment and cash received from disposals of property, plant and equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year ended December&#160;31, 2021, cash flow used in investing activities was &#8364;5,360&#160;thousand, as compared to cash flow used of &#8364;16,151&#160;thousand in investing activities for the year ended December&#160;31, 2020. The decrease was mainly due to the reduction in investments made in respect of COVID-19 testing. Total investments in COVID-19 testing during the year ended December 31, 2021 amounted to &#8364;2,834 thousand compared to &#8364;9,346 thousand for the year ended December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cash used in investment activities in our rare disease business included mainly costs incurred in the development of new products and solutions, and the development of our IT driven and interpretation-based solutions. It also includes investment in property, plant and equipment used in the laboratories and other business operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financing Activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year ended December&#160;31, 2021, cash used in financing activities was &#8364;3,203&#160;thousand, an increase of &#8364;18,045&#160;thousand as compared to cash generated of &#8364;14,842&#160;thousand for the year ended December&#160;31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our cash flow provided by financing activities for the year ended December&#160;31, 2020 was primarily driven by the cash received in our follow-on offering in July 2020, which contributed &#8364;22,430 thousand, net of underwriting discounts, commissions and transaction costs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cash used in financing activities includes repayment of lease liabilities of &#8364;4,244 thousand, an increase of &#8364;774 thousand as compared to repayment of &#8364;5,018 thousand for the year ended December 31, 2020.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">111</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the discussion of our cash flows for the year ended December&#160;31, 2019 compared to year ended December&#160;31, 2020, see &#8220;Comparative Cash Flows &#8212;Year Ended December&#160;31, 2019 Compared to Year Ended 31, 2020&#8221; included in our annual report for the year ended December 31, 2020 on Form 20-F (File No.&#160;001-39124) filed with the SEC on April&#160;15, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Indebtedness</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Syndicated Loan Facility</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On August&#160;4, 2015, we entered into a loan agreement (as amended or supplemented to date, the &#8220;Syndicated Loan Facility&#8221;) with certain German commercial banks. The Syndicated Loan Facility consists of four tranches. As of December&#160;31, 2021, we had &#8364;2,834&#160;thousand outstanding under the Syndicated Loan Facility, of which &#8364;505 thousand was outstanding under Tranche&#160;B and &#8364;2,329 thousand was outstanding under the Tranche D. As of December&#160;31, 2020, we had &#8364;1,596&#160;thousand outstanding under the Syndicated Loan Facility, of which &#8364;968&#160;thousand was outstanding under Tranche&#160;B and &#8364;628&#160;thousand was outstanding under the Tranche&#160;D Loan. As of December&#160;31, 2021 and 2020, there were no balances outstanding under Tranches A and&#160;C.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The outstanding portions of the Syndicated Loan Facility consist of:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Tranche<span style="font-family:'Symbol';">&#160;</span>B loan has an aggregate original principal amount of <span style="font-family:'Symbol';">&#8364;</span>5,410<span style="font-family:'Symbol';">&#160;</span>thousand that is scheduled to mature on December<span style="font-family:'Symbol';">&#160;</span>30, 2022 (the <span style="font-family:'Symbol';">&#8220;</span>Tranche<span style="font-family:'Symbol';">&#160;</span>B Loan<span style="font-family:'Symbol';">&#8221;</span>) and bears interest at a floating rate of EURIBOR plus a margin of 2.95% per annum. Since December 2019, we have pledged <span style="font-family:'Symbol';">&#8364;</span>1,500<span style="font-family:'Symbol';">&#160;</span>thousand in cash in connection with amounts outstanding thereunder;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Tranche<span style="font-family:'Symbol';">&#160;</span>D loan has an aggregate principal amount of up to <span style="font-family:'Symbol';">&#8364;</span>2,500<span style="font-family:'Symbol';">&#160;</span>thousand as overdraft facility (the <span style="font-family:'Symbol';">&#8220;</span>Tranche<span style="font-family:'Symbol';">&#160;</span>D Loan<span style="font-family:'Symbol';">&#8221;</span>) and bears interest at EURIBOR plus a margin of 3.5% per annum. Pursuant to a cash pledge that we entered into in January 2018 with the lenders under the Tranche<span style="font-family:'Symbol';">&#160;</span>D loan, as of July<span style="font-family:'Symbol';">&#160;</span>1, 2019, we had pledged <span style="font-family:'Symbol';">&#8364;</span>2,500<span style="font-family:'Symbol';">&#160;</span>thousand in cash in connection with amounts outstanding thereunder.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Tranche&#160;B Loan has been used to purchase laboratory equipment on a pro rata basis. In addition, it served to refinance rental purchases for short-term investments in laboratory equipment and IT equipment. The Tranche&#160;D Loan serves us as a working capital line in an aggregate amount of &#8364;&#160;2,500&#160;thousand. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December&#160;31, 2019, after Tranche&#160;A loan was fully repaid following our sale and leaseback transaction, the terms of the Syndicated Loan Facility were renegotiated with the relevant banks and &#8364;1,500&#160;thousand in cash was arranged and pledged for the Tranche&#160;B Loan. In exchange, the assignment of assets and receivables was released, and the requirement of compliance with covenants and restrictions were also removed. As of December&#160;31, 2021, there was no requirement to comply with the covenants and no liens on assets, except for cash deposits pledged, remaining under the Syndicated Loan Facility.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Revolving Credit Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have entered into two further secured bank overdraft agreements totaling &#8364;1,000&#160;thousand which we use to finance our day-to-day business operations. &#8364;981&#160;thousand was utilized as of December&#160;31, 2021 and &#8364;910 thousand was utilized as of December&#160;31, 2020. Our first &#8364;500&#160;thousand bank overdraft agreement had an initial floating interest rate of 4.23% per annum (adjusted on EURIBOR) when utilized as an overdraft facility. This is secured by a term deposit of &#8364;500 thousand. Our second &#8364;500&#160;thousand bank overdraft agreement had an initial floating interest rate of 4.5% per annum when utilized as an overdraft facility and is secured by a term deposit of &#8364;500 thousand.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Research and Development, Patents and Licenses, etc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For a description of our research and development policies for the last three years see &#8220;Item&#160;4. Information on the Company&#8212;B. Business Overview&#8212;Research and Development.&#8221; For a description of our intellectual property, see &#8220;Item&#160;4. Information on the Company&#8212;B. Business Overview&#8212;Intellectual Property.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Trend Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For a discussion of trend information, see &#8220;Item&#160;5. Operating and Financial Review and Prospects.&#8221;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">112</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Critical Accounting Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our consolidated financial statements are prepared in accordance with IFRS as issued by the IASB. Some of the accounting methods and policies used in preparing the financial statements under IFRS are based on complex and subjective assessments by our management or on estimates based on past experience and assumptions deemed realistic and reasonable based on the circumstances concerned. The actual value of our assets, liabilities and shareholders&#8217; equity and of our earnings could differ from the value derived from these estimates if conditions changed and these changes had an impact on the assumptions adopted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our significant accounting policies that we believe to be critical to the judgments and estimates used in the preparation of our financial statements are included in &#8220;Note 2.2&#8212;Going concern, Note&#160;6&#8212;Accounting judgments and estimates&#8221; and &#8220;Note&#160;20&#8212;Share-based payments&#8221; to our consolidated financial statements as of and for the year ended December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_4af61fbb_2e89_4acb_9db9_89c71fa3d2f3"></a><a id="Item6DirectorsSeniorManagementandEmploye"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">6.  Directors, Senior Management and Employees</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Directors and Senior Management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Board Structure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have a two-tier board structure consisting of a management board (<i style="font-style:italic;">bestuur</i>) and a separate supervisory board (<i style="font-style:italic;">raad van commissarissen</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Management Board </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our management board consists of three members, who we refer to as our managing directors (and who are also our executive officers). Each managing director of Centogene&#160;N.V. holds office for the term set by our general meeting of shareholders (as set forth in the table below), except in the case of his earlier death, resignation or removal. Our managing directors do not have a retirement age requirement under our articles of association. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our managing directors are responsible for the management and representation of our company. We have a strong centralized management team led by our CEO, with broad experience in strategy, operations, finance, information technology, sales, communications and training. </p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:10pt;">The following table lists the current members of our management board, as well as the year of expiration of their terms as management board members of Centogene&#160;N.V.</span> <span style="font-size:10pt;">We consider all persons named in the table below key executive officers. Mr. Coego Rios does not serve on our management board, but does serve as our Interim Chief Financial Officer effective as of April 1, 2022 and we consider him also to be a key executive officer.</span></p><a id="_86fa69f2_e7fb_4b3d_8c73_e9f8db3d7a24"></a><a id="_fd946e1a_3b85_4569_aad9_6cb383a47908"></a><a id="_30cd5171_895c_455a_a49e_78921df04c98"></a><a id="_5bbc3a20_7034_47d0_b4a4_d4da01552160"></a><a id="_1884bf52_c4cf_4447_a821_1a3d752e9ae2"></a><a id="_e8b9ae22_68bd_446b_a28b_5e83bcc59a0e"></a><a id="_fb130f7a_49b7_42d9_a0c2_651cb560de1b"></a><a id="_7952e525_6dd1_44ce_8122_8657aba0c81d"></a><a id="_df7d8773_9fb2_4e6f_9a79_be017d646143"></a><a id="_f11792bf_1cac_4ce3_a282_d7b584d77034"></a><a id="_59916cbb_1071_4d85_8f00_80ed677c6563"></a><a id="_03f60f0d_4492_4f6e_beb8_e91ced483552"></a><a id="_38aeb4bd_1422_47f4_89f8_63a6790654e8"></a><a id="_d475a25b_5f9b_42b6_af8c_41b06110d7d3"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:54.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:22.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year&#160;of&#160;Expiration&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of&#160;Term</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Kim Stratton</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 59</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:bottom;width:54.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ren&#233; Just</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 54</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:54.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volkmar Weckesser, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Information Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 55</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2022</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:35.25pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Effective as of February 1, 2022, Dr. Andrin Oswald resigned from the management board and his position as our Chief Executive Officer. Mrs. Stratton was appointed as Centogene&#8217;s managing director and Chief Executive Officer on February 18, 2022, after having served as interim managing director and Chief Executive Officer from December 20, 2021</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:35.3pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">On June 30, 2021, Richard Stoffelen stepped down from the management board and his role as our CFO. He was succeeded by Ren&#233; Just. Effective as of March 31, 2022, Ren&#233; Just resigned from the management board and his position as our Chief Financial Officer of Centogene. Jose Miguel Coego Rios was appointed as our Interim CFO with effect as of April 1, 2022 and Executive Vice President of Finance &amp; Legal on February 8, 2022.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following is a brief summary of the business experience of our managing directors and Mr. Coego Rios. Unless otherwise indicated, the current business addresses for our managing directors is Am Strande 7, 18055 Rostock, Germany.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Kim Stratton</i>, was appointed as our managing director and Chief Executive Officer on February 18, 2022, after having served as interim managing director and Chief Executive Officer as of December 20, 2021. Mrs. Stratton has more than 25 years of global commercial expertise in the biopharmaceutical space, with significant experience across multiple geographies, including the United Kingdom, the United States, Europe, and emerging markets. Most recently, Mrs. Stratton was CEO of Orphazyme, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases. Prior to this role, she worked at Shire Pharmaceuticals, where she served as Head of International Commercial for Shire&#8217;s Specialty and Rare Diseases portfolio. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">113</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Before Shire, Mrs. Stratton spent nearly 15 years at Novartis in a number of senior management roles, including global product development, commercial, marketing, general manager, and various global corporate functions, including government and external affairs. Mrs. Stratton is on the Board of Recordati S.p.A, Novozymes A/S and Vifor Pharma AG.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Ren&#233; Just,</i><span style="white-space:pre-wrap;">  Mr.&#160;Just has served as our CFO since June 2021 and will step down from the management board and as our CFO on March 31, 2022. He has over 20 years of industry experience. During his career, Mr. Just has held positions of increasing responsibility in both listed and private equity owned companies, spanning a range of industries, including Pharma, IT, and Services. Throughout this time, Mr. Just has gained extensive experience in building and leading efficient finance operations &#8211; supporting the development and implementation of value creation strategies, as well as the planning and execution of financing strategies. Mr. Just holds a Master of Economics from Aarhus University (Denmark). Prior to joining Centogene, he was the Group CFO at Riemser Pharma Holding, previously owned by the private investment and private equity firm Ardian.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Volkmar Weckesser, Ph.D.</i><span style="white-space:pre-wrap;">  Dr.&#160;Weckesser has served as our chief information officer since 2016. Prior to joining us, he served as chief executive officer and group chief information officer at Gothaer Systems&#160;GmbH from 2014 to 2016. He served as a Member of the Executive Council and head of Information Technology at Dekabank Deutsche Girozentrale from 2009 to 2014, as a central division manager of the Information Technology Division of HSH Nordbank AG from 2003 to 2009, division manager of Landesbank Schleswig-Holstein Girozentrale from 1999 to 2003, personal assistant to the CEO at Deutsche Apotheker und &#196;rtzebank EG from 1998 to 1999, project manager at Mitchell Madison Group from 1996 to 1998, consultant and project manager at Monitor Company from 1993 to 1996 and lecturer at Universitat Karlsruhe 1991 to 1993. He holds a Ph.D. from Universitat Karlsruhe.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Jose Miguel Coego Rios, </i><span style="white-space:pre-wrap;">our Executive Vice President of Finance &amp; Legal, is an experienced senior executive with broad expertise in finance and commercial leadership roles in the pharmaceutical and biotech sectors. Effective April 1, 2022, he will assume the role of  Interim CFO. Mr. Rios has an extensive track record in achieving sales and expenses targets, team management and development, and steering multi-country projects. Most recently, he was Vice President &amp; General Manager South Europe at Orphazyme A/S, a late-stage clinical biotech company. Before that he was Vice President &amp; CFO EMEA at Mundipharma, a multinational pharmaceutical company. Earlier in his career, Mr. Rios served in several senior management positions at Shire Pharmaceuticals between 2011 and 2019, most recently as CFO LATAM and General Manager of the Andean region. Mr. Rios has gained notable international exposure having completed positions in Colombia, Brazil, Spain, and the United Kingdom. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table lists those of our key executive officers as of December 31, 2021 who are not members of our management board:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_7cdbac11_50a4_4379_88c6_a3c773f1cd49"></a><a id="_5894b50b_ac82_4f94_8918_b0d5c6b29c57"></a><a id="_cec5ffa9_1022_4fe3_8c1b_968b7bbd8734"></a><a id="_2439157e_e2ca_488b_a197_52869aa07d89"></a><a id="_46fcdd97_68b1_43a4_bad9_c01dd60491bc"></a><a id="_b46d1354_4f86_406e_b855_5cd1d941a473"></a><a id="_dcc50f8b_d0c1_4b0b_8f19_6f8a764d63e1"></a><a id="_36bd4927_9d62_44cc_a77c_c8390b8646f1"></a><a id="_90be66b1_7ddd_4d0a_b2a1_c4e2dccb06be"></a><a id="_24bfe126_278d_4f28_a477_0e57ecfc4078"></a><a id="_264c55d9_0606_4b50_a08b_1e556070c189"></a><a id="_ad47f50a_7f8c_4f22_af55_cd07ba03ebf2"></a><a id="_34e0855e_99d1_455c_816c_1215726f969e"></a><a id="_62126d0f_c14b_45ab_acfc_fb48185955a5"></a><a id="_f77d0a5f_dc4e_4ca9_9c12_43f0f33a3fd4"></a><a id="_eef9beec_5463_444a_9e52_26dd4003d9f2"></a><a id="_d8c6412f_1ce3_41b5_b147_c3daa6ce7363"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:39.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year&#160;of&#160;Expiration&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of&#160;Term</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Maximilian Schmid, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Commercial Officer &#8211; Diagnostics</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 44</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Michael Motz, Ph.D. (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Commercial Officer - Pharmaceuticals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 49</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Patrice P. Den&#232;fle, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Scientific Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 62</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Nathalie Daste</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Human Resources Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 45</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Florian Vogel, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Process Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 41</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Prof. Peter Bauer, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:38.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Genomic Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 52</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:35.25pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Mr. Motz served as Centogene&#8217;s Chief Commercial Officer &#8211; Pharmaceuticals. He resigned his position at the end of </span><span style="display:inline-block;width:20.41pt;"></span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">February 2022.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Maximilian Schmid, M.D.,</i><span style="white-space:pre-wrap;">  Mr. Schmid serves as Centogene&#8217;s Chief Commercial Officer Diagnostics. Bringing over two decades of Experience, Mr. Schmid has the overall responsibility of driving the Company&#8217;s Diagnostic business strategy and growth. He joined Centogene from Roche Diagnostics, where he most recently served as Global Head of Medical Affairs of its Sequencing Business Unit. Within this role, he was responsible for developing and executing the medical strategy across different countries and disease areas, such as Oncology and Women&#8217;s Health. Mr. Schmid came to Roche following its acquisition of Silicon Valley startup Ariosa Diagnostics Inc., where after a successful career in academic medicine, he helped build a leading global NIPT business. Prior to his medical career, Mr. Schmid worked as a Management Consultant for McKinsey &amp; Company, developing and implementing strategies and solutions to overcome complex challenges in the pharmaceutical and biotechnology industry. He holds a medical degree from the University of Vienna and is board-certified with habilitation in Obstetrics and Gynecology and sub-specialty training in Maternal-Fetal Medicine, as well as certification in Clinical Genetics.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Michael Motz, Ph.D</i>., Mr. Motz serves as Chief Commercial Officer, Pharmaceuticals, overseeing the Company&#39;s Pharma business strategy and growth. He is an entrepreneur and executive with over 25 years of industry experience and has held positions of increasing responsibility in both biotech and pharmaceutical companies during his career. Mr. Motz worked on several large </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">114</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">transactions, licensing (in- and out-), and acquisitions with EU and U.S.-based life science companies, on both the buy side and the sell side. His experiences have also allowed him to gain expert knowledge in drug discovery and development for rare diseases, such as lysosomal storage diseases (LSDs) and certain rare bone disorders. He holds a doctorate in Biochemistry from the Max Planck Institute for Evolutionary Anthropology, obtained under the supervision of renowned human geneticist Prof. Dr. h.c. Svante P&#228;&#228;bo. Before joining Centogene, he was in leadership positions at several pharma and biotech companies, such as LION Bioscience AG, ALTANA Pharma, Sandoz, F. Hoffmann-La Roche AG, and Zealand Pharma. Most recently, Mr. Motz was Entrepreneur in Residence at BB Pureos Bioventures in Zurich, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Patrice P. Den&#232;fle, Ph.D.,</i> Mr. Den&#232;fle serves as Centogene&#8217;s Chief Scientific Officer. Within this role, he is responsible for overseeing the Company&#8217;s scientific activities to deliver on its vision and strategy,&#160;while driving value creation. Mr. Den&#232;fle is a seasoned executive and scientific pioneer with over 35 years of experience at pharmaceutical and biotechnology companies in Europe and the U.S., spearheading translational R&amp;D to deliver breakthrough treatments to patients.&#160;Prior to joining Centogene, Mr. Den&#232;fle served as Chief Scientific Officer at 4P-Pharma, where he led the R&amp;D drug repositioning strategy and operations towards potential full clinical demonstration and asset-value transfer to large pharma companies. Over the past three decades, he has held several leadership positions, including as the General Manager of the Roche Institute for Research and Translational Medicine, as well as other senior roles at Sanofi Aventis and Ipsen. Mr. Den&#232;fle also served as CSO at Genethon, a biotech company dedicated to the development of gene therapy treatments for rare diseases. Mr. Den&#232;fle lecular Pharmacology at the University of Lille, graduated as Adjunct University Professor, and taught Biotechnology for 10 years at the University Paris-Descartes. Mr. Den&#232;fle was also trained as a CEDEP fellow at INSEAD and has co-authored more than 150 scientific papers and patents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Nathalie Daste,</i> Bringing extensive experience in organization and capability building in the healthcare sector, Ms. Daste is responsible for further developing the company&#8217;s global talent, fostering company culture, and expanding organizational capabilities to deliver against a purpose-driven growth strategy. Ms. Daste has a proven track record in successfully supporting the growth and strategy of leading companies in the healthcare sector globally in industry and consulting positions, including at McKinsey &amp; Company and Novartis. Over the past decade, she has spearheaded a number of large-scale efforts in the area of culture change, performance improvement, top team alignment, and talent and organizational development. Ms. Daste holds both a master&#39;s in Management from ESSEC and an MBA from INSEAD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Florian Vogel, Ph.D</i>., Mr. Vogel currently serves as Chief Process Officer. Within his role, he holds disciplinary and budget responsibility for all five Diagnostic wet lab production departments in Rostock, Germany, and the CLIA &amp; CAP lab processing facility in Cambridge, Massachusetts. In addition, he is responsible for the Method &amp; Process Development in Rostock. Before taking on this position, he served as Senior Director Research &amp; Development from 2015-2018 at Centogene. Mr. Vogel has extensive experience in product development and streamlining of workflows for genetically based methods enabling the highest quality as well as high throughput testing. Mr. Vogel has more than ten years of know-how in molecular genetic assay design and international leadership in various industry sections. Prior to joining Centogene, he was living in South Korea to set up the local branch of a German university and labs for chemical and bioengineering as Head of the White Biotechnology department, including lab build out and starting industry collaborations. Mr. Vogel studied Biology at Friedrich-Alexander-University of Erlangen-Nurnberg and received his doctoral degree in Molecular Biology <i style="font-style:italic;">summa cum laude</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Prof. Peter Bauer, M.D.</i><span style="white-space:pre-wrap;">  </span>Prof. Bauer has served as our chief genomic officer since December 2019, prior to which he served as our chief scientific officer from January 2017 to November 2019 and chief operating officer since joining us in 2016. Prof. Bauer is a professor of human genetics at the University of T&#252;bingen and a board-certified human geneticist with expertise in molecular genetics, diagnostic testing, genetic counselling, functional validation of genetic variants and bioinformatics tools for medical interpretation of clinical sequencing. Prior to joining us, he served as head of the diagnostic and research laboratory at the Institute of Medical Genetics and Applied Genomics, University Hospital T&#252;bingen from 2001 to 2015. Prof. Bauer has been vice president of the German Society of Neurogenetics since 2004. Prof. Bauer received a degree in medicine from the Freie University Berlin and the approbation as physician (German official license to practice medicine) from the Board of Physicians in Berlin in 1998.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Supervisory Board</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our supervisory board consists of nine members. Each supervisory board member holds office for the term set by our general meeting of shareholders (as set forth in the table below), except in the case of his earlier death, resignation or removal. Our supervisory board members do not have a retirement age requirement under our articles of association.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">115</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table presents the names of the current members of our supervisory board, as well as the year of expiration of their terms as supervisory board members of Centogene&#160;N.V.:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_3b2632c4_f264_460c_be80_92ee698242c6"></a><a id="_79cb8785_9757_4256_ad41_a44b8da25e37"></a><a id="_940260e9_0540_47e8_8a50_b266e743d3e3"></a><a id="_d4ca97b3_834c_482a_b7e4_91b0c1543ff0"></a><a id="_fc604046_0ed0_4462_9674_c8bb7848ca4b"></a><a id="_85a14bc0_e12b_4f48_8c5e_9115520c5e5a"></a><a id="_10a35281_c0db_452c_b5fa_02392cbb9364"></a><a id="_bb175c7e_9382_4c05_931d_089b070a3ebb"></a><a id="_8696de9c_a447_4ff6_ac1f_283520b2a08b"></a><a id="_2c1a940e_8d42_4031_864c_b047a81733a2"></a><a id="_93fa1ec4_41b2_48f7_a47b_9568960d6cf2"></a><a id="_195cb1ae_4e1e_42df_b6b7_f1dcddafd05d"></a><a id="_7d1838a3_4d31_421d_a104_9dc955b0feb1"></a><a id="_a5d95812_e89a_4753_b22f_0a4b7cdda414"></a><a id="_ebc2f006_8351_4140_a27f_ab1b107ae96d"></a><a id="_5727f7f5_b70a_4972_81b4_1dd16ca2fa79"></a><a id="_aef718e5_7cce_4ca9_84ad_eb7f5bb79703"></a><a id="_e777a487_f34c_49ed_aff5_5fc5d494cd2d"></a><a id="_94de66fc_74d7_440e_928c_39b1372d5bc9"></a><a id="_7680f987_43ad_4c42_b41f_d84402d46899"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:30.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year&#160;of&#160;Expiration&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of&#160;Term</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Peer M. Schatz (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chairman of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 56</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Andreas Busch, Ph.D. (2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member and Vice-Chairman of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 58</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Flemming Ornskov, M.D. (3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 64</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2025</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jonathan G. Sheldon, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 50</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2025</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Holger Friedrich</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 55</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2025</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Guido Prehn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 44</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2025</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Sou&#234;tre, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 66</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2025</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Berndt Modig</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 63</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2025</p></td></tr><tr><td style="vertical-align:bottom;width:30.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Hubert Birner, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Member of the Supervisory Board</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 55</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">2025</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 8pt 0pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Effective from January 1, 2021, Peer Schatz has been appointed Chairman of the supervisory board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 8pt 0pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Andreas Busch was appointed on February 18, 2022 as a member and Vice Chairman of the supervisory board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">(3)</span></span>On March 30, 2022, Flemming Ornskov informed the Supervisory Board that he most likely would step down as a member of the Supervisory Board by</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 8pt 0pt;">the end of 2022 due to increased responsibilities as CEO of Galderma S.A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following is a brief summary of the business experience of our supervisory board members. Unless otherwise indicated, the current business address for our directors is Am Strande 7, 18055 Rostock, Germany.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Peer M. Schatz</i><span style="white-space:pre-wrap;">  From January 1, 2021, Peer Schatz has served as chairman of our supervisory board. Mr.&#160;Schatz joined the supervisory board of Centogene in March 2020 as interim member and interim vice-chairman of the supervisory board. His appointment was approved in the annual general meeting of shareholders in June 2020. He joined Centogene from his position as long-time Chief Executive Officer of QIAGEN&#160;N.V. (Nasdaq: QGEN; Frankfurt: QIA), a leading provider of molecular sample and assay technologies. From 1993 to 2019, he led QIAGEN&#8217;s rapid expansion from a start-up company with $2&#160;million in sales into a global leader in molecular testing with over $1.6&#160;billion in revenues. Mr.&#160;Schatz also serves as a supervisory board director of Siemens Healthineers AG and as Chairman of the Board of Resolve Biosciences GmbH and as managing director of PS Capital Management GmbH. He also served as a founding member of the German Corporate Governance Commission and as a supervisory board member of Evotec AG (Frankfurt: EVT). Mr.&#160;Schatz graduated from the University of St.&#160;Gallen, Switzerland with a Masters Degree in Finance and from the University of Chicago Graduate School of Business with an MBA.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Andreas Busch, Ph.D.,</i> Dr. Busch was appointed member and vice-chairman of the supervisory board on February 18, 2022 and brings over 20 years of experience and leadership in the pharmaceutical industry. Since 2019, he has served as Chief Innovation Officer and Chief Scientific Officer at Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function. Prior to this, Dr. Busch served as Head of R&amp;D and CSO at Shire plc., a global biotechnology leader serving patients with rare diseases. Previously, he held a variety of senior leadership positions in his 13-year tenure at Bayer group, most recently as Head of Drug Discovery and a member of the Executive Committee for the Pharmaceuticals division of Bayer. Prior to joining Bayer, Dr. Busch was Global Head of Cardiovascular Research at Hoechst and Sanofi-Aventis. Dr. Busch has served as a member of numerous Supervisory and Scientific Boards of research institutions and companies, including the German Cancer Research Center, the University of T&#252;bingen, the Max Delbr&#252;ck Center, and the Max Planck Institute of Molecular Genetics, as well as Takeda and start-up companies, such as Omeicos and BerlinCures. He also holds the title of Extraordinary Professor of Pharmacology at the Johann Wolfgang Goethe-University in Frankfurt, Germany. Dr. Busch received his license to practice Pharmacy and Ph.D. in Pharmacology from the Johann-Wolfgang-Goethe-University, Frankfurt. He is the author of over 400 publications and abstracts, and received the prestigious Sir Bernard Katz and Franz Volhard Awards for his work on renal and cardiac ion channels and transporters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Flemming Ornskov, M.D., MPH, MBA.</i>&#160; Dr.&#160;Ornskov has served as a member of our supervisory board since April 2019. From April 2019 until December 31, 2020 he also served as the chairman of the supervisory board. &#160;He has served as the Chief Executive Officer of Galderma&#160;S.A. since October 2019.&#160;He currently also serves as the Chairman of the Board of Director of Waters Corporation. Dr Ornskov was the&#160;Chief Executive Officer and a Board Member of Shire&#160;Plc from April 2013 to January 2019, when Shire was acquired by Takeda.&#160;&#160;Earlier in his career, Dr. Ornskov worked in executive roles at Bayer, Novartis and Merck &amp; Co. Dr.&#160;Ornskov received his M.D. from the University of Copenhagen, MBA from INSEAD, and Masters of Public Health from Harvard University.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">116</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Jonathan G. Sheldon, PhD</i><i style="font-size:12pt;font-style:italic;">.</i><span style="font-size:12pt;white-space:pre-wrap;">  </span>Dr.&#160;Sheldon joined our supervisory board as a an interim member at November 10, 2020, and his appointment was approved by the shareholders in the extraordinary general meeting of shareholders on December 18, 2020. Mr. Sheldon has an extensive track record in the life science and healthcare industry &#8211; having spearheaded growth and strategy development of multiple global companies. He serves as Senior Vice President of the Digital Insights Business Area and member of the Executive Committee at QIAGEN N.V., a leading provider of molecular sample and assay technologies. Prior to joining QIAGEN, Jonathan served as the Global Vice President of Oracle Health Services &#8211; further positioning the Company&#8217;s product portfolio, defining its healthcare strategy, and its convergence with Life Sciences. Previously, he was the Head of Bioinformatics at Roche Pharmaceutical, where he established the Company&#8217;s first bioinformatics department in the UK as well as providing leadership to a variety of software and data companies serving both the life science and healthcare sectors. Until recently, Mr. Sheldon was a Board Member of the Drug Information Association (DIA) and served on the board of the American College of Medical Genetics Foundation. He completed his B.Sc. in Biochemistry and Molecular Biology at the University of Manchester, and went on to receive his Ph.D. in Biochemistry and Molecular Biology from the University of Cambridge. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Holger Friedrich.</i> Mr. Friedrich has been a member of our supervisory board since 2017. Since 2010, Mr. Friedrich has been the Managing Director of the consulting division of CORE SE (acquired by EPAM). Prior to that, he was Chairman of SPM Technologies (acquired by SAP) from 1993 to 2003 and Senior Vice President, IT Architecture, at SAP from 2003 to 2005. From 2005 to 2008, he was a partner at McKinsey, responsible for IT Enterprise Architecture in Europe. From 2009 to 2010, he was a member of the Executive Board at Software AG. Friedrich studied computer science and German language and literature.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Guido Prehn. </i>Mr.&#160;Prehn joined our supervisory board as a member in 2019. Mr.&#160;Prehn has over 15&#160;years of experience in the private equity industry. He currently serves on the boards of OmniaMed Holding&#160;GmbH, Calvias&#160;GmbH, Everest TopCo&#160;B.V., Auerbach Holding AG, VTU Group GmbH, FinCo GmbH, B plus L Group Holding GmbH, M-Personal Protection Holding GmbH and M-Personal Protection Management GmbH. Mr.&#160;Prehn is a managing director of DPE Deutsche Private Equity which he joined in 2010, shortly after its foundation. Between 2002 and 2009, he worked in various positions at Allianz Capital Partners, TPG Capital and Merrill Lynch. Mr.&#160;Prehn studied business administration at the European Business School, Oestrich-Winkel, De Paul University Chicago and Universidad Argentina de la Empresa, Buenos Aires.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Eric Sou&#234;tre, M.D.</i><span style="white-space:pre-wrap;">  Dr.&#160;Sou&#234;tre joined our supervisory board as a member in 2017. After various research positions at National Institute of Mental Health, Dr.&#160;Sou&#234;tre founded &#8220;BENEFIT&#8221; in 1990, a research and consulting company in health economics (subsequently acquired by QUINTILES&#160;Inc. (USA) in 1995). He then served as a board member at QUINTILES Inc., where he was responsible for the global consulting function. In 2003, Dr.&#160;Sou&#234;tre co-founded LABCO&#160;-&#160;a network of clinical laboratories&#160;- and led the company to a European leadership as chairman and CEO until late 2010. He remained as an active board member until LABCO was sold to CINVEN in 2015. Dr.&#160;Sou&#234;tre has since co-founded a private equity fund, Careventures, focused on pan European healthcare service ventures. He currently serves on the board of OPERA&#160;SA. Dr.&#160;Sou&#234;tre holds a Ph.D. in neurosciences by the Marseille University, an M.D. by the Medical University of Nice and an MBA from HEC school of Paris.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Berndt Modig, MBA.</i><span style="white-space:pre-wrap;">  Mr.&#160;Modig joined our supervisory board as a member in April 2018. He also serves as chief executive officer of Pharvaris&#160;N.V. He served as chief financial officer of Prosensa Holding&#160;N.V., a public pharmaceutical company, from March 2010 until its acquisition by BioMarin Pharmaceutical&#160;Inc. in January 2015. From October 2003 to November 2008, Mr.&#160;Modig was chief financial officer at Jerini AG where he directed private financing rounds, its initial public offering in 2005, and its acquisition by Shire&#160;Plc in 2008. Before that, Mr.&#160;Modig served as chief financial officer at Surplex AG from 2001 to 2003 and as finance director Europe of U.S.-based Hayward Industrial Products&#160;Inc. from 1999 to 2001. In previous positions, Mr.&#160;Modig was a partner in the Brussels-based private equity firm, Agra Industria, from 1994 to 1999 and a senior manager in the Financial Services Industry Group of Price Waterhouse&#160;LLP in New York from 1991 to 1994. Mr.&#160;Modig currently serves as a director, chair of the compensation committee and member of the audit committee of Sio Gene Therapies Inc. In addition, until April 2021 he served as vice-chairman of the supervisory board and chairman of the audit committee of Kiadis Pharma&#160;N.V., all of which are publicly held pharmaceutical companies, and he was a director of Mobile Loyalty&#160;plc from 2012 to 2013. Mr.&#160;Modig received a bachelor&#8217;s degree in business administration, economics and German language from the University of Lund, Sweden, and an MBA from INSEAD, Fontainebleau, France. He is a certified public accountant (inactive).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Hubert Birner, Ph.D.</i><span style="white-space:pre-wrap;">  Dr.&#160;Birner joined our supervisory board as chairman from July 2017 to March&#160;30, 2019, and as vice-chairman from April&#160;1, 2019 to March&#160;</span><span style="white-space:pre-wrap;">16, 2020. Dr. Birner is responsible for TVM Capital Life Science&#8217;s overall investment strategy and global fund operations. He currently serves as Chairman of the board of directors of Leon-nanodrugs GmbH and AL-S Pharma AG. Dr. Birner previously served on the board of  Acer Therapeutics, Argos Therapeutic, Horizon Pharma, Inc., Bioxell SA, Evotec AG, Jerini AG, Noxxon Pharma, Probiodrug AG, Proteon Therapeutics Inc. and SpePharm Holdings BV. Prior to his current tenure, he was Head of Business Development Europe and Director of Marketing for Germany at Zeneca Agrochemicals. Dr. Birner </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">117</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">joined Zeneca from McKinsey &amp; Company&#8217;s European Health Care and Pharmaceutical practice and as Assistant Professor for biochemistry at the Ludwig-Maximilian-University (&#8220;LMU&#8221;), following his summa cum laude doctoral degree in biochemistry at LMU; his doctoral thesis was honoured with the Hoffmann-La Roche prize for outstanding basic research in metabolic diseases. Dr. Birner also holds an MBA from Harvard Business School.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Compensation of Managing Directors, Supervisory Board Members and Officers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are a foreign private issuer. As a result, in accordance with Nasdaq listing requirements, we are complying with home country compensation requirements and certain exemptions thereunder rather than with Nasdaq compensation requirements. Dutch law does not provide for limitations with respect to the aggregate annual compensation paid to members of our management board or supervisory board, provided that such compensation is consistent with our compensation policy. Such compensation policy requires approval by our general meeting of shareholders. The supervisory board determines the remuneration of individual managing directors with due observance of the remuneration policy. A proposal with respect to remuneration schemes in the form of shares or rights to shares in which managing directors may participate is subject to approval by our general meeting of shareholders. Such a proposal must set out at least the maximum number of shares or rights to subscribe for shares to be granted to the managing directors and the criteria for granting or amendment. The compensation for our supervisory board members is set by the general meeting of shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The compensation, including benefits in kind, accrued or paid to our managing directors and supervisory board members with respect to the year ended December&#160;31, 2021, for services in all capacities is shown below on an individual basis. Further details for the compensation for our managing directors and supervisory board members are provided in note&#160;25 to our consolidated financial statements as of and for the year ended December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Directors Compensation 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt;">Supervisory Board Members</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On December 18, 2020, in an extraordinary general meeting of the Company, our shareholders approved changes to the cash remuneration payable to members of our supervisory board. Pursuant to the new cash remuneration scheme, each member of the supervisory board will receive a fixed cash fee of &#8364;80,000 (gross) per annum. The chairman of the supervisory board will receive an additional fixed cash fee of &#8364;60,000 (gross) per annum as of the financial year 2023, and the vice-chairman of the supervisory board will receive an additional fixed cash fee of &#8364;40,000 (gross) per annum as of the financial year 2023. The chairman of the audit committee will receive an additional fixed cash fee of &#8364;40,000 (gross) per annum, and the chairman of the compensation committee will receive an additional fixed cash fee of &#8364;8,000 (gross) per annum. If a supervisory board member serves for only part of a financial year, the fixed cash fees referred to above payable to such member will be adjusted and, if already paid, will be reimbursed by such member to us on a pro rata basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_c83c040e_6d19_4639_81ba_da7ca7b89773"></a><a id="_a7a590b8_b531_4c1a_ab65_5ed563ecadec"></a><a id="_42c152f1_c28b_41cb_be2d_77ae84af6384"></a><a id="_a84aa604_948d_4561_bdbf_28fa966a9d3e"></a><a id="_280a2fb6_fac9_4542_83b8_2824fd292b13"></a><a id="_a191bdcc_303c_44dc_a98b_b1bcf4dcea80"></a><a id="_ab0da71f_dca7_4953_bbfc_9baf4e77bfe5"></a><a id="_af58f797_e786_44c8_a2b0_5bde271918cc"></a><a id="_ad316891_bce4_427a_bd25_a5f356fd4c15"></a><a id="_27831edf_167f_4303_80f4_67cd26477278"></a><a id="_1c623b98_9cc7_438e_a953_c5e4064f83cc"></a><a id="_1644517d_4b15_4972_8767_6dfac2adce57"></a><a id="_2fa682e2_188c_4abd_b517_c7a5ce17ed0c"></a><a id="_ad9b61a8_eb96_4136_bd08_251552778e1b"></a><a id="_117b96df_7992_498b_ac4f_07975b4ca5e8"></a><a id="_fc151bce_c92a_4480_a563_086f15df1015"></a><a id="_1b91819c_2a9f_4c5d_b026_0605d997fe42"></a><a id="_ec92508b_f947_4d4d_9df3_98676911d7bc"></a><a id="_933ecbb3_d119_49fc_ad6c_d96747b3ee9f"></a><a id="_b07459b8_84a8_4676_bf70_3cb9430627a5"></a><a id="_39c55751_8e5e_4512_ab11_28a6b9c6a766"></a><a id="_5dddb379_f22e_45e6_a26b_f47b69f3ddc0"></a><a id="_dc03a667_ee0e_43da_94da_4e554a761e7d"></a><a id="_63ec47c1_0fc2_40c8_8f4d_9b915f8e6877"></a><a id="_918cb4ae_15c6_4c0f_88a8_eaede5c32ac9"></a><a id="_481fe766_41e8_4117_8e9c_47ad368c2fc8"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:26.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:26.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">P. Schatz</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">F.&#160;Ornskov</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">H.&#160;Birner</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">J. Sheldon</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">H.&#160;Friedrich</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">G.&#160;Prehn</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">E.&#160;Sou&#234;tre</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">B.&#160;Modig</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="18" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:26.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:70.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in&#160;&#8364;&#160;thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:26.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Periodically paid compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 80</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 80</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 88</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 80</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 80</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 80</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 80</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 120</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:26.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total cash compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 80</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 80</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 88</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 80</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 80</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 80</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 80</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 120</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2019 Equity Incentive Plan <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,559</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 765</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:26.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total share</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">based payment compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,559</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 765</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 60</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:33.1pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This amount represents the portion of the grant date fair value of the option and RSU awards recognized as an expense in 2020 under the provisions of IFRS&#160;2.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">118</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt;">Managing Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_5cf41197_b933_401a_9e8b_9243f8f1971f"></a><a id="_6d5268a4_bbb5_4376_9f3c_79066191ca8a"></a><a id="_068ef772_d669_42bb_8ce4_9f42dacbfc52"></a><a id="_c845a3dc_3121_4899_8e15_1540744394c2"></a><a id="_b02a04d5_dd83_49b1_88a4_ac2b41cd8847"></a><a id="_4b889579_729f_41ba_a0d5_8b98b83966e8"></a><a id="_c71d24fe_39e8_451a_8540_5f25b88ef766"></a><a id="_c63a5046_342f_46c7_a788_afb3621e9ddb"></a><a id="_c267879e_59f4_494e_9d41_00899dd7bc70"></a><a id="_0723d243_6986_4ccf_a178_6afbe2998a5b"></a><a id="_2cf159a9_1134_4aa0_b327_df6ea13c9849"></a><a id="_d3a9c0ab_bb5b_43fa_81d8_bfea31921c5f"></a><a id="_ac6a9ff2_f4df_4342_85a7_28c9221b4fce"></a><a id="_76e530cd_126a_40f5_b784_209773cf5a80"></a><a id="_5ed9711c_a408_452f_9519_009722c7d293"></a><a id="_85987ac8_05dd_4b57_8eb0_09ac578608d4"></a><a id="_ecaf520c_effc_4cd5_b85c_54d716c61e92"></a><a id="_e97aa872_a08d_4045_aae0_8ff28d94b10c"></a><a id="_747edc79_7326_4e2f_84f0_758a488338c9"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">A. Oswald</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">R.&#160;Just</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">V.&#160;Weckesser</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">R. Stoffelen </b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="9" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:59.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in&#160;&#8364;&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Periodically paid compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 439</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 262</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 431</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 308</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 390</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 218</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Termination benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 235</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total cash compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 439</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 262</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 821</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 761</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2019 Equity Incentive Plan(3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,339</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 106</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 537</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total share</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">based payment compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,339</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 106</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 537</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:7pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:28.35pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">On February 1, 2022, Andrin Oswald Stepped down from the management board and his role as the CEO.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:7pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:28.35pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">On June 30, 2021, Richard Stoffelen stepped down from the management board and his role as our CFO.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:28.35pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This amount represents fair value of the option awards issued in September 2020 under the 2019 Plan (as defined and discussed below), recognized in 2021 under the provisions of IFRS 2.</span></td></tr></table><div style="margin-top:7pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:35.45pt;margin:0pt 0pt 12pt 0pt;">For the year ended December&#160;31, 2021, our performance-based compensation programs are described below. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"></span>2016 Virtual Share Option Plan </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under Centogene AG&#8217;s virtual share option program 2016 (our &#8220;2016 Plan&#8221;), we have granted virtual share options to our employees, management board members and selected consultants. Under this program, holders of vested options are entitled to receive a direct cash payment from Centogene N.V., which payment to the option holders will be reimbursed by the original shareholders of Centogene AG at the same time as the obligation to pay the option holders arises.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Immediately prior to the consummation of our initial public offering, the outstanding awards under the 2016 Plan covered an aggregate of 8,223 common shares of Centogene AG derived from 802,283 options. Upon the completion of our initial public offering, all options granted under the 2016 Plan vested immediately in full and the cash payment to each option holder was calculated based on the initial public offering price of the shares of Centogene&#160;N.V. and the exercise prices of the vested options. Upon the completion of the July 2020 Offering (as described and defined below), the relevant payables to the holders of vested options were settled. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For further details of this plan, please see note&#160;20(i) to our consolidated financial statements as of and for the year ended December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below shows the cash payments our managing directors received in 2020 as a result of their vested and exercised option awards under the 2016 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_317b401f_92c1_4e7f_90fe_e5ff6264376a"></a><a id="_0b3ae76d_bf8e_4b5c_9d88_da2900af4c49"></a><a id="_dd5dffde_fecd_46f5_b412_949ffc5a2ee1"></a><a id="_25aa780e_0c75_4bee_87d9_d79001b3ca83"></a><a id="_02957d52_7b13_4633_acbb_a2a8c78a7aed"></a><a id="_f59b5a74_04d7_423b_80a1_1bf75a43f379"></a><a id="_d1527ca7_48f5_47a9_acda_464667254ca7"></a><a id="_ca20676e_573b_46b5_b313_1028da4ad9b6"></a><a id="_b45027d2_697a_425f_b60c_dd7021dfd38d"></a><a id="_4406130f_9759_4950_851f_2b55c886302e"></a><a id="_d602e491_0c6d_47bf_b71d_8658ddfd1348"></a><a id="_0854368c_58aa_4cc1_9aa5_56c311a726c3"></a><a id="_38691ec4_5670_4556_8473_5e26b1518d84"></a><a id="_72e1e4d3_b888_4268_95da_53fd20ea2ced"></a><a id="_49a5c964_54fc_4b02_86c5_09877fbf6f50"></a><a id="_72c18335_a596_4b6f_8682_61d217dc86da"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:49.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Options&#160;at&#160;the&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Consummation&#160;of&#160;the&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cash&#160;Payment</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Beneficiary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Initial&#160;Public&#160;Offering</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise Price&#160;EUR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EUR&#160;Thousand</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Richard Stoffelen (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 272,683</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 702</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Richard Stoffelen (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 46,200</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 261</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volkmar Weckesser</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 138,600</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 200</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 641</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 457,483</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,604</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:33.1pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">On June 30, 2021, Richard Stoffelen stepped down from the management board and his role as our CFO.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">2019 Equity Incentive Plan </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In conjunction with the consummation of our initial public offering, we have established a new long-term incentive plan (our &#8220;2019 Plan&#8221;) with the purpose of advancing the interests of our shareholders and other stakeholders by enhancing our ability to attract, retain and motivate individuals who are expected to make important contributions to us. The 2019 Plan governs issuances of equity and equity-based incentive awards from and after the consummation of our initial public offering. The maximum number of common shares underlying awards that may be granted pursuant to the 2019 Plan (other than replacement awards) will not exceed 13% of the Company&#8217;s issued share capital immediately following our initial public offering. Such maximum number has been increased on January&#160;1, 2020, and will be increased on January&#160;1 of each calendar year thereafter, by an additional number of common shares equal </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">119</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">to 3% of the Company&#8217;s issued share capital on such date (or a lower number of common shares as determined by the management board or supervisory board, where appropriate on the basis of a recommendation of the compensation committee (as the case may be, as prescribed by the 2019 Plan and, collectively, the &#8220;Committee&#8221;)). On September 11, 2020, the 2019 Plan was modified to reflect the leaver arrangements described under &#8220;Termination of Service&#8221; below. This modification was later amended, on November 25, 2020, to restore the original leaver arrangement terms of the 2019 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Plan Administration.</i><span style="white-space:pre-wrap;">  The 2019 Plan is administered by the Committee.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Eligibility.</i><span style="white-space:pre-wrap;">  Awards under the 2019 Plan may be granted to our employees, the members of our management board and supervisory board, consultants or other advisors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Awards.</i><span style="white-space:pre-wrap;">  Awards under the 2019 Plan may be granted in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, other share-based awards or a combination of the foregoing. The Committee may condition the right of an individual to exercise his or her awards upon the achievement or satisfaction of performance criteria.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Vesting.</i><span style="white-space:pre-wrap;">  The vesting conditions for awards under the 2019 Plan are determined by the Committee and are set forth in the applicable award documentation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Termination of Service.</i><span style="white-space:pre-wrap;">  In the event of a good leaver&#8217;s (as defined in the 2019 Plan) termination of employment or service, all vested awards will be exercised or settled in accordance with their terms within a period specified by the Committee and all unvested awards will be cancelled automatically unless decided otherwise by the Committee. In the event of a bad leaver&#8217;s (as defined in the 2019 Plan) termination of employment or service, all vested and unvested awards will be cancelled automatically without compensation.  Pursuant to an amendment to the 2019 Plan applicable to awards granted in the period between September 11, 2020 and November 25, 2020, unless otherwise determined by the Committee, in the event of a good leaver&#8217;s termination of employment or service, all unvested awards will vest in full and all vested awards that have not yet been exercised or settled must be exercised or settled in accordance with their terms within a period specified by the Committee. If those awards are not exercised or settled within such period, they will be cancelled automatically without compensation. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Change in Control.</i><span style="white-space:pre-wrap;">  In the event of a change in control of the Company (as defined in the 2019 Plan), outstanding awards that will be substituted or exchanged for equivalent replacement awards, in connection with the change in control will be cancelled. Outstanding rewards that are not substituted or exchanged for equivalent replacement awards, in connection with the change in control will immediately vest and settle in full, unless otherwise decided by the Committee.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December&#160;31, 2021, the following options were granted under 2019 Plan:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Equity Share Option &#8211; Replacement (2017 Plan)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In 2017, the Group established a virtual share option program (the &#8220;2017 Plan&#8221;) that entitled the management board to grant virtual share options to individuals, in regard to services they provide and their continuous commitment to the Group. As part of the corporate reorganization, in connection with the IPO, the options granted under the 2017 Plan of Centogene AG were converted into option awards under the 2019 Plan exercisable for common shares of Centogene&#160;N.V. immediately prior to the completion of our initial public offering in 2019. For further details of this plan, please see note&#160;20(iii) to our consolidated financial statements as of and for the year ended December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table shows the options outstanding as of December 31, 2021 held by our managing directors under the 2019 Plan to replace their options under the 2017 Plan: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_54e73a1e_b3f3_48e8_aa8f_0877830bd921"></a><a id="_164b3a53_59ff_4771_80d3_7d0d96fdd0d3"></a><a id="_e99fa9d4_85ba_49d7_9659_3666ca19e496"></a><a id="_21aa18b0_1da2_4538_a6e0_9295bc6161a9"></a><a id="_d3119843_0272_41e9_83d2_fbe83dcbec44"></a><a id="_8475ecb5_d64d_460a_9a3c_8b22c1f37169"></a><a id="_49a37e2a_9700_4760_8072_2af695d34251"></a><a id="_893341a5_6d22_44e3_8251_6f7a1a36e005"></a><a id="_f4a91736_03d5_4ca4_aacc_aa411d7d9f44"></a><a id="_db60a9ce_2358_443e_8782_6ac5a30519e8"></a><a id="_d9f27be1_25fe_4ed6_993b_ee5ae88c37bc"></a><a id="_1ad744c4_2076_4755_a3fc_c27eab03f92a"></a><a id="_46a8c649_b56e_4e2d_b920_26cc12392267"></a><a id="_5543dad1_9c05_4b04_9d91_d89de9ccded0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Beneficiary</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant&#160;Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise Price&#160;EUR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration&#160;Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volkmar Weckesser</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">November 9, 2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 33,773</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.12</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">October 31, 2029</p></td></tr><tr><td style="vertical-align:bottom;width:33.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 33,773</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">In 2021, Mr. Richard Stoffelen left the Company; therefore the number of options outstanding for him is no longer included in the table. </span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">120</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Equity Share Option (ESOP 2019) to Flemming Ornskov</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In connection with his appointment as a member of the supervisory board, the Company entered into an agreement with Flemming Ornskov, pursuant to which Mr.&#160;Ornskov was granted a total of 396,522 options, with each option representing the right to acquire one common share with an exercise price equaling the IPO price, which was &#8364;12.58 per share on the date of our IPO. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On December 18, 2020, in an extraordinary general meeting of shareholders of the Company, the shareholders approved the grant of 300,000 restricted stock units (&#8220;RSUs&#8221;) to Mr. Ornskov under the 2019 Plan, which replaced the ESOP 2019 and pursuant to which Mr. Ornskov will forfeit the options granted to him thereunder in exchange for the RSUs granted to him. The RSUs will expire after ten years, will not be subject to any other performance criteria, will have no exercise price and will be settled in shares. With respect to the RSUs granted 33% vested immediately and the remaining 67% will vest in two equal annual instalments on each anniversary of October 1 following the date of grant. For further details of this plan, please see note&#160;20(iv) to our consolidated financial statements as of and for the year ended December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">2021 Grants to Employees, Management Board and Selected Consultants</span></p><a id="_Hlk97298096"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Under the 2019 Plan, we granted 15,000 share options and 163,491 RSUs to our employees, management board members and select consultants in 2021.  Apart from one award that vests in three equal tranches on each anniversary of the grant date, and  another four awards which will vest in four equal tranches on January 1 of each year following the grant date, all other awards referred to above will vest in four equal tranches in each year following the grant date.  All of the foregoing awards will vest in full when the participant is considered to be a good leaver within the meaning of the 2019 Plan effective as of the grant date.  The options referred to above  will vest only if the 20 trading day volume-weighted average stock price of the Company&#8217;s shares preceding the vesting date of each tranche exceeds the exercise price of USD 12,52.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table shows the options and RSUs granted to the members of the management board in 2021 and outstanding as of December 31, 2021 under the 2019 Plan:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_468117bd_d7db_47d3_9099_ef89edd35880"></a><a id="_04e1b2cd_1b76_4b0b_84e3_7ea9cb51c7ce"></a><a id="_b321f3de_643a_4735_9e83_e5c8a078bc1b"></a><a id="_e71af4d9_e32a_4a11_8880_2ba75802554f"></a><a id="_f76c6d7f_4dff_4f27_888c_d5c8f8a61628"></a><a id="_5fed8d5c_9bb8_4212_b2a1_27a073324ffe"></a><a id="_c700a417_01e4_4ef5_997d_6c1aa7b99037"></a><a id="_caf50339_2667_4660_8ecb_07bcd837252c"></a><a id="_0b6554c0_f959_4618_988c_de7438fae738"></a><a id="_93139d5b_a8d8_449a_993b_9648dbe74e29"></a><a id="_6698ec41_367d_49cc_81cb_fad29095078b"></a><a id="_6829f549_1ab1_4f64_8f80_622f6cb73f1b"></a><a id="_77c2a796_465c_4ec7_a4c6_18ec4e87d341"></a><a id="_86c4b0c1_fb6d_4eff_aeb8_f96bfa3dbb6b"></a><a id="_2ead7a67_d77d_48d8_8b36_6107b37ee0fe"></a><a id="_7e21c2d3_bf52_4068_8533_a392cde57e13"></a><a id="_4bf818e0_8634_49e6_94a9_bd0861e49f38"></a><a id="_ac5c59a0_a8c8_4555_9249_1a3bf8d3e1a6"></a><a id="_8de71152_1784_4597_a1ee_0cb5b0a32b41"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:20.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:20.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Beneficiary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant&#160;Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration&#160;Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:20.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RSUs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:20.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ren&#233; Just</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">June 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 37,871</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">June 1, 2031</p></td></tr><tr><td style="vertical-align:bottom;width:20.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volkmar Weckesser</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">March 17, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 15,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 12.52</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">March 17, 2031</p></td></tr><tr><td style="vertical-align:bottom;width:20.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 15,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 67,871</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:28.9pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">On June 30, 2021, Richard Stoffelen stepped down from the management board and his role as CFO of Centogene. As a result, his 15,250 options and 32,250 RSUs vested in full.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For further details of this plan, please see note 20(vi) to our consolidated financial statements as of and for the year ended December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">2021 Grants to Dr. Andrin Oswald</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2020, the Company and Andrin Oswald entered into an award agreement under the 2019 Plan pursuant to which a total of 324,000 RSUs were granted to Mr. Oswald on December 1, 2020 subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF&#160;<span style="white-space:pre-wrap;">1,000,000 after the grant date. The RSUs had no exercise price and would have vested in four equal annual installments following December 1, 2020, subject to the CEO&#8217;s continued service with the Company and continued ownership of  a number of shares equal or higher than the number of purchased shares. This award agreement was amended on September 5, 2021 for the following points; the RSUs will vest in 14 equal quarterly installments following July 30, 2021 with final vesting date on December 1, 2024, subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF 1,000,000 by June 30, 2022. Further, under the award agreement, the RSUs will vest pro rata to the number of shares actually purchased up to the full investment amount of CHF 1,000,000 on each quarterly installment prior to the share purchase deadline and are subject to the continued ownership of a number of shares equal or higher than the pro rata number of shares actually purchased on each applicable vesting date or share purchase deadline. The amendment did not result in incremental fair value of the award. The grant date fair value of the award will be recognized in the statement of comprehensive loss over the remaining vesting period based on the modified vesting schedule using the graded approach.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additionally, a total of 500,000 performance-based vesting RSUs were granted to Mr. Oswald on December 1, 2020, subject to the following conditions:</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">121</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">1.</span>200,000 RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD 24 in any consecutive three month period prior to January 1, 2023 (for these RSUs the &#8220;Initial Vesting Date&#8221;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">2.</span>300,000 RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD 33 in any consecutive three month period prior to January 1, 2024 (for these RSUs the &#8220;Initial Vesting Date&#8221;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the award agreement, all of these RSUs will vest in four equal annual installments following the relevant Initial Vesting Date, if the applicable performance hurdles are met, and subject to Mr. Oswald&#8217;s continued service with the Company as of the vesting date. The contractual term of the RSUs is ten years from the respective grant dates. The RSUs issued are equity-settled. (See &#8220;Note 27 &#8211; Subsequent Developments&#8221; of our consolidated financial statements as of and for the year ended December 31, 2021.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">2021 Supervisory Board Incentive Compensation Scheme</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the Company&#8217;s extraordinary general meeting of shareholders on December 18, 2020, shareholders approved a new incentive compensation scheme for supervisory board members which is designed to attract and incentivize such members.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to this scheme, certain members of the supervisory board will annually receive an award of options and RSUs for ordinary shares of the Company under the 2019 Plan with a value of EUR 80,000 multiplied by the LTI factor. For each award, RSUs will constitute 75% of the value of the award while options will constitute the remaining 25% of the value of the award. The LTI factor will be 100% or less based on the volume-weighted average stock price of our shares over a 60 trading day period preceding December 31 of the relevant financial year. Furthermore, the chairman and vice-chairman of the supervisory board, will each annually receive an additional award with a value of EUR 60,000 and EUR 40,000, respectively, multiplied by the LTI factor as of the financial year 2023; the chairman of the audit committee and chairman of the compensation committee will each annually receive an additional award with a value of EUR 40,000 and EUR 8,000, respectively, multiplied by the LTI factor. The awards will be granted retrospectively for the preceding financial year following the audit of the Company&#8217;s annual accounts over such financial year. The LTI factor for 2021 with respect of the 2020 financial year was set to 100% which resulted in a grant of 9,427 RSUs to Mr. Berndt Modig and 878 RSUs to Mr. Jonathan Sheldon. In the same respect 4,713 share options were granted to Mr. Modig and 439 share options were granted to Mr. Sheldon, each with a strike price of USD 9,92. The awards will vest in four equal annual instalments on each relevant anniversary of the grant date and will vest in full upon a change in control of the Company (provided that the holder remains an eligible participant on the date of the change in control). The awards will expire on the ten-year anniversary of the grant date, are not subject to any performance criteria and will be settled in shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In connection with the appointment of Peer Schatz as a member of our supervisory board in 2020, the Company entered into an agreement with Mr. Schatz, pursuant to which a total of 300,000 RSUs were granted pursuant to the 2019 Plan to Mr. Schatz. These RSUs will vest in four equal annual instalments on each relevant anniversary of November 25, 2020. The contractual term of the RSUs is ten years from grant date. The RSUs are not subject to performance criteria and will be settled in shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additionally, in connection to our initial public offering, 10,000 share options have been granted as an extraordinary incentive to Mr. Modig as approved in the annual general meeting of shareholders on June 24, 2021. The options have a strike price of USD 14 and will vest in four equal installments following the grant date. For further details of the 2021 Supervisory Board incentive compensation scheme, please see note 20(viii) to our consolidated financial statements as of and for the year ended December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Board Practices</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Date of expiration</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year of expiration of the current term of the supervisory and management board members of Centogene&#160;N.V. see &#8220;&#8212;A. Directors and Senior Management.&#8221;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">122</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Service Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of the consummation of our initial public offering, we entered into service agreements with all of the managing directors and supervisory board members of the Company. All of these agreements provide for notice of termination periods after certain minimum appointment periods and all of them include restrictive covenants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Committees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Audit Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The audit committee, which consists of Berndt Modig, Peer Schatz and Jonathan G.Sheldon, assists the supervisory board in overseeing our accounting and financial reporting processes and the audits of our financial statements. In addition, the audit committee is responsible for the appointment, compensation, retention and oversight of the work of our independent registered public accounting firm. Our supervisory board has determined that Berndt Modig, Peer Schatz and Jonathan G.Sheldon each satisfy the &#8220;independence&#8221; requirements set forth in Rule&#160;10A-3 under the Exchange Act and Berndt Modig qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined in the rules of the SEC. Peer Schatz has assumed Jacob Kaluski&#8217;s role as independent audit committee member following Jacob Kaluski&#8217;s resignation from the supervisory board effective March&#160;16, 2020. The composition of our audit committee is consistent with the best practice provisions of the DCGC. The audit committee is governed by a charter that is available on our website.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The audit committee&#8217;s responsibilities include:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">monitoring the management board with respect to (i)<span style="font-family:'Symbol';">&#160;</span>the relations with, and the compliance with recommendations and follow-up of comments made by, the Company<span style="font-family:'Symbol';">&#8217;</span>s internal audit function and the Dutch independent auditor, (ii)<span style="font-family:'Symbol';">&#160;</span>the Company<span style="font-family:'Symbol';">&#8217;</span>s funding, (iii)<span style="font-family:'Symbol';">&#160;</span>the application of information and communication technology by the Company, including risks relating to cybersecurity and (iv)<span style="font-family:'Symbol';">&#160;</span>the Company<span style="font-family:'Symbol';">&#8217;</span>s tax policy;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">issuing recommendations concerning the appointment and the dismissal of the head of the Company<span style="font-family:'Symbol';">&#8217;</span>s internal audit function;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and discussing the performance of the Company<span style="font-family:'Symbol';">&#8217;</span>s internal audit function;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Company<span style="font-family:'Symbol';">&#8217;</span>s compliance with applicable legal and regulatory requirements;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the operation of the Company<span style="font-family:'Symbol';">&#8217;</span>s code of conduct and ethics and its other internal policies;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and discussing the Company<span style="font-family:'Symbol';">&#8217;</span>s audit plan, including with the Dutch independent auditor and the internal audit function;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and discussing the essence of the audit results, including (i)<span style="font-family:'Symbol';">&#160;</span>flaws in the effectiveness of the internal controls, (ii)<span style="font-family:'Symbol';">&#160;</span>findings and observations with a material impact on the Company<span style="font-family:'Symbol';">&#8217;</span>s risk profile and (iii)<span style="font-family:'Symbol';">&#160;</span>failings in the follow-up of recommendations made previously by the internal audit function;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">receiving from the Dutch independent auditor a formal written statement at least annually delineating all relationships between the Dutch independent auditor and the Company consistent with applicable requirements of the Public Company Accounting Oversight Board (PCAOB) regarding the communications of the Dutch independent auditor with the Audit Committee concerning independence;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and discussing with the Dutch independent auditor, at least annually (i)<span style="font-family:'Symbol';">&#160;</span>the scope and materiality of the Company<span style="font-family:'Symbol';">&#8217;</span>s audit plan and the principal risks of the Company<span style="font-family:'Symbol';">&#8217;</span>s annual financial reporting identified in such audit plan, (ii)<span style="font-family:'Symbol';">&#160;</span>the findings and outcome of the Dutch independent auditor<span style="font-family:'Symbol';">&#8217;</span>s audit of the Company<span style="font-family:'Symbol';">&#8217;</span>s financial statements and the management letter and (iii)<span style="font-family:'Symbol';">&#160;</span>significant findings from the audit and any problems or difficulties encountered, including restrictions on the scope of the Dutch independent auditor<span style="font-family:'Symbol';">&#8217;</span>s activities or on access to requested information, as well as significant disagreements with the Company<span style="font-family:'Symbol';">&#8217;</span>s management;</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">123</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">determining whether and, if so, how the Dutch independent auditor should be involved in the content and publication of financial reports other than the Company<span style="font-family:'Symbol';">&#8217;</span>s financial statements;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">resolving disagreements between management and the Dutch independent auditor regarding the Company<span style="font-family:'Symbol';">&#8217;</span>s financial reporting;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and discussing with the Dutch independent auditor any audit problems or difficulties and the response of the Company<span style="font-family:'Symbol';">&#8217;</span>s management thereto, including those matters required to be discussed with the Audit Committee by the Dutch independent auditor pursuant to established auditing standards, such as (i)<span style="font-family:'Symbol';">&#160;</span>restrictions on the scope of the activities of the Dutch independent auditor or on access to requested information, (ii)<span style="font-family:'Symbol';">&#160;</span>accounting adjustments that were noted or proposed by the Dutch independent auditor but were <span style="font-family:'Symbol';">&#8220;</span>passed<span style="font-family:'Symbol';">&#8221;</span> (as immaterial or otherwise), (iii)<span style="font-family:'Symbol';">&#160;</span>communications between the audit team and the audit firm<span style="font-family:'Symbol';">&#8217;</span>s national office regarding auditing or accounting issues presented by the engagement and (iv)<span style="font-family:'Symbol';">&#160;</span>management or internal control letters issued, or proposed to be issued, by the Dutch independent auditor;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and discussing the effectiveness of the design and operation of the internal controls with the management board, the chief executive officer and the chief financial officer, as appropriate, including identified material failings, deficiencies or material weaknesses in the internal controls and material changes made to, and material improvements planned for, the internal controls;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">assisting the Company in preparing the disclosure to be included in the Company<span style="font-family:'Symbol';">&#8217;</span>s applicable filings as required by the Securities Act, the Exchange Act and their related rules;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">advising the management board regarding the Dutch independent auditor<span style="font-family:'Symbol';">&#8217;</span>s nomination for (re)appointment or dismissal (including confirmation and evaluation on the rotation of the audit partners on the audit engagement team as required by applicable laws) and preparing the selection of the Dutch independent auditor for such purpose, as relevant;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and discussing the terms of engagement of the Dutch independent auditor to audit the Company<span style="font-family:'Symbol';">&#8217;</span>s financial statements, to prepare or issue an audit report, or to perform other audit, review or attest services, including the scope of the audit, the materiality standard to be applied, and causing the Company, without further action, to pay the compensation of the Dutch independent auditor as approved by the audit committee;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">engagement of such independent legal, accounting and other advisors as the audit committee deems necessary or appropriate to carry out its responsibilities, including causing the Company, without further action, to pay the reasonable compensation of such advisors as approved by the audit committee;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">causing the Company to pay, without further action, the ordinary administrative expenses of the audit committee that are necessary or appropriate in carrying out its duties;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">preparing the audit committee report that the SEC rules require to be included in the Company<span style="font-family:'Symbol';">&#8217;</span>s annual proxy statement (if and when the Company would become subject to those rules);</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">establishing policies for the Company<span style="font-family:'Symbol';">&#8217;</span>s hiring of current or former employees of the Dutch independent auditor;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">establishing procedures for (i)<span style="font-family:'Symbol';">&#160;</span>the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters and (ii)<span style="font-family:'Symbol';">&#160;</span>the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing potential conflicts of interest involving managing or supervisory board members, including whether they may take part in the deliberations in the decision-making process on any issue as to which there may be a conflict; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">developing and recommending to the supervisory board the Company<span style="font-family:'Symbol';">&#8217;</span>s related person transaction policy.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">124</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Compensation Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The compensation committee consists of Hubert Birner, Guido Prehn and Eric Sou&#234;tre.  The compensation committee assists the supervisory board in determining compensation for our executive officers and the members of our management board and supervisory board. The composition of our compensation committee is consistent with the best practice provisions of the DCGC.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The compensation committee&#8217;s responsibilities include:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing and evaluating the Company<span style="font-family:'Symbol';">&#8217;</span>s compensation policy and benefits policies generally, including the review and recommendation of incentive-compensation and equity-based plans of the Company that are subject to approval of the supervisory board, as well as the compensation of the chief executive officer and the Company<span style="font-family:'Symbol';">&#8217;</span>s other executive officers;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">submitting proposals to the supervisory board concerning changes to the Company<span style="font-family:'Symbol';">&#8217;</span>s compensation policy, as relevant;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">submitting proposals to the supervisory board concerning the compensation of individual managing directors and the Company<span style="font-family:'Symbol';">&#8217;</span>s other executive officers, at least covering (i)<span style="font-family:'Symbol';">&#160;</span>the compensation structure, (ii)<span style="font-family:'Symbol';">&#160;</span>the amount of the fixed and variable compensation components, (iii)<span style="font-family:'Symbol';">&#160;</span>the applicable performance criteria, (iv)<span style="font-family:'Symbol';">&#160;</span>the scenario analyses that have been carried out, (v)<span style="font-family:'Symbol';">&#160;</span>the pay ratios within the Company<span style="font-family:'Symbol';">&#8217;</span>s peer group, (vi)<span style="font-family:'Symbol';">&#160;</span>the views of any managing director concerned with regard to the amount and structure of his own compensation and (vii)<span style="font-family:'Symbol';">&#160;</span>if considered appropriate by the management board or the compensation committee, the views of any executive officer concerned with regard to the amount and structure of his own compensation;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">submitting proposals to the supervisory board concerning the compensation of individual supervisory board members;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the review and assessment of risks arising from the Company<span style="font-family:'Symbol';">&#8217;</span>s employee compensation policies and practices and whether any such risks are reasonably likely to have a material adverse effect on the Company;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the preparation of the Company<span style="font-family:'Symbol';">&#8217;</span>s compensation report for the supervisory board;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the preparation of the compensation committee report required by SEC rules or the rules of any other regulatory body; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the retention of or obtaining advice from a compensation consultant, legal counsel or other advisor as the compensation committee deems necessary or appropriate to carry out its responsibilities, including the appointment of such consultant, counsel or advisor and the ability to cause the Company, without further approval, to pay with Company funds the reasonable compensation of such consultant, counsel or advisor as approved by the compensation committee, provided, however, that (i)<span style="font-family:'Symbol';">&#160;</span>in retaining or obtaining the advice of such consultant, counsel or advisor, other than in-house legal counsel, the compensation committee shall take into consideration the factors affecting independence required by applicable SEC rules and Nasdaq rules and (ii)<span style="font-family:'Symbol';">&#160;</span>the compensation committee will be responsible for the oversight of the work of any such consultant, counsel or advisor.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under SEC and Nasdaq rules, there are heightened independence standards for members of the compensation committee, including a prohibition against the receipt of any compensation from us other than standard director fees. As permitted by the listing requirements of Nasdaq, we have opted out of Nasdaq Listing Rule&#160;5605(d), which requires that a compensation committee consist entirely of independent directors. The compensation committee is governed by a charter that is available on our website.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Nomination and Corporate Governance Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The nomination and corporate governance committee consists of Eric Sou&#234;tre, Peer Schatz, Guido Prehn and Hubert Birner.   The nomination and corporate governance committee assists our supervisory board in identifying individuals qualified to become members of our management board or supervisory board consistent with criteria established by us and in developing our code of business conduct and ethics. The composition of our nomination and corporate governance committee is consistent with the best practice provisions of the DCGC.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The nomination and corporate governance committee&#8217;s responsibilities include: </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">125</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">drawing up selection criteria and appointment procedures for the managing directors and supervisory board members;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing the size and composition of the management board and the supervisory board and submitting proposals for the composition profile of the supervisory board;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">making recommendations to the supervisory board as to determinations of supervisory board members independence;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">reviewing the functioning of individual managing directors and supervisory board members and reporting on such review to the supervisory board;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">drawing up a plan for the succession of managing directors and supervisory board members;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">submitting proposals for (re)appointment of managing directors and supervisory board members;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">supervising the policy of the management board regarding the selection criteria and appointment procedures for the Company<span style="font-family:'Symbol';">&#8217;</span>s executive officers;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">overseeing the self-evaluation of the management board and the supervisory board to determine whether it and its committees are functioning effectively; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">developing and recommending to the management board the code of conduct and ethics and overseeing compliance with the code of conduct and ethics, including<span style="font-family:'Symbol';">&#160;</span><span style="font-family:'Symbol';">-</span><span style="font-family:'Symbol';">&#160;</span>at least annually<span style="font-family:'Symbol';">&#160;</span><span style="font-family:'Symbol';">-</span> reviewing and reassessing the adequacy of the code of conduct and ethics and recommending any proposed changes to the management board.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As permitted by the listing requirements of Nasdaq, we have opted out of Nasdaq Listing Rule&#160;5605(e), which requires independent director oversight of director nominations. The nomination and corporate governance committee is governed by a charter that is available on our website.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of December&#160;31, 2021, we employed approximately 808 highly qualified personnel (including consultants) from over 55 nationalities. All of our employees are engaged in either operations, sales, research and development, corporate and other supporting functions. None of our employees are covered by collective bargaining agreements. The following tables provide breakdowns of our full-time equivalent employees as of December&#160;31, 2021 by function and by region:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_d9707010_a2a5_4a87_95e8_2cf6e2d4771a"></a><a id="_75c743e7_9f77_4295_937d_866c5bea1df5"></a><a id="_e9672e0c_d141_4860_8846_198b8f2b6468"></a><a id="_6ce3d961_af8b_4f2a_bbc7_83ad19607d6f"></a><a id="_442044f1_6dd8_459a_b711_eb8ed1ec95de"></a><a id="_3e979cc5_81a4_41a0_a007_6200066aa6f2"></a><a id="_7af32ebb_651e_4581_b27d_8c167887ca51"></a><a id="_dfba98aa_450e_4408_bbb6_5cb431fa096f"></a><a id="_e063a360_c61a_46a1_9567_f9369756c6b9"></a><a id="_d5a710ca_3f1f_493f_8e4e_16f69f26f48d"></a><a id="_f99b6719_1faa_4714_84e4_d220d5e7a3dc"></a><a id="_d716c4db_ab09_44af_868c_b5d4e9153c82"></a><a id="_bcb11d43_1c89_4616_afef_f3556b90a40f"></a><a id="_a229908a_a558_4da9_8e55_5a61e8d410b9"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diagnostics Operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 225</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">COVID-19 Operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 200</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmaceutical Operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sales and Marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 69</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmaceutical Business Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 58</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Corporate and other supporting functions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 187</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total employees (including consultants and apprentices)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 808</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_db6f0386_eda0_4319_ae9e_3c2629aaa9a0"></a><a id="_cd1246d3_34cd_4788_83d9_623267dbe166"></a><a id="_fa28e956_81aa_49de_90d8_bf75b38add49"></a><a id="_a7e438e2_62fe_4b3f_96c2_842584d522c4"></a><a id="_22b89301_4115_47b2_bed2_c1917f2e4c96"></a><a id="_4ca5fa95_b56a_4e78_b07a_c6ea844b4cd2"></a><a id="_c9873e8e_6ef9_4167_ba17_df28498ad28e"></a><a id="_5c3d9358_2825_4969_a4a7_bbba9c59d10f"></a><a id="_43de90c2_3a04_450b_bd90_d65dd1971999"></a><a id="_2deaf526_7b0b_4ca0_a13d_3ca6238f5b07"></a><a id="_18476de7_28e1_4d60_99fe_5ce9c2fa7482"></a><a id="_baa1547b_cb70_4b11_a197_dcbbcc8e9e64"></a><a id="_112efc5c_1ac7_45ce_b00d_5f7080b84827"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 719</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United States</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 21</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">India</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 13</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consultants (located mainly in Europe, Asia, Middle East and Latin America)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 55</p></td></tr><tr><td style="vertical-align:bottom;width:82.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total employees (including consultants and apprentices)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.09%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 808</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">126</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Share Ownership</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">See &#8220;Item&#160;7. Major Shareholders and Related Party Transactions&#8212;A. Major Shareholders.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_230b620f_ee45_4b3f_991b_95c49a872836"></a><a id="Item7MajorShareholdersandRelatedPartyTra"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">7.  Major Shareholders and Related Party Transactions</b> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Major Shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">As of the date of this Annual Report, our authorized share capital was &#8364;9,480,000, consisting of 79,000,000 common shares, par value &#8364;0.12 per share.  Each of our common shares entitles its holder to one vote. The following table presents information relating to the beneficial ownership of our common shares as of the date of this Annual Report by: </span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">each person, or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding shares;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">each member of our management board and supervisory board; and</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all members of our management board and supervisory board as a group</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Common&#160;Shares&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">beneficially&#160;owned</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Shareholder</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Percentage</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&gt;<b style="font-weight:bold;">5% Shareholders:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Entities affiliated with DPE Deutsche Private Equity GmbH(1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,067,465</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 26.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Careventures Fund II S.C.Sp(2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,947,594</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 13.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Entities affiliated with TVM Life Science Innovation I, L.P.(3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,489,748</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Platinum Asset Management Ltd.(4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,277,150</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Arndt Rolfs(5)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,317,179</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5.8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Management Board Members and Key Officers:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Kim Stratton</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ren&#233; Just</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Miguel Coego Rios </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volkmar Weckesser</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 46,644</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Maximilian Schmid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patrice P. Den&#232;fle</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nathalie Daste</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Florian Vogel</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,029</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Peter Bauer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,488</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Supervisory Board Members:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Guido Prehn(8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,067,465</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 26.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Sou&#234;tre(9)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,947,594</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 13.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Hubert Birner(6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,489,748</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Holger Friedrich(7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 350,145</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Flemming Ornskov</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Peer Schatz(10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Berndt Modig</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jonathan G. Sheldon</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Andreas Busch</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">*&#160;&#160;&#160;&#160;&#160;&#160;Less than 1% ownership.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(1)&#160;&#160;&#160;&#160;The 6,067,465 common shares held by entities affiliated with DPE Deutsche Private Equity GmbH consist of (a)&#160;3,987,224 common shares held by DPE Deutschland&#160;II A&#160;GmbH&#160;&amp;&#160;Co.&#160;KG (&#8220;DPE&#160;II&#160;A&#8221;) and (b)&#160;2,080,241 common shares held by DPE Deutschland&#160;II B&#160;GmbH&#160;&amp;&#160;Co.&#160;KG (&#8220;DPE&#160;II&#160;B&#8221;). DPE Deutsche Private Equity&#160;GmbH is the managing limited partner of DPE&#160;II&#160;A and DPE&#160;II&#160;B and may be deemed to beneficially own the common shares held by such entities, but disclaims beneficial ownership of such shares. Marc Thiery is the managing director of DPE Deutsche Private Equity&#160;GmbH and has sole power to vote the common shares beneficially owned by DPE Deutsche Private Equity&#160;GmbH. Guido Prehn has decision-making power over the common shares beneficially owned by DPE Deutsche Private Equity&#160;GmbH but disclaims beneficial ownership of such shares. The address for DPE Deutsche Private Equity&#160;GmbH, DPE&#160;II&#160;A and DPE&#160;II&#160;B is Ludwigstrasse&#160;7,&#160;80539 Munich, Germany.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">127</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(2) &#160;&#160;&#160;Careventures Fund II S.C.Sp (&#8220;Careventures&#160;II&#8221;) is managed by its general partner Careventures Fund II&#160;GP Sarl (&#8220;General Partner&#8221;), and Eric Sou&#234;tre, being a founder and shareholder of General Partner, participates in the collective decisions of the shareholders in relation to the General Partner. The registered address of Careventures&#160;II and the General Partner is 42-44, Avenue&#160;de&#160;la&#160;Gare,&#160;1610 Luxembourg, Luxembourg.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(3)&#160;&#160;&#160;&#160;The 2,489,748 common shares held by entities affiliated with TVM Life Science Innovation I, L.P. consist of (a)&#160;1,632,606 common shares held by TVM Life Science Innovation&#160;I,&#160;L.P and (b)&#160;857,142 common shares held by TVM Life Science Innovation&#160;II SCSp. The governance, investment strategy and decision-making with respect to investments held by TVM Life Science Innovation&#160;I,&#160;L.P. is directed by TVM Life Science Innovation&#160;I&#160;(GP) Limited, whose directors are Reshentha Beeby, Hubert Birner and Gary Leatt, and who have shared power to vote the common shares beneficially owned by TVM Life Science Innovation&#160;I,&#160;L.P. As a result, each may be deemed to beneficially own the shares beneficially owned by TVM Life Science Innovation&#160;I,&#160;L.P. The address for TVM Life Science Innovation&#160;I,&#160;L.P. is 500-1 Place Ville-Marie, Montr&#233;al (Qu&#233;bec)&#160;H3B 1R1, Canada. The governance, investment strategy and decision-making process with respect to investments held by TVM Life Science Innovation&#160;II,&#160;SCSp. is directed by TVM Life Science Innovation&#160;II (GP) S.&#224;&#160;r.l., whose directors are Monica Morsch, Ganash Lokanathen and Jens Hoellermann, and who have shared power to vote the common shares beneficially owned by TVM Life Science Innovation&#160;II&#160;SCSp. As a result, each may be deemed to beneficially own the shares beneficially owned by TVM Life Science Innovation&#160;II&#160;SCSp. The address for TVM Life Science Innovation&#160;II&#160;SCSp is 8&#160;rue&#160;Lou Hemmer, L-1748, Senningerberg, Grand Duchy of Luxembourg.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;"><span style="font-size:8pt;">(4)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;"><span style="font-size:8pt;">Platinum Investment Management Limited (&#8220;Platinum&#8221;) is a Sydney, Australia-based investment advisory firm founded by Kerr Neilson and Andrew Clifford in 1994. Platinum is a fully owned subsidiary of Platinum Asset Management Limited (ABN 13 050 064 287), a company listed on the Australian Securities Exchange.&#160; Approximately 27% of Platinum Asset Management Limited&#8217;s issued share capital is owned by staff and directors (including by their related parties). The firm caters to retail and institutional investors. The address for Platinum is Level 8, 7 Macquarie Place, Sydney NSW 2000, Australia.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(5) &#160;&#160;&#160;Prof. Arndt Rolfs, our former CEO and a former member of our management board, also directly owns 10% of the shares in Centogene&#160;GmbH, Vienna, Austria (&#8220;Centogene Vienna&#8221;), an immaterial subsidiary of ours. The remaining 90% of the shares in Centogene Vienna are directly owned by Centogene GmbH.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(6) &#160;&#160;&#160;Hubert Birner beneficially owns common shares through his indirect ownership of interests in TVM Life Science Innovation&#160;I,&#160;L.P and TVM Life Science Innovation&#160;II&#160;(GP) S.&#224;&#160;r.l.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(7) &#160;&#160;&#160;Common shares are held by CCG-Commercial Coordination Germany&#160;GmbH and are beneficially owned by Holger Friedrich. The address for CCG-Commercial Coordination Germany&#160;GmbH is Mauerstra&#223;e&#160;78,&#160;10117 Berlin, Germany.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(8) &#160;&#160;&#160;Guido Prehn has decision-making power over the common shares beneficially owned by DPE Deutsche Private Equity&#160;GmbH but disclaims beneficial ownership of such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 8pt 0pt;">(9) &#160;&#160;Eric Sou&#234;tre beneficially owns common shares through his indirect ownership of interests in Careventures Fund.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;"><span style="font-size:8pt;">(10)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;"><span style="font-size:8pt;">The 25,000 Common shares are held by PS Capital Management GmbH and are beneficially owned by Peer Schatz.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Each of our shareholders is entitled to one vote per common share. None of the holders of our shares have different voting rights from other holders of shares. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our common shares are held through the book-entry system provided by The Depository Trust Company (&#8220;DTC&#8221;) and are registered in the register of shareholders in the name of Cede &amp; Co., as DTC&#8217;s nominee. We are, therefore, not aware of the identity of our beneficial owners, the number of common shares they hold, nor where such beneficial owners reside.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Related Party Transactions </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following is a description of related party transactions we have entered into since January&#160;1, 2021 with any of our officers, directors and the holders of more than 5% of our voting securities, or any member of the immediate family of any of the foregoing persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Transaction with Shareholders </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 31, 2022, pursuant to the Securities Purchase Agreement and the Warrant Agreement, each signed with certain Investors, each of whom is (or is affiliated with) a significant shareholder of the Company, the Group received &#8364; 15.0 million in exchange for the issuance of an aggregate of 4,479,088 common shares at a price per share of USD 3.73 and Warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72. The Warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Private Placement of Common Shares and Warrants&#8221; for more information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Transactions Involving Members of Our Supervisory Board, Management Board and Other Related Parties</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">128</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company purchased supplies used for COVID-19 testing from an entity related to a member of the supervisory board that joined the board in 2021. Expenses totaling &#8364;5 thousand were charged to profit and loss related to the period of service of the board member. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2021, revenues totaling &#8364;14 thousand were recognized in profit and loss in relation performance of COVID-19 testing services for entities related to members of the supervisory board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 31, 2022 (the &#8220;Closing Date&#8221;), we entered into a Loan and Security Agreement (the &#8220;Loan Agreement&#8221;) with Centogene GmbH, CentoSafe B.V. and Centogene US, LLC (together, with the Company, &#8220;Borrowers&#8221;), Oxford Finance LLC (&#8220;Oxford&#8221;) and the other financial institutions or entities from time to time parties to the Loan Agreement (collectively, referred to as &#8220;Lenders&#8221;) and Oxford, in its capacity as collateral agent for itself and Lenders (in such capacity, &#8220;Agent&#8221;). Under the Loan Agreement, Lenders agreed to make available to Borrowers certain term loans in an aggregate principal amount of up to $45.0 million, subject to funding in two tranches as follows: (a) on the Closing Date, a loan in the aggregate principal amount of $25.0 million (the &#8220;Term A Loan&#8221;) and (b) on and after the Term B Milestone (as defined below) until the earlier of 60 days thereafter and July 31, 2023, a loan in the aggregate principal amount of $20.0 million (the &#8220;Term B Loan&#8221; and collectively with the Term A Loan, the &#8220;Term Loans&#8221;). The obligations of Lenders to fund the Term Loans are subject to certain conditions precedent, including with respect to the Term A Loan, the receipt by us on the Closing Date of &#8364;15.0 million net cash proceeds from the issuance and sale of the our equity securities (including from the Private Placement) and, with respect to the Term B Loan, the achievement by us of at least $50.0 million in gross product revenue from the diagnostics and pharma services segments of the Company and its subsidiaries, calculated on a consolidated and trailing twelve (12) month basis as of the last day of any fiscal month (such achievement, the &#8220;Term B Milestone&#8221;). As security for Borrowers&#8217; obligations under the Loan Agreement, Borrowers granted Lenders a first priority security interest on Borrowers&#8217; assets. In connection with the foregoing, Borrowers have agreed to pay certain fees to Oxford that are customary for facilities of this type. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Loan and Security Agreement&#8221; for more information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Insurance and Indemnification Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our current and future managing directors and supervisory board members (and such other officer or employee as designated by our management board) have the benefit of indemnification provisions in our articles of association. These provisions give the indemnified persons the right to recover from us amounts, including but not limited to litigation expenses, and any damages they are ordered to pay, in relation to acts or omissions in the performance of their duties, subject to certain exceptions. In particular, there is no entitlement to indemnification for acts or omissions which have been determined to constitute malice, gross negligence, intentional recklessness and/or serious culpability attributable to such indemnified person. In addition, we have entered into agreements with our managing directors and supervisory board members to indemnify them against expenses and liabilities to the fullest extent permitted by law. These agreements also provide, subject to certain exceptions, for indemnification for related expenses including, among others, attorneys&#8217; fees, judgments, penalties, fines and settlement amounts incurred by any of these individuals in any action or proceeding. In addition to such indemnification, we provide our managing directors and supervisory board members with directors&#8217; and officers&#8217; liability insurance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Registration Rights Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In connection with our initial public offering which closed on November 12, 2019, we entered into a registration rights agreement with certain of our existing shareholders pursuant to which we agreed under certain circumstances to file a registration statement to register the resale of the shares held by such holders, subject to certain exceptions, as well as to cooperate in certain public offerings of such shares. Registration of these shares under the Securities Act would result in these shares becoming freely tradable without restriction under the Securities Act immediately upon the effectiveness of the registration, except for shares purchased by affiliates. For more details, see the Form of Our Registration Rights Agreement attached as Exhibit 4.1 to our Registration Statement on Form F-1 filed with the SEC on October 11, 2019. On June 18, 2020, the Registration Rights Agreement was amended in accordance with its terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Interests of Experts and Counsel</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">129</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_7bdb321b_b10d_487a_ace2_35f9ed02f549"></a><a id="Item8FinancialInformation_194908"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">8.  Financial Information</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A.</span></span><span style="font-weight:normal;">Consolidated Statements and Other Financial Information</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;18. Financial Statements&#8221;, which contains our audited financial statements prepared in accordance with IFRS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Legal Proceedings </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sanofi has filed an opposition proceeding in the EPO against the &#8217;725 Patent, a European patent that we own relating to our biomarker for Gaucher disease. The EPO opposition proceeding challenges the patentability of the &#8217;725 Patent in its entirety. The EPO rejected the opposition in the first instance in the oral proceedings on February&#160;<span style="white-space:pre-wrap;">4, 2020. Sanofi has appealed the opposition decision and we cannot predict the outcome of the proceedings. If  the Board of Appeal does not uphold the opposition decision, the &#8217;725 Patent may still be revoked or maintained in amended form, in whole or in part, which could materially harm our business.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On April 15, 2021, Sanofi filed an opposition proceeding in the EPO against EP 3,318,881 (the &#39;881 Patent), an European patent that we own relating to our biomarker for Gaucher disease. Oral proceedings concerning the European patent will take place before the opposition division of the EPO on May 04, 2022. We cannot predict the outcome of the proceedings. The &#39;881 Patent may be revoked or maintained in an amended form, in whole or in part, which could materially harm our business. Should the &#39;881 Patent be revoked or maintained in amended form, we would have the right to appeal against the decision of the Opposition Division, the outcome of which is unclear. For more information regarding risks related to intellectual property, including this opposition proceeding, see &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8212;Intellectual Property Risks Related to Our Business.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In May 2016, we were informed in writing by the Universitair Medisch Centrum Utrecht (&#8220;UMCU&#8221;) that a claim had been initiated against UMCU regarding a prenatal diagnostic test that we conducted at UMCU&#8217;s request which failed to identify a specific mutation present in a patient. On October&#160;1, 2018, the UMCU and Neon Underwriting Limited brought an action at the Regional Court of Rostock (Landgericht Rostock), Germany against us for damages, alleging that our negligence in performing the test resulted in the misdiagnosis of the patient. With the action, UMCU is seeking recovery for compensatory damages as a result of the alleged misdiagnosis. By court order of November&#160;8, 2018, the Regional Court of Rostock set the amount in dispute at &#8364;880&#160;thousand and opened the written preliminary proceedings against the Company. On November&#160;12, 2018, we submitted a notice to the Regional Court of Rostock of our intention to defend against the claim. On January&#160;3, 2019 we filed a motion to dismiss in which we denied the merits of the claim. UMCU and Neon Underwriting Limited responded to this motion on March&#160;15, 2019 with a statement of reply, and the parties made several court filings setting out their arguments since. By order dated June&#160;3, 2019, the Regional Court of Rostock provided a first set of questions to be answered by an expert witness. Following a request by the Court, the Director of the Institute of Genetics at the University of Bonn recommended a professor for human genetics from the University of Aachen to be appointed as such expert witness in this case. We agreed to such recommendation. As of December 31, 2020, the amount in dispute was &#8364;1.3 million. The matter was assigned to a new judge, due to the illness of the prior judge, and the decision to appoint the recommended expert witness is still pending. Since then, several potential experts were approached by the court, but eventually declined to prepare an expert witness report due to the possibility of bias. With its letter dated December 12, 2021, the court asked Prof. Dr. Christian H&#252;bner to prepare his expert witness statement by March 10, 2022. Centogene did not object to such appointment. For more information regarding risks related to liability claims, including this proceeding, see &#8220;Item&#160;3. Key Information&#8212;D.&#160;Risk Factors&#8212;We may become subject to substantial product liability or professional liability claims that could exceed our resources.&#8221; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On August 7, 2021, our partnering laboratory physician, and a key officer of ours, Prof. Dr. Peter Bauer was informed in writing by the Public Prosecutor&#39;s Office in Fulda that a criminal investigation had been initiated against him regarding allegedly falsely billing statements submitted to the Association of Statutory Health Insurance Physicians in Hessen (Kassen&#228;rztliche Vereinigung Hessen). The aggregate amount in question is EUR 42,268.50. The investigation and claims were subsequently dropped on January 17, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The higher regional court of Rostock issued a final decision by which it has retroactively invalidated a contract entered into between Centogene GmbH (the &#8220;Company&#8221;) and the State of Mecklenburg-Western Pomerania (&#8220;MVP&#8221;) for COVID-19 testing, due to non-compliance by MVP with the public tender requirements of the German government. As a result of the invalidation, MVP now has a claim under German law against the Company for repayment of the full amount invoiced and received under the contract (EUR 2.3 million). The Company also has a claim against MVP for compensation for the value of services provided in expectation of the validity of the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">130</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The understanding between MVP and Centogene is that the Company&#8217;s services were provided at market value and that despite the court&#8217;s invalidation of the contract, Centogene has a claim against MVP for EUR 2.3 million. Thus the amounts of these two claims would be expected to equal each other and could be offset against one another. A contractual agreement putting this understanding in writing has been finalized and signed. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Dividends and Dividend Policy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under Dutch law, we may only pay dividends to the extent our shareholders&#8217; equity (<i style="font-style:italic;">eigen vermogen</i>) exceeds the sum of the paid-up and called-up share capital plus the reserves required to be maintained by Dutch law or by our articles of association. Subject to such restrictions, the amount of any distributions will depend on many factors, such as our results of operations, financial condition, cash requirements, prospects and other factors deemed relevant by our management board and supervisory board. We have not adopted a formal dividend policy with respect to future dividends. We may adopt such a policy in the future, in which case we intend either to place a discussion of such policy on the agenda for our annual general meetings of shareholders, consistent with the DCGC, or to disclose a deviation from the DCGC in this respect in our statutory annual report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Significant Changes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Except as disclosed in this Annual Report, there have been no other significant changes to our business since December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_ad091c7e_ac24_4b04_9fb2_f07c7b39e74f"></a><a id="Item9TheOfferandListing_971973"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">9.  The Offer and Listing</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Offer and Listing Details</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our common shares, with a par value of &#8364;0.12 per share, have traded on Nasdaq under the symbol &#8220;CNTG&#8221; since November&#160;7, 2019.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Plan of Distribution</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Markets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For a description of our publicly traded common shares, see &#8220;&#8212;A. Offer and Listing Details.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Selling Shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Dilution</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Expenses of the Issue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_fbd6b330_16cd_409e_bca4_608fc166bfe4"></a><a id="Item10AdditionalInformation_632065"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">10.  Additional Information</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Share Capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">131</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Memorandum and Articles of Association</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We incorporate by reference into this Annual Report our articles of association included as Exhibit&#160;3.1 to Amendment No.&#160;1 (File No.&#160;333-234177) filed with the SEC on October&#160;28, 2019. Such description sets forth an English translation of the official Dutch version of our articles of association as currently in effect. We also incorporate by reference into this Annual Report the section &#8220;Description of Share Capital and Articles of Association&#8221; included in our F-1 registration statement (File No. 333-239735) filed with the SEC on July 7, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Material Contracts </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Shire/Takeda</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have entered into a strategic collaboration with Shire International&#160;GmbH (&#8220;Shire&#8221;), now a subsidiary of Takeda Pharmaceutical Company Limited, pursuant to a global master services agreement originally entered into in January 2015, as subsequently amended and further extended in December 2019, a supply agreement with Shire Pharmaceuticals Ireland&#160;Ltd. originally entered into in December 2013, as subsequently amended and further extended in December 2019, and two project services agreements with Shire, respectively, each as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Global Master Services Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under the global master services agreement with Takeda Pharmaceutical Company Limited, the parent company of Shire International GmbH, we provide diagnostic services to Takeda and its affiliates. Takeda makes an annual fee payment to us for performance of an unlimited number of diagnostic tests for Morbus Fabry, Morbus Gaucher, Morbus Hunter, MPS1, MPS2, MPS3, MPS4, MPS6 and MPS7. Tests for some of these diseases are eligible for incremental payments from Takeda upon meeting a minimum quantity threshold. Pursuant to the December 2019 amendment and the most recent amendment in March 2021, the annual fee payable to us was increased and the minimum quantity threshold for the tests of some diseases was removed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Supply Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under the supply agreement with Takeda, we develop, manufacture and supply customized CentoCards and kits for use in approximately 50 countries as requested by Takeda. These kits are language-specific and include a filter-card with requested patient/clinician information, self-addressed and labeled envelopes, barcode/tracking stickers, an informed consent form and instructions. Payments are calculated at fixed and variable rates, including fixed rates per newly designed language-specific kits and related storage and quality control fees. Kits are then billed at variable rates based on volumes, with minimum order requirements. We granted Takeda and its affiliates a non-exclusive license to use any intellectual property in our existing kits or these custom-developed kits as necessary to distribute and provide the kits pursuant to the agreement. The supply agreement has been extended together with the extension of the Global Master Services Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Project Services Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have also entered into a project services agreement with Shire, now a subsidiary of Takeda, dated March 2018 for a collaborative research project on HAE dried-blood-spot-based diagnostic testing screening algorithm. All charges under the agreement are to be paid by Takeda. We and Takeda have granted each other the limited right to use each other&#8217;s data and intellectual property related to such testing and screening for the sole purpose of performing research under the agreement. Any subsequent research results and inventions achieved under the agreement will be co-owned by us and Takeda, and Takeda has the exclusive right, for six months after our delivery of a research report, to negotiate with us to purchase ownership of or a license to our rights in any research results or inventions on commercially reasonable terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2019, we entered into a collaborative research agreement with Shire, now a subsidiary of Takeda, related to HAE Kininogen assay mass spectrometry testing and screening. We and Takeda granted each other the limited right to use each other&#8217;s data and intellectual property related to such testing and screening for the sole purpose of performing research under the agreement. Any subsequent research results and inventions achieved under the agreement will be co-owned by us and Takeda, and Takeda has the exclusive right, for six months following the delivery of our research report, to negotiate with us to purchase ownership of or a license to our rights in any such research results or inventions on commercially reasonable terms. This project described under the agreement is funded by Takeda and is anticipated to be completed before December 2022.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">132</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pfizer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Global Master Scientific Services Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2019, we entered into a strategic collaboration with Pfizer&#160;Inc. (&#8220;Pfizer&#8221;), pursuant to a global master scientific services agreement (&#8220;MSSA&#8221;). Further to the MSSA, we entered into a statement of work (&#8220;SOW&#8221;) in November 2019 to provide sequencing services to Pfizer, for patients in the United States or Puerto Rico with transthyretin amyloid cardiomyopathy (&#8220;ATTR-CM&#8221;), patients suspected of having ATTR-CM, or individuals with a confirmed family history of hereditary ATTR-CM. Pfizer makes an annual flat-fee payment to us for performance of a limited number of diagnostic tests. In addition, CentoCards and kits will be delivered to qualified healthcare providers for sample collection. These will be billed at a fixed rate per kit to Pfizer and the fee includes access to CentoPortal. The number of diagnostic tests covered in SOW was further increased under an amended SOW entered into as of December 2019, as well as another SOW for the customization and manufacturing of CentoCards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Data access and collaboration</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In October 2019, we entered into a DACA with Pfizer, pursuant to which we granted Pfizer access to our data repository, which may be used in the discovery and validation of novel genetic and biochemical targets for the potential development of new therapies for rare diseases. See &#8220;Item&#160;4. Information on the Company&#8212;B. Business Overview&#8212;Key Partnerships.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 Testing</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Dr. Bauer Laboratory partnership</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2020, we entered into a service agreement with Dr. Bauer Laboratoriums GmbH (&#8220;Dr. Bauer Laboratory&#8221;) pursuant to which we provide laboratory resources, organization of logistics and IT services required for the detection of the SARS-CoV2 virus. We offer SARS-CoV2 analysis kits to customers, in particular at Frankfurt International Airport and other airports, which we analyze in partnership with Dr. Bauer Laboratory to detect the SARS-CoV2 virus. Dr. Bauer Laboratory or physicians employed by Dr. Bauer Laboratory also provide professional medical services and supervision in the laboratories. The agreement may be terminated by either party with 10 days&#8217; notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Fraport test center</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2020, we entered into a license agreement with Fraport AG that permitted us to operate a test center for COVID-19 testing/diagnostics at Frankfurt Airport, Frankfurt Germany. This has been extended to open additional testing sites in November 2020 and June 2021 at Frankfurt Airport. The license is granted to us on a non-exclusive basis and Fraport is not subject to restrictive covenants preventing Fraport from permitting other testing companies to provide the same or similar services on its premises. This agreement was terminated in February 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Bavaria mobile test centers </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on a tender award dated August 21, 2020, we entered into a service agreement with the Free State of Bavaria, Germany, for the provision of PCR tests for COVID-19 at mobile test centers in each of the Bavarian government districts of Upper Palatinate, Upper Franconia and Lower Franconia. This agreement terminated in October 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on a tender award dated October 30, 2020, we entered into a service agreement with the Free State of Bavaria, Germany, for the provision of PCR tests for COVID-19 at mobile test centers in each of the Bavarian government districts of Upper Palatinate, Upper Franconia and Lower Franconia. This agreement terminated in February 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Based on a tender award dated February 23, 2021, we entered into a service agreement with the Free State of Bavaria, Germany, for the provision of PCR tests for COVID-19 at mobile test centers in each of the Bavarian government districts of Upper Palatinate, Upper Franconia, Middle Franconia, Lower Franconia and Lower Bavaria, and four mobile test centers in Upper Bavaria. This agreement terminated in April 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">133</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt;"><span style="font-weight:normal;">Based on a tender award dated April 29, 2021, we entered into a service agreement with the Free State of Bavaria, Germany, for the provision of PCR tests for COVID-19 at mobile test centers in each of the Bavarian government districts of Upper Palatinate and Upper Franconia. This agreement terminated in June 2021.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Berlin test centers </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on a tender awarded to 21DX GmbH, we entered into a contract with 21DX GmbH for the provision of publicly funded PCR tests at state owned test centers in Berlin. The agreement expires on March 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Exchange Controls</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under Dutch law, there are no exchange controls applicable to the transfer to persons outside of the Netherlands of dividends or other distributions with respect to, or of the proceeds from the sale of, shares of a Dutch company, subject to applicable restrictions under sanctions and measures, including those concerning export control, pursuant to European Union regulations, the Sanctions Act 1977 (<i style="font-style:italic;">Sanctiewet 1977</i>) or other legislation, applicable anti-boycott regulations and similar rules. There are no special restrictions in the articles of association or Dutch law that limit the rights of shareholders who are not citizens or residents of the Netherlands to hold or vote shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">However, we are present in some countries, and could become elsewhere, subject to strict restrictions on the movement of cash and the exchange of foreign currencies, which limits our ability to use this cash across our global operations. We also face risks related to the collection of payments due to us from our major pharmaceutical partners or clients that are located in certain geographical regions with foreign currency or international monetary controls. This risk could increase as we continue our geographic expansion. In particular, for the years ended December&#160;31, 2021 and December&#160;31, 2020, we derived 8.7% and 9.8%, respectively, of our total revenues from our Middle East region. Certain Middle East economies have adopted or been subject to international restrictions on the ability to transfer funds out of the country and convert local currencies into euros. This may increase our costs and limit our ability to convert local currency into euros and transfer funds out of certain countries. Any shortages or restrictions may impede our ability to convert these currencies into euros and to transfer funds, including for the payment of dividends or interest or principal on our outstanding debt. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">The following summary contains a description of certain U.S. federal, Dutch and German income tax consequences of the acquisition, ownership and disposition of common shares, but it does not purport to be a comprehensive description of all the tax considerations that may be relevant to a decision to purchase common shares. The summary is based upon the tax laws of the United States and regulations thereunder, the tax laws of the Netherlands and regulations thereunder and the tax laws of Germany and regulations thereunder as of the date hereof, which are subject to change.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Material U.S. Federal Income Tax Considerations for U.S. Holders </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following is a description of the material U.S. federal income tax consequences to the U.S. Holders, described below, of owning and disposing of our common shares. It does not set forth all tax considerations that may be relevant to a particular person&#8217;s decision to own or dispose of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This section applies only to a U.S. Holder that holds our common shares as capital assets for U.S. federal income tax purposes. In addition, it does not set forth all of the U.S. federal income tax consequences that may be relevant in light of the U.S. Holder&#8217;s particular circumstances, including alternative minimum tax consequences, the potential application of the provisions of the Code known as the Medicare contribution tax and tax consequences applicable to U.S. persons subject to special rules, such as:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">certain financial institutions;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">dealers or traders in securities who use a mark-to-market method of tax accounting;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons holding our common shares as part of a hedging transaction, straddle, wash sale, conversion transaction or other integrated transaction or persons entering into a constructive sale with respect to our common shares;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">134</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">entities classified as partnerships for U.S. federal income tax purposes;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">tax-exempt entities, <span style="font-family:'Symbol';">&#8220;</span>individual retirement accounts<span style="font-family:'Symbol';">&#8221;</span> or <span style="font-family:'Symbol';">&#8220;</span>Roth IRAs<span style="font-family:'Symbol';">&#8221;</span>;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons who acquired our common shares pursuant to the exercise of an employee stock option or otherwise as compensation;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons that own or are deemed to own 10% or more of our shares (by vote or value); or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">persons holding our common shares in connection with a trade or business conducted outside of the United States.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If an entity that is classified as a partnership for U.S. federal income tax purposes holds our common shares, the U.S. federal income tax treatment of a partner will depend on the status of the partner and the activities of the partnership. Partnerships holding our common shares and partners in such partnerships should consult their tax advisers as to the particular U.S. federal income tax consequences of owning and disposing of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This section is based on the Code, administrative pronouncements, judicial decisions, final, temporary and proposed Treasury regulations, and the income tax treaty between Germany and the United States (the &#8220;Treaty&#8221;) all as of the date hereof, any of which is subject to change or differing interpretations, possibly with retroactive effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A &#8220;U.S. Holder&#8221; is a holder who is, for U.S. federal income tax purposes, a beneficial owner of our common shares, eligible for the benefits of the Treaty and:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a citizen or individual resident of the United States;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Treasury regulations that apply to taxable years beginning on or after December 28, 2021 may in some circumstances prohibit a U.S. person from claiming a foreign tax credit with respect to certain non-U.S. taxes that are not creditable under applicable income tax treaties. Accordingly, U.S. investors that are not eligible for Treaty benefits should consult their tax advisers regarding the</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">creditability or deductibility of any non-U.S. taxes imposed on them. This discussion does not apply to investors in this special</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">situation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">This discussion assumes that our position as to our German tax residence is respected. U.S. Holders should consult their own</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">tax advisers regarding any tax consequences that may arise if we were also treated as a tax resident of the Netherlands.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">This discussion does not address the effects of any state, local or non-U.S. tax laws, or any U.S. federal tax laws other than</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">income tax laws (such as U.S. federal estate or gift tax laws). U.S. Holders should consult their tax advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of owning and disposing of our common shares in their particular circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of Distributions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This discussion is subject to the discussion under &#8220;<i style="font-style:italic;">Passive Foreign Investment Company Rules</i>&#8221; below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Distributions of cash or other property, if any, that are made on our common shares, other than certain pro rata distributions of our common shares, will be treated as dividends to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). For so long as our common shares are listed on Nasdaq or another established securities market in the United States or we are eligible for benefits under the Treaty, subject to applicable limitations (that depend on a U.S. Holder&#8217;s particular circumstances) dividends paid to certain non-corporate U.S. Holders will be eligible for taxation as &#8220;qualified dividend income,&#8221; which is taxable at rates not in excess of the long-term capital gain rate applicable to such U.S. Holders. U.S. Holders should consult their tax advisers regarding the availability of the reduced tax rate on dividends in their particular circumstances. The amount of a dividend will include any amounts withheld by us in respect of German income taxes. Dividends will not be eligible for the dividends-received deduction available to U.S. corporations under the Code. Dividends will be included in a </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">135</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">U.S. Holder&#8217;s income on the date of the U.S. Holder&#8217;s receipt of the dividend. The amount of any dividend income paid in euros will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dividends will be foreign-source income to U.S. Holders. German income taxes withheld from dividends on our common shares at a rate not exceeding the rate provided by the Treaty will be eligible for credit against the U.S. Holder&#8217;s U.S. federal income tax liability. German taxes withheld in excess of the rate applicable under the Treaty will not be eligible for credit against a U.S. Holder&#8217;s federal income tax liability. The rules governing foreign tax credits are complex and U.S. Holders should consult their tax advisers regarding the creditability of foreign taxes in their particular circumstances. In lieu of claiming a foreign tax credit, U.S. Holders may elect to deduct foreign taxes, including any German income tax, in computing their taxable income. An election to deduct foreign taxes instead of claiming foreign tax credits applies to all foreign taxes paid or accrued in the taxable year. If Dutch income taxes are withheld from dividends paid to U.S. Holders, U.S. Holders are urged to consult their tax advisers regarding the creditability or deductibility of such Dutch income taxes against their U.S. federal income tax liabilities. See &#8220;Item&#160;3. Key Information&#8212;D. Risk factors&#8212;Certain Factors Relating to Our Common Shares&#8212;If we do pay dividends, we may need to withhold tax on such dividends payable to holders of our shares in both Germany and the Netherlands.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sale or Other Disposition of Common Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This discussion is subject to the discussion under &#8220;<i style="font-style:italic;">Passive Foreign Investment Company Rules&#8221; </i>below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Gain or loss realized on the sale or other disposition of our  common shares will be capital gain or loss, and will be long-term capital gain or loss if the U.S. Holder held our common shares for more than one year. The amount of the gain or loss will equal the difference between the U.S. Holder&#8217;s tax basis in the common shares disposed of and the amount realized on the disposition, in each case as determined in U.S. dollars. Any gain or loss generally will be treated as U.S.-source gain or loss. German taxes on disposition gains (if any) generally will not be creditable or deductible for U.S. federal income tax purposes. The deductibility of capital losses is subject to limitations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Passive Foreign Investment Company Rules</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Under the Code, we will be a passive foreign investment company (&#8220;PFIC&#8221;) for any taxable year in which, after the application of certain &#8220;look-through&#8221; rules with respect to our subsidiaries, either (i) 75% or more of our gross income consists of &#8220;passive income&#8221; or (ii) 50% or more of the average value of our assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, &#8220;passive income.&#8221; For purposes of the above calculations, we will be treated as if we hold our proportionate share of the assets of, and receive directly our proportionate share of the income of, any other corporation in which we directly or indirectly own at least 25%, by value, of the shares of such corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Passive income includes, among other things, interest, dividends, rents, certain non-active royalties and investment gains. For these purposes cash is generally a passive asset. Goodwill is generally an active asset to the extent associated with business activities that produce active income. Based on our current operations and composition of our income and assets, and certain estimates as to the value of our assets, we do not believe that we were a PFIC for our 2021 taxable year. However, there can be no assurance that the IRS will agree with our conclusion. In addition, whether we will be a PFIC in 2022 or any future taxable year is uncertain because, among other things, (i)&#160;we currently own, and expect to continue to own, a substantial amount of passive assets, including cash, (ii)&#160;the value of our assets that generate non-passive income for PFIC purposes, including our intangible assets, is uncertain and may vary substantially over time (and may be determined, in large part, by reference to our market capitalization, which has been, and may continue to be, volatile) and (iii)&#160;the composition of our income may vary substantially over time. Accordingly, there can be no assurance that we will not be a PFIC for any taxable year. If we are a PFIC for any year during which a U.S. Holder holds our common shares, we would continue to be treated as a PFIC with respect to that U.S. Holder for all succeeding years during which the U.S. Holder holds our common shares, even if we ceased to meet the threshold requirements for PFIC status, unless the U.S. Holder makes a valid deemed sale or deemed dividend election under the applicable Treasury regulations with respect to our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If we are a PFIC for any taxable year and any entity in which it owned equity interests is also a PFIC (a &#8220;Lower-tier PFIC&#8221;), a U.S. Holder will be deemed to own a proportionate amount (by value) of the shares of each Lower-tier PFIC and will be subject to U.S. federal income tax according to the rules described in the next paragraph on (i) certain distributions by the Lower-tier PFIC and (ii) dispositions of shares of the Lower-tier PFIC, in each case as if the U.S. Holder held such shares directly, even though the U.S. Holder will not receive any proceeds of those distributions or dispositions.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">136</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If we were a PFIC for any taxable year during which a U.S. Holder held our common shares (assuming such U.S. Holder has not made a timely mark-to-market election, as described below), gain recognized by a U.S. Holder on a sale or other disposition (including certain pledges) of our common shares would be allocated ratably over the U.S. Holder&#8217;s holding period for our common shares. The amounts allocated to the taxable year of the sale or other disposition and to any year before we became a PFIC would be taxed as ordinary income. The amount allocated to each other taxable year would be subject to tax at the highest rate in effect for individuals or corporations, as appropriate, for that taxable year, and an additional tax effectively representing a deferred interest charge would be imposed on the amount allocated to that taxable year. Further, to the extent that distributions received by a U.S. Holder on our common shares in any taxable year exceed 125% of the average of the annual distributions on our common shares received during the preceding three taxable years or the U.S. Holder&#8217;s holding period, whichever is shorter, the excess distribution would be subject to taxation in the same manner as gain, described immediately above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A U.S. Holder can avoid certain of the adverse rules described above by making a mark-to-market election with respect to our common shares, provided that our common shares are &#8220;marketable.&#8221; Our common shares will be marketable if they are &#8220;regularly traded&#8221; on a &#8220;qualified exchange&#8221; or other market within the meaning of applicable Treasury regulations. If a U.S. Holder makes the mark-to-market election, it will recognize as ordinary income any excess of the fair market value of our common shares at the end of each taxable year over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of our common shares over their fair market value at the end of the taxable year (but only to the extent of the net amount of income previously included as a result of the mark-to-market election). If a U.S. Holder makes the election, the U.S. Holder&#8217;s tax basis in our common shares will be adjusted to reflect the amount of income or loss that is recognized. Any gain recognized on the sale or other disposition of our common shares in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market election with any excess treated as a capital loss). U.S. Holders should consult their tax advisers regarding the availability and advisability of making a mark-to-market election in their particular circumstances. In particular, U.S. Holders should consider the impact of a mark-to-market election with respect to their common shares given that we may have Lower-tier PFICs, and there is no provision in the Code, Treasury regulations or other official guidance that would give U.S. Holders the right to apply a mark-to-market treatment to any Lower-tier PFIC the shares of which are not regularly traded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition, in order to avoid the application of the foregoing rules, a United States person that owns stock in a PFIC for U.S. federal income tax purposes may make a qualified electing fund (&#8220;QEF&#8221;) election with respect to such PFIC that results in a tax treatment different from the treatment described above. We do not intend to provide information necessary for U.S. Holders to make QEF elections and therefore these elections will not be available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, if we were a PFIC or, with respect to a particular U.S. Holder, were treated as a PFIC for the taxable year in which we paid a dividend or for the prior taxable year, the preferential dividend rates discussed above with respect to dividends paid to certain non-corporate U.S. Holders would not apply.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If a U.S. Holder owns our common shares during any year in which we are a PFIC, subject to certain exceptions, the U.S. Holder must file annual reports on IRS Form&#160;8621 (or any successor form) with respect to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">U.S. Holders should consult their tax advisers concerning our potential PFIC status and the potential application of the PFIC rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Information Reporting and Backup Withholding</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries are subject to information reporting, and may be subject to backup withholding, unless (i)&#160;the U.S. Holder is a corporation or other exempt recipient or (ii)&#160;in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to backup withholding. The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the holder&#8217;s U.S. federal income tax liability and may entitle it to a refund, provided that the required information is timely furnished to the IRS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Reporting With Respect to Foreign Financial Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Certain U.S. Holders who are individuals and certain entities may be required to report information relating to an interest in our common shares by filing a Form&#160;8398 with their U.S. federal income tax return, subject to certain exceptions (including an </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">137</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">exception for our common shares held in accounts maintained by certain U.S. financial institutions). Failure to file&#160;a Form&#160;8398 where required can result in monetary penalties and the extension of the relevant statute of limitations with respect to all or a part of the relevant U.S. tax return. U.S. Holders should consult their tax advisers regarding this reporting requirement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Material Dutch Tax Considerations </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following is a summary of certain material Dutch tax consequences of the acquisition, holding and disposal of common shares. This summary does not purport to describe all possible tax considerations or consequences that may be relevant to a holder or prospective holder of common shares and does not purport to deal with the tax consequences applicable to all categories of investors, some of which (such as trusts or similar arrangements) may be subject to special rules. In view of its general nature, this summary should be treated with corresponding caution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For the purposes of this discussion, we assume that we are a tax resident of Germany under German national tax laws since we intended to have, from our incorporation and on a continuous basis, our place of effective management in Germany. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;We may become taxable in a jurisdiction other than Germany and this may increase the aggregate tax burden on us.&#8221; Except as otherwise indicated, this summary is based on the tax laws of the Netherlands, published regulations thereunder and published authoritative case law, all as in effect on the date hereof, and all of which are subject to change, possibly with retroactive effect. Where the summary refers to &#8220;the Netherlands&#8221; or &#8220;Dutch&#8221; it refers only to the part of the Kingdom of the Netherlands located in Europe. The applicable tax laws or interpretations thereof may change, or the relevant facts and circumstances may change, and such changes may affect the contents of this section, which will not be up-dated to reflect any such changes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This discussion is for general information purposes only and is not Dutch tax advice or a complete description of all Dutch tax consequences relating to the acquisition, holding and disposal of the common shares. Holders or prospective holders of common shares should consult their own tax advisors regarding the Dutch tax consequences relating to the acquisition, holding and disposal of the common shares in light of their particular circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Please note that the summary does not describe the Dutch tax consequences for:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 9.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>holders of common shares if such holders, and in the case of individuals, such holder&#8217;s partner or certain of its relatives by blood or marriage in the direct line (including foster children), have a substantial interest (<i style="font-style:italic;">aanmerkelijk belang</i>) or deemed substantial interest (<i style="font-style:italic;">fictief aanmerkelijk belang</i>) in us under the Dutch Income Tax Act 2001 (<i style="font-style:italic;">Wet inkomstenbelasting 2001</i>). A holder of securities in a company is considered to hold a substantial interest in such company, if such holder alone or, in the case of individuals, together with such holder&#8217;s partner (as defined in the Dutch Income Tax Act 2001), directly or indirectly, holds (i)&#160;an interest of 5% or more of the total issued and outstanding capital of that company or of 5% or more of the issued and outstanding capital of a certain class of shares of that company; or (ii)&#160;rights to acquire, directly or indirectly, such interest; or (iii)&#160;certain profit sharing rights in that company that relate to 5% or more of the company&#8217;s annual profits or to 5% or more of the company&#8217;s liquidation proceeds. A deemed substantial interest may arise if a substantial interest (or part thereof) in a company has been disposed of, or is deemed to have been dis-posed of, on a non-recognition basis;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>holders of common shares, if the common shares held by such holders qualify or qualified as a participation (<i style="font-style:italic;">deelneming</i>) for purposes of the Dutch Corporate Income Tax Act 1969 (<i style="font-style:italic;">Wet op de vennootschapsbelasting 1969</i>). Generally, a holder&#8217;s shareholding of 5% or more in a company&#8217;s nominal paid-up share capital qualifies as a participation. A holder may also have a participation if such holder does not have a shareholding of 5% or more but a related entity (statutorily defined term) has a participation or if the company in which the shares are held is a related entity (statutorily defined term).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>pension funds, investment institutions (<i style="font-style:italic;">fiscale beleggingsinstellingen</i>), exempt investment institutions (<i style="font-style:italic;">vrijgestelde beleggingsinstellingen</i>) (as defined in the Dutch Corporate Income Tax Act 1969) and other entities that are, in whole or in part, not subject to or exempt from Dutch corporate income tax as well as entities that are exempt from corporate income tax in their country of residence, such country of residence being another state of the European Union, Norway, Liechtenstein, Iceland or any other state with which the Netherlands has agreed to exchange information in line with international standards; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>holders of common shares who are individuals for whom the common shares or any benefit derived from the common shares are a remuneration or deemed to be a remuneration for activities performed by such holders or certain individuals related to such holders (as defined in the Dutch Income Tax Act 2001).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">138</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Dividend Withholding tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are required to withhold Dutch dividend withholding tax at a rate of 15% from dividends distributed by us (which withholding tax will not be borne by us, but will be withheld by us from the gross dividends paid on the common shares). However, as long as we continue to have our place of effective management in Germany, and not in the Netherlands, under the Convention between the Federal Republic of Germany and the Netherlands for the avoidance of double taxation with respect to taxes on income of 2012, we will be considered to be exclusively tax resident in Germany and we will not be required to withhold Dutch dividend withholding tax. This exemption from withholding does not apply to dividends distributed by us to a holder who is resident or deemed to be resident in the Netherlands for Dutch income tax purposes or Dutch corporate income tax purposes or to holders of common shares that are neither resident nor deemed to be resident of the Netherlands if the common shares are attributable to a Dutch permanent establishment of such non-resident holder, in which case the following paragraph applies. See &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8212;If we do pay dividends, we may need to withhold tax on such dividends payable to holders of our shares in both Germany and the Netherlands&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dividends distributed by us to individuals and corporate legal entities who are resident or deemed to be resident in the Netherlands for Dutch (corporate) income tax purposes (&#8220;Dutch Resident Individuals&#8221; and &#8220;Dutch Resident Entities,&#8221; as the case may be) or to holders of common shares that are neither resident nor deemed to be resident of the Netherlands if the common shares are attributable to a Dutch permanent establishment of such non-resident holder are subject to Dutch dividend withholding tax at a rate of 15%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The expression &#8220;dividends distributed&#8221; includes, among other things:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">distributions in cash or in kind, deemed and constructive distributions and repayments of paid-in capital not recognized for Dutch dividend withholding tax purposes;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">liquidation proceeds, proceeds of redemption of shares, or proceeds of the repurchase of shares by us or one of our subsidiaries or other affiliated entities to the extent such proceeds exceed the average paid-in capital of those shares as recognized for purposes of Dutch dividend withholding tax;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">an amount equal to the par value of shares issued or an increase of the par value of shares, to the extent that it does not appear that a contribution, recognized for purposes of Dutch dividend withholding tax, has been made or will be made; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">partial repayment of the paid-in capital, recognized for purposes of Dutch dividend withholding tax, if and to the extent that we have net profits (<i style="font-style:italic;">zuivere winst</i>), unless (i)&#160;the general meeting has resolved in advance to make such repayment and (ii)&#160;the par value of the shares concerned has been reduced by an equal amount by way of an amendment to our articles of association.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dutch Resident Individuals and Dutch Resident Entities can generally credit the Dutch dividend withholding tax against their income tax or corporate income tax liability and to a refund of any residual Dutch dividend withholding tax. The same generally applies to holders of common shares that are neither resident nor deemed to be resident of the Netherlands if the common shares are attributable to a Dutch permanent establishment of such non-resident holder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to legislation to counteract &#8220;dividend stripping&#8221;, a reduction, exemption, credit or refund of Dutch dividend withholding tax is denied if the recipient of the dividend is not the beneficial owner as described in the Dutch Dividend Withholding Tax Act 1965 (<i style="font-style:italic;">Wet op de dividendbelasting 1965</i>). This legislation generally targets situations in which a shareholder retains its economic interest in shares but reduces the withholding tax costs on dividends by a transaction with another party. It is not required for these rules to apply that the recipient of the dividends is aware that a dividend stripping transaction took place. The Dutch State Secretary of Finance takes the position that the definition of beneficial ownership introduced by this legislation will also be applied in the context of a double taxation convention.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Conditional withholding tax on dividends (as of January 1, 2024)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition to the above, it cannot be excluded that dividends distributed by us to certain related entities which are not</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">resident in the Netherlands for Dutch tax purposes will become subject to a Dutch conditional withholding tax in certain specific</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">139</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">situations (see below), irrespectively of the fact that we have our place of effective management in Germany and, therefore, are a tax resident of Germany under German national tax laws. As of January 1, 2024, a Dutch conditional withholding tax will be imposed on dividends distributed by us to related (<i style="font-style:italic;">gelieerd</i>) entities (within the meaning of the Dutch Withholding Tax Act 2021; <i style="font-style:italic;">Wet bronbelasting 2021</i>), if such related entity:</p><div style="margin-top:6pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">is considered to be resident (</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">gevestigd</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) in a jurisdiction that is listed in the yearly updated Dutch Regulation on low-taxing states and non-cooperative jurisdictions for tax purposes (</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regeling laagbelastende staten en niet-co&#246;peratieve rechtsgebieden voor belastingdoeleinden</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) (a &quot;Listed Jurisdiction&quot;); or </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">has a permanent establishment located in a Listed Jurisdiction to which the ordinary shares are attributable; or </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">holds the ordinary shares for the main purpose or one of the main purposes to avoid taxation for another person or entity and there is an artificial arrangement or transaction or a series of artificial arrangements or transactions; or </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">is not considered to be the beneficial owner of the ordinary shares in its jurisdiction of residence because such jurisdiction treats another entity as the beneficial owner of the ordinary shares (a hybrid mismatch); or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">is not resident in any jurisdiction (also a hybrid mismatch); or </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">is a reverse hybrid (within the meaning of Article 2(12) of the Dutch Corporate Income Tax Act 1969), if and to the extent (x) there is a participant in the reverse hybrid which is related (</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">gelieerd</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) to the reverse hybrid, (y) the jurisdiction of residence of such participant treats the reverse hybrid as transparent for tax purposes and (z) such participant would have been subject to the Dutch conditional withholding tax in respect of dividends distributed by the Company without the interposition of the reverse hybrid,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:6pt 0pt 12pt 0pt;">all within the meaning of the Dutch Withholding Tax Act 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The <i style="font-style:italic;">Dutch</i> conditional withholding tax on dividends will be imposed at the highest Dutch corporate income tax rate in effect at the time of the distribution (currently 25.8%). The Dutch conditional withholding tax on dividends will be reduced, but not below zero, by any regular Dutch dividend withholding tax withheld in respect of the same dividend distribution. As such, based on the currently applicable rates, the overall effective tax rate of withholding the regular Dutch dividend withholding tax (as described above) and the Dutch conditional withholding tax on dividends will not exceed the highest corporate income tax rate in effect at the time of the distribution (currently 25.8%).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Taxes on income and capital gains</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dutch Resident Entities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Any benefit derived or deemed to be derived from the shares held by a Dutch Resident Entity, including any capital gains realized on the disposal thereof, will generally be subject to Dutch corporate income tax at a rate of 15 percent with respect to taxable profits up to &#8364;395,000 and 25.8 percent with respect to taxable profits in excess of that amount (rates and brackets for 2022). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Dutch Resident Individuals</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If a holder of common shares is a Dutch Resident Individual, any benefit derived or deemed to be derived from the common shares is taxable at the progressive Dutch income tax rates (with a maximum of 49.50% in 2022), if:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>the common shares are attributable to an enterprise from which the holder of common shares derives a share of the profit, whether as an entrepreneur (<i style="font-style:italic;">ondernemer</i>) or as a person who has a co-entitlement to the net worth (<i style="font-style:italic;">medegerechtigd tot het vermogen</i>) of such enterprise without being an entrepreneur or a shareholder in such enterprise (as defined in the Dutch Income Tax Act 2001); or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>the holder of shares is considered to perform activities with respect to the common shares that go beyond ordinary asset management (<i style="font-style:italic;">normaal, actief vermogensbeheer</i>) or derives benefits from the common shares that are taxable as benefits from other activities (<i style="font-style:italic;">resultaat uit overige werkzaamheden</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If the above-mentioned conditions&#160;(i) and (ii)&#160;do not apply to the individual holder of common shares, such holder will be taxed annually on a deemed variable return (with a maximum of 5.53% in 2022) on the individual&#8217;s net investment assets (<i style="font-style:italic;">rendementsgrondslag</i>) for the year, insofar the individual&#8217;s net investment assets for the year exceed a statutory threshold (<i style="font-style:italic;">heffingvrij </i></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">140</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">vermogen</i>). The deemed return on the individual&#8217;s net investment assets for the year is taxed at a rate of 31%. Actual income, gains or losses in respect of the common shares are as such not subject to Dutch income tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The net investment assets for the year are the fair market value of the investment assets less the allowable liabilities on January&#160;1 of the relevant calendar year. The common shares are included as investment assets. For the net investment assets on January&#160;1, 2022, the deemed return ranges from 1.82% up to 5.53% (depending on the aggregate amount of the net investment). The deemed return will be adjusted annually on the basis of historic market yields.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On 24 December 2021, the Dutch Supreme Court ruled that the Dutch income tax levy on savings and investments, in 2017 and 2018, violated the European Convention on Human Rights. The tax consequences of the Dutch Supreme Court are not immediately clear. The new Dutch Government intends to start calculating the taxation on savings and investments on actual returns realized from savings and investments (instead of on a deemed return) starting in 2025. The Supreme Court ruling could make the Dutch Government move faster on the issue. Holders and prospective holders of our common shares should carefully consider the tax consequences of this Supreme Court ruling and consult their own tax adviser about their own tax situation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Non-residents of the Netherlands</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A holder of common shares that is neither a Dutch Resident Entity nor a Dutch Resident Individual will not be subject to Dutch corporate income tax in respect of income derived or deemed to be derived from the common shares or in respect of any gain or loss realized on the disposal or deemed disposal of the common shares, provided that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>such holder does not have an interest in an enterprise or a deemed enterprise (as defined in the Dutch Income Tax Act 2001 and the Dutch Corporate Income Tax Act 1969) which, in whole or in part, is either effectively managed in the Netherlands or is carried out on through a permanent establishment, a deemed permanent establishment or a permanent representative in the Netherlands and to which enterprise or part of an enterprise the common shares are attributable; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>in the event such holder is an individual, such holder does not carry out any activities in the Netherlands with respect to the common shares that go beyond ordinary asset management and does not derive benefits from the shares that are taxable as benefits from other activities in the Netherlands.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Gift and inheritance taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Residents of the Netherlands</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Gift or inheritance taxes will arise in the Netherlands with respect to a transfer of common shares by way of a gift by, or on the death of, a holder of such common shares who is resident or deemed resident of the Netherlands at the time of the gift or the holder&#8217;s death.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Non-residents of the Netherlands</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No gift or inheritance taxes will arise in the Netherlands with respect to a transfer of the shares by way of gift by, or on the death of, a holder of common shares who is neither resident nor deemed to be resident of the Netherlands, unless:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 9.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>in the case of a gift of common shares by an individual who at the date of the gift was neither resident nor deemed to be resident of the Netherlands, such individual dies within 180&#160;days after the date of the gift, while being resident or deemed to be resident of the Netherlands; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 9.1pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>the transfer is otherwise construed as a gift or inheritance made by, or on behalf of, a person who, at the time of the gift or death, is or is deemed to be resident of the Netherlands.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For purposes of Dutch gift and inheritance taxes, amongst others, a person that holds the Dutch nationality will be deemed to be resident of the Netherlands if such person has been resident in the Netherlands at any time during the ten years preceding the date of the gift or the holder&#8217;s death. Additionally, for purposes of Dutch gift tax, amongst others, a person not holding the Dutch nationality will be deemed to be resident of the Netherlands if such person has been resident in the Netherlands at any time during the twelve months preceding the date of the gift. Applicable tax treaties may override deemed residency.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">141</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Value added tax (VAT)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No Dutch VAT will be payable by a holder of common shares in respect of any payment in consideration for the holding or disposal of the common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Other taxes and duties</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No Dutch registration tax, stamp duty or any other similar documentary tax or duty will be payable by a holder of common shares in respect of any payment in consideration for the holding or disposal of the common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Material German Tax Considerations </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following is a summary of certain material German tax considerations of the acquisition, holding and disposal the Company&#8217;s common shares. For the purposes of this discussion, we assume that we are a tax resident of Germany under German national tax laws since we intended to have, from our incorporation and on a continuous basis, our place of effective management in Germany. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;We may become taxable in a jurisdiction other than Germany and this may increase the aggregate tax burden on us.&#8221; This section does not set forth all German tax aspects that may be relevant for shareholders. The section is based on the German tax law applicable as of the date of this Annual Report. It should be noted that the law may change following the issuance of this Prospectus and that such changes may have retroactive effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The material German tax principles of purchasing, owning and transferring of shares are set forth in the following. This section does not purport to be a comprehensive or complete analysis or listing of all potential tax effects of the purchase, ownership or disposition of shares and does not set forth all tax considerations that may be relevant to a particular person&#8217;s decision to acquire common shares. All of the following is subject to change. Such changes could apply retroactively and could affect the consequences set forth below. This section does not refer to any U.S. Foreign Account Tax Compliance Act aspects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Shareholders are advised to consult their own tax advisers with regard to the application of German tax law to their particular situations, in particular with respect to the procedure to be complied with to obtain a relief of withholding tax on dividends and on capital gains (<i style="font-style:italic;">Kapitalertragsteuer</i>) and with respect to the influence of double tax treaty provisions, as well as any tax consequences arising under the laws of any state, local or other foreign jurisdiction. For German tax purposes, a shareholder may include an individual who or an entity that does not have the legal title to the shares, but to whom nevertheless the shares are attributed, based either on such individual or entity owning a beneficial interest in the shares or based on specific statutory provisions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This section does not constitute a particular tax advice. Potential purchasers of the Company&#8217;s shares are urged to consult their own tax advisers regarding the tax consequences of the purchase, ownership and disposition of shares in light of their particular circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of Dividends</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Withholding Tax on Dividends</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dividends distributed from a company to its shareholders are subject to withholding tax, subject to certain exemptions (for example, repayments of capital from the tax equity account (<i style="font-style:italic;">steuerliches Einlagekonto</i>)), as described in the following. The withholding tax rate is 25% plus 5.5% solidarity surcharge (<i style="font-style:italic;">Solidarit&#228;tszuschlag</i>) thereon (in total 26.375% plus, in the case of individuals as shareholders, church tax if applicable subject to further prerequisites) of the gross dividend approved by the ordinary shareholders&#8217; meeting. Withholding tax is to be withheld and passed on for the account of the shareholders by a domestic branch of a domestic or foreign credit or financial services institution (<i style="font-style:italic;">Kredit- und Finanzdienstleistungsinstitut</i>), by the domestic securities trading company (<i style="font-style:italic;">inl&#228;ndisches Wertpapierhandelsunternehmen</i>) or a domestic securities trading bank (<i style="font-style:italic;">inl&#228;ndische Wertpapierhandelsbank</i>) which keeps and administers the shares and disburses or credits the dividends or disburses the dividends to a foreign agent, or by the securities custodian bank (<i style="font-style:italic;">Wertpapiersammelbank</i>) to which the shares were entrusted for collective custody if the dividends are distributed to a foreign agent by such securities custodian bank (which is referred to as the &#8220;Dividend Paying Agent&#8221;). In case the shares are not held in collective deposit with a Dividend Paying Agent, the Company is responsible for withholding and remitting the tax to the competent tax office.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">142</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Such withholding tax is levied and withheld irrespective of whether and to what extent the dividend distribution is taxable at the level of the shareholder and whether the shareholder is a person residing in Germany or in a foreign country.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the case of dividends distributed to a company within the meaning of Art.&#160;2 of the amended EU Directive 2011/96/EU of the Council of November&#160;30, 2011 (the &#8220;EU Parent Subsidiary Directive&#8221;) domiciled in another Member State of the European Union, an exemption from withholding tax will be granted upon request if further prerequisites are satisfied (<i style="font-style:italic;">Freistellung im Steuerabzugsverfahren</i>). This also applies to dividends distributed to a permanent establishment located in another Member State of the European Union of such a parent company or of a parent company tax resident in Germany if the participation in the Company is effectively connected with this permanent establishment. The key prerequisite for the application of the EU Parent Subsidiary Directive is that the shareholder has held a direct participation in the share capital of the Company of at least 10% for at least one year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The withholding tax on distributions to other foreign resident shareholders can be reduced in accordance with a double taxation treaty (subject to domestic anti-treaty shopping rules or specific anti-abuse provisions in an applicable treaty, please see below) if Germany has concluded such double taxation treaty with the country of residence of the shareholder and if the shareholder does not hold his shares either as part of the assets of a permanent establishment or a fixed place of business in Germany or as business assets for which a permanent representative has been appointed in Germany. The reduction of the withholding tax is procedurally granted in such a manner that the difference between the total amount withheld, including the solidarity surcharge, and the tax liability determined on the basis of the tax rate set forth in the applicable double taxation treaty (generally 15% under German tax treaties providing for a dividend article in line with the OECD Model Treaty, or a lower rate subject to further prerequisites being met) is refunded by the German tax administration upon request (Federal Central Office for Taxes (<i style="font-style:italic;">Bundeszentralamt f&#252;r Steuern</i>), main office in Bonn-Beuel, An der K&#252;ppe&#160;1, 53225 Bonn, Germany).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the case of dividends received by corporations whose statutory seat and effective place of management are not located in Germany and who are therefore not tax resident in Germany, two-fifths of the withholding tax deducted and remitted are refunded without the need to fulfill all prerequisites required for such refund under the EU Parent Subsidiary Directive or under a double taxation treaty or if no double taxation treaty has been concluded between the state of residence of the shareholder (but subject to domestic anti-abuse rules such as substance requirements, please see below).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In order to receive a refund pursuant to a double taxation treaty or the aforementioned option for foreign corporations, the shareholder has to submit a completed form for refund (available at the Federal Central Office for Taxes (http://www.bzst.de) as well as at the German embassies and consulates) together with a withholding tax certificate (<i style="font-style:italic;">Kapitalertragsteuerbescheinigung</i>) issued by the institution that withheld the tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The exemption from withholding tax in accordance with the EU Parent Subsidiary Directive or a double tax treaty and the aforementioned options for a refund of the withholding tax (with or without protection under a double taxation treaty) depend on whether certain additional prerequisites (in particular so-called substance requirements) are fulfilled. The applicable withholding tax relief will only be granted if the preconditions of the German anti avoidance rules (so called Directive Override or Treaty Override), in particular Section&#160;50d, paragraph&#160;3, German Income Tax Act (<i style="font-style:italic;">Einkommensteuergesetz</i>) are fulfilled.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The aforementioned reductions of (or exemptions from) withholding tax are further restricted if (i)&#160;the applicable double taxation treaty provides for a tax reduction resulting in an applicable tax rate of less than 15% and (ii)&#160;the shareholder is not a corporation that directly holds at least 10% in the equity capital of the Company and is subject to tax on its income and profits in its state of residence without being exempt. In this case, the reduction of (or exemption from) withholding tax is subject to the following three cumulative prerequisites: (i)&#160;the shareholder must qualify as beneficial owner of the shares in the Company for a minimum holding period of 45 consecutive days occurring within a period of 45&#160;days prior and 45&#160;days after the due date of the dividends, (ii)&#160;the shareholder has to bear at least 70% of the change in value risk related to the shares in the Company during the minimum holding period without being directly or indirectly hedged and (iii)&#160;the shareholder must not be required to fully or largely compensate directly or indirectly the dividends to third parties. However, these further prerequisites do not apply if the shareholder has been the beneficial owner of the shares in the Company for at least one uninterrupted year upon receipt of the dividends.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">143</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For individual or corporate shareholders tax resident outside Germany not holding the shares through a permanent establishment (<i style="font-style:italic;">Betriebsst&#228;tte</i>) in Germany or as business assets (<i style="font-style:italic;">Betriebsverm&#246;gen</i>) for which a permanent representative (<i style="font-style:italic;">st&#228;ndiger Vertreter</i>) has been appointed in Germany, the remaining and paid withholding tax (if any) is final (i.e.,&#160;not refundable) and settles the shareholder&#8217;s limited tax liability in Germany. For individual or corporate shareholders tax resident in Germany (that are, for example, shareholders whose residence, domicile, registered office or place of management is located in Germany) holding their shares as business assets, as well as for shareholders tax resident outside of Germany holding their shares through a permanent establishment in Germany or as business assets for which a permanent representative has been appointed in Germany, the withholding tax withheld (including solidarity surcharge) can be credited against the shareholder&#8217;s personal income tax or corporate income tax liability in Germany. Any withholding tax (including solidarity surcharge) in excess of such tax liability is refunded. For individual shareholders tax resident in Germany holding the Company&#8217;s shares as private assets, the withholding tax is a final tax (<i style="font-style:italic;">Abgeltungsteuer</i>), subject to the exceptions described in the following section.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to special rules on the restriction of withholding tax credit, the credit of withholding tax is subject to the following three cumulative prerequisites: (i)&#160;the shareholder must qualify as beneficial owner of the shares in the Company for a minimum holding period of 45 consecutive days occurring within a period of 45&#160;days prior and 45&#160;days after the due date of the dividends, (ii)&#160;the shareholder has to bear at least 70% of the change in value risk related to the shares in the Company during the minimum holding period without being directly or indirectly hedged and (iii)&#160;the shareholder must not be required to fully or largely compensate directly or indirectly the dividends to third parties. Absent the fulfillment of all of the three prerequisites, three-fifths of the withholding tax imposed on the dividends must not be credited against the shareholder&#8217;s (corporate) income tax liability, but may, upon application, be deducted from the shareholder&#8217;s tax base for the relevant assessment period. A shareholder that has received gross dividends without any deduction of withholding tax due to a tax exemption without qualifying for a full tax credit has to notify the competent local tax office accordingly and has to make a payment in the amount of the omitted withholding tax deduction. The special rules on the restriction of withholding tax credit do not apply to a shareholder whose overall dividend earnings within an assessment period do not exceed &#8364;&#160;20,000 or that has been the beneficial owner of the shares in the Company for at least one uninterrupted year upon receipt of the dividends.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of dividend income of shareholders tax resident in Germany holding the Company&#8217;s shares as private assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For individual shareholders (individuals) resident in Germany holding the Company&#8217;s shares as private assets, dividends are subject to a flat tax rate which is satisfied by the withholding tax actually withheld (<i style="font-style:italic;">Abgeltungsteuer</i>). Accordingly, dividend income will be taxed at a flat tax rate of 25% plus 5.5% solidarity surcharge thereon (in total 26.375%) and church tax (<i style="font-style:italic;">Kirchensteuer</i>) in case the shareholder is subject to church tax because of his individual circumstances. An automatic procedure for deduction of church tax by way of withholding will apply to shareholders being subject to church tax unless the shareholder has filed a blocking notice (<i style="font-style:italic;">Sperrvermerk</i>) with the German Federal Tax Office (details related to the computation of the concrete tax rate including church tax are to be discussed with the individual tax adviser of the relevant shareholder). Except for an annual lump sum savings allowance (<i style="font-style:italic;">Sparer</i>-<i style="font-style:italic;">Pauschbetrag</i>) of up to &#8364;801 (for individual filers) or up to &#8364;&#160;1,602 (for married couples and for partners in accordance with the registered partnership law (<i style="font-style:italic;">Gesetz &#252;ber die Eingetragene Lebenspartnerschaft</i>) filing jointly), private individual shareholders will not be entitled to deduct expenses incurred in connection with the capital investment from their dividend income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The income tax owed for the dividend income is satisfied by the withholding tax withheld by the Dividend Paying Agent. However, if the flat tax results in a higher tax burden as opposed to the private shareholder&#8217;s individual tax rate, the private shareholder can opt for taxation at his individual personal income tax rate. In that case, the final withholding tax will be credited against the income tax. However, pursuant to the German tax authorities and a court ruling, private shareholders are nevertheless not entitled to deduct expenses incurred in connection with the capital investment from their income. The option can be exercised only for all capital income from capital investments received in the relevant assessment period uniformly, and married couples as well as partners in accordance with the registered partnership law filing jointly may only jointly exercise the option.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">144</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Exceptions from the flat tax rate (satisfied by withholding at source) (<i style="font-style:italic;">Abgeltungsteuer</i>) may apply&#8212;that is, only upon application&#8212;for shareholders who have a shareholding of at least 25% in a company and for shareholders who have a shareholding of at least 1% in the Company and work for the Company in a professional capacity. In such a case, the same rules apply as for sole proprietors holding the shares as business assets. See &#8220;&#8212;Taxation of dividend income of shareholders tax resident in Germany holding the Company&#8217;s shares as business assets&#8212;Sole proprietors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of dividend income of shareholders tax resident in Germany holding the Company&#8217;s shares as business assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If a shareholder holds the Company&#8217;s shares as business assets, the taxation of the dividend income depends on whether the respective shareholder is a corporation, a sole proprietor or a partnership.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Corporations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dividend income of corporate shareholders is exempt from corporate income tax, provided that the incorporated entity holds a direct participation of at least 10% in the share capital of a company at the beginning of the calendar year in which the dividends are paid. The acquisition of a participation of at least 10% in the course of a calendar year is deemed to have occurred at the beginning of such calendar year for the purpose of this rule. Participations in the share capital of the Company which a corporate shareholder holds through a partnership, including co-entrepreneurships (<i style="font-style:italic;">Mitunternehmerschaften</i>), are attributable to such corporate shareholder only on a pro rata basis at the ratio of the interest share of the corporate shareholder in the assets of the relevant partnership. However, 5% of the tax exempt dividends are deemed to be non-deductible business expenses for tax purposes and therefore are subject to corporate income tax (plus solidarity surcharge) and trade tax, i.e.,&#160;tax exemption of 95%. Business expenses incurred in connection with the dividends received are entirely tax-deductible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For trade tax purposes the entire dividend income is subject to trade tax (i.e.,&#160;the tax-exempt dividends must be added back when determining the trade taxable income), unless the corporation shareholder holds at least 15% of the Company&#8217;s registered share capital at the beginning of the relevant tax assessment period (<i style="font-style:italic;">Erhebungszeitraum</i>). In case of an indirect participation via a partnership please refer to the section &#8220;Partnerships&#8221; below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the shareholding is below 10% in the share capital, dividends are taxable at the applicable corporate income tax rate of 15% plus 5.5% solidarity surcharge thereon and trade tax (the rate of which depends on the municipalities the corporate shareholder resides in).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Special regulations apply which abolish the 95% tax exemption if the Company&#8217;s shares are held as trading portfolio assets in the meaning of Section&#160;340e of the German commercial code (<i style="font-style:italic;">Handelsgesetzbuch</i>) by (i)&#160;a credit institution (<i style="font-style:italic;">Kreditinstitut</i>), (ii)&#160;a financial service institution (<i style="font-style:italic;">Finanzdienstleistungsinstitut</i>) or (iii)&#160;a financial enterprise within the meaning of the German Banking Act (<i style="font-style:italic;">Kreditwesengesetz</i>), in case more than 50% of the shares of such financial enterprise are held directly or indirectly by a credit institution or a financial service institution, as well as by a life insurance company, a health insurance company or a pension fund in case the shares are attributable to the capital investments, resulting in fully taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sole proprietors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For sole proprietors (individuals) resident in Germany holding shares as business assets dividends are subject to the partial income rule (<i style="font-style:italic;">Teileink&#252;nfteverfahren</i>). Accordingly, only (i)&#160;60% of the dividend income will be taxed at his/her individual personal income tax rate plus 5.5% solidarity surcharge thereon and church tax (if applicable) and (ii)&#160;60% of the business expenses related to the dividend income are deductible for tax purposes. In addition, the dividend income is entirely subject to trade tax if the shares are held as business assets of a permanent establishment in Germany within the meaning of the German Trade Tax Act (<i style="font-style:italic;">Gewerbesteuergesetz</i>), unless the shareholder holds at least 15% of the Company&#8217;s registered share capital at the beginning of the relevant assessment period. The trade tax levied will be eligible for credit against the shareholder&#8217;s personal income tax liability based on the applicable municipal trade tax rate and the individual tax situation of the shareholder.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">145</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Partnerships</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In case shares are held by a partnership, the partnership itself is not subject to corporate income tax or personal income tax. In this regard, corporate income tax or personal income tax (and church tax, if applicable) as well as solidarity surcharge, are levied only at the level of the partner with respect to their relevant part of the profit and depending on their individual circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the partner is a corporation, the dividend income will be subject to corporate income tax plus solidarity surcharge. See &#8220;&#8212;Corporations.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the partner is a sole proprietor (individual), the dividend income will be subject to the partial income rule. See &#8220;&#8212;Sole Proprietors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The dividend income is subject to trade tax at the level of the partnership (provided that the partnership is liable to trade tax), unless the partnership holds at least 15% of a company&#8217;s registered share capital at the beginning of the relevant assessment period, in which case the dividend income is exempt from trade tax. In the case of dividends received by a corporate shareholder of the partnership. However, trade tax will be levied on 5% of the dividends to the extent they are attributable to the shares of such corporate partners to whom at least 10% of the shares of the Company are attributable on a look-through basis, since such portion of the dividends will be deemed to be non-deductible business expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If a partner is an individual, depending on the applicable municipal trade tax rate and the individual tax situation, the trade tax paid at the level of the partnership is partly or entirely be credited against the partner&#8217;s personal income tax liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In case of a corporation being a partner, special regulations will apply with respect to trading portfolio assets of credit institutions, financial service institutions or financial enterprises within the meaning of the German Banking Act (<i style="font-style:italic;">Kreditwesengesetz</i>) or life insurance companies, health insurance companies or pension funds. See &#8220;&#8212;Corporations.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Thus, the actual trade tax charge, if any, at the level of the partnership depends on the shareholding quota of the partnership and the nature of the partners (e.g.,&#160;individual or corporation).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of dividend income of shareholders tax resident outside of Germany</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For foreign individual or corporate shareholders tax resident outside of Germany not holding the shares through a permanent establishment in Germany or as business assets for which a permanent representative has been appointed in Germany, the deducted withholding tax (possibly reduced by way of a tax relief under a double tax treaty or domestic tax law, such as in connection with the EU Parent Subsidiary Directive) is final (that is, not refundable) and settles the shareholder&#8217;s limited tax liability in Germany, unless the shareholder is entitled to apply for a withholding tax refund or exemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In contrast, individual or corporate shareholders tax resident outside of Germany holding the Company&#8217;s shares through a permanent establishment in Germany or as business assets for which a permanent representative has been appointed in Germany are subject to the same rules as applicable (and described above) to shareholders resident in Germany holding the shares as business assets. The withholding tax withheld (including solidarity surcharge) is credited against the shareholder&#8217;s personal income tax or corporate income tax liability in Germany.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of Capital Gains</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Withholding tax on capital gains</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Capital gains realized on the disposal of shares are only subject to withholding tax if a German branch of a German or foreign credit or financial institution, a German securities trading Company or a German securities trading bank holds in safe custody or administers the shares or carries out the sale of the shares and pays or credits the capital gains in its capacity as disbursing agent. In those cases, the disbursing agent (and not the company) is required to deduct the withholding tax at the time of payment for the account of the shareholder and has to pay the withholding tax to the competent tax authority. However, no withholding tax should be levied by the disbursing agent from capital gains realized on the disposal of the shares by a shareholder that is tax resident outside of Germany and not subject to German taxation (see below section &#8220;Taxation of capital gains realized by shareholders tax resident outside of Germany&#8221;). In case the shares in Centogene&#160;N.V. are held (i)&#160;as business assets by a sole proprietor, a partnership or a corporation and such shares are attributable to a German business or (ii)&#160;in case of a corporation being subject to unlimited corporate </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">146</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">income tax liability in Germany, the capital gains are not subject to withholding tax. In case of clause&#160;(i), the withholding tax exemption is subject to the condition that the paying agent has been notified by the beneficiary (<i style="font-style:italic;">Gl&#228;ubiger</i>) that the capital gains are exempt from withholding tax. The respective notification has to be filed by using the officially prescribed form.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of capital gains realized by shareholders tax resident in Germany holding shares as private assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For individual shareholders (individuals) resident in Germany holding shares as private assets, capital gains realized on the disposal of shares are subject to final withholding tax. Accordingly, capital gains will be taxed at a flat tax rate of 25% plus a 5.5% solidarity surcharge thereon (in total 26.375%) and church tax, in case the shareholder is subject to church tax because of his individual circumstances. An automatic procedure for deduction of church tax by way of withholding will apply to shareholders being subject to church tax unless the shareholder has filed a blocking notice (<i style="font-style:italic;">Sperrvermerk</i>) with the German Federal Tax Office (details related to the computation of the concrete tax rate including church tax are to be discussed with the individual tax adviser of the relevant shareholder). The taxable capital gain is calculated by deducting the acquisition costs of the shares and the expenses directly related to the disposal from the proceeds of the disposal. Apart from that, except for an annual lump sum savings allowance (<i style="font-style:italic;">Sparer-Pauschbetrag</i>) of up to &#8364;801 (for individual filers) or up to &#8364;1,602 (for married couples and for partners in accordance with the registered partnership law (<i style="font-style:italic;">Gesetz &#252;ber die Eingetragene Lebenspartnerschaft</i>) filing jointly), private individual shareholders will not be entitled to deduct expenses incurred in connection with the capital investment from their capital gain.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In case the flat tax results in a higher tax burden as opposed to the private shareholder&#8217;s individual tax rate, the private shareholder can opt for taxation at his individual personal income tax rate. In that case, the withholding tax (including solidarity surcharge) withheld will be credited against the income tax. However, pursuant to the German tax authorities the private shareholders are nevertheless not entitled to deduct expenses incurred in connection with the capital investment from their income. The option can be exercised only for all capital income from capital investments received in the relevant assessment period uniformly, and married couples as well as for partners in accordance with the registered partnership law filing jointly may only jointly exercise the option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capital losses arising from the sale of the shares can only be offset against other capital gains resulting from the disposition of the shares or shares in other stock corporations during the same calendar year. Offsetting of overall losses with other income (such as business or rental income) and other capital income is not possible. Such losses are to be carried forward and to be offset against positive capital gains deriving from the sale of shares in stock corporations in future years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The final withholding tax will not apply if the seller of the shares or in case of gratuitous transfer, its legal predecessor has held, directly or indirectly, at least 1% of the Company&#8217;s registered share capital at any time during the five years prior to the disposal. In that case capital gains are subject to the partial income rule. Accordingly, only (i)&#160;60% of the capital gains will be taxed at his individual personal income tax rate plus a 5.5% solidarity surcharge thereon and church tax (if applicable) and (ii)&#160;60% of the business expenses related to the capital gains are deductible for tax purposes. The withholding tax withheld (including solidarity surcharge) will be credited against the shareholder&#8217;s personal income tax liability in Germany.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of capital gains realized by shareholders tax resident in Germany holding the Company&#8217;s shares as business assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If a shareholder holds shares as business assets, the taxation of capital gains realized on the disposal of such shares depends on whether the respective shareholder is a corporation, a sole proprietor or a partnership:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Corporations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capital gains realized on the disposal of shares by a corporate shareholder are generally exempt from corporate income tax and trade tax. However, 5% of the tax-exempt capital gains are deemed to be non-deductible business expenses for tax purposes and therefore are subject to corporate income tax (plus solidarity surcharge) and trade tax, i.e.,&#160;tax exemption of 95%. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capital losses incurred upon the disposal of shares or other impairments of the share value are not tax-deductible. A reduction of profit is also defined as any losses incurred in connection with a loan or security in the event the loan or the security is granted by a shareholder or by a related party thereto or by a third person with the right of recourse against the before-mentioned persons, and the shareholder holds directly or indirectly more than 25% of the company&#8217;s registered share capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Special regulations apply if the shares are held as trading portfolio assets by a credit institution, a financial service institution or a financial enterprise within the meaning of the German Banking Act (<i style="font-style:italic;">Kreditwesengesetz</i>) as well as by a life insurance company, a health insurance company or a pension fund. See &#8220;&#8212;Corporations.&#8221;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">147</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sole Proprietors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the shares are held by a sole proprietor, capital gains realized on the disposal of the shares are subject to the partial income rule. Accordingly, only (i)&#160;60% of the capital gains will be taxed at his/her individual personal income tax rate plus a 5.5% solidarity surcharge thereon and church tax (if applicable) and (ii)&#160;60% of the business expenses related to the dividend income are deductible for tax purposes. In addition, 60% of the capital gains are subject to trade tax if the shares are held as business assets of a permanent establishment in Germany within the meaning of the German Trade Tax Act (<i style="font-style:italic;">Gewerbesteuergesetz</i>). The trade tax levied, depending on the applicable municipal trade tax rate and the individual tax situation, is partly or entirely credited against the shareholder&#8217;s personal income tax liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Partnerships</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In case the shares are held by a partnership, the partnership itself is not subject to corporate income tax or personal income tax as well as a solidarity surcharge (and church tax) since partnerships qualify as transparent for German tax purposes. In this regard, corporate income tax or personal income tax as well as a solidarity surcharge (and church tax, if applicable) are levied only at the level of the partner with respect to their relevant part of the profit and depending on their individual circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the partner is a corporation, the capital gains will be subject to corporate income tax plus a solidarity surcharge. See &#8220;&#8212;Corporations.&#8221; Trade tax will be levied additionally at the level of the partner insofar as the relevant profit of the partnership is not subject to trade tax at the level of the partnership. However, with respect to both corporate income and trade tax, the 95% exemption rule as described above applies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the partner is a sole proprietor (individual), the capital gains are subject to the partial income rule. See &#8220;&#8212;Sole Proprietors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, if the partnership is liable to trade tax, 60% of the capital gains are subject to trade tax at the level of the partnership, to the extent the partners are individuals, and 5% of the capital gains are subject to trade tax, to the extent the partners are corporations. However, if a partner is an individual, depending on the applicable municipal trade tax rate and the individual tax situation, the trade tax paid at the level of the partnership is credited against the partner&#8217;s personal income tax liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">With regard to corporate partners, special regulations apply if they are held as trading portfolio assets by credit institutions, financial service institutions or financial enterprises within the meaning of the German Banking Act or life insurance companies, health insurance companies or pension funds, as described above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Taxation of capital gains realized by shareholders tax resident outside of Germany</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capital gains realized on the disposal of the shares by a shareholder tax resident outside of Germany are subject to German taxation provided that (i)&#160;the Company&#8217;s shares are held as business assets of a permanent establishment or as business assets for which a permanent representative has been appointed in Germany, or (ii)&#160;the shareholder or, in case of a gratuitous transfer, its legal predecessor has held, directly or indirectly, at least 1% of the company&#8217;s shares capital at any time during a five-year period prior to the disposal. In these cases, capital gains are generally subject to the same rules as described above for shareholders resident in Germany. However, in case the shares are not attributable to a German permanent establishment or permanent representative the 5% taxation (see &#8220;&#8212;Corporations&#8212;Taxation of capital gains realized by shareholders tax resident in Germany holding the Company&#8217;s shares as business assets&#8221;) should not apply and the capital gains are fully exempt from German tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">However, except for the cases referred to in clause&#160;(i) above, some of the double tax treaties concluded with Germany (including the German-U.S. tax treaty) provide for a full exemption from German taxation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inheritance and Gift Tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The transfer of the Company&#8217;s shares to another person by way of succession or donation is subject to German inheritance and gift tax (<i style="font-style:italic;">Erbschaft- und Schenkungsteuer</i>) if:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>the decedent, the donor, the heir, the donee or any other beneficiary has his/her/its residence, domicile, registered office or place of management in Germany at the time of the transfer, or is a German citizen who has not stayed abroad for more than five consecutive years without having a residence in Germany; or</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">148</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>(irrespective of the personal circumstances) the shares are held by the decedent or donor as business assets for which a permanent establishment in Germany is maintained or a permanent representative is appointed in Germany; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>(irrespective of the personal circumstances) at least 10% of the shares are held, directly or indirectly by, the decedent or person making the gift, himself or together with a related party in terms of Section&#160;6 Foreign Tax Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Special regulations apply to qualified German citizens who maintain neither a residence nor their domicile in Germany but in a low tax jurisdiction, and to former German citizens, also resulting in inheritance and gift tax. The few double tax treaties on inheritance and gift tax which Germany has entered into provide that German inheritance and gift tax is levied only in case of (i)&#160;and, with certain restrictions, in case of (ii).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Imposition of Solidarity Surcharge</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">With effect as from the assessment period 2021, the solidarity surcharge has been partially abolished for certain individuals. The solidarity surcharge shall, however, continue to apply for capital investment and, thus, on withholding taxes levied. If the individual income tax burden for an individual shareholder is lower than 25%, the shareholder can apply for his/her capital investment income to be assessed at his/her individual tariff-based income tax rate, in which case the solidarity surcharge would be refunded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No German capital transfer tax (<i style="font-style:italic;">Kapitalverkehrsteuer</i>), value-added tax (<i style="font-style:italic;">Umsatzsteuer</i>), stamp duty (<i style="font-style:italic;">Stempelgeb&#252;hr</i>) or similar taxes are levied when acquiring, holding or transferring the Company&#8217;s shares. No value-added tax will be levied unless the shareholder validly opts for it. Net wealth tax (<i style="font-style:italic;">Verm&#246;gensteuer</i>) is currently not levied in Germany.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 14, 2013, the EU Commission adopted a proposal for a Council Directive (the &quot;Draft Directive&quot;) on a common financial transaction tax (&#8220;FTT&#8221;) to be implemented in Austria, Belgium, France, Germany, Greece, Italy, Portugal, Spain, Slovakia, and Slovenia (the &#8220;Participating Member States&#8221;). Estonia has stated in 2015 that it will not participate in implementing the proposed FTT.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Draft Directive has a very broad scope and could, if introduced, apply to certain dealings in the shares or subscription rights (including secondary market transactions) in certain circumstances. The Draft Directive focused on levying a FTT on financial transactions (as defined in the Draft Directive), including the purchase, sale and exchange of financial instruments. Under the Draft Directive, the rate of the FTT would not be lower than 0.1% (0.01% for derivatives), generally based on the amount of the paid or owed consideration or in case of derivatives, the notional amount referred to in the derivatives contract at the time of the financial transaction. The issuance and subscription of shares should, however, be exempt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Since the date of the publication of the Draft Directive, discussions have taken place between the Participating Member States. According to a statement of the German Federal Ministry of Finance (<i style="font-style:italic;">Bundesministerium der Finanzen</i>) dated May 25, 2020, the work on the legal framework for the FTT was expected to be finalized in the second half of the calendar year 2020 based on the model of the existing French FTT legislation. Accordingly, the scope of application of the FTT to be levied at a rate of 0.2%, if enacted at all, could be confined to secondary market acquisitions of shares in domestic companies with a market capitalization of more than EUR 1 billion, while initial public offerings, market making and intraday trading should not be within the scope of taxation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Nevertheless, the FTT remains subject to negotiation between the Participating Member States and was (and most probably will be) the subject of legal challenge. It may still be altered prior to its adoption. Moreover, once any directive has been adopted, it will need to be implemented into the respective domestic laws of the participating member states, and the domestic provisions implementing the directive might deviate from the directive itself. Finally, additional EU member states may decide to participate in or to dismiss the implementation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A joint statement issued by 10 of the 11 participating EU member states in October 2016 reaffirmed the intention to introduce FTT. However, at the moment not many details are available. Thus, it is not known to what extent the elements of the European Commission&#8217;s proposal outlined in the preceding paragraph will be followed in relation to the taxation of shares. The FTT proposal remains subject to negotiation between the participating Member States and is subject to political discussion. It may, therefore, be altered prior to the implementation, the timing of which remains unclear. Additional EU member states may decide to participate.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">149</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Prospective holders of the shares are advised to monitor future developments closely and to seek their own professional advice in relation to FTT.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Dividends and Paying Agents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">G.</b></span>Statement by Experts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">H.</b></span>Documents on Display</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file reports and other information with the SEC, including annual reports on Form&#160;20-F and reports on Form&#160;6-K. The SEC maintains an internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We also make available on our website, free of charge, our Annual Report and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is www.centogene.com. The information contained on our website is not incorporated by reference in this Annual Report and our website address is included in this Annual Report as an inactive textual reference only.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">I.</b></span>Subsidiary Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_69a30bd2_2033_4aef_9434_11ab5aaecccc"></a><a id="Item11QuantitativeandQualitativeDisclosu"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">11.  Quantitative and Qualitative Disclosures About Market Risk</b> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the ordinary course of our business activities, we are exposed to various risks that are beyond our control, including credit risk, liquidity risk, market and sales risk and currency risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our default risk generally arises from trade and other receivables and is influenced mainly by the characteristics of individual international customers, as well as deposits with banks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our customers in the pharmaceutical segment are mainly pharmaceutical companies which are usually listed companies, or strongly financed by private equity funds. Our customers in the diagnostics segment are mainly hospitals, labs and physicians, of which a large part are considered by management to be recurring revenues. To avoid defaults, we may request prepayment when entering into new business relationships with physicians. Our customers in the COVID-19 segment are private customers that pay us directly or through the German health insurance system, government funded institutions and privately owned companies.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">150</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition to the macroeconomic situation generally, the development of international healthcare markets is a key economic factor affecting our business. These markets are closely monitored by our sales and other staff. The maximum default risk for trade receivables as of December&#160;31, 2021 and 2020 by geographical region was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14,550</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10,515</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 10,904</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 20,017</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 683</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 387</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,787</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,870</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 130</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 178</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total trade receivables, gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 30,054</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 33,967</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected credit loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,717</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,768</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total trade receivables, net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 24,337</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 29,199</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Overdue trade receivables in the Middle East region mainly relate to major customers from the diagnostics segment. The trade receivables due from the top 10 diagnostics customers in the MENA region as of December&#160;31, 2021 represent over 80% of overdue balances for the Middle East. These customers are mainly government hospitals administered by the Ministry of Health in the respective countries as well as distributors and, based on our past experience, they normally require a longer period to settle outstanding trade receivables.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Liquidity Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We are exposed to liquidity risk in both the availability of finance and the repayment of borrowings, as we may not be in a position to meet our financial liabilities as contractually agreed by providing cash or other financial assets. See discussion in Note 2.2 of our consolidated financial statements for the year ended December&#160;31, 2021 as it relates to the Group&#8217;s ability to continue as a going concern. We manage our liquidity in order to ensure that sufficient cash and cash equivalents are available for us to meet our payment obligations when these fall due, without incurring unacceptable losses or damaging our reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We strive to maintain cash and cash equivalents at a level above that of the expected cash outflows for financial liabilities (apart from trade payables) during the next 60&#160;days.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We completed our initial public offering in November 2019 and our Follow-on Equity Offering in July 2020. As of December&#160;31, 2021, we had cash and cash equivalents of &#8364;17.8&#160;million. The cash and cash equivalents are deposited principally with financial institutions with investment grade credit ratings. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to the cash and cash equivalent available as of December&#160;31, 2021, we also have access to other sources of funding, including the amount of expected cash inflows from trade and other receivables. We also have secured credit lines of &#8364;3,500&#160;thousand that bear interest at 3.75% to 4.75%, of which &#8364;3,310&#160;thousand was utilized as of December&#160;31, 2021 and &#8364;1,538&#160;thousand was utilized as of December&#160;31, 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Subsequent to the year ending December 31, 2021, we successfully secured &#8364;55.0 million in aggregate of equity and debt financings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Private Placement of Common Shares and Warrants&#8221; and &#8220;&#8212;Loan and Security Agreement&#8221; for more information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Market and Sales Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Market risks primarily arise from changing reimbursement structures as well as pricing pressure and pressure to innovate in the highly dynamic market environment of genetic diagnostic testing. We monitor developments very closely through our local sales teams and their reporting structures. We also closely monitor our individual segmental results by conducting periodic analyses of our competitive landscape, with the aim of enabling rapid pricing and product enhancements, if necessary.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">151</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Currency Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We are also exposed to currency risks where contracts are concluded in foreign currencies. The vast majority of the products and services we provide, however, are invoiced in Euros. Our main functional currencies other than the euro are the U.S. dollar, the Indian rupee (the &#8220;INR&#8221;) and the Arab Emirates Dirham (the &#8220;AED&#8221;), as shown in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AED</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="7" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(&#8364;&#160;in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,604</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables and other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2,394)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (4)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net risk statement of financial position</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 210</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The impact on our earnings before tax for the years ended December&#160;31, 2021 and 2020 or equity as of December&#160;31, 2021 and 2020 of a 10% change in the U.S. dollar exchange rate as compared to the euro would not be material. In the future, we expect our exposure to the U.S. dollar to increase over time as our business grows. The impact on our earnings before tax for the years ended December&#160;31, 2021 and 2020 or equity as of December&#160;31, 2021 and 2020 of a 10% change in the INR and AED would not be material.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_1ab44cb1_3523_4146_a6ac_9bbbb354720d"></a><a id="Item12DescriptionofSecuritiesOtherThanEq"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">12.  Description of Securities Other Than Equity Securities</b> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Debt Securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Warrants and Rights</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Other Securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>American Depositary Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">152</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_28aad2fa_3250_4de4_bbe7_1e97a8633e96"></a><a id="PARTTWO_300980"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PART TWO</b></p><a id="Item13DefaultsDividendArrearagesandDelin"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">13.  Defaults, Dividend Arrearages and Delinquencies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">None.</p><a id="_7572c4d7_b559_4c40_9546_985adc693b48"></a><a id="Item14MaterialModificationstotheRightsOf"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">14.  Material Modifications to the Rights of Security Holders and Use of Proceeds</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Material Modifications to Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Material Modifications to Rights</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Withdrawal or Substitution of Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Changes in Trustees or Paying Agents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Use of Proceeds </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2020, we completed a follow-on public offering of 3,500,000 common shares of the Company, consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of $14.00 per common share (i.e., &#8364;12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, to the Company were &#8364;22 million. Credit Suisse Securities (USA) LLC and SVB Leerink LLC were the managing underwriters for the Follow-on Equity Offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">From July 2020 to December&#160;31, 2021, we used the net proceeds from our Follow-on Equity Offering as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">research and development activities to support orphan drug development with our knowledge-driven information platform; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">working capital and other general corporate purposes.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We plan to continue to use the net remaining proceeds for such purposes in 2022, including to acquire or invest in complementary businesses, assets or technologies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_836679dc_1196_4649_8bb0_e612a1d46e10"></a><a id="Item15ControlsandProcedures_352699"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">15.  Controls and Procedures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Disclosure Controls and Procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As required by Rule 13a-15 under the Exchange Act, management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Disclosure controls and procedures include, without limitations, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding our required disclosures.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">153</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on the foregoing, including the material weaknesses noted below, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of December 31, 2021, the design and operation of our disclosure controls and procedures were not effective at the reasonable assurance level.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Management&#8217;s Annual Report on Internal Control Over Financial Reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections or any evaluation or effectiveness for future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p><a id="_Hlk99545170"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As part of our continued risk assessment and implementation of controls, we identified two material weaknesses related to ensuring the amounts in each financial statement account are complete and accurate. These relate to a lack of effectively designed review and monitoring financial statement close process controls, including the ability of our business to timely and appropriately communicate unexpected or new transactions to the finance function and the lack of timely and appropriate assessment of the related accounting implications of these transactions; and a lack of an effectively designed and complete general IT controls framework (including system interfaces).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2021, using the criteria established in &#8220;Internal Control - Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation and the criteria issued by COSO, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, concluded that, as of December 31, 2021, our internal control over financial reporting was not effective because of the material weaknesses related to the design and maintenance of effective controls described above, which has not been remediated. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">With the oversight of the Management Board and our Audit Committee, our management has been and is actively undertaking remediation efforts to address the material weaknesses identified above through the following actions:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Performing risk assessments to identify relevant financial risks and designing and implementing a formalized framework for internal control, based on the &#8220;Internal Control - Integrated Framework (2013)&#8221; issued by COSO, to reasonably address those risks.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Designing and formalizing policies and procedures to ensure routine transactions and judgmental and complex areas of the financial statement close process are sufficiently analyzed and assessed against the requirements of IFRS and our corporate governance standards, and that contemporaneous documentation is prepared and reviewed in a timely manner.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Designing and formalizing general IT control policies and procedures, including automation and integration of financially relevant processes, to assist in controlling certain routine processes within the finance function to improve effectiveness and efficiency</span><span style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We shall finalize the design of the internal control framework in 2022, including the implementation and monitoring of effectiveness of internal controls over financial reporting and disclosure related to risk assessment, compliance, and oversight of the Company&#8217;s businesses.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These remediation efforts will be time consuming, costly and might place significant demands on our financial and operational resources. Because the reliability of the internal controls process requires repeatable execution, the successful remediation of the material weaknesses will require review and evidence of effectiveness prior to management concluding that the Company&#8217;s internal controls over financial reporting are effective. As management continues to evaluate and improve the Company&#8217;s internal controls over financial reporting, it may take additional measures to address control deficiencies or to modify the remediation plan described above. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">154</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During 2022, management shall test and evaluate the implementation of these internal controls to ascertain whether they are designed and operating effectively in order to provide reasonable assurance that they will prevent or detect a material misstatement in the Company&#8217;s consolidated financial statements. If our efforts to remediate these material weaknesses are not successful, the material weaknesses may reoccur, or other material weaknesses could occur in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the identified material weaknesses, our management believes that the financial statements and related notes thereto included in this annual report on Form 20-F fairly present, in all material respects, our financial condition, results of operations and cash flows as of and for the periods presented in accordance with IFRS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Attestation Report of the Registered Public Accounting Firm</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting due to a transition period established by rules of the SEC for emerging growth companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Changes in Internal Control Over Financial Reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our management is committed to improving the internal control over financial reporting and will undertake consistent improvements or enhancements on an ongoing basis, in addition to the remediation plans noted above. During the period covered by this annual report our management has taken steps toward improving our internal controls over financial reporting and remediating the identified material weaknesses. However, the changes during the period covered by this annual report have not yet fully affected the remediation of the material weaknesses or our internal control over financial reporting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_db54534a_c53c_48eb_a398_88bc8f792975"></a><a id="Item16Reserved_598589"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16.  [Reserved]</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_fec1ec2a_9660_4504_9d47_106058a73dba"></a><a id="Item16AAuditCommitteeFinancialExpert_983"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16A.  Audit Committee Financial Expert</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our supervisory board has determined that Berndt Modig, Peer Schatz and Jonathan G. Sheldon each satisfy the &#8220;independence&#8221; requirements set forth in Rule&#160;10A-3 under the Exchange Act and Berndt Modig qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined in the rules of the SEC. For more information see &#8220;Item&#160;6. Directors, Senior Management and Employees&#8212;C. Board Practices&#8212;Committees&#8212;Audit Committee.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_65c9c5b7_576c_4664_ae71_6018077ba71a"></a><a id="Item16BCodeofEthics_42095"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16B.  Code of Ethics</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We adopted a Code of Business Conduct and Ethics (the &#8220;Code&#8221;) applicable to our management board, our supervisory board, and company personnel, which is a code of ethics as defined in Item&#160;16B of Form&#160;20-F promulgated by the SEC. The full text of the Code can be found on our website at www.centogene.com. Information contained on, or that can be accessed through, our website does not constitute a part of this Annual Report and is not incorporated by reference herein. If we make any amendment to the Code or grant any waivers, including any implicit waiver, from a provision of the Code, we will disclose the nature of such amendment or waiver on our website to the extent required by the rules and regulations of the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_0a094574_c45c_4297_bc5d_27af67cc9ea7"></a><a id="Item16CPrincipalAccountantFeesandService"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16C.  Principal Accountant Fees and Services</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our financial statements have been prepared in accordance with IFRS and are audited by Ernst&#160;&amp; Young&#160;GmbH Wirtschaftspr&#252;fungsgesellschaft (&#8220;Ernst&#160;&amp; Young&#8221;), our independent registered public accounting firm registered with the Public Company Accounting Oversight Board in the United States.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">155</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Ernst&#160;&amp; Young has served as our independent registered public accounting firm for each of the three years ended December&#160;31, 2021, 2020 and 2019, for which audited financial statements appear in this Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For&#160;the&#160;year ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:78.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="5" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in&#160;thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,050</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 681</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audit&#8209;related fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">All other fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,050</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 681</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Audit fees relate to (i)&#160;audit services, (ii)&#160;certain procedures on our quarterly results, (iii)&#160;services related to our statutory and regulatory filings for certain of our subsidiaries, including Centogene GmbH and (iv)&#160;fees in connection with the issuance of a comfort letter for our follow-on public offering in July 2020 and fees for other services related thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Audit Committee&#8217;s Pre-Approval Policies and Procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The audit committee is responsible for the appointment, compensation, retention and oversight of the work of our independent registered public accounting firm.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Audit Committee evaluates the qualifications, independence and performance of the independent registered public accounting firm as well as pre-approves and reviews the audit and non-audit services to be performed by the independent registered public accounting firm. The external audit plan and fees for professional audit services and other services rendered by Ernst&#160;&amp; Young for the years ended December&#160;31, 2021 and 2020 were approved by the Audit Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Audit Committee monitors compliance with the German, Dutch and U.S. rules on non-audit services provided by an independent registered public accounting firm.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Audit Work Performed by Persons Other Than Principal Accountant if Greater than 50%</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_dd49ca3e_7862_4a6d_aefa_2ca1e8f89987"></a><a id="Item16DExemptionsfromtheListingStandards"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16D.  Exemptions from the Listing Standards for Audit Committees</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_48b55529_84b0_4d11_975e_6a8f8b32ee12"></a><a id="Item16EPurchasesofEquitySecuritiesbytheI"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16E.  Purchases of Equity Securities by the Issuer and Affiliated Purchasers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Neither we nor any affiliated purchaser has purchased any shares or other units of any class of our equity securities registered pursuant to Section&#160;12 of the Exchange Act during the fiscal year ended December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_646cd8a6_9635_4aff_b2b0_5138c42b5833"></a><a id="Item16FChangeinRegistrantsCertifyingAcco"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16F.  Change in Registrant&#8217;s Certifying Accountant</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e86c3869_7dad_4898_b6c9_f67c24ce2d37"></a><a id="Item16GCorporateGovernance_223061"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16G.  Corporate Governance</b> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As a &#8220;foreign private issuer&#8221;, as defined by the SEC, we are permitted to rely on home country governance requirements and certain exemptions thereunder rather than on the corporate governance requirements of Nasdaq. For example, in accordance with Dutch law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. To this extent, our practice varies from the requirement of Nasdaq Listing Rule&#160;5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting shares. Although we must provide shareholders with an agenda and other relevant documents for the general meeting of shareholders, Dutch law does not have a regulatory regime for the solicitation of proxies and the solicitation of proxies is not a generally accepted business practice in the Netherlands, thus our practice varies from the requirement of </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">156</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nasdaq Listing Rule&#160;5620(b). As permitted by the listing requirements of Nasdaq, we have also opted out of the requirements of Nasdaq Listing Rule&#160;5605(d), which requires, among other things, an issuer to have a compensation committee that consists entirely of independent directors, Nasdaq Listing Rule&#160;5605(e), which requires independent director oversight of director nominations, and Nasdaq Listing Rule&#160;5605(b), which requires an issuer to have a majority of independent directors on its board. In addition, we have opted out of shareholder approval requirements, as included in the Nasdaq Listing Rules, for the issuance of securities in connection with certain events such as the acquisition of shares or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of the Company and certain private placements. To this extent, our practice varies from the requirements of Nasdaq Rule&#160;5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_056154f4_12e3_4d4d_8625_28b059de8394"></a><a id="Item16HMineSafetyDisclosure_410828"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">16H.  Mine Safety Disclosure</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_4f1f81ba_1960_416d_964b_b3f85704d680"></a><a id="MiscellaneousDisclosureunderIranThreatRe"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;white-space:pre-wrap;">Miscellaneous.  Disclosure under Iran Threat Reduction and Syria Human Rights Act of 2012 (ITRA)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Section&#160;219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 added Section&#160;13(r) to the Exchange Act. Section&#160;13(r) requires an issuer to disclose in its annual or quarterly reports, as applicable, whether it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to Iran or with designated natural persons or entities sanctioned under programs relating to terrorism or the proliferation of weapons of mass destruction. Disclosure is required even where the activities, transactions or dealings are conducted outside the US by non-US affiliates in compliance with applicable law, and whether or not the activities are sanctionable under US law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of the date of this Annual Report, we are not aware of any activity, transaction or dealing by us during the financial year ended December&#160;31, 2021 that is disclosable under Section&#160;219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section&#160;13(r) of the Exchange Act, except as set forth below. This information is to the best of our knowledge.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Centogene N.V., which is not a U.S. person and is not owned or controlled by U.S. persons, does not have any branches or subsidiaries based in Iran. However, we have contracts with several laboratories and one distributor in Iran through which we provide diagnostic tests to patients in Iran, primarily NIPT for pregnant women. These laboratories and our third-party distributor are not owned or controlled by the Iranian government and we do not have any agreements, commercial arrangements, or other contracts with the Iranian government. Moreover, neither our distributor nor we have entered into any arrangements with or sold any products to persons included on the Specially Designated Nationals and Blocked Persons List maintained by the U.S. Department of the Treasury&#8217;s Office of Foreign Asset Control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the year ended December&#160;31, 2021, our gross revenues from activities in Iran amounted to &#8364;1&#160;<span style="white-space:pre-wrap;">thousand, which represented  0.001% of our total gross revenues. We did not generate any net profits for the year ended December&#160;31, 2021 from authorities in Iran.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We do not receive information regarding the identity of our distributor&#8217;s downstream customers and intermediaries in Iran, and it is possible that these parties include entities, such as government-owned hospitals and pharmacies, that are owned directly or indirectly by the Iranian government or by persons or entities sanctioned in connection with terrorism or proliferation activities. As a result, we cannot establish the proportion of gross revenue or sales potentially attributable to entities affiliated with the Iranian government or parties sanctioned for disclosable activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe that our business with Iranian parties is conducted in compliance with all applicable sanctions and export controls and that such activities, which involve providing genetic testing services to patients, are not sanctionable under U.S. secondary sanctions targeting Iran. For further information, see &#8220;Item&#160;3. Key Information&#8212;D. Risk Factors&#8212;Transactions involving Iran or other countries or parties that are targets of U.S. or other economic sanctions could expose us to certain risks and may lead some potential customers and investors to avoid doing business with us or investing in our securities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of the date of this Annual Report, our management does not anticipate any change in our activities in Iran that would result in a material impact on Centogene.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">No<span style="color:#0000ff;">t </span>applicable.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">157</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_c0426e42_46f4_4951_b9b2_a4927f1ac953"></a><a id="PARTTHREE_737517"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PART THREE</b></p><a id="Item17FinancialStatements_723098"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">17.  Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We have responded to Item&#160;18 in lieu of this item.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_54b8dcc2_38ae_4ec4_bf88_e03f2e7c6e9e"></a><a id="Item18FinancialStatements_676801"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">18.  Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our audited consolidated financial statements are included in this Annual Report beginning at Page&#160;F-1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e5cc73c4_1672_479b_bad9_6d6942cc19b7"></a><a id="Item19Exhibits_577974"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Item&#160;<b style="font-weight:bold;white-space:pre-wrap;">19.  Exhibits</b> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:88.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">Exhibit no.</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:88.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">Description</b></p></th></tr><tr><td style="vertical-align:top;width:9.81%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">1.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005919/a2239934zex-3_1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Articles of Association of Centogene&#160;N.V. (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;3.1 to Amendment No.&#160;1 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;28, 2019).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">2.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-4_1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Registration Rights Agreement (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;4.1 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">2.2</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746920004012/a2242021zex-4_2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amendment No. 1 to Registration Rights Agreement (incorporated into this Annual Report on Form 20-F by reference to Exhibit 4.2 to our Registration Statement on Form F-1 (File No. 333-239735), filed with the SEC on July 7, 2020.</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">2.3</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000155837021004303/cntg-20201231ex229fd0bb4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Description of the rights of each class of securities registered under Section&#160;12 of the Securities Exchange Act of 1934 as of December&#160;31, 2021. (incorporated into this Annual Report on Form 20-F by reference to Exhibit 2.2 to our Annual Report on Form 20-F for the year ended December 31, 2020 (File No. 001-39124), filed with the SEC on April 15, 2021).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Global Master Services Agreement between Centogene AG and Shire International&#160;GmbH, dated January&#160;1, 2015 (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.1 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.2</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Supply Agreement between Centogene AG and Shire Pharmaceuticals Ireland&#160;Ltd, dated January&#160;1, 2016 (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.2 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.3</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amendment to the Global Master Services Agreement and Supply Agreement among Centogene AG, Shire International&#160;GmbH and Shire Pharmaceuticals Ireland&#160;Ltd., dated May&#160;3, 2017 (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.3 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.4</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amendment to the Global Master Services Agreement and Supply Agreement among Centogene AG, Shire International&#160;GmbH and Shire Pharmaceuticals Ireland&#160;Ltd., dated July&#160;2, 2018 (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.4 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.5</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746920002522/a2241422zex-4_5.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amendment to the Global Master Services Agreement and Supply Agreement among Centogene AG, Shire International&#160;GmbH and Shire Pharmaceuticals Ireland&#160;Ltd., dated December&#160;10, 2019 (incorporated into this Annual Report on Form 20-F by reference to Exhibit 4.5 to our Annual Report on Form 20-F for the year ended December 31, 2019 (File No. 001-39124), filed with the SEC on April 23, 2020).&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.6</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000155837021004303/cntg-20201231ex46f2954f5.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amendment to the Global Master Services Agreement and Supply Agreement among Centogene AG, Shire International, dated March 17, 2021. (incorporated into this Annual Report on Form 20-F by reference to Exhibit 4.6 to our Annual Report on Form 20-F for the year ended December 31, 2020 (File No. 001-39124), filed with the SEC on April 15, 2021).&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.7</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_5.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Long Term Incentive Plan of Centogene&#160;N.V. (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.5 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.8</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_6.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of indemnification agreement between Centogene&#160;N.V. and members of the Supervisory Board or Management Board (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.6 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).</span></a></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">158</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:9.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:88.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:9.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">Exhibit no.</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:88.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">Description</b></p></th></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.9</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_7.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">English summary of the Property Sale Agreement between Centogene AG and Ludewig-Wasserbau- und Werft-&#160;GmbH, dated June&#160;28, 2019 (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.7 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.10</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_8.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">English summary of the Lease Agreement between Centogene AG and Ludewig-Wasserbau- und Werft-&#160;GmbH, dated June&#160;28, 2019 (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.8 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.11</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-10_9.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">English summary of the Securities Sale Agreement between Centogene AG and K&amp;L Immobilien&#160;GmbH and F&amp;G IT&#160;GmbH, dated July&#160;22, 2019 (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;10.9 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.12</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex4d12.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">English summary of the Service Agreement between Centogene GmbH and the Free State of Bavaria, Germany, represented by the Bavarian State Office for Health and Food Safety, dated April 29, 2021.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.13</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000155837021004303/cntg-20201231ex4174c0809.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">English summary of the Cooperation Agreement between Centogene GmbH and Dr. Bauer Laboratoriums GmbH, dated June 25, 2020. (incorporated into this Annual Report on Form 20-F by reference to Exhibit 4.17 to our Annual Report on Form 20-F for the year ended December 31, 2020 (File No. 001-39124), filed with the SEC on April 15, 2021).&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.14</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex4d14.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Framework Agreement between Centogene GmbH and 21Dx GmbH (as main contractor to the state of Berlin), dated June 25, 2021.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.15</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000095010322001729/dp166353_ex9904.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Securities Purchase Agreement, dated January 31, 2022, by and among Centogene N.V. and the Investors identified on Schedule 1 attached thereto, incorporated into this Annual Report on Form 20-F by reference to our Report on Form 6-K filed with the SEC on February 1, 2022 (File No. 001-39124).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.16</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000095010322001729/dp166353_ex9905.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Warrant Agreement, dated January 31, 2022, by and among Centogene N.V. and the Investors identified on Schedule 1 attached thereto, incorporated into this Annual Report on Form 20-F by reference to our Report on Form 6-K filed with the SEC on February 1, 2022 (File No. 001-39124).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">4.17</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000095010322001729/dp166353_ex9906.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Loan and Security Agreement dated as of January 31, 2022 between Centogene N.V., Oxford Finance LLC, as Collateral Agent, and the Lenders named in Schedule 1.1 attached thereto, incorporated into this Annual Report on Form 20-F by reference to our Report on Form 6-K filed with the SEC on February 1, 2022 (File No. 001-39124).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">8.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex8d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">List of subsidiaries.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">11.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1757097/000104746919005715/a2239081zex-14_1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Code of Business Conduct and Ethics of Centogene&#160;N.V. (incorporated into this Annual Report on Form&#160;20-F by reference to Exhibit&#160;14.1 to our Registration Statement on Form&#160;F-1 (File No.&#160;333-234177), filed with the SEC on October&#160;11, 2019).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">12.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex12d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">12.2</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex12d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">13.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex13d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.**</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">13.2</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex13d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.**</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">15.1</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="cntg-20211231xex15d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Ernst&#160;&amp; Young&#160;GmbH Wirtschaftspr&#252;fungsgesellschaft.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">101</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">The following materials from this Annual Report on Form&#160;20-F formatted in iXBRL (Inline Extensible Business Reporting Language) are furnished herewith: (i)&#160;the Report of Independent Registered Public Accounting Firm, (ii)&#160;the consolidated statements of comprehensive loss data, (iii)&#160;the consolidated statements of financial position, (iv)&#160;the consolidated statements of cash flows, (v)&#160;the consolidated statements of changes in equity, and (vi)&#160;the notes to consolidated financial statements, in each case tagged as blocks of text and in detail.**</p></td></tr><tr><td style="vertical-align:top;width:9.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:right;text-indent:-10pt;margin:0pt 0pt 2pt 0pt;">104</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="color:#3b3838;">Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed herewith.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;">**&#160;&#160;&#160;&#160;&#160;&#160;&#160;Furnished herewith.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;">&#8224;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certain information has been excluded from the exhibit because it both (i)&#160;is not material and (ii)&#160;would likely cause competitive harm to the Company if publicly disclosed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">159</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_7d6dadc7_7b43_452e_a977_ca71a11e932e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The registrant hereby certifies that it meets all of the requirements for filing on Form&#160;20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:5.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td colspan="2" style="vertical-align:bottom;width:47.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CENTOGENE&#160;N.V.</p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:52.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:bottom;width:47.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ KIM STRATTON</p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:41.58%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Kim Stratton</p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:41.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Chief Executive Officer</i></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 31, 2022 </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">160</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_91960c82_2627_447c_8c7b_53381f5de683"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">INDEX TO FINANCIAL STATEMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:48.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;border-bottom:1px solid #000000;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">Audited Consolidated Financial Statements&#8212;Centogene&#160;N.V.</b></p></td><td style="vertical-align:bottom;width:48.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 1pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:93.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1pt 0pt;"><a href="#ReportofIndependentRegisteredPublicAccou"><span style="font-style:normal;font-weight:normal;">Report of Independent Registered Public Accounting Firm</span></a> <i style="font-style:italic;">(PCAOB ID </i><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:AuditorFirmId" id="Narr_QZuxaj-uZEmiReMbMSsU1A"><i style="font-style:italic;">1251</i></ix:nonNumeric><i style="font-style:italic;">)</i></p></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1pt 0pt;">F-2</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:93.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1pt 0pt;"><a href="#comprehensiveloss_862435"><span style="font-style:normal;font-weight:normal;">Consolidated statements of comprehensive loss for the years ended December&#160;31, 2021, 2020 and 2019</span></a></p></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1pt 0pt;">F-3</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:93.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1pt 0pt;"><a href="#financialposition_223464"><span style="font-style:normal;font-weight:normal;">Consolidated statements of financial position as of December&#160;31, 2021 and 2020</span></a></p></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1pt 0pt;">F-4</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:93.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1pt 0pt;"><a href="#cashflows_997770"><span style="font-style:normal;font-weight:normal;">Consolidated statements of cash flows for the years ended December&#160;31, 2021, 2020 and 2019</span></a></p></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1pt 0pt;">F-5</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:93.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1pt 0pt;"><a href="#changesinequity_17793"><span style="font-style:normal;font-weight:normal;">Consolidated statements of changes in equity for the years ended December&#160;31, 2021, 2020 and 2019</span></a></p></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1pt 0pt;">F-6</p></td></tr><tr><td colspan="2" style="vertical-align:top;width:93.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 1pt 0pt;"><a href="#a1Generalcompanyinformation_139854"><span style="font-style:normal;font-weight:normal;">Notes to the consolidated financial statements as of December&#160;31, 2021 and 2020 and for the three years ended December&#160;31, 2021, 2020 and 2019</span></a></p></td><td style="vertical-align:bottom;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 1pt 0pt;">F-7</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_231cd064_e061_4b88_a843_cb17eaf8948f"></a><a id="ReportofIndependentRegisteredPublicAccou"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Report of Independent Registered Public Accounting Firm</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">To the Shareholders and the Supervisory Board of Centogene&#160;N.V.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Opinion on the Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have audited the accompanying consolidated statements of financial position of Centogene&#160;N.V. (the Company) as of December&#160;31, 2021 and 2020, the related consolidated statements of comprehensive loss, changes in equity and cash flows for each of the three years in the period ended December&#160;31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2021, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Restatement of Previously Issued Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As discussed in Note&#160;2.4 to the consolidated financial statements, the 2020 consolidated financial statements have been restated to correct a misstatement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis for Opinion</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">/s/ <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:AuditorName" id="Narr_0j-lkqVy6EebMwvnDnSBjw">Ernst&#160;&amp; Young&#160;GmbH Wirtschaftspr&#252;fungsgesellschaft</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We have served as the Company&#8217;s auditor since 2010.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="dei:AuditorLocation" id="Narr_VyKI78usGkKl4rIvhrM7rQ">Berlin, Germany</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">March 31, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6ed8300c_6daa_4130_afce_e221f2564f7f"></a><a id="_Hlk97124950"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Centogene N.V.</b></p><a id="comprehensiveloss_862435"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Consolidated statements of comprehensive loss for the&#160;years ended December&#160;31, 2021, 2020 and </b><b style="font-weight:bold;">2019</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(in EUR k)</b></p><a id="_a84c1ef3_dce1_4911_956a_83c36fc5194e"></a><a id="Tc_l5ubBJ_dXkG_8i9tS6elDA_1_2"></a><a id="Tc_2qPq8U1rAkykXTuvP5o2aw_1_4"></a><a id="Tc_92CzPzksu0yUFWPBkhXZ3Q_1_6"></a><a id="Tc_V8xALeKFdU2L4eHg8p_UvA_1_8"></a><a id="Tc_g595MWEU50iR7tgwLSmcbw_2_6"></a><a id="Tc_szjl9Xi9XkO5MsT07A6pCA_3_0"></a><a id="Tc_t67231Ms1Uyzc5LCaaBUOg_3_2"></a><a id="Tc_u1KFr-jkckiCGsFXQZOoBQ_4_0"></a><a id="Tc_6YDWJOZlvUOE4JLsa6KFmw_5_0"></a><a id="Tc_yUhmljoDGkq2U_vEvkUnyg_6_0"></a><a id="Tc_B9LcCzCqZk2cFAFFtoz8Yw_7_0"></a><a id="Tc_K7r1DtX4Fk6tviQ2SOzuew_8_0"></a><a id="Tc_cOmnW75rJkuyxoUmqSQoKw_9_0"></a><a id="Tc_vJsoCqbsbkSWZsppkrvnQg_9_2"></a><a id="Tc_RXJwMaRrNEWL7zSMbkekYQ_10_0"></a><a id="Tc_AFkIK8RtFkyVgQC8zWH11w_10_2"></a><a id="Tc_iUuGcDnN2keYCivvMIB7Vg_11_0"></a><a id="Tc_4Y25Axslv0mVBvBq_Ititw_11_2"></a><a id="Tc_Ao4fum8VQk-2Ab9Qsy2udQ_12_0"></a><a id="Tc_KDImYi6KLEOM9yWXAKKgig_12_4"></a><a id="Tc_F-l1nO1X-EScizMJkdqKmg_12_6"></a><a id="Tc_Od5CRFp4EEO4tf_yVUg9WA_13_0"></a><a id="Tc_e3rxFvalV0ytJ6O_Lan8Pw_14_0"></a><a id="Tc_mWWxrf2Pf0qjTROzIrVV5w_15_0"></a><a id="Tc_NMMPHHcuBE20rnrX7xQcyw_16_0"></a><a id="Tc_rqIBJ9u7jEGiRF_XI3cJGQ_16_2"></a><a id="Tc_Hc1z538-fEyeQi9rRN30CQ_17_0"></a><a id="Tc_XbRDfzCtDkGapYZUyf3M1Q_18_0"></a><a id="Tc_zVtnyJKeCkGiTjYCg1JjiQ_18_2"></a><a id="Tc_ZCGHoTDhr0q6OK1j0V6uYQ_19_0"></a><a id="Tc_YLRKhYk_l0ClfYPr-qNcdg_20_0"></a><a id="Tc_3-EU1NPhC0aO2kHeWSAetQ_21_0"></a><a id="Tc_39F-65dGTE-BurB1kXLGlg_22_0"></a><a id="Tc_CNceornS1kyu2JE81qD_Zw_23_0"></a><a id="Tc_cpCm0D8QJk2yCV7piAISWQ_24_0"></a><a id="Tc_Msi9PX4TKE6VqTaqdARRpA_24_2"></a><a id="Tc_puhs1s-EAEuc1cy8z9kMJg_26_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_kI7R-Fys3kyRQuwf934IYg_3_4">189,923</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_YI365N1eTkS8_g_gFWG89A_3_6">128,381</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_nn9Y21dDikOXQyqlqvRbLg_3_8">48,780</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfSales" scale="3" id="Tc_DT_cbMy180ub_5gJt3x9iQ_4_4">161,765</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfSales" scale="3" id="Tc_vt1s6xlTAEC7X5FYynorUg_4_6">83,437</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfSales" scale="3" id="Tc_EEiG9Tlvv0ugO3ucPNN7TQ_4_8">26,005</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Gross profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossProfit" scale="3" id="Tc_3MDWeJTekkGKXFCtAnOQGQ_5_4">28,158</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossProfit" scale="3" id="Tc_bQFqeGUrW0-CnffYIhcEfw_5_6">44,944</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossProfit" scale="3" id="Tc_oGV-eRaZqkyZNM0hcQKZ-w_5_8">22,775</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_KSCYpOCv70i7L9LB-FHXAQ_6_4">19,297</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_0YcHF5SVJEeyaIeJ_bBVoA_6_6">14,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_OqU5a6DFr0CWsPgsIVv3Mg_6_8">9,590</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_a2KwvwoXvkuB3qT3gpw8Hg_7_4">46,739</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_7KKEvfFt8kyhKkhxPukGSQ_7_6">40,160</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_Kuer2Gz69U2RBq8N6sWL9A_7_8">23,160</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SellingExpense" scale="3" id="Tc_Rh_jyRY0dkm4GaEvTBGKuw_8_4">9,860</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SellingExpense" scale="3" id="Tc_35_tnJMJ7k6Jm86UhN0E9A_8_6">8,026</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SellingExpense" scale="3" id="Tc_Sdhqk-lsaEGr8xRgurVa3g_8_8">9,254</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Impairment of financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">21.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ImpairmentLossOnFinancialAssets" scale="3" id="Tc_J3f3lNBYyE-pvjgnIfNd9w_9_4">1,140</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ImpairmentLossOnFinancialAssets" scale="3" id="Tc_X40L-do4v0yCAeJVo0xpaA_9_6">3,738</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ImpairmentLossOnFinancialAssets" scale="3" id="Tc_u1CqWK4Xt06MmBVR_aUPnQ_9_8">752</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other operating income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">8.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherIncome" scale="3" id="Tc_kMHNK7h3mkWbwsNCKoo2Yg_10_4">2,936</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherIncome" scale="3" id="Tc_perZEneRaU2G-cCcwgC08g_10_6">2,394</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherIncome" scale="3" id="Tc_miiGLo1EjES19tyMyDQujQ_10_8">3,781</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">8.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherExpenseByFunction" scale="3" id="Tc_wqpHVb1qnUKQA0wVL3-09g_11_4">86</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherExpenseByFunction" scale="3" id="Tc_1DqrdGXF2E2cAocwcnf8rA_11_6">182</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherExpenseByFunction" scale="3" id="Tc_5hNAzwAfqUCoBe--yTwf4A_11_8">1,284</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Real estate transfer tax expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:RealEstateTransferTaxExpenses" scale="3" id="Tc_wFHRqsapZ0Kfv1a9D-cK6Q_12_8">1,200</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_aenT9UG0XEu5eIFc2tQ8-Q_13_4">46,028</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_IIdr40QN4ki5OjvFTgJ3rw_13_6">19,703</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_X2k0Vfbq30qFS5mdE2VxXA_13_8">18,684</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest and similar income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeOnLoansAndReceivables" scale="3" id="Tc_ORueScTjoky87SVdYOFlxA_14_4">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeOnLoansAndReceivables" scale="3" id="Tc_fzGJdJK1gEGD-OAZ5gU6-A_14_6">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeOnLoansAndReceivables" scale="3" id="Tc_4zKnyZk8DU-tm6KUWdIc2A_14_8">16</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest and similar expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpense" scale="3" id="Tc_SLSgl53eW0qSVRQBFucH6g_15_4">851</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpense" scale="3" id="Tc_IMPVC9DK20G8miL-gycXGw_15_6">1,400</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpense" scale="3" id="Tc_x3T5F01BuE6BimST5GbVkg_15_8">2,029</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Financial costs, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">8.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_2qnfmZmJI061nfMqq4OhGw_16_4">848</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_qO-sUsvgqkCBZqEKlY_oIQ_16_6">1,394</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_rJYq3_NEyUadIeIpHLdWPg_16_8">2,013</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Loss before taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_FQeteoA8dEqwjI7yHVz2Ug_17_4">46,876</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_Zxjl3mpqdESI1-THUcOFWQ_17_6">21,097</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_zr1O7YfzSE6jKo6XZUHhew_17_8">20,697</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income taxes expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" sign="-" scale="3" id="Tc_7fQERJ4kXUiHYXovWzB69g_18_4">24</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc__tahpzJqgEiCTghHsYoKCQ_18_6">281</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_OQ1cg7tBTkqmDQf816JEng_18_8">158</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Loss for the year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_gI7gFhZ-JE-H7cRODi5ZUQ_19_4">46,852</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_26k_Z9JdQU61GdmfT963Zw_19_6">21,378</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_7qwxu_r-MEmJeLJL_6ACMQ_19_8">20,855</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other comprehensive income/(loss), all attributable to equity holders of the parent</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent" scale="3" id="Tc_B3v4FqPAUUK4GZtdWDLkbQ_20_4">543</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent" sign="-" scale="3" id="Tc_vusIrOxeL0aYgCUwjdQXnQ_20_6">48</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent" scale="3" id="Tc_40qgl2vZJUetN5kpoFGfGw_20_8">16</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_GlsrxuZS00SyfCh4k6bPCg_21_4">46,309</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_pjIwZHmZ5UKHYvfVvPZMUw_21_6">21,426</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_Cp5AflAxNky-U4J-g3zvMQ_21_8">20,839</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attributable to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity holders of the parent</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" sign="-" scale="3" id="Tc_ZXWiqgpvh0iOERfIu1YuDQ_23_4">46,407</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" sign="-" scale="3" id="Tc_57gqbvBNVUqXtREAlfekXw_23_6">21,486</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" sign="-" scale="3" id="Tc_dwaKrqFmrE-2pQQQ74RXog_23_8">20,658</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="3" id="Tc_iRQGIRitAUW_KYtXLMZqPg_24_4">98</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="3" id="Tc_urAcgFHmtE-_fuLAdijsgg_24_6">60</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" sign="-" scale="3" id="Tc_qSKM4Rs88E6Dn85XQHaR5A_24_8">181</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_v6dwPtGgKE2jn4itu7yTPg_25_4">46,309</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_4sSK8SjEPE2WZdkQZ5YQyw_25_6">21,426</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_LqEUjC3Feka1i_CcaePyNA_25_8">20,839</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:45.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Loss per share&#8212;Basic and diluted (in EUR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_hV4cTAvZfE2P4_g00iNZTw_26_4">2.06</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_m-pkLZTI0Umywozzp_czmw_26_6">1.02</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_cHA9pDI1YEWEYpyQt0IMYQ_26_8">1.27</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;">The accompanying notes form an integral part of these consolidated financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b3f1ecbf_5678_49ac_ab6b_d9e6a84c4adb"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Centogene N.V.</b></p><a id="financialposition_223464"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Consolidated statements of financial position as of December 31, 2021 and </b><b style="font-weight:bold;">2020</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(in EUR k)</b></p><a id="_c7c55478_6c52_4abc_82d9_f56dc04cefcc"></a><a id="Tc_70ZZfPacnU2Aw_C_FEX0CQ_1_0"></a><a id="Tc_Q4ztHQTRS0maSeZF0vc6WA_1_2"></a><a id="Tc_H0DLhWRU2E2G5p5lr_WYnA_1_4"></a><a id="Tc_aVK5JRsB9k--wVZw-Rk8VA_1_6"></a><a id="Tc_4K4UoqkCC0OvYdHoMIwqCg_2_0"></a><a id="Tc_DvFpGrIF_UiI64UAdo0Vaw_3_0"></a><a id="Tc_Ls87vJz2L0-1L2riPhWTeQ_3_2"></a><a id="Tc_fP7Ocj07VEqZRSHwjI5_8w_4_0"></a><a id="Tc_YAJ8mt6LpECzC_UhTxrExw_4_2"></a><a id="Tc_qiNUHUwcBkqvKLoiY3KM9g_5_0"></a><a id="Tc_hfNLYhaMMUCpXTj2KYO9VA_5_2"></a><a id="Tc_kytL9mY1FUi2LVGRSe5ycQ_6_0"></a><a id="Tc_7zLYORpdzECPln-6gkSZRw_6_2"></a><a id="Tc_H3qpkjhfJESfuUf4b-HHGA_8_0"></a><a id="Tc_34weAq5uMki534BvF1YGDQ_9_0"></a><a id="Tc_Or3h2uZMhE6n5vE6AiR2zQ_9_2"></a><a id="Tc_UuidbjhsEEW9ZZSI1vQRLg_10_0"></a><a id="Tc_iDAit2zKREeNddHpvF_Pnw_10_2"></a><a id="Tc_i1Kw8KH5hEK0lyDn7DGiEQ_11_0"></a><a id="Tc_P662jPvxqkWTwFTYY4jwPw_11_2"></a><a id="Tc_jknNn1fdw0mYmIGih1lb6w_12_0"></a><a id="Tc_u-IbBQSzdkOTjgdLWI8SoQ_12_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_qQlqMrk2m0avJKpUdohsmA_3_4">9,194</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_L93nupeLOkGrkoQfDvwYmw_3_6">12,407</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_XYFJJKBB-UKrwzPhPYQ8cQ_4_4">8,147</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_HGP7-RqT1EudGsSA8leePg_4_6">16,590</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_fK6oAlSvPUeEHG_SGzCS5g_5_4">18,904</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_wn76efGBNE20QuP259AIkQ_5_6">22,120</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" id="Tc_vzmAsbSJUEaiMkDfbgJP3w_6_4">2,972</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" id="Tc_uqjB8dTOXk-wF5oJRlX3Uw_6_6">1,967</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentAssets" scale="3" id="Tc_-i9Y2TCr10Ki7mgvTvxAlg_7_4">39,217</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentAssets" scale="3" id="Tc_8KGNZnJyokOtDynh4gGdIg_7_6">53,084</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Inventories" scale="3" id="Tc_UqIGY5BzAEupfuwATnobLA_9_4">3,869</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Inventories" scale="3" id="Tc_j7OKmu71w0ae1hM41fUHOQ_9_6">11,405</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Trade receivables and contract assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentTradeReceivablesAndContractAssets" scale="3" id="Tc_Orx-m9BdQ0ed13bWarcXOw_10_4">24,337</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentTradeReceivablesAndContractAssets" scale="3" id="Tc_mABCGFJne0CKOncqzXipCA_10_6">29,199</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentAssets" scale="3" id="Tc_RdCQY1buX02PAyI3g4uMhw_11_4">5,453</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentAssets" scale="3" id="Tc_TGHqXp-hsUir_Vj944TpCg_11_6">8,286</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_OIrioP3Yzka0nj6SzFS4qQ_12_4">17,818</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_BW0XsByQMkGqsX50ZdI3TQ_12_6">48,156</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAssets" scale="3" id="Tc_u33Qk53fC0utwL5l4swl4A_13_4">51,477</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAssets" scale="3" id="Tc_d45oRkPFq0my7RRh9rjwXw_13_6">97,046</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:59.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Assets" scale="3" id="Tc_gODxXvzfLUaUOL5a8X_o1Q_14_4">90,694</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Assets" scale="3" id="Tc_OaaTJ0jGDUifKA0ShEFUlA_14_6">150,130</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_f6d43932_ce95_42f6_9fec_19beaff0ff7a"></a><a id="Tc_KFV-GQEjb0-BfCZ83Phafw_1_0"></a><a id="Tc_2YsxKTVNEkOcLSdBWyddPg_1_2"></a><a id="Tc_IcDpnLZNgkadpByOseXoXw_1_4"></a><a id="Tc_D7Jfyq9TRUWzxInmwbSQiQ_1_6"></a><a id="Tc_L3zNwk0g10i3PnZ64j_yGQ_2_0"></a><a id="Tc_RT3U2yvhGE2Wi31t3w4CMQ_3_0"></a><a id="Tc_pzbIkq2aHUWY9ehNGuBukg_3_2"></a><a id="Tc_IlT1r4iSLE-5Obh0PmoPLg_4_0"></a><a id="Tc_soH1nidpyUi6oAx8up4wJg_4_2"></a><a id="Tc_NQoRXmKTYEq-BglAdS8uZg_5_0"></a><a id="Tc_5XNGwD3Ye029eo08TXp7Lw_6_0"></a><a id="Tc_4YlYknbbnk2hJEpksCfCog_8_0"></a><a id="Tc_MzFji4kSWUyfIKhrlv7z7g_9_0"></a><a id="Tc_svOpWGo9sEmz8AUbRf7VFA_9_2"></a><a id="Tc_csE3rV8NlkufTv_sXLHEVg_9_4"></a><a id="Tc_TzlgZTLAkke24rjgPm6hlA_10_0"></a><a id="Tc_VimNE2qY4Uiugtz8DCMI3g_10_2"></a><a id="Tc_uYUmu2zLeEqgWIR1y1DDwA_11_0"></a><a id="Tc_wEf22_NmTEC-JJgzWk97Lg_12_0"></a><a id="Tc_lw-km_DVbUyWTmrgcDcHPA_12_2"></a><a id="Tc_hiIBoISuoUyfd5Ku8Zb2zw_14_0"></a><a id="Tc_XrJzotk4okSwXHmZ1eEpRA_15_0"></a><a id="Tc_rU43l5aLh0eMqeY0_UaScA_15_2"></a><a id="Tc_TzDxh-A-X0OLPEoTGJVfyw_16_0"></a><a id="Tc_d9NMVGw4YE2yVFDdxR7o5Q_16_2"></a><a id="Tc_PzMoWNjQmkGUqJuWnyfJ9g_17_0"></a><a id="Tc_YRSx930g_06vclALAJmsGA_17_2"></a><a id="Tc_0AtiKYB2oEykCSifftluMg_18_0"></a><a id="Tc_UzDyZxx6x0SUS6yFP4YzMw_18_2"></a><a id="Tc_xU99XD3wW0m8hNpZ4HH-lg_19_0"></a><a id="Tc_MaJNZVrVYU24LAZE28x6EA_19_2"></a><a id="Tc_Eot2FrHM8EynkyJIj3S4ZQ_20_0"></a><a id="Tc_L1LQD0qR_UmDJ9Yi2epYcg_20_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Issued capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="3" id="Tc_0hAwHS0X20aqH5KTdrESQw_3_4">2,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="3" id="Tc_R4Ma11M7xECjFn-e2kg-cA_3_6">2,654</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Capital reserve</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CapitalReserve" scale="3" id="Tc_1CduIpKMwECAwSre01bk_Q_4_4">133,897</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CapitalReserve" scale="3" id="Tc_EBCpuHzvuE-bDPke5IbMgg_4_6">125,916</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Retained earnings and other reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RetainedEarnings" sign="-" scale="3" id="Tc_71R4pc1mHkiCH3Hcn8L_0g_5_4">109,295</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RetainedEarnings" sign="-" scale="3" id="Tc_S1yJIckRkkeV51DV4eRdkg_5_6">62,888</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncontrollingInterests" scale="3" id="Tc_SE56LSGob0ioaUwPubRw8A_6_4">193</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncontrollingInterests" scale="3" id="Tc_one_l6aWgkmCTCnf2PtO3w_6_6">95</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_ehiC7KPiCkGs3A0768Ackg_7_4">27,503</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_yxL23TUPy0CZfMwARNqwJA_7_6">65,777</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Non&#8209;current loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LongtermBorrowings" scale="3" id="Tc_bm567TG3x0O9ApF2hAj-JQ_9_6">401</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_LFA_KgoREkGnyGIwjiyKZQ_10_4">15,588</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_Vb5LT12150e7_Q9KBx-28Q_10_6">17,677</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="Tc_v_dpTO7zxUi1QylrQ9D9aw_11_4">79</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="Tc_w6MFp8udaEWhK9KPVZ8eIA_11_6">207</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Government grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentGovernmentGrants" scale="3" id="Tc_y80Xj1ixp0Cbtfb6jsAP9g_12_4">8,028</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentGovernmentGrants" scale="3" id="Tc_ZmNmMAEO7kOABVmf7SPx_A_12_6">8,950</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLiabilities" scale="3" id="Tc_igY_cwLLdk2Wr62auzazFw_13_4">23,695</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLiabilities" scale="3" id="Tc_T4bd-eSLmUebNHYr9dO3Qw_13_6">27,235</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Government grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentGovernmentGrants" scale="3" id="Tc__ixty6V9jEmuhKX-pcccrw_15_4">1,368</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentGovernmentGrants" scale="3" id="Tc_y0pXOW7S40iMoH7p-fhoXA_15_6">1,342</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Current loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" scale="3" id="Tc_J0A4UwAHRES101zuSjPAjg_16_4">3,815</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" scale="3" id="Tc_M_0MaxJPEkObmEVlCBB0hA_16_6">2,492</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_HmlVBKD0jEa75nyw0_lLdA_17_4">3,409</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_eZx8OcRGFEW5aKYheqctpg_17_6">3,528</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Liabilities from income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxLiabilitiesCurrent" scale="3" id="Tc_NgzNMJAv50Kbx86cJ2NIBQ_18_4">178</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxLiabilitiesCurrent" scale="3" id="Tc_xoy0InF8mUCVFKbJhN7FOA_18_6">58</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="3" id="Tc_ZhSxtenLn0aI0hUnc7Si5w_19_4">11,252</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="3" id="Tc_g0EO_tbLGESeSfXUmh6Ygg_19_6">31,736</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.2, 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentLiabilities" scale="3" id="Tc_AsEg6NY86UyIUpCB9CkXpg_20_4">19,474</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentLiabilities" scale="3" id="Tc_dsmw2mqPIE6PeW1PbfwyqQ_20_6">17,962</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLiabilities" scale="3" id="Tc_XrL2PMIrRkWNCM3vGjxFgQ_21_4">39,496</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLiabilities" scale="3" id="Tc_rbcVftUbmUKSHbxBF41EyQ_21_6">57,118</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:60.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EquityAndLiabilities" scale="3" id="Tc_XjLmmhIObkKkrRZSMhLVVQ_22_4">90,694</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EquityAndLiabilities" scale="3" id="Tc_qTligW4WvE-7C-o95b4SBg_22_6">150,130</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;">The accompanying notes form an integral part of these consolidated financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_0a1582bc_ba04_41df_aea3_b373af83175f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Centogene N.V.</b></p><a id="cashflows_997770"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Consolidated statements of cash flows for the&#160;years ended December&#160;</b><b style="font-weight:bold;white-space:pre-wrap;">31,  2021, 2020 and </b><b style="font-weight:bold;">2019</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(in EUR k)</b></p><a id="_e71b105a_7374_4d0e_a900_8fa4bfe08895"></a><a id="Tc_TpwqNxv_W0-i3fHxVNbvNw_1_2"></a><a id="Tc_OS97hw4UAES2S4_V8UBIxA_1_4"></a><a id="Tc_l1yj621XwE6JQxG-L29O1A_1_6"></a><a id="Tc_-iInOtuZbkyLheecWBQv1g_1_8"></a><a id="Tc_ivlY0sM3N0CHwg4X6UNhfw_2_0"></a><a id="Tc_9DCxZjQq4EKo3Zf20INFqg_4_0"></a><a id="Tc_6dItyHXbak69cuxlrJV88Q_5_0"></a><a id="Tc_bvwSrNBr8kWPSiDIpYVMbA_7_0"></a><a id="Tc_EohsaD3Kh0OaxcMOEDqh9A_7_2"></a><a id="Tc_YiQ1HiBgrkSt4UBGO9hkFw_8_0"></a><a id="Tc_9VCleDsomEKwwIkbGHchGQ_8_6"></a><a id="Tc_rGPEWvUD0UaDAhreSSPX7Q_8_8"></a><a id="Tc_77WpaYvBNkS-2Pwj2F093g_9_0"></a><a id="Tc_nKo5fEO3WkOQ3FESxP5BcQ_9_2"></a><a id="Tc_QSTRaLVqQkGBs2VK6X92qQ_10_0"></a><a id="Tc_claEJT4QnUi9vkgze7HpJw_10_2"></a><a id="Tc_MYAPHDgD2keEv7-NV8Qoxw_11_0"></a><a id="Tc_RpvX9p3T5kWjE5pGP1JR8g_11_6"></a><a id="Tc_lp_jXRFBA0SiUuBkk23Qaw_12_0"></a><a id="Tc_Ryvlyg2cPkGuQ1zwDG82SA_13_0"></a><a id="Tc_pCjOGA0h7UyLf0mmd9kmXw_13_2"></a><a id="Tc_zuuS_x1Sr0ub828NWokTLw_14_0"></a><a id="Tc_5wJg54JLtUuXoeTExLnhQA_14_4"></a><a id="Tc_P9NkM0X9g0GIOEqWv7m6gQ_14_6"></a><a id="Tc_LQaKaTmz5U6Q2LhbjTm06w_15_0"></a><a id="Tc_zvlPyBDb_0WWh9tI0KMB1g_17_0"></a><a id="Tc_KWje9LrOyEyL_4Iu6qvFPA_18_0"></a><a id="Tc_Idcw8VgE_Eq_3wUFFU-jjw_18_2"></a><a id="Tc_bSfOW-GPwEuYBEHEY2Lnxg_19_0"></a><a id="Tc_htdlKJCHZ0qw2LK2xgpKUQ_19_2"></a><a id="Tc_T0nRlLYJ30qY8_CLyP1Mbw_20_0"></a><a id="Tc_Xf7HKlj1YEC5WMfXWHf9gw_20_2"></a><a id="Tc_Zgobl8Fv1UOW50E_LIKONA_21_0"></a><a id="Tc_5inXRodinkqnBMJo-sC-TA_21_2"></a><a id="Tc_UJYnMvDVyEKEQyYGIvSQSw_22_0"></a><a id="Tc_Ns7ek4X5tUeNh7QV0zxelg_24_0"></a><a id="Tc_e06mqu6jTUysDrGENI2fDA_26_0"></a><a id="Tc_pC3eQmgb5Eu7YXgI5Yf-ag_28_0"></a><a id="Tc_dYnS76MbO0OvbwrPtBxtdA_28_2"></a><a id="Tc_ql43tvhE0E-p2o-_6RIufg_29_0"></a><a id="Tc_qg9FfWSgL021ojy5_6ywMA_29_2"></a><a id="Tc_LlBdXLClE0ejLh6FCuubnA_30_0"></a><a id="Tc_yx0MyVoYR0ytdMDwtk3PHg_30_2"></a><a id="Tc_HpNuoB839EmuHlvX4zxljg_31_0"></a><a id="Tc_lRpcjkdn4Ei6L7UPdwMKfg_31_2"></a><a id="Tc_z1XZzTXBUEaIreDefBPDEg_31_4"></a><a id="Tc_qzRpIvY3LU6dwGDSoZPdVQ_31_6"></a><a id="Tc_FbkogrCKPE69PYFwWaQJVg_32_0"></a><a id="Tc_Yg3LEr1nm0WgztR60ptfgQ_32_6"></a><a id="Tc_0Fb966c-tUa11leQ-o3dMw_33_0"></a><a id="Tc_aqJH2o6f6UuLh24hF9Sv5A_35_0"></a><a id="Tc_utQu59RL6E-d6no5uZUIVw_37_0"></a><a id="Tc_9rsYPOa5OESPEynw8h0AEQ_38_0"></a><a id="Tc_8GrmOng8zEutyCIBMG4y3w_38_2"></a><a id="Tc_vQ5Fq45dz06t_xnLPwrFOw_38_4"></a><a id="Tc_A9qhUgBknkmSSyTBvFHWmA_39_0"></a><a id="Tc_EfMVlt3vxEqz-2ize9Gx5g_39_4"></a><a id="Tc_5IgjA4qKw0CGu0BWLsHxkw_39_8"></a><a id="Tc_vFbCvJNeG0WMcgvVfNeRUg_40_0"></a><a id="Tc_2kcYEvvcnkK6565nS_I3lg_40_2"></a><a id="Tc_eEpM_ElqBE--h0e-iFJfJA_41_0"></a><a id="Tc_0fH8rl02tk2XilRxFM1vww_41_2"></a><a id="Tc_KwhN5NhToEyZJ2rOD-tW4g_42_0"></a><a id="Tc_Q-UTNkdYNEC_Tsu0iU-mgQ_42_2"></a><a id="Tc_4T1oGPPM50W9jqHNJn0JKg_43_0"></a><a id="Tc_D7-N5DGgOkiJ7C4ONHC6pg_43_2"></a><a id="Tc_q-CS_YPVekWlpbNEFjEA-Q_45_0"></a><a id="Tc_xGu25Ekg9062RpfoLaG0vw_48_0"></a><a id="Tc_zWRiKZ78wUO8KhYvK4q0ew_49_0"></a><a id="Tc_DMjcqPmXq0masN3Ids7UrA_50_0"></a><a id="Tc_5ZPASHmg_UW9Ow9zeOpNGg_50_8"></a><a id="Tc_GhREUKrBJUCwZrif-uZnwQ_51_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Loss before taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_AmM04Z9N9EmqZdY59htsKg_4_4">46,876</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_WeiIk8IoH0iIMr9ArpKVgQ_4_6">21,097</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_tArb5TLgIk2ZXn0jGefvxw_4_8">20,697</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Adjustments to reconcile earnings to cash flow from operating activities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Amortization (including impairments) and depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11,12,13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="3" id="Tc_tDL3P_vgcUubIDjj5thA5g_7_4">21,291</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="3" id="Tc_0c-wOJ9KJkO14oNNVHdYng_7_6">15,128</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="3" id="Tc_y21Uuc5V40GlQbR48lNM4w_7_8">6,579</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Inventory write-off</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InventoryWritedown2011" scale="3" id="Tc_gzxTFOW34EuXk2sUxg5pCg_8_4">1,795</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Interest income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestIncome" scale="3" id="Tc_BxEmvduIrk20g-yBqfnbqw_9_4">3</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestIncome" scale="3" id="Tc_d8hgBc0xAkOXAiRJ5DzSVg_9_6">6</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestIncome" scale="3" id="Tc_R-ILQnRsi0CAFLRzp2yV0A_9_8">16</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_QVwH7-9E-U-0vh51U8LHNw_10_4">851</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_xqPdfjVj-UWtanytmBJlNw_10_6">1,400</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_xVV77f9PgUeG0wEuMlkcEw_10_8">2,029</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Gain on the disposal of non&#8209;current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" sign="-" scale="3" id="Tc_teewl5P2XUi8K_Jye6AA3g_11_4">18</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" sign="-" scale="3" id="Tc_fm8P23AQtEOpIlU8ImGYqA_11_8">532</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Expected credit loss allowances on trade receivables and contract assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_TCyxBwcHi0illb6D8DI7QQ_12_4">1,140</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_G-RF-zOhLk-ujEzr53cGWg_12_6">3,738</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_hKnN1qthd0aUdDNol4_MLQ_12_8">752</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Share&#8209;based payment expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_5iGZGuWlSUy6wY63uSL71Q_13_4">8,035</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_x9ZfrPYqKEmEfgQYUxkdOg_13_6">5,658</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_4ZZ7rl9aUkK0hN5LXZO72w_13_8">6,418</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Real estate transfer tax expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:RealEstateTransferTaxExpenses" scale="3" id="Tc_SKWiRdOdsE-Jz6xDXmbpnQ_14_8">1,200</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Other non&#8209;cash items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherAdjustmentsForNoncashItems" sign="-" scale="3" id="Tc_nKwM3Ao0xkqIC9VbS458Qw_15_4">862</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherAdjustmentsForNoncashItems" sign="-" scale="3" id="Tc_Q3WlGvHRO0--Irt6GtWLCA_15_6">915</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherAdjustmentsForNoncashItems" sign="-" scale="3" id="Tc_Ovz9ALeV5UWTMf6HPNZl_w_15_8">1,856</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><span style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Changes in operating assets and liabilities:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" id="Tc_a9LkA9SUxEK3tg2IvytdWw_18_4">5,741</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" sign="-" scale="3" id="Tc_lcgZderpdk6exdSmjpW91A_18_6">9,596</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" sign="-" scale="3" id="Tc_BfzWFO3a-kqOVC3lXAhRtw_18_8">463</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Trade receivables and contract assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" scale="3" id="Tc_kXqUdUPE40iHOt07gMJaoQ_19_4">4,191</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" sign="-" scale="3" id="Tc_TSHpnH4LL0msaZ1ssiRLJQ_19_6">16,344</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" sign="-" scale="3" id="Tc_jjUWAeelbUem8osUGXcGOQ_19_8">6,444</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" id="Tc_kZRpCmfaDEe0Y0VY30QreA_20_4">1,828</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" id="Tc_8wC4Z6yJBk-faTUCj1mBug_20_6">255</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" sign="-" scale="3" id="Tc_amPmvH_iTkySyfOm1MwQtw_20_8">1,169</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" sign="-" scale="3" id="Tc_2dsTzlpsDESDIoFEwthpTw_21_4">20,484</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="3" id="Tc_11GF007iNEeGvgnu5iHfcQ_21_6">23,996</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="3" id="Tc_6iQE1Cb5JUWKey6sAhgf7Q_21_8">3,125</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;">Other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" scale="3" id="Tc_ZozCo3KYUUyYGO3xLCwdwg_22_4">1,632</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" scale="3" id="Tc_ns3xXOeaFkGLqMsRjqae3Q_22_6">6,245</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" scale="3" id="Tc_AbRygJkuEkqzr3FQO_5KxQ_22_8">3,299</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><span style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flow (used in)/from operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc_UL-An_ecmEiUcA_mHeVUww_24_4">21,739</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" id="Tc_jnGjNFY-rEKrwoinaUj9Sg_24_6">8,462</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc_fGTPCUFDuEm1mbRIS9WwMw_24_8">7,775</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for investments in intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_tIiGChd040W-uQQdqsAjQg_28_4">2,787</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_xb4my2dC1EiwkAjg3SYgIQ_28_6">6,657</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_jQUDmnJ8ZEikKuRgdaACjQ_28_8">7,280</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for investments in property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_L_0isg-KF0yF4ZabAu6ivA_29_4">2,915</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_F_RrfXdo0EWQ5WLXbNpPZA_29_6">9,890</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_QBEuqKYVNkel-xcvnPdCSA_29_8">296</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Grants received for investment in property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_Q_qrP-GNo0KjIV46eD--6Q_30_4">168</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc__xxVy8PTYUOTiv3-pBmcIQ_30_6">390</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_5QRvAGQqcUiDP587y-s0Bw_30_8">793</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Grants refunded related to disposed property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" scale="3" id="Tc_Iliug9X2CE6CjRMFilC3_g_31_8">358</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash received from disposals of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_RCvGffQbkEuGAuxeFpRYMA_32_4">171</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_O3bpmlMlR02PDol5GYZDWQ_32_8">21,300</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Interest received</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="3" id="Tc_IQ57IgaG_U2fdvpK_kK-iQ_33_4">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="3" id="Tc_MtQs5o4G0Eeqv1_WwQuY8w_33_6">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="3" id="Tc_8VrO4Jgz30Gku0Waz2geAQ_33_8">16</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flow (used in)/from investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" sign="-" scale="3" id="Tc_fdHqBT-8rUW7eqZ_wDoDuw_35_4">5,360</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" sign="-" scale="3" id="Tc_icdHsvWsLEiTYeomUXiyNA_35_6">16,151</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" id="Tc_mwA1RGW_XU-_7Z9NjH345g_35_8">14,175</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash received from the issuance of shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssuingShares" scale="3" id="Tc_deagoZIUTkWNi3t0uWNC4g_38_6">22,430</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssuingShares" scale="3" id="Tc_rfyN1UscfkqI6H-kq-xLPg_38_8">41,899</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for acquisition of non-wholly owned subsidiary</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries" scale="3" id="Tc_VosXx0b5AUumy5zeMar4MA_39_6">75</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash received from loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19, 21.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="3" id="Tc_cteKEk9kyUu_lDBsyav96g_40_4">1,772</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="3" id="Tc_tj0k2kHsFUy1SQtcOYlr0A_40_6">438</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="3" id="Tc_wILHR51hVEKSk7ulyf03CA_40_8">721</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash repayments of loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19, 21.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="3" id="Tc_PpTkiBEj3k-W9sQ8z9__gQ_41_4">464</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="3" id="Tc_XO3A9KwVREKE5egiwy_K6g_41_6">2,760</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="3" id="Tc_Zg26ONDeZEqZJBqZc_zyhQ_41_8">12,072</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash repayments of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19, 21.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_yN-Xi76UxkGDLPq1W4R4Fw_42_4">4,244</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_Qecqi95kg0WcloE0Np5WFA_42_6">5,018</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_Wto0HBXwAE-s9EbhWib54w_42_8">3,046</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Interest paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" id="Tc_HGuM5GwzNUS-uAR9TJZZsQ_43_4">267</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" id="Tc_NBzlHoVim0enN7ZmI65LRg_43_6">173</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" id="Tc_ZB5dqS3KK0-oXEk3UngAfw_43_8">2,029</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flow from financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" sign="-" scale="3" id="Tc_c3fKc-QfnE6wXtQjnJlxBA_45_4">3,203</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" id="Tc_xvodQIiOZE2G-JK2XSXKHg_45_6">14,842</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" id="Tc_etF7p-o_IkS5cZUU-HJ1yw_45_8">25,473</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Changes in cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" sign="-" scale="3" id="Tc_huv9AR4F6kGtR4NtQuyFUA_48_4">30,302</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" id="Tc_Zg5txhFiFk2J5sneE2I0UA_48_6">7,153</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" id="Tc_9OzQLW23LEW491JUqjLHxQ_48_8">31,873</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents at the beginning of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_yXMR5Xw5hEiiWJnjtSpLfg_49_4">48,156</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_r9ab0mhF90uaunUA1fz_QA_49_6">41,095</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_mmip9BVluE-UTcolIDlfkA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_mQ6qLLZADUGTfM0Pmtkxgw_49_8">9,222</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Effect of movements in exchange rates on cash held</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" sign="-" scale="3" id="Tc_Wr96Wu-ZCEqgDtugHcI1kw_50_4">36</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" sign="-" scale="3" id="Tc_h6TIU3JwEU6cDiNsfeFW3A_50_6">92</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:62.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents at the end of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_iY4oG08dgUmOC8l9ukM__A_51_4">17,818</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_Y_sxXJeINUqG_92wsCnjAQ_51_6">48,156</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_WUK_RXTg60mQ7YNd3vQtBQ_51_8">41,095</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;">The accompanying notes form an integral part of these consolidated financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_72cf3435_49d7_4796_938c_f9fa6b763840"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Centogene N.V.</b></p><a id="changesinequity_17793"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Consolidated statements of changes in equity for the&#160;years ended December&#160;31, 2021, 2020 and </b><b style="font-weight:bold;">2019</b></p><a id="_8bb7b7e1_883b_4131_8bc6_aa6646f6bf5a"></a><a id="Tc_yy3uC4dcq0KBjrZVcGrWSg_1_4"></a><a id="Tc_BXG5WQwQ_UOXL0bfAL9GqQ_2_8"></a><a id="Tc_k-uKb29g00arJwGiwpuY1A_2_14"></a><a id="Tc__qmHZfyDH0eqv8lHvzcgOw_3_4"></a><a id="Tc_WReDNuHkOEaHtqnRd3AJaw_3_6"></a><a id="Tc_7kYKeBkU2UKdxTW7axcCRQ_3_8"></a><a id="Tc_iKoTM1Y5xUC9NVlcHnd4nQ_3_10"></a><a id="Tc_I6sS6jGz50Wh0x-tmDDfaw_3_14"></a><a id="Tc_a_cvX9VWCUucyyslEl_g9A_3_16"></a><a id="Tc_2cQ2JaP-u0OWmNeQFV13ow_4_0"></a><a id="Tc_RGXxI8AjYk6PFDjx1WwEzQ_4_2"></a><a id="Tc_-VnlUWvMPEOc-cGAM1p1gg_4_4"></a><a id="Tc_i2A0raj85Uu9vNNrVMdfvA_4_6"></a><a id="Tc_3j9DO0WYtECVvfPSm1NuaA_4_8"></a><a id="Tc_2_5vski3bEKtPCjhRAoMvA_4_10"></a><a id="Tc_fKf9169-U02QL586_4UWrg_4_12"></a><a id="Tc_tdnonVKcykueksO5qRQ2ig_4_14"></a><a id="Tc_LiwYs9vLokK1wnXOx01BAw_4_16"></a><a id="Tc_JJPRxjM3YU23zT0NdevB1Q_6_0"></a><a id="Tc_-5b4I-YooEa533ghKgk2tw_6_2"></a><a id="Tc_IRnLKy1y1EGyKTLm6sgoYw_7_0"></a><a id="Tc_EyakaZ7ulEe2pS3B7YFkdA_7_4"></a><a id="Tc_QdzSVtofe0Krn1B7lBXxuw_7_6"></a><a id="Tc_bZRfw5TmeU6A5nbksrOnqg_7_8"></a><a id="Tc_F1jpFWV8akO76y7JOe-fBg_8_0"></a><a id="Tc_r8Vy1luCx06Sq1r_0nIjMQ_8_4"></a><a id="Tc_ORaE9PQIwkiHrh6vkkRZZw_8_6"></a><a id="Tc_s85yBsKXm06YwnAmYIij3A_8_10"></a><a id="Tc_uDAgF3iAv0KLaJKjD6irWg_8_14"></a><a id="Tc_s9VfFJDwsk2PAjoipb6qeA_9_0"></a><a id="Tc_abBih7PZ5Ee_jHyGhkEAEg_9_4"></a><a id="Tc_Sob-nCDowkq2Rta6DXs5sw_9_6"></a><a id="Tc_3WLTjd0g6UiRVuNdIRSvrw_10_0"></a><a id="Tc_bOZaKIVa00uqf2ZCZCLO4g_10_2"></a><a id="Tc_5-ZANP3TTEeJTQ511oYGCg_10_8"></a><a id="Tc_GVZ6zII1j0ioPi4GIuzFOQ_10_10"></a><a id="Tc_z4uTws0xREagjRXjbSikVA_10_14"></a><a id="Tc_h2FwWcny706reIwxrPd86A_11_0"></a><a id="Tc_o1b-busJgESc8ca5liE6eA_11_2"></a><a id="Tc_WUuuNfopgU-aOoDvIOwlQQ_11_4"></a><a id="Tc_435XrUnlw0G6YREcdUI0GA_11_8"></a><a id="Tc_4vw9bpbYok65g1rtEdtVdw_11_10"></a><a id="Tc_LONVfGBF1kmJAEUVHtfTRA_11_14"></a><a id="Tc_84CIow_fO0KfsnFgxEXLlg_12_0"></a><a id="Tc_CA3tzKuMc0qf9NE7bgBlFQ_12_2"></a><a id="Tc_mSbHBGIY7EqSf4AE7a_6dA_12_4"></a><a id="Tc_nLxaaEJz0U2S7tnO2spmeQ_12_8"></a><a id="Tc_7i1GRb22tUemXal69Y-ujA_12_10"></a><a id="Tc_sOO2HP-3tEeOfQX-i6ey7g_12_14"></a><a id="Tc_bfC64brxZUmrrEBwF1XjGQ_13_0"></a><a id="Tc_6UItyU7knkuE0bXc0ceLiA_13_2"></a><a id="Tc_C1jVdpMd5U6GNfhjlkL7Qw_13_4"></a><a id="Tc_aR6en5fAq0SjJoiQ7u1nVQ_13_8"></a><a id="Tc_X8qQOKGCnUaeOOf1QvSRZw_13_10"></a><a id="Tc_fgOx-sd4ZEiM8O3oimUxOw_13_14"></a><a id="Tc_KjYN8ciOp0qS5QbIyikKzg_14_0"></a><a id="Tc_qZgE2Ao7q0KpUJ_iHrVX6A_14_8"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:99.91%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:36.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Attributable&#160;to&#160;the&#160;owners&#160;of&#160;the&#160;parent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Issued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">controlling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reserve</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reserve</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of January&#160;1, 2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_zkuIRUT7fkmPld_mOMD4eA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_Hr8YkAMEH0ySnagat8ShBQ_6_4">1,903</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Dsbd-0Y1U0K6IobP1taD7g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_hco1yEQBkkGuwI2ugSmTUA_6_6">45,342</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_WefR96CjT0i-wI_gc8Tt-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_QCRoDoW_6kalBHTgnNtNrg_6_8">16</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_ASav9p4dxEO3JQhjgj2p-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_7hs5QCO0EkeHtDhom4N0Ew_6_10">19,948</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_1IhyUssZbUOMIOgGzDA_QQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_J-ruygEKAUiMTpAmv2tg4Q_6_12">27,281</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_ep_o1_bT5EeKC78nBN7dbg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_2itMsMFH5E2hsBCobhRtOQ_6_14">757</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2018_mmip9BVluE-UTcolIDlfkA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_-wwNWav2c0u0CZlMwol8gw_6_16">26,524</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Loss for the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_7QvO56SloEm_LGEAxTptVA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_MzXp-k6Ntk-Ekig8XcMtfg_7_10">20,674</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_KX1JGGhHBUykuasw7hRl5Q_7_12">20,674</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_PAP0ZlgjQEKQn4Hcd138ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_MwRuJNaj5Eefk2OfB0FZjw_7_14">181</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_395IWrjwEU6P_u0AbebH0g_7_16">20,855</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-tikKSwR3UCPoT5YzJiKAg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_GzSOELVogkiHpIG8QZiw8Q_8_8">16</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_YNSs5c9Mj0uHdBp_kawGuQ_8_12">16</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc__5HIVphVa02juRPaVlKFmQ_8_16">16</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-tikKSwR3UCPoT5YzJiKAg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_Q0LrdS81YEGfozHiYXa5pA_9_8">16</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_7QvO56SloEm_LGEAxTptVA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_2vNoL6pSakypNSBjvjQHDA_9_10">20,674</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_9m2EoLR-M0KKZeHfmls7Ww_9_12">20,658</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_PAP0ZlgjQEKQn4Hcd138ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_tzHj3wEj1k-PMKG9zppGCw_9_14">181</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_gpWnoj5OIUKg87A_qSs9Nw_9_16">20,839</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares at IPO</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BL1i3OTWXkiZ1SLLgFTjaw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_TTWSkv5hbUa475sO8Nm7eg_10_4">480</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_p19A4o4_AEqVGNl_bay8Ag_10_6">46,318</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_-7gVc9pPGEW7uYxZTggEzg_10_12">46,798</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_XANsmdfT60mUX-84MZZyqg_10_16">46,798</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_-GT1UbMF80O-m_AxJcm9sA_11_6">4,899</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_U-87UZcYQ0S94iIPbtmSbg_11_12">4,899</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_K7hfullMFk6zUr7HPWWHTQ_11_16">4,899</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_CBbD55PvYEymgLWs1D0SEw_12_6">1,300</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_PnhXlRKOiU2HEAQ-m46GkA_12_12">1,300</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_M10LBl_WhkK2yYC08UZf5Q_12_16">1,300</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Share-based payments -modification at IPO</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">20(ii)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" scale="3" id="Tc_-T-XLihpokSIVkSjKavteQ_13_6">10,038</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" scale="3" id="Tc_KjIu-XaQ5U2NTwG4IROwgg_13_12">10,038</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" scale="3" id="Tc_ylDPkmVO40m1gtj-T1JobQ_13_16">10,038</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31, 2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_D3EKD6FKfkq_ZzWKmtMzhQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_SKsRYnD_t0ChB2tRk4502Q_14_4">2,383</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_A_FsM08yS06J9681vM0x0g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_WKg1L0fu1U-LhvJ6sliL1w_14_6">98,099</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.85%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_s8pyC--PfU2a1cGfakOyRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_Dv1OsG1ia06HaNsF-gY44A_14_10">40,622</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_qttKShlhOUaMLtKd7DFFOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_t105cxVGmEm-nUuDWtUR2A_14_12">59,860</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_k6D4DSCZeEKWLGaxOgVzTg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_y25pPNFrhEafEVqaH6CYSg_14_14">938</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_5FwdPLHYYE-Vhh5w7uJFXw_14_16">58,922</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e1c62227_1386_41f4_946e_61139c43ab17"></a><a id="Tc_b_7__yaSUEa65wdqP42Bkw_1_4"></a><a id="Tc_JZtBfh5LK0uA0ZWU_9u6CQ_2_8"></a><a id="Tc_H6ogZGT5y0CBAqCElcnk1Q_2_14"></a><a id="Tc_bEncZOLYUES_UQ_nuJtiGw_3_4"></a><a id="Tc_Oo-LtyBIWE6CAyugfoGuiw_3_6"></a><a id="Tc_Tn41-qq0VUacMmf4RKKNcw_3_8"></a><a id="Tc_hc-jSuiO5k6dYDP_uu7pRw_3_10"></a><a id="Tc_txwwftQkD0-U0GW9XMCGzw_3_14"></a><a id="Tc_M-Q5ok4eukiXbZ5Q6YKgSg_3_16"></a><a id="Tc_XakyLCu-q02nHUILPCSmnA_4_0"></a><a id="Tc_469ohlkW4U2huhQE24UBRg_4_2"></a><a id="Tc_NKz4_Fqt-0qi8xFBK6yavQ_4_4"></a><a id="Tc_n-LsYkOosUWcZ8IIUp00SA_4_6"></a><a id="Tc_ltpd1BuJF0W0J3J8yptLjA_4_8"></a><a id="Tc_rtYY4udXq0C--PECQOUtrQ_4_10"></a><a id="Tc_8CVHIFyOy0mYIBh0Bl-hiA_4_12"></a><a id="Tc_LaUaqfJPxUSt31xtwQ7Fnw_4_14"></a><a id="Tc_iUoDVa9VokGHRU48mNjyQg_4_16"></a><a id="Tc_-TjeSiS59EavtrU9AcVoRw_6_0"></a><a id="Tc_6Zo9YkKnjUqBQbvnBbZlIg_6_2"></a><a id="Tc_DJdklt_r5EWzRHOWzaD1PA_6_8"></a><a id="Tc_er2eqxd2LEab5zX1RIwAkA_7_0"></a><a id="Tc_Bq5JzLkMjEWn4Yl4vizUAA_7_4"></a><a id="Tc_iScMQXGjk0qpKcaoKULYPg_7_6"></a><a id="Tc_eokteee2hUmPCJhLCx49rg_7_8"></a><a id="Tc_TH-OzWpKRUCmxoqMw7rxug_8_0"></a><a id="Tc_MiGBbe-8LkCV_prZg2EZ8w_8_4"></a><a id="Tc_ekMb9LSN70O-jXP6Albvnw_8_6"></a><a id="Tc_fGEzHwpyzU2ai8KaUxQAOg_8_10"></a><a id="Tc_X5_8mvZjFkircTHmaGLgiw_8_14"></a><a id="Tc__cbhcmuog0uLJYwqgEqCMw_9_0"></a><a id="Tc_IPidYTNgkEW96nzCRG74-g_9_4"></a><a id="Tc_VVStYWYJJECEqx-xH70kaA_9_6"></a><a id="Tc_Dj8dKA7BK0OSGY0lLMMfoQ_10_0"></a><a id="Tc_mnqb390TikmkgILu3r-tNw_10_2"></a><a id="Tc_4yt3zchEk0GY8SJ-57TgIw_10_8"></a><a id="Tc_J1llWx_PnkufDYRiyqDsNA_10_10"></a><a id="Tc_y9k9xaY3Y0SVE9qmvV5bqw_10_14"></a><a id="Tc_nYW-9SkN00O8icm3ERmmbA_11_0"></a><a id="Tc_MEBk9DAJBEmAWAyeyd-jsw_11_2"></a><a id="Tc_KuE0NWHTOECIiCnl9cPBPw_11_4"></a><a id="Tc_DUvCvRQ3zU-ETr1pZKY0kA_11_8"></a><a id="Tc_78YKPLiMGEeRSJAUnzAv0g_11_10"></a><a id="Tc_z4Cm9muePEiBAyUc_c_iYQ_11_14"></a><a id="Tc_bevhwFcu6k6Z8pLLCGSNcA_12_0"></a><a id="Tc_XsagFtwyUkS9HZJ2nxe5rQ_12_2"></a><a id="Tc_UNppo2ipFE-BThsV6ywjBQ_12_4"></a><a id="Tc_JtpnsV5aqkmKp8Sbq-28mA_12_8"></a><a id="Tc_G1yzTzlLt0ucfXqLmmhbGQ_12_10"></a><a id="Tc_Xb13L5V3f0O7Ql08PSvICQ_12_14"></a><a id="Tc_sJ1miH4wmku7dTD5-R8yDQ_13_0"></a><a id="Tc_j_uRk5Woy0aq8GSyd1XnRw_13_8"></a><a id="Tc_cSU2oR8590SQfhqUthVBJA_13_10"></a><a id="Tc_Vjzj3Cosn0ak4G5OzcUZ5A_13_12"></a><a id="Tc_6MrSnEx-NkKn0RlFchbBvg_13_14"></a><a id="Tc_vEXAwWTCckSNhjvdOrN_pg_13_16"></a><a id="Tc_yBC5lLqVakWM1ZYVDxYv3Q_14_0"></a><a id="Tc_mynGk6deSkmjhIgjA5EyGg_14_2"></a><a id="Tc_FkM7Nc2zkEqeNSefn7_yBg_14_4"></a><a id="Tc_NO_6HMiDiEmHqp4JhC8_pA_14_6"></a><a id="Tc_w5t3X5btJkOh4tjHh8M21A_14_8"></a><a id="Tc_37jPoAUF-ESjkYnLVBghEg_14_10"></a><a id="Tc_XTtuzg8aQEa3mtj143jtEQ_14_12"></a><a id="Tc_iINFHp1AzE6-TxrV-iNCfQ_15_0"></a><a id="Tc_EFitFuj7sESHhA-tfxBIRQ_15_2"></a><a id="Tc_uoJ0fdzQ_EGUlVvFPE8uOQ_15_4"></a><a id="Tc_0jItDbxYW0K7Ohmpu4fO2Q_15_6"></a><a id="Tc_CQM-REuHSkq05KOcvsRuyg_15_8"></a><a id="Tc_RTiImzXA8U2bOceJJpckFg_16_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:36.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Attributable&#160;to&#160;the&#160;owners&#160;of&#160;the&#160;parent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Issued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">controlling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reserve</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reserve</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of January&#160;1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_D3EKD6FKfkq_ZzWKmtMzhQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_Dr4rtG6ICEmkCu8MScR7gg_6_4">2,383</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_A_FsM08yS06J9681vM0x0g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_8CwVoBiVJU-os0ISF_1Iwg_6_6">98,099</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_s8pyC--PfU2a1cGfakOyRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_sS9zSSYOHUyv_GkyjWuLzA_6_10">40,622</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_qttKShlhOUaMLtKd7DFFOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_AMLs-Ov3o0-pAfuDI3KEuw_6_12">59,860</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_k6D4DSCZeEKWLGaxOgVzTg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_Yg37ZERSGEOsfZ5geBdv0w_6_14">938</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_ba0DA9r4Hk-ZFbjizitEaQ_6_16">58,922</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Loss for the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_cKzDzlGXDUiygHDBhzLipg_7_10">21,438</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_rBeeTCg9lE6cL62y-eEY2g_7_12">21,438</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" scale="3" id="Tc_Si2rL0g_C0OcJXXeZ0j2BQ_7_14">60</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_lAaJqzVhh0SB9Tms2kVi1w_7_16">21,378</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_897mirp3Ske02sLLpjt71A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" sign="-" scale="3" id="Tc_X9wq5UaCvEGzaiGk4TfDMQ_8_8">48</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" sign="-" scale="3" id="Tc_lPdJEAXlw0ykeejEUyuRfQ_8_12">48</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" sign="-" scale="3" id="Tc_dsV4sKroZ06M8GmqDsyvEA_8_16">48</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_897mirp3Ske02sLLpjt71A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_TrC0XkS52E6-_yazhkwogg_9_8">48</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_H4nwvWqkUkO9wzzcwrQ27g_9_10">21,438</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_YMRIeSvyDEukfbOzG20W5Q_9_12">21,486</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_TQvnrCZ490SZ_YiMY0jdiA_9_14">60</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc__YI-wWwTBkGz8-YKGr-aQA_9_16">21,426</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_FHvvZ20F_UCAedsf03EZGw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_KHcMhxzOG02sktUxlxBGKA_10_4">240</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_LE_1i4R0TU6EKFbDO_L5zA_10_6">22,969</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_Fieo4nhJPU2_AnURQctdiw_10_12">23,209</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssueOfEquity" scale="3" id="Tc_uFG7yUIsckeRYtEos9LUqw_10_16">23,209</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_IIkY4vN5EUiHtwiR084rMA_11_6">779</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_uVImODSjYUiK4odT27TMxQ_11_12">779</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_eCM50PTX9EW-e7ZEq4uSsw_11_16">779</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_I8V_zxTDb0Sx-GTD4OEnow_12_6">5,658</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_mhXDMtAPhkWUnRY9Poc0WA_12_12">5,658</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_zkSHT5eEP0aW2b9kKHoW9Q_12_16">5,658</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_FHvvZ20F_UCAedsf03EZGw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_P-g3T09oU0qxm6-yn4te1Q_13_4">31</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" sign="-" scale="3" id="Tc_G50z5kPr4U6TQyAN9Y_pYg_13_6">31</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Disposal of non-wholly owned subsidiary</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8.2, 23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary" scale="3" id="Tc_C6GyxDZKDEybZzR-foOr_g_14_14">268</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary" scale="3" id="Tc_XT13ntnL2kS97BgJgX1ZBA_14_16">268</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Acquisition of non-wholly owned subsidiary</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary" sign="-" scale="3" id="Tc_fwFFtriZJ0SAY07qImyH-Q_15_10">780</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary" sign="-" scale="3" id="Tc__MLDnuRH_0SIs4z7v6E3Dg_15_12">780</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary" scale="3" id="Tc_YJgXoYxtwUiRFHxbAd--Rg_15_14">705</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary" sign="-" scale="3" id="Tc_b_8mD3ZbvUqi-4P5R6Vj4w_15_16">75</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:38.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_d0QbT8X_7EC8vnyFCWMmUA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_LGyJEpMeAkKEPqn2fEOL0Q_16_4">2,654</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_9G4FZctvvkOOH47LSCtbFA_16_6">125,916</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_OJOdfR7_SU-Nboe2Mk7i5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_Gcp2vsWNZUOhHEzs-ojl8A_16_8">48</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_-iDqdbmCPEajuOsNr85IOA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_KLZ5IUzGDEa4yrRt2p-IXg_16_10">62,840</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_ZdfnsggUIk2dILdWP3oszw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_xA7uyI1u8kCbdbCSpiIOeQ_16_12">65,682</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_B3S0Y9EU7EC4i2truDPkCg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_JqhCw1ZAVk6jiphjak4meg_16_14">95</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_nidZ-zQKakOFk_BNYFgD_A_16_16">65,777</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_51086fc9_d7fa_41ad_8d62_c27fcbf6bf71"></a><a id="Tc_qJdce0Y4mk6hjQRNA4ijvA_1_3"></a><a id="Tc_S63BVlzwHE-55nqX3qgaUQ_2_8"></a><a id="Tc_dYU6dbFIU0mP6_FhaqQKxA_2_14"></a><a id="Tc_kDcTxlZUFEqia40EVtALzA_3_4"></a><a id="Tc_3jYubA5gZEahHGy_YzKpgg_3_6"></a><a id="Tc_Imaylhzj6UiQdIZgjYp5GA_3_8"></a><a id="Tc_m-FflXixVkS1bzZzbnP9JQ_3_10"></a><a id="Tc_u6SrdcMaAU-W68jCUIQ7og_3_14"></a><a id="Tc_Jd3M03yFvUiSeXeoJr8-sg_3_16"></a><a id="Tc_f38_wzcobk2o9OFuh3J9rw_4_0"></a><a id="Tc_nitAP3WuNEah3nyIHmXNFQ_4_2"></a><a id="Tc_LYHhcZkORkavED3LakxiEg_4_4"></a><a id="Tc_wmq6g2toE0Op0v0qiDkdAA_4_6"></a><a id="Tc_A22Yw_wjtkWhmqveh_ZR9Q_4_8"></a><a id="Tc_tC7roM4MrEOU7JW34_pkHw_4_10"></a><a id="Tc_sD5-bSAyGUKNzDF_iI1iqw_4_12"></a><a id="Tc_eMQheGHQ0kmoXGy-2r5Ipg_4_14"></a><a id="Tc_dJR_T0j110SldicJtpMF6g_4_16"></a><a id="Tc_wq4hDAOBgkaPrGRvHS-rDg_6_0"></a><a id="Tc_XLCULjCgfkm-3rrC2ftMrg_6_2"></a><a id="Tc_s32g7oydTE606Agrf3-Rww_7_0"></a><a id="Tc_ZIGwPEMDP0-YutUEfxtWiw_7_4"></a><a id="Tc_AtPDnNZOdUWan2k6zZ7Sqw_7_6"></a><a id="Tc_grlJL2ZBLkm12nHZI7OYvg_7_8"></a><a id="Tc_6lOTz-vivUCLdDXmWhGK4A_8_0"></a><a id="Tc_5Hi7uxnoqU2ehQcsWuCzIQ_8_4"></a><a id="Tc__UuWRNa89UqmXkCEJxWgCQ_8_6"></a><a id="Tc_awDkZpWfe06HSERVPMmdvw_8_10"></a><a id="Tc_oCEblA-hwEubi7jMw3HxJg_8_14"></a><a id="Tc_AcQlgYIiNEST9wZ8iTFMrQ_9_0"></a><a id="Tc_iQGQwOfUGEuFwW2gMhdRvg_9_4"></a><a id="Tc_b2Rq006OqkSRngMamwbOvA_9_6"></a><a id="Tc_oOZr_RBlQ0SmmmKoKONOOQ_10_0"></a><a id="Tc_XXFKj_7WgUOXvRAD4Kej9Q_10_2"></a><a id="Tc_51ZbP4z23k6NnGrX8R_Vlg_10_4"></a><a id="Tc_2-ObMNogZkyVe47NyWsFTA_10_8"></a><a id="Tc_TDit_pL-PESBBbWJxchONg_10_10"></a><a id="Tc_ywlaFuGU0EKRU83ZuvKUSA_10_14"></a><a id="Tc_2m5bxic53kOane7OOGDxiA_11_0"></a><a id="Tc_rugcIt4KzECK9PoYdAEETg_11_8"></a><a id="Tc_jSeJee10GUCwCoEKt018og_11_10"></a><a id="Tc_VI5UPO02mE2gSCt2na_7Pg_11_12"></a><a id="Tc_33rTlpP69EWhIba6C7qxVA_11_14"></a><a id="Tc_GXU2lGyo2UCzx7lAq6tSjw_11_16"></a><a id="Tc_4OVAXfj-P0K6uKP2-JBJYw_12_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="10" style="vertical-align:bottom;white-space:nowrap;width:38.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Attributable&#160;to&#160;the&#160;owners&#160;of&#160;the&#160;parent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Issued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">controlling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reserve</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reserve</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of January&#160;1, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_d0QbT8X_7EC8vnyFCWMmUA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_VY7b4Sk8qkuzp0PSIfemDw_6_4">2,654</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc__9uwwRxgpUuZKg98RxuKFw_6_6">125,916</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_OJOdfR7_SU-Nboe2Mk7i5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_uazZTP1B9UyQsOYmVPdowg_6_8">48</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_-iDqdbmCPEajuOsNr85IOA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_YVnbz7mJ4Umv8-pFjNT-WQ_6_10">62,840</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_ZdfnsggUIk2dILdWP3oszw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_pJ0qp0rJ_Eela17YtQyGag_6_12">65,682</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_B3S0Y9EU7EC4i2truDPkCg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_VbcWh-yfG0GwaNv_9jGD8w_6_14">95</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_FXFjEBaYH0yssVgQkwNEcQ_6_16">65,777</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Loss for the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_jyXlykJnhUCcrgqw5ohJ0A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_6RJ5yH8rKUOZXC5mTzxg8Q_7_10">46,950</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_WaO0COkwm0WVcrHfVvsn_g_7_12">46,950</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_GU9QgCbQgECYTx4q1I_gFA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" scale="3" id="Tc_FQRevEEvMU68makFgIv4lw_7_14">98</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_AAAjm3ejmkexKWpidSrU-w_7_16">46,852</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2MOgA84ZvUenL2B0HVv5GA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_bLXwpF5LBE2Q-GJwfxpzMw_8_8">543</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_gdXpkRJn0EWkHGsR1JLLQw_8_12">543</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_wtVnMWkmTEWtQgo0UZJWCw_8_16">543</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2MOgA84ZvUenL2B0HVv5GA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_K07q23lcIkqeWnD6YTAaYA_9_8">543</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_jyXlykJnhUCcrgqw5ohJ0A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_zIVul_d-nUS3tjQmcTxZtQ_9_10">46,950</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_Wx66ETZlPESv6nrnKGhfmw_9_12">46,407</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_GU9QgCbQgECYTx4q1I_gFA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_Rh3IVTBCyU6GQb-auiBPEA_9_14">98</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_ho6rukmJ3k273nLIkUxyYA_9_16">46,309</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_h8KVGyeyBUaFAxgh3PnrpA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_o8B9UkDHVEaXtsrW6CxIZQ_10_6">8,035</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_6r6AEBD-wk2aVdjERnfjFA_10_12">8,035</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_n5Vwx8fbzEmIiQKz42X_oQ_10_16">8,035</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_KqENbDNqJkWj590bxS6xEQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_2eBLTS8v-EmbRyeVj1LgAw_11_4">54</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_h8KVGyeyBUaFAxgh3PnrpA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" sign="-" scale="3" id="Tc_wmB2UiuWmkKafNs4FRg-yw_11_6">54</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:38.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_OD742rXyRkCCIa1akqAdkw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_uVgoMi9p1UK1VOrdl5Mi_Q_12_4">2,708</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_ZDgDGUnu8EW3xuDq9mpNZQ_12_6">133,897</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_S0MC9TMobkCnNHOB62yknw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_Avn8Rwkid06ePyGsQpGsOg_12_8">495</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_F1HqNUC0w0yF40_NYU5-pA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_xCGhCsQuB0ui-irsT0VpnQ_12_10">109,790</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_yKg2jE127UGpUbOS8qY3Tw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_-L1gsFF8_06qkRhU-h4gNQ_12_12">27,310</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_X97kRl32r0SL4FxM_6oahw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_m0X8yF3bDkmcuL_iZ9xkTQ_12_14">193</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_NAeAhDWuHEKfg3F4tRgmww_12_16">27,503</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;">The accompanying notes form an integral part of these consolidated financial statements </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="a1Generalcompanyinformation_139854"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" id="Tb_yxewA3ZtuUa4mxbzrLDhPw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1 General company information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Centogene N.V. (&#8220;the Company&#8221;) and its subsidiaries focus on rare diseases that transforms real-world clinical and genetic or other data into actionable information for patients, physicians and pharmaceutical companies.  The mission of the Company is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">On November 7, 2019, the Company completed an initial public offering (&#8220;IPO&#8221;) and has since been listed on Nasdaq Global Market under stock code &#8220;CNTG&#8221;.  We have historically conducted our business through Centogene AG (which is now known as Centogene GmbH), and therefore our historical financial statements present the results of operations and financial condition of Centogene AG and its controlled subsidiaries. In connection with our initial public offering, Centogene N.V. became the holding company of Centogene AG on November 12, 2019, and the historical consolidated financial statements of Centogene AG became the historical consolidated financial statements of Centogene N.V. Centogene N.V. is a public company with limited liability incorporated in the Netherlands, with registered office located at Am Strande 7 in 18055 Rostock, Germany and Dutch trade register number 72822872.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On March 5, 2020, the Company resolved that Centogene AG shall be converted into a German limited liability company and renamed Centogene GmbH. Such conversion became effective upon the registration in the German commercial register on June 29, 2020. Unless otherwise stated, &#8220;Centogene GmbH&#8221; also refers to the historical operations of Centogene AG throughout the notes. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In July 2020, the Company completed a follow-on public offering of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" scale="0" id="Narr_Tn1XlrQvTE69Nezz8fZwEg">3,500,000</ix:nonFraction> common shares of the Company (the &#8220;July 2020 Offering&#8221;), consisting of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_VdrlZSWEREarVoh3zIZywA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" scale="0" id="Narr_J1XK7XklVUy5cLYXiBUHLQ">2,000,000</ix:nonFraction> common shares offered by the Company and <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SellingShareholdersMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_XLF3uUzrWEa3kZA0wFlJcw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" scale="0" id="Narr_0kfBukv4fkWnkDAAyIkuOw">1,500,000</ix:nonFraction> common shares offered by selling shareholders at a price to the public of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g" decimals="2" format="ixt:numdotdecimal" name="cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues" scale="0" id="Narr_rYaXfHCI5E-VEL2qKVsgmA">14.00</ix:nonFraction> per common share (i.e. EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g" decimals="2" format="ixt:numdotdecimal" name="cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues" scale="0" id="Narr_iha5aPW4FEGHo8-A73BuyA">12.71</ix:nonFraction> per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_VdrlZSWEREarVoh3zIZywA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_ihMUbPoFVkS-txjNSO_zMQ">22</ix:nonFraction> million to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" id="Tb_JDRHJX6QGEKarA7N89EHSg" continuedAt="Tb_JDRHJX6QGEKarA7N89EHSg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2 Basis of preparation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise specified, &#8220;the Company&#8221; refers to Centogene N.V. and Centogene GmbH throughout the remainder of these notes, while &#8220;the Group&#8221; refers to Centogene N.V., Centogene GmbH and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The consolidated financial statements of the Group were prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board (the &#8220;IASB&#8221;).  The accounting policies used in the fiscal year 2021 generally correspond to the policies applied in the prior year, except for certain amendments to the standards which are effective for annual periods beginning on or after January 1, 2021 (see note 3).  In addition, certain prior period information has been reclassified to conform with current year presentation (see note 2). </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">These consolidated financial statements are presented in euro, which is the Group&#8217;s functional currency. Unless otherwise specified, all financial information presented in euro is rounded to the nearest thousand (EUR k) in line with customary commercial practice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.1</b></span><b style="font-weight:bold;">New significant accounting policies and accounting judgments and estimates </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 54pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Revenues from contracts with customer </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group has a diagnostics customer in the Middle Eastern region with a history of significant payment delays. This history has resulted in the recognition of significant subsequent impairment losses by applying the expected credit loss method as the collection of the contractual consideration was historically considered probable upon recognition of revenue. Based on recent developments in its collection experience, recent negotiations with the customer, and past experiences, the Group considered it necessary to reassess its judgments related to the recognition of revenue from contracts with this customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group&#8217;s management concluded, based on the facts and circumstances and management&#8217;s expectations regarding this customer, that this uncertainty in the amount of the contract consideration it expects to collect, and the likelihood of accepting a lower amount or changing payment terms represents an &#8220;implicit price concession&#8221; such that the contract consideration is variable. </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_JDRHJX6QGEKarA7N89EHSg_cont1" continuedAt="Tb_JDRHJX6QGEKarA7N89EHSg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Therefore, the Group&#8217;s management estimates the amount of the contractual consideration it expects to ultimately collect and for which it is highly probable that related revenue recognized would not be subject to significant future reversals when such uncertainty is resolved. The Group&#8217;s management estimates the implicit price concessions by applying an estimated rate of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_5GYsZrZiqEGPJtHs8Ny2fw" decimals="2" format="ixt:numdotdecimal" name="cntg:EstimatedRateOfImplicitPriceConcessions" scale="-2" id="Narr_5dGZFaj58kK2ov_8CtkW_A">18</ix:nonFraction>% based primarily upon past collection history. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Despite the uncertainties related to the amount expected to be collected from the customer, based on experience and the facts and circumstances related to the customer, the Group considers it probable that it will collect <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="2" format="ixt:numdotdecimal" name="cntg:PercentageOfEstimatedVariableTransactionPrice" scale="-2" id="Narr_84m93eMi2kO1ImK92Jo8Lw">82</ix:nonFraction>% of the amount of estimated variable transaction price due to newly agreed payment plans established with the customer. Therefore, the Group records the difference between the billed amount and the amount estimated to be collectible as a reduction to revenue. At the end of each reporting period, and if necessary upon receipt of new information, the Group may revise the amount of the variable consideration included in the transaction price. The Group has applied this accounting policy and accounting estimate to arrangements with this customer prospectively with effect from the third quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.2 </b></span><b style="font-weight:bold;">Going Concern</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As an early commercial-stage company, the Group is still in progress towards reaching break-even in its diagnostic and pharma businesses. The Group and Company are subject to a number of risks similar to those of other development and early commercial stage companies. These risks include, among other things, the failure to enter into and successfully execute further collaborations with pharmaceutical partners, the failure to generate revenue from the Company&#8217;s development portfolio and risks associated with research, development, testing and obtaining related regulatory approvals in relation to our product candidates. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group&#180;s ongoing success and ultimately the attainment of profitable operations depends on future uncertain events which include, among other things, obtaining adequate financing to promote our commercial and development activities until the Group can generate sufficient revenues to support its operating cash requirements. The Group has incurred operating losses since inception. For the year ended December 31, 2021 the Group incurred a net loss of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="6" id="Narr_MpO07lU3ikORnmzbd7wvxA">46.9</ix:nonFraction> million of which EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="6" id="Narr_A63Gm3IKvk6dNl2dlWGCBw">46.0</ix:nonFraction> million is related to loss of operations, resulting in an operating cash outflow of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="6" id="Narr_95oIYfwehkasMVb15gYj2Q">21.7</ix:nonFraction> million driven mainly by the repayment of trade payables of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" sign="-" scale="6" id="Narr_QGHPwJKG2UyBfBlXMem-iQ">20.5</ix:nonFraction> million. As of December 31, 2021, the Group had generated an accumulated deficit of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RetainedEarnings" sign="-" scale="6" id="Narr_H2aw74aDTky8LgMrnkjN6w">109.3</ix:nonFraction> million, and had an equity position of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="6" id="Narr_NzYQN5S3R0KPabTRELrjBg">27.5</ix:nonFraction> million. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of December 31, 2021 the Group had cash and cash equivalents of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="6" id="Narr_ulOezOi6FE-8bG8xKTcoOA">17.8</ix:nonFraction> million with relatively low short term debt obligations of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ShorttermBorrowings" scale="6" id="Narr_At3qRJ3Af0e_fT_Ov5qh4g">3.8</ix:nonFraction> million and <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="0" format="ixt-sec:numwordsen" name="cntg:FinancialCovenants" scale="0" id="Narr_3rhvqt-8_kiwbECwQ89Hig">no</ix:nonFraction> financial covenants. In addition, on January 31, 2022 the Company, Centogene GmbH, CentoSafe B.V. and Centogene US, LLC (together, the &#8220;Borrowers&#8221;), entered into a debt financing agreement in the total amount of up to USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="6" id="Narr_Nu6SLiNx4UmI6Ob3xFE6aA">45.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="6" id="Narr_9HE-Ig303EK8qEf1Spdreg">40.2</ix:nonFraction> million) on January 31, 2022 (the &#8220;Loan Facility&#8221;). Under the terms of the Loan Facility, the Company drew down USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="6" id="Narr_GrIa9zoFF029SZcYDk1Dig">25.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="6" id="Narr_fhZqxGxvVUOMOiozAvd9kw">22.3</ix:nonFraction> million) on January 31, 2022 and will have access to a second tranche of USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue" scale="6" id="Narr_ocPBo37nZU-6WekR8aYUSw">20.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue" scale="6" id="Narr_e4RwcA7IxEmf0lcGHlKWLA">17.9</ix:nonFraction> million) upon achievement prior to July 31, 2023, of product revenue from our diagnostics and pharmaceutical services segments of at least USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsRevenueAchievementThreshold" scale="6" id="Narr_zCngIPi020Sf2sMU79OSSA">50.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsRevenueAchievementThreshold" scale="6" id="Narr_pE4aIRyJKE-nOrttzzpPfw">44.7</ix:nonFraction> million) calculated on a trailing twelve month basis as of the last day of any fiscal month. The Loan Facility also includes covenants such that the Group is required to maintain product revenue of at least EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsCovenantMinimumRequiredRevenue" scale="6" id="Narr_R9WmbBvEYEO0seRqPcekBg">30.0</ix:nonFraction> million as of the last day of each fiscal quarter and on a trailing twelve month basis prior to obtaining the second tranche EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsCovenantMinimumRequiredRevenue" scale="6" id="Narr_DEiR7SenJ0mIdqd66eZsUQ">40.0</ix:nonFraction> million on or after obtaining the second tranche. Both tranches mature on January 29, 2027 with amortized repayments commencing March 1, 2025. The loans extended under the Loan Facility bear monthly interest payments at an interest rate of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Narr_h-Qox0YeI0KO3tgz67THRw">7.93</ix:nonFraction>% per annum plus the 1-month CME Term SOFR reference rate as published by the CME Group Benchmark Administration Limited (subject to a floor of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_ifrs-full_TypesOfInterestRatesAxis_cntg_FloorRateMember_xBPN5MEG9E6vID66HBPpOQ" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="Narr_NFeEPFVrqU67esecxA_Lvg">0.07</ix:nonFraction>%). As security for the Borrowers&#8217; obligations under the Loan Facility, the Borrowers granted the lenders thereunder a first priority security interest on all of each Borrower&#8217;s assets. In addition, pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors on January 31, 2022, the Group also received EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_0hUMenMtj0mI6XpC932cXg">15.0</ix:nonFraction> million in exchange for the issuance of an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg" decimals="INF" format="ixt:numdotdecimal" name="cntg:IfrsStockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_iQ8Bzzyk4k-oEOtScPohJA">4,479,088</ix:nonFraction> common shares at a price per share of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsSharePrice" scale="0" id="Narr_p-tWofdHpkGULozNVEGLaw">3.73</ix:nonFraction> (EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsSharePrice" scale="0" id="Narr_Rr9a9buWWkSG39uMCOhZCQ">3.35</ix:nonFraction>) and warrants initially exercisable for the purchase of up to an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="INF" format="ixt:numdotdecimal" name="cntg:IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="Narr_bmxmcuYEPEWvl7LzZHkm3A">1,343,727</ix:nonFraction> additional common shares at an initial exercise price per common share of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" scale="0" id="Narr_tn1vGUA7h0-N9J6DCcA7HA">7.72</ix:nonFraction>. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026. The Group believes that its cash and cash equivalents will be sufficient to fund its planned operating cash requirements for the next twelve months from the date of issuance of these financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The accompanying consolidated financial statements for the year ended December 31, 2021 have been therefore prepared on a going concern basis contingent upon the successful implementation of the plans described above. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The audited consolidated financial statements do not reflect any adjustments relating to the recoverability and </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_Y9oaWNy7IESmy7waoi6oKA_1_0"></a><a id="Tc_S8kLrKvoukC_QKKrNeZL7A_1_2"></a><a id="Tc_6cLjQI6ykUivyIZzyOPlNw_1_4"></a><a id="Tc_rmQANfUI80KALyvIc3CHjg_1_6"></a><a id="Tc_e8bRvpRPcEqwWBnz6W3-yQ_2_0"></a><a id="Tc_ggiUkBItIEmCfkY_T50hSw_3_0"></a><a id="Tc__9_TaJqpak2WkK77bTbmww_4_0"></a><a id="Tc_BQuyk-gRPU2h-BTqcuQ6vQ_5_0"></a><ix:continuation id="Tb_JDRHJX6QGEKarA7N89EHSg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:35.45pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.3</b></span><b style="font-weight:bold;">COVID-19 Pandemic</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The COVID-19 pandemic has spread worldwide and continues to cause many governments to maintain measures to slow the spread of the outbreak through quarantines, travel restrictions, closures of borders and requiring maintenance of physical distance between individuals. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The COVID-19 pandemic resulted in a slowdown in our diagnostics and pharmaceutical businesses. As part of the Company&#8217;s initiative to assist local, national and international authorities as well as other partners in their efforts to facilitate the earliest possible diagnosis of COVID-19 and thereby contribute to allowing society to return to a &#8220;new&#8221; normal, the Company commenced testing for COVID-19 in March 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended December 31, 2021, the Group continued the COVID-19 testing activities started in 2020 with a leading role in providing testing services at airports in Germany. Furthermore, new variants of the virus have emerged since mid-December 2020. How these mutations develop and their impact on the effectiveness of vaccines is not yet fully clear. Furthermore, vaccination campaigns in many countries started during the year ended December 31, 2021, and due to the expected increase in the availability of vaccines the expectation is that governments will further reduce restrictions moving forward. As a result of these developments in the COVID-19 pandemic, the Group has noticed a decrease in COVID-19 test order intakes in the year ended December 31, 2021. How and when these developments would affect the potential prolongation of the need for testing on a broader scale remains uncertain. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Although the Group is taking a number of measures aimed at minimizing disruptions to the business and operations, and while the provision of testing for the COVID-19 virus is anticipated to generate additional revenues for us, the full extent to which the global COVID-19 pandemic may continue to impact the business will depend on future developments, which are highly uncertain and cannot be predicted, such as the duration of the pandemic, the availability and effectiveness of vaccines against new variants, the probability of the occurrence of further outbreaks and the ultimate impact on the financial markets and the global economy, could result in an unforeseen negative impact on the business and future results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.4</b></span><b style="font-weight:bold;">Reclassification of certain Selling and General Administrative expenses</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group made changes to the classification of several items related to its Covid-19 segment, in the statement of comprehensive loss for the financial year 2020 to conform to the changes made in the fiscal year 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The Company has COVID-19 related advertising expenses, credit card fees and other selling expenses which were recognized under cost of sales in the statement of comprehensive loss in the fiscal year 2020 when the COVID-19 business was added to the operations of the Group in the first quarter of 2020. During the year end close process, management identified this as a classification error and corrected it retrospectively. Accordingly, the Group reclassified  EUR </span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_TVcAOmx4hE6T2TjYZkvryA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfSales" sign="-" scale="3" id="Narr_1nF_cgmTzkWTbjy_0ni5Og">2,941</ix:nonFraction>k from cost of sales to general administration expenses and selling expenses. The following table shows the reconciliation of the Statement of Comprehensive Loss for fiscal year 2020 prior to and following the revision of the aforementioned costs: </p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock" id="Tb_aahy_I2ZpUOsDTLqznnM6A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:17.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:18.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:15.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:17.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 (restated)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 (as previously reported)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of Sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfSales" scale="3" id="Tc_tMU0UZnanUC2lEl3BmpXUQ_2_2">83,437</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfSales" scale="3" id="Tc_9C15SR1gMUGqUPTiEZl2OA_2_4">86,378</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfSales" sign="-" scale="3" id="Tc_8wiHc5sXS0afIVG24If3IQ_2_6">2,941</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Gross profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossProfit" scale="3" id="Tc_2OB2iJbOOU-ESyK7KlsrXQ_3_2">44,944</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossProfit" scale="3" id="Tc__m6tISUzrECv3mPY-h15xg_3_4">42,003</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossProfit" scale="3" id="Tc_RCYW5gLePEyfquAe1rR01w_3_6">2,941</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_aEipstwprUKqCeZFVOE5Lg_4_2">40,160</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_56WruoNcd0Ws9_HYggbF-Q_4_4">37,665</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_ngJt0YVlYEaarQ66kP3bSg_4_6">2,495</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SellingExpense" scale="3" id="Tc_8gwRVkfBTkCQumxRz_0f3Q_5_2">8,026</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SellingExpense" scale="3" id="Tc_aYGnTkKEjEqVQbf0s_KjPQ_5_4">7,580</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SellingExpense" scale="3" id="Tc_K2qMK1fD20qf7c2o7pmhJg_5_6">446</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The changes to the presentation above have no impact to the consolidated statements of financial position (inclusive of December 31, 2020 and January 1, 2020), segment reporting, cash flows or equity and no impact on loss per share.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations" id="Tb_elUZVu29bUKLW77sUU-Tuw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">3 Effects of new accounting standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></span>New standards adopted by the Group as of January&#160;1, 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following amendments and interpretations apply for the first time in 2021 and had no impact on the consolidated financial statements of the Group:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amendments to IFRS 4 &#8211; Insurance contracts- deferral of IFRS 9</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amendments to IFRS 7, 9, IAS 39 &#8211; Interest rate benchmark reform- Phase 2: Modification of financial assets, financial liabilities and leasing liabilities, requirements regarding accounting and disclosure of hedging relationships </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amendments to IFRS 16 &#8211; Covid-19 related rent concessions</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></span>New standards not yet effective</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Furthermore, certain new and amended standards and interpretations have been published that are not mandatory for December 31, 2021 reporting periods and have not been early adopted by the Group. The Group intends to adopt these new and amended standards and interpretations, if applicable, when they become effective. There are no new or amended standards or interpretations that are issued and become effective for the 2022 annual reporting period, that are expected to have a material impact on the Group. </p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfBasisOfConsolidationExplanatory" id="Tb_ILC97jAmu0idta3eBKneKQ" continuedAt="Tb_ILC97jAmu0idta3eBKneKQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">4 Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The basis of consolidation includes the entities over which Centogene N.V. has control within the meaning of IFRS 10 Consolidated Financial Statements. According to IFRS 10, Centogene N.V. has control of an investee when it has direct or indirect power over the investee, exposure, or rights to variable returns from its involvement with the investee and the ability to use its power over the investee to affect those returns. Control is established when it is possible to influence operating and financial policies of the investee, typically with a share in the voting rights or shareholding of more than 50% in the investee. An entity is included in the Group&#8217;s basis of consolidation from the point in time when the Group obtains control of the entity and ceases when the Group loses control of the subsidiary.  Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated financial statements from the date the Group gains control until the date the Group ceases to control the subsidiary.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Profit or loss and each component of other comprehensive income are attributed to the equity holders of the parent of the Group and to the non-controlling interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to transactions between members of the Group are eliminated in full upon consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If the Group loses control over a subsidiary, it derecognizes the related assets, liabilities, non-controlling interest and other components of equity, while any resultant gain or loss is recognized in profit or loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the third quarter of 2020, the Company entered into a collaboration agreement with Dr. Bauer Laboratoriums GmbH, Rostock (hereafter &#8216;Bauer GmbH&#8217;). Bauer GmbH supports Centogene in certain areas of its COVID-19 testing business by providing the medical laboratory services to facilitate Centogene to perform its COVID-19 testing business activities. Bauer GmbH is wholly owned by a long-time employee of Centogene, who from a medical perspective and by observing the Medical Association&#39;s professional code of conduct continues to operate as an independent medical physician.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As per the criteria in IFRS 10, Centogene assessed the control it has over Bauer GmbH and concluded to consolidate the activities of Bauer GmbH in the Group from the third quarter of 2020. Centogene does not own any shares in Bauer GmbH. However, based on the analysis of all facts and circumstances surrounding the close collaboration with Bauer GmbH and the employment relationship with the sole shareholder of Bauer GmbH, this shareholder is considered as a de facto agent. Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns. Bauer GmbH </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_ILC97jAmu0idta3eBKneKQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">has a share in the net result of the respective COVID-19 testing business which has been accounted for under non-controlling interest (see note 23).</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_jmB5yAbV60GJMwePZQvgtQ_1_2"></a><a id="Tc_CrSCj0JlxUaTziJEOoNcxg_1_8"></a><a id="Tc_Dm30YAeoAUOVCzEaCteQfA_2_8"></a><a id="Tc_g5xsLwmBZU2qHSmGzgST5A_2_10"></a><a id="Tc_DF6eljd-jU22oo-0_Vxv-w_2_12"></a><a id="Tc_BoruJVbMYkqgzcmxfNOu9Q_3_2"></a><a id="Tc_CLjzCWtwLUKNYtnLTYktoA_3_4"></a><a id="Tc_puaiiUkpe0Kvq8Bj_LOKLg_3_6"></a><a id="Tc_DijtcHSVhE6MHpEObGPJqw_3_8"></a><a id="Tc_9nSlqG1fNESI_SIQIEtimA_3_10"></a><a id="Tc_tYyTCHW9vU-m86wjVLBcKg_3_12"></a><a id="Tc_tX15y-zzxE6MquCRrn9knQ_4_0"></a><a id="Tc_AtghIZdylEGBGsuuZ060XQ_5_0"></a><a id="Tc_Qt-ci5ms-E-pdmQOP93G3w_6_0"></a><a id="Tc_3ylEHNmKeEiz5awASkmt5w_7_0"></a><a id="Tc_c2ZI7LlNcUOPBrAbvvirZg_7_4"></a><a id="Tc_vn1lxKtfOkewUf0F3Nqsig_7_6"></a><a id="Tc_XyfEbg4Xi0OHNhufA5PNKw_7_10"></a><a id="Tc_QpgQ5Obsw0mQ9ppF-v7BHg_7_12"></a><a id="Tc_-TtQnudF8UKX7R0xyjXNBg_8_0"></a><a id="Tc_IjfiMUVPNECtJAXtekyYig_8_4"></a><a id="Tc_qr4kmQh4IUaoEc7ca4YwnQ_8_6"></a><a id="Tc_051xv20cM0yzpvmWXSpoNg_8_10"></a><a id="Tc_hGK4SNjX70GCo0NYdZBp5g_8_12"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" id="Tb_gsP_I8VnpEK3lPt1ip6RZg" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">5 Significant accounting policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applied the following accounting policies consistently for all of the periods presented in these consolidated financial statements. </p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="Tb_z3JAnWXu-U2NXOMDsO3V0Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></span>Foreign currency and currency translation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s consolidated financial statements are presented based on the parent company&#8217;s functional currency. For each entity, the Group determines the functional currency and items included in the financial statements of each entity are measured using that functional currency. The Group uses the direct method of consolidation and on disposal of a foreign operation, the gain or loss that is reclassified to profit or loss reflects the amount that arises from using this method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Transactions in foreign currency are translated into the respective entity&#8217;s functional currency at the spot rate prevailing on the date of the transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The functional currency of each entity is the respective local currency, since the entities carry out their business activities independently from a financial, economic and organizational perspective.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Monetary assets and liabilities denominated in foreign currency are translated to the functional currency using the closing rate at the reporting date. Currency translation differences are recognized immediately through profit or loss. Non-monetary items denominated in a foreign currency that are measured at historical cost are not translated at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On consolidation, the assets and liabilities of foreign operations are translated into euros using the closing rate on the reporting date. Income and expenses of foreign operations are translated using the exchange rate prevailing on the date of the transaction or the annual average exchange rate. Equity is translated using historical rates until the entity is removed from the Group&#8217;s basis of consolidation. Any resulting currency translation differences are recorded in other comprehensive income and recognized under the currency translation reserve in equity if the exchange difference is not allocable to the non-controlling interests. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The exchange rates used are presented in the following table:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:DisclosureOfForeignExchangeRatesUsedExplanatory" id="Tb_djFnQ_3hY0OGLJsV-pAPNQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Closing&#160;rate</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USD (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_fot_rPDa_U65GjIaEzM9Pg_4_2">1.1304</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_Gjkv91UOekGkXgCKDqeL8g_4_4">1.1412</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_JTxYuPTmukyQBtGk8AIYVg_4_6">1.1191</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_dSvSxPgrI0Clujtg_mhkpw_4_8">1.1326</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_vTfdrj8M1kKC4wStW4TLHw_4_10">1.2271</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_kK2zyt2vhkOLxumLpc9JLg_4_12">1.1234</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AED (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_V0iYyeglJkGiaJoHtYT_iA_5_2">4.1500</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_PIPQA6WVtkWyvbP_dLpGCA_5_4">4.2091</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_Zl_6LeiPBUKD0A3nXt5DqA_5_6">4.0985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_78kF66dmG0yj-6WSf0DAGQ_5_8">4.1654</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_lroWQUAyckyjZwLag5lhiw_5_10">4.5045</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_XyTc1qQn6EiNWMHhuK8edA_5_12">4.0795</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">INR (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_h7mnkPabAES8Npm-uQVp2g_6_2">85.1761</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_RwhI90TvZEu7S8enLG1nCQ_6_4">84.5737</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_b68Cy5A6UEmIhbWm6JQ8CQ_6_6">78.7980</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_yOYHDlnEV0WhnUKkCfxjJA_6_8">84.2292</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_ldlQ9jN6nUa-1VdMmBnGpg_6_10">89.6605</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_ZBkaMToBsEG3yad5N38vbQ_6_12">80.1870</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CHF (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_EUR_09Qkxn-hrkG46Zlsshurbw" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_4l2gsdgC6Uev3dr8P0E_HQ_7_2">1.0814</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_EUR_09Qkxn-hrkG46Zlsshurbw" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_-Q804Y3ZX0GP1Kk5MLahwg_7_8">1.0331</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RSD (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_RSD_EUR_oVrkuRnZ4UOXTq9NNZ3SYA" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_8f-9X_DYMkeMoI8yUrNIgA_8_2">117.3909</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_RSD_EUR_oVrkuRnZ4UOXTq9NNZ3SYA" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_NIVREes-50WN9QMjJcRpbQ_8_8">117.2747</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr></table></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" id="Tb_jZ2TL6xYhUOwqm0Xr_PmSg" continuedAt="Tb_jZ2TL6xYhUOwqm0Xr_PmSg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></span>Revenues from contracts with customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The Group provides pharmaceutical solutions and diagnostic tests, as well as COVID-19 tests, enabled by its knowledge and interpretation-based platform. Revenue from contracts with customers is recognized when control of the goods or services are transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those goods or services, usually on delivery of the goods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Pharmaceutical segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">The Group&#39;s contracts with customers relate to a variety of solutions provided to the Group&#39;s pharmaceutical partners in order to accelerate their development of treatments for rare diseases, including early patient recruitment and identification, </p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont1" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont2"><ix:continuation id="Tb_jZ2TL6xYhUOwqm0Xr_PmSg_cont1" continuedAt="Tb_jZ2TL6xYhUOwqm0Xr_PmSg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">epidemiological insights, biomarker discovery and patient monitoring. The collaboration agreements are structured on a fee per analysis basis, milestone basis, fixed fee basis, or a combination of these. In addition, some of the Group&#39;s contracts with its pharmaceutical partners also include sales of CentoCards for the collection of biological samples from patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The performance obligations in Pharmaceutical segment can either be satisfied over time or at a point in time depending on the structure of the collaborations, which are determined based on nature of the service provided, as detailed below.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring is based on fee per analysis, milestone fees and fixed fees. The revenues from these solutions are recognized over time using an input method based on the work rendered in order to measure progress towards complete satisfaction of the services.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from the licensing of intellectual property for an unlimited period, usually in the structure of an upfront fee, is recognized at a point in time, when the right (or license) to use intellectual property is conveyed.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenues from the licensing of intellectual property for a certain period, being a right to access such intellectual property as defined in IFRS 15, is recognized over time over the licensing period.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from the sale of CentoCards is recognized at a point in time when the control of the CentoCards has transferred to the customer, which typically occurs on delivery.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Diagnostics segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">Revenues from the Group&#39;s diagnostics segment are typically generated from genetic sequencing and diagnostics services that the Group provides to clients, who are typically physicians, laboratories or hospitals, either directly or through distributors. Revenues are based on a negotiated price per test or on the basis of agreements to provide certain testing volumes over defined periods. The Group has concluded that the services rendered in the diagnostics segment comprise one performance obligation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The performance obligation in the Diagnostics segment is recognized over time, using an input method to measure progress towards complete satisfaction of the service. In order to measure progress, the Group uses a standardized process which measures progress to completion by stages, consisting of (i) a preparation stage, (ii) a clarification stage, (iii) a sequencing stage, and (iv) an output stage. The percentages attributed to those stages are indicative of the cost incurred in performing the respective stage in relation to total cost. &#160; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>COVID-19 segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">COVID-19 revenues are based on a negotiated price per test, government driven or on the basis of agreements covering tests to be performed over defined periods. Given the short turnaround time for the COVID-19 tests, revenues from COVID-19 tests that are on a price per test basis are recognized at a point in time. Revenues from COVID-19 tests that are on the basis of agreements covering tests to be performed over defined periods are recognized over time over the agreement period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The Group has disaggregated revenue recognized from contracts with customers into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Group has also disclosed information about the relationship between the disclosure of disaggregated revenue and the revenue information disclosed for each reportable segment. See note 7 for the disclosure on disaggregated revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contract balances </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contract assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A contract asset is the right to consideration in exchange for goods or services transferred to the customer. If the Group satisfies a performance obligation by transferring goods or services to a customer before the customer pays consideration or before </p></ix:continuation></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont2" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont3"><ix:continuation id="Tb_jZ2TL6xYhUOwqm0Xr_PmSg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">payment is due, a contract asset is recognized for the earned consideration that is conditional.  Contract assets are subject to impairment assessment, refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A receivable represents the Group&#8217;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Contract liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A contract liability is the obligation to transfer goods or services to a customer for which the Group has received consideration or an amount of consideration is due from the customer (whichever is earlier). If a customer pays consideration before the Group transfers goods or services to the customer, a contract liability is recognized when the payment is made or the payment is due (whichever is earlier). Contract liabilities are recognized as revenue when the Group performs under the contract.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" id="Tb_nW_qgYlhVk6rP_QX-O0DNQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></span>Finance income and finance costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Interest income and expenses are recognized in the period which they relate to through profit or loss using the effective interest rate method. </p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory" id="Tb_iF5inXn_VEiu1IUIuQjXaA" continuedAt="Tb_iF5inXn_VEiu1IUIuQjXaA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></span>Current versus non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Expected to be realized or intended to be sold or consumed in the normal operating cycle</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Held primarily for the purpose of trading</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Expected to be realized within twelve months after the reporting period; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All other assets are classified as non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A liability is current when:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is expected to be settled in the normal operating cycle</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is held primarily for the purpose of trading</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is due to be settled within twelve months after the reporting period; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The terms of the liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group classifies all other liabilities as non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are classified as non-current assets and liabilities</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont3" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont4"><ix:continuation id="Tb_iF5inXn_VEiu1IUIuQjXaA_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" id="Tb_VZU0ms35Nk6mV5-kav4YxA" continuedAt="Tb_VZU0ms35Nk6mV5-kav4YxA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></span>Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Expenses for research activities are recognized through profit or loss in the period in which they are incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Development expenditures on an individual project are recognized as an intangible asset from the date the Group can demonstrate: </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the product or process is technically and commercially feasible so that the asset will be available for use or sale</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Group has the ability and intention to use or sell the asset</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a future economic benefit is probable </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Group has sufficient resources to complete the development and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the development costs can be measured reliably. </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group&#8217;s research and development activities mainly relate to development of biomarkers and IT driven solutions.  With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#8217;s internal validation test. Before such dates, any development costs are recognized in profit or loss and may not be subsequently capitalized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized development costs are recognized at cost less accumulated amortization and any accumulated impairment losses. They are only amortized as from the date the asset is ready for its intended use, which in the case of biomarkers is normally at the time the patent application for such biomarker is made. Amortization expense commences when the assets are ready to be put in use, and is recorded in cost of sales and research and development expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized development costs which are still under development are tested for impairment annually and when circumstances indicate that the carrying value may be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Other intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other intangible assets purchased by the Group with finite useful lives are recognized at cost less accumulated amortization and any accumulated impairment losses. Subsequent expenditure is only capitalized if it increases the future economic benefits of the respective asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Intangible assets are amortized over their estimated useful life using the straight-line method and assessed for impairment whenever there is an indication that the intangible asset may be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The estimated useful lives are as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Software, patents and trademarks: </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_H6sJ9CbA3Uqak-twBHs28g" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="Narr_rFxBEfy6Z06YXICtqmTUuA"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-</span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IJi6tizcMkqoRBY2BmqqJA" format="ixt-sec:durwordsen" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="Narr_oIeS_7Gxt0SBsuiJZ8Oo7A"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 years</span></ix:nonNumeric></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Corona Test Portal: </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_CoronaTestPortalMember_LjhxO9L-BkaT6QFPOJAsSQ" format="ixt-sec:durwordsen" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="Narr_f-uZndP-jE6YO0SvqX1MUw"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2 years</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Capitalized development costs: </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_QclbJBn7ZU-bkYebSJREIA" format="ixt-sec:durwordsen" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="Narr_Mq4SykV_qESrN65DoLh3MA"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 years</span></ix:nonNumeric></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The useful lives and depreciation methods are reviewed annually to ensure that the methods and periods of depreciation are consistent with the expected economic benefit from the asset.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont4" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont5"><ix:continuation id="Tb_VZU0ms35Nk6mV5-kav4YxA_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="Tb_I3sebnZ22kKzbMNDxmk9kg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(f)</b></span>Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment are carried at cost less any accumulated depreciation and any accumulated impairment losses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The cost of property, plant and equipment comprises its purchase price including customs duties and non-refundable acquisition taxes, and proportionate VAT not deductible from input tax as well as any directly attributable costs of bringing the asset to its working condition and location for its intended use.       </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> Subsequent expenditure is only capitalized if it is probable that the future economic benefits associated with the expenditure will flow to the Group. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Depreciation is calculated over the estimated useful life using the straight-line method. The Group has assessed that none of its property, plant and equipment has a residual value. The estimated useful lives of significant property, plant and equipment are as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Freehold land is not depreciated</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Buildings: </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_9C85cYkhmEagnhCDbgR3AQ" format="ixt-sec:durwordsen" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Narr_SR6RyC1ZyUCW1KRCSWmu7A"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">33 years</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Plant and other equipment, furniture and fixtures: </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_x92x8S-RsEqIAad9QHOnPw" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Narr_97u5u3SPf0SeAumYt1rJZQ"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-</span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_VmnidKUOw0WoRlLrj829EQ" format="ixt-sec:durwordsen" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Narr_NFnooShfWkuEyztb1gmVNA"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">15 years</span></ix:nonNumeric></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">An item of property, plant and equipment is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of comprehensive loss when the asset is derecognized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The depreciation methods, useful lives and residual values are reviewed, and adjusted prospectively if appropriate, as of each reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Assets under construction are reported at cost and are allocated to property, plant and equipment until they are completed and put into operational use, from which point onwards they are depreciated.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="Tb_ppM0lxXvBEyijrA9pUQPuw" continuedAt="Tb_ppM0lxXvBEyijrA9pUQPuw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(g)</b></span>Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Group as a lessee</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Right-of-use assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group recognizes right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its lease term and the estimated useful lives, as follows:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Buildings: <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_9C85cYkhmEagnhCDbgR3AQ" format="ixt-sec:durwordsen" name="cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" id="Narr_4tFCiN5RKUmlP_To8b26DQ">33 years</ix:nonNumeric><span style="white-space:pre-wrap;">  </span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Offices: <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_s-Pt6IBZJU6njzi-YxbBHA" format="ixt-sec:duryear" name="cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" id="Narr_qNFrqNx1JEyMnfWsOQ4yhQ">4</ix:nonNumeric> &#8211; <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ha2hcVFm9USAnZurtaYg4g" format="ixt-sec:durwordsen" name="cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" id="Narr_SVnenezYakqS8khy6M8RLQ">12 years</ix:nonNumeric> and</p></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont5" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont6"><ix:continuation id="Tb_ppM0lxXvBEyijrA9pUQPuw_cont1"><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Plant and other equipment, furniture and fixtures: <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_x92x8S-RsEqIAad9QHOnPw" format="ixt-sec:duryear" name="cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" id="Narr_xFqLBwTyM068JPRg-iIyrA">2</ix:nonNumeric>-<ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_VmnidKUOw0WoRlLrj829EQ" format="ixt-sec:durwordsen" name="cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" id="Narr_QVy8i3JmgECWEC8s7Cxl3w">15 years</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If ownership of the leased asset transfers to the Group at the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The right-of-use assets are also subject to impairment. Refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">At the commencement date of the lease, the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for leases reasonably certain to be terminated. The variable lease payments that do not depend on an index or a rate are recognized as expenses in the period during which the event or condition that triggers the payment occurs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>Short-term leases and leases of low-value assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption to leases of office equipment that are considered of low value (i.e., below EUR 5k). Lease payments on short-term leases and leases of low-value assets are recognized as expenses on a straight-line basis over the lease term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>Sale and leaseback transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group applies IFRS 15 for determining if the transfer of an asset to the buyer (lessor) is to be accounted for as a sale of assets.  After the sale of assets is concluded, the Group measures the right-of-use assets arising from the leaseback at the proportion of the previous carrying value of the asset that relates to the right of use retained by the Group.  Accordingly, the Group recognizes only the amount of any gain or loss that relates to the rights transferred to the buyer (lessor).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the fair value of the consideration for the sale of an asset does not equal the fair value of the asset, or if the payments for the leases are not at market rates, the Group makes the following adjustments to measure the sale proceeds at fair value: </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">any below-market terms shall be accounted for as a prepayment of lease payments</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">any above-market terms shall be accounted for as additional financing provided by the buyer-lessor to the seller-lessee</p></td></tr></table></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" id="Tb_M0qaGXsDAUysS45XuUnnrg" continuedAt="Tb_M0qaGXsDAUysS45XuUnnrg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(h)</b></span>Impairment of non-financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment and intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Whenever the carrying amount of an asset exceeds its recoverable amount, an impairment loss is recognized in profit or loss. The recoverable amount is measured as the higher of fair value less costs to sell and value in use. Recoverable amounts are estimated either for individual assets or, if an individual asset does not generate cash flows independently of other assets, for the whole cash-generating unit.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont6" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont7"><ix:continuation id="Tb_M0qaGXsDAUysS45XuUnnrg_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" id="Tb_yvVREf9f-k6FFhnn1exAcg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></span>Inventories</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inventories are measured at the lower of cost and net realizable value. Inventories are recognized at cost based on the first in first out (FIFO) method. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants" id="Tb_efWKeTl9fU-cUgfu7Q1BAg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(j)</b></span>Government grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. Grants that are intended to compensate the Group for expenses incurred are recognized through profit or loss in the period in which expenses are submitted and claimed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants which relate to an asset are initially recognized as deferred income at nominal amounts. They are subsequently released to profit or loss on a systematic basis over the expected useful life of the related asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The release of deferred income related to either type of grant is presented as other operating income (see note 8).<b style="font-weight:bold;"> </b></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" id="Tb_Z2S-vOxyN0eFJ8F8WfrPJQ" continuedAt="Tb_Z2S-vOxyN0eFJ8F8WfrPJQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(k)</b></span>Share-based payments </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Plan recipients (including senior executives and certain member of Supervisory Board) of the Group receive remuneration in the form of share-based payments, whereby the recipients render services as consideration for equity instruments (equity-settled transactions) or settled in cash (cash-settled transactions).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Equity settled transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The cost of equity-settled transactions is determined by the fair value of the granted options when the grant is made, using a Black-Scholes or Monte Carlo simulation model, with further details given in note 20.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The cost is recognized in employee benefits expense (see note 8.4) or other relevant expenses, together with a corresponding increase in equity (capital reserves), over the period in which the service conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest.  The expense or credit in profit or loss for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cash-settled transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A liability is recognized for the fair value of cash-settled transactions. The fair value is measured initially and at each reporting date up to and including the settlement date, with changes in fair value recognized in employee benefits expense (see note 8.4). The fair value per option is determined using the Black-Scholes model, further details of which are given in note 20. The fair value per option is then multiplied by the Group&#8217;s best estimate of the number of awards expected to vest and the portion of the expired vesting period (period in which the service conditions are fulfilled). The cumulative amount of expense recognized will be equal to the cash that is paid on settlement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Service and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont7" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont8"><ix:continuation id="Tb_Z2S-vOxyN0eFJ8F8WfrPJQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">If the terms and conditions of a cash-settled share-based payment transaction are modified with the result that it becomes an equity-settled share-based payment transaction, the transaction is accounted for as such from the date of the modification.  Specifically, the equity-settled share-based payment transaction is measured by reference to the fair value of the equity instruments granted at the modification date and recognized in equity.  The liability for the cash-settled share-based payment transaction as at the modification date is derecognized on that date.  Any difference between the carrying amount of the liability derecognized and the amount of equity recognised on the modification date is recognised immediately in profit or loss.</span><b style="font-weight:bold;"> </b></p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="Tb_l1rPywNYOE64AEWpmvVKog" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(l)</b></span>Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">A provision is recognized when the Group has a present obligation (legal, contractual or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.  When the Group expects some or all of a provision to be reimbursed, for example, under an insurance contract, the reimbursement misrecognized as a separate asset, but only when the reimbursement is virtually certain. The expense relating to a provision is presented in the profit or loss net of any reimbursement.  Provisions are reviewed at each reporting date and adjusted to reflect the current best estimate. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the requirements for recognizing a provision are not satisfied, the corresponding obligations are recorded as contingent liabilities unless the possibility of an outflow of resources embodying economic benefits is remote.<b style="font-weight:bold;"> </b></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="Tb_orJd1NbdRkewNfJumdCW7Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(m)</b></span>Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tax expense comprises current and deferred taxes. Current taxes and deferred taxes are recognized through profit or loss apart from deferred taxes related to items recognized outside profit or loss, in which case it is recognized in correlation to the underlying transaction either directly in equity or in other comprehensive income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Group operates and generates taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred taxes are set up for temporary differences between the carrying amounts of assets and liabilities for group financial reporting purposes at the reporting date and the amounts used for tax purposes. Deferred tax liabilities are recognized for all taxable temporary differences, except:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">temporary differences arising from the initial recognition of assets or liabilities in the course of a business transaction that is not a business combination and does not affect either the accounting profit or the taxable profit or loss</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">temporary differences associated with investments in subsidiaries if the Group controls the timing of the reversal of the temporary differences, and it is probable that the differences will not reverse in the foreseeable future.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and deferred tax liabilities are offset against each other if certain conditions are met.<b style="font-weight:bold;"> </b></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont8" continuedAt="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont9"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" id="Tb_HYYxUgfUBk2g9URowao3tg" continuedAt="Tb_HYYxUgfUBk2g9URowao3tg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(n)</b></span>Financial instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">(i) Financial assets </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s financial assets principally consist of those accounted for as receivables, contract assets, cash and cash equivalents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Receivables and contract assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Receivables, including contract assets, are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.  Contract assets and trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are measured at the transaction price determined under IFRS 15.  Refer to the accounting policies in note 5(b) &#8220;Revenues from contracts with customers&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">After initial recognition, receivables and contract assets are subsequently carried at amortized cost using the effective interest rate method less any impairment losses.  Gains and losses are recognized in the profit or loss for the period when the assets are derecognized or impaired.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Derecognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A financial asset or a part of a financial asset is derecognized when the Group no longer has the contractual rights to the asset or the right to receive cash flows from the asset have expired. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group recognizes an allowance for expected credit losses (ECLs). ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies a simplified approach in calculating ECLs. Therefore, the Group does not track changes in credit risk, but instead recognizes a loss allowance based on lifetime ECLs at each reporting date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group considers a financial asset in default when contractual payments are <ix:nonFraction unitRef="Unit_Standard_D_v74mkiZpokKNiaOyAGgw5A" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="0" format="ixt:numdotdecimal" name="cntg:FinancialAssetInDefaultNumberOfDaysPastDueConsidered" scale="0" id="Narr_eEa9Xr7r1kqNfPg30IsJ-g">360</ix:nonFraction> days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Further disclosures relating to impairment of trade receivables, including contract assets, are in note 21.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(ii)&#160;Financial liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s financial liabilities include trade and other payables (include contract liabilities), as well as loans and borrowings including bank overdrafts.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_gsP_I8VnpEK3lPt1ip6RZg_cont9"><ix:continuation id="Tb_HYYxUgfUBk2g9URowao3tg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Loans and borrowings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Loans and borrowings are initially recognized at fair value and subsequently measured at amortized cost using the effective interest rate method, taking into account any principal repayments and any discount or premium on acquisition and including transaction costs and fees that are an integral part of the effective interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Gains or losses are recognized through profit or loss at the time the liabilities are derecognized or disposed of.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Derecognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A financial liability is derecognized when the obligation underlying the liability is discharged, canceled or expires.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized through profit or loss.<b style="font-weight:bold;"> </b></p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" id="Tb_lF1SxP1oqkeu4yeO0Q_jlA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(o) Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Cash and cash equivalents comprise cash on hand and bank balances, including short-term, highly liquid investments that can be quickly converted into cash amounts. These have original maturities of three months or less and are subject to a low risk of fluctuation in value.</p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" id="Tb_aBnszJnnWEC0cnGG-9qIjg" continuedAt="Tb_aBnszJnnWEC0cnGG-9qIjg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">6 Accounting judgments and estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements requires the management board to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures. Actual results could differ from those estimates. Estimates and underlying assumptions are reviewed on an ongoing basis and revisions of estimates are recorded prospectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.1</b></span>Judgments </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Development costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Development costs are recognized in accordance with the accounting policy for certain internally generated assets. The Group&#8217;s research and development activities mainly relate to development of biomarkers and IT driven solutions. With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#8217;s internal validation test. Before such date, any development costs are recognized in profit or loss and may not be subsequently capitalized. As of December&#160;31, 2021, the carrying amount of capitalized development costs was EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_Fj9Rp4R76k2ZiXVlDvyuMQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Narr_Krk_7RuDDUWStBP3zAXYLA">7,941</ix:nonFraction>k (2020: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_pMqKy82tCkCyUZNqkklFgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Narr_UcEIfV86zE-6Goz-d0ZbSA">9,680</ix:nonFraction>k). This amount includes investments in the development of biomarkers and IT driven solutions (e.g.,&#160;the Group&#8217;s CentoMetabolome and CentoPortal online platform). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Provision for expected credit losses of trade receivables and contract assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group uses a provision matrix to calculate ECLs for trade receivables and contract assets. The provision rates are based on days past due for groupings of various customer segments that have similar loss patterns (e.g. by segment, geography, customer type and rating).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The provision matrix is initially based on the Group&#39;s historical observed default rates. The Group will calibrate the matrix to adjust the historical credit loss experience with forward-looking information. For instance, if forecasted economic conditions (i.e., gross domestic product) are expected to deteriorate over the next year which can lead to an increased number of defaults in the manufacturing sector, the historical default rates are adjusted. At every reporting date, the historical observed default rates are updated and changes in the forward-looking estimates are analyzed.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_aBnszJnnWEC0cnGG-9qIjg_cont1" continuedAt="Tb_aBnszJnnWEC0cnGG-9qIjg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The assessment of the correlation between historical observed default rates, forecasted economic conditions and ECLs is a significant estimate. The amount of ECLs is sensitive to changes in circumstances and of forecasted economic conditions. The Group&#39;s historical credit loss experience and forecast of economic conditions may also not be representative of customer&#39;s actual default in the future. The information about the ECLs on the Group&#39;s trade receivables and contract assets is disclosed in note 21.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Deferred tax asset on loss carryforwards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The tax losses carried forward do not expire. In the light of the Company&#8217;s loss history, the recognition of deferred taxes for tax losses carried forward and deductible temporary differences is limited to the future reversal of existing taxable temporary differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue implicit concession</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group reassessed revenue recognition from contracts linked to a customer with a history of significant payment delays resulting in significant impairment losses through the application of the expected credit loss method. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group concluded, based on the facts and circumstances and management&#8217;s expectations regarding this customer, that this uncertainty in the amount of the contract consideration it expects to collect, and the likelihood of accepting a lower amount or changing payment terms represents an &#8220;implicit price concession&#8221; such that the contract consideration is variable. Therefore, the Group estimates the amount of the contractual consideration it expects to ultimately collect and for which it is highly probable that related revenue recognized would not be subject to significant future reversals when such uncertainty is resolved. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group records the difference between the billed amount and the amount estimated to be collectible as a reduction to revenue. At the end of each reporting period, and if necessary upon receipt of new information, the Group may revise the amount of the variable consideration included in the transaction price. The Group has applied this accounting policy and accounting estimate to arrangements with this customer prospectively with effect from the third quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">6.2         Assumptions and estimation uncertainties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Information concerning assumptions and estimation uncertainty that have a significant risk of causing a material adjustment to the fiscal&#160;year ended on December&#160;31, 2021 are presented in the following disclosures. The Group based its assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising that are beyond the control of the Group. Such changes are reflected in the assumptions when they occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Share-based payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Estimating fair value for share-based payment transactions requires a determination of the most appropriate valuation model, which depends on the terms and conditions of the grant.  For the measurement of the fair value of equity-settled transactions at the grant date (including those issued to replace the cash-settled transactions), the Group uses the Monte Carlo simulation model (previously the Black-Scholes model). The fair value at grant date of equity-settled transactions is not updated at the end of each reporting period. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Valuation of Share Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Black-Scholes option pricing model requires the input of subjective assumptions, including assumptions about the expected life of share-based awards and share price volatility.  The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved.  As a company listed on the NASDAQ stock exchange in 2019, the Group&#8217;s share price only has limited sufficient historical information to be used as a reference, and therefore subjective inputs were included when estimating the fair value of our common shares to be used in both option pricing model. </span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_aBnszJnnWEC0cnGG-9qIjg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In addition, our management used different key assumptions in the models to calculate the fair value.  The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in note 20. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group intends to continue to consistently apply this methodology using the same comparable companies until a sufficient amount of historical information regarding the volatility of our own share price as a public company becomes available.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_aa7f7273_f7e9_4413_94fe_5ab72e09c46c"></a><a id="Tc_hfKfYNC3FUW0gbYgXAwlfg_1_2"></a><a id="Tc_4TeQcodaSUWN2QXp9hn8LA_2_0"></a><a id="Tc_ZIGt6IhfUEmWaaVXtBMvag_2_2"></a><a id="Tc_AgxGTd1OMU-6Cr5Y9YPonA_2_4"></a><a id="Tc_Zt3llznl_02-fZLMDnQUBA_2_6"></a><a id="Tc_CQWMFm0QGEyPf1eKPWopSg_2_8"></a><a id="Tc_JNWlFLiMzEmKJyv7-AsHdA_2_10"></a><a id="Tc_xcgoxTnlPkynQbKhypk_YQ_3_0"></a><a id="Tc_FJrXIvLoS0ycBzOvDbQOTw_3_8"></a><a id="Tc_y5K0svHZPk6RkpBIiNavUg_5_0"></a><a id="Tc_Fr9TaGzbSEqDVgtmg4DWMg_7_0"></a><a id="Tc_slvjCHKkSkC03qk-k0adAw_8_0"></a><a id="Tc_em_T4poRbEWP-Sc_-k20tQ_9_0"></a><a id="Tc_OslaYoERgUKOxarRxE_RBw_9_4"></a><a id="Tc_d-67adaxaE25JZWuQA-oFQ_9_8"></a><a id="Tc_7GYUbFgjikyNYjQ2KWO32A_11_0"></a><a id="Tc_pXR8wj-uRkSgARkyDU2c7Q_12_0"></a><a id="Tc_hgf-rCKWP0Wvqlz4aWKa5w_13_0"></a><a id="Tc_2u7eCaaVoEGvj-kVMtl-Ww_13_2"></a><a id="Tc_KP1DoD52sUGtch9UnO0r6w_13_4"></a><a id="Tc__5I6vkwGWEKA6pjUjhfK4Q_13_6"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" id="Tb_DNzIVSpV00CdZUlwQk-hiQ" continuedAt="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">7 Segment information and revenue from contracts with customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">7.1 Segment information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For management purposes, the Group is organized into business units based on its products and services. In line with the management approach, the operating segments were identified on the basis of the Group&#8217;s internal reporting and how the chief operating decision maker (&#8220;CODM&#8221;) assesses the performance of the business. On this basis, the Group has the following <ix:nonFraction unitRef="Unit_Standard_segment_fj3IE5HhAk64wBBglbJJCQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="INF" format="ixt-sec:numwordsen" name="cntg:IfrsNumberOfReportableSegments" scale="0" id="Narr_Iy3yBWpZSk-8cd1CbE6muA">three</ix:nonFraction> operating segments, which also represent the Group&#8217;s reportable segments:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Pharmaceutical segment:</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">  This segment provides a variety of solutions to our pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring, in order to accelerate their development of treatments for rare diseases; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Diagnostics segment:</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">  This segment provides genetic sequencing and diagnostics services to our clients, who are typically physicians, laboratories or hospitals, either directly or through distributors; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">COVID-19 segment: </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">This segment provides COVID-19 testing services to our clients. Our original COVID-19 test is a molecular diagnostic test performed for the in vitro qualitative detection of RNA from the SAR-CoV-2 in oropharyngeal samples from presymptomatic probands according to the recommended testing by public health authority guidelines. In addition, we also offer COVID-19 antigen testing. </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The management board is the Chief Operating Decision Maker and monitors the operating results of the segments separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on segment results and is measured with reference to the Adjusted EBITDA. Adjusted EBITDA is a financial measure which is not prescribed by IFRS, which the Group defines as income/loss before finance costs (net), taxes, and depreciation and amortization (including impairments), adjusted to exclude corporate expenses as well as share-based payment expenses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Corporate expenses, interest and similar income and expenses, as well as share-based payment expenses are not allocated to individual segments as the underlying instruments are managed on a group basis. Assets and liabilities are managed on a Group basis and are not allocated to the different segments for internal reporting purposes. Therefore, our CODM does not regularly review this information by segment and accordingly we do not report this information by segment.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock" id="Group_SLzNYBk83k6Si3ccfGKfuA" continuedAt="Group_SLzNYBk83k6Si3ccfGKfuA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc__XJsuzGfQ0y7Jm7nNYJqwA_3_2">15,641</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_0RrSOVQKT0-F6eRqLmdtzA_3_4">27,900</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_xp7qyPN3Z0-uA6oXu6rMjA_3_6">146,382</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_rD_fPknHp0mHBR6S5U2bow_3_10">189,923</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_4AHwFwGi20WmWQC1Nnk-Sg_5_2">4,843</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_cdX-pGdn6EGby_MYbDmHQA_5_4">4,024</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_wH1f4G5oX0y8FcIKw4i8SQ_5_6">20,678</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" sign="-" scale="3" id="Tc_NHGOgTfaikCLQc4mup1Qiw_5_8">46,247</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" sign="-" scale="3" id="Tc_UUok8178iEaDyJSjvoCBag_5_10">16,702</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_ow5FPpcVwECeKd2rOJlZaA_8_2">690</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_9F6eSAArHU-7jHXwUVTP5w_8_4">261</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_BwzNQZLl7EqZQwsb0Z7z1g_8_6">2,480</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_UCbzhagSBUOdlXt-uWlLPg_8_8">936</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_EVGZI9NlCkWjEVJlU9fqNA_8_10">4,367</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_AP2K3ufxKES2Lbw3o89ccA_9_2">2,401</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_NtarL5e4i0qj6pcKVWdimA_9_6">386</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_Jyd-Y0BHzUyyU9iY1KidSA_9_10">2,787</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_BxyNEwev5E2SfrAhgBx19Q_12_2">2,076</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_4efmSlL9iEqnCadQQnJbZg_12_4">2,539</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_KVpSsuFSoUiAWz3F0zK09w_12_6">10,828</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_7MB1rSb2-k-nugaZu38JIg_12_8">5,849</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_El8QqdU48EeylSHF934dCg_12_10">21,291</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_857XTQXm9EOmkOVDlxx8Qg_13_8">19,297</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_1g83KVhK5k291d83IAJeVg_13_10">19,297</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_a6c12974_a05f_4a40_887a_3dde0082f8f5"></a><a id="Tc_STdkUh0W30WPG9HctpAvSg_1_2"></a><a id="Tc_W0uOR5_Pe0CaxuTkW8XtyA_2_0"></a><a id="Tc_Iwzamrcb90GGt09AQmmfWg_2_2"></a><a id="Tc_wbo60Lezqkq-BDvGw1qxlw_2_4"></a><a id="Tc_F9PF613WOkKf50z8RAJYPg_2_6"></a><a id="Tc_yEt3HfGZMkGYt0CZNIsryg_2_8"></a><a id="Tc_uO_-r30D-ECnuCA4r8bF4Q_2_10"></a><a id="Tc_hUd3aQyxm0OJ2MlndRVJiA_3_0"></a><a id="Tc_6cTCDFYNVUyK7PrEdkmXaA_3_8"></a><a id="Tc_Ut38KQKc20uXzmH4c3G5oA_5_0"></a><a id="Tc_OG20_kP6EkOhyW3vVf-qyg_7_0"></a><a id="Tc_hMpYNqBFl0io1I47maSkEA_8_0"></a><a id="Tc_P3aUrKGgs0eQr0VEHS-a1Q_9_0"></a><a id="Tc_Le9DRPYjakW84E8d-AGN6g_9_4"></a><a id="Tc_AhTMxB8tCUqsPLyPCK9INw_11_0"></a><a id="Tc_-yp6L1FlLEKrcT7YodV4Og_12_0"></a><a id="Tc_3aG-uzcR3EKZvvOumefkrQ_13_0"></a><a id="Tc_0-aNr2hLeU-AlI-9gcpyFQ_13_2"></a><a id="Tc_953EqVJUlEOYMs4yv5emVw_13_4"></a><a id="Tc_SuqMqdErfEyulN25vykKWg_13_6"></a><a id="_7fc151e6_5046_4b8f_bd30_b3ee6a77e65d"></a><a id="Tc_zD7qVgyAC021MydX3szPsQ_1_2"></a><a id="Tc_UfKPDhrH1Ue-6bVFDuIyvA_2_0"></a><a id="Tc_5tj3cNfTUUaul7ryKjFN5w_2_2"></a><a id="Tc_Xx2uGVHCnUWK0FHCfSSxHw_2_4"></a><a id="Tc_7-fV9jB7QU6axNFpnlv2sQ_2_6"></a><a id="Tc_8kUvMg04bUOi-UHuRNz1KA_2_8"></a><a id="Tc_LAh9ECf8VUeKRjyz02gA5w_3_0"></a><a id="Tc_41m_eW0kkUaCXQ496J-XZQ_3_6"></a><a id="Tc_KkdTqL5ROEGbyqR_hPxkZA_5_0"></a><a id="Tc_uOfk4lgYXUqIiHNhNCrtHg_7_0"></a><a id="Tc_Y6wCKWM3fE-gItnKyiRyPA_8_0"></a><a id="Tc_BXHgTbuTuEGA_R0__8c6Rw_9_0"></a><a id="Tc_6OCLib36C0isEqES7_oeCA_9_4"></a><a id="Tc_LCGpl1mNjkiPhATIWc5UOg_11_0"></a><a id="Tc_8wC0hFNx7U-Wpek5T5bJ4w_12_0"></a><a id="Tc_M1QnaswEtEOpAtjn8v8zmg_13_0"></a><a id="Tc_zU3_SgIrNkmHKM_GC-x3eg_13_2"></a><a id="Tc_ayNLt4YlxEyT1k60h8qihQ_13_4"></a><ix:continuation id="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont1" continuedAt="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont2"><ix:continuation id="Group_SLzNYBk83k6Si3ccfGKfuA_cont1" continuedAt="Group_SLzNYBk83k6Si3ccfGKfuA_2"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19 </b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_epU5IxDhC0eW_zgC-QHBDA_3_2">16,951</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_i-Gp51oIvkCtEQFRKE9vyA_3_4">22,108</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vN-7Edu_qEGP7sYzn9mKUA_3_6">89,322</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_NyDA1ogoTki5EE_In6o16g_3_10">128,381</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_sAcTpLP3wk6dnOPc67UHfA_5_2">6,194</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" sign="-" scale="3" id="Tc_kcrrKQU8ukibaFE-xphLOw_5_4">2,408</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_SDLIShmSzUKnAqp-c0cx3g_5_6">37,215</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" sign="-" scale="3" id="Tc_nfwRGDIGxUazNVy6Qk-pUw_5_8">39,918</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_KwIp1Btrrk2wTLE5ofL2SQ_5_10">1,083</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_D7q703es10uHSAI9cst52w_8_2">333</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_d3UZSgVYaUOti3s6b7HkFw_8_4">602</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_wtGyJRnNZEqY7gHmwHkSNg_8_6">9,113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_QACaBAT6AUO8Pk7dh78YKA_8_8">2,682</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_GqiNF8sC1kizlAOrxdMHIw_8_10">12,730</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_08tLJLmWV02F6toQugtOCQ_9_2">3,183</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_WdfqTy07JkmFGos1sRUeBA_9_6">1,672</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_tBrgJPSankKF6LR3LOVpHg_9_8">1,802</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_PMWuffbankKZljCWaqQ5GQ_9_10">6,657</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_BA2nKtqX5k-k32GxzknPDg_12_2">6,769</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_V8Ddy_jnCU-PL2K9AmkmWg_12_4">2,289</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc__N7vZdoYCE6_OV7nAsXkmQ_12_6">1,400</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_I_pMT3AjL0-UxcZYWxQuhg_12_8">4,670</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_DbJLxsFsl0yo7fWlXV0JAg_12_10">15,128</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_ltySzAw4T0i3wk4wXhykMg_13_8">14,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_iKJ9D8CCmUuVPEABKKOcsw_13_10">14,935</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:47.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_n82iOyhD8kuzYg-qoHiJ9w_3_2">21,522</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vHJz9kCjmk-WE2pCLcHVbg_3_4">27,258</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_qfNw_Wc7Rk-YS5OUqAHvqw_3_8">48,780</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_Ip2_2kqqck-K-SI7BSvjDw_5_2">14,956</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="Tc_OHAe9QQu3EuSW-wwNGv3tg_5_4">2,306</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" sign="-" scale="3" id="Tc_OBTaXfs9J0GNviSEgfA0-g_5_6">22,949</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" sign="-" scale="3" id="Tc_Zh17cilDXECsjYuLGbmMfw_5_8">5,687</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_TktUgaD9VkuXV7G4mv6e4A_8_2">1,362</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_8vHIIPvVAkeUJBQNLB3vPA_8_4">1,998</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_2KNQ8WJio0GGB-uWwcfp2Q_8_6">17,908</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" scale="3" id="Tc_XR6qjtetfUuWJwBJQ79YyQ_8_8">21,268</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_ijx2LsSWP0K2XvU9VD0D1w_9_2">3,603</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_SIRZkSM-pE6a_U26RrNlFg_9_6">3,677</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_ZtImMSrWtEeWh2TzOzzxxA_9_8">7,280</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_sCrgdvRvUEGOnsbJCKGB1g_12_2">1,308</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_KrjmzBgCVU28bKhQbFPKTg_12_4">2,032</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_ZiJyWA5O80SaQZWOqSwwZw_12_6">3,239</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_1-EaA4c5HEKySFXm7MlCmg_12_8">6,579</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_waqtHfTlBkOjPeQijltmeA_13_6">9,590</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_uVrgoDj7vkiBgvKLApWenQ_13_8">9,590</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:7.1pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:28.9pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As discussed in note 2, in March 2020 the Group commenced testing for COVID-19 in response to the COVID-19 pandemic and in the third quarter started managing and reporting the COVID-19 business as a separate segment. As such, the Group did not have any activities related to the COVID-19 business prior to 2020 and retrospective presentation in prior year segment reporting is not applicable. </span></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Adjustments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Adjustments include non-cash charges in relation to depreciation, amortization (including impairments), and share-based payments as well as net financial costs, and income taxes. Certain costs, and related income, are not allocated to our reporting segment results and represent the residual operating activities of the Group reported as &#8216;Corporate&#8217;. These include corporate overheads, which are responsible for centralized functions such as communications, information technology, facilities, legal, finance and accounting, insurance (D&amp;O), human resources, business development and strategic initiatives, certain professional and consulting services, procurement, research and development and other supporting activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Corporate expenses also includes expenses incurred in relation to capital raising activities. For the year ended December 31, 2021, <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Narr_gCPdXn3jFkWozmbOkFYa7Q">no</ix:nonFraction> expenses were incurred (2020 July Offering: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_h1P9Uyda7EyoO2LPxzrHJg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Narr_rWGOyTRprEiVMm350u67pg">278</ix:nonFraction>k ; 2019 IPO: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_IfrsIPOMember_d-_7q8doLUSyk01ZAKC7zA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Narr_yq1kskiCuUC7y2Vhg4574w">1,092</ix:nonFraction>k) (see note 8.2). The corporate expenses for the year ended December 31, 2019 also includes a real estate transfer tax of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:RealEstateTransferTaxExpenses" scale="3" id="Narr_fvayHq6PW064LGztSv57QA">1,200</ix:nonFraction>k related to an intercompany sale of land and building (see note 13).</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_461a9643_4c1f_40e7_8170_6b2571a1f334"></a><a id="Tc_UqH2vUsac0uEMzkL996sAQ_1_0"></a><a id="Tc_-adHICiPKUuvvxoks0U9mA_1_2"></a><a id="Tc_JP6SisENjUWjVg21zwmuHA_1_4"></a><a id="Tc_GnWE2x8I7Uiq3KJ3BWI9lA_1_6"></a><a id="Tc_0Wc3rRPi3UaFfY0zDQuOFg_2_0"></a><a id="Tc_ccgAhEpuAEeLMnGT_9QxFg_3_0"></a><a id="Tc_fQI7-AHakUyHDbmsJYLXGQ_5_0"></a><a id="Tc_03YaBb6b30axeNU5tbXd2A_6_0"></a><a id="Tc_D2g4icBNPka1d0YsSOOC3g_7_0"></a><a id="Tc_uw44lXBZ8kGxVv2LA70gwA_8_0"></a><a id="Tc_qTo2mrYJrk63qHUJEzB9mw_9_0"></a><a id="Tc__XYO0Kp3bUifW1_LEEPm8w_10_0"></a><a id="_ed76e420_6d71_4751_95fe_0521ba66a768"></a><a id="Tc_JUxWxyA_nE-v8w0MmIY-fA_1_0"></a><a id="Tc_g7x29dQfK0SD-UYP9nJntQ_1_2"></a><a id="Tc_WAx5HglhZUai-bF0cYnu0g_2_2"></a><a id="Tc_1K2FfDMdZU2MCTuX16Uijw_2_4"></a><a id="Tc_av84YSulvEWuzFelBx3MUg_2_6"></a><a id="Tc_ZQGhdlCHjUiDg8U07yCCZw_2_8"></a><a id="Tc_vR5lTgBPvUSWtsPYiRDlkw_3_0"></a><a id="Tc_Fq6cJic89kWqEQCsuam-jw_4_0"></a><a id="Tc_LLzaf9IvHUWMIqODl78GaA_4_4"></a><a id="Tc_k_ZoHWQuWky7xWZbgM3Ebw_5_0"></a><a id="Tc_Yu_xVQzClE-d2rt5SoxjNQ_7_0"></a><a id="Tc_KRhNf4vI4kiUPNiVcbGJpQ_8_0"></a><a id="Tc_XvL0NVeN7U6cA48dzPlWOQ_8_4"></a><a id="Tc_BgcIlCHWBUCDcIaZVVE0gw_9_0"></a><a id="Tc_SG11qLsbSEmr2BtHN7vO5A_11_0"></a><a id="Tc_Hka_zBbKHEaYDjw59wqSHA_12_0"></a><a id="Tc_pnYuzp99SU-r5JzLgZZiGQ_13_0"></a><a id="Tc_7wcVgQMEOkS3QemsqZ7dDA_13_2"></a><a id="Tc_lTlyS9rA8EaLn0wQBn7BeQ_14_0"></a><a id="Tc_0eZTsdfHIU-HTQARjcJW8g_14_2"></a><a id="Tc_c80qQc-NO0ucRg1YPjicTQ_15_0"></a><a id="Tc_jV94zJoGoEmATuPccYR3LQ_15_6"></a><a id="Tc_yEXJ-wjO40-BM8l4LJmVag_16_0"></a><a id="Tc_t148pOCB8kOPQL3VmtXGlA_17_0"></a><a id="Tc_LhcDIaDFY0up6RSSWBojBg_18_0"></a><a id="Tc_P6VDE0JXFEm-WX7ftJ2JXQ_18_6"></a><a id="Tc_iPK-R_RnZUqyS-NNkyAdxg_19_0"></a><a id="Tc_YfzX-mTFLkq4dBcDfYuqeg_19_2"></a><a id="Tc_vokGsz08_kai5gP50g3ykQ_20_0"></a><ix:continuation id="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont2" continuedAt="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont3"><ix:continuation id="Group_SLzNYBk83k6Si3ccfGKfuA_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Reconciliation of segment Adjusted EBITDA to Group loss for the period</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reportable segment Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" scale="3" id="Tc_v7UZ_oS2RUi1wSjZcSb1rw_2_2">29,545</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" scale="3" id="Tc_5TRNCr1PcEW69B-_c2iPlQ_2_4">41,001</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" scale="3" id="Tc_s7-0A47inEeWhDMevt7D5Q_2_6">17,262</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Corporate expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdministrativeExpense" scale="3" id="Tc_BZXHwepcrUWwjthabQjV0w_3_2">46,247</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdministrativeExpense" scale="3" id="Tc_uLw6PZOTG0S_3o0ozQJMHg_3_4">39,918</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdministrativeExpense" scale="3" id="Tc_SCEbno8n_kisSUphBI7otQ_3_6">22,949</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" sign="-" scale="3" id="Tc_fv-Dok8prU-KkQrEVwgWCQ_4_2">16,702</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" scale="3" id="Tc_J3adgAfPsEC7VkDrxif6ZA_4_4">1,083</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" sign="-" scale="3" id="Tc_9SIhYrPynUyOtirACmUxzg_4_6">5,687</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payment expenses (Note 20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_2eYckct7zEO-8jBTYOIllw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Tc_b2FXIQGK3UyQmmVbj9b_Dg_5_2">8,035</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_3jNAkLwyqECFEAQq580h_A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Tc_LgiFsrBpu0mt-rvJKcgTZw_5_4">5,658</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_gS9HG6od70ei9gUMi0zxBw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Tc_Y-7zgQ_NR0OaIPcSFK9EtA_5_6">6,418</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_Iz_MtPVKxkKthZpts8RjoA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_FSlysEEiLkSV_E70OeDtYg_6_2">21,291</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_f4ic3iZXSU6dqSWwhtj5RA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_u82FPKsN80Ov5drySXVEmw_6_4">15,128</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_yMvM3I89g0uOJQ1FgVa7uw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="3" id="Tc_TfIKTYce30W0T9v_ttOm3g_6_6">6,579</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_3B8MCvPqek-sTnh15Pydqg_7_2">46,028</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_V8EdBWiMR0CaMSgHRi9c5w_7_4">19,703</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_O05x4K1SHUiCu1VN3Lh2sA_7_6">18,684</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financial costs, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_SjVPy9Eyz0WtdRsNtca7yQ_8_2">848</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_SvR1Ernmq02EAZ4viwCMhQ_8_4">1,394</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_FThgoFCElUuqX3N-oEWP8A_8_6">2,013</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" sign="-" scale="3" id="Tc_WPFj22i7DkqpFu3CsgEMXA_9_2">24</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_jKlL6WzE_UqMoh2CKtwLLA_9_4">281</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_mCQtlnx7CEqIXU4wmhDacQ_9_6">158</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss for the year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_yw-Tjtzg40eUZbzoY_DENw_10_2">46,852</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_V1dodp0zpU6RYeq79N5GDQ_10_4">21,378</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_ovxlxiTv-ki7UXhZOn36bQ_10_6">20,855</ix:nonFraction>)</b></p></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Non-current asset locations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Non-current assets of the Group consist of right-of-use assets (under IFRS 16), property, plant and equipment, as well as intangible assets. All of such assets are located in Germany, which is the country of the business address of the Centogene GmbH, except for property, plant and equipment of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_kpzFl95A4Eihik8AD-vh0Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Narr_U1YSn99VU0uBBS5ULegNQw">147</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_eqR6NyQJOkW920BqJk1jTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Narr_ZvjiY0qkNE-v1PR-aZWgnA">516</ix:nonFraction>k; 2019: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_FJL5PQArUkCuYTb_22g-4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Narr_0Ce8ef3U_E6YnYbZKCP5CA">286</ix:nonFraction>k) and right-of-use assets of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_kpzFl95A4Eihik8AD-vh0Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Narr_8I93HuMDhUWUeX129FrrFg">137</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_eqR6NyQJOkW920BqJk1jTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Narr_BYmAj3A3ZEGUbqS4A2LSNg">709</ix:nonFraction>k; 2019: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_FJL5PQArUkCuYTb_22g-4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Narr_c9GRrUxXPEeWMg2y3GEqXg">1,042</ix:nonFraction>k), which are located in the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">7.2 Revenue from contracts with customers</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" id="Tb_8SVUtQypPkKymb0tpY15Jg" continuedAt="Tb_8SVUtQypPkKymb0tpY15Jg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_oxpR1Yp8EkG5vb1G99OvVg_3_2">14,879</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_vdrEryrgf0iYVrKL6-nySQ_3_4">27,900</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_PTiu4FrXsUOkBQgyhpnYig_3_6">146,380</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_1QkGkLPYVkOdGhE7Jon4SA_3_8">189,159</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_jiimMwq6RU-Wt3ChZl5wXQ_4_2">762</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_GoDSPayRWUGxOPI2FyC0_A_4_6">2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_uijL1yjQb0urngRSyE8Fuw_4_8">764</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_2cGxwXY_pEGGdlRm9-DsRQ_5_2">15,641</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_1qt6K85m_0C60a-p2vXtZQ_5_4">27,900</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ytoUaHhIC0yp0xLQFOoR-w_5_6">146,382</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_eUzNamP2KkyfSE-kwkFqoQ_5_8">189,923</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_rP9H_6ZxBUiMxdA5czmkLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_XvbaX9aBx0WRxwwLb7hQTA_7_2">14,879</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_UQLS1jqBcUaiRdVG9-LbFQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_YOPbt2BSjk2jBBVJVlvRkw_7_4">27,900</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_mMrEFk5yCEeTQec-FbsYew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_8KX5wD_sOkGULyG2zOpcwA_7_6">19,131</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Ybu5gGcGb0CLhwhCRJoJzQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_s7G6_aLf_UKRF_xgHOMa2A_7_8">61,910</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3ijtgqtaKE687iwfHUfycw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_-3SFV3YHBEGN-ihpMdC8WA_8_2">762</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mdFt7GHH9kCbATPAUndvBQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_DWsyMCJLo02Lp0xQbGOnKw_8_6">127,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3R-RJj8W30CmqBQ9_P-L6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_X1M-zwz9akCbExg-raSzLw_8_8">128,013</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_6-UJMD7vAkaCQb_XPCBLcg_9_2">15,641</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_RBIsoCMg9EmWMaBoQgecmw_9_4">27,900</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vQHhseR2gEGpnzcEbInIVw_9_6">146,382</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_aZBboYzmp06DgaDRZRDorQ_9_8">189,923</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_0EhnM-nI9U60TimMN9cS6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_m_H12tJANUimXNq77T-_nA_12_2">490</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_t5U2pU1llkyqTaF2VHf4kQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vsEDVvDg6ku8wqB4ucBqAw_12_4">5,425</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_r9aWl2b-v0OSqz3If8MAOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_x9fb_UVBG0-zqVLfJE6PjA_12_6">144,669</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_cOG0cWgzz0yXAS58I-gQ_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_6BXUKssdsUeWzKah1Bwliw_12_8">150,584</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Germany*#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_clx9prwtLE2o24g-cVlXXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_92pVNsk20kOnUc3UqLkH1w_13_4">211</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_cV4yyZGsZUiiKrDyDu6AAw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_NfEwQjVNcEK4kXhwgqQ4mA_13_6">140,922</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_gQTQ8dl_nkqEQsnhaCYVXg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_8ci5rZjVikuUDCHTimKq4g_13_8">141,133</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_st_41JliCE2l_ojbTOAjxg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Du0cpQB1rUivHYg51GmdeQ_14_4">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_Bo1twD2K6U6g1a4dtlQlRg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_iCWci3pbOEuVPvh0iTdecQ_14_6">3,616</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_HinXUd8jiU-OqKDtmHiBBA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_QhLnzDphBEq2AyL7uK-JRg_14_8">3,622</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hWWVNS2x5kyprvvsloH-qg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_zO1f_QYW4kG7STRaBrli8A_15_2">117</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HT11Yq7HqEiuy71IFa5GQg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ElOv1TrebEq6b67f6B8z5Q_15_4">16,315</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_6jOQBXEji0iws7Kj-GYZLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_3HHfWZD1oUmg_4lv4JDR7g_15_8">16,432</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_3QEbeOJ5BkaO7w7EMQ7ebw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_e1Wqu2D5mUS5S4OpJ3AaTg_16_2">14,940</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_npNxfNEcOEiHMRcMz1OMNQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Zo5QW2IS3kSgjAopDxwoiA_16_4">2,950</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_PCFksdHhDEW2XtLHDI7Jvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_IG7IBEhoGEO41yWoLiGErw_16_6">1,606</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_9xKbq0HvrE23nctfL9kqJw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_FULwdPVKUUuJZRCzcmA1ug_16_8">19,496</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_8iKdtQU-_Eu7d8Hvzi8aSw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vWvI-QE0kkWgQKJPlI71-w_17_2">14,940</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sey9N6DwsECg7Y8DnOwQ7g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ZnvhfT0QiUKxOIacMYE22g_17_4">2,763</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_DOZiypy0h0yBjpMQ3UPvww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_OLK-TLEPMUKoVjDFt8J2Mw_17_6">1,606</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_wr28CgnaFUihv57zlIv9nw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_GDs5IZF28k-xnOzynhNQHw_17_8">19,309</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hY1buzymRUmo804bWIJEcw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_jpbxoebsyEW-v2l-LfECtg_18_2">94</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_-Trx4lnT9EqhKeaem--7cw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_P2TRCrPr_U2GfZF-oyMCjg_18_4">2,499</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_uhttJnikwUygDyIGsX0K2w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_-df86GhYckKjk1RcQ_bKHA_18_8">2,593</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_D52k1rmdSkSQ8eJxUeQTMg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_yAbg5r3IfUqAu8zRHKOymw_19_4">711</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_5om3Tuoy6U67GcuWFQxn_w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_78x44yBJsEiCCT7l5Ydumg_19_6">107</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_khmhDdbQsUmgB98c9HcKgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_PjCE8GTNHkCkcDlPs6sjFQ_19_8">818</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_xRJMr3vRDkuKKk97xy650A_20_2">15,641</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_g5Za1l0nBUad7HtrGEsS-g_20_4">27,900</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_jHwYRLRAmECAPl8ROmFRww_20_6">146,382</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Jif0mLHN1UmmlFXEmQFuRg_20_8">189,923</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_cc5955a4_4f62_41b1_a624_b34275ea85ba"></a><a id="Tc_3rYSeIbjbESL22lhuYc0Ng_1_2"></a><a id="Tc_Abbs0pEz6UiqvD1tntqEeA_2_2"></a><a id="Tc_XFy4YtzysESDxrVRGkhQGg_2_4"></a><a id="Tc_qa6CYZXRf0yweJFuxOOqHQ_2_6"></a><a id="Tc_vxY2b-njcEa8ihcyS4ExhA_2_8"></a><a id="Tc_hstQ409HwkG2s7LCv6G5TQ_3_0"></a><a id="Tc_N9e2j0-ZqUWNMuU7UaoPdQ_4_0"></a><a id="Tc_JiCJ4anMjkijzKw_2twy4w_4_4"></a><a id="Tc_ldgQIT4SIkGsJY781SJbzQ_5_0"></a><a id="Tc_KyzfX9cWm0eUfjAzPVxLpw_7_0"></a><a id="Tc_2wMRm8L1ukKS2BMNutUoow_8_0"></a><a id="Tc_ahuAzLG_CUyQdeEpG-M7-A_8_4"></a><a id="Tc_jkKHlSDLsUGhSYtf0AkSZQ_9_0"></a><a id="Tc_Wg5hgcViJ06PS9KTCy-6dw_11_0"></a><a id="Tc_fu4Q64QM6EmdMq6iIk7tLA_12_0"></a><a id="Tc_hKa8glNWREWwWoWFvZNg9g_13_0"></a><a id="Tc_cTuM5bo1NEWLOQpI34O-mA_13_2"></a><a id="Tc_PTfypgYRV06txsvKrKInaw_14_0"></a><a id="Tc_Tgv-tr98y0OEw0nsl6EvfA_14_2"></a><a id="Tc_l9M6roepkkOPF_RagMQAYQ_15_0"></a><a id="Tc_DDkDWCoQZU-wO8BdJZgKBg_15_6"></a><a id="Tc_oWOh4pGXO0i3sgQ4PzlwRQ_16_0"></a><a id="Tc_UvnaLtj0tEaz158YVjFo-A_17_0"></a><a id="Tc_w3yQk_bdpkSi3pcGav-XNA_18_0"></a><a id="Tc_ewRPIpgGVUOwFCfsRnFkRg_19_0"></a><a id="Tc_Fk1e4aSSf0myi-8oK2-3qA_19_2"></a><a id="Tc_E2tg_EmG8UOn9o2XqFbgSQ_20_0"></a><a id="_47f559f0_e858_4f88_b6d8_4025216e0119"></a><a id="Tc_GksMw8yHPEi3QCxLS15vww_1_0"></a><a id="Tc_KcrDPT8Qek-H36LL5fQ1SQ_1_2"></a><a id="Tc_bYyH_eFyoEab2glu4PXsTw_2_2"></a><a id="Tc_rikxO9UyeEWb3bOI4n37eg_2_4"></a><a id="Tc_NHAulfCC40SFIYIYRic7Eg_2_6"></a><a id="Tc_BX8Xqfcq2E-yyokdU2hJHg_3_0"></a><a id="Tc_3V5pIvNAlEGjIzBHYaFQCg_4_0"></a><a id="Tc_tpFjj3_4xEmKcgrl7lbQHw_4_4"></a><a id="Tc_JeUsEY3dO0erniKNxc6lPg_5_0"></a><a id="Tc_mPND4WFFuEeGaUv1nj-qkw_7_0"></a><a id="Tc_UXOur6iqUUOP4_Ypw2E8iw_8_0"></a><a id="Tc_npi4w2AgREOu6JI6tsCbkA_8_4"></a><a id="Tc_1BlVRgSWY0CQVfCnLKFezw_9_0"></a><a id="Tc_PrFbRgefZUieI1iFXiETyQ_11_0"></a><a id="Tc_U-cvVuLVpkiysmeNkL3bdg_12_0"></a><a id="Tc_2cait86yhUm53xq4CAhMpw_13_0"></a><a id="Tc_5I3qRdhW4UKSMV__1yWvJA_14_0"></a><a id="Tc_r8kFQXRgJkWUrEXOulJxXA_14_2"></a><a id="Tc_kMS2NeLfZEy0DPbRY82NdQ_15_0"></a><a id="Tc_cM5P3X0CZ02acEjfp_eHBA_16_0"></a><a id="Tc_13HoyxlWtE2X-WnbaXV1dQ_16_2"></a><a id="Tc_xS5f1weWe0K3HvX3DSjA2g_17_0"></a><a id="Tc_02ij3ey2UkCK3O6F8X940A_18_0"></a><a id="Tc_GJxGQCLZaUOtWDzL3htMLw_19_0"></a><a id="Tc_1HE_dZUkQU-Ok9UXlGWYHA_20_0"></a><a id="Tc_m6jTOHLuCE6vpup-KyJwbQ_20_2"></a><a id="Tc_sKUeSl8mOEmQ-aycyb2mvg_21_0"></a><ix:continuation id="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont3" continuedAt="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont4"><ix:continuation id="Tb_8SVUtQypPkKymb0tpY15Jg_cont1" continuedAt="Tb_8SVUtQypPkKymb0tpY15Jg_cont2"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">                                                          </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_WzEfcy9FAk2mBd6laj28eA_3_2">15,947</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_RqwSVSnbekmz2bqjjK-Vzw_3_4">22,108</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_16kri3KP80er17SmVnzkww_3_6">88,587</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_ZZWk6TRRX02tasVfWN68ZQ_3_8">126,642</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_XjAZYe-l6kam65iemkVrPg_4_2">1,004</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_wzsj0i0hs0i83huVlDpp2g_4_6">735</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_N2nIGdVjc0K7FNqp7yJmCQ_4_8">1,739</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_H8NeQFBKPUS0UPXUFrv5yg_5_2">16,951</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_b3M8r_P1MEmAOHOVZM3MRw_5_4">22,108</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_B9xdDqtFlky-rleRSkBDLg_5_6">89,322</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_upEwo_2wMUqDI-UikvZvUA_5_8">128,381</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_W3F58Jfx80ii3Fx2Pkj0bg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_FkcED2gI-UC55J4LClZakg_7_2">15,947</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_HHPssicdQUqnZ5X69XqpQA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_y-6caKsGg0KjnkrC6s7_7A_7_4">22,108</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_dIyWF4ygA0iQzM7wM628QQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_knBqGJvUJkiRVlDMtyfGQQ_7_6">24,684</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_n86T_jTggkKRt30kBqsVZw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_p9ge-8yw1UiB4bDQ14p8cw_7_8">62,739</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_iS_M28fhFE6M9oKHCruHBg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_81DDU7Fg2kyHyh6OkxNUpQ_8_2">1,004</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_OiigMHAcVkuVDMVMzBsepg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_2swhiELYMUC8cO4eAgylKw_8_6">64,638</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mVhL40cYQEePQ61JZHkZ5g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_PzraEugssE2uMAeVNalUiA_8_8">65,642</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_UP3Q2F9H50yW_PicALOQQg_9_2">16,951</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_A4c4sRpksE2UdPHjDlRv2A_9_4">22,108</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_2HrgsbsDR0CBCq5dOfBHSQ_9_6">89,322</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_NIsul4cvRUiDCYyk1M-K1A_9_8">128,381</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Pq1dqziFrECoxJA6IUPO0A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_yRsAtrAcZk2Msk1UkPZZbg_12_2">149</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_g9Q4KqtnV0uSsn7ARpe8uA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_-Xi7z3g-mku4Yxo6mPUYTg_12_4">5,605</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_RO2fs0emCUu9jR98AuIlGw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_g9Mgba8HX0eroJ7506xGfQ_12_6">88,314</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_c1SgMStWuEuH_usbmcBK0w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_-YeRz4HSoUGnX8bnsHh0VA_12_8">94,068</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;Germany*#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ZXy9HwJvXUaEjtHUhuk8ow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_08xh4P5zjUOEojHK9Uxp3A_13_4">186</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_McmJjgE_k0alVLPoqAURaw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_9N4qoArICEiWb79h5mHLyg_13_6">80,879</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Z8iyfz_ZhEyQVS1VVRoDQQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_6leY_yFJ2UyIqRI-V0qhKg_13_8">81,065</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_5aArgCY3JUK83G5Z3yyuaA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_oLY8H-3CoUywFedSG6pHzw_14_4">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_zy3jWFs1Ikq8JSLXUCeHJQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_klsSY23wOE6a93F31Z2Smg_14_6">6,572</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_80vPPmzZsEK-rHwOiITf5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_f-vWo8BFmEutI1BWoxGwWg_14_8">6,575</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_HkDJI80zTkuUmk--Ej4yXw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_NweX7W0EqEOe_TxrHV7aag_15_2">56</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_jPRbVhHuNkuHoAHPHl0FHA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_gi47sxyQQ02-_igjIUzFvg_15_4">12,568</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember__5AEW953l0KC20ixoMs7ow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_okf2xhYoLE-Fk3Wnk_nH3Q_15_8">12,624</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Ys662UuLNkyBTJCZFPfCxg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_VWJLAPPJwUSH4wqNV1Hm3g_16_2">16,711</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ythndJ_8XEOkXQ82UmIkkQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_LBCNfHa8hk-3ZMyas8sSZQ_16_4">1,576</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_pCwwsigl0U2m5E7-eDM8uA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_QaIXYKFa4UuyrlKgVMtQ-Q_16_6">978</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_4JRA7asUB0ioKSQ0gqeV8A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_tCmrKtEkNkm3hlGbZ2mH5w_16_8">19,265</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_6zdpYcOa-ESFJJRwZE-Oag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_P_ETtWDmrUiwlJtJ9SYCnQ_17_2">16,711</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_l03HHyyeUEi1A6xEJ5Edmg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_AtG9-LxquUKSqPqbJ4qeSQ_17_4">1,370</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_R_eEBY9qmE-NM3Tvk2KDqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_PapinNsdGki4zUHeLtDYwA_17_6">978</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ROnDIAnWzk-FwbKaqoEgXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_t3PENPP_NEyLYnet5zJQKg_17_8">19,059</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PF_KqP6LSESi2HEzjtBOPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_NPAS0k0VBkOMfGcnZ5V0hA_18_2">35</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HrC70U1Yj0u0D_A7_q4GXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Sa6474KYOE2zB2inot8iDQ_18_4">1,851</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_hrmD1qRunUmmMLok8OgVQQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_HZqct216hkWyV1qg3XYAkw_18_6">2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_oREizo1DqkCFGwT7ENil_w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_BDGNurnjK0iCU6Wbahdu5Q_18_8">1,888</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_q9a-MHMvKUK5U_xsAmy2MQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_JYxKnoCYUUySErq0TJIEqA_19_4">508</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_i4C0ubETiUCzWqGtU1jx2g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_6DBHW2vvGUq4IfJHmZgRNA_19_6">28</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_j0CQFn_gS0GfVtrcdtpKYA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vvLsyXU6xUCjQQhhla2lug_19_8">536</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_VWWxczorsEaflaBPtipamA_20_2">16,951</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_VUbkYhioX0i88se4LsUsPA_20_4">22,108</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_fKOz07qWLUmxCykAVwSsNw_20_6">89,322</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_jQvYtpx36UCcrm5OeH11iA_20_8">128,381</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_tEbVgBUGHEGauNg7CeG1aQ_3_2">19,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_PP2mOoRDY0aQ4KvOX3FB8Q_3_4">27,258</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="3" id="Tc_FvP2OR7TRUOO3zFLOKJY5g_3_6">46,347</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_7_6NpjMkg0-a-QGlXanbUw_4_2">2,433</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="3" id="Tc_3GgsjFCduEKiaM37cpIQiA_4_6">2,433</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_7fKnhPXA_U-oamgVCRi4Dw_5_2">21,522</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_dgb5s75L-UW838cCq_q4xg_5_4">27,258</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_hqXjsxZcwkWSY7WaOSAC6w_5_6">48,780</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Gn5qMK_C4UePkU4n8Ymluw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_mknhD3AMJUmXI_4bgDH2kw_7_2">17,159</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Oy3dJv22rkSAReGZRjnSUA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_dJ9F-4JqHUmqNE9xBLEqmQ_7_4">27,258</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_D-7kMsmp8Uer11pu6XnQCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_AuoMcuCRnkyEfk-_HAFLzw_7_6">44,417</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_FeVjB1MUOEeh9_f7uvi5AA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_nvGwD466BUmEBtDr0CueeQ_8_2">4,363</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_fKiyneNNIEaYn8UkC13EtA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_tJVeLTCsXUWD-QHpNdw40A_8_6">4,363</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_0OgYlSBwD0uJii_i30FXwQ_9_2">21,522</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_UDspRZ9Cv0KhljVqRZKcAA_9_4">27,258</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_KPhTpHbLLEadKCtTsI29VA_9_6">48,780</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_9Ui5l_nU70uEou7uc-87Jw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_onPiO_yhK0Wa134YYTUaZg_12_2">381</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RI1XvAcXBkW1sMvmWPyezA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_jBklO6hv8ky97w7cJL7cnw_12_4">7,066</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_OeyM4bZnmk-KdBoTF1lVhQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_KBzkRvyQz0WQunRP0nSiFA_12_6">7,447</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Germany*</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hgIa0VboT0mS4D8xJQpCCg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_rg6eE_0MB02_u_7tRWy8ZA_13_2">233</ix:nonFraction></i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_DO-kg8eAVE-lWMef-KoDVQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_VjsXzgcN2k6nNLJlq1OhWA_13_4">275</ix:nonFraction></i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_tYw_3cgR1Ueq-Gbz16oQHg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_CyXjBwMHK0-A49d6WmwkFA_13_6">508</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> &#8212;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_wJkGwu7MkUC7XJrNmADbTA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_6DbfIh8aM0e6YbpfFnWUBg_14_4">25</ix:nonFraction></i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_Uoe9zKqJoESD7LidLdm1YA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_tsxk9zbVFkiIfE0OmIPVlw_14_6">25</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ZnrF_dp5Y0KfdoqcK2Js3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_SyHJ-UwFUkK0wVHBmWFnEw_15_2">122</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_7PcrTsViCkCTYuQCigBbTw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ax96Pwcqv0iw2yjANW65dg_15_4">13,977</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_v3fS0Y4zQ0uHtd_W4YK3ng" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_GBN_GVvF4EWmhfNEoSq57w_15_6">14,099</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">&#8212;<i style="font-style:italic;">Saudi Arabia#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> &#8212;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RZW3v4iO4kG8NHVW3fjBIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_bpxlYXfHzUqQrh9B7FGLVw_16_4">7,417</ix:nonFraction></i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_1IGbd19w8k2QJL4QJn5QLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_XnBw-xQ3iUqUDCNyI_2oMw_16_6">7,417</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_zA1NYJLwcUaXbGpQUDVDuQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_fXfaUM9E80CKBKvDQArnBw_17_2">20,896</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_gNfrmr6fLUixQ62x_Fwrew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_T0kcVIvMpk-2cGrYHAiwnw_17_4">2,380</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_tB9oEnXM7EW6ytrbi0USWw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_0zDioZ574kSCDFSsqFhoFg_17_6">23,276</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YTUjyWxrfkmjjtjGT1KC5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Tjq5J9WC9USbExOHmhpJfw_18_2">20,896</ix:nonFraction></i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_n9XhJgrCrEySPhrU20QprQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_EnGb4_hDAkyZ3_Ro4tq_pw_18_4">1,882</ix:nonFraction></i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_OP1UzlIcX0OmY9sJACaIww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_gK0DW3aH_UC6MyMPvnXWDg_18_6">22,778</ix:nonFraction></i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_AZFndmgY0UCwCIG8wtdz9g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_F_AFlfdX8EONPJzAnix9NA_19_2">123</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_km5pa8EmQ0OS81LK01_wkg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_meLwNgDfqEu94OtW41BNsQ_19_4">2,864</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_MTbFAzD3FUiK7SEe_WS1Jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ATaori8rrkSZT_Q7TTyWUg_19_6">2,987</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_azRhFhatK0S_v248GkC16A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ow3xz6sd90O7-YD5BVWRYA_20_4">971</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_N_D2fMybOEioJzSGBTNgVw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_r3zL7b8rjUaPhWfuj8GQ_Q_20_6">971</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ocK1NY_R7UCPc_BkWFNN1w_21_2">21,522</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_atm_E8_ZAUqwaJO05dvxGA_21_4">27,258</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_K3umCmGaEkKaSIkHqoYJMQ_21_6">48,780</ix:nonFraction></b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">*&#160;&#160;country of the incorporation of Centogene GmbH</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">**&#160;country of the incorporation of Centogene N.V.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">#&#160;&#160;&#160;&#160;countries contributing more than 10% of the Group&#39;s total consolidated revenues for the respective year ended December 31, 2021, 2020 or 2019 </p></ix:continuation></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_GGtL2jxH-Uu_wVEjukIOHA_1_0"></a><a id="Tc_NBhHqjRPUEed0jadvpN1iQ_1_2"></a><a id="Tc_C8wnHwc5Dk-jGExuWMH8OQ_1_4"></a><a id="Tc_3i7gC_enyku3TJYESNPcLw_2_0"></a><a id="Tc_XA1NTE6u2EGSYkkcUwnjFA_3_0"></a><a id="Tc_iUA7IP1auUCip71PUFBApA_4_0"></a><ix:continuation id="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont4" continuedAt="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont5"><ix:continuation id="Tb_8SVUtQypPkKymb0tpY15Jg_cont2"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group collaborated with the majority of our pharmaceutical partners on a worldwide basis in 2021, 2020 and 2019. In addition, in cases where our pharmaceutical partners are developing a new rare disease treatment, it is generally anticipated that the final approved treatment will be made available globally. As a result, we allocate the revenues of our pharmaceutical segment by geographical region by reference to the location where each pharmaceutical partner mainly operates, which is based on the region from which most of their revenues are generated. The allocation of revenues in our diagnostics and COVID-19 segments are based on the location of each customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmaceutical segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the&#160;year ended December&#160;31, 2021, revenues from <ix:nonFraction unitRef="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfCustomersInGroup" scale="0" id="Narr_WnIMK273fUWt8SgDFrLyPg">one</ix:nonFraction> pharmaceutical partner represented <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_0GJReRXlV0W3pRxWLTlB3Q">5.1</ix:nonFraction>% of the Group&#8217;s total revenues (2020: <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PGxsbLEs7UOMIWZf7Z03Zg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_VUsOFwg1WE2sEskrTjwiiA">8.6</ix:nonFraction>%; 2019: <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_sgzRGPjWTEKksOKAeqNcwg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_alYvYx6ZuEOdCidgO_6DpQ">24.3</ix:nonFraction>%).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December&#160;31, 2021, we entered into collaboration agreements with certain pharmaceutical partners, of which upfront fees of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Narr_jD9IhYjtVECbhY3fT_QMyw">455</ix:nonFraction>k were received in relation to setup fees which will be recognized as revenue over the period of the partnership collaboration. <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PGxsbLEs7UOMIWZf7Z03Zg" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Narr_rrXhNLxsLkimX9vKPiJtSA">No</ix:nonFraction> such payments were received or revenues recognized for the year ended December 31, 2020. During the year ended December 31, 2019, Centogene entered into several collaborations with pharmaceutical partners, of which upfront fees totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_sgzRGPjWTEKksOKAeqNcwg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Narr_dd2Hi5MMaUqEtfPhifLD1w">1,930</ix:nonFraction><span style="white-space:pre-wrap;">k were received.  Such upfront payments were recognized as revenues during the year as they represented the transaction price allocated to the one-off transfer of the Group&#8217;s intellectual property&#8212;provision of epidemiological insights of relevant rare diseases and relevant data. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2021, revenues from <ix:nonFraction unitRef="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfCustomersInGroup" scale="0" id="Narr_6uIWDsakd0mCqYpw9eyk_g">two</ix:nonFraction> COVID-19 partners represented <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_bm2QM3qwUEqolDwi7dS3oQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_U86HS5PHkUGKAb1hvZTSeA">6.4</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_XwVB5e8oEUO5d47G1QgffA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_Uu9m4zMIEUSZE8lNGmHjfw">9.4</ix:nonFraction>%, respectively, of the Group&#8217;s total revenues. (2020: <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_-u-gDw9Kw02XQH5X4XgSEQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_qX1WmHfk_U25U2MmZ3eqWg">14.6</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_vD7DKV3Hb0uFeh-tXovtcw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_JkvkzdyF_kKrQu11gqprCA">13.5</ix:nonFraction>%, respectively).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To support the expansion of test offerings, the Company acquired laboratory facilities and equipment, developed a Corona Test Portal and leased laboratory space at several locations in Germany. Additionally, COVID-19 testing capacity is provided through our custom-built CentoTruck, a mobile laboratory in a container designed to carry out COVID-19 analysis. Total capitalized investments in COVID-19 testing as of December 31, 2021 amounted to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_cV4yyZGsZUiiKrDyDu6AAw" decimals="-5" format="ixt:numdotdecimal" name="cntg:CapitalizedInvestment" scale="6" id="Narr_Fy-LMbyYnUu-Jbrf0I-eyQ">2.8</ix:nonFraction> million (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_McmJjgE_k0alVLPoqAURaw" decimals="-5" format="ixt:numdotdecimal" name="cntg:CapitalizedInvestment" scale="6" id="Narr_Y9VCSSfVkkqBqa8kjL1SyQ">10.8</ix:nonFraction> million), of which EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_WmW2dmc1-kKD6NAJoNXQBA" decimals="-5" format="ixt:numdotdecimal" name="cntg:CapitalizedInvestment" scale="6" id="Narr_QGpeNDkggEeOVnycy-M8jA">2.4</ix:nonFraction> million (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_hG3SF9wOgkiDoa6rqpCHSg" decimals="-5" format="ixt:numdotdecimal" name="cntg:CapitalizedInvestment" scale="6" id="Narr_ZrP8pBwpWEmfXMJCV_4_6A">7.7</ix:nonFraction> million) are included in property, plant and equipment and EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xN3cXJlN6kKKfXv-f-akRg" decimals="-5" format="ixt:numdotdecimal" name="cntg:CapitalizedInvestment" scale="6" id="Narr_nqmrcG1GHUOmg0JcSH_l4w">0.4</ix:nonFraction> million (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xItn-kSCNkSjgL0_YwgUQw" decimals="-5" format="ixt:numdotdecimal" name="cntg:CapitalizedInvestment" scale="6" id="Narr_duRfdSB8Rk2CWYHVhh7pIw">1.7</ix:nonFraction> million) is included in intangible assets and relates to the development of the Corona Test Portal. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Contract balances</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:DisclosureOfContractBalancesExplanatory" id="Tb_0IYyGA0_SUqAxZSwnVha8Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Trade receivables (note 15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" scale="3" id="Tc_MuxD9rW0jkeSYtHpntMO2g_2_2">21,065</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" scale="3" id="Tc_jhfeL_ySwUCUJkjarQUBHQ_2_4">25,656</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Contract assets (note 15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentContractAssets" scale="3" id="Tc_D2NTwhyr9k2wPiSdpclU_A_3_2">3,272</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentContractAssets" scale="3" id="Tc_3KbxF-aowUStXlanXGpuWg_3_4">3,543</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Contract liabilities (note 19.2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractLiabilities" scale="3" id="Tc_pgsLUB7ByEexZjCtgikR3A_4_2">4,842</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractLiabilities" scale="3" id="Tc_f2-zy2Ioo0ebAxbL9SYZMg_4_4">4,479</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contract assets primarily relate to the Group&#8217;s rights to consideration for work completed but not billed at the reporting date on the tests for the diagnostics segment, with the satisfaction of the respective performance obligation measured by reference to stages in a standardized process. The contract assets also include work performed for pharmaceutical partners which are based on milestone fees. In 2021, EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:ProvisionForExpectedCreditLossesOnContractAssets" scale="3" id="Narr_pt18FCBe106oeEApdSPbRA">483</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:ProvisionForExpectedCreditLossesOnContractAssets" scale="3" id="Narr_YP6lDqLX_0uin_8AhF-2Jg">356</ix:nonFraction><span style="white-space:pre-wrap;">k) was recognised as provision for expected credit losses on contract assets (see note 21).  The contract assets are transferred to receivables when the rights become unconditional. This usually occurs when the Group issues an invoice to the customer. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contract liabilities include EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" id="Narr_7pv-GgsmDUitIFWZU3JFVA">2,506</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" id="Narr_NrQGelycSUyAps5eVXxEFg">2,516</ix:nonFraction>k) which relate to the advance consideration, including various contracts with performance obligations, received from pharmaceutical partners for which revenue is recognized over time, and consideration from sales of CentoCards which have not yet been delivered. In addition, EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" id="Narr_qlqTrq1LokCZ6m0DO-ruyA">2,336</ix:nonFraction>k relates to COVID-19 performance obligations that have not been met as of December 31, 2021 (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" id="Narr_Plvod4DR0UKJ5veP8v-7gA">1,963</ix:nonFraction>k). </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_DNzIVSpV00CdZUlwQk-hiQ_cont5"></ix:continuation><a id="Tc_3_WEf8oHCE-RN_49oelmag_1_0"></a><a id="Tc_JbVzos9bkUuUfIELD96nOg_1_2"></a><a id="Tc_QiMqmtvJ4Uy4sL8Iffl_PQ_1_4"></a><a id="Tc_LmucUYARMkSkVzqBVv_SgA_1_6"></a><a id="Tc_I_1BUGO6Xk2VYIUG-1L74w_2_0"></a><a id="Tc_Ctq1TKkbQ06OcTq91fIY8A_3_0"></a><a id="Tc_o9wTiv7GL0OR3O6Y4_md0w_4_0"></a><a id="Tc_j9qHezNeNkKHL5xv6B6WLw_4_2"></a><a id="Tc_Om_j8Nkjlk26IG1kY7Opkw_4_4"></a><a id="Tc_3zEYJkjyz0mmYWWJhWzxPw_5_0"></a><a id="Tc_JsjadmhxVECB7nQX_TcwOQ_5_2"></a><a id="Tc_iQF859E6w0aZJN1Qj5GIAw_5_4"></a><a id="Tc_ubGuuajbPU-KoEkqwWdNaA_6_0"></a><a id="Tc_lYXRosfPAEeq1I-2Mt21uA_7_0"></a><a id="Tc_5bAjNmLNxUm2XuQj5HUgrg_1_0"></a><a id="Tc_1zWr3g8h-U2xLuBskpjFlQ_1_2"></a><a id="Tc_P5ipoAUi0kOqkwABMItvdw_1_4"></a><a id="Tc_d14jdtLsCUqw_buNilJsjA_1_6"></a><a id="Tc_xEZEVQSUVU6loAIJomFoGg_2_0"></a><a id="Tc_ZzTT2tkhAkWSh8d_pQqBdw_3_0"></a><a id="Tc_iFRD_rBxQE2yit5oPi4vfw_3_2"></a><a id="Tc_tMKckpdAU0mu1bL6HP-vpg_4_0"></a><a id="Tc_7u2JpIN5Ak-jGwUeCZzUsQ_1_0"></a><a id="Tc_AGsfG3khXEubGttu9jMaig_1_2"></a><a id="Tc_E9QokNQmZ0uuRpqc6EjlKA_1_4"></a><a id="Tc_c4q8OxwJukCgWK8upcfYcg_1_6"></a><a id="Tc_xrdVnME5rUm_MX50YY9l3w_2_0"></a><a id="Tc_zmO-_4z3YkCxlHkKBlnJXw_3_0"></a><a id="Tc_KyiC-L8TdUeejJuTyBvhVw_3_2"></a><a id="Tc_JQQMTuPV10-Js4hhOtDnDA_3_6"></a><a id="Tc_YZTmHnbaTEym9NoTiuy0vA_4_0"></a><a id="Tc_dKUutjgl3UmLZzq0rynGQg_5_0"></a><a id="Tc_1x7rfoVXCUySgtz8hKKm-A_6_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock" id="Tb_xm-qhVC7zEynpX3hKdY93A" continuedAt="Tb_xm-qhVC7zEynpX3hKdY93A_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">8 Other income and expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.1</b></span>Other operating income</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory" id="Tb_2FwW3eTMyk6S7q5pWNpjnw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" id="Tc_brwav0xvake-zEnOr704aA_2_2">2,263</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" id="Tc_cUuYc1p9TEGLNVihatdYZA_2_4">2,152</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" id="Tc_IF-cAIokXE2bBPNzycckIg_2_6">2641</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gain on disposal of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" scale="3" id="Tc_R5pfzt1gekaLKdUDGQT28w_3_2">18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" scale="3" id="Tc_vLG_YDOWNUSF9RDIaJRc0Q_3_4">2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" scale="3" id="Tc_hoUfFPD_pEugKd1krk8eJw_3_6">532</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exchange rate gains</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetForeignExchangeGain" scale="3" id="Tc_kDnHdOjtC0yzd9gDS2nQGw_4_6">314</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income from the reversal of provisions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherReversalsOfProvisions" scale="3" id="Tc_vcCUclbKrEKGfN-JYbjqkQ_5_6">89</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="3" id="Tc_IrJGR4opd0GmnxsiiUZtCA_6_2">656</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="3" id="Tc_NEl12jltx0ycVbtE3tBQPQ_6_4">240</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="3" id="Tc_OejMv-Fcjk6RPkXXTGxfqA_6_6">205</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherIncome" scale="3" id="Tc_3AwBfgN0akqMVfRzrthyoQ_7_2">2,936</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherIncome" scale="3" id="Tc_hBOVwDnEZkyDap4e9exrtQ_7_4">2,394</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherIncome" scale="3" id="Tc_wO4kj0ppREK5L5w9PGRyZA_7_6">3,781</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants contain performance-based grants to subsidize research, development and innovation in the state of Mecklenburg-Western Pomerania from funds granted by the European Regional Development Fund. Furthermore, government grants contain the release of deferred income from investment related grants. Other operating income includes a gain of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_InfrequentItemsAxis_cntg_Covid19Member_jq7vmuWOsU2bxZzrIIp5CA" decimals="-3" format="ixt:numdotdecimal" name="cntg:GainLossFromForgivenessOfLoan" scale="3" id="Narr_FcrsUCpRjkikSBWy2CWuaQ">387</ix:nonFraction>k from the forgiveness of a bank loan granted under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_InfrequentItemsAxis_cntg_Covid19Member_4cfu7k0uNkCbmNqwluM_rg" decimals="-3" format="ixt-sec:numwordsen" name="cntg:GainLossFromForgivenessOfLoan" scale="3" id="Narr_U17oYBhqikCOy-Vp71DSvw">Nil</ix:nonFraction>). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2019, the Group entered into a sale and leaseback transaction. According to which, the Group sold the Rostock headquarters building to a third party and then leased the building from the third party for a period of <ix:nonNumeric contextRef="Duration_7_1_2019_To_7_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_5mtjV-dSjU23MM1xhgok7g" format="ixt-sec:durwordsen" name="cntg:LeaseTerm" id="Narr_r6_V9mA1IEefNGg69raOvA">12 years</ix:nonNumeric> at a fixed rate per month with the option to extend. The sale of the Rostock headquarters in 2019 resulted in a gain of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" scale="3" id="Narr_f3anBHE6HEaNEpaun0BTyA">532</ix:nonFraction>k and was recognized in the period of sale. (See note 13)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.2</b></span>Other operating expenses</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory" id="Tb_a1BHwSU7HEyn2y1XFWxIoA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Currency losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetForeignExchangeLoss" scale="3" id="Tc_nQO9-tlBZ0eC769rR0R24A_2_2">86</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetForeignExchangeLoss" scale="3" id="Tc_qIkc6JP_ukW0KdqkC7p-MQ_2_4">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetForeignExchangeLoss" scale="3" id="Tc_3qSboAb4hEmtOlSeEqdvgQ_2_6">192</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="3" id="Tc_AWVJmlqmW0ykjtWC-Ep0sA_3_4">172</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="3" id="Tc_HmfskwjvmU2hqr4JAlAKDw_3_6">1,092</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherExpenseByFunction" scale="3" id="Tc__WQVW2e7IUKuRAQRqpdJ5g_4_2">86</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherExpenseByFunction" scale="3" id="Tc_jpWGUCgGCUaBWCRO6BwnhQ_4_4">182</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherExpenseByFunction" scale="3" id="Tc_2Hmu7c2WGUGDxdz-PH9X1Q_4_6">1,284</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Other operating expenses for the year ended December 31, 2019 included costs incurred related to the IPO charged to profit and loss of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_IfrsIPOMember_d-_7q8doLUSyk01ZAKC7zA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Narr_n36eBIbQc0qBMAa1PKLxwg">1,092</ix:nonFraction>k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended December 31, 2020, the Group disposed of its entire <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Narr_EakkEN49IEe4gU5YMSCFrw">51</ix:nonFraction>% interest in LPC GmbH (&#8220;LPC&#8221;) to the minority shareholders for a consideration of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ConsiderationPaidReceived" scale="3" id="Narr_RBHxjVnQmE-iKDuzwk2xUA">213</ix:nonFraction>k, of which EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg" decimals="-3" format="ixt:numdotdecimal" name="cntg:ConsiderationToBePaidOverTime" scale="3" id="Narr_SlU7YLuupUyfuixGIGjGhA">200</ix:nonFraction>k is to be paid over a period of <ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg" format="ixt-sec:durwordsen" name="cntg:ConsiderationPaymentDuePeriod" id="Narr_AMk9_bJTz02RN-gwcyhvQA">four years</ix:nonNumeric> and EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_laKnVzYd2k-Sn9PzEQVwzg" decimals="-3" format="ixt:numdotdecimal" name="cntg:ConsiderationOutstanding" scale="3" id="Narr_dEkV8sWRE0mfX5FQXzTIcA">100</ix:nonFraction>k is outstanding as of December 31, 2021 (included in other assets, see note 15). The related non-controlling interest of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_laKnVzYd2k-Sn9PzEQVwzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncontrollingInterests" sign="-" scale="3" id="Narr_aLjbD6iW8EShWayocWaqNw">268</ix:nonFraction>k (accumulated share of loss) was debited to profit or loss, and the sale resulted in a loss of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" sign="-" scale="3" id="Narr_lIIbu_M60UCwKmp_EFN9GA">101</ix:nonFraction>k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.3</b></span>Financial costs, net </p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="Tb_8NDe2_gYOkKEsYGSE4ZBKw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest expenses from loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" id="Tc_3TD2Glztk0qxYoKJwOGTIg_2_2">267</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" id="Tc_Rm2dK1d8xEelM2vkkg0yYw_2_4">173</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" id="Tc_5AYwfttHaEy09XwDaKKIsg_2_6">1,690</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Currency losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrencyLossesFinanceCost" scale="3" id="Tc_h2W2bf3Q1UWUC9altG27-g_3_4">362</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unwinding of the discount on lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_ixS1HVEH1E6L1vJa5p0CDw_4_2">584</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_crNgh0ZWzUOYSWBIjeCNkw_4_4">865</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_9sdxvVvpB0G4bRgAc4EWkQ_4_6">339</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest income from loans and receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeOnLoansAndReceivables" scale="3" id="Tc_7wDmag-3T0-ITZDb_Gybug_5_2">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeOnLoansAndReceivables" scale="3" id="Tc_7DiTYTOgi0GCRod7yLzDqA_5_4">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeOnLoansAndReceivables" scale="3" id="Tc_TFWjUPgOxEy8tBX678HYtQ_5_6">16</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_dUkVdPqrMk6kNKhtHjjhYg_6_2">848</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_FLA8xo143kysrAAD1u-1wQ_6_4">1,394</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_Bdhx8vlM40aa-Ys2aqSOYg_6_6">2,013</ix:nonFraction>)</b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_GHmznGHGqEWsL0I3ESMqTw_1_0"></a><a id="Tc_Rg9-Mwok-EWgbgzALNkOmg_1_2"></a><a id="Tc_hwKSmwIPzU6K3UjeOzNLAA_1_4"></a><a id="Tc_8YUh8u_4P0qBpuTc2xodiw_1_6"></a><a id="Tc__y5k19dd2UKSTrDYF1wdcg_2_0"></a><a id="Tc_ctaXFkWihEaClH_cBsyupg_3_0"></a><a id="Tc_bkQq7v6xiU-YNPH4KxMmAg_4_0"></a><a id="Tc_gcTc1XWD4Ua7vN6WKvVXCA_5_0"></a><a id="Tc_d6oaPQtlakm9ahq3Hz7u2g_6_0"></a><ix:continuation id="Tb_xm-qhVC7zEynpX3hKdY93A_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.4</b></span>Employee benefits expense</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfEmployeeBenefitsExplanatory" id="Tb_JhuRiPntzEqP9vFfm81LrQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Wages and salaries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:WagesAndSalaries" scale="3" id="Tc_KVH9A5VXA0KHYo07hsRW7Q_2_2">43,533</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:WagesAndSalaries" scale="3" id="Tc_Kr0CUPSasUG7FnwOGJwMkQ_2_4">31,121</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:WagesAndSalaries" scale="3" id="Tc_E_E8mdpmR0GkfRsWJJyojw_2_6">23,854</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Social security contributions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SocialSecurityContributions" scale="3" id="Tc_lVNfxbOY_ESGgtgNdZEreg_3_2">6,134</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SocialSecurityContributions" scale="3" id="Tc_mlMIumD1RU-0580T_tOOdQ_3_4">4,095</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SocialSecurityContributions" scale="3" id="Tc_t1vLfBMpSkKT5YmzuzpG_Q_3_6">3,212</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Tc_l-SJuG_1FkWQvEmlclN39Q_4_2">5,471</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Tc_2qGsXm4kTk6dzV3h3KCm2A_4_4">3,486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Tc_XEBWvD8au0ei2zkkQoeJ-w_4_6">5,714</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Termination benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TerminationBenefitsExpense" scale="3" id="Tc_Al9FbHw2rUyzF7w0Dk9YZQ_5_2">1,158</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TerminationBenefitsExpense" scale="3" id="Tc_w34w8RgfxkCadqmAddrNWg_5_4">569</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TerminationBenefitsExpense" scale="3" id="Tc_sj5hLg9ZZkKCvSZeM5NWJg_5_6">63</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EmployeeBenefitsExpense" scale="3" id="Tc__vFn9yRhGUyOSbhXrHs3yg_6_2">56,296</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EmployeeBenefitsExpense" scale="3" id="Tc_CkojBIRg30q9NNhDHomQfg_6_4">39,271</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EmployeeBenefitsExpense" scale="3" id="Tc_BhZy9Kwas02Ck0pULDWV7A_6_6">32,843</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Social security contributions include contributions to state pension scheme of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="3" id="Narr_lRa3sX5GY0WOtx5dWmUM4Q">2,706</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="3" id="Narr_vWyDePzLIUq1yRw36KhWdw">1,851</ix:nonFraction>k; 2019: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="3" id="Narr_7i1XsaHcG0aZM7mzmor91g">1,136</ix:nonFraction>k) as defined contribution plan expenses. Additionally, the Company recognized compensation expense of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_uWLOxsW1eEmoFw2X5N9jYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EmployeeBenefitsExpense" scale="3" id="Narr_5mbRlnmzaUKtbrVQiepjfg">3,252</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_FDERhT7zokOtLHTy2PLLsA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EmployeeBenefitsExpense" scale="3" id="Narr_mJR4gCr0J0GCcigRqsGRBg">2,775</ix:nonFraction>k; 2019: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_gFxC2tLdrUODGcKQ8Sm_rg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EmployeeBenefitsExpense" scale="3" id="Narr_yjUTnMCjdEa8o47wZXWesA">1,203</ix:nonFraction>k) for remuneration of supervisory board members, including share-based payments (see note 25). </p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_GpglYAx0pkKyR_ZC-r_D5g_1_0"></a><a id="Tc_I8SsxM7RBEmNQrLKS8UgsA_1_2"></a><a id="Tc_LtrRA-ulsEytQTAEXZPODw_1_4"></a><a id="Tc_Me4RkqdOTk6NIPtVw9cKtQ_1_6"></a><a id="Tc_dmPAmoGhIUebJbP8daXByA_2_0"></a><a id="Tc_PBqIHnZ3P0-L0ic9JCMjFg_3_0"></a><a id="Tc_uFc2af7dP0-SJYbOvFKXWw_4_0"></a><a id="Tc_5Cz2IybCXEWttr2o0MFdgg_5_0"></a><a id="Tc_5wn0BGnimES6nBOeAr0COw_5_6"></a><a id="Tc_p6qmyxHsOEK45zh_6c3Smw_6_0"></a><a id="Tc_dpqQFqnurk2Rze6RY9DOEA_7_0"></a><a id="Tc_SEKD8ZOIek-QblzB6BUkHQ_7_2"></a><a id="Tc_Q-rpzINgtkSrCit5d2fzwQ_8_0"></a><a id="Tc_hHJ3vl61g0q_p3kEaD08Cw_1_0"></a><a id="Tc_m0kVTZdnf02gkEwgys59qw_1_2"></a><a id="Tc_ahIjdswMfkCDKrhupFRonQ_1_4"></a><a id="Tc_tOp-kQc_GkKJ3Tp1yVPmLg_1_6"></a><a id="Tc_EZJqaQde3E-6T-V06BAsJQ_2_0"></a><a id="Tc_yXKczAAFF0eQsc_jwMLf8A_3_0"></a><a id="Tc_wjonYEanoUeZHk387CzW9w_4_0"></a><a id="Tc_xo0jWlLTx0GLOJIbFd4JFA_5_0"></a><a id="Tc_Srcd8spjuEWJS_lg-9LChw_6_0"></a><a id="Tc_bso7lmURsEGKo71nSg4AYg_7_0"></a><a id="Tc_ikg6u73XF0Sbzucr_-h71A_8_0"></a><a id="Tc_sb_kZB3LmESV2oRvqRqpzg_9_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="Tb_5QMH-_ZcDEqF-HzRGN6WXg" continuedAt="Tb_5QMH-_ZcDEqF-HzRGN6WXg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">9 Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Taxes recognized through profit or loss:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Tb_jjbFVXkzZkW1RB0KBeu52A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current tax expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" scale="3" id="Tc_SxGUz3V2rkynIzyHVbo_lA_2_2">118</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" scale="3" id="Tc_BZB0UkmqqUyrQtIfvCrw6A_2_4">74</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" scale="3" id="Tc_nYIIW3B_TUy8nYUMXZOD_w_2_6">158</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Current year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="3" id="Tc_sg8BdQOPqE6tptlijAG_kA_3_2">102</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="3" id="Tc_WrcUhE2tIEa5sncVXkATiA_3_4">58</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="3" id="Tc_e4D5H1903kizCgEH5a7mVg_3_6">1</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Adjustments for prior periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="Tc_nuSCIo8OOEa9nwt08SOinQ_4_2">16</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="Tc_CtFNf52RqUuDSHgRVuiqIg_4_4">16</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="Tc_dnhUo7hxNECmNdtYspelAA_4_6">157</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred tax (expense)/income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" sign="-" scale="3" id="Tc_-0BvXdsMykiBtHaKSG9kgA_5_2">142</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="Tc_4HnqUBH270C2WFty8dtIIg_5_4">207</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Temporary differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" sign="-" scale="3" id="Tc_rv0BlH6yQUessgKFy7e-GA_6_2">142</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" scale="3" id="Tc_bjdkQwx3GkGbCs_HNF-i-A_6_4">182</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" scale="3" id="Tc_6m9jxS_uJEWDkU8Fse5XSA_6_6">514</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Tax losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" sign="-" scale="3" id="Tc_RR_c2CKlfEiGcKGoog0rjA_7_4">25</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" scale="3" id="Tc_E9CarYDcq0yrjiZbOgctag_7_6">514</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total income tax (expenses)/benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" sign="-" scale="3" id="Tc_dtIWfUnob0SvI0oQPJj-3A_8_2">24</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_vj5Mt8I-VE2F8qkhTRUwow_8_4">281</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_WM7FaU3JMkugYBp7nk1tzg_8_6">158</ix:nonFraction>)</b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="3" id="Narr_YCEhJO9CckmrlC447fjQIQ"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="3" id="Narr_yAZZdR4wNUK70-ZV1WRLdw"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="3" id="Narr_asZ1E94wU0ufruGYECS7fA">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> income taxes were recognized directly in other comprehensive income for the years ended December 31, 2021, 2020 and 2019. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A reconciliation of the effective tax rate to the Group&#8217;s statutory rate of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_1lSCQx3K0Eu71Ir5tRQ12g">31.1</ix:nonFraction>%<span style="white-space:pre-wrap;"> for the year ended December 31, 2021, and  </span><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_BuUzrZuIwkuAYyabweqIzQ"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr__6c7G70wNkSGWVao_2k3NQ">31.1</ix:nonFraction></ix:nonFraction>% for the years ended December, 31, 2020 and December, 31, 2019, respectively are presented in the table below.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Tb_BKoP-nbn2kOmpUjWCJ3ztA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss before tax</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_vWGeSZ6upk24yS_dcd-l_g_2_2">46,876</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_9mDPCnRhjUuPVQGeKEyL3w_2_4">21,097</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_H-Xw7CDLF0KE-g4i-BKCqA_2_6">20,697</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Taxes on the basis of the Company&#8217;s domestic tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_UsX8xkjnsUCf-bwqOn2JAQ_3_2">14,596</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_WuEK9TznIUyNoqCrhkCkig_3_4">6,570</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_LJXqrWyqQ0u3q3WVeG4Q0A_3_6">6,445</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax rate effect of foreign tax jurisdictions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfForeignTaxRates" sign="-" scale="3" id="Tc_Q-mmvwtCoU2L-pUzecRyAQ_4_2">882</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfForeignTaxRates" sign="-" scale="3" id="Tc_roubQ7M_CUCSaVj9n5dLXQ_4_4">65</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfForeignTaxRates" sign="-" scale="3" id="Tc_cqYBLxe8ekWB0Q1TgPUrKg_4_6">412</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non&#8209;deductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" id="Tc_WOW6b26A4USiBUPUM9QzuA_5_2">3,030</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" id="Tc_imM7oIEgRUa4b-OwpCxmGA_5_4">903</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" id="Tc_CvXyznnWlE2W0WlK2e_RAA_5_6">441</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current year losses for which no deferred tax assets were recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_Md2uNFQ3OUa2rW5XzsM_Dw_6_2">12,211</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_Ge06HOelhESGLLh8ummrIw_6_4">5,792</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_FAK5KQxVZUKiIE1aux8bLQ_6_6">6,416</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax income related to prior years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" scale="3" id="Tc_ZXL0NXVxN0yI1lIyMYu-fw_7_2">17</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" scale="3" id="Tc_7r_skojp9U2QYi6lrEwyFw_7_4">137</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" scale="3" id="Tc_8RxMSwtVL0a3zordXhY5_A_7_6">157</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other effects</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="Tc_Fjv_R1T_yES9cG4cMlQsZQ_8_2">196</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="Tc_yFR5Dk3xCU-GFj9TdltKNw_8_4">84</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="Tc_mkdARYgt-U-NwBDM1lpOQg_8_6">1</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income tax (expenses)/ benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" sign="-" scale="3" id="Tc_jimXim7FLUmQGoWHgP_y9w_9_2">24</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_FH4QYqnCZ0evMTXzAB4xVQ_9_4">281</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_pA8br9L4602GwyLtZ8-fRg_9_6">158</ix:nonFraction>)</b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The domestic tax rate of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_L6OSm05Z10ebNUdSNibWeQ">31.1</ix:nonFraction>% is composed of the corporate income tax rate of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ" decimals="2" format="ixt:numdotdecimal" name="cntg:CorporateIncomeTaxRate" scale="-2" id="Narr_jJ4dMRm7ik2vkwOTV0AZig">15</ix:nonFraction>%, the solidarity surcharge of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ" decimals="3" format="ixt:numdotdecimal" name="cntg:SolidaritySurchargeRate" scale="-2" id="Narr_AQpLhg9Lc0uLjg3E7y5jog">5.5</ix:nonFraction>% of this corporate income tax, as well as trade tax of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ" decimals="3" format="ixt:numdotdecimal" name="cntg:TradeTaxRate" scale="-2" id="Narr_OFbkoWOq3kC8hHSphCUkXg">15.3</ix:nonFraction>%. The tax rate effects from foreign tax jurisdictions are primarily attributable to the tax-exempt profit of a Group subsidiary located in Dubai.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tax losses carryforwards for which no deferred tax assets were recognized amount to EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_Nljnlu_Jg0W2A_crlX3lqA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Narr_Pu4qBQiSoUaTZo0Ep8S5hQ">85,639</ix:nonFraction>k in Germany (2020: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Vx47RrdIq0GQ-Ki9-H37zA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Narr_v9gQXE-rrkqQpARDOAWM5Q">64,464</ix:nonFraction>k; 2019: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_hl6aZ99S1EmWbvQH7J5vNQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Narr_Z35OZSeJ_0W8DsX93KnglQ">41,570</ix:nonFraction>k) and to EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_t0eueDKCHEKgNoS0LdjhcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Narr_B7ZierKhRUqJtqnfrtBrwA">1,083</ix:nonFraction>k in other countries (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_4T1vNzsxNkCbKq5j-Bd34w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Narr_gvM6X_dHnEiiZCC1fKAFFQ">1,002</ix:nonFraction>k; 2019: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_ZLDQszdhKEWtIgEyyR7CjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Narr_YMj6DtWjM0SrLCFJ1nuu_w">505</ix:nonFraction>k). Deductable temporary differences, for which no deferred tax asset is recognized, amount to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Narr_8hs8Sp_qc02913n2InDQRQ">1,117</ix:nonFraction>k.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_6WkWLN7S4EuGUeenW2f6bg_1_2"></a><a id="Tc_nXWoADEPBU2XdVBnTzGDDA_1_6"></a><a id="Tc_nH6sbRGAkUiDeX3SwbIsxA_2_2"></a><a id="Tc_qotcX-j_vkaO8gwYAz-F2g_2_4"></a><a id="Tc_hF3mLvTqVk2A7yOZxT770w_2_6"></a><a id="Tc_XyblaHW6KUemxIMllAClBA_2_8"></a><a id="Tc_yiQdz00CC0mHO4hi4uKhRA_3_0"></a><a id="Tc_gfVMcHEjTEKBLF8gn1sikA_3_2"></a><a id="Tc_e1GEBsjAFUiNWyfKVIW3BA_3_4"></a><a id="Tc_5AWtWea1yUilPBN4MV-s9w_3_6"></a><a id="Tc_drFOmikoWEuD8cKlad0low_3_8"></a><a id="Tc__UpEQZPdnUy20gCNOnJ8SQ_4_0"></a><a id="Tc_K1Q1xWTVGEaThFOiWZpIvg_4_2"></a><a id="Tc_w-GFEOd33ECP93XM__k0_w_4_6"></a><a id="Tc_gn9znlRuq0CiAlIgA_WdMQ_5_0"></a><a id="Tc_0v_Ai2oMOkGlr4C_bv2IpA_5_2"></a><a id="Tc_RjpqhyP9tUKDqAVZOaa97A_5_6"></a><a id="Tc_C9YNmDfWk0eL8TwNVReUow_6_0"></a><a id="Tc_vw0UMlurykSZB5fIOLZ1dQ_6_2"></a><a id="Tc_x7FozY6kz0eWDY7kE4Hncg_6_6"></a><a id="Tc_lQe2JWlgOUC_wSJWgxP6aQ_7_0"></a><a id="Tc_etfTbWYdxk6yUetD7VPmdQ_7_2"></a><a id="Tc_NGVt_sZSmUGewrpqANORqw_7_6"></a><a id="Tc_sPcsdNmH2kqtucqjmrleBA_8_0"></a><a id="Tc_nIvzU86kf06b12hpXu6y8Q_8_4"></a><a id="Tc_4ZeJOgvabE2PKEAblyeDyw_8_8"></a><a id="Tc_f384M_z58kuJzv3DRGSc0A_9_0"></a><a id="Tc_bW2D9PVwCEaqqOZfK8IsfA_9_4"></a><a id="Tc_HVEVah_j902yAfMH6iRgQA_9_8"></a><a id="Tc_m0EGafqv1E2eg7f2rEcf-w_10_0"></a><a id="Tc_mCWuKXKEZUGArEYRBIuWbg_10_4"></a><a id="Tc_Xxqib1aMGEyFqxmweNYbuw_10_8"></a><a id="Tc_7BU0mYJUV0unLdEI4FmO1Q_11_0"></a><a id="Tc_HJ8YQ79450OuWo1U2zPb-g_12_0"></a><a id="Tc_NgcujZIKV0O4sQvvVLQsMw_13_0"></a><a id="Tc_Mnilvj4QV0CHaEcP-B1cEw_13_2"></a><a id="Tc_ek0bhmfgP02Mzf_TiJu4jg_13_6"></a><ix:continuation id="Tb_5QMH-_ZcDEqF-HzRGN6WXg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tax losses carried forward in Germany do not expire. Foreign tax losses carried forward may be restricted. In the light of the Group&#8217;s loss history, the recognition of deferred taxes for tax losses carried forward and deductible temporary differences was limited to the future reversal of existing taxable temporary differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For temporary differences associated with investments in the amount of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" scale="3" id="Narr_lirgKrv6cEWXhmKtzSmzoQ">5,656</ix:nonFraction>k (2020:&#160;EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" scale="3" id="Narr_IO6xkyw8fkiYRhcjCl6QaA">4,313</ix:nonFraction>k; 2019: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" scale="3" id="Narr_yljZVbMeBEu307VgYypriw">4,360</ix:nonFraction>k), no deferred tax liability has been recognized because the Company is able to control the timing of the reversal and it is probable that the difference will not reverse in the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The below table shows a breakdown of deferred taxes in the Group&#8217;s statement of financial position.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory" id="Tb_8BRIf1cWaEmWEESpTgGFMg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;liabilities</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_QzlZ2gHa9UmZqgp-gMT1xA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_MakMnMkp3EemSLDB_oPCIQ_4_4">2,439</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_J4CTxkjWd0i7eimj-78dVQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_rzSUQlnCQkmZf-pU9A1x6A_4_8">2,934</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_G9S6WR6LUkWpOgDW2ba0hg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_GsWTqcNo4kuEPddqp4_a3g_5_4">14</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_PzgOubk0sUiPtObl6v_YAQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_MFC_gqLjLU6fACWzGtfPDg_5_8">133</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_eDNvK1TmeEG14kTMUgQaLg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_T0to9ClbI0i-Wwc52fzpvw_6_4">4,617</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_6cqIyIHrEkyiYD7ANN1bDg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_pbLDW2ip8k-tSyy7Cn6T0A_6_8">5,029</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Measurement of service contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_BcIW7LDHy0CnsUV9Pv217w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_gRLf00bEX0mtwCH--uS9og_7_4">42</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_3fVvStyvDkODlS0OB9wu2g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_9kE3pYHYW0eMlI7fV2J5vg_7_8">145</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasing liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_EftQ82OO8kC-o269ZjHJoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_uRr0bP5PeE-6surVGkAAjA_8_2">4,563</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_k0i-lMHYs0mveCZGWLchMQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_yy4p_Z_HsE6Pto5AWb_1hg_8_6">4,865</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_-qIGtGSHJkaH45QX4EJ-vQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_zCFOStjzB0W9cxlddP7Kdg_9_2">1,693</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_nSTQU73o0Ei4uWEp9Ik9Ww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_BZ1VGOUgMUmmkZ-mqA1v0g_9_6">1,903</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unused tax losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_9Epnx9NGxUyO_NrCcxyv3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_oqN35zPaMUecic0bIAFMjw_10_2">777</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_6JeY3hzvoUmiYLFCkMlKPA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_t77fgSmMKESdotsSQtOApQ_10_6">1,266</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Sum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_tMpkg4ICakSxrIBCg-ZNHQ_11_2">7,033</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_ZvJaXqJv002xpaPhvTNX-g_11_4">7,112</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxAssets" scale="3" id="Tc_kbB4ACgQgkWRn3Tclg4OgA_11_6">8,034</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="Tc_d5W8eBpNGE-YhWUV-Dfk6A_11_8">8,241</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Offset</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:DeferredTaxAssetsOffset" scale="3" id="Tc_2Jiv8HDyU0-YWlAuI1iVsg_12_2">7,033</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:DeferredTaxLiabilitiesOffset" scale="3" id="Tc_45q7Kxw2KUqj21o2XpxvNQ_12_4">7,033</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:DeferredTaxAssetsOffset" scale="3" id="Tc_anabdRK2HUy3nUnu9H3TTA_12_6">8,034</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:DeferredTaxLiabilitiesOffset" scale="3" id="Tc_c-ChSAqIIUaxZJJDrpusTA_12_8">8,034</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred Taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:DeferredTaxLiabilitiesNet" sign="-" scale="3" id="Tc_nWDo1TN1dkOvoh8NzorbIQ_13_4">79</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:DeferredTaxLiabilitiesNet" scale="3" id="Tc_r3QCIZxXlUW14m-f0bvtYA_13_8">207</ix:nonFraction>)</b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="Tb_azlnn4NisUaGL3PknkIOdg" continuedAt="Tb_azlnn4NisUaGL3PknkIOdg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">10 Loss Per Share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Basic loss per share is calculated by dividing loss for the period attributable to equity holders of the Group by the weighted average number of shares outstanding during the same period, adjusted for the effect of the corporate reorganization as discussed in Note 1 and applied retrospectively to all prior periods presented. The weighted average number of outstanding shares for the year ended December 31, 2021 was <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" id="Narr_ZjK6r56f20-k7pUXKthRvQ">22,437,301</ix:nonFraction> (2020: <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" id="Narr_IUYm9jcajkOGYF1W-NOedw">20,909,673</ix:nonFraction>; 2019: <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" id="Narr_cSLhPb8u60G7cq_NGgKkIg">16,409,285</ix:nonFraction>), adjusted for the effect of the 2019 corporate reorganization).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the periods included in these financial statements, the share options are not included in the diluted loss per share calculation as the Company was loss-making in all these periods. Due to the anti-dilutive nature of the outstanding options, basic and diluted loss per share is equal.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><ix:continuation id="Tb_azlnn4NisUaGL3PknkIOdg_cont1"></ix:continuation><a id="_9223afe7_9057_4f0b_b1ef_56782b935697"></a><a id="Tc_011qXDvChUOIYETS7o-73Q_1_2"></a><a id="Tc_PUlLWFe38EyEkWvtmjqzTQ_2_2"></a><a id="Tc_1KzJlGYFkkeEDHUCjV4kcw_2_4"></a><a id="Tc_LNlDZMwaPEG6ohlulJDy6g_2_6"></a><a id="Tc_BxDLLo2kB02NtQdo_VvQZw_3_2"></a><a id="Tc_jx611OwzJEygy0qTJHUmdQ_3_4"></a><a id="Tc_E1Opce48t0eMdbqoNz7Bxg_3_6"></a><a id="Tc_-_cRuewfMUS2F__17M1CHA_4_0"></a><a id="Tc_2b8v-BARe0u4M1Y1ODXOOA_4_2"></a><a id="Tc_jDZowTvWSUuMoOdQ1FpFHw_4_4"></a><a id="Tc_PT024i7UKUSMzB4uy33bQA_4_6"></a><a id="Tc_gR-IE1eo3U2BjqCI8VClZw_4_8"></a><a id="Tc_PBZ-dMpMnkCdIOsr6vgeVg_5_0"></a><a id="Tc_WXPI1ombFUqtliBByb2ITw_6_0"></a><a id="Tc_--hBsf45KkuSYWYs37-pNA_7_0"></a><a id="Tc_jbzpt3BlDkiZUDYb80fokQ_8_0"></a><a id="Tc_XCz5wITCCESJz0smhKSkMw_8_2"></a><a id="Tc_PTq4gdKx2USxWSwJqHncWg_8_4"></a><a id="Tc_YvwOrdXY7U2oefZJoNoH1w_9_0"></a><a id="Tc_gxm3jvNdi0KrFPJ2o3Xvdw_10_0"></a><a id="Tc_XD-jrbLl7kOmaoHiAcDlWA_11_0"></a><a id="Tc_LB74QSOzqkauuuMiLzfI5A_11_6"></a><a id="Tc_6JOhac4cIEyx9nYvR16jzA_11_8"></a><a id="Tc_colEmntP30--3ecvsEBQYw_12_0"></a><a id="Tc_w_K-6iiX6UibG-HuIBCnRg_14_0"></a><a id="Tc_x_0wgSBR0UyleL2BsgCj5Q_15_0"></a><a id="Tc_tBHiL4fE8kO2-96UkOWIbg_16_0"></a><a id="Tc_Xwo5Eo9oskqvoTFX9-FrEg_17_0"></a><a id="Tc_gLbq-QQFPEuCLXnVZqskVw_17_2"></a><a id="Tc_iyqWOXZ19kq5_iYwsr0r1w_17_4"></a><a id="Tc_q9ZjenMxDEqJUqptp5mbtA_18_0"></a><a id="Tc_UX1v1YNrIUu9UVAqAjlNLw_19_0"></a><a id="Tc_rmsmcDDRukuZX5JVvpBZug_20_0"></a><a id="Tc_CSNFz_YDoUaUodqtdrYAVA_20_6"></a><a id="Tc_Bb0nOMG_M0qn7ktW7G0TaA_20_8"></a><a id="Tc_XhmTO1AZp0CenvgGUS88Tg_21_0"></a><a id="Tc_TsOD-OG-tkqxF7H_Tn1NYw_23_0"></a><a id="Tc_buluG_BRjk2HeWuV7IMSDA_24_0"></a><a id="Tc_yolIMtQSZkG417ddE7Pvhg_25_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" id="Tb_AtRVzuIzB0-ojdcaPwqwKA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">11 Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Reconciliation of carrying amounts</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" id="Tb_O07tOhJ-HEWAjyCrm6psgw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Internally</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">generated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Internally</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased&#160;rights,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">/acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">developed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">licenses,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">biomarkers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">databases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">software</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_KXY4hB06pEyeR-sh2ouA0A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_WCLwihjs20e_WYahst8waw_6_2">12,022</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_b6v3zHDw4ki2KCugNSJoWQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_c7DJ2MUysU6L_JqghSA1Zw_6_4">6,502</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_dYyKiaYqrE-5cSLRxZqoFg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_SppHi0s1b0-oqTHUuPlcbQ_6_6">3,010</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_52eSLkL1IEKzP0P0QbaXNg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_DI0vHbcZlU2ZVwf-C2TY8w_6_8">21,534</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_JX-s2F9e10SlNE7SMW4K0Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_z-K3eZzd_kCvG7FFfMBhrg_7_2">1,900</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_78Nr_Jks_0OKR7JkB9K_fQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_4I0fwiK2m0GlfVvF0ZW_Lg_7_4">2,717</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_o6x3iNUNZEKJCglE3V0-6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_9hBrCCHd0UKFOnhKGMs20Q_7_6">2,040</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_uuoDkseYfUSWS5fP4Qbozg_7_8">6,657</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deconsolidation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_o6x3iNUNZEKJCglE3V0-6w" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_Oj1blNctVEqs2rHVlRAcHA_8_6">151</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_ryBVcDVlB0i2zQThCZuBqA_8_8">151</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Zn-0UMVx3E2y3vqaDMW_5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_UP9UxDbijEiHojBGzH4Udw_9_2">13,922</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Z8byyXazL0CZp8NK1au0EA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_HrNN6Wem_0yUib8XiKlBNA_9_4">9,219</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_t3uvbKfeMUqBA08LcKFV-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_LdXcudwULU6O5WHxnOgDmA_9_6">4,899</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_DVwpaAKq20WetXOFxByNKQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_U8aZvKyjsE6qnyvutHZxUQ_9_8">28,040</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5hTATt8HAUSJCLPDnOCGvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_3eQx68o9bUWT36gWHdL_kg_10_2">749</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_dcozlUxUTEm0gw3SLkH3-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_yGZ3ipngnke-z1Sk-906Fw_10_4">1,652</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_8tdZRFUyHUy1cqWB5uPVCA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_meV1A7WJMk62pcABhuYkmQ_10_6">386</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_tYGGWa5Bh0aQ94xJe2bf8Q_10_8">2,787</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5hTATt8HAUSJCLPDnOCGvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_GLakr7ufn0CLqSO6gutvmA_11_2">297</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_dcozlUxUTEm0gw3SLkH3-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_2TSMHcpON06KNTeWkW8ODg_11_4">297</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_tFtzIuvOnk6eFcAYgKYnZA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_MagL1XQcS0K3k4KVY1m63Q_12_2">14,374</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_uYV506SBMkuvBE_EZMSfgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_Bm3Bc0vk7EeF7OhBcxYhCA_12_4">11,168</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_9Fb3pxnGaUSRHrSKjMx4ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_sT1qZkyeb0iiLNrNx5jUcA_12_6">5,285</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_uGud5JzQG02kaS3Mgza75Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_m5EblUlECEGoZrHsfVZSNA_12_8">30,827</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated amortization and impairment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_7xeJVhJvYUmbsnvDHQ8d3g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_seE_8EuCnU-9e6QQw41YUQ_15_2">3,831</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_kHvSJAIc5Uy3c7q4gg9Klg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_uzfP_0cNbkW8sqkIRbNCpQ_15_4">1,770</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_-0qkA_V1Hk2dqGzpyUy7Dg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_n9jDKLEcGU2FN0Xe90RXcA_15_6">1,788</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_zDoz25BuFEmJyAnqcxNW5Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_NehvDJeEzkq-F3E-0jtp-w_15_8">7,389</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Amortization and impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_1oxG-ulhZkewdx8UmyncDQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_NRQJc2zVwk24SsxnV684iQ_16_2">6,917</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MkH40joHJkuDjye7-7vt4A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_849eESDRGU-s9E3SGAitXw_16_4">943</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_nUy4aXz07EqtEkGVtRBxvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_qByIgCnClE2xVa04XLfXVA_16_6">508</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_Igb_qNlxMEmHJyucK2Sd8w_16_8">8,368</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deconsolidation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_nUy4aXz07EqtEkGVtRBxvw" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_2WFTaGO8K0uVnaJ7Bj4FQw_17_6">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_8VeYMxbIe0GTbhZMOVBZRg_17_8">124</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_smkCz2ptokGCqin3TdKpUA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_3FKP3e6110CQrnbyjQxgVg_18_2">10,748</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_PJiIvVIxGUC41eoN-l986A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_oZwDPBKL00CFBCvHDUmcQA_18_4">2,713</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VBSTmHETgUeIl7NqPr5fzw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc__ajVkUUXI0KLv_fCCBXyjg_18_6">2,172</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_t6wM7AhQ-EmoLvKXt9OZvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_1la73vlZt0esO5sqVz6s9Q_18_8">15,633</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Amortization and impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MYgrX_n3jkaDz1IqXgfPzQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_udGnDsOQNUGMAKFOp8RdIQ_19_2">2,149</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_xEzYX8OnjUOMl3IAx5vk2w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_PFtFMbkp5U61JP4QyBG6qg_19_4">1,991</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VMdLXHYHe0mBFblmw8jl9g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_I3lEKbEtDUuEIn0bcknYtQ_19_6">1,860</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_pxNU40m6ukiHlHAgf4o94g_19_8">6,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MYgrX_n3jkaDz1IqXgfPzQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_z2m7nTaYV0-VNI0qdm7vDg_20_2">68</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_xEzYX8OnjUOMl3IAx5vk2w" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_R3z23fXF00C_6ji9fg3XVw_20_4">68</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5eaVP-7_1UKBsld_2DURNg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_30-t3BuHQEW7r1OMS1-V-g_21_2">12,829</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_-D-lKyd0xUG2GJXr65MPdg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_qWYPiULVWUyS6vgMr94egQ_21_4">4,772</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_cquxSQFt7EuMikBUJNV8XQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_c_o9Q6gHwkiXnOMsHvMqhg_21_6">4,032</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_nHe0IepNs0m-_JVwFYjKRg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" sign="-" scale="3" id="Tc_cQPkbcgLxEeTzauz5kP3Kw_21_8">21,633</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_SRmpcImuLkKr7Mhauf75CA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_RastMsBV6kybqKuynxdahA_24_2">3,174</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_BYnxal9n_UyhTA2Zunv0qg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_WR48IqQs9UmExnpMb2T0Hw_24_4">6,506</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_3NmcgXK8lEOsvBWBRUv4vA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_2O5_4P8DH0W-FTN2Vm1_3A_24_6">2,727</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_z62Dud7JDEqg0-E4NWE5eQ_24_8">12,407</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_mCcyce8TbkO8Vgcxe5L8zw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_gfoeEIqir065bvaF2usHaA_25_2">1,545</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_4KIQ2EJM10KtGQbtSjZSUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_8I5bx3EMZEGWx7lBMfDfDA_25_4">6,396</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_6ZxMHT3Ak06Btt3uetZikw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_iUYLLjDPkUWeU5kDJObJ1Q_25_6">1,253</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_qDiDC_1kbEWBM2H41QyRGg_25_8">9,194</ix:nonFraction></b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">*&#160;&#160;&#160;&#160;&#160;The net reclassification of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_vYQneCL0Uki_zA6xML9L3Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="3" id="Narr_x6pSX-bON06FLrGP9X3Wnw">229</ix:nonFraction><span style="white-space:pre-wrap;">k from internally generated biomarkers to internally developed databases represents internal costs incurred in the process of developing internal IT driven solutions on biomarkers.  Reclassification is made to allow more transparent presentation considering this is more in line with each sub-group of intangible assets.</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Development costs and amortization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Internally generated intangible assets include capitalized development costs for biomarkers and IT driven solutions such as CentoPortal, CentoMetabolome and CentoMD (see notes&#160;5 and 6 regarding measurement). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The amortization of patents, trademarks and development costs is expensed and recorded under &#8220;cost of sales&#8221; to the extent the related intangible asset are used in generating revenue and recorded in research and development expenses to the extent the related intangible assets are used for R&amp;D purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of December 31, 2021, certain identified biomarkers and internally developed databases amounting to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersAndDatabasesMember_z7T7AVbVWEqN5q7cJhF12Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="Narr_JdodeRLmiEOe-OI-fGbhOQ">1.1</ix:nonFraction> million (2020: EUR 4.7 million) were impaired as part of the Company&#8217;s strategy reassessment which occurred in Q4 2021. The impairment is expensed under cost of sales and included in amortization and impairment expense in the Pharma segment.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_43da7314_f6fc_43ab_8844_241ce27e0974"></a><a id="Tc_LT7S_EZNHUCFmwOw7RnBkQ_1_6"></a><a id="Tc_-WUag8BsvU2u6gMxmrJ-Fg_2_6"></a><a id="Tc_Zgy9Qq58cU2_cGRftDOqjQ_3_6"></a><a id="Tc_ZU_whEHih0mJi1QNYBOv-w_4_0"></a><a id="Tc_4bB8ez80bU-vUab0LUC_-A_4_2"></a><a id="Tc_AL_2x3dBF0-A0FC_xHHwaw_4_4"></a><a id="Tc_vR8wDw0TrUOsz3KwPXCKOw_4_6"></a><a id="Tc_U_9mrBn5_Eqw6n2VqjAapg_4_8"></a><a id="Tc_kAie8DHTCUmVDTC9XfoSgQ_5_0"></a><a id="Tc_CDAei1B470qagZbVCuwrCA_6_0"></a><a id="Tc_koLajG5UJkujeAhc-shANg_7_0"></a><a id="Tc_-FRiQVfi7EWAB_oZijxSbw_8_0"></a><a id="Tc_AkSirfod3UC_NEOQwiDNjA_8_2"></a><a id="Tc_4J5DlT75a0KNNr-XRoauhQ_8_4"></a><a id="Tc_Pwlq-tvPnEa9YnrxhHQJeg_9_0"></a><a id="Tc_em5gJqZTak6nmXeF_8W2Qg_9_2"></a><a id="Tc_lJH0hhzyVEaXZ2l2lJ5-SA_9_6"></a><a id="Tc_452-jlviLkWCE0zbn7i1og_10_0"></a><a id="Tc_JQrqOu3hr0qi1AyxthKiUw_11_0"></a><a id="Tc_Yrb0XvUhxUirDO0Jm4Uyrg_12_0"></a><a id="Tc_ZGGRervFtEOxF8aweqmm6g_12_2"></a><a id="Tc_eA-cC_IBW0qjfJHwhiAExg_13_0"></a><a id="Tc_V1Z1JwV0s0uzWSWiSwx62A_13_2"></a><a id="Tc_98MzVlrVFkSm8T2HdyrOkg_13_6"></a><a id="Tc_hAg9M84R80626v2KDcSUWw_14_0"></a><a id="Tc_iC5Smfzw3ku3UkcJ21bPsQ_16_0"></a><a id="Tc_G3dcdzBhFEirO_bQu_z1Gg_17_0"></a><a id="Tc_1qP0tQUt0E-Iw0-KCe0owQ_18_0"></a><a id="Tc_ZDweb41xfk2s2dowOVVIBw_19_0"></a><a id="Tc_KRZ_MKSglka9OL-61xXoww_19_2"></a><a id="Tc_nn7_UcSxo0y20TaKyf9WuQ_19_4"></a><a id="Tc_1jYQKDFXo0OwMdVUeJSLfQ_20_0"></a><a id="Tc_OfHysf8C10uYf6Y5a_svzg_20_2"></a><a id="Tc_RsZIb7DmbEqjhW9L3F2FjQ_20_6"></a><a id="Tc_U-1lYwNNb062aqZlJaNjjA_21_0"></a><a id="Tc_c28jFuGe4E6jAQlHuSh0GQ_22_0"></a><a id="Tc_I3ifv4rD0Eq53aRdZ81aew_23_0"></a><a id="Tc_QkyTuv0sE0OA_CxokjyFyg_23_2"></a><a id="Tc_pk2S3jsGC06RFPY4h6BABA_24_0"></a><a id="Tc_8dsND4si1k6VlCR6erq5wQ_24_2"></a><a id="Tc_fy4Fmobtu06fKGzDT-QahQ_24_6"></a><a id="Tc_l0-cfY3ui0abjDWU5TG_WQ_25_0"></a><a id="Tc_N69hftk3OU2UjuV3xrlHmg_27_0"></a><a id="Tc_E6tBPr6cZEK2y7yB17HyUQ_28_0"></a><a id="Tc__RlMjQ_6HUGC-J-AIhxdFw_29_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="Tb_ZGElzQrWUEOol6UVTWtvWw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">12 Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Please refer to the following table for the development from January 1, 2020 to December 31, 2021:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="Tb_Jgtu3lUEIUWc4gJhwf3ahA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&#160;fixtures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">As of Jan 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_YVVpLHmHuUCyVsz8RIAg9Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_A4opH8uE5ku46dWk2_Oiww_6_2">3,254</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rBalwrMaEkicgxSJdYTFzQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_qIWGsxnObkiymPik9iECPQ_6_4">9,730</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_9xS0NR0lGEmdKJ-O-1K3zQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_oe9jd5HZtUG4S-sctzkDJQ_6_6">4,712</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_52eSLkL1IEKzP0P0QbaXNg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_KQAxuUh-xUeDTXZLHS1Ktg_6_8">17,696</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_5Ul6LbHt3Uml3dMdzr_SfQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_DW9Wt46YqkmBkgPAiTcC8Q_7_2">105</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rZ2pIjWt-0-tbNOWGJRkUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_3zNnXOn2lkG6J6doJ8UkvQ_7_4">1,295</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_JJuBkPLnakebKDZ6svlPTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_u7SdiEfY-E6LB7iFuuYp_w_7_6">8,490</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_iljyShE3kkWceH2mzrAuiw_7_8">9,890</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_JJuBkPLnakebKDZ6svlPTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_mhgTYlHNE0K-8nss16rEaQ_8_6">612</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_rLb2ElMph0C34RPNZv79Fg_8_8">612</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rZ2pIjWt-0-tbNOWGJRkUw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" scale="3" id="Tc_rIQ-iWfzs0aA-tezLlwKJw_9_4">3,099</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" scale="3" id="Tc_UEId6O_Eqkq4_uK3w-3ILQ_9_8">3,099</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_pqgYMySFy0mCl4qrOYa00Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_nIASkJe3B0KKCsoDEdtsHg_10_2">3,359</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_pDjbDgn5b0qPOlPHWmNdPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_rOTvqxgVP0e_knkrlME5pQ_10_4">14,124</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_yS6hjJywgUWf5TfLOUo9lQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_hZMKLf1u_UKP3jRPIUth1w_10_6">12,590</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_DVwpaAKq20WetXOFxByNKQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_UrvQGSYsqEqWqLcvo5fPFQ_10_8">30,073</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jB3v8yGjV0Wzi4l46Yp0Ww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_bHEMSf3DmkSg2De0GtXMKQ_11_2">5</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_AGA4Bs0UqkaGsk1rQprwRw_11_4">144</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_a9m-Txeoa0yrNuKt2KsrgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_7yfoU-omNkmnBZW_3n4GeQ_11_6">2,766</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_J8_TPGAeKUWDDyxMB0hPEg_11_8">2,915</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_3NQjF1EBREqYM34TZjEt1A_12_4">379</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_a9m-Txeoa0yrNuKt2KsrgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_9Gvkn3V3O0WGztzODwfXUg_12_6">718</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_XVg6hfu8CE67YOWYirc69Q_12_8">1,097</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" scale="3" id="Tc_kWN3G6EyW0CnwEk5G7s_dQ_13_4">1,165</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" scale="3" id="Tc__70NILmhA0yitYucgyUz4g_13_8">1,165</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_gykS6db5-UCUac4tLpVtSg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_gcIZFMqNxU-Kj9hvOfJHwA_14_2">3,364</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_cybCz_DIdUCl_xWyu3Pv8g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_uvOvjEDWJU2XsHKcdIvPTA_14_4">15,054</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_I8JCso4MK0qgaLEwIyMTbg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc___mo3q4dP0WD0Wi5ad81Pg_14_6">14,638</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_uGud5JzQG02kaS3Mgza75Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_ZoG-1jPKn0SzYNEDIAkxnA_14_8">33,056</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation and impairment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">As of Jan 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_KLZzrB9iaka5B8A46KUKYA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_DwmQGUdw-EGwnA-CHDeV3g_17_2">392</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_bOr7Q08nUkCJL9UFD5xgEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_BPPyxzmizEiJMcG5NfJc_A_17_4">6,155</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_MPE_bAH260S1MVcfmAfdbg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_YSULlYwdyk-tpoyEdq3_Mw_17_6">2,773</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_zDoz25BuFEmJyAnqcxNW5Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_tY7rNbRUF0Sx0Tm32n1rzw_17_8">9,320</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_yBvnu7QHa0K2BszKcg5KZA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_swqeszqP40aTWWX15H0xLQ_18_2">194</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_LiVI1zychE6WlZz_18uRbw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_6H04yImEuUi59vnSx5DHrA_18_4">993</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember__luwaUE-_Ei_x9Oj9E5zMA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_3oOdePvIIE-wQdVCgqvTZQ_18_6">1,913</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_okmPVcJbwka8OHwnFJXn5w_18_8">3,100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember__luwaUE-_Ei_x9Oj9E5zMA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_Rl4G1G_lZUygU-t1Z4LwRw_19_6">44</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_BlyNyKgXp0qw8_Gwa73qXA_19_8">44</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_LiVI1zychE6WlZz_18uRbw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_24L8DZng8U6bdd1JGtOcfQ_20_4">1,107</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_FaM6KOnJPEGqsHvqGrv2tQ_20_8">1,107</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_-qbWr3ldhUuv7EtvkZChEQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_j5G25t2sdEespmI0meI-og_21_2">586</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_2vB3kEQ9kke7ig8iaxIHWg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_uCeQZKTEtUG1pTCuNOFMaA_21_4">8,255</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_-cmNgE1L_UWx4FtHzGHuYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_egLto_vEKUu-oTHSZulTnw_21_6">4,642</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_t6wM7AhQ-EmoLvKXt9OZvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_0v6WxyxS9kOD9X2jBZmtRA_21_8">13,483</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember__QDyppugek-Sh2NBifnpow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_N_agrjIb2EuJxD1KJZm_5w_22_2">315</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_O6_A5J2iwU-WfgG2xCCmYw_22_4">3,519</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_Wsje2nrQu02pAKwNiLBXBg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_9J1L_StY60-P_-gW-7Bmpg_22_6">7,473</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_NBH_Ptda20aheT3ya16UUg_22_8">11,307</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_6DekvPpLeEakoofTprwHMQ_23_4">157</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_Wsje2nrQu02pAKwNiLBXBg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_ZS_RuHPIZ0KDKR6Kni9fVQ_23_6">217</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_3lEoD3iE9UuqMDTpsgGvcA_23_8">374</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_LOGoXrtZSUG2WOtnXBByjQ_24_4">493</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_0GV29zkdAkyv-UDBo_YJqA_24_8">493</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_lEC-E1pPPkKKZSA0ZSkDSw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_7yTQi-EoNEWXwOxQCIvMNA_25_2">901</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_edmJJe7tlEedyQZh-3w6bA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_DMGbzlKx9UWgY2BxyYoRMg_25_4">12,110</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_fuZVkW08oEaKwXZ7YfUYkg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_E5HDknBXl0mOOdls3OSGxQ_25_6">11,898</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_nHe0IepNs0m-_JVwFYjKRg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_FPCUfjA8EEKNtWOlhwlp6A_25_8">24,909</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jxm_mplIxEmZEcgIhg-8iQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_s85zntYqL02W4gHcznFBUQ_28_2">2,773</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_PrcgwTEj0kWm_mcSL5ht7g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_-jykLyXQhEW2IBZ2gpmNjA_28_4">5,869</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_H9IaZfpHHEeg-x_U6Loa3Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_-AGJI8xAgkGojTVOMfYBcQ_28_6">7,948</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_RwWmN_4E9kCwDtgdFaDTPw_28_8">16,590</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_I6xfcf-C2UWRvm-kxsFGQg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_fp4kfCO-DU6OEWSfC8rwWQ_29_2">2,463</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_imxgf1UU7EmYdPJ5WDOOCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_u2REgqopHkW33Y_w-UOM7w_29_4">2,944</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_bR_4j4cSckicZd6QmHkZiw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_qvCdYq7spUWdmtw3sQV7Bg_29_6">2,740</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_rQG6P-4TJU-Ae_dVavKcrg_29_8">8,147</ix:nonFraction></b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="white-space:pre-wrap;">*     The disposal relates to the sale of a CentoTruck as part of a contract with a COVID-19 customer</span><span style="font-size:10pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="white-space:pre-wrap;">**   The disposal relates to various obsolete plant and machinery equipment mainly in relation to the ramp down of the COVID-19 business segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">*** The reclass from right-of-use assets represents assets purchased at the end of the lease.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Group prospectively adjusted the estimated useful lives of COVID-19 related property, plant and equipment to a remaining estimated useful life of <ix:nonNumeric contextRef="Duration_6_30_2021_To_6_30_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_nqnnCqAqhkms8MmscboYow" format="ixt-sec:durwordsen" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Narr_k2_Fjk4HLEWp1W3ig99UNw">eight months</ix:nonNumeric>, with effect at the beginning of the third quarter 2021 due to management&#8217;s decision to ramp down the COVID-19 business segment. This prospective change in estimate resulted in accelerated depreciation expense of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Narr_j8G0Cri8KUmh1EaLZTftOQ">4,138</ix:nonFraction>k for the year ended December 31, 2021. </p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfLeasesExplanatory" id="Tb_KPfJ9M5OvE2CiAgY4ggk1w" continuedAt="Tb_KPfJ9M5OvE2CiAgY4ggk1w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.79;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><b style="font-weight:bold;">13 Right-of-use assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group has lease contracts for land and buildings and offices in Germany and the United States, as well as various items of plant, machinery, motor vehicles and other equipment used in its operations.  Leases for land and buildings is related to the sale and leaseback transaction of the Rostock headquarters building with a lease term of </span><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q" format="ixt-sec:durwordsen" name="cntg:LeaseTerm" id="Narr_DVul-qwNoU-IX9jISccCog">12 years</ix:nonNumeric>, while the lease terms of offices in Berlin and Boston, Massachusetts are <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBerlinMember_PZ93SKoOakme1tsNGTWckg" format="ixt-sec:durwordsen" name="cntg:LeaseTerm" id="Narr_5iITBTkSK0Soqx2elp0CzQ">12 years</ix:nonNumeric> and <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBostonMember_uzMhEfk4nEWX7K-ikyO7JQ" format="ixt-sec:durwordsen" name="cntg:LeaseTerm" id="Narr_14mI8B5sOEeHre5HQ10L0Q">4 years</ix:nonNumeric> respectively. Leases of plant and machinery and other equipment generally have lease terms between <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_mQOuHcBww0qhWOVQnUs6Sg" format="ixt-sec:duryear" name="cntg:LeaseTerm" id="Narr_8j_Uy10XH0Sr5dv2Ca956g">2</ix:nonNumeric> and <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w" format="ixt-sec:durwordsen" name="cntg:LeaseTerm" id="Narr_Tkdf_DYUeU29eeCd1TkVzA">4 years</ix:nonNumeric>, while motor vehicles generally have lease terms of <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ" format="ixt-sec:durwordsen" name="cntg:LeaseTerm" id="Narr_9X7FroP1hUGjDT99X03Law">3 years</ix:nonNumeric><span style="white-space:pre-wrap;">. The Group&#8217;s obligations under its leases are secured by the lessor&#8217;s title to the leased assets. Generally, the Group is restricted from subleasing the leased assets.  In addition, a bank guarantee of EUR </span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_YXoCaUO5F0KnHQTBrV0F9A" decimals="-3" format="ixt:numdotdecimal" name="cntg:BankGuarantee" scale="3" id="Narr_qQ6BYGnFpUOzHOR5AMAkgA">3,000</ix:nonFraction>k (which is secured by cash deposit of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_YXoCaUO5F0KnHQTBrV0F9A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_agoz2Sxx5ESqPYHqVGtgJw">2,443</ix:nonFraction><span style="white-space:pre-wrap;">k) is required to be maintained for the leases of Rostock headquarters building and Berlin offices until the expiry or termination of the leases.  Leases of certain plant and machineries were also secured with rental deposits of EUR </span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_s1PTQMK510ykabqlfipOvQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:RentalDeposits" scale="3" id="Narr_3JMwUNWbME-J-e24dfj1rw">190</ix:nonFraction>k.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_0a56ccc3_92c9_4db8_95e8_711ac87b4a7b"></a><a id="Tc_OKSMxRXqbEqOUnNl92sqog_1_6"></a><a id="Tc_ehMd2xOq2UyQyVrI6kgXOg_1_8"></a><a id="Tc_1HUGEJ1qLU2-jZB9PLQG3w_1_10"></a><a id="Tc_EuI04D3cxUKzGnLZFi78HA_2_0"></a><a id="Tc_0_N4pIF0CEKluRGlBM8fdg_2_2"></a><a id="Tc_Zpa5GY6o1k2wgBvi3K-N8Q_2_4"></a><a id="Tc_dURXrqhUGkmpIwyi0BjvZQ_2_6"></a><a id="Tc_8hco3VmQT06MS2iGOHvfkw_2_8"></a><a id="Tc_KxcD5XkAhEyFh5V_QzbWzw_2_10"></a><a id="Tc_hkG2NucSPkCHQluPjvzOjA_2_12"></a><a id="Tc_udMRmkmE1kuNxuMhZMYZUQ_4_0"></a><a id="Tc_bctALF7dMUOPSM0RZ3Zeag_5_0"></a><a id="Tc_UCeMQMfO7kSGhOA99jGxoQ_5_2"></a><a id="Tc_IkdL4VjgQ02bIeJL7ozEnw_6_0"></a><a id="Tc_V7HrpoRXQE23Dn9_T93MBQ_6_2"></a><a id="Tc_qo2EhLDQaEG8n0ShJY4ufQ_6_4"></a><a id="Tc_Aoef7NxF40a30x29yPxVoA_6_8"></a><a id="Tc_yNvahB3ZZUCB3EtJroX6fg_6_10"></a><a id="Tc_m9WxFZ5zY0ejbB5BAIQ2Pg_7_0"></a><a id="Tc_QTVHK-v8fku9vJQu2cy5sw_8_0"></a><a id="Tc_XngchByv2Eelf8ERYySfwA_9_0"></a><a id="Tc_MvHlM4b5pE2S4a2nGmsVJw_9_2"></a><a id="Tc_MTYZVL5m7ECtMyLStNMiSg_10_0"></a><a id="Tc_FjeBBC2YAkuLvVV7CBIxzw_10_2"></a><a id="Tc_OfVaYzRo_UqExh19Ud4wHg_10_4"></a><a id="Tc_9SRgaYBt30K2MbZZDSVNJg_10_8"></a><a id="Tc_iTCwq56XgE-gYnZt-3eXPA_10_10"></a><a id="Tc_4koAhf6SjkqwGBA-XHv_jg_11_0"></a><a id="Tc_IrE4YdTcm0mRQ4eRy8zRww_12_0"></a><a id="Tc_7Y0Pb1pczkCsjSeHsctQfw_1_0"></a><a id="Tc_hseXKHlHskiAASq3Q5gMAg_1_2"></a><a id="Tc_Ul_uAfsgukaXYLRVVkMglA_1_4"></a><a id="Tc_deFFoLwEJEq7jFhWIBDt_A_3_0"></a><a id="Tc_QND4v1J7fkqQYP5gXxpY_Q_4_0"></a><a id="Tc_7e8JFPhMfkWAfrdpWSax-g_5_0"></a><a id="Tc_3CazY4gGF0iL0xuofDFBew_6_0"></a><a id="Tc_kI4yHJDvqkuDz2ZHGfBDyg_7_0"></a><a id="Tc_VLs2XFcv5kyOW6EODJNvmg_9_0"></a><a id="Tc_vXRqxEw6-0GSUDRTwWdNbQ_10_0"></a><a id="Tc_bj-1iI-KQEKaHs4cofUrgA_1_0"></a><a id="Tc_Hno6wdIQfE2gsbvkkqJcNQ_1_2"></a><a id="Tc_0nPkFnr1j0yVmYJdnuVhLQ_1_4"></a><a id="Tc_l9Yyvjp0EU6IFPUacp5N7A_1_6"></a><a id="Tc_GHh_inYPRUKGIIP1VkB3DA_2_0"></a><a id="Tc_XiG85QeZBE-0bLJVXWudQQ_3_0"></a><a id="Tc_oMVJILfcykumebo61Yaz3Q_4_0"></a><a id="Tc_ZUBncSamvkeJVfolczYw-A_5_0"></a><a id="Tc_jCVNvXHr6kiRmUbV1uTNCw_6_0"></a><ix:continuation id="Tb_KPfJ9M5OvE2CiAgY4ggk1w_cont1" continuedAt="Tb_KPfJ9M5OvE2CiAgY4ggk1w_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The lease contract of Rostock headquarters building includes extension options.  These options are negotiated by management to provide flexibility in managing the leased-asset portfolio and align with the Group&#8217;s business needs.  The lease of Rostock headquarters building allows the Group to extend the rental contract </span><span style="-sec-ix-hidden:Hidden_iUFcya4OnkmTbsk8Tv6XcQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twice</span></span>, each for a period of <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q" format="ixt-sec:durwordsen" name="cntg:LeaseExtensionTerm" id="Narr_f7b1TlMoxUGhEkgUQhtqBQ">6 years</ix:nonNumeric>, after the expiration of agreement in September 2031 with rental payments of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RentalExpense" scale="3" id="Narr_2ZpcXkHzjU2y7AK2ya-jwQ">1,400</ix:nonFraction><span style="white-space:pre-wrap;">k per annum.  Such extension option was not included in the right-of-use assets and lease liabilities, as it is not reasonably certain that such extension option will be exercised.   </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group also has certain leases of motor vehicles and premises with lease terms of <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_GQnaSesZO02Ad6SmW22DGQ" format="ixt-sec:durwordsen" name="cntg:LeaseTerm" id="Narr_uANWOZQDik-a8w2--V8TXA">12 months</ix:nonNumeric> or less and leases of office equipment with low value. The Group applies the &#8216;short-term lease&#8217; and &#8216;lease of low-value assets&#8217; recognition exemptions for these leases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below are the carrying amounts of right-of-use assets and movements during the period:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="Tb_n_ZGNv-qq0Oa4-1jGmR49Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Plant&#160;and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Motor</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">In EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Buildings*</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Offices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Vehicles</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of January 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_jzVLa-F6DkiRRjGQ1jjAxg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_TOD0VYIUOkSDqJgAhtrMQA_4_2">13,126</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_-5Y_ZC3Cy06jqSRg2rkNWg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_-h2yv1fUskm4ujKkhQW6jg_4_4">4,407</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_8GUO8-vudkOK8pX-AcOLCA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_lB6MF5JEtUam1E_QVet6MQ_4_6">6,989</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_C-SoSBT-jUu6aB0HnuOW3g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_TMiAc3VwTESnCLL6uyPkVA_4_8">390</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_7LGAWQ8N8EWHfyuzxK-yzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_UlsQFWellEehx36Fz2_HWw_4_10">20</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_AoP6j5nOxUm5hblpIrL04A_4_12">24,932</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_COIkXqsq3EuSXQ8ccGnOYw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_4FePoV6JX0yASTitMDNzpg_5_4">426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_IkR9yLIEe0yXV5m3AEf9OA_5_6">1,265</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_06MXARpagUinzCDOWZ3Lzw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_spj7Du2TR02R95CjIOratg_5_8">1,112</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_OSY64BhwkUypKBgHktTxdA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc__q7xwZETg0Kwx159zUZ8NA_5_10">37</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_Jv-WfhEofE6qszWXSLBk-A_5_12">2,840</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reclass to property, plant &amp; equipment**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow" decimals="-3" format="ixt:numdotdecimal" name="cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment" scale="3" id="Tc_pQAV6F2AJUyoSV3qWIeHqg_6_6">1,992</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment" scale="3" id="Tc_uDWfmBMpQEG-_T0rx9HhNw_6_12">1,992</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Ws6ILO8IfUWKpcaFtKnMBQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_cnFSIizzY06cpS7W6-TiTA_7_2">1,121</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_COIkXqsq3EuSXQ8ccGnOYw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_XGeWolCl_0-Th_b3bS-ReQ_7_4">657</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_GjADpXGwm0mLkTQGA0uieg_7_6">1,675</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_06MXARpagUinzCDOWZ3Lzw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_mPBljKCmQ0qQFHaI53n03A_7_8">187</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_OSY64BhwkUypKBgHktTxdA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_VzN3G-Id0U6IB-NC0e4weQ_7_10">20</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_Y4JZVzu5R0mKIlgJWijzlA_7_12">3,660</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_-k8208qQ10SHd_-JTl8E2Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_kNNhtOH-iUqjzVF1WnXWsw_8_2">12,005</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_aKCHQwKnTkW-WicxuBEYgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_EJgujLEgE0uPkmF6qeK-aQ_8_4">4,176</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_r79EEaTrbE2YzRa5xIlIIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_cjIf6PG_30KCbGnhW79szA_8_6">4,587</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_cMFBX5CjWEKs38l_X26NEw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_KpjLJTKRQkedrQTwbKqqvQ_8_8">1,315</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_WHyj8PIaVEykw5TtSMGt3Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_me1Hxnr9lUOtlAEHVJv_dg_8_10">37</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_31f8ZPCWekyiARFE5Vv0KA_8_12">22,120</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_mfxVmFR_xEyQeUhCH23gEQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_CtGJy-nq8EmGnmFus7-Pkw_9_4">133</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_9UQd0CTawEKQ5P3K8NsFtw_9_6">1,121</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc__QWuzJb_tEe3xlu_uvu3xw_9_8">179</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_TaBZADcJRUu0DjfBcweKLA_9_10">19</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_O3zIRmm9-kiwrJ2zczZF1Q_9_12">1,452</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reclass to property, plant &amp; equipment**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment" scale="3" id="Tc_kUCvT2nVC0OXwfo3SowPSw_10_6">672</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment" scale="3" id="Tc_uV0HyL3Wb0aRrhU0NCgkhQ_10_12">672</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_u7fv_dcK-kmlAC640STiRQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_38c4K7GNlEGlRnKcgAvB2g_11_2">1,121</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_mfxVmFR_xEyQeUhCH23gEQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_jk49Sm9OpkiO1nw7Pii7NQ_11_4">970</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_gVcUhAdK6Eu3y3fOnQOZkQ_11_6">1,745</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_DALg24qPSkCNhlojKywoxw_11_8">138</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_x2v73PqrGkuvJrMX6lSP9Q_11_10">22</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_ZElEkkRjNE6MFeRjf0Fu_A_11_12">3,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_gr8iddTpHUKdwj10hqL1EA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_bjbvjqoQ20CfkqVeqCjxvA_12_2">10,884</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_y0Lzs-KudUaAjZAL7q9mYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_Q3quzy0y80OBMHIeDER0XA_12_4">3,339</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_Y0wjUE1Kn0Cww5TD7WEkoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_x8Z_H1I8lkSTpC2gGtziHw_12_6">3,291</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_yU8ydiLypEye2GvazPiV4w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_C3DT4saejUWcL_B9vlQMeQ_12_8">1,356</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_DH-VjAVOi0q0q4n9FC79TA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_9saIT23wJEy3RGSq9S0Mxw_12_10">34</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_IM2zTj2yoEa6p2-04wFtjw_12_12">18,904</ix:nonFraction></b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.79em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">*&#160;&#160;&#160;As the lease of land and buildings are made through one contract, all the related right-of-use assets are allocated to Buildings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">** Reclass of leased assets to PP&amp;E (note 12) represents purchased assets at the end of lease term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below are the carrying amounts of lease liabilities and the movements during the period:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory" id="Tb_4FQyH7Gvqka8HZrbMkT7ZQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of January 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LeaseLiabilities" scale="3" id="Tc__6PMn3pGcUaQhkPSTcIPTg_3_2">21,205</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LeaseLiabilities" scale="3" id="Tc_JacIAf1T5kKDJ-j4Muy1Bg_3_4">21,704</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsLeaseLiabilities" scale="3" id="Tc_m-w-1rULJk2Xzhm1nY_4Tg_4_2">1,452</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsLeaseLiabilities" scale="3" id="Tc_aVFqKxPd_0mH66osK3BrBQ_4_4">3,654</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_6-eLcSCsQU-yesW_ZQGhkw_5_2">584</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_cMg4tOk-dU-RqJ4qL2pVQA_5_4">865</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseThroughPaymentsLeaseLiabilities" scale="3" id="Tc_1K73IkC3O0eQevFuzwj78w_6_2">4,244</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:DecreaseThroughPaymentsLeaseLiabilities" scale="3" id="Tc_D5WNBV8LlEutseZXecoeHQ_6_4">5,018</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December 31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LeaseLiabilities" scale="3" id="Tc_TZ4ZZOwVzUy2vhHrizc-_w_7_2">18,997</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LeaseLiabilities" scale="3" id="Tc_sD0tFAcbZUalsecoSByv7A_7_4">21,205</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_S5JtMxDlC0CRFh9VtIyOsQ_9_2">3,409</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_YxgT12517kGrXWEmQNt-lQ_9_4">3,528</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Non-current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_gl7d-JOGNUyJO7OVBBHNpg_10_2">15,588</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_B2ti329oPEid_Bgr4q1GjA_10_4">17,677</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The maturity analysis of lease liabilities is disclosed in note 21.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following are the amounts recognised in profit or loss:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" id="Tb_2LaOICDf-UWYGRvu2j0rFA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Depreciation expense of right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_o5AyOhSDNEaqRbL6Hl2cOg_2_2">3,996</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_DsKCuwl6V02-5YzblpZ5Gw_2_4">3,660</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_ws9hnnGbKEqgAD5AUfq0hg_2_6">1,807</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Interest expenses on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_PmHBy3Js70iXQqcdpFZDMw_3_2">584</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_wBFPwTkSYk-E_xrbdzUOkQ_3_4">865</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_IJgYZMp270KfpDNEfDmAig_3_6">339</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rent expenses&#8212;short-term leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_Bjr_Hbk7uE23rHmVpAZQBQ_4_2">7,175</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_i3UrikjR20-oUhfjVhTvEQ_4_4">1,695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_SiX3BBeBNk6BsADAK5H6kQ_4_6">185</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rent expense&#8212;leases of low-value assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_vN1NwbID2k-J5uMO2n9PeQ_5_2">48</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_ux-f9Z3G7UyjfQFMP882pA_5_4">33</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_6uSjvmTYZkOKCn_PLHtT-A_5_6">25</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Total amounts recognized in profit or loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:TotalLeaseExpensesRecognisedInProfitOrLoss" scale="3" id="Tc_mBwHgKo62068XCGLbII6Xw_6_2">11,803</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:TotalLeaseExpensesRecognisedInProfitOrLoss" scale="3" id="Tc_rYu5B6DT3kKRA8z22QP0Pg_6_4">6,253</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TotalLeaseExpensesRecognisedInProfitOrLoss" scale="3" id="Tc_4xSu2RwkdUONxNRkbkNxHQ_6_6">2,356</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_KPfJ9M5OvE2CiAgY4ggk1w_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Group had total cash outflows for leases of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashOutflowForLeases" scale="3" id="Narr_8Y5k8cAPq0W1Riru2hEv5Q">11,467</ix:nonFraction>k in 2021 (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashOutflowForLeases" scale="3" id="Narr_lVIHp779qUaKXqVBfX-plg">6,746</ix:nonFraction>k; 2019: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashOutflowForLeases" scale="3" id="Narr_Bp8IDy_Ql0WhkEqr0PL43Q">3,256</ix:nonFraction>k). The future cash outflows relating to non-cancellable short-term leases and leases of low-value assets, are disclosed in note 24.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="Tc_9dDtQk50nEGNTTS1veXhiw_1_0"></a><a id="Tc_Q7-czqm_3kG-kaS3au8m7g_1_2"></a><a id="Tc_4twvGSI0w06UACeCII7ctA_1_4"></a><a id="Tc_P8FvvD8tc0u5OzQj1DAzyg_2_0"></a><a id="Tc_tJlXQiKJJUO7CsPPgE3UnQ_3_0"></a><a id="Tc_Dz2A0bt9E0WBPBnrcUjUww_4_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfInventoriesExplanatory" id="Tb_jQKH3VTkI0-7a222FNUCqQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">14 Inventories</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:DisclosureOfInventoriesTableTextBlock" id="Tb_a6AwE_1lrUiV8cG4iJvk5g" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Raw materials, consumables and supplies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies" scale="3" id="Tc_PxUz52lFIUGZK2BNDaO3aQ_2_2">3,831</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies" scale="3" id="Tc_mgZMJU8YF0SaY0Hbk9XLMA_2_4">11,167</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Finished goods and merchandise</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinishedGoods" scale="3" id="Tc_vpvcRPbcyk6qSd_s6Q29Sw_3_2">38</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinishedGoods" scale="3" id="Tc_QxTIRyJhK0it3cD1iO6BxQ_3_4">238</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Inventories</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Inventories" scale="3" id="Tc_mWYmJRkmXUmZkh-G9X76QQ_4_2">3,869</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Inventories" scale="3" id="Tc_vMnmpnNeQ0SzkbfO4dc-HQ_4_4">11,405</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Management assessed inventory obsolescence on all COVID-19 related inventories which resulted in an inventory write-off included within cost of sales in the amount of &#8364; <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InventoryWritedown2011" scale="3" id="Narr_DIpD1aSnj0KjEbWoe__hsw">1,795</ix:nonFraction>k (2020: <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:InventoryWritedown2011" scale="3" id="Narr_nHibbpQwLU-HByekTll-Ew">nil</ix:nonFraction>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In the&#160;year ended December&#160;31, 2021, raw materials, consumables and changes in inventories of finished goods recorded as expenses under &#8220;cost of sales&#8221; came to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" scale="3" id="Narr_8Jo7f6VT3k6sHlJuB6X_vA">70,089</ix:nonFraction>k (2020: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" scale="3" id="Narr_hSjMnFTq10WTU2iqTkUIFA">41,594</ix:nonFraction>k; 2019:&#160;EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" scale="3" id="Narr_k9Ds69_fFUaYNbFCjFsiDA">11,285</ix:nonFraction>k). </p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="Tc_unIKuuABWkSg-wl9sZZ8GQ_1_0"></a><a id="Tc_aSV66ToplUm3jhZnl0IlbA_1_2"></a><a id="Tc_BNFLadn0ZECbTwc5VN1OhA_1_4"></a><a id="Tc_uJHtm6HW1ESRXWw1BLhRGA_2_0"></a><a id="Tc_qWMY2KBBv0-ApfKNCGmzAA_3_0"></a><a id="Tc_-dJ0HnMV-0uBD5A1XkNSRg_4_0"></a><a id="Tc_9GK2f5A-xUeXPwKRgGohbw_6_0"></a><a id="Tc_rzVP1EWb3UmG1RpDVsrPCA_7_0"></a><a id="Tc_ZhchAoZqBkiLDd-O9POa-g_8_0"></a><a id="Tc_oXOHYbMD7k6V39WWgJrr6g_9_0"></a><a id="Tc_RrIooahBskeEdW6ruhkqOg_11_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock" id="Tb_GYPjuLeXWEGQAaILfhmBtQ" continuedAt="Tb_GYPjuLeXWEGQAaILfhmBtQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">15 Trade and other receivables and other assets</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" id="Tb_NxAHQLYKqUmoxzc024D-fQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:93.5%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets&#8212;Rental deposits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:RentalDepositsNoncurrent" scale="3" id="Tc_K8g4VQ-Uf0C_Y2tuitDFjw_3_2">2,922</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:RentalDepositsNoncurrent" scale="3" id="Tc_Ai8g4HNpMEWYMlGn6-1BRA_3_4">1,867</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets&#8212;Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherNoncurrentReceivables" scale="3" id="Tc_FzYkcSs43UeEHlyXwytPxw_4_2">50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherNoncurrentReceivables" scale="3" id="Tc_juC6uvuZZk-yTX2CFLFLPg_4_4">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherReceivablesAndOtherAssetsNoncurrent" scale="3" id="Tc_jrw75RVplEanskSkTqlwew_5_2">2,972</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherReceivablesAndOtherAssetsNoncurrent" scale="3" id="Tc_zhjnQWHz9U-zNzVWngKpkA_5_4">1,967</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" scale="3" id="Tc_tttgsHDPWkCPbgUJsAGCgg_7_2">21,065</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" scale="3" id="Tc_f9AxArUVekCvdvLRDD1gKQ_7_4">25,656</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contract assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentContractAssets" scale="3" id="Tc_Roxqwk9_o0iYLX_6sft3bw_8_2">3,272</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentContractAssets" scale="3" id="Tc_BqAEJWKmHUinh5TlO3f2SQ_8_4">3,543</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:OtherCurrentAssetsExcludingReceivablesDueFromShareholders" scale="3" id="Tc_ZuzpDYdJA0WTXI8jFby0xA_9_2">5,453</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:OtherCurrentAssetsExcludingReceivablesDueFromShareholders" scale="3" id="Tc_4cqQIsJ3xEWJ6qadrlbqnQ_9_4">8,286</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherReceivablesAndOtherAssetsCurrent" scale="3" id="Tc_fCN7p8QZjE2KavQ0XVgLzQ_10_2">29,790</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherReceivablesAndOtherAssetsCurrent" scale="3" id="Tc_oYGLnOB92EC796XSq9FiwA_10_4">37,485</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Total non-current and current trade and other receivables and other assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" scale="3" id="Tc_KgdvaJerE0GfOnTbiQ7RtQ_11_2">32,762</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" scale="3" id="Tc_vivOn8R-pEG_IyXJCx__vg_11_4">39,452</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Other non-current assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The non-current portion of other assets mainly include cash deposit of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_RostockHeadquartersBuildingMember_qSoBB62nPUyoN1idod-5Jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_AY8VjJeOk0aQnIhPd8c3Ew">2,250</ix:nonFraction>k, used to secure a bank guarantee of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_RostockHeadquartersBuildingMember_qSoBB62nPUyoN1idod-5Jg" decimals="-3" format="ixt:numdotdecimal" name="cntg:BankGuarantee" scale="3" id="Narr_B5cYDpQ_WECqTIxGfUjfUw">3,000</ix:nonFraction>k, relating to the leases of Rostock headquarters building, cash deposits of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_BerlinOfficesMember_1-SX3GoaW06QetWW2MQe4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_NUuOBHzdYkGzQx02Gs6piA">193</ix:nonFraction>k, used to secure a bank guarantee of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_BerlinOfficesMember_1-SX3GoaW06QetWW2MQe4Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:BankGuarantee" scale="3" id="Narr_SsaLgMlGB0GrioxhM4yQJQ">257</ix:nonFraction>k, relating to the leases of Berlin office, cash deposits of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherOfficeAndLaboratoriesMember_OVbtCKe6kk-CtIPs5TAqeA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_LJig_czkYE2MFhHlrMPc_g">289</ix:nonFraction><span style="white-space:pre-wrap;">k relating to the leases of other offices and laboratories  located in Germany and EUR </span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_Chzm4i2edE6J2DMBM3190g" decimals="-3" format="ixt:numdotdecimal" name="cntg:RentalDepositsNoncurrent" scale="3" id="Narr_phu7mduXZkaTVY8JouUd3A">190</ix:nonFraction>k for the leases of certain plant and machineries. It also includes the non-current part of the consideration receivable for the sale of LPC of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_ByAFGvd16EGpT4q2K6NblA" decimals="-3" format="ixt:numdotdecimal" name="cntg:ConsiderationReceivableForSaleOfLpc" scale="3" id="Narr_BJaDW_H3UUm4yPPOfM3qVA">50</ix:nonFraction>k (see note 8.2). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Trade receivables</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Trade receivables are non-interest bearing and are generally due in <span style="-sec-ix-hidden:Hidden_01i51NYs8kukTb1nNEXfkg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span> to <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_nN1e1Q0e8kGM1jF00oCH2w" format="ixt-sec:durwordsen" name="cntg:ReceivablesPaymentTerms" id="Narr_4548dG-J2ESKpOi2Yh4iQg">90 days</ix:nonNumeric>. In general, portfolio-based expected credit loss allowances are recognized on trade receivables and contract assets (see note&#160;21.2). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Other current assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other current assets include VAT receivables of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxReceivables" scale="3" id="Narr_M2q5TWt2CUitjWilSK13sg">253</ix:nonFraction>k (2020: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxReceivables" scale="3" id="Narr_XtWVDDLngEqiiWTDU7dw-g">226</ix:nonFraction>k), prepaid expenses of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Narr_MIwom-loXkKMcUHftlU0Xw">3,346</ix:nonFraction>k (2020:&#160;EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Narr_r6XGprE460OmckrPJnAD5Q">4,431</ix:nonFraction>k), receivables related to exercised share-based payment grants of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" scale="3" id="Narr_WQIN2K3qekCXYT2b_nxBcw">116</ix:nonFraction>k (2020; EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" scale="3" id="Narr_HF9yqAe9IEiqszYY_yjMPA">1,253</ix:nonFraction>k), receivables related to COVID-19 bank or credit card transactions of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentReceivablesFromCovid19BankOrCreditCardTransactions" scale="3" id="Narr_0P3ntA_dnkqMT76JFIIq9Q">612</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentReceivablesFromCovid19BankOrCreditCardTransactions" scale="3" id="Narr_ecKb2umnFkmsRvRzurq0uA">1,076</ix:nonFraction>k), as well as receivables from grants of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q" decimals="-3" format="ixt-sec:numwordsen" name="cntg:GrantsReceivables" scale="3" id="Narr_vLiR8ZW69U-m5d7I6TU20g">Nil</ix:nonFraction> (2020:&#160;EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:GrantsReceivables" scale="3" id="Narr_ys6FIXFyLkOuiIzh4sb_DQ">442</ix:nonFraction>k).<i style="font-style:italic;"> </i></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_GYPjuLeXWEGQAaILfhmBtQ_cont1"></ix:continuation><a id="_Hlk65085303"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" id="Tb_qWa_yKiGzku6QVBOaepZeA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">16 Cash and short-term deposits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Group has pledged its short-term deposits with carrying amount of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_TE1FCKSJ10Wnq3AFudeGVQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_V_IgYhoORkOKgvzZbxp5dg">938</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_KNPG7ftQ40y3-jayGIuG_w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_UHCsIEclWEutIQA5A6DOYg">1,500</ix:nonFraction>k) and EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_Wi4g3sYqFki41PmpP44cRQ">2,500</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_M_ofTAJmRkyW0qYhKuCWYA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_G3uHKhH3x0idZDXlmed8Iw">2,500</ix:nonFraction>k) respectively, to fulfil collateral requirements in respect of existing secured bank loan and overdraft facility up to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="Narr_5Azu9p7vXES1CG9vqffEug"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="Narr_eqkdEqx9_Uql7uLisBQO6g">2,500</ix:nonFraction></ix:nonFraction>k. In addition, the Group has pledged its short-term deposits of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_llexk3x_AUmw6uyZBIrKZg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_qVh9CaDi002jY7X1hLF1sA">1,000</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_eAQrHbDIbE2JWeOzUkgTzQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_GpHVpfEEu0mJS7WD1f7mBQ">1,000</ix:nonFraction>k) related to two other overdraft facilities worth EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityTwoMember_z-vR9ah280KWInpHt2Pf-A" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="Narr_NLuZhdgnfUGUSgaAHbB2dg">500</ix:nonFraction>k <span style="-sec-ix-hidden:Hidden_SQJSZp5xzU-f4eqciOHicg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The restriction applying to the collateral may be terminated at any time subject to the full amount of the relevant bank loans and the overdrafts being repaid.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_93025240_0fc5_4e5e_9109_6be8f1d76044"></a><a id="Tc_4SPSZKwg1EWLeN20N1Digg_1_0"></a><a id="Tc_qJSYoexK7E2VBpf7Chlezg_1_2"></a><a id="Tc_XrYev9R8qk-mjfEI0x5wGg_1_4"></a><a id="Tc_UdRxDL0ijUuCE8-2NLlwjw_2_0"></a><a id="Tc_3EImmlFROkGDlyDNNa23wA_3_0"></a><a id="Tc_7d-iaaZZu0iPyMmaT3uYcg_3_2"></a><a id="Tc_Mq5Vrat5fku9JOH425dXpw_4_0"></a><a id="Tc_VMm4ToMYdUuD9wlXac5TFg_5_0"></a><a id="_6b88664e_e1d1_429c_80d8_928f10fc050d"></a><a id="Tc_4ENY8zvpKky6UqQsJr9woQ_1_2"></a><a id="Tc_GyYDapMRaU6k-2-k5H4bPA_1_4"></a><a id="Tc_H4RqVVBK1USuuGjDxU-i5g_2_0"></a><a id="Tc_27NxYZO9G0K7Noujkkgelg_2_2"></a><a id="Tc_RLhKDF7__UaqHBxzJpBFtw_2_4"></a><a id="Tc_SgcVOvia5UiZpiNsb9B-aw_3_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="Tb_e8GNH3iUCEeYvcRMOAyo_w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">17 Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Issued capital and capital reserve</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" id="Tb_w1O19ysKPkixGezFlWnJ3g" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in thousands of shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Common shares as of Jan 1, fully paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="3" id="Tc_v7A7NetO0UeU6yGdJOMY6w_2_2">22,118</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember__CSueLWvfkaKMbg97rwstw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="3" id="Tc_lbcnowgHU0G2IE348WK21w_2_4">19,861</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Issued shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="3" id="Tc_W4v9z1sS6EOitCkdHfL1Bg_3_4">2,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:ExerciseOfOptionsShares" scale="3" id="Tc_UqWB2AGw8UWQ2x6k91tZBg_4_2">450</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ExerciseOfOptionsShares" scale="3" id="Tc_i8vJW8YKwUyBeYcOA9PcAw_4_4">256</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Common shares issued as of Dec 31, fully paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="3" id="Tc_QcE2hCHsiU6UobMvWavEQg_5_2">22,568</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="3" id="Tc_tTUxzRoHH0m82cuSmtRnkA_5_4">22,118</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">as&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">as&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in thousands of shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Authorized common shares of EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_nExfVi5yM06p0ttKKgQ84g"><ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_O3iMfclVXkeJWwz2V1N_kg">0.12</ix:nonFraction></ix:nonFraction> each</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesAuthorised" scale="3" id="Tc_vc2VmiAVw0uFVNbNFBNOAg_3_2">79,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesAuthorised" scale="3" id="Tc_ACP5dWAcW06OslLl53Rvqg_3_4">79,000</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Common Shares</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2020, the Company completed a follow-on public offering of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" scale="0" id="Narr_GC4pkn-rOUGvoCTv022lmg">3,500,000</ix:nonFraction> common shares of the Company, consisting of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_LRKY6gLhMEChXFAJqFrQYw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" id="Narr_3PJGmHN1C0eKXHdnp72rAQ">2,000,000</ix:nonFraction> common shares offered by the Company and <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfCommonSharesOfferedByPriorShareholders" scale="0" id="Narr_ErGmpvj3fkCaK9MeuNQJkg">1,500,000</ix:nonFraction> common shares offered by selling shareholders at a price to the public of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA" decimals="2" format="ixt:numdotdecimal" name="cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues" scale="0" id="Narr_LIl247JxjUGI--JvosdQxA">14.00</ix:nonFraction> per common share (i.e. EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA" decimals="2" format="ixt:numdotdecimal" name="cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues" scale="0" id="Narr_LI-Lf14Bfk29YPEcUl2HqA">12.71</ix:nonFraction> per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_Yo-DMXNOEkqp3f-wlRkAEg">22</ix:nonFraction> million to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31 2021, <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="0" id="Narr_nS8nGZ3WpEWHLKcxJekD7A">22,567,971</ix:nonFraction> common shares of Centogene N.V. with a nominal value of EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_JQcXhg5ewUGvactMzDngHw">0.12</ix:nonFraction> were issued and fully paid up (2020: <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="0" id="Narr_Ctm8QfY6ZUaR7887v8kZww">22,117,643</ix:nonFraction>). As of December 31, 2021, the authorized, but unissued common share capital amounted to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:AuthorizedButUnissuedShareCapital" scale="3" id="Narr_rZg-vbCF7061UyWd0dygEw">6,772</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw" decimals="-3" format="ixt:numdotdecimal" name="cntg:AuthorizedButUnissuedShareCapital" scale="3" id="Narr_aWQRXn3tFkWy2T24htl54g">6,826</ix:nonFraction>k).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The holders of common shares are entitled to the Company&#39;s approved dividends and other distributions as may be declared from time to time by the Company, and is entitled to vote per share on all matters to be voted at the Company&#39;s annual general meetings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Capital reserve</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, capital reserve included a share premium of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SharePremium" scale="3" id="Narr_7dHa0K-F-E686NK_1a9C3Q">106,665</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SharePremium" scale="3" id="Narr_m-V5GGJSiEaUhK7SH4_osw">107,498</ix:nonFraction>k), being amounts paid in by shareholders at the issuance of shares in excess of the par value of the shares issued, net of any transaction costs incurred for the share issuance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The capital reserve consists of the share premium account and amounts recorded in respect of share-based payments. For additional information on the share-based payments, please refer to note&#160;20.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" id="Tb_57KnDNeWO0iA3t_hyCLBCA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">18 Capital management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#39;s objectives when managing capital are to safeguard the Company&#39;s ability to continue as a going concern and finance all necessary sustainable developments, so that it can continue to provide returns for shareholders and benefits for other stakeholders. In particular, care is taken and an optimal capital structure is strived for to reduce the cost of capital. With the IPO in November 2019, follow-on public offering of July 2020, warrant issuance and aggregate debt financing in February 2022, the Group is focused on achieving a healthy capital base to increase the confidence of investors and the capital market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group manages its capital structure and makes adjustments in light of changes in economic conditions and the risk characteristics of its activities. To maintain or adjust the capital structure, the Group may adjust the return to shareholders, issue new shares, or pay additional interests to reduce debt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_Yeh1gpxa7UiQolLfIbEr1Q_1_0"></a><a id="Tc_J6YX9p_g0kmuApInLJfJXg_1_2"></a><a id="Tc_RwHuQbchYUuuqsxninnXLw_1_4"></a><a id="Tc_kJCrhJ_K_Ey62_R12532rg_2_0"></a><a id="Tc_KJea84kbyU2WEp3RbHVK5g_3_0"></a><a id="Tc_fXWr6kmp-kqaaCzB89oX8g_3_2"></a><a id="Tc_sK4rxjH4jk2sdHmJd53l_w_4_0"></a><a id="Tc_EmTy0wBZwUaMpPYxDF3Xpw_4_2"></a><a id="Tc_GShSLx6tCE66tEC8K_jfzw_5_0"></a><a id="Tc_rWs9Ionq4E6BE8SUODB28Q_6_0"></a><a id="Tc_VQlNZWNYyESSXqmJG3t4yg_8_0"></a><a id="Tc_HshntW-0vkuDF3PVc2vUpg_9_0"></a><a id="Tc_9Qna7W5G7EGLDSWQ9E0eqg_10_0"></a><a id="Tc_vPmWe9XspEmANBlwj0njvg_10_2"></a><a id="Tc_NoDr8p6Nbk6J45AvYN8w9w_11_0"></a><a id="Tc_vvQN51qXXkKgpku3_wt-rQ_12_0"></a><a id="Tc_vTzpTC0MoECwXwdn2MbPYg_13_0"></a><a id="Tc_GoNa99GH2k20mDnjlMh9fA_14_0"></a><a id="Tc_Juzk14-YI0G0erp7HHqHdg_16_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory" id="Tb_81DAHHNTVki3s4dSmdibrQ" continuedAt="Tb_81DAHHNTVki3s4dSmdibrQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">19 Financial liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.1</b></span>Interest-bearing loans</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfBorrowingsExplanatory" id="Tb_Rclh6jKCw0u8d0Zd50ZQFg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non&#8209;current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g" decimals="-3" format="ixt:numdotdecimal" name="cntg:NonCurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_SNErCC6INU-VvmcR47jVOg_3_4">401</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current loans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> -</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_5QwdsOAvnkeo5LIcezl3Dw" decimals="-3" format="ixt:numdotdecimal" name="cntg:NonCurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_ErqcLyLmHEuWjPJfdMZIvw_4_4">401</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw" decimals="-3" format="ixt:numdotdecimal" name="cntg:NonCurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_p4r9x3XWk0-nW2hutpT1gg_5_2">15,588</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:NonCurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_Xftml7P9zk2dwEq8-CZOXg_5_4">17,677</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:NonCurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_vNPLT9UNs065TCdzsgfptw_6_2">15,588</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:NonCurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_9xuNGh_DxUW7gSYGQ2jzJw_6_4">18,078</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_EVd8k1wgy0qJRv3QcJNjwg" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_cDbrdNtf-0GrLTsZIRtlcQ_9_2">505</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_GUuxUf0ZfESeLHJf_dIE2A_9_4">567</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_Vx0h4SIOS0GdX8qdvb10RA_10_4">387</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_M1EU4d6N9kCphLDz7bVjpw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_6BJp_gKYl0i4wRY4lJ5VPw_11_2">3,310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_l-qjFsXgx02dSZIZxayWmA" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_WrE-Mw6cHUSpo9QEh7QVdQ_11_4">1,538</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current loans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_D3CrI-gxmka4zS7T_IluDA" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_b_jwtvKk5UGyX0qKoeeZaQ_12_2">3,815</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_5QwdsOAvnkeo5LIcezl3Dw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_sXhlxS2eOkyD_HDdWFBqEA_12_4">2,492</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_eDy5ku6jSkycUgTy_gPK7w_13_2">3,409</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_F8_330c4DUqUgs2csF704w_13_4">3,528</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_otc_S8aYYkS5mH0m5zGnRg_14_2">7,224</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:CurrentFinancialLiabilitiesInterestBearing" scale="3" id="Tc_jK6dRf3hW0aDawEjADBrYg_14_4">6,020</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current and current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_3rTw41ZQvUaBhE0RgSYMxg_16_2">22,812</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_dufkgawG4U6-nEjZIauNEg_16_4">24,098</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 2021, short-term cash deposits of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_EVd8k1wgy0qJRv3QcJNjwg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_tuRneWNBrUWxJnoTYn7gfg">938</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="3" id="Narr_jiL92RAQTkqZYyYUTyoq6w">1,500</ix:nonFraction>k) were used to secure the remaining bank loan outstanding (see note 16).</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_34a6bd38_84b3_48d7_ade6_3bba07031fb7"></a><a id="Tc_iFW4GPzQmEGiNg3gNZj43A_1_8"></a><a id="Tc_ynPR9MJY90KVIKS_OSTtAA_1_12"></a><a id="Tc_zgVVevK64UamOKcqnIVmqw_2_4"></a><a id="Tc_2KIfwQykrkuS04jzTxIiOg_2_8"></a><a id="Tc_NlvE40cxnki6eX-Lq9ZUEw_2_10"></a><a id="Tc_C4GqbreHM0-WDLY93ogF0A_2_12"></a><a id="Tc_U4_rUsBT5kq50g5W1N3Ekw_2_14"></a><a id="Tc_Tm0--QCeaUmOxooMPS9I1w_3_0"></a><a id="Tc_QhUZFWBrTkitJmVtWByBUQ_3_2"></a><a id="Tc_r9t3jqdICEq19j9WjIylHg_3_4"></a><a id="Tc_D3d0umYfqky_5y2J0brAgQ_3_6"></a><a id="Tc_6vvj9TvYkkqmgulIryfWSA_3_8"></a><a id="Tc_QmoZqIveoku9tRKvRGXT8A_3_10"></a><a id="Tc_kb4GHkq6CkWg3KBX7Dr_oA_3_12"></a><a id="Tc_yBPzdvS3KEGHODrzmKtnmA_3_14"></a><a id="Tc_qRQ69NFIUkCJDbWb62S1Rg_4_0"></a><a id="Tc_h3ZWChiEIkmNbfLmWhLFMw_4_2"></a><a id="Tc_U8jAnsCXFUC_u_3nn6wxXQ_4_6"></a><a id="Tc_qlgr5wINy02rwp4yc0jXgg_5_0"></a><a id="Tc_r81_sraSKE6oKrlu_RPbWA_5_2"></a><a id="Tc_3_OMj1jag0yzbTRlcgGpgA_5_6"></a><a id="Tc_p6o982qd80aQyJAshcnMZg_5_8"></a><a id="Tc_Ny_xVO-Kh0qXaOS1SvmHmw_5_10"></a><a id="Tc_HQJnqeb_wkaKSA5k2kIR3g_6_0"></a><a id="Tc_VhQn9xzSjEuOjXNrzEZHEA_6_2"></a><a id="Tc_dSh6GiEI7EeyO8JNLtzv7g_6_6"></a><a id="Tc__JTbxzVFFkKCS4mGhZbcOQ_7_0"></a><a id="Tc_7N3tbQCw10OkMpxZjpaEmg_7_2"></a><a id="Tc_CAlLfbHBWUa94uV1KyN0cA_7_6"></a><a id="Tc_MdufN3k1zU2AQE3iBRjubA_8_0"></a><a id="Tc_KAi14Tl0f0y-SnmFZQ_1xQ_8_2"></a><a id="Tc_Zq4xz1AxTUyztegPljZ50Q_8_6"></a><a id="Tc_l8fujJMJT0WnKtOVWu48jg_9_0"></a><a id="Tc_59lT230lXE-eR4KYWArdiw_9_2"></a><a id="Tc_zFZjPYJvDUir6DkRC6f1EQ_9_4"></a><a id="Tc_EQE3nFmfOk-Xk-uFJE3KDw_9_6"></a><a id="Tc_S0PsCC3bhEOjyCbN054irg_10_0"></a><a id="Tc_3FS2BTaZkU-ZlWG-QL_Ozg_1_0"></a><a id="Tc_tg3miZ54a0-tvNcSFwq2Ew_1_2"></a><a id="Tc_QJzl9tbkU0-pIetV0dk08A_1_4"></a><a id="Tc_Xk6yVDOGBUG4Yf4YcHnqvw_2_0"></a><a id="Tc_cXpNQHy0GE-w9ezA6FwfQg_3_0"></a><a id="Tc_zfySCs0ECEuoTZdsS74hgA_4_0"></a><a id="Tc_QsU0m7pKlEu8yYaoCdGk3w_5_0"></a><a id="Tc_2wr9T2uQnkGF255hyXmi2w_6_0"></a><a id="Tc_aQrE4TNRuk-_l8rVo20YLw_7_0"></a><a id="Tc_7TxFGomvAU-cMeGZXfBNdg_8_0"></a><ix:continuation id="Tb_81DAHHNTVki3s4dSmdibrQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table is based on the original terms and conditions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Conditions and statement of liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The outstanding interest-bearing loans as of December&#160;31, 2021 and 2020 have the following conditions:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory" id="Tb_LzMBW9gaz028Y5vBMkMS9A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">interest&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Maturity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Secured bank loan</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Tc_IXE4rpUyvUiPPLB14HNk5g_4_4">2.95</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2017&#8209;22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_rXm3DvGM8UiYyX6I9sKG5g_4_8">505</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_-9PtfuZveE2APzH1aTl08g_4_10">505</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_B-4Za9jSeEuOpXOxxvEANg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_R3r1C_zoPUKav8kjMPlMJw_4_12">968</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_B-4Za9jSeEuOpXOxxvEANg" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_DDSHXiGqg0CcQCScFyT2KA_4_14">968</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loan</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">USD</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_ZMDElsu6kkCNvAhR--AP0A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Tc_CpSvbO_z8k-NjSgQRfepvw_5_4">1</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2020-22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_batS-sYagE-QDWp7TZ56Xw_5_12">387</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_EmeDgqfzdkOaT-hjWhcmAA_5_14">387</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Tc_1RZx2UNrakKiw2XAP0SvyQ_6_4">4.75</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_FOpZtyxtE0qOTWIWz6ob1A_6_8">499</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_hboJDQCbrEKkHYQUZV3Uow_6_10">499</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Bvjg5Ricb0CsHHRkM2oKiw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_UMmh-fVlJUaXgyo_FhTfvQ_6_12">498</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Bvjg5Ricb0CsHHRkM2oKiw" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_11CaYxC55Eqli1Yj-Nwcrg_6_14">498</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Tc__YeMhL5bSkqLNnyoezwu_Q_7_4">3.75</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_kUkfI0jcKUaJ2oj3RiePDg_7_8">2,329</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_juEMvYRhw0uo6ZrieADZGw_7_10">2,329</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_PliM0JjAKkmUwZ2G-hrauQ_7_12">628</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_u3rOoyv3M0SpFAESNRELqw_7_14">628</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Tc_Espk9Rka1k-pARgLNkFZKQ_8_4">4.50</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_wHeCdmK4aE6S50Hl6XUBog_8_8">482</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_FaPQ6blrsE6Vetk2AIEMbQ_8_10">482</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_tH9SKU_4CEueGcGPE4KKrA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_ieRBZnrvn0-1sihICW1_Og_8_12">412</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_tH9SKU_4CEueGcGPE4KKrA" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_V4sGxEN0dUip11QR8MMY6Q_8_14">412</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_T7-iENiVYUyPsm2u4I6Pqw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_v-cawZbRg0CKBl15LVoJrg">2.1</ix:nonFraction>%-<ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_1MoZEasurUyfu0ObaxOLFw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_8plfUY1E8UqXa1RiIsmfdA">3.5</ix:nonFraction>%*, <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_T7-iENiVYUyPsm2u4I6Pqw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Narr_zMjPpdA_90m93DGYRANnZQ">5.4</ix:nonFraction>%-<ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_1MoZEasurUyfu0ObaxOLFw" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="Narr_4iSjJVMcQEq197yCT4phKA">9.1</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2017-31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_6tjd6J6-50qX91bWKC21Iw_9_8">18,997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_4okpTuGiiUKz5deaOhahQQ_9_10">18,997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_B9wwck9zp0e9_SOSUB7ntQ_9_12">21,205</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_yCU1kmokekmqliHJG1wugw_9_14">21,205</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total interest</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">bearing financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_1UnOSBWM9E2epK4n800W-A_10_8">22,812</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_-Idw3JiLXUi2fL8FxvMkeA_10_10">22,812</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Tc_IKcw2_7uvEm1b6LMo8yteg_10_12">24,098</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:FinancialLiabilitiesInterestBearing" scale="3" id="Tc_UW5OZHQ_yUGLise6LHigDQ_10_14">24,098</ix:nonFraction></b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">*&#160;&#160;&#160;&#160;&#160;represents the incremental borrowing rate of the Group at the commencement of the leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The bank overdrafts of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Narr_byYMEH6z5EyIdIGsGEovyw">2,329</ix:nonFraction>k as of December 31, 2021 (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="3" id="Narr_m0ukmlUR1kyvQ4ZXljcZYw">628</ix:nonFraction>k) were secured by short-term deposits with a carrying amount of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_llexk3x_AUmw6uyZBIrKZg" decimals="-3" format="ixt:numdotdecimal" name="cntg:ShortTermDepositsPledgedAsSecurityForLiabilities" scale="3" id="Narr_TMvURLSNZ0CXntRaZFK64w">2,500</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_eAQrHbDIbE2JWeOzUkgTzQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:ShortTermDepositsPledgedAsSecurityForLiabilities" scale="3" id="Narr_Qh1Vce5U_Em42sWAEgGAWw">2,500</ix:nonFraction><span style="white-space:pre-wrap;">k) (see note 16).  The other bank overdrafts of EUR </span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="3" id="Narr_DSJZa96GuEC5_0WXZ4BVag">981</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="3" id="Narr_Q1DbtLOZH0OX5G216yU_7A">910</ix:nonFraction>k) are secured over two short-term deposits with a carrying amount of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneAndThreeMember_1pwVmq3z50WQKX7nCXD94A" decimals="-3" format="ixt:numdotdecimal" name="cntg:ShortTermDepositsPledgedAsSecurityForLiabilities" scale="3" id="Narr_NE0GII52302Zzk0_xWojOQ">500</ix:nonFraction>k each as at year end December 31, 2021 (see note 16). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.2</b></span>Trade payables and other liabilities</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" id="Tb_B9-X4_hQ30yoq6e1PKrQ0w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="3" id="Tc_r-CHEK_QPkWNFftEdWX5Jg_2_2">11,252</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="3" id="Tc_l9_q4upCWkWrMDKoNfkrxw_2_4">31,736</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants (deferred income)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GovernmentGrants" scale="3" id="Tc_b_Fy_aQzPk-x5h-T-IsQlw_3_2">9,396</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GovernmentGrants" scale="3" id="Tc_DiCsJnkbbU6BeboOID5fEQ_3_4">10,292</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contract liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractLiabilities" scale="3" id="Tc_v4mfea3M_EGsI8nJaTeGGw_4_2">4,842</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractLiabilities" scale="3" id="Tc_hYPQyHIBEUKGXkMpnsRl2A_4_4">4,479</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherPayablesOther" scale="3" id="Tc_jXtmBRdiYEifjoUpoOe5zg_5_2">14,632</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:TradeAndOtherPayablesOther" scale="3" id="Tc_H1exWaB9OUWs-hvb6nwVtg_5_4">13,483</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Trade payables and other liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherPayables" scale="3" id="Tc_Y674ToFL6kG_B2Q38bxn_w_6_2">40,122</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherPayables" scale="3" id="Tc_Wzk6zqe99UuFwgJjBxFOWg_6_4">59,990</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentPayables" scale="3" id="Tc_ABcJ1boxBUiCtGqOFAiz-A_7_2">8,028</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentPayables" scale="3" id="Tc_4pgxwZBLb0SDu4nCeIGQIw_7_4">8,950</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_MS7rNAi-ukW7kslCFM99wQ_8_2">32,094</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_5cIpFW0b6UeW-WLDhGDbQg_8_4">51,040</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Government grants mainly include investment-related government grants.  These were received for the purchase of certain items of property, plant and equipment for the research and development facilities in Mecklenburg-Western Pomerania, including the Rostock facility. The grants were issued in the form of investment subsidies as part of the joint federal and state program, &#8220;Verbesserung der regionalen Wirtschaftsstruktur&#8221; (improvement of the regional economic structure) in connection with funds from the European Regional Development Fund. Additional grants received during the year ended December 31, 2021 amounted to EUR </span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Narr_HownMObnFEGjeTBeqXgvMg">168</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Narr_xKyztGeqck6141zz0AIeuQ">390</ix:nonFraction><span style="white-space:pre-wrap;">k).  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition, other liabilities include a provision for outstanding invoices of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ProvisionForOutstandingInvoices" scale="3" id="Narr_wGZMYneIaUaHN9QUB0qPow">4,978</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ProvisionForOutstandingInvoices" scale="3" id="Narr_8Vk1MKi5eUasGBi7Jl21Dw">1,245</ix:nonFraction>k), personnel-related liabilities for vacation and bonuses totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="3" id="Narr_4OnQv4YpZEGujXHQFeV2Cw">4,812</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="3" id="Narr_JZbEC-V61Uu22sFWgA-Zog">4,032</ix:nonFraction>k), a VAT payable of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxPayables" scale="3" id="Narr_FwDNC3IfVUSthlNOdI3VDA">905</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxPayables" scale="3" id="Narr_aSLOpv7nd0yIeGkFKxFHQw">4,578</ix:nonFraction>k), as well as liabilities for wage and church tax of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:LiabilitiesForWageAndChurchTax" scale="3" id="Narr_ez_gN1ZXhkuNYqcapve3dA">1,040</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="cntg:LiabilitiesForWageAndChurchTax" scale="3" id="Narr_IdzxW1q4CkCOzEOxT9EOAw">1,988</ix:nonFraction>k). </p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="Tb_TQrIWtB550iFByrQD7hiTA" continuedAt="Tb_TQrIWtB550iFByrQD7hiTA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">20 Share-based payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021 and 2020, the Group had the following share-based payment arrangements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(i)&#160; Virtual share option program 2016 (cash-settled)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On July&#160;<span style="white-space:pre-wrap;">1, 2016, the Group established a virtual share option program (the &#8220;2016 VSOP&#8221;) under Centogene AG. The completion of IPO in November 2019 was defined as one of the &#8220;exit events&#8221; in the 2016 VSOP program.  Accordingly, all options </span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_TQrIWtB550iFByrQD7hiTA_cont1" continuedAt="Tb_TQrIWtB550iFByrQD7hiTA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">granted under the 2016 VSOP vested immediately in full upon the completion of the IPO. In addition, holders of vested options are entitled to receive a direct cash payment from the Company according to the calculation as stipulated in the program, which is determined based on the IPO price of the shares of Centogene N.V. and the exercise prices of the vested options The payment to the option holders will be reimbursed by the original shareholders of the Company at the same time as the obligation to pay the options holders arises.  Upon the completion of the July 2020 Offering, the relevant payments of EUR </span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_7_1_2020_To_7_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_LUjbd8sTrEGlOUAQswnsuw" decimals="-3" format="ixt:numdotdecimal" name="cntg:PaymentForSettlementOfStockOptions" scale="3" id="Narr_ZhlVc0Rm70yhYqJIpzeGEw">2,768</ix:nonFraction>k to the holders of vested options were settled by the proceeds received from such original shareholders from the sale of their shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(ii)&#160; 2019 Equity Incentive Plan (2019 Plan) </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In conjunction with the consummation of the IPO, the Company established a new long&#8209;term incentive plan (the &#8220;2019 Plan&#8221;) with the purpose of advancing the interests of our shareholders and other stakeholders by enhancing our ability to attract, retain and motivate individuals who are expected to make important contributions to us. The 2019 Plan governs issuances of equity and equity&#8209;based incentive awards from and after the consummation of the IPO. Awards under the 2019 Plan may be granted to our employees, the members of our management board and supervisory board, consultants or other advisors. As of January 1, 2022 the maximum number of common shares underlying awards that may be granted pursuant to the 2019 Plan (other than replacement awards) will not exceed <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw" decimals="2" format="ixt:numdotdecimal" name="cntg:SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" scale="-2" id="Narr_QCC3g2vuA0OFV-PR2D-tag">22</ix:nonFraction>% of the Company&#8217;s issued share capital. Such maximum number will be increased on January&#160;1 of each calendar year, by an additional number of common shares equal to <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw" decimals="2" format="ixt:numdotdecimal" name="cntg:AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" scale="-2" id="Narr_zJ2LPHQJxUea7Y--vcgYuA">3</ix:nonFraction>% of the Company&#8217;s issued share capital on such date (or a lower number of common shares as determined by the management board or supervisory board, where appropriate on the basis of a recommendation of the compensation committee (as the case may be, as prescribed by the 2019 Plan and, collectively, the &#8220;Committee&#8221;)). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In the event of a good leaver&#8217;s (as defined in the 2019 Plan) termination of employment or service, all vested awards will be exercised or settled in accordance with their terms within a period specified by the Committee and all unvested awards will be cancelled automatically unless decided otherwise by the Committee. In the event of a bad leaver&#8217;s (as defined in the 2019 Plan) termination of employment or service, all vested and unvested awards will be cancelled automatically without compensation.  Pursuant to an amendment to the 2019 Plan applicable to awards granted in the period between September 11, 2020 and November 25, 2020, unless otherwise determined by the Committee, in the event of a good leaver&#8217;s termination of employment or service, all unvested awards will vest in full and all vested awards that have not yet been exercised or settled must be exercised or settled in accordance with their terms within a period specified by the Committee. If those awards are not exercised or settled within such period, they will be cancelled automatically without compensation. This arrangement is applicable to awards granted in the above-mentioned period only (see note 20(v)). </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the event of a change in control of the Company (as defined in the 2019 Plan), outstanding awards that will be substituted or exchanged for equivalent replacement awards, in connection with the change in control will be cancelled. Outstanding rewards that are not substituted or exchanged for equivalent replacement awards, in connection with the change in control will immediately vest and settle in full, unless otherwise decided by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The grants disclosed in the following paragraphs were granted under the 2019 Plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(iii)&#160; Equity share option - Replacement (ESOP/ VSOP 2017)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2017, the Group established another virtual share option program (the &#8220;2017 VSOP&#8221;) that entitled the management board to grant virtual share options to individuals, in regard to services they provide and their continuous commitment to the Group.<b style="font-weight:bold;"> </b> As part of the corporate reorganization, in connection with the IPO (see note 1), a transfer agreement was entered into between the holders of options granted under the 2017 VSOP, Centogene AG and the Company in November 2019, according to which, the 2017 VSOP was terminated, and the option holders were instead granted new share options of the Centogene N.V. under the 2019 Plan (as defined and discussed above), determined based on the IPO price of the shares of Centogene N.V. and the number of options granted under the 2017 VSOP. These share options were issued to the holders of options originally granted under 2017 VSOP as part of the corporate reorganization to replace the cash-settled share-based program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The number of options granted to each holder was based on the number of options granted to them under 2017 VSOP and the IPO price of Centogene N.V. Accordingly, during 2019, <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_Am_wCa6iC0GIiYv0shNH_Q">805,308</ix:nonFraction> new share options were granted pursuant to the Centogene N.V. 2019 Plan, with each option representing the right to acquire <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg" decimals="INF" format="ixt-sec:numwordsen" name="cntg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" scale="0" id="Narr_wHBophN4DU6aL5iB7WDUxg">one</ix:nonFraction> common share of Centogene N.V., with an exercise price equal to the </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_Lb1yMSSMEkaaheXnVpr76w_1_2"></a><a id="Tc_SJ0QaZ1Gkk6wvfNbQ3HCQA_1_6"></a><a id="Tc_BY36WtM3Jku_EFiTVamR1w_2_2"></a><a id="Tc_urokX59420ixFAg60uswNw_2_4"></a><a id="Tc_L5_rnkn8l0-GeHOHM4Tpvw_2_6"></a><a id="Tc_xwOZUxnt-kS-gwqSNTntpQ_2_8"></a><a id="Tc_TqGZQaWmN0OTHiAH1N8ZKA_3_0"></a><a id="Tc_f8QyRCJrV0-EB3IvhO7BGw_4_0"></a><a id="Tc_bXJGXhYSGESlLYpn0gvEWA_4_2"></a><a id="Tc_OSlRRpKW7UeD2bKHckScnw_4_6"></a><a id="Tc_2NuaN1_5EkmwWhepKhjlsQ_5_0"></a><a id="Tc_XBLVUXif202SSBLFriAS0g_5_2"></a><a id="Tc_GOrXegwZKU2t2e4mKUaz6A_5_6"></a><a id="Tc_AZMoasOjfUaX4W_wJqMNDg_6_0"></a><a id="Tc_kthzyJc-hkOScF4Bz5kzNg_7_0"></a><a id="Tc_u9qSHPhYTkGMLsRsxRKaXw_8_0"></a><a id="Tc_Q1Mv4kHnqUOZBTKf6U8KHQ_9_0"></a><a id="_add64202_5031_4d84_864c_1045a0af6287"></a><a id="_add64202_5031_4d84_864c_1045a0af6287_2"></a><a id="_add64202_5031_4d84_864c_1045a0af6287_3"></a><a id="_add64202_5031_4d84_864c_1045a0af6287_4"></a><ix:continuation id="Tb_TQrIWtB550iFByrQD7hiTA_cont2" continuedAt="Tb_TQrIWtB550iFByrQD7hiTA_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">nominal value of a share of Centogene N.V., which is EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_-8F_QYhOEU6YD7GUD5UCgg">0.12</ix:nonFraction><span style="white-space:pre-wrap;">.  The options were considered vested upon the completion of the IPO, but were not exercisable in the first </span><ix:nonNumeric contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg" format="ixt-sec:durwordsen" name="cntg:LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" id="Narr_iRVofv-Nu0qeW-9XpZPvHQ">180 days</ix:nonNumeric> after the IPO (lock-up period). </p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" id="Tb_YaH8ceRrm0Ky7RFQZIiPRQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_dNove82cp0CGLO5zNIEobg_3_2">549,005</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_HjTaXMhYVkWTESmYsg1jdw_3_4">0.12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_e7pwRt_d5Ey8miVUeDmHnQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_52YFiGkVW0OqCg5mLIk-Tw_3_6">805,308</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_e7pwRt_d5Ey8miVUeDmHnQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_vI5GvOCbIku3X4rLfHMkDg_3_8">0.12</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_T8SDgiOnzEq9JeF6-UzXZA_4_4">0.12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_fWsidVZhO0O1il74nkggRA_4_8">0.12</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cancelled during the year </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="0" id="Tc_M8dcnfT7VECcCMsKUzV-pA_5_4">0.12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="0" id="Tc_pdKFf6IpqEeY48_NQAarHA_5_8">0.12</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_AT7kn4qSika81IVFngucww_6_2">191,565</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_3qv-Zp_KBEi1aKHoZ68CNQ_6_4">0.12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_OyHO9Uptq0O1qKhtiKvWWw_6_6">256,303</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_gng_PIY2UEOvr8uygM5NuQ_6_8">0.12</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_h-hfQBkQaEapb-AlAKGZIQ_7_2">357,440</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_VRfUUfxaL0WcMf7YrKvRJQ_7_4">0.12</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_iFfhi9fFQ0OCy2kA1SG84w_7_6">549,005</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_LAgfXVhttEi4IGuAgS9swQ_7_8">0.12</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement" scale="0" id="Tc_hxYxBLj63EKNy1GjLeNLFw_8_2">357,440</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" scale="0" id="Tc_aUOO-aLlQUWTWDikE4QmyA_8_4">0.12</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement" scale="0" id="Tc_EbuCrHe-M0-D38q0JuKdIA_8_6">549,005</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" scale="0" id="Tc_BhYBFXklBEqBhACF6d5_IA_8_8">0.12</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_Fqjp7_2Ij0GmKbqq7cXJzg_9_2">357,440</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_KhnQ5agUdk6K8uMdGoy0Rw_9_4">0.12</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_odEs-CmFTEGkj5y9cY98Vw_9_6">549,005</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_h5iPqH9wNk-JXqOBZCrNTA_9_8">0.12</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During 2020, <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Narr_Nj16-3xlpUO_AZk5lBdQ6g">256,303</ix:nonFraction> options were exercised. The weighted average share price at the date of exercise was USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Narr_XKwfJHQbMEuZl7VHV1VIbg">12.13</ix:nonFraction><span style="white-space:pre-wrap;">.  During 2021, </span><ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Narr_SZWhPt5cME-6nFQl4-buZw">191,565</ix:nonFraction> options were exercised. The weighted average share price at the date of exercise was USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Narr_-3PrERXhskq6YdKykpJSXg">9.76</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contractual term of the share options as of December 31, 2021 is <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" format="ixt-sec:durwordsen" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Narr_TMom24coW0KS2dif2ckpSQ">eight years</ix:nonNumeric>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The share options issued under ESOP 2017 are equity-settled and the fair value of the options were recognized in equity under capital reserve on the date of grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></span><b style="font-weight:bold;">Equity share option 2019 (ESOP 2019) to Flemming Ornskov</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">In 2019, an agreement was entered into between the Company and Flemming Ornskov. According to this agreement, a total of </span><span style="font-size:10pt;"><ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_27tVEIT76kyaZ6QvlR45JA">396,522</ix:nonFraction></span><span style="font-size:10pt;"> options, each option representing the right to acquire </span><span style="font-size:10pt;"><ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ" decimals="INF" format="ixt-sec:numwordsen" name="cntg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" scale="0" id="Narr_DWhCQF0eQECWNRwG1YEHBA">one</ix:nonFraction></span><span style="font-size:10pt;"> common share, were granted pursuant to the 2019 Plan for his services as chairman of the supervisory board, with an exercise price equaling the IPO price, which is EUR </span><span style="font-size:10pt;"><ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_0DigrR_K4kqQpyFewhkgZg">12.58</ix:nonFraction></span><span style="font-size:10pt;"> per share, on the date of the IPO of the Company. The vesting period was </span><ix:nonNumeric contextRef="Duration_3_31_2019_To_3_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_3U_fG7sutUSP4d2rpl_g0w" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" id="Narr_wG9QEV5iFEK5qFu07NNzpw"><span style="font-size:10pt;">three years</span></ix:nonNumeric><span style="font-size:10pt;"> commencing on March 31, 2019 as the grant date, during which </span><span style="font-size:10pt;">one</span><span style="font-size:10pt;">-third of the granted options would vest at the end of each year of grant.</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contractual term of the share options as of December 31, 2019 was <ix:nonNumeric contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ" format="ixt-sec:durwordsen" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Narr_Zb8h6tWrckatccS4tRQypw">ten years</ix:nonNumeric> and the weighted average fair value of options outstanding was EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_lo0H8n9Nq0O6cFGGChm3OA" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOfShareOptionsOutstanding" scale="0" id="Narr_TRjUSoJDxkeqOp5WlbO1_Q">9.08</ix:nonFraction><span style="white-space:pre-wrap;">.  The share options issued under &#8220;ESOP 2019&#8221; will be equity-settled and the fair value of the options were recognized in equity under capital reserve, based on the fair value on the date of grant, and will be charged to profit or loss over the vesting period using the graded approach. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On December 18, 2020, in an extraordinary general meeting of shareholders of Centogene N.V., the shareholders approved the grant of <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg" contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_P4QuY9PyE0m3yFf7W6apMg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_zdWC3YBbNkGIoPzx90vfig">300,000</ix:nonFraction> restricted stock units (&#8220;RSUs&#8221;) to Flemming Ornskov under the 2019 Plan, which replaced the ESOP 2019 and pursuant to which Flemming Ornskov will forfeit the options awarded to him thereunder in exchange for the RSUs granted to him. The RSUs will expire after <ix:nonNumeric contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_P4QuY9PyE0m3yFf7W6apMg" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Narr_2QDODHxjjEKsl6SyJy1IYA">ten years</ix:nonNumeric>, will not be subject to any other performance criteria, will have <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_12_18_2020_To_12_18_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_PW37pFbf_ECSJNc8ERvHPg" decimals="INF" format="ixt-sec:numwordsen" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_kLA14L8WQkyOyM4aFn3sMg">no</ix:nonFraction> exercise price and will be settled in shares. With respect to the RSUs granted: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GosQtpqEsUy9vxX2amQi1g" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="Narr_fBd1SX8v1UiVQvW7LMTQZA">33</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> will vest immediately;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the remaining </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_SC_KXEUc3E6xppndc2mfrg" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="Narr_6n386dL_kkKgFWdT5qjGQA">67</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> will vest in two equal annual instalments on each relevant anniversary of October 1 following the date of grant; and</span></td></tr></table></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_Cu0bD9nHBEyNhMzNgl0c4g_1_2"></a><a id="Tc_HiLdcwB1kEKOpnoqx-kQkg_1_6"></a><a id="Tc_bjgCXQaCTUOl26XrJ5pmJQ_2_2"></a><a id="Tc_-mcf7rOklkCoclBmkN9z7g_2_4"></a><a id="Tc_rO02Dxl_0UWUYEbm5u3hRw_2_6"></a><a id="Tc_GWKCywBGCkq2uG0HSkxNnA_2_8"></a><a id="Tc_3HMGIVXslkaLmMtWaKIjnA_3_0"></a><a id="Tc_XAZWBoAdhkq9Kf1fSM209g_3_4"></a><a id="Tc_DGZDe4HAA0iymrZInqmI_w_4_0"></a><a id="Tc_-bQzFe9RM0qiIe8MFyuH3Q_4_2"></a><a id="Tc_a5G3SiPCH0u5Gvfzzfoo4w_4_4"></a><a id="Tc_JkPROGFDpkONOmFFvDomCg_5_0"></a><a id="Tc_jeJe_xQloEqBXn2Osul0wg_5_2"></a><a id="Tc_cqWIDwG2b0ahnnVAxx5g9g_5_4"></a><a id="Tc_SnYl07_MKk6eTVzOlmCSQg_5_8"></a><a id="Tc_AKDGsDfM50GZRJsvW97PzQ_6_0"></a><a id="Tc_3gdIG5mPlUe_gWUM9GSAIw_6_2"></a><a id="Tc_bELQukIvyUGTT87JZnc25g_6_4"></a><a id="Tc_xBXkNOC4PkSu0Js7f4x_kg_6_6"></a><a id="Tc_ssSFRIAm00G0qSWwlo1y2w_6_8"></a><a id="Tc_QFdmFU65e0iZrGfpy-rWMQ_7_0"></a><a id="Tc_Kg1VFyG4UE-eQX_U20R6Qw_7_2"></a><a id="Tc_xFzpb-KmFUOw05ftxgi0mg_7_4"></a><a id="Tc_ciKzNtd2eEW5-zz6AS83lg_7_6"></a><a id="Tc_lhsqJnlEBUO8rp0m4u5B_g_7_8"></a><a id="Tc_LlT3UzFg0km72NiDI1Zbxw_8_0"></a><a id="Tc_LxzPbqEDyUKm2tXz8dhhWQ_8_4"></a><a id="Tc_hPH4gdSSSkycHHpzqX6cNQ_8_8"></a><a id="Tc_KZ9UrrOTaUeD9x1nCXoGcg_9_0"></a><a id="Tc_CssKGXGmwUSjyiOt9rA1KQ_9_4"></a><a id="Tc_p5D0ngGJyUSx6z64NJBVRQ_9_8"></a><a id="Tc__lfcCmNzU0KiZ-Mw5GynBQ_10_0"></a><a id="Tc_v0SPOZ43hUCdo4xwO6j24A_10_4"></a><a id="Tc_PaIWxXFbDE2O6US5E34b2g_10_8"></a><ix:continuation id="Tb_TQrIWtB550iFByrQD7hiTA_cont3" continuedAt="Tb_TQrIWtB550iFByrQD7hiTA_cont4"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">will vest in full upon the occurrence of a change in control (as defined in the 2019 Plan), provided that the holder of the awards is an eligible participant (as defined in the 2019 Plan) on the date of such change in control.</span></td></tr></table><div style="margin-top:12pt;"></div><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" id="Tb_fTSBOfsvm065oMaYOItquQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP (EUR)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_wMwUCttlRkaa7oWL-AqNWA_3_2">300,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_WYFrUDbkkUihIyr9HpBc4g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_fGJiOawZ_k2c-9ZMtY0o7Q_3_6">396,522</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_WYFrUDbkkUihIyr9HpBc4g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_WeLrkEw_702WqgZDDZuv8g_3_8">12.58</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cancelled during the year </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="0" id="Tc_-6eXns3x6ECH-RuI8ka1uQ_4_6">396,522</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="0" id="Tc_KR4m-TlPGkSDepQAVKvgxA_4_8">12.58</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Replacement awards granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" scale="0" id="Tc_Hl90vTmhpkKqtGjdSZOxYg_5_6">300,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_cnPD8qHnh0adpD-n8-9PsA_8_2">300,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_bP4nkeiyRUaEZJ5BOerC_Q_8_6">300,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement" scale="0" id="Tc_bNu6uYT5zkiZMAFpmfT9ig_9_2">200,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement" scale="0" id="Tc_bZ-e8gw9ZkOeAzUgZjB1Wg_9_6">100,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_Kpei5KgED0GlOlvzmehdkQ_10_2">200,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_xTY6tS2b7Uql2O4Y6Cfs2Q_10_6">100,000</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The replacement of the ESOP 2019 and the grant of new RSUs of Centogene N.V. was accounted for as modification under IFRS 2. The incremental fair value of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" scale="3" id="Narr_rB54wt7ApU-4pIo0uScntw">135</ix:nonFraction>k has been recorded in the statement of comprehensive income over the vesting period of the replacement grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(v)&#160;2020 grants to management board and employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On September 11, 2020, the Supervisory Board granted members of the management board the following options and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">RSUs under the 2019 Plan:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:35.45pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.45pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to the Company&#8217;s former CEO Arndt Rolfs: <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_uNK3cJ2KukGhjB1H809MEg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_KQxIN9OyjUKLzTN8FXVh5Q">36,175</ix:nonFraction> Options and <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WUAkQyT5QUKI_CA2QFIqng" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_a2bGsKk2U0WxjARcU-Xi7A">72,350</ix:nonFraction> RSUs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:35.45pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.45pt;padding:0pt;">b.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to the Company&#8217;s former CFO Richard Stoffelen: <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_I_CkDW4jyE2fLJmcucRgFA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_bZBGh6S6_ke6UYJqTTZl4Q">16,250</ix:nonFraction> Options and <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RzmMZK-ny0O74pah0YcM8w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_-ej1Fj0KAUiokCQmiSAq-Q">32,250</ix:nonFraction> RSUs; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:35.3pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.3pt;padding:0pt;">c.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to the Company&#8217;s CIO Volkmar Weckesser: <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_kVJa9lQw5EeR7IQzDBa0jg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_SGpVE3SW-Uawtq2MJ64BKg">15,000</ix:nonFraction> Options and <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EYVETEm8qkGi1WMdtZbI0w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_avRlBuBJZUusgvsMyA9GaA">30,000</ix:nonFraction> RSUs.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On September 11, 2020, the management board granted <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Cm6rxbg5V02howDd6-HKiA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_I5ietvi4M0KvubF4xTNGhw">87,500</ix:nonFraction> options and <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DtkVOppjHkWA1R9t0aDNNw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_DpJgpG76zkigVptANTm6lA">75,000</ix:nonFraction> RSUs to other key current and former executive officers under the 2019 Plan. On October 15, 2020, <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_10_15_2020_To_10_15_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_V6gW_1JbeU2rr1ZWiZ89Tw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_4nMhsJovQ0yPqZtbe9LYRQ">251,500</ix:nonFraction> RSUs were granted to employees, subject to the terms of the 2019 Plan, the applicable award agreement and the terms specified in the authorization from the Supervisory Board for this purpose. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Apart from one award that immediately vested in full on the grant date and another award that vests in three equal tranches on each anniversary of its date of first employment, all other awards referred to above will vest in three equal tranches from January 1 following the grant date, in accordance with the following vesting schedule:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">i.</span></span><span style="-sec-ix-hidden:Hidden_Di3UQRQ2MUWSk55FplrgzQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> third of the award vests on January 1, 2021;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ii.</span></span><span style="-sec-ix-hidden:Hidden_lq4xIkppPkuJR_e8mjx1ZA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> third of the award vests on January 1, 2022; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">iii.</span></span><span style="-sec-ix-hidden:Hidden_EQTkAO2Ni02-Mndxnfpk_A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> third of the award vests on January 1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All of the foregoing awards vest in full when the participant is considered to be a good leaver within the meaning of the 2019 Plan effective as of grant date, as discussed in note 20(ii). As a result, unrecognized costs related to any unvested part of the award of a good leaver will result in accelerated recognition of these unrecognized costs in the statement of comprehensive income in the period when the employment contract has been terminated. Furthermore, all of the foregoing awards vest upon the occurrence of a change of control as defined by the 2019 Plan, unless the holder is no longer eligible to participate in the 2019 Plan at that time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The options referred to above vest only if the <ix:nonNumeric contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw" format="ixt-sec:durday" name="cntg:ThresholdTradingDays" id="Narr_4EfkezdPzEyhUV5UpaxFgQ">20</ix:nonNumeric> trading day volume-weighted average stock price of the Company&#8217;s shares preceding the vesting date of each tranche exceeds the exercise price of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" id="Narr_Idpskh2iI0y4Esw4p7SX5g">11.60</ix:nonFraction>. This hurdle is considered a market condition. Therefore, expenses would not be reversed, if the tranches do not ultimately vest. As the <span style="-sec-ix-hidden:Hidden_2x0a_zAG40CpBOwHDJxpzQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading day volume-weighted average stock price did not exceed the exercise price as of January 1, 2022, the second tranche did not vest on January 1, 2022. </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_Zhkh-B0vfUu7YvsBJLo9UQ_1_0"></a><a id="Tc_KznJ0Ck9z0KG31vhugVasw_1_2"></a><a id="Tc_YW2GSllRukSvDPADuny6mg_1_4"></a><a id="Tc_9YD8wiF8rEqpK-TDAt2PaQ_1_6"></a><a id="Tc_ZaY07aEgjkeZFz9x30-LmA_1_8"></a><a id="Tc_ZBdb4M-RFES0r7YS4fQ7vw_2_0"></a><a id="Tc_mRVZ2cVU10-iLysGGHayTQ_2_2"></a><a id="Tc_PlUIjwZP-EusQUvJlF5fow_2_6"></a><a id="Tc_glwknHW1DUya52bCWxj5Iw_2_8"></a><a id="Tc_N_QuQOnQdESRKhZsQSkfeQ_3_0"></a><a id="Tc_dBFdVgXJ9Ei36U6OkRbMWw_3_2"></a><a id="Tc_w5lTQ-kFjUWGdItmjBAqjA_3_6"></a><a id="Tc_zD8eENN_UkmkvZ-QdxDzWQ_3_8"></a><a id="Tc_9-6YBfJOgkyMeYxN8o72lg_4_0"></a><a id="Tc_ZWyGmu9EOUWYvzApTEu1Sw_4_2"></a><a id="Tc_b1dG5wYldUeTrK1wOJJLMA_4_6"></a><a id="Tc_GvO8KsXH7E64GJQJ61Merg_4_8"></a><a id="Tc_u4p7dKxLf0-a9Pcjc9Dttw_5_0"></a><a id="Tc_lsXHZYtMD02EGD5YOkyshg_5_2"></a><a id="Tc_oWM27VCneEq2piUD-z9TZw_5_6"></a><a id="Tc_33TrUVEWvkWoOsM8IZ6peA_5_8"></a><a id="Tc_ELAZZlgBLUSGXkNT0ZzlJQ_6_0"></a><a id="Tc_eaHdHArNFE6GqquuCCARSQ_6_2"></a><a id="Tc_W5ixkgF1WEK9dSuSUhvwTg_6_6"></a><a id="Tc_1v8P0hJO80O9lIA8MGHDEA_6_8"></a><a id="Tc_UL0Wh0LLfkOvKaYivk1rGQ_7_0"></a><a id="Tc_fDne55d5XEuo5VgwVz_OCg_7_2"></a><a id="Tc_wkASlD2oFUWKtrHO1-GoCQ_7_6"></a><a id="Tc_fdceKJq7A0Kq5olCIJGG0A_7_8"></a><ix:continuation id="Tb_TQrIWtB550iFByrQD7hiTA_cont4" continuedAt="Tb_TQrIWtB550iFByrQD7hiTA_cont5"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(vi)&#160; 2021 grants to management board and employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended December 31, 2021 the following awards were granted under 2019 Plan:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6yWOMiPRDECERNx2-xKf8w" name="ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" id="Tb_HrK_vOvd5Ei-vWOLiq8dZQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"><tr style="height:1pt;"><td style="vertical-align:top;width:10.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:16.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Award Type (2019 Plan)</b></p></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Market/ Performance Based</b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">Vesting Conditions</b></p></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Number of Awards</b></p></td><td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Vesting Conditions</b></p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration Date</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_UX-48ti_3USQLBTVUjWqUA_2_4">95,499</ix:nonFraction></span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfTranches" scale="0" id="Narr_3rVgj-GzYU2rCp9r19bN4A">Four</ix:nonFraction> equal tranches over a <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_JT5I4ZtgKEOG9ew79wgmDw">four-year</ix:nonNumeric> period, starting January 1, 2022, April 1, 2022 or on each anniversary of the grant date</p></td><td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_j7I3SlyuWU6KYGVcxzrMkg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_m7PoOqw3vUuW4wbIEFjONQ_3_4">30,000</ix:nonFraction></span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfTranches" scale="0" id="Narr_9LqGBvbi9UqaCsgr69gKVA">Three</ix:nonFraction> equal tranches over a <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_hKFi-yAJTU-h22lkh4bf4A">three-year</ix:nonNumeric> period starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_YStt1HXTrUSZGYMRD2aLHg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc__R_eHsuWKUavy9wnMKZYYA_4_4">15,000</ix:nonFraction></span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfTranches" scale="0" id="Narr_xFWf4stNDEK_UAxuwVcWcQ">Three</ix:nonFraction> equal tranches of which the first tranche vested immediately and the two remaining annual tranches will vest starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_YVS6AVoIeUKeeejiDsF3JA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_TRCScpLXX0ueIRx6JPt4Iw_5_4">22,936</ix:nonFraction></span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfTranches" scale="0" id="Narr_tyspVN7iqUOwH7JG0TpWSg">Four</ix:nonFraction> equal tranches over a <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr__TZVmeg1lUKtzJPL5gsXHw">four-year</ix:nonNumeric> period, starting October 1, 2022 on each anniversary of the grant date</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_AdWcPoKHd0iDW7odOEhQgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Options</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Yes</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_p7m2lvwPqUqNTeESUzOJZA_6_4">15,000</ix:nonFraction></span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfTranches" scale="0" id="Narr_33fwTOZB-EO0yLiBWy1xPA">Three</ix:nonFraction> equal tranches over a <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_bluO8PnwMEy6V3t-TT3Mfw">three-year</ix:nonNumeric> period starting January 1, 2022</p></td><td style="vertical-align:bottom;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_HW0l6QwPxEehXDxtNMXdTA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_gpgSHoPgDUWAbAx4UPa2eQ_7_4">3,891</ix:nonFraction></span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfTranches" scale="0" id="Narr_Wpe4WcN-y0CUpFLK0pN5tQ">Four</ix:nonFraction> equal tranches over a <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_JyHkg5U1xEiORD_NaXE8fg">four-year</ix:nonNumeric> period starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_y1wywXdbVUOTeWK6mrdN-A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The grant date fair value of these grants will be recognized in profit or loss over the service period by using the graded approach. <ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_vLjL-EvSzEC2RNYzgXU1MA">15,000</ix:nonFraction> of the options referred to above vest only if the <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA" format="ixt-sec:durday" name="cntg:ThresholdTradingDays" id="Narr_feUrPfWYgkq0h13SsJEHLg">20</ix:nonNumeric> trading day volume-weighted average stock price of the Company&#8217;s shares preceding the vesting date of each tranche exceeds the exercise price of US$ <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" id="Narr_vk7r6doJzEOyCID7egq2xA">12.52</ix:nonFraction>. This hurdle is considered a market condition. Therefore, expenses would not be reversed, if the tranches do not ultimately vest. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The RSUs referred to above have no performance-based vesting criteria. Each RSU represents a right to receive a payment in cash or shares equal to the value of the RSU at the exercise date. The Company has a choice to settle either in cash, in shares or a combination thereof. In line with this policy, both types of awards are to be settled in shares and expire on the <span style="-sec-ix-hidden:Hidden_YZDLiCDl6EqhXBUv-LZuNw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10</span></span>th anniversary of the grant date. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(vii)&#160; 2020 grants to Dr. Andrin Oswald</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In 2020, the Company and Mr. Oswald entered into an award agreement under the 2019 Plan pursuant to which Mr. Oswald will receive certain awards in the form of RSUs. According to the award agreement, a total of <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_5BgL8gvkB06Ow57f8rxdoQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_rtpFNzyC6EebEKpQ0yPZVg">324,000</ix:nonFraction> RSUs were granted on December 1, 2020, subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w" contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_5BgL8gvkB06Ow57f8rxdoQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments" scale="3" id="Narr_SaoY48j9vUqHnUKSU8cExA">1,000</ix:nonFraction>k after the grant date, which will vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tFCvLv4fB0W8h2vSoBrRIw" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_vGWKh0IeDkupy3NcpCSeJg">four</ix:nonFraction> equal annual installments following December 1, 2020, subject to Mr. Oswald&#8217;s continued services with the Company and continued ownership of the a number of shares equal or higher than the number of purchased shares. On September 5, 2021 the Supervisory Board approved an amendment to this agreement. Under the amended award agreement, the RSUs vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_w5uFjzeAFkaVyynChFMU0g" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfInstallments" scale="0" id="Narr_Se9FBfbMEkadVGUYXiclfw">14</ix:nonFraction> equal quarterly installments following July 30, 2021 with final vesting date on December 1, 2024, subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w" contextRef="Duration_9_5_2021_To_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Wnp1O-SE3EaWTFbyh8ZNrw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments" scale="3" id="Narr_vghz6NonG06ixhQVrxKyMg">1,000</ix:nonFraction>k by June 30, 2022, and Mr. Oswald&#8217;s continued services with the Company. Further, the RSUs will vest pro rata to the number of shares actually purchased up to the full investment amount of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w" contextRef="Duration_9_5_2021_To_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Wnp1O-SE3EaWTFbyh8ZNrw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments" scale="3" id="Narr_AdOPaBywW0-1us04VPhjDg">1,000</ix:nonFraction>k on each quarterly installment prior to the share purchase deadline and are subject to the continued ownership of a number of shares equal or higher than the pro rata number of shares actually purchased on each applicable vesting date or share purchase deadline. The amendment did not result in incremental fair value of the award. The grant date fair value shall be recognized in the statement of comprehensive loss over the remaining vesting period based on the modified vesting schedule using the graded approach<span style="font-style:italic;font-weight:bold;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The RSUs referred to above have no performance-based vesting criteria. RSUs represent a right to receive a payment equal to the value of the RSU at the exercise date. All the RSUs will vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_1v4SxiTooEOxh0OPstkkmg" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_K-xxB-gLZkyxMosLWWF6wQ">four</ix:nonFraction> equal annual installments following the grant date, subject to </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_TQrIWtB550iFByrQD7hiTA_cont5" continuedAt="Tb_TQrIWtB550iFByrQD7hiTA_cont6"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mr. Oswald&#8217;s continued service with the Company as of the vesting date and will be charged to profit or loss over the period by using the graded approach.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additionally, a total of <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dLhT7Cmve0CdytDI3taX5Q" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_Kp6EzzZOaUmkGU5DPuQAcQ">500,000</ix:nonFraction> performance-based vesting RSUs were granted to Mr. Oswald on December 1, 2020, subject to the following conditions:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">1.</span><ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_QxSd-SnvrUqPZtQeLpmFXg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Narr_Yz_CSruBVUeNZXDdfkibtg">200,000</ix:nonFraction> RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_QxSd-SnvrUqPZtQeLpmFXg" decimals="0" format="ixt:numdotdecimal" name="cntg:AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" scale="0" id="Narr_7cOLSgMle0Wbhw17TCGw_A">24</ix:nonFraction> in any consecutive three month period prior to January 1, 2023 (for these RSUs, the &#8220;initial vesting date&#8221;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">2.</span><ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_wBoe6UcpT0q8rlfoh6cZ6w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Narr_sahBKr3cmk6S-oyxIxfHjA">300,000</ix:nonFraction> RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_wBoe6UcpT0q8rlfoh6cZ6w" decimals="0" format="ixt:numdotdecimal" name="cntg:AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" scale="0" id="Narr_YxOAMr09bEOT-0bDc7rTGQ">33</ix:nonFraction> in any consecutive three month period prior to January 1, 2024 (for these RSUs, the &#8220;initial vesting date&#8221;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The hurdle to the performance-vesting RSUs is considered a market condition. Therefore, expenses would not be reversed, if the market condition is not met. All the performance-vesting RSUs will vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WQu1wOdXfU6jJWFMBs7BmA" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_tL4HBehor06rR-hC6A8AZw">four</ix:nonFraction> equal annual installments following the relevant initial vesting date, if the applicable performance hurdles are met, and subject to Mr. Oswald&#8217;s continued service with the Company as of the vesting date and will be charged to profit or loss over the vesting period using the graded approach. If Mr. Oswald&#8217;s service with the Company terminates for any reason, any unvested RSUs will immediately be forfeited. The foregoing awards that have been granted vest in full upon the occurrence of a change in control as defined in the agreement, provided that Mr. Oswald is still eligible to participate in the 2019 Plan and in continuous service with the Company through the date of such change in control (see &#8220;Note 27</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Subsequent Developments&#8221; of our consolidated financial statements as of and for the year ended December 31, 2021).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#0000ff;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contractual term of the RSUs is <ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_FG-eKZsRE0Of78EHPSAZ_w" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Narr_R1FYrr8HKkugkYFGO2ak-Q">ten years</ix:nonNumeric> from the respective grant dates. The RSUs issued are equity-settled. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(viii)&#160; 2021 and 2020 supervisory board grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In connection to the IPO <ix:nonFraction unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w" contextRef="Duration_6_24_2021_To_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_Lggp4PkrtEW3C7ZFnD1fIQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_BdaZ4MMxkU2rksIQbB_V1w">10,000</ix:nonFraction> Share Options have been granted as an extraordinary incentive to Mr. Berndt Modig as approved in the Annual General Meeting on June 24<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">, </sup>2021. The Options have a strike price of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="As_Of_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_oC-Mfx2jaUiilWSjgsPQBA" decimals="0" format="ixt:numdotdecimal" name="cntg:OptionsStrikePrice" scale="0" id="Narr_CvaPxEK_DEaJmIP0wuR1wA">14</ix:nonFraction> and getting vested in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_6_25_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_sgqoRzpr6kyNzDY9rq2YQA" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_FTEkK3kHdE-kNkbv7Wg3Mg">four</ix:nonFraction> equal installments following the grant date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2020, an agreement was entered into between the Company and Peer Schatz, as member of our supervisory board. According to this agreement, a total of <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_LCJaveMDmkGVp9ON5ZIyPw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_QVyVGH2hAUeyxq1GV664mA">300,000</ix:nonFraction> RSUs were granted pursuant to the 2019 Plan to Mr. Schatz. The RSUs will vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_11_25_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_oVuQnUbma0GfMOyRtTtgqg" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_Y41wyVT6k0KOHEVitb1AxQ">four</ix:nonFraction> equal annual instalments on each relevant anniversary of November 25, 2020. The grant was approved in the Company&#8217;s extraordinary general meeting of shareholders on December 18, 2020. The contractual term of the RSUs is <ix:nonNumeric contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_6lvAjzC9w0a-ExtvrVissA" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Narr_58TwUE7ZxU2trEQmBoi1BA">ten years</ix:nonNumeric> from grant date. The RSUs are not subject to performance criteria and will be settled in shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the same extraordinary general meeting of shareholders on December 18, 2020, shareholders also approved a new incentive compensation scheme for supervisory board members, under which certain members of the supervisory board will annually receive an award of options and RSUs for ordinary shares of the Company under the 2019 Plan with a target value of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" scale="3" id="Narr_rHKg6VgVB0mSXWOGUyhWSw">80,000</ix:nonFraction> multiplied by the LTI factor. For each award, RSUs will constitute <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VugOHEd-30i25LugBEmvOw" decimals="2" format="ixt:numdotdecimal" name="cntg:PercentageOfAwardConstitutesRestrictedStockUnits" scale="-2" id="Narr_9LbULMP4SEmMXrxN_YbTPQ">75</ix:nonFraction>% of the value of the award while options will constitute the remaining <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Jxfmi8_7z0KhYrUFcANEng" decimals="2" format="ixt:numdotdecimal" name="cntg:PercentageOfAwardConstitutesStockOptions" scale="-2" id="Narr_h86hj6mXVEOkT6YQsDhb4A">25</ix:nonFraction>% of the value of the award. The LTI factor will be <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g" decimals="INF" format="ixt:numdotdecimal" name="cntg:MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" scale="-2" id="Narr_QYbkUqUGI0GGGMYpW3QVdA">100</ix:nonFraction>% or less based on the volume-weighted average stock price of the shares over a <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g" format="ixt-sec:durday" name="cntg:VolumeWeightedAverageStockPriceComputationTradingDays" id="Narr_BGoT1fAS-UmK7p6LgvajGg">60</ix:nonNumeric> trading day period preceding December 31 of the relevant financial year. Furthermore, the chairman and vice-chairman of the supervisory board will each annually receive an additional award with a value of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_vuU72Kbpq0W86SjCUL5Wog" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" scale="3" id="Narr_6LWbmVPPNUuuvpFWQgzO5A">60,000</ix:nonFraction> and EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ViceChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RRXiYNlkWkq3h07ypEAPTQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" scale="3" id="Narr_2t6p9n1sbkeZf4i0nD6r2A">40,000</ix:nonFraction>, respectively, multiplied by the LTI factor as of the financial year 2023; the chairman of the audit committee and the chairman of the compensation committee will each annually receive an additional award with a value of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfAuditCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Tb9WXS3-AUy4C6w9hUDAdw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" scale="3" id="Narr_A5uSV1t_z0OJWWSHOsZB0g">40,000</ix:nonFraction> and EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfCompensationCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_serqoK5ea0CVflGxqcVFGg" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" scale="3" id="Narr_C_jzIXVOs0WliQ-rbKf1ig">8,000</ix:nonFraction>, respectively, multiplied by the LTI factor. The awards will be granted retrospectively for the preceding financial year following the audit of the Company&#8217;s annual accounts over such financial year, with the first annual awards to be granted in 2021 (in respect of the 2020 financial year). The awards will vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6BAEvdBRvEWAG0lUbPv9tg" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_j0iMczECHkKgPAk6KU-80A">four</ix:nonFraction> equal annual instalments on each relevant anniversary of the grant date, will expire on the <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VugOHEd-30i25LugBEmvOw" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Narr_LSySPZozWEO6G_sDkgluzA">ten-year</ix:nonNumeric> anniversary of the grant date and are not subject to any performance criteria. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The options and RSU awards referred above have a service commencement date of December 18, 2020, based on when the understanding was reached between the Company and the holders regarding the required services to contribute to the achievement of </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk96277930"></a><a id="Tc_B7FdEJqGoEKV4INPi5H23w_1_2"></a><a id="Tc_sT439lpn9UqJIxs1a5BQ-w_2_2"></a><a id="Tc_YAV28z-XW02ltgysM7hyFw_2_4"></a><a id="Tc_bcqW4VQHFEWlvuf0y_ptDg_3_0"></a><a id="Tc_im43t6QgEkuXKHvq7O9-rg_4_0"></a><a id="Tc_cSgcxBd2okmPSiChEDjgeA_5_0"></a><a id="Tc_fHZjgEIOF06Y0qcml_Xdyw_6_0"></a><a id="Tc_58YMz18J5UuVsEcsS0PwFQ_7_0"></a><a id="Tc_dEHiiReBzU-NTRyL593G9w_8_0"></a><ix:continuation id="Tb_TQrIWtB550iFByrQD7hiTA_cont6" continuedAt="Tb_TQrIWtB550iFByrQD7hiTA_cont7"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">the long-term incentive targets. However, the grant date criteria for these awards will be met at each future annual grant date, upon the approval of the audited annual accounts, at such time when the terms and value of the awards to be granted become fixed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The foregoing awards are equity-settled and will vest in full upon the occurrence of a change in control as defined in the agreement, unless the holder is no longer eligible to participate in the plan at that time. The awards will be charged to profit or loss over the service period using the graded approach, pursuant to the equal annual vesting instalments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additionally, in connection to this plan, Mr. Modig was granted <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_cKZBZTR-hUKsYvIbDIFtyw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_tU8k9q-Zz0q4OHpspGebow">9,427</ix:nonFraction> RSUs and <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_NfDBPr_PCU-WeXMIEGto4Q" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_xQmaksRLu0iM1UHlJl16pw">4,713</ix:nonFraction> Share Options and Mr. Sheldon was granted <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_ECxfpRaeB0icCiSqRrYWNQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_vikfvIdvFk-4TLPTkR9y1w">878</ix:nonFraction> RSUs and <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_scfLHvbOHEyhfw0eoqJLjQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_S4tRSFJKoEqDK_ZNJtn7CA">439</ix:nonFraction> Share Options in 2021. The Options have a strike price of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_mLSkDz_SwkeNhCK3FKDtYA" decimals="2" format="ixt:numdotdecimal" name="cntg:OptionsStrikePrice" scale="0" id="Narr_bF1ZNaRc_0yI3p7XrQcG6Q">9.92</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The awards will vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GI6jpuFNvkutlq0qWaVoUA" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_AdkMNyabo0qE55vkMnjAoQ">four</ix:nonFraction> equal annual instalments on each relevant anniversary of the grant date and will vest in full upon a change in control of the Company (provided that the holder remains an eligible participant on the date of the change in control). The awards will expire on the <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Narr_3rO9ic9Oz0KMBhGQGmr0fw">ten-year</ix:nonNumeric> anniversary of the grant date, are not subject to any performance criteria and will be settled in shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Valuation of Options</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Virtual share option program 2016 and 2017</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The fair values of the 2016 VSOP upon its exercise and 2017 VSOP upon its cancellation in 2019 were based on the cash payments to which the holders of the virtual options are entitled, which were calculated according to the formulae as stipulated in the respective programs.  The cash payment is with reference to the share price of Centogene N.V. at the date of IPO.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Equity share option 2017 and Equity share option 2019</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The fair values of ESOP 2017 and ESOP 2019 were estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions under which the share options were granted.  The model takes into account historical and expected dividends, and the share price volatility of other public companies in the relevant industries to predict the share performance.  There are no cash settlement alternatives for either the option holders or the Company.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The key assumptions used to derive the option value are set out below:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" id="Tb_jbMKzGSr-E2jhnsvtDsC3Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ESOP 2017</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ESOP 2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price (EUR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Tc_WYwsuiDyMkGhW3r_INt0lg_3_2">0.12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Tc_dnyDvbPD7UOpb7DZn5ZfUw_3_4">12.58</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share price at grant date (EUR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_wAGpjVb-fE-aJv8qH_IhWA_4_2">12.58</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_vVheOBSkGk2X3QF1S06ATw_4_4">12.58</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Tc_asOGfFS59kuR1IOldCaicA_5_2">70</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Tc_0g5sVJHNbk-LHPDVVeU2VQ_5_4">70</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Tc_Nhiy4zShskqMF5d6fvRMrw_6_2">0.7</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Tc_gkLuAF6p5EGPHz2diVJZ9Q_6_4">0.7</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_NdDf16HekkOvfAz5iyLd7g_7_2">0</ix:nonFraction> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_NXIg35pG60WOhsKdSsmNCQ_7_4">0</ix:nonFraction> </p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Option term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Tc_KBYFPfyBv0qG7WjP7snUjw_8_2">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Tc_MLSv-kSNcUylj8JuRkGf1A_8_4">10</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Valuation of 2020 grants </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The fair value of the replacement awards granted to Flemming Ornskov under the 2019 Plan and the awards granted to other participants under the 2019 Plan in 2020 were estimated at the grant date. The fair value of the standard RSUs (i.e., those without performance-based vesting criteria) is based on the observed value of the underlying shares. As no dividend payments are expected over the vesting period, no further adjustment is required. The weighted average fair value of standard RSUs granted under the 2019 Plan during the year ended December 31, 2020 was USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_jzWpq6P7GkC8v17Iacya0g" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Narr_aUbZiy5LP0OSlkqSuDbRxA">11.62</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The fair value of the ESOP 2019 replacement was estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions on which the options were granted. The fair value of the options and performance-based RSUs as of the grant date was determined using a Monte Carlo simulation model. The Monte Carlo simulation model utilizes </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_XuZmtwQX40yS8oPKzLLlrA_1_2"></a><a id="Tc_HX1cDeFZhUy8oN_0yYhphA_2_2"></a><a id="Tc_W4YwcsqKJUi5s9NMq7w2bA_2_4"></a><a id="Tc_pAEI-GrQyk2Av3K5OIDIsA_2_6"></a><a id="Tc_RCfy9gevIEqooYNjUo0EfQ_3_2"></a><a id="Tc_q2E89H--m0Cbp3qMkS9vCQ_3_6"></a><a id="Tc_JQiGylQ2-06L7O4t6Pk8UQ_4_0"></a><a id="Tc_AzD3MWKG50W6Cdfohh7MKA_4_6"></a><a id="Tc_Np9GFZ8zwkCMGAHZswduQw_5_0"></a><a id="Tc__gVze3V3gEOl5mfOREEnrg_6_0"></a><a id="Tc_JH-D5toG6EuT5rt9XVl0yA_7_0"></a><a id="Tc_hKqCEIL8aEKJ6KUmHZzgoQ_7_6"></a><a id="Tc_pRvA1pVmRESWbnmrq3qh6w_8_0"></a><a id="Tc_bR2KuzVsvU2nChJPiQpu2Q_9_0"></a><a id="Tc_Hg-Kt7hsgk2snXWtbLOLRA_9_6"></a><a id="Tc_49XpRVQZKU-I9Cjq7VwHvg_10_0"></a><a id="Tc_aWjCzuqqtUa7Uh1ugF-CUQ_1_2"></a><a id="Tc_KfRBWC6CZUiY6QFWDT7D6w_2_2"></a><a id="Tc_M0SsJfxjKUKm8K8HrSjeRA_2_4"></a><a id="Tc_iuwXgq6DVEOEYKFtPaUveg_2_6"></a><a id="Tc_7CdbAlQTjUuEYKEqje-hoA_2_8"></a><a id="Tc_BPpp9aiCzUy62Oi_Vczb7A_3_2"></a><a id="Tc_poE1o_bpEU-NXJp_iahyiA_3_4"></a><a id="Tc_w6ClWlk2V0e4LLoKWIUZEA_3_6"></a><a id="Tc_KBQc2x8BSUqxtRMlNIlCqA_3_8"></a><a id="Tc_Yb1pSMvikUWQ-XOosKGrFA_4_2"></a><a id="Tc_54lKvf5UiUiiOx0fo3gnpg_5_0"></a><a id="Tc_0BlARoL5eEC8Bbd3kjmLwQ_6_0"></a><a id="Tc_zPf9VKcCfUSV4VlbpN7KnA_7_0"></a><a id="Tc__lu6pYmXvUmmci0tBaB87w_8_0"></a><a id="Tc_zJF0y5vLmU-N9QaY9Y9_oQ_9_0"></a><a id="Tc_6YsA59QZyEmQ5U8m_nTL_w_10_0"></a><a id="Tc_y028bS86yUy85vXb09lMgw_11_0"></a><a id="Tc_Bp4SbZ8REkukspwnRDgNig_1_0"></a><a id="Tc_X2aQfZAjtk-6ksXPAzag5w_1_2"></a><a id="Tc_GD--UhxSoECp8aTV5BfxVA_1_4"></a><a id="Tc_GLBdJNkaiEaUxSud1RZn5g_1_6"></a><a id="Tc_emmj33ZQIUWyouO8IcXeOA_2_0"></a><a id="Tc_6EC6el2IVUWBUflvia9LUA_2_2"></a><a id="Tc_rLKpPoH_JkOI6pliyDeCNg_2_4"></a><a id="Tc_BHAcbvVKYk604_vhEAGaFA_3_0"></a><a id="Tc_0L0J6a79BEW-9xbUn8wVQg_3_2"></a><a id="Tc_Q6v9aoi6bUysl-ZUyDhCiQ_3_4"></a><a id="Tc_r8hnttXzHkmLSavGaVNDhw_4_0"></a><a id="Tc_szLF_CmC3ky7fQadJbjIJQ_4_2"></a><a id="Tc_IEwkQDzCiEOrJA1ch9Qq4w_4_4"></a><a id="Tc_0SG6codfb0-DHg8AW56p7A_5_0"></a><a id="Tc_M8EYDbdkSEGHgZsEiX2iQA_6_0"></a><a id="Tc_X3zcjmLISEm5RVhTcV5NhA_7_0"></a><a id="Tc_U9Qyp1r1nECQv83l8pCnBQ_7_6"></a><a id="Tc_FO2buyD740OlQllcLQAvoA_8_0"></a><a id="Tc_Pf6ES3oVIUyXkzInKO0jJQ_8_2"></a><a id="Tc_FFS4Ce0hhEmlj-1e1JXhEw_8_6"></a><a id="Tc_-mecPchJU0mLHiL4_ysqrw_9_0"></a><a id="Tc_PzkPwZoq4EWCrIg0wY0PYg_9_6"></a><a id="Tc_bzCpqdzpqUWSBTVctqeUIA_10_0"></a><ix:continuation id="Tb_TQrIWtB550iFByrQD7hiTA_cont7"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">multiple input variables to estimate the probability that market conditions will be achieved. The key assumptions used to derive the option and performance-based RSUs value and the weighted average fair value are set out below: </p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6yWOMiPRDECERNx2-xKf8w" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" id="Group_4dqvl66igkm_qZoArtz2YA" continuedAt="Group_4dqvl66igkm_qZoArtz2YA_2" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:37.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 Fair Value assumptions</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ESOP 2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Performance</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Replacement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Based RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_7qmxFQMMQk2EUq4uUCQkTQ_4_2">14.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw" decimals="2" format="ixt:numdotdecimal" name="cntg:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_jT52EJGwX0-QIKnQfeUQfQ_4_4">11.60</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">n/a</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price at grant date (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_ywLl3WKYtEmocJHHaFWK3g_5_2">12.02</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_BJajiBQUFkOhD3JYfweeBQ_5_4">11.05</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_nos_TJSHVUKBP2otr9cgTA_5_6">12.54</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="Tc_K4zcQjcj-0G1zL4W-Hx3dw_6_2">75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="Tc_U0EYoUo7kEmaf39mw73npw_6_4">75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="Tc_U3dL2UW8w0astct0HgHDXQ_6_6">88</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Tc_M1fiIOYIW0KcYb2my31JwA_7_2">1.0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Tc_IHVUSL9A_kaMuU23dVnXmg_7_4">0.8</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_q1nYC9yqtEWW20MzQIkwFQ" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Narr_DjQNc5v5LU6PrY_o5Zn4MA">0.2</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_UZb9Ik94skWa-HFbTuSMPg" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Narr_LTSG_eQOiEKu1efS1JIc1w">0.3</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" scale="-2" id="Tc_aym4bDgTdUGRKwi3KSlRGA_8_2">0</ix:nonFraction> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" scale="-2" id="Tc_eJNdcHtb-EWTyNPmBDHQkA_8_4">0</ix:nonFraction> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" scale="-2" id="Tc_rRQNye40_0K0B6_LgC_qSg_8_6">0</ix:nonFraction> </p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected contractual life (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ" decimals="INF" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Tc_j7WDesr-QEqqGk39DcRJWQ_9_2">8.9</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw" decimals="0" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Tc_6uiDOv2FwE-WW-IDUs_P_g_9_4">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_q1nYC9yqtEWW20MzQIkwFQ" decimals="2" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Narr_LJx_bv0HR0CfPp2elHi04g">12.08</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_UZb9Ik94skWa-HFbTuSMPg" decimals="2" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Narr_i0jFySjFxUCbUKj_SoZgag">13.08</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average fair value (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_UvqGtu9jFE-maNSZKxMTdw_10_2">12.02</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_AlCRK2GcoUK6WPX8HlPA4Q_10_4">6.20</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_qfZG3vLNEEmWS2Lm_dE5yg_10_6">8.23</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Valuation of 2021 grants </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The fair value of the options granted to the Mr. Modig and Mr. Sheldon  was estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions on which the options were granted. In addition to that the fair value of the options granted to the Mr. Kim  was estimated at the date of modification also using the Black-Scholes option pricing model. The awards granted to participants under the 2019 Plan in 2021 were estimated at the grant date. The fair value of the standard RSUs (i.e., those without performance-based vesting criteria) is based on the observed value of the underlying shares. As no dividend payments are expected over the vesting period, no further adjustment is required. The weighted average fair value of standard RSUs granted under the 2019 Plan during the year ended December 31, 2021 was USD </span><ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GA3_hAw990K3e4HpR8KZlg" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Narr_fKUrEmy53UabchIhp8siJA">10.96</ix:nonFraction>. The key assumptions used to derive the option and performance-based RSUs value and the weighted average fair value are set out below: </p><ix:continuation id="Group_4dqvl66igkm_qZoArtz2YA_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:43.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021 Fair Value assumptions</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Add. Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Modig and </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Modig</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Kim</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019 Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr.Sheldon</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_YewQlsdnLk652Zw4RewnZA_5_2">9.92</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_6GuQ8IJBjESXSttS7aSO3w_5_4">14.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q" decimals="2" format="ixt:numdotdecimal" name="cntg:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_ApA6I9dG5EiTiCY0sbN10A_5_6">11.60</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" decimals="2" format="ixt:numdotdecimal" name="cntg:ExercisePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_gtschjwo6EiWOOsJE69qVQ_5_8">12.52</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price at grant date (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_bFmnaoMk4k6jMoE2cRy9bA_6_2">10.01</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_J0ggkk5fOUOMOdwxnkLDDw_6_4">10.01</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_unI_p9Zr_0-7trtiuWGEnA_6_6">10.80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted" scale="0" id="Tc_tbQohHSGb0O6IPfEwf7ANg_6_8">12.54</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="Tc_EDYw8de1e0Sf0NzTMkXQ5g_7_2">75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="Tc_C87tVGi3-ESgX0mP4Cp5_w_7_4">75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="Tc_gB_F5P9klkuY4B0yLpCfyQ_7_6">75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedVolatilityOtherEquityInstrumentsGranted" scale="-2" id="Tc_gMD60fJtKUGVCCczmSprlw_7_8">75</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Tc_WjT2dQQ76EqYakaj_DgIyA_8_2">1.7</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Tc_fW9J3OCCzkmzMJQcaCDwFg_8_4">1.7</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Tc_JjM4FP0boku3hyVhvE-FYQ_8_6">1.7</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" decimals="3" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Tc_i0XMq9GiS0ysXlkEes9AmQ_8_8"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_TvyCsMUqekaRcguge2kBDA" decimals="4" format="ixt:numdotdecimal" name="cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted" scale="-2" id="Narr_wskYj88WnU2CXEGI_AM_Tg">1.9</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" scale="-2" id="Tc_VAuWMZgmIUmPXfBWXcyeKw_9_2">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" scale="-2" id="Tc_2ciOVKnWm0WQ2jjTQg_C6g_9_4">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" scale="-2" id="Tc_LyWTajzXuUGh7FDTADP7tQ_9_6">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" decimals="2" format="ixt:numdotdecimal" name="cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" scale="-2" id="Tc_2tKexMT_s0iL6ZdT6awZDw_9_8">0</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected contractual life (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ" decimals="1" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Tc_24sSvyMV5ECMYimkQoAhow_10_2">10.0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ" decimals="0" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Tc_6hMk-JNwrEKy2qSqxUcuqg_10_4">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q" decimals="0" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Tc_WDf-Fj4EQ0Oq4hcrdsBXoA_10_6">9</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" decimals="0" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Tc_yZFTXhQ3j0iRyr_uZEzsMQ_10_8"><ix:nonFraction unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_TvyCsMUqekaRcguge2kBDA" decimals="2" format="ixt:numdotdecimal" name="cntg:OptionLifeOtherEquityInstrumentsGranted" scale="0" id="Narr_I1rCAsrPQkmEDDsnjwdoEg">10</ix:nonFraction></ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average fair value (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_LHMSasOI_UKrRC5MWGqOBg_11_2">7.86</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_5qMOlS6S00W-fNeD4aIUTg_11_4">7.45</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_KifMm3YDI0SvYnypKuGl1Q_11_6">8.21</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA" decimals="2" format="ixt:numdotdecimal" name="cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_icPGmVFojU2VLviNHBm4HA_11_8">7.36</ix:nonFraction></p></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The expense recognized for the above share-based payment transactions during the year is shown in the following table: </p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="cntg:DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" id="Tb_RaeoBkxFsk2bshEhtxofzA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expenses arising from cash-settled share-based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_f5HI1KD04EmB7usSkHFfrQ_2_6">5,714</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- 2016 VSOP</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_QBlrGqBAdESpyQFY-rXeBw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_fQ8u-8x8vEu4Nk2m0JC67A_3_6">596</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- 2017 VSOP (2019: including modification gain)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2017CashSettledMember_ddZeCSMPQkigLGIMskIdRw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_h_ALBLMaQkmHouZfpqAjIQ_4_6">5,118</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expenses arising from equity-settled share-based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_FdwDE7Iil0yD0UfM6qPnfA_5_2">8,035</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_Y0FLGBLSsUOi8XOAx5OviQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_6C-RoTp7u0myNRwtRsUZiw_5_4">5,658</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_jYUqoxf5w0aSVW5kiFp4kQ_5_6">704</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- ESOP 2019, including replacement by RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_KnBtKjQfNUiN6nVy9SE1jg_6_2">7,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_EO7NXiyF70S2OlhMfL7rDQ_6_4">2,105</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_J6cKOx758Uan9G_GzTxF7Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_q3aCf5BIr0KJdoHwgbswng_6_6">704</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Grants to management board and employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DpbCs0wmDU6o6dQo732WVg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_v8iCuTJmqU2hDuofjXYWww_7_2">985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Pv_4vLW3B0ydriIBKiHLXw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_YrKQ4B_s20mqqdf8SmB6iw_7_4">3,217</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Grants to the CEO</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_aEEdjxkwJUmQ8BYGV087NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_pG9TT6POq0ug5Z7RsXlpWQ_8_4">269</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Supervisory board grant</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_K1oTeO_vXUid_7vKJtffcA_9_2">50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dHEoTjnDeE6r34FsHbGMEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_THB15o9o50W6zgbEa6v-LA_9_4">67</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total expenses arising from share</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">based payment transactions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_IK_Ext4ibE2I4UjdvOg95A_10_2">8,035</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_Y0FLGBLSsUOi8XOAx5OviQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_ehwQhZZ-IkKIzaNInUjONQ_10_4">5,658</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_f7m7zamK8EiyOIBjoUd0vg_10_6">6,418</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory" id="Tb_FcqkeGXwfEGiYyANVgJytA" continuedAt="Tb_FcqkeGXwfEGiYyANVgJytA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Financial instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">21 Financial instruments-fair values and risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.1</b></span>Classifications and fair values</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The carrying values of the Group&#8217;s financial assets and financial liabilities approximate their fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.2</b></span>Financial risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group is exposed to the following risks from the use of financial instruments:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Credit risk</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Liquidity risk</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Currency risk</i></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss.  The Group is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities, including deposits with banks and financial institutions and foreign exchange transactions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The carrying amount of the financial assets corresponds to the maximum default risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Trade receivables and contract assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group utilizes a receivables management system that closely manages open items of major customers. The Group&#8217;s customers in the pharmaceutical segment are mainly pharmaceutical companies which are usually listed companies, or strongly financed by private equity funds. The Group&#8217;s customers in the diagnostics segment are mainly hospitals, labs and physicians, of which a large part are generating revenues. To avoid default, the Company may request prepayment for new business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to the macroeconomic situation generally, the development of international healthcare markets is a key economic factor in assessing the default risk related to trade receivables and contract assets. These markets are closely monitored by the Group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on&#160;days past due for groupings of various customer segments with similar loss patterns (i.e.&#160;by customers from different segment; customers from different geographical region and customer type). The calculation reflects the probability weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. The maximum exposure to credit risk at the reporting date is the carrying value of each class of financial assets disclosed in note&#160;15. The Group does not hold collateral as security and does not request letters of credit or other forms of credit insurance. The Group evaluates the concentration of risk with respect to trade receivables and contract assets and recorded credit losses reflecting the expected lifetime loss, based on different types of customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Considering the major exposure to the credit risk arising from the diagnostics segment, the Group focused its impairment analysis on the trade receivables due from customers in the diagnostic segment, in particular the MENA and Europe regions as they represent the majority of that segment&#8217;s revenue. In addition to applying the provision matrix, the Group performed an individual customer analysis on major debtors, with reference to the past history (such as sales and collection in the previous periods) and the assessment of their current financial condition and other relevant factors and evaluated if additional specific impairment losses would be necessary.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_3cc1f7a2_1732_4d6e_b725_81d33bf92a01"></a><a id="Tc_NgRgDN_D7E2sAkPjidO9eQ_1_0"></a><a id="Tc_WF_rIAMk4kaq6ekNQwMwDA_2_10"></a><a id="Tc_eqxjXPJXKEOe63B4DwGvVg_3_2"></a><a id="Tc_zVS2iMg880OYm5OE2iB-3A_3_6"></a><a id="Tc_z5Gj-IVnE0y9LoeeMukAeQ_3_8"></a><a id="Tc_KhqwH9SE2Em9Jzr3xHpHVg_3_10"></a><a id="Tc_zK3MJ-jpKUink7Y_HIa-tg_4_0"></a><a id="Tc_0Hs_llBy-k6XDSxyGuhMHA_4_2"></a><a id="Tc_S6rrLKUEJEyAOYPpY4Mdgg_4_4"></a><a id="Tc_sMuA8BMUUUSNLzRULba67A_4_6"></a><a id="Tc_GSCNE0d6WUqdhof-zRB_kQ_4_8"></a><a id="Tc_0cYeh1Qi-UWgnAdUbTw5SQ_4_10"></a><a id="Tc_8gSvG6r_yEmbYMFZI6j5cQ_5_0"></a><a id="Tc_OvdcyBiAjUeNJxXjy5DAjQ_6_0"></a><a id="Tc_jBYrJATNwUi8uH_FwT9a_Q_7_0"></a><a id="Tc_rmgKZN1_7kOQSDLySEKPbg_8_0"></a><a id="Tc_FpZ6BR2c4EymmR69mtdh7A_9_0"></a><a id="Tc_gRsD0LIMzkeVhNslmmJ8_w_10_0"></a><a id="Tc_dg-Hxku_NkSElSDe7Rb7Qg_11_0"></a><a id="Tc_7rZZgpckeEiKqN0YH4VW7w_11_3"></a><a id="Tc___Tu6h-R5Emks_1pWME4JQ_11_5"></a><a id="Tc_d2xf5eQ8w0Oxqrz37dUQ0w_11_7"></a><a id="Tc_nxO0Zcb9AU6vOTlhaHpnLQ_11_9"></a><a id="Tc_SeVHHqPumE-ZeJm80eGE_Q_11_11"></a><a id="Tc_ThEiGdjjJUidydNH7fK3tA_12_0"></a><a id="_ca4ca1a6_3d94_477e_b586_6b4e153318a2"></a><a id="Tc_Jq_zhVUSxkCj6wGGNQ4DSg_1_0"></a><a id="Tc_oEcJShSmG0ua5NrCTEMw5A_2_10"></a><a id="Tc_ntx_DWbMA0GuSmebG2FzxA_3_2"></a><a id="Tc_5nM_--3XgEeistUcwEuqUw_3_6"></a><a id="Tc_KsDz_Sw1VU21dqoq5BIFCg_3_8"></a><a id="Tc_m6S_syv9jEG76w1ApLaDdQ_3_10"></a><a id="Tc_ba3LBYo4WEqBZdrJwTLuLw_4_0"></a><a id="Tc_uao-1AqkOkiXID_-d6pwvg_4_2"></a><a id="Tc_F-LC0lQmEEqa6cVXG1NkYQ_4_4"></a><a id="Tc_GnFr_Elyb0mgSDoKP2LHyg_4_6"></a><a id="Tc_ZJfxmmhP20-5mc1HxrRs7g_4_8"></a><a id="Tc_XzFcTYO63kmG6Y8500t1_A_4_10"></a><a id="Tc_SzL_pTJi4kWUvF5F0vC3EA_5_0"></a><a id="Tc_bp-8DfQU-Ee5h6Ixl-rN5A_6_0"></a><a id="Tc_fXEHf0guWk-O50JI-jiI0g_7_0"></a><a id="Tc_wSqgr7gO70WMArvWA3nv2A_8_0"></a><a id="Tc_UkLlUfWGL0OYNg_CGX-N3w_9_0"></a><a id="Tc_H5iz495wfU-VQAPABsciVw_9_10"></a><a id="Tc_t2PzMYiLe06LCrs-CHn0Sw_10_0"></a><a id="Tc_ox2eeikeoE-uF6SYxuRMSA_11_0"></a><a id="Tc_MNIKxl_5nUqCKhS0kbX8dw_11_3"></a><a id="Tc_kOqiDpumM0CkA5iyulWrqQ_11_5"></a><a id="Tc_Ihy8bApg10C8WjvZRnKpow_11_7"></a><a id="Tc_8USpEwvTZUGoShb2mxGMAg_11_9"></a><a id="Tc_eFEr9aJSFUme3Mx9Eezkug_11_11"></a><a id="Tc_S7YyglT9M0G14ArA_1KwcA_12_0"></a><a id="Tc_3r33A9A4lUW2WeyK_D9fVg_1_0"></a><a id="Tc_LpnuBi8zIk-d8qJnDwyjIw_1_2"></a><a id="Tc_ROgIDsRGZUauGtqhOZVrAA_1_4"></a><a id="Tc_CrpV_9JW8EGVxV7LR6LCEQ_2_0"></a><a id="Tc_NthRnF6htU-N-wooRCkvDg_3_0"></a><a id="Tc_iq2Zl9lONkarhK2X5pPVOg_4_0"></a><a id="Tc_RjWfOCrXGUO3Z7v3G56ltw_5_0"></a><ix:continuation id="Tb_FcqkeGXwfEGiYyANVgJytA_cont1" continuedAt="Tb_FcqkeGXwfEGiYyANVgJytA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below is the information regarding the credit risk exposure of the Group&#8217;s trade receivables and contract assets using a provision matrix.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfCreditRiskExposureExplanatory" id="Tb_H0rM1e-FoEWXaRCRAPAGfQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;by</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;1&#160;-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;31</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;"> 90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">more&#160;than&#160;90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not&#160;past&#160;due</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">30&#160;days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_im24XRyLI0GqUcsxo8IrZA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_9JjtUgLAbE2wOiSGuQUa8w_5_2">13,968</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_AWSNyH90oEO0mlR_BPIyQw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_nTkZL5fzbU-GZiY4-BzJoA_5_4">3,999</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_Nr5CKDFzgEmOhALcEcaUKA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_jZrctc6-8k60SCTcgwA0DA_5_6">1,013</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_9o0XhkZxGky0b7QNSp7Ieg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_uHF5eSLlfEq9BBegSXj4nQ_5_8">2,056</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_c3WvXYkgjU2w62UITw_QoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_1aidK71z30mTBFdfhWlxow_5_10">6,900</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_qMKixKGV5UWRZqRsEsGsdw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_m6VrfdCIM0e0wyxBKHb6aQ_6_2">11,486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_-KBY6U1X6EOR-VWQfNcPHA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_cg6g4Gqj0US64SnKYf3K6A_6_4">10,771</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember_8g_ZitjpWU2j9Bs86BqZrw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_VFMTY9LeFkW3POw2-56-6g_6_6">351</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_YGwYj8iWBkW5FDEsRlrh0w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_9qYelMj6pkGtIOcIoDW-hw_6_8">259</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_1I2zB8P7-EGuayPURgq3Xg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_xUDF6u8EY0ujk92yWdMFlQ_6_10">105</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_mTPqfJbCUUm--tsL4sV-ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_GbE__KHYVE2wdTmhvACTfw_7_2">683</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_VNENwsckGUiWfp5ITIZVqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_OwlHrNDUrUGq7iCuB_0k4Q_7_4">531</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_iNZqJbVbKki0oB6o29DKAw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_KW-MoPllyE6VY5ToEVUxhQ_7_6">23</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_jAebtKB3PUWEhq3JPxUl8w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_N6c5UPV0B0qgRbfl39VVQQ_7_8">72</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nrmK-W5eVkeDWBDFsK1gbQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_myiwVN3fzkyEfUPRmC4Apw_7_10">57</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_nBhxP_A8lkWu92Je-mOYBA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_KhiOGSvyhkKGqvXFeEp_6A_8_2">3,787</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_q-OwjmoAGkCq9QP-5ONw2Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_T-7t_gEWlk2DEeJshQgNEw_8_4">2,562</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_kqTayYwJoEGJgu7xk2O20Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_aS9RTFX2IUSx5emw2WvBPA_8_6">79</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_iBTWkttdV062pZ701mLkyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_xgUe2M9TXUSceLIa4SSfig_8_8">203</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_vfEsDhfpBk2COGW2LU7q1A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_xJdFfxYYo06MklfZFS1wag_8_10">943</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_quezt-h_1EWrq43Pa0YWsg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_r62w91iZc0KKStEDoSEqBQ_9_2">130</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_Z_smm4P60EyfOSuzKxAlhQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_4rf9u7cwKEuGdfKVj0kLow_9_4">115</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_XEJ63VPP90SKEPNBmiOU_Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_rFCZEY6Qq02lqRmwWpcbHA_9_6">9</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_v7Uhyrox_UqVpbuf1EAC0Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_dPQitgfgG0CQ5c21QCLBsg_9_8">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_gmTaq6Yn1ECvIEhMtnPX0w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" sign="-" scale="3" id="Tc_hD-lq1hKdU-FfbxI72PMLA_9_10">1</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_7SyEmzNi9kO8uN3NICcsRQ_10_2">30,054</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_VKwo4ltU0Eu-PsFinYDHPw_10_4">17,978</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_1XhI2NxhtkyG9BnYVdZUTQ_10_6">1,475</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_iw8OPryKP0eyAGWxp6s09g_10_8">2,596</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_T0RPq1FNd0OLmlR80VkInA_10_10">8,004</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_2E800b-WzUqJ2F8D3lcZjw_11_2">19</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_Ph04-bIgaUqJHKor4wuvyQ_11_4">0.9</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_2AAEmSUFGEWq_yEwotPSLg_11_6">7.7</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_0ebZJVXAi0KSN937uEDnhQ_11_8">11.7</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_fslTFiPS1Eu3QrRL9quSpw_11_10">64.1</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_vkSEFITnzUmXDI5SzMZ-GQ_12_2">5,717</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_AHBqq1lctUmLRuf2X2rymQ_12_4">167</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_iMJK-s33vE-yy4-HiqyAjw_12_6">114</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_wa3K-iwIOUaMZCQ8b0FHtw_12_8">304</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_ZIbC2vKf3k28skyQdmJifQ_12_10">5,132</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;by</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;1&#160;-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;31</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;"> 90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">more&#160;than&#160;90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not&#160;past&#160;due</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">30&#160;days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_lKSmRPULxECSr0eRnZJv2g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_ZHxr2DPjskqhXqtiiyM9lg_5_2">10,515</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_MAiDhc93mEuXQd1PbNze4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_YTyQNN2nVUaTnyJ0ls0InQ_5_4">3,338</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_oDDkh1PJbE2F8ijvw05Pvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_u6m_Yed7SEqxutCUGRDesw_5_6">486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_h3ZfOluujEiPQeT9NlQKMA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_pnhAYwMsf0Olk6dImpxqyg_5_8">385</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_aSbUFoGlt0-vDtnrIjva9Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_3VvzXc0jukOd6JsHBJf4Zg_5_10">6,306</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_2o28VsnJ302Wcsmk8ET49g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_wfH976ejkUm--3QpMW30jw_6_2">20,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_YEwbUrATUE6gX9KIiJ2XJg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_x9sJRzwJYUGcx1LLY0gyng_6_4">19,193</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember__GLD_N50Q0qJTvDIg66vCg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_ErgisO8R-kCWreWA-zfb2w_6_6">706</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_53uzl0nKCEWKL9P-aqzedw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_P8e3nH29S0amwFBPstGnpg_6_8">113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_AHlMhGU4RUO4AYFCEWNB4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_feAody0TM0C7Xe0bNLfB2w_6_10">5</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_2zZ4FqgNmU6u242fuMe22Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_bp6Mlu13m0W7bNWESgqKbg_7_2">387</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_bV11S-JGL0-qYfeSG-mqaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_tVj0kRf5O0m7e5ExvpgFdQ_7_4">313</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_Gg9_HCfVqkyGfAYx_drdzw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_o7CFssGmpkGz92oNDAGr7A_7_6">24</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_CeCE8jbz0EGNqIacDltO2Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_gIJpI3cdQUSjke84yIFkqA_7_8">13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nnGZ6V0R5Ui7TR-RGngNEQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_wSpQAEr3LkW6MbyqQeZJMA_7_10">37</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_Q0uVwOjO7ECfq8SqO9fgPg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_ZrBi_nuLP0WkHTLdXABXBw_8_2">2,870</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_IGCBy0alu02k3K8HN8HMVQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_g_DfF030IUi-mkV7T2IISQ_8_4">1,205</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_7zHmJCcCi0iHo0JtjolMqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_EfRFR9JlnECpK9ReMuecSA_8_6">994</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_YBYcui1xWESYnTn6QF0bXw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_FXxcs8jgYE--eOnALsn4Qw_8_8">262</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_VIL6RPyEFkOt1QnphczzYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_VHdxlT-nF0iPbHX2Uxq2Bw_8_10">409</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_3_Qlw4YfQ0qJvktlFzldsA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_ygi-4VfQmk6Xibc3cHVYaQ_9_2">178</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_alAn4anr30uPH3nv6D0QTA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_amuKvSwNjE-X-wEQ62HIbg_9_4">136</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_sDI8Zd37_kGSZzcJnjDK3g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_SkewiIzrxE6cGlvbR9ggWg_9_6">18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_6HnJiRc8uEOIwyqFZl2paw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_EPEblYu3K029Cxzhlahuzw_9_8">24</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_JkMHBuxVHE21CWqUtVYhWA_10_2">33,967</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_rKrWrsLwqEWN_yIQiWtyxw_10_4">24,185</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_JbBTJlzGA0-0J8jOQ8y6Pw_10_6">2,228</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_b4L1eSmwBEOngGH3XLCJJQ_10_8">797</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_wLsBLyI82ECAAZ4YaZ9_Og_10_10">6,757</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_-0IxtnnFyky2sT9-QkDDvg_11_2">14.0</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_KGqRiZoVbEipvam_d01O8A_11_4">1.6</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_iXln2W9AkEyrDP6ak4-WYg_11_6">3.1</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_j4NF056ALkqTD4U6rselfA_11_8">7.7</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ExpectedCreditLossRate" scale="-2" id="Tc_nTBvxjYG3UiRxR-7XgMtJw_11_10">63.0</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_nRXdp9fEtkCp3Em7I3NR5A_12_2">4,768</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_DXmMrbJrOkK0-r60akJ__w_12_4">382</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_90oXq7goVUqdcKePv0zfvw_12_6">70</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_xsj5ew1MuUq69PcaL-RHAA_12_8">61</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_GH-53fgKPEuoGpxKLhl4rw_12_10">4,255</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Overdue trade receivables from the Middle East region mainly relate to major customers from the diagnostics segment. The trade receivables due from the top <ix:nonFraction unitRef="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_64L26hAwIkSVEZySJMUuIA" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfTopDiagnosticCustomersDueInTradeReceivables" scale="0" id="Narr_4pdriHhBJE2GHXniQqabPg">10</ix:nonFraction> diagnostics customers in the MENA region as of December&#160;31, 2021 represent over <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_fT4qcBDw9EGETB6DVY3dyQ" decimals="2" format="ixt:numdotdecimal" name="cntg:PercentageOfOverdueBalances" scale="-2" id="Narr_hZlXvB2DU0uiBnVuqCW7pg">80</ix:nonFraction>% of total overdue balances for this region. These customers are mainly government hospitals administered by the Ministry of Health in the respective countries as well as distributors and, based on our past experience, these customers normally require a longer period to settle outstanding trade receivables. The average turnover period from these customers are <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_VE4Zb24yM0-210qngfcykg" format="ixt-sec:durwordsen" name="cntg:TradeReceivablesAverageTurnoverPeriod" id="Narr_XKniojgU_06DwCkuYt0u2A">278 days</ix:nonNumeric>. Therefore, a higher country specific loss rate has been used for the MENA region. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below is the movement in the allowance for expected credit losses of trade receivables and contract assets:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfAllowanceForCreditLossesExplanatory" id="Tb_gAy1sDsf7EuuQT-My0HvSg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of January 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_yaEih7N5-0KOOF5zjhU-TA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_NJsrNGkH7UGNuEyfBdBf4g_2_2">4,768</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_PpfrBDRiYE6X2aaNart3Kw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_pKMT6IDEZUmLXlAXd5i8FA_2_4">2,355</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for expected credit losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_oIZwdOmoREqE4B_LSTBrPg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_NnOo77CfVUyYRjhnEYUfwg_3_2">956</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_h73Wub4Up0GkkBugURy3GA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_ydkYHXjxFUGHTYyzO5EcBg_3_4">3,879</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Derecognition of trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_oIZwdOmoREqE4B_LSTBrPg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_Z7BmirTh-kGC2Rg4i9BhTg_4_2">7</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_h73Wub4Up0GkkBugURy3GA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_1ECxqVgeu0WO1Ll6hs11ug_4_4">1,466</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_fYFW5_Lv4Eu7pT63KH2LHA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_bt31yd1qdUiy0oyz5o-UfQ_5_2">5,717</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_yaEih7N5-0KOOF5zjhU-TA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Tc_y0ozVQImk0StaPLNxVjBoA_5_4">4,768</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The addition to the allowance for expected credit losses includes an amount of EUR </span><span style="font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_mgdgQ6ZdVEWu7MZBFuxPcA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ImpairmentLossOnFinancialAssets" scale="3" id="Narr_LB8Qd-kc4UufC4gkgcsn5g">949</ix:nonFraction></span><span style="font-style:normal;font-weight:normal;">k which was included in the impairment of financial assets in the profit and loss account. In 2021, trade receivables of EUR </span><span style="font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_tsk8qBlLdUKKx-fMOsu2-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Narr_SYRJ6FanMEKOjhz5t8-R1g">7</ix:nonFraction></span><span style="font-style:normal;font-weight:normal;">k (2020: EUR </span><span style="font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_Q4DmiPOJc06nX5FPcvcI3A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets" scale="3" id="Narr_YDsTZ6wR4E6OaOEkyWpZEA">1,466</ix:nonFraction></span><span style="font-style:normal;font-weight:normal;">k) were outstanding for more than 365 days and were derecognized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of December 31, 2021, the Group held cash and cash equivalents of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_vbrOgTDfJ0e6FyvtY_qOlg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Narr_KMxbgwJ2aEydRHBrrkwOhA">17,818</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_OdjXVnK2IkSMmsnB2jcPFQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Narr_k56-tlvah0yfKohCGjZHOA">48,156</ix:nonFraction>k). This total, therefore, also represents the maximum default risk with regard to these assets. The cash and cash equivalents are deposited principally with financial institutions with investment grade credit ratings. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-45</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_f7a9d05b_d9b6_4ae3_bdc8_41ac6ff23253"></a><a id="Tc_T_fzTm9eC0SpMh3TtDR5yg_1_4"></a><a id="Tc_dwdj0__z7kimKxej6i4sCA_2_12"></a><a id="Tc_F8p-kIgVxEK65IxeVK5UPw_3_0"></a><a id="Tc_r2r8lZ-M00akfei9l0iO5Q_3_2"></a><a id="Tc_sfrrChmzZUS3qKWHjW0u_g_3_6"></a><a id="Tc_gemujJZGj0m6uYK_CKXi1g_3_8"></a><a id="Tc_koQj-jGRVUioGAN-tSEznA_3_10"></a><a id="Tc_Tp2oIX5zbk6kGk0PIK-cUA_3_12"></a><a id="Tc_cTGSvrRz8EWREgrDAqOsqg_4_0"></a><a id="Tc_b-nDgERWUUSFB1vi11VRYA_4_2"></a><a id="Tc_xI9w2kY5C0O21luZrOfCYw_4_4"></a><a id="Tc_kVGuaTi7kku0T9gGHJcfIA_4_6"></a><a id="Tc_OBHBsgo7xk2xy59_GOgM4w_4_8"></a><a id="Tc_u7MpWttTkkOhuV9VZjqYDA_4_10"></a><a id="Tc__wJeCXV5DUmnk_0dZpgvhw_4_12"></a><a id="Tc_vWNMeV-wTkO1M3Be7rv-QA_5_0"></a><a id="Tc_1oMJqQthakSpYhWz-zRUzg_5_8"></a><a id="Tc_NTF9BH9KhUqwzddN5ZDMoA_5_10"></a><a id="Tc_cEtau-z_L0ORLYYw3NBOvA_5_12"></a><a id="Tc_83B3Z0vK50m5pAi-LxfYMQ_6_0"></a><a id="Tc_1i73KSj8Ak212DaUsdIRHg_6_10"></a><a id="Tc_VEmpcgjJfEmTr9T7RHUFqA_6_12"></a><a id="Tc_JV-P8KN_c0q_KqZODDPe5Q_7_0"></a><a id="Tc_oF51g-1vG0SHWsvSuXXAvA_8_0"></a><a id="Tc_lfuywiQZ5k60GSzfrpyNTg_8_8"></a><a id="Tc_Km8qZ-sNok-q7qmJHbfymQ_8_10"></a><a id="Tc_T7HM9mj1LUie6M3Wy0-kGQ_8_12"></a><a id="_47d69207_a28e_4680_8719_71c67263f74f"></a><a id="Tc_qtPw140mkEGDIa7CU139-Q_1_4"></a><a id="Tc_9M2H_NHbMkq2mN_IpLfJUQ_2_12"></a><a id="Tc_cy1PJTY-d0SUtS8rv6KTBA_3_0"></a><a id="Tc_kbnxKgUcT0CdYesOxbfNKA_3_2"></a><a id="Tc_9yC7ouNTo02ApwbWmKIx5w_3_6"></a><a id="Tc_c9HYgOr5JkWl-Oytxbqtag_3_8"></a><a id="Tc_9CnfotbO40CmSUMdoAVrfg_3_10"></a><a id="Tc_WzkLcazsw0GW53o8MKpUKA_3_12"></a><a id="Tc_rTegSvEiOUm9SUjx6W-l0A_4_0"></a><a id="Tc_ErSyQ-OlBUG4NjHOuk8PBA_4_2"></a><a id="Tc_V6lycUtzfEOxMLChnn4q0Q_4_4"></a><a id="Tc_swOVPxZ3ykOrB9hiQmMqCw_4_6"></a><a id="Tc_xqubv1V1ekaLLdSTW2MVgQ_4_8"></a><a id="Tc_4VQi7psOKUyCNmMQahRxHw_4_10"></a><a id="Tc_g1feX7oJhkeF92XINicySA_4_12"></a><a id="Tc_uOZ_ObBv7EeFk6pcN9cSpg_5_0"></a><a id="Tc_teIG1E9Gt063XIpR94DAJw_5_8"></a><a id="Tc_C9khAZosU0aMdZsitP7iuw_5_10"></a><a id="Tc_WO24WWHoQUewx0ae-f0KNQ_5_12"></a><a id="Tc_ZrqlFRbI4UapS9ApwFm5Jg_6_0"></a><a id="Tc_FyC9tC1DREKaLVrhxw2goA_6_12"></a><a id="Tc_aQZ5FfYtAUio5P5ytjSWGA_7_0"></a><a id="Tc_mpQNAjYNe0iOy7LKLsXi7g_7_6"></a><a id="Tc_LdsUuQNJz0ek0vqYPFvuTA_7_10"></a><a id="Tc_fiutwdiDOE2oXAJZhV1jXw_7_12"></a><a id="Tc_BSQ0tbM3G0O4ADa7X13Q0g_8_0"></a><a id="Tc__9zkNwEPDkS9UUcnEaeSqQ_9_0"></a><a id="Tc_pz-OiKYAkEaopdunh4-J7A_9_10"></a><a id="Tc_nVG-mPZjCkm2w5PwSEeWiw_9_12"></a><ix:continuation id="Tb_FcqkeGXwfEGiYyANVgJytA_cont2" continuedAt="Tb_FcqkeGXwfEGiYyANVgJytA_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidity risk </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The liquidity risk is the risk of the Group possibly not being in a position to meet its financial liabilities as contractually agreed by providing cash or other financial assets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#39;s objective is to maintain a balance between continuity of funding and flexibility through the use of bank overdrafts and lease contracts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Managing liquidity within the Group is intended to ensure that - as far as possible - sufficient cash and cash equivalents are always available to meet payment obligations when these fall due, in both normal and challenging conditions, without incurring unacceptable losses or damaging the Group&#8217;s reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group strives to maintain cash and cash equivalents at a level above that of the expected cash outflows for financial liabilities (apart from trade payables) during the next 60 days. As of December 31, 2021, <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_4MGHm-fiQ0S-NkUoqSHdJQ" decimals="3" format="ixt:numdotdecimal" name="cntg:PercentageOfInterestBearingLoansMatureInOneYear" scale="-2" id="Narr_qqs8Jct6pkuPMkbFouUtPg">30.7</ix:nonFraction>% of the Group&#8217;s interest-bearing liabilities mature in less than one year (2020: <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_gE_fMmwbY0-dkhMzL5yzoQ" decimals="3" format="ixt:numdotdecimal" name="cntg:PercentageOfInterestBearingLoansMatureInOneYear" scale="-2" id="Narr_GHvcINjqOk2eGfcVEVGfkQ">25.0</ix:nonFraction>%) based on the carrying value of borrowings reflected in the financial statements. As of December 31, 2021, the expected cash inflows from trade and other receivables within two months amounts to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_8WV5gyv1i0GftN0I4C3eiQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk" scale="3" id="Narr_BnwEwUxSDEK1eT5u4J2XUw">6,418</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_z1xLnpmvrEaXgiuUBqzwfw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk" scale="3" id="Narr_gXS7QOUTD0SrwkbJsGyBxQ">14,857</ix:nonFraction>k), which would be EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="cntg:ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" scale="3" id="Narr_XAwKuSPnr0CfJZw74ZEzjw">4,834</ix:nonFraction>k lower than the amount of trade payables due as of then.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company completed the IPO in November 2019. In July 2020, the Company completed a follow-on public offering of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l3DMVfcSck6NtIEREMfo0w" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" scale="0" id="Narr_FY6EWW5ahUiwgKEajlAVSg">3,500,000</ix:nonFraction> common shares of the Company, consisting of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_3znQxHgm3kWUN47RhL_tkg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" id="Narr_QfxbOF9lNkGc8V4jEpK63g">2,000,000</ix:nonFraction> common shares offered by the Company and <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l3DMVfcSck6NtIEREMfo0w" decimals="INF" format="ixt:numdotdecimal" name="cntg:NumberOfCommonSharesOfferedByPriorShareholders" scale="0" id="Narr_raRIGTlYa02NVj0tT5d3PA">1,500,000</ix:nonFraction> common shares offered by selling shareholders at a price to the public of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="As_Of_7_31_2020_jjcjEUhSo06U9XQl7FB8sw" decimals="INF" format="ixt:numdotdecimal" name="cntg:IfrsSharesIssuedPricePerShare" scale="0" id="Narr_7xDhfdUcoEekQECsfcRduw">14.00</ix:nonFraction> per common share (i.e. EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_7_31_2020_jjcjEUhSo06U9XQl7FB8sw" decimals="INF" format="ixt:numdotdecimal" name="cntg:IfrsSharesIssuedPricePerShare" scale="0" id="Narr_dbk8jxJctESltv2lrOG0sQ">12.71</ix:nonFraction> per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_u1oRH-U820CdaIuG7lDGdw">22</ix:nonFraction> million to the Company. As of December 31, 2021, the Group had cash and cash equivalent of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Narr_D1drPQr1q0q737HT0qzUKQ">17,818</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Narr_JCW74FIF-k239gwzf4Ojqw">48,156</ix:nonFraction><span style="white-space:pre-wrap;">k). The cash and cash equivalents are deposited principally with financial institutions with investment grade credit ratings.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to the cash and cash equivalent available as of December 31, 2021, the Group also has access to other sources of funding. As of December 31, 2021, the Group has secured credit lines totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" scale="3" id="Narr_jwW4X_aZCESSgOMtJk3SgA">3,500</ix:nonFraction>k. These bear interest of <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_yHGXCfJRZUmQPTopPKil4w" decimals="4" format="ixt:numdotdecimal" name="cntg:SecuredCreditLinesInterestRate" scale="-2" id="Narr_ZfXE9A8lZEKe-aBCDhstBA">3.75</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_EWLOPAf3s06Yaf102xYwkw" decimals="4" format="ixt:numdotdecimal" name="cntg:SecuredCreditLinesInterestRate" scale="-2" id="Narr_3bDrVDb3EUWx5v0FUiWq4Q">4.75</ix:nonFraction>% (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" scale="3" id="Narr_mR6eN6qM5ke5iTRSfC5Flw">3,500</ix:nonFraction>k; <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_hvAwpduUMkS_--hMwyClRw" decimals="4" format="ixt:numdotdecimal" name="cntg:SecuredCreditLinesInterestRate" scale="-2" id="Narr_eZhJ8AzJ60OUg24cF8e87Q">3.75</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_LRSLwc9jLEWT_6ss8x1zQw" decimals="4" format="ixt:numdotdecimal" name="cntg:SecuredCreditLinesInterestRate" scale="-2" id="Narr_U4U3eIZNCkm1kYztWqwjyQ">4.75</ix:nonFraction>%). EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA" decimals="-3" format="ixt:numdotdecimal" name="cntg:SecuredCreditLinesUtilized" scale="3" id="Narr_Chiox0C2VEuBnpGA-pNRrA">3,310</ix:nonFraction>k were utilized as of December 31, 2021 (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg" decimals="-3" format="ixt:numdotdecimal" name="cntg:SecuredCreditLinesUtilized" scale="3" id="Narr_9xq-thEZ_Uivgn_uxG2erA">1,538</ix:nonFraction>k).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below presents the remaining contractual terms of the financial liabilities on the reporting date, including estimated interest payments. The figures are undiscounted gross amounts, including estimated interest payments and interest on undrawn loan funds, but without showing the impact of offsetting.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities" id="Tb_ypN6cf5jwUqIXmv-sMO4pg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractually&#160;agreed&#160;cash&#160;flows</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">More</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Less than</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2 to 12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">1 to 5</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">than</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2&#160;months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">5&#160;years</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ClpwBom6cUqWd-ufPXZ0UQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_ClzUacjHeEmEVobSapvTZQ_5_2">3,310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ClpwBom6cUqWd-ufPXZ0UQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_7-FlBEX6cEOZXQOzrmBSBw_5_4">3,310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_pbC3EeTlG02DpVQruwf4Tw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_6Kaecxn1uEqlY68azOX6zA_5_6">3,310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_QpH5Ilre3kqzF-W0QaEVCg_6_2">505</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_oduN0WNssUmJL4DTLxeT7Q_6_4">505</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_rIlXfTTwmU-ysaRC7xDcSQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_Yi_wE8GMcUGlr3GX5esrow_6_6">105</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_XfZVUuusyE6sKx1xn01SHw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_tXsYmauIHEWcVMAwQrTASg_6_8">400</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_a3Yg9ypl1k2iDGuR8xuRyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_QEYKoZF4AUSJbFbJGXBvZA_7_2">18,997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_a3Yg9ypl1k2iDGuR8xuRyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_ThrwxFUg1keLDS4l96NQuQ_7_4">22,050</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_vd39B4F3FUO_Erq6z5AVPA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_WF-o3pC-5UyStSSYofy5rg_7_6">716</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_iozvi2N5fUy5-JmDwCHMOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_ZfFkURx2TUSzHzw-T8C-Uw_7_8">3,403</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_mRyO_XlQBEWt7q8iQ7G_8A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_yg1c-rbY1k25G9WNpSCNMQ_7_10">9,038</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_XrpCDWtFQUmPxSAiXPTXUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_PJqcfrNwcU-OsQKJeNHA_A_7_12">8,893</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_3g8HtBjL_kykX8R0GC1k4g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_XaUSHGjOgUORizkIpl512Q_8_2">11,252</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_3g8HtBjL_kykX8R0GC1k4g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_ROX7PKM7bUyuOpHrYEixZQ_8_4">11,252</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_FuwgOdOK2EGp4zWT_laRCg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_zrA-ltqzV0ygAiygKaM6hw_8_6">11,252</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_1hiBXJfI_EKgD4yyz3Pq0g_9_2">34,064</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_Ujg80_ymDEu1MuT6xY1rRg_9_4">37,117</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_3v-ci-9RIE-ahgs5Q3wFMA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_6kVhSFkzTkeXwHO-qlLXvw_9_6">15,383</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_xTVVLa1l40W4cNlLaMYVqg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_ItwGncdPpked97QNaVZH6w_9_8">3,803</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_4eI5LpLv_0eo4uPM2ev0NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_iLRmzlufb0aJbTjOhWg6Xg_9_10">9,038</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_B6gQoQkzLU6SHuMVF2-iZw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_WHto9fIKO0aYJ6Ox6ntHWA_9_12">8,893</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractually&#160;agreed&#160;cash&#160;flows</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">More</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Less than</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2 to 12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">1 to 5</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">than</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2&#160;months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">5&#160;years</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_3oFLP2tExkCs_4EjAnnqvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_bknb7zv_GEirVzDl9Ehr2g_5_2">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_3oFLP2tExkCs_4EjAnnqvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc__OUuDcXs5Uy7EpzKkSukIg_5_4">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_091uV2Fq_0qIxxVqOPG-zw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_ZbR-MKl-706zjab8L5sStw_5_6">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_cyd52sbaY02A1-_pjd1iRQ_6_2">968</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_rfw5EaOIZEO9ikfpHEIUGg_6_4">997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_9Pk-XO-w6kazSFU2ZKTLMQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_tU1eMxIwb0qn7faplyNpAQ_6_6">5</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZXCGb0Im-UKu347o-AvPMA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_Vc4IJOcuzkSPCPSqfQd1OQ_6_8">584</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_PUdDMYJxs0uelX1OleXC9A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_5jxYa_Wi7Uq-Doq3LiVGoA_6_10">408</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_SpNNQ_JBZUOkx3nQnjLf9g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_PwexXvLEy0-u1e9yqquCcw_7_2">387</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_SpNNQ_JBZUOkx3nQnjLf9g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_a4NZNuWSGUqaX7iq5S9mug_7_4">394</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_HgkA9kih00i_kzO7PaqJPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_NWutEw8r30-67642BhnPRw_7_8">394</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_LzHf5lcGX0618OATPQ19RA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_o8MEQ-zT20iaZUWedNozbw_8_2">21,205</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_LzHf5lcGX0618OATPQ19RA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_u6LlJvcDmEKJhyUfGnB45g_8_4">24,897</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_CUAJUdk83Um44_JFEP8vXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_gKUPTlZPk0K7nA7Ms_Q1JA_8_6">716</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZZvNtzkppE2H6789cVRd6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_tb-oOSRE-UygOBpUDCliEg_8_8">3,580</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1ld6bOFbL0-jZ3xi0wJJeg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_pTIvRj8OSE-UOPmqIAkiQg_8_10">9,861</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_zZC6MbCQ0E-4cbWihISE2w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_H1pH8qajbU6YQPSDymYbXg_8_12">10,740</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_UUEtJvvNV0G4AhFLi2cvzw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_eupuvdqWJ0GOaVOSZTuuxQ_9_2">31,736</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_UUEtJvvNV0G4AhFLi2cvzw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_Bqvc2xAmu0arn6AZJRZo1g_9_4">31,525</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_bVwoyln2AUi08pK8bb-Xcg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_4ybqaNcYikKMqufttMavTg_9_6">31,011</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_exG11_HvBUqZzNaMA2BROg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_fWXrbpjrnkm0OAdeqy9Etw_9_8">514</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_mBD111ZqN0SbmSka4TmvrQ_10_2">55,834</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_Gg1wTDQqDEum8by69-39OA_10_4">59,351</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_5wg1Zs52TkaxKu1Aw0P4Pw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_4YqJ5Nr1akSy-WLNCvdy7Q_10_6">33,270</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_9xKYcirppUaOjw1XbQSfdA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_9eNT1tXanU-fp7HhEybDrw_10_8">5,072</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_QZfp6KzOOkKZiy-H5CT4mw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_hwQAkC1L80CO_ga8C4JceQ_10_10">10,269</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_iTqtnBHt_kCG66_LrnRX5Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" id="Tc_4azmXKmbwEm_4uvkYqEnug_10_12">10,740</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-46</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_f40e8cf0_1802_4ce4_acb0_33f0bf9fff8b"></a><a id="Tc_31c2A7sGl0Kv0vvOi5Vgsg_1_6"></a><a id="Tc_GfMSAlWDZ0qzMAALmMw0pA_2_8"></a><a id="Tc_P4ZdLi71fkeYFjUboaH2IA_3_0"></a><a id="Tc_g_11G-T-GkahroPjnBq0-w_3_2"></a><a id="Tc_WStib1X0HkG5O_bosV2WXw_3_4"></a><a id="Tc_fL_X401tAUSXl-k6VUjfjw_3_6"></a><a id="Tc_QWE4sMSWBUif-T6f4Nrnmw_3_8"></a><a id="Tc_tnFd8h-_u0SbDBWuPZ2jZA_3_10"></a><a id="Tc_BfJ28EALSUiWD7z8NOskrw_4_0"></a><a id="Tc_CHcl5MhCkE2hiCjZFnIzMg_5_0"></a><a id="Tc_oVtN3KqT8EOY_p20OaiOug_5_6"></a><a id="Tc_RxF7je9DnEiiM0zGrY0y3g_5_8"></a><a id="Tc_9K2CMzf4s0Sarmzp4Z28iw_5_10"></a><a id="Tc_wSYxkCQqbUixW-uyelITrw_6_0"></a><a id="Tc_SAcxeVJ1dUqVvxh9DSwoLw_6_4"></a><a id="Tc_CULvA-jh7UuVj28P1w_YgA_7_0"></a><a id="Tc_c6vBK3LUlE-fpQ7cQan-gQ_8_0"></a><a id="Tc_K6BdGfEX6kmjP_H5VHVEhg_8_6"></a><a id="Tc_THUhSEkDY0ay3ks3LrTLZg_8_8"></a><a id="Tc_4tEvnNgpWUmsVtl4WzjQiA_9_0"></a><a id="Tc_SmyaPWsTAU6ClFb_R_2TgA_9_4"></a><a id="Tc_N8D0Bn0wLk2B7Cbsvz-kYg_9_6"></a><a id="Tc_BPq2A_AxdkSQDbic19N2Rg_9_10"></a><a id="Tc_MM9-4lZkTUqQFqqFM5_LoQ_10_0"></a><a id="Tc_rS11E2_bCUCFuzheWkGphg_10_8"></a><a id="Tc_tVLxMRTUuUuXyeYCe-BKbw_11_0"></a><a id="Tc_vvVgQ5MMIkSGidzjLjH8Vw_12_0"></a><a id="_47e5b610_6911_4c73_846a_0117278c3031"></a><a id="Tc_evueIfMwO0WE3BFR-bimXA_1_6"></a><a id="Tc_y41csHNENES70DEMdtBjIg_2_8"></a><a id="Tc_Rpj2X-dLekqVLQv-8MkhXQ_3_0"></a><a id="Tc_J17tl0cWoEOI0egM0Q9ZRg_3_2"></a><a id="Tc_9AFFrWjqe0eNf8Y8WVFhUQ_3_4"></a><a id="Tc_kjIHl6ywVESAnt-qAFErgQ_3_6"></a><a id="Tc_6bUB8NHnV0uBYt0ZZ82AwA_3_8"></a><a id="Tc_tZ1Y_Hep-kiyMHbLQaVGLg_3_10"></a><a id="Tc_6cjULwrvekuvXxOSOBdoBg_4_0"></a><a id="Tc_OrOtQ3-18kqxe4NrHPBRZw_5_0"></a><a id="Tc_QlJyGNMdZ0SNxTNG-hAN5A_5_4"></a><a id="Tc_kTLs8-bET02LzRn7ODUc0g_5_6"></a><a id="Tc_4majOwqAEkqYjBwLuUKANQ_6_0"></a><a id="Tc_O9ik7JlNckSt85nn9E2CUg_6_6"></a><a id="Tc_hIXz5s4jY0m14eZEs_5-yg_6_8"></a><a id="Tc_Gze_bBepBUCv3p_gaX29GA_6_10"></a><a id="Tc_iv9-xOrcEk2f4WC9R4sgpQ_7_0"></a><a id="Tc_JsAdRlR2Iku9OlLEujGrbQ_8_0"></a><a id="Tc_RL9f2-5Z1EKfqVNmghWQrA_9_0"></a><a id="Tc_KER1hU7N7UyZd74gG33FNg_10_0"></a><a id="Tc_M2UlynLsPE2EbkbOFEFSlw_10_2"></a><a id="Tc_YfqnW-mYv0mIwpVZ0VieTw_10_6"></a><a id="Tc_ke6VsC5PLEGc9ZAdgnvS4Q_11_0"></a><a id="Tc_9lxZbRodpE6xhUzq5mwrKg_11_8"></a><a id="Tc_gNbR0YAWdkuY8VJPuplL2g_12_0"></a><a id="Tc_olf4JRCg5UOCACkZCxIYaQ_12_6"></a><a id="Tc_oXY8__5C8EOS6KRHNI0qHQ_12_8"></a><a id="Tc_R8VdktygXEGp8GonPlXz4Q_12_10"></a><a id="Tc_PRbQKnQn1E2kbx54RKp55w_13_0"></a><a id="Tc_Cbqt60hkekS42C-ktUbAkw_14_0"></a><a id="_d4c23f51_f9e1_4e04_99a3_4bcc5c08b953"></a><a id="Tc_85DrvrPzUkiRGpZ7-lAPoQ_1_2"></a><a id="Tc_2Iz4j93zSkSK-uhaZx7iMw_2_0"></a><a id="Tc_pc6ib04toUiqN1T5g7TeUw_2_2"></a><a id="Tc__D_D4e_ehEi56KZw-uGJog_2_4"></a><a id="Tc_nL2c6sMyO06cafltxaFcBw_2_6"></a><a id="Tc_esSyVmW9mkCKvRJmAAtp8g_3_0"></a><a id="Tc_oESnRI6MYk-Dtktj2ENSDg_3_6"></a><a id="Tc_qPHKgTn0UkunsOtyCnO4Dg_4_0"></a><a id="Tc_REhuydYgIU-eWQBzdVL7Kw_4_6"></a><a id="Tc_10Jb88lAtEuQAD1mhqKxfA_5_0"></a><a id="Tc_uO7zsfeaDkuDb4-vfXic_w_5_6"></a><a id="_2be978cc_503c_4d5f_9edd_0d94289f8132"></a><a id="Tc_hRD2zzR6rE6jRwwEw8oBSw_1_2"></a><a id="Tc_zOIHuR2w50SDW5padcZLZQ_2_0"></a><a id="Tc_sdw-PH6JC0qlEMubF3lkeg_2_2"></a><a id="Tc_0-Vy_72hpkmMXBbW-cetCA_2_4"></a><a id="Tc_oVLPInWkkkWGVN7SvkobGQ_2_6"></a><a id="Tc_ip_JC_yLn0e9aKQSPaT4Ug_3_0"></a><a id="Tc_6P6uRPHj4kONbcih5M5aKQ_3_6"></a><a id="Tc_UWxZaRq6A0iB8Lj2vVjy9Q_4_0"></a><a id="Tc_LU3HC_TKFUCLRni94NwFAA_5_0"></a><ix:continuation id="Tb_FcqkeGXwfEGiYyANVgJytA_cont3" continuedAt="Tb_FcqkeGXwfEGiYyANVgJytA_cont4"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Reconciliation of liabilities arising from financing activities</b></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" id="Tb_qbAkh0qoUkOq6hEK27Bkzg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-cash changes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Jan 1, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flows</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">maturity and FX</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_TenVHCDHtEWBdBEcmQJ5Ow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_4eqjIXPypEOFJkQ7Z3j2TQ_4_2">18,078</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_QS63WKzCGkeFVE5tbwp_Tw_4_4">401</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_3DV6lOw0Ck6YDwghfx2eYw_4_6">865</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_r2eNHxsPz0Wj_JUZWZqyFA_4_8">2,954</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_6QowRtO2bEKJIQeTYviHqA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_v23W3KY60kKLF3GcRks2oA_4_10">15,588</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_vQpey-VclkGOtoNQ0QvVjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_kOxFRdQngU6eev45ml9o7g_5_2">401</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_6nXywAwdyk2CprWek0Ldig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_XQiOYQUlekqGCGXTjhbVyw_5_4">401</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_alWkS9-7z0m53IksGJp1Wg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_MAHx5DwU9U-Am9iLOWBADA_6_2">17,677</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_5NYYA4fPLkOwhQf6kwQBhQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_qJ2ptkQhp0yqozY0gsE5sA_6_6">865</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_5NYYA4fPLkOwhQf6kwQBhQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_EbK6rsYsKEWdwrpFpwHCmA_6_8">2,954</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_Nt_CcI-0j0aio14DEtDbsA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_I4VkJB5zKUG82Ap4dF9dCw_6_10">15,588</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_w4OmoUQNEkmOiPw-yYz1gg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_DMu3fZPZdUijpwijBhanHA_7_2">6,020</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_1iKApBV_VUeolfj8yZHnbA_7_4">2,802</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_t0cjufIzb0W-QuZBo4poKw_7_6">1,438</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_F-iEy5uUEEGB5GwuijW5jw_7_8">2,567</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_wO1nyt_hYEmFefkfmJrSBA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_L6RTMYZ39UqBtr7ZSxhwAQ_7_10">7,223</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_OLnDAxQ4XESWJVC9_RdH_A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_2JoEci9nMUmvav9QmZxhdA_8_2">567</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_xGvnCbYIxkKMBxggavLiYw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_yAqUllaC7UG4sHpIoiCwIA_8_4">62</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_gGgYwThhA0yTgQ_UqSHevA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_66kQ9wJsEE-ZCctMw2SRBA_8_10">505</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_RgosDLxdDkaOOiIDh22DcA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_FeVhcC0Y2EWLdRgziSaN0Q_9_2">387</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_PsYZ_Pee1keOQx_1jfic9g" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_1xktjJObpEuEU0gh6zlQiA_9_8">387</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_F94moY9-wE6MiLBgNhWeLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_B3TXdMGtxUGWZAQPEtonfw_10_2">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_lnY-Exnu_Ei1u4vGqsRWWg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_Ucr7N3ZBsEOhDy8kYrtwTg_10_4">1,505</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_lnY-Exnu_Ei1u4vGqsRWWg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_44bLbsx7g0WcmqBU1aWP0Q_10_6">267</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_IY8Y75xLuUqO-v68GXjtQQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_83ed-IaC90ePfQrAtUnHQA_10_10">3,310</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_zxwIfxJDvUW4PlzvkDXuFg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_njMdyopzR0GzNJaJmmINSw_11_2">3,528</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_cRNrW39x40efl2w8qN3UeA_11_4">4,245</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_QM4I3hzjWU2BHqdp9vbmhw_11_6">1,171</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_PT49kS_2TkOdcjflN9QDSQ_11_8">2,954</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_tZJnFmxuvESALxdrRN7PBA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_tDgQc3KZmkagyHW0Wz1Cig_11_10">3,408</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_nhhmYMldF0CUWqhi36Qfrw_12_2">24,098</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_Q8mBgLyZRUufMp-biczt5A_12_4">3,203</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_2s0W5H4zUE23o4U5dDKpbw_12_6">2,303</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_ws8g8p225UO0lU0mxApvrw_12_8">387</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_ua1vFCt-7UGHonFxeMO3wQ_12_10">22,811</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-cash changes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flows</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">maturity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cArnp-3_30mf8DvP_LdFug" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_AJIviUGrFkaZbmMKR2r3RQ_4_2">19,647</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_ulKON3ArBESlzhu6QE921g_4_4">1,993</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_rf2UP7nTWE-CZevEAlpbxg_4_6">2,029</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_MZXS74HX802UNatMxkbHsw_4_8">1,605</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_TenVHCDHtEWBdBEcmQJ5Ow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_1TdWGs4Xg0K3ZHKQSBt9LQ_4_10">18,078</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_eqHyAFkkLECwnDL6Bn6VjQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_9xzA89FgLU-DeuxCYZxn7A_5_2">968</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_pxPW_PzRlkKEtKb4tqL2Uw" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_8eKTbnR3HEG17h1BEKQrDQ_5_8">567</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_vQpey-VclkGOtoNQ0QvVjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_Tdre_HO1ZE2miGUd3I4eUg_5_10">401</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Municipal loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_NANDNBjf2EaG0Ib3x2YeUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_sfXyrDGmjEyoB3Dj1DfN1w_6_2">610</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_abKhok6QA0qwwg9SxU0qaA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_739X0Aoq2USfgPjcfG2a7A_6_4">610</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_mWZOLj7bwU68ESmKMOpaew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_kfrx77ICeUi3BE-B_cTxAA_7_2">18,069</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_ilJH2SLZy0KHSnoFaQ2P4w_7_4">1,383</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_XvymHspzUUqC1owAytzzlQ_7_6">2,029</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_rQsW8U1s6E2hgefoJf4QRQ_7_8">1,038</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_alWkS9-7z0m53IksGJp1Wg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_Y3cXh99f8UK7yix38ngMxA_7_10">17,677</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_0I3YNkAwCUaxTut_BdZ8UA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_vqzUop8bLkaizFLi5gFLRQ_8_2">7,323</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_WXXGiAZiAEWlH0Czns801w_8_4">5,520</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_f6ULlssHEUmmjTOkDHnkng_8_6">2,663</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_e8_P7E1DiEqSEsHqLAJ7PQ_8_8">1,554</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_w4OmoUQNEkmOiPw-yYz1gg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_rFW16WQ4xUyrbct4uUb1WQ_8_10">6,020</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_DtG1lO2ItU27MlS9ffm2uw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_60pq9NcdWkmUWREn6M5rDA_9_2">802</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_hdYR85AR1kGfxJPtO-VLWA_9_4">865</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_fYsDKOhFNkybQGg1b38TDQ_9_6">63</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_-b5PjdfPDk-Pk7zCC45nxQ_9_8">567</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_OLnDAxQ4XESWJVC9_RdH_A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_lqAeVrhdd0GU9Mjeh920MA_9_10">567</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_jBSfbMY2lki0j7PbxL_v1A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_Ik_jVGhIqk2fHUGyuhDEdg_10_4">438</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_jBSfbMY2lki0j7PbxL_v1A" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_Lbx0mDWFaEqydoAUbitM9g_10_8">51</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_RgosDLxdDkaOOiIDh22DcA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_mj8KFaMAckSBR9f2jRuBng_10_10">387</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_s1T9fhanpEauW0zp7hr-Dg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_abNv3NrBaEGxrUMwk3Zi5w_11_2">2,636</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_x2UJf7_pxkOnSeiJ7yIVHQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_3XqMquP6RkKy9ROSzfPL8w_11_4">1,208</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_x2UJf7_pxkOnSeiJ7yIVHQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_HFiOdZ-Y4kyBlsipBiqfig_11_6">110</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_F94moY9-wE6MiLBgNhWeLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_0g0ElfNkVEeN-j-MC4yhTA_11_10">1,538</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Municipal loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_OrZxBSCrjECX-zhxs899wA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_jrcQF3W98kqNhgh8MZKzvg_12_2">250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_cNSOgL4hV0ag41MiwnIxFw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_lh3tzwT700e4kKuoDfAFoA_12_4">250</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_d-rj6ZvYbkKxosbQKnX2KQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_ogqp7WhmgEOM0Xmy6JBnWg_13_2">3,635</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_BHYx8uF8eE2LNChZCOm7uw_13_4">3,635</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_1JWtm7LJN0WprstxLyniFg_13_6">2,490</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_0i8E4ucgD0-2XnuMdGZfAA_13_8">1,038</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_zxwIfxJDvUW4PlzvkDXuFg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_9DRzWLPV2kKhUslw8RkUbg_13_10">3,528</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_JH4HT5voa0u8oHnbmcr-oA_14_2">26,970</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc_zJ926KDgOkOvAYPlZqSjMQ_14_4">7,513</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_0oecJmP9Q0C65pyFE0DM1Q_14_6">4,692</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" sign="-" scale="3" id="Tc__C4uXEVBPk6TH-s69zxaNA_14_8">51</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" id="Tc_5D3u_9f_g0KFJcOGmUjhtw_14_10">24,098</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Currency risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group is exposed to currency risk in cases where contracts are concluded in foreign currencies. The vast majority of goods delivered and services the Company provided, including those for international customers, are invoiced in euro.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The main functional currencies of group companies are the euro, USD, the Indian rupee and the Arab Emirates Dirham. The following table presents the net foreign currency exposure of the Group as of December&#160;31, 2021 and 2020.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfMarketRiskExplanatory" id="Tb_UB1q1bVu6UaMz10KGZlzOQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">INR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">AED</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_JO38uhlHsEqj0m4RCxwbMA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="3" id="Tc_PR-vy-OBLEq6RpL3QZTsAQ_3_2">2,604</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_qUqCYL8yF0CdfM0hT5d4hw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="3" id="Tc_HVVZ9wAmh0ewd5Im8bMr3g_3_4">8</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables and other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_GV4YMZdmTU6rHuLJZRyL-Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_o2MU-mHcF0OnnMbONy4B1Q_4_2">2,394</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_hqryZrQyo0u9vk198ZL9tw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_SQXq54jQAU-yWEuCSgjjBQ_4_4">4</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net exposure</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_-gQEIJhhKESSr-jRSWvRtA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="3" id="Tc_dSGfnPgM-EymHajaLn9rDg_5_2">210</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_u8KGLF7B5U-cOI8U7qgNTg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="3" id="Tc_k7okwAoBJkalzAC7KLgHdg_5_4">4</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AED</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_vHwIWQCj6UO2OcggKwqNGA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="3" id="Tc_266ZtC7CZ0us19U2UHV-2w_3_2">1,224</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_NqWV89gKk0OodA4cK3KhyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="3" id="Tc_TvLBtzBNB02oOsKUHvp7OQ_3_4">18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables and other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_PjLMlUODRk2FbEMI9yrkqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_QAL5F6kshkKrLWu930_zYw_4_2">3,631</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_cHFYMEOjEEeAbEoJwPK02w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_lX8qTMWsMEi-43zppyJrzg_4_4">55</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_hqCpXOTPc0ife4tCRqxAhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_mOyNcon8C0-_3dpcd7yNjw_4_6">17</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net exposure</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_zoJoP5b4TE-XfyAcw6W03g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_hL3Gb0rkQk2mFv6qOHHbcw_5_2">2,407</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_mqnnjQQULE6jGbqjlZnJgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_aPIXchJQrkaovZPPdDvxaQ_5_4">37</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_cloQKLoTo0WfQp8u9x2sCA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" sign="-" scale="3" id="Tc_wMH-_ZleYU2n3mUhmiZ6Gw_5_6">17</ix:nonFraction>)</b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sensitivity analysis relating to changes in exchange rates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Given the exposure to foreign currencies as presented above, the impact to the Group&#8217;s earnings before tax or equity from a 10% change in the US dollar exchange rate would not be material.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-47</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><ix:continuation id="Tb_FcqkeGXwfEGiYyANVgJytA_cont4"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_e85609ab_18e2_4d66_b7c4_cbd4a62ae163"></a><a id="Tc_3NHikBJIlE6IEJxD8nP3mw_1_4"></a><a id="Tc_wgsCLQ9bk0-FtGKdiTkFWA_2_2"></a><a id="Tc_YZcNYRDklE6NoGE5CBiFCA_3_2"></a><a id="Tc_JXUP-Z-g1U-uDx1yG282Ig_4_0"></a><a id="Tc_DiXit_g3XEuK6aXR9ZrlcQ_4_2"></a><a id="Tc_mygEID3z1EmEm0_Eg-4asQ_4_4"></a><a id="Tc_zNxA2v2BWkmQBilirT8OZA_4_6"></a><a id="Tc_ERTtgIQP7U6s_9EPDBPu8g_5_0"></a><a id="Tc_Bq_Rg3wmh0qJ7xIrxztfAg_5_2"></a><a id="Tc_zkQJlCkf6EOEhKxPgo3iSQ_6_0"></a><a id="Tc_SDKP_HKZAEWAJf8sFGHw9Q_6_2"></a><a id="Tc_54DVGmLA_UK8KZX4NDVhkA_7_0"></a><a id="Tc_R1ExpvR880W28VefTmP9mA_7_2"></a><a id="Tc_gtdSac2PqkuRJrXovGRUUg_8_0"></a><a id="Tc_tmcqvr_Z5USto1lYI5JWyg_8_2"></a><a id="Tc_AgQNpeBhO0SMxiAGRo1uDw_9_0"></a><a id="Tc_aHzXqOWPnUOBC0pr27ThBQ_9_2"></a><a id="Tc_QKAuDtxidUO1DXWIBJxRhw_10_0"></a><a id="Tc_cD6h2JAJlUqrWqHK2vgSYg_10_2"></a><a id="Tc_KH2pS0A5dkKm_UELuQxK1A_11_0"></a><a id="Tc_snA5DdMHGkWwl2Ftf-X12Q_11_2"></a><a id="Tc_sg82XYdCIUCQgXKMdWwhhA_12_0"></a><a id="Tc_JFV6436NKUeCrisTadlgsg_12_2"></a><a id="Tc_eg3E0UwsKUixalAMMW3YoQ_13_0"></a><a id="Tc_oo7JA7M-hE22mWl8_kT_CQ_13_2"></a><a id="Tc_9YORSJaCdUePQYJ11bUxRg_13_4"></a><a id="Tc_ubAdtAHK3kexYwC6oJHvtA_13_6"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" id="Tb_BiJuVZ4RGUaRIt50TDldTQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">22 List of subsidiaries</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The major subsidiaries of the Group are listed below.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory" id="Tb_lxcl3rnzGUOO9pON5c8Qdw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity&#160;interests&#160;(%)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Country&#160;in&#160;which</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">primary&#160;activities&#160;are</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">pursued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene GmbH*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_gdQ7ArXwUU29FpifO1d2Tg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_G8nEM-VVPU2hafKaph0I7Q_5_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_nM4VKfdToUCleIioxMHAVA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_HWTpwnGTK0SC6clbUadoEQ_5_6">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene FZ-LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Arab Emirates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_6ilmlbgLQUaozewCaC7r6g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_ZuDB41W95UmG0qIx-dcIIQ_6_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_aJjp5Hfn9ECKKXqBeqaLXQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_UY5q5qJHYUSK6Opz08AiTA_6_6">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene US, LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USA</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_fxCJFiGsDU2tRIrSA3JTfw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_AN0WMpBl3kmdkbawKi8LSA_7_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_UnWKT0VVDEW_wX3NeqiDeA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_EiehPPcljEaUl9VtZIGXIQ_7_6">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene&#160;GmbH</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Austria</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc__RVynQHV-0GFfD7Wxt8mow_8_4">90</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_iMJS3h6DEkmyZ2QlkZkBcA_8_6">90</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene India Pvt.&#160;Ltd**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">India</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_1RkheOIhVU2eH6psyo77cw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_9VqieLtNfUupz5kLjzqblQ_9_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_tcRN6jVWa0CvEfR4vmQr5g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_4Sw5d8VocE2wr2mGpa89zA_9_6">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene Switzerland AG</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Switzerland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_SSqn3JwlZEKIYquVSRVj4A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_vkMr0jwQj0maLPHrsfw2ZQ_10_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_99jSw-B3lEmA9RjJZquI8g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_AOhqy_UXp0meQKqRuTQffw_10_6">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centosafe B.V.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Netherlands</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_WqUWe927Nk6uSgbaCxFjkA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_YCeC3eNu-EeTx4uHpuEpqw_11_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_9ANqzl7ZTUajud4xjfwt1Q" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_-udDoKVDV0ion86V43IGQw_11_6">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene d.o.o Belgrade</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Serbia</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_jno_GFKBDk6OafQHIJLx7w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_oLyqhUkN60mC3FK4S8288Q_12_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_LsRE2steYEuxjfr5k30J1Q" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="Tc_mHftXLOAhkW2pwOUh2cynQ_12_6">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Bauer Laboratoriums GmbH***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">(*)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Centogene IP GmbH and Centogene Shared Service GmbH were merged with Centogene GmbH on January 1, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">(**)</span></span>The Group acquired the remaining <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_MbQzBIokME2nAKgB5upFAA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" id="Narr_WneCGMFxw0WaYUvBA0Voqg">49</ix:nonFraction>% of Centogene India Pvt. Ltd. in 2020, previously accounted for as non-controlling interest.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(***)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Centogene does not own any shares in Dr. Bauer Laboratoriums GmbH. However, Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns (see note 4). </span></p></td></tr></table></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e9f7980c_022e_434d_9119_1d859fa9e75b"></a><a id="Tc_BHQkYzK6pEygj3iXC-hcMA_1_0"></a><a id="Tc_mqbOzO28b0mCvi7DbXKRVg_1_2"></a><a id="Tc_Qpd9sp_umUKxb8ndUvZfDg_1_4"></a><a id="Tc_5GnxpMOUp0iwo1VmZRkLPw_2_0"></a><a id="Tc_rRpJ3nX7c0WqiiQYxU1B_Q_3_0"></a><a id="Tc_FECcpKtUykuPf-OeEL2aAg_4_0"></a><a id="Tc_fPYEnoffREmBrTbDMt5p-w_4_4"></a><a id="Tc_j6sGnv123U-pZXb2WYKdCg_5_0"></a><a id="Tc_D8r3oGqeuUG6dD8_i069eg_5_2"></a><a id="Tc_Fgu1CpGsvkGyUQIIXhNbqA_6_0"></a><a id="Tc_fkEzqLiH60uPaZfVGy6kTA_7_0"></a><a id="_f62bdcbd_f193_4f37_9398_03cb9479ba26"></a><a id="Tc_hYKJjQc8MUeQsqwt-2qKIg_1_0"></a><a id="Tc_38hrVcolT02P_nQeKj4u4g_1_2"></a><a id="Tc_MBGRKb8cMkyTYmHdcarP1g_1_4"></a><a id="Tc_PF0bQ79yCkqDy2YlIgEb9A_2_0"></a><a id="Tc_LTk8JQfp3kuO5jxl1sAmTw_3_0"></a><a id="Tc_SP9ibXyw_EORrHR15aPmuQ_4_0"></a><a id="Tc_9VDC9E1NOUiIOsoiifGosw_4_4"></a><a id="Tc_VesfJoqh3EGC7Hh-O-IAQg_5_0"></a><a id="Tc_1P2WbEE_yU-QE0Qm6DsdEQ_5_2"></a><a id="Tc_bru1fYsHG0ilpMbDLLyjxg_6_0"></a><a id="Tc_vSgXm2T86EO429SguLxQDg_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory" id="Tb_bdJ2MveWp0Wb3cklyIDN2w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">23 Non-controlling interests </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below shows information on each subsidiary of the Group with material, non-controlling interests before intercompany eliminations. The Group acquired the remaining <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_MbQzBIokME2nAKgB5upFAA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" id="Narr_lopWH0tNrEiIAFDieA5kZg">49</ix:nonFraction>% of Centogene India Pvt. Ltd in 2020 and disposed of its entire <ix:nonFraction unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg" decimals="2" format="ixt:numdotdecimal" name="cntg:ProportionOfOwnershipInterestInNonControllingInterestDisposal" scale="-2" id="Narr_ROI6v__qmUuEgbgVjmoA2Q">51</ix:nonFraction>% interest in LPC GmbH in 2020. The non-controlling interest in Dr. Bauer Laboratoriums GmbH relates to the share in the net result of Dr. Bauer Laboratoriums GmbH that is included in the results of the Company&#8217;s COVID-19 testing business (see note 4).</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfCompositionOfGroupExplanatory" id="Tb_EMcANNxHcE-Oy7QPsW-zXQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Centogene GmbH, Vienna</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dr. Bauer Laboratoriums GmbH</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net assets/(liabilities)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_goSBvtoOwUimSgVTIL8xDA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetAssetsLiabilities" sign="-" scale="3" id="Tc_v9iAxHXr50uMI9eXNxSO4A_3_2">528</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_LIP-LQLQ8UqI_DwDXlei1Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetAssetsLiabilities" scale="3" id="Tc_PTcVR-BDKUCy-TmXTib-4w_3_4">245</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Carrying amount of non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_goSBvtoOwUimSgVTIL8xDA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncontrollingInterests" scale="3" id="Tc__REgU0rrLES4hIhNUeNRHw_4_2">53</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Revenue" scale="3" id="Tc_tiVI4Ca3A0ujGu8nxtirVA_5_4">109,015</ix:nonFraction> </p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profit/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_3w8hQiQkGkSWlrHdh0P2EA_6_2">6</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" scale="3" id="Tc_UHyP2bUQJUO0AX5z7dBTNg_6_4">98</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profit/loss allocated to non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" sign="-" scale="3" id="Tc_TR6Ioej2TUWC9ZtqhJcBzw_7_2">1</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="3" id="Tc_tT5GddUzHkKBkOpkSyHEkQ_7_4">98</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Centogene GmbH, Vienna</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dr. Bauer Laboratoriums GmbH</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net assets/(liabilities)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_N4HdUneZ4E-AHlGZSokgjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetAssetsLiabilities" sign="-" scale="3" id="Tc_hFxjeS8FzEOVORCzwQQ6bQ_3_2">522</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_loohpHzHaEaNrs2gcMBUCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NetAssetsLiabilities" scale="3" id="Tc_PxjjbsvS4USz6ZtfdZ2jNQ_3_4">148</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Carrying amount of non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_N4HdUneZ4E-AHlGZSokgjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncontrollingInterests" scale="3" id="Tc_8RBEJLjKL0W6chS1tQ0q6g_4_2">52</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Revenue" scale="3" id="Tc_no40aXQfcUiTh-rgQr2e1A_5_4">55,596</ix:nonFraction> </p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Profit/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_2H98c9So_U6BEUu5UUb7Gw_6_2">1</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" scale="3" id="Tc_G2fx8-BQxEm2ef7tCGdR8g_6_4">122</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Profit/loss allocated to non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="3" id="Tc_Rg36bPI0ekmxWwrd6VzhRg_7_2">0</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="3" id="Tc_V8Sb_z2vFE2XYXvuJYojnw_7_4">122</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-48</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfCommitmentsExplanatory" id="Tb_vjlAyeyEM0ebQpm6_1TKGg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">24 Commitments<span style="font-style:italic;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Future payments for non-cancellable leases</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Group has various lease contracts in relation to the expansion of the Rostock headquarters and leasing of the Frankfurt laboratory, Berlin Airport, D&#252;sseldorf Airport, Frankfurt Airport and additional laboratory space in Hamburg. The future lease payments and utilities for these non-cancellable lease contracts are EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_aP3WLzf6M0CLLqABTJdjzQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_RwctMCgMfUqZgnHA0rn5eg">107</ix:nonFraction></span><span style="font-weight:normal;">k within one year, EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_TgPeSvqouUGI0WVPV6Fpag" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_-UCv7e8yekKwM8vGMNMzqA">2,370</ix:nonFraction></span><span style="font-weight:normal;">k within five years and EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_5Ec6abUhxEqrvssO3I3V1A" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_FzFLTHZmrE-JUgHbkZABvw">4,219</ix:nonFraction></span><span style="font-weight:normal;">k thereafter (2020: EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_sqSmjjzLIUyAz8bHBnf8gw" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_DLOvALFr0kqMITYoKAYNrg">283</ix:nonFraction></span><span style="font-weight:normal;">k within one year, EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_pxx5jMplQ023eMujrnK7Mg" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_1BNUDDirG0udlLoX8M473w">1,686</ix:nonFraction></span><span style="font-weight:normal;">k within five years and EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_HQ7jbEAacECvHaRSqE6IBg" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_lG3u2aJ-ZEmF60wLRqXyYA">4,855</ix:nonFraction></span><span style="font-weight:normal;">k thereafter).</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Group has various non-cancellable lease contracts of office equipment and storage spaces which had a lease term of less than 12 months or were related to leases of low-value assets, and therefore the short-term lease recognition exemption was applied to these contracts. The future lease payments for these non-cancellable lease contracts are EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_h_nPcgoxBEe8fAs9VKUdBw" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_NQIztkmHHEOoGB6SECyqiw">44</ix:nonFraction></span><span style="font-weight:normal;">k within one year (2020: EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ryAYBZr5MkGcAGRJi9dXVQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_VWt7AeeDFUenC6PhIo32hA">33</ix:nonFraction></span><span style="font-weight:normal;">k) and EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_Lv3jrzK6k02RPZdSdWq4Rw" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_CvUkCaEkYECd30gNV47i4w">49</ix:nonFraction></span><span style="font-weight:normal;">k within five years (2020: EUR </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_K_VUIvDBuUOw0I-5hs6miw" decimals="-3" format="ixt:numdotdecimal" name="cntg:UndiscountedLeasePaymentsToBeMade" scale="3" id="Narr_75wX3Cd-XkGtxs6HIBWmFw">9</ix:nonFraction></span><span style="font-weight:normal;">k). </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Future payment obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During 2021, the Group concluded agreements with suppliers, for goods and services to be provided in 2022 with a total payment obligation of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="cntg:FuturePaymentObligationToSuppliersForGoodsAndServices" scale="3" id="Narr_739Kzt-dNESkM4dq5WqElg">6,620</ix:nonFraction>k (2020: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="cntg:FuturePaymentObligationToSuppliersForGoodsAndServices" scale="3" id="Narr_1S1nUlJdWk2KrAU_Mg4JWg">4,669</ix:nonFraction>k).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_Hlk99389408_0"></a><a id="_290d2d6d_5173_433d_8a08_0fd94176a51a"></a><a id="_b9dffdd0_29f2_48b9_9c20_47b4f51db399"></a><a id="_027f47be_608c_4e97_8d7f_db0bddfddfd3"></a><a id="_4442a263_3ecb_48ee_9842_08bdc44d2ede"></a><a id="_7e3bc9be_7030_4da0_812e_23164ba1462d"></a><a id="_1b4c3fc8_5ad9_4fb6_9c04_aea83f56a3a4"></a><a id="_6fda5775_d190_4e8a_929c_61f621c4819c"></a><a id="_058d7b6b_893e_4ba1_8ee0_ad98d5ace283"></a><a id="_50d5b467_e12f_440c_8f07_42e09439b46c"></a><a id="Tc_HetMeCd9M0S879bnM-l1zA_1_0"></a><a id="Tc_FC0nf4y0skakAIPBJmxHdw_1_2"></a><a id="Tc_9g5yCTC-aEGBawFgQRzcHw_1_4"></a><a id="Tc_izhCAT8-kUmUSbM-pUDw0Q_1_6"></a><a id="_3252a299_3042_4d7f_87a3_096c0a694e5b"></a><a id="Tc_TG3Scd6-RUqxgaFfxhoBkw_2_0"></a><a id="_1f48f218_37f8_48cb_9b72_b92dbe5cd255"></a><a id="Tc_5PtDMIwfskGCs9cXUxviFw_3_0"></a><a id="_96121110_cfb0_43b2_876b_a8df1fbd22d7"></a><a id="Tc_LS_45mQ_JEGYVH04IXI6vw_4_0"></a><a id="Tc_9hQh-F0n00imdP04c6tRaw_4_6"></a><a id="_ef6b7350_3248_4b49_9365_fb272f6dc4e0"></a><a id="Tc_OORwcpeeFEe8LKoAB4cqjQ_5_0"></a><a id="_6fb4575e_fd28_4d01_b01c_25228efb45f6"></a><a id="Tc_8Dx77C-Cak60wtsdHZ1JwQ_6_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="Tb_ILeAe7x0x0eYefBdnXErew" continuedAt="Tb_ILeAe7x0x0eYefBdnXErew_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">25 Related parties </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Transaction with shareholders </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July&#160;2020, we completed a follow-on public offering of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_GTBMEUx2bE2fzTJ4qOUR-Q" decimals="0" format="ixt:numdotdecimal" name="cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" scale="0" id="Narr_E3b57ggAI0uxi9OopMF-xw">3,500,000</ix:nonFraction> common shares of the Company (the &#8220;Follow-on Equity Offering&#8221;), consisting of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_8do-YyNisUSwYP5bueDYNA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" id="Narr_bSpsNumra0GN4elpA7-elA">2,000,000</ix:nonFraction> common shares offered by the Company and <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw" decimals="0" format="ixt:numdotdecimal" name="cntg:NumberOfCommonSharesOfferedByPriorShareholders" scale="0" id="Narr_bMoqabtO3UmacNgCA2g5Nw">1,500,000</ix:nonFraction> common shares offered by selling shareholders at a price to the public of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw" decimals="2" format="ixt:numdotdecimal" name="cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues" scale="0" id="Narr_s2hMoGUk_USN72EFMqnmDQ">14.00</ix:nonFraction> per common share (i.e., EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw" decimals="2" format="ixt:numdotdecimal" name="cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues" scale="0" id="Narr_YdeR0vJvC0-7G98IJMXAQw">12.71</ix:nonFraction> per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, to the Company were EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_hfwJZjPdJkaOC_0kWqYy3Q">22</ix:nonFraction> million. We are not aware of any ordinary shares which were issued by the Company and sold in this transaction to related parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on a shareholder agreement from January 2016 the payment to the option holders of the VSOP 2016 will be reimbursed by the original shareholders to the Company at the same time when the obligation to pay the options holders arises. The payables by the Group to the holders of vested options were recorded as a liability with a carrying value of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011" scale="3" id="Narr_kgRGLkYQlkeIrrZMDDLOOA">2,769</ix:nonFraction>k as of December 31, 2019 and a corresponding receivable against shareholders was recorded (see note 15). The shareholders agreement had a term until December 31, 2023. Upon completion of the July 2020 Offering, the relevant payables to the holders of vested options were settled mainly by the proceeds received from such original shareholders from the sale of their shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During 2020, the Company entered into a service contract with the former CEO, a major shareholder, to serve as an advisor during the transition period after his departure from the Company until December 31, 2020. For the year ended December 31, 2020, fees totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_aVpyI5X7v02azktZKILDIQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_yLLVkt4tu0CNsxgneohp7A">11</ix:nonFraction>k were charged to profit or loss related to these services and the Group had payables of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_ad_D9-9ZjU6KAfCtl8pHWQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="3" id="Narr_SaOWnS-0-0qWf7k31OENDQ">12</ix:nonFraction>k outstanding as of December 31, 2020. In 2021, no further service agreement have been entered into. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Remuneration of management in key positions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Key management have been defined as the members of the management board and the Company&#8217;s other key executive officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" id="Tb_TzGt5k02KU24muzvFzlSKg" escape="true"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:75.22%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short&#8209;term employee benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_PASyBMbq_kOKFJb4KDKuvA_2_2">4,098</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_t7-I26YIbEmNBhzN-uePsA_2_4">4,273</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_bDvczoc11k-2eDF-Udn0RQ_2_6">3,313</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Post&#8209;employment pension and medical benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_q6mnXcDSO0aPvVeKi3lnNw_3_2">23</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_Yo99T2TvvEufczfK9aMdJA_3_4">23</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_3GccoFHI60i9i8bzC7ihDw_3_6">10</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Termination benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits" scale="3" id="Tc_tDMFeMAbGUSSrb-eh3olMQ_4_2">235</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits" scale="3" id="Tc_qoaVyxoLvkWI0Z88L8dHVQ_4_4">565</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_TR5tXJJHR0GAnbITgZZaFA_5_2">822</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_jAg1gti6FkSAEridGE5AYA_5_4">1,822</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_h7RMIc2i90GI5UWKLeBnDg_5_6">3,395</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation to key management</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_OCzoIwdcBEKRtdFJFcJmkg_6_2">5,178</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_w-6GO53SxUCFTK0vm_vOUQ_6_4">6,683</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_rWe-d70qOU-DMi2yGf9Prw_6_6">6,718</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-49</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_841e5f31_0293_4a8a_a045_b6c62c26fc9a"></a><a id="_f7be2ef4_ad88_4450_8dbe_63a32e663c45"></a><a id="_1022219c_4225_465c_9627_2cdbf4d658ba"></a><ix:continuation id="Tb_ILeAe7x0x0eYefBdnXErew_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Due to the departure of the former CEO Arndt Rolfs in 2020, share-based payments include additional share-based expenses of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_AWKL1ObmqUyfc9ddDXBLhg" decimals="-3" format="ixt:numdotdecimal" name="cntg:IfrsShareBasedPaymentArrangementAcceleratedCost" scale="3" id="Narr_QhVEBNK-z0Gto2VvnHrg9w">776</ix:nonFraction>k for the accelerated vesting of outstanding equity awards and termination benefits include the severance payout of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_AWKL1ObmqUyfc9ddDXBLhg" decimals="-3" format="ixt:numdotdecimal" name="cntg:KeyManagementPersonnelCompensationSeverancePayout" scale="3" id="Narr_LxokMPAk6k2yL1d6fAR3ZQ">565</ix:nonFraction>k. As of December 31, 2020, the Group had amounts of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_T02QWHkiiU6Rq5vnTMYTIA" decimals="-3" format="ixt:numdotdecimal" name="cntg:KeyManagementPersonnelCompensationAccruedAmount" scale="3" id="Narr_LGQ0Io8d7UWYcOttEe5Hzg">1,325</ix:nonFraction>k (2019: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_cIYko65EgkiZ7oKBWF8NyQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:KeyManagementPersonnelCompensationAccruedAmount" scale="3" id="Narr_3cUWnnB9UEaWdSZQsG1gig">769</ix:nonFraction>k) accrued for key management compensation. (See &#8220;Note 27 &#8211; Subsequent Developments&#8221; of our consolidated financial statements as of and for the year ended December 31, 2021.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">There are <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_HpZLjBEdXU2I8BB2YamhLg" decimals="-3" format="ixt-sec:numwordsen" name="cntg:PensionCommitments" scale="3" id="Narr_MnkCMN1KFkSzy2BNR6ZJlQ">no</ix:nonFraction> pension commitments for members of the management board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During 2021, <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_ui7vsg5w4EG0lJsC-MuuLA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_jKHUAGS16k6SrFfcXj077Q">15,000</ix:nonFraction> share options and <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VP9HWW5A2E-7VpFzEFjsVA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_-ZPgOU3NwkSHRu3DYC37og">142,764</ix:nonFraction> RSUs were granted under the 2019 Plan to key management personnel which are recognized as share-based payment expenses in profit and loss (see notes 20(vi)).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Group has receivables of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_UJLB8dmYAkWtWhi5WI1mgA" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:AmountsReceivableRelatedPartyTransactions" scale="3" id="Narr_3pk6uwz0gUe4TTdLiVvRvw">Nil</ix:nonFraction> (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_T02QWHkiiU6Rq5vnTMYTIA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AmountsReceivableRelatedPartyTransactions" scale="3" id="Narr_XR_5j4sszkKVgohoqPhLnw">561</ix:nonFraction>k) recognized related to the exercise of options by key management personnel, including the former CEO Arndt Rolfs in 2000 who was a member of key management during the periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Remuneration of members of the Supervisory Board</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The supervisory board received remuneration for its activities of EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_-kfNLSIGS0CnDBcj9PVDWQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_pnWpMsBUkUqxs5V-B7VoBg">688</ix:nonFraction>k in the reporting year (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_OO2fJYJiZ0i04iwTzazmNQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_trdBhrzcTUueXnB-lduZGw">603</ix:nonFraction>k; 2019: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_cu0LEFW0kkCkn6XxXp6-EA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_upyS1Lvwe0Kgbe9SlLiSnw">499</ix:nonFraction><span style="white-space:pre-wrap;">k).  In addition, as disclosed in note 20, certain members of the supervisory board received share-based awards under the 2019 Plan. For the year ended December 31, 2021, share-based payment expenses of EUR&#160;</span><ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_uWLOxsW1eEmoFw2X5N9jYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Narr_CcbVNbo83EO3EpdW4BGz_Q">2,564</ix:nonFraction>k (2020: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_FDERhT7zokOtLHTy2PLLsA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Narr_JEVQ6ELaTkSpdEEFUWvZ8w">2172</ix:nonFraction>k, 2019: EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_gFxC2tLdrUODGcKQ8Sm_rg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="3" id="Narr_Kdf0KMf7k0KvgpOr2Cp6bw">704</ix:nonFraction>k) related to these awards were charged to profit and loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Transactions with members of management in key positions and other related parties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company purchased supplies used for COVID-19 testing from an entity related to a member of the supervisory board that joined the board in 2021. Expenses totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingSuppliesPurchasesMember_PMe3DYqonU-W4y4ejGN9NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_LQ1JGeWKGkeWMhUml2YwXA">5</ix:nonFraction> thousand were charged to profit and loss related to the period of service of the board member. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2021, revenues totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingServicesMember_ybA9VqNfoU6JvMqlmNzzdg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromRenderingOfServicesRelatedPartyTransactions" scale="3" id="Narr_jHPd97YNA0GBf6YnGoLd8g">14</ix:nonFraction> thousand were recognized in profit and loss in relation performance of COVID-19 testing services for entities related to members of the supervisory board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For the year ended December 31, 2021, fees totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_BvghgdBxEEK2gQ296xhPFA" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_w0qiCrZhrESL4aoN7aUqYQ">nil</ix:nonFraction> (2020: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_UKYRDn2W90unJoMzUYsVTQ" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_KN-rBH9g5kmABipvW0R0lQ">nil</ix:nonFraction>; 2019: EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_hqH7Ao9bKk-C9CGDc25eug" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ServicesReceivedRelatedPartyTransactions" scale="3" id="Narr_XrgE1jM06kC6TESMnrlDBg">152</ix:nonFraction>k) were charged to profit or loss in relation to consulting services provided by a member of the supervisory board. </p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfContingentLiabilitiesExplanatory" id="Tb_5g3mR-oXF0ieCs5Nz-dkKg" continuedAt="Tb_5g3mR-oXF0ieCs5Nz-dkKg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">26 Contingent liabilities </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In May 2016, the Company was informed in writing by the Universitair Medisch Centrum Utrecht (&quot;UMCU&quot;) that a claim had been initiated against UMCU regarding a prenatal diagnostic test that the Company conducted at their request which failed to identify a specific mutation present in a patient. On October 1, 2018, the UMCU and Neon Underwriting Limited formally filed a legal claim in the local court in Rostock, Germany against the Company alleging that the Company&#8217;s negligence in performing the test resulted in the misdiagnosis of the patient. UMCU is seeking recovery for compensatory damages as a result of the alleged misdiagnosis. By court order of November 8, 2018, the Regional Court of Rostock set the amount in dispute at EUR&#160;<ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_11_8_2018_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_0CIYtds9E0mzIEud1TfR8g" decimals="-3" format="ixt:numdotdecimal" name="cntg:DamagesSought" scale="3" id="Narr_IgQu2xrI9kGtCgB8CbRNQw">880</ix:nonFraction>k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On November 12, 2018, the Company submitted a notice to the Regional Court of Rostock of the intention to defend against the claim. On January 3, 2019, the Company filed a motion to dismiss in which the Company denied the merits of the claim. UMCU and Neon Underwriting Limited responded to this motion on March 15, 2019 with a statement of reply, and the parties made several court filings setting out their arguments since. By order dated June 3, 2019, the Regional Court of Rostock provided a first set of questions to be answered by an expert witness. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2020, the amount in dispute was EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_zf-wHnQpt06jb4tX_HSi1Q" decimals="-5" format="ixt:numdotdecimal" name="cntg:DamagesSought" scale="6" id="Narr_F-pRJTDvhUmIQF6GJBdcsg">1.3</ix:nonFraction> million. The matter was assigned to a new judge, due to the illness of the prior judge, and the decision to appoint the recommended expert witness is still pending. Since then, several potential experts were approached by the court but eventually declined to prepare an expert witness report due to the possibility of bias. </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-50</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_5g3mR-oXF0ieCs5Nz-dkKg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company intends to continue to rigorously defend its position and considers that it is not probable the legal claim towards the Company will be successful and as a result has not recognized a provision for this claim as of December 31, 2021. In addition, in case a settlement would be required, the Company believes that the corresponding liability will be fully covered by the respective existing insurance policies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On August 7, 2021, our partnering laboratory physician and a key executive officer of ours, Prof. Dr. Peter Bauer was informed in writing by the Public Prosecutor&#39;s Office in Fulda that a criminal investigation had been initiated against him regarding allegedly falsely billing statements submitted to the Association of Statutory Health Insurance Physicians in Hessen (Kassen&#228;rztliche Vereinigung Hessen). The aggregate amount in question was EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_8_7_2021_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_kqeqzG7A9E-5ZgMWESZGzA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" scale="0" id="Narr_DrNaBcerSEWcWX1rbnwHhw">42,268.50</ix:nonFraction>. The investigation and claims were subsequently dropped in January 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Certain of our original shareholders agreed to reimburse us for the payments that we make to option holders under the 2016 Plan. Upon completion of the Follow-on Equity Offering, the relevant payables to the holders of vested options were settled mainly by the proceeds received from such original shareholders from the sale of their shares in the Follow-on Equity Offering. We have received a demand from one such original shareholder that alleges that it should have paid less to us in connection with the settlement of such payables. While we continue to believe that such demand has little chance of being successfully enforced through legal proceedings, we see the benefit of settling this pending issue. We have therefore agreed to a settlement agreement with the relevant shareholders pursuant to which we will make a one-time-payment in the total amount of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_StockOptionPlan2016Member_GI6mBJf-uEaspTZUbL_7cg" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" scale="0" id="Narr_jAwQWBXpvUKUY6dSmJZPxQ">550,000</ix:nonFraction> to be divided up between such shareholders. On November 22, 2021, we signed a settlement agreement with the relevant shareholders. </p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q" name="ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" id="Tb_ej5azOKb_UWRaq8VKnGDmg" continuedAt="Tb_ej5azOKb_UWRaq8VKnGDmg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">27 Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 31, 2022, pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors, the Group received EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_j0PDncpUlEae0gbZhafoqQ">15.0</ix:nonFraction> million in exchange for the issuance of an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg" decimals="INF" format="ixt:numdotdecimal" name="cntg:IfrsStockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_aRhRL31qK0GesOzHiEACsQ">4,479,088</ix:nonFraction> common shares at a price per share of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsSharePrice" scale="0" id="Narr_h6WGsLpXJ0-LsyKqcdn7Sg">3.73</ix:nonFraction> (EUR <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsSharePrice" scale="0" id="Narr_nvGGHpbgz0mwQJQjcRvBaw">3.35</ix:nonFraction>) and warrants initially exercisable for the purchase of up to an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="INF" format="ixt:numdotdecimal" name="cntg:IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="Narr_e1IXOCGGp0ic-mNPRjXvpQ">1,343,727</ix:nonFraction> additional common shares at an initial exercise price per common share of USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA" contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw" decimals="2" format="ixt:numdotdecimal" name="cntg:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" scale="0" id="Narr_8sH7FwG3a06h2j8tuXvsAg">7.72</ix:nonFraction>. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026. Based on the fair value per share at the issuance date, the Group expects to recognize USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ" decimals="-5" format="ixt:numdotdecimal" name="cntg:ValueOfOtherEquityInstrumentsGranted" scale="6" id="Narr_UIUadL-fLkSFLVnlMPSgBg"><ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ" decimals="-5" format="ixt:numdotdecimal" name="cntg:ValueOfOtherEquityInstrumentsGranted" scale="6" id="Narr_L2U7mXVoSkyrvHOgagDcAA">3.2</ix:nonFraction></ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ" decimals="-5" format="ixt:numdotdecimal" name="cntg:ValueOfOtherEquityInstrumentsGranted" scale="6" id="Narr_mfGNMdWL1E6fxWRpcgQjkg">2.8</ix:nonFraction> million) under equity in the first quarter of the financial&#160;year 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition on January 31, 2022, the Company and certain of its subsidiaries entered into the Loan Facility, providing for debt financing agreement in the total amount of up to USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="6" id="Narr_BrnQ6w1yZkifNfMVgjUwTg">45.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:NotionalAmount" scale="6" id="Narr_GPVPqlybA06fzIvF7DCMqg">40.2</ix:nonFraction> million). Under the terms the Loan Facility, the Group drew down USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="6" id="Narr_-jX5-4e5PUK7RzZV7gi8pw">25.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="6" id="Narr__rE_aoSvq0GxXdsVtdoVdw">22.3</ix:nonFraction> million) on January 31, 2022 and will have access to a second tranche of USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue" scale="6" id="Narr_bSjTM6DdQU-k8ITbjL2BDg">20.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue" scale="6" id="Narr_WoIxTMj36UKZmZ46upRYUw">17.9</ix:nonFraction> million) upon achievement, prior to July 31, 2023, of product revenue from our diagnostics and pharmaceutical services segments of at least USD <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsRevenueAchievementThreshold" scale="6" id="Narr_NwD8VWRJ6UG_9hP2yIrrLQ">50.0</ix:nonFraction> million (EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_SvSryWkeDES4Mz3BiNpI4g" decimals="-5" format="ixt:numdotdecimal" name="cntg:BorrowingsRevenueAchievementThreshold" scale="6" id="Narr_OY98Irvs9UOmlM9ACY_kJw">44.7</ix:nonFraction> million) calculated on a trailing twelve month basis as of the last day of any fiscal month. As security for the Borrowers&#8217;s obligations under the Loan Facility, the Borrowers granted the lenders thereunder a first priority security interest on all of each Borrowers&#8217; assets. Refer to note 2.2 Going concern for further details of the Loan Facility.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On February 1, 2022, the Group announced the resignation of Dr. Andrin Oswald as CEO, effective immediately, due to his prolonged medical leave. According to his separation agreement, all unvested RSUs held by Mr. Oswald under the Company&#8217;s LTIP will continue to vest in accordance with their terms through the date of his termination on April 30, 2022, however; the number of RSUs shall not exceed <ix:nonFraction unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA" contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_yqUJXsPgDUScDg3m6hyHWw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_SAeuWp0xa0acQU_psQaNTQ">62,284</ix:nonFraction> RSUs. As a result, unvested RSUs granted to Mr. Oswald shall be forfeited as of January 31, 2022 when Mr. Oswald stopped rendering services for the Group. Total RSUs in the amount of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusDerecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_vmSzJlkTlU2f0ogmnllTIQ" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfOtherEquityInstrumentsGranted" scale="3" id="Narr_8hmA3-5L4EqExDdvI1pVEg">1,358</ix:nonFraction>k that was recognized in the financial statements in the previous periods will be derecognized in 2022 financial year and additional RSUs in the amount of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ" contextRef="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusRecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_Gr0aLoEJnkKrHhlW3a8QGg" decimals="-3" format="ixt:numdotdecimal" name="cntg:ValueOfOtherEquityInstrumentsGranted" scale="3" id="Narr_vpEC0L9XN0KXo9rGE3GcgQ">201</ix:nonFraction>k will be recognized in 2022 financial statements to match <ix:nonFraction unitRef="Unit_Standard_item_-qWnVJTSfkeBJ1EtMUURPA" contextRef="Duration_1_1_2022_To_1_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_9zMVFYEdmk-gHU2SpZ4EMQ" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_D4Ba5x7RHUqYgG2e4Sf-Nw">62,284</ix:nonFraction> RSUs granted to Mr. Oswald.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On February 1, 2022, Kim Stratton was appointed as the new CEO (the &#8220;New CEO&#8221;). The New CEO and the Company entered into an award agreement pursuant to which the New CEO will receive certain RSUs, which have <ix:nonFraction unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q" contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_CV9SX4hApkWmqEt_60wM4g" decimals="INF" format="ixt-sec:numwordsen" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_a1XsZWYI5kyzlDByLjZ1gQ">no</ix:nonFraction> exercise price. According to the agreement, the RSUs are awarded in two forms as&#160;&#160;<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg" contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_pLa-1tNWhkaifjyG5-55CA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_oRex0nq_FEmBfBA9A8C_Mg">174,394</ix:nonFraction>&#160;&#160;&#160;initial performance RSUs subject to time-vesting and performance vesting and <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg" contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_EZ4EQKl6u0y4U2G9Chnqbw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Narr_ib51hwuN_EilaWo0ZpYgpg">166,667</ix:nonFraction> initial time-vested RSUs subject to only time-vesting. Both awards vest in <ix:nonFraction unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ" contextRef="As_Of_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_E6OgGNIl3kmP-TkRKZ6LGg" decimals="INF" format="ixt-sec:numwordsen" name="cntg:NumberOfInstallments" scale="0" id="Narr_p6gHpr-Omk2zjb5wJ0Bteg">four</ix:nonFraction> equal installments after the grant date and have a grant date of February 1, 2022 and expiration date of February 1, 2032.&#160;However; initial performance RSUs that have not performance-vested by January 1, 2024 expire on January 2, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-51</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:21.6pt;min-height:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Notes to the consolidated financial statements as of December 31, 2021 and 2020 and </b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">for the three years ended December 31, 2021, 2020 and 2019</b></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_ej5azOKb_UWRaq8VKnGDmg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On February 7, 2022, the Company announced the resignation&#160;of Ren&#233; Just as CFO effective March 31, 2022. According to the separation agreement signed on the same date, all vested RSUs held by the Mr. Just as of March 31, 2022 that have not yet been exercised and settled must be exercised and settled in accordance with their terms within <ix:nonNumeric contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_E0hk7XwMHkiMLSQWwvqDyw" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Narr_EoTvK5j-b06NE_wudxnEFA">six months</ix:nonNumeric> following this date and, if such RSUs are not exercised and settled within such period, they will be cancelled automatically upon the expiry of such <ix:nonNumeric contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_E0hk7XwMHkiMLSQWwvqDyw" format="ixt-sec:durwordsen" name="cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" id="Narr_fAfhR8pG5kikKMC7LnPHZw">six-month</ix:nonNumeric> period without compensation for the loss of such RSUs. All unvested RSUs as of March 31, 2022 will be cancelled automatically without compensation for the loss of such RSUs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 7, 2022, Jose Miguel Coego Rios was appointed as Executive Vice President of Finance &amp; Legal and Interim CFO (&#8220;Interim CFO&#8221;). The Interim CFO was awarded <ix:nonFraction unitRef="Unit_Standard_item_-qWnVJTSfkeBJ1EtMUURPA" contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MiguelCoegoRiosMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_AnpIXYXhBkuyC6Ni6BiUGA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" scale="0" id="Narr_jpZWlIskAUql68qJ8FKl0Q">30,995</ix:nonFraction> RSUs vesting in <ix:nonFraction unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw" contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ManagementMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_f5-2plb0q0-wYgUIlGZSEQ" decimals="0" format="ixt-sec:numwordsen" name="cntg:NumberOfTranches" scale="0" id="Narr_lcMJ_X_KtUaAk4moGwDWTw">four</ix:nonFraction> equal tranches from January 1 following the grant date of February 2, 2022. The award is not subject to any performance criteria and vested tranches may be exercised at the option of the Interim CFO and will be settled in shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">In February 2022, a number of countries (including the United States, United Kingdom and the European Union) imposed sanctions against certain individuals and entities in Russia and Belarus as a result of the recognition of the so-called Donetsk People and the so-called Republic and Luhansk People Republic by the Russian Federation. Announcements of potential additional sanctions have been made following the war initiated by Russia against Ukraine on February 24, 2022.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;">Due to the war in Ukraine, there has been a significant increase in volatility on the securities and currency markets. It is expected that these events may affect the activities of Russian enterprises in various sectors of the economy. Although neither Centogene&#8217;s operations, performance nor going concern basis has been significantly affected by the conflict, the impact of the conflict and its broader economic implications, such as higher costs of consumer goods, cannot be reliably quantified at this point in time. Therefore, at the date of this report, the Management Board regards these events as non-adjusting events after the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">These consolidated financial statements were approved by management on March 31, 2022. </p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-52</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.12
<SEQUENCE>2
<FILENAME>cntg-20211231xex4d12.htm
<DESCRIPTION>EX-4.12
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:26 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0pt 18pt;"><b style="font-weight:bold;">Exhibit 4.12</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><b style="font-weight:bold;">English Summary</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Service Agreement</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">This Service Agreement (hereinafter referred to as the &#8220;</font><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Service Agreement</b><font style="font-family:'Arial','Helvetica','sans-serif';">&#8221;) is entered into based on the tender award dated April 29, 2021 between:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 8pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Free State of Bavaria, Germany, represented by the Bavarian State Office for Health and Food Safety with address at Eggenreuther Weg 43, 91058 Erlangen, Germany (&#8220;</font><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Contracting Authority</b><font style="font-family:'Arial','Helvetica','sans-serif';">&#8221;)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 16pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Centogene GmbH (the &#8220;</font><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Contractor</b><font style="font-family:'Arial','Helvetica','sans-serif';">&#8221;), a company incorporated in accordance with the laws of the Federal Republic of Germany with a registered address at Am Strande 7, 18055 Rostock, Germany.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">1.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;text-align:left;">Subject Matter of the Contract</b></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 36pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">The Contractor undertakes to establish two mobile test centers to conduct PCR tests for SARS-CoV-2 in each of the Bavarian government districts of Upper Palatinate and Upper Franconia.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:2.65pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.35pt;padding:0pt;">2.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;text-align:left;">Scope of Services</b></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 15pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Amongst other obligations, the Contractor shall undertake the establishment and operation of mobile test centers and provide sufficient physicians and expert personnel in the test centers. The Contractor shall operate the mobile test centers on a 7-day per week basis and shall maintain test capacities to accommodate daily requirements which are estimated to be up to 500 per day per site.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 33pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">The Contractor is permitted to engage subcontractors subject to prior approval by the Contracting Authority. The Contractor employs 21 Dx GmbH and Dr. Bauer Laboratoriums GmbH as subcontractors.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">3.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;text-align:left;">Obligations of the Contractor</b></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">The Contractor&#8217;s obligations include, among other things,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:28.05pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:20.95pt;padding:0pt;">i.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">performance of tests by a physician or qualified personnel, especially in connection with breakout clusters or in a close spatial context (e.g. elderly care facilities)</font></td><td style="width:19pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:25.55pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:23.45pt;padding:0pt;">ii.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">establishment of mobile test centers at agreed places and times</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:23.05pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:25.95pt;padding:0pt;">iii.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">provision of mobile test facilities (e.g. tents, vehicles, containers)</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:24.15pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:24.85pt;padding:0pt;">iv.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">change of locations overnight</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:26.65pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:22.35pt;padding:0pt;">v.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">setup of test center locations within 24 hours upon request</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:23.55pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:25.45pt;padding:0pt;">vi.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">achievement of fully operational status within four hours after arrival at a test location</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:21.05pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:27.95pt;padding:0pt;">vii.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">provision of personal protective equipment for personnel and testing materials</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.55pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:30.45pt;padding:0pt;">viii.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">provision of notifications on test results to tested persons and health authorities</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:23.55pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:25.45pt;padding:0pt;">ix.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">provision of data on tested persons and findings to the health authorities and tested persons, carried out exclusively in a suitable manner using a data protection compliant web application</font></td><td style="width:18pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:26.05pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:22.95pt;padding:0pt;">x.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">general compliance with applicable law and regulations</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">4.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;text-align:left;">Remuneration</b></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 7pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">In consideration of the Contractor providing the services under the Service Agreement, the Contracting Authority shall pay the Contractor a weekly basic flat rate (including expenses) per mobile test center a daily fee for operating the mobile test center during the term of the Service Agreement minus what the Contractor is entitled to under the Regulation on the entitlement to be tested with regard to a direct determination of the pathogen of the coronavirus SARS-CoV-2 (Coronavirus-Test-Verordnung - TestV).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">5.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;text-align:left;">Term and Termination</b></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 1pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">The term of the Service Agreement commenced on April 29, 2021 and has expired on June 30, 2021.</font><font style="font-size:10pt;"><a name="page225"></a></font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>3
<FILENAME>cntg-20211231xex4d14.htm
<DESCRIPTION>EX-4.14
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:29 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 8pt 18pt;"><b style="font-weight:bold;">Exhibit 4.14</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 8pt 17pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">English Summary</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:11.25pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11.25pt;line-height:1.28;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Framework agreement on the</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">performance of confirmatory</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">diagnostics for SARS-CoV-2</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 33pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">This Agreement (hereinafter referred to as the &#8220;</font><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Service Agreement</b><font style="font-family:'Arial','Helvetica','sans-serif';">&#8221;) is entered into between:</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 33pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">21Dx GmbH, with the address at Kreillerstra&#223;e 210, 81825 M&#252;nchen, Germany (&#8220;</font><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Customer</b><font style="font-family:'Arial','Helvetica','sans-serif';">&#8221;)</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">and</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 33pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Centogene GmbH (&#8220;</font><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">CENTOGENE</b><font style="font-family:'Arial','Helvetica','sans-serif';">&#8221;), a company incorporated in accordance with the laws of the Federal Republic of Germany with a registered address at Am Strande 7, 18055 Rostock, Germany.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">1.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;line-height:1.19;text-align:left;">Subject Matter of the Contract</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 33pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Customer is the main contractor of the Berlin Senate due to a tender won to establish and operate state-run test centers in Berlin to carry out so-called antigen &quot;citizen tests&quot;. The parties undertake to establish a cooperation in carrying out publicly billed PCR tests in those state-run test centers for eligible persons according to the Regulation on the entitlement to be tested with regard to a direct determination of the pathogen of the coronavirus SARS-CoV-2 (Coronavirus-Test-Verordnung - TestV).</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">2.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;line-height:1.19;text-align:left;">Scope of Services</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 33pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Amongst other obligations, CENTOGENE together with its laboratory partner are responsible for the provision of laboratory analysis to conduct PCR tests for SARS-CoV-2 whereas Customer shall be responsible for taking throat swabs, logistics and the operation of CENTOGENE&#8217;s web portal to link and register samples.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">3.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;line-height:1.19;text-align:left;">Obligations of CENTOGENE</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Obligations include, among other things,</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:28.05pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:20.95pt;padding:0pt;">i.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">performance of laboratory analysis tests</font></td><td style="width:19pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:25.55pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:23.45pt;padding:0pt;">ii.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">delivery of swabs and labels to link samples within the web portal</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:24.15pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:24.85pt;padding:0pt;">iii.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">notification of results to test persons and to public health offices in case of positive tests</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:24.15pt;"></td><td style="font-family:'Arial';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:24.85pt;padding:0pt;">iv.</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">support of Customer with documentation requirements in case of billing checks by public </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">4.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;line-height:1.19;text-align:left;">Remuneration</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 17pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">The test kits as well as the access to the web portal are provided to Customer free of charge. As for the laboratory analysis and the throat swabs both parties shall invoice their services and costs separately from each other with the public cost unit according to the Regulation on the entitlement to be tested with regard to a direct determination of the pathogen of the coronavirus SARS-CoV-2 (Coronavirus-Test-Verordnung - TestV).</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:0.4pt;"></td><td style="font-family:'Arial';font-size:9pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:16.6pt;padding:0pt;">5.</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:bold;line-height:1.19;text-align:left;">Term and Termination</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">The term of the Service Agreement commenced on June 26, 2021 and expires on March 31, 2022</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>cntg-20211231xex8d1.htm
<DESCRIPTION>EX-8.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:32 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Exhibit 8.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">List of subsidiaries</p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="line-height:1.07;">(1)</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:48.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr style="height:15pt;"><td colspan="3" style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Subsidiaries of the Registrant</b></p></td></tr><tr style="height:15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:15pt;"><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #000000;border-left:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Entity name</b></p></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #000000;border-right:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Jurisdiction of organization</b></p></td></tr><tr style="height:15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centogene GmbH</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Germany</p></td></tr><tr style="height:15pt;"><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centogene FZ-LLC</p></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">United Arab Emirates</p></td></tr><tr style="height:15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centogene US, LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Delaware, USA</p></td></tr><tr style="height:15pt;"><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centogene GmbH</p></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Austria</p></td></tr><tr style="height:15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centogene India Pvt. Ltd</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">India</p></td></tr><tr style="height:15pt;"><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centogene Switzerland AG</p></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Switzerland</p></td></tr><tr style="height:15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centosafe B.V.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Netherlands</p></td></tr><tr style="height:15pt;"><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Centogene d.o.o Belgrade</p></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="background-color:#d9e1f2;vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Serbia</p></td></tr><tr style="height:15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.14%;border-bottom:1px solid #8ea9db;border-left:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><font style="line-height:1.19;">Dr. Bauer Laboratoriums GmbH</font><sup style="font-size:8.25pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.77%;border-bottom:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:48.07%;border-bottom:1px solid #8ea9db;border-right:1px solid #8ea9db;border-top:1px solid #8ea9db;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Germany</p></td></tr></table></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Centogene does not own any shares in Bauer GmbH. However, Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns</font></td></tr></table><div style="margin-top:8pt;"></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>cntg-20211231xex12d1.htm
<DESCRIPTION>EX-12.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:34 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 12.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">I, Kim Stratton, certify that:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;padding-left:27pt;text-indent:-27pt;"><font style="display:inline-block;font-family:'Calibri';font-size:9pt;min-width:13.5pt;text-indent:0pt;white-space:nowrap;">1.</font><font style="font-size:9pt;">I have reviewed this Annual Report on Form 20-F of Centogene N.V.;</font></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 27pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">2.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">3.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">4.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">c. Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">d. Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">5.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">Date: March 31, 2022</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;"><u style="text-decoration:underline;text-decoration-color:#000000;">/s/ Kim Stratton</u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:13.43pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">Kim Stratton</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">Chief Executive Officer</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>cntg-20211231xex12d2.htm
<DESCRIPTION>EX-12.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:37 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 12.2</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">I, Ren&#233; Just, certify that:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;padding-left:27pt;text-indent:-27pt;"><font style="display:inline-block;font-family:'Calibri';font-size:9pt;min-width:13.5pt;text-indent:0pt;white-space:nowrap;">1.</font><font style="font-size:9pt;">I have reviewed this Annual Report on Form 20-F of Centogene N.V.;</font></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 27pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">2.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">3.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">4.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">c. Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">d. Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">5.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;font-style:normal;font-weight:normal;line-height:1.28;text-align:left;">The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 13.5pt;"><font style="font-size:9pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">Date: March 31, 2022</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;"><u style="text-decoration:underline;text-decoration-color:#000000;">/s/ Ren&#233; Just</u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:24.75pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">Ren&#233; Just </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.28;margin:0pt;">Chief Financial Officer</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>cntg-20211231xex13d1.htm
<DESCRIPTION>EX-13.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:39 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 13.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><font style="font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">In connection with the Annual Report on Form 20-F of Centogene N.V. (the &#8220;Company&#8221;) for the fiscal year ended December 31, 2021 (the &#8220;Report&#8221;), I, Kim Stratton, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">Date: March 31, 2022 </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><u style="text-decoration:underline;text-decoration-color:#000000;">/s/ Kim Stratton </u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:33.92pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;">Kim Stratton</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;">Chief Executive Officer</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>cntg-20211231xex13d2.htm
<DESCRIPTION>EX-13.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:42 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 13.2</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><font style="font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">In connection with the Annual Report on Form 20-F of Centogene N.V. (the &#8220;Company&#8221;) for the fiscal year ended December 31, 2021 (the &#8220;Report&#8221;), I, Rene Just, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">Date: March 31, 2022 </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><u style="text-decoration:underline;text-decoration-color:#000000;">/s/ Ren&#233; Just </u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:11.77pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;">Ren&#233; Just</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;">Chief Financial Officer</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>9
<FILENAME>cntg-20211231xex15d1.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 3/31/2022 03:13:44 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Exhibit 15.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Consent of Independent Registered Public Accounting Firm</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-234551) pertaining to the Centogene N.V. Long-Term Incentive Plan of our report dated March 31, 2022, with respect to the consolidated financial statements of Centogene N.V. included in this Annual Report (Form 20-F) for the year ended December 31, 2021. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;">/s/ Ernst &amp; Young GmbH Wirtschaftspr&#252;fungsgesellschaft </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;">Berlin, Germany </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;">March 31, 2022</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>cntg-20211231x20f004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ': LP# 2(  A$! Q$!_\0
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MC"EV]6QU/UJ>B@"G=Z3IM_(LEYI]K<NOW6FA5R/Q(JU'%'#&L<2*B*,*JC
M]A3J* *UYIUCJ"JM[9V]RJ\@31*X'YBA-/LH[,VB6ENMLPP85C 0CTVXQ5FB
M@!D44<$*0Q1I'$BA$1% 55'  '851_L#1MTC?V38;I01(?LR9<'KGCFM&B@"
MM-I]E<VJVL]G;RVZ@!8GC#( .G!&*;%I>GP6KVL-A:QV\@P\20J$8>X P:MT
M4 ,BBC@B2*&-8XT 5408"@= !VIDUG;7$T,TUM#)+ 28G= 6C)ZE2>GX5-10
M!#;V=K:&4VUM#"96WR&- N]O4XZGWIL=C9Q),D=I BSL6F58P!(3U+>I/?-6
M** *4>C:7#:R6L>FV:6\AR\*P*$8^I&,&F1:%H\)C,6E6,9C<2)LMT&UO[PX
MX/O6A10!!;V5K:&4VUM#"96WR&.,+O;U..I]ZB32=-CMI+9-/M5@E;=)$(5"
MN?4C&":N44 5;/3;#3PPLK*VM@W40Q*F?R%12:'I$MR;F32K%YR<F5K="Q/K
MG&:OT4 0-96C7B7C6L)ND7:LQC&]1Z!NH%22PQ3Q-%-&DD;##(Z@@CW!I]%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8&O\
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M[>"*UMHK>% D42!$4=  , 5)110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$"12>@(JZ)4)P&&: 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% &3=&?4K^2QCE:&UA ^T.AP[DC(0'L,<D]>1BI+R>R\.Z
M+<7*6ZI!;1F0QQ  D#T]Z9=)<:?J#7\$9FMY@!<Q*/G!' =?7C@CZ8Z8,6I6
M6F>*](GM@\+EXR@EV!GA)'4 \@T 4]:\07%K/I'V5O+M;M)))Y?LSSF,!05X
M3U)_G574=>U:WTF;4[2XL9;&*!7AF,9/VIR?NJH;*^G<YK5;09K:*U32+V.P
M$2%9$%L&CFXQN901\W'7-9UOX/NK0V"PZI"\%DI,<,]H7'F%BQDXD'.2<>E
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M)"\8.?0D]*O56T^)H=/A5V9G*[F+*%))Y.0,X_.K- !4%U]Q?K4]077W%^M
M%2BBB@ HHHH ='_K4_WA6A6?'_K4_P!X5H4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI4<.HVL]S+;QR$R1 E\J0!@X/)&#S0!:HJC9ZQ97\WE02.7*[U#QLF]>F5)
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M$X'Z4 6:IS:I903>2UPK3_\ /&/+O_WRN344\&CP'&HZG)<-_P \VE.#_P
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M8+498!8EST/ V\=!P>M4]?NY]5L'N_M^J2QQW1C-M>R%@A()!7G P 01VXH
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M_;NQA@>F1Z5I45J>4>>_\*P/_07_ /);_P"RI\/PT,4\<G]K9V,&Q]GZX/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5M[:>-))!/.7>$-U!QC/&".!P15N/6KZ2"UN(-;UNWMF$[/"]T&<I& 0RD
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M^M=30 =!@4444 %%%% !1110 4444 %%%% !1534Y[NWT^62QMQ<7(&(XR<
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M***V/&"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FNZ11L\C*B*,EF. !
M5;4M2M-)LI+R^G6&!!RS'K[#U-<*$U?XBW&Z42Z=X:4\)TDNA_0?YYH FO\
MQ%J?BV]DTGPL3':(=MSJ9& !W">_^?>NF\.^&M/\-V7D6D>97YEG?EY#ZD_T
MK0L-/M-+LTM+*!(8$& JBK- !1110 4444 %%%% !1110 4444 %%%% %35!
M.=,N?LUU':R^62)Y1E8_5C]*X4+H_P#94%H/$VAQRV]REXDZW 9I)E.2SY;G
M.375^+KO[%X1U6?9OQ;.NW./O#;_ %KY\2X:7PW<0LL>V&:+80@#<[\Y/4T
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M.OFSPQ_R-FC?]?T'_HP5])UTX?9GSG$7\6'H%%%%=!\X%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <UJG@^WUOQ!#J.I7,L]K"@\NR;_5ANY/KVKI%544
M*JA5 P !P*6B@ HHHH **** "BBN>NY;JU\9:3 MY,T%U'<L\3$;1M";<<=M
MQH Z&BN$T7Q67D.IZNUY#;7%S)#;MA1;(%) !YR3\IY(QFF^'O$MWJOCJ027
MB#3[BQ:6VM@XX(D"@G_:(!./0T =[17%SW]UIFJWMSK/]II9/>+':O"X\I5(
M  (SGDY[5AW?B/5],T#2=:%]+-)J$4QEB< HIVDJ5';&* /4**Y/3+B]L_$E
MC8RWTUU#=V'GOYN#AP1R/0'/2NLH **** .>\=#/@C5A_P!,/ZBOG93*L#PJ
M^(Y&5F&.I&<?S-?1/CG_ )$G5?\ KC_45\\5SUIRC+0^CR? 4,50;JJ]GW\D
M7UUK4?)B@DF22&,IE?+4,ZJ<A6<#<1[$D4#6]203K#.D:3.[X$2DQ[_O!&(R
MN?8BJ%%8^VGW/6_L3!?R_BRU_:NH_P!G_8?M"^1LV?ZI=^S.=N_&[;GMG%%W
MJNHWMJ+:XN%>,;<D1J&?:,#<P&6P/4FJM%'MI]P_L3!?R_BSZ7T#_D6]+_Z]
M(O\ T 5HUG:!_P BWI?_ %Z1?^@"M&NU;'Q5;^)+U84444S,^=M!G0*$:SM6
MMHR9+V>XB5_DZ!5)&5/8;>236AHN@N;&>X.ES7!NK>5H#Y)=8E .TYQC>2./
M0?45'KFFZIX-C@TR\&G7$<V9UVQE^>G)8"N<@O);::26':K2(R$;>,-P0*X+
M\NC/T!1=>+G2>C_'^O\ @'07EA;_ -E+9V4EOY\=G'>3JUO^\;*!V_>'I@-T
M&!@=S4F@0075M96\:Z8R2,ZWGVC9YV<G&W=\V,8QL[YS6*NMW?V86[;"FP1,
MP0!VC!^YNZXXQ2?VQ-%-=/;10P?:&8Y5 60'^%3VHYE>XW0JN#C^/]?>NUC;
M:&WB:/2A:V[0OICW)E,0\SS/*:0'?C/! &,XQ4=]' _]JZ<+:U2.Q@62&5(@
MK[@R Y8<MG<>N>V*R%UN]6R^RADV^680^P;PA.2N[KBM#2O[4\47<>BP26T<
MDZX:5TVEP@R S $GI^@HNGHB94I4_?D]%OKYWO\ <?0-I_QY0?\ 7-?Y5-4<
M"&*WCC.,JH4X]A4E=Y\#+=A4%[_QX7/_ %R;^1J>H+W_ (\+G_KDW\C0./Q(
M^7J***\P_30HHHH *]L^$G_(H3?]?C_^@I7B=>V?"3_D4)O^OQ__ $%*VH?&
M>-GW^Z?-'>4445VGQ(5YW\7HWDT*P"(S'[3V&?X37HE<3\2_^019_P#7?_V4
MU,H\RL;X:N\/5C52O8\2^S3_ //&3_ODT?9I_P#GC)_WR:Z"BL?JZ[GN?ZQ5
M?Y$<_P#9I_\ GC)_WR:/LT__ #QD_P"^37044?5UW#_6*K_(BGX9@F'BO1R8
MI !?0Y)4_P!\5]'UX9H/_(Q:9_U]Q?\ H8KW.M*=/D1Y>/Q\L9)2DK6"BBBM
M#@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHIKG$;'., \^E #J*\:\-7VHRZOX=FF
MN-0BAOIKJ.349+EF@O@<[%C3)V' R"0N-IQFNV\*&2+Q;XNLS<3RP6]S;")9
MI6?9NMT8XSTR23^- '7T5Y9?7-[X:N;S5=4MFO+>ZU&1+6ZM]4D8P,0?+5H>
M%VY7!P3]*YW6]9U30/!.@ZUI^H7KW^IZ9-)=%YV<;S'OWA2<*5)XQB@#W6BN
M!\/^;I7Q AT>"[NI[&?0A>.)YVEQ*)%7<"Q.,AC[<5WU !1110 5CZVVEZ?-
M:Z[J=PT"V0>-6P2O[S:#D $G[HK8KQ_XB^.#=1ZAX=&GF,Q3J!<B?.=I!SMV
M_P!:3:6Y<:<YW<5>VK-B+5_ ,-VDPUN8P1SM<1VC(YA20]6 V9[DXSCVI=3\
M1>$+F\DU&PU\6E^;;[*DBP/M1=X8G&S[W&,YKS2?4]1/AP0W-]=3M?2#;'+*
MS_NT/7!/=O\ T&I;34+NUTAWNI/+LO(:WAM!TG<\%BOMU+'O@"F0>C2:UX%E
MN3+)K]P86N%NGMMK^4TH_BQLSU&<9Q[4VVO/ #S0P?VQ-<1*'BMK:57\N+S.
M"%^0'OCDG%<7=.6N;_3Y99!I,6GPO$H'RKQ&0P'3))//?)HO;N?9K3WF]X[#
M4(C:1MP$P[?*OH"HZ#T!H#<]ETSPY:Z9=K="XNKF9(1!&UPX;RXQ_", ?F<G
MWK8KCO!WCO\ X2R^N+;^S3:>3&)-WG[\\XQC:*[&DFGJBZE.=.7+-6?F%%%%
M,@X'XG:Q<65G9Z8CP1V^HK(D\DJL2@7801CZGL:\FET^VMKUX)[W:GEI(DBQ
M%MP90PXSQP:]#^,O71?^V_\ [3K@'FLKK6;9YY2+588%D;:<G9$H90/<J1G\
M>E<=9WFS[3)X\N$C*/5-NW=/_(E?052=P;U1;QPI+),\9&S=]U=O4DU0M+2*
MYNWB:ZCAA0,QFDXX'H.I)]*UM-UIC_:2F_;3YKMTD6=0V%V[OE^4$@8;MZ4M
MV-.O=2DU%[TPQ2/L1_*R2ZHO[QE_NLV20!GFL[+H=ZJ5(MQG]]O3R]?NV*S:
M$JGSC>H++R!/Y^P]"VT#;USG^5(VAI!),;J^CBMT\O9*$+>8'7<I Z].3Z5I
M7.J6=W'-8S7\>9;:-&NQ"PC\Q') V@;@-IQD+U[5%=WFFZDCV37WD10B!89Y
M(F(<(FQCA02,\D?KBG9$1J5OM7^[T\M]_P#(].\ ZUJ-ZU]I5^MN!IB0Q1-"
M"-PPPR22<\*/2NUKS?X9WD=_K7B*YA#")S $W=2 ' )_*O2*ZZ;O$^.S*"AB
M9)*VWWV5_P 0HHHK0X#R#XP_\AC3?^O=O_0J\VKTGXP_\AC3?^O=O_0J\VK@
MJ_&S[[*?]RI^GZL****S/1"NN^&?_(]V/^[+_P"@-7(UUWPS_P"1[L?]V7_T
M!JN'Q(Y,?_NM3_"_R/>J***] _.PJ"]_X\+G_KDW\C4]0W7_ !YS_P#7-OY4
M#3L[GR[172T5S?5_,^F_UD_Z=?C_ , YJBNEHH^K^8?ZR?\ 3K\?^ <U7MGP
ME_Y%";_K\?\ ]!2O.*]4^''_ "+<O_7RW_H*U=.CR.]SCQ^<?6Z/LN2VO>_Z
M'7T445L>(%<3\2_^019_]=__ &4UVU<3\2_^019_]=__ &4T >94444 %%%%
M &AH/_(Q:9_U]Q?^ABO<Z\,T'_D8M,_Z^XO_ $,5[G0 4444 %%%% !1110
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MB222'POJTL3LDB6<K*ZG!4A#@@]C7S]<&"\TF6\99FO$GC26:64N9"RN2?\
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M>6<D#\C7K'A_5SK>D1WS0B$NS#8&W8P<=:\VBN;:74+;5#<0I' 93)&S /\
M?=E 7J<[@.*[?P%_R*<'_71__0C0!TU%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%0W%U;V<?
MF7,\<*?WI&"C]:9=:A9V)075U# 7^[YCA<_3- %FBH9[NWM8//GGCBB_ONP
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M6 3M=W<8C="@VKR"Q!SD_=]!UH ]GA8O!&S')*@G\J?4=O\ \>T7^X/Y5)0
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MSAEC@#8RS#)^8D]AW[5])5XY;^#_ !)%<Q2-HTNU'#'$\/8_[]>H_P!IW?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>cntg-20211231x20f005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %_ N@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSX!=XK;5M-\QWMK"_D@MRQR0@/ S[4 7;_Q#?0^)AHEAI<=U)]E%R9)+KR@
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MZ.=:CT!FTP N'-R!*8_[VS;C\,U<O?%44:Z6FGVK7MSJ:B2WB#[!LQDLS8.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\ <FGVE]:W\;26LZ2HIVDJ>A]* +%%%% !1110 4444 %%%% !1110 4444
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MZ&U??HP..B$5SXA>ZF>[D,[5I0[K\C&HHHKC/J@HHHH **** "BBB@ HHHH
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MYSCYPA!_.@#M*C::))4B9P'DSL4_Q8ZXKG-5M((=4$VH:;)>:8L*I"D4?F)
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MWO\ &BO-E6G%V:/T;#9-@\1256$I6?I_D;WVZU_Y[K_WRW^%'VZU_P">Z_\
M?+?X5@T5/UB1TKA_"]Y?>O\ (W#?VH_Y:Y_X"?\ "FG4K<=V/T%8M%'MYC_L
M#">?W_\  -G^T[;U?_OFE_M*U]9/^^?_ *]8M%+V\RO["P?9_>;/]IVWJ_\
MWS33JD/97/X5D44>WF4LCP?\K^]FK_:L?_/-OSI?[5A_YY/^8K)HI>VGW*62
M8+^7\6:W]JQ?\\G_ #%(=63M$WYUE44>VGW&LFP7\GXO_,TCJQ[1?F:/[6/_
M #P'_?7_ -:LVBCVL^Y7]D8+^3\7_F:?]K_],/\ Q_\ ^M7IGPGO#=1ZD-FW
M:4[Y]:\@KUCX.K_HVJ/_ +:#]#5TJDG))LX,TR_#4<+*=.%GI^9ZA11176?(
MA1110 54N2?-'/:K=5+K_6CZ4 0Y/J:,GU-)10!<M?\ 5'ZU2&M1?V7>WKQ,
MOV1I$>//)*GI^/'YU<M?]4?K7,7@*>)9M( .R_FANP.VU0?,_6-?^^J -D:[
M"VB6FI+$Y^TM&B1?Q;W8+M^H).?H:FTW4?MT=PSJL9BN98 -W78Q7/XXKGX(
M2WBJ/2<8AM+F74,=L,ORC_OMW/X5!_9EG+X>\1W<L*O<+/>,DC<F,J6QM/\
M#SSQ0!VK,J_>8#ZFJ5WJ!MM2TZU"!A=NZEL_=VH6_I6)8QVNHZI.-66.9EM8
M&@2?!&PIEF /'WLY/TJE8.QN])$+,\"7UXMHQ.<QB-MN#W'4#VQ0!VNY=VW<
M-WIGFEZ5P=G;7%QI,%P(M,AO?/4M>R7C>:)-_*D>7WY&W..:Z7Q*0-'(=RD)
MFB$Q'_/,N-V?;% &JKJWW6!^AI0ZEMH8$CMFN4N8+:RUXKI,<,<_]F3,L<.
M,Y7:<#^=5]-M7:'2;F&'3+=S(I:Y6\9I9N/G4CRQDGT)XH [+>F<;ESZ9I6=
M5^\P&?4UQ/\ 9UH/#&K7I@4W2W5RZ3$99")6Q@]OPK2@@L[[6=4&JI%*8UB,
M*SX(6(QJ2PST^;=D^U '2%E7J0/J:3S$P#O7!Z'-<;9V\=_+H$=T#- #=>6'
M.0R#&S/J,8ZU<T_1--FU36()+2-H4D14C(RJ90$[1T'/I0!TY95&20!ZDTH(
M(R#D5PEH]S>KH<<T%M=1&S.R.[G*(\@;']UMS8'?WKI/#T,D%I<1L]OL%PWE
MQV\ID6(8'R9('0YXQWH U=ZAMNX;O3/-*65<;F SZFN*NH;> 7VH/':WML;L
MEIE<QW4#[L;1D'.#T&1QZU(\4U[KFL+=65C<^6RB(7ERT92'8IRH$;<;MV6S
MU&.U '8LRJ,LP'U-&Y3T(Y]ZY"PMX[C5K6WUB6"[5-.1K<EM\<C;FWL">I V
M<XZ&JE@;:"\T^6%T%HFN7**X;*C="ZJ,_7B@#N\C.,\^E('5LX8''7!KC->N
MV;4-=:QF#2Q:?;I(8WP4'FR%^1G!"DGIQ3Q9F&XAE@ATRSC-M-N6VNVD:X38
M<<;%S@X.<^OK0!UX=2<!@3Z9I2Z@@%@">Q-<6NGVMEX;\.W<$06Z,]EF;^,A
MV4,">N""1CI5B"WTJZL]6N-6,?VF.XE$TCGYX5!^38>J_+M(QWH ZA96-Q+&
MT15$"D2%AALYR,=1C'?UJ0.K$@,"1U -<9J8#P>( 'D96L;8;FX8CY^3[UH2
MV-MIVMZ1]B@2%I4F1R@P7 3(W>O/K0!T6],XW+GTS4=U<QV=I+<RG$<2%VQZ
M"N*N+?3?^$02[?ROM[31AY6/[PR>8-RD]?7BND\3Y_L"?TW)N_W=XS^E #[/
M4IVN;>UO(E2>>%IUV'A0"/E]R 1S3M/UJ#4=0O[.-&5[-@"2>'!R,CVRK#\*
MI>);A--%CK# ^7:S;9,?W'4K_P"A%:QM02?1M*LKN-<75U;R6LA_Z:2_,GY,
M3^= &['XC2XM+.2VM9)I[S>T$*L!E%.-Y/0+T_,"K-IJK2W<EI=VK6MPB>8
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MLL;:X\OE/.B5]OTR.*M44 1F"$O&YB3?&"$;:,J#UQZ4J0QQN[I&BO(078*
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M$;6!8V18YBS#*DC:NP9)QSSQ[U8CU>^CN;1;[3%MX;M_+B9;C>RM@D!UVC'
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M:]J5NW!NXUGB)_BP-K#\./SIG]A/)X9L]/>417EK&GE3ISY<BC@CU'8CN":
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M!1115G$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y[XX^&
M\.M;]1TH+!?]7CZ+-_@WOWKQ6[M+BQNI+6ZA>&>,[7C<8(-?5E<_XF\'Z7XH
MM\7<?EW*C$=P@^9?\1[4 ?-M%='XF\%:MX8F8W$7FVF?DN8QE2/?T/L:YR@
MK3M?#VJWMO'/;VC-'*2(\LJF3'7:"<M^&:S*Z'1WMWU2Q;6;NZADM_+%LGDC
M85!RH+9RHR>H5NM &79:3?:AYIMH"RPX\QW8(J9. "6( /M3ET746OIK,VS)
M/ -TJR,$"#U))  Y'.>];/B#[0FE3+.BQS-J]R;E$.5$@Q@?AEL5+JFH1VUM
MIL=U;O.EWI$2RA)-C_+(^T@X/8+U% '+W-O-:7$EO<1F.6,[64]0:BKN-2L)
MKZW6"!K6VFNI CI*Y+NR("L*D*?N@J23C+,/2N'/!Q0 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cntg-20211231x20f007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'W!!L# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]M]FOS1>HKCH?&&JMIRZE)X?8V)&XRQW() ]<8K=;4YYX]/GL+=)K>Y.79Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ R<\\54M+B"W\-ZI875Q=FT@O?(A%NWSN#T0$]JZ6Y\(VMQ?3WJ7M];W,V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 9;:_8PZ@UC<M):R[L(9T*))_NMT/YYK'
MU3Q*$UV6Q_M%;&WM0C32+ 96<GGT(1<=2:TKS0#JERYU*]FGLR<I9J D>/\
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MHFN7&HV\B7?F7#MY@" CJ>#[C%9UA8QKX;T"&*2>%;K4V68Q3,I88D&,YXX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)KFV_O#/'<10P0PDQ/& RLSL,^^>.AK3FOX+>Z%O(6#&%YLXR JD _\ H0H
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M[NBCEEW#ZSA_^?*^^7^9PG_"Q;I/]=X4U9,=?W9./_':/^%H6:<3Z)J\?_;
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M>2Z@8_LV^ Q2XN$F7# 8Z8Y'/'(- &E15*\U*.TGC@$,\\S@MY<*Y(4=SD@
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MM;[4FC_Y9PJS)Z%F/2KECX=TQ=/MUN-*M/.$:A\PJ3G'/- &C_:%E_S]P?\
M?Q?\:/[0LO\ G[@_[^+_ (UG7FC:7;6YDBT"WN7SCRXX4!_7 K(N[2&:SFCA
M\'&.1T*JX2'Y3C@]: -,3Q3^,8S#*D@%D<E&!_C]JWJYOP_)86K16;:;]@OS
M& 0\04RXZD,.#724 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% &#XHT\75I#=B,N]G*)2HZLH^\/R_E6U;SQW-O'/"X>.10RL.X-
M/.",'I6(;2]T:9Y-.A^TV3DLUKN"M&>Y0GC'L: -RL76S]IN[#3UY:282OCL
MB\Y_.@Z]-(NRWT;4FF/19(A&H/NQ./RS4^F:?-#-+>WSJ][-P=OW8U[*O^-
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MTQ=H00&=2C*=N>,C.<>QK1C=98UD7[K#(S4=U:P7L!AN(EDC)S@]CV(]#[T
M<VWVC4;S4PEJ\;![0A&8;L!B23@X''.,_P ZU+E;BSU9KV.U>YBDA$;+%C<I
M!)'!(R#D_I5^TL[>QB,=O$(U)+-CDL?4D\D_6EAN8[B2=$SF%]CY'? /\B*
M.?FTW4/L!N(H0+R2Y:7R@P^16 4@GIG'-6+;29K?6D 3_0HT\Q6R/]9C;C'T
MYK>HH **** "BBB@ KS+5]#LO$'Q1FL;]7:(V(<;&VD,,8(/XUZ;7"1?\ECE
M_P"P?_A6=17LGW/0R^<H.I*+LU%_H,_X0/6M-_Y ?BN\A0?=AN!O4?T_2E\O
MXDV)XETK4%'J-I/_ *#7>T4_9KH3_:%27\2,9>J7YJS.#_X2;QO:G_2_"*S
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M9^&O^@W9?]_149\=>&%&3K5K^#$_TI?^$'\,_P#0%M/^^:D'@WPXIR-%LO\
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M .AFF^*#G2 F3MDFC1AZJ6Y% %LZWI()!U.S!';SU_QI/[<TC_H)V7_?]?\
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MW7)Y+'<3^=$FG6DL5Q&\(9+AMTH)/S' &?;H.E %H# Q12* JA1G &.3FEH
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MY).*S<7<]*C7IN"N^7E]-='Y?+6^Y4M;J>[\&7$DUS/<J+P+%-.NUF02#!/
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M'@HM^[5B_FU^:.\HKA/[4^(L ^?0-.G]XYL?^S4G_"5>-(?];X-+_P#7.?\
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MH]<#@_A71U<-KW.''2?.H.+CRJUGO_6H44459QA1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !152^U2PTR-7O[RWM4<X5II @)]!FJ/_  EOAW_H.Z;_
M .!*?XT ;-%8W_"6^'?^@[IO_@2G^-'_  EOAW_H.Z;_ .!*?XT ;-%8W_"6
M^'?^@[IO_@2G^-'_  EOAW_H.Z;_ .!*?XT ;-%8W_"6^'?^@[IO_@2G^-'_
M  EOAW_H.Z;_ .!*?XT ;-%8W_"6^'?^@[IO_@2G^-'_  EOAW_H.Z;_ .!*
M?XT ;-%8W_"6^'?^@[IO_@2G^-'_  EOAW_H.Z;_ .!*?XT ;-%8W_"6^'?^
M@[IO_@2G^-'_  EOAW_H.Z;_ .!*?XT ;-%8W_"6^'?^@[IO_@2G^-'_  EO
MAW_H.Z;_ .!*?XT ;-%8W_"6^'?^@[IO_@2G^-17/B_0%M96BUS3O,"$KBX0
M\XX[T ;U%>5>'?B\C%;?7H-IZ?:8%X_X$O\ A^5>F6&HV>IVJW-C<QW$+='C
M;(_^M0!9HHHH **** "O*_$5AJ6H_$]ETN>"*[AM%EC,ZAE..V"#ZUZI7"1?
M\ECE_P"P?_A6=17LO,]'+ING*I-=(O\ 08/$WC32\+J?A<7:KUELGSGWP,_T
MIZ?%+3(CMU#3=3LW[AX<C^==W3617&'4,/0C-/EDMF3]9P\OCI+Y-K\[G+6_
MQ(\*S@?\301GTEB=?Z5I0^+?#UQCR]:L>?68+_.K$^@:/<Y\_2[*3/4M N?Y
M5FR^ O"\WW]&MA_N97^1H]_R%? OI)?<_P#(V(]5TZ;_ %5_:O\ [LRG^M6%
MDCD^XZM]"#7(R_##PK(<BQDC_P!R=A_6J[?"GP\?N3:A'_N7'^(HO/L'L\&]
MJDE_VZO_ )([FBN#/PNLD_U&M:O%Z8G'^%)_PK:=#^Z\5:PF.G[S/]:.:78/
M887_ )_?^2L[VDKA/^%?ZHO">,]5 ]\G_P!FI?\ A!_$ ^[XWU'/;*G_ .*H
MYI=@^K8?_G\ONE_D=UQ1Q7"?\(3XF_Z'F]_[]'_XJC_A"?$W_0\WO_?H_P#Q
M5'-+^4/JU#_G\ONE_D=WQ1Q7"?\ "$^)O^AYO?\ OT?_ (JC_A"?$W?QQ??]
M^S_\51S2_E#ZM0_Y_+[I?Y'>45PG_"#:_P!_&^I?]\G_ .*I/^%?ZJW#>,]5
M([@9'_LU'-+L'U;#_P#/Y?=+_([RBN"_X5O<.?WOBO6'SU_>8S^M*/A?9O\
MZ_6]7D^LX_PHYI=@]AA?^?W_ )*SNF>-/O,J_4XJM)J>GP_ZV^MD_P!Z51_6
MN17X4^'Q]^?49/\ >N/\!4\7PO\ "L9RUE+)_OSL?ZT7GV#V>#6]23_[=_\
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M V87:(/+&P#Z5%I>@Z5HN_\ LZPAMB_WF1>3^/6M&B@ HHHH **** "BBB@
MHHHH JZC=O8V,MQ':373H,B&$ LWTR:\.\3_ !%U[5)9;10^F0 E6A3(D^C-
MU_ 8KWNL77?"NC^(HBM_:*TF,+,GRR+]#_C0!B:'XCOXM"LHU\-:K,%A4>8O
MEX;CJ,M6A_PD^H?]"KK'Y1?_ !=;EA9)I]A!:1L62% @+=2!5G ]* .:_P"$
MGU#_ *%76/RB_P#BZ/\ A)]0_P"A5UC\HO\ XNNEP/2C ]* .:_X2?4/^A5U
MC\HO_BZ/^$GU#_H5=8_*+_XNNEP/2C ]* .:_P"$GU#_ *%76/RB_P#BZ/\
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M<"V\:13SQSQR&47((,A<\$G(P<CC&,8^E-308!'.'N;F266193,S#>K@8!7
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M7^9=_P"%7^$_^@>__@0_^-'_  J_PG_T#W_\"'_QJE_PE_B__H29O^__ /\
M6H_X2_Q?_P!"3-_W_P#_ *U'[OM^!5LQ_P"?O_DZ_P R[_PJ_P )_P#0/?\
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MVTKI )HYG3RU7G!#8)XJ/2]6FEU1;1[R*\22(R"1(3'M(/(&>"* -\D*"20
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M[N);JV@2-XE=80[1J6^7<"#C(QSCMS5D1QVG]G7BO=2P&]>2222$J065AG:
M, GOCO0!K6.NVM[+?+DQ+:.5=Y 57 4$MD@ =?TJ2/6].E@GG6Z3RX%W2%@5
M*KV)!&<>]8=[%+/%K5FBS><;N.Y"+'DR1#RR=N1M;[I&/;%1WJ1WUEJ$\=U>
M7LJV3Q?/:[%PQ!QPH)/'3MSZT =1:7MO?1&6VD$D88KN ."1Z9Z_6LW4?$5K
M;!X[:>)[A9%C*D'&21D9Z9YZ9K8*_N]J\<8&.U<?).L>AII;03F\CN!O00,1
M_K,[\XQCG.<T ='_ &G#"ES)=7$"1PR[,J3D<#@^_L*?#JMC/:R7*7*>5%_K
M&;Y=GU!Y%8<\L]H+V18F53?9:8P&0Q+M'SA>_P!:I,LUV^H3)]KN45H)"TL&
MPRJO7: !G\J .DBU[3)E<I=I\B>8P(((7U((SBI+75["]N#!;W*22!=V!GD>
MH]1]*YK5;N'4[FZ-JDK@Z>ZY,3+N.[H,C)K0U*UFE_LZ*!"K&WE0$ @*2@ S
MZ<T :D&LZ?<W7V:&Z1Y3G:!G#8ZX/0X]J0:SI[7GV472&;<4 YP6'50>A/MG
M-8QG2\L]-T^WMIDN89HF=&B91 $/S$G&.F0,'G/I3(I!#=0VUJMPP-UF2PN;
M?<(LODNK@< ?>!)([#V -"'Q%%>6UY)!MB:WG\K,ZN%/(&>GOTJ[<:QI]I<B
MWGND27C(.<+GID]!^.*P)MWV'6+3RY?/%\)0NQN4+)@@XP1]*M)<1:>^I6M[
M;32R7$[2(BQ,PG4J  #C';'/2@#HZ*9" L**$V *!LS]WCI3Z "BBB@ HHHH
M *X2+_DL<O\ V#_\*[NN$B_Y+'+_ -@__"HGT]3NP7_+S_"_T.[HHHJSA"BB
MLV[NKJ74!8V311N$\R265"P49P  ",G\: -*BL*XU#4;:%4G5%E6YCC\U$^2
M1&[@'.#^-6FU>WM?.:YN,JMQY*A82"K$9"]]Q]Q0!IT5E2:Q#)97,D<CV\D!
M4.)H&RF2,';P2#_GI4MUK-I:3/$_FL8P&E:.)G6('NQ XXY^G- &A1BL^YUJ
MTMY"O[V7:H=VAB:0(IZ$D4V*^>;6A DBM;-:B5<#J2PP<_0T :6!Z48'I66V
MKK;S:@UVRI;VQ3#!23R.].768)$GV1S^9%&9 CPLI=?5<]10!I8'I1@>E8.F
M:NW]FI=WTD[23MB.+R,'Z*!R1[FKC:[8I:?:'>1%$@B9&B8.KGH"N,T :5%9
MCZY:HRQ^5=&8QB7R5MV+A22,D8XZ4D7B"PG>'RGE:*5@BS")O+W'HN[& <\?
M7CK0!J45G3:W9P3O&YEV1L$DE6)C&C>A;&!U'T[U$-79]2O;,PRQK!$KB9HB
M5YW?F../7F@#6HK-;6+>&&#<9)Y9(A)B"%B=N/O%1G ^M+)KEB@@VN\AG4M$
ML<;,S8ZC '6@#1HJO9WD-];B:$MMR00RE2".H(/0U8H **** .%U7_DL.A?]
M>4G\I*[JN%U7_DL.A?\ 7E)_*2NZJ(;OU.[&?#2_PK\V%%%%6<(4444 %<KK
M8R^OCUT]/_9JZJDP#VH P+F"&WU+21%#M7R)D(B7!*[5.!BJ6E2VJ7>EVL$M
MK>QHKB(JFR>V&T_? XQ_"<A>2.#76X%1236]NZ"22.-Y6VJ&8 N?0>IH Y+3
M)+>V_L>XOFC2V%M*D4DN BR%QW/ )4''XU'9QV=S<VGE1QM;G5I64;<*?W9.
M0/KS757UI-<HGD7;V[*>R*RL/0@TZPL4L+<QAWD=F,CR/C+L>IX_I0!S6HJD
M0U@X"QK/!(W& /4G\JFU.XLTN[F>.\M-TD #0W2 I.O;8P.?;C/TKIC)$"07
M0'N"10!&Z@KM('3'.* ,J^(;PI*5A,*FWXC/\/'2J=A;PRZUJ#21(Y^RPKEE
MSQLZ5TE&!0!R>G2K%-HC22)&7L7CC9S@%\K@#W]JA\VT/AVVL(=HU82IB+_E
MJLP8%G/<=R6Z8^M=CM!QP..E&T;MV!GUH Q]>,:'3IKK'V.*Z#3EONK\K!6;
MV#%?IP:Q+R:SN)-<DLVC="+7<\8^5FW-WZ'MS79G&TYQCOFD 7:, 8[8H Y3
M5);6WN=1Q-;2-(R^=8W4>'EX 'EL.3GMP><]*CFVI>ZE'>7EI:"<+M6[@+LT
M>T8"G<,X.>!WKKF,8<;BN[MGK3BH."0#CIF@#C[RZ@MQ<VKSV<++:JIDN(2T
MMR-O&T9''YTL<L$=O8W#7L%O/]C"C[9'F*1?0$D8/T/X5UY4$Y(&1054C!4$
M?2@#C8Y ES8W+-;:=;M:;81<1%XU;)W $LN,C'7J*E2.SLX["1-3AC=5E,,T
MUOBW96.2HR>,<8P>GK76E0PP0"/0T%588(!'H: ,W0)(Y=(B>.WC@4L^%CSL
M/S'YES_">H]C6G110 4444 %9#Z3>)=W4UKJ/DK<L&8& ,5(&."3_2M>B@#)
MCT"VC$*;G:..%XF5NK[NI)]:8NBSAH1-?O<0VQW012(!\P! +L.6QGVJU<ZS
MI]G.89[@*XQNPK,$STW$#"_CBBZUK3[.4QS7 $@4/L568[3WP >/>@!(-,V:
M*U@\GS21LLD@'5F!R?S)JY!$(+>.('(10N3WP*JSZO86\$$SW *3C,6Q2Y<8
MSD!021BF:/J)U*WFFW(R+<21HR="JM@?C0 QM%1M+N['SVVW$LDA?:,KO<MC
M\,U#<Z%-,]VL.I2P6]V2TL:QJ3NP!D,>0, <?RJVNLZ>]Y]E6Y4R[S&/E.TL
M.JAL8)]LYH.M:>MW]F-ROF;_ "_NG:&_N[L8S[9S0 6NF+;3/)YI8M D)&,?
M=!Y_6HQHZ#38+/SFQ#() V!DX8G'ZTL^O:9;2O%+=*K1MMD^5B$/^T0,+UZF
MGP:SI]S.T,5P&<*6^Z0& ZE21AOPS0!'>Z+'>SSR/,Z^;"(L*!\N&W _G3+7
M2;B/4(KVZU&2X>.,QA/+5%P>^!WXIP\1:22!]M0!@<,00IQV#8P3[=:GM]7L
M;F&:6.X 2'_6;P4*=^0P!H K7>CS2SW#VM^]JERN)D6-6R<8W*3T./K35T22
MV6%K&^>"5(5A=C&'$@7H2#W'K5B/7-.DAFF%R D*AI-ZLI53T.",X]^E)_;F
MG?9EN//)C=]B8C8ES_LC&6^H&* &7^B1ZC;6D,]Q*Q@D5RYQF4?Q*W&,,.N*
M?=Z;-)=_:[.\:VG9!')\@=7 SC(/<9.#[]Z<NI13O9-;7$+17#LO(.YL*20/
M0@CG/H>])'K>G2W0MDN5,C,44[3M9AU ;&TGV!H 8VC)+-YEQ/)-FV:W?< "
MP)!)X[\5"-&FS&;F^DNH[=3Y,;1@'., L1]XC\*+;59I0YD:!,7QMQD-\RC'
M Q_%^E6'UNQCG2!WE1W?RUW6\@!;T!*XH S=*T:YDL;-;RZE\B(^9]F:(*=P
M)P"W4CVJ\NB(LT,GGM^ZN'G VCDMVIR:S:PP![NZA!:1D38&YQVQU)J5=9T]
MK%[S[2H@1MK$@@AO3:1G/MC- %/4],3R[NYW7!D=TD7R$#-&RC ('?W%0Z+%
M=2ZM=7L\EQ)&8DB5YH?)R023M0\@<]3U-:EGJEG?N\=M,'>, NA4JRYZ9! (
MJY0 4444 %%%% !1110 V4L(G*J&;!PI[GTKDQ<3W,FGJYO3(MR#)"+39%#P
M>^W/X@FNNIDLB0Q-+(P5$!9F/84 <Y';RCPQ<IY+B0W);;L.3^]!SBF7$ILK
M'6;26WN'GN/->(1PL_FAEXY QQTY]*ZA65T#*<J1D'UI: ,/689)?"<L*QL[
MF)!L"Y)Y'&*-;M)[NZ6*!6W/97$88= 3LQS6S%-%/&)(9$D0D@,C9'!P>?K3
MZ .9M0)FMRKZA-/;1DK!-;K&J':1M)"#Z<$YJ"*>:ZN]++/>R.DF94:T\N.$
M[3Q]T'VZFNMILDB11M([!549)/84 <S LEM::5++%*%CN9-^(V)7)."0!G%2
M?9Y/[#U51"^][AV V'+<C!]ZWX[F"9ML<R,VT/M#<[3T./2I: ,767$-CI[N
MCL%N(R55=QZ'M5"_#:BU[<V\$Q@,<,66B9?,829. 1D@ ]<>M='<6L=UY7F9
M_=R"1<''(_\ UU-0!C73?8M9BO9HY&MVM_*WHA?RVW9Y &0#QS[50:*>.SN-
M6BM9MR7INH8 A#M'M",-O4%AN;'T[UU%% '/QV,T TA74M,9)))V X#LC$Y_
M$XJHLVW2;+33:W/VJ&>,2*(&*C#@EMV,8/7.>]=0TL:!BSJH098D]!ZFE1TD
MC5T8,C %64Y!![B@#E8[8HD^GW4^H*SSLWE16ZLK@MD$-L/ZG(Q6C;V_^A:J
MLEM)('G<[%&&<8'2MNB@# TJ61M02.-I[BW2+'F7-OL>$_W=V!G_ #S6_5>V
MOK:[>5;>99#&=K[>@/UZ58H **** "BBB@ HI&. :Y<:AJ,&C_;I+MYI9YC#
M&BP B,;R < 98X'K0!U-%<VEYJH2[CMOM=QB(/')<6OEL&SR!D*&XY%,_M&Y
MBL[QH]1DE>-4.RY@$<T9+ '(P 5(]OQH Z61TBC:21@J*"S,>@ I(Y8Y45XW
M5E8;E(/4>M8FL7<XE^SA_P!U)83NZX') &/YFJ=A [:WI<@N9E']GYV#;MZK
MQTS^M '55&\\4<T<3R*)),[%)Y;')Q7/V5Y?_;K>.\O)(;EY&$EM/ !$PYXB
M<#DC /+'(SD#M8UB.6;6M)2&<P,3-EU4$@;.V>,_4&@#<HKG3?W,,=W:3:AL
M>"=$6X\D-(ZL,@!0,%^HZ>^*9#?ZD\&I06S3SRPA&B:> ))ALY^4@ D8XX%
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M=PS"$VK0Y6)F,;;\X( R,CV[5K>']S6EU(T,L/F7<SJLJ%6P7.#@^O6MBD)
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MX?N\<_3WJ:VU&WO-9>XN3,GE,8K:)H9!CL7/&,GH/;ZUTE% '+6EM+]KT\M
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M8<&@"DNIZHD,=[-8Q?8Y,'RXW9ID4]"1C!/J!^M2KJLS/=AC @ANU@4OD9!
M]._-0Q:TQM(;:"UF-^ J- \3*$/ )+8QCWSS526&4_;L12<ZE&P^4\C"\_2@
M#7?7=,CF\E[Q X?81@X5O0G&!^-2?;DCGN_/F@6* *2<D%01_%GC\JQOL[C0
M]9 A;>]PY V'+=,'WJ*YMIWDNI!!(ZH]O(RA3EE5><>N/3VH W8-8T^X@EF2
MZ0)",R%\IM'J0<'%0R:W:RZ?>S6<JR2V\+2;'4J?ND@D'!P<=:IW>HQW,-S<
MV5C),\<:J9W@;&-W("G!;;][ K+D>2[N;QTEO+I3I<JB62U\L%O[J_*,_3F@
M#KK25I[2&5@ SH&..G(J:JU@"NGVX(((C7(/TJS0 4444 %%%% !1110 5B.
M;S4-2OTCOI+:*TVQHB(IW,4#%FR#D?,!@8Z'\-NLVZT>.XNI+A+FYMFE4),(
M'"B0#IG(.#CC(P?TH Q=&:\G_LJT2]>"W33(I76-%RS9 ZD' JS/J5VGAJ6[
M68B<7#H&VCH)2N.GIQ6I9:1;6#PM"9"8;9;9=S9^1>F?>JL_ARWN/,1KJ\6W
M>7S3;K( @;.<],]><9Q0!3GN-0N;;4KZ&_DM_LSM'%$J*5^4#);(R2<^HI+J
MZOU*S375U;6_D(T<T,*R1[B.3)P2!^0]Z;JVG7$TUW#;6]\HN<9\N9! YQ@L
MV?F4^N.N*TFT)'7Y;NZAW1K'*L+@+( ,="#C\,4 2Z@&G\/SYGPS6Y)DAQ@_
M+VSG@UF6GVG9I^FQ7LR(UOYTDQVER.@4<8'Y5NFTB-D;0 K$8_+P#R!C%5YM
M)ADCMPDLT,MNNV.:-@& [@Y!!'U% &/)=ZD9DTX7Q61+T0M<!%+,AC+],8W=
M.<?A6EK4MS8>'YGM[AOM$:J%F< G.X#)&,'K4D.BVT(A(:5I(YC.9';+.Y!&
M6_ ^U6;VSCO[1[:8L$?&=IP>"#_2@#*O#+:K;V\FJW;.^]F$,"O-)TZ87"J,
M^G<<^M*&_P!1O+:Q@6[DAD:^EMY)3$H=D56(RI& W [8]NU;=[I27D\5PMQ<
M6T\:E!) P!*G!*G(((R >E1VNA6MH(@DD[>5</<*9'W$LP(.2>2.30!DSWUZ
M]Y=V\=Q?J+3;'&T-L)/,?:"2YV^XX&*Z*SDEFLH9)XS'*R NA_A..156XTB.
M:Y>XBNKFV>0 2^0X DQTSD'!]Q@U-;6\\5S.TDQ:$A5B0DG: .22>Y_I0!;H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH YN]U^X6PUB1(9+=K-P$E=!C&
M$)SR>?F/X8K5@U>VFGDB99H65#(#-&4#(#@L">W3WY%9&HVUT\&N6J6LS-<.
MDT3*!M8808SGKE3Q5S6-/FO[E8XU(5[2>(OV4MMQ_(T 6(-9MKEQ&@FC+H7B
M:2(J) !U7/7U[5%'K<"1VD;>=<3SQ"1?*@/S#(!..W7UJI9VOFRQ^9::FLL*
M$YN)MT:-M(XY^;K_ /JJ72;.X@N+)I864)8^6Q/9MPXH TK[48+ 1><)"TK;
M$6-"Q8^F!4*:U:M:R3,)D,;!'B:(^8&/0;>^:KZW*T-WILBPO+B8Y5,9QM[9
MZU4E74)/M=_!;W$(E9$\L!1*8QU(!X!]* +=SKR1Z?=S0VT_VBW7+021X8>A
MQGI[@U/%J/F3P&1F@#VYE:*2/&,$<EL\?2L=+.ZN/[3*6MXJ36@2(W4FYG;G
MCJ<5/<6=QJ>T+#+"LEA)"3(-I5CC - &C#KEI-(%VS(&0O$TD142J.I7/7Z=
M:;;:_:730>6EQY=PN89&B(20XS@'UQGZX.*SH+1I2JO9ZF)HHV.9Y]T:MM*\
M<_-G)Z58CL[@:5H$9A;? \1E7NF(R#G\: )+/7EEL9KFZMYH=D[0JOEY+G>5
M  !.3QS[U>LM0BO?,55DCEB(#QRIM9<]/P]Q6.L,HL;NVFTV>8)>/*0K;259
MRP:-@>2..,@U>T?[5NN/-%S]GR/)-T!YG?.<<XZ8SSUH U:*** "BBB@ HHH
MH **** "BBB@#%U-IK?6K.Z6TN)X4C=7,*[BN>G'?\*IPV=U)<179MY(Q-?>
M;L8?,B;2,MZ5TU% '+-%=_V*=$^P3&<GRQ*%S%MSG?N^G;KFEET^Z\UL0.P_
MM.*3..J! "WTS7444 8.I6EQ+-K!CA=A+IHCCP/O-^\X'OR/SITB36.H6M\;
M:6:+[)Y#B)=S1G((.WJ0>0<>@K6ENH89X87;$DY*QC!Y(&3^@I;>XBNK=)X6
MW1N,J<$9_.@# MK2[>_@O7M7B6:^:<QG&8T\DH"WH3C]15V"VF6^U=S$P654
M$9Q][Y3TK7J">[AMGA65]IF?8G!.30!BFSN?[.T1! ^^&6,R#'W0!SFL^Z74
M;H*DUOJ;W*W"EP,"!5#=1C[PQ]378T<4 <S=6]SMUJW%K,6G99(V"95AQT/K
MQTJ:-[C2KB\#6%Q<_:")(C$H()V@;6/\/(ZGC%=!Q10!S-_'-',TD=C>VUT8
M5$<EB0Z.0/NLI^7@GJ1T[UIWC:BF@AH8_P#30B;UB )'(W[ >"0,XSWQ6GQ4
M$M[;0PRRO,NR([9"OS;3QP0._(_.@#E)+:ZN7OWBM=2:-]-EC1[O[SN2/E Z
MC],_A6O=64\S:6JQL B.KM_<S$1S^-;?%% '+QO=O!I5C_9MTLEM-&)G* 1@
M+QN!SR#[5U%%% !1110 4444 %<)%_R6.7_L'_X5W=<)%_R6.7_L'_X5$^GJ
M=V"_Y>?X7^AW=%%%6<(4444 %%%% $;PQ2??C1OJH-0MIMB^=UG;MGUB4_TJ
MU56]O#:B)(XC-/,VR.,,%R<9))[  &BQ2E);,C.BZ4QRVF69/O O^%1GP[HC
M#!TBP(/_ $[)_A3X-3'F2Q7J+:RQ ,<R H5/ (;CN,<@4_\ M73MH;[=;;2V
MT'S5Z^G6E9%*K46TG]Y6_P"$8T'_ * NG?\ @,G^%'_",:#_ - 73O\ P&3_
M  JZ;N-&F,KQ1QQ $N9!QGU]*3^T+(6WVG[7!Y&<>9Y@VY^M'*NP_;U?YG]Y
M3_X1C0?^@+IW_@,G^%'_  C.@@Y_L73O_ 9/\*LW>H1V^F27L6V=%7<NUQAO
MQJ.#49?M$<-W;+"95S&R2;U;')'0$'\*.5=@]O5_F?WC?^$?T7_H$6'_ (#)
M_A4@T72E.1IEF#ZB!?\ "B36-/CM9[C[7"\<"EI-CAB*>=3L5BBD:[@1)AF,
MM(!N^E%D+VM3^9_>*NFV*?=LK=<>D2C^E3)!#']R)%^B@5)13L2Y2>["BBB@
MD**** "BBB@#A=5_Y+#H7_7E)_*2NZKA=5_Y+#H7_7E)_*2NZJ(;OU.[&?#2
M_P *_-A1115G"%%%% !1110 54?4]/CN/L[WULL^=OEM,H;/IC.<U;K$TZV@
MN6UB*>&.2-KU@RNH((V)0!MT5Q]IJ=P(+*P2>Z$:I,S300^=(RI(40=#CCJ2
M.WO5ZSU._BDMGOC((&:2$F2+RRQ'*/CJ,@$>F: .BJHL=K;ZBS^9BXN0 %+=
M=H["L#^UKV5K:)I;F-9T>X+V]OYCJF<*H&"!P0<D4)>71N[":[20O$)\&2/R
MVD4+D$KVS0!U5%<X;G4;>QMM4DO3()'7S+?8H0*QP IQG(R.I-1"[U,:9<:H
M=08^1,V(/+0(R!L8)QG..^: .HHKF9+G4KB+5KF/4&A6T):&-8E(.$#8;(R1
M],5(MW?65SITT]XTZ7@<21>6H5"$+@I@9'W<<D]: .@=%D1D<95A@@]Q1&B1
M1K'&H5% 55 P !VKEK#5=1N!8W8-Y(;AE,L!M"L2(W]U\9^7(.23G!XY&%MK
MS4SI-OJDNH,Q:Y\MH!$@0H92GIG..<Y[=* .I!!)P0<=:6L/0H'BU#5V:YFE
M'VK&U]N/N+SP!]*35KJ5+MXXM0N(V2/<L-K;>8P/JY(/'MQ0!NT5S5O?:AJ=
MS8Q+=FV26T,LICC7=N#8XW XI+>_O[TVMA]K,4A>42W"(NYE0XX!! )SZ4 =
M%'/%*\B1R*S1MM< _=/H:DK$T%)8[G5$FF\YQ<_?*A21M'7'&:VZ "BBB@ H
MHHH **** "BBB@ HHHH R[G7K6VN+B#R[F5[?:9O*A+; 1D$X[8_'BEM]>L[
MF>&.,3".?_4S-&1'+QGY6^GY]JCAMIUO-9<Q,%F*>6?[V(P./QJI+87+Z;H,
M0A<-"T7FC^YA"#G\: +PUZS:X$868H7,:S>4?+9_[H;USQZ9J"Q\0":UNI[J
MVFA6&8QJ/+)+>@ !.36=8Z68DAL+FUU.1HI.HG/D$ Y#=?TQFI@-1MK2^A@M
MKE7^U&0O&%R\9QG83QN^M %J\UU?[+O)(1+;W%NJLR31X902.<=Q5JUUJWG<
MQR+- XC\P&>,H&4=6&>U8#6EY*-1DALK\J]N@B^U2 N[!LD<D[?QJY=076ML
ML:VDUJL5O(A>< 9=@  ,$Y'')H T[;6[6YN(X@D\8ESY,DD159<?W2?SYQ53
M2]3FN+?3&N+@>9<"3</*^_M]Q]W'ZTQOM>HO86QL)[?[/*LLTDF-HV@C"D'Y
MLY[=JK6>EW?V728I(7C*1SK(?[FX8&: -:#7;2XGCC59ECF;;#.\1$<I]%;\
M#CUQQFDUR^EL;> QRQ0++,(WGE7<L0(/)''< <^M5M.FNX[>RTY]+D$D 5)9
M9,")0H^\I_BSQ@8[\XQ3M>M3<RVOGVDMW8+N\Z"/D[CC:Q7^(#G\2#VH NZ1
M<SW>G1RW &\DX8*5#J#PV#R,CG%7JP-!.IF[G6^6Y%NJ 6QFQEESU?!/S=![
M@9ZYK?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BEMX
MII(I)$#-$=R'/0U+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7'XO3H\-^-3NQ<-.$SORNTOC&WH>._6NPJG_9=J+-;78?)5PX&X]<YZ_6
M@#!OKJZT2>[BM[B>?-JLJB=]Y5R^W(S^>.G%(\^I:=!/=11W_E+:NSF]D1P)
M !M888D=\CIQ70S:=:SW#S2Q!V>+R6#'(*9SC'XU#;Z-:6Y;_72JR&/;-,TB
MA3U !.,4 99L&M-9T5C>W4^YY-_G/N!;RSR/[OT''M4.F37.J)IUK/=W"(;1
MIY'CD*O(V_: 6'.![>HK7M] L;:Y@N%\]Y+?<(?,G=Q&",$ $],4YM$LC;6\
M*"6/[."(GCE974'J-P.<'TH H7(DB2WLY;^\N7WOA+7"R.HZ;WR,8R,G(SQ5
M&*:>46*3F4F'4S&OG$%]H7(W$'!//6MM] L&AAC198C$6*R13,CY;[V6!R<]
M\]:=!H=A;*BQ1, D_GC,C'Y\8)Y/- %;55FN-6L+5;J>"*0.9!"^TM@<#/;\
M*S7EU&[DNW@34C)!*8X/*D01C;C[P+ MGOD?2NFDM8I+J*X929(@0ASTSUJK
M/HUI/<-.?.1G(,BQ3,BR8_O 'F@#(6*[O&U.66_NH9("#&L<F%C.P$\=QGL>
M*?8R3Z[*_GW4\"QQ1X2W<QDLRY+$CK[#I4Z>'XY[V^DN1*L<T@PL<[*)%  P
MP!YJ]<Z/:7+J^)8G">7N@E:,E?[IVGD4 85G-=ZK>V<,U].B+#+YA@?9YI20
M*&)'3\/6H_+:PTWQ!/;W%PLBW> S3,V.(_4]>>M=+#IMI;RPR0Q!##$84 )P
M%)!QC\!44FBV<KW982;;K!E02,%)&.<=CP.1Z4 94L=Q>7^MYU"ZB6V9/)2*
M3:$/E*V??GL>*6UDN-9G4S7<\"Q6<,H6!]FYW!)8XZ@8X'3K6VMC;K)=.%.Z
MZ(,OS'G"A?PX%9.I:6R-;BTL7D$</DJ\5V86"CHK?WE_6@"[H,DTNC0//*TT
MN7#._5L,1S6E5'1[$Z;I5O:,5W1J<[.@)).![<U>H **** "BBB@ KA(O^2Q
MR_\ 8/\ \*[NO.M>NI/#/Q!77KNTGDTZ6U\DRPKNV'W_ "_6LZFEF=^ 3E*<
M%NXM+S/1:*P+#QKX=U$#R-6MU8_P2MY;?DV*W(YHIEW12(Z^JL"/TJTT]CDJ
M4:E-VG%KU0^BBBF9A1110 5GZE%,)[2\AB:8V[MNC4@,59<'&>,C@X^M:%%
M'.WEG<:D\MT;1T0^5&D4F-S 2!F)&>!^O6K<U@S7FI2"W4^=;HBM@?,1NX_4
M5KT4 <TNGW: 2M;NXC,#-'QE]J\XYZ@U/<Q-,HN5TZYA;S=P>(KY@XQN*G@^
MF.M;U% &$]M=2>&9XFM@)VR0B*%+<YR0#@$T3)=:@(MEDRI;QL<7 "^8Y7 7
M&>GJ:W:* .56SO[EYLP7 #6,D*^8D<:ACT4!3G'UI]\E]<1R".RN$$UIY8*1
M1EW.#E7+'"@=OJ>:Z>B@""R5TL;=7!#B-0P/4' J>BB@ HHHH **** "BF/+
M'$NZ1U11W8X%8U_XQ\/::#]HU:VW#^&-][?DN:3:6YI"E.H[0BWZ&#JO_)8=
M"_Z\I/Y25W5><:;J!\6?$>QUC3[2X&GV5N\3SRIM#$AL8_%AQUKT>HIZW?F=
M>/BX>SA+=15_+5A1116AP!1110 4444 %93Z)F6Y,>H7D4=Q)YDD<90 G !P
MVW<.@Z&M6B@#.ET>W*6PMGDM'MEV1/ 0"%X^4@@@C@=1VHN=&@O-+-A<S7$J
MDAC*TGSYSG.<<?@*KS:M/!XHBL'6/[)) #NQ\RR$MCGT(4CZXI-1U>>WURPL
M;=4*2-_I#,.5!SM ]R0?R- %RZTR*X:%XY9;:6$;8Y(2 0/3!!!'U%(FDQ"2
MWDDFGF>$, TK [MPP<\?RQ48UVS-P(\3A&?RQ.86$9;IC=TZ\>E07NNQ^5>Q
M6GFF>W#!G\H[$8=B3Q0!)'H,"/$IN+E[:)]\=LS HI[=LG'8$U3L-!>2W=;N
M>Z2)KAI&MMZ[&^;(SQG'0XSBM&/6+49227YXX1+,P'RH".YZ ^U5Y?$, M;E
MXH;CSHX3*D3PLI=<=1GJ* +G]EP"*]C#/MO,^9R.,KMXX]*5]-A=[)RSYLR3
M'R.<J5Y_ TNFW;7VGPW+1/$SJ"5=<$50EUB6/Q"EH%C^QY$,CG[PF9=RCZ;1
M^;"@"Q;:,MJ\8BO+L6T9)2VWC8OMG&X@=@3BE31K=-,2P#R^4DGF Y&[._?Z
M>M+=ZS:VD[0LL\C(H>7R8F<1J>A;'3OQUXIL^MVD+*J":X+1B4_9XC)M0]&.
M.Q[>M $]O8+;7MQ<QS2XN"&>(D% V -PXSG '?%5[K1DN;J2=+NZMS*H2587
M $@'3.02#SU&*6;7+*(1E#)<&2/S0((RY"?WCCH*)=<LT6(Q^;<>8GF 01%R
M$_O''2@!UGH]O8O \;RL88?)7>P.5SGGCK4;:'!Y:B*>>&5)6E29&&Y2W4<@
M@CV(ITFMVBQPM$)K@S+O18(F<[>Y([?C5RUNH;RV2X@??&XR#C'Z4 0:=ID>
MG"<I--,\TGF.\S DG&.P%7:** "BBB@ HHHH **** "BBL&6&2_\17=M)>74
M<"6\;!(92GS$MSD<T ;U%<?!?7U_]AMG%W,@M?-D^S2K&\C;BH)8LIXQGCN:
MOV$FH1W]A!>-,I,5S\LC@LRADV%MO!;!_G0!T-%<FTMU=7!M_MMS&K:P\1,<
MF#Y8B)V@]AFKD=LU[=WT+WMU&EIMBB6.=E(^4'>QSECSWR.* .@J&VNHKN(R
MPG<NXKDC'(.#7.:=/<:W<11W-U,BQ6^[]Q(8_,;<5W''TSCIS52SENMEK8)]
MKFB+3/(8)%CD<A\#+97]* .THKF(AJ$L]IIUW+=P1,TC@^:!*Z+C:"ZG^1S5
M9[F]@GEL8Y[R='O/+R)!YBIMSM5F(Q]>M '845R-S_:D$2Q;[RUMY+R)8FEF
M5Y #G<N03D?7UJ6^GNM*:_M[6>XD!2W,?F2>8T9DD*,06]AD9.,T =317)7G
M]I6=AJ,D0O[>#[$Y#W-PLC+*,8*D,2,C.>W J_>6ZVHMK07.ISR2,TACBF^>
M3 &27)&U1D< @<T ;<DL<.WS'5-S!5W'&2>@I$GCDEDB4DO'C<"I&,^_?\*Y
M%D>\LX([I[K,&J)$FZ<[PN5.&*GD\]>M7KF:Z2XU%XIY<6DD+A-YP5P=P_&@
M#I**Y6[U&[G,D]J\S0SW"6\?E. =N,L5R0 3ZUI:1'>Q74ZRQ726A ,8NIED
M8-W (8G'U- &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C*KJ58 J>"",@TM%
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MCZ5T]% '-SI<&"TEO;2\%P(B/M%D?G4YZ,HXYZ]QFM?2OM7]G1&]7;/CYA@
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M&%IJ"Q@VT=J\;-N'#$C''6MB6))X7BD4,CJ58'N#0!XEX.\5^)-0\0?8K22
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MVTC20W=S$98[>6,A]HZY[#\Z-#URVUZR>ZM8Y419&B(D !RIP>A- &G1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0D*"20 .I-
M9*^(;8E9#;W2VC,%6[:/$1R< YSG!/?&* ->BDR/7K2Y H **@^UP_;1:;_W
MQ0R;<?P@@?UJ?(H **RY]<ABFE2.VNKA(3B66&/<J'N.HSCVS4\.IP3WD<$6
M7$D/G+(/ND9Q0!=HHR** "BJU_>I86<ERZLRIC*KUY(']:@O-9MK.7RB&DD
M!8*5 7/3+,0H)],YH T**K6=]#>HQCW*Z'#QN,,I]Q_7H:LT %%%% !1110
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M+ZGI4FE-OM8X&6Z:3^$ $C:/45U]A]M^Q1?VC]G^UX_>?9\[,^V>: +-%%%
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MM;JN1%<)*3%MV[&1\9V_PD@\J. 1Q714 %%%% !1110 4444 %%%% !1110
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M1!\_Q.!DGTSVKMO!D4L7@Z1'NX+F,-)Y30.S(J]E!8 \4 =2MS Q4+-&2W(
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M[@P'(_#/-6FUF6"UOS-"GVJU<(L:,2)"P&S''<G'YTL>EW!FL9I3:HT#NS)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%9!V.![5;TSQ+XDU);6[71K?^S[X-Y#I(S/#UVM+VVD^E '72VEO.X>6")W
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M2!![X'6IJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH) &2< 5DKXAM&=3Y
M=R+9F"+=&(B(DG ^;T)XSC'O0!K4444 %%0_:8?M8M=_[XH9-N#]T$#.?J14
MU !15.QU.VU!KA(&;=;R&*0,,8/^%)#JEM<:I<:?&S&>W56D^7@9Z<^M %VB
MF2RI#"\LAPB*68XZ <FB*5)HEDC.489!QU% #Z*K7%XEO<VT#*Q:X<HI'0$*
M3S^56: "BJU_>QZ?8S7<JLR1+N(7J?SJ1)MT\D7ER+L .\CY6SZ'\* ):*:[
MK&C.[!549)/0"LT:]:EL[)A%_P ]2GRX]2,Y ]R,4 :E%("& (((/((I: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK_ZMOH:=2$;E(]1B@#C
M;5!=^'5M(M)FDG9G"2F)553O/S;B>,?G5[4+V[M?-"ZFWFV\8/E0VIE!('/F
M'!QGZBMVRM$L;1+>-F94S@MUY)/]:H76@BXDN?+U"[@BN?\ 6Q1%<$XQD$@D
M?@: *<'G3:_]J-S( ]@LABVKMY/3IG'XU7CU>X>*QM5EDMPUOYTDMO:F0\D@
M  *0.GI6T-(5+B":.YE0QP^0RX4B1>V>.#],5'_8B1Q6_P!FNIX)H$\M95VD
MLOHP(P?RH SH;_5;RXL;7SOLYD28R2&WVLP1E 95;IG/>JUT]Y=I8QRWT@EM
M]4\@R)&@WX#88@@X./3CVKH(M,6.YM[A[B:66&-X]TA!W;B"2>/;M4,VAQ21
M2*EQ-%(;K[4LB[24?V!&",9'/K0!%XJC:3PU=JLK)\@R5 .X9Z'(-0:A=7-A
M<3JDHD>+3I)1(\:[BP88S@=/;I6O?627]A):2NP61<%EQFHKS28;V661Y)%,
MENUN=N.%8@Y^O% &;'=ZA:264MS=B=+F)B\8B"A&";OE(YQQCG-5I/[0G@TN
M]N+Q72>YC<P^4 $!.0%(YX]\UNMIL3FTW,Q%L"%''S97;S^!JFGA\*]NIO[H
MV]O()(H"5VKCH"<9(^IH H)?7SFV@MYHX3-=RQNPB'"@=AZU(=0U"+S=/^TJ
M]P;E84N&C (4KNR5'!(K2CT6".6%Q)(3%,\HSCDMU'3I4.HZ9&(;F9%N9)9)
M%E'D%=Z,HP"N>#]#UH 73Y+V/6+FSN;H7$20HZ,8PK9).<XX/2M>L'1+:Z.H
MW=[.;HK(B1J;D*K-C.2%'"CFMZ@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cntg-20211231x20f008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '. VD# 2(  A$! Q$!_\0
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M$P/.>>N*T==BM=3N %+&*6)6DP<9YX_K4NG:W<V41MKBSFECC.(Y%=2=OO\
M2BZORR86ERJ<$4BFN2R+%#8.&"9<R,5 /H#T/YT WUD4@OB3,X)14;<Y'N!6
MG)K]U<MFTA$$0/#3*2S?\!XP/QJ$ZG<;7BO&+PS#898E"O'GO[BE:&URDZUN
M=K0U-$L);:V9KD*'<Y"!BP4?4]ZU-B?W%_*H[6!+:UBAC)*(H )[BIJV2L<;
M=W=D,T4>TMLR1Z<54\LGD(<5HT@4#H!3$4?)<#.RF8'I6E5>XB7;O'!% %7
M]*,#THHH ,#THP/2BB@ P/2C ]*** # ]*,#THHH ,#TJ6$1DG>!QSFHJ4 D
MX% %T1IN)"+R.N*=L3^XOY4V%]T:YZ^E24 -V)_<7\J-B?W%_*G44 -V)_<7
M\J-B?W%_*G44 -V)_<7\J-B?W%_*G44 -V)_<7\J#&A!!1?RIU% #!&@4#:.
M/:EV)_<7\J=10 W8G]Q?RHV)_<7\J=10 W8G]Q?RHV)_<7\J=10 W8G]Q?RH
MV)_<7\J=10 W8G]Q?RHV)_<7\J=10 W8G]Q?RI'$4:EG"*HZDX %.9@BEF(
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M&BEF"A0,DD=*?39(UEC:-U#(P(8'N#0!R.H:LL\AN-YAM8TW(O&6]7..<<C
MJ/3XKZ29'N7=89&$JNQ.T+D;57W)K2;PC91RQRVYE7RH]JQ;_E<]?F)SQTZ8
MZ5FR6]S!>VB3;FN9)UEF\M@=BCA1SQCEN!VQ67+K=G2JB<>6".KO[Z'3K*2Z
MGW^6@Y"+N)^@J"WUFUN&5!YJ/N*.KH5,9 SAO3BEUFP?4M+FM8Y%C=\;68$@
M$'/(%9C^')+B=KFYFADFD9FD7RV"$%"@4<YQSG-:G,:;:UIJRQQ?;8&DE4O&
MBN"7 ZXQUJ:'4+681A9D#R+N$;, V,9Z=:Q(?#UU&8'>ZB=T62,AHR=J,!@
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MJ01UI50E@#P/4TY5E63:$!&<\B@"U'M<!\<],]*DHHH **** "BBB@ HHHH
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MM/$?XF&&4?D<_I6!2UHJTD82P=)[:'46VN6-U<>2CNI)PC.A4/\ 0FM*N!F
M,,@//RG^53Z5//:PVUQ#([,(P&221BK @>IX/O6L:U]SEJX-Q^!G;U5OM1M]
M.B#SN02<*BC+-]!7)ZI>W&K7WDLMQ;6PARI5\9;(SG!ZCC'2FM:QRI()RTS2
M8\R1S\S8Z9/X54JJ6QG3PLI:O0U6\3*]U9R6XW6KAA<HP&Z+) 5C_/'IS6L-
M4MCJDFGY831Q"9R1\H7..OK7+B*-5*K&H5NH P#4/V0>?+,9I&>4;7+8)*X
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M]:E<UX39W-\[P*A:1274GYCMQW'; %=+79';4\>:2DT@HHHIDA1110 4444
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M,K"W[Z$''V@-PH/0'/7ZBM@'(J306BBB@ HHS2$\<4 &:6F_-0,]Q0 M%%%
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M6:Z??;@0(;@EE[;6[C^OYU!:_P#'W#_OC^=<3CRRL>U&HJE+F\CM:***[CQ
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MJPRC#N/<54P#P:Z"VFL/%VL06WVDVX!8#*8<C';M5'7=(?1=3:U9F="-T;D
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M\T01"0_QA!G\Z%<;:>R)$=9$#*>",C(Q3JBD(BS*%D<\#:G/?KBI:9(4444
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M&?QK8# UO3@EJT<5>JV^5/06J&KX^Q*?X_.0(?0DXS^6:OYK*OYA<W MU^Y
MX9V]6QPH^F>:N3LC&G%RDDAA (((X/455-HT.6M'$??RFYC/X?P_A^56JAN)
MQ!&#L9W8[41<98GZURH]1VZD.FB5K<W,KJ7N-LA"# 7Y0,=?:KF3ZG\Z@LXV
MAL8(G&'2-589[@5/0P6P9/J?SIT$BPZC:SR'"*Q#,3P 01S3:HW3)+<B&63;
M B;I 6VALG !_6G%V=R:BO%HR?B%X4A@CDURSW#<X,Z#E>?XA_6O.:]PTR]A
MO[6;1W9 5C*JQVL'!)X /!P,5RUGX1TI8Y!/;F1_,<?,2I49X& :VG;<VP..
M<(NE-7MMZ'G4<<DT@CB1G<]%522?P%:47AW5I'0&RDB#G :7Y1FO0].T+3](
MEEFM8V0L,%G?.T>Q/2KZVKZH!! K[&/,VP[5]P3U/TJ$[O0Z*V8-:QT1SN@>
M'O[$:2YN9T>5EVX4'"_XUVVB:>ZL;V?S5E8%5C< !5]0.H-3VNAVT$JRRN]Q
M(OW3+C"GU  K3K2$+.[/&Q&)=5A1116ARE6\TZUOPOVB+<5Z$,5/YBN5O84M
M]4N88XUC12NU5&!C KM*YGQ!;F*_CN /DE783_M#_P"M_*LJRO$Z<).U1)F9
M24M3V.GW&I2,(R(X4.UY3R<^@']:Y8Q<G9'JU*D::YI#;2TGOYC%;[1MY=W!
M*K^74^U=98V:6-G';H2P08W'J3W-/M[:&TA6&",(B]A4M=D*:@CR*U>55Z[&
M3KVEG4+02P-LO+<%X'"AN<<K@]CC%8L$IEMDDD1HV(^=&'*-W!^AKL*Y=='U
M:>]NUE>"WMVF>1)8F+NRD\#!& ?4\TJD.;8="KR73V,DBXU&U$Q,0MV =82,
M^8,Y^<D<<#H*LW7V1]/C:!(X[AEQ%%'+L()Y(XZ]<XJ'3"\D4\;A?+1]F ,8
M;'SCZ9Z59-M;QPLBQQ1J5V9P!Q6:ERZ&\J7M+23+>C6=OJ*_:KG$S0, L9!&
M& ^\5]<YQGIBH]-3[9XD:]6")1M*R)L/R<]2?[QJK#<36<L-[;LGF,?(GC9L
MB0CC=Z\XKK8;@7EDLT'!<< G&#W!_&MDELCEFVVVRQ12+NVC=C=WQ2GIQ5&1
MGR:G;#4H[/SL29Y /&?3ZUH5R%K,;K5U226**8W!<@-TQV'N177TD[E2BHV"
MBBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4=0TZ&[
MB9_+(N%&4=&*-D=/F'.*?IK7;V2&]C5)^X!S5NB@ HHHH **** "BBB@ HHH
MH *:_P!QOI3J:_W&^E #J*** "BBB@ HHHH **** "BBB@ HHHH :G^K7Z"G
M4U/]6OT%.H **** "BBB@"M=6%M>@>?'N(Z,"58?0CFL"\\*-$IETZ[EC<')
M4X.X=^>Y]S7444FDRE)K9G#QQ6^^.WA*M*\JK('?+]><YYKMU&.!T[#TKG=6
MT-U::^M T\I.\0L%)#>JGJ#^-5X/$&ILD=E)! M^< [R0>>A*]OSJ8KET-*D
MO:6:.KK,O]?TW3HY&FNHRZ#_ %2,&<_A6'<^*KB&.:QN+?%Z05W)PJ^YYR/:
MN9&(Y86;&P/\WKD\9_,U$ZRBU%&U'"2J1<WLOQ.]M?$EE/Y2R;H'D0,0_(7/
M8L. ?:M4R*OK@C@^M<C;0>3;"$A=HR-JYP!Z<TY(%CYB:2,^J2$'^='M5U$\
M*[:,ZQ94>/S%=2G7<#Q3E974,I!4C(([UPD^CVC0XAB$94<!>C<YP<^IKK]+
MOEOK))1&T9Q@JW\QZBM(S4C&I2=/<NT4451D%%%% !1110 4444 %%%% $%Y
M$9[.:)0I9D( ;IG%>:6%Q>^<$6YGDFC?8\,C94XX[*< >N:]2K,UBP6XMVN(
MEQ<Q*2C #GV/J*F4;HTISY6<O$UY!-+FS9E<[@$E4@'OR<<5;MYUN(?, VD$
MAE/\)'4526XEC$,HDDN5E!+JNW" =QTX%36-K:ZA<7;-&9(MRD,'(4G'/ -8
M*/,=LJJ@KEB&W6Z'VBZDV6N?DB? 5QZM_A5YI[7"K'<P*R_="R#IZ8':JNHV
MZI9HF\E5D7:C8(^E9NH01PR03Q(B.A8@JH!SC/\ 3]:UNH:',H2JIS;-&YN9
MII8X,20@J79D?!89P!GJ*:INXN(KLE1R%E3?^!.<XI/,:YNY)' 'E_NU'ZDU
M)6<YM2T-Z-*+@N9#3)?$[OM80_W4B!4?GS^M4()I(-5DM&D\V.0&0.>65^I!
M^O6KMQ+Y$#2;2QX"K_>)X _.LYHOL<D$MS.PCW9+*P4"0YSGCD&IYF]R^2,'
M[J-6J5RWEZE9LY38VY%!/(8C@_D"/QIS7IEPMF@F8GEF#*@'KNQS]!39;)I(
M9G?9)=LOR,1@(1]T*>HP><TD:-WV+M%9MNDURTDC2R6]VK89#\P5>PQT.<9R
M.]3BUN&(,MX^5^[Y2A1]2.<_3I2L"=Q5OD:_>UV."B[BYQCMQZ]Z9;P)=2F]
MEBC.]0(@RY*KSS]3FH+VWB_T>U&\RR2!BY(&X9&X$^X[5J  #   '0"F):O4
MI7EO;Q0-.H6!XAN62-0",?2IM$@NM5BEG\^!5,F'*DLV<#)]/Z5.0",$ @]0
M:HFW:W)$< EA))VJ^UAGJ,=&'L:J,ELR*D&W>.AOBTTFRD!NKM))5.1Y\@X_
MX",#]*NVVIPWCNELKR;,9)&T$'N":YBVN+;>88XVA=1N*-$4P/RQ6]HEJ566
M[<$--C;D_P (Z5K"5W9(Y:M/E7,W=E^U>Y>,FZBCB?)P(Y"XQ]<"IZ**T.<*
M*** "J.KVK7FFRQ(,R ;D_WAS5ZB@:=G='"*VY0:Z#PU&1:3RG[LDIP/H /Z
M50OM(NQJ,B6T68YF++)_"F>N?QJ71+I[*[DL9&!@:5DC)7!##KDD\YY(KGIP
MY9.YW8BLJE-*/JSI:***Z#@*.I3W$/V5;96+2W*(Y5<X3JQ]N!5ZH;C8B"9D
MW>5\PPN2.,' 'M4H.1D=Z .$B2:X\47MG 'A,DCDYY*@ '?R.A)Q^E2S63QZ
MHT&HQ1R,T8,)(W(<?>V@]\XS4]O(FF^*[J1L1>?,$?S%P2IP%*GN"W!KI-1T
MZVU*W\NXA$A4[D.2"#[$<BLW%.YNJLH-7V.,,5L;H1VD"AX9%>20 !4]1GUQ
MV'K75Z '_LXEAA&E<Q^ZYZ_SJCI/AI+>19KQ$8^6H$*_<4CN?[Q]ZZ$  8 P
M*<(VU85:JEHA:1F5$+,P50,DD\"E(R.N*R[Z.XU&<V*@Q6@ ,\G0N/[J_P!3
M5F!RNL61FN3?R?:$M9VW*_F %".AXSP>O^%7?">LR+<-I5VQ>?)8.TQ?CJ!S
MGMZ&M;7[73H]!:*X,<,2 +&2N[:>V!7)Z1:K926]U:/*!&W[UV(&_/4!<=.^
M:EM(M)RV/1Z*0'(!'0TM40%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4U_N-]*=37^XWTH =1110 4
M444 %%%% !1110 4444 %%%% #4_U:_04ZFI_JU^@IU !1110 4444 %%-=U
M099@*<#D9% !3#%&7#F-"XZ,5&13Z@N[N*RMS-,3M!QA1DD^E ''>*Y(SJR%
M456V$,0>6P>]89*L"",@]1BK.IWT]Q?L]^Q1\GRU;  7/&/6H.O->;6=YMH^
MCP<>6BHL; S6S;K9S"3P0H!!_ \5NV$[-ID<\\N\[=S/C_"N?=Y#<)#%&&9@
M3DYP/K@5HZ?=26-NUO<1/(P8[#$F0P/J>WXU5-OJ9UU&_NHN7&HVCV[+%=(S
MNORB,[B?RY%:6E:@/L2O#!Y+(?+\DG.T]AGTKG[6%H8MKD9SP .@[#/>KD%Y
M):VTD"VXDWN6#%L 9]>^?I6U.HDVGL<>(P\I132NSJ7U*10OR)RP%68M1MI+
MA;?S%6X92XC)Y('>N+-[J+G+W$:C(PBQY7CZ\U"^H/ITXU.21&E1P3N^4/D;
M=H]..E:>VC>R.?ZG42;EH>B44V.198UD1@RL 00<@CZTZMCD"BBB@ HHHH *
M*** "BBB@"J^G6K,[I#&DC_>95 )^OK5**PFAF:-$ C(R/0'VK7HH PM3TRY
M>.&2!1*\;Y* @9&.>O>J_P#8%Q?HHN76W0'.U/F?\^@_6NEHJ7%-W9<:DHQY
M48\V@QA9)+::992,A2P*EL=QBL.::Y6&7R[&[,J#_GW;:#]3U KM*8)%9V52
MIV\-AN5-*4$RH5IP5D<9;VELVRX0F1OO>9O)W'U/;/\ *EDP=1A$G*[&,?IO
M[_CC^M->5[B\=K&<_9G=VWM;\#GH#GGOVJ*.WOM0MYH))(TE0CYBF-I[%2">
M<>OK6/*[V.SVJ44VBZTV9%BB'FRMG"!@.!UR>U,^U*6V+%.TO_/,1'</SX_6
MKL%I;P3_ +J&-3'&$#!0#S[_ ("K7;%:>R1@\5*^B,6>VO9=LT5JJ3)]TO*N
M3[''\)^O6I!<KD"1)8B>"9$*J#Z9Z5K53U,JUD\# EIP8U'OC^0ZTW3C84,1
M._<H75S:&$QR21ONP%17!8G/&.>N>]);W3(JPW@,<PPNXYVO[AL8S[4L\,$5
MFX>)/F7:?+0 L3QQ^-3HK/;(EP%=BH#@C()QS6'0[=;C9;RV@;;+/&AQG#-C
MBH_M4DO%O;NRGI*V%7ZX/)_*F2P0Q/;11Q(D;RY9%7 . 2,_E6C;VT][(4@P
M #\\C<A?\30E?8F4N57DR&SL#/+]G4EBQW32'KC_ #P!76*H50JC  P!4%I:
M1V</EQY)/+,>K'U-6*Z8QY4>?5J<[N%%%%49A1110 4G>EI.=W;% "UFC1X?
M[0-T9'(+^8(N,!O7UK2HHL--K8****!",H=2K %2,$'O63>7T^ESQ0QVL36G
MEA8_G*X8=L\CIC%:]5+^V:XA^4E@H.82 5DXZ'/Z'(I,::3U,36EM]:T8W*-
M(DMLV60-@IS\V1WXY'KQ4NAW5S;R1V5S.;@,#M<C!4CMUZ5FJ)HI0JNT4_E!
MD,J?,5.05=>^".?P-9JZI/IEW#"]O,TL; IY0)!3O@GK@=CS]:SN^8Z'!*#?
M3H>A2RI#$TDC!4498DX %.!#*"""#R#4*QQ\RA7)EQG.3Q].U<U>:Y?,)((;
M>18_,PDT+9<*#@@@]#Q6C:6YA&#D[(U-;U^'1XPOEO+._P!U5&0ONQ["L"PU
M&1-5!L]US/<'=-$R,H;_ &@3T Z4QA<W \IX3&KG,DC3;RP]/7/\JNV=Q'9:
MQ%(L18R)Y;E%R57/!)[#-9*=Y'2Z/)!LVQ92WEPD]Y\L:-N2#@[6'<D=?I56
M]T*VDO1=SS'[.C&5HR.C =01SCVIS^)[!)G0+.Z(=ID2,LN?YU+9ZDFJW8:"
M!S;Q _OI%VY8]@#S6NC.75&G&RO&K(<J1D?2G5@Z3K;W^K7T#X2* [4! '?U
MZFMX$$9%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !37^XWTIU-?[C?2@!U%%% !1110 4444 %%%
M% !1110 4444 -3_ %:_04ZFI_JU^@IU !1110 4444 4M1TNWU2.-+C?B-P
MZE&*D$>XJS#%Y,>S>[^[G)J2B@ K \23/!]E<H[P[]I"D?>/3BM^N;\1V1EN
M8)W,H1!\KJ>(V_SZU,MC2E\:,^:=9"]O&GFO@@_+E5^IZ?A67<:2]L$-FAD7
MH\>0,'U'^%:\$(@B" ECDDL>I)ZFJU]<.C1P1-MD?)+ 9*KZUR.S5F>K%M.Z
MW,:,2QZHD4D9CD"$MA@1CMTK2J&.UBCG:?YFF88:1V))%35D[=#JCS;RW"BB
MBI&%1S6\-PJK-&KA6W ,,C/^34E%,&K[C;7S[,R"WN9849@RI$=JKP!TZ'I6
MMIWBB>&22WU".2X*X99H8@!@YX;GKQV]>E9=%:1JRB<]3"TY]+'61>(M,E*@
MSM&6_P">D;*!]21@5J A@"""#T(KS^K5KJM[I\6R!T:)>1%(N<>P.>*VAB$_
MB..K@&E>#N=O14<$J7,$<R<JZAE_&I*Z3SPHHHH **** "BBB@ HHHH *CFB
M\V"2-7,9=2-Z]1[U)10!QDSO9!+8PC[1N\M8]P4$XX.3V.*L6<<\<UQ/+#Y2
ME!\N\'<1GGC\!6OKMN\FF3S6Z)]KC0^7(5RRCO@]CBL**YG")NMYYL ??G3Y
MO?BLU&,7<W=2=162-1$*KDG+'DFG5%'=126BW)8)&R[B6.,?6G12QSH'BD21
M3T96R*T,!]86O27*S*T(F011YWH@(RQQR3T P/?FMVL^_3-U;,V?+^88[;N"
MN??KBIEL73^-%62S=U7-[<%D8,NX(1D=/X1FE6X>-UCN4"ECM61.58^GJ#]?
MSJS39(TE0HZAE/4&N6YZEK; ME)J%W%%$2AC8.\G91R/Q)YKJ888[>%8HE"H
MHP!6/X7C9=/D=]V6D(P_+#'')SS6Y73"-D>;5J.<@HHHJS(**8RY97+E<=@>
M#3Z "BBB@ I,#<3SS[TM (/0T %%%% !1110 4444 8.K6<B222J R2LI0JG
M,<O3)/=6X!]*R+FW2]@Y7YUS@,.AQ@@C\2#7:UE7^EO.\EQ 56?LO19./XO0
M^XK.<;ZK<WI5%&\9;,H:;XA?;/%=V$ENL)"QB%&D&W@ 9'>H+ZU-A>RNWFM!
M+F7<(R50]QD=/7GWI^E:J+)KJ"XMY#,)<MY1W # '&<$]/2M8ZYIIP/M*D'J
M I./KQQ^--VDK,2;A+FBM# 2>WD8JDB$XSC/:I[>VM1I$VJ2Y:1P0IW?* #@
M<?7UK6>ZTC4(\2S6<HC.[!<-M]ZN?9XQ8F"W6-$*$( HVC/L*48<KN.I7<U9
MHXN-)+@PV$=^]O'&?ED4<I(?0]QFNB,VIZ?;Q_:I+*2W1562>21E8^IQ@C\*
MR9O#=W=Z:;:.X2VNHI2"_4.IQT[UT]O"WV)8+E4<JNQNX8#OS5132U,YM-Z'
M*1W.CV$%[:1WUO,\LA<(0Y09]3\V#[BJ]Q%-HB0P6LL]P&3= \<IC51Z9)VF
MNU$%LF46*-21@A5'3_"L^[MK653$MI;7$,!+,A;E#CH%QWIM7%&5F92:K>_:
M(YK:82B2,"6*;(\IO4@<9]ABM&+7C& +R C) \R+E>?4'D?K5>QTM+S38KF!
M)K%W&?(?YE7VP1D?ABLR>420R1Y7S8Y5210?NL&'%9MR3-X0IRB^YVB.KC*L
M"/:G5BJS*<J2#[5I6]P95QM.X=3VK4YBQFBHCYKD J$&>3G-2$[0."10 M%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4U_N
M-]*=37^XWTH =1110 4444 %%%% !1110 4444 %%%% #4_U:_04ZFI_JU^@
MIU !1110 4444 %%%% !3)HDGB:*10R,,$&GT4 <D8WAED@D^]&V,^H[&J%]
M!)YBW$,>]@-KJ#R5]O>NBURW5 EXO# A'']X'_"LK:?6N6<;.QZ="ISQOU1D
M).&=U=&B*XXDP#TSTI/M (#*CM&6"^8H&W/U[_A5O4+6W<1RO!$\HD4!F0'\
M_:K=S;+<0&(G;T*D?PD=*SY$='M9;&?11)!=0?>C$Z_WH1@C_@)/]::CK(@=
M3E2,BLW%HWC-2V'49%%(0"<U)09'K2TFT4M !3HX9+F98(1F5^![>Y]A4<C;
M(V;&<#.*Z_1-,-A:EIMIN9<&0J<@>B@^@K:E3YWY'-B:_LHZ;LOVL"VMK% O
M*QH%!^@J6BBNX\0**** "BBB@ HHHH **** "BBB@ /2N0B4HI0KM9&*E/[O
M/2NJN9TM;:2>3.V-2QQUKF,L\DLS@!Y7+D#H/;]*RJ['5A;\S(3:QLW)DV[M
M^SS#LSG/3IUYJ2T5(-2?"J@EBSP ,E3R3^#4^JET0\Z1"T2=PA<;V  &0.X-
M91DT[G34IIQ:6AM]@>QZ&LF[$MW-/"9WCCC90%0+UP&SDC/7^55[/3S:6:11
M3RPML"R>4W!(],@X_#%+$MXE\0V'B<EG<*!DXX[\=.F,?RK251-:'/3H.,KR
M6@&YN+=PEQ$LBD$^;&0. ,G*GV],U='/2H(RD^HF-74E(6!7.2=V!BK2Z9:D
M  SL@XVM,V/QYJ53NKFDJZA)Q9<\/R1H]U;9/G!_,())RIZ?3O6Y6;I<$-N'
M2&-4!Y(4=:MI!(ERT@F8QMR4;G!QV/:MTK*QQ2=VV2HS,OSIM;TSFG9YQ4<T
MPA3)//8>M/1MZ!O44R1:*** "BBB@ I H484 <YX%+10 4444 %%%% !1110
M 4444 5[FQM;S'VBWCD(Z%AR/H>HJH^@VAQY330?]<Y#S^!R*TZ*32>XU)K9
MG/\ _",>3<>?9ZC<02$Y8A$.[Z\"DFT[Q NYTUD,$!VQQVR O[<G KH:*+ V
MWN<O;+JDZ.]UJILWR0P>U0.,>C=",4_3(KC5&E\Z:[FL2!MDF;87(/4!57C\
M372$!@00"#V-1S3P6L6^:5(D'&6.!]*87(TLD08$LV,Y W]/;Z465A;V$;)
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M<D#DUQNCVKW6JPE1\D!\QSV]A]<_RKLZ[</&T;GDX^:=1170****W.$****
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M&Q1WS5$%665YFRWX"M*)=D:KZ"LV!-\RCWS6K0 4444 %%%% !1110 4444
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M840D[2RMDDG=DYSGWK>G*^C//Q--1?,NIJT445J<PA4$@D<CH:6BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK_<;Z4ZFO]QOI0 Z
MBBB@ HHHH **** "BBB@ HHHH **** &I_JU^@IU-3_5K]!3J "BBB@ HHHH
M **** "BBB@ I&8*I8] ,TM,E94B=F^Z%)/TH X-7\Z_7/S;59R?=CU/OBKE
M4HAY=YM''FQ[\'V./Y8JW\V>U<4MSVJ2M$=CBHKB;R(2X0NW 51U8G@"I,-Z
MBH)\F>U0XYESS[ TEN5)V13A_P!9(9?^/H_ZT'J/0?3TJ8*[LJ1KND=@J+ZD
M]*NWT$<MN[N,-&I97 ^9<#M_A6MX=TQHK=+R[C N7'R@_P "GV[$_P#UJ<:7
M-(SJ8E4X>9J:?8QZ?:"%,DD[G8]6;N:M445V['D-MN["BBB@04444 %%%% !
M1110 4444 %%%% !1110 4R:*.>)HI5#(PP0>]/HH X)M/%O)/9M),(T<JT8
M;Y6'8^O(P>OK4HR!C' ]*T=>&W6(\A5\R'Y>>7P>?RR/SK,:1(VP\R*2> 6Q
M7'45I6/7H23IJ0LAD$;%%!?!V@^M,0[I!]G6=E8!5$Q^:1R>H'\(_P _5T3^
M<X2#=.W]V)2W\N!^-=)I6D_9B+BY"FX(^51R(Q[>I]350@WI8BO5C#5/7L6M
M.L$L+<J#ND<[I']3_A5RBBNI*QYC;;NPHHHH$%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 96O1@V:S@?-$X.?0'@_I6170:K+'%ILYD&0
M5V@8SDG@5SL8*Q*&ZA0#^5855J=V$;LT.HJ+[3#UW\>NTX_/&*O6FFW%Z@D,
MGD0G[IVY=O?!X J%%LWE5A%7;*U%;$>@68'[\RW!]9&P/R&!39]!M]C&U:2!
ML?*JME,^X.?TJ_9,Q^MQOL90ZTE122O"CAXSYZ9!C'J/Z>]/1B\:L1@D9(K)
MIHZ%)/8=11104'6MG04(TT2'_EJ[/^!/'Z5BK')<3);Q'$DF1N_NCN?\]\5U
M%O EM;QP)]V-0H_"MJ2ZG%BIK2)+1116QQA1110 449&:* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *:_P!QOI3J:_W&^E #J*** "BBB@ H
MHHH **** "BBB@ HHHH :G^K7Z"G4U/]6OT%.H **** "BBB@ HHHH ****
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M3Y<NT. .IY_^O4N5F:0AS)OL=K13(8_*A2,L6VJ%W'J<=Z?5&84444 %%%%
M!1110 4444 %%%% !1110 4444 %-?[C?2G4U_N-]* '4444 %%%% !1110
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M!4>F!R?QK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH J:EI\.IV+VEQN\MR"=IP<@@C]1618:-=7"[M0(2(L?W/
M&\KGC<P..>O KHL9ZT4FD]RE.4=$PHHHIDA12 Y&<$?6EH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "FO]QOI3J:_W&^E #J*** "BBB@ HHHH ***
M* "BBB@ HHHH :G^K7Z"G4U/]6OT%.H **** "BBB@ HHHH **** $90R%2
M01@@]Z\6(?3==N[=K)U;S?O$E @SU'/3ZU[57 >.O#UPTR:M8B1RH/G1@;L?
M[0!I-714)<KN.CU*&&[M&FBD4>8" R@[NW8GUKO 00".AKQNPNX9EF58C"6"
M@-LW;CD=^V*]/TW6;>6!([B5(I@ OS, ']U/>HA:/NFU9N?OFM48:0OC9A?7
M-.1TD0.C*RGH5.0:=6ASA1110 4444 %%%)D @>M "T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!%+ DLD,C[MT3%EPQ S@CD=^M2;EW[-PW8SC/.*6C SG'- !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !37^XWTIU-?[C?2@!U%%
M% !1110 4444 %%%% !1110 4444 -3_ %:_04ZFI_JU^@IU !1110 4444
M%%%% !1110 4444 <QJ_@32-4E,R*]I,QR[08 ?ZCI5C0_#%KID#":""27<<
M, 2,=N&Z''7%;]% 7&I&D2!(T5%' 51@"G444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !37^XWTIU-?[C?2@!U%%% !1110 4444 %%%% !1110 4444
M-3_5K]!3J:G^K7Z"G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cntg-20211231x20f009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %O Z@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M OT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%0-,RN0 .*3SW]!0!8HJOY[^@H\]_04
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MH?P- &A11UHH *;%_P A*/\ ZXO_ .A+3J;%_P A*/\ ZXO_ .A+0!?HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH J2?ZQOK3:=)_K&^M-H **** "BLJW2ZU!)+@W\T*
MF5T6.)$PH5BO)())XS4W]GW/_05O/^^8_P#XF@"_15#^S[G_ *"MY_WS'_\
M$T?V?<_]!6\_[YC_ /B: +]%4/[/N?\ H*WG_?,?_P 31_9]S_T%;S_OF/\
M^)H OT50_L^Y_P"@K>?]\Q__ !-']GW/_05O/^^8_P#XF@"_15#^S[G_ *"M
MY_WS'_\ $T64DZ7MU9S3F<1+&Z2,H#8;/!QP>GZT 7Z*** "I[?HU05/;]&H
M FHHHH **** "JDG^L;ZU;JI)_K&^M #:*** "BBB@ ILDB0QM)(P5%&68]
M*=3719$9&&58%2/8T  =3'Y@.5*[@1SD8S5'^V;7^Y=?^ LG^%+I4I6#[#,?
M](M0$;_:7^%Q[$?KD58N;U+4J'2X?=T\J)GQ]<=* ,7_ (3'3_[>.D^1>^:(
MO,W_ &=L>N,?>_'&*WI)4BB:61@L:KN9CV'K45M<Q73-(D4J.H"EI82A(]L]
M15;5'^T*NFQG,MS]_'\$6?F8_P AZDTE?J7-P=N56TU]>YH@@@$=#S11P.@P
M.U%,@**** "BBB@">WZ-]:FJ&WZ-]:FH **** "BBB@ HHHH **** "BBB@
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MA+A&9 PVL5(9<$&@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!YD).<?[2GNI]: +=%%% !1110 4444 3V_1OK4U0V_1OK4U !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G
M#_C^NOJG_H-25&/^/ZZ^J?\ H-24 4]7_P"0-??]>[_^@FGR2S0VT)AMFG)4
M JKJN..O-,U?_D#7W_7N_P#Z":+@ VL&;TVG ^8%!NXZ?,#0 S[;??\ 0)E_
M\"(_\:9+-<3@"71#(!R \L38_,U'A?\ H8'_ .^H?_B:T&F2WLC-)*9$CC+M
M)P=P SGCB@#.V'_H78_SAIVL_P#(*@_=^7_I%O\ )Q\O[Q>..*AU6^83Z1)
MY\IYA-)VS'PO_LXJQKO&GQ_]?4'_ *,6@#3/4T4'J:BNKA+2UEN),[(D+''?
M':@"6LUEETRXDEBB>6SF8O(D8RT3GJP'<'N!R#SWICK>0V<NH7=TX>*)I?L\
M>%C7"D[3W;\ZCM6N+8:4T\\D@N+=8969LGS=NX-]3\P_*E?4KE]WF+!UNR88
M@:2XE/W8HHVW$_B!C\:EL+:6)99[G;]IN&WR!3D* ,*H/H!^9S6-ICSOJB6C
MWMZ9+0L;II)RT<@' VCOU!/IC%3&YN/LMC?>;($N;]24!_Y9/E%'_H+?6F]
MA'F=D;]%9<OVC2]DK74EQ:;U219@"Z G 8,,9 )&0:U*"0J!O^/^+_KD_P#-
M:GJ!O^/^+_KD_P#-: )Z73_^7G_KLW\A24MA_P O/_79OY"@"Y1110 4444
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MPQ/*YPJ*6/T%/J*Z@6ZM98&Z2(5_,4 5M*A*V@N9>;BZQ+*?J.%^@& *:_\
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M_P!]"JG]D:;_ ,^%M_WZ%']D:;_SX6W_ 'Z% %OS$_OI_P!]"CS$_P">B?\
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M\?UU]4_]!J2@ K.;0-'=V=]+LV9CDDQ#)-:-% &;_P (]HO_ $";/_OR*/\
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M0!4D_P!8WUIM.D_UC?6FT %%%% !1110!%<0?:(PGG318.<POM-5O[,_Z?\
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MU-)10 N3ZFC)]3244 +D^IHR?4TE% "Y/J:3)]352\O&@:.&",2W4N?+0G
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M_P"+HV:A_P _-I_X#M_\70 Y9[LN U@54GEOM"''OBK-552^WC=<6Q7/($#
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M )!-G_UP3_T$4 :-O_%4U0V_\534 %%%% !1110!4D_UC?6FTZ3_ %C?6FT
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M+6*U98\B$2,[E0QSGHH!'3D\\T :M%9HU*6WBMXKNUD>_="S06J[\ '!;DC
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M&7)[G!QGVJ]52YTZ&XD\Y6>&YQA9XFPP],]F'L:;IM[]LMV60H+F%C'<(O\
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M>VA>*)) 9U+&7=G[H!' QR>>O2@"I#I=]9:E+J$,<4S/+.#"9-I,;LK*0Q&
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MPI(](FA-S%/9W-S%=I'GR;D(H_=JC*X+#CCJ,\&NI$3*H54P ,  =!2^6_\
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M %:.&\DU.XMFU2XVQQ1N"$C&2V[/\/L*FB%Q;:M# ]Y+/')#(Y$BJ,%2N,8
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M_@+_ /95/'<B2\GM]I!B5&+9Z[L_X5/0!1\C4_\ G_M__ 7_ .RH\C4_^?\
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MK@]![#BD32=/CMI;=+.(13#$BD$[AZ$GG_"L>?6M0M+Z6PD:&24R0QQ2I W
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ML&>E;IY)H05;<JO:^NUO*VWS&0Q^3!'%G.Q0N?7 I]%%48!4]OT:H*GM^C4
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M?_(=TS_<G_\ 05K1K.N_^0[IG^Y/_P"@K6C3)"BBB@">WZ-]:FJ&WZ-]:FH
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M^7Y>/3=0!N454T^]^W6[NT1BDCE:&2/=NVNIP<'N/>K= $]O_%4U0V_\534
M%%%% !1110!4D_UC?6FTZ3_6-]:;0 4444 %4+3G5M2*_<S$I_W]O/Z%:?>W
MDD,D5O;Q>9<S!BFXX10,9+'VR.!R:DLK46=OY>\R.S%Y)#U=SU/^>V* (!QX
M@;=_%9C;^#G/\Q5^J.HP3GR;JU4-<6Y)"$X\Q#]Y<^IP"/<"K%K=17ELD\#;
MD;U&"#W!'8CTH FHHK(U 3W.MVMFE[<6T1MI)6\@J"S!E R2#ZFDW8N$.=VO
M8UZH:KN9+2-99(Q)=(C&-RI(PW&1]!6=-:75OK%A;+J^H-'.DQ?<Z$_* 1CY
M?>FZSI\H.GH-3O\ ]Y>QIGS%!&0W(^7K1<OV7O))[_\ !_R+=S9BT^SRQ75X
M6^T1*0]PS @N 00?:M>N>OM+DM!:3?VIJ,V+R &.:8,IS(!R-HKH:$R9P22:
M=PHHHIF85/;]&J"I[?HU $U%%% !1110 54D_P!8WUJW523_ %C?6@!M%%%
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MV><?4UH#16A.;.^EMV:%(92(U;>$& PS]UL<9_3BF_\ ".VJD"*22.-1;A4
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M  #G JW110 4444 3V_1OK4U0V_1OK4U !1110 4444 0M!EB=W4^E)]G/\
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MN:LT4 4_L!_Y^KG_ +Z'^%4X(I)(@S75QG<PX9>S$>GM6Q69:_\ 'N/]Y_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M _0=JEHHH **** "BBB@ HHHH 6Q_P!==_\ 71?_ $!:*+'_ %UW_P!=%_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB%8R"P8N ,#J<T!9LGHJ(W, B64S1^6PRK;A@C&>#]*6*XAGA$T4J21'D.C
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M#1_A7:T4<C[A]:I_\^H_^3?_ "1Q7]O>-_\ H4X/_ T?X4?V]XW_ .A3@_\
M T?X5VM%'(^X?6J?_/J/_DW_ ,D<5_;WC?\ Z%.#_P #1_A1_;WC?_H4X/\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cntg-20211231x20f010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &> Z@# 2(  A$! Q$!_\0
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MG]MC_G@?^^J/[;'_ #P/_?58]%'M9=Q_5J78VEUH-N_<GA<_>IO]MC_G@?\
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MBB@85(_^JB^A_G4=2/\ ZJ+Z'^= GT(Z***!CX^DG^X?YBF4^/I)_N'^8IE
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M% !1110 4444 9.N?ZN'_>/\JQJV=<_U</\ O'^58U<E7XCU<+_"04445F=
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >AJ2?_7/^'\JC/0U)
M/_KG_#^5/H+J1T444AA1110 4444 %%%% !3S_Q[C_?/\A3*>?\ CW'^^?Y"
M@3&4444#"E'4?6DI1U'UH =-_KY/]X_SIE/F_P!?)_O'^=,H8EL%20_Z^/\
MWA_.HZDA_P!?'_O#^="W"6Q'1110,*DB_P"6G^XU1U)%_P M/]QJ$)[$=%%%
M PJ1_P#51?0_SJ.I'_U47T/\Z!/H1T444#'Q])/]P_S%,I\?23_</\Q3*!(*
M?'TD_P!P_P Q3*?'TD_W#_,4(&,HHHH&7].Q]GO<]/)_H:YP-!@?NG_[[_\
MK5T>G_\ 'M??]<3_ "-<N.@I5-D5AU><_E^1+N@S_JG_ .^__K4^401S.@C<
M[6(SO]#]*KCJ*EN?^/N;_KHW\ZROH=5M1PFA6-U$38;&?G]/PI91!'*4$;G
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M\<D?EN  9/O]P#[>]1R_ZBW_ -UO_0C20=9?^N3?RIWU%;W0W0?\\G_[[_\
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M^KA_WC_*L:N2K\1ZN%_A(****S.@**** "BBB@ HHHH **** "BBB@ HHHH
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M8)0>I]<UDKG2TKJR(3<RX/[S]!4UR(FN&9I6#$*3\O\ LBHC<RX/S+_WPO\
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M9!-6M'M;JT>X68'RR059GW,3DYS^E7K.[2]MQ-&K!3_>&#4] !1110 4444
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M89%]\_[C?R-1U(LB*<B+J"/OGN*5_+7;^[/*@_?- 7UV$;_4Q?\  OYTD/\
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M/R2_]]C_  J6Y$'GMDR@X7H ?X1[T= ^TM_ZL$?DB"<@.W"\'C^(>E1;XO\
MGB?^^S4L;1I#.8P6.%XD4$?>%1^<<?ZB'_OU0P6[)+I(3=S$R$'>>-GO]:>Z
MR!(#%#YBB,8;RR>YIET\7VN;,.3O/_+0CO1,L;K"1((QY0^4Y..3WQ3ZLE7L
MK_U]P^25XECD:%%D<N3E,?YZFE9PLMU$(H]BAB!M]#Q_.DVD6L00PR#+\N/I
MZT33,@1BD!>7=O(0'/-,FPQYLVT1,4?5Q]WMP?ZFIO-S??ZN/)3<3M[E,TR2
M0#[2GE0[8F^0;!QEL?R%'GGS+9O+AW. &.P>I7^7% 6NMN_^8P3?Z&3Y4?\
MK!_#_LFIEE_TV(>7'_JU_A_V*C,V(9P(H<+(,#8/]H4\3?O$;RX=WV<MG8.H
M! _E20-;Z$23?Z&Q\J/_ %B_P^QJ9)?]-MQY<?W$_A_V:;#(&%LABAVR2'<-
MG7' _F:(9RQMG,<.XR;,[!T&W_$TT#6^G]?TB-)O]$<^5']]/X?9JD\XB>W
MCCY1 ?E['@_SJ-IMMHV(H1^]Q_JQV''\ZEFEV-<$10YA953Y!P,FE<;6NW]:
M(8)?W=POE1[4.0-O?=C^5:6M(\WAO3MB9.5.!QCY35!Y0K70$4. JG[@[E?\
M:OZTC3>&].VH"<J<#@#Y35KX9>GZF,_XD'Y_H8$-M,(IP8\$Q@#YAS\R^]+;
MVEPL[!HB#L<8)'7:1BH/LDW_ #S'YBK  _MIN!_KF_K6"Z':V[.S_K[Q+2UG
M%W"QCPJN"3D< 'KUIL%I.)XV,1PKJ2<C@9'O45H!E^!_J7_]!-+"!Y5SP/\
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M'_SS/_?5&Z/_ )YG_OJ@+^0RBG[H_P#GF?\ OJC='_SS/_?5 7\AE%/W1_\
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M/&\X^1?6B4W(6$"14_=C@$#N>U-]24]%_F-W@VL1C:)!E^'.?3VITFXP0_\
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MG_[[_P#K5-39&N'^.>G;\@\Y?^>$7Y'_ !J69%D6%O,BCS$/E.?4^U1;H/\
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M?]:DB#;FW;@-C9)!]*$$MA/+D_O#_OX/\:?('#*/*#?(O.W/;UJ+;'_ST/\
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M?W3^5+YC_P!]OS-'F/\ WV_,T@U$V-_=/Y4;&_NG\J7S'_OM^9H\Q_[[?F:
MU)'3(CRZ+\@X8G/?VIGEC_GK'^9_PI923Y9)R=@Z_C4=-@D[#_+'_/6/\S_A
M4DJQ[QESG:O1<CH/>H*?-]\?[J_R%'05G<7$7_/1O^^/_KT]-BQRE6+' X9.
M.H]Z@S[U)$5V2Y&1M'0^XH0-:">:?[J?]\BI(9"9T&U.O914>8_[C?\ ?520
M&/STPK [N.::W$UH]"$.^!\[?G4D3DLVXL1L;(S[4T328'[P_G3XI7+,"Q;Y
M&X//:DAR3ML,S%_<;_OO_P"M4DAY7$0(V+R03VIGF-_<7_OFI)#DKF4K\B\
M'CBF)[BC<8.( ?G/&T^E"@JDA:(H-HY4$'J/6D.TP#=*Q^<]O841;560J[YV
M]A[BF+H*C I)M+$X'^L(QU%*6*QHQ:)6Y&0N>/P^M"MNCD!<MP.'X'44N2(4
MQ@<M]Q\#M03U_KL*RMM<+&A VE>!Z<FGE'\PYC3#.V[@<@<BF.N9)28\YC[-
MDG@4]U&X_NG_ (__ $$4R1H64J-T2Y*'/ ZCI^F*&65E;]VI+(N.!R?_ -6:
M=M&4_=/U_P#9!0B#]U^Z?JG_ *":+!?J6;5'D^V+A5#QX5N,="*Q1X>GQ_Q]
MVG_?9_PK2"@:5?81E_T,]?HU>2Q0R2IF-"V,"LZLDDKJYUX*A*HYN,^6UNE^
MGJ>D_P#"/3_\_=I_WV?\*?)H,SB,"ZM?E0*?G/J?;WKS'!QG!Q]*-K9QM.?I
M6/M(?R_B=_U"K_S\_#_@GI7_  CT^/\ C[M/^^S_ (5)-H,TDI875K@@=7/8
M >E>8E6#%2I##J,<B@ GH"?PH]I#^7\0^H5=_:?A_P $].309EBE4W5KEP /
MG/8Y]*9_PCT__/W:?]]G_"O- K$9 .*,'&<''TH]I#^7\0^H5?\ GY^'_!/3
MYM#GDGD<7=L S$@%S_A2OHER5C"WMN-J ']X??V]Z\NJS??Z^/\ ZX1?^BUI
M^UCOR_B3]0JW2]I_Y+_P3THZ1=^2B+?VX*EB?WA[X]J&TF\,<:B_M\KG/[P\
MY/TKRRBCVT?Y?Q'_ &=4_P"?G_DO_!/4Y-)NV5 +VUR$"DELY//M4G]F7/VW
MS?M=ILW[L9YQ^5>444>VCV_$7]FS_P"?G_DO_!/4UT><0NGGV&6*X].,^WO4
ML>ES*(LSV>$#!L,1USZ?6O)ZLQ_\@RX_Z[1?R>FJT?Y?Q%++JEOXGX?+N>FI
MI,JI&IEL?EDW'#MTX_PJ6VTN97/[ZV),F_$;8XP?;WKR2ND\"_\ (UP?]<I/
MY54*L7)*WXF6(P$Z=*4^>]DWM_P3N/[,E\K89X<["O\ K1UW9_NT_P"P/YI;
MSX<&4/\ ZP=.?]FO-K[_ )"-U_UV?_T(U7J7B$G\/X@LME)7Y_P_X)Z>NG2A
M%43VX(W'B3(Z#'\/8C-.U;3VO]-M[:*>!6C?)+-@8P1QCZUYM9?Z]O\ KC+_
M .@-5>CZPN6W+OY@LMGSI\^VNW_!.V_X1:Y_Y^[/_OL_X5-/X;NI+F5Q>6H#
M.2 7/'/TK@ZL7_\ R$;K_KL_\S4>TA;X?Q-GA:W,OWGX?\$[=M!OMD:QW]NH
M1 I_>'KS[4KZ'?,D0%]:95<$LV<G)/I[UP\/_'G=_2/_ -"JL>AI^UC_ "_B
M)8.JW\:T_N_\$]"GT*_"QJ;RS4B/!W<9.3[>]..CSFZED^T6.UU8##8;D8Z@
M5R?Q*_Y#5C_UYC_T(UQ=:SE&,FK?B3AL'4KT8U.>U_[O_!/84T>57MR9[(^6
MQ)S*Q/7M3K;2IHE4/<VG#[ODE/3:1W!_I7CE%3[2/;\39Y74:LZGX?\ !/91
MI4WDA!<P%O+*?ZX==V?[GI3VTYS(6%Q;@&8/Q*.G/^S7D6F?\A&/_=?_ - :
MJ8^Z/I3]K&VWXD?V7-R:]I^'?Y^1[;;6$JSPEKF#*R D(^<@'IR,],?D*WZ\
M)\,_\C1I?_7RG\Z]V[5U4)*2=D>-FF&>'G&+E>Z[6"BBBMSRPHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R=
M<_U</^\?Y5C5LZY_JX?]X_RK&KDJ_$>KA?X2"BBBLSH"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH #T-332.)F =@.._M4)Z&I)_P#7/^'\J?03
MW$\V3^^WYT>;)_?;\Z912N.R'^;)_?;\Z/-D_OM^=,HHN%D/\V3^^WYT>;)_
M?;\Z911<+(?YLG]]OSH\V3^^WYTRBBX60_S9/[[?G3F9G@7))^<]?H*BJ4,R
MVXVL1\YZ'V%-":[$>#Z48/I3O-D_YZ-^='FR?\]&_.D&HW!]*,'TIWFR?\]&
M_.CS9/\ GHWYT!J/=V58QA?N#JH/K3/-;T7_ +Y%/D <1EI #L'7\:9L3_GJ
MOY&F[B5@\UO1?^^14DLT@<8; VKT'L*CV)_SU7\C4DJ+O'[P?=7L?04:V%I<
M9YTG]\T]':2.4,X P.OU%1[$_P">J_D:>D>8Y0K!C@<#ZBA7!V&;%_YZI^O^
M%20HHGC(E0D,/7_"F>3)_=_44^&)UG0[>C>HIK<)-6>I&)I,#YC4D4DC,PW'
M[C>W:HQ-)@?-^@I\<C.6#-\I1L\>U),<EIL&)_[Y_P"^Q_C2RG#@-&&;8N22
M>>/K4>V/^^?^^:EDW J%FPNQ<#)':F+J .8/E6-/G/WN_'O3D)"29=?N]8\9
MZBDPS0#.9?G/0GCBA!L20E'C^7KGW%,D5#NCD&7?@</P.H]Z& $*96)>6X.6
M]/K2(PD209=^!PQ]Q3MK+ @"NO+<*X]J!=?Z[#C_ *U_]3CR^V<]!^-.$89,
M[R/W8/R].&]Z0M^^<%QG9TQST'>I!@I_$?W7OZU2(;:2 PY!PTG.[H/[PSZT
M>40=V9."&QM]%QCK2X4L 57DJ/3JI%&%P68(,CU/3O\ S:G9$W8/&8]-U#EC
M_HK#D8Z*17E%G>&UC90F[=M/WL= ?\:]8D &FZAC;DVSDX/LU>26_D^21(0&
M^7!(/3OCWKGQ&G+;S/6RJS53FUU1,-1?9(K1AMX '/0!=N/I3WU,N"!"!P /
MFZ$$D'I[T.VGAL*I(/4C/'';\<4*;#!WC)WC[N?NY'],USZ]SU+1WY6,%^1/
M)(8\AVW8W<@YS][&2/:G1:D8W1S"I*CG!QDY'/Y "HH9(XKI9BJE2&(3KM."
M!_2I@U@JQDKO; W=?5<_^S4)ON.48[<I&+]M^6C# !0!G&, CC\\T7%^]P'4
MH%5NP/0YSFG"6U"'"X)7ICH?E_P-.+60B;8?WC!@"1TSG&?THU[A:-[\I0JS
M??Z^/_KA%_Z+6J[ !B 00#C([U8OO]?'_P!<(O\ T6M3T-'\2_KL5J***184
M444 %68_^09<?]=HOY/5:K,?_(,N/^NT7\GIHB>WW?F5JZ3P+_R-<'_7*3^5
M<W72>!?^1K@_ZY2?RJZ7\1>IAC?]VJ>C_(HWW_(1NO\ KL__ *$:KU8OO^0C
M=?\ 79__ $(U7K.6Y4/A18LO]>W_ %QE_P#0&JO5BR_U[?\ 7&7_ - :J]'0
M%\3_ *[A5B__ .0C=?\ 79_YFJ]6+_\ Y"-U_P!=G_F:.@/XE_78(?\ CSN_
MI'_Z%58]#5F'_CSN_I'_ .A56/0T/H$=WZ_HC8^)7_(:L?\ KS'_ *$:XNNT
M^)7_ "&K'_KS'_H1KBZZ*WQLG+?]UAZ!11169W%O2_\ D(1_[K_^@-5,?='T
MJYI?_(0C_P!U_P#T!JIC[H^E/H0OC?HOU-;PS_R-&E_]?2?SKW;M7A/AG_D:
M-+_Z^D_G7NW:NW"_"SYG/_XL/3]0HHHKJ/ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#)US_5P_[Q_E6-6[
MJ]ZUE'$5C1]S$?,/:LK^W)?^?>'_ +YKEJ\O-JST\-S^S5E^)7HJQ_;DO_/O
M#_WS1_;DO_/O#_WS6?N]SH_>_P OXE>BK']N2_\ /O#_ -\T?VY+_P ^\/\
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M #[P_P#?-+W>X_WO\OXE>BK<.LR23(A@AP3C[M1C7)<?\>\/_?-/W>XOWO\
M+^)!15C^W)?^?>'_ +YH_MR7_GWA_P"^:/=[C_>_R_B5ZD/_ ![K_OG^0J:3
M6I48 00\JI^[Z@&F_P!NS?\ /O#^5'N]Q?O7KR_B5Z*L#7)21_H\/_?-.EUJ
M5)706\.%8C[OO1[O</WO\OXE6BK']N2_\^\/_?-._MJ7R=_D0YW[?N^U'N]P
M_>_R_B0R=(_]P?UJ.K!UV;'_ ![P_E3YM9DCF=!!#A3C[M'N]P7M5IR_B5*D
ME^^/]U?Y"IO[:E\G?Y$.=^W[OMFD77)6=08(>2!TH]WN'[W?E_$K5(G^KE^@
M_F*E?6Y5D91;PX#$?=]Z=_;4ODE_(ASOV]/;-'N]P?M?Y?Q*E209%Q'_ +PJ
M:+6I9)D0P0X9@/NTW^W9A_R[P_E1[N]P?M7IR_B1":7 ^=OSJ2*5R6#$L-C<
M'H>*>VM2K'&WD0_,#GY?0XI8]:E8M^XA&$8]/04[Q[DM3M\/XD&\?\\D_7_&
MGRLFY<Q#[B]&([4O]N2_\^\/_?-/DUJ564>1"<JIZ>HI7CW_  ':I?X?Q(\Q
MF ?*R_.?NG/8>M+&5"R%7D4[>I ]1[T\:U*86;R(>& QCU!_PI(];E:15\B'
M#, >/>G>/<7+4_E_$$8-')ND+# X=3CJ/0T,5\E,&(<M_ 3Z>M(=<E#,/(AZ
MXZ4Y]:E5(SY$/S GI[D?THO'N+EJ7^'\20D;GZ?ZOKN '0>V13U/[L<9_=]N
M>_J:@36Y661C!#E5ST]P/ZTP:Y*6 \B'GCI3YH]R?9U']G\2Z#\Z\D?,G7Z?
M6FKGRP.1\K?=)_S^E5I-;E25U$$/RL1T]*5]:E5(R((?F7/3W(_I3YX]Q>RJ
M=OQ+4K$Z;J&2?^/9SRV>H:O([6$312_*Y9(]RE>@/O7JR7[WNF:DK1HFRV;&
MT>QKR-2=HY[5SXAI\K/6RF,E[1/1W04445RGM!1110 4444 %6;[_7Q_]<(O
M_1:U6JS??Z^/_KA%_P"BUI]"'\2^?Z%:BBBD6%%%% !5F/\ Y!EQ_P!=HOY/
M5:K,?_(,N/\ KM%_)Z:(GM]WYE:ND\"_\C7!_P!<I/Y5S==)X%_Y&N#_ *Y2
M?RJZ7\1>IAC?]VJ>C_(@O9;<:A<YM,GSGY\YN?F-0>=;?\^?_D9J+[_D(W7_
M %V?_P!"-5^]0WJ$(+E7^;+[S6]K*A2TR7A!.9F_C3G^=0&:VQ_QY_\ D9J+
MS_60_P#7"+_T$57/0T-ZA"":3_5EVX-K#,46T)&U3S,W=0?ZT]Y;>XCN+I[3
MY_,4D"9L?-N)_E4%]_Q]G_<C_P#0%I(_^0?<_P#72/\ ]GIWU:)Y5RI]=.K\
MBQ:2V\DAMS:824?,1,V?E!8?J*K>=;%<_8^W_/9J=8?\?T?T;_T$U5'W/PI7
MT*4%S/Y=7YFS\2O^0U8_]>8_]"-<57=?$6=8M8L@T$4G^B Y?.?O&N/^UQ_\
M^=O^1_QKHK?&R<N;^JPTZ%6BK7VN/_GSM_R/^-3WLT,%_<0I9P;(Y65<YZ D
M>M9V.SG=[6(M,_Y",?\ NO\ ^@-5(?='TK1M+Y4NX2MI "7"YP>AX/?T)IL]
MQ%%<RQK9P;4=E'7H"1ZT=!<SYWIT_P R?PS_ ,C1I?\ U\I_.O=NU>(^'+E&
M\3:8HM8%)N4&0#D<_6O;J[<+\+/F<^;=6%UT_4****ZCP@HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q/$?^
MIM_]X_RKADO+N.Y=F\V2,2NLJM'@1KYF%*D#GY>>_K7<^(_]3;_[Q_E7/5Q5
MG[[/9PBO11D"^OK@1B.)86+Q_*R,<J>I/MV]>*2/4M0EE$?V-4)$?+!N-VS)
M^@W-_P!\UL45G='3RON8YU'45A,ILE/&-H#9!V@Y^G)X]JF:\OFAMVCMX]SK
ME]P8@?.J]O8EOPK2HI7#E?<R#J=V(ROV51,,]0P7 4G/YC%/34IR5:2#:G[O
M(*-NPV,M^&>GM6I11=!9]S%74[Y?*9K5B99%^4J?E4K'G!]BS'GT-275[?QZ
M4DHB1+B5&/RJS>6=N0,>N>/2M:BG=!RON9+ZG=*S@6ZD12B)S@DGO\H'7C;^
M)/I2)>ZB(F+01R,@E+$*PY#84 ?3G\*U@ N=H R<G%+1<.5]S#EU2^82110K
MYGE$J51LG[X##/0?*#@^M6DOKI;F*WE@0M([*&7(&%P2>>V#Q[UI8&<]SWI-
MHW;L#=C&:+H%%]Q:***DL9JK2+;R&%PD@C3#$9QP/8_R-8\>IW;;HDA9F6/)
M# [_ +K'.0,=0!TR<UMW\ZVRF5PQ"JG"C).0H'ZFJ$>K6S[B5D0A2QW+R0N<
MG_QT_E5&7;4KSZC?PI(PM5/7R_E;LQ&#]0 ?QJ]9232Q.\RLI,C;0PZ+Q@5&
MFJ0NY1%E+@D%=O.!U./3I2/JL*LF Q4KN)Z$?*&'YAA1\AII=2]152TU"&]8
MB$2$!0Q9EP!GM]>#5ND6G?8EB^Y-_N?^S"HJEB^Y-_N?^S"HJ&);L****0R6
MV_X^8_\ >J(=!]*EM?\ CZB_WJ01I@?OEZ>AI]";^\1T5)Y:?\]E_(T>6G_/
M9?R-%AW0L_WU_P!Q/_014569I61U4;2 B\[?]D5%Y[^B?]\BF[7%&]D,'4?6
MI)P?M$O!^^W\Z!.^1PG7^Z*=/-(+B7$C??/?WHTL&MR':?0U)@BU.1_RT'\C
M3?.E_P">C?G4H;S+8^9(W$@QQGL:$#;ZE<]#4MS_ ,?4O^\:5(HY'5!*<L<#
M*?\ UZ67R9)G<2, QS]S_P"O1;0+JXW_ )=3_P!=!_(TR/\ UB?[P_G4Y6);
M=09#\S;A\OIQZTV..(OD2GY?F^[Z<^M%A<RLR.7_ %TG^^?YT[_EU/\ UT_I
M2N(6=V\QN23]S_Z]/=8HT,1D.0P;.WV^OO18+[(CMO\ CZB_WQ_.HJLQ+%&R
M3&0E5<<;?3GUIB11NVT2G."?N^@SZT6'S*]Q)/\ 40_1OYTD/WG_ .N;?RI[
M>2T<:^8WR@_P>ISZTH6*%R#(3E,<+ZCZ^]%M17TL5^]2S_?3_KFO\A2^5'Y9
M?S3@''W?_KT\K%,XQ(1A!U7T'U]J+#YE>Y&/^/5_]]?Y-38?]?'_ +Z_SJ0>
M2(63S&Y8'[GIGW]Z79%#,NZ4G:5;A?H?6BPK[D+_ 'V^II\O^JA_W3_Z$:<\
M<?#^:</DCY??ZTXK$\((D/[L8/R^I/O[T6#F6A'%_JYO]P?^A"HU^^OU%6(5
MB8M&)#F0!1\ON#Z^U1A8@0?-;U^Y_P#7HL-/<2;_ %\G^^W\Z67[D/\ N?\
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MA<YFF!\Y\_NA_>/^U49@M1 LWGS8+E,>2.H /][WIE]_R$;K_KL__H1H8_\
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M7U"U[;7A/AC_ )&C2O\ KY3^=>[=J[,*_=9\YGT4JL++I^H4445U'A!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!B>(_]3;_ .\?Y5SU=#XC_P!3;_[Q_E7/5PUOC9[>#_@H****R.D****
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M-_M@ -N%'[IN=K,#V]:2"&VM#'<O> I(DJC$39^Z5_FPJO=?\>=A_P!<G_\
M1CTES_R"[/\ [;?^A"G?J0HMI1ONVNGGY&OH5G#:^*].C-VK2)<Q\"-N>AZ_
MC7M5>*Z;_P CW8_]?47_ *"M>U=J[<-LSYK.[N=-M] HHHKI/$"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M$\1_ZFW_ -X_RKGJZ'Q'_J;?_>/\JYZN&M\;/;P?\%!11161TA1110 4444
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MAVUZ"QB$1S'=)]T#H.Y'O[4B"%89&W/AL)T'U]?:E6"18I5*@$A< L.><^M
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M]D4V&2';##]C@V3V[2N,'ED\S;W_ -D4"O9;/IU];]2YI=Q$_B_2C]DB#R/
MY8,^02HZ<XKV2O&]%N$DUW0)#:PAY)54L > K;1CGT KV2NO#;,^>SI6G!>7
MZA11172>*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% &)XC_U-O\ [Q_E7/5T/B/_ %-O_O'^5<]7#6^-GMX/
M^"@HHHK(Z0HHHH **** "BBB@ HHHH **** "BBB@9+<?ZT?[B_^@BHJGFBD
M:0$1N1L7D*?[HJ/R9?\ GF__ 'R:;6I$6K(913_)E_YYO_WR:/)E_P">;_\
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MBBBM3S@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Q/$?^IM_]X_RKGJZ/Q"$,4&\L/F.-HSV^M8.(/[\O_?
M_P :XJR]]GM8-_N4145+B#^_+_WP/\:,0?WY?^^!_C65CIN145+B#^_+_P!\
M#_&C$']^7_O@?XT6"Y%14N(/[\O_ 'P/\:,0?WY?^^!_C18+D5%2X@_OR_\
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M>6_#( .GU-737OQ,<3-.A4]/T/,M4_Y"]]_U\R_^AFJE6]4_Y"]]_P!?,O\
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MYO/G>K#T_4****V/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$>N=C_E7N-;TMF?/YT[U(Z]'^84445J>*%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &)XC_U-O\ [Q_E7/5T
M/B/_ %-O_O'^5<]7#6^-GMX/^"@HHHK(Z0HHHH **** "BBB@ HHHH ****
M"BBB@98FB9G!!3!1>K ?PBH_(;U3_OL4MQ_K1_N+_P"@BHJIVN1&]D2>0WJG
M_?8H\AO5/^^Q4=%+0>I)Y#>J?]]BCR&]4_[[%1T4:!J6$C9(IB2OW.S _P 0
MJO4T&W;-N!(V=C_M"FY@_NR_]]#_  IL2;NR.BI,P?W9?^^A_A1F#^[+_P!]
M#_"D._D+:\747^]2"=\#A.G]T5+;F$W,8"R [N,L,?RJ(1# _>Q]/[U/IH3I
M?47SV]$_[Y%)Y[>B?]\BCRA_SUC_ .^J/*'_ #UC_P"^J-1^Z2S2_.N8T)V+
MV_V147FC_GG'^52S0L77#)C8O\0_NBH_(?U3_OL4.]Q1Y;(!+R/W<?7TI\\:
M&XE_>J/G/8^M,$#Y'*=?[XHG1OM$ORG[[=O>CH&E]&'EI_SV7\C3C\EK\LF<
MR#[N1V-1;&_NG\JE5GBM3@ 9D'50>Q]:$-^I%YC_ -]OSJ7*M:KYC/\ ZPXQ
MSV%-\^3_ &/^^%_PJ0R*]LIE!/[PXV87L/:A"=]"+$/]Z3\A4SJ3%#Y;X7:?
MO,!_$:AS!_=E_P"^A_A4DB*\4)5@HVGAVY^\:$#Z#H5D63+.I 5LC>#_  GW
MJ'SA_P \X_RJ6WC*S K(A8!L8;G[IHS=_P!Y_P Z?05U<2;RFD!8L"47@ 8^
MZ*>HQ;+Y17&\YWX'84LWF^8,PJQVKDE,D_**:^/LZ>;$5^<X" +V%'<2V0I.
M+;]XP7]YQY9'I[4(Z_9WVR'[Z_ZP9[&A&"VQ\N1HOWG.XYSQ["G!F:W?=-')
M\Z_?!P.#ZTQ,0LWV==LL8^<]L=A[43!2D>\PLWE]2Q'<TI!:W7$4+_.?NY '
M ]#3G\Q8XP%E7]WT1P .3ZYH$/(/VJ;']UL8D![>E(N\6[?ZP_./X?8^E#E3
M=3Y\D_*V05(/3N:8@3[._P L(^<?=.>Q]33)Z?<3ON,LPY/R=-S>W:G*N(,%
M6SY9Z!O[U,?_ %D^<$;.A=B.W8?TIR*/L_! _=G@#_:_V@35=2'LB49W#:I^
M^G\JC(78/E7(!8  _P!XCM]33R!N7=\P\Q,?+TX^G^%-Y$9 "XV-]/O?2F0@
M<)\Y^0';QG/H3_44.8MK$%-IW$]>A#'_  IQ9N@8CE 0K8ZK_GL*&=B6&YP"
M,?ZQ>.&/^?I0!+'M^R7^W;_J'Z9Z?-BO.A]T?2O2(VS:WVXL0(7'WP>FX5Y\
M&M-H_=W'3_GHO_Q-88C[)WY<[.?R(:*GW6O_ #SN/^_B_P#Q-&ZU_P">=Q_W
M\7_XFN:QZ?,^Q!0.H^M3[K7_ )YW'_?Q?_B: UKD?NY^O_/1?_B:+!S/L37=
MOF]N#Y\(S*W!8^I]J@^S?]-X/^^C_A2WO_']<?\ 75__ $(U!3;5R8)\JU+L
M%O\ N+K]_#S&O\1_OK[5!]F_Z;P?]]'_  I]J$:*Z#OM7RQR!G^->U-\NV_Y
M^6_[]'_&GT1*NF]?P\D6)55(+96NBO[L_P"KR0?G;Z4+Y/V*??<2N-\?;I][
MU-$I18+8) LZ^6?G8,#]]N, T^&0K:3E56T.Z/YQOY^]QSFJZ_UV,W\/S\N_
MWD<8MS93;?.?]XF0,<<-4BND=BNUY(09F^\H;/RK3EDD>RES?2-B1.4#$CAO
MI079;),W765N9XB?X5Z9!HZ";N[>?Z>A.K))<01MB02)&26A^]A>.<\46YDD
M\B0I:EC,[N0P^]M!!Z_6GQ.QO;7D,"B<K/M!^7^YT_#%1HR+!"SJF1-@;I57
MJN/X%&>O>K,7V_KJ2!"L2[([;*H2GS#JZ+COW;<*TM%0+KMOL2 (%F52C G:
M&..]4Q:0*Z1A!QM7F8Y^1@!V]3@U>T2*!=7M'C"\K(0?-)^\ W3'^U6D%[R,
M*TDZ<O1_D_,\)U?_ )#>H?\ 7U+_ .AFJ=7-7_Y#>H?]?4O_ *&:IUN?20^%
M&FLENFAV_GP-+FYFQARN/EBJN9[#!_T%_P#O^:L*+4Z';?:7G4_:9MOE(K?P
MQ=<D5 5TS!_>WO\ WZ3_ .*H,XV\^O?N:NHIJS7FZU\];<Q0F-5E& /*3WI$
MBU,Z/=BZN6A'G0[6EFP.DF1QFH-5TYY=0,D3P^6T4)7S)45L>4G49X-)#9QV
M^CWINY,(TT 'V=DD.?WG49Z4S)6Y%JNG37H36 EAAOW?55VBU/,4K.P_>)S@
MXJQ#>B.QLIFUJ0)'?,S&16!( C) QGW_ #JIIGV14OVM)Y%E^RG!N8DV >9'
MG/)_E5])YQHJ$W:$_:).;.:*$?<3K\O)H(FM?GZ=/02<7*6NI1'6@'-Q#@_/
M\NX2$#IZ$?E6@)G6_N9CJW[N*^5B,/PD2L9%Z>AZ=Z;<P+<7.I1I!9R3,;=U
M\YY06DRJC<P(4_?/W>#5C[+$T]P3;:=]GFN?,)\Z3)BD3]Z?O=<%<?6F<\I1
M:U_3LC8M$GMOA7J,,UZ9)HM0V-*B%\$,G&#UKF[(O/:WR-++<?NT.QK(_P#/
M1><#K74Q"9OAEJAD BN#J.9/L#,QW;DSC+?GS7*VX*V5\;B2\=/+3B^#A,^8
MO]QB<U,]T3AG=3[\W^1HVMFC3Z3NM>2&3F$I@-(X/!;C@FDM8&MK>T:2"RC$
M<;LVZ1QC9O:/@CIDMFFV*VK7&BL$M3\WRE4!Q^^;H9&W_H?:M*WD>&Q1HB1M
MAF?:C! V"OIQZCE3U-)#J2:=OZZC-"@CBUG3HBEDJQFU*;9F+;@^#^1D?'X5
M[%7F&GRR+K5I&99SB>)26N$Y)9,#&,\A"V/<UZ?6U/8\/,Y.4XMA1116AY84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 8GB/_4V_^\?Y5SU=G>6,-ZJ";=A3D8.*J_V#9>DG_?=<U2E*4KH]
M+#XJG3IJ,CEJ*ZG^P;+TD_[[H_L&R])/^^ZCV$S;Z]2\SEJ*ZG^P;+TD_P"^
MZ/[!LO23_ONCV$P^O4O,Y:BNI_L&R])/^^Z/[!LO23_ONCV$P^O4O,Y:BNI_
ML&R])/\ ONC^P;+TD_[[H]A,/KU+S.6HKJ?[!LO23_ONC^P;+TD_[[H]A,/K
MU+S.6HKJ?[!LO23_ +[H_L&R])/^^Z/83#Z]2\SEJ*ZG^P;+TD_[[I/[!LO2
M3_ONCV$P^O4O,YRX_P!:/]Q?_0145=4VAV;MDB3. /O^@Q2?V#9>DG_?=#H2
M$L=22MJ<M174_P!@V7I)_P!]T?V#9>DG_?='L)C^O4O,Y:BNI_L&R])/^^Z/
M[!LO23_ONCV$P^O4O,YN+[DW^Y_[,*BKJET.S4, )/F&#\_OG^E)_8-EZ2?]
M]T>PD)8ZEYG+45U/]@V7I)_WW1_8-EZ2?]]T>PF/Z]2\SF[;_CYC_P!ZHAT'
MTKJDT.S1PZB3(.1\]-_L"R])/^^Z/82%]>I7OJ<O174_V#9>DG_?=']@V7I)
M_P!]T>PF/Z]2\SFY_P#6+_N)_P"@BHJZIM#LW()$G0#[_H,4G]@V7I)_WW0Z
M$A+'4DNIRPZCZU//+(+B7YV^^>_O71?V#9>DG_?=*VAV;NS$298DGYZ/83!X
MVDWU.8\V3^^WYU*)6^S$G#?O!][GL:Z'^P;+TD_[[I?[#L]FS$F,[OOTU1F#
MQE%G,^<?[B?]\U(9%-LI:-3^\/3CL*Z'^P;+TD_[[I?[#L]@3$F <_?_ ,^E
M'L9B>,H^9S.^/_GB/^^C4DAB,4)*LORGA3_M&NA_L&R])/\ ONE.AV;*H(DP
MHP/G]\T>QF#QE+3<YZ#RC+P7!VMUQ_=-1;(_^>P_[X-=,NAV:-N DS@C[_J,
M4W^P;+TD_P"^Z/82#Z[2OU,"94\P?O\ 'R+_  G^Z*<,K;+LN /G/)!'85OM
MH=FYR1)G 'W_ $&*/[#L]@3$F 2?O_Y]*/8R%]<I62U,'+FV.9(G_>?Q'V]Z
M ";=\B _.O\ $/0UO?V'9[-F),9W??H_L.S"%,28)!^_Z9_QI^QD+ZW2_I&"
M4#6ZY1#\Y^XX'84LBA8XQY;?ZO\ N;^Y[UN_V'9E F), D_?_P ^E*=%M2JK
MF4!1@8D(_P ]:/8R#ZW3\S(8/]HF^6;&UL?*,=*CSMMVW@K\XQO '8^U;9T6
MT,CN0^Y@0?F]:5-&M8T*H95!.3M<BG[*1/UJG8R&SYLQYQL[%O:E7'D=O]6?
MO=?O>]:YTBW+.Q:;+#!_>'_/:E&E0!-H>8#&/]8?7-/V4B?K-.R,LG##YE_U
MB<9'I33CRST'R-P2,?>^M;']FPYSE^H/4=ACTI/[,AQC?+T(SOYY.>M/V<B?
MK$#*)& -P'S1]"/2D^3DX!^9AP >@^OID?C6O_9L/]Y^H/)!Z#'I0--A!R&D
M')/#8ZC%'LY!]8@9\>/LE_@$?N'S\N.?FKSD?='TKUA;")8Y(RSL)$*'+=CG
M_&LG_A#=)QTG_P"_IK*M0G.UCKP>.I47+FOK8\^HKT'_ (0W2?2?_OZ:/^$-
MTGTG_P"_IK'ZI4.W^UL/Y_<>?4#J/K7H/_"&Z3Z3_P#?TT?\(=I6>D__ ']-
M'U2H']K8?S^XXN[NIA>W !7 E8?<'J:A^US>J_\ ? KO)/".ERRO(PFW.Q8X
MD/4TW_A#=)])_P#OZ:;PU6Y$<SPR25G]QQ<$YE@NEF/R>6I^10#]]:@_T7_I
MO^E=\OA'2T1U FPX /[P^H/]*9_PAND^D_\ W]-'U:IY"69X=-[G'2L@M[;R
M[IXE\L_*0?[[>E.B)-I/BY24[H^)> /O>M=BWA'2W5%(FP@VC]X>F2?ZTH\(
MZ6L;Q@3;7()_>'MG'\Z?U:H3_:5"W7?LNYR$0E-G-A%<^8G%LP!Z-UQVJ0),
M;)?W=RI\UOO)YA^Z/7I75#PCI8B:/;-M8AC^\[C/^)H_X1'2_*$>V;:&+?ZS
MN0!_2G]7F2\PH7Z_=_P3G$CE^W6Q(FP$3.8 /X?7M3K6,&U7<6.)AC<K'L/8
M5TB^%=-6:.4";?& %_>>@P*?'X:L8HPBM.0&W?-)NY_$52H3,Y8ZBUHW]Q@
ME) T0+#=*2%;J0P;L#Z8_&KVD*ZZE;#;-M0,NYCD'C&>G^P/SK5_L*TW!MTF
M06/4?Q=>U26NC6MI/'-'O+H, D_7_$UI&E)-,PJ8JG*#2W_X<^=M6O8AK-^#
M86QQ<RC)!Y^<^]4_ML7_ $#[7\C_ (U[?<?"OPW<W,MQ(MWOE=G;%P0,DY/\
MZC_X5)X8_NWG_@0:OD9[$<XPBBD[_P!?,\@EELYM%M6FA:'%Q, +?&#\L?7-
M4C_9F#S>?^.?X5[@WPK\-M;);E;O8CLX_P!(.<L%!_\ 0147_"I/#']V\_\
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/ %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cntg-20211231x20f011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '. \L# 2(  A$! Q$!_\0
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MVO%1UVI.OG%P%;H25/X'&:OO+-K&J::8K*Z@AM93/++<1F/G8RA5!Y.=W/;
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M:YN$C9Y"8H5 Z[,X;&<\_A5:*YDM-1TDP?VR//G$4TEZ3Y<RE&.=I/RMD C
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MH;-KJXBMOL32/'#*4W$2 #D<CKVK+EOKZVM)M-@EN)C_ &I]D1S*!*(S'YF
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M:.WNA 6:3/).02!C  /KGM2F+5=FE6-[<75OYM](@*S@R-#Y3, S#J>,9Z\
M]:W9M"M)4M@C3PRVT8BCFAE*.$X^4D=1P.M/CT>TB^RD"4M;2M*C/(6)=E*D
ML3UX8T<K!XFFE:*_#R?G^GY&->I"E^;3S]7NU@A0"WM'<&+.?F>3<"S'L">
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MD9[M17A/_"2ZY_T%KS_O\:/^$EUS_H+7G_?XT?5WW#^WZ7\C/=J*\)_X277
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M9XB_Z#E__P!_S1_PEGB+_H.7_P#W_-'UA=@_U=K?SK\3Z0HKYO\ ^$L\1?\
M0<O_ /O^:/\ A+/$7_0<O_\ O^:/K"[!_J[6_G7XGTA17S?_ ,)9XB_Z#E__
M -_S1_PEGB+_ *#E_P#]_P T?6%V#_5VM_.OQ/I"BOF__A+/$7_0<O\ _O\
MFC_A+/$7_0<O_P#O^:/K"[!_J[6_G7XGTA17S?\ \)9XB_Z#E_\ ]_S1_P )
M9XB_Z#E__P!_S1]878/]7:W\Z_$^D**^;_\ A+/$7_0<O_\ O^:/^$L\1?\
M0<O_ /O^:/K"[!_J[6_G7XGTA17S?_PEGB+_ *#E_P#]_P T?\)9XB_Z#E__
M -_S1]878/\ 5VM_.OQ/I"BOF_\ X2SQ%_T'+_\ [_FC_A+/$7_0<O\ _O\
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M'5Q!0C"O&I'[2U^04445N> %5M0_Y!US_P!<G_\ 035FJVH?\@ZY_P"N3_\
MH)IK<#YW0D*A'4 5?N]:U2_@\B[U"YGBSG9)(2/RJ@H.Q>.PI<'TKW6DSJ+\
M>MZK%<-<1ZC<K,R!"XD()4=!]!20ZSJ=NTS0ZA<QM.=TI60_.?4^]4<'THP?
M2ERQ[!9%R'5=1M[1[2&^N([=\[HED(4YZU$+RY%D;(3R?92^_P G/R[O7'K4
M&#Z48/I3L@+W]M:H;>.W_M"Y\F,@I'YAPI'(_*K6D:Z=,OKG49(Y+B_D1A'*
MTF K,""S#'S5CX/I1@^E)PBU:P61+!<SVLZSP3/',IRLB-A@?K5R37M7E</)
MJ5T[!64%I,D!NH_' K.P?2C!]*;BGN@L7(M6U&!X7AO9XVAC\J(J^-B?W1[5
M'=WUW?S":[N)9Y0H4/(V2 .@_6J^#Z48/I1RK<"X=5U!I;B4WDQDN%V3,6YD
M7T/J*F_X2'6?)$/]J7?E!=FPR$C&,8K-P?2C!]*7+'L%D7Y-;U66T^R/J-RU
MOM">49#MVCH,>E4*,'THP?2FDEL 448/I1@^E,8448/I1@^E !11@^E&#Z4
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MX1+P_P#] BS_ ._8K5\P^E'F'THYY]PNS*_X1+P__P! BS_[]BC_ (1+P_\
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M%'_"%>&O^@)8_P#?H5M>:?2CS3Z4<L>P?6*_\[^]F+_PA7AK_H"6/_?H4?\
M"%>&O^@)8_\ ?H5M>:?2CS3Z4<L>P?6*_P#._O9B_P#"%>&O^@)8_P#?H4?\
M(5X:_P"@)8_]^A6UYI]*/-/I1RQ[!]8K_P [^]F+_P (5X:_Z EC_P!^A1_P
MA7AK_H"6/_?H5M>:?2CS3Z4<L>P?6*_\[^]F+_PA7AK_ * EC_WZ%'_"%>&O
M^@)8_P#?H5M>:?2CS3Z4<L>P?6*_\[^]F+_PA7AK_H"6/_?H4?\ "%>&O^@)
M8_\ ?H5M>:?2CS3Z4<L>P?6*_P#._O9D1^#_  ["X=-%L0P[^2*V(H8X(Q'%
M&D:#HJ* !^ I/-/I1YI]*:26Q$ZE2?QMOU9)148D)(&*DIF5@HHHH *#THH/
M2@""BBHK@S+;2FW56G"'RU<X!;'&?:J&2TR::*WB:6>5(HU^\[L% ^I-5=*?
M4)-.C;5(H8KPYWK$<J.>*9K6/[/7=C'VFWSG_KLE#5G8"PM]:/;-<I<PM OW
MI%<%1^(JQ7+ZO-Y&H7\U@ZH4L09VBQP_F#9GMG;N]\4Y[FXBUHR->221-=F&
M/R904!QQ$\9Y!X^\,^O2D!TU%<A87]^+5=2N;K$+V\DDZK<AVR%S\D>T;2IX
MQ^>:2.\O8Y+VT^VB FVBE4S78E*,S[>6V_+N''< \BBX'845R#7UXJ+9)+.&
M:\\J42W2@Q_NRP590#D,<=>>W&16Q:3SVV@W,U].'\@2GS(9!*P09QS@ L.G
M3L,T :]%<1<:A?VT5] EW)$WV:*52;H3O&6E5<YQ@9!Z<CTK2NY+BRN[BR6^
MN!;M+;!II'R\2N6#88],[0/;-%P.B2:.222-'#/$0K@?PD@$ _@12+<0N4"S
M1L7SLPP.['7'KCO67H2)'?:LB7#SJMT@W.^\C]VG!/?'YUB65FUY;Z0(7$=Q
M$M[+!)_=<2KU]CD@^Q- '6RWEM DC37$,:QD!R[@!2>F<],TZ"XAN8A+!+'+
M&>C1L&!_$5R,%VM[>7DS1^6W]I6:RQMU1PJ@J?H:VK+RCXEO?LNSR?L\?G>7
MT\W<W7'&[;C]* -BBN?M9FEF%U-J4D4_VUX3;%LIM#$!-GK@ YZ]^E9)U6ZC
M'FPW,PCNK*XF3S;E9'^5-ROM PA^A]B,T7 [:H9+RWB=DDF160*S G& QPOY
MD8KFIKB\T^U#1WT\C3:>)G>8AMC;D!<#M@,3CIP*)C]BU"^%M?RS$16@WO*'
M90TQ!&?<']: .GEFCA*"1PN]PBY[L>@J3-<J[F:>SN9KZ0SG53&;<N-JA68!
M0OJ  <]>:;I]Y-<:I9(+B?[-?QRD"2[#2%0,A@H'R$>Q]CS0!UF117%VLEU]
MAT:QMIY/*>P\[<;SRV9Q@$!BIX4<[??VK:N9;L^&[<O>01W3^6K2I)A)"2,A
M7QP6' ..IH VJC\Z/SQ!O'FE-^SOMSC/YURAOKQA!91RS_-<R1R>;<A64JJD
M1B4 YSDGUXQVIMS=W]I$9S-')<K9,HE64, IN%7<6QC(4\G'4=*+@=C1FN56
M2^A9;:>]\NVFN(T+K="62,%6)&[:,!B% ^IQVJ5X(WU/2U_M*>=8KV2-2)2,
M8C)VL1]XCIGTXHN!T44T<\8DB=70Y 93D'!P?UI]<O97,M^]O#=ZA-!'Y$DH
M=)-C2,)64_-Z* ./?FJ]O<WVH17<TFH7,9@TY)HQ$0@9\R8<C'<*#CIS0!V%
M%16LC36D,K8W/&K''J0#4M, HHHH *?'][\*93X_O?A2 DHHHI""HY.HJ2HY
M.HH$]AE%%9US)JJZQ:I;P0-IQ4^?(S8=3[#\J:5S*4N57L:-037EK;2)'/<P
MQ._W5>0*6^@/6IZPH_L/VG7/[0\K)<;_ #<9\GRQC&?X?O?CGO06:S7ENDQB
M:9%D4H"I/.6SM'XX-3$@ DD8'-<PLWDWX^S/*D;-8(-Y^8H=PPV>^.M,TV:[
M%II=W)?W,LET\R2*[@K@+(1@=B-HYH"QU,<J31)+&X=' 96!X(/0BG5REM=2
MW5JTMUJLMHUO9021L' !+)DR,/X_FXQ[>II;G4)EU1)H9Y0@OHK9O,N0JL2R
MAE6+'(P<Y)![]* L=*MS \+S+*GEH6#/G 4J<')]L&F6U_9WA86MU!.5Y(BD
M#8_(UB2?\B?K7UO/_0FIEU::E<V:W8MX;>2WLY!%Y,A>21FCP!PHP._?G% &
M_%>6L\SQ0W,,DB?>1) 2OU Z4"\M6N3;"YA,XZQ"0;A^'6L1_L7E:%_9_D[_
M #5\GRL9\O8=_P"'KGOCO3=/&F_V!IPGQY_FQYV_ZW[1NYSWSG.?;/:@#I**
M**!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5,O
MW1]*AJ9?NCZ4BHBT444%#)?NCZU%4LOW1]:BI%+8**R]9EUF,VG]CV]M-NF
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MU",A4AEQN4@]",@X- $PM+9;DW(MX1.1@RB,;S^/6G1V\,,;1Q0QHC$DJJ
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M[>N?+GF,=M8"=+=#A9'W/U[GH!BLN*^U:+36O?M *2VAD+-<++AB5^=5"C
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M45)4<G44">PRBBBF0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@!5^\/K4]0+]X?6IZ9,@HHHH)"@]**#TH
M@HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4^/[WX4RGQ_>_"D!)1112$%1R=14
ME1R=10)[#****9 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %3+]T?2H:F7[H^E(J(M%
M%%!0R7[H^M15++]T?6HJ12V"BBB@H**** "BBB@ HHHH **** "BBB@!JHB$
ME55=QR<#&3[TZBB@ HHHH *:J(@(154$Y(48YIU% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% "K]X?6IZ@7[P^M3TR9!11102%!Z44'I
M0!!1115#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ I\?WOPIE/C^]^%("2BBBD(*CDZ
MBI*CDZB@3V&4444R HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *F7[H^E0U,OW1]*141
M:***"ADOW1]:BJ67[H^M14BEL%%%%!04444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "K]X?6IZ@7[P^M3TR9!11102%(1D$=*6B@#.^P7O_02?_ORE'V"]_Z";_\
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MX3_"C^S;_P#Z"S_]^$_PK4HHL@]M+R^Y?Y&7_9M__P!!9_\ OPG^%']FW_\
MT%G_ ._"?X5J4460>VEY?<O\C+_LV_\ ^@L__?A/\*/[-O\ _H+/_P!^$_PK
M4HHL@]M+R^Y?Y&7_ &;?_P#06?\ [\)_A1_9M_\ ]!9_^_"?X5J4460>VEY?
M<O\ (R_[-O\ _H+/_P!^$_PH_LV__P"@L_\ WX3_  K4HHL@]M+R^Y?Y&7_9
MM_\ ]!9_^_"?X4?V;?\ _06?_OPG^%:E%%D'MI>7W+_(R_[-O_\ H+/_ -^$
M_P */[-O_P#H+/\ ]^$_PK4HHL@]M+R^Y?Y&7_9M_P#]!9_^_"?X4?V;?_\
M06?_ +\)_A6I119![:7E]R_R,O\ LV__ .@L_P#WX3_"C^S;_P#Z"S_]^$_P
MK4HHL@]M+R^Y?Y&7_9M__P!!9_\ OPG^%']FW_\ T%G_ ._"?X5J4460>VEY
M?<O\C+_LV_\ ^@L__?A/\*/[-O\ _H+/_P!^$_PK4HHL@]M+R^Y?Y&7_ &;?
M_P#06?\ [\)_A1_9M_\ ]!9_^_"?X5J4460>VEY?<O\ (R_[-O\ _H+/_P!^
M$_PH_LV__P"@L_\ WX3_  K4HHL@]M+R^Y?Y&7_9M_\ ]!9_^_"?X4?V;?\
M_06?_OPG^%:E%%D'MI>7W+_(R_[-O_\ H+/_ -^$_P */[-O_P#H+/\ ]^$_
MPK4HHL@]M+R^Y?Y&=#87D<R.^I/(BG)0PH,_B*T:**=B)2<MPHHHH)"BBB@
MHHHH ***I7.L:;93>3<WUO#)Q\DD@4\].M %VBHX9HKB%989%DC<95E.014E
M !112%@,9(&3@4 +115>"^MKEE6&4,6#$ >BMM/Z\4 6**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "B@G R:BBN89B1%*CD=0K XH EHHIDDL<2;I'5%R!EC@9)P!^=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *S-6.L">R_LL6QC\W_2?.)SLXZ?K6G133L[@%8WB#[VE
M?]A"+^35LTUD5\;E!P<C(S@T@.3\2:@T$UZ\,S126D"N&DNS&H8Y(VH =_OG
MCM3KF2<'7;K[9<*8IXHEPYVPQLD>]@O3(#,<GI73R6T$T@>6&-W4$!F0$@4D
M]N)8)8T8Q-(,%XP,@XQGD?SH Y"ZNY+6XU&&POI)8%%HK-)<DB(.SASOY*Y
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MP&+'#^9_J_KA,BNEJM9V4=DLNUY)'E<R222'+,>GY   ?2K- !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %0S75O;-&L\\<;2MM0.P!8^@]:FJE?Z18:G);R7ELLSV[[XBQ/RG_(%-
M6OJ!=K*NKG47U62ULOLP6*!)3YP;+%F<8R.GW??K6K65<V^HQZK+=6:6SK+
MD7[V1EVE6<YP%.1\WJ.E("*+Q! T*7,S>2GD/))$4+,K*X0\C@\Y&,<U,NNV
MIAD=H[A)$<)Y+1$.6(R,#OD _D?2J:^'YH8E2.2"0BVDC;SD)5W>0.V5]#S]
M,U7;PY<RP'>(-L<ZS0VC2N\:_*58;B,C.<\# (^M &K_ &W ULLT<%U(2Q1H
MTA)9".H8=NH^N>*9+XALDCB=/.F5XO./E1%BB9QEAVY!]^#5%]!N/*A"6UFJ
M!W:2V$KJA)VA6+ 98@ C!&.?:H1X=OH],M;8+9M+#"8UE5WC:)RQ.Y6')'(^
M4^G6@#8EURSBN!&?,*Y4/*L9*(6QM#'MG(_,9J6^U2&PEAA=)9)IPWEQQ(6+
M;<9_G6._AQ_M\TKP6=TL[I(\DY8,I 4-\HX.=N1R,9K6N;&2;6+&\5E$=NLJ
ML#U.X+C'Y4 0VOB"SNY(1&)@DQ*I(\152XSE<GN,'\C2V^O65PX&9(T=6>*6
M1"J2*!DE2>O'/TYJNVB3/8V5N\B?N;MYI"">5;S.!QU^<5$-%OKBUMK*\D@6
MWMHV17BR6D)C,8)!&%P&/&3S0!+%X@CFU!!MDBM/LLEPSS1%<J"N&!/;!/Z4
MZ77!(BK!')%,)X59)XBIV.X7(!_'Z&JTVB:AJ"&&^:VCC%D]L&B9F+,2A#$$
M# ^3IG\:6#090 QM;*WD$D+%H79BP1]QY(X]A^M &C;ZU:W-X+=%F^9F1)3&
M0CLN=P#>V#^1K1K"M=)O(=76Y_T>% [M*T#L//!!P&3[H(R#G).1[UNT %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %0PW5O</(D,\<C1-MD","5/H?2IJI66D6&G3W,]I;+%+<OOE8$_,?\ )--6
MMJ!:FD,4$D@1G*J6"KU.!T%8=GK%]+ MVT=O<V[QEV2U8EXB!D*0>OIVYK<F
M1Y()$CD,;LI"N!G:<<'%8D>E7LU_!<W,=G"\:N));<G=/E2N",# R=W)/(%(
M"WINLPZBMNOE2PS36XN/+=>BDXZ_6JU]XCMXM.>:V665S:?:1MB+!%*DJ6],
MXZ>QJ*WTK4[0V4T0M&GAM/LCAI&"X!!5Q\OMR/?K40T/4K;3FM[9[5WFL([:
M5I&8!75"NX8!R#GIQ0!J)K%NMI))*QWPM''(JJ<[G"XP.^=PJ6]U*&RDBB9)
M99I 2L<2%VVC&6P.PR/SK(^Q++XFM8XI%98(%:[11_&G$63Z_,Q_ 5I7MG=_
MVC%?60A9Q$T+I,Q48)!!! /((Z=\T 4[3Q%'_9=I/<K(\LD(FD\F(D(N3\Q'
M8<'\CZ5;?7;1;H0@2NNY%:5(R44MC:"WOD?F*QT\+SQ1PL\-E=2?9E@E$K.J
MJRDX9<#D?,<@XZ=:MS:+=&^CDMUM80C1[9XF9'5%QE"HX<$ @9/ /M0!;_MF
M*)$#>9/+)+*JI!"Q.$<J3CT' SW[=:A7Q382(C0K<R[X?/PD#$A-Q4D^G*GC
MK52YC;1)X+HSVRNS7"D3,RH5>4R#Y@#AAQQWYQTIOA[1[J.SCN)BJF6P\G80
M00Q=WR1V&''O0!TL4J31)+&P:-U#*P[@\@T^J]A UKIUM;N06BB1"1T)  JQ
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGD$XYS@_RS4JW^K7&HSM;K*8X+L0;"T0C* @,6R=VX@DC'MP: .HI"ZJ"2P
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MBV D93Y?R8V@'D$[L_CF@#MZ*** "BBB@ HHHH **** "BBB@ HHHH ****
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MZS);//#YT3*) !G(SC(Z?G0!K"")5C"QH!']P!1\O;CTIDEE:S*%EMH74,7
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M3R3+Y9\L2?W=W3/;Z\4 :-%9=GK]E?311PF7$I98W:)E5F7.5!(ZC:?RK4H
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MW#RR$$X(*R#CC_;'ZUM444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5&QT>PTVXNI[2W$<MT^^5@2=Q_'ZFKU%.[6@$5U$TUI
M-$I 9T91GU(Q658>'X;'3(HXE2.^2V\H3C+;&VX)&??Z5M4@=2VT,"1VS2 Y
M>V\/7GFS-(D$0DLI+9F$[RLSMCYB6'3BI;O0KN_A#3"!)5A@ 0.Q4O&[-@D
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M<.TF[.3U]SZUN44 8NF:7=6%S:,WE/&MFMO*0QR&4D@CCD'/M6U110 4444
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MC21+L =201C?UVC)X^E.L=&>VOQ=SW9GD6(Q*WEA25)!RY'WCP/3OQS6K10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5F:K)JZ3V8TN"WDC:3%R96P53CD?KZUIT4T[.X!6
M)XA12^E$JI/]H1=1[-6W37C23;O16VG<NX9P?4>](#GY)6CUC5II;FX6WLK6
M-UBB(P,J^XXQR>!UXXK%GU"_MXKV!+J2,FVBE4FX$SH3*JYSCC(/3D>E=R(H
MP[N$7<X 8XY8#IFH(]-L8E*QV=NBGJ%B4 \Y]/6@# N_M-K)?646H2 9@9#/
M+@DL6W*'QQNV\>AJ"&\VS6KRRW!^S27(<.5=TQ$#@,.&QG@_@>E=7);P3!Q)
M#&XD #AE!W = ?6DCM;>%$2*")%CSL"H %SUQZ4 <6\T\UOJ%K)/,(I=+DN
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,#.<<T8&
M<XYHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB@].*
M"BJ?E:C_ ,_=O_X#G_XNCRM1_P"?NW_\!S_\70!<HJGY6H_\_=O_ . Y_P#B
MZ/*U'_G[M_\ P'/_ ,70!<HJGY6H_P#/W;_^ Y_^+H\K4?\ G[M__ <__%T
M7**I^5J/_/W;_P#@.?\ XNCRM1_Y^[?_ ,!S_P#%T 7**I^5J/\ S]V__@.?
M_BZ/*U'_ )^[?_P'/_Q= %RBJ?E:C_S]V_\ X#G_ .+H\K4?^?NW_P# <_\
MQ= %RBJ?E:C_ ,_=O_X#G_XNCRM1_P"?NW_\!S_\70!<HJGY6H_\_=O_ . Y
M_P#BZ/*U'_G[M_\ P'/_ ,70!<HJGY6H_P#/W;_^ Y_^+H\K4?\ G[M__ <_
M_%T 7**I^5J/_/W;_P#@.?\ XNCRM1_Y^[?_ ,!S_P#%T 7**I^5J/\ S]V_
M_@.?_BZ/*U'_ )^[?_P'/_Q= %RBJ?E:C_S]V_\ X#G_ .+H\K4?^?NW_P#
M<_\ Q= %RBJ?E:C_ ,_=O_X#G_XNCRM1_P"?NW_\!S_\70!<HJGY6H_\_=O_
M . Y_P#BZ/*U'_G[M_\ P'/_ ,70!<HJGY6H_P#/W;_^ Y_^+H\K4?\ G[M_
M_ <__%T 7**I^5J/_/W;_P#@.?\ XNCRM1_Y^[?_ ,!S_P#%T 7**I^5J/\
MS]V__@.?_BZ/*U'_ )^[?_P'/_Q= %RBJ?E:C_S]V_\ X#G_ .+J2&.[63,]
MQ$Z8Z)$5.?KN- %BBBB@ HHJ&=+AMOV>:./UWQEL_J* )J*I^5J/_/W;_P#@
M.?\ XNCRM1_Y^[?_ ,!S_P#%T 7**I^5J/\ S]V__@.?_BZ/*U'_ )^[?_P'
M/_Q= %RBJ?E:C_S]V_\ X#G_ .+H\K4?^?NW_P# <_\ Q= %RBJ?E:C_ ,_=
MO_X#G_XNCRM1_P"?NW_\!S_\70!<HJGY6H_\_=O_ . Y_P#BZ/*U'_G[M_\
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MH **CF69H\02)&^>KIN&/ID57\K4?^?NW_\  <__ != %RBJ?E:C_P _=O\
M^ Y_^+H\K4?^?NW_ / <_P#Q= %RBJ?E:C_S]V__ (#G_P"+H\K4?^?NW_\
M <__ != %RBJ?E:C_P _=O\ ^ Y_^+H\K4?^?NW_ / <_P#Q= %RBJ?E:C_S
M]V__ (#G_P"+H\K4?^?NW_\  <__ != %RBJ?E:C_P _=O\ ^ Y_^+H\K4?^
M?NW_ / <_P#Q= %RBJ?E:C_S]V__ (#G_P"+H\K4?^?NW_\  <__ != %RBJ
M?E:C_P _=O\ ^ Y_^+H\K4?^?NW_ / <_P#Q= %RBJ?E:C_S]V__ (#G_P"+
MH\K4?^?NW_\  <__ != %RBJ?E:C_P _=O\ ^ Y_^+H\K4?^?NW_ / <_P#Q
M= %RBJ?E:C_S]V__ (#G_P"+H\K4?^?NW_\  <__ != %RBJ?E:C_P _=O\
M^ Y_^+H\K4?^?NW_ / <_P#Q= %RBJ?E:C_S]V__ (#G_P"+H\K4?^?NW_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
,% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cntg-20211231x20f012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $X _,# 2(  A$! Q$!_\0
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MLVL?]!O_ ,E4H^S:Q_T&_P#R52@#>HK!^S:Q_P!!O_R52C[-K'_0;_\ )5*
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M9VB\H%S-'MVRYY5?48K?HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:%4I/^0U;_\ 7O+_ .A1T 7:*** "BBB@ HHHH **** "BBB@ HHHH ****
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MF3_GX?\ 2@":BH?)D_Y^'_2CR9/^?A_TH FHJ'R9/^?A_P!*/)D_Y^'_ $H
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M(W)]>M9_VS2_E8<Z/2Z*\V^R)_STE_[^-_C1]D3_ )Z2_P#?QO\ &C^V:/\
M*Q<Z/2:*YWP:S'2[A6=F"7+JNXYP..*Z*O5A-3BI+J6%%%%6 4444 %%%% !
M1110 4444 %%%% %"#_D;/\ MQ_]GK<K#@_Y&S_MQ_\ 9ZW*0PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "J5]_P ?.G_]?'_M-ZNU2OO^/C3_
M /KX_P#:;T 7:AD_X^HOH:EW+_>'7'6HI/\ CZB^AH FHHHH **** "BBB@
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MZ"*LTQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>=OBM2@(E('RKQQ72U3U?_D#7O\ UP?_ -!- %33!C2K/_K@G_H(JU573/\
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M_OD4S FHJ'RYO^>Y_P"^11Y<W_/<_P#?(H FHJ'RYO\ GN?^^11Y<W_/<_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@"A!_P C9_VX_P#L];E8<'_(V?\
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M-'FW'_/1?^^:2HYYXK:!YIG"1H,LQ["BR&KO1$OFW'_/1?\ OFCS;C_GHO\
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MNN\_\".?ZTDD:5)/E;[\OY?\ AU#S%U[2[HR?./,BX''./\ "M?S;C_GHO\
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M* .3\(VVJQ7M^-1FOGCLU2P@-RS$3!&=O.Y^\S*\8+<\H1G@UUE%% !1110
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MWRM'<^5(8VS.H^8=:VZR]$ZZE_U_2?TH ?!>W\DZI+I;1(3R_G*V/PK1HHH
M**** "BBB@"A!_R-G_;C_P"SUN5AP?\ (V?]N/\ [/6Y2&%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5D:^D\D-HEMGSFN,*0<;?D?FM>J5]_Q
M\Z?_ -?'_M-Z ,9++71%'$9B2)0[.7_^M^E;=PCO-"JL <')(JW4,G_'U%]#
M0!#]EF_YZ+^5'V6;_GHOY5<HIW8K(Y+7]"U>[U"RDT^:%(G/EWA;()C]O6M]
M+%HD6.)D6-1A5"]!5ZBDNYK.HY1C!]#/&G8G,X$0F(VE]O)'I4AM9B"/,4>^
MVKE%.[,]SD/#=I=V.HZII5S=!WCD$\7RX!C;//7U%6[!);CQ-JF'3; D48..
MYR34FNC^S]6TW6%X4/\ 9;C']Q^A/T8#\Z7PV/-N-8N_^>MZRCZ* /ZU";V.
MZ:4H2K=TOONK_E?YFG]EF_YZ+^5'V6;_ )Z+^57**N[."R*?V6;_ )Z+^5'V
M6;_GHOY5<HHNPLBG]EF_YZ+^5'V6;_GHOY5<HHNPLBG]EF_YZ+^5'V6;_GHO
MY5<HHNPLBG]EF_YZ+^5'V6;_ )Z+^57**+L+(I_99O\ GHOY4?99O^>B_E5R
MBB["R*?V6;_GHOY4?99O^>B_E5RBB["R*?V6;_GHOY5B:^9--N-.OW=!$DK1
MRL1T5AG^8KIZY_QII-[K?AFXL-/,7GR,N/,X& >>>QJ9-VT.C"J'MHJ>B>C]
M'H)X<MKB318KAV57N&:5AM]6./TQ6/XHCOX_$&D6]O;/+#=MY=S(J9 4$,.]
M=AI\,EMIMM!+M\R.)4;9TR!CBK-&K5BHUE"LZEK[_P!?(I_9)1P'4 =/EH^R
MS?\ /1?RJY1579RV.?TSP[/IU_?W)O1+]J?<%*8V_KS6I]EF_P">B_E5RBDM
M"YR<WS2*?V6;_GHOY4?99O\ GHOY5<HIW9%D8<-M+_PD5Z-ZY%I;GI_MS5H?
M99O^>B_E4,'_ ",M]_UYV_\ Z'-6E239G27N_-_FRG]EF_YZ+^5'V6;_ )Z+
M^57**=V:613^RS?\]%_*L_0;:5O#NF$.H!M(CT_V!6Y6;X>_Y%K2O^O.'_T
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MN[$C,A!\T.S;A_AT]JW9A)]HAV%=V#G(]J +-%0XN?[\?_?)_P :,7/]^/\
M[Y/^- $U%0XN?[\?_?)_QHQ<_P!^/_OD_P"- $U%0XN?[\?_ 'R?\:,7/]^/
M_OD_XT 5M:MOM>BWD'EF1FB;:@/)8<C'X@5D> HKV'PI NH6SP76]BX?JW/6
MN@Q<_P!^/_OD_P"-&+G^_'_WR?\ &E;6YLJS5%TK;NY-14.+G^_'_P!\G_&C
M%S_?C_[Y/^-,Q)J*AQ<_WX_^^3_C1BY_OQ_]\G_&@":BH<7/]^/_ +Y/^-&+
MG^_'_P!\G_&@":BH<7/]^/\ [Y/^-&+G^_'_ -\G_&@":BH<7/\ ?C_[Y/\
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M?G4%T9_(/V5H?-[>:3M_2O,M8TSQ-_;E^UOHIN8'G+1RF5AE?P-43IWBL?\
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M\BUI7_7G#_Z *TJS?#W_ "+6E?\ 7G#_ .@"EU,W_$7H_P!#2HHHIF@4444
M%%%% !5*3_D-V_\ U[2_^A1U=JE)_P ANW_Z]I?_ $*.@"[1110 4444 %%%
M% !1110 4444 %%%% !1110!%<V\5W;/!,NZ-QAAZUG:OIMD=(NV:T@9UMW
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MS%FQ*W)/>M>B@"A;Z/:6LRRQ^;N7IND)%7\T44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'E>I1:N^O:H;.YMHXOM+862,DYP.]0>1XA_Y_;+_ +]&
MMB?_ )#&I_\ 7TW\A2U\CC*K6(FK+?L92>IC>1XA_P"?VR_[]&CR/$/_ #^V
M7_?HULT5S>V?9?<A7,;R/$/_ #^V7_?HT>1XA_Y_;+_OT:V:*/;/LON07-CP
M&MPNDW0NI$>7[4^XH,#M755S?@W_ )!]Y_U]/_2NDK['#N]&+\D;+8****V
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M: UP%VC'.&SR: .@\VX4X<PJ2<*">M();CA6\D2$9"9Y-8NLV9EO+!5A4E4
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M4AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4K[_CYT[_KY/\
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M!<[L8R.E='0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *:JA5V@<?2BB@!U%%% "%01BA5"@
M=!110 M%%% !1110 4C*&QGL<]*** %Q1110 UD# @C@^U. P,444 %%%% !
M1110 4T(H8MCD^U%% #J,444 )BD5 I) Y/7BBB@!U%%% !1110 4UD#$9'0
MYZ444 .HQ110 F*0H"P..1TXHHH =1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
(0 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cntg-20211231x20f014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'W SL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHJDNKZ:]Q]G6_MFFW;=@E&<^F/6BY2BY;(NT52EUC38)W@EO[=)8\
M!T:0 KGGD5+%?6DUP;>*YB>8()#&K@L%/0X]#2N@<))7:+%%56U&R2"2=KN
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MLEP%GN-;FLHYC&I\J)2<8&,$X&.?QK:TNZD.K7%HVKQ7R"/>J,JK,A!P<[0
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M( P1W'ZFK,>C6\=O<0%Y&6=$1LD9&U0H(QWXS4]I:RVY;S;V:YR !Y@48Q]
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M&NM UYO/,(XV]LXXK5HI6UN6IV@XV6OWA6/XA$[06(MI8XIOMD>UY8RZCKU
M(S^8K8J*XMH+N+RKF".:/.=DB!AGZ&F08^I3ZG8Z8DS7,-S>K,!%%;PF)9L_
MP$%F[9.<\8JG:W37L]M!/J\J1M9_: Z$1&60L0_7H$P/E[;N>E=!!IUC:X^S
MV=O#@[AY<2KSC&>!Z4LMC:3ILFM8)$W%]KQ@C<>_/?WH YFRFO=469GU*=4B
ML4D1H<+YI+S 2=.ZHIQTYJ&:_P!2LM*L;Z.[FGGN[!YI%?!16VJVY1VQD_AU
MKL1%&"2(UR5"DXZ@9P/IR?SH$,2A (D'EC:F%'RCT'I0!B:++=&_DC>5WMV@
M5P)KA)'W9^\-O\)'X<<56:\N8M5,C7$LJ-=&*/RIE*$X_P!6R$ @\=1GUZ5T
M-O:6UH&%M;Q0ASEO+0+D^^*3[%:_:OM7V:'[1C'F^6-^/KUH XZ+5=771UU%
M)':>2UDDD665&7>$)^1!\P*GC'IUYJ;4;U["1EL]9FN%_LZ6X;=(K;</$ _
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M"BBBJ.8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+^6$$+F3?_=\O&_/?&,U5F\26D5S:D.7M9XG8%(7>3<I QM W<9.1CC':@"
MZ9J#WDFJB**.Z\])$MR^0RJA0AF ^\0QY[86H;K1+S48[S]VUJLBQE8C<L^]
MTD#_ / 0<;>/6M:;7M-@BAD:=F69/,3RXG?Y/[Q"@[5]S@4R?Q)I-M,\4MT0
M8]OF,L3LJ;@""S 8 ((Y)Q0!031[B6[M[E[>1'CN(V8S71E)10_X#!;CZU(=
M,O;?6+G48HHYMUV9%C+X)0P1(2#V(:,_A5K^W[*6WFDMYL&+9N\Z&1!AF !
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M4AH< YV\ -C/(R2!Z4K.QM&M1YW>UKWVZ:Z?UH,L=0NY(?%)>=R;6>18,_\
M+,",$ ?C6+IFJZA>76A13SWLR3Z6TTJP.%9GWXW$Y':NHNO#5O<7%Y+'>7EL
MMX!]IB@=0LG&,\J2#CC@BA_#-L+RTNK2ZN;)[6V^RQ"#80(\YQAU;T%#C(<:
M]!)]WY;>[;\^QE:M=ZC::QH$%B]R%D6YDEMYFW-*$"$*3D\\G'/>JM_XCNUD
MUR:QN<Q^59BV+#(C,NX%L?EU]*Z;^Q4>_L+Z>[N9[BR$HC9]@W"0 '<%4#C
MQC'XU7/A73&DU1F61EU(()HRWRKMS@K@9!RQ/UH<9=/ZT)A7H)+G5[+MO[]_
MR_R)(-.O[/4K=X]2DGM?+99XKEMS,W&&4XX[Y'2N5M=7UF?1O"DL-T[W-R96
ME#$?OMN3M/UZ9KJ[70(8+^&]GO+N\G@0QPM<,I\L'K@*HY..IR:CM/#%E9PZ
M5%'+<%=,W>3N9<MNZ[N.?PQ0XOI_6PH5Z4?BU?IY2_5K^D8%]XGNH;S6;JUE
M9H8=,2:&)QPCEB#D>H[CVK0BEDL;O2EEUB[::4JLRSPNT4Y9<X5@NU3^/05H
MCPSIW]HW]XR.YOHO*FB8C81WP,9!/UID'AF")[/S;Z^N(K-@]O#,ZE4(&!R%
M!. >Y-%I%.MAW&RTT[;Z6_/_ #-NBBBM#S0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "J&HZ)IVK36LM]:K,]J_F0DDC:W'H>>@X-7Z*&KE1G*
M#O%V84444$G.7.CW#WFJ-_9MC<"[E#QS3/AD'E(G3;G@H3P>] T2^@O1>1R1
M32QM$5$C$>9MC*-DXX/.1UKHZ* .>72]034&U79;FY>;<;?S"%"; GWL?>XS
MG'M5VWL[HZC!>3I;H5BD5UBSP692/KP.3Q6I10!R_P#PC]S&T,FSS6^RK;NJ
M7LL &&8Y^3[P._OZ5.F@RQZ?K=M&(E%Y$(X%WDA<0JF"3SU'O70T4 8FKZ3<
M7TTS0F,!X$C&XXY60,>WH*6UL]1M4%FL5HUNLS2"=V);!8M]W'WLGKGWK:HH
M Y:'1-3:[AFN6#.D4J22/=N^]F7 (0C:H^@J[JEN]OHUC(7C$EC)%(=V=C$#
M:02 2!R><<=ZW** .+MM/N=9O+S4PB@"\5XECN'C60"$(=LBX/?KC!P16QIN
MC/::A'=>4L0*R^8#</,Q9BF#N?GHE;E% '+)X=NH?*DV^:_EO&Z)>20  NS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNAD7RR2#\J[1R?0]*TFTB%[:ZADFE;[2RM(YP#D #(P,?PT :%%%% !1110
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M^GUK3HH AM+J.\MDGB/RMV/4'N#5/6II([1$1O+2601R2_W%/>KL5O% SF)
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MF@G\P9.<@@@%2,=".]:E9]AI2V-Q-<O=7%U<3*J-+/MSM7.!A54?Q'MFM"@
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MT2PDBBC,+J(@50QRNC8/4%@02#WR>:E&F6:Q3QK H2X01RJ"0&4+M ]N..*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4TR+5(X(IB/+BF64J1G=@'CKQUZ^U)_8FG?9Q"+90@<R AB&W'@G=G.<<=:
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M>4W'HI;IN/IUI7+=*737T+]%%%,R"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K(TNYUN;5-0CU*Q@@LHW M)8WRT@YZC)]O
M2M>BE8N,DDU:]_P] K)\4_\ (HZU_P!>$_\ Z+:M:F30Q7,$D$R+)%(I1T89
M#*1@@TR#F+RSN+*&XU&TTZVTTVMK,^Z(J3(=AV@@#! //-.GNM62:ULDN+N5
MY+<W$DT,4.[.0 H#X&T=^IY'-=++%'/"\,J!XW4JRL,@@\$&H;G3[2[1$N+>
M.14^X&'W?I0!S?VW6[@7S/=_8WM+*.8Q)$C9D(<D$G/RG:. ?QI-4UN]CBFO
M+2>=A;)&TD20Q^2I(#%79CN)P?X<8R.M=,MC:HLBK;Q@2((W 7[RC( /MR?S
MJ";1=,N'+36,#DJ%.Y.H P/R% &#;SW-H^O.^IW6?[16&)?*20C,<1P@P.>2
M.>!U(ZDNL[V[N-0AMKMI6:UU((C3*@D*FV=OFV?+G)/3'&*Z";2[&=YGEM8G
M:;'F$K]['3/TP/RHM]+L;4Y@M(HSO\S*KCYL%<_7!(H R=2>XMO$L5PEU<-$
MEC/)]E&W8Q7;@?=SW]>WID&K;7VNFT>8E_WUJ75[D0K''(<;0NULE>?XL].M
M=+):P2SQ3R1*TL6=CD<KGK4$>D:?%YFRSA D!5QMX(/44 <IJMQJ#:3<P2:C
M?13Q7-HV'CB60*\RJ?F4;67TQ@\$'(XJ^+F^?6+FQM[L0 ZAY32B%"Q46L3Y
MZ8+9)Y/\ABMQ-(T]+>6W6SB$4N/,7;]['3/TJ6.QM8I?,2WC5]V_<!SNVA,_
M7: /H* ,&WO=0NI(=/-^T3B:='NEC3>XC;  !&T$Y&>.W05I>'KJXO-'66ZE
M$LPFGC+A0N0LKJ.![ 4NH:.EW (X?(BQ(92)(0ZLQZDC(.?<$5/I6G1Z5IL5
MG$=RIN). ,EF+$X'3DF@"Y1110 4444 %%%% !1110 4444 %%%% !1110 5
M5U'R3I]PL\ACC,;98'! QVJU63?J(=1^V3V;7%ND&-RA6\L@DDX)ST]/2DS2
MDKR!)KJ2"TM$BB2\\E7D;;E8!C' ]3S@>QJ?^S6V\W]X9/\ GIY@_EC;^E%L
MZ_VK= D9D1)$/JN"./Q_G5^A(J<W%Z:&49[F);FSD2*2[,+/"^W G XY'J,C
M(]ZL:3Y"Z5:K;RF2,1*59CR1COZ?3M3+ME;5;%!C>F^5C_=3:5.?J2/R]JKV
M(6YU2.^M[-H+9K=AO8*OF%F4J< YZ ]0.M+J6US0[=?S-BLS5HS$(M0C&9+8
MY8?WD/45IUDW!;5;TVB?\>D)!G8?QMV7_&J1RLTXI$FB26,Y1U#*?4&J4UY+
M::@J3A?LLW"2 ?=;T/UJ^ %    '  J.XMXKJ!H9EW(PP10,EHK)AN9=+D6U
MO6+0$XBN#_)O0^]:P((R#D4 %%%% !1110 4444 %17%Q':P/-*VU$&2:+FY
MAM(6EG<(@[GO]*SH89M4G2YND*6R',4!ZL?[S?X4 6]/EN;B SW"A YS''CE
M5[9]ZCU6Z>"U$</_ !\3MY<?L3W_  J_5:^LTOK9HG)4]5<=5;L10(=:6RVE
MI' G1!C/J>YJ>J&FWCS*]O<?+=0':X_O#LP^M7Z!F;KFPZ<1N'G!T,2==[[A
MM4CN">#^=$LL]Y=O;VS"'RL":<*&*DC.Q<\9Q@Y/3(J [;/5KFXNK1BDTL8B
MN,*P3*JN#SD?-[=ZM:8P!NX3Q*EPY?WW'<I_(C\JGJ=-N6&FO_!M^0-IKA<P
MW]TD@Z,S[P?JI&/RQ5&]N))-*N[:6%$FB*^?M7(\LGF1?PW'V([XYW:S)YX8
M]2N)GP8X+7]\1SU.0/K@'CW'K38J<VWJKVU-"(IY:A&#*!@'.?UI]9NFPLEU
M=3"S:UAD5 B-M!)&<G"DXZBM*FC*<5&5DPHHHH("BBB@ HHHH ***YFTUC6]
M5TZ?4M/M[1H1,Z06S@[Y55MI._< "2#CBDW8UITG--K1>?F=-17.Q>(;@>*K
MC3;B"-+1%B59 #N61UR QSC!P0#ZX]:HV?BN_=;&XN8;<6DVH2V4K(K H02(
MSU[D<_TI<Z-5@ZK5_)/[U?\ 0["BLC2]5FU+5M3C18_L5I(($< [FD ^?G.,
M \=*6]U.X37[#3+1(V,BO-<LX)V1#@8P>I8@4^96N9>QES<O6U_PN:U%9NN:
MD^EZ8TT(1KAW6*!'SAG8X'3\_H*R9/$UP?!XU2-($O4F2WF1U)1)/-$;\9![
MDCGTI.214,/4G%26S=OF=117+R^(+VVO-0MB]G=?9[%KI9H4955@<!&&X]>O
M7M3+7Q%?F?1%DDL;D:BH,D<",KPY3=G[S9 Z=J.=%_5*EK_UM?\ JYU=%<V_
MB29/%"V7EQ'3C+]E,V#N$^W>!G.,8R.G6B^\0W.FSZC;7$,37"A6L%0$>>&.
MT \\D-UQV-',B?JM2Z5MU<Z2BJT:WIL$#R0+>;!O81DQAN^%W9Q^-8VE:GJM
M[)J1FFLMEE</#A+=@7"C.<F0X_(T[D1I.2;3V.BHKE_#>OW.LV-G<3:CIB33
MC+6J1'>.3P,R>WI3+#7]6ON0MA'.MP4?3Y 4F5 V,[BV"<<_=P:7.C5X2HFX
MOIO_ %^NQU=%<Y<ZCK$/B>UTE9['9<023>8;5\KM(&/]9SUJ/4?$-]8C7U"6
M[MIMK!+&2C ,SAMV1NZ?*,#]31S(2PLY6LUKK][M^9T]%<V_B*Y6RTQ_*B6X
MGO$M;E""0N5))7GO@$9[&D36-5O([^XL_L$<5O<2011W .Z4H<'YMP"Y(XX-
M',@^JU-WH=+14<#M+;QR.H1F0,5#9P2.F1UJ2J.9JP4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-X9A9S?9T5YMAV
M*W0FIJ*!IV=SGTGT[[!:0QSW"S6ZA5E$9+PX&#OXX'8@\?EFKHGO3;><+FQ,
M.,^?@XQZXS_6M(* 20 ">N!UK-_LJ38T(NR+9I3)Y7ECNV[&?3-38W]I&6_X
MZ_H5!<:?]ENHY;F9Y;A2&F,94R]L1\8(&> *UK'S_L,'VI%2?8-ZKT!J<J#C
M(!P<C(Z4M-(B=125DBCJ\\UOITCP [N 6 SL'=L>U2:=%;PV,2VS!X\9W_WC
MZFK748-9$L4FD3-<6ZE[-SF6$=4_VE]O:F8FO13(IHYXEEB<.C#(([TYF"J6
M8@ <DGM0,22-)HS'(@=&X((R#69]CN].)-@_FP=?L\AZ?[K?XT/JTTLA-C:-
M<0I]^0'&?9?6K5KJ5M=_*C[9.\;\,/PIB(8=9MG;R[@-;3?W)AC\CT-:"NKC
M*L&'J#FFR11S+MEC1U]&&16>^A618M%YL#'O#(5I :=%9@TF51A=3O /=\TA
MT8OCS=0O6'H)< T 7YKF"W4M-*B ?WFQ5!M6>X;R].MVG/\ SU8;8Q^/>I8-
M&L(&W" ._P#>D)<_K5[Y47LJC\ * ,^#3"9Q<WTOVB<?=&,(GT%:-9TVK(7,
M-E&;J?IA/NK]6Z4ZTU(2R?9[F,V]T/X&Z-[J>],"_1152_OULHP IDG?B.)>
MK'_"D,IZR1;S6]S ?],#;40#)D4]0:UE)*@D8..1Z50L;!HY&N[IA)=R#D]D
M']T5H4",_6EEDTN5(XRZMA90HRP3^(J.YQT_KTJI/>V,LT<]M>-'*B[?/"%H
MR/[KGI^H(K;IIC0QM'M 5@00!ZTFC:%1)6:,Z::\C@WS75G#&>!*%))SZ GK
M^=49I+-]--K;-,;HR+(B/&0\L@((9@0,J<#)Z >F*T(--EC:V$MV98[<Y1#&
M!_"5&3]#6AM&X-@9'>E:Y?M(Q>FOII^@+NV+O #8Y Z9I:**HYPHHHH ****
M "BBB@ KFXO#VH65C<:;8:BL-G+*TB/L/FQ!CEE4@XZYP?>NDK/TO7--UKS_
M .S[D3>0^R3"D;3^(YI-)[FU*=2,6XK32^EUY%5- !U'4[B6;?'>Q1QA<?,I
M08SGUSS5*V\*/%X4NM&FNQ)+-*\JSA,;7+;E./8@5T]4]4NWL=.DGC4-("JH
M#T+,P49_$BERHI8JJNO;\-B#0-(71-&AL?,\V1<M+*1S(['+-^9INGZ=/%K.
MHZC=&,O.5CA"$G;$HX!R.I))-07LVKZ?9W,LDT4T8MG<2QQA3&XQ@8).0>?R
M]Z4>(XH[>9[FRO86BB67:Z+F12=N5 8]^QP?:G9$.M-N3>\M_ON.U?0O[8U+
M3Y9YV6TM&:0Q1LR,TF,*=RD$8YZ5GR^$#]GU*U@NL6MY<0W 24M(5975GR22
M3NV]_6M)]>V87^R[]I0GF2Q*L9:%<D M\^#G&<*2?:F7'B6WA+M':7=Q#'$D
MTDT*KM6-AD-RP)X[ $^U)Q3+ABJL$E%Z+_._YD,WALBZU)K.6.&WU"W\N2+9
MP),8#C'MU%-@\,M8W&EW5E+%%<6MN+:?]W\LZ;0.<=\C.:M+XB@ E,]I=V^V
M,2H)47,JDX&T!B<Y(&#@\CBE/B"&*WN)+FTNK:2!59H90F]@QPI!#%>3QUX[
MXHY4'UJK:U_ZM;\C(7P0HT9H6O9CJ33FY-QYK[/-W;MWE[MOMTK7U#1FO]6T
MB^,J*;%G9EVYW[EQQZ<\TO\ ;R"!6>PO%N'D\N.U*H9'.,\$-LQCG.[%,;Q'
M"/)C6RO7N97>/[,JJ'5E&2#E@HX.<YQ[T<J"6*JR=V^_XJS-FLK3M(>Q_M3=
M,K_;;AYA@8V[AC'O4=MXCBN7CQ87T<3R^0TLB(%CDSMV'YLYSQD CWI[ZU^^
M,#V5Y;^8'$$TJ*$D95+8 #%AP"?F Z4[&49RBFEU(-"TK4='TFUTTS6TD,"[
M2X#!B,D_GS5:X\.ZA>6D-G=ZA%,D4RR+<F+]_@-D#.< ]LU?M]6,'AFQU&[$
MDSR00E_+4;F=P.@X'4U"_B98Q/YFE:BC6PWW *Q_NDQG<2'P1C/"DG@\4N56
ML:_6:G,YZ7>NW4L3Z0\WB:SU83 +;V\D)CQR=Q!SG\*IZCX;DOFUTK<JG]IV
M\4*Y7/E[-W)]<[JN2ZREO--$([BYF\[RHX(E4,QVACC) P!SDD4U?$$;W5M:
MI87IN)U9C'L4&,*P5MQ+8XW#IG/;-/E1,<14C9I[:?<[_F5]0\-M=W>F7$5R
M(C:R1O,NW(EV @'V(R>?0_2H9_#=SY&I6EO/;&UO7DD GB+-"S_>*G/J215^
MVU^"ZFA"VUTMO.VV"Z95\N4^V#N&<<$@ ]J:_B&*%G%Q8WMNHB>6-Y44"4(,
MD !B0<<X8+2Y44L5522OM_PY?T^T%AIMK9JQ=;>%(@QZD* ,_I5FL9?$*O+:
M1+IM^9+M7DB7:@RBE 6/S\#YQUYX/'3+Y-=$,K))IM^H(?RG*)B8J"=JC=D$
M@'&X#-48-MN[-:BLFX\16,$:2+YDRO LX,8'W6(5 <D8+$\?0YQ5NPOOMT+.
M;:>V96VF.8+GIG(*D@CGJ":!%NBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHKF9I)M2\;3:;+<SQ6EM9+*L<,K1EV9B,DJ02!CI2;L:4J?/?71*YTU%
M<AJUZ=+T!+(ZV)9+F\^S+=F0*T*DY;+9^\JYYX/2LZYUN6?P*YAOY'N+6]6V
MDGAF.YP'&#N!R<J1WJ7-(Z88*4TFGHW;_@GH%%<,UY.;W7!87%]';6FG/YJ7
M,S%DF*DJR;B6''>FZ/>337V@0VT^H"X> 3W?VF9V22/;@D!B<G=CI1SC>":B
MW?\ JU]3NZ*\^>_O7TBU)N;N1GUUH6$<[*[IO(V!LC [=0*O^(VFLM%CDA74
M[1GO8$;?>,[LI;D AVQG\*.?2X?4FI*+EJW;^M3LJ*Y;0KB2X\3:@EK+=_8+
M>)8Y(KN1F99B2<J&)(&W%7/$,T\USIVDVL\D,EU,'E>-BK+"G+8(Y&>!^-/F
MTN8O#M5%"_2_HK7_ "-VBN,TMY[O6-<6:/4[I(;XI&8;THL:[1QCS%_E5;Q3
MX@:UUADM=1$/]E1QS20M/M^T%F&4()^;"9/?DTN>RN:QP4I5/9Q>MK_E_G8[
MRBN,U;69K?Q9IUW!<2MI_P!D62:,.=A1GV[R.F1D'/H#0^I7ESXVB9+B5+$P
MW$4<:N0KF,#+XZ$[BP!_V:.="6"FTG?HW]W3U.SHKB-&O[R4^$/,NYW\^.<S
M;I"?,PAQN]<>];'B*XN-)>WUJ.25K:W^2Z@#':R-P& Z;@<?AFFI75R985QJ
M*G?5W_!M6^=C?HK*\/V]W'I_VB^GEDN;IC,ZLY*Q ]$4=@!CIWS6;<6BCQE:
M6@N;X6\EG-*\8O9@"P= #][W-%]+D*BG-QOM?\#IZ*XZ-II?%VLVS)J5S# L
M C2&]9!'E!GK(O7\:GU""[759'=[^;3UME58[2Z(D@?N7 8%LCODTN8T^K*Z
M3ET3^])]_/R.JHKBM7<-X&CU&UU6\GE!A1;E)Y(BP,RJ<JK 9P2#QFKVM!].
MU/P_#:W%TL<U\1(&N'?>-AX.XG(]NE',"PM]+ZW:V_E5SIZ*X#3=4OH-,UF6
MYNYWBEN+F*&1Y"3"ZYVJ#V!'3W'O5NQN;C4;S2[6XN[OR4TA+IUAE97F<X&2
MP.3^?4T*=RY8&46[O1':45B^';B.2*\@2]N;GR+AD(N4(>+OL)/+8]:VJI.Z
M.2I#DDXL****9 4444 %%%% !1110 4444 %%%% &1)#+I,QGM$:2U<YE@4<
MJ?5?\*5;6YU4B2^!AMLY6V!Y;_>/]*UJ*=Q6&HBQH$10J@8  P!4%UI]K>C]
M_$K,.C#AA^-+'?V<LOE1W<#R=-BR G\JL4BG%K<R9K6]L+>22UO7D2-2WES+
MNS@=,]:T+.?[39PSD %T#$#L:E90RE3T(P:SM")_LJ.,G)B9HS^!-,DTJ***
M0RAJ-S/$]M!;%!+.Y7<XR% &2<5&=(-P0;ZZEN/]C.Q/R%$Q\WQ%;1Y_U,+2
M$?4X_I6G3$,BAB@C$<4:H@Z!1@5%>64%]%Y<RYQRK#@J?4&K%5YKZTMY/+FN
MH(GQG:\@4_K2*2;T1GM<:CIP,4D+7BGB*1.N>P;_ !JS8V#12-=W3>9=R#D]
MD']T5?!!&0<BB@FP4444#"BBB@ HHHH **** "BBB@ HHHH **** "H+:RM;
M/S/LMM#!YC;W\J,+N;U..IJ>B@=W:P56O[-;^RDMF8IOP0PZJ000?P(%6:*!
M&1+I=]>12I>:@K!H&B58HBBY;'S,-QW'CCZFG7VC&\D+>?LS L.-F>CAL]?;
M%:M% &;<Z?=F]FN;*\2$S1A)!)%OZ9P5Y&#S[U$FA)%87-G',0DMLENI*Y*A
M5*@]>:UZ* ,F^T7[;*LGV@QLL C7"YPP=7#=?5>E(=*NY6N)KB[A>XDC6)2+
M?Y%4')!4DYSWYK7HH Y^#PY):LLUO<00SQRF2-8H"L*@KM8;-W?KP1S5BWT6
M2/4(;Z:Z$DZO(\F(]H;<H4 #/   ]:V** ,Q-(*VQA\_.;TW>=OK)OV]?PS6
M9;^$S#=V]PUQ;O)"SDS?9OWTNY&7YWW9/WL]AQTKIJ* ,P:21HEGIWG?\>RP
MCS-OWMF.V>,XHNM)-PFJKYVW[?!Y7W<[/E*YZ\]?:M.B@#'ET63[:U[;W*I<
M><9$+Q[E *!2I&1GH#G(J:WTV=-2BOKB[$TB0/$0(]H.YE;CG@#;CO\ 6M*B
M@#$M=#N+>&SM&O5:RLR/)018?"C"@MD@XX[#.*SX_!I3:6N;;S!#+"TZVN)9
M=Z%=SN6)8\YKJZ* **:=MO[*Y\W/V:UDM]NW[VXQG/MCR^GO[5DVWAG['?07
MSRP2/;N\AD6U_?RY!&&?))Z]AVZ5TE% '/Z9I$BZ?>%,P/<RED6>,/LC!^5"
MOIR>.VZKVD:7_9<<Z[HL2R;Q'#'Y<:< 85<G'3/U-:5% !1110 4444 %%%%
M !1110 4444 %%%% !1110 50O-'M;V[CNV\R.YC0QB:%RC;3_"2.HJ_61)J
MUXGB:/2QI,[6C0^8;X'Y%//R],=O7//2D[=32DIW;AT7X#[?P_IUK-:RQ0L&
MM=YCRQ/S/]YCZD^IIESX;TV[FNI98WS=-&\H5R S)]TX]:UZ*.5#]O5O?F=_
M^#?\]3/N=%LKJ[FNI(V$L]N;:4JQ&]#V/OR<&@:+9 :?M1@;#B!@QRHQ@@GN
M"*QX8C:RVLET]RLCSJ!>QSEXI=S<*5SP#G'3BI+77KF358X&D@G@F+A3%:RH
MJ%03_K6^63IVQ19"]K.UKEUO#>GM;) %E54N3=J5D((D)SG/UJ2?0[:ZA6*Z
MEN9T65)5$DI.&4Y%9<>O:E:Z?%?WZVKQ2V+W8B@1E9"J!L;BQSG/H,>]%[KF
MJZ,Y%^EI<!K9Y4%M&ZG>&10O5LC+CD=?3U.5#]O4_F-Q=-MDU5]21"MS)&(G
M(. P'3([D>M-73(AK+ZHSR-,81"JDC:B@Y...I/6L$:_JP A$,;RO+$B3R64
M]O'\[8((?DD=<@\^@K9U*XU&STM'@2.>ZW*KLD+%0.[",-DX]-V:+(GVDN_2
MWR)[/3;:PFNY8%(>ZE\Z7+9RV /PZ4RVTBSM1>^7&3]M<R3ESG>2,?ECM6&W
MB.[,%O%&T37$C2!YH[*>4*$QP8E^=6Y'!/'O5B'5M5O_ "X[:*"UE2W\Z874
M$F6^9E "DJ5SL)R<]1P:+(/:3UUW+D7AO38D11&[!+4V8#.3^Z/4?K3X- T^
MW-H8XV!M(GBBRY.%;[V?4GUJM::S<SVL\CI$&CT^*Z 4'&]O,R.O3Y!^M9S^
M*+Z2:7[-;,Z6^P/&ME/(9F**Y"NH*IPV!G/O@<T<J*=>H]Y,UAX<L$BL8XO.
MB^PAA R2$%0PP>>]6;C2H+O3)K"Y>::&7[V]_F['K^%98U?4P8[IUM!9M?M:
M>6$;S"/-,8;=G Q@9&#GGD=*GM;S5+J-;PBT-C+NQ$%82(N#@EMV&S@9&!C/
M4XHLA.M4;3;V_P"'-E%"(J+T48%0/80/J46H,I^T1Q-$ISQM8@GCZJ*P4U35
M&MBUH+***"QBN6$D;L6+;\J/F&!A!SS]#3KO6]3-MJ-Y9+:+!8(-\<R,S2,8
MED."&   <=CG!Z4R%)K5&FVB6QU"XOHY;B&>XVB4QRD!MHP./I39=!M);EKD
M/<1SO&(Y)(Y2ID Z;L=3[UI1L6C5CU(!IU*R+]M4[F:^A:>^C+I/DE;-2I"*
MQ'*L''/^\,U/>:;;7UQ:3SJQ>TD\V(AL8;&/QZU;HHLA>UGO?O\ CO\ >9BZ
M!IZZ;=Z?Y1-O=2/)*I8G+,<D@]N:1] L72S"B6)[.,10R1R%75< 8SW' ZUJ
M44617MJG\S*>G:7:Z6DJVRMF9S)([N69V/<DU<HHIF<I.3O)ZA1110(****
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M HHHH *C>"*1MSQ(Q]2H-244 G8.E%%% !1110 4444 %%%% !1110 4444
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M-K_P;_GJ8W_"-6$5_97EE%':26H9<0Q@>8A&-K?H:=H^CW&CVD%G'?"2VBR
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MN5D%^9H_LSX;(3Y<!2.@SNS^M=I5&;2+*XO%NI8G:0$-CS7"$CH2F=I(]2*
M.<%O,^MRF>:**[^V;HV,4AD\H'Y5!!QM*]>V<YYI+33Y;;2M+NK2)UU&2616
MD;.2"DF V?X<A>#P*[*B@#S^+3C<Z5/&K(\YT^59X#!)OED*\&0L2-X;H>O)
MQQ5V1!Y<8M8W6S^PP"185*_+YIW@ =\9SCFNSHH RM&6P4W/]G)(EN2O&W;'
MG'.P?EGMG\:YS1_LOV;3)+..9]0#N9RH8,R8;(8GC'3'OC%=Q45M;0VENEO
MFR)!A5R3C\Z //Y2[6TK6< B:73+H21P)+NW;,J)&;[SYSR>>M:VK:=+97,L
M6F+*BRV1\YE+$OB1,DD')?:6YZ_I77T4 <=;6^%9K:2)K=KBV/DP0NJ(P<Y8
M;NY&,X].>M2Z>D<>OQM&OF2/-*7;RW25 <G$AY#+T _#%=910 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[*?\K^XO45$MU;M/+ L\1FB :2,.-R ]"1VJ*VU.PO)#':WUM.X&2L4JL1^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNVEB8P!\HY)^E"C9DU<3&<%%+;Y]$OEMT,5W:#Q]#-JIB2-M.*P-G]V'WDL
M3WQC\*H7TE@RZ5)I*BVA.LL?,E!*,^ULL!N^Z3Z$"NT1K74+:.5?*N('&Y&P
M&4CU%17LNGVL""\,$<1;:@D QGV%'(..+2:=ME;?3KT^9S_B4?:M,T^&ZGMK
ML/JMJK>2FU=I<#!&YO?O4:221^--&L)BS2VMO<@,W\<9\O8V>_0@^ZFNBMI=
M,EC5K7[.R/)@&-1C>.>W<5<*(7#E%+@8#8Y%'+U%'%*,>6W?\58YS1O^1X\3
M_P"[:?\ HMJYB;SW\,7<$RPIILVK21SW&"7@4R_> Z=<#/O7H$]_I]E(YFN(
M(I"5#Y(!.0=N?P!I]M+97MNQMFAFA)(;9@@GOGWH<+E0QBC+FY?Y?_)58X/7
M(IY+SQ?'9[WD^Q6V-G)*_P 7_CN:Z2*YT*:^T9;=!+<"-C;-"?\ 5)LYWX/3
M''.>:W=L,3;L(C-A<\ GT%$=O#"Q:.&-">I50,T*%F*>*4XJ-GIY_P!U+]/T
M,#79$C\4>'7D=5423Y+' _U9K FU,Z?-XGN],7=#</#;V@C^[)<,NTE>QQG)
M^E=TAM-1@64(DT>2 73N#@]1[5(((@JJ(D"J<J-HP#[4.-PIXJ,(I.-]+?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cntg-20211231x20f015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &4 ](# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHJEJFJVFCV;75Y)L0< #DL?0"@"[4
M,]W;6HS<7$40_P"FCA?YUY]+KOB/Q5,\&DPM;6H."R'!_P"!/_058MOANT@\
MR_U(F0\L(US_ ./'_"@#LDUC3)&VQZC:,?19U/\ 6KH((!!R#T(KB9/AK8E?
MW=_<J?5E4_X5G2^&/$GATF?2;UIXUY*1$@GZH<@_K0!Z/17'^'O&\5_,MEJ:
M"VN\[0W17/H<_=/^?:NPH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** (KBXBM;:6XF8+%&I=B>P%>;VEO=>.
M_$$ES<%H]/@X '9>RCW/4G_ZU;7Q%U%K?2H+%&P;ER7Q_=7''YD?E6SHUI!X
M<\,*9OD$,1GN&QWQEC^'3\* -2UM8+*V2WMHEBB0855%35YE_P +=,T[I:>'
MY9E&2/\ 2/FVCN0$../>HA\8RS!5T DDX %WU_\ '* /4J*\OD^,$D,C1R^'
M6213AE:ZP0?<;*5_B[-'$DK^''6.3.QVNB V.N#Y?- '4>*_"D.LP-<VJ+'?
MH,@C@2^Q]_0U6\$>(9;Z)]+OF/VNW'R,_5E'&#[C_/0UL>&?$5MXFT@7]O&\
M6',<D;\E6 !QGOP0?QKD/%,9\/>,;35X 1',WF,%'4CAQ^(/ZT >CT4BL&4,
MIR",@CO2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 >>>-QYWB_2H&Y0K'D?60@_RKKO$W_(J:Q_UXS_ /H!KD_B
M&C6VIZ9J"CH"N?=6##^9KJ]<;[=X0U)K8&3S["4QA1DMNC.,?G0!X[\.T5_$
M,P8 C[*_!_WEKG]% ;7M.!Z&ZC!_[Z%:7@_5[71=8DN;LL(V@9 0"><@CI],
M5D:;<)::I:7,@)2&9)&QUP&!H UO&P"^+[\ 8Y0_^.+6]XG11\/=$( R##^L
M;$US'B>_@U/Q%=WELQ:&0KM8@C.% Z'Z5JZWK]E?^#M+TZ%F-S 4\Q2I&W:A
M7KT.<T =[\(O^14NO^OY_P#T".K/Q)C4Z39R?Q+/M'T*G_ 5!\)$9/"4[,I
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MT.U%[,WK_GVK.I)K1;LSJ3<;*.[ 0:CX@_>WDK6UFW*0)U8>_P#]>K\.AZ;
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MVZ4OB2XEU[Q)#HL#D6\+?O2/7J3^ X^M=5;6T5I;QP0($C084"NC2E%/[3_
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MXB'0K-["U5+F['"LQ^6+Z^OTH [_ %76M.T2U^T:C=) G;/)8^@ Y->8:_\
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M7M(TY-*TN"S0Y\M?F;^\QY)_.KM%%8MMN[(;N[A1112$%%%% !1110 4444
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M;\H<\@CM77Z;<F[TZ"=OO,OS?4<'^58OB(#[#&W<2 ?H:TM _P"0);_\"_\
M0C7EX:FJ.,G3CLU?\CMK2Y\/&3WO8TJ***]4X@HHHH IZK=FRTNYN%^\B?+]
M3P/U-<'HFF'5;QFF)\I/FD/=B>U=CXH_Y%V[_P" ?^AK65X24#39FQR9B#^
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MSGCZ&LH?&7PZ3C['JG_?J/\ ^+KR7_A%?$7_ $ =4_\  .3_  H_X17Q%_T
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MG7TUI-W]OT>RO/\ GO DO_?2@_UKYEKO-(^*%]I.DVNGKI\$JVZ! [.P) H
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MSYS-<'#"U5"'5?JU^@5R&E?\CN?^N\W\FKKZ\YU/6)- U6\U.*)97@G?",<
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M11L#D\S*&/!/J!TKAP7_ "\_Q,Z<1]GT1VP>P958:C>88!AB1NAY]*0G3_\
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MR,L!FM; QE&DD[][_P":/G?_ (5CXP_Z!'_DS%_\71_PK+QA_P! C_R9A_\
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M2)K_ %:7_CUM% Q;C^^^?XO;_P"OC,TOQ;JVD:A>72W0GDNFW3)<WT#+NZ9
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MWCW_ ) 4'_7RO_H+5Z^%_C1/BJ_\-FQX+_Y%*Q_[:?\ HQJWJP?!?_(I6/\
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MA[^U-4VG?F9,\9&:Y52BK]4G?\SROX)?\QW_ +=__:E>M5Y+\$O^8[_V[_\
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M\Z[.O._$&BW?AW5/MMGN6V+[HI$_Y9D_PG_/(_&M*Q\=H(E6^M7W@<O#@Y_
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MC7J%<IX,\/R:9 ][=H4N9EVJAZHO7GW-=73Q$E*>G0PK23EH%%%%8&04444
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M?Y >P'%>E?"SPN=QU^[CXP4M58?@7_F!^-<IX*\)2^)]4'FJRZ?"<SR#C/\
MLCW/Z"O>X88[>"."%%2*-0B(HP% X % #Z*** "BBB@ H(!&",@T44 8EUX0
MT"\E,DNFQ;SR?+9DS^"D5!_P@OAO_H'?^1Y/_BJZ*BH]G#LCH6,Q"5E4?WLY
MW_A!?#?_ $#O_(\G_P 51_P@OAO_ *!W_D>3_P"*KHJ*/9P[(?UW$_\ /R7W
MLYW_ (07PW_T#O\ R/)_\51_P@OAO_H'?^1Y/_BJZ*BCV<.R#Z[B?^?DOO9S
MO_""^&_^@=_Y'D_^*H_X07PW_P! [_R/)_\ %5T5%'LX=D'UW$_\_)?>S'LO
M"VAZ?*);;3HED7D,Y+D'VW$XK8HHJE%+8QG4G4=YMM^84444R HHHH ****
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M?_%4?\(;H'_/A_Y&D_\ BJW:*?M9_P S'SR[F%_PAN@?\^'_ )&D_P#BJ/\
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M4^(>AVEHUNI.H2LFV185VQDXP?F/;KTS0!T-_/<VGEV]A;#<ZL458_E!'KC
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M; Y_&DM="TBQECEM-*L;>2/=L>*W1"N>#@@<9[U.VH6274-JUW MQ.I:&(R
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MI-:I);WV5OD%%%%6<P4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^P7/_07O?^^(?_C='V"Y_P"@O>_]\0__ !NK]%/F8[E#[!<_]!>]_P"^(?\
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M\!2O\2_>9<\XSBMZLZPLK22VT^\>UA:ZCMT6.9HP70%>@;J.I_.M&@ HHHH
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MB4O.!C";V)8;<<')!XX&3BW+::M)>V]Y+;6,MQ:*YC<.Z[@^-R = >!\QSG
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M;26T9!2%XE*+C@87&!U- %E5"J%4 *!@ =!2T@      Z 4M !1110 4444
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M X;&#G&,5UVDZ5!HU@+.W>1HP[OF0@G+,6/0#N:O4 <1I$,<_BO0I)5#O%H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJR
MZA:OJ3Z<LN;I(A,T>T\(3@'.,=127.HVEG<VMO<2[);IRD*[2=S 9(X'''K0
M!C^,%,5A9:B%W+I][%<R>OE\JWZ-G\*76-!GU'6[&_MI81#M5+M7)S)&DBR)
MMP.>01R>C5T-54U&TDU.33EES=QQB5X]IX4G .<8H PK'PO*FI:F]Y)$UG-'
M+#:I$3NC25B\F<C .2,8SQ3-(\,OIYLXI-(T(_9B!]N2+,T@7HVW8-KG@D[S
M@YZUU54H=6L[C4);&&222:$[9"D+E$.,X+XV@X(XSF@"EI.FWNF:GJ7%O)97
MERUT'\QA(K,J@J5VX(RO7=^%-O=&NKGQ(FHQ3I%&+"2VW G>KL00P'3C'K6Y
M10!Q-AX1O8+S1YGM=*B:QDW3W$3,TUT=I!9B5'.3G!)Z]1C!EB\/:[#I>J:4
MLMA]GU">5C-N??"DC?,-NW#G;[K@]S78T4 9FHZ-%?\ AR;1EE:*-X/)5\9*
MX& <<9Z#CBN<U?PGJFOP6L=S_9]C+;P^4US;O([3KQ^[*X3:AY.,MCMWSVU5
M;G4;6TN[6UGEV37;,L*[2=Q R>0,#CUH ?9"=;*%;F.&.8* Z0,2@/\ LY .
M/PJ>BD)P"3GCT% "T57LKVWU&SBN[20202C*-@C/;H>15B@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M41N3C<,[=X!QR P')]:GG\.V4]S=SEI4-U9?8F1" JQ\_=&.#S]/:@#%@O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>cntg-20211231x20f016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %\ N4# 2(  A$! Q$!_\0
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MCO5O3[J.Z:">WGDDMYX2Z[QCN*=]; X245*VC-.BBB@D**** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIEGJ&TW4"R%/NMT(_$<TU](T][);-K6/[.IRJ 8P?4>_O4C:A:+ )C<1>6>
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MT[Y/?-6M*2ZLYVBFMR%G<LKX&5 4#YR."2>![5LT4 <Y_85P)9KC<S,;SSA
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7:BJJCLHP*=4L04V218HGD<X506)] *=5+4OWD4-M_SWE5#_ +H^9OT!'XT
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M4,0,\$#/K72:-)J#?:$O8YA&K#R7F"!V!'((0D<'O[U+)HVGRK*KVR[9516
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M+X@?4[B.)?+A\B#:V6*DY)/'';BI(]%L(;GSXXF4[S)L$C>6&/5@F=H)R>U
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MA<$%DX/US6?9:,+:\%U-=27,B(4CWJJ[0<9/R@9)P.30!S^KZC;7L@6UNDF
ML&+;&R!RO7WJO?7<(E>5&BCN([B- 9)6,W51\J]EP?I7<B&-<XC49]!08HRV
MXQJ6]<4 8V@VL9NM0NVW-,;J5-S,3A=W0>@K.OK.*YO/$DTN]GAC0Q?,1Y9\
MK.5]#FNL  Z "C:O/ YZ\=: ..G6/34L;B,3$SV;M<%'.Z0[ <D^N>]4?M*H
M]U':RVX1K$NRVTI<9R,$GUKO]J\?*..G%-$,:C"QJ!["@#&\.9+:@3_SW'_H
M(K<I H'0 9]*6@ HHHH *1ONGZ4M(?NGZ4 ?*-X?WY7T)_G4!5@.'-37[#^T
M)AZ.1^M1L010 ZW+F9!\IYJ*X.+B1BO&:GM!^_7DG':H+MOF/N: &3R[-&=/
MXI9A^0'_ ->J@SC!Z8J;45,=K8J>K!G_ %JO$=QH I7]L$N5 ;)9 QXK:\-(
M$D((^\P JA>1DWSC).$ %:=C;O!"CJ=K89A^ H R;O9/>%N@WDG/'>NN\-W[
M6*%8W4":-MY_45RH5RQ'7/Y5TFF6,=W':PR J#@L1P0 #D?C0 :S>2MHEP2P
M9G=4P#V//]*Q]%<B_!XSM;K]*NZ[#%;PB&'(1I2<$YX JOX>TL:K>O 79!M+
M97V% $5M#-+XCMW1ED\N0/DG QG)YKH?&UP_]NPPEF>(1#,BKA2S')(Q6 8%
MMHKP\L FP'W)_P#K5%I>J7T*[!-OB/'EN-R_D: /3;&>UU:[@TN6&-EA@#%R
M,,.!@9ZUD:UKLN@W1M[6YD1<E"N<C'>H$LY[R2*Y\D)Y(#-)&V,@_P#UA7"7
MQENKZ:8RL29&(W'/>@#LVU^74K$V@<RP$Y9">N*Z31?!5M<26E_I5]%*>&DM
MG;YU]17)>");2.RN3=X+/D)DCZ5M:''#>0ZA?6]T]H;?<\+ ]0O&#]2/UH V
M?B3+<K%#!,249QLXQ]T?_7K2^')6&VOG.!L11D^@%5XM8UJULK>75[.+4]-F
M7)8X8C_Z]33Z]X>M=&O?[-+6TUPI5HFY.2.HH \J7.J^/HOXUEO<\>FZO1/'
MDIN=6L[,?=$C/C_= 4?SKF_"OA?5;'Q;IVH3VOG61)9;B([DS[GL?K6]X@E-
M[\01 J_<"+CT.<F@"SXWG6S\"&WX#7%PD?'=5'-5=&\[2? 9U $;4C< 9YRW
M J#XIDV\&C:6K[F4/,Q]<G%+KLIM?A[8V9^5IRHZ<G% '1?#]X[/PHE]*%3-
MQND<C^'O7H5E>VM_=6L]G(DD)63#(>#]VO+5F-C\,"<8:0D#\:ZGX:1K'H=E
M@C+&4D#M]V@#T&BBB@ I'^Z:6D?[IH Y/QYXHF\.:*9K.U2XG\Q$)D4F.(,?
MO-BN$'Q#UM\HMSX?&Y<[E#CCZ^M>J$PBZOS<('B 7<I7=GCTJ#S-$P3]@B_\
M!1_A0!Y"/&NLM>& 7^E@HFXOYLH5CZ9[FIE\8ZQ.A_T_1P-W&Z649KV**RTN
M:W$ZV%OL()Y@4'\L54BF\/3VSW"06GEH,MF%0?RQ32;$Y);GD?\ PE^L"0 Z
MAI9.,8$TN *[+P;J<NNPW;7]N\TENPC6>RD<Q2#&>,]Q73RW7AZ&-7>UMAN;
M:%, !SUZ8K8LQ;_9D:VB2.)N0JJ%'Y"AIK<%)/1&0MK N<6VI<C'WC_C0+:%
M>!;ZEC&"-QY_6MZBD,Y];*V6&.(6VI[47:/WC9Q^=.DM()'+FWU,$^CL/ZUO
M57O=K6<F7=!C[T?4?2@#+>"&0 &VU$8_NL1G]:C^S0*QS'J9+'@&0_IS1"\$
M-S&YOKY\#.UEX/Z5/J.FVJ-+?37-Q'DKRC?<.<<>F::$W8B2VB0']UJASZN?
M\:OI>E$519W1 &.5S5.*ZL;:>XTY]0=Y@F]B[9V@=L^M5F:QN&65M1NX S!
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M[V:WHU/:1YC@QN&^K5G3O<R]/N4GED"# QD#'49ZUZ#I7_(-M_I7 V"QJSE
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M8I  (9VVC+'LJ^O:L70J>UYCOAF&%6#]F][6M;J=4ET[^'5DM9!)-Y0VM/\
M+D9QN:O*_$]Q*=8FM1\D$!VQQKPH]_QKT9C%+>H9+>=A.IBD@ENE!5?4KGOZ
M5S^J^&(]9,EW9AL1,(56)"7P./G5B.1Z]ZWQ$)3A:)YV65Z>'K<U79K<Y[PG
M?W,>KI9+-((+A61P#]W@_,/0BN]6;S;>"3S'?>BY=UPS<=2.QK+TGPC_ &0\
M\S2313*%"71VYP?O!%[$CC)K7N',AWG );CVIX:$H0M(G-,12KUN:EM;?N5[
M4@R2?-D]@&S@5W>E?\@VW^E>>Z9]H\V4SR;AVR<Y]Q[5Z%I7_(-M_I70C@G'
MEE9.Y?HHHH("BBB@ JG)_P ABW_ZX2?^A)5RJ<G_ "&+?_KA)_Z$E %RHYXA
M/;R0EF4.I7*G!&?0U)10"=M3!\.Z#<:89;C4;O[9>-^[64_PQC[J_P"-;U%%
M)*RLC2I4E4ES2W,7Q-&)-/@W),T:W4+/Y*L6"AQD_+S^58TD>Q[Z73[.YN+1
MT3S#<Q.QW[NJAOF8 9..E=G13,S@WM9[N>[!@N)H'DMSN:U,2OAN<+CM[UL7
M,<%IJ>H?:["6>&>)5@$4)<%0N"G ^4YR><#FNDHH Y94BLKJ^^W:=<2+<11B
M +$9OD" &/(S@ALGG .[.:HQVTECI]Y;ZE8SSW4UK&L92$RYPF-F0, @YZXZ
MUV]% '#1V$@$T%Z;V/STBV"*V$F0% QNVG:0<]2*Z/7+=I= :%(WE8&+ QDG
M#K_2M:B@#FY1#9ZKJ#WUC-/'/&@A,<!D!4+@Q\#@YR><#FF^&=-FM;F=[R B
MX6WMX_,89Z(<@'OCI7344 8FH)LU^WE,+LKVTD8=8RP#9! )'3\:S!;M8Z!I
MBK9;#O)ED-N9&B//S;!R3[]JZZB@#B+&*>.9+JYMKE[..^E9E:W(/S*-K[ .
MF<]!WJ?4+"?4/L@TJ&:P62YF8R-&1D&,C=CJ@8\=CW[UV%% '$WMK)=0!$TV
M6%%M/)>$(<*PD7(![COGN*MZSI\GV^8V]HQ@$,9D2-.' ?D>YQVKJZBN+>.Z
M@>&4$HPP<,0?P(Y% &'I4MM/XFO9+:!XD-K%DO$8]WS-V(!KH:IV6FV]@9&B
M\QY),;Y)9"[MCH,D]*N4 %%%% !2-]T_2EI&^Z?I0!\A09>ZFSSAV/ZFLQVR
M['/>M.,&-;M^X9A^M9@!QG=C\* (G:M6UC9-+W@#+'/-9$F<]:WY0L>A6X8_
M,3D4 4[")I]4B5>JY?GV&:>/-(D>0 $FKGAZ,;M1NV&1%;%1[%C@5$5Q'T_,
MT 4[Y2MI;G/4DFJZLR1.PR1G%7+\$F%"O'&!2ZA:>781-G#LS-CT4<"@#"E<
MGJ,5UGARRNY=(>ZMKAK<0N&=U]VP/RKCI$^; .:]C\!VBIX)U#*G,K1Q<#/!
MZT 9?B>\UH>&U34)EE@DD"PN!CS .K5Q4+YD4$=Z]$^+#HATNTBP%1&? ].G
M]*\_T^$RWT:=<L!^M 'L>B^([&T\,6MI<D,\3A6BQR>,].]>0:G=?;=:O+P<
M>=.SCV!->FVFEQ ZM?2[@+*!N ."V,BO*U4L^5QR<\T =5I$ZQZ-(N"9&=>W
M\/?\JYSQ8R#63#&V](XU 8=\\UZSX(TZU;PRLMW$&^8DD^W_ .NO(/$$BWGB
M2^:/ 4SE4 & !0!O^!+96\5::CXV(/,;T%;OQ6\02WD\%DO^I@G<Q@=UP!_.
MJ_PUTX:AXBN5)*+%#RPZ@C_]59/CI)UU\P7&2\2\D=]QS0!H>#!)]AN'RQW3
M1Q@9_'^E7K[]]XTNFW%\3",$]< ?XU)X.T^Z.B6=S$@*M=%I%/!.T9SGZ$TS
M04>\U][B.,RL7DE"CN3TH L?$'4[G2['2X;"1X99$)D('4>AK9\+WU\W@47M
MQ.,'?@@;>!ST%<3\0YY)M=MX)%9'@@564]CUKI'NEM? -O9(3D6QSC^\YQ_*
M@#:TS6#X-^&D.J>2LD_E"148X#LS=S3M&\?OXDM&O;NT2W2.*0;58L#QUK!^
M)DWV+P%H]BK8+A<CV S5'PZ$LOA?/,R@32DJI]CZ4 =3X1O8=*\(7>J7,'F$
M2M*^T?-CMUKM/"&M6VNVMI=VL,L<0\Q<2#!)^6O.M00V/PJ1@=K2X0C/4$UW
MGP]MUMO#^D1@8_=.Q^IVT =Q1110 4C_ '32TC_=- &6Y"W5\Q#'!0@+U)J:
MWO99YA&;:XC!'WW3 J%RJW-^SL55=AR!DCCTI7OT39FZ?YP",1>M &CM?^_^
ME85S<Z,NK/'<$B[B'FG<IQTZBKPNP94C^U-N==R_NNU4IET^2X2YF;=+(O#&
M'G%5%I;DS3>PLFHZ/-IBN\_^C"0   CYJC\C1FGG@*2':GF2$[BI YZ]Z<8=
M-CVY*CS>%'D\?EVH6TT^,R;68;?OXC//;\:KF7F1RR>]BU;V.F7@:2"./(^0
MLJ[3Q_\ KJ>#2+.UN#/!!&DI&-P7\*I026<9DGAF92!ECY1^E2C4XB,B\<C_
M *XU+EV+45U1J;6_O_I5>9HH+!W>0^6G)8#)Z^E0&[ 7=]J;:5W9\KM5RW"B
MV4@EE(SDCK4E&))?Z)>DM*Z2EP/F:(D\>GI4<MWHC+/$L@CD*&!R(CG'7FM7
M49YX(E2RM1),^<$CY5]S5'2@]I9$,DMS>S'S)69< L?Y =*M7M>YFW&]K%]+
M:WO;97!#HZ!0<8R!0=(M",&)#\I7)&20>O-,%QJ>8R;.,(?O*'Y%-FAU*9MW
MVA8TVGY$'.>PS2U[C;78G_LNV!0^5'E"&4[>01TJUM?_ )Z?I5"W:\BMDB6
MEE'+2OUJ01WK_,]R(R3]U$SC\:&O,:?9%O:__/3]*IW\16SN)"V24QTJS!&(
M5(+N[,<EFJ+43G3Y_P#=J2D9GB#_ (\K;_/:N4%B@U-K[>=Y39MQQ75^(/\
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M21%7CE[!=J,./SIIAE0*J02^6C97]VV<_G70_9KW_G^;_OVM'V:]_P"?YO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBN76(H,C/\.[TI8]$2/3K2T\YBMO.)PV.I#%L?K2?V];37+6UND\C"(2M*B
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M^((]2\$6"Y0W$FUI2.O3O7!Z> MW&_&4.[\JA+2"TC5PP1B2I/0_2A)-L<K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>cntg-20211231x20f018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &T :X# 2(  A$! Q$!_\0
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MD9*GI@8[50:UUW3O"GBCPO\ \(YJ4]Q=W4L\=Q%'F$QG;R#W/R\ 9)S7MM%
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M;3EC+S[@58L,X [5O5GZ7HMEHYNVM(V$EW.UQ/([%F=SZD]AT [5H4 %%%%
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M Z3P[\2+2SEUB/Q+J_SIJ,D=NOE$E(@<#[B\#W-=GJOBW0M&L+>]O=0C2"Y
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M<7-K#.J.@E17"R+M89&<$=C[5+0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 &**** "BBB@ HHHH ,48HHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** "L_7(=1N=#O8-)EBAOY862"64D+&Q&-W
M/3.?J*M7,K0QAE )SCFJOVZ7^ZGY4 8FI>$2/#^B6.DF!9-%GBFMDN0?+EV*
M5(<@$C(8G.#@X/-7/#6BW>FW&K7]^UN+O4[H3O#:Y\J(*BH "0"QPN2<#)/2
MK_VZ7^ZGY4?;I?[J?E0!H45!;3-,C%@!@XXJ>@ HHHH **** "BBB@ HHHH
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M@RD97#%<_>&T''-=QX4TN[T7PIIFFWUQ]HNK:W6.23<6!([ GD@=,^U>=_\
M"[F_Z  _\"__ +"C_A=K9_Y  _\  O\ ^PHYD:?V-C?Y/Q7^9Z[169X=U?\
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M?V+@_P"7\6?1W@[QK!XP^V^39RVWV79GS&!W;MW3'^[74UY)\$?^8Y_VP_\
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MN) "%W.!E@NXX'';.:\@UGQQXFM==U"W@UBX2**YD1$ 7"J&( Z>E4?^$_\
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M  *_Y)5IW_7:?_T8U>D5YO\  K_DE6G?]=I__1C5Z10 4444 %%%% !1110
M4444 %%%% !1110!G7O_ !\?\!%5ZL7O_'Q_P$57H *4=124HZB@#YR\0_\
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MPN<_[[/Y?D@HHHIGF'UO\"O^25:=_P!=I_\ T8U>D5YO\"O^25:=_P!=I_\
MT8U>D4 %%%% !1110 4444 %%%% !1110 4444 9U[_Q\?\  15>K%[_ ,?'
M_ 15>@ I1U%)2CJ* /G+Q#_R,NJ_]?DW_H9K-K2\0_\ (RZK_P!?DW_H9K-K
M(_2:/\./H@JEJW_((N_^N?\ 45=JEJW_ ""+O_KG_44+<G$_P)^C_(X2BBBM
M3\X"O9?V;_\ D=M4_P"P<?\ T:E>-5[+^S?_ ,CMJG_8./\ Z-2@#Z:HHHH
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MLVM+Q#_R,NJ_]?DW_H9K-K(_2:/\./H@JEJW_((N_P#KG_45=JEJW_((N_\
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MB@#DOB5_R(]W_P!=8?\ T,5X=7N/Q*_Y$>[_ .NL/_H8KPZLY;GV60?[J_\
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M[IW_ %Z'_P!#->>UF]S[W*O]SI^GZL****1Z!PVM_P#(9NO]_P#I5"K^M_\
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MNK=&,<0997&\X(VY48/J%YI?!>BQ36WB">P$^G:%J<R_V?% 3&5C5 K3(/X
MYR1[ 'O6ZW@G07TN^TZ2UED@OPJW+27,C22JOW5,A;=@>F<<GU-36/A;3M.M
MKFWMGOA'<($???S.0!_=+,2O7^'% &1\.+>.TT/4;:%2L4.L7\:*6+$*+AP!
MD\GIWKL:R-$\-:;X>\\:<MPHG<R2"6YDE!8DEFP['!)))/>M>@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>cntg-20211231x20f019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &H >8# 2(  A$! Q$!_\0
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M>HJEIUU>W7G_ &S3FLMDA6/,RR>8O9OEZ?0U=H **** "BBB@ HHHH ****
M"BBB@ HJA=:UI]EJ=IIUQ<;+N[SY$>QCOQUY P/QJ_0 4444 %%%% !1110
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M-PT;,4^88') /Z5FZ?X&U+3=+T.:VN[9-9TOS5))8PS1N[-M)P".&ZX[GV-
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M 'DWQL_Y@?\ V\?^TZ\FKUGXV?\ ,#_[>/\ VG7DU !1110 4444 >L_!/\
MYCG_ &[_ /M2O6:\F^"?_,<_[=__ &I7K- !1110 5XA\8_^1OM/^O!/_1DE
M>WUXA\8_^1OM/^O!/_1DE 'GE%%% !1110 5[?\ !S_D4+O_ *_W_P#1<=>(
M5[?\'/\ D4+O_K_?_P!%QT >AT444 5+K_6C_=J"M*B@"I:_ZT_[M<YK>E7%
MSJE^XTW4+A9X8TB>"\6*($;L[T,@W#D=5:NNHH YF2PU"&]^W/:"\:.Z$IB1
ME4OF"-"Z;B!D,K#!(X)_&*VT^^L)$NCI(N1+',OV2.2/_1]\A;&6(!!!PV,]
M. :ZNB@#F9-%N/L]^%M(Q)(;7R]K \1[<@$\X!!QFLZ70-287ENRWTN!=O"Q
M>V$+-(K@=%$F3OYR<9'4@5V]% &!>Z+ONKQH+.+8VF&UB.%'.6POTY'M58Z;
M?V]ZEY]C:X$4L3^2KIN?$)0D;B!D$]R.]=110!R&J:=J5S8F%-,N1%+!*$M;
M6]$*QRLS',A##<"".!D YX(.:W-'M9[;[89TVF25&7)!R!#&IZ>ZL/PK3HH
MXM]*U7[-IQ^S7J&WLS9210-;,3C W?O0R[&Q[-P,@U:ATN^M=4MUMK6Y2(&'
MS9))HI(I%5%4LP(WB0 8!48X!SR:ZJB@#EIM-U":%H19NICFO2&+IAQ+YA0C
MG/\ $!R!@Y[<TW4=/>S@-P;:$00VEL&5G5%)CE#%<DX''0GCGK75T4 8/A>[
M34$U.^B@$44]YN3#JVX"*-2<H2IY!Z$_6MZBB@ HHHH **** "BBB@ HHHH
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M]%R4 >(4444 %%%% !7H?P<_Y&^[_P"O!_\ T9'7GE>A_!S_ )&^[_Z\'_\
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M^BY* /$**** "BBB@ KT/X.?\C?=_P#7@_\ Z,CKSRO0_@Y_R-]W_P!>#_\
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M#-IS(\LC.\S+YF3G:07W\;\[\[?EZ8KIO@Y_R-]W_P!>#_\ HR.@#V^BBB@
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\\^,?\
MR*%I_P!?Z?\ HN2O0Z\\^,?_ "*%I_U_I_Z+DH \0HHHH **** "O0_@Y_R-
M]W_UX/\ ^C(Z\\KT/X.?\C?=_P#7@_\ Z,CH ]OHHHH **** /*?C2F_^P^<
M8\__ -IUY1Y/^U^E>L_&;_F"?]M__:=>5UR5*DHR:3/K<LRS"U\+"I4A=N_5
M]WYD7D_[7Z4>3_M?I4M%1[:?<[O[&P/\GXO_ #(O)_VOTH\G_:_2I:*/;3[A
M_8V!_D_%_P"9ZE\%DV?VYSG/D?\ M2O5J\K^#/\ S&_^V'_M2O5*ZJ<G**;/
MD\SHPH8J=.FK)6_)!1116AP!7B'QC_Y&^T_Z\$_]&25[?7B'QC_Y&^T_Z\$_
M]&24 >>4444 %%%% !7M_P '/^10N_\ K_?_ -%QUXA7M_P<_P"10N_^O]__
M $7'0!Z'1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5YY\8_^10M/^O\ 3_T7)7H=>>?&
M/_D4+3_K_3_T7)0!XA1110 4444 %>A_!S_D;[O_ *\'_P#1D=>>5Z'\'/\
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MHKM%M;6+4]6TJ\T]X)7FF=2;-3MB(.T@G#(%/(VCYLA>]<UK%A+I^H-');K
MKY:-%F67"Y*_>!()RI!]P>E)QL52Q$9RY?F>B_!G_F-_]L/_ &I7JE>5_!G_
M )C?_;#_ -J5ZI791^!'QF<_[]/Y?D@HHHK4\L*\4^+Z*WBVU)'_ "XI_P"C
M)*]KKQ;XO?\ (V6O_7BG_HR2LJS:CH>MDM.%3%*,TFK/?4\]\M/3]:/+3T_6
MGT5R<\NY]?\ 4<+_ ,^X_<AGEIZ?K1Y:>GZT^BCGEW#ZCA?^?<?N0SRT]/UK
MVOX0*%\)70'_ #_/_P"BXZ\7KVGX0_\ (IW7_7\__HN.M:,I.6K/*SK#4*>%
M<H02=ULDCOZ***ZSX\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\\^,?_(H6G_7^G_HN2O0Z
M\\^,?_(H6G_7^G_HN2@#Q"BBB@ HHHH *]#^#G_(WW?_ %X/_P"C(Z\\KT/X
M.?\ (WW?_7@__HR.@#V^BBB@ HHHH \K^,W_ #!/^V__ +3KS?3]3NM,:5K8
MP_O4V.)8$E#+G.,.".H%>D?&;_F"?]M__:=>5UPUOC9]UD\5+ 04E=:_FS1C
MUR^AN9+B$V\,TB[2\5K$A4?[.%&T^ZX-5)IDEC@18E0Q1[&8=7.YCD^_('T
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M+?=$D97/TS445E+,RK&"Q<X7CJ:/:1V!9;B''F25N_-'_,K5Z'\'/^1ON_\
MKP?_ -&1UQ5UI-Y9,JW=M/ 6^Z)(RN?IFNP^%EU;:7XEN;B\G2&)[-T5GXW-
MO0X'J< \#THYXWL3+ 5XTW4LN5=4XO\ )GNE%1V\Z7,"31[MCC*[T*G'T(!%
M259QA1110!Y7\9O^8)_VW_\ :=>5UZK\6A]ONM'M;1EGN$\_=%&P++GR\9'7
ML:\PN;.YLY?*NK>6"3&=DJ%3^1KBK1?.W8^VR>O26$A!R5]=+Z[LAHJ:"TN+
MF18X87=V&54#EOIZT7-G<V<OE75O+!)C.R5"I_(UGRNU['J?6*7-R<ROVNKD
M-%306EQ<R+'#"[NPRJ@<M]/6BYL[FSE\JZMY8),9V2H5/Y&CE=KV#ZQ2YN3F
M5^UU<].^#/\ S&_^V'_M2O5*\A^%&I6>F#5OMDXB:7R?*0@EI,;\[5')QD=!
MW%>NHP=%89PPR,@@_D>E=E'X$?$9RT\;.WE^2%HHHK4\P*\6^+W_ "-EK_UX
MI_Z,DKVFO&?B=$^K>+H%TY?M;QV2*RVYWL#O?C YS[5E63<=#ULEJ0IXKFF[
M*SW..TZ]LK>)DO+!YR)!)')#/Y3J1VSM.0>/?C@BM%?%$;S"YN-.$EW#/+/;
M.LVU(V=MV&7!W -R.16#-!-;2M%/$\<B_>5UP14EO87=W(8[:VEFD SL126Q
M[#J:Y%S;(^NG]6DO:2DK=[Z?F:>FZO#HEU(]JUW*KQ1_*MR8D9]H+!U RZAB
M<#(X^M0:?KD]C?M=M&DSR3++*Q&&;#;L ]N<'IU4>E9\T$UM*T4\3QR+]Y77
M!%26]A=W<ACMK:6:0#.Q%);'L.IH][8&\-RN<I*SZW)=6O\ ^T]2DN]LB[U1
M?WLGF.=JA<LV!DG&2<#DUZY\(?\ D4[K_K^?_P!%QUXU-!-;2M%/$\<B_>5U
MP17K/PMU2SL/#L]K<3;;F2]9EA52SD%$ .T G&0>>G!K2BGSZGFYS*G]1M3:
M:NK:GI=%%%=A\:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %<EXB\46/A6.:[319Y)'E\MI5B
M$2NY!/+GENAY -=;7 ?%[_D4[7_K^3_T7)4S?+%M'5@J,:V(A3ELV4;7XO:=
M<AHM4T>:.-N/W;K,#]00O]:DE^)7A;2%8:-I32.PR?)@6!"3ZGK^AKR"BN7V
M\CZA\/X9RNF[=CUNU^+VG7(:+5-'FCC;C]VZS _4$+_6I)?B5X6TA6&C:4TC
ML,GR8%@0D^IZ_H:\@HH]O('P_AG*Z;MV/6[7XO:=<AHM4T>:.-N/W;K,#]00
MO]:V-&\6:#=7SV/AG2&FF\LRN884@0#(SDL0>I'0&O#*[_X0_P#(V77_ %XO
M_P"C(ZJ%:3:3.;'9+0HT958-Z+8]EMVF>!&GC6*4CYD1]X4^F<#/Y5)1174?
M+!1110!Q&O\ C6R\))&MMH,X\]GVDQBW1RN,GIGN.W>LNV^*^BZA'Y&L:3+$
MK'! "SI]3G!_0U:^)_\ S"O^VW_LE>>U+4KZ,Z83PZA:4&WWYK?A9G<3_%#P
M]I,9@T/2'D4'C8BV\9^G&?THMOBOHNH1^1K&DRQ*QP0 LZ?4YP?T-</12M*^
MY7M,-RV]F[]^;_[4[B?XH>'M)C,&AZ0\B@\;$6WC/TXS^E%M\5]%U"/R-8TF
M6)6." %G3ZG.#^AKAZ*+2ON'M,-RV]F[]^;_ .U/5-"\3Z;J!N+7POHS21V^
MW>ZJEO$,YQ_M=C_#77(6**7 #8Y .0#]:\_^&'_,5_[8_P#L]>@U:.:3BW[J
ML@HHHH)&2[#"_F+N3:=R[=V1W&._TK@M=^(5KX8EBLK70)EW1B15DQ;KM)(R
M% )['J!7H%>+?%[_ )&RU_Z\4_\ 1DE9U9.,;H]'*\-#$XA4ZFUF=#!\3_#>
MKQ"#6M+>,'J)(EGC']?_ !VHKGXLZ38((-'T:1XU/\16!/P !_D*\DHKG^L2
ML?0KA_#<U[NW8]@@^)_AO5XA!K6EO&#U$D2SQC^O_CM17/Q9TFP00:/HTCQJ
M?XBL"?@ #_(5Y)11]8E8%P_AN:]W;L>P0?$_PWJ\0@UK2WC!ZB2)9XQ_7_QV
MN@T'Q)#K%LQ\/Z,XLXY?*,DA2",' )P!ENA'\-?/]>T_"'_D4[K_ *_G_P#1
M<=:4JKD[,\_,\IHX:BZL&]T=_11170?.A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7 ?%[_D
M4[7_ *_D_P#1<E=_7 ?%[_D4[7_K^3_T7)6=7X&=^6?[Y3]3Q:BI(()KJ=(+
M>*2:5SA8XU+,Q]@.M6$TG4I+Q[./3[MKJ,9>!86+J/=<9'45PV/OG.*W93HI
MXAE,_D"-_.W;/+VG=NSC&/7/:K!TK41)/&;"Z\RW7=,ODMF(8SEAC@8]:+ Y
M16[*E=_\(?\ D;+K_KQ?_P!&1UP%=_\ "'_D;+K_ *\7_P#1D=72^-'%FG^Y
MU/0]IHHHKO/S\**** //OB?_ ,PK_MM_[)7GM>A?$_\ YA7_ &V_]DKSV@ H
MHHH **** /0OAA_S%?\ MC_[/7H->??##_F*_P#;'_V>O0: "BBB@ KQ;XO?
M\C9:_P#7BG_HR2O::\6^+W_(V6O_ %XI_P"C)*QK_ >SD7^^+T9P%%%%<1]L
M%%%% !7M/PA_Y%.Z_P"OY_\ T7'7BU>T_"'_ )%.Z_Z_G_\ 1<=;4/C/&SW_
M '-^J._HHHKM/B0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ K@/B]_P BG:_]?R?^BY*[^N ^
M+W_(IVO_ %_)_P"BY*SJ_ SORS_?*?J>4Z%:ZA?7[6NG!_,EC99&1"Q6/^(\
M<]/3DYQWKIU@NYS?6EQI>J.D4-LD-HH,-S(B,P$AR"=N=V1M8 E>1MS7"T5Q
M*5C[>K0=25[V^7GZG;0[H_'&IS^7]HF9)A;*K%=\NT90,#G< 2#@YST.2*A%
MP-&U2-6M(;(S0+<W4,KL6MY%WCY,MG>5.0K;N7&>E<FT\C6Z0%OW2,SJOH6P
M"?\ QT?E4=/G(6$O\3Z6^[YV\]M^MCH/%.FM9W$-R9&(GR$0Q;%55"[=AR=R
M8( ;C.T\5O\ PA_Y&RZ_Z\7_ /1D=<!7?_"'_D;+K_KQ?_T9'50=YHPQ\'#
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MDW[<7BG.,_P/45$W%I'7@*L*6)A.;LDSP^BM+^R?^F__ (Y_]>C^R?\ IO\
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M$'_@#\?^/4R?XD7RHL6EZ5:6D*\*)6+X'^ZNT#\S0!R\VG7MO<?9YK66.8G
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M#2N2OI]04Q)J'VE2J[8EN0PP/1=W;Z5T/@#4K6PUV:6\GCAC:U95+'&YMRG
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M+*),+DC[P)YR"#[@]*KP&<R^7;F3S''"(3EL$'H.O.*FU.ZO)[I?[15HYPN
MCPB(@9)/RX'<DGCJ::LG:Y$XSJ4N9P?K;0[OX5_\Q;_MC_[/7HM>7?#G5++3
M?[2%W<+&TGE>6G)=\;\[5')ZCH.]>H(P=%89PPR,@@_D>E<E;XV?4Y2FL'"_
MG^;%HHHK(]$*\H^)W_(R6_\ UYK_ .AO7J]>3_$)AJ/B>)+$BZ=+10R0?O&!
MWOQA<G-:T6E/4\O-X2GAN6"N[K8Y_2%MI)!$]B+RXD< ([LB(@Y9B5(.?<\
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M_A&**>'83;MI\32$-G:1MR,'![\8.<4KV/AK[)93V_A:UN7NXO.CABLH=X3
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M&<XPBC<W0\';76(&"*'(+8Y(& 3]*RO^$6\/?] '2_\ P#C_ ,*/^$6\/?\
M0!TO_P  X_\ "H?D=,5)+WG=FM163_PBWA[_ * .E_\ @''_ (4?\(MX>_Z
M.E_^ <?^%!1IR[#"_F+N3:=R[=V1W&._TK@]=\:S:"4L=.T-;3?'YD;7 "
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M2#P]HEK.D]OH^GPS(<I)';(K*?4$#BI-S2HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1
MN$;Y2W'W1W]JY?R-2U2VOQ=:7=6]W<0E8WFDA,48'*QC8Y;D]6QS[8 KJ:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>cntg-20211231x20f021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %Y IP# 2(  A$! Q$!_\0
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ME21VUS=PZE&7B:!06SV&WJ3GBETKXA6]_-J%K=:7>Z??6<)F-M< ;G4#/!%
M'945YPOQ=L_L5O?-H>IK8NVR6YVJ4C;TS_%^%:>F?$:UO]=M]-FTK4+);M2U
MI/<(%68>H'44 =I17#7_ ,2H+>[NULM%U+4+.S;9<WD"CRXR.O7KBIM6^(VG
M::^E&.TNKR/4HC)"8 "Q]%V]<F@#LZ*X.+XA-J&GZO#%HNH6^JV418VC[=^#
M_$.W'6F?#'Q)JVMZ3Y>I6MY)LW$7\I79+S]T8[B@#OZ*YCQ+XRCT"_M=.@TV
M[U&_N%+I!;8SM'?)KDO&/C?68O[!EL--U.S6>8-)&P56D.<&+![_ .- 'JE%
M<C>^,K^UM[3R_"FL7%U/%YCP1HO[KG&&;IGVIEO\1M*F\+W&MR07,7V>7R)+
M9E!D\SLH[4 =C17"Z9\19[[7XM*N/#6HV3LAE=YV4"./&=Y'I4<GQ2M59KI-
M$U-]'23RVU)4'E@YQG&<XS0!WU%<=K'CZ*QU5=.T[2+[5K@0B>1;0+\B$9!Y
M//X5U5E<_;+*&Y\J2+S4#^7(,,N1T(]: )Z*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *\T/@U=7^*^KW>L:,+G2WMD,,LRY0R (..>O6O2Z* .'^(N@RW
M'@%],T33MQ26(I;VZ 8 ;)P*K^)]&U*ZUKP3+;V<TD=G.&N63I$,+U_(UZ!1
M0!X9KOA/Q!?:KK:WV@W^IW<TKO97JWFV&*/D@;<\G&!BMV+P]JXN_AZYTZ<+
M8Q@71('[DX'WN>*]6Q1B@#A==TG4+CXI>'=1AM)7LX(95EF ^5"<XS46AZ/J
M-OX_\5WLUG*EM<Q*()2!MD.!TKOZ* /%H?#7BB+X96]E#97<<BZ@\EU9I)Y<
MLL1[ Y]:D\+^$+]?%%W(N@W>D:?=:=)$@GG\TJQX^9L\$^E>RXHQ0!YGX.F\
M4:!86WAJX\+S.L4I0WRS*(A&3DMZD]:Y<^!Y]+U&^M]0\'WVLB2=GM[JUOC&
MI0GHP!XKW3%&* /+M:T#5=+N?"NK:5H4DR:;&5EL(I][QYP<!CU[\U-X;TK7
MKGQCX@U+4]*:P6_M (P7#J#P I([X'->ET4 >2Z#INOVW@'6O#5SH%S'*D4I
MBGW*5F9CPJBFMX=U_3;'PCK-KI<EU<:9"8[BQW!7 )[9[UZYBB@#R_Q7_P )
M7XFT&WF70KVTMX[G]_81W($TT6/4=.>U4/!_AC4;#Q#JMPOA^ZTVRN-/98(Y
MIO-.XD<%L]3CI7K^*,4 <?\ #33;W2O!D-K?VTEM<"5R8Y!@@$\5S_V+Q)X:
M\7ZY+8Z$^IV^K8,4R2JBQMC^+/05ZA10!XH/"VOCX<_8'TJ?[8-5\UHE )VY
M&6'/2NS^(.A:CJWA2T33K?SKFTECE, (!8#J![UW&!10!Y3Y7B+5O&^D:W?:
M!+IUG;P.A,CA]OR]7QT&>E<;IGV..VEU35-'UJ[TY+MY'EM;A4LV.[@^6<&O
MH9T5T*,H*D8((ZBN2/PP\(&\^T_V0N[=NV><^S/^[G% &Z3#K?ATFT.V*[M_
MW9(Q@,O'%>2-I?BZ+P)<^$U\,RL8F)^UB5=KKG/RCJ37M<<:0QK'&@1% 554
M8  [4[% 'CWB7P;?RW6CZG+HD^JVR6*07%G#/Y4J,!V(-;.@>$K>Y\+ZU:CP
MW/H_VM-B)<W9F=\#@G)^7FO2** /(_ _A?7;G49[C7K26U-K9&RMC(.N<C<.
M:Q+/P1/IY>QU'P/?:E<B0A+N#4#'"ZYX) /%>[T8% 'G7_".WP^(MI-'8RPZ
M>NEF R@[EC8KC;G.36+96OBS0/#]_P"%HO#4MWYTCB&]251'M8]6[UZ_1B@#
MQ36-+O\ PQ>^";*"%+N^MD8^5OVAVZD ULVFDZ_KOB/5_$-[H\FG*;!K:"VD
M8%W)&.U=_?Z!IVI:G9:C=0%[FS),#AV&W/L#@_C6GB@#R67P[K!^#,.EC3;@
MWXF#&WP-X&[TS6MK>BZE<>)_"$\5E,\-JF+AU Q'QWKT3%% 'ALG@BXTW5+Z
M+4/"%]K0EF9[>YM+TQ+M/9AD8KIIO#E]%XC\'/:Z1+;VEG$PF19/,$&<\%B<
MFO3,44 >?+H>I2?$C7KK[)(MI<V BCG;[C-MQBG_  TAUC2M.DT74M%GM5MV
M9A=.ZE),GHH'-=]10!YY\1-/EU"X@0>%KO4BL9\F]LK@1R0OZ'V[UD:IX?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3N/$/V';(39ZA;G@,.HSBN?\&Z==:KXOU/4]*U>[NXHK4P1:I>1[M\A[@<9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** "BFN2$8CJ!6=]JF_O_H* -.BLS[5-_?\
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MK(H **** "BBB@ J[8?Q_A5*KMA_'^% %RBBB@ HHHH BN/^/=_I676I<?\
M'N_TK+H **** "BBB@ J[8_QU2J[8_QT 7**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@!LG^K;Z5D5KR?ZMOI610 4444 %%%% !5VP_
MC_"J57;#^/\ "@"Y1110 4444 17'_'N_P!*RZU+C_CW?Z5ET %%%% !1110
M 5=L?XZI5=L?XZ +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 V3_5M]*R*UY/]6WTK(H Q/$EY/8VJ3KKEAI$ SOFNH@Y8XX"AB!_,
M^E4;7Q+>#P/;ZM=VZ_;[@;(8D4J)G+$(0#R W!QV%:FL?VF1&MEIMA?Q$$21
M74WED'L02K CU'6L'3? ]Q#I>G1RZO/:7-I-+.BVBH\<9D)^51(IX4' .!0!
M1MO%6L-X9T^>\O+2VNIKV:VGO/)7RH]F[&%)QR1C)]?6M?1/$EUK4]A&'MX
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M &A5VQ_CJE5VQ_CH N4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% #9/]6WTK(K7D_P!6WTK(H **** "BBB@ J[8?Q_A5*KMA_'^% %R
MBBB@ HHHH BN/^/=_I676I<?\>[_ $K+H XSQDFI37B$:1<WFFVUO)+F&2(
MS8(!8,P.%'-9EGXPBT'X>:*DP2TO;J(0VPNI55._[QFS@*.OK7HU-:*-@ T:
M,!T!4'% '!C3M"A\'6=Q9ZNUP;8NB75@Z,UQ+)PZ#((^8GZBJ-A-J'AO6$M/
M/@%S(;=7MFC#-,C<%58\X0>G?.:]*"(H 5% '( 4"E*J6#%5+#H2.10 IZFK
MMC_'5*KMC_'0!<HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6/\ K0I-LX\PR>AA\/*K!NZMO;OZ'K=%%%6?-!1110!%<?\ 'N_TK+K4N/\
MCW?Z5ET %%%% !1110 5=L?XZI5=L?XZ +E%%% !5:^_U(^M6:9)&LBX<9%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<2P.;A1NBD*'&#W%=[7GOQA_Y%*+_KY7^1I/8[<M2>+II]SQG^W=7_Z"M_\
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M&_T@Q ?P[=N[''7WI;>VTF?Q!XH7PQ;@V4N@!8Q;QL(W?<V1'GCT^[QG/?-
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MPIWPU_SVU+_O^/\ XFOE7_A(];_Z#&H?^!4G^-'_  D>M_\ 08U#_P "I/\
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MIQW.?./]SG\OS/6Z***T/A0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<@=LXS6[63X;T7^P-#@L#-YTBEGEEQC>[,68@=ADUK4 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>cntg-20211231x20f022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cntg-20211231x20f022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &L :\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME!)->7Z[)+87'C2"S)AA9[?>(QC:&)W'CIVKK/%VF:9!\.I?*AB1;:%'MY%
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M#9^=<;X8L(9/'FOR7,<<TT2QJ'89QD<X^M<UJ2"W\->,[2+Y8(=2&Q!T7D4
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M10 4444 %%%% !1110 4444 %%%% !1534+UK*&,QPF:6601QQAL;FP3U[<
MU##JOFZ8]T;:198W,;0 Y8.&VXS]>] &C16!<>)&M+662XL3'-%,(GC:88^X
M7R&Z'@=/7 K8M;N*\B,D6[:&VY(QSW_P^H- $]%%% !1110 4444 %%%9.IZ
MA>P7!ALHH7,<)GD\TD97.,#'?B@#6HK.GO+N6TMY+&*(M*N\O,3L08SSBLQO
M$=Q&UB\MJJQ31AY,!B>_W3T[#KZB@#I**9$YDA1V0H6 )4]J?0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY4LKB-651T^8@'],UC[:)Z\<DQ+W:7S_ ,DSTN\LK^:R%G;O!#;PD F8$B1
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M9?[-6QCS\J!@2?<@<#\S6A56RGNKA':YL_LW/R*9 S$>^.!^9JU6YX84444
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ML .?S)JU110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;<OMW=.E/TC3(](T];2)RX#%BQ&,DG)JW%+'-&)(I%D1NC(<@_C3Z "BBB@
MHHHH **** "BBB@ HHHH **** "J$O\ K6^M7ZH2_P"M;ZT 8=YJEU:ZBD1%
MJ(GD5$B+'S9 >K 9Z#Z=J33M<6_U*6$/$L0++&NUMSD'DY^[^ YJ2ZTR[N;L
M,;J+[-YBR -%F1<$'"MG@''IWJ%=*N[4J8Y8I(;9GEMXMF&+D$ ,V>G)[4 .
MDU:<:XUEYMO%&LBH!)$Y9\J#PP^4'D@#VI--UFXNKMK>>WPY.1A67:.=V<]<
M8'(X.X5/<:?>7%T-UU']D,J3&,QY<%2" &STR!VJ+5]#.HY9)PLC-R9%W!1M
M(&,$8())!]30!LUH1_ZM?H*SZT(_]6OT% #J*** "D;[I^E+2-]T_2@#.HHH
MH **** "G1_ZQ/J*;3H_]8GU% &A1110 4444 %%%% !7D/QB_Y"NF?]<&_]
M"KUZF/#%*09(T<CIN4&HG'FC8[,#BOJM=5;7L?+5=Q\*?^1R_P"W:3^8KVK[
M);?\^\7_ 'P*<D$,;;DB13ZJH%91H<KO<];$Y\JU&5+V=KJV_P#P#!UJ"=KN
M22&PN6F*8AN+60*<^C@D<9^M0RVE_'%J2+9MYT_E.98@OS !0ZC/\7#5U%%=
M!\Z<AIFCRFYB,MC.MLMVT@2Y<.P7R@,GG^]GBHY=-N8+"6)])>Z,EJ\$07:?
M*.]R,Y/ (9>1_=KLZ* .-NM.OI-1MF:TNW:*:U,3QNJQI&I0ONYR3D-^&*NO
MI[V]I!*=.-P5U">>6) "SJS2[3R<'[RGFNEHH YM;25/!D\+6WD-F9_(9@,*
M9&8 D<#(-8^TZP]U=:9;/#!')#NCB6-R^ ^<#)4XR._:N[(!!! (/8TB1I&N
MU$51Z*,4 <O9:(Q5//MGD7[-,%$ZH"K,P(&%X'?I52/1K_[=#YZW)#>4VY$C
M(3:H!!8_,.<]*[6B@#DUTN[:'R([1H622?Y^ K!AP1C\J)K(W%@0NBW$!38#
MY;(')'<#."![]:ZRB@#.T..XBTM%N8_+DR?EVA3C/&0. ?I6C110 4444 %%
M%% !1110 4444 %%%% !1110 50E_P!:WUJ>]\W[*YAN([=A_P M9%W!1],B
MN7DGTAI#]I\17MU*#RUJQVH??REP/^!4 ;U%9$"F>-FL/$]O/"OWS,B.R#ZJ
M5Q^(-5VFT<M^_P#$5[=2 _?MF)1#[^4NW_OJ@#?HK)@5IHV>Q\3VT\"_?:5$
M=D'U4KC\0:K--HQ;]]XBOKJ0'_66S,40^_E+M_[ZH WZT(_]6OT%<S K31,]
MEXGMI[=?OO*B.R#ZJ5 _$&K6D36<M[B+6KC4I@I&5;,2_P#? "?GS0!O4444
M %(WW3]*6L[5FD2$-_:D.GPC[\CJN?P+' _(T )17/\ G:)G=_PD6H;_ /GY
MW-Y7Y[?+JT4D%OYQ\46@L_\ GOLCW?\ ?6=O_CM &M17/^=HF=P\1:@K_P#/
MR6;ROS*^75HI(MOYS^*+1;/M.(XPW_?1.W_QV@#6IT?^L3ZBN=\[1,[AXBOT
M?_GY9F\H_B5\NK966. 3R>*+1+3M.(XPW_?1)3_QV@#IZ*R]%DM9(I6MKZYO
M!N&Z68L03_L\!<?[M:E !1110 4444 %>/?&662/5M,".RY@;H<?Q5[#7 ?$
M+P1J?BN^LI["6U18(F1O.=E.2<\84T >(?:)_P#GM)_WT:[KX332OXTP\CL/
MLTG!8GN*?_PI[Q%_S\Z;_P!_7_\ B*Z7P+\/M7\->(O[0O9K-X?):/$+L6R<
M>JCTH Z36=4:WU2XA;74T\1P*\43",^8QSV8$G\*E?Q.]O-9PS6H8RB,2E"Y
M:,N0!D!"!R>["MI;&);Z6[.6DD55(., #TJE>:$EW=M-]MNHD>2.22&,J%=D
M(P3D9_A' .* (3X@>.=VGLO+LA++$)_-!):,,3\N.A"-W[53@\5K?J4@-NDH
MDMR/)N%F^1Y50AL?=;!Z>_!K8;1[:2)8G+L@GDG()'S%PX(/M\Y_2H8=#6.(
MQR7UU,@>-D$FSY-CAP.%&>0.3D^] !?:A=6FMVT0CC-B;6::9V?!&TIR!M.<
M!O49R?3G-A\9PSVTTJ0P2,L:RHD-TLGRE@OS[1\A&X$\'C/7%;EYIR7ES!.T
MLB&)70JN")$;&Y6R#P=HZ8/%4XM!,-N\"ZG>[<!8R"@,8!R ,+STQ\V<B@"K
M'K=]=7>F&&&V^SSF02F.Y#C@9RIV\_IZ4B^([A8,QV37'EQ&65WF"D+N(XPO
M)XZ<?6KL6@QP^0ZW=QYT<S3-*=N9"PP01MP 1Z 4L>@VT<,L8DE(EA,)R1P"
M2?3KS0!$^N7'VM5CT_=:&=(#.9L,&;'.W'(Y'>MJN:ET*_.L1-#/LT]9DF=#
M-G<R@?P[,]A_%CVKI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH CGMX+J/R[B&.6/.=LBAAGZ&J3HD;LJ*JJ#@ # %:-4)?\ 6M]: *4^FV-U
M(LEQ9V\KKR&DC#$?G5A45%"JH51T %.HH JSZ;874BR7%E;RR*<JSQ!B/Q(J
MRJ*JA54 #@ "EHH JSZ987,JRSV5O+(O*N\0)'XD5LPJJPH%4 !1@ 50K0C_
M -6OT% #J*** "H)[2VG99)K>*1T!V,Z E?H>U3TC?=/TH S<#&,#%51I>GB
MX^T"QMO._P">GE+N_/%6CG!QC/;-8%O?7%KJCQ7=[-*BQL\HD@$:+CIY9P"W
MYF@#?P,8P,55&EZ>MQ]H%C;";_GH(EW?GBH-,NIYFNWNG4 ,&5>/W:E0<$U5
M%Y?W;7AMGP&B5K=!MW ;B">>Y XSQTH V\#&,#%5X=+T]+U;A;&V68D9D$2[
MOSQ6;I&IRR2BTO9HUG&0J2,OFR8)YPO!P.#CC.:W8_\ 6)]10!H=**** "BB
MB@ HHHH *8\B(<,<9]J?56Z^\OTH F^T1?WOT-*LJ.<*V3]*H5-;?ZW\* +E
M%<SK,+/J4FGABBZFJ L.Q7.X_P#?(4?C5&X+ZCI-[++##,R&VM3%-PC%9%+!
MN#QEB#P>E ':45R=QI-L+*"V>PT:QD>XWK:Q_-!<$+T<A%YYR.#T[]M7PZ81
M8RPPP" 0S,C1))OC0]2$.!\O/H,<T :]%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 50E_UK?6K]4)?]:WUH 91110 4444
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MT_2EI&^Z?I0!G4444 %%%% !3H_]8GU%-IT?^L3ZB@#0HHHH **** "BBB@
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M]>5Z]XRU>RUZ^M87A$<4S*N8\G JX0<W9'+B\93PL5*IU['H5%>6?\)YK?\
M?@_[]4?\)YK?]^#_ +]5I]7F</\ ;F%\_N_X)ZG17EG_  GFM_WX/^_5'_">
M:W_?@_[]4?5YA_;F%\_N_P"">IUH1_ZM?H*\<_X3S6_[\'_?JO6M*G>YTBRG
MDQOE@C=L#N5!-1.FX;G5A,PI8IM4[Z=RW11169W!2-]T_2EI&^Z?I0!G4444
M %%%% !3H_\ 6)]13:='_K$^HH T**** "BBB@ HHHH *XWQI_Q]VO\ US/\
MZ[*L/7="EU>:&2.9(Q&I!# G/- ' UO>$?\ D-_]LF_I5K_A"[C_ )^XO^^3
M6AHOAR;2[_[0]PCC85PH(ZT /N=0NK3Q%(6<M8+&@D7'W"2<-_0U3;4[O^R4
MF^TN&-E=R%AC[R[=I_#)KHFL8'GGE=-QF01N#T('M^-5H]"LH[..U42>5'#)
M"N6YVOC=_(4 9&G/]NN_L]IJU_/;M#NEE)P8W!& &*]_FXQVJ_X<AF^Q?:9K
MZZN'=G7$S@@88@8P!Z5LJH50HZ 8J*UM8[.W$,((0$GDYZDD_P Z )J*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPOQ3_R
M-.I_]?#?SKW2O"_%/_(TZG_U\-_.NC#_ !,\'/\ ^##U_0@2*U?1)91&XN8I
M4!<MP0V[@#\!4K_89-(EG%B(9-XCC82L<GJQP?;'YU02X9+2:W"C;*RL3W&W
M/_Q52BZ24V<,Z8MH3AE0\L"<L?J?\*ZK'SJG&UM-K;?UT->/2;9M$\\P-G[,
M9O/\SD.&QMV>G;/XTR]TJRDM/M%@6DVY7;$2Y8_+@GCC@G/8<>M5!K)6V\L6
ML7G"$P"?)R$(QTZ9QQFC3M<GT_:!&DB*H"J<K@AMV>.O(_&IM(VYZ#M%KIO;
M^OU]3+KWS0_^1?TW_KUB_P#0!7@=>^:'_P B_IO_ %ZQ?^@"LL3LCTL@_B3]
M$7Z***Y#Z@*1ONGZ4M(WW3]* ,ZBF2S10)OFD2-.FYV 'ZU!_:>G_P#/];?]
M_5_QIV9+G%:-EJBJO]IZ?_S_ %M_W]7_ !H_M/3_ /G^MO\ OZO^-%F+VD.Z
M+5.C_P!8GU%4_P"T]/\ ^?ZV_P"_J_XU<C_UB?44K#4HRV9H4444%!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 0W4SP0&2.!YW'1$(!/YUYU?^ M5U?4;N_>2"
MU,TAD6,L7.#V)XQ7HMTEP\!6UE2*4]'=-P'X9%>.^(-<UVWUZ[@.LW6()2B^
M6VP<>PXK6DI-^Z>=F4\/"">(5U<6?P'XA@E5!:),"<;XI 0/KG%:$'PTU>6$
MM+/;POV7);/\L?K5"W\?^(X(3&;J*;C >6(%E_+&?QS6?/XHU^XF\V36+H-V
M$;;%'X#BMK5F>/SY5#WE%ORU+\_@/Q#!,L?V1)0QQOBD! ^N<5H0?#35I(2T
MMQ;0OV3);/X\8_6J,'C_ ,1P0M&;J&4D85Y(AN7\L9_'-9TWBC7[B;S9-8N@
MW81OL4?@.*+5F'/E4/>46_O+\W@/Q##,L?V-903C?%("H^N<&O3]$CU6"TM;
M>[AMHHH8%CPKEV8@ 9SP!TKS*'X@>(X8&C-U#*2,"22$;E_+ /XUZ;H5O<26
M5I?W5_<7$LT"N58A4!90?NJ *RJ\]O>/2RWZGS2>&WZ[FQ1116)ZX50U66Y6
MV:&ULWGDE1ESO"JN1W/_ -:K]4-5COGMF-E=I;[48DF/<QXXQG@?E0)['EFM
M^$-2T?2/MUY>(Z[@IB4EN3WS_P#6K)N[:"6*P-E Z-.I#!FW%F#8S[5/J+Z[
M<PM]MU">Z0D$Q^82,_[O2JBRW\:VWE12QO;[MCHI!Y.:[J;=M6?'8VG%56H4
MVE9=-=_\A^HV]K:?9/)'F#:?,))P[!B#]!5M1ICP6LD]G';"60\K(Y^0#J<D
M\$^GI4,]]?W]MY-\+F81H?+R&/S$YR?PR*J7)NKEXR;9U6- BJ$. !5>K.=Q
M<6W&-UIT+FK:9#!&+BT1VB;!)0$H@('<\\G.,]L>M:^F>%O$UOJ]M*UJQ2&1
M)<M. C@'.,]>WI60VI:A)836LMJ7\S/[S8P*@D'  X_A':NGLO$'BFZGM+-[
MRVC1Y51YDB&_:2!W&/TK*I*25DSTL#AJ-2HY2B^FR:UU/0K(WS(S7RP(Q/RK
M$2<#W)Z_E5JJME9M9HP>ZGN'8Y+3/G\AT'X5:KD/J HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "O+M=M+=]=O6:",L96))4<UZC7FFM_\ (;O/^NK4TVMB90C/
M22N9/V*U_P"?>+_OD4?8K7_GWB_[Y%3T4<S[D>PI?RK[B#[%:_\ /O%_WR*/
ML5K_ ,^\7_?(J>BCF?</84OY5]Q!]BM?^?>+_OD5ZMI8"Z39*H  @0 #_=%>
M85ZAIO\ R"K/_K@G_H(H;;W*C3A#X4D6J***185%=?\ 'I-_US;^52U%=?\
M'I-_US;^5 'E5%%% !1110 5:TS_ )"UG_UW3_T(55JUIG_(6L_^NZ?^A"@#
MU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O--;_Y#=Y_UU:O2Z\TUO\
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MBKHT.Q6\:Z"2>823CS6VAB,%@N< ^_6ET_1;737W6\EWC! 22ZD=!G_98D4
M)HAD^PR)+-),T=Q-&'D.6(#D#)^@K2J*"WCMU98EP&=I#SGYF.3^IJ6@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>25
<FILENAME>cntg-20211231.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8042.36810 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/31/2022 3:12:46 PM-->
<!--Modified on: 3/31/2022 3:12:46 PM-->
<xsd:schema targetNamespace="http://centogene.com/20211231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cntg="http://centogene.com/20211231" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:fact-explanatoryFact="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dei="http://xbrl.sec.gov/dei/2021q4">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://centogene.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" id="StatementConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>00100 - Statement - Consolidated statements of comprehensive loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLossCalc2" id="StatementConsolidatedStatementsOfComprehensiveLossCalc2">
        <link:definition>00105 - Statement - Consolidated statements of comprehensive loss (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition" id="StatementConsolidatedStatementsOfFinancialPosition">
        <link:definition>00200 - Statement - Consolidated statements of financial position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>00300 - Statement - Consolidated statements of cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" id="DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails">
        <link:definition>40702 - Disclosure - Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" id="DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails">
        <link:definition>40703 - Disclosure - Segment information and revenue from contracts with customers - Geographical information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" id="DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails">
        <link:definition>40801 - Disclosure - Other income and expenses - Other Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" id="DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails">
        <link:definition>40802 - Disclosure - Other income and expenses - Other Operating Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails" id="DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails">
        <link:definition>40804 - Disclosure - Other income and expenses - Financial costs, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails" id="DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails">
        <link:definition>40805 - Disclosure - Other income and expenses - Employee benefits expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails" id="DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails">
        <link:definition>40901 - Disclosure - Income taxes - Taxes recognized through profit or loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" id="DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails">
        <link:definition>40902 - Disclosure - Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails" id="DisclosureIncomeTaxesDeferredTaxesDetails">
        <link:definition>40903 - Disclosure - Income taxes - Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails" id="DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails">
        <link:definition>41304 - Disclosure - Right-of-use assets - Amounts recognised in profit or loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureInventoriesDetails" id="DisclosureInventoriesDetails">
        <link:definition>41401 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" id="DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails">
        <link:definition>41501 - Disclosure - Trade and other receivables and other assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2" id="DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2">
        <link:definition>41805 - Disclosure - Financial liabilities - Trade payables and other liabilities (Details) Calc2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails" id="DisclosureFinancialLiabilitiesInterestBearingLoansDetails">
        <link:definition>41901 - Disclosure - Financial liabilities - Interest-bearing loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails" id="DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails">
        <link:definition>41903 - Disclosure - Financial liabilities - Trade payables and other liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails" id="DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails">
        <link:definition>42501 - Disclosure - Related parties - Remuneration of members of key management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity" id="StatementConsolidatedStatementsOfChangesInEquity">
        <link:definition>00400 - Statement - Consolidated statements of changes in equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsTables" id="DisclosureShareBasedPaymentsTables">
        <link:definition>32003 - Disclosure - Share-based payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureGeneralCompanyInformationDetails" id="DisclosureGeneralCompanyInformationDetails">
        <link:definition>40101 - Disclosure - General Company Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureBasisOfPreparationDetails" id="DisclosureBasisOfPreparationDetails">
        <link:definition>40201 - Disclosure - Basis of Preparation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails" id="DisclosureBasisOfPreparationReconciliationDetails">
        <link:definition>40202 - Disclosure - Basis of Preparation - Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails" id="DisclosureSignificantAccountingPoliciesDetails">
        <link:definition>40501 - Disclosure - Significant accounting policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails" id="DisclosureAccountingJudgmentsAndEstimatesDetails">
        <link:definition>40601 - Disclosure - Accounting judgments and estimates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails" id="DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails">
        <link:definition>40701 - Disclosure - Segment information and revenue from contracts with customers - Information by operating segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails" id="DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails">
        <link:definition>40705 - Disclosure - Segment information and revenue from contracts with customers - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails" id="DisclosureOtherIncomeAndExpensesLpcGmbhDetails">
        <link:definition>40803 - Disclosure - Other income and expenses - LPC GmbH (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIntangibleAssetsDetails" id="DisclosureIntangibleAssetsDetails">
        <link:definition>41101 - Disclosure - Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails" id="DisclosurePropertyPlantAndEquipmentDetails">
        <link:definition>41201 - Disclosure - Property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsDetails" id="DisclosureRightOfUseAssetsDetails">
        <link:definition>41301 - Disclosure - Right-of-use assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails" id="DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails">
        <link:definition>41302 - Disclosure - Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails" id="DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails">
        <link:definition>41305 - Disclosure - Right-of-use assets - Sale and Leaseback transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails" id="DisclosureCashAndShortTermDepositsDetails">
        <link:definition>41601 - Disclosure - Cash and short-term deposits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails" id="DisclosureEquityIssuedCapitalAndCapitalReserveDetails">
        <link:definition>41701 - Disclosure - Equity - Issued capital and capital reserve (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureEquityCommonSharesDetails" id="DisclosureEquityCommonSharesDetails">
        <link:definition>41702 - Disclosure - Equity - Common Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureEquityCapitalReservesDetails" id="DisclosureEquityCapitalReservesDetails">
        <link:definition>41703 - Disclosure - Equity - Capital Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails" id="DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails">
        <link:definition>41902 - Disclosure - Financial liabilities - Conditions and statement of liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails" id="DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails">
        <link:definition>42001 - Disclosure - Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails" id="DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails">
        <link:definition>42002 - Disclosure - Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details" id="DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details">
        <link:definition>42003 - Disclosure - Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details" id="DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details">
        <link:definition>42004 - Disclosure - Share-based payments - Equity Share Option (ESOP 2019) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails" id="DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails">
        <link:definition>42005 - Disclosure - Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails" id="DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails">
        <link:definition>42006 - Disclosure - Share-based payments - Grants to new CEO and supervisory board grant (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails" id="DisclosureShareBasedPaymentsValuationOfOptionsDetails">
        <link:definition>42007 - Disclosure - Share-based payments - Valuation of Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails" id="DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails">
        <link:definition>42101 - Disclosure - Financial instruments - fair values and risk management - Credit risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails" id="DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails">
        <link:definition>42102 - Disclosure - Financial instruments - fair values and risk management - Liquidity risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails" id="DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails">
        <link:definition>42103 - Disclosure - Financial instruments - fair values and risk management - Currency risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureListOfSubsidiariesDetails" id="DisclosureListOfSubsidiariesDetails">
        <link:definition>42201 - Disclosure - List of subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureNonControllingInterestsDetails" id="DisclosureNonControllingInterestsDetails">
        <link:definition>42301 - Disclosure - Non-controlling interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureCommitmentsDetails" id="DisclosureCommitmentsDetails">
        <link:definition>42401 - Disclosure - Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails" id="DisclosureRelatedPartiesAdditionalInformationDetails">
        <link:definition>42502 - Disclosure - Related parties - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureContingentLiabilitiesDetails" id="DisclosureContingentLiabilitiesDetails">
        <link:definition>42601 - Disclosure - Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSubsequentEventsDetails" id="DisclosureSubsequentEventsDetails">
        <link:definition>42701 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureGeneralCompanyInformation" id="DisclosureGeneralCompanyInformation">
        <link:definition>10101 - Disclosure - General Company Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureBasisOfPreparation" id="DisclosureBasisOfPreparation">
        <link:definition>10201 - Disclosure - Basis of Preparation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureEffectsOfNewAccountingStandards" id="DisclosureEffectsOfNewAccountingStandards">
        <link:definition>10301 - Disclosure - Effects of new accounting standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureBasisOfConsolidation" id="DisclosureBasisOfConsolidation">
        <link:definition>10401 - Disclosure - Basis of consolidation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSignificantAccountingPolicies" id="DisclosureSignificantAccountingPolicies">
        <link:definition>10501 - Disclosure - Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimates" id="DisclosureAccountingJudgmentsAndEstimates">
        <link:definition>10601 - Disclosure - Accounting judgments and estimates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomers" id="DisclosureSegmentInformationAndRevenueFromContractsWithCustomers">
        <link:definition>10701 - Disclosure - Segment information and revenue from contracts with customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpenses" id="DisclosureOtherIncomeAndExpenses">
        <link:definition>10801 - Disclosure - Other income and expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>10901 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureLossPerShare" id="DisclosureLossPerShare">
        <link:definition>11001 - Disclosure - Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIntangibleAssets" id="DisclosureIntangibleAssets">
        <link:definition>11101 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosurePropertyPlantAndEquipment" id="DisclosurePropertyPlantAndEquipment">
        <link:definition>11201 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRightOfUseAssets" id="DisclosureRightOfUseAssets">
        <link:definition>11301 - Disclosure - Right-of-use assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureInventories" id="DisclosureInventories">
        <link:definition>11401 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssets" id="DisclosureTradeAndOtherReceivablesAndOtherAssets">
        <link:definition>11501 - Disclosure - Trade and other receivables and other assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureCashAndShortTermDeposits" id="DisclosureCashAndShortTermDeposits">
        <link:definition>11601 - Disclosure - Cash and short-term deposits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureEquity" id="DisclosureEquity">
        <link:definition>11701 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureCapitalManagement" id="DisclosureCapitalManagement">
        <link:definition>11801 - Disclosure - Capital management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialLiabilities" id="DisclosureFinancialLiabilities">
        <link:definition>11901 - Disclosure - Financial liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureShareBasedPayments" id="DisclosureShareBasedPayments">
        <link:definition>12001 - Disclosure - Share-based payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagement" id="DisclosureFinancialInstrumentsFairValuesAndRiskManagement">
        <link:definition>12101 - Disclosure - Financial instruments - fair values and risk management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureListOfSubsidiaries" id="DisclosureListOfSubsidiaries">
        <link:definition>12201 - Disclosure - List of subsidiaries</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureNonControllingInterests" id="DisclosureNonControllingInterests">
        <link:definition>12301 - Disclosure - Non-controlling interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureCommitments" id="DisclosureCommitments">
        <link:definition>12401 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRelatedParties" id="DisclosureRelatedParties">
        <link:definition>12501 - Disclosure - Related parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureContingentLiabilities" id="DisclosureContingentLiabilities">
        <link:definition>12601 - Disclosure - Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>12701 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies" id="DisclosureSignificantAccountingPoliciesPolicies">
        <link:definition>20502 - Disclosure - Significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureBasisOfPreparationTables" id="DisclosureBasisOfPreparationTables">
        <link:definition>30203 - Disclosure - Basis of preparation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSignificantAccountingPoliciesTables" id="DisclosureSignificantAccountingPoliciesTables">
        <link:definition>30503 - Disclosure - Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables" id="DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables">
        <link:definition>30703 - Disclosure - Segment information and revenue from contracts with customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables" id="DisclosureOtherIncomeAndExpensesTables">
        <link:definition>30803 - Disclosure - Other income and expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>30903 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureIntangibleAssetsTables" id="DisclosureIntangibleAssetsTables">
        <link:definition>31103 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentTables" id="DisclosurePropertyPlantAndEquipmentTables">
        <link:definition>31203 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsTables" id="DisclosureRightOfUseAssetsTables">
        <link:definition>31303 - Disclosure - Right-of-use assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureInventoriesTables" id="DisclosureInventoriesTables">
        <link:definition>31403 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsTables" id="DisclosureTradeAndOtherReceivablesAndOtherAssetsTables">
        <link:definition>31503 - Disclosure - Trade and other receivables and other assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureEquityTables" id="DisclosureEquityTables">
        <link:definition>31703 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesTables" id="DisclosureFinancialLiabilitiesTables">
        <link:definition>31903 - Disclosure - Financial liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables" id="DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables">
        <link:definition>32103 - Disclosure - Financial instruments - fair values and risk management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureListOfSubsidiariesTables" id="DisclosureListOfSubsidiariesTables">
        <link:definition>32203 - Disclosure - List of subsidiaries (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureNonControllingInterestsTables" id="DisclosureNonControllingInterestsTables">
        <link:definition>32303 - Disclosure - Non-controlling interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRelatedPartiesTables" id="DisclosureRelatedPartiesTables">
        <link:definition>32503 - Disclosure - Related parties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails" id="DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails">
        <link:definition>40704 - Disclosure - Segment information and revenue from contracts with customers - Contract balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureLossPerShareDetails" id="DisclosureLossPerShareDetails">
        <link:definition>41001 - Disclosure - Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails" id="DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails">
        <link:definition>41303 - Disclosure - Right-of-use assets - Carrying amounts of lease liabilities and the movements during the period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="cntg-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cntg-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cntg-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cntg-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links, all" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xsd:import namespace="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xsd:element id="cntg_NonControllingInterestsAbstract" name="NonControllingInterestsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentogeneUsLlcBurlingtonUsaMember" name="CentogeneUsLlcBurlingtonUsaMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentogeneGmbhViennaMember" name="CentogeneGmbhViennaMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentogeneIndiaPvt.LtdMember" name="CentogeneIndiaPvt.LtdMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_LpcGmbhMember" name="LpcGmbhMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" name="FuturePaymentObligationToSuppliersForGoodsAndServices" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_SupervisoryBoardMember" name="SupervisoryBoardMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract" name="IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" name="IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_BiomarkersMember" name="BiomarkersMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DatabaseMember" name="DatabaseMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_GrantsReceivables" name="GrantsReceivables" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" name="IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" name="IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_CorporateIncomeTaxRate" name="CorporateIncomeTaxRate" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_SolidaritySurchargeRate" name="SolidaritySurchargeRate" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_TradeTaxRate" name="TradeTaxRate" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_OtherCountriesMember" name="OtherCountriesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_MeasurementOfServiceContractsMember" name="MeasurementOfServiceContractsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DeferredTaxAssetsOffset" name="DeferredTaxAssetsOffset" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_DeferredTaxLiabilitiesOffset" name="DeferredTaxLiabilitiesOffset" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_PlantMember" name="PlantMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OtherEquipmentFurnitureAndFixturesMember" name="OtherEquipmentFurnitureAndFixturesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" name="IfrsStockIssuedDuringPeriodSharesNewIssues" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsBankOverdraftsMember" name="IfrsBankOverdraftsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_BankOverdraftsOneMember" name="BankOverdraftsOneMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_BankOverdraftsTwoMember" name="BankOverdraftsTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_BankOverdraftsThreeMember" name="BankOverdraftsThreeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CurrentFinancialLiabilitiesMember" name="CurrentFinancialLiabilitiesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_TradeAndOtherPayablesOther" name="TradeAndOtherPayablesOther" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_LiabilitiesForWageAndChurchTax" name="LiabilitiesForWageAndChurchTax" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_VirtualShareOptionProgram2016CashSettledMember" name="VirtualShareOptionProgram2016CashSettledMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_VirtualShareOptionProgram2017CashSettledMember" name="VirtualShareOptionProgram2017CashSettledMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" name="DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfOutstandingShareOptionsAbstract" name="NumberOfOutstandingShareOptionsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" name="NumberOfShareOptionsVestedInShareBasedPaymentArrangement" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" />
  <xsd:element id="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" name="WeightedAverageExercisePriceOfShareOptionsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" name="WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" />
  <xsd:element id="cntg_GeneralInformationAboutFinancialStatementsAbstract" name="GeneralInformationAboutFinancialStatementsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_BasisOfPreparationOfFinancialStatementsAbstract" name="BasisOfPreparationOfFinancialStatementsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_BasisOfConsolidationAbstract" name="BasisOfConsolidationAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" name="AccountingAndMeasurementPrinciplesDisclosureAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OtherIncomeExpenseDisclosureAbstract" name="OtherIncomeExpenseDisclosureAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory" name="DisclosureOfForeignExchangeRatesUsedExplanatory" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" name="AccountingAndMeasurementPrinciplesDisclosureTable" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_SoftwarePatentsAndTrademarksMember" name="SoftwarePatentsAndTrademarksMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" name="AccountingAndMeasurementPrinciplesDisclosureLineItems" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsLeasesAbstract" name="IfrsLeasesAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_FinancialInstrumentsAbstract" name="FinancialInstrumentsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" name="FinancialAssetInDefaultNumberOfDaysPastDueConsidered" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_PharmaceuticalSegmentMember" name="PharmaceuticalSegmentMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DiagnosticsSegmentMember" name="DiagnosticsSegmentMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsNumberOfReportableSegments" name="IfrsNumberOfReportableSegments" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" name="AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_OtherSegmentInformationAbstract" name="OtherSegmentInformationAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" name="AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" name="AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_IfrsMiddleEastMember" name="IfrsMiddleEastMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_WeightedAverageFairValueOfShareOptionsOutstanding" name="WeightedAverageFairValueOfShareOptionsOutstanding" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" />
  <xsd:element id="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" name="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" name="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_EquityShareOption2017EquitySettledMember" name="EquityShareOption2017EquitySettledMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" name="KeyAssumptionsUsedToDeriveOptionValueAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_TradeReceivablesAndContractAssetsMember" name="TradeReceivablesAndContractAssetsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" name="LaterThanOneDayAndNotLaterThanOneMonthMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_SecuredCreditLinesMember" name="SecuredCreditLinesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NotLaterThanTwoMonthsMember" name="NotLaterThanTwoMonthsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" name="LaterThanTwoMonthsAndNotLaterThanOneYearMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_PercentageOfInterestBearingLoansMatureInOneYear" name="PercentageOfInterestBearingLoansMatureInOneYear" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_SecuredCreditLinesInterestRate" name="SecuredCreditLinesInterestRate" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_SecuredCreditLinesUtilized" name="SecuredCreditLinesUtilized" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_TradePayableAndOtherLiabilitiesMember" name="TradePayableAndOtherLiabilitiesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock" name="DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock" name="DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_UnallocatedAmountsShareBasedPaymentsMember" name="UnallocatedAmountsShareBasedPaymentsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_UnallocatedAmountsDepreciationAndAmortizationMember" name="UnallocatedAmountsDepreciationAndAmortizationMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_PharmaceuticalPartnerMember" name="PharmaceuticalPartnerMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfCustomersInGroup" name="NumberOfCustomersInGroup" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ReceivablesPaymentTerms" name="ReceivablesPaymentTerms" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_NonCurrentFinancialLiabilitiesInterestBearing" name="NonCurrentFinancialLiabilitiesInterestBearing" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_CurrentFinancialLiabilitiesInterestBearing" name="CurrentFinancialLiabilitiesInterestBearing" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_FinancialLiabilitiesInterestBearing" name="FinancialLiabilitiesInterestBearing" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" name="TradeAndOtherReceivablesDueWithInTwoMonthsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_TradePayablesMember" name="TradePayablesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DamagesSought" name="DamagesSought" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_UniversitairMedischCentrumUtrechtMember" name="UniversitairMedischCentrumUtrechtMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DisclosureOfInventoriesTableTextBlock" name="DisclosureOfInventoriesTableTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" name="TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" name="OtherCurrentAssetsExcludingReceivablesDueFromShareholders" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory" name="DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_OtherEquipmentMember" name="OtherEquipmentMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_PlantAndMachineryMember" name="PlantAndMachineryMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OfficesInBostonMember" name="OfficesInBostonMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OfficesInBerlinMember" name="OfficesInBerlinMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_RostockHeadquartersBuildingMember" name="RostockHeadquartersBuildingMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_LeaseExtensionTerm" name="LeaseExtensionTerm" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfTimesLeaseContractCanBeExtended" name="NumberOfTimesLeaseContractCanBeExtended" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_RentalDeposits" name="RentalDeposits" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_BankGuarantee" name="BankGuarantee" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_LeaseTerm" name="LeaseTerm" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_PlantAndEquipmentMember" name="PlantAndEquipmentMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OfficesMember" name="OfficesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DecreaseThroughPaymentsLeaseLiabilities" name="DecreaseThroughPaymentsLeaseLiabilities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_IncreaseThroughAdditionsLeaseLiabilities" name="IncreaseThroughAdditionsLeaseLiabilities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" name="TotalLeaseExpensesRecognisedInProfitOrLoss" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_RealEstateTransferTaxExpenses" name="RealEstateTransferTaxExpenses" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_GeneralInformationAboutFinancialStatementsTable" name="GeneralInformationAboutFinancialStatementsTable" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_MemberOfSupervisoryBoardMember" name="MemberOfSupervisoryBoardMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsRelatedPartyTransactionAxis" name="IfrsRelatedPartyTransactionAxis" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_PensionCommitments" name="PensionCommitments" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_DisclosureOfCommitmentsAbstract" name="DisclosureOfCommitmentsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_UndiscountedLeasePaymentsToBeMade" name="UndiscountedLeasePaymentsToBeMade" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" name="TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" name="UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory" name="AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_SecuredBankLoanMember" name="SecuredBankLoanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OverdraftFacilityMember" name="OverdraftFacilityMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" name="IfrsLineOfCreditFacilityMaximumBorrowingCapacity" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" name="IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_GeneralInformationAboutFinancialStatementsLineItems" name="GeneralInformationAboutFinancialStatementsLineItems" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsSubsidiarySaleOfStockAxis" name="IfrsSubsidiarySaleOfStockAxis" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsSaleOfStockNameOfTransactionDomain" name="IfrsSaleOfStockNameOfTransactionDomain" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsIPOMember" name="IfrsIPOMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentogeneGMember" name="CentogeneGMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" name="StockIssuedDuringPeriodOfferingPricePerShareNewIssues" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" name="IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_OtherIncomeExpenseTable" name="OtherIncomeExpenseTable" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OtherIncomeExpenseLineItems" name="OtherIncomeExpenseLineItems" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DisclosureOfContractBalancesExplanatory" name="DisclosureOfContractBalancesExplanatory" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ProvisionForExpectedCreditLossesOnContractAssets" name="ProvisionForExpectedCreditLossesOnContractAssets" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" name="LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" name="LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" name="IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" name="IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" name="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_EquityShareOption2019EquitySettledMember" name="EquityShareOption2019EquitySettledMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" name="LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_VirtualShareOptionPrograms2016And2017Member" name="VirtualShareOptionPrograms2016And2017Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_EquityShareOption2017And2019Member" name="EquityShareOption2017And2019Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_RentalDepositsNoncurrent" name="RentalDepositsNoncurrent" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_NonCurrentFinancialLiabilitiesMember" name="NonCurrentFinancialLiabilitiesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsRelatedPartyTransactionDomain" name="IfrsRelatedPartyTransactionDomain" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CorporateStrategyServiceMember" name="CorporateStrategyServiceMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_RelatedPartyServicesMember" name="RelatedPartyServicesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_SupervisoryBoardActivitiesMember" name="SupervisoryBoardActivitiesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" name="CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" name="PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" name="AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_GovernmentGrantsMember" name="GovernmentGrantsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" name="NumberOfTopDiagnosticCustomersDueInTradeReceivables" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_PercentageOfOverdueBalances" name="PercentageOfOverdueBalances" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" />
  <xsd:element id="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" name="MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NoncurrentSecuredBankLoansMember" name="NoncurrentSecuredBankLoansMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CurrentSecuredBankLoansMember" name="CurrentSecuredBankLoansMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" name="WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" nillable="true" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" />
  <xsd:element id="cntg_BerlinOfficesMember" name="BerlinOfficesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock" name="IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ConsiderationReceivableForSaleOfLpc" name="ConsiderationReceivableForSaleOfLpc" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" name="TradeAndOtherReceivablesAndOtherAssetsCurrent" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" name="TradeAndOtherReceivablesAndOtherAssetsNoncurrent" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_ConsiderationPaymentDuePeriod" name="ConsiderationPaymentDuePeriod" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ConsiderationToBePaidOverTime" name="ConsiderationToBePaidOverTime" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_OverdraftFacilityOneMember" name="OverdraftFacilityOneMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OverdraftFacilityTwoMember" name="OverdraftFacilityTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OfficeEquipmentAndStorageSpacesMember" name="OfficeEquipmentAndStorageSpacesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentogeneN.vMember" name="CentogeneN.vMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_SellingShareholdersMember" name="SellingShareholdersMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CurrentTradeReceivablesAndContractAssets" name="CurrentTradeReceivablesAndContractAssets" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" name="AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_OtherBankLoansMember" name="OtherBankLoansMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_Covid19Member" name="Covid19Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_LongTermIncentivePlanMember" name="LongTermIncentivePlanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsVestingAxis" name="IfrsVestingAxis" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsVestingDomain" name="IfrsVestingDomain" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ProvisionForOutstandingInvoices" name="ProvisionForOutstandingInvoices" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_IfrsChiefExecutiveOfficerMember" name="IfrsChiefExecutiveOfficerMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ChiefInformationOfficerMember" name="ChiefInformationOfficerMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" name="IfrsShareBasedPaymentArrangementTrancheOneMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsAwardTypeAxis" name="IfrsAwardTypeAxis" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_AwardTypeDomain" name="AwardTypeDomain" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsRestrictedStockUnitsRsusMember" name="IfrsRestrictedStockUnitsRsusMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" name="IfrsShareBasedPaymentArrangementTrancheTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" name="IfrsShareBasedPaymentArrangementTrancheThreeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ThresholdTradingDays" name="ThresholdTradingDays" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" name="SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" name="AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_StockOptionsMember" name="StockOptionsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_GrantOfRestrictedStockUnitsMember" name="GrantOfRestrictedStockUnitsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" name="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" name="SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsCorporateMember" name="IfrsCorporateMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CoronaTestPortalMember" name="CoronaTestPortalMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_Covid19PartnerOneMember" name="Covid19PartnerOneMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_Covid19PartnerTwoMember" name="Covid19PartnerTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" name="DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" name="ReclassRightOfUseAssetsToPropertyPlantEquipment" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_OverdraftFacilityThreeMember" name="OverdraftFacilityThreeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsBalanceSheetLocationAxis" name="IfrsBalanceSheetLocationAxis" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsBalanceSheetLocationDomain" name="IfrsBalanceSheetLocationDomain" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CapitalizedInvestment" name="CapitalizedInvestment" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_ConsiderationOutstanding" name="ConsiderationOutstanding" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_ExerciseOfOptionsShares" name="ExerciseOfOptionsShares" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" name="ShortTermDepositsPledgedAsSecurityForLiabilities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_ShareBasedPaymentArrangementTrancheOneMember" name="ShareBasedPaymentArrangementTrancheOneMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ShareBasedPaymentArrangementTrancheTwoMember" name="ShareBasedPaymentArrangementTrancheTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_EmployeesMember" name="EmployeesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" name="KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ExercisePriceOtherEquityInstrumentsGranted" name="ExercisePriceOtherEquityInstrumentsGranted" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" name="WeightedAverageSharePriceOtherEquityInstrumentsGranted" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" name="ExpectedVolatilityOtherEquityInstrumentsGranted" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" name="RiskFreeInterestRateOtherEquityInstrumentsGranted" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" name="ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_OptionLifeOtherEquityInstrumentsGranted" name="OptionLifeOtherEquityInstrumentsGranted" nillable="true" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_PerformanceBasedRestrictedStockUnitsMember" name="PerformanceBasedRestrictedStockUnitsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ManagementBoardAndEmployeesMember" name="ManagementBoardAndEmployeesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" name="CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" name="CurrentReceivablesFromCovid19BankOrCreditCardTransactions" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" name="VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" name="VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" name="ValueOfOrdinarySharesToBeIssuedShareBasedPayments" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_ValueOfOtherEquityInstrumentsGranted" name="ValueOfOtherEquityInstrumentsGranted" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" name="ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" name="MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_VolumeWeightedAverageStockPriceComputationTradingDays" name="VolumeWeightedAverageStockPriceComputationTradingDays" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" name="ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_CentogeneSwitzerlandAgMember" name="CentogeneSwitzerlandAgMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentosafeB.v.Member" name="CentosafeB.v.Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentogeneD.o.oBelgradeMember" name="CentogeneD.o.oBelgradeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_Dr.BauerLaboratoriumsGmbhMember" name="Dr.BauerLaboratoriumsGmbhMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_BankLoansMember" name="BankLoansMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_FinancingActivitiesMunicipalLoansMember" name="FinancingActivitiesMunicipalLoansMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsSharesIssuedPricePerShare" name="IfrsSharesIssuedPricePerShare" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" />
  <xsd:element id="cntg_IfrsSaleOfStockAxis" name="IfrsSaleOfStockAxis" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_SaleOfStockDomain" name="SaleOfStockDomain" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" name="NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" nillable="true" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" name="NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" nillable="true" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" name="ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="cntg_FormerCeoAndMajorShareholderMember" name="FormerCeoAndMajorShareholderMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" name="IfrsShareBasedPaymentArrangementAcceleratedCost" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_KeyManagementPersonnelCompensationAccruedAmount" name="KeyManagementPersonnelCompensationAccruedAmount" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_KeyManagementPersonnelCompensationSeverancePayout" name="KeyManagementPersonnelCompensationSeverancePayout" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_CovidTestingSuppliesPurchasesMember" name="CovidTestingSuppliesPurchasesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CovidTestingServicesMember" name="CovidTestingServicesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfCommonSharesOfferedByPriorShareholders" name="NumberOfCommonSharesOfferedByPriorShareholders" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" name="NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_AuthorizedButUnissuedShareCapital" name="AuthorizedButUnissuedShareCapital" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" />
  <xsd:element id="cntg_DeferredTaxLiabilitiesNet" name="DeferredTaxLiabilitiesNet" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_ChairmanMember" name="ChairmanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ViceChairmanMember" name="ViceChairmanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ChairmanOfAuditCommitteeMember" name="ChairmanOfAuditCommitteeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_ChairmanOfCompensationCommitteeMember" name="ChairmanOfCompensationCommitteeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_PercentageOfAwardConstitutesRestrictedStockUnits" name="PercentageOfAwardConstitutesRestrictedStockUnits" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_PercentageOfAwardConstitutesStockOptions" name="PercentageOfAwardConstitutesStockOptions" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_NonCurrentMunicipalLoansMember" name="NonCurrentMunicipalLoansMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_CurrencyLossesFinanceCost" name="CurrencyLossesFinanceCost" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" name="AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_CentogeneFzLlcUnitedArabEmiratesMember" name="CentogeneFzLlcUnitedArabEmiratesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" name="AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" />
  <xsd:element id="cntg_NumberOfTranches" name="NumberOfTranches" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_VestingInFourTranchesMember" name="VestingInFourTranchesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" name="WeightedAverageFairValueOtherEquityInstrumentsGranted" nillable="true" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsIncomeStatementLocationAxis" name="IfrsIncomeStatementLocationAxis" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_IfrsIncomeStatementLocationDomain" name="IfrsIncomeStatementLocationDomain" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_FollowOnEquityOfferingMember" name="FollowOnEquityOfferingMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfOtherEquityInstrumentsAbstract" name="NumberOfOtherEquityInstrumentsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" name="WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" name="PartneringLaboratoryPhysicianProfDrPeterBauerMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_RsuGrantedOneMember" name="RsuGrantedOneMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_RsuGrantedTwoMember" name="RsuGrantedTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_RsuGrantedThreeMember" name="RsuGrantedThreeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_OptionsGrantedTwoMember" name="OptionsGrantedTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_RsuGrantedFourMember" name="RsuGrantedFourMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_EstimatedRateOfImplicitPriceConcessions" name="EstimatedRateOfImplicitPriceConcessions" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="cntg_NumberOfInstallments" name="NumberOfInstallments" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" />
  <xsd:element id="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" name="CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="cntg_FinancialCovenants" name="FinancialCovenants" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element id="cntg_PercentageOfEstimatedVariableTransactionPrice" name="PercentageOfEstimatedVariableTransactionPrice" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element name="FollowOnPublicOfferingMember" id="cntg_FollowOnPublicOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="BankOverdraftsOneAndThreeMember" id="cntg_BankOverdraftsOneAndThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="OptionsStrikePrice" id="cntg_OptionsStrikePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="PeerSchatzMember" id="cntg_PeerSchatzMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="OtherOfficeAndLaboratoriesMember" id="cntg_OtherOfficeAndLaboratoriesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PaymentForSettlementOfStockOptions" id="cntg_PaymentForSettlementOfStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="EnteringInToDebtFinancingAgreementMember" id="cntg_EnteringInToDebtFinancingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LoanFacilityMember" id="cntg_LoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="BorrowingsAvailableSubjectToAchievementOfProductRevenue" id="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="BorrowingsRevenueAchievementThreshold" id="cntg_BorrowingsRevenueAchievementThreshold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="BorrowingsCovenantMinimumRequiredRevenue" id="cntg_BorrowingsCovenantMinimumRequiredRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="IfrsSharePrice" id="cntg_IfrsSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" id="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock" id="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MiguelCoegoRiosMember" id="cntg_MiguelCoegoRiosMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IfrsFormerChiefExecutiveOfficerMember" id="cntg_IfrsFormerChiefExecutiveOfficerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RsuGrantedFiveMember" id="cntg_RsuGrantedFiveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MrBerndtModigMember" id="cntg_MrBerndtModigMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MrJonathanGSheldonMember" id="cntg_MrJonathanGSheldonMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="BiomarkersAndDatabasesMember" id="cntg_BiomarkersAndDatabasesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="TradeReceivablesAverageTurnoverPeriod" id="cntg_TradeReceivablesAverageTurnoverPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="RostockHeadquartersBuildingAndBerlinOfficesMember" id="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="StockOptionPlan2016Member" id="cntg_StockOptionPlan2016Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="FloorRateMember" id="cntg_FloorRateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="GainLossFromForgivenessOfLoan" id="cntg_GainLossFromForgivenessOfLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="InfrequentItemsAxis" id="cntg_InfrequentItemsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="InfrequentItemsDomain" id="cntg_InfrequentItemsDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MrModigAndMrSheldonMember" id="cntg_MrModigAndMrSheldonMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Mr.KimMember" id="cntg_Mr.KimMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RetainedEarningsExcludingCurrencyTranslationReserveMember" id="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LoanFacilityTrancheOneMember" id="cntg_LoanFacilityTrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LoanFacilityTrancheTwoMember" id="cntg_LoanFacilityTrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="FormerChiefFinancialOfficerMember" id="cntg_FormerChiefFinancialOfficerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ProportionOfOwnershipInterestInNonControllingInterestDisposal" id="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="RsusDerecognizedMember" id="cntg_RsusDerecognizedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RsusRecognizedMember" id="cntg_RsusRecognizedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" id="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ShareBasedAwardsSubjectToTimeVestingMember" id="cntg_ShareBasedAwardsSubjectToTimeVestingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>26
<FILENAME>cntg-20211231_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8042.36810 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/31/2022 3:12:46 PM-->
<!--Modified on: 3/31/2022 3:12:46 PM-->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfComprehensiveLoss" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfComprehensiveLossCalc2" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLossCalc2" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfFinancialPosition" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesDeferredTaxesDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureInventoriesDetails" roleURI="http://centogene.com/role/DisclosureInventoriesDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesInterestBearingLoansDetails" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails" roleURI="http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails" />
  <calculationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended" xlink:title="00100 - Statement - Consolidated statements of comprehensive loss">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent_637843363588354706" order="1" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss_637843363588354706" order="2" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss_637843363588354706" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363588354706" order="1" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss_637843363588354706" xlink:to="ifrs-full_ProfitLossBeforeTax_637843363588354706" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax_637843363588354706" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" order="1" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="ifrs-full_GrossProfit_637843363588354706" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit_637843363588354706" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_637843363588354706" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales_637843363588354706" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit_637843363588354706" xlink:to="ifrs-full_CostOfSales_637843363588354706" order="2" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_637843363588364699" order="2" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="cntg_RealEstateTransferTaxExpenses_637843363588364699" order="3" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_637843363588364699" order="4" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingExpense" xlink:label="ifrs-full_SellingExpense_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="ifrs-full_SellingExpense_637843363588364699" order="5" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="ifrs-full_ImpairmentLossOnFinancialAssets_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="ifrs-full_ImpairmentLossOnFinancialAssets_637843363588364699" order="6" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="ifrs-full_OtherIncome_637843363588364699" order="7" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="ifrs-full_OtherExpenseByFunction_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588354706" xlink:to="ifrs-full_OtherExpenseByFunction_637843363588364699" order="8" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_637843363588364699" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax_637843363588354706" xlink:to="ifrs-full_FinanceIncomeCost_637843363588364699" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpense" xlink:label="ifrs-full_InterestExpense_637843363588374694" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_637843363588364699" xlink:to="ifrs-full_InterestExpense_637843363588374694" order="1" use="optional" weight="-1" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeOnLoansAndReceivables" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363588374694" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_637843363588364699" xlink:to="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363588374694" order="2" use="optional" weight="1" priority="4" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLossCalc2" xlink:type="extended" xlink:title="00105 - Statement - Consolidated statements of comprehensive loss (Calc 2)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_637843363588374694" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_637843363588374694" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_637843363588374694" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_637843363588374694" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition" xlink:type="extended" xlink:title="00200 - Statement - Consolidated statements of financial position">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets_637843363588374694" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_NoncurrentAssets_637843363588374694" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363588374694" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_637843363588374694" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363588374694" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_637843363588374694" xlink:to="ifrs-full_PropertyPlantAndEquipment_637843363588385150" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_637843363588374694" xlink:to="ifrs-full_RightofuseAssets_637843363588385150" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="ifrs-full_OtherNoncurrentAssets_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_637843363588374694" xlink:to="ifrs-full_OtherNoncurrentAssets_637843363588385150" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets_637843363588385150" order="2" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_637843363588385150" xlink:to="ifrs-full_Inventories_637843363588385150" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets" xlink:label="ifrs-full_OtherCurrentAssets_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_637843363588385150" xlink:to="ifrs-full_OtherCurrentAssets_637843363588385150" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_637843363588385150" xlink:to="ifrs-full_CashAndCashEquivalents_637843363588385150" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentTradeReceivablesAndContractAssets" xlink:label="cntg_CurrentTradeReceivablesAndContractAssets_637843363588385150" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_637843363588385150" xlink:to="cntg_CurrentTradeReceivablesAndContractAssets_637843363588385150" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_637843363588394675" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Equity_637843363588394675" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_637843363588394675" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_637843363588394675" xlink:to="ifrs-full_IssuedCapital_637843363588394675" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserve" xlink:label="ifrs-full_CapitalReserve_637843363588394675" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_637843363588394675" xlink:to="ifrs-full_CapitalReserve_637843363588394675" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings_637843363588394675" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_637843363588394675" xlink:to="ifrs-full_RetainedEarnings_637843363588394675" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests_637843363588394675" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_637843363588394675" xlink:to="ifrs-full_NoncontrollingInterests_637843363588394675" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities_637843363588394675" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_637843363588394675" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="ifrs-full_LongtermBorrowings_637843363588394675" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_637843363588394675" xlink:to="ifrs-full_LongtermBorrowings_637843363588394675" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_637843363588404720" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_637843363588394675" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_637843363588404720" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_637843363588404720" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_637843363588394675" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_637843363588404720" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="ifrs-full_NoncurrentGovernmentGrants_637843363588404720" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_637843363588394675" xlink:to="ifrs-full_NoncurrentGovernmentGrants_637843363588404720" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities_637843363588404720" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_CurrentLiabilities_637843363588404720" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="ifrs-full_CurrentGovernmentGrants_637843363588404720" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_637843363588404720" xlink:to="ifrs-full_CurrentGovernmentGrants_637843363588404720" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_637843363588404720" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_637843363588404720" xlink:to="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_637843363588404720" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_637843363588414848" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_637843363588404720" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_637843363588414848" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities_637843363588414848" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_637843363588404720" xlink:to="ifrs-full_CurrentLeaseLiabilities_637843363588414848" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363588414848" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_637843363588404720" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363588414848" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="ifrs-full_OtherCurrentLiabilities_637843363588414848" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_637843363588404720" xlink:to="ifrs-full_OtherCurrentLiabilities_637843363588414848" order="6" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00300 - Statement - Consolidated statements of cash flows">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_ProfitLossBeforeTax_637843363588424791" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_637843363588424791" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryWritedown2011" xlink:label="ifrs-full_InventoryWritedown2011_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_InventoryWritedown2011_637843363588424791" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="ifrs-full_AdjustmentsForInterestIncome_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForInterestIncome_637843363588424791" order="4" use="optional" weight="-1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForInterestExpense_637843363588424791" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_637843363588424791" order="6" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="cntg_RealEstateTransferTaxExpenses_637843363588424791" order="7" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_637843363588424791" order="8" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_637843363588424791" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_637843363588424791" order="9" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_637843363588434771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_637843363588434771" order="10" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_637843363588434771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_637843363588434771" order="11" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_637843363588434771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_637843363588434771" order="12" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_637843363588434771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_637843363588434771" order="13" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_637843363588434771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_637843363588434771" order="14" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" xlink:label="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_637843363588434771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363588424791" xlink:to="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_637843363588434771" order="15" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_637843363588444788" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_637843363588444788" order="1" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363588444788" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363588444788" order="2" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_637843363588444788" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" xlink:to="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_637843363588444788" order="3" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363588444788" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" xlink:to="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363588444788" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363588444788" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363588444788" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_637843363588444788" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363588434771" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_637843363588444788" order="6" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="ifrs-full_ProceedsFromIssuingShares_637843363588454685" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" xlink:to="ifrs-full_ProceedsFromIssuingShares_637843363588454685" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363588454685" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363588454685" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_637843363588454685" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_637843363588454685" order="3" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_637843363588454685" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_637843363588454685" order="4" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_637843363588454685" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_637843363588454685" order="5" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:label="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_637843363588454685" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363588444788" xlink:to="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_637843363588454685" order="6" use="optional" weight="-1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" xlink:type="extended" xlink:title="40702 - Disclosure - Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_637843363588464891" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_FinanceIncomeCost_637843363588464891" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363588464891" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363588464891" order="2" use="optional" weight="-1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_637843363588464891" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_637843363588464891" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_637843363588464891" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588464891" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_637843363588464891" order="1" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363588464891" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588464891" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363588464891" order="2" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_637843363588464891" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_637843363588464891" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_637843363588464891" order="3" use="optional" weight="1" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_637843363588464891" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_637843363588464891" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_637843363588464891" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdministrativeExpense" xlink:label="ifrs-full_AdministrativeExpense_637843363588474677" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_637843363588464891" xlink:to="ifrs-full_AdministrativeExpense_637843363588474677" order="2" use="optional" weight="-1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" xlink:type="extended" xlink:title="40703 - Disclosure - Segment information and revenue from contracts with customers - Geographical information (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="ifrs-full_RevenueFromSaleOfGoods_637843363588474677" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromSaleOfGoods_637843363588474677" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="ifrs-full_RevenueFromRenderingOfServices_637843363588474677" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromRenderingOfServices_637843363588474677" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Other income and expenses - Other Operating Income (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="ifrs-full_RevenueFromGovernmentGrants_637843363588474677" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_RevenueFromGovernmentGrants_637843363588474677" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReversalsOfProvisions" xlink:label="ifrs-full_OtherReversalsOfProvisions_637843363588474677" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherReversalsOfProvisions_637843363588474677" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_637843363588474677" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_637843363588474677" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="ifrs-full_MiscellaneousOtherOperatingIncome_637843363588474677" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_MiscellaneousOtherOperatingIncome_637843363588474677" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="ifrs-full_NetForeignExchangeGain_637843363588484785" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_NetForeignExchangeGain_637843363588484785" order="5" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Other income and expenses - Other Operating Expenses (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="ifrs-full_OtherExpenseByFunction" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_637843363588484785" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByFunction" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense_637843363588484785" order="1" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="ifrs-full_NetForeignExchangeLoss_637843363588484785" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByFunction" xlink:to="ifrs-full_NetForeignExchangeLoss_637843363588484785" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails" xlink:type="extended" xlink:title="40804 - Disclosure - Other income and expenses - Financial costs, net (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="ifrs-full_InterestExpenseOnBorrowings_637843363588484785" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_InterestExpenseOnBorrowings_637843363588484785" order="1" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrencyLossesFinanceCost" xlink:label="cntg_CurrencyLossesFinanceCost_637843363588484785" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="cntg_CurrencyLossesFinanceCost_637843363588484785" order="2" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363588484785" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363588484785" order="3" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeOnLoansAndReceivables" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363588484785" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363588484785" order="4" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails" xlink:type="extended" xlink:title="40805 - Disclosure - Other income and expenses - Employee benefits expense (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="ifrs-full_EmployeeBenefitsExpense" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363588494826" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EmployeeBenefitsExpense" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363588494826" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SocialSecurityContributions" xlink:label="ifrs-full_SocialSecurityContributions_637843363588494826" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EmployeeBenefitsExpense" xlink:to="ifrs-full_SocialSecurityContributions_637843363588494826" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TerminationBenefitsExpense" xlink:label="ifrs-full_TerminationBenefitsExpense_637843363588494826" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EmployeeBenefitsExpense" xlink:to="ifrs-full_TerminationBenefitsExpense_637843363588494826" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries" xlink:label="ifrs-full_WagesAndSalaries_637843363588494826" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EmployeeBenefitsExpense" xlink:to="ifrs-full_WagesAndSalaries_637843363588494826" order="4" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Income taxes - Taxes recognized through profit or loss (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_637843363588494826" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_637843363588494826" order="1" use="optional" weight="-1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_637843363588494826" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_637843363588494826" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_637843363588494826" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" xlink:label="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_637843363588494826" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_637843363588494826" xlink:to="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_637843363588494826" order="2" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_637843363588504801" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_637843363588504801" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="ifrs-full_CurrentTaxExpenseIncome_637843363588504801" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_637843363588504801" xlink:to="ifrs-full_CurrentTaxExpenseIncome_637843363588504801" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_637843363588504801" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_637843363588504801" xlink:to="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_637843363588504801" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" xlink:type="extended" xlink:title="40902 - Disclosure - Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" xlink:label="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_637843363588504801" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_637843363588504801" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_637843363588504801" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_637843363588504801" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_637843363588504801" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_637843363588504801" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates_637843363588514810" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates_637843363588514810" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses_637843363588514810" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectOfTaxLosses_637843363588514810" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_637843363588514810" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_637843363588514810" order="6" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails" xlink:type="extended" xlink:title="40903 - Disclosure - Income taxes - Deferred Taxes (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets_637843363588514810" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxAssets_637843363588514810" order="1" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities_637843363588514810" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilities_637843363588514810" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails" xlink:type="extended" xlink:title="41304 - Disclosure - Right-of-use assets - Amounts recognised in profit or loss (Details)">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:label="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_637843363588514810" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:to="ifrs-full_DepreciationRightofuseAssets_637843363588514810" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_637843363588514810" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_637843363588514810" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_637843363588524683" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_637843363588524683" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363588524683" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363588524683" order="4" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureInventoriesDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Inventories (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinishedGoods" xlink:label="ifrs-full_FinishedGoods_637843363588524683" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_FinishedGoods_637843363588524683" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:label="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_637843363588524683" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_637843363588524683" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Trade and other receivables and other assets (Details)">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_637843363588524683" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_637843363588524683" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="ifrs-full_OtherNoncurrentReceivables_637843363588524683" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_637843363588524683" xlink:to="ifrs-full_OtherNoncurrentReceivables_637843363588524683" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RentalDepositsNoncurrent" xlink:label="cntg_RentalDepositsNoncurrent_637843363588524683" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_637843363588524683" xlink:to="cntg_RentalDepositsNoncurrent_637843363588524683" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363588534804" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363588534804" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers_637843363588534804" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363588534804" xlink:to="ifrs-full_CurrentReceivablesFromContractsWithCustomers_637843363588534804" order="1" use="optional" weight="1" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" xlink:label="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_637843363588534804" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363588534804" xlink:to="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_637843363588534804" order="2" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractAssets" xlink:label="ifrs-full_CurrentContractAssets_637843363588534804" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363588534804" xlink:to="ifrs-full_CurrentContractAssets_637843363588534804" order="3" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_637843363588534804" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363588534804" xlink:to="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_637843363588534804" order="4" use="optional" weight="-1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2" xlink:type="extended" xlink:title="41805 - Disclosure - Financial liabilities - Trade payables and other liabilities (Details) Calc2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="ifrs-full_TradeAndOtherPayables" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayables" xlink:label="ifrs-full_NoncurrentPayables_637843363588534804" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_NoncurrentPayables_637843363588534804" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_637843363588544924" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_637843363588544924" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails" xlink:type="extended" xlink:title="41901 - Disclosure - Financial liabilities - Interest-bearing loans (Details)">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialLiabilitiesInterestBearing" xlink:label="cntg_FinancialLiabilitiesInterestBearing" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_CurrentFinancialLiabilitiesInterestBearing_637843363588544924" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_FinancialLiabilitiesInterestBearing" xlink:to="cntg_CurrentFinancialLiabilitiesInterestBearing_637843363588544924" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_NonCurrentFinancialLiabilitiesInterestBearing_637843363588544924" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cntg_FinancialLiabilitiesInterestBearing" xlink:to="cntg_NonCurrentFinancialLiabilitiesInterestBearing_637843363588544924" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails" xlink:type="extended" xlink:title="41903 - Disclosure - Financial liabilities - Trade payables and other liabilities (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="ifrs-full_TradeAndOtherPayables" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GovernmentGrants" xlink:label="ifrs-full_GovernmentGrants_637843363588544924" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_GovernmentGrants_637843363588544924" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities_637843363588544924" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_ContractLiabilities_637843363588544924" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherPayablesOther" xlink:label="cntg_TradeAndOtherPayablesOther_637843363588544924" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="cntg_TradeAndOtherPayablesOther_637843363588544924" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363588554766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363588554766" order="4" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails" xlink:type="extended" xlink:title="42501 - Disclosure - Related parties - Remuneration of members of key management (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_637843363588554766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_637843363588554766" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_637843363588554766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_637843363588554766" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_637843363588554766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_637843363588554766" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_637843363588554766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_637843363588554766" order="4" use="optional" weight="1" priority="2" />
  </calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>27
<FILENAME>cntg-20211231_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8042.36810 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/31/2022 3:12:46 PM-->
<!--Modified on: 3/31/2022 3:12:46 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://centogene.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfChangesInEquity" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsTables" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureGeneralCompanyInformationDetails" roleURI="http://centogene.com/role/DisclosureGeneralCompanyInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureBasisOfPreparationDetails" roleURI="http://centogene.com/role/DisclosureBasisOfPreparationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureBasisOfPreparationReconciliationDetails" roleURI="http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSignificantAccountingPoliciesDetails" roleURI="http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureAccountingJudgmentsAndEstimatesDetails" roleURI="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesLpcGmbhDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesDeferredTaxesDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIntangibleAssetsDetails" roleURI="http://centogene.com/role/DisclosureIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosurePropertyPlantAndEquipmentDetails" roleURI="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureCashAndShortTermDepositsDetails" roleURI="http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquityIssuedCapitalAndCapitalReserveDetails" roleURI="http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquityCommonSharesDetails" roleURI="http://centogene.com/role/DisclosureEquityCommonSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquityCapitalReservesDetails" roleURI="http://centogene.com/role/DisclosureEquityCapitalReservesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesInterestBearingLoansDetails" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsValuationOfOptionsDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureListOfSubsidiariesDetails" roleURI="http://centogene.com/role/DisclosureListOfSubsidiariesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureNonControllingInterestsDetails" roleURI="http://centogene.com/role/DisclosureNonControllingInterestsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureCommitmentsDetails" roleURI="http://centogene.com/role/DisclosureCommitmentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRelatedPartiesAdditionalInformationDetails" roleURI="http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureContingentLiabilitiesDetails" roleURI="http://centogene.com/role/DisclosureContingentLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSubsequentEventsDetails" roleURI="http://centogene.com/role/DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:roleRef roleURI="http://centogene.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="cntg-20211231.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <roleRef xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm" roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended" xlink:title="Extensible Enumeration Domain Members" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:definitionLink xlink:role="http://centogene.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="extended" xlink:title="99900 - Disclosure - Standard And Custom Axis Domain Defaults">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_1" xlink:title="ifrs-full_ClassesOfShareCapitalAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_1" xlink:title="ifrs-full_ClassesOfShareCapitalMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="ifrs-full_ClassesOfShareCapitalMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfShareCapitalAxis_1 To ifrs-full_ClassesOfShareCapitalMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_1" xlink:title="dei_LegalEntityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_1" xlink:title="dei_EntityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_LegalEntityAxis_1" xlink:to="dei_EntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_LegalEntityAxis_1 To dei_EntityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis_1" xlink:title="dei_EntityAddressesAddressTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_1" xlink:title="dei_AddressTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_EntityAddressesAddressTypeAxis_1" xlink:to="dei_AddressTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_EntityAddressesAddressTypeAxis_1 To dei_AddressTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis_1" xlink:title="ifrs-full_ComponentsOfEquityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember_1" xlink:title="ifrs-full_EquityMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ComponentsOfEquityAxis_1" xlink:to="ifrs-full_EquityMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ComponentsOfEquityAxis_1 To ifrs-full_EquityMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:title="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:title="ifrs-full_SharebasedPaymentArrangementsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1 To ifrs-full_SharebasedPaymentArrangementsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_1" xlink:title="cntg_IfrsSubsidiarySaleOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_1" xlink:title="cntg_IfrsSaleOfStockNameOfTransactionDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis_1" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_IfrsSubsidiarySaleOfStockAxis_1 To cntg_IfrsSaleOfStockNameOfTransactionDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:title="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:title="ifrs-full_EntitysTotalForSubsidiariesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1 To ifrs-full_EntitysTotalForSubsidiariesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:title="ifrs-full_CategoriesOfRelatedPartiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:title="ifrs-full_EntitysTotalForRelatedPartiesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_CategoriesOfRelatedPartiesAxis_1 To ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:title="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember_1" xlink:title="ifrs-full_NonadjustingEventsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="ifrs-full_NonadjustingEventsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1 To ifrs-full_NonadjustingEventsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_1" xlink:title="ifrs-full_RangeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_1" xlink:title="ifrs-full_RangesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_RangeAxis_1" xlink:to="ifrs-full_RangesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_RangeAxis_1 To ifrs-full_RangesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_1" xlink:title="us-gaap_RelatedPartyDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="us-gaap_RelatedPartyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1 To us-gaap_RelatedPartyDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis_1" xlink:title="ifrs-full_SegmentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember_1" xlink:title="ifrs-full_SegmentsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_SegmentsAxis_1" xlink:to="ifrs-full_SegmentsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_SegmentsAxis_1 To ifrs-full_SegmentsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis_1" xlink:title="ifrs-full_PerformanceObligationsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember_1" xlink:title="ifrs-full_PerformanceObligationsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_PerformanceObligationsAxis_1" xlink:to="ifrs-full_PerformanceObligationsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_PerformanceObligationsAxis_1 To ifrs-full_PerformanceObligationsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_1" xlink:title="ifrs-full_GeographicalAreasAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_1" xlink:title="ifrs-full_GeographicalAreasMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_GeographicalAreasAxis_1" xlink:to="ifrs-full_GeographicalAreasMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_GeographicalAreasAxis_1 To ifrs-full_GeographicalAreasMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="ifrs-full_MajorCustomersAxis_1" xlink:title="ifrs-full_MajorCustomersAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="ifrs-full_MajorCustomersMember_1" xlink:title="ifrs-full_MajorCustomersMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_MajorCustomersAxis_1" xlink:to="ifrs-full_MajorCustomersMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_MajorCustomersAxis_1 To ifrs-full_MajorCustomersMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_1" xlink:title="ifrs-full_MaturityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_1" xlink:title="ifrs-full_AggregatedTimeBandsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_MaturityAxis_1" xlink:to="ifrs-full_AggregatedTimeBandsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_MaturityAxis_1 To ifrs-full_AggregatedTimeBandsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationAxis" xlink:label="cntg_IfrsBalanceSheetLocationAxis_1" xlink:title="cntg_IfrsBalanceSheetLocationAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationDomain" xlink:label="cntg_IfrsBalanceSheetLocationDomain_1" xlink:title="cntg_IfrsBalanceSheetLocationDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_IfrsBalanceSheetLocationAxis_1" xlink:to="cntg_IfrsBalanceSheetLocationDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_IfrsBalanceSheetLocationAxis_1 To cntg_IfrsBalanceSheetLocationDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:title="ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="ifrs-full_ContinuingOperationsMember_1" xlink:title="ifrs-full_ContinuingOperationsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="ifrs-full_ContinuingOperationsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1 To ifrs-full_ContinuingOperationsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIncomeStatementLocationAxis" xlink:label="cntg_IfrsIncomeStatementLocationAxis_1" xlink:title="cntg_IfrsIncomeStatementLocationAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIncomeStatementLocationDomain" xlink:label="cntg_IfrsIncomeStatementLocationDomain_1" xlink:title="cntg_IfrsIncomeStatementLocationDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_IfrsIncomeStatementLocationAxis_1" xlink:to="cntg_IfrsIncomeStatementLocationDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_IfrsIncomeStatementLocationAxis_1 To cntg_IfrsIncomeStatementLocationDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis_1" xlink:title="ifrs-full_SegmentConsolidationItemsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_1" xlink:title="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_SegmentConsolidationItemsAxis_1" xlink:to="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_SegmentConsolidationItemsAxis_1 To ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_1" xlink:title="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_1" xlink:title="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_1" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_1 To ifrs-full_TimingOfTransferOfGoodsOrServicesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_1" xlink:title="ifrs-full_ClassesOfAssetsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_1" xlink:title="ifrs-full_ClassesOfAssetsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfAssetsAxis_1" xlink:to="ifrs-full_ClassesOfAssetsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfAssetsAxis_1 To ifrs-full_ClassesOfAssetsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_1" xlink:title="srt_RangeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_1" xlink:title="srt_RangeMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_RangeAxis_1" xlink:to="srt_RangeMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_RangeAxis_1 To srt_RangeMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:title="ifrs-full_ClassesOfFinancialInstrumentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:title="ifrs-full_ClassesOfFinancialInstrumentsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfFinancialInstrumentsAxis_1 To ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusAxis" xlink:label="ifrs-full_PastDueStatusAxis_1" xlink:title="ifrs-full_PastDueStatusAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusMember" xlink:label="ifrs-full_PastDueStatusMember_1" xlink:title="ifrs-full_PastDueStatusMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_PastDueStatusAxis_1" xlink:to="ifrs-full_PastDueStatusMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_PastDueStatusAxis_1 To ifrs-full_PastDueStatusMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:title="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:title="ifrs-full_PropertyPlantAndEquipmentMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1 To ifrs-full_PropertyPlantAndEquipmentMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis_1" xlink:title="ifrs-full_BorrowingsByNameAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember_1" xlink:title="ifrs-full_BorrowingsByNameMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_BorrowingsByNameAxis_1" xlink:to="ifrs-full_BorrowingsByNameMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_BorrowingsByNameAxis_1 To ifrs-full_BorrowingsByNameMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:title="ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember_1" xlink:title="ifrs-full_FinancialLiabilitiesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="ifrs-full_FinancialLiabilitiesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfFinancialLiabilitiesAxis_1 To ifrs-full_FinancialLiabilitiesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:title="ifrs-full_ClassesOfLiabilitiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember" xlink:label="ifrs-full_LiabilitiesMember_1" xlink:title="ifrs-full_LiabilitiesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="ifrs-full_LiabilitiesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfLiabilitiesAxis_1 To ifrs-full_LiabilitiesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_1" xlink:title="cntg_IfrsAwardTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_1" xlink:title="cntg_AwardTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_IfrsAwardTypeAxis_1" xlink:to="cntg_AwardTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_IfrsAwardTypeAxis_1 To cntg_AwardTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis_1" xlink:title="cntg_IfrsVestingAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain_1" xlink:title="cntg_IfrsVestingDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_IfrsVestingAxis_1" xlink:to="cntg_IfrsVestingDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_IfrsVestingAxis_1 To cntg_IfrsVestingDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_1" xlink:title="srt_StatementScenarioAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_1" xlink:title="srt_ScenarioUnspecifiedDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_StatementScenarioAxis_1" xlink:to="srt_ScenarioUnspecifiedDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_StatementScenarioAxis_1 To srt_ScenarioUnspecifiedDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis_1" xlink:title="ifrs-full_ClassesOfContingentLiabilitiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="ifrs-full_ContingentLiabilitiesMember_1" xlink:title="ifrs-full_ContingentLiabilitiesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis_1" xlink:to="ifrs-full_ContingentLiabilitiesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfContingentLiabilitiesAxis_1 To ifrs-full_ContingentLiabilitiesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_1" xlink:title="ifrs-full_ProductsAndServicesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_1" xlink:title="ifrs-full_ProductsAndServicesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ProductsAndServicesAxis_1" xlink:to="ifrs-full_ProductsAndServicesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ProductsAndServicesAxis_1 To ifrs-full_ProductsAndServicesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis_1" xlink:title="ifrs-full_InitiallyAppliedIFRSsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InitiallyAppliedIFRSsMember" xlink:label="ifrs-full_InitiallyAppliedIFRSsMember_1" xlink:title="ifrs-full_InitiallyAppliedIFRSsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis_1" xlink:to="ifrs-full_InitiallyAppliedIFRSsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_InitiallyAppliedIFRSsAxis_1 To ifrs-full_InitiallyAppliedIFRSsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis_1" xlink:title="srt_CurrencyAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain_1" xlink:title="currency_AllCurrenciesDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_CurrencyAxis_1" xlink:to="currency_AllCurrenciesDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_CurrencyAxis_1 To currency_AllCurrenciesDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:title="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:title="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1 To ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:title="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_1" xlink:title="ifrs-full_CarryingAmountMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="ifrs-full_CarryingAmountMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1 To ifrs-full_CarryingAmountMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:title="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:title="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1 To ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="ifrs-full_MethodsOfGenerationAxis_1" xlink:title="ifrs-full_MethodsOfGenerationAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationMember" xlink:label="ifrs-full_MethodsOfGenerationMember_1" xlink:title="ifrs-full_MethodsOfGenerationMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_MethodsOfGenerationAxis_1" xlink:to="ifrs-full_MethodsOfGenerationMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_MethodsOfGenerationAxis_1 To ifrs-full_MethodsOfGenerationMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis" xlink:label="ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" xlink:title="ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusMember_1" xlink:title="ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" xlink:to="ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1 To ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_1" xlink:title="srt_StatementGeographicalAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_1" xlink:title="srt_SegmentGeographicalDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_StatementGeographicalAxis_1" xlink:to="srt_SegmentGeographicalDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_StatementGeographicalAxis_1 To srt_SegmentGeographicalDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis_1" xlink:title="ifrs-full_ImpairmentOfFinancialAssetsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_1" xlink:title="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ImpairmentOfFinancialAssetsAxis_1" xlink:to="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ImpairmentOfFinancialAssetsAxis_1 To ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis_1" xlink:title="ifrs-full_TypesOfRisksAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember_1" xlink:title="ifrs-full_TypesOfRisksMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_TypesOfRisksAxis_1" xlink:to="ifrs-full_TypesOfRisksMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_TypesOfRisksAxis_1 To ifrs-full_TypesOfRisksMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConcentrationsOfRiskAxis" xlink:label="ifrs-full_ConcentrationsOfRiskAxis_1" xlink:title="ifrs-full_ConcentrationsOfRiskAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConcentrationsOfRiskMember" xlink:label="ifrs-full_ConcentrationsOfRiskMember_1" xlink:title="ifrs-full_ConcentrationsOfRiskMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ConcentrationsOfRiskAxis_1" xlink:to="ifrs-full_ConcentrationsOfRiskMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ConcentrationsOfRiskAxis_1 To ifrs-full_ConcentrationsOfRiskMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockAxis" xlink:label="cntg_IfrsSaleOfStockAxis_1" xlink:title="cntg_IfrsSaleOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SaleOfStockDomain" xlink:label="cntg_SaleOfStockDomain_1" xlink:title="cntg_SaleOfStockDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_IfrsSaleOfStockAxis_1" xlink:to="cntg_SaleOfStockDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_IfrsSaleOfStockAxis_1 To cntg_SaleOfStockDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:title="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:title="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1 To ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis_1" xlink:title="ifrs-full_AssetsAndLiabilitiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="ifrs-full_AssetsAndLiabilitiesMember_1" xlink:title="ifrs-full_AssetsAndLiabilitiesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis_1" xlink:to="ifrs-full_AssetsAndLiabilitiesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_AssetsAndLiabilitiesAxis_1 To ifrs-full_AssetsAndLiabilitiesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionAxis" xlink:label="cntg_IfrsRelatedPartyTransactionAxis_1" xlink:title="cntg_IfrsRelatedPartyTransactionAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionDomain" xlink:label="cntg_IfrsRelatedPartyTransactionDomain_1" xlink:title="cntg_IfrsRelatedPartyTransactionDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_IfrsRelatedPartyTransactionAxis_1" xlink:to="cntg_IfrsRelatedPartyTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_IfrsRelatedPartyTransactionAxis_1 To cntg_IfrsRelatedPartyTransactionDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:title="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember_1" xlink:title="ifrs-full_LineItemsByFunctionMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="ifrs-full_LineItemsByFunctionMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1 To ifrs-full_LineItemsByFunctionMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_1" xlink:title="srt_TitleOfIndividualAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_TitleOfIndividualAxis_1" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_TitleOfIndividualAxis_1 To srt_TitleOfIndividualWithRelationshipToEntityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis_1" xlink:title="srt_RestatementAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain_1" xlink:title="srt_RestatementDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_RestatementAxis_1" xlink:to="srt_RestatementDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_RestatementAxis_1 To srt_RestatementDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="ifrs-full_TypesOfInterestRatesAxis_1" xlink:title="ifrs-full_TypesOfInterestRatesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember" xlink:label="ifrs-full_InterestRateTypesMember_1" xlink:title="ifrs-full_InterestRateTypesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_TypesOfInterestRatesAxis_1" xlink:to="ifrs-full_InterestRateTypesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_TypesOfInterestRatesAxis_1 To ifrs-full_InterestRateTypesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsAxis" xlink:label="cntg_InfrequentItemsAxis_1" xlink:title="cntg_InfrequentItemsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsDomain" xlink:label="cntg_InfrequentItemsDomain_1" xlink:title="cntg_InfrequentItemsDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="cntg_InfrequentItemsAxis_1" xlink:to="cntg_InfrequentItemsDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:cntg_InfrequentItemsAxis_1 To cntg_InfrequentItemsDomain_1" order="1" />
  </link:definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress" xlink:label="dei_ContactPersonnelEmailAddress" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="27" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="28" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="29" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="30" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="31" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="32" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="33" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="34" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="35" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="36" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="37" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="38" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="39" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="40" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity" xlink:type="extended" xlink:title="00400 - Statement - Consolidated statements of changes in equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_IssuedCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserveMember" xlink:label="ifrs-full_CapitalReserveMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_CapitalReserveMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_RetainedEarningsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" xlink:label="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="ifrs-full_NoncontrollingInterestsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_NoncontrollingInterestsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ComprehensiveIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="ifrs-full_IssueOfEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:label="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:label="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" xlink:label="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsTables" xlink:type="extended" xlink:title="32003 - Disclosure - Share-based payments (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017And2019Member" xlink:label="cntg_EquityShareOption2017And2019Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_EquityShareOption2017And2019Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_EquityShareOption2017And2019Member" xlink:to="cntg_EquityShareOption2017EquitySettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2019EquitySettledMember" xlink:label="cntg_EquityShareOption2019EquitySettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_EquityShareOption2017And2019Member" xlink:to="cntg_EquityShareOption2019EquitySettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" xlink:label="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureGeneralCompanyInformationDetails" xlink:type="extended" xlink:title="40101 - Disclosure - General Company Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsTable" xlink:label="cntg_GeneralInformationAboutFinancialStatementsTable" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnEquityOfferingMember" xlink:label="cntg_FollowOnEquityOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_FollowOnEquityOfferingMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnPublicOfferingMember" xlink:label="cntg_FollowOnPublicOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_FollowOnPublicOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable" xlink:to="dei_LegalEntityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_EntityDomain" xlink:to="cntg_CentogeneN.vMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SellingShareholdersMember" xlink:label="cntg_SellingShareholdersMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_SellingShareholdersMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorPurchasesOfAssetsMember" xlink:label="ifrs-full_MajorPurchasesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="ifrs-full_MajorPurchasesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:label="cntg_GeneralInformationAboutFinancialStatementsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:to="cntg_GeneralInformationAboutFinancialStatementsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:to="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureBasisOfPreparationDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Basis of Preparation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" xlink:label="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EnteringInToDebtFinancingAgreementMember" xlink:label="cntg_EnteringInToDebtFinancingAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="cntg_EnteringInToDebtFinancingAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="ifrs-full_MajorOrdinaryShareTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="ifrs-full_MajorOrdinaryShareTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_BorrowingsByNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityMember" xlink:label="cntg_LoanFacilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="cntg_LoanFacilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheOneMember" xlink:label="cntg_LoanFacilityTrancheOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_LoanFacilityMember" xlink:to="cntg_LoanFacilityTrancheOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheTwoMember" xlink:label="cntg_LoanFacilityTrancheTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_LoanFacilityMember" xlink:to="cntg_LoanFacilityTrancheTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="ifrs-full_TypesOfInterestRatesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_TypesOfInterestRatesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember" xlink:label="ifrs-full_InterestRateTypesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfInterestRatesAxis" xlink:to="ifrs-full_InterestRateTypesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FloorRateMember" xlink:label="cntg_FloorRateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_InterestRateTypesMember" xlink:to="cntg_FloorRateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EstimatedRateOfImplicitPriceConcessions" xlink:label="cntg_EstimatedRateOfImplicitPriceConcessions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_EstimatedRateOfImplicitPriceConcessions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfEstimatedVariableTransactionPrice" xlink:label="cntg_PercentageOfEstimatedVariableTransactionPrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_PercentageOfEstimatedVariableTransactionPrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_ProfitLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_RetainedEarnings" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_Equity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_CashAndCashEquivalents" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="ifrs-full_ShorttermBorrowings" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_ShorttermBorrowings" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialCovenants" xlink:label="cntg_FinancialCovenants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_FinancialCovenants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_NotionalAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsRevenueAchievementThreshold" xlink:label="cntg_BorrowingsRevenueAchievementThreshold" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_BorrowingsRevenueAchievementThreshold" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsCovenantMinimumRequiredRevenue" xlink:label="cntg_BorrowingsCovenantMinimumRequiredRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_BorrowingsCovenantMinimumRequiredRevenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="ifrs-full_BorrowingsInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:label="ifrs-full_BorrowingsAdjustmentToInterestRateBasis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_BorrowingsAdjustmentToInterestRateBasis" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharePrice" xlink:label="cntg_IfrsSharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_IfrsSharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails" xlink:type="extended" xlink:title="40202 - Disclosure - Basis of Preparation - Reconciliation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="srt_RestatementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RestatementDomain" xlink:to="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_CostOfSales" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_GrossProfit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_GeneralAndAdministrativeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingExpense" xlink:label="ifrs-full_SellingExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_SellingExpense" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Significant accounting policies (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SoftwarePatentsAndTrademarksMember" xlink:label="cntg_SoftwarePatentsAndTrademarksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cntg_SoftwarePatentsAndTrademarksMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CoronaTestPortalMember" xlink:label="cntg_CoronaTestPortalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cntg_CoronaTestPortalMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="ifrs-full_CapitalisedDevelopmentExpenditureMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="ifrs-full_CapitalisedDevelopmentExpenditureMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_BuildingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesMember" xlink:label="cntg_OfficesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cntg_OfficesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:to="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="ifrs-full_ForeignExchangeRatesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:to="ifrs-full_ForeignExchangeRatesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="ifrs-full_AverageForeignExchangeRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ForeignExchangeRatesAbstract" xlink:to="ifrs-full_AverageForeignExchangeRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ForeignExchangeRatesAbstract" xlink:to="ifrs-full_ClosingForeignExchangeRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsLeasesAbstract" xlink:label="cntg_IfrsLeasesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:to="cntg_IfrsLeasesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" xlink:label="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsLeasesAbstract" xlink:to="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialInstrumentsAbstract" xlink:label="cntg_FinancialInstrumentsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:to="cntg_FinancialInstrumentsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" xlink:label="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_FinancialInstrumentsAbstract" xlink:to="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Accounting judgments and estimates (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="ifrs-full_CapitalisedDevelopmentExpenditureMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="ifrs-full_CapitalisedDevelopmentExpenditureMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Segment information and revenue from contracts with customers - Information by operating segments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_SegmentConsolidationItemsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SegmentConsolidationItemsAxis" xlink:to="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="ifrs-full_OperatingSegmentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="ifrs-full_MaterialReconcilingItemsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="ifrs-full_MaterialReconcilingItemsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsCorporateMember" xlink:label="cntg_IfrsCorporateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_MaterialReconcilingItemsMember" xlink:to="cntg_IfrsCorporateMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_SegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalSegmentMember" xlink:label="cntg_PharmaceuticalSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_PharmaceuticalSegmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DiagnosticsSegmentMember" xlink:label="cntg_DiagnosticsSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_DiagnosticsSegmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_Covid19Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="ifrs-full_MajorCustomersAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_MajorCustomersAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="ifrs-full_MajorCustomersMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="ifrs-full_MajorCustomersMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalPartnerMember" xlink:label="cntg_PharmaceuticalPartnerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_MajorCustomersMember" xlink:to="cntg_PharmaceuticalPartnerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsNumberOfReportableSegments" xlink:label="cntg_IfrsNumberOfReportableSegments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="cntg_IfrsNumberOfReportableSegments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" xlink:label="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherSegmentInformationAbstract" xlink:label="cntg_OtherSegmentInformationAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="cntg_OtherSegmentInformationAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_OtherSegmentInformationAbstract" xlink:to="ifrs-full_DepreciationAndAmortisationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_OtherSegmentInformationAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" xlink:type="extended" xlink:title="40702 - Disclosure - Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_SegmentConsolidationItemsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SegmentConsolidationItemsAxis" xlink:to="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="ifrs-full_OperatingSegmentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="ifrs-full_MaterialReconcilingItemsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="ifrs-full_MaterialReconcilingItemsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsCorporateMember" xlink:label="cntg_IfrsCorporateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_MaterialReconcilingItemsMember" xlink:to="cntg_IfrsCorporateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="ifrs-full_UnallocatedAmountsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="ifrs-full_UnallocatedAmountsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UnallocatedAmountsShareBasedPaymentsMember" xlink:label="cntg_UnallocatedAmountsShareBasedPaymentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_UnallocatedAmountsMember" xlink:to="cntg_UnallocatedAmountsShareBasedPaymentsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UnallocatedAmountsDepreciationAndAmortizationMember" xlink:label="cntg_UnallocatedAmountsDepreciationAndAmortizationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_UnallocatedAmountsMember" xlink:to="cntg_UnallocatedAmountsDepreciationAndAmortizationMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdministrativeExpense" xlink:label="ifrs-full_AdministrativeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_AdministrativeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_DepreciationAndAmortisationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_FinanceIncomeCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_ProfitLoss" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" xlink:type="extended" xlink:title="40703 - Disclosure - Segment information and revenue from contracts with customers - Geographical information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_SegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalSegmentMember" xlink:label="cntg_PharmaceuticalSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_PharmaceuticalSegmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DiagnosticsSegmentMember" xlink:label="cntg_DiagnosticsSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_DiagnosticsSegmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_Covid19Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_GeographicalAreasAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="srt_EuropeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_DE" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL" xlink:label="country_NL" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_NL" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsMiddleEastMember" xlink:label="cntg_IfrsMiddleEastMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="cntg_IfrsMiddleEastMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SA" xlink:label="country_SA" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_SA" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="srt_NorthAmericaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_US" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember" xlink:label="srt_LatinAmericaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="srt_LatinAmericaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember" xlink:label="srt_AsiaPacificMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="srt_AsiaPacificMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="ifrs-full_RevenueFromRenderingOfServices" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_RevenueFromRenderingOfServices" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="ifrs-full_RevenueFromSaleOfGoods" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_RevenueFromSaleOfGoods" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails" xlink:type="extended" xlink:title="40705 - Disclosure - Segment information and revenue from contracts with customers - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="ifrs-full_DisclosureOfMajorCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable" xlink:to="ifrs-full_SegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalSegmentMember" xlink:label="cntg_PharmaceuticalSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_PharmaceuticalSegmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_Covid19Member" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnEquityOfferingMember" xlink:label="cntg_FollowOnEquityOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_FollowOnEquityOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIPOMember" xlink:label="cntg_IfrsIPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_IfrsIPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable" xlink:to="ifrs-full_GeographicalAreasAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_US" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_DE" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="ifrs-full_MajorCustomersAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable" xlink:to="ifrs-full_MajorCustomersAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="ifrs-full_MajorCustomersMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="ifrs-full_MajorCustomersMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalPartnerMember" xlink:label="cntg_PharmaceuticalPartnerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_MajorCustomersMember" xlink:to="cntg_PharmaceuticalPartnerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19PartnerOneMember" xlink:label="cntg_Covid19PartnerOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_MajorCustomersMember" xlink:to="cntg_Covid19PartnerOneMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19PartnerTwoMember" xlink:label="cntg_Covid19PartnerTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_MajorCustomersMember" xlink:to="cntg_Covid19PartnerTwoMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationAxis" xlink:label="cntg_IfrsBalanceSheetLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable" xlink:to="cntg_IfrsBalanceSheetLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationDomain" xlink:label="cntg_IfrsBalanceSheetLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsBalanceSheetLocationAxis" xlink:to="cntg_IfrsBalanceSheetLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsBalanceSheetLocationDomain" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsBalanceSheetLocationDomain" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="ifrs-full_DisclosureOfMajorCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_DisclosureOfMajorCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="cntg_RealEstateTransferTaxExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_RightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCustomersInGroup" xlink:label="cntg_NumberOfCustomersInGroup" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="cntg_NumberOfCustomersInGroup" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_PercentageOfEntitysRevenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CapitalizedInvestment" xlink:label="cntg_CapitalizedInvestment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="cntg_CapitalizedInvestment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProvisionForExpectedCreditLossesOnContractAssets" xlink:label="cntg_ProvisionForExpectedCreditLossesOnContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="cntg_ProvisionForExpectedCreditLossesOnContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Other income and expenses - Other Operating Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseTable" xlink:label="cntg_OtherIncomeExpenseTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cntg_OtherIncomeExpenseTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_RostockHeadquartersBuildingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="cntg_OtherIncomeExpenseTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_SupervisoryBoardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsAxis" xlink:label="cntg_InfrequentItemsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="cntg_OtherIncomeExpenseTable" xlink:to="cntg_InfrequentItemsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsDomain" xlink:label="cntg_InfrequentItemsDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_InfrequentItemsAxis" xlink:to="cntg_InfrequentItemsDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_InfrequentItemsDomain" xlink:to="cntg_Covid19Member" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseLineItems" xlink:label="cntg_OtherIncomeExpenseLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_OtherIncomeExpenseTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="ifrs-full_RevenueFromGovernmentGrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_RevenueFromGovernmentGrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="ifrs-full_NetForeignExchangeGain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_NetForeignExchangeGain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReversalsOfProvisions" xlink:label="ifrs-full_OtherReversalsOfProvisions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_OtherReversalsOfProvisions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="ifrs-full_MiscellaneousOtherOperatingIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_MiscellaneousOtherOperatingIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_OtherIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GainLossFromForgivenessOfLoan" xlink:label="cntg_GainLossFromForgivenessOfLoan" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_GainLossFromForgivenessOfLoan" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseTerm" xlink:label="cntg_LeaseTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_LeaseTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="ifrs-full_EmployeeBenefitsExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_EmployeeBenefitsExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Other income and expenses - Other Operating Expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseTable" xlink:label="cntg_OtherIncomeExpenseTable" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cntg_OtherIncomeExpenseTable" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIPOMember" xlink:label="cntg_IfrsIPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_IfrsIPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseLineItems" xlink:label="cntg_OtherIncomeExpenseLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_OtherIncomeExpenseTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="ifrs-full_NetForeignExchangeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_NetForeignExchangeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="ifrs-full_OtherExpenseByFunction" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_OtherExpenseByFunction" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails" xlink:type="extended" xlink:title="40803 - Disclosure - Other income and expenses - LPC GmbH (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseTable" xlink:label="cntg_OtherIncomeExpenseTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cntg_OtherIncomeExpenseTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LpcGmbhMember" xlink:label="cntg_LpcGmbhMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_LpcGmbhMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseLineItems" xlink:label="cntg_OtherIncomeExpenseLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_OtherIncomeExpenseTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="ifrs-full_ConsiderationPaidReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_ConsiderationPaidReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationToBePaidOverTime" xlink:label="cntg_ConsiderationToBePaidOverTime" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_ConsiderationToBePaidOverTime" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationPaymentDuePeriod" xlink:label="cntg_ConsiderationPaymentDuePeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_ConsiderationPaymentDuePeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationOutstanding" xlink:label="cntg_ConsiderationOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_ConsiderationOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_NoncontrollingInterests" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" xlink:type="extended" xlink:title="40902 - Disclosure - Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncomeTaxDisclosureTable" xlink:label="cntg_IncomeTaxDisclosureTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cntg_IncomeTaxDisclosureTable" xlink:to="ifrs-full_GeographicalAreasAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="ifrs-full_CountryOfDomicileMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="ifrs-full_CountryOfDomicileMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncomeTaxDisclosureLineItems" xlink:label="cntg_IncomeTaxDisclosureLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="cntg_IncomeTaxDisclosureTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_ApplicableTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_AccountingProfit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_TaxEffectOfTaxLosses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" xlink:label="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CorporateIncomeTaxRate" xlink:label="cntg_CorporateIncomeTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="cntg_CorporateIncomeTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SolidaritySurchargeRate" xlink:label="cntg_SolidaritySurchargeRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="cntg_SolidaritySurchargeRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeTaxRate" xlink:label="cntg_TradeTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="cntg_TradeTaxRate" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails" xlink:type="extended" xlink:title="40903 - Disclosure - Income taxes - Deferred Taxes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="ifrs-full_RightofuseAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_RightofuseAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MeasurementOfServiceContractsMember" xlink:label="cntg_MeasurementOfServiceContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="cntg_MeasurementOfServiceContractsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_LeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GovernmentGrantsMember" xlink:label="cntg_GovernmentGrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="cntg_GovernmentGrantsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_UnusedTaxLossesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_GeographicalAreasAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_DE" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherCountriesMember" xlink:label="cntg_OtherCountriesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="cntg_OtherCountriesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:label="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxAssetsOffset" xlink:label="cntg_DeferredTaxAssetsOffset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="cntg_DeferredTaxAssetsOffset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxLiabilitiesOffset" xlink:label="cntg_DeferredTaxLiabilitiesOffset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="cntg_DeferredTaxLiabilitiesOffset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxLiabilitiesNet" xlink:label="cntg_DeferredTaxLiabilitiesNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="cntg_DeferredTaxLiabilitiesNet" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureIntangibleAssetsDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Intangible assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="ifrs-full_MethodsOfGenerationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_MethodsOfGenerationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationMember" xlink:label="ifrs-full_MethodsOfGenerationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MethodsOfGenerationAxis" xlink:to="ifrs-full_MethodsOfGenerationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InternallyGeneratedMember" xlink:label="ifrs-full_InternallyGeneratedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_MethodsOfGenerationMember" xlink:to="ifrs-full_InternallyGeneratedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotInternallyGeneratedMember" xlink:label="ifrs-full_NotInternallyGeneratedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_MethodsOfGenerationMember" xlink:to="ifrs-full_NotInternallyGeneratedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BiomarkersMember" xlink:label="cntg_BiomarkersMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cntg_BiomarkersMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DatabaseMember" xlink:label="cntg_DatabaseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cntg_DatabaseMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="ifrs-full_LicencesAndFranchisesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="ifrs-full_LicencesAndFranchisesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BiomarkersAndDatabasesMember" xlink:label="cntg_BiomarkersAndDatabasesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cntg_BiomarkersAndDatabasesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" xlink:label="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_BuildingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantMember" xlink:label="cntg_PlantMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cntg_PlantMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentFurnitureAndFixturesMember" xlink:label="cntg_OtherEquipmentFurnitureAndFixturesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cntg_OtherEquipmentFurnitureAndFixturesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_SegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_Covid19Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" xlink:label="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Right-of-use assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_RostockHeadquartersBuildingMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" xlink:label="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesInBerlinMember" xlink:label="cntg_OfficesInBerlinMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_OfficesInBerlinMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesInBostonMember" xlink:label="cntg_OfficesInBostonMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_OfficesInBostonMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantAndMachineryMember" xlink:label="cntg_PlantAndMachineryMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_PlantAndMachineryMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentMember" xlink:label="cntg_OtherEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_OtherEquipmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="ifrs-full_MotorVehiclesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_MotorVehiclesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" xlink:label="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseTerm" xlink:label="cntg_LeaseTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_LeaseTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankGuarantee" xlink:label="cntg_BankGuarantee" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_BankGuarantee" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RentalDeposits" xlink:label="cntg_RentalDeposits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_RentalDeposits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTimesLeaseContractCanBeExtended" xlink:label="cntg_NumberOfTimesLeaseContractCanBeExtended" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_NumberOfTimesLeaseContractCanBeExtended" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseExtensionTerm" xlink:label="cntg_LeaseExtensionTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_LeaseExtensionTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RentalExpense" xlink:label="ifrs-full_RentalExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_RentalExpense" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails" xlink:type="extended" xlink:title="41302 - Disclosure - Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_BuildingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesMember" xlink:label="cntg_OfficesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_OfficesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantAndEquipmentMember" xlink:label="cntg_PlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_PlantAndEquipmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentMember" xlink:label="cntg_OtherEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_OtherEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="ifrs-full_MotorVehiclesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_MotorVehiclesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_RightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" xlink:label="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DepreciationRightofuseAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails" xlink:type="extended" xlink:title="41305 - Disclosure - Right-of-use assets - Sale and Leaseback transactions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_RostockHeadquartersBuildingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_RealEstateTransferTaxExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseTerm" xlink:label="cntg_LeaseTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_LeaseTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Trade and other receivables and other assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember" xlink:label="ifrs-full_OtherAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_OtherAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LpcGmbhMember" xlink:label="cntg_LpcGmbhMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_LpcGmbhMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cntg_RostockHeadquartersBuildingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BerlinOfficesMember" xlink:label="cntg_BerlinOfficesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cntg_BerlinOfficesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherOfficeAndLaboratoriesMember" xlink:label="cntg_OtherOfficeAndLaboratoriesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cntg_OtherOfficeAndLaboratoriesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_NoncurrentReceivablesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RentalDepositsNoncurrent" xlink:label="cntg_RentalDepositsNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="cntg_RentalDepositsNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="ifrs-full_OtherNoncurrentReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="ifrs-full_OtherNoncurrentReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_CurrentReceivablesFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractAssets" xlink:label="ifrs-full_CurrentContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_CurrentContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" xlink:label="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ReceivablesPaymentTerms" xlink:label="cntg_ReceivablesPaymentTerms" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="cntg_ReceivablesPaymentTerms" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankGuarantee" xlink:label="cntg_BankGuarantee" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="cntg_BankGuarantee" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationReceivableForSaleOfLpc" xlink:label="cntg_ConsiderationReceivableForSaleOfLpc" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="cntg_ConsiderationReceivableForSaleOfLpc" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_CurrentPrepaidExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" xlink:label="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" xlink:label="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantsReceivables" xlink:label="cntg_GrantsReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="cntg_GrantsReceivables" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Cash and short-term deposits (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredBankLoanMember" xlink:label="cntg_SecuredBankLoanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="cntg_SecuredBankLoanMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityMember" xlink:label="cntg_OverdraftFacilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="cntg_OverdraftFacilityMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityOneMember" xlink:label="cntg_OverdraftFacilityOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_OverdraftFacilityMember" xlink:to="cntg_OverdraftFacilityOneMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityTwoMember" xlink:label="cntg_OverdraftFacilityTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_OverdraftFacilityMember" xlink:to="cntg_OverdraftFacilityTwoMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityThreeMember" xlink:label="cntg_OverdraftFacilityThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_OverdraftFacilityMember" xlink:to="cntg_OverdraftFacilityThreeMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Equity - Issued capital and capital reserve (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExerciseOfOptionsShares" xlink:label="cntg_ExerciseOfOptionsShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="cntg_ExerciseOfOptionsShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="ifrs-full_NumberOfSharesAuthorised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesAuthorised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureEquityCommonSharesDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Equity - Common Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="dei_LegalEntityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_EntityDomain" xlink:to="cntg_CentogeneN.vMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnPublicOfferingMember" xlink:label="cntg_FollowOnPublicOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_FollowOnPublicOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="cntg_NumberOfCommonSharesOfferedByPriorShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AuthorizedButUnissuedShareCapital" xlink:label="cntg_AuthorizedButUnissuedShareCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="cntg_AuthorizedButUnissuedShareCapital" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureEquityCapitalReservesDetails" xlink:type="extended" xlink:title="41703 - Disclosure - Equity - Capital Reserves (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserveMember" xlink:label="ifrs-full_CapitalReserveMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_CapitalReserveMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_SharePremium" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails" xlink:type="extended" xlink:title="41901 - Disclosure - Financial liabilities - Interest-bearing loans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_FinancialLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="ifrs-full_BorrowingsByNameMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesMember" xlink:label="cntg_SecuredCreditLinesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="cntg_SecuredCreditLinesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherBankLoansMember" xlink:label="cntg_OtherBankLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="cntg_OtherBankLoansMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="cntg_IfrsBankOverdraftsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_NonCurrentFinancialLiabilitiesInterestBearing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="cntg_NonCurrentFinancialLiabilitiesInterestBearing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_CurrentFinancialLiabilitiesInterestBearing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="cntg_CurrentFinancialLiabilitiesInterestBearing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialLiabilitiesInterestBearing" xlink:label="cntg_FinancialLiabilitiesInterestBearing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="cntg_FinancialLiabilitiesInterestBearing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails" xlink:type="extended" xlink:title="41902 - Disclosure - Financial liabilities - Conditions and statement of liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_BorrowingsByNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityMember" xlink:label="cntg_OverdraftFacilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="cntg_OverdraftFacilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_FinancialLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesMember" xlink:label="cntg_SecuredCreditLinesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="cntg_SecuredCreditLinesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" xlink:label="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_SecuredCreditLinesMember" xlink:to="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherBankLoansMember" xlink:label="cntg_OtherBankLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="cntg_OtherBankLoansMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="cntg_IfrsBankOverdraftsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsOneMember" xlink:label="cntg_BankOverdraftsOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsBankOverdraftsMember" xlink:to="cntg_BankOverdraftsOneMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsTwoMember" xlink:label="cntg_BankOverdraftsTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsBankOverdraftsMember" xlink:to="cntg_BankOverdraftsTwoMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsThreeMember" xlink:label="cntg_BankOverdraftsThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_IfrsBankOverdraftsMember" xlink:to="cntg_BankOverdraftsThreeMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsOneAndThreeMember" xlink:label="cntg_BankOverdraftsOneAndThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_IfrsBankOverdraftsMember" xlink:to="cntg_BankOverdraftsOneAndThreeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="ifrs-full_BorrowingsInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_NotionalAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_FinancialLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialLiabilitiesInterestBearing" xlink:label="cntg_FinancialLiabilitiesInterestBearing" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="cntg_FinancialLiabilitiesInterestBearing" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" xlink:label="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:label="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails" xlink:type="extended" xlink:title="42001 - Disclosure - Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2016CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2016CashSettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_VirtualShareOptionProgram2016CashSettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentForSettlementOfStockOptions" xlink:label="cntg_PaymentForSettlementOfStockOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_PaymentForSettlementOfStockOptions" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails" xlink:type="extended" xlink:title="42002 - Disclosure - Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" xlink:label="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" xlink:label="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details" xlink:type="extended" xlink:title="42003 - Disclosure - Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_EquityShareOption2017EquitySettledMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsAwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_AwardTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_StockOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" xlink:label="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOutstandingShareOptionsAbstract" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_NumberOfOutstandingShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details" xlink:type="extended" xlink:title="42004 - Disclosure - Share-based payments - Equity Share Option (ESOP 2019) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2019EquitySettledMember" xlink:label="cntg_EquityShareOption2019EquitySettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_EquityShareOption2019EquitySettledMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsVestingAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsVestingAxis" xlink:to="cntg_IfrsVestingDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedPaymentArrangementTrancheOneMember" xlink:label="cntg_ShareBasedPaymentArrangementTrancheOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_ShareBasedPaymentArrangementTrancheOneMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedPaymentArrangementTrancheTwoMember" xlink:label="cntg_ShareBasedPaymentArrangementTrancheTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_ShareBasedPaymentArrangementTrancheTwoMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsAwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_AwardTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_StockOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MemberOfSupervisoryBoardMember" xlink:label="cntg_MemberOfSupervisoryBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_MemberOfSupervisoryBoardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:label="srt_ManagementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="srt_ManagementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VestingInFourTranchesMember" xlink:label="cntg_VestingInFourTranchesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="cntg_VestingInFourTranchesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantOfRestrictedStockUnitsMember" xlink:label="cntg_GrantOfRestrictedStockUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="cntg_GrantOfRestrictedStockUnitsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageFairValueOfShareOptionsOutstanding" xlink:label="cntg_WeightedAverageFairValueOfShareOptionsOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_WeightedAverageFairValueOfShareOptionsOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xlink:label="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTranches" xlink:label="cntg_NumberOfTranches" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_NumberOfTranches" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOutstandingShareOptionsAbstract" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_NumberOfOutstandingShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails" xlink:type="extended" xlink:title="42005 - Disclosure - Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsVestingAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsVestingAxis" xlink:to="cntg_IfrsVestingDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsAwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_AwardTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedOneMember" xlink:label="cntg_RsuGrantedOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember" xlink:to="cntg_RsuGrantedOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedTwoMember" xlink:label="cntg_RsuGrantedTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember" xlink:to="cntg_RsuGrantedTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedThreeMember" xlink:label="cntg_RsuGrantedThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember" xlink:to="cntg_RsuGrantedThreeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedFourMember" xlink:label="cntg_RsuGrantedFourMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember" xlink:to="cntg_RsuGrantedFourMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedFiveMember" xlink:label="cntg_RsuGrantedFiveMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember" xlink:to="cntg_RsuGrantedFiveMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_StockOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionsGrantedTwoMember" xlink:label="cntg_OptionsGrantedTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_StockOptionsMember" xlink:to="cntg_OptionsGrantedTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:label="srt_ManagementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="srt_ManagementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerChiefFinancialOfficerMember" xlink:label="cntg_FormerChiefFinancialOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_FormerChiefFinancialOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChiefInformationOfficerMember" xlink:label="cntg_ChiefInformationOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_ChiefInformationOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EmployeesMember" xlink:label="cntg_EmployeesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_EmployeesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_SupervisoryBoardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VestingInFourTranchesMember" xlink:label="cntg_VestingInFourTranchesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="cntg_VestingInFourTranchesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ThresholdTradingDays" xlink:label="cntg_ThresholdTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_ThresholdTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageSharePrice2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTranches" xlink:label="cntg_NumberOfTranches" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_NumberOfTranches" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails" xlink:type="extended" xlink:title="42006 - Disclosure - Share-based payments - Grants to new CEO and supervisory board grant (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_SupervisoryBoardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanMember" xlink:label="cntg_ChairmanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_ChairmanMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ViceChairmanMember" xlink:label="cntg_ViceChairmanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_ViceChairmanMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanOfAuditCommitteeMember" xlink:label="cntg_ChairmanOfAuditCommitteeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_ChairmanOfAuditCommitteeMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanOfCompensationCommitteeMember" xlink:label="cntg_ChairmanOfCompensationCommitteeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_ChairmanOfCompensationCommitteeMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsAwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_AwardTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_PerformanceBasedRestrictedStockUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_StockOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="srt_TitleOfIndividualAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrBerndtModigMember" xlink:label="cntg_MrBerndtModigMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="cntg_MrBerndtModigMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PeerSchatzMember" xlink:label="cntg_PeerSchatzMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="cntg_PeerSchatzMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrJonathanGSheldonMember" xlink:label="cntg_MrJonathanGSheldonMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="cntg_MrJonathanGSheldonMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockAxis" xlink:label="cntg_IfrsSaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsSaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SaleOfStockDomain" xlink:label="cntg_SaleOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsSaleOfStockAxis" xlink:to="cntg_SaleOfStockDomain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIPOMember" xlink:label="cntg_IfrsIPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_SaleOfStockDomain" xlink:to="cntg_IfrsIPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="ifrs-full_IssueOfEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_IssueOfEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfInstallments" xlink:label="cntg_NumberOfInstallments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_NumberOfInstallments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" xlink:label="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" xlink:label="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:label="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionsStrikePrice" xlink:label="cntg_OptionsStrikePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_OptionsStrikePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" xlink:label="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceComputationTradingDays" xlink:label="cntg_VolumeWeightedAverageStockPriceComputationTradingDays" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_VolumeWeightedAverageStockPriceComputationTradingDays" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:label="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfAwardConstitutesRestrictedStockUnits" xlink:label="cntg_PercentageOfAwardConstitutesRestrictedStockUnits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_PercentageOfAwardConstitutesRestrictedStockUnits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfAwardConstitutesStockOptions" xlink:label="cntg_PercentageOfAwardConstitutesStockOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_PercentageOfAwardConstitutesStockOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOutstandingShareOptionsAbstract" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_NumberOfOutstandingShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOtherEquityInstrumentsAbstract" xlink:label="cntg_NumberOfOtherEquityInstrumentsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_NumberOfOtherEquityInstrumentsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails" xlink:type="extended" xlink:title="42007 - Disclosure - Share-based payments - Valuation of Options (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionPrograms2016And2017Member" xlink:label="cntg_VirtualShareOptionPrograms2016And2017Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_VirtualShareOptionPrograms2016And2017Member" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2017CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2017CashSettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_VirtualShareOptionPrograms2016And2017Member" xlink:to="cntg_VirtualShareOptionProgram2017CashSettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2016CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2016CashSettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_VirtualShareOptionPrograms2016And2017Member" xlink:to="cntg_VirtualShareOptionProgram2016CashSettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017And2019Member" xlink:label="cntg_EquityShareOption2017And2019Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_EquityShareOption2017And2019Member" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_EquityShareOption2017And2019Member" xlink:to="cntg_EquityShareOption2017EquitySettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2019EquitySettledMember" xlink:label="cntg_EquityShareOption2019EquitySettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_EquityShareOption2017And2019Member" xlink:to="cntg_EquityShareOption2019EquitySettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="cntg_IfrsAwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_AwardTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_StockOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_PerformanceBasedRestrictedStockUnitsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ManagementBoardAndEmployeesMember" xlink:label="cntg_ManagementBoardAndEmployeesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_ManagementBoardAndEmployeesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="srt_ChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_SupervisoryBoardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="srt_TitleOfIndividualAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrModigAndMrSheldonMember" xlink:label="cntg_MrModigAndMrSheldonMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="cntg_MrModigAndMrSheldonMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrBerndtModigMember" xlink:label="cntg_MrBerndtModigMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="cntg_MrBerndtModigMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Mr.KimMember" xlink:label="cntg_Mr.KimMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="cntg_Mr.KimMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:label="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:label="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExercisePriceOtherEquityInstrumentsGranted" xlink:label="cntg_ExercisePriceOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_ExercisePriceOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" xlink:label="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:label="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:label="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" xlink:label="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionLifeOtherEquityInstrumentsGranted" xlink:label="cntg_OptionLifeOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_OptionLifeOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" xlink:label="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xlink:to="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xlink:to="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails" xlink:type="extended" xlink:title="42101 - Disclosure - Financial instruments - fair values and risk management - Credit risk (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="ifrs-full_DisclosureOfProvisionMatrixTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_SegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DiagnosticsSegmentMember" xlink:label="cntg_DiagnosticsSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SegmentsMember" xlink:to="cntg_DiagnosticsSegmentMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeReceivablesAndContractAssetsMember" xlink:label="cntg_TradeReceivablesAndContractAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="cntg_TradeReceivablesAndContractAssetsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="ifrs-full_TradeReceivablesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusAxis" xlink:label="ifrs-full_PastDueStatusAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_PastDueStatusAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusMember" xlink:label="ifrs-full_PastDueStatusMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_PastDueStatusAxis" xlink:to="ifrs-full_PastDueStatusMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentMember" xlink:label="ifrs-full_CurrentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PastDueStatusMember" xlink:to="ifrs-full_CurrentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" xlink:label="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PastDueStatusMember" xlink:to="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PastDueStatusMember" xlink:to="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsMember" xlink:label="ifrs-full_LaterThanThreeMonthsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_PastDueStatusMember" xlink:to="ifrs-full_LaterThanThreeMonthsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="ifrs-full_LaterThanOneYearMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_PastDueStatusMember" xlink:to="ifrs-full_LaterThanOneYearMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="srt_StatementGeographicalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsMiddleEastMember" xlink:label="cntg_IfrsMiddleEastMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="cntg_IfrsMiddleEastMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember" xlink:label="srt_LatinAmericaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_LatinAmericaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_NorthAmericaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember" xlink:label="srt_AsiaPacificMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_AsiaPacificMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" xlink:label="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="srt_SegmentGeographicalDomain" xlink:to="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_ImpairmentOfFinancialAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:to="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPastDueButNotImpairedMember" xlink:label="ifrs-full_FinancialAssetsPastDueButNotImpairedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:to="ifrs-full_FinancialAssetsPastDueButNotImpairedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="7" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_TypesOfRisksAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_CreditRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="8" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="ifrs-full_DisclosureOfProvisionMatrixLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="ifrs-full_DisclosureOfProvisionMatrixTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="ifrs-full_FinancialAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedCreditLossRate" xlink:label="ifrs-full_ExpectedCreditLossRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="ifrs-full_ExpectedCreditLossRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="ifrs-full_CashAndCashEquivalents" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" xlink:label="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfOverdueBalances" xlink:label="cntg_PercentageOfOverdueBalances" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="cntg_PercentageOfOverdueBalances" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeReceivablesAverageTurnoverPeriod" xlink:label="cntg_TradeReceivablesAverageTurnoverPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="cntg_TradeReceivablesAverageTurnoverPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:to="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:to="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="ifrs-full_ImpairmentLossOnFinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:to="ifrs-full_ImpairmentLossOnFinancialAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails" xlink:type="extended" xlink:title="42102 - Disclosure - Financial instruments - fair values and risk management - Liquidity risk (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="dei_LegalEntityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_EntityDomain" xlink:to="cntg_CentogeneN.vMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" xlink:label="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="cntg_IfrsBankOverdraftsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesMember" xlink:label="cntg_SecuredCreditLinesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="cntg_SecuredCreditLinesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherBankLoansMember" xlink:label="cntg_OtherBankLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="cntg_OtherBankLoansMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="ifrs-full_LeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradePayablesMember" xlink:label="cntg_TradePayablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="cntg_TradePayablesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NotLaterThanTwoMonthsMember" xlink:label="cntg_NotLaterThanTwoMonthsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="cntg_NotLaterThanTwoMonthsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" xlink:label="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockAxis" xlink:label="cntg_IfrsSaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="cntg_IfrsSaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SaleOfStockDomain" xlink:label="cntg_SaleOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsSaleOfStockAxis" xlink:to="cntg_SaleOfStockDomain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnPublicOfferingMember" xlink:label="cntg_FollowOnPublicOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_SaleOfStockDomain" xlink:to="cntg_FollowOnPublicOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="7" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentFinancialLiabilitiesMember" xlink:label="cntg_NonCurrentFinancialLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_NonCurrentFinancialLiabilitiesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentFinancialLiabilitiesMember" xlink:label="cntg_CurrentFinancialLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_CurrentFinancialLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NoncurrentSecuredBankLoansMember" xlink:label="cntg_NoncurrentSecuredBankLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_NoncurrentSecuredBankLoansMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentMunicipalLoansMember" xlink:label="cntg_NonCurrentMunicipalLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_NonCurrentMunicipalLoansMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentSecuredBankLoansMember" xlink:label="cntg_CurrentSecuredBankLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_CurrentSecuredBankLoansMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankLoansMember" xlink:label="cntg_BankLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_BankLoansMember" priority="1" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_IfrsBankOverdraftsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancingActivitiesMunicipalLoansMember" xlink:label="cntg_FinancingActivitiesMunicipalLoansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_FinancingActivitiesMunicipalLoansMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfInterestBearingLoansMatureInOneYear" xlink:label="cntg_PercentageOfInterestBearingLoansMatureInOneYear" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="cntg_PercentageOfInterestBearingLoansMatureInOneYear" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:label="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" xlink:label="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharesIssuedPricePerShare" xlink:label="cntg_IfrsSharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="cntg_IfrsSharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_CashAndCashEquivalents" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesInterestRate" xlink:label="cntg_SecuredCreditLinesInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="cntg_SecuredCreditLinesInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesUtilized" xlink:label="cntg_SecuredCreditLinesUtilized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="cntg_SecuredCreditLinesUtilized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_FinancialLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="cntg_NumberOfCommonSharesOfferedByPriorShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="ifrs-full_BankBorrowingsUndiscountedCashFlows" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_BankBorrowingsUndiscountedCashFlows" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails" xlink:type="extended" xlink:title="42103 - Disclosure - Financial instruments - fair values and risk management - Currency risk (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="srt_CurrencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CurrencyAxis" xlink:to="currency_AllCurrenciesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="currency_USD" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_USD" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_INR" xlink:label="currency_INR" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_INR" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AED" xlink:label="currency_AED" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_AED" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_AssetsAndLiabilitiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="ifrs-full_AssetsAndLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="ifrs-full_AssetsAndLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AssetsAndLiabilitiesMember" xlink:to="ifrs-full_TradeReceivablesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradePayableAndOtherLiabilitiesMember" xlink:label="cntg_TradePayableAndOtherLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AssetsAndLiabilitiesMember" xlink:to="cntg_TradePayableAndOtherLiabilitiesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_TypesOfRisksAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_CurrencyRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureListOfSubsidiariesDetails" xlink:type="extended" xlink:title="42201 - Disclosure - List of subsidiaries (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGMember" xlink:label="cntg_CentogeneGMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneGMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneFzLlcUnitedArabEmiratesMember" xlink:label="cntg_CentogeneFzLlcUnitedArabEmiratesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneFzLlcUnitedArabEmiratesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneUsLlcBurlingtonUsaMember" xlink:label="cntg_CentogeneUsLlcBurlingtonUsaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneUsLlcBurlingtonUsaMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGmbhViennaMember" xlink:label="cntg_CentogeneGmbhViennaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneGmbhViennaMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneIndiaPvt.LtdMember" xlink:label="cntg_CentogeneIndiaPvt.LtdMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneIndiaPvt.LtdMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneSwitzerlandAgMember" xlink:label="cntg_CentogeneSwitzerlandAgMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneSwitzerlandAgMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentosafeB.v.Member" xlink:label="cntg_CentosafeB.v.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentosafeB.v.Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneD.o.oBelgradeMember" xlink:label="cntg_CentogeneD.o.oBelgradeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneD.o.oBelgradeMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureNonControllingInterestsDetails" xlink:type="extended" xlink:title="42301 - Disclosure - Non-controlling interests (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGmbhViennaMember" xlink:label="cntg_CentogeneGmbhViennaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneGmbhViennaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Dr.BauerLaboratoriumsGmbhMember" xlink:label="cntg_Dr.BauerLaboratoriumsGmbhMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_Dr.BauerLaboratoriumsGmbhMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneIndiaPvt.LtdMember" xlink:label="cntg_CentogeneIndiaPvt.LtdMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_CentogeneIndiaPvt.LtdMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LpcGmbhMember" xlink:label="cntg_LpcGmbhMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="cntg_LpcGmbhMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" xlink:label="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="ifrs-full_NetAssetsLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_NetAssetsLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_NoncontrollingInterests" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_Revenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProfitLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureCommitmentsDetails" xlink:type="extended" xlink:title="42401 - Disclosure - Commitments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_RostockHeadquartersBuildingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficeEquipmentAndStorageSpacesMember" xlink:label="cntg_OfficeEquipmentAndStorageSpacesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cntg_OfficeEquipmentAndStorageSpacesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_NotLaterThanOneYearMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UndiscountedLeasePaymentsToBeMade" xlink:label="cntg_UndiscountedLeasePaymentsToBeMade" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="cntg_UndiscountedLeasePaymentsToBeMade" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" xlink:label="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails" xlink:type="extended" xlink:title="42502 - Disclosure - Related parties - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="dei_LegalEntityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_EntityDomain" xlink:to="cntg_CentogeneN.vMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_SupervisoryBoardMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MemberOfSupervisoryBoardMember" xlink:label="cntg_MemberOfSupervisoryBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_SupervisoryBoardMember" xlink:to="cntg_MemberOfSupervisoryBoardMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerCeoAndMajorShareholderMember" xlink:label="cntg_FormerCeoAndMajorShareholderMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_FormerCeoAndMajorShareholderMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_EquityShareOption2017EquitySettledMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_LongTermIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionAxis" xlink:label="cntg_IfrsRelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="cntg_IfrsRelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionDomain" xlink:label="cntg_IfrsRelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsRelatedPartyTransactionAxis" xlink:to="cntg_IfrsRelatedPartyTransactionDomain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardActivitiesMember" xlink:label="cntg_SupervisoryBoardActivitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsRelatedPartyTransactionDomain" xlink:to="cntg_SupervisoryBoardActivitiesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CorporateStrategyServiceMember" xlink:label="cntg_CorporateStrategyServiceMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsRelatedPartyTransactionDomain" xlink:to="cntg_CorporateStrategyServiceMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RelatedPartyServicesMember" xlink:label="cntg_RelatedPartyServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_IfrsRelatedPartyTransactionDomain" xlink:to="cntg_RelatedPartyServicesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CovidTestingSuppliesPurchasesMember" xlink:label="cntg_CovidTestingSuppliesPurchasesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_IfrsRelatedPartyTransactionDomain" xlink:to="cntg_CovidTestingSuppliesPurchasesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CovidTestingServicesMember" xlink:label="cntg_CovidTestingServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cntg_IfrsRelatedPartyTransactionDomain" xlink:to="cntg_CovidTestingServicesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnEquityOfferingMember" xlink:label="cntg_FollowOnEquityOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_FollowOnEquityOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="7" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="cntg_IfrsAwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_AwardTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_StockOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PensionCommitments" xlink:label="cntg_PensionCommitments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_PensionCommitments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ServicesReceivedRelatedPartyTransactions" xlink:label="ifrs-full_ServicesReceivedRelatedPartyTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_ServicesReceivedRelatedPartyTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_NumberOfCommonSharesOfferedByPriorShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" xlink:label="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyManagementPersonnelCompensationSeverancePayout" xlink:label="cntg_KeyManagementPersonnelCompensationSeverancePayout" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_KeyManagementPersonnelCompensationSeverancePayout" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyManagementPersonnelCompensationAccruedAmount" xlink:label="cntg_KeyManagementPersonnelCompensationAccruedAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_KeyManagementPersonnelCompensationAccruedAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOtherEquityInstrumentsGranted" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_ValueOfOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_AmountsReceivableRelatedPartyTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions" xlink:label="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureContingentLiabilitiesDetails" xlink:type="extended" xlink:title="42601 - Disclosure - Contingent Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="ifrs-full_ContingentLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ContingentLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ContingentLiabilitiesMember" xlink:to="ifrs-full_LegalProceedingsContingentLiabilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UniversitairMedischCentrumUtrechtMember" xlink:label="cntg_UniversitairMedischCentrumUtrechtMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:to="cntg_UniversitairMedischCentrumUtrechtMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" xlink:label="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:to="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionPlan2016Member" xlink:label="cntg_StockOptionPlan2016Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="cntg_StockOptionPlan2016Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DamagesSought" xlink:label="cntg_DamagesSought" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:to="cntg_DamagesSought" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://centogene.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="42701 - Disclosure - Subsequent Events (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantOfRestrictedStockUnitsMember" xlink:label="cntg_GrantOfRestrictedStockUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="cntg_GrantOfRestrictedStockUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="ifrs-full_MajorOrdinaryShareTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="ifrs-full_MajorOrdinaryShareTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EnteringInToDebtFinancingAgreementMember" xlink:label="cntg_EnteringInToDebtFinancingAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="cntg_EnteringInToDebtFinancingAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VestingInFourTranchesMember" xlink:label="cntg_VestingInFourTranchesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="cntg_VestingInFourTranchesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="cntg_IfrsAwardTypeAxis" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_AwardTypeDomain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsusDerecognizedMember" xlink:label="cntg_RsusDerecognizedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_RsusDerecognizedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsusRecognizedMember" xlink:label="cntg_RsusRecognizedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_RsusRecognizedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_PerformanceBasedRestrictedStockUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="cntg_IfrsVestingAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="cntg_IfrsVestingAxis" xlink:to="cntg_IfrsVestingDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedAwardsSubjectToTimeVestingMember" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_ShareBasedAwardsSubjectToTimeVestingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerChiefFinancialOfficerMember" xlink:label="cntg_FormerChiefFinancialOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_FormerChiefFinancialOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_IfrsChiefExecutiveOfficerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MiguelCoegoRiosMember" xlink:label="cntg_MiguelCoegoRiosMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cntg_MiguelCoegoRiosMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:label="srt_ManagementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="srt_ManagementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_BorrowingsByNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityMember" xlink:label="cntg_LoanFacilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="cntg_LoanFacilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheOneMember" xlink:label="cntg_LoanFacilityTrancheOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cntg_LoanFacilityMember" xlink:to="cntg_LoanFacilityTrancheOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheTwoMember" xlink:label="cntg_LoanFacilityTrancheTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cntg_LoanFacilityMember" xlink:to="cntg_LoanFacilityTrancheTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="7" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTranches" xlink:label="cntg_NumberOfTranches" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_NumberOfTranches" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharePrice" xlink:label="cntg_IfrsSharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_IfrsSharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_NotionalAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsRevenueAchievementThreshold" xlink:label="cntg_BorrowingsRevenueAchievementThreshold" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_BorrowingsRevenueAchievementThreshold" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOtherEquityInstrumentsGranted" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_ValueOfOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfInstallments" xlink:label="cntg_NumberOfInstallments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="cntg_NumberOfInstallments" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>28
<FILENAME>cntg-20211231_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8042.36810 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/31/2022 3:12:46 PM-->
<!--Modified on: 3/31/2022 3:12:46 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Information [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses, Address Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Address Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Contact [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Information [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Well-known Seasoned Issuer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Voluntary Filers</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contact Personnel Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Country</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress" xlink:label="dei_ContactPersonnelEmailAddress" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contact Personnel Email Address</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Units, Units Outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Accounting Standard</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Registration Statement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Annual Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Shell Company Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Ex Transition Period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ICFR Auditor Attestation Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Firm ID</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Location</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated statements of comprehensive loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Revenues from contracts with external customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Revenues from contracts with external customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of sales</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross profit</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General administrative expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingExpense" xlink:label="ifrs-full_SellingExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingExpense" xlink:to="ifrs-full_SellingExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_SellingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="ifrs-full_ImpairmentLossOnFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLossOnFinancialAssets" xlink:to="ifrs-full_ImpairmentLossOnFinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentLossOnFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment loss on financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ImpairmentLossOnFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of financial assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Other operating income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other operating income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other operating income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="ifrs-full_OtherExpenseByFunction" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByFunction" xlink:to="ifrs-full_OtherExpenseByFunction_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherExpenseByFunction_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Other operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherExpenseByFunction_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherExpenseByFunction_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other operating expenses</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RealEstateTransferTaxExpenses" xlink:to="cntg_RealEstateTransferTaxExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RealEstateTransferTaxExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount represents the real estate transfer tax expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RealEstateTransferTaxExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Real Estate Transfer Tax Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_RealEstateTransferTaxExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Real estate transfer tax expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_RealEstateTransferTaxExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Real estate transfer tax expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit Loss from operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss of operations</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeOnLoansAndReceivables" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestIncomeOnLoansAndReceivables" xlink:to="ifrs-full_InterestIncomeOnLoansAndReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income on loans and receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income from loans and receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest and similar income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpense" xlink:label="ifrs-full_InterestExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest and similar expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial costs, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial costs, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss) before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax (expenses)/ benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit/(loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income, attributable to owners of parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income/(loss), all attributable to equity holders of the parent</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total comprehensive loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss), attributable to [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Attributable to:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive income, attributable to owners of parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity holders of the parent</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive income, attributable to non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Noncontrolling interests</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss per share - Basic (in EUR)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss per share - Basic (in EUR)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss per share - Diluted (in EUR)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated statements of financial position</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-Current Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="ifrs-full_OtherNoncurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other non-current assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentTradeReceivablesAndContractAssets" xlink:label="cntg_CurrentTradeReceivablesAndContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CurrentTradeReceivablesAndContractAssets" xlink:to="cntg_CurrentTradeReceivablesAndContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CurrentTradeReceivablesAndContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of Trade receivables and contract assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CurrentTradeReceivablesAndContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Trade Receivables and Contract Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_CurrentTradeReceivablesAndContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables and contract assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets" xlink:label="ifrs-full_OtherCurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentAssets" xlink:to="ifrs-full_OtherCurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherCurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity and liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity and liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserve" xlink:label="ifrs-full_CapitalReserve" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserve" xlink:to="ifrs-full_CapitalReserve_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalReserve_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital reserve.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CapitalReserve_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital reserve</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings and other reserves</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount of noncontrolling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Noncontrolling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Noncontrolling interests</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="ifrs-full_LongtermBorrowings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current portion of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Noncurrent loans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="ifrs-full_NoncurrentGovernmentGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentGovernmentGrants" xlink:to="ifrs-full_NoncurrentGovernmentGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government grants</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="ifrs-full_CurrentGovernmentGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentGovernmentGrants" xlink:to="ifrs-full_CurrentGovernmentGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government grants</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:to="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current borrowings and current portion of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current loans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current tax liabilities, current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities from income taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade And Other Current Payables To Trade Suppliers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="ifrs-full_OtherCurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity and liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated statements of cash flows</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operating activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile profit (loss) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile earnings to cash flow from operating activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization (including impairments) and depreciation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="ifrs-full_AdjustmentsForInterestIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForInterestIncome" xlink:to="ifrs-full_AdjustmentsForInterestIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForInterestIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForInterestIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryWritedown2011" xlink:label="ifrs-full_InventoryWritedown2011" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoryWritedown2011" xlink:to="ifrs-full_InventoryWritedown2011_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InventoryWritedown2011_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InventoryWritedown2011_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory write-off</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForInterestExpense" xlink:to="ifrs-full_AdjustmentsForInterestExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForInterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForInterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for losses (gains) on disposal of non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on the disposal of noncurrent assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional allowance recognised in profit or loss, allowance account for credit losses of financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected credit loss allowances on trade receivables and contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected credit loss allowances on trade receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other adjustments to reconcile profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other non-cash items</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract" xlink:label="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract" xlink:to="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ifrs Increase Decrease in Operating Assets and Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in operating assets and liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" xlink:label="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" xlink:to="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in trade accounts receivable and contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for Decrease (Increase) in Trade Accounts Receivable and Contract Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables and contract assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment of trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss of operations resulting in operating cash outflow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flow (used in)/from operating activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase of intangible assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash paid for investments in intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions to intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash paid for investments in property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow from grants received for investment in property, plant and equipment, classified as investing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ifrs Grants Received for Investment In Property, Plant And Equipment, Classified As Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants received for investment in property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" xlink:to="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of cash outflow relating to grants refunded related to disposal of property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of Grants Refunded on Disposal of Property, Plant and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants refunded related to disposed property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants refunded related to disposed property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sales of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash received from disposals of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of land and building</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest received, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest received</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flow (used in)/from investing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) financing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="ifrs-full_ProceedsFromIssuingShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuing shares or units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash received from the issuance of shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:label="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:to="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments from changes in ownership interests in subsidiaries that do not result in loss of control</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash paid for acquisition of non-wholly owned subsidiary</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings drawdowns</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash received from loans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayments of borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash repayments of loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loans repaid using the consideration from sale of land and building</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash repayments of lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flow from financing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of exchange rate changes on cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of movements in exchange rates on cash held</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated statements of changes in equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of changes in equity [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of equity [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_EquityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Owners' Capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserveMember" xlink:label="ifrs-full_CapitalReserveMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserveMember" xlink:to="ifrs-full_CapitalReserveMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalReserveMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital reserve</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency translation reserve</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" xlink:label="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" xlink:to="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit, excluding the currency translation reserve.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings excluding currency translation reserve [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="ifrs-full_NoncontrollingInterestsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non- controlling interests</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of changes in equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="ifrs-full_IssueOfEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issue of equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost incurred related to the IPO</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of options</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:label="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:to="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through disposal of subsidiary, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposal of non-wholly owned subsidiary</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:label="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:to="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through acquisition of subsidiary, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition of non-wholly owned subsidiary</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" xlink:label="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" xlink:to="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity resulting from share-based payment transactions or modifications at initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase Decrease Through Sharebased Payment Transactions At Initial Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments - modification at IPO</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsAbstract" xlink:label="cntg_GeneralInformationAboutFinancialStatementsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_GeneralInformationAboutFinancialStatementsAbstract" xlink:to="cntg_GeneralInformationAboutFinancialStatementsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_GeneralInformationAboutFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_GeneralInformationAboutFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General Company Information</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of general information about financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General Company Information</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BasisOfPreparationOfFinancialStatementsAbstract" xlink:label="cntg_BasisOfPreparationOfFinancialStatementsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BasisOfPreparationOfFinancialStatementsAbstract" xlink:to="cntg_BasisOfPreparationOfFinancialStatementsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BasisOfPreparationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BasisOfPreparationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Preparation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Preparation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effects of new accounting standards</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:to="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of initial application of standards or interpretations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effects of new accounting standards</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BasisOfConsolidationAbstract" xlink:label="cntg_BasisOfConsolidationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BasisOfConsolidationAbstract" xlink:to="cntg_BasisOfConsolidationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BasisOfConsolidationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BasisOfConsolidationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of consolidation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description Of Accounting Policy For Basis Of Consolidation [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of consolidation</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" xlink:to="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant accounting policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of significant accounting policies [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant accounting policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting judgments and estimates</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting judgements and estimates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting judgments and estimates</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment information and revenue from contracts with customers</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DisclosureOfOperatingSegmentsExplanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Information</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="cntg_OtherIncomeExpenseDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income and expenses</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock" xlink:label="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock" xlink:to="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure for other income (expense).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of Other Income And Expenses Explanatory [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income and expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss Per Share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss Per Share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_ClassesOfInventoriesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfInventoriesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other receivables and other assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock" xlink:label="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock" xlink:to="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure for trade receivables and contract assets and other assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Trade And Other Receivables And Other Assets Explanatory [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other receivables and other assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_CashAndCashEquivalentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and short-term deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and short-term deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of objectives, policies and processes for managing capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of share-based payment arrangements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments-fair values and risk management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments-fair values and risk management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">List of subsidiaries</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of subsidiaries [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">List of subsidiaries</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonControllingInterestsAbstract" xlink:label="cntg_NonControllingInterestsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NonControllingInterestsAbstract" xlink:to="cntg_NonControllingInterestsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NonControllingInterestsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NonControllingInterestsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-controlling interests.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:to="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of non-controlling interests [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-controlling interests</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfCommitmentsAbstract" xlink:label="cntg_DisclosureOfCommitmentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfCommitmentsAbstract" xlink:to="cntg_DisclosureOfCommitmentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfCommitmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfCommitmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of commitments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_RelatedPartyTransactionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related parties</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of related party [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related parties</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Events</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of non-adjusting events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Events</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for foreign currency translation [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency and currency translation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues from contracts with customers</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for finance income and costs [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance income and finance costs</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory" xlink:label="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory" xlink:to="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The policy of Accounting Policy For Current Versus Noncurrent Classification, Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting Policy For Current Versus Noncurrent Classification, Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current versus non-current classification</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for impairment of non-financial assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of non-financial assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for measuring inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for government grants [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government grants</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for provisions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provisions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock" xlink:label="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock" xlink:to="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of reclassification of cost on comprehensive income statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of Effect of Reclassification of cost on Comprehensive Income Statement [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of reconciliation of the Statement of Comprehensive Income</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfForeignExchangeRatesUsedExplanatory" xlink:label="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory" xlink:to="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about foreign exchange rates used.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Foreign Exchange Rates Used, Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of exchange rates used</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock" xlink:label="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock" xlink:to="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of segment information and reconciliation of segment adjusted EBITDA to group loss for the period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:to="ifrs-full_DisclosureOfGeographicalAreasExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of geographical areas [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of geographical information</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfContractBalancesExplanatory" xlink:label="cntg_DisclosureOfContractBalancesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfContractBalancesExplanatory" xlink:to="cntg_DisclosureOfContractBalancesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfContractBalancesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about contract balances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfContractBalancesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Contract Balances, Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_DisclosureOfContractBalancesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contract balances</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other operating income [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of other operating income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other operating expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of other operating expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of Financial Income and Costs [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of finance costs, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of employee benefits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of employee benefits expense</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of the components of income tax expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of tax recognized through profit or loss</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Schedule Of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of reconciliation of the effective tax rate to the statutory rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of deferred taxes [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of breakdown of deferred taxes in the statement of financial position</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of reconciliation of carrying amounts of intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of development of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of carrying amounts of right-of-use assets and movements during the period</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory" xlink:label="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory" xlink:to="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about carrying amounts of lease liabilities and their movements during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Carrying Amounts Of Lease Liabilities And Their Movements During The Period, Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of carrying amounts of lease liabilities and the movements during the period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" xlink:label="ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" xlink:to="ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of additional information about leasing activities for lessee [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of amounts recognised in profit or loss related to leases</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfInventoriesTableTextBlock" xlink:label="cntg_DisclosureOfInventoriesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfInventoriesTableTextBlock" xlink:to="cntg_DisclosureOfInventoriesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfInventoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The tabular disclosure of inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfInventoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Inventories [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DisclosureOfInventoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of inventories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of trade and other receivables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of trade receivables and other assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares issued and authorized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:to="ifrs-full_DisclosureOfBorrowingsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of interest-bearing liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of outstanding interest-bearing liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of trade and other payables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of trade payables and other liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of share-based payment arrangements [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment arrangements [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017And2019Member" xlink:label="cntg_EquityShareOption2017And2019Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_EquityShareOption2017And2019Member" xlink:to="cntg_EquityShareOption2017And2019Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_EquityShareOption2017And2019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for equity share option 2017 and 2019 .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_EquityShareOption2017And2019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity share option 2017 and 2019</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_EquityShareOption2017EquitySettledMember" xlink:to="cntg_EquityShareOption2017EquitySettledMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_EquityShareOption2017EquitySettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for equity share option 2017 (equity settled).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_EquityShareOption2017EquitySettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity share option 2017 (Equity settled)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2019EquitySettledMember" xlink:label="cntg_EquityShareOption2019EquitySettledMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_EquityShareOption2019EquitySettledMember" xlink:to="cntg_EquityShareOption2019EquitySettledMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_EquityShareOption2019EquitySettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for equity share option 2019 (equity settled).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_EquityShareOption2019EquitySettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity share option 2019 (Equity settled)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LongTermIncentivePlanMember" xlink:to="cntg_LongTermIncentivePlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LongTermIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Long-Term Incentive Plan (LTIP).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LongTermIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2019 Plan</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" xlink:label="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" xlink:to="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about expenses arising from share based payment transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Expenses Arising From Share-based Payment Transactions, Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of total expenses arising from sharebased payment transactions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of share option activity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of key assumptions used to derive the option value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of awards granted</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of credit risk exposure [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of information regarding the credit risk exposure of trade receivables and contract assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:label="ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:to="ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of allowance for credit losses [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of development of impairment losses relating to trade and other receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis for non-derivative financial liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of residual contractual terms of financial liabilities, including estimated interest payments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of reconciliation of liabilities arising from financing activities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of reconciliation of liabilities arising from financing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:to="ifrs-full_DisclosureOfMarketRiskExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of market risk [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of net foreign currency exposure</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of interests in subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of major subsidiaries</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:label="ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:to="ifrs-full_DisclosureOfCompositionOfGroupExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCompositionOfGroupExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of composition of group [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCompositionOfGroupExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of information related to each subsidiary of the Group with material, non-controlling interests before intercompany eliminations</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of information about key management personnel [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of remuneration of members of key management</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsTable" xlink:label="cntg_GeneralInformationAboutFinancialStatementsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable" xlink:to="cntg_GeneralInformationAboutFinancialStatementsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_GeneralInformationAboutFinancialStatementsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information pertaining to general information about financial statements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_GeneralInformationAboutFinancialStatementsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General Information About Financial Statements [Table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information by type of sale of the entity's stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Subsidiary Sale Of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Sale Of Stock Name Of Transaction [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnEquityOfferingMember" xlink:label="cntg_FollowOnEquityOfferingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FollowOnEquityOfferingMember" xlink:to="cntg_FollowOnEquityOfferingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FollowOnEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a follow-on offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FollowOnEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on Equity Offering</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnPublicOfferingMember" xlink:label="cntg_FollowOnPublicOfferingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FollowOnPublicOfferingMember" xlink:to="cntg_FollowOnPublicOfferingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FollowOnPublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for follow-on public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FollowOnPublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on public offering</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of share capital [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Legal Entity [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneN.vMember" xlink:to="cntg_CentogeneN.vMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneN.vMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Centogene N.V.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneN.vMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The Company</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Categories of related parties [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity's total for related parties [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SellingShareholdersMember" xlink:label="cntg_SellingShareholdersMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SellingShareholdersMember" xlink:to="cntg_SellingShareholdersMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SellingShareholdersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for selling shareholders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SellingShareholdersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling shareholders</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-adjusting events after reporting period [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="ifrs-full_NonadjustingEventsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-adjusting events after reporting period [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorPurchasesOfAssetsMember" xlink:label="ifrs-full_MajorPurchasesOfAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorPurchasesOfAssetsMember" xlink:to="ifrs-full_MajorPurchasesOfAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorPurchasesOfAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Major purchases of assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:label="cntg_GeneralInformationAboutFinancialStatementsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:to="cntg_GeneralInformationAboutFinancialStatementsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_GeneralInformationAboutFinancialStatementsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General Information About Financial Statements [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_GeneralInformationAboutFinancialStatementsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General Information About Financial Statements [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_GeneralInformationAboutFinancialStatementsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General Company Information</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of common shares issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:to="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offering price per share of new stock issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Offering Price Per Share, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public offering price (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public offering price (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issue of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of changes in accounting estimates [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_RangesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ranges [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" xlink:label="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" xlink:to="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Centogene N.V., Centogene GmbH and its subsidiaries.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Group</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EnteringInToDebtFinancingAgreementMember" xlink:label="cntg_EnteringInToDebtFinancingAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_EnteringInToDebtFinancingAgreementMember" xlink:to="cntg_EnteringInToDebtFinancingAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_EnteringInToDebtFinancingAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for entering into debt financing agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_EnteringInToDebtFinancingAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entering into debt financing agreement</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="ifrs-full_MajorOrdinaryShareTransactionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:to="ifrs-full_MajorOrdinaryShareTransactionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorOrdinaryShareTransactionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Major ordinary share transactions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings by name [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="ifrs-full_BorrowingsByNameMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityMember" xlink:label="cntg_LoanFacilityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LoanFacilityMember" xlink:to="cntg_LoanFacilityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LoanFacilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member represents the debt financing agreement secured on January 31, 2022 (the "Loan Facility").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LoanFacilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan facility</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheOneMember" xlink:label="cntg_LoanFacilityTrancheOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LoanFacilityTrancheOneMember" xlink:to="cntg_LoanFacilityTrancheOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LoanFacilityTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member represents the first tranche of the debt financing agreement secured on January 31, 2022 (the "Loan Facility").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LoanFacilityTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan facility tranche one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_LoanFacilityTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan facility first tranche</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheTwoMember" xlink:label="cntg_LoanFacilityTrancheTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LoanFacilityTrancheTwoMember" xlink:to="cntg_LoanFacilityTrancheTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LoanFacilityTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member represents the second tranche of the debt financing agreement secured on January 31, 2022 (the "Loan Facility").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LoanFacilityTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan facility tranche two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_LoanFacilityTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan facility second tranche</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="ifrs-full_TypesOfInterestRatesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfInterestRatesAxis" xlink:to="ifrs-full_TypesOfInterestRatesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfInterestRatesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of interest rates [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember" xlink:label="ifrs-full_InterestRateTypesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateTypesMember" xlink:to="ifrs-full_InterestRateTypesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateTypesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate types [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FloorRateMember" xlink:label="cntg_FloorRateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FloorRateMember" xlink:to="cntg_FloorRateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FloorRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for floor rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FloorRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Floor rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of changes in accounting estimates [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting judgments and estimates</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EstimatedRateOfImplicitPriceConcessions" xlink:label="cntg_EstimatedRateOfImplicitPriceConcessions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_EstimatedRateOfImplicitPriceConcessions" xlink:to="cntg_EstimatedRateOfImplicitPriceConcessions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_EstimatedRateOfImplicitPriceConcessions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated rate of implicit price concessions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_EstimatedRateOfImplicitPriceConcessions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated Rate of Implicit Price Concessions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_EstimatedRateOfImplicitPriceConcessions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated rate of implicit price concessions</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfEstimatedVariableTransactionPrice" xlink:label="cntg_PercentageOfEstimatedVariableTransactionPrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PercentageOfEstimatedVariableTransactionPrice" xlink:to="cntg_PercentageOfEstimatedVariableTransactionPrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PercentageOfEstimatedVariableTransactionPrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of estimated variable transaction price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PercentageOfEstimatedVariableTransactionPrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of estimated Variable Transaction Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_PercentageOfEstimatedVariableTransactionPrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of estimated variable transaction price</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="ifrs-full_ShorttermBorrowings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short term debt obligation</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialCovenants" xlink:label="cntg_FinancialCovenants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FinancialCovenants" xlink:to="cntg_FinancialCovenants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FinancialCovenants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of financial covenants as at the end of the reporting period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FinancialCovenants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Covenants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_FinancialCovenants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial covenants</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotionalAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Notional amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotionalAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nominal amount</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" xlink:to="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of borrowing available subject to achievement of product revenue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings Available, Subject to Achievement of Product Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings available, Subject to achievement of product revenue</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsRevenueAchievementThreshold" xlink:label="cntg_BorrowingsRevenueAchievementThreshold" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BorrowingsRevenueAchievementThreshold" xlink:to="cntg_BorrowingsRevenueAchievementThreshold_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BorrowingsRevenueAchievementThreshold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of revenue threshold for borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BorrowingsRevenueAchievementThreshold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings, Revenue Achievement Threshold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_BorrowingsRevenueAchievementThreshold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings, Revenue achievement threshold</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsCovenantMinimumRequiredRevenue" xlink:label="cntg_BorrowingsCovenantMinimumRequiredRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BorrowingsCovenantMinimumRequiredRevenue" xlink:to="cntg_BorrowingsCovenantMinimumRequiredRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BorrowingsCovenantMinimumRequiredRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of minimum revenue to be maintained as per the borrowings covenant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BorrowingsCovenantMinimumRequiredRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings Covenant, Minimum Required Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_BorrowingsCovenantMinimumRequiredRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings covenant, Minimum required revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="ifrs-full_BorrowingsInterestRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nominal interest rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:label="ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:to="ifrs-full_BorrowingsAdjustmentToInterestRateBasis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsAdjustmentToInterestRateBasis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings, adjustment to interest rate basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsAdjustmentToInterestRateBasis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustment to interest rate</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of new stock issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of common shares issued (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued during period</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharePrice" xlink:label="cntg_IfrsSharePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsSharePrice" xlink:to="cntg_IfrsSharePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsSharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Price of a single share of a number of saleable stocks of a company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsSharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsSharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of warrant or right, Number of securities called by warrants or rights</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price per share or per unit of warrants or rights outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of warrant or right, Exercise price of warrants or rights</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revision of Prior Period [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revision of Prior Period [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Previously Reported</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xlink:to="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of information pertaining to accounting and measurement principles.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting And Measurement Principles, Disclosure [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of intangible assets other than goodwill [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets other than goodwill [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SoftwarePatentsAndTrademarksMember" xlink:label="cntg_SoftwarePatentsAndTrademarksMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SoftwarePatentsAndTrademarksMember" xlink:to="cntg_SoftwarePatentsAndTrademarksMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SoftwarePatentsAndTrademarksMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for software, patents and trademarks.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SoftwarePatentsAndTrademarksMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Software, patents and trademarks</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CoronaTestPortalMember" xlink:label="cntg_CoronaTestPortalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CoronaTestPortalMember" xlink:to="cntg_CoronaTestPortalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CoronaTestPortalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the Corona Test Portal.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CoronaTestPortalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corona Test Portal</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="ifrs-full_CapitalisedDevelopmentExpenditureMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:to="ifrs-full_CapitalisedDevelopmentExpenditureMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalisedDevelopmentExpenditureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capitalized development costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of property, plant and equipment [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property Plant And Equipment [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesMember" xlink:label="cntg_OfficesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OfficesMember" xlink:to="cntg_OfficesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OfficesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member stands for offices.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OfficesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offices</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:to="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting And Measurement Principles, Disclosure [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant accounting policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="ifrs-full_ForeignExchangeRatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ForeignExchangeRatesAbstract" xlink:to="ifrs-full_ForeignExchangeRatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ForeignExchangeRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forward foreign exchange contracts held for trading</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ForeignExchangeRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency and currency translation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="ifrs-full_AverageForeignExchangeRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageForeignExchangeRate" xlink:to="ifrs-full_AverageForeignExchangeRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AverageForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average foreign exchange rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AverageForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Closing foreign exchange rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Closing rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets other than goodwill [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Useful life measured as period of time, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful lives</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Useful Lives, Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsLeasesAbstract" xlink:label="cntg_IfrsLeasesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsLeasesAbstract" xlink:to="cntg_IfrsLeasesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsLeasesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsLeasesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsLeasesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" xlink:label="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" xlink:to="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The useful life, measured as period of time, used for right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Useful Life Measured As Period Of Time, Right-of-use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialInstrumentsAbstract" xlink:label="cntg_FinancialInstrumentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FinancialInstrumentsAbstract" xlink:to="cntg_FinancialInstrumentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FinancialInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FinancialInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Instruments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_FinancialInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" xlink:label="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" xlink:to="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of days for which the contractual payments is past due, used for considering the financial asset as default.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Asset In Default, Number Of Days Past Due Considered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of days past due, to consider a financial asset as default</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_CarryingAmountMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of operating segments [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentConsolidationItemsAxis" xlink:to="ifrs-full_SegmentConsolidationItemsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentConsolidationItemsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment consolidation items [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity's total for segment consolidation items [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingSegmentsMember" xlink:to="ifrs-full_OperatingSegmentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OperatingSegmentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating segment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="ifrs-full_MaterialReconcilingItemsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaterialReconcilingItemsMember" xlink:to="ifrs-full_MaterialReconcilingItemsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaterialReconcilingItemsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Material reconciling items [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsCorporateMember" xlink:label="cntg_IfrsCorporateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsCorporateMember" xlink:to="cntg_IfrsCorporateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsCorporateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for corporate segment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsCorporateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segments [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentsMember" xlink:to="ifrs-full_SegmentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segments [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalSegmentMember" xlink:label="cntg_PharmaceuticalSegmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PharmaceuticalSegmentMember" xlink:to="cntg_PharmaceuticalSegmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PharmaceuticalSegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for pharmaceutical segment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PharmaceuticalSegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pharmaceutical</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DiagnosticsSegmentMember" xlink:label="cntg_DiagnosticsSegmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DiagnosticsSegmentMember" xlink:to="cntg_DiagnosticsSegmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DiagnosticsSegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for diagnostics segment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DiagnosticsSegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diagnostics</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_Covid19Member" xlink:to="cntg_Covid19Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_Covid19Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for covid-19 segment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_Covid19Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COVID-19</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="ifrs-full_MajorCustomersAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="ifrs-full_MajorCustomersAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorCustomersAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Major customers [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="ifrs-full_MajorCustomersMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorCustomersMember" xlink:to="ifrs-full_MajorCustomersMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorCustomersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Customers [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalPartnerMember" xlink:label="cntg_PharmaceuticalPartnerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PharmaceuticalPartnerMember" xlink:to="cntg_PharmaceuticalPartnerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PharmaceuticalPartnerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for pharmaceutical partner.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PharmaceuticalPartnerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pharmaceutical Partner</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Timing of transfer of goods or services [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Timing of transfer of goods or services [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recognized over time.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recognized at a point in time.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of operating segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment information and revenue from contracts with customers</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsNumberOfReportableSegments" xlink:label="cntg_IfrsNumberOfReportableSegments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsNumberOfReportableSegments" xlink:to="cntg_IfrsNumberOfReportableSegments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsNumberOfReportableSegments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsNumberOfReportableSegments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Number Of Reportable Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsNumberOfReportableSegments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of reportable segments</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of operating income (loss) before adjusting corporate expenses, depreciation and amortization as well as share based payment expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjusted Earnings Before Interest Taxes Depreciation And Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjusted EBITDA</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" xlink:label="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" xlink:to="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of additions to property, plant and equipment and right-of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions to Property, plant and Equipment and Right-of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions to property, plant and equipment and right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherSegmentInformationAbstract" xlink:label="cntg_OtherSegmentInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherSegmentInformationAbstract" xlink:to="cntg_OtherSegmentInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherSegmentInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherSegmentInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Segment Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_OtherSegmentInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other segment information</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationAndAmortisationExpense" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortization (including impairments)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="ifrs-full_UnallocatedAmountsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnallocatedAmountsMember" xlink:to="ifrs-full_UnallocatedAmountsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnallocatedAmountsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unallocated amounts</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UnallocatedAmountsShareBasedPaymentsMember" xlink:label="cntg_UnallocatedAmountsShareBasedPaymentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_UnallocatedAmountsShareBasedPaymentsMember" xlink:to="cntg_UnallocatedAmountsShareBasedPaymentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_UnallocatedAmountsShareBasedPaymentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for unallocated amounts share based payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_UnallocatedAmountsShareBasedPaymentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sharebased payment expenses</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UnallocatedAmountsDepreciationAndAmortizationMember" xlink:label="cntg_UnallocatedAmountsDepreciationAndAmortizationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_UnallocatedAmountsDepreciationAndAmortizationMember" xlink:to="cntg_UnallocatedAmountsDepreciationAndAmortizationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_UnallocatedAmountsDepreciationAndAmortizationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for unallocated amounts depreciation and amortization.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_UnallocatedAmountsDepreciationAndAmortizationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortization</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of operating income (loss) before adjusting corporate expenses, depreciation and amortization as well as share based payment expenses, attributable to reportable segment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjusted Earnings Before Interest Taxes Depreciation And Amortization, Attributable To Reportable Segment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reportable segment Adjusted EBITDA</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdministrativeExpense" xlink:label="ifrs-full_AdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_AdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate expenses</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of operating income (loss) before adjusting depreciation and amortization as well as share based payment expenses but after adjusting corporate expenses, attributable to reportable segment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjusted Earnings Before Interest Taxes Depreciation And Amortization After Corporate Expenses, Attributable To Reportable Segment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reportable segment Adjusted EBITDA after corporate expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from share-based payment transactions with employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical areas [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="ifrs-full_GeographicalAreasMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical areas [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Europe</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">-Germany</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL" xlink:label="country_NL" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_NL" xlink:to="country_NL_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_NL_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">-Netherlands</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsMiddleEastMember" xlink:label="cntg_IfrsMiddleEastMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsMiddleEastMember" xlink:to="cntg_IfrsMiddleEastMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsMiddleEastMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for middle east member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsMiddleEastMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Middle East</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SA" xlink:label="country_SA" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_SA" xlink:to="country_SA_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_SA_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">-Saudi Arabia</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NorthAmericaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">North America</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">-United States</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember" xlink:label="srt_LatinAmericaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LatinAmericaMember" xlink:to="srt_LatinAmericaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LatinAmericaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Latin America</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember" xlink:label="srt_AsiaPacificMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaPacificMember" xlink:to="srt_AsiaPacificMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaPacificMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asia Pacific</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="ifrs-full_RevenueFromRenderingOfServices" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfServices" xlink:to="ifrs-full_RevenueFromRenderingOfServices_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromRenderingOfServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from rendering of services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromRenderingOfServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rendering of services</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="ifrs-full_RevenueFromSaleOfGoods" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromSaleOfGoods" xlink:to="ifrs-full_RevenueFromSaleOfGoods_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromSaleOfGoods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from sale of goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromSaleOfGoods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sales of goods</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:to="ifrs-full_CurrentReceivablesFromContractsWithCustomers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current receivables from contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables (note 15)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractAssets" xlink:label="ifrs-full_CurrentContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentContractAssets" xlink:to="ifrs-full_CurrentContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract assets (note 15)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractLiabilities" xlink:to="ifrs-full_ContractLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract liabilities (note 19.2)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="ifrs-full_DisclosureOfMajorCustomersTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable" xlink:to="ifrs-full_DisclosureOfMajorCustomersTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMajorCustomersTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of major customers [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIPOMember" xlink:label="cntg_IfrsIPOMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsIPOMember" xlink:to="cntg_IfrsIPOMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsIPOMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First sale of stock by a private company to the public.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsIPOMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPO</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19PartnerOneMember" xlink:label="cntg_Covid19PartnerOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_Covid19PartnerOneMember" xlink:to="cntg_Covid19PartnerOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_Covid19PartnerOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the first Covid-19 partner.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_Covid19PartnerOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Covid-19 Partner One</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19PartnerTwoMember" xlink:label="cntg_Covid19PartnerTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_Covid19PartnerTwoMember" xlink:to="cntg_Covid19PartnerTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_Covid19PartnerTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the second Covid-19 partner.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_Covid19PartnerTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Covid-19 Partner Two</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationAxis" xlink:label="cntg_IfrsBalanceSheetLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsBalanceSheetLocationAxis" xlink:to="cntg_IfrsBalanceSheetLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsBalanceSheetLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information by location on balance sheet (statement of financial position).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsBalanceSheetLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Balance Sheet Location [Axis]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationDomain" xlink:label="cntg_IfrsBalanceSheetLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsBalanceSheetLocationDomain" xlink:to="cntg_IfrsBalanceSheetLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsBalanceSheetLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Location in the balance sheet (statement of financial position).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsBalanceSheetLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Balance Sheet Location [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="ifrs-full_DisclosureOfMajorCustomersLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:to="ifrs-full_DisclosureOfMajorCustomersLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMajorCustomersLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of major customers [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfMajorCustomersLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment information and revenue from contracts with customers</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCustomersInGroup" xlink:label="cntg_NumberOfCustomersInGroup" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfCustomersInGroup" xlink:to="cntg_NumberOfCustomersInGroup_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfCustomersInGroup_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">It represents the number of customer in group.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfCustomersInGroup_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Customers In Group</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfCustomersInGroup_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of customer in group</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfEntitysRevenue" xlink:to="ifrs-full_PercentageOfEntitysRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of entity's revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of revenue</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CapitalizedInvestment" xlink:label="cntg_CapitalizedInvestment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CapitalizedInvestment" xlink:to="cntg_CapitalizedInvestment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CapitalizedInvestment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of capitalized investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CapitalizedInvestment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capitalized Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_CapitalizedInvestment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capitalized investment</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProvisionForExpectedCreditLossesOnContractAssets" xlink:label="cntg_ProvisionForExpectedCreditLossesOnContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ProvisionForExpectedCreditLossesOnContractAssets" xlink:to="cntg_ProvisionForExpectedCreditLossesOnContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ProvisionForExpectedCreditLossesOnContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of provision for expected credit losses on contract assets, recognized by the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ProvisionForExpectedCreditLossesOnContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provision For Expected Credit Losses On Contract Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_ProvisionForExpectedCreditLossesOnContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provision for expected credit losses on contract assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue that was included in contract liability balance at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues recognized for contract liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction price allocated to remaining performance obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseTable" xlink:label="cntg_OtherIncomeExpenseTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherIncomeExpenseTable" xlink:to="cntg_OtherIncomeExpenseTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherIncomeExpenseTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">na</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherIncomeExpenseTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Income Expense [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of assets [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_ClassesOfAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RostockHeadquartersBuildingMember" xlink:to="cntg_RostockHeadquartersBuildingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RostockHeadquartersBuildingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member stands for Rostock Headquarters Building.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RostockHeadquartersBuildingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rostock headquarters building</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SupervisoryBoardMember" xlink:to="cntg_SupervisoryBoardMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SupervisoryBoardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for supervisory board.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SupervisoryBoardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supervisory board members</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsAxis" xlink:label="cntg_InfrequentItemsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_InfrequentItemsAxis" xlink:to="cntg_InfrequentItemsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_InfrequentItemsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents axis for infrequent items.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_InfrequentItemsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Infrequent Items [Axis]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsDomain" xlink:label="cntg_InfrequentItemsDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_InfrequentItemsDomain" xlink:to="cntg_InfrequentItemsDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_InfrequentItemsDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents domain for infrequent items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_InfrequentItemsDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Infrequent Items [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseLineItems" xlink:label="cntg_OtherIncomeExpenseLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherIncomeExpenseLineItems" xlink:to="cntg_OtherIncomeExpenseLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherIncomeExpenseLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The information about other income expense line items.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherIncomeExpenseLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Income Expense Line Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_OtherIncomeExpenseLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income and expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromGovernmentGrants" xlink:to="ifrs-full_RevenueFromGovernmentGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income from government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromGovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government grants</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gains on disposals of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on disposal of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="ifrs-full_NetForeignExchangeGain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeGain" xlink:to="ifrs-full_NetForeignExchangeGain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net foreign exchange gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetForeignExchangeGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exchange rate gains</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReversalsOfProvisions" xlink:label="ifrs-full_OtherReversalsOfProvisions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReversalsOfProvisions" xlink:to="ifrs-full_OtherReversalsOfProvisions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReversalsOfProvisions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other reversals of provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherReversalsOfProvisions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income from the reversal of provisions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="ifrs-full_MiscellaneousOtherOperatingIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiscellaneousOtherOperatingIncome" xlink:to="ifrs-full_MiscellaneousOtherOperatingIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MiscellaneousOtherOperatingIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miscellaneous other operating income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MiscellaneousOtherOperatingIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Others</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GainLossFromForgivenessOfLoan" xlink:label="cntg_GainLossFromForgivenessOfLoan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_GainLossFromForgivenessOfLoan" xlink:to="cntg_GainLossFromForgivenessOfLoan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_GainLossFromForgivenessOfLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of gain (loss) recognized due to forgiveness of loan from bank.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_GainLossFromForgivenessOfLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain (Loss) from Forgiveness of Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_GainLossFromForgivenessOfLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain from forgiveness of loan</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseTerm" xlink:label="cntg_LeaseTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LeaseTerm" xlink:to="cntg_LeaseTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period for lease term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_LeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease term</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="ifrs-full_EmployeeBenefitsExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EmployeeBenefitsExpense" xlink:to="ifrs-full_EmployeeBenefitsExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EmployeeBenefitsExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee benefits expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EmployeeBenefitsExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Post-employment benefit expense, defined contribution plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contributions to state pension scheme (defined contribution plan)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="ifrs-full_NetForeignExchangeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_NetForeignExchangeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetForeignExchangeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency losses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miscellaneous other operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsidiaries [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity's total for subsidiaries [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LpcGmbhMember" xlink:label="cntg_LpcGmbhMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LpcGmbhMember" xlink:to="cntg_LpcGmbhMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LpcGmbhMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for LPC GmbH.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LpcGmbhMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LPC GmbH</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proportion of ownership interest in subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ownership interest in subsidiary (in percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="ifrs-full_ConsiderationPaidReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsiderationPaidReceived" xlink:to="ifrs-full_ConsiderationPaidReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConsiderationPaidReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration paid (received)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ConsiderationPaidReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration for disposal of subsidiary</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationToBePaidOverTime" xlink:label="cntg_ConsiderationToBePaidOverTime" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ConsiderationToBePaidOverTime" xlink:to="cntg_ConsiderationToBePaidOverTime_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ConsiderationToBePaidOverTime_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of consideration to be paid over time.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ConsiderationToBePaidOverTime_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration To Be Paid Over Time</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ConsiderationToBePaidOverTime_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration to be paid over time</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationPaymentDuePeriod" xlink:label="cntg_ConsiderationPaymentDuePeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ConsiderationPaymentDuePeriod" xlink:to="cntg_ConsiderationPaymentDuePeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ConsiderationPaymentDuePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration payment due period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ConsiderationPaymentDuePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration Payment Due Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ConsiderationPaymentDuePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment due period (in years)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationOutstanding" xlink:label="cntg_ConsiderationOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ConsiderationOutstanding" xlink:to="cntg_ConsiderationOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ConsiderationOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of consideration outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ConsiderationOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ConsiderationOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration outstanding</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss), attributable to non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit/(loss) allocated to non-controlling interest</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="ifrs-full_InterestExpenseOnBorrowings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnBorrowings" xlink:to="ifrs-full_InterestExpenseOnBorrowings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense on borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestExpenseOnBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expenses from loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrencyLossesFinanceCost" xlink:label="cntg_CurrencyLossesFinanceCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CurrencyLossesFinanceCost" xlink:to="cntg_CurrencyLossesFinanceCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CurrencyLossesFinanceCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of cost associated with interest and other financing activities due to currency losses incurred by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CurrencyLossesFinanceCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency Losses Finance Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_CurrencyLossesFinanceCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency losses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unwinding of the discount on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expenses on lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries" xlink:label="ifrs-full_WagesAndSalaries" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WagesAndSalaries" xlink:to="ifrs-full_WagesAndSalaries_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WagesAndSalaries_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Wages and salaries</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SocialSecurityContributions" xlink:label="ifrs-full_SocialSecurityContributions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SocialSecurityContributions" xlink:to="ifrs-full_SocialSecurityContributions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SocialSecurityContributions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Social security contributions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TerminationBenefitsExpense" xlink:label="ifrs-full_TerminationBenefitsExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TerminationBenefitsExpense" xlink:to="ifrs-full_TerminationBenefitsExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TerminationBenefitsExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Termination benefits expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TerminationBenefitsExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Termination benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:to="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current tax expense (income) and adjustments for current tax of prior periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current tax expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:to="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for current tax of prior periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for prior periods</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax expense (income) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax (expense)/income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax expense (income) relating to origination and reversal of temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary differences</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" xlink:label="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" xlink:to="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of benefit/(expense) arising from a previously unrecognised tax loss, tax credit or temporary difference of a prior period that is used to reduce/(increase) deferred tax expense. [Refer: Deferred tax expense (income); Temporary differences [member]; Unused tax losses [member]; Unused tax credits [member]]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Benefit Expense Arising From Previously Unrecognised Tax Loss Tax Credit Or Temporary Difference Of Prior Period Used To Increase Decrease Deferred Tax Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:to="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax relating to components of other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes recognized directly in other comprehensive income</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncomeTaxDisclosureTable" xlink:label="cntg_IncomeTaxDisclosureTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IncomeTaxDisclosureTable" xlink:to="cntg_IncomeTaxDisclosureTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IncomeTaxDisclosureTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule disclosing information related to income tax disclosures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IncomeTaxDisclosureTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Disclosure [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="ifrs-full_CountryOfDomicileMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfDomicileMember" xlink:to="ifrs-full_CountryOfDomicileMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CountryOfDomicileMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic tax rate</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncomeTaxDisclosureLineItems" xlink:label="cntg_IncomeTaxDisclosureLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IncomeTaxDisclosureLineItems" xlink:to="cntg_IncomeTaxDisclosureLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IncomeTaxDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IncomeTaxDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Disclosure [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statutory rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccountingProfit" xlink:to="ifrs-full_AccountingProfit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccountingProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AccountingProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before tax</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax expense (income) at applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Taxes on the basis of the Company's domestic tax rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfForeignTaxRates" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of foreign tax rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax rate effect of foreign tax jurisdictions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-deductible expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current year losses for which no deferred tax assets were recognized</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" xlink:label="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" xlink:to="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments of tax expense (income) recognised in the period for current tax of prior periods, including deferred tax impact.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments For Current Tax Of Prior Period Including Deferred Tax Impact</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax income related to prior years</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other tax effects for reconciliation between accounting profit and tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other effects</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CorporateIncomeTaxRate" xlink:label="cntg_CorporateIncomeTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CorporateIncomeTaxRate" xlink:to="cntg_CorporateIncomeTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CorporateIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of corporate income tax rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CorporateIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate Income Tax Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_CorporateIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate income tax rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SolidaritySurchargeRate" xlink:label="cntg_SolidaritySurchargeRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SolidaritySurchargeRate" xlink:to="cntg_SolidaritySurchargeRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SolidaritySurchargeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of solidarity surcharge on corporate income tax rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SolidaritySurchargeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Solidarity Surcharge Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_SolidaritySurchargeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Solidarity surcharge (as a percent)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeTaxRate" xlink:label="cntg_TradeTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeTaxRate" xlink:to="cntg_TradeTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of trade tax rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade Tax Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_TradeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade tax rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="ifrs-full_RightofuseAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsMember" xlink:to="ifrs-full_RightofuseAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use asset</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MeasurementOfServiceContractsMember" xlink:label="cntg_MeasurementOfServiceContractsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MeasurementOfServiceContractsMember" xlink:to="cntg_MeasurementOfServiceContractsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MeasurementOfServiceContractsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for measurement of service contracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MeasurementOfServiceContractsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement of service contracts</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GovernmentGrantsMember" xlink:label="cntg_GovernmentGrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_GovernmentGrantsMember" xlink:to="cntg_GovernmentGrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_GovernmentGrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tis member stands for grant received from governments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_GovernmentGrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government grants</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesMember" xlink:to="ifrs-full_UnusedTaxLossesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unused tax losses</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherCountriesMember" xlink:label="cntg_OtherCountriesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherCountriesMember" xlink:to="cntg_OtherCountriesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherCountriesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for other countries.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherCountriesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other countries</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unused tax losses for which no deferred tax asset recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses carryforwards for which no deferred tax assets were recognized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deductible temporary differences, for which no deferred tax asset is recognized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:label="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:to="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary differences associated with investments for which no deferred tax liability has been recognized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxAssetsOffset" xlink:label="cntg_DeferredTaxAssetsOffset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DeferredTaxAssetsOffset" xlink:to="cntg_DeferredTaxAssetsOffset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DeferredTaxAssetsOffset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of deferred tax asset offset against deferred tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DeferredTaxAssetsOffset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Offset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_DeferredTaxAssetsOffset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax assets, Offset</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxLiabilitiesOffset" xlink:label="cntg_DeferredTaxLiabilitiesOffset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DeferredTaxLiabilitiesOffset" xlink:to="cntg_DeferredTaxLiabilitiesOffset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DeferredTaxLiabilitiesOffset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of deferred tax liabilities offset against deferred tax assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DeferredTaxLiabilitiesOffset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Offset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DeferredTaxLiabilitiesOffset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liabilities, Offset</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxLiabilitiesNet" xlink:label="cntg_DeferredTaxLiabilitiesNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DeferredTaxLiabilitiesNet" xlink:to="cntg_DeferredTaxLiabilitiesNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DeferredTaxLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of deferred tax liabilities net of offsets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DeferredTaxLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_DeferredTaxLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average number of outstanding shares after adjusted for the effect of the corporate reorganization</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:to="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated depreciation, amortization and impairment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="ifrs-full_MethodsOfGenerationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MethodsOfGenerationAxis" xlink:to="ifrs-full_MethodsOfGenerationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MethodsOfGenerationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Methods of generation [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationMember" xlink:label="ifrs-full_MethodsOfGenerationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MethodsOfGenerationMember" xlink:to="ifrs-full_MethodsOfGenerationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MethodsOfGenerationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Methods of generation [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InternallyGeneratedMember" xlink:label="ifrs-full_InternallyGeneratedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InternallyGeneratedMember" xlink:to="ifrs-full_InternallyGeneratedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InternallyGeneratedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Internally generated /acquired</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotInternallyGeneratedMember" xlink:label="ifrs-full_NotInternallyGeneratedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotInternallyGeneratedMember" xlink:to="ifrs-full_NotInternallyGeneratedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotInternallyGeneratedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchased</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BiomarkersMember" xlink:label="cntg_BiomarkersMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BiomarkersMember" xlink:to="cntg_BiomarkersMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BiomarkersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for biomarkers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BiomarkersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Biomarkers</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DatabaseMember" xlink:label="cntg_DatabaseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DatabaseMember" xlink:to="cntg_DatabaseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DatabaseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for database.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DatabaseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Database</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="ifrs-full_LicencesAndFranchisesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesAndFranchisesMember" xlink:to="ifrs-full_LicencesAndFranchisesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesAndFranchisesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rights, licenses, software</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BiomarkersAndDatabasesMember" xlink:label="cntg_BiomarkersAndDatabasesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BiomarkersAndDatabasesMember" xlink:to="cntg_BiomarkersAndDatabasesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BiomarkersAndDatabasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for biomarkers and databases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BiomarkersAndDatabasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Biomarkers and databases</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of changes in intangible assets other than goodwill [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through transfers, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclass</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" xlink:label="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" xlink:to="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The decrease (increase) in intangible assets other than goodwill resulting from deconsolidations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease Increase Through Deconsolidation Intangible Assets Other Than Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deconsolidation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortisation, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization and impairment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment loss recognised in profit or loss, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantMember" xlink:label="cntg_PlantMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PlantMember" xlink:to="cntg_PlantMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PlantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for plant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PlantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plant</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentFurnitureAndFixturesMember" xlink:label="cntg_OtherEquipmentFurnitureAndFixturesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherEquipmentFurnitureAndFixturesMember" xlink:to="cntg_OtherEquipmentFurnitureAndFixturesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherEquipmentFurnitureAndFixturesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for other equipment furniture and fixtures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherEquipmentFurnitureAndFixturesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other equipment, furniture and fixtures</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of changes in property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" xlink:label="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" xlink:to="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in property, plant and equipment resulting from transfers from (to) right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) Through Transfers From (To) Right-of-use Assets, Property, Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclass from (to) right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions other than through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposal of property</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" xlink:label="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" xlink:to="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member stands for the Rostock headquarters building and the Berlin offices.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rostock headquarters building and Berlin offices</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesInBerlinMember" xlink:label="cntg_OfficesInBerlinMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OfficesInBerlinMember" xlink:to="cntg_OfficesInBerlinMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OfficesInBerlinMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for offices in Berlin.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OfficesInBerlinMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offices in Berlin</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesInBostonMember" xlink:label="cntg_OfficesInBostonMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OfficesInBostonMember" xlink:to="cntg_OfficesInBostonMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OfficesInBostonMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for offices in Boston.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OfficesInBostonMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offices in Boston</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantAndMachineryMember" xlink:label="cntg_PlantAndMachineryMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PlantAndMachineryMember" xlink:to="cntg_PlantAndMachineryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PlantAndMachineryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for plant and machinery.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PlantAndMachineryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plant and machinery</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentMember" xlink:label="cntg_OtherEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherEquipmentMember" xlink:to="cntg_OtherEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for other equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="ifrs-full_MotorVehiclesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MotorVehiclesMember" xlink:to="ifrs-full_MotorVehiclesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MotorVehiclesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Motor vehicles</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" xlink:label="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" xlink:to="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for certain motor vehicles and premises with lease terms less than 12 months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Certain motor vehicles and premises</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankGuarantee" xlink:label="cntg_BankGuarantee" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BankGuarantee" xlink:to="cntg_BankGuarantee_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BankGuarantee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of guarantee provided by bank.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BankGuarantee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank Guarantee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_BankGuarantee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank guarantee</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets pledged as collateral for liabilities or contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short term deposits pledged as security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash deposits provided as security for bank loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RentalDeposits" xlink:label="cntg_RentalDeposits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RentalDeposits" xlink:to="cntg_RentalDeposits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RentalDeposits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of rental deposits to be maintained by the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RentalDeposits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_RentalDeposits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental deposits</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTimesLeaseContractCanBeExtended" xlink:label="cntg_NumberOfTimesLeaseContractCanBeExtended" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfTimesLeaseContractCanBeExtended" xlink:to="cntg_NumberOfTimesLeaseContractCanBeExtended_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfTimesLeaseContractCanBeExtended_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of times the lease contract can be extended.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfTimesLeaseContractCanBeExtended_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Times Lease Contract Can Be Extended</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfTimesLeaseContractCanBeExtended_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of times the lease contract can be extended</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseExtensionTerm" xlink:label="cntg_LeaseExtensionTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LeaseExtensionTerm" xlink:to="cntg_LeaseExtensionTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LeaseExtensionTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Extension term of the lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LeaseExtensionTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease Extension Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_LeaseExtensionTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease contract extension term</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RentalExpense" xlink:label="ifrs-full_RentalExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RentalExpense" xlink:to="ifrs-full_RentalExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RentalExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental expense</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantAndEquipmentMember" xlink:label="cntg_PlantAndEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PlantAndEquipmentMember" xlink:to="cntg_PlantAndEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PlantAndEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PlantAndEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions to right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" xlink:label="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" xlink:to="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of right-of-use assets reclassed to property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclass Right of use Assets To Property Plant Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclass to property, plant &amp; equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation expense of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="ifrs-full_LeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughAdditionsLeaseLiabilities" xlink:label="cntg_IncreaseThroughAdditionsLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IncreaseThroughAdditionsLeaseLiabilities" xlink:to="cntg_IncreaseThroughAdditionsLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IncreaseThroughAdditionsLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in lease liabilities, resulting from additions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IncreaseThroughAdditionsLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase Through Additions, Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IncreaseThroughAdditionsLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DecreaseThroughPaymentsLeaseLiabilities" xlink:label="cntg_DecreaseThroughPaymentsLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DecreaseThroughPaymentsLeaseLiabilities" xlink:to="cntg_DecreaseThroughPaymentsLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DecreaseThroughPaymentsLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The decrease in lease liabilities, resulting from payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DecreaseThroughPaymentsLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease Through Payments, Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_DecreaseThroughPaymentsLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense relating to short-term leases for which recognition exemption has been used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rent expenses - short-term leases</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense relating to leases of low-value assets for which recognition exemption has been used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rent expense - leases of low-value assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:label="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:to="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total amount of lease expenses recognised in profit or loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Lease Expenses Recognised In Profit Or Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total amounts recognized in profit or loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashOutflowForLeases" xlink:to="ifrs-full_CashOutflowForLeases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash outflow for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total cash outflows for leases</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:label="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:to="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current raw materials and current production supplies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Raw materials, consumables and supplies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinishedGoods" xlink:label="ifrs-full_FinishedGoods" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinishedGoods" xlink:to="ifrs-full_FinishedGoods_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinishedGoods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current finished goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinishedGoods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finished goods and merchandise</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:to="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of inventories recognised as expense during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Raw materials, consumables and changes in inventories of finished goods and work in process recorded as expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about borrowings [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember" xlink:label="ifrs-full_OtherAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAssetsMember" xlink:to="ifrs-full_OtherAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BerlinOfficesMember" xlink:label="cntg_BerlinOfficesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BerlinOfficesMember" xlink:to="cntg_BerlinOfficesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BerlinOfficesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">It represents the Berlin Offices member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BerlinOfficesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Berlin Offices</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherOfficeAndLaboratoriesMember" xlink:label="cntg_OtherOfficeAndLaboratoriesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherOfficeAndLaboratoriesMember" xlink:to="cntg_OtherOfficeAndLaboratoriesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherOfficeAndLaboratoriesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for other office and laboratories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherOfficeAndLaboratoriesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other office and laboratories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about borrowings [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other receivables and other assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="ifrs-full_NoncurrentReceivablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other non-current receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RentalDepositsNoncurrent" xlink:label="cntg_RentalDepositsNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RentalDepositsNoncurrent" xlink:to="cntg_RentalDepositsNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RentalDepositsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of rental deposits maintained by the company, classified as non-current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RentalDepositsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental Deposits, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_RentalDepositsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets-Rental deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="ifrs-full_OtherNoncurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentReceivables" xlink:to="ifrs-full_OtherNoncurrentReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other non-current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets-Others</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of trade and other receivables and other assets, classified as non-current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade And Other Receivables And Other Assets Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables and contract assets and other assets non-current</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:to="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payables due to holders of vested options</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" xlink:label="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" xlink:to="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current assets, excluding receivables due from shareholders, that the entity does not separately disclose in the same statement or note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Current Assets Excluding Receivables Due From Shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of trade and other receivables and other assets, classified as current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade And Other Receivables And Other Assets Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables and contract assets and other assets current</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The aggregate amount of trade receivables and contract assets and other assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade And Other Receivables And Other Assets, Current And Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total non-current and current trade and other receivables and other assets</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ReceivablesPaymentTerms" xlink:label="cntg_ReceivablesPaymentTerms" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ReceivablesPaymentTerms" xlink:to="cntg_ReceivablesPaymentTerms_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ReceivablesPaymentTerms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period of time after invoice when trade receivables are due.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ReceivablesPaymentTerms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables Payment Terms</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ReceivablesPaymentTerms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables payment terms</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationReceivableForSaleOfLpc" xlink:label="cntg_ConsiderationReceivableForSaleOfLpc" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ConsiderationReceivableForSaleOfLpc" xlink:to="cntg_ConsiderationReceivableForSaleOfLpc_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ConsiderationReceivableForSaleOfLpc_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the amount of consideration receivable for the sale of LPC.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ConsiderationReceivableForSaleOfLpc_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration Receivable For The Sale of LPC</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_ConsiderationReceivableForSaleOfLpc_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration receivable for the sale of LPC</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current value added tax receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaidExpenses" xlink:to="ifrs-full_CurrentPrepaidExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" xlink:label="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" xlink:to="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current receivables from exercise of share based payments granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Receivables from Exercise of Share Based Payments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables from exercise of share based payments granted</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" xlink:label="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" xlink:to="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current receivables from COVID 19 bank or credit card transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Receivables from COVID 19 Bank or Credit Card Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables from COVID 19 bank or credit card transactions</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantsReceivables" xlink:label="cntg_GrantsReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_GrantsReceivables" xlink:to="cntg_GrantsReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_GrantsReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The carrying amount of grants receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_GrantsReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_GrantsReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables from grants</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredBankLoanMember" xlink:label="cntg_SecuredBankLoanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SecuredBankLoanMember" xlink:to="cntg_SecuredBankLoanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SecuredBankLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a secured bank loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SecuredBankLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured bank loan</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityMember" xlink:label="cntg_OverdraftFacilityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OverdraftFacilityMember" xlink:to="cntg_OverdraftFacilityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OverdraftFacilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for an overdraft facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OverdraftFacilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Overdraft facility</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityOneMember" xlink:label="cntg_OverdraftFacilityOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OverdraftFacilityOneMember" xlink:to="cntg_OverdraftFacilityOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OverdraftFacilityOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the first overdraft facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OverdraftFacilityOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Existing Overdraft facility</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityTwoMember" xlink:label="cntg_OverdraftFacilityTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OverdraftFacilityTwoMember" xlink:to="cntg_OverdraftFacilityTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OverdraftFacilityTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the second overdraft facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OverdraftFacilityTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second Overdraft facility</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityThreeMember" xlink:label="cntg_OverdraftFacilityThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OverdraftFacilityThreeMember" xlink:to="cntg_OverdraftFacilityThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OverdraftFacilityThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the third overdraft facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OverdraftFacilityThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Third Overdraft facility</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Line Of Credit Facility Maximum Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum borrowing capacity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued and fully paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued and fully paid, Ending</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued and fully paid, Beginning</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in number of ordinary shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued shares</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExerciseOfOptionsShares" xlink:label="cntg_ExerciseOfOptionsShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ExerciseOfOptionsShares" xlink:to="cntg_ExerciseOfOptionsShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ExerciseOfOptionsShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of shares exercise of stock options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ExerciseOfOptionsShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Of Options Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ExerciseOfOptionsShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of options</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="ifrs-full_NumberOfSharesAuthorised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesAuthorised" xlink:to="ifrs-full_NumberOfSharesAuthorised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesAuthorised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares authorised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesAuthorised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Authorized common shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Par value per share (in euros per share)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:to="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The total number of common shares issued and offered by existing shareholders in conjunction with the follow-on public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Common Shares Issued And Offered By Prior Shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total number of shares issued and sold in follow-on public offering</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:to="cntg_NumberOfCommonSharesOfferedByPriorShareholders_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of shares offered by existing shareholders in conjunction with the follow-on public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Common Shares Offered By Prior Shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares offered by existing shareholders</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AuthorizedButUnissuedShareCapital" xlink:label="cntg_AuthorizedButUnissuedShareCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AuthorizedButUnissuedShareCapital" xlink:to="cntg_AuthorizedButUnissuedShareCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AuthorizedButUnissuedShareCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of authorized but unissued share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AuthorizedButUnissuedShareCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Authorized But Unissued Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AuthorizedButUnissuedShareCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Authorized but unissued share capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share premium included in capital reserve</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial liabilities [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of financial liabilities [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="ifrs-full_FinancialLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities, class [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesMember" xlink:label="cntg_SecuredCreditLinesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SecuredCreditLinesMember" xlink:to="cntg_SecuredCreditLinesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SecuredCreditLinesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for secured credit lines.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SecuredCreditLinesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured bank loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherBankLoansMember" xlink:label="cntg_OtherBankLoansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OtherBankLoansMember" xlink:to="cntg_OtherBankLoansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OtherBankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for liabilities arising from financing activities related to other bank loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OtherBankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other bank loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsBankOverdraftsMember" xlink:to="cntg_IfrsBankOverdraftsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsBankOverdraftsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for bank overdrafts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsBankOverdraftsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IFRS Bank overdrafts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsBankOverdraftsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank overdrafts</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_NonCurrentFinancialLiabilitiesInterestBearing" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NonCurrentFinancialLiabilitiesInterestBearing" xlink:to="cntg_NonCurrentFinancialLiabilitiesInterestBearing_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NonCurrentFinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of non-current financial liabilities interest bearing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NonCurrentFinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non current Financial Liabilities Interest Bearing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NonCurrentFinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_CurrentFinancialLiabilitiesInterestBearing" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CurrentFinancialLiabilitiesInterestBearing" xlink:to="cntg_CurrentFinancialLiabilitiesInterestBearing_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CurrentFinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current financial liabilities interest bearing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CurrentFinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Financial Liabilities Interest Bearing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_CurrentFinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialLiabilitiesInterestBearing" xlink:label="cntg_FinancialLiabilitiesInterestBearing" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FinancialLiabilitiesInterestBearing" xlink:to="cntg_FinancialLiabilitiesInterestBearing_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of financial liabilities interest bearing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Liabilities Interest Bearing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cntg_FinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total non-current and current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_FinancialLiabilitiesInterestBearing_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" xlink:label="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" xlink:to="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for secured bank loans, bearing a maturity period of 2017-25, three.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured bank loans, bearing maturity period of 2017-25, three</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsOneMember" xlink:label="cntg_BankOverdraftsOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BankOverdraftsOneMember" xlink:to="cntg_BankOverdraftsOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BankOverdraftsOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for bank overdrafts, one.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BankOverdraftsOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank overdrafts, one</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsTwoMember" xlink:label="cntg_BankOverdraftsTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BankOverdraftsTwoMember" xlink:to="cntg_BankOverdraftsTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BankOverdraftsTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for bank overdrafts, two.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BankOverdraftsTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank overdrafts, two</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsThreeMember" xlink:label="cntg_BankOverdraftsThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BankOverdraftsThreeMember" xlink:to="cntg_BankOverdraftsThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BankOverdraftsThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for bank overdrafts, three.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BankOverdraftsThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank overdrafts, three</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsOneAndThreeMember" xlink:label="cntg_BankOverdraftsOneAndThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BankOverdraftsOneAndThreeMember" xlink:to="cntg_BankOverdraftsOneAndThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BankOverdraftsOneAndThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for both the categories of bank overdrafts, namely, one and three together.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BankOverdraftsOneAndThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank overdrafts, one and three</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nominal interest rate at commencement of leases</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" xlink:label="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" xlink:to="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of short-term deposits pledged as security for liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short Term Deposits Pledged as Security for Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term deposits, pledged as security</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:label="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:to="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank overdrafts</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of reconciliation of liabilities arising from financing activities [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of reconciliation of liabilities arising from financing activities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of reconciliation of liabilities arising from financing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GovernmentGrants" xlink:label="ifrs-full_GovernmentGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GovernmentGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government grants (deferred income)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherPayablesOther" xlink:label="cntg_TradeAndOtherPayablesOther" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeAndOtherPayablesOther" xlink:to="cntg_TradeAndOtherPayablesOther_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeAndOtherPayablesOther_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of trade and other payables, classified as other.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeAndOtherPayablesOther_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade And Other Payables, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_TradeAndOtherPayablesOther_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Others</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="ifrs-full_TradeAndOtherPayables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TradeAndOtherPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables and other liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayables" xlink:label="ifrs-full_NoncurrentPayables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_NoncurrentPayables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other non-current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProvisionForOutstandingInvoices" xlink:label="cntg_ProvisionForOutstandingInvoices" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ProvisionForOutstandingInvoices" xlink:to="cntg_ProvisionForOutstandingInvoices_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ProvisionForOutstandingInvoices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of provision for outstanding invoices.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ProvisionForOutstandingInvoices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provision for Outstanding Invoices</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ProvisionForOutstandingInvoices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provision for outstanding invoices</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term employee benefits accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Personnel related liabilities for vacation and bonuses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxPayables" xlink:label="ifrs-full_CurrentValueAddedTaxPayables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentValueAddedTaxPayables" xlink:to="ifrs-full_CurrentValueAddedTaxPayables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentValueAddedTaxPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current value added tax payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentValueAddedTaxPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">VAT payable</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesForWageAndChurchTax" xlink:label="cntg_LiabilitiesForWageAndChurchTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LiabilitiesForWageAndChurchTax" xlink:to="cntg_LiabilitiesForWageAndChurchTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LiabilitiesForWageAndChurchTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of liabilities for wage and church tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LiabilitiesForWageAndChurchTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities For Wage And Church Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_LiabilitiesForWageAndChurchTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities for wage and church tax</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2016CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2016CashSettledMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_VirtualShareOptionProgram2016CashSettledMember" xlink:to="cntg_VirtualShareOptionProgram2016CashSettledMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_VirtualShareOptionProgram2016CashSettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for virtual share option program 2016 (cash settled).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_VirtualShareOptionProgram2016CashSettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Virtual share option program 2016 (Cash-settled)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentForSettlementOfStockOptions" xlink:label="cntg_PaymentForSettlementOfStockOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PaymentForSettlementOfStockOptions" xlink:to="cntg_PaymentForSettlementOfStockOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PaymentForSettlementOfStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash outflow for payment for settlement of stock options. [Refer: Property, plant and equipment]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PaymentForSettlementOfStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment for Settlement of Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_PaymentForSettlementOfStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for settlement of stock options</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" xlink:label="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" xlink:to="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum amount of share-based award grants allowed under the plan expressed as a percentage of issued share capital immediately following the completion of the initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Threshold Maximum As Percentage Of Issued Share Capital Allowed For Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum amount of share-based award grants allowed under the plan (as a percent)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" xlink:label="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" xlink:to="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of additional share-based award grants allowed under the plan on January 1 2020 and on January 1 of each calendar year thereafter, expressed as a percentage of issued share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Subsequent Shares Authorized Annually As Percentage Of Issued Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional share-based award grants allowed under the plan (as a percent)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsAwardTypeAxis" xlink:to="cntg_IfrsAwardTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsAwardTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information by type of award under share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsAwardTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Award Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AwardTypeDomain" xlink:to="cntg_AwardTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AwardTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award under share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AwardTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_StockOptionsMember" xlink:to="cntg_StockOptionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_StockOptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for stock options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_StockOptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" xlink:to="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of common shares per share options granted in a share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement By Share-based Payment Award, Number Of Common Shares Per Option Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of common shares per option granted</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price of share options granted</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" xlink:label="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" xlink:to="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period subsequent to the completion of the initial public offering in which the options may not be exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lock Up Period Subsequent To Completion Of Initial Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lock-up period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel compensation, share-based payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment transactions</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOutstandingShareOptionsAbstract" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract" xlink:to="cntg_NumberOfOutstandingShareOptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Outstanding Share Options [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding as of December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at January 1</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:to="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of share options cancelled in share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Share Options Cancelled In Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cancelled during the year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:to="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of share options vested in a share-based payment arrangement."</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Share Options Vested In Share-based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested as of December 31</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable as of December 31</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Exercise Price Of Share Options [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">WAEP</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding as of December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding as of January 1</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The weighted average exercise price of share options cancelled in share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Exercise Price Of Share Options Cancelled In Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cancelled during the year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">"The weighted average exercise price of share options vested in a share-based payment arrangement."</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Exercise Price Of Share Options Vested In Share-based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested as of December 31</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable as of December 31</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsVestingAxis" xlink:to="cntg_IfrsVestingAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsVestingAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Vesting [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsVestingAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Vesting [Axis]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsVestingDomain" xlink:to="cntg_IfrsVestingDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsVestingDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Vesting [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsVestingDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Vesting [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedPaymentArrangementTrancheOneMember" xlink:label="cntg_ShareBasedPaymentArrangementTrancheOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ShareBasedPaymentArrangementTrancheOneMember" xlink:to="cntg_ShareBasedPaymentArrangementTrancheOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ShareBasedPaymentArrangementTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ShareBasedPaymentArrangementTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vest immediately</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedPaymentArrangementTrancheTwoMember" xlink:label="cntg_ShareBasedPaymentArrangementTrancheTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ShareBasedPaymentArrangementTrancheTwoMember" xlink:to="cntg_ShareBasedPaymentArrangementTrancheTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ShareBasedPaymentArrangementTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ShareBasedPaymentArrangementTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vest in two equal annual instalments</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSUs</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MemberOfSupervisoryBoardMember" xlink:label="cntg_MemberOfSupervisoryBoardMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MemberOfSupervisoryBoardMember" xlink:to="cntg_MemberOfSupervisoryBoardMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MemberOfSupervisoryBoardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for member of the supervisory board.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MemberOfSupervisoryBoardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Member of the supervisory board</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:label="srt_ManagementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ManagementMember" xlink:to="srt_ManagementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ManagementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Management</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VestingInFourTranchesMember" xlink:label="cntg_VestingInFourTranchesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_VestingInFourTranchesMember" xlink:to="cntg_VestingInFourTranchesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_VestingInFourTranchesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Vesting in four tranches.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_VestingInFourTranchesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting in four tranches</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantOfRestrictedStockUnitsMember" xlink:label="cntg_GrantOfRestrictedStockUnitsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_GrantOfRestrictedStockUnitsMember" xlink:to="cntg_GrantOfRestrictedStockUnitsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_GrantOfRestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the grant of restricted stock units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_GrantOfRestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant of RSUs</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of vesting of award under share-based payment arrangement each year after grant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting percentage</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageFairValueOfShareOptionsOutstanding" xlink:label="cntg_WeightedAverageFairValueOfShareOptionsOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_WeightedAverageFairValueOfShareOptionsOutstanding" xlink:to="cntg_WeightedAverageFairValueOfShareOptionsOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_WeightedAverageFairValueOfShareOptionsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The weighted average fair value of share options outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_WeightedAverageFairValueOfShareOptionsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Fair Value Of Share Options Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_WeightedAverageFairValueOfShareOptionsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average fair value of options outstanding</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period which the right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSUs granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period subsequent to grant date after which the share-based award expires.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Share based Compensation Arrangement By Share based Payment Award Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expiration Date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xlink:label="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xlink:to="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Incremental fair value granted, modified share-based payment arrangements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Incremental fair value</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTranches" xlink:label="cntg_NumberOfTranches" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfTranches" xlink:to="cntg_NumberOfTranches_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfTranches_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of equal tranches in which the granted RSU and options shall vest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfTranches_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Tranches</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfTranches_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of tranches</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IFRS Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period 1.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting period</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" xlink:to="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of replacement awards granted in a share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Share Options Replacement Awards Granted In Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Replacement awards granted during the year</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tranche one</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tranche two</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tranche three</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedOneMember" xlink:label="cntg_RsuGrantedOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RsuGrantedOneMember" xlink:to="cntg_RsuGrantedOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RsuGrantedOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to RSU granted one.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RsuGrantedOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSU Granted One</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedTwoMember" xlink:label="cntg_RsuGrantedTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RsuGrantedTwoMember" xlink:to="cntg_RsuGrantedTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RsuGrantedTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to RSU granted two.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RsuGrantedTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSU Granted Two</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedThreeMember" xlink:label="cntg_RsuGrantedThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RsuGrantedThreeMember" xlink:to="cntg_RsuGrantedThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RsuGrantedThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to RSU granted one.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RsuGrantedThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSU Granted Three</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedFourMember" xlink:label="cntg_RsuGrantedFourMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RsuGrantedFourMember" xlink:to="cntg_RsuGrantedFourMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RsuGrantedFourMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to RSU granted four.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RsuGrantedFourMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSU Granted Four</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedFiveMember" xlink:label="cntg_RsuGrantedFiveMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RsuGrantedFiveMember" xlink:to="cntg_RsuGrantedFiveMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RsuGrantedFiveMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to RSU granted five.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RsuGrantedFiveMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSU Granted Five</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionsGrantedTwoMember" xlink:label="cntg_OptionsGrantedTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OptionsGrantedTwoMember" xlink:to="cntg_OptionsGrantedTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OptionsGrantedTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to Options granted two.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OptionsGrantedTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Granted Two</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsChiefExecutiveOfficerMember" xlink:to="cntg_IfrsChiefExecutiveOfficerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsChiefExecutiveOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Person with designation of chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsChiefExecutiveOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chief Executive Officer</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Person with former designation of chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Former Chief Executive Officer</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerChiefFinancialOfficerMember" xlink:label="cntg_FormerChiefFinancialOfficerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FormerChiefFinancialOfficerMember" xlink:to="cntg_FormerChiefFinancialOfficerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FormerChiefFinancialOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Person with designation of former chief financial officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FormerChiefFinancialOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Former Chief Financial Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_FormerChiefFinancialOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Former Chief Financial Officer</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChiefInformationOfficerMember" xlink:label="cntg_ChiefInformationOfficerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ChiefInformationOfficerMember" xlink:to="cntg_ChiefInformationOfficerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ChiefInformationOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Person with designation of chief information officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ChiefInformationOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chief Information Officer</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EmployeesMember" xlink:label="cntg_EmployeesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_EmployeesMember" xlink:to="cntg_EmployeesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_EmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to employees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_EmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employees</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ThresholdTradingDays" xlink:label="cntg_ThresholdTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ThresholdTradingDays" xlink:to="cntg_ThresholdTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold trading days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ThresholdTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading days</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePrice2019" xlink:to="ifrs-full_WeightedAverageSharePrice2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePrice2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageSharePrice2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Awards</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanMember" xlink:label="cntg_ChairmanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ChairmanMember" xlink:to="cntg_ChairmanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ChairmanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to chairman.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ChairmanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chairman</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ViceChairmanMember" xlink:label="cntg_ViceChairmanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ViceChairmanMember" xlink:to="cntg_ViceChairmanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ViceChairmanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to vice chairman.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ViceChairmanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vice chairman</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanOfAuditCommitteeMember" xlink:label="cntg_ChairmanOfAuditCommitteeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ChairmanOfAuditCommitteeMember" xlink:to="cntg_ChairmanOfAuditCommitteeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ChairmanOfAuditCommitteeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to chairman of the audit committee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ChairmanOfAuditCommitteeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chairman of audit committee</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanOfCompensationCommitteeMember" xlink:label="cntg_ChairmanOfCompensationCommitteeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ChairmanOfCompensationCommitteeMember" xlink:to="cntg_ChairmanOfCompensationCommitteeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ChairmanOfCompensationCommitteeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to chairman of the compensation committee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ChairmanOfCompensationCommitteeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Chairman of compensation committee</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" xlink:to="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to when the volume weighted average stock price equals or exceeds USD 24 prior to January 1st, 2023.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Volume weighted average stock price equals or exceeds USD 24 prior to January 1st, 2023</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" xlink:to="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to when the volume weighted average stock price equals or exceeds USD 33 prior to January 1st, 2024.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Volume weighted average stock price equals or exceeds USD 33 prior to January 1st, 2024.</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:to="cntg_PerformanceBasedRestrictedStockUnitsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to performance based restricted stock units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance Based RSUs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of Individual [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of Individual [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrBerndtModigMember" xlink:label="cntg_MrBerndtModigMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MrBerndtModigMember" xlink:to="cntg_MrBerndtModigMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MrBerndtModigMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Mr. Berndt Modig.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MrBerndtModigMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Mr. Berndt Modig</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_MrBerndtModigMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Mr, Modig</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PeerSchatzMember" xlink:label="cntg_PeerSchatzMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PeerSchatzMember" xlink:to="cntg_PeerSchatzMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PeerSchatzMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the member of supervisory board, namely, Peer Schatz.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PeerSchatzMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Peer Schatz</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrJonathanGSheldonMember" xlink:label="cntg_MrJonathanGSheldonMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MrJonathanGSheldonMember" xlink:to="cntg_MrJonathanGSheldonMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MrJonathanGSheldonMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Mr. Jonathan G. Sheldon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MrJonathanGSheldonMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Mr. Jonathan G. Sheldon</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockAxis" xlink:label="cntg_IfrsSaleOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsSaleOfStockAxis" xlink:to="cntg_IfrsSaleOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsSaleOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information by type of sale of the entity's stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsSaleOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IFRS Sale of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SaleOfStockDomain" xlink:label="cntg_SaleOfStockDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SaleOfStockDomain" xlink:to="cntg_SaleOfStockDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SaleOfStockDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SaleOfStockDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfInstallments" xlink:label="cntg_NumberOfInstallments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfInstallments" xlink:to="cntg_NumberOfInstallments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of installments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Installments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_NumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of installments</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" xlink:label="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" xlink:to="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The value of ordinary shares to be issued as per share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of Ordinary Shares To be Issued, Share Based Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of ordinary shares to be issued as per share based payment arrangement</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No of RSUs exercised during the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of units vested during the period</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" xlink:label="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" xlink:to="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The average stock price that must be met or exceeded for vesting in the share-based payment arrangement. If this price is not met in the defined period, the shares will be forfeited in their entirety.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average Stock Price Hurdle Price For Vesting Sharebased Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share hurdle price</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:label="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:to="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of equity ordinary shares taken as base for issuance of units under share based payment arrangements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of Equity, Base For Issuance of Units Under Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of equity ordinary shares</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionsStrikePrice" xlink:label="cntg_OptionsStrikePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OptionsStrikePrice" xlink:to="cntg_OptionsStrikePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OptionsStrikePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options strike price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OptionsStrikePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Strike Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_OptionsStrikePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Strike price of options</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" xlink:label="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" xlink:to="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum percentage of lost time injury will be taken as base under share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Lost Time Injury Factor, Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum percentage of lost time injury</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceComputationTradingDays" xlink:label="cntg_VolumeWeightedAverageStockPriceComputationTradingDays" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_VolumeWeightedAverageStockPriceComputationTradingDays" xlink:to="cntg_VolumeWeightedAverageStockPriceComputationTradingDays_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_VolumeWeightedAverageStockPriceComputationTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period of tradings days will be taken as base for computation volume weighted average stock price under share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_VolumeWeightedAverageStockPriceComputationTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Volume Weighted Average Stock Price Computation Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_VolumeWeightedAverageStockPriceComputationTradingDays_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period of tradings days</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:label="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:to="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of additional equity ordinary shares taken as base for issuance of units under share based payment arrangements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of Additional Equity, Base For Issuance of Units Under Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of additional equity ordinary shares</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfAwardConstitutesRestrictedStockUnits" xlink:label="cntg_PercentageOfAwardConstitutesRestrictedStockUnits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PercentageOfAwardConstitutesRestrictedStockUnits" xlink:to="cntg_PercentageOfAwardConstitutesRestrictedStockUnits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PercentageOfAwardConstitutesRestrictedStockUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of awards issued represents restricted stock units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PercentageOfAwardConstitutesRestrictedStockUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Award Constitutes Restricted Stock Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_PercentageOfAwardConstitutesRestrictedStockUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of award constitutes RSU's</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfAwardConstitutesStockOptions" xlink:label="cntg_PercentageOfAwardConstitutesStockOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PercentageOfAwardConstitutesStockOptions" xlink:to="cntg_PercentageOfAwardConstitutesStockOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PercentageOfAwardConstitutesStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of awards issued represents Stock Options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PercentageOfAwardConstitutesStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Award Constitutes Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_PercentageOfAwardConstitutesStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of award constitutes stock options</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOtherEquityInstrumentsAbstract" xlink:label="cntg_NumberOfOtherEquityInstrumentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfOtherEquityInstrumentsAbstract" xlink:to="cntg_NumberOfOtherEquityInstrumentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfOtherEquityInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to number of other equity instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfOtherEquityInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" xlink:to="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">WAEP</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionPrograms2016And2017Member" xlink:label="cntg_VirtualShareOptionPrograms2016And2017Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_VirtualShareOptionPrograms2016And2017Member" xlink:to="cntg_VirtualShareOptionPrograms2016And2017Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_VirtualShareOptionPrograms2016And2017Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for virtual share option programs 2016 and 2017.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_VirtualShareOptionPrograms2016And2017Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Virtual share option programs 2016 and 2017</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2017CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2017CashSettledMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_VirtualShareOptionProgram2017CashSettledMember" xlink:to="cntg_VirtualShareOptionProgram2017CashSettledMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_VirtualShareOptionProgram2017CashSettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for virtual share option program 2017 (cash settled).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_VirtualShareOptionProgram2017CashSettledMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Virtual share option program 2017 (Cash settled)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ManagementBoardAndEmployeesMember" xlink:label="cntg_ManagementBoardAndEmployeesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ManagementBoardAndEmployeesMember" xlink:to="cntg_ManagementBoardAndEmployeesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ManagementBoardAndEmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to management board and employees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ManagementBoardAndEmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Management board and employees</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New CEO</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrModigAndMrSheldonMember" xlink:label="cntg_MrModigAndMrSheldonMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MrModigAndMrSheldonMember" xlink:to="cntg_MrModigAndMrSheldonMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MrModigAndMrSheldonMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Mr. Modig and Mr. Sheldon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MrModigAndMrSheldonMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Mr. Modig and Mr. Sheldon</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Mr.KimMember" xlink:label="cntg_Mr.KimMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_Mr.KimMember" xlink:to="cntg_Mr.KimMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_Mr.KimMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Mr. Kim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_Mr.KimMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Mr. Kim</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:label="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:to="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key Assumptions Used To Derive Option Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key assumptions used to derive the option value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average share price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price at grant date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected volatility, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Volatility (%)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk free interest rate, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free interest rate (%)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected dividend as percentage, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dividend yield (%)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option life, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option term (years)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:label="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:to="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">N/a</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key Assumptions Used to Derive Other Equity Instruments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key assumptions used to derive other equity instruments value</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExercisePriceOtherEquityInstrumentsGranted" xlink:label="cntg_ExercisePriceOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ExercisePriceOtherEquityInstrumentsGranted" xlink:to="cntg_ExercisePriceOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ExercisePriceOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The exercise price of other equity instruments granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ExercisePriceOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price, Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ExercisePriceOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price (USD)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" xlink:label="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" xlink:to="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The weighted average share price used as input to the option pricing model to calculate the fair value of other equity instruments granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Share Price, Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price at grant date (USD)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:label="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:to="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The expected volatility of the share price used to calculate the fair value of the other equity instruments granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected Volatility, Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Volatility (%)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:label="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:to="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for other equity instruments granted is expressed, with a remaining term equal to the expected term of the option being valued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk Free Interest Rate, Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Riskfree interest rate (%)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" xlink:label="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" xlink:to="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of an expected dividend used to calculate the fair value of other equity instruments granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected Dividend As Percentage, Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dividend yield (%)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionLifeOtherEquityInstrumentsGranted" xlink:label="cntg_OptionLifeOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OptionLifeOtherEquityInstrumentsGranted" xlink:to="cntg_OptionLifeOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OptionLifeOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The option life of other equity instruments granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OptionLifeOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option Life, Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_OptionLifeOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected contractual life (years)</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" xlink:label="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" xlink:to="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The weighted average fair value per share used as input to the option pricing model to calculate the fair value of other equity instruments granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Fair Value Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average fair value (USD)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from share-based payment transactions [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses arising from share-based payment transactions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from cash-settled share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses arising from cash-settled share-based payment transactions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from equity-settled share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses arising from equity-settled share-based payment transactions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="ifrs-full_DisclosureOfProvisionMatrixTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable" xlink:to="ifrs-full_DisclosureOfProvisionMatrixTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProvisionMatrixTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of provision matrix [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of financial instruments [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments, class [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeReceivablesAndContractAssetsMember" xlink:label="cntg_TradeReceivablesAndContractAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeReceivablesAndContractAssetsMember" xlink:to="cntg_TradeReceivablesAndContractAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeReceivablesAndContractAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for trade receivables and contract assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeReceivablesAndContractAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables and contract assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivablesMember" xlink:to="ifrs-full_TradeReceivablesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusAxis" xlink:label="ifrs-full_PastDueStatusAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PastDueStatusAxis" xlink:to="ifrs-full_PastDueStatusAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PastDueStatusAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Past due status [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusMember" xlink:label="ifrs-full_PastDueStatusMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PastDueStatusMember" xlink:to="ifrs-full_PastDueStatusMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PastDueStatusMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Past due status [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentMember" xlink:label="ifrs-full_CurrentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentMember" xlink:to="ifrs-full_CurrentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Not past due</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" xlink:label="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" xlink:to="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a time band of later than one day and not later than one month.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Past due 1 to 30 day</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:to="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">1 - 3 months</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsMember" xlink:label="ifrs-full_LaterThanThreeMonthsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeMonthsMember" xlink:to="ifrs-full_LaterThanThreeMonthsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Past due more than 90 days</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="ifrs-full_LaterThanOneYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearMember" xlink:to="ifrs-full_LaterThanOneYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">More than 365 days</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" xlink:label="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" xlink:to="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Middle East, Europe, North America, Asia Pacific Regions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">MENA</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:to="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of financial assets [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:to="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity's total for impairment of financial assets [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPastDueButNotImpairedMember" xlink:label="ifrs-full_FinancialAssetsPastDueButNotImpairedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsPastDueButNotImpairedMember" xlink:to="ifrs-full_FinancialAssetsPastDueButNotImpairedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsPastDueButNotImpairedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Specific bad debt allowances</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of risks [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_TypesOfRisksMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risks [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreditRiskMember" xlink:to="ifrs-full_CreditRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CreditRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit risk</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="ifrs-full_DisclosureOfProvisionMatrixLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:to="ifrs-full_DisclosureOfProvisionMatrixLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProvisionMatrixLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of provision matrix [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfProvisionMatrixLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit risk exposure</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables and contract assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedCreditLossRate" xlink:label="ifrs-full_ExpectedCreditLossRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedCreditLossRate" xlink:to="ifrs-full_ExpectedCreditLossRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedCreditLossRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected credit loss rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpectedCreditLossRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected credit loss rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allowance account for credit losses of financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">As of December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">As of January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected credit loss</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" xlink:label="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" xlink:to="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of top diagnostic customers due in trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Top Diagnostic Customers Due in Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of top diagnostic customers</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfOverdueBalances" xlink:label="cntg_PercentageOfOverdueBalances" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PercentageOfOverdueBalances" xlink:to="cntg_PercentageOfOverdueBalances_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PercentageOfOverdueBalances_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The over due balances as a percentage of total overdue balances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PercentageOfOverdueBalances_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Overdue Balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_PercentageOfOverdueBalances_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of overdue balances</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeReceivablesAverageTurnoverPeriod" xlink:label="cntg_TradeReceivablesAverageTurnoverPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeReceivablesAverageTurnoverPeriod" xlink:to="cntg_TradeReceivablesAverageTurnoverPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeReceivablesAverageTurnoverPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The average turnover period on trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeReceivablesAverageTurnoverPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade Receivables Average Turnover Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_TradeReceivablesAverageTurnoverPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average turnover period on trade receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:to="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of changes in allowance account for credit losses of financial assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Development of impairment losses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reversal, allowance account for credit losses of financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derecognition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis for financial assets held for managing liquidity risk [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" xlink:label="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" xlink:to="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member stands for trade and other receivables due with in two months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other receivables due with in two months</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradePayablesMember" xlink:label="cntg_TradePayablesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradePayablesMember" xlink:to="cntg_TradePayablesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradePayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member stands for trade payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradePayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_AggregatedTimeBandsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AggregatedTimeBandsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregated time bands [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NotLaterThanTwoMonthsMember" xlink:label="cntg_NotLaterThanTwoMonthsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NotLaterThanTwoMonthsMember" xlink:to="cntg_NotLaterThanTwoMonthsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NotLaterThanTwoMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a time band of not later than two months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NotLaterThanTwoMonthsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less than 2 months</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" xlink:label="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" xlink:to="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a time band of later than two months and not later than one year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2 to 12 months</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">1 - 5 years</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">More than five years</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities arising from financing activities [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities arising from financing activities [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentFinancialLiabilitiesMember" xlink:label="cntg_NonCurrentFinancialLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NonCurrentFinancialLiabilitiesMember" xlink:to="cntg_NonCurrentFinancialLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NonCurrentFinancialLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for non-current financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NonCurrentFinancialLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current financial liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" xlink:to="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for liabilities arising from financing activities related to non-current portion of lease liabilities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current lease liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentFinancialLiabilitiesMember" xlink:label="cntg_CurrentFinancialLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CurrentFinancialLiabilitiesMember" xlink:to="cntg_CurrentFinancialLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CurrentFinancialLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for current financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CurrentFinancialLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current financial liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NoncurrentSecuredBankLoansMember" xlink:label="cntg_NoncurrentSecuredBankLoansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NoncurrentSecuredBankLoansMember" xlink:to="cntg_NoncurrentSecuredBankLoansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NoncurrentSecuredBankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for noncurrent secured bank loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NoncurrentSecuredBankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current portion of secured bank loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentMunicipalLoansMember" xlink:label="cntg_NonCurrentMunicipalLoansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_NonCurrentMunicipalLoansMember" xlink:to="cntg_NonCurrentMunicipalLoansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_NonCurrentMunicipalLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">It stands for Non current municipal loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_NonCurrentMunicipalLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Municipal loan</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentSecuredBankLoansMember" xlink:label="cntg_CurrentSecuredBankLoansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CurrentSecuredBankLoansMember" xlink:to="cntg_CurrentSecuredBankLoansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CurrentSecuredBankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for current secured bank loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CurrentSecuredBankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current portion of secured bank loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankLoansMember" xlink:label="cntg_BankLoansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_BankLoansMember" xlink:to="cntg_BankLoansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_BankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Bank loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_BankLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank Loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancingActivitiesMunicipalLoansMember" xlink:label="cntg_FinancingActivitiesMunicipalLoansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FinancingActivitiesMunicipalLoansMember" xlink:to="cntg_FinancingActivitiesMunicipalLoansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FinancingActivitiesMunicipalLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for liabilities arising from financing activities related to municipal loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FinancingActivitiesMunicipalLoansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Municipal loans</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" xlink:to="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for liabilities arising from financing activities related to current portion of lease liabilities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis for financial assets held for managing liquidity risk [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity risk</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfInterestBearingLoansMatureInOneYear" xlink:label="cntg_PercentageOfInterestBearingLoansMatureInOneYear" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PercentageOfInterestBearingLoansMatureInOneYear" xlink:to="cntg_PercentageOfInterestBearingLoansMatureInOneYear_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PercentageOfInterestBearingLoansMatureInOneYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of interest-bearing loans will mature in one year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PercentageOfInterestBearingLoansMatureInOneYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Interest-Bearing Loans Mature in One Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_PercentageOfInterestBearingLoansMatureInOneYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest-bearing loans will mature in less than one year (in percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:label="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:to="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets held for managing liquidity risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected cash flows</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" xlink:label="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" xlink:to="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The expected difference between the cash outflows from trade payables and the cash inflow from receivables within two months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected Difference Between Cash Outflow From Trade Payables And Cash Inflow From Receivables With in Two Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected cash flows receivables with in two months</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharesIssuedPricePerShare" xlink:label="cntg_IfrsSharesIssuedPricePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsSharesIssuedPricePerShare" xlink:to="cntg_IfrsSharesIssuedPricePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsSharesIssuedPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Per share or per unit amount of equity securities issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsSharesIssuedPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Shares Issued, Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsSharesIssuedPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common per share</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesInterestRate" xlink:label="cntg_SecuredCreditLinesInterestRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SecuredCreditLinesInterestRate" xlink:to="cntg_SecuredCreditLinesInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SecuredCreditLinesInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of interest rate on secured credit lines.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SecuredCreditLinesInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured Credit Lines, Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_SecuredCreditLinesInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate on secured credit lines</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesUtilized" xlink:label="cntg_SecuredCreditLinesUtilized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SecuredCreditLinesUtilized" xlink:to="cntg_SecuredCreditLinesUtilized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SecuredCreditLinesUtilized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The utilized amount on secured credit lines.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SecuredCreditLinesUtilized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured Credit Lines, Utilized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_SecuredCreditLinesUtilized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Utilized amount of secured credit lines</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="ifrs-full_BankBorrowingsUndiscountedCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:to="ifrs-full_BankBorrowingsUndiscountedCashFlows_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BankBorrowingsUndiscountedCashFlows_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bank borrowings, undiscounted cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BankBorrowingsUndiscountedCashFlows_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured bank loans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-derivative financial liabilities, undiscounted cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in liabilities arising from financing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of liabilities arising from financing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">End of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning of year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through financing cash flows, liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in liabilities arising from financing activities resulting from additions. [Refer: Liabilities arising from financing activities]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase Through Additions Financing Cash Flows Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in liabilities arising from financing activities resulting from changes in maturity. [Refer: Liabilities arising from financing activities]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase Through Changes In Maturity Financing Cash Flows Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in maturity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of nature and extent of risks arising from financial instruments [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_AllCurrenciesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_AllCurrenciesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">All Currencies [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="currency_USD" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_USD_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_INR" xlink:label="currency_INR" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_INR" xlink:to="currency_INR_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_INR_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INR</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AED" xlink:label="currency_AED" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_AED" xlink:to="currency_AED_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_AED_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">AED</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="ifrs-full_AssetsAndLiabilitiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets and liabilities [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="ifrs-full_AssetsAndLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAndLiabilitiesMember" xlink:to="ifrs-full_AssetsAndLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAndLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets and liabilities [member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradePayableAndOtherLiabilitiesMember" xlink:label="cntg_TradePayableAndOtherLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_TradePayableAndOtherLiabilitiesMember" xlink:to="cntg_TradePayableAndOtherLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_TradePayableAndOtherLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for trade payables and other liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_TradePayableAndOtherLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables and other liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency risk</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of nature and extent of risks arising from financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency risk</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk exposure associated with instruments sharing characteristic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net exposure</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of subsidiaries [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGMember" xlink:label="cntg_CentogeneGMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneGMember" xlink:to="cntg_CentogeneGMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneGMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Centogene AG.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneGMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centogene GmbH</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneFzLlcUnitedArabEmiratesMember" xlink:label="cntg_CentogeneFzLlcUnitedArabEmiratesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneFzLlcUnitedArabEmiratesMember" xlink:to="cntg_CentogeneFzLlcUnitedArabEmiratesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneFzLlcUnitedArabEmiratesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to Centogene Fzllc, United arab emirates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneFzLlcUnitedArabEmiratesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centogene Fz Llc, United Arab Emirates</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneUsLlcBurlingtonUsaMember" xlink:label="cntg_CentogeneUsLlcBurlingtonUsaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneUsLlcBurlingtonUsaMember" xlink:to="cntg_CentogeneUsLlcBurlingtonUsaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneUsLlcBurlingtonUsaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Centogene US LLC, Burlington, USA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneUsLlcBurlingtonUsaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centogene US LLC, Burlington, USA</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGmbhViennaMember" xlink:label="cntg_CentogeneGmbhViennaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneGmbhViennaMember" xlink:to="cntg_CentogeneGmbhViennaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneGmbhViennaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Centogene GmbH, Vienna.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneGmbhViennaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centogene GmbH, Vienna</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneIndiaPvt.LtdMember" xlink:label="cntg_CentogeneIndiaPvt.LtdMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneIndiaPvt.LtdMember" xlink:to="cntg_CentogeneIndiaPvt.LtdMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneIndiaPvt.LtdMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Centogene India Pvt. Ltd.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneIndiaPvt.LtdMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centogene India Pvt. Ltd</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneSwitzerlandAgMember" xlink:label="cntg_CentogeneSwitzerlandAgMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneSwitzerlandAgMember" xlink:to="cntg_CentogeneSwitzerlandAgMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneSwitzerlandAgMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">It represents the information pertaining to the Centogene Switzerland AG.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneSwitzerlandAgMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centogene Switzerland AG</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentosafeB.v.Member" xlink:label="cntg_CentosafeB.v.Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentosafeB.v.Member" xlink:to="cntg_CentosafeB.v.Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentosafeB.v.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">It represents the information the pertaining to the Centosafe B.V.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentosafeB.v.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centosafe B.V.</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneD.o.oBelgradeMember" xlink:label="cntg_CentogeneD.o.oBelgradeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CentogeneD.o.oBelgradeMember" xlink:to="cntg_CentogeneD.o.oBelgradeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CentogeneD.o.oBelgradeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">It represents the information pertaining to Centogene d.o.o Belgrade.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CentogeneD.o.oBelgradeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Centogene d.o.o Belgrade</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of subsidiaries [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">List of subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-controlling interests</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of voting equity interests acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional percentage ownership in subsidiary acquired</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Dr.BauerLaboratoriumsGmbhMember" xlink:label="cntg_Dr.BauerLaboratoriumsGmbhMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_Dr.BauerLaboratoriumsGmbhMember" xlink:to="cntg_Dr.BauerLaboratoriumsGmbhMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_Dr.BauerLaboratoriumsGmbhMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">It represents the information pertaining to the Dr. Bauer Laboratoriums GmbH.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_Dr.BauerLaboratoriumsGmbhMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dr. Bauer Laboratoriums GmbH</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" xlink:label="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" xlink:to="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of ownership interest disposed in non-controlling interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proportion Of Ownership Interest In Non-controlling Interest Disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proportion of ownership in subsidiary disposed</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="ifrs-full_NetAssetsLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetAssetsLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetAssetsLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net assets/(liabilities)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis of operating lease payments [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficeEquipmentAndStorageSpacesMember" xlink:label="cntg_OfficeEquipmentAndStorageSpacesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_OfficeEquipmentAndStorageSpacesMember" xlink:to="cntg_OfficeEquipmentAndStorageSpacesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_OfficeEquipmentAndStorageSpacesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for office equipment and storage spaces.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_OfficeEquipmentAndStorageSpacesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office equipment and storage spaces</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneYearMember" xlink:to="ifrs-full_NotLaterThanOneYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Not later than one year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease commitments</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UndiscountedLeasePaymentsToBeMade" xlink:label="cntg_UndiscountedLeasePaymentsToBeMade" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_UndiscountedLeasePaymentsToBeMade" xlink:to="cntg_UndiscountedLeasePaymentsToBeMade_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_UndiscountedLeasePaymentsToBeMade_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of undiscounted lease payments to be made by the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_UndiscountedLeasePaymentsToBeMade_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Undiscounted Lease Payments To Be Made</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_UndiscountedLeasePaymentsToBeMade_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Future lease payments to be made</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" xlink:label="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" xlink:to="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of future payment obligation to suppliers for goods and services to be provided.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Future Payment Obligation To Suppliers For Goods and Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total payment obligation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel compensation, short-term employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term employee benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel compensation, post-employment benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Post-employment pension and medical benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel compensation, termination benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Termination benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total compensation paid to key management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of transactions between related parties [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerCeoAndMajorShareholderMember" xlink:label="cntg_FormerCeoAndMajorShareholderMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_FormerCeoAndMajorShareholderMember" xlink:to="cntg_FormerCeoAndMajorShareholderMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_FormerCeoAndMajorShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for former CEO and major shareholder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_FormerCeoAndMajorShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Former CEO And Major Shareholder [Member]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionAxis" xlink:label="cntg_IfrsRelatedPartyTransactionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsRelatedPartyTransactionAxis" xlink:to="cntg_IfrsRelatedPartyTransactionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsRelatedPartyTransactionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information by type of related party transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsRelatedPartyTransactionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Related Party Transaction [Axis]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionDomain" xlink:label="cntg_IfrsRelatedPartyTransactionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsRelatedPartyTransactionDomain" xlink:to="cntg_IfrsRelatedPartyTransactionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsRelatedPartyTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction type between related parties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsRelatedPartyTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Related Party Transaction [Domain]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardActivitiesMember" xlink:label="cntg_SupervisoryBoardActivitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_SupervisoryBoardActivitiesMember" xlink:to="cntg_SupervisoryBoardActivitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_SupervisoryBoardActivitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pertaining to supervisory board activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_SupervisoryBoardActivitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supervisory board activities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CorporateStrategyServiceMember" xlink:label="cntg_CorporateStrategyServiceMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CorporateStrategyServiceMember" xlink:to="cntg_CorporateStrategyServiceMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CorporateStrategyServiceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pertaining to corporate strategy services provided.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CorporateStrategyServiceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate strategy services</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RelatedPartyServicesMember" xlink:label="cntg_RelatedPartyServicesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RelatedPartyServicesMember" xlink:to="cntg_RelatedPartyServicesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RelatedPartyServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pertaining to services provided by a related party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RelatedPartyServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Services</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CovidTestingSuppliesPurchasesMember" xlink:label="cntg_CovidTestingSuppliesPurchasesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CovidTestingSuppliesPurchasesMember" xlink:to="cntg_CovidTestingSuppliesPurchasesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CovidTestingSuppliesPurchasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for COVID testing supplies purchased.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CovidTestingSuppliesPurchasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COVID Testing Supplies Purchases</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CovidTestingServicesMember" xlink:label="cntg_CovidTestingServicesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_CovidTestingServicesMember" xlink:to="cntg_CovidTestingServicesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_CovidTestingServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for COVID testing services.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_CovidTestingServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COVID Testing Services</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of transactions between related parties [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related parties</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PensionCommitments" xlink:label="cntg_PensionCommitments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PensionCommitments" xlink:to="cntg_PensionCommitments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PensionCommitments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of pension commitments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PensionCommitments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pension Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_PensionCommitments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pension commitments for members of the management board</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ServicesReceivedRelatedPartyTransactions" xlink:label="ifrs-full_ServicesReceivedRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ServicesReceivedRelatedPartyTransactions" xlink:to="ifrs-full_ServicesReceivedRelatedPartyTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ServicesReceivedRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Services received, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ServicesReceivedRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for services</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amounts payable, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payable for services</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" xlink:label="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" xlink:to="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ifrs Share-based Payment Arrangement, Accelerated Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional share-based expenses</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyManagementPersonnelCompensationSeverancePayout" xlink:label="cntg_KeyManagementPersonnelCompensationSeverancePayout" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_KeyManagementPersonnelCompensationSeverancePayout" xlink:to="cntg_KeyManagementPersonnelCompensationSeverancePayout_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_KeyManagementPersonnelCompensationSeverancePayout_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of compensation to key management personnel in the form of severance payout.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_KeyManagementPersonnelCompensationSeverancePayout_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key Management Personnel Compensation, Severance Payout</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_KeyManagementPersonnelCompensationSeverancePayout_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Severance payout</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyManagementPersonnelCompensationAccruedAmount" xlink:label="cntg_KeyManagementPersonnelCompensationAccruedAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_KeyManagementPersonnelCompensationAccruedAmount" xlink:to="cntg_KeyManagementPersonnelCompensationAccruedAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_KeyManagementPersonnelCompensationAccruedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amounts payable resulting from key management personnel compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_KeyManagementPersonnelCompensationAccruedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key Management Personnel Compensation, Accrued Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_KeyManagementPersonnelCompensationAccruedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued for key management compensation</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOtherEquityInstrumentsGranted" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ValueOfOtherEquityInstrumentsGranted" xlink:to="cntg_ValueOfOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The value of other equity instruments granted under share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of Other Equity Instruments Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of other equity instruments granted under share based payment arrangement</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amounts receivable, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables of related to the exercise of options</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions" xlink:label="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions" xlink:to="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from rendering of services, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues recognized in profit and loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of contingent liabilities [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of contingent liabilities [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="ifrs-full_ContingentLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentLiabilitiesMember" xlink:to="ifrs-full_ContingentLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContingentLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent liabilities [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:to="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Legal proceedings contingent liability</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UniversitairMedischCentrumUtrechtMember" xlink:label="cntg_UniversitairMedischCentrumUtrechtMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_UniversitairMedischCentrumUtrechtMember" xlink:to="cntg_UniversitairMedischCentrumUtrechtMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_UniversitairMedischCentrumUtrechtMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member stands for Universitair Medisch Centrum Utrecht.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_UniversitairMedischCentrumUtrechtMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Universitair Medisch Centrum Utrecht</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" xlink:label="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" xlink:to="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for our partnering laboratory physician Prof. Dr. Peter Bauer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prof. Dr. Peter Bauer</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionPlan2016Member" xlink:label="cntg_StockOptionPlan2016Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_StockOptionPlan2016Member" xlink:to="cntg_StockOptionPlan2016Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_StockOptionPlan2016Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to stock option plan 2016.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_StockOptionPlan2016Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Option Plan 2016 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_StockOptionPlan2016Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Option Plan 2016</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of contingent liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Liabilities</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DamagesSought" xlink:label="cntg_DamagesSought" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_DamagesSought" xlink:to="cntg_DamagesSought_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_DamagesSought_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of damages sought.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_DamagesSought_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Damages Sought</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cntg_DamagesSought_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount in dispute</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated financial effect of contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate amount in question</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of non-adjusting events after reporting period [table]</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsusDerecognizedMember" xlink:label="cntg_RsusDerecognizedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RsusDerecognizedMember" xlink:to="cntg_RsusDerecognizedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RsusDerecognizedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted stock units that have been derecognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RsusDerecognizedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSUs Derecognized [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_RsusDerecognizedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSUs derecognized</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsusRecognizedMember" xlink:label="cntg_RsusRecognizedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_RsusRecognizedMember" xlink:to="cntg_RsusRecognizedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_RsusRecognizedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted stock units that have been recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_RsusRecognizedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSUs Recognized [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_RsusRecognizedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RSUs recognized</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" xlink:to="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share based awards subject to time-vesting and performance vesting.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share based awards subject to time-vesting and performance vesting [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subject to time-vesting and performance vesting</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedAwardsSubjectToTimeVestingMember" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_ShareBasedAwardsSubjectToTimeVestingMember" xlink:to="cntg_ShareBasedAwardsSubjectToTimeVestingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share based awards subject to time-vesting.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share based awards subject to time-vesting [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subject to time-vesting and performance vesting</label>
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MiguelCoegoRiosMember" xlink:label="cntg_MiguelCoegoRiosMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cntg_MiguelCoegoRiosMember" xlink:to="cntg_MiguelCoegoRiosMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cntg_MiguelCoegoRiosMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Miguel Coego Rios.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cntg_MiguelCoegoRiosMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miguel Coego Rios [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>29
<FILENAME>cntg-20211231_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8042.36810 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/31/2022 3:12:46 PM-->
<!--Modified on: 3/31/2022 3:12:46 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://centogene.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfComprehensiveLoss" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfFinancialPosition" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#StatementConsolidatedStatementsOfChangesInEquity" roleURI="http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureGeneralCompanyInformation" roleURI="http://centogene.com/role/DisclosureGeneralCompanyInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureBasisOfPreparation" roleURI="http://centogene.com/role/DisclosureBasisOfPreparation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEffectsOfNewAccountingStandards" roleURI="http://centogene.com/role/DisclosureEffectsOfNewAccountingStandards" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureBasisOfConsolidation" roleURI="http://centogene.com/role/DisclosureBasisOfConsolidation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSignificantAccountingPolicies" roleURI="http://centogene.com/role/DisclosureSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureAccountingJudgmentsAndEstimates" roleURI="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimates" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomers" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpenses" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxes" roleURI="http://centogene.com/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureLossPerShare" roleURI="http://centogene.com/role/DisclosureLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIntangibleAssets" roleURI="http://centogene.com/role/DisclosureIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosurePropertyPlantAndEquipment" roleURI="http://centogene.com/role/DisclosurePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssets" roleURI="http://centogene.com/role/DisclosureRightOfUseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureInventories" roleURI="http://centogene.com/role/DisclosureInventories" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureTradeAndOtherReceivablesAndOtherAssets" roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureCashAndShortTermDeposits" roleURI="http://centogene.com/role/DisclosureCashAndShortTermDeposits" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquity" roleURI="http://centogene.com/role/DisclosureEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureCapitalManagement" roleURI="http://centogene.com/role/DisclosureCapitalManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilities" roleURI="http://centogene.com/role/DisclosureFinancialLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPayments" roleURI="http://centogene.com/role/DisclosureShareBasedPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagement" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureListOfSubsidiaries" roleURI="http://centogene.com/role/DisclosureListOfSubsidiaries" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureNonControllingInterests" roleURI="http://centogene.com/role/DisclosureNonControllingInterests" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureCommitments" roleURI="http://centogene.com/role/DisclosureCommitments" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRelatedParties" roleURI="http://centogene.com/role/DisclosureRelatedParties" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureContingentLiabilities" roleURI="http://centogene.com/role/DisclosureContingentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSubsequentEvents" roleURI="http://centogene.com/role/DisclosureSubsequentEvents" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSignificantAccountingPoliciesPolicies" roleURI="http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureBasisOfPreparationTables" roleURI="http://centogene.com/role/DisclosureBasisOfPreparationTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSignificantAccountingPoliciesTables" roleURI="http://centogene.com/role/DisclosureSignificantAccountingPoliciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesTables" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesTables" roleURI="http://centogene.com/role/DisclosureIncomeTaxesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIntangibleAssetsTables" roleURI="http://centogene.com/role/DisclosureIntangibleAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosurePropertyPlantAndEquipmentTables" roleURI="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsTables" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureInventoriesTables" roleURI="http://centogene.com/role/DisclosureInventoriesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureTradeAndOtherReceivablesAndOtherAssetsTables" roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquityTables" roleURI="http://centogene.com/role/DisclosureEquityTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesTables" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsTables" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureListOfSubsidiariesTables" roleURI="http://centogene.com/role/DisclosureListOfSubsidiariesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureNonControllingInterestsTables" roleURI="http://centogene.com/role/DisclosureNonControllingInterestsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRelatedPartiesTables" roleURI="http://centogene.com/role/DisclosureRelatedPartiesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureGeneralCompanyInformationDetails" roleURI="http://centogene.com/role/DisclosureGeneralCompanyInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureBasisOfPreparationDetails" roleURI="http://centogene.com/role/DisclosureBasisOfPreparationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureBasisOfPreparationReconciliationDetails" roleURI="http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSignificantAccountingPoliciesDetails" roleURI="http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureAccountingJudgmentsAndEstimatesDetails" roleURI="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails" roleURI="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesLpcGmbhDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails" roleURI="http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIncomeTaxesDeferredTaxesDetails" roleURI="http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureLossPerShareDetails" roleURI="http://centogene.com/role/DisclosureLossPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureIntangibleAssetsDetails" roleURI="http://centogene.com/role/DisclosureIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosurePropertyPlantAndEquipmentDetails" roleURI="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails" roleURI="http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureInventoriesDetails" roleURI="http://centogene.com/role/DisclosureInventoriesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" roleURI="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureCashAndShortTermDepositsDetails" roleURI="http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquityIssuedCapitalAndCapitalReserveDetails" roleURI="http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquityCommonSharesDetails" roleURI="http://centogene.com/role/DisclosureEquityCommonSharesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureEquityCapitalReservesDetails" roleURI="http://centogene.com/role/DisclosureEquityCapitalReservesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesInterestBearingLoansDetails" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails" roleURI="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureShareBasedPaymentsValuationOfOptionsDetails" roleURI="http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails" roleURI="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureListOfSubsidiariesDetails" roleURI="http://centogene.com/role/DisclosureListOfSubsidiariesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureNonControllingInterestsDetails" roleURI="http://centogene.com/role/DisclosureNonControllingInterestsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureCommitmentsDetails" roleURI="http://centogene.com/role/DisclosureCommitmentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails" roleURI="http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureRelatedPartiesAdditionalInformationDetails" roleURI="http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureContingentLiabilitiesDetails" roleURI="http://centogene.com/role/DisclosureContingentLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cntg-20211231.xsd#DisclosureSubsequentEventsDetails" roleURI="http://centogene.com/role/DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://centogene.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable_637843363591134809" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable_637843363591134809" xlink:to="dei_EntityAddressesAddressTypeAxis_637843363591134809" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis_637843363591134809" xlink:to="dei_AddressTypeDomain_637843363591134809" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain_637843363591134809" xlink:to="dei_BusinessContactMember_637843363591134809" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable_637843363591134809" xlink:to="dei_DocumentInformationLineItems_637843363591134809" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityRegistrantName_637843363591134809" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityFileNumber_637843363591134809" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityIncorporationStateCountryCode_637843363591134809" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityCentralIndexKey_637843363591134809" order="4" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentType_637843363591134809" order="5" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637843363591134809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentPeriodEndDate_637843363591134809" order="6" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_AmendmentFlag_637843363591144704" order="7" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_CurrentFiscalYearEndDate_637843363591144704" order="8" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityWellKnownSeasonedIssuer_637843363591144704" order="9" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityVoluntaryFilers_637843363591144704" order="10" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityCurrentReportingStatus_637843363591144704" order="11" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityFilerCategory_637843363591144704" order="12" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_ContactPersonnelName_637843363591144704" order="13" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityAddressAddressLine1_637843363591144704" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityAddressCityOrTown_637843363591144704" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry_637843363591144704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityAddressCountry_637843363591144704" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637843363591155238" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityAddressPostalZipCode_637843363591155238" order="17" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637843363591155238" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_CityAreaCode_637843363591155238" order="18" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637843363591155238" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_LocalPhoneNumber_637843363591155238" order="19" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress" xlink:label="dei_ContactPersonnelEmailAddress_637843363591155238" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_ContactPersonnelEmailAddress_637843363591155238" order="20" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637843363591155238" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_Security12bTitle_637843363591155238" order="21" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637843363591155238" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_TradingSymbol_637843363591155238" order="22" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637843363591155238" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_SecurityExchangeName_637843363591155238" order="23" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_637843363591164724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityCommonStockSharesOutstanding_637843363591164724" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637843363591164724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityEmergingGrowthCompany_637843363591164724" order="25" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard_637843363591164724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentAccountingStandard_637843363591164724" order="26" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_637843363591164724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityShellCompany_637843363591164724" order="27" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_637843363591164724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentFiscalYearFocus_637843363591164724" order="28" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_637843363591164724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentFiscalPeriodFocus_637843363591164724" order="29" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_637843363591174710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityInteractiveDataCurrent_637843363591174710" order="30" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement_637843363591174710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentRegistrationStatement_637843363591174710" order="31" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_637843363591174710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentAnnualReport_637843363591174710" order="32" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_637843363591174710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentTransitionReport_637843363591174710" order="33" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport_637843363591174710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_DocumentShellCompanyReport_637843363591174710" order="34" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_637843363591174710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_EntityExTransitionPeriod_637843363591174710" order="35" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_637843363591184740" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_IcfrAuditorAttestationFlag_637843363591184740" order="36" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName_637843363591184740" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_AuditorName_637843363591184740" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_637843363591184740" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_AuditorFirmId_637843363591184740" order="38" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_637843363591184740" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_637843363591134809" xlink:to="dei_AuditorLocation_637843363591184740" order="39" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended" xlink:title="00100 - Statement - Consolidated statements of comprehensive loss" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_637843363591194858" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_CostOfSales_637843363591194858" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_GrossProfit_637843363591194858" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_637843363591194858" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_637843363591194858" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingExpense" xlink:label="ifrs-full_SellingExpense_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_SellingExpense_637843363591194858" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="ifrs-full_ImpairmentLossOnFinancialAssets_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ImpairmentLossOnFinancialAssets_637843363591194858" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherIncome_637843363591194858" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="ifrs-full_OtherExpenseByFunction_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherExpenseByFunction_637843363591194858" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="cntg_RealEstateTransferTaxExpenses_637843363591194858" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_637843363591194858" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_637843363591194858" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeOnLoansAndReceivables" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363591204697" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpense" xlink:label="ifrs-full_InterestExpense_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_InterestExpense_637843363591204697" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncomeCost_637843363591204697" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax_637843363591204697" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591204697" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss_637843363591204697" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent_637843363591204697" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ComprehensiveIncome_637843363591204697" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_637843363591204697" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_637843363591204697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract_637843363591204697" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_637843363591204697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_637843363591214726" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract_637843363591204697" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_637843363591214726" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome_637843363591214726" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract_637843363591204697" xlink:to="ifrs-full_ComprehensiveIncome_637843363591214726" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare_637843363591214726" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare_637843363591214726" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare_637843363591214726" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare_637843363591214726" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition" xlink:type="extended" xlink:title="00200 - Statement - Consolidated statements of financial position" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract_637843363591214726" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_AssetsAbstract_637843363591214726" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract_637843363591214726" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_637843363591214726" xlink:to="ifrs-full_NoncurrentAssetsAbstract_637843363591214726" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363591214726" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_637843363591214726" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363591214726" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_637843363591214726" xlink:to="ifrs-full_PropertyPlantAndEquipment_637843363591224921" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_637843363591214726" xlink:to="ifrs-full_RightofuseAssets_637843363591224921" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="ifrs-full_OtherNoncurrentAssets_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_637843363591214726" xlink:to="ifrs-full_OtherNoncurrentAssets_637843363591224921" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_637843363591214726" xlink:to="ifrs-full_NoncurrentAssets_637843363591224921" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_637843363591214726" xlink:to="ifrs-full_CurrentAssetsAbstract_637843363591224921" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_637843363591224921" xlink:to="ifrs-full_Inventories_637843363591224921" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentTradeReceivablesAndContractAssets" xlink:label="cntg_CurrentTradeReceivablesAndContractAssets_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_637843363591224921" xlink:to="cntg_CurrentTradeReceivablesAndContractAssets_637843363591224921" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets" xlink:label="ifrs-full_OtherCurrentAssets_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_637843363591224921" xlink:to="ifrs-full_OtherCurrentAssets_637843363591224921" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_637843363591224921" xlink:to="ifrs-full_CashAndCashEquivalents_637843363591224921" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets_637843363591224921" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_637843363591224921" xlink:to="ifrs-full_CurrentAssets_637843363591224921" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_637843363591214726" xlink:to="ifrs-full_Assets_637843363591234855" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilitiesAbstract_637843363591234855" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_EquityAbstract_637843363591234855" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_637843363591234855" xlink:to="ifrs-full_IssuedCapital_637843363591234855" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserve" xlink:label="ifrs-full_CapitalReserve_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_637843363591234855" xlink:to="ifrs-full_CapitalReserve_637843363591234855" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_637843363591234855" xlink:to="ifrs-full_RetainedEarnings_637843363591234855" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_637843363591234855" xlink:to="ifrs-full_NoncontrollingInterests_637843363591234855" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_637843363591234855" xlink:to="ifrs-full_Equity_637843363591234855" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_637843363591234855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_637843363591234855" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="ifrs-full_LongtermBorrowings_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_LongtermBorrowings_637843363591244724" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_637843363591244724" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_637843363591244724" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="ifrs-full_NoncurrentGovernmentGrants_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_NoncurrentGovernmentGrants_637843363591244724" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_NoncurrentLiabilities_637843363591244724" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="ifrs-full_CurrentGovernmentGrants_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" xlink:to="ifrs-full_CurrentGovernmentGrants_637843363591244724" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_637843363591244724" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" xlink:to="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_637843363591244724" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities_637843363591254806" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" xlink:to="ifrs-full_CurrentLeaseLiabilities_637843363591254806" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_637843363591254806" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_637843363591254806" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363591254806" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363591254806" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="ifrs-full_OtherCurrentLiabilities_637843363591254806" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" xlink:to="ifrs-full_OtherCurrentLiabilities_637843363591254806" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities_637843363591254806" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_637843363591244724" xlink:to="ifrs-full_CurrentLiabilities_637843363591254806" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities_637843363591254806" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_637843363591234855" xlink:to="ifrs-full_EquityAndLiabilities_637843363591254806" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00300 - Statement - Consolidated statements of cash flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_637843363591265066" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_637843363591265066" xlink:to="ifrs-full_ProfitLossBeforeTax_637843363591265066" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_637843363591265066" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_637843363591265066" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="ifrs-full_AdjustmentsForInterestIncome_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_AdjustmentsForInterestIncome_637843363591265066" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryWritedown2011" xlink:label="ifrs-full_InventoryWritedown2011_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_InventoryWritedown2011_637843363591265066" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_AdjustmentsForInterestExpense_637843363591265066" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_637843363591265066" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_637843363591265066" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_637843363591265066" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_637843363591274963" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="cntg_RealEstateTransferTaxExpenses_637843363591274963" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_637843363591274963" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract" xlink:label="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_637843363591265066" xlink:to="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_637843363591274963" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_637843363591274963" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_637843363591274963" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets" xlink:label="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_637843363591274963" xlink:to="cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets_637843363591274963" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_637843363591274963" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_637843363591274963" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_637843363591274963" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_637843363591274963" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_637843363591274963" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract_637843363591274963" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_637843363591274963" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_637843363591265066" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363591284750" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_637843363591284750" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363591284750" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" xlink:to="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363591284750" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" xlink:to="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_637843363591284750" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363591284750" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_637843363591284750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_637843363591284750" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_637843363591284750" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_637843363591294709" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="ifrs-full_ProceedsFromIssuingShares_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" xlink:to="ifrs-full_ProceedsFromIssuingShares_637843363591294709" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:label="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" xlink:to="ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_637843363591294709" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363591294709" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_637843363591294709" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_637843363591294709" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_637843363591294709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_637843363591294709" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363591304755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_637843363591294709" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_637843363591304755" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_637843363591304755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_637843363591304755" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_637843363591344795" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_637843363591344795" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_637843363591344795" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_637843363591344795" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_6378433635913447951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_6378433635913447951" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity" xlink:type="extended" xlink:title="00400 - Statement - Consolidated statements of changes in equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable_637843363591355011" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_637843363591355011" xlink:to="ifrs-full_ComponentsOfEquityAxis_637843363591355011" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember_637843363591355011" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="ifrs-full_IssuedCapitalMember_637843363591355011" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserveMember" xlink:label="ifrs-full_CapitalReserveMember_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="ifrs-full_CapitalReserveMember_637843363591355011" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="ifrs-full_RetainedEarningsMember_637843363591355011" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_637843363591355011" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember" xlink:label="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_637843363591355011" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_637843363591355011" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="ifrs-full_NoncontrollingInterestsMember_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="ifrs-full_NoncontrollingInterestsMember_637843363591364864" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363591355011" xlink:to="ifrs-full_EquityMember_637843363591364864" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_637843363591355011" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_Equity_637843363591364864" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_ProfitLoss_637843363591364864" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_OtherComprehensiveIncome_637843363591364864" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_ComprehensiveIncome_637843363591364864" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="ifrs-full_IssueOfEquity_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_IssueOfEquity_637843363591364864" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_ShareIssueRelatedCost_637843363591364864" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_637843363591364864" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_637843363591364864" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_637843363591374749" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_637843363591374749" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:label="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_637843363591374749" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_637843363591374749" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:label="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_637843363591374749" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_637843363591374749" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering" xlink:label="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering_637843363591374749" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering_637843363591374749" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_637843363591374749" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363591364864" xlink:to="ifrs-full_Equity_637843363591374749" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureGeneralCompanyInformation" xlink:type="extended" xlink:title="10101 - Disclosure - General Company Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsAbstract" xlink:label="cntg_GeneralInformationAboutFinancialStatementsAbstract_637166015163744860" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_637843363591374749" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsAbstract_637166015163744860" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_637843363591374749" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureBasisOfPreparation" xlink:type="extended" xlink:title="10201 - Disclosure - Basis of Preparation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BasisOfPreparationOfFinancialStatementsAbstract" xlink:label="cntg_BasisOfPreparationOfFinancialStatementsAbstract_637166015163964417" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_637843363591384974" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_BasisOfPreparationOfFinancialStatementsAbstract_637166015163964417" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_637843363591384974" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureEffectsOfNewAccountingStandards" xlink:type="extended" xlink:title="10301 - Disclosure - Effects of new accounting standards" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_637166015163974382" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_637843363591384974" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_637166015163974382" xlink:to="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_637843363591384974" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureBasisOfConsolidation" xlink:type="extended" xlink:title="10401 - Disclosure - Basis of consolidation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BasisOfConsolidationAbstract" xlink:label="cntg_BasisOfConsolidationAbstract_637166015163974382" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_637843363591384974" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_BasisOfConsolidationAbstract_637166015163974382" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_637843363591384974" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSignificantAccountingPolicies" xlink:type="extended" xlink:title="10501 - Disclosure - Significant accounting policies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163974382" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_637843363591395025" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163974382" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_637843363591395025" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimates" xlink:type="extended" xlink:title="10601 - Disclosure - Accounting judgments and estimates" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract_637166015163974382" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_637843363591395025" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract_637166015163974382" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_637843363591395025" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomers" xlink:type="extended" xlink:title="10701 - Disclosure - Segment information and revenue from contracts with customers" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_637843363591395025" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_637843363591395025" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpenses" xlink:type="extended" xlink:title="10801 - Disclosure - Other income and expenses" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract_637166015163984381" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock" xlink:label="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock_637843363591404729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract_637166015163984381" xlink:to="cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock_637843363591404729" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="10901 - Disclosure - Income taxes" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_637843363591404729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_637843363591404729" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureLossPerShare" xlink:type="extended" xlink:title="11001 - Disclosure - Loss Per Share" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_637843363591404729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_637843363591404729" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIntangibleAssets" xlink:type="extended" xlink:title="11101 - Disclosure - Intangible assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_637843363591414755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_637843363591414755" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosurePropertyPlantAndEquipment" xlink:type="extended" xlink:title="11201 - Disclosure - Property, plant and equipment" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_637843363591414755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_637843363591414755" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssets" xlink:type="extended" xlink:title="11301 - Disclosure - Right-of-use assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_637843363591414755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_637843363591414755" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureInventories" xlink:type="extended" xlink:title="11401 - Disclosure - Inventories" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_637843363591414755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_637843363591414755" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssets" xlink:type="extended" xlink:title="11501 - Disclosure - Trade and other receivables and other assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock" xlink:label="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock_637843363591424855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock_637843363591424855" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureCashAndShortTermDeposits" xlink:type="extended" xlink:title="11601 - Disclosure - Cash and short-term deposits" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_637843363591424855" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_637843363591424855" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureEquity" xlink:type="extended" xlink:title="11701 - Disclosure - Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_637843363591434796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_637843363591434796" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureCapitalManagement" xlink:type="extended" xlink:title="11801 - Disclosure - Capital management" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_637843363591434796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_637843363591434796" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilities" xlink:type="extended" xlink:title="11901 - Disclosure - Financial liabilities" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_637843363591434796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_637843363591434796" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPayments" xlink:type="extended" xlink:title="12001 - Disclosure - Share-based payments" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_637843363591444684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_637843363591444684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagement" xlink:type="extended" xlink:title="12101 - Disclosure - Financial instruments - fair values and risk management" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_637843363591444684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_637843363591444684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureListOfSubsidiaries" xlink:type="extended" xlink:title="12201 - Disclosure - List of subsidiaries" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_637165081213427975" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_637843363591444684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_637165081213427975" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_637843363591444684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureNonControllingInterests" xlink:type="extended" xlink:title="12301 - Disclosure - Non-controlling interests" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonControllingInterestsAbstract" xlink:label="cntg_NonControllingInterestsAbstract_637165081213777763" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_637843363591454781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NonControllingInterestsAbstract_637165081213777763" xlink:to="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_637843363591454781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureCommitments" xlink:type="extended" xlink:title="12401 - Disclosure - Commitments" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfCommitmentsAbstract" xlink:label="cntg_DisclosureOfCommitmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_637843363591454781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_DisclosureOfCommitmentsAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_637843363591454781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRelatedParties" xlink:type="extended" xlink:title="12501 - Disclosure - Related parties" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract_637165081213787766" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_637843363591454781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract_637165081213787766" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_637843363591454781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureContingentLiabilities" xlink:type="extended" xlink:title="12601 - Disclosure - Contingent Liabilities" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract_637165081213787766" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_637843363591464820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract_637165081213787766" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_637843363591464820" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSubsequentEvents" xlink:type="extended" xlink:title="12701 - Disclosure - Subsequent Events" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_637843363591464820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_637843363591464820" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies" xlink:type="extended" xlink:title="20502 - Disclosure - Significant accounting policies (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_637843363591474822" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_637843363591474822" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_637843363591474822" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory" xlink:label="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory_637843363591474822" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_637843363591474822" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_637843363591474822" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_637843363591474822" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_637843363591474822" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_637843363591474822" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_637843363591474822" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_637843363591474822" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_637843363591474822" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_637843363591474822" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_637843363591474822" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_637843363591484710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_637843363591484710" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_637843363591484710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163984381" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_637843363591484710" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureBasisOfPreparationTables" xlink:type="extended" xlink:title="30203 - Disclosure - Basis of preparation (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BasisOfPreparationOfFinancialStatementsAbstract" xlink:label="cntg_BasisOfPreparationOfFinancialStatementsAbstract_2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock" xlink:label="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock_637843363591484710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_BasisOfPreparationOfFinancialStatementsAbstract_2" xlink:to="cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock_637843363591484710" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSignificantAccountingPoliciesTables" xlink:type="extended" xlink:title="30503 - Disclosure - Significant accounting policies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163994351" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfForeignExchangeRatesUsedExplanatory" xlink:label="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory_637843363591494820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015163994351" xlink:to="cntg_DisclosureOfForeignExchangeRatesUsedExplanatory_637843363591494820" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables" xlink:type="extended" xlink:title="30703 - Disclosure - Segment information and revenue from contracts with customers (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock" xlink:label="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock_637843363591494820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock_637843363591494820" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory_637843363591494820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfGeographicalAreasExplanatory_637843363591494820" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfContractBalancesExplanatory" xlink:label="cntg_DisclosureOfContractBalancesExplanatory_637843363591494820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="cntg_DisclosureOfContractBalancesExplanatory_637843363591494820" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables" xlink:type="extended" xlink:title="30803 - Disclosure - Other income and expenses (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_637843363591494820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_637843363591494820" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_637843363591494820" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_637843363591494820" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_637843363591505194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_637843363591505194" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_637843363591505194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_637843363591505194" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="30903 - Disclosure - Income taxes (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_637843363591505194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_637843363591505194" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_637843363591505194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_637843363591505194" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_637843363591505194" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_637843363591505194" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIntangibleAssetsTables" xlink:type="extended" xlink:title="31103 - Disclosure - Intangible assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_637843363591514796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_637843363591514796" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentTables" xlink:type="extended" xlink:title="31203 - Disclosure - Property, plant and equipment (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_637843363591514796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_637843363591514796" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsTables" xlink:type="extended" xlink:title="31303 - Disclosure - Right-of-use assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_637843363591524739" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_637843363591524739" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory" xlink:label="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory_637843363591524739" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory_637843363591524739" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" xlink:label="ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_637843363591524739" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_637843363591524739" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureInventoriesTables" xlink:type="extended" xlink:title="31403 - Disclosure - Inventories (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfInventoriesTableTextBlock" xlink:label="cntg_DisclosureOfInventoriesTableTextBlock_637843363591524739" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="cntg_DisclosureOfInventoriesTableTextBlock_637843363591524739" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsTables" xlink:type="extended" xlink:title="31503 - Disclosure - Trade and other receivables and other assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_637843363591535103" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_637843363591535103" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureEquityTables" xlink:type="extended" xlink:title="31703 - Disclosure - Equity (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_637843363591535103" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_637843363591535103" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesTables" xlink:type="extended" xlink:title="31903 - Disclosure - Financial liabilities (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfBorrowingsExplanatory_637843363591544802" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_637843363591544802" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_637843363591544802" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsTables" xlink:type="extended" xlink:title="32003 - Disclosure - Share-based payments (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363591544802" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363591544802" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363591544802" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363591544802" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363591544802" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017And2019Member" xlink:label="cntg_EquityShareOption2017And2019Member_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363591544802" xlink:to="cntg_EquityShareOption2017And2019Member_637843363591544802" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_EquityShareOption2017And2019Member_637843363591544802" xlink:to="cntg_EquityShareOption2017EquitySettledMember_637843363591544802" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2019EquitySettledMember" xlink:label="cntg_EquityShareOption2019EquitySettledMember_637843363591544802" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_EquityShareOption2017And2019Member_637843363591544802" xlink:to="cntg_EquityShareOption2019EquitySettledMember_637843363591544802" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363591554845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363591544802" xlink:to="cntg_LongTermIncentivePlanMember_637843363591554845" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363591554845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363591544802" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363591554845" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory" xlink:label="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory_637843363591554845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363591554845" xlink:to="cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory_637843363591554845" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_637843363591554845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363591554845" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_637843363591554845" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_637843363591554845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363591554845" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_637843363591554845" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_637843363591554845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363591554845" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_637843363591554845" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables" xlink:type="extended" xlink:title="32103 - Disclosure - Financial instruments - fair values and risk management (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_637843363591564881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_637843363591564881" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:label="ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory_637843363591564881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory_637843363591564881" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_637843363591564881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_637843363591564881" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_637843363591564881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_637843363591564881" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory_637843363591564881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfMarketRiskExplanatory_637843363591564881" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureListOfSubsidiariesTables" xlink:type="extended" xlink:title="32203 - Disclosure - List of subsidiaries (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_637165081213787766" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_637843363591564881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_637165081213787766" xlink:to="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_637843363591564881" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureNonControllingInterestsTables" xlink:type="extended" xlink:title="32303 - Disclosure - Non-controlling interests (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonControllingInterestsAbstract" xlink:label="cntg_NonControllingInterestsAbstract_637165081213797753" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:label="ifrs-full_DisclosureOfCompositionOfGroupExplanatory_637843363591574798" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NonControllingInterestsAbstract_637165081213797753" xlink:to="ifrs-full_DisclosureOfCompositionOfGroupExplanatory_637843363591574798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRelatedPartiesTables" xlink:type="extended" xlink:title="32503 - Disclosure - Related parties (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract_637165081213797753" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_637843363591574798" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract_637165081213797753" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_637843363591574798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureGeneralCompanyInformationDetails" xlink:type="extended" xlink:title="40101 - Disclosure - General Company Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsAbstract" xlink:label="cntg_GeneralInformationAboutFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsTable" xlink:label="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsAbstract" xlink:to="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591584741" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591584741" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591584741" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnEquityOfferingMember" xlink:label="cntg_FollowOnEquityOfferingMember_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591584741" xlink:to="cntg_FollowOnEquityOfferingMember_637843363591584741" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnPublicOfferingMember" xlink:label="cntg_FollowOnPublicOfferingMember_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591584741" xlink:to="cntg_FollowOnPublicOfferingMember_637843363591584741" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_637843363591584741" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_637843363591584741" xlink:to="ifrs-full_ClassesOfShareCapitalMember_637843363591584741" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_637843363591584741" xlink:to="ifrs-full_OrdinarySharesMember_637843363591584741" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" xlink:to="dei_LegalEntityAxis_637843363591584741" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_637843363591584741" xlink:to="dei_EntityDomain_637843363591584741" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_637843363591584741" xlink:to="cntg_CentogeneN.vMember_637843363591584741" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591584741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591584741" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591584741" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591594735" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SellingShareholdersMember" xlink:label="cntg_SellingShareholdersMember_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591594735" xlink:to="cntg_SellingShareholdersMember_637843363591594735" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363591594735" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363591594735" xlink:to="ifrs-full_NonadjustingEventsMember_637843363591594735" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorPurchasesOfAssetsMember" xlink:label="ifrs-full_MajorPurchasesOfAssetsMember_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_637843363591594735" xlink:to="ifrs-full_MajorPurchasesOfAssetsMember_637843363591594735" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GeneralInformationAboutFinancialStatementsLineItems" xlink:label="cntg_GeneralInformationAboutFinancialStatementsLineItems_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsTable_637843363591584741" xlink:to="cntg_GeneralInformationAboutFinancialStatementsLineItems_637843363591594735" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems_637843363591594735" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_637843363591594735" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems_637843363591594735" xlink:to="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_637843363591594735" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363591594735" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_GeneralInformationAboutFinancialStatementsLineItems_637843363591594735" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363591594735" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureBasisOfPreparationDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Basis of Preparation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BasisOfPreparationOfFinancialStatementsAbstract" xlink:label="cntg_BasisOfPreparationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_BasisOfPreparationOfFinancialStatementsAbstract" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" xlink:to="ifrs-full_RangeAxis_637843363591604785" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363591604785" xlink:to="ifrs-full_RangesMember_637843363591604785" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363591604785" xlink:to="ifrs-full_BottomOfRangeMember_637843363591604785" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591604785" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591604785" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591604785" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember" xlink:label="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591604785" xlink:to="cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_637843363591604785" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363591604785" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363591604785" xlink:to="ifrs-full_NonadjustingEventsMember_637843363591604785" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EnteringInToDebtFinancingAgreementMember" xlink:label="cntg_EnteringInToDebtFinancingAgreementMember_637843363591604785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_637843363591604785" xlink:to="cntg_EnteringInToDebtFinancingAgreementMember_637843363591604785" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="ifrs-full_MajorOrdinaryShareTransactionsMember_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_637843363591604785" xlink:to="ifrs-full_MajorOrdinaryShareTransactionsMember_637843363591614784" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" xlink:to="ifrs-full_BorrowingsByNameAxis_637843363591614784" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis_637843363591614784" xlink:to="ifrs-full_BorrowingsByNameMember_637843363591614784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityMember" xlink:label="cntg_LoanFacilityMember_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameMember_637843363591614784" xlink:to="cntg_LoanFacilityMember_637843363591614784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheOneMember" xlink:label="cntg_LoanFacilityTrancheOneMember_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_LoanFacilityMember_637843363591614784" xlink:to="cntg_LoanFacilityTrancheOneMember_637843363591614784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheTwoMember" xlink:label="cntg_LoanFacilityTrancheTwoMember_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_LoanFacilityMember_637843363591614784" xlink:to="cntg_LoanFacilityTrancheTwoMember_637843363591614784" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="ifrs-full_TypesOfInterestRatesAxis_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" xlink:to="ifrs-full_TypesOfInterestRatesAxis_637843363591614784" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember" xlink:label="ifrs-full_InterestRateTypesMember_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfInterestRatesAxis_637843363591614784" xlink:to="ifrs-full_InterestRateTypesMember_637843363591614784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FloorRateMember" xlink:label="cntg_FloorRateMember_637843363591614784" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_InterestRateTypesMember_637843363591614784" xlink:to="cntg_FloorRateMember_637843363591614784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591604785" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EstimatedRateOfImplicitPriceConcessions" xlink:label="cntg_EstimatedRateOfImplicitPriceConcessions_637843363591624689" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_EstimatedRateOfImplicitPriceConcessions_637843363591624689" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfEstimatedVariableTransactionPrice" xlink:label="cntg_PercentageOfEstimatedVariableTransactionPrice_637843363591624689" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_PercentageOfEstimatedVariableTransactionPrice_637843363591624689" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_637843363591624689" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_ProfitLoss_637843363591624689" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_637843363591624689" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_637843363591624689" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363591624689" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_637843363591624689" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_637843363591624689" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_637843363591624689" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings_637843363591634951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_RetainedEarnings_637843363591634951" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_637843363591634951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_Equity_637843363591634951" order="8" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_637843363591634951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_CashAndCashEquivalents_637843363591634951" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="ifrs-full_ShorttermBorrowings_637843363591634951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_ShorttermBorrowings_637843363591634951" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialCovenants" xlink:label="cntg_FinancialCovenants_637843363591634951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_FinancialCovenants_637843363591634951" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount_637843363591634951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_NotionalAmount_637843363591634951" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363591644391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363591644391" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_637843363591644391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_637843363591644391" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsRevenueAchievementThreshold" xlink:label="cntg_BorrowingsRevenueAchievementThreshold_637843363591644391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_BorrowingsRevenueAchievementThreshold_637843363591644391" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsCovenantMinimumRequiredRevenue" xlink:label="cntg_BorrowingsCovenantMinimumRequiredRevenue_637843363591644391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_BorrowingsCovenantMinimumRequiredRevenue_637843363591644391" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="ifrs-full_BorrowingsInterestRate_637843363591644391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_BorrowingsInterestRate_637843363591644391" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:label="ifrs-full_BorrowingsAdjustmentToInterestRateBasis_637843363591644391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_BorrowingsAdjustmentToInterestRateBasis_637843363591644391" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363591644391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363591644391" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363591654705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363591654705" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharePrice" xlink:label="cntg_IfrsSharePrice_637843363591654705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_IfrsSharePrice_637843363591654705" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_637843363591654705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_637843363591654705" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_637843363591654705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591624689" xlink:to="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_637843363591654705" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails" xlink:type="extended" xlink:title="40202 - Disclosure - Basis of Preparation - Reconciliation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BasisOfPreparationOfFinancialStatementsAbstract" xlink:label="cntg_BasisOfPreparationOfFinancialStatementsAbstract_1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_BasisOfPreparationOfFinancialStatementsAbstract_1" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591664805" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591664805" xlink:to="srt_RestatementAxis_637843363591664805" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis_637843363591664805" xlink:to="srt_RestatementDomain_637843363591664805" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain_637843363591664805" xlink:to="srt_ScenarioPreviouslyReportedMember_637843363591664805" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain_637843363591664805" xlink:to="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_637843363591664805" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591664805" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591664805" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591664805" xlink:to="ifrs-full_CostOfSales_637843363591664805" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591664805" xlink:to="ifrs-full_GrossProfit_637843363591664805" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591664805" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_637843363591664805" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingExpense" xlink:label="ifrs-full_SellingExpense_637843363591664805" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591664805" xlink:to="ifrs-full_SellingExpense_637843363591664805" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Significant accounting policies (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015164014283" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureTable" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract_637166015164014283" xlink:to="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_637843363591674914" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_637843363591674914" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363591674914" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363591674914" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591674914" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SoftwarePatentsAndTrademarksMember" xlink:label="cntg_SoftwarePatentsAndTrademarksMember_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591674914" xlink:to="cntg_SoftwarePatentsAndTrademarksMember_637843363591674914" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CoronaTestPortalMember" xlink:label="cntg_CoronaTestPortalMember_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591674914" xlink:to="cntg_CoronaTestPortalMember_637843363591674914" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="ifrs-full_CapitalisedDevelopmentExpenditureMember_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591674914" xlink:to="ifrs-full_CapitalisedDevelopmentExpenditureMember_637843363591674914" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_637843363591674914" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363591674914" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363591674914" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_637843363591674914" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363591674914" xlink:to="ifrs-full_BuildingsMember_637843363591674914" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesMember" xlink:label="cntg_OfficesMember_637843363591674914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363591674914" xlink:to="cntg_OfficesMember_637843363591674914" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363591674914" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember_637843363591684701" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_637843363591674914" xlink:to="ifrs-full_RangeAxis_637843363591684701" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363591684701" xlink:to="ifrs-full_RangesMember_637843363591684701" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363591684701" xlink:to="ifrs-full_BottomOfRangeMember_637843363591684701" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363591684701" xlink:to="ifrs-full_TopOfRangeMember_637843363591684701" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems" xlink:label="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureTable_637843363591674914" xlink:to="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_637843363591684701" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="ifrs-full_ForeignExchangeRatesAbstract_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_637843363591684701" xlink:to="ifrs-full_ForeignExchangeRatesAbstract_637843363591684701" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="ifrs-full_AverageForeignExchangeRate_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ForeignExchangeRatesAbstract_637843363591684701" xlink:to="ifrs-full_AverageForeignExchangeRate_637843363591684701" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ForeignExchangeRatesAbstract_637843363591684701" xlink:to="ifrs-full_ClosingForeignExchangeRate_637843363591684701" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_637843363591684701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_637843363591684701" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_637843363591684701" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_637843363591694692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_637843363591684701" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_637843363591694692" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract_637843363591694692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_637843363591684701" xlink:to="ifrs-full_PropertyPlantAndEquipmentAbstract_637843363591694692" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_637843363591694692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract_637843363591694692" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_637843363591694692" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsLeasesAbstract" xlink:label="cntg_IfrsLeasesAbstract_637843363591694692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_637843363591684701" xlink:to="cntg_IfrsLeasesAbstract_637843363591694692" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets" xlink:label="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets_637843363591694692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsLeasesAbstract_637843363591694692" xlink:to="cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets_637843363591694692" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialInstrumentsAbstract" xlink:label="cntg_FinancialInstrumentsAbstract_637843363591694692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems_637843363591684701" xlink:to="cntg_FinancialInstrumentsAbstract_637843363591694692" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered" xlink:label="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered_637843363591694692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_FinancialInstrumentsAbstract_637843363591694692" xlink:to="cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered_637843363591694692" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Accounting judgments and estimates (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591704696" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591704696" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363591704696" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363591704696" xlink:to="ifrs-full_CarryingAmountMember_637843363591704696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_637843363591704696" xlink:to="ifrs-full_GrossCarryingAmountMember_637843363591704696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591704696" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363591704696" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363591704696" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591704696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="ifrs-full_CapitalisedDevelopmentExpenditureMember_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591704696" xlink:to="ifrs-full_CapitalisedDevelopmentExpenditureMember_637843363591704696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_637843363591704696" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591704696" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363591704696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_637843363591704696" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363591704696" order="1" use="optional" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Segment information and revenue from contracts with customers - Information by operating segments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591714738" order="1" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591714738" xlink:to="ifrs-full_SegmentConsolidationItemsAxis_637843363591714738" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentConsolidationItemsAxis_637843363591714738" xlink:to="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591714738" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591714738" xlink:to="ifrs-full_OperatingSegmentsMember_637843363591714738" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="ifrs-full_MaterialReconcilingItemsMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591714738" xlink:to="ifrs-full_MaterialReconcilingItemsMember_637843363591714738" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsCorporateMember" xlink:label="cntg_IfrsCorporateMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaterialReconcilingItemsMember_637843363591714738" xlink:to="cntg_IfrsCorporateMember_637843363591714738" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591714738" xlink:to="ifrs-full_SegmentsAxis_637843363591714738" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis_637843363591714738" xlink:to="ifrs-full_SegmentsMember_637843363591714738" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalSegmentMember" xlink:label="cntg_PharmaceuticalSegmentMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591714738" xlink:to="cntg_PharmaceuticalSegmentMember_637843363591714738" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DiagnosticsSegmentMember" xlink:label="cntg_DiagnosticsSegmentMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591714738" xlink:to="cntg_DiagnosticsSegmentMember_637843363591714738" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591714738" xlink:to="cntg_Covid19Member_637843363591714738" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="ifrs-full_MajorCustomersAxis_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591714738" xlink:to="ifrs-full_MajorCustomersAxis_637843363591714738" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="ifrs-full_MajorCustomersMember_637843363591714738" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersAxis_637843363591714738" xlink:to="ifrs-full_MajorCustomersMember_637843363591714738" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalPartnerMember" xlink:label="cntg_PharmaceuticalPartnerMember_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersMember_637843363591714738" xlink:to="cntg_PharmaceuticalPartnerMember_637843363591724714" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591714738" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_637843363591724714" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_637843363591724714" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591724714" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591724714" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember_637843363591724714" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591724714" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_637843363591724714" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591714738" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsNumberOfReportableSegments" xlink:label="cntg_IfrsNumberOfReportableSegments_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" xlink:to="cntg_IfrsNumberOfReportableSegments_637843363591724714" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_637843363591724714" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_637843363591724714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_637843363591724714" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets" xlink:label="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets_637843363591734451" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" xlink:to="cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets_637843363591734451" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_637843363591734451" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_637843363591734451" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherSegmentInformationAbstract" xlink:label="cntg_OtherSegmentInformationAbstract_637843363591734451" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591724714" xlink:to="cntg_OtherSegmentInformationAbstract_637843363591734451" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_637843363591734451" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherSegmentInformationAbstract_637843363591734451" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_637843363591734451" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_637843363591734451" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherSegmentInformationAbstract_637843363591734451" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_637843363591734451" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails" xlink:type="extended" xlink:title="40702 - Disclosure - Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591744697" order="1" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591744697" xlink:to="ifrs-full_SegmentConsolidationItemsAxis_637843363591744697" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentConsolidationItemsAxis_637843363591744697" xlink:to="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591744697" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591744697" xlink:to="ifrs-full_OperatingSegmentsMember_637843363591744697" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="ifrs-full_MaterialReconcilingItemsMember_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591744697" xlink:to="ifrs-full_MaterialReconcilingItemsMember_637843363591744697" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsCorporateMember" xlink:label="cntg_IfrsCorporateMember_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaterialReconcilingItemsMember_637843363591744697" xlink:to="cntg_IfrsCorporateMember_637843363591744697" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="ifrs-full_UnallocatedAmountsMember_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_637843363591744697" xlink:to="ifrs-full_UnallocatedAmountsMember_637843363591744697" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UnallocatedAmountsShareBasedPaymentsMember" xlink:label="cntg_UnallocatedAmountsShareBasedPaymentsMember_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnallocatedAmountsMember_637843363591744697" xlink:to="cntg_UnallocatedAmountsShareBasedPaymentsMember_637843363591744697" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UnallocatedAmountsDepreciationAndAmortizationMember" xlink:label="cntg_UnallocatedAmountsDepreciationAndAmortizationMember_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnallocatedAmountsMember_637843363591744697" xlink:to="cntg_UnallocatedAmountsDepreciationAndAmortizationMember_637843363591744697" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591744697" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment_637843363591744697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdministrativeExpense" xlink:label="ifrs-full_AdministrativeExpense_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="ifrs-full_AdministrativeExpense_637843363591744697" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment" xlink:label="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_637843363591744697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment_637843363591744697" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363591754694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363591754694" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_637843363591754694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_637843363591754694" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_637843363591754694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_637843363591754694" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_637843363591754694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="ifrs-full_FinanceIncomeCost_637843363591754694" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591754694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591754694" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_637843363591754694" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591744697" xlink:to="ifrs-full_ProfitLoss_637843363591754694" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="9" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails" xlink:type="extended" xlink:title="40703 - Disclosure - Segment information and revenue from contracts with customers - Geographical information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591804714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591804714" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis_637843363591804714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591804714" xlink:to="ifrs-full_SegmentsAxis_637843363591804714" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember_637843363591804714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis_637843363591804714" xlink:to="ifrs-full_SegmentsMember_637843363591804714" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalSegmentMember" xlink:label="cntg_PharmaceuticalSegmentMember_637843363591804714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591804714" xlink:to="cntg_PharmaceuticalSegmentMember_637843363591804714" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DiagnosticsSegmentMember" xlink:label="cntg_DiagnosticsSegmentMember_637843363591804714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591804714" xlink:to="cntg_DiagnosticsSegmentMember_637843363591804714" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member_637843363591804714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591804714" xlink:to="cntg_Covid19Member_637843363591804714" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_637843363591804714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591804714" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_637843363591804714" order="2" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesMember" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_637843363591804714" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591814693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591814693" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember_637843363591814693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesMember_637843363591814693" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_637843363591814693" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591804714" xlink:to="ifrs-full_GeographicalAreasAxis_637843363591814693" order="3" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis_637843363591814693" xlink:to="ifrs-full_GeographicalAreasMember_637843363591814693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="srt_EuropeMember_637843363591814693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="country_DE_637843363591814693" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL" xlink:label="country_NL_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="country_NL_637843363591814693" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsMiddleEastMember" xlink:label="cntg_IfrsMiddleEastMember_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="cntg_IfrsMiddleEastMember_637843363591814693" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SA" xlink:label="country_SA_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="country_SA_637843363591814693" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember_637843363591814693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="srt_NorthAmericaMember_637843363591814693" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="country_US_637843363591824710" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember" xlink:label="srt_LatinAmericaMember_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="srt_LatinAmericaMember_637843363591824710" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember" xlink:label="srt_AsiaPacificMember_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591814693" xlink:to="srt_AsiaPacificMember_637843363591824710" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable_637843363591804714" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591824710" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="ifrs-full_RevenueFromRenderingOfServices_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591824710" xlink:to="ifrs-full_RevenueFromRenderingOfServices_637843363591824710" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="ifrs-full_RevenueFromSaleOfGoods_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591824710" xlink:to="ifrs-full_RevenueFromSaleOfGoods_637843363591824710" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems_637843363591824710" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_637843363591824710" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails" xlink:type="extended" xlink:title="40704 - Disclosure - Segment information and revenue from contracts with customers - Contract balances (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_CurrentReceivablesFromContractsWithCustomers_637843363591824710" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractAssets" xlink:label="ifrs-full_CurrentContractAssets_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_CurrentContractAssets_637843363591824710" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities_637843363591824710" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_ContractLiabilities_637843363591824710" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails" xlink:type="extended" xlink:title="40705 - Disclosure - Segment information and revenue from contracts with customers - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" xlink:to="ifrs-full_SegmentsAxis_637843363591844359" order="1" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis_637843363591844359" xlink:to="ifrs-full_SegmentsMember_637843363591844359" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalSegmentMember" xlink:label="cntg_PharmaceuticalSegmentMember_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591844359" xlink:to="cntg_PharmaceuticalSegmentMember_637843363591844359" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363591844359" xlink:to="cntg_Covid19Member_637843363591844359" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591844359" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591844359" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591844359" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnEquityOfferingMember" xlink:label="cntg_FollowOnEquityOfferingMember_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591844359" xlink:to="cntg_FollowOnEquityOfferingMember_637843363591844359" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIPOMember" xlink:label="cntg_IfrsIPOMember_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591844359" xlink:to="cntg_IfrsIPOMember_637843363591844359" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" xlink:to="ifrs-full_GeographicalAreasAxis_637843363591844359" order="3" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis_637843363591844359" xlink:to="ifrs-full_GeographicalAreasMember_637843363591844359" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US_637843363591844359" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591844359" xlink:to="country_US_637843363591844359" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591844359" xlink:to="country_DE_637843363591854980" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="ifrs-full_MajorCustomersAxis_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" xlink:to="ifrs-full_MajorCustomersAxis_637843363591854980" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="ifrs-full_MajorCustomersMember_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersAxis_637843363591854980" xlink:to="ifrs-full_MajorCustomersMember_637843363591854980" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PharmaceuticalPartnerMember" xlink:label="cntg_PharmaceuticalPartnerMember_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersMember_637843363591854980" xlink:to="cntg_PharmaceuticalPartnerMember_637843363591854980" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19PartnerOneMember" xlink:label="cntg_Covid19PartnerOneMember_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersMember_637843363591854980" xlink:to="cntg_Covid19PartnerOneMember_637843363591854980" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19PartnerTwoMember" xlink:label="cntg_Covid19PartnerTwoMember_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersMember_637843363591854980" xlink:to="cntg_Covid19PartnerTwoMember_637843363591854980" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationAxis" xlink:label="cntg_IfrsBalanceSheetLocationAxis_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" xlink:to="cntg_IfrsBalanceSheetLocationAxis_637843363591854980" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBalanceSheetLocationDomain" xlink:label="cntg_IfrsBalanceSheetLocationDomain_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsBalanceSheetLocationAxis_637843363591854980" xlink:to="cntg_IfrsBalanceSheetLocationDomain_637843363591854980" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_637843363591854980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsBalanceSheetLocationDomain_637843363591854980" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_637843363591854980" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591864766" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsBalanceSheetLocationDomain_637843363591854980" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591864766" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersTable_637843363591844359" xlink:to="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_637843363591864766" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="ifrs-full_ShareIssueRelatedCost_637843363591864766" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses_637843363591864766" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="cntg_RealEstateTransferTaxExpenses_637843363591864766" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_637843363591864766" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="ifrs-full_PropertyPlantAndEquipment_637843363591864766" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_637843363591864766" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="ifrs-full_RightofuseAssets_637843363591864766" order="4" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCustomersInGroup" xlink:label="cntg_NumberOfCustomersInGroup_637843363591864766" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="cntg_NumberOfCustomersInGroup_637843363591864766" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue_637843363591874698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="ifrs-full_PercentageOfEntitysRevenue_637843363591874698" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_637843363591874698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_637843363591874698" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CapitalizedInvestment" xlink:label="cntg_CapitalizedInvestment_637843363591874698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="cntg_CapitalizedInvestment_637843363591874698" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProvisionForExpectedCreditLossesOnContractAssets" xlink:label="cntg_ProvisionForExpectedCreditLossesOnContractAssets_637843363591874698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="cntg_ProvisionForExpectedCreditLossesOnContractAssets_637843363591874698" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_637843363591874698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_637843363591874698" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_637843363591874698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMajorCustomersLineItems_637843363591864766" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_637843363591874698" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Other income and expenses - Other Operating Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseTable" xlink:label="cntg_OtherIncomeExpenseTable_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="cntg_OtherIncomeExpenseTable_637843363591884876" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591884876" xlink:to="ifrs-full_ClassesOfAssetsAxis_637843363591884876" order="1" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_637843363591884876" xlink:to="ifrs-full_ClassesOfAssetsMember_637843363591884876" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363591884876" xlink:to="cntg_RostockHeadquartersBuildingMember_637843363591884876" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591884876" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591884876" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363591884876" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591884876" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363591884876" xlink:to="cntg_SupervisoryBoardMember_637843363591884876" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsAxis" xlink:label="cntg_InfrequentItemsAxis_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591884876" xlink:to="cntg_InfrequentItemsAxis_637843363591884876" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_InfrequentItemsDomain" xlink:label="cntg_InfrequentItemsDomain_637843363591884876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_InfrequentItemsAxis_637843363591884876" xlink:to="cntg_InfrequentItemsDomain_637843363591884876" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_InfrequentItemsDomain_637843363591884876" xlink:to="cntg_Covid19Member_637843363591894988" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseLineItems" xlink:label="cntg_OtherIncomeExpenseLineItems_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591884876" xlink:to="cntg_OtherIncomeExpenseLineItems_637843363591894988" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="ifrs-full_RevenueFromGovernmentGrants_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_RevenueFromGovernmentGrants_637843363591894988" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_637843363591894988" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="ifrs-full_NetForeignExchangeGain_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_NetForeignExchangeGain_637843363591894988" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReversalsOfProvisions" xlink:label="ifrs-full_OtherReversalsOfProvisions_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_OtherReversalsOfProvisions_637843363591894988" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="ifrs-full_MiscellaneousOtherOperatingIncome_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_MiscellaneousOtherOperatingIncome_637843363591894988" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_OtherIncome_637843363591894988" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GainLossFromForgivenessOfLoan" xlink:label="cntg_GainLossFromForgivenessOfLoan_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="cntg_GainLossFromForgivenessOfLoan_637843363591894988" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseTerm" xlink:label="cntg_LeaseTerm_637843363591894988" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="cntg_LeaseTerm_637843363591894988" order="8" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="ifrs-full_EmployeeBenefitsExpense_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_EmployeeBenefitsExpense_637843363591904697" order="9" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591894988" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_637843363591904697" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Other income and expenses - Other Operating Expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseTable" xlink:label="cntg_OtherIncomeExpenseTable_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="cntg_OtherIncomeExpenseTable_637843363591904697" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591904697" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591904697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis_637843363591904697" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591904697" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIPOMember" xlink:label="cntg_IfrsIPOMember_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363591904697" xlink:to="cntg_IfrsIPOMember_637843363591904697" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseLineItems" xlink:label="cntg_OtherIncomeExpenseLineItems_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591904697" xlink:to="cntg_OtherIncomeExpenseLineItems_637843363591904697" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="ifrs-full_NetForeignExchangeLoss_637843363591904697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591904697" xlink:to="ifrs-full_NetForeignExchangeLoss_637843363591904697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591904697" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense_637843363591914861" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="ifrs-full_OtherExpenseByFunction_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591904697" xlink:to="ifrs-full_OtherExpenseByFunction_637843363591914861" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591904697" xlink:to="ifrs-full_ShareIssueRelatedCost_637843363591914861" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails" xlink:type="extended" xlink:title="40803 - Disclosure - Other income and expenses - LPC GmbH (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract_637269589887103694" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseTable" xlink:label="cntg_OtherIncomeExpenseTable_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract_637269589887103694" xlink:to="cntg_OtherIncomeExpenseTable_637843363591914861" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591914861" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363591914861" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363591914861" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember_637843363591914861" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LpcGmbhMember" xlink:label="cntg_LpcGmbhMember_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363591914861" xlink:to="cntg_LpcGmbhMember_637843363591914861" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseLineItems" xlink:label="cntg_OtherIncomeExpenseLineItems_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseTable_637843363591914861" xlink:to="cntg_OtherIncomeExpenseLineItems_637843363591914861" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591914861" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_637843363591914861" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="ifrs-full_ConsiderationPaidReceived_637843363591914861" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591914861" xlink:to="ifrs-full_ConsiderationPaidReceived_637843363591914861" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationToBePaidOverTime" xlink:label="cntg_ConsiderationToBePaidOverTime_637843363591924810" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591914861" xlink:to="cntg_ConsiderationToBePaidOverTime_637843363591924810" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationPaymentDuePeriod" xlink:label="cntg_ConsiderationPaymentDuePeriod_637843363591924810" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591914861" xlink:to="cntg_ConsiderationPaymentDuePeriod_637843363591924810" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationOutstanding" xlink:label="cntg_ConsiderationOutstanding_637843363591924810" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591914861" xlink:to="cntg_ConsiderationOutstanding_637843363591924810" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests_637843363591924810" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591914861" xlink:to="ifrs-full_NoncontrollingInterests_637843363591924810" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_637843363591924810" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseLineItems_637843363591914861" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_637843363591924810" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails" xlink:type="extended" xlink:title="40804 - Disclosure - Other income and expenses - Financial costs, net (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="ifrs-full_InterestExpenseOnBorrowings_637843363591924810" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_InterestExpenseOnBorrowings_637843363591924810" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrencyLossesFinanceCost" xlink:label="cntg_CurrencyLossesFinanceCost_637843363591924810" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="cntg_CurrencyLossesFinanceCost_637843363591924810" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363591934429" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeOnLoansAndReceivables" xlink:label="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_InterestIncomeOnLoansAndReceivables_637843363591934429" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_FinanceIncomeCost_637843363591934429" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails" xlink:type="extended" xlink:title="40805 - Disclosure - Other income and expenses - Employee benefits expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherIncomeExpenseDisclosureAbstract" xlink:label="cntg_OtherIncomeExpenseDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries" xlink:label="ifrs-full_WagesAndSalaries_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_WagesAndSalaries_637843363591934429" order="1" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SocialSecurityContributions" xlink:label="ifrs-full_SocialSecurityContributions_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_SocialSecurityContributions_637843363591934429" order="2" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363591934429" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TerminationBenefitsExpense" xlink:label="ifrs-full_TerminationBenefitsExpense_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_TerminationBenefitsExpense_637843363591934429" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="ifrs-full_EmployeeBenefitsExpense_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OtherIncomeExpenseDisclosureAbstract" xlink:to="ifrs-full_EmployeeBenefitsExpense_637843363591934429" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Income taxes - Taxes recognized through profit or loss (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_637843363591934429" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_637843363591934429" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="ifrs-full_CurrentTaxExpenseIncome_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_CurrentTaxExpenseIncome_637843363591944829" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_637843363591944829" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_637843363591944829" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_637843363591944829" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense" xlink:label="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense_637843363591944829" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591944829" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_637843363591944829" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails" xlink:type="extended" xlink:title="40902 - Disclosure - Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncomeTaxDisclosureTable" xlink:label="cntg_IncomeTaxDisclosureTable_637843363591944829" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="cntg_IncomeTaxDisclosureTable_637843363591944829" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureTable_637843363591944829" xlink:to="ifrs-full_GeographicalAreasAxis_637843363591954925" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis_637843363591954925" xlink:to="ifrs-full_GeographicalAreasMember_637843363591954925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="ifrs-full_CountryOfDomicileMember_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591954925" xlink:to="ifrs-full_CountryOfDomicileMember_637843363591954925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncomeTaxDisclosureLineItems" xlink:label="cntg_IncomeTaxDisclosureLineItems_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureTable_637843363591944829" xlink:to="cntg_IncomeTaxDisclosureLineItems_637843363591954925" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_ApplicableTaxRate_637843363591954925" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_AccountingProfit_637843363591954925" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_637843363591954925" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates_637843363591954925" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_637843363591954925" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_TaxEffectOfTaxLosses_637843363591954925" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact" xlink:label="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_637843363591954925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact_637843363591954925" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_637843363591964745" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_637843363591964745" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CorporateIncomeTaxRate" xlink:label="cntg_CorporateIncomeTaxRate_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="cntg_CorporateIncomeTaxRate_637843363591964745" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SolidaritySurchargeRate" xlink:label="cntg_SolidaritySurchargeRate_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="cntg_SolidaritySurchargeRate_637843363591964745" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeTaxRate" xlink:label="cntg_TradeTaxRate_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IncomeTaxDisclosureLineItems_637843363591954925" xlink:to="cntg_TradeTaxRate_637843363591964745" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails" xlink:type="extended" xlink:title="40903 - Disclosure - Income taxes - Deferred Taxes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_637843363591964745" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_637843363591964745" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_637843363591964745" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_637843363591964745" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591964745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363591964745" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_637843363591974731" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="ifrs-full_RightofuseAssetsMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" xlink:to="ifrs-full_RightofuseAssetsMember_637843363591974731" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MeasurementOfServiceContractsMember" xlink:label="cntg_MeasurementOfServiceContractsMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" xlink:to="cntg_MeasurementOfServiceContractsMember_637843363591974731" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" xlink:to="ifrs-full_LeaseLiabilitiesMember_637843363591974731" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GovernmentGrantsMember" xlink:label="cntg_GovernmentGrantsMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" xlink:to="cntg_GovernmentGrantsMember_637843363591974731" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_637843363591964745" xlink:to="ifrs-full_UnusedTaxLossesMember_637843363591974731" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_637843363591964745" xlink:to="ifrs-full_GeographicalAreasAxis_637843363591974731" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis_637843363591974731" xlink:to="ifrs-full_GeographicalAreasMember_637843363591974731" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591974731" xlink:to="country_DE_637843363591974731" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherCountriesMember" xlink:label="cntg_OtherCountriesMember_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_637843363591974731" xlink:to="cntg_OtherCountriesMember_637843363591974731" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_637843363591964745" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_637843363591984720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_637843363591984720" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:label="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_637843363591984720" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="ifrs-full_DeferredTaxAssets_637843363591984720" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="ifrs-full_DeferredTaxLiabilities_637843363591984720" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxAssetsOffset" xlink:label="cntg_DeferredTaxAssetsOffset_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="cntg_DeferredTaxAssetsOffset_637843363591984720" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxLiabilitiesOffset" xlink:label="cntg_DeferredTaxLiabilitiesOffset_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="cntg_DeferredTaxLiabilitiesOffset_637843363591984720" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_637843363591984720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_637843363591984720" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DeferredTaxLiabilitiesNet" xlink:label="cntg_DeferredTaxLiabilitiesNet_637843363591994989" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_637843363591974731" xlink:to="cntg_DeferredTaxLiabilitiesNet_637843363591994989" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureLossPerShareDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Loss Per Share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares_637843363591994989" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares_637843363591994989" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureIntangibleAssetsDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Intangible assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_637843363592004799" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_637843363592004799" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592004799" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592004799" xlink:to="ifrs-full_CarryingAmountMember_637843363592004799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_637843363592004799" xlink:to="ifrs-full_GrossCarryingAmountMember_637843363592004799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_637843363592004799" xlink:to="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_637843363592004799" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="ifrs-full_MethodsOfGenerationAxis_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_637843363592004799" xlink:to="ifrs-full_MethodsOfGenerationAxis_637843363592004799" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MethodsOfGenerationMember" xlink:label="ifrs-full_MethodsOfGenerationMember_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MethodsOfGenerationAxis_637843363592004799" xlink:to="ifrs-full_MethodsOfGenerationMember_637843363592004799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InternallyGeneratedMember" xlink:label="ifrs-full_InternallyGeneratedMember_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MethodsOfGenerationMember_637843363592004799" xlink:to="ifrs-full_InternallyGeneratedMember_637843363592004799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotInternallyGeneratedMember" xlink:label="ifrs-full_NotInternallyGeneratedMember_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MethodsOfGenerationMember_637843363592004799" xlink:to="ifrs-full_NotInternallyGeneratedMember_637843363592004799" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363592004799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_637843363592004799" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363592004799" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_637843363592004799" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363592014845" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BiomarkersMember" xlink:label="cntg_BiomarkersMember_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363592014845" xlink:to="cntg_BiomarkersMember_637843363592014845" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DatabaseMember" xlink:label="cntg_DatabaseMember_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363592014845" xlink:to="cntg_DatabaseMember_637843363592014845" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="ifrs-full_LicencesAndFranchisesMember_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363592014845" xlink:to="ifrs-full_LicencesAndFranchisesMember_637843363592014845" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BiomarkersAndDatabasesMember" xlink:label="cntg_BiomarkersAndDatabasesMember_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_637843363592014845" xlink:to="cntg_BiomarkersAndDatabasesMember_637843363592014845" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_637843363592004799" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_637843363592014845" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_637843363592014845" xlink:to="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363592014845" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_637843363592014845" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_637843363592014845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_637843363592014845" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill" xlink:label="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill_637843363592024969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" xlink:to="cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill_637843363592024969" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_637843363592024969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_637843363592024969" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_637843363592024969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_637843363592024969" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363592024969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_637843363592014845" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_637843363592024969" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_637843363592034486" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_637843363592034486" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592034486" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592034486" xlink:to="ifrs-full_CarryingAmountMember_637843363592034486" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_637843363592034486" xlink:to="ifrs-full_GrossCarryingAmountMember_637843363592034486" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_637843363592034486" xlink:to="ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_637843363592034486" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_637843363592034486" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363592034486" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363592034486" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_637843363592034486" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363592034486" xlink:to="ifrs-full_BuildingsMember_637843363592034486" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantMember" xlink:label="cntg_PlantMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363592034486" xlink:to="cntg_PlantMember_637843363592034486" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentFurnitureAndFixturesMember" xlink:label="cntg_OtherEquipmentFurnitureAndFixturesMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363592034486" xlink:to="cntg_OtherEquipmentFurnitureAndFixturesMember_637843363592034486" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_637843363592034486" xlink:to="ifrs-full_SegmentsAxis_637843363592034486" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis_637843363592034486" xlink:to="ifrs-full_SegmentsMember_637843363592034486" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Covid19Member" xlink:label="cntg_Covid19Member_637843363592034486" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363592034486" xlink:to="cntg_Covid19Member_637843363592034486" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_637843363592034486" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_637843363592044415" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_637843363592044415" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_637843363592044415" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_637843363592044415" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" xlink:to="ifrs-full_PropertyPlantAndEquipment_637843363592044415" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment" xlink:label="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" xlink:to="cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment_637843363592044415" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_637843363592044415" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_637843363592044415" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_637843363592044415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_637843363592044415" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_6378433635920444151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_637843363592044415" xlink:to="ifrs-full_PropertyPlantAndEquipment_6378433635920444151" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Right-of-use assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592054937" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592054937" xlink:to="ifrs-full_ClassesOfAssetsAxis_637843363592054937" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_637843363592054937" xlink:to="ifrs-full_ClassesOfAssetsMember_637843363592054937" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="cntg_RostockHeadquartersBuildingMember_637843363592054937" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingAndBerlinOfficesMember" xlink:label="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_637843363592054937" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesInBerlinMember" xlink:label="cntg_OfficesInBerlinMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="cntg_OfficesInBerlinMember_637843363592054937" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesInBostonMember" xlink:label="cntg_OfficesInBostonMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="cntg_OfficesInBostonMember_637843363592054937" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantAndMachineryMember" xlink:label="cntg_PlantAndMachineryMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="cntg_PlantAndMachineryMember_637843363592054937" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentMember" xlink:label="cntg_OtherEquipmentMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="cntg_OtherEquipmentMember_637843363592054937" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="ifrs-full_MotorVehiclesMember_637843363592054937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="ifrs-full_MotorVehiclesMember_637843363592054937" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember" xlink:label="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592054937" xlink:to="cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_637843363592064714" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592054937" xlink:to="ifrs-full_RangeAxis_637843363592064714" order="2" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363592064714" xlink:to="ifrs-full_RangesMember_637843363592064714" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592064714" xlink:to="ifrs-full_TopOfRangeMember_637843363592064714" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592054937" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseTerm" xlink:label="cntg_LeaseTerm_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" xlink:to="cntg_LeaseTerm_637843363592064714" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankGuarantee" xlink:label="cntg_BankGuarantee_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" xlink:to="cntg_BankGuarantee_637843363592064714" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592064714" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RentalDeposits" xlink:label="cntg_RentalDeposits_637843363592064714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" xlink:to="cntg_RentalDeposits_637843363592064714" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTimesLeaseContractCanBeExtended" xlink:label="cntg_NumberOfTimesLeaseContractCanBeExtended_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" xlink:to="cntg_NumberOfTimesLeaseContractCanBeExtended_637843363592074708" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseExtensionTerm" xlink:label="cntg_LeaseExtensionTerm_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" xlink:to="cntg_LeaseExtensionTerm_637843363592074708" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RentalExpense" xlink:label="ifrs-full_RentalExpense_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592064714" xlink:to="ifrs-full_RentalExpense_637843363592074708" order="7" use="optional" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails" xlink:type="extended" xlink:title="41302 - Disclosure - Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592074708" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592074708" xlink:to="ifrs-full_ClassesOfAssetsAxis_637843363592074708" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_637843363592074708" xlink:to="ifrs-full_ClassesOfAssetsMember_637843363592074708" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592074708" xlink:to="ifrs-full_BuildingsMember_637843363592074708" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficesMember" xlink:label="cntg_OfficesMember_637843363592074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592074708" xlink:to="cntg_OfficesMember_637843363592074708" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PlantAndEquipmentMember" xlink:label="cntg_PlantAndEquipmentMember_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592074708" xlink:to="cntg_PlantAndEquipmentMember_637843363592084976" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherEquipmentMember" xlink:label="cntg_OtherEquipmentMember_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592074708" xlink:to="cntg_OtherEquipmentMember_637843363592084976" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="ifrs-full_MotorVehiclesMember_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592074708" xlink:to="ifrs-full_MotorVehiclesMember_637843363592084976" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592074708" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592084976" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592084976" xlink:to="ifrs-full_RightofuseAssets_637843363592084976" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592084976" xlink:to="ifrs-full_AdditionsToRightofuseAssets_637843363592084976" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment" xlink:label="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592084976" xlink:to="cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment_637843363592084976" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_637843363592084976" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592084976" xlink:to="ifrs-full_DepreciationRightofuseAssets_637843363592084976" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_6378433635920849761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592084976" xlink:to="ifrs-full_RightofuseAssets_6378433635920849761" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails" xlink:type="extended" xlink:title="41303 - Disclosure - Right-of-use assets - Carrying amounts of lease liabilities and the movements during the period (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="ifrs-full_LeaseLiabilities_637843363592094841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_LeaseLiabilities_637843363592094841" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughAdditionsLeaseLiabilities" xlink:label="cntg_IncreaseThroughAdditionsLeaseLiabilities_637843363592094841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="cntg_IncreaseThroughAdditionsLeaseLiabilities_637843363592094841" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363592094841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363592094841" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DecreaseThroughPaymentsLeaseLiabilities" xlink:label="cntg_DecreaseThroughPaymentsLeaseLiabilities_637843363592094841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="cntg_DecreaseThroughPaymentsLeaseLiabilities_637843363592094841" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="ifrs-full_LeaseLiabilities_6378433635920948411" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_LeaseLiabilities_6378433635920948411" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities_637843363592094841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities_637843363592094841" order="6" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_637843363592094841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_637843363592094841" order="7" use="optional" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails" xlink:type="extended" xlink:title="41304 - Disclosure - Right-of-use assets - Amounts recognised in profit or loss (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_637843363592104911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DepreciationRightofuseAssets_637843363592104911" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363592104911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_637843363592104911" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_637843363592104911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_637843363592104911" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_637843363592104911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_637843363592104911" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TotalLeaseExpensesRecognisedInProfitOrLoss" xlink:label="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss_637843363592104911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="cntg_TotalLeaseExpensesRecognisedInProfitOrLoss_637843363592104911" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases_637843363592104911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_CashOutflowForLeases_637843363592104911" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails" xlink:type="extended" xlink:title="41305 - Disclosure - Right-of-use assets - Sale and Leaseback transactions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592104911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592104911" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592104911" xlink:to="ifrs-full_ClassesOfAssetsAxis_637843363592114818" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_637843363592114818" xlink:to="ifrs-full_ClassesOfAssetsMember_637843363592114818" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592114818" xlink:to="cntg_RostockHeadquartersBuildingMember_637843363592114818" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_637843363592104911" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_637843363592114818" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RealEstateTransferTaxExpenses" xlink:label="cntg_RealEstateTransferTaxExpenses_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" xlink:to="cntg_RealEstateTransferTaxExpenses_637843363592114818" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363592114818" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LeaseTerm" xlink:label="cntg_LeaseTerm_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" xlink:to="cntg_LeaseTerm_637843363592114818" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_637843363592114818" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592114818" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment" xlink:label="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_637843363592114818" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_637843363592114818" xlink:to="cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment_637843363592114818" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureInventoriesDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Inventories (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:label="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_637843363592124866" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinishedGoods" xlink:label="ifrs-full_FinishedGoods_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_FinishedGoods_637843363592124866" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_Inventories_637843363592124866" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryWritedown2011" xlink:label="ifrs-full_InventoryWritedown2011_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_InventoryWritedown2011_637843363592124866" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_637843363592124866" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Trade and other receivables and other assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592124866" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592124866" xlink:to="ifrs-full_ClassesOfAssetsAxis_637843363592124866" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_637843363592124866" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_637843363592124866" xlink:to="ifrs-full_ClassesOfAssetsMember_637843363592124866" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember" xlink:label="ifrs-full_OtherAssetsMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592124866" xlink:to="ifrs-full_OtherAssetsMember_637843363592134485" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592124866" xlink:to="ifrs-full_RangeAxis_637843363592134485" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363592134485" xlink:to="ifrs-full_RangesMember_637843363592134485" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592134485" xlink:to="ifrs-full_BottomOfRangeMember_637843363592134485" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592134485" xlink:to="ifrs-full_TopOfRangeMember_637843363592134485" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592124866" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592134485" order="3" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592134485" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592134485" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LpcGmbhMember" xlink:label="cntg_LpcGmbhMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592134485" xlink:to="cntg_LpcGmbhMember_637843363592134485" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592124866" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363592134485" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_637843363592134485" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_637843363592134485" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363592134485" xlink:to="cntg_RostockHeadquartersBuildingMember_637843363592134485" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BerlinOfficesMember" xlink:label="cntg_BerlinOfficesMember_637843363592134485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363592134485" xlink:to="cntg_BerlinOfficesMember_637843363592134485" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363592134485" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember_637843363592144729" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherOfficeAndLaboratoriesMember" xlink:label="cntg_OtherOfficeAndLaboratoriesMember_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_637843363592134485" xlink:to="cntg_OtherOfficeAndLaboratoriesMember_637843363592144729" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592124866" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="ifrs-full_NoncurrentReceivablesAbstract_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="ifrs-full_NoncurrentReceivablesAbstract_637843363592144729" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RentalDepositsNoncurrent" xlink:label="cntg_RentalDepositsNoncurrent_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentReceivablesAbstract_637843363592144729" xlink:to="cntg_RentalDepositsNoncurrent_637843363592144729" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="ifrs-full_OtherNoncurrentReceivables_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentReceivablesAbstract_637843363592144729" xlink:to="ifrs-full_OtherNoncurrentReceivables_637843363592144729" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentReceivablesAbstract_637843363592144729" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent_637843363592144729" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_CurrentReceivablesFromContractsWithCustomers_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" xlink:to="ifrs-full_CurrentReceivablesFromContractsWithCustomers_637843363592154946" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractAssets" xlink:label="ifrs-full_CurrentContractAssets_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" xlink:to="ifrs-full_CurrentContractAssets_637843363592154946" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" xlink:to="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_637843363592154946" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders" xlink:label="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" xlink:to="cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders_637843363592154946" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent_637843363592154946" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent" xlink:label="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_637843363592144729" xlink:to="cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent_637843363592154946" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ReceivablesPaymentTerms" xlink:label="cntg_ReceivablesPaymentTerms_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="cntg_ReceivablesPaymentTerms_637843363592154946" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592154946" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592154946" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankGuarantee" xlink:label="cntg_BankGuarantee_637843363592164940" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="cntg_BankGuarantee_637843363592164940" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ConsiderationReceivableForSaleOfLpc" xlink:label="cntg_ConsiderationReceivableForSaleOfLpc_637843363592164940" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="cntg_ConsiderationReceivableForSaleOfLpc_637843363592164940" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_637843363592164940" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_637843363592164940" order="7" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_637843363592164940" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="ifrs-full_CurrentPrepaidExpenses_637843363592164940" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted" xlink:label="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted_637843363592164940" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted_637843363592164940" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions" xlink:label="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions_637843363592164940" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions_637843363592164940" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantsReceivables" xlink:label="cntg_GrantsReceivables_637843363592174878" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592144729" xlink:to="cntg_GrantsReceivables_637843363592174878" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Cash and short-term deposits (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592174878" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592174878" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis_637843363592174878" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592174878" xlink:to="ifrs-full_BorrowingsByNameAxis_637843363592174878" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember_637843363592174878" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis_637843363592174878" xlink:to="ifrs-full_BorrowingsByNameMember_637843363592174878" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredBankLoanMember" xlink:label="cntg_SecuredBankLoanMember_637843363592174878" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameMember_637843363592174878" xlink:to="cntg_SecuredBankLoanMember_637843363592174878" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityMember" xlink:label="cntg_OverdraftFacilityMember_637843363592174878" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameMember_637843363592174878" xlink:to="cntg_OverdraftFacilityMember_637843363592174878" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityOneMember" xlink:label="cntg_OverdraftFacilityOneMember_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OverdraftFacilityMember_637843363592174878" xlink:to="cntg_OverdraftFacilityOneMember_637843363592184711" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityTwoMember" xlink:label="cntg_OverdraftFacilityTwoMember_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OverdraftFacilityMember_637843363592174878" xlink:to="cntg_OverdraftFacilityTwoMember_637843363592184711" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityThreeMember" xlink:label="cntg_OverdraftFacilityThreeMember_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_OverdraftFacilityMember_637843363592174878" xlink:to="cntg_OverdraftFacilityThreeMember_637843363592184711" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_637843363592174878" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592184711" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592184711" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592184711" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_637843363592184711" xlink:to="cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity_637843363592184711" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Equity - Issued capital and capital reserve (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592184711" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_637843363592184711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592184711" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_637843363592184711" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_637843363592184711" xlink:to="ifrs-full_ClassesOfShareCapitalMember_637843363592194885" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_637843363592194885" xlink:to="ifrs-full_OrdinarySharesMember_637843363592194885" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592184711" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid_637843363592194885" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363592194885" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExerciseOfOptionsShares" xlink:label="cntg_ExerciseOfOptionsShares_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" xlink:to="cntg_ExerciseOfOptionsShares_637843363592194885" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_6378433635921948851" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid_6378433635921948851" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="ifrs-full_NumberOfSharesAuthorised_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" xlink:to="ifrs-full_NumberOfSharesAuthorised_637843363592194885" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_637843363592194885" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592194885" xlink:to="ifrs-full_ParValuePerShare_637843363592194885" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureEquityCommonSharesDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Equity - Common Shares (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592204755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592204755" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_637843363592204755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592204755" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis_637843363592204755" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363592204755" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis_637843363592204755" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363592204755" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnPublicOfferingMember" xlink:label="cntg_FollowOnPublicOfferingMember_637843363592244703" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363592204755" xlink:to="cntg_FollowOnPublicOfferingMember_637843363592244703" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_637843363592244703" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592204755" xlink:to="dei_LegalEntityAxis_637843363592244703" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_637843363592244703" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_637843363592244703" xlink:to="dei_EntityDomain_637843363592244703" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_637843363592244703" xlink:to="cntg_CentogeneN.vMember_637843363592254715" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592204755" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_637843363592254715" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_637843363592254715" xlink:to="ifrs-full_ClassesOfShareCapitalMember_637843363592254715" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_637843363592254715" xlink:to="ifrs-full_OrdinarySharesMember_637843363592254715" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_637843363592204755" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="ifrs-full_ParValuePerShare_637843363592254715" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363592254715" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363592254715" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_637843363592254715" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="cntg_NumberOfCommonSharesOfferedByPriorShareholders_637843363592254715" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_637843363592254715" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_637843363592254715" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363592264890" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AuthorizedButUnissuedShareCapital" xlink:label="cntg_AuthorizedButUnissuedShareCapital_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="cntg_AuthorizedButUnissuedShareCapital_637843363592264890" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_637843363592254715" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid_637843363592264890" order="9" use="optional" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureEquityCapitalReservesDetails" xlink:type="extended" xlink:title="41703 - Disclosure - Equity - Capital Reserves (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable_637843363592264890" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_637843363592264890" xlink:to="ifrs-full_ComponentsOfEquityAxis_637843363592264890" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_637843363592264890" xlink:to="ifrs-full_EquityMember_637843363592264890" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CapitalReserveMember" xlink:label="ifrs-full_CapitalReserveMember_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityMember_637843363592264890" xlink:to="ifrs-full_CapitalReserveMember_637843363592264890" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_637843363592264890" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_637843363592264890" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_637843363592264890" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_637843363592264890" xlink:to="ifrs-full_SharePremium_637843363592274734" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails" xlink:type="extended" xlink:title="41901 - Disclosure - Financial liabilities - Interest-bearing loans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592274734" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592274734" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_637843363592274734" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis_637843363592274734" xlink:to="ifrs-full_FinancialLiabilitiesMember_637843363592274734" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592274734" xlink:to="ifrs-full_BorrowingsByNameMember_637843363592274734" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesMember" xlink:label="cntg_SecuredCreditLinesMember_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592274734" xlink:to="cntg_SecuredCreditLinesMember_637843363592274734" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherBankLoansMember" xlink:label="cntg_OtherBankLoansMember_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592274734" xlink:to="cntg_OtherBankLoansMember_637843363592274734" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592274734" xlink:to="cntg_IfrsBankOverdraftsMember_637843363592274734" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592274734" xlink:to="ifrs-full_LeaseLiabilitiesMember_637843363592274734" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592274734" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592274734" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_NonCurrentFinancialLiabilitiesInterestBearing_637843363592274734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592274734" xlink:to="cntg_NonCurrentFinancialLiabilitiesInterestBearing_637843363592274734" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentFinancialLiabilitiesInterestBearing" xlink:label="cntg_CurrentFinancialLiabilitiesInterestBearing_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592274734" xlink:to="cntg_CurrentFinancialLiabilitiesInterestBearing_637843363592284713" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialLiabilitiesInterestBearing" xlink:label="cntg_FinancialLiabilitiesInterestBearing_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592274734" xlink:to="cntg_FinancialLiabilitiesInterestBearing_637843363592284713" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592274734" xlink:to="ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_637843363592284713" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails" xlink:type="extended" xlink:title="41902 - Disclosure - Financial liabilities - Conditions and statement of liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592284713" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592284713" xlink:to="ifrs-full_BorrowingsByNameAxis_637843363592284713" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis_637843363592284713" xlink:to="ifrs-full_BorrowingsByNameMember_637843363592284713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OverdraftFacilityMember" xlink:label="cntg_OverdraftFacilityMember_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameMember_637843363592284713" xlink:to="cntg_OverdraftFacilityMember_637843363592284713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592284713" xlink:to="ifrs-full_RangeAxis_637843363592284713" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363592284713" xlink:to="ifrs-full_RangesMember_637843363592284713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_637843363592284713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592284713" xlink:to="ifrs-full_BottomOfRangeMember_637843363592284713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592284713" xlink:to="ifrs-full_TopOfRangeMember_637843363592294804" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592284713" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_637843363592294804" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis_637843363592294804" xlink:to="ifrs-full_FinancialLiabilitiesMember_637843363592294804" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesMember" xlink:label="cntg_SecuredCreditLinesMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592294804" xlink:to="cntg_SecuredCreditLinesMember_637843363592294804" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember" xlink:label="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_SecuredCreditLinesMember_637843363592294804" xlink:to="cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_637843363592294804" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherBankLoansMember" xlink:label="cntg_OtherBankLoansMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592294804" xlink:to="cntg_OtherBankLoansMember_637843363592294804" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592294804" xlink:to="cntg_IfrsBankOverdraftsMember_637843363592294804" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsOneMember" xlink:label="cntg_BankOverdraftsOneMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsBankOverdraftsMember_637843363592294804" xlink:to="cntg_BankOverdraftsOneMember_637843363592294804" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsTwoMember" xlink:label="cntg_BankOverdraftsTwoMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsBankOverdraftsMember_637843363592294804" xlink:to="cntg_BankOverdraftsTwoMember_637843363592294804" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsThreeMember" xlink:label="cntg_BankOverdraftsThreeMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsBankOverdraftsMember_637843363592294804" xlink:to="cntg_BankOverdraftsThreeMember_637843363592294804" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankOverdraftsOneAndThreeMember" xlink:label="cntg_BankOverdraftsOneAndThreeMember_637843363592294804" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsBankOverdraftsMember_637843363592294804" xlink:to="cntg_BankOverdraftsOneAndThreeMember_637843363592294804" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_637843363592294804" xlink:to="ifrs-full_LeaseLiabilitiesMember_637843363592304779" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable_637843363592284713" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="ifrs-full_BorrowingsInterestRate_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" xlink:to="ifrs-full_BorrowingsInterestRate_637843363592304779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_637843363592304779" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" xlink:to="ifrs-full_NotionalAmount_637843363592304779" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" xlink:to="ifrs-full_FinancialLiabilities_637843363592304779" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancialLiabilitiesInterestBearing" xlink:label="cntg_FinancialLiabilitiesInterestBearing_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" xlink:to="cntg_FinancialLiabilitiesInterestBearing_637843363592304779" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShortTermDepositsPledgedAsSecurityForLiabilities" xlink:label="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" xlink:to="cntg_ShortTermDepositsPledgedAsSecurityForLiabilities_637843363592304779" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:label="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_637843363592304779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_637843363592304779" xlink:to="ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_637843363592304779" order="7" use="optional" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails" xlink:type="extended" xlink:title="41903 - Disclosure - Financial liabilities - Trade payables and other liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_637843363592315014" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GovernmentGrants" xlink:label="ifrs-full_GovernmentGrants_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_GovernmentGrants_637843363592315014" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_ContractLiabilities_637843363592315014" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherPayablesOther" xlink:label="cntg_TradeAndOtherPayablesOther_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="cntg_TradeAndOtherPayablesOther_637843363592315014" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="ifrs-full_TradeAndOtherPayables_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherPayables_637843363592315014" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayables" xlink:label="ifrs-full_NoncurrentPayables_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentPayables_637843363592315014" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_637843363592315014" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities_637843363592315014" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProvisionForOutstandingInvoices" xlink:label="cntg_ProvisionForOutstandingInvoices_637843363592315014" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="cntg_ProvisionForOutstandingInvoices_637843363592315014" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_637843363592324723" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxPayables" xlink:label="ifrs-full_CurrentValueAddedTaxPayables_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_CurrentValueAddedTaxPayables_637843363592324723" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesForWageAndChurchTax" xlink:label="cntg_LiabilitiesForWageAndChurchTax_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="cntg_LiabilitiesForWageAndChurchTax_637843363592324723" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails" xlink:type="extended" xlink:title="42001 - Disclosure - Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592324723" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592324723" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592324723" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592324723" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592324723" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2016CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2016CashSettledMember_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592324723" xlink:to="cntg_VirtualShareOptionProgram2016CashSettledMember_637843363592324723" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592324723" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592324723" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PaymentForSettlementOfStockOptions" xlink:label="cntg_PaymentForSettlementOfStockOptions_637843363592324723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592324723" xlink:to="cntg_PaymentForSettlementOfStockOptions_637843363592324723" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails" xlink:type="extended" xlink:title="42002 - Disclosure - Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592334790" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_1" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592334790" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592334790" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592334790" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592334790" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592334790" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592334790" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592334790" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363592334790" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592334790" xlink:to="cntg_LongTermIncentivePlanMember_637843363592334790" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592334790" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592334790" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592334790" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants" xlink:label="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants_637843363592334790" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592334790" xlink:to="cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants_637843363592334790" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital" xlink:label="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital_637843363592334790" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592334790" xlink:to="cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital_637843363592334790" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details" xlink:type="extended" xlink:title="42003 - Disclosure - Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592344771" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592344771" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592344771" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592344771" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592344771" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592344771" xlink:to="cntg_EquityShareOption2017EquitySettledMember_637843363592344771" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592344771" xlink:to="cntg_LongTermIncentivePlanMember_637843363592344771" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592344771" xlink:to="cntg_IfrsAwardTypeAxis_637843363592344771" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsAwardTypeAxis_637843363592344771" xlink:to="cntg_AwardTypeDomain_637843363592344771" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592344771" xlink:to="cntg_StockOptionsMember_637843363592344771" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592344771" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" xlink:to="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_637843363592344771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592344771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering" xlink:label="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering_637843363592344771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" xlink:to="cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering_637843363592344771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_637843363592354714" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOutstandingShareOptionsAbstract" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" xlink:to="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_637843363592354714" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592354714" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" xlink:to="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592354714" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_637843363592354714" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_6378433635923547141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_6378433635923547141" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" xlink:to="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592354714" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_637843363592354714" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592344771" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592354714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592354714" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592364759" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592364759" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592364759" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592364759" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_637843363592364759" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_637843363592364759" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592364759" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592364759" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592364759" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592364759" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_637843363592364759" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_637843363592364759" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592354714" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_637843363592374970" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details" xlink:type="extended" xlink:title="42004 - Disclosure - Share-based payments - Equity Share Option (ESOP 2019) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592374970" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592374970" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592374970" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2019EquitySettledMember" xlink:label="cntg_EquityShareOption2019EquitySettledMember_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592374970" xlink:to="cntg_EquityShareOption2019EquitySettledMember_637843363592374970" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592374970" xlink:to="cntg_LongTermIncentivePlanMember_637843363592374970" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" xlink:to="cntg_IfrsVestingAxis_637843363592374970" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain_637843363592374970" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingAxis_637843363592374970" xlink:to="cntg_IfrsVestingDomain_637843363592374970" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedPaymentArrangementTrancheOneMember" xlink:label="cntg_ShareBasedPaymentArrangementTrancheOneMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingDomain_637843363592374970" xlink:to="cntg_ShareBasedPaymentArrangementTrancheOneMember_637843363592384722" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedPaymentArrangementTrancheTwoMember" xlink:label="cntg_ShareBasedPaymentArrangementTrancheTwoMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingDomain_637843363592374970" xlink:to="cntg_ShareBasedPaymentArrangementTrancheTwoMember_637843363592384722" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" xlink:to="cntg_IfrsAwardTypeAxis_637843363592384722" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsAwardTypeAxis_637843363592384722" xlink:to="cntg_AwardTypeDomain_637843363592384722" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592384722" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592384722" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592384722" xlink:to="cntg_StockOptionsMember_637843363592384722" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592384722" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592384722" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592384722" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MemberOfSupervisoryBoardMember" xlink:label="cntg_MemberOfSupervisoryBoardMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592384722" xlink:to="cntg_MemberOfSupervisoryBoardMember_637843363592384722" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592384722" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_637843363592384722" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:label="srt_ManagementMember_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592384722" xlink:to="srt_ManagementMember_637843363592384722" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637843363592384722" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" xlink:to="srt_StatementScenarioAxis_637843363592384722" order="5" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637843363592384722" xlink:to="srt_ScenarioUnspecifiedDomain_637843363592394786" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VestingInFourTranchesMember" xlink:label="cntg_VestingInFourTranchesMember_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637843363592394786" xlink:to="cntg_VestingInFourTranchesMember_637843363592394786" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363592394786" order="6" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363592394786" xlink:to="ifrs-full_NonadjustingEventsMember_637843363592394786" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantOfRestrictedStockUnitsMember" xlink:label="cntg_GrantOfRestrictedStockUnitsMember_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_637843363592394786" xlink:to="cntg_GrantOfRestrictedStockUnitsMember_637843363592394786" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592374970" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592394786" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592394786" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted" xlink:label="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_637843363592394786" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted_637843363592394786" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_637843363592404717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_637843363592404717" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_637843363592404717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_637843363592404717" order="5" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageFairValueOfShareOptionsOutstanding" xlink:label="cntg_WeightedAverageFairValueOfShareOptionsOutstanding_637843363592404717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_WeightedAverageFairValueOfShareOptionsOutstanding_637843363592404717" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_637843363592404717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_637843363592404717" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592404717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592404717" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363592404717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363592404717" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xlink:label="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_637843363592404717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_637843363592404717" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTranches" xlink:label="cntg_NumberOfTranches_637843363592414937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_NumberOfTranches_637843363592414937" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637843363592414937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637843363592414937" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOutstandingShareOptionsAbstract" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_637843363592414937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_637843363592414937" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592414937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592414937" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement_637843363592414937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement_637843363592414937" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592424870" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592424870" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_637843363592424870" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_637843363592424870" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_637843363592424870" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_637843363592424870" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592424870" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592424870" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_637843363592424870" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592414937" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_637843363592424870" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592394786" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592434714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592434714" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592434714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_637843363592434714" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592434714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592434714" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_637843363592434714" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_637843363592434714" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_6378433635924347141" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_6378433635924347141" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592444958" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592444958" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_637843363592444958" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592424870" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_637843363592444958" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails" xlink:type="extended" xlink:title="42005 - Disclosure - Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592454811" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592454811" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592454811" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592454811" xlink:to="cntg_LongTermIncentivePlanMember_637843363592454811" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" xlink:to="cntg_IfrsVestingAxis_637843363592454811" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingAxis_637843363592454811" xlink:to="cntg_IfrsVestingDomain_637843363592454811" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheOneMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingDomain_637843363592454811" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_637843363592454811" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingDomain_637843363592454811" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_637843363592454811" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember" xlink:label="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingDomain_637843363592454811" xlink:to="cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_637843363592454811" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" xlink:to="cntg_IfrsAwardTypeAxis_637843363592454811" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_637843363592454811" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsAwardTypeAxis_637843363592454811" xlink:to="cntg_AwardTypeDomain_637843363592454811" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592454811" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592464690" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedOneMember" xlink:label="cntg_RsuGrantedOneMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592464690" xlink:to="cntg_RsuGrantedOneMember_637843363592464690" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedTwoMember" xlink:label="cntg_RsuGrantedTwoMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592464690" xlink:to="cntg_RsuGrantedTwoMember_637843363592464690" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedThreeMember" xlink:label="cntg_RsuGrantedThreeMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592464690" xlink:to="cntg_RsuGrantedThreeMember_637843363592464690" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedFourMember" xlink:label="cntg_RsuGrantedFourMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592464690" xlink:to="cntg_RsuGrantedFourMember_637843363592464690" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsuGrantedFiveMember" xlink:label="cntg_RsuGrantedFiveMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592464690" xlink:to="cntg_RsuGrantedFiveMember_637843363592464690" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592454811" xlink:to="cntg_StockOptionsMember_637843363592464690" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionsGrantedTwoMember" xlink:label="cntg_OptionsGrantedTwoMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_StockOptionsMember_637843363592464690" xlink:to="cntg_OptionsGrantedTwoMember_637843363592464690" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592464690" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592464690" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:label="srt_ManagementMember_637843363592464690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="srt_ManagementMember_637843363592464690" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_637843363592474826" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="cntg_IfrsChiefExecutiveOfficerMember_637843363592474826" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363592474826" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerChiefFinancialOfficerMember" xlink:label="cntg_FormerChiefFinancialOfficerMember_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="cntg_FormerChiefFinancialOfficerMember_637843363592474826" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChiefInformationOfficerMember" xlink:label="cntg_ChiefInformationOfficerMember_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="cntg_ChiefInformationOfficerMember_637843363592474826" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EmployeesMember" xlink:label="cntg_EmployeesMember_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="cntg_EmployeesMember_637843363592474826" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592464690" xlink:to="cntg_SupervisoryBoardMember_637843363592474826" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637843363592474826" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" xlink:to="srt_StatementScenarioAxis_637843363592474826" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637843363592484691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637843363592474826" xlink:to="srt_ScenarioUnspecifiedDomain_637843363592484691" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VestingInFourTranchesMember" xlink:label="cntg_VestingInFourTranchesMember_637843363592484691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637843363592484691" xlink:to="cntg_VestingInFourTranchesMember_637843363592484691" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363592484691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" xlink:to="ifrs-full_RangeAxis_637843363592484691" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363592484691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363592484691" xlink:to="ifrs-full_RangesMember_637843363592484691" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363592484691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592484691" xlink:to="ifrs-full_TopOfRangeMember_637843363592484691" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592454811" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" order="7" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592484691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592484691" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592494881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592494881" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_637843363592494881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_637843363592494881" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ThresholdTradingDays" xlink:label="cntg_ThresholdTradingDays_637843363592494881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="cntg_ThresholdTradingDays_637843363592494881" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019_637843363592494881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="ifrs-full_WeightedAverageSharePrice2019_637843363592494881" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_637843363592494881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_637843363592494881" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTranches" xlink:label="cntg_NumberOfTranches_637843363592494881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="cntg_NumberOfTranches_637843363592494881" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637843363592504712" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637843363592504712" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363592504712" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592484691" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363592504712" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails" xlink:type="extended" xlink:title="42006 - Disclosure - Share-based payments - Grants to new CEO and supervisory board grant (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592514693" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592514693" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592514693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592514693" xlink:to="cntg_LongTermIncentivePlanMember_637843363592514693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592514693" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592514693" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" xlink:to="cntg_IfrsChiefExecutiveOfficerMember_637843363592514693" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" xlink:to="cntg_SupervisoryBoardMember_637843363592514693" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363592514693" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanMember" xlink:label="cntg_ChairmanMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" xlink:to="cntg_ChairmanMember_637843363592514693" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ViceChairmanMember" xlink:label="cntg_ViceChairmanMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" xlink:to="cntg_ViceChairmanMember_637843363592514693" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanOfAuditCommitteeMember" xlink:label="cntg_ChairmanOfAuditCommitteeMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" xlink:to="cntg_ChairmanOfAuditCommitteeMember_637843363592514693" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ChairmanOfCompensationCommitteeMember" xlink:label="cntg_ChairmanOfCompensationCommitteeMember_637843363592514693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592514693" xlink:to="cntg_ChairmanOfCompensationCommitteeMember_637843363592514693" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" xlink:to="srt_StatementScenarioAxis_637843363592524691" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637843363592524691" xlink:to="srt_ScenarioUnspecifiedDomain_637843363592524691" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637843363592524691" xlink:to="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_637843363592524691" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member" xlink:label="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637843363592524691" xlink:to="cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_637843363592524691" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" xlink:to="cntg_IfrsAwardTypeAxis_637843363592524691" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsAwardTypeAxis_637843363592524691" xlink:to="cntg_AwardTypeDomain_637843363592524691" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592524691" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592524691" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592524691" xlink:to="cntg_PerformanceBasedRestrictedStockUnitsMember_637843363592524691" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592524691" xlink:to="cntg_StockOptionsMember_637843363592524691" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_637843363592524691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" xlink:to="srt_TitleOfIndividualAxis_637843363592524691" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592534692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_637843363592524691" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592534692" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrBerndtModigMember" xlink:label="cntg_MrBerndtModigMember_637843363592534692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592534692" xlink:to="cntg_MrBerndtModigMember_637843363592534692" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PeerSchatzMember" xlink:label="cntg_PeerSchatzMember_637843363592534692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592534692" xlink:to="cntg_PeerSchatzMember_637843363592534692" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrJonathanGSheldonMember" xlink:label="cntg_MrJonathanGSheldonMember_637843363592534692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592534692" xlink:to="cntg_MrJonathanGSheldonMember_637843363592534692" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockAxis" xlink:label="cntg_IfrsSaleOfStockAxis_637843363592534692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" xlink:to="cntg_IfrsSaleOfStockAxis_637843363592534692" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SaleOfStockDomain" xlink:label="cntg_SaleOfStockDomain_637843363592534692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockAxis_637843363592534692" xlink:to="cntg_SaleOfStockDomain_637843363592534692" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsIPOMember" xlink:label="cntg_IfrsIPOMember_637843363592534692" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_SaleOfStockDomain_637843363592534692" xlink:to="cntg_IfrsIPOMember_637843363592534692" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592504712" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592544782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592544782" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="ifrs-full_IssueOfEquity_637843363592544782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="ifrs-full_IssueOfEquity_637843363592544782" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfInstallments" xlink:label="cntg_NumberOfInstallments_637843363592544782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_NumberOfInstallments_637843363592544782" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments" xlink:label="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments_637843363592544782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments_637843363592544782" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_637843363592544782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_637843363592544782" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement" xlink:label="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement_637843363592544782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement_637843363592544782" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363592554720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363592554720" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:label="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_637843363592554720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_637843363592554720" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592554720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592554720" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionsStrikePrice" xlink:label="cntg_OptionsStrikePrice_637843363592554720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_OptionsStrikePrice_637843363592554720" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement" xlink:label="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement_637843363592554720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement_637843363592554720" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VolumeWeightedAverageStockPriceComputationTradingDays" xlink:label="cntg_VolumeWeightedAverageStockPriceComputationTradingDays_637843363592554720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_VolumeWeightedAverageStockPriceComputationTradingDays_637843363592554720" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement" xlink:label="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_637843363592564717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement_637843363592564717" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfAwardConstitutesRestrictedStockUnits" xlink:label="cntg_PercentageOfAwardConstitutesRestrictedStockUnits_637843363592564717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_PercentageOfAwardConstitutesRestrictedStockUnits_637843363592564717" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfAwardConstitutesStockOptions" xlink:label="cntg_PercentageOfAwardConstitutesStockOptions_637843363592564717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_PercentageOfAwardConstitutesStockOptions_637843363592564717" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOutstandingShareOptionsAbstract" xlink:label="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_637843363592564717" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_637843363592564717" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592574693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363592574693" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_637843363592574693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_637843363592574693" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_637843363592574693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_637843363592574693" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592574693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" xlink:to="cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592574693" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_637843363592574693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOutstandingShareOptionsAbstract_637843363592564717" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_637843363592574693" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592584693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_637843363592584693" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592584693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363592584693" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_637843363592584693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_637843363592584693" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_6378433635925846931" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_6378433635925846931" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement" xlink:label="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592584693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" xlink:to="cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement_637843363592584693" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_637843363592594690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfShareOptionsAbstract_637843363592574693" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_637843363592594690" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfOtherEquityInstrumentsAbstract" xlink:label="cntg_NumberOfOtherEquityInstrumentsAbstract_637843363592594690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_NumberOfOtherEquityInstrumentsAbstract_637843363592594690" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592594690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOtherEquityInstrumentsAbstract_637843363592594690" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363592594690" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_637843363592594690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NumberOfOtherEquityInstrumentsAbstract_637843363592594690" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_637843363592594690" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract" xlink:label="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract_637843363592604778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592544782" xlink:to="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract_637843363592604778" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_637843363592604778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract_637843363592604778" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_637843363592604778" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails" xlink:type="extended" xlink:title="42007 - Disclosure - Share-based payments - Valuation of Options (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592614705" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592614705" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592614705" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionPrograms2016And2017Member" xlink:label="cntg_VirtualShareOptionPrograms2016And2017Member_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592614705" xlink:to="cntg_VirtualShareOptionPrograms2016And2017Member_637843363592614705" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2017CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2017CashSettledMember_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_VirtualShareOptionPrograms2016And2017Member_637843363592614705" xlink:to="cntg_VirtualShareOptionProgram2017CashSettledMember_637843363592614705" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VirtualShareOptionProgram2016CashSettledMember" xlink:label="cntg_VirtualShareOptionProgram2016CashSettledMember_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_VirtualShareOptionPrograms2016And2017Member_637843363592614705" xlink:to="cntg_VirtualShareOptionProgram2016CashSettledMember_637843363592614705" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017And2019Member" xlink:label="cntg_EquityShareOption2017And2019Member_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592614705" xlink:to="cntg_EquityShareOption2017And2019Member_637843363592614705" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_EquityShareOption2017And2019Member_637843363592614705" xlink:to="cntg_EquityShareOption2017EquitySettledMember_637843363592614705" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2019EquitySettledMember" xlink:label="cntg_EquityShareOption2019EquitySettledMember_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_EquityShareOption2017And2019Member_637843363592614705" xlink:to="cntg_EquityShareOption2019EquitySettledMember_637843363592614705" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592614705" xlink:to="cntg_LongTermIncentivePlanMember_637843363592614705" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_637843363592614705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" xlink:to="cntg_IfrsAwardTypeAxis_637843363592614705" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsAwardTypeAxis_637843363592614705" xlink:to="cntg_AwardTypeDomain_637843363592624696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592624696" xlink:to="cntg_StockOptionsMember_637843363592624696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592624696" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember_637843363592624696" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363592624696" xlink:to="cntg_PerformanceBasedRestrictedStockUnitsMember_637843363592624696" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592624696" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592624696" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592624696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ManagementBoardAndEmployeesMember" xlink:label="cntg_ManagementBoardAndEmployeesMember_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592624696" xlink:to="cntg_ManagementBoardAndEmployeesMember_637843363592624696" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592624696" xlink:to="srt_ChiefExecutiveOfficerMember_637843363592624696" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592624696" xlink:to="cntg_SupervisoryBoardMember_637843363592624696" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_637843363592624696" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" xlink:to="srt_TitleOfIndividualAxis_637843363592624696" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592634706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_637843363592624696" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592634706" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrModigAndMrSheldonMember" xlink:label="cntg_MrModigAndMrSheldonMember_637843363592634706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592634706" xlink:to="cntg_MrModigAndMrSheldonMember_637843363592634706" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MrBerndtModigMember" xlink:label="cntg_MrBerndtModigMember_637843363592634706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592634706" xlink:to="cntg_MrBerndtModigMember_637843363592634706" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Mr.KimMember" xlink:label="cntg_Mr.KimMember_637843363592634706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_637843363592634706" xlink:to="cntg_Mr.KimMember_637843363592634706" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363592634706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" xlink:to="ifrs-full_RangeAxis_637843363592634706" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363592634706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363592634706" xlink:to="ifrs-full_RangesMember_637843363592634706" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_637843363592634706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592634706" xlink:to="ifrs-full_BottomOfRangeMember_637843363592634706" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592634706" xlink:to="ifrs-full_TopOfRangeMember_637843363592644845" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_637843363592614705" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592644845" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract" xlink:label="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592644845" xlink:to="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_637843363592644845" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_637843363592644845" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_637843363592644845" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_637843363592644845" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_637843363592644845" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_637843363592644845" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_637843363592654777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract_637843363592644845" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_637843363592654777" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract" xlink:label="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592644845" xlink:to="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExercisePriceOtherEquityInstrumentsGranted" xlink:label="cntg_ExercisePriceOtherEquityInstrumentsGranted_637843363592654777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" xlink:to="cntg_ExercisePriceOtherEquityInstrumentsGranted_637843363592654777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted" xlink:label="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted_637843363592654777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" xlink:to="cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted_637843363592654777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedVolatilityOtherEquityInstrumentsGranted" xlink:label="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted_637843363592654777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" xlink:to="cntg_ExpectedVolatilityOtherEquityInstrumentsGranted_637843363592654777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted" xlink:label="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted_637843363592654777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" xlink:to="cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted_637843363592654777" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted" xlink:label="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted_637843363592664730" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" xlink:to="cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted_637843363592664730" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OptionLifeOtherEquityInstrumentsGranted" xlink:label="cntg_OptionLifeOtherEquityInstrumentsGranted_637843363592664730" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" xlink:to="cntg_OptionLifeOtherEquityInstrumentsGranted_637843363592664730" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted" xlink:label="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted_637843363592704697" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract_637843363592654777" xlink:to="cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted_637843363592704697" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_637843363592714700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_637843363592644845" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_637843363592714700" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_637843363592714700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_637843363592714700" xlink:to="ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_637843363592714700" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_637843363592714700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_637843363592714700" xlink:to="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_637843363592714700" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_637843363592714700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract_637843363592714700" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_637843363592714700" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails" xlink:type="extended" xlink:title="42101 - Disclosure - Financial instruments - fair values and risk management - Credit risk (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_SegmentsAxis_637843363592724734" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="ifrs-full_SegmentsMember_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis_637843363592724734" xlink:to="ifrs-full_SegmentsMember_637843363592724734" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DiagnosticsSegmentMember" xlink:label="cntg_DiagnosticsSegmentMember_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsMember_637843363592724734" xlink:to="cntg_DiagnosticsSegmentMember_637843363592724734" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis_637843363592724734" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis_637843363592724734" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592724734" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeReceivablesAndContractAssetsMember" xlink:label="cntg_TradeReceivablesAndContractAssetsMember_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592724734" xlink:to="cntg_TradeReceivablesAndContractAssetsMember_637843363592724734" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592724734" xlink:to="ifrs-full_TradeReceivablesMember_637843363592724734" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusAxis" xlink:label="ifrs-full_PastDueStatusAxis_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_PastDueStatusAxis_637843363592724734" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusMember" xlink:label="ifrs-full_PastDueStatusMember_637843363592724734" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PastDueStatusAxis_637843363592724734" xlink:to="ifrs-full_PastDueStatusMember_637843363592724734" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentMember" xlink:label="ifrs-full_CurrentMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PastDueStatusMember_637843363592724734" xlink:to="ifrs-full_CurrentMember_637843363592734683" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LaterThanOneDayAndNotLaterThanOneMonthMember" xlink:label="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PastDueStatusMember_637843363592724734" xlink:to="cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_637843363592734683" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PastDueStatusMember_637843363592724734" xlink:to="ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_637843363592734683" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsMember" xlink:label="ifrs-full_LaterThanThreeMonthsMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PastDueStatusMember_637843363592724734" xlink:to="ifrs-full_LaterThanThreeMonthsMember_637843363592734683" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="ifrs-full_LaterThanOneYearMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PastDueStatusMember_637843363592724734" xlink:to="ifrs-full_LaterThanOneYearMember_637843363592734683" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="srt_StatementGeographicalAxis_637843363592734683" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_637843363592734683" xlink:to="srt_SegmentGeographicalDomain_637843363592734683" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsMiddleEastMember" xlink:label="cntg_IfrsMiddleEastMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_637843363592734683" xlink:to="cntg_IfrsMiddleEastMember_637843363592734683" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_637843363592734683" xlink:to="srt_EuropeMember_637843363592734683" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember" xlink:label="srt_LatinAmericaMember_637843363592734683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_637843363592734683" xlink:to="srt_LatinAmericaMember_637843363592734683" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_637843363592734683" xlink:to="srt_NorthAmericaMember_637843363592744944" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember" xlink:label="srt_AsiaPacificMember_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_637843363592734683" xlink:to="srt_AsiaPacificMember_637843363592744944" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember" xlink:label="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_637843363592734683" xlink:to="cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_637843363592744944" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592744944" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_637843363592744944" xlink:to="ifrs-full_CarryingAmountMember_637843363592744944" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_637843363592744944" xlink:to="ifrs-full_GrossCarryingAmountMember_637843363592744944" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_ImpairmentOfFinancialAssetsAxis_637843363592744944" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_637843363592744944" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ImpairmentOfFinancialAssetsAxis_637843363592744944" xlink:to="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_637843363592744944" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsPastDueButNotImpairedMember" xlink:label="ifrs-full_FinancialAssetsPastDueButNotImpairedMember_637843363592754800" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember_637843363592744944" xlink:to="ifrs-full_FinancialAssetsPastDueButNotImpairedMember_637843363592754800" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis_637843363592754800" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_TypesOfRisksAxis_637843363592754800" order="7" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember_637843363592754800" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis_637843363592754800" xlink:to="ifrs-full_TypesOfRisksMember_637843363592754800" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember_637843363592754800" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_637843363592754800" xlink:to="ifrs-full_CreditRiskMember_637843363592754800" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363592754800" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_RangeAxis_637843363592754800" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363592754800" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363592754800" xlink:to="ifrs-full_RangesMember_637843363592754800" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_637843363592754800" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592754800" xlink:to="ifrs-full_BottomOfRangeMember_637843363592754800" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixTable_637843363592724734" xlink:to="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets_637843363592764699" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="ifrs-full_FinancialAssets_637843363592764699" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedCreditLossRate" xlink:label="ifrs-full_ExpectedCreditLossRate_637843363592764699" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="ifrs-full_ExpectedCreditLossRate_637843363592764699" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_637843363592764699" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_637843363592764699" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_637843363592764699" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="ifrs-full_CashAndCashEquivalents_637843363592764699" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables" xlink:label="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables_637843363592764699" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables_637843363592764699" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfOverdueBalances" xlink:label="cntg_PercentageOfOverdueBalances_637843363592764699" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="cntg_PercentageOfOverdueBalances_637843363592764699" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeReceivablesAverageTurnoverPeriod" xlink:label="cntg_TradeReceivablesAverageTurnoverPeriod_637843363592774841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="cntg_TradeReceivablesAverageTurnoverPeriod_637843363592774841" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_637843363592774841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProvisionMatrixLineItems_637843363592764699" xlink:to="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_637843363592774841" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_637843363592774841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_637843363592774841" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_637843363592774841" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_637843363592774841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_637843363592774841" xlink:to="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_637843363592774841" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets_637843363592774841" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_637843363592774841" xlink:to="ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets_637843363592774841" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_637843363592784730" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_637843363592774841" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_637843363592784730" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="ifrs-full_ImpairmentLossOnFinancialAssets_637843363592784730" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_637843363592774841" xlink:to="ifrs-full_ImpairmentLossOnFinancialAssets_637843363592784730" order="5" use="optional" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails" xlink:type="extended" xlink:title="42102 - Disclosure - Financial instruments - fair values and risk management - Liquidity risk (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_637167837283373951" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_637167837283373951" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_637843363592784730" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="dei_LegalEntityAxis_637843363592784730" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_637843363592784730" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_637843363592784730" xlink:to="dei_EntityDomain_637843363592784730" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_637843363592784730" xlink:to="cntg_CentogeneN.vMember_637843363592794761" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_637843363592794761" order="2" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_637843363592794761" xlink:to="ifrs-full_ClassesOfShareCapitalMember_637843363592794761" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_637843363592794761" xlink:to="ifrs-full_OrdinarySharesMember_637843363592794761" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis_637843363592794761" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis_637843363592794761" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember" xlink:label="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" xlink:to="cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_637843363592794761" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" xlink:to="cntg_IfrsBankOverdraftsMember_637843363592794761" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesMember" xlink:label="cntg_SecuredCreditLinesMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" xlink:to="cntg_SecuredCreditLinesMember_637843363592794761" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OtherBankLoansMember" xlink:label="cntg_OtherBankLoansMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" xlink:to="cntg_OtherBankLoansMember_637843363592794761" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" xlink:to="ifrs-full_LeaseLiabilitiesMember_637843363592794761" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradePayablesMember" xlink:label="cntg_TradePayablesMember_637843363592794761" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember_637843363592794761" xlink:to="cntg_TradePayablesMember_637843363592794761" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="ifrs-full_MaturityAxis_637843363592804690" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_637843363592804690" xlink:to="ifrs-full_AggregatedTimeBandsMember_637843363592804690" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NotLaterThanTwoMonthsMember" xlink:label="cntg_NotLaterThanTwoMonthsMember_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_637843363592804690" xlink:to="cntg_NotLaterThanTwoMonthsMember_637843363592804690" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember" xlink:label="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_637843363592804690" xlink:to="cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_637843363592804690" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_637843363592804690" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_637843363592804690" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_637843363592804690" xlink:to="ifrs-full_LaterThanFiveYearsMember_637843363592804690" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockAxis" xlink:label="cntg_IfrsSaleOfStockAxis_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="cntg_IfrsSaleOfStockAxis_637843363592804690" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SaleOfStockDomain" xlink:label="cntg_SaleOfStockDomain_637843363592804690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockAxis_637843363592804690" xlink:to="cntg_SaleOfStockDomain_637843363592804690" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnPublicOfferingMember" xlink:label="cntg_FollowOnPublicOfferingMember_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_SaleOfStockDomain_637843363592804690" xlink:to="cntg_FollowOnPublicOfferingMember_637843363592814799" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="ifrs-full_RangeAxis_637843363592814799" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363592814799" xlink:to="ifrs-full_RangesMember_637843363592814799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592814799" xlink:to="ifrs-full_BottomOfRangeMember_637843363592814799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363592814799" xlink:to="ifrs-full_TopOfRangeMember_637843363592814799" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_637843363592814799" order="7" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_637843363592814799" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentFinancialLiabilitiesMember" xlink:label="cntg_NonCurrentFinancialLiabilitiesMember_637843363592814799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_NonCurrentFinancialLiabilitiesMember_637843363592814799" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_637843363592824690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_637843363592824690" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentFinancialLiabilitiesMember" xlink:label="cntg_CurrentFinancialLiabilitiesMember_637843363592824690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_CurrentFinancialLiabilitiesMember_637843363592824690" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NoncurrentSecuredBankLoansMember" xlink:label="cntg_NoncurrentSecuredBankLoansMember_637843363592824690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_NoncurrentSecuredBankLoansMember_637843363592824690" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonCurrentMunicipalLoansMember" xlink:label="cntg_NonCurrentMunicipalLoansMember_637843363592824690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_NonCurrentMunicipalLoansMember_637843363592824690" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CurrentSecuredBankLoansMember" xlink:label="cntg_CurrentSecuredBankLoansMember_637843363592824690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_CurrentSecuredBankLoansMember_637843363592824690" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BankLoansMember" xlink:label="cntg_BankLoansMember_637843363592824690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_BankLoansMember_637843363592824690" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsBankOverdraftsMember" xlink:label="cntg_IfrsBankOverdraftsMember_637843363592824690" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_IfrsBankOverdraftsMember_637843363592824690" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FinancingActivitiesMunicipalLoansMember" xlink:label="cntg_FinancingActivitiesMunicipalLoansMember_637843363592834686" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_FinancingActivitiesMunicipalLoansMember_637843363592834686" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember" xlink:label="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_637843363592834686" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_637843363592814799" xlink:to="cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_637843363592834686" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable_637843363592784730" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PercentageOfInterestBearingLoansMatureInOneYear" xlink:label="cntg_PercentageOfInterestBearingLoansMatureInOneYear_637843363592834686" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="cntg_PercentageOfInterestBearingLoansMatureInOneYear_637843363592834686" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:label="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_637843363592847470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_637843363592847470" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths" xlink:label="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths_637843363592847470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths_637843363592847470" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharesIssuedPricePerShare" xlink:label="cntg_IfrsSharesIssuedPricePerShare_637843363592854423" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="cntg_IfrsSharesIssuedPricePerShare_637843363592854423" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363592854423" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363592854423" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_637843363592854423" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_CashAndCashEquivalents_637843363592854423" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesInterestRate" xlink:label="cntg_SecuredCreditLinesInterestRate_637843363592864745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="cntg_SecuredCreditLinesInterestRate_637843363592864745" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SecuredCreditLinesUtilized" xlink:label="cntg_SecuredCreditLinesUtilized_637843363592864745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="cntg_SecuredCreditLinesUtilized_637843363592864745" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities_637843363592864745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_FinancialLiabilities_637843363592864745" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363592864745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363592864745" order="10" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_637843363592874967" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_637843363592874967" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders_637843363592874967" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="cntg_NumberOfCommonSharesOfferedByPriorShareholders_637843363592874967" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="ifrs-full_BankBorrowingsUndiscountedCashFlows_637843363592874967" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_BankBorrowingsUndiscountedCashFlows_637843363592874967" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_637843363592884693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_637843363592884693" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_637843363592884693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_637843363592834686" xlink:to="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_637843363592884693" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_637843363592884693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_637843363592884693" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_637843363592884693" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_637843363592884693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_637843363592884693" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_637843363592884693" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_637843363592894704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_637843363592884693" xlink:to="cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_637843363592894704" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_637843363592894704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_637843363592884693" xlink:to="cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_637843363592894704" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_637843363592894704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_637843363592884693" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_637843363592894704" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails" xlink:type="extended" xlink:title="42103 - Disclosure - Financial instruments - fair values and risk management - Currency risk (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_637167879024287956" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_637843363592904713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_637167879024287956" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_637843363592904713" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis_637843363592904713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_637843363592904713" xlink:to="srt_CurrencyAxis_637843363592904713" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain_637843363592904713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CurrencyAxis_637843363592904713" xlink:to="currency_AllCurrenciesDomain_637843363592904713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="currency_USD_637843363592904713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_637843363592904713" xlink:to="currency_USD_637843363592904713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_INR" xlink:label="currency_INR_637843363592904713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_637843363592904713" xlink:to="currency_INR_637843363592904713" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AED" xlink:label="currency_AED_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_637843363592904713" xlink:to="currency_AED_637843363592914704" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_637843363592904713" xlink:to="ifrs-full_AssetsAndLiabilitiesAxis_637843363592914704" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="ifrs-full_AssetsAndLiabilitiesMember_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis_637843363592914704" xlink:to="ifrs-full_AssetsAndLiabilitiesMember_637843363592914704" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAndLiabilitiesMember_637843363592914704" xlink:to="ifrs-full_TradeReceivablesMember_637843363592914704" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_TradePayableAndOtherLiabilitiesMember" xlink:label="cntg_TradePayableAndOtherLiabilitiesMember_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAndLiabilitiesMember_637843363592914704" xlink:to="cntg_TradePayableAndOtherLiabilitiesMember_637843363592914704" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_637843363592904713" xlink:to="ifrs-full_TypesOfRisksAxis_637843363592914704" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis_637843363592914704" xlink:to="ifrs-full_TypesOfRisksMember_637843363592914704" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_637843363592914704" xlink:to="ifrs-full_CurrencyRiskMember_637843363592914704" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_637843363592904713" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_637843363592914704" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_637843363592914704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_637843363592914704" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_637843363592914704" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureListOfSubsidiariesDetails" xlink:type="extended" xlink:title="42201 - Disclosure - List of subsidiaries (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_637165081213957648" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592924733" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_637165081213957648" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592924733" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592924733" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592924733" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592924733" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592924733" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGMember" xlink:label="cntg_CentogeneGMember_637843363592924733" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentogeneGMember_637843363592924733" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneFzLlcUnitedArabEmiratesMember" xlink:label="cntg_CentogeneFzLlcUnitedArabEmiratesMember_637843363592924733" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentogeneFzLlcUnitedArabEmiratesMember_637843363592924733" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneUsLlcBurlingtonUsaMember" xlink:label="cntg_CentogeneUsLlcBurlingtonUsaMember_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentogeneUsLlcBurlingtonUsaMember_637843363592935067" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGmbhViennaMember" xlink:label="cntg_CentogeneGmbhViennaMember_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentogeneGmbhViennaMember_637843363592935067" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneIndiaPvt.LtdMember" xlink:label="cntg_CentogeneIndiaPvt.LtdMember_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentogeneIndiaPvt.LtdMember_637843363592935067" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneSwitzerlandAgMember" xlink:label="cntg_CentogeneSwitzerlandAgMember_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentogeneSwitzerlandAgMember_637843363592935067" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentosafeB.v.Member" xlink:label="cntg_CentosafeB.v.Member_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentosafeB.v.Member_637843363592935067" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneD.o.oBelgradeMember" xlink:label="cntg_CentogeneD.o.oBelgradeMember_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592924733" xlink:to="cntg_CentogeneD.o.oBelgradeMember_637843363592935067" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592924733" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592935067" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592935067" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_637843363592935067" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_637843363592935067" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592935067" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_637843363592935067" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureNonControllingInterestsDetails" xlink:type="extended" xlink:title="42301 - Disclosure - Non-controlling interests (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NonControllingInterestsAbstract" xlink:label="cntg_NonControllingInterestsAbstract_637165081214297440" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592944872" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_NonControllingInterestsAbstract_637165081214297440" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592944872" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592944872" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592944872" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592944872" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592944872" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_637843363592944872" xlink:to="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592944872" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneGmbhViennaMember" xlink:label="cntg_CentogeneGmbhViennaMember_637843363592944872" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592944872" xlink:to="cntg_CentogeneGmbhViennaMember_637843363592944872" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_Dr.BauerLaboratoriumsGmbhMember" xlink:label="cntg_Dr.BauerLaboratoriumsGmbhMember_637843363592944872" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592944872" xlink:to="cntg_Dr.BauerLaboratoriumsGmbhMember_637843363592944872" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneIndiaPvt.LtdMember" xlink:label="cntg_CentogeneIndiaPvt.LtdMember_637843363592944872" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592944872" xlink:to="cntg_CentogeneIndiaPvt.LtdMember_637843363592944872" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LpcGmbhMember" xlink:label="cntg_LpcGmbhMember_637843363592944872" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForSubsidiariesMember_637843363592944872" xlink:to="cntg_LpcGmbhMember_637843363592944872" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_637843363592944872" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_637843363592954917" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal" xlink:label="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" xlink:to="cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal_637843363592954917" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="ifrs-full_NetAssetsLiabilities_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" xlink:to="ifrs-full_NetAssetsLiabilities_637843363592954917" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" xlink:to="ifrs-full_NoncontrollingInterests_637843363592954917" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" xlink:to="ifrs-full_Revenue_637843363592954917" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" xlink:to="ifrs-full_ProfitLoss_637843363592954917" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_637843363592954917" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_637843363592954917" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_637843363592954917" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureCommitmentsDetails" xlink:type="extended" xlink:title="42401 - Disclosure - Commitments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DisclosureOfCommitmentsAbstract" xlink:label="cntg_DisclosureOfCommitmentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_DisclosureOfCommitmentsAbstract" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_637843363592964700" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_637843363592964700" xlink:to="ifrs-full_ClassesOfAssetsAxis_637843363592964700" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_637843363592964700" xlink:to="ifrs-full_ClassesOfAssetsMember_637843363592964700" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RostockHeadquartersBuildingMember" xlink:label="cntg_RostockHeadquartersBuildingMember_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592964700" xlink:to="cntg_RostockHeadquartersBuildingMember_637843363592964700" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_OfficeEquipmentAndStorageSpacesMember" xlink:label="cntg_OfficeEquipmentAndStorageSpacesMember_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_637843363592964700" xlink:to="cntg_OfficeEquipmentAndStorageSpacesMember_637843363592964700" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_637843363592964700" xlink:to="ifrs-full_MaturityAxis_637843363592964700" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_637843363592964700" xlink:to="ifrs-full_AggregatedTimeBandsMember_637843363592964700" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_637843363592964700" xlink:to="ifrs-full_NotLaterThanOneYearMember_637843363592964700" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_637843363592964700" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_637843363592964700" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_637843363592964700" xlink:to="ifrs-full_LaterThanFiveYearsMember_637843363592964700" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_637843363592964700" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_637843363592964700" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UndiscountedLeasePaymentsToBeMade" xlink:label="cntg_UndiscountedLeasePaymentsToBeMade_637843363592964700" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_637843363592964700" xlink:to="cntg_UndiscountedLeasePaymentsToBeMade_637843363592964700" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FuturePaymentObligationToSuppliersForGoodsAndServices" xlink:label="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices_637843363592974775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_637843363592964700" xlink:to="cntg_FuturePaymentObligationToSuppliersForGoodsAndServices_637843363592974775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails" xlink:type="extended" xlink:title="42501 - Disclosure - Related parties - Remuneration of members of key management (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_637843363592974775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_637843363592974775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_637843363592974775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_637843363592974775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_637843363592974775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_637843363592974775" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_637843363592974775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_637843363592974775" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_637843363592974775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_637843363592974775" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails" xlink:type="extended" xlink:title="42502 - Disclosure - Related parties - Additional information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract_637165081214427361" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract_637165081214427361" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="dei_LegalEntityAxis_637843363592984925" order="1" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_637843363592984925" xlink:to="dei_EntityDomain_637843363592984925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CentogeneN.vMember" xlink:label="cntg_CentogeneN.vMember_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_637843363592984925" xlink:to="cntg_CentogeneN.vMember_637843363592984925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_637843363592984925" order="2" use="optional" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_637843363592984925" xlink:to="ifrs-full_ClassesOfShareCapitalMember_637843363592984925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_637843363592984925" xlink:to="ifrs-full_OrdinarySharesMember_637843363592984925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592984925" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363592984925" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592984925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardMember" xlink:label="cntg_SupervisoryBoardMember_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592984925" xlink:to="cntg_SupervisoryBoardMember_637843363592984925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MemberOfSupervisoryBoardMember" xlink:label="cntg_MemberOfSupervisoryBoardMember_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_SupervisoryBoardMember_637843363592984925" xlink:to="cntg_MemberOfSupervisoryBoardMember_637843363592984925" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_637843363592984925" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592984925" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_637843363592984925" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerCeoAndMajorShareholderMember" xlink:label="cntg_FormerCeoAndMajorShareholderMember_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592984925" xlink:to="cntg_FormerCeoAndMajorShareholderMember_637843363592994711" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592984925" xlink:to="cntg_IfrsChiefExecutiveOfficerMember_637843363592994711" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363592984925" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363592994711" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592994711" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363592994711" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363592994711" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EquityShareOption2017EquitySettledMember" xlink:label="cntg_EquityShareOption2017EquitySettledMember_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592994711" xlink:to="cntg_EquityShareOption2017EquitySettledMember_637843363592994711" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LongTermIncentivePlanMember" xlink:label="cntg_LongTermIncentivePlanMember_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363592994711" xlink:to="cntg_LongTermIncentivePlanMember_637843363592994711" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionAxis" xlink:label="cntg_IfrsRelatedPartyTransactionAxis_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="cntg_IfrsRelatedPartyTransactionAxis_637843363592994711" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRelatedPartyTransactionDomain" xlink:label="cntg_IfrsRelatedPartyTransactionDomain_637843363592994711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRelatedPartyTransactionAxis_637843363592994711" xlink:to="cntg_IfrsRelatedPartyTransactionDomain_637843363592994711" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_SupervisoryBoardActivitiesMember" xlink:label="cntg_SupervisoryBoardActivitiesMember_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRelatedPartyTransactionDomain_637843363592994711" xlink:to="cntg_SupervisoryBoardActivitiesMember_637843363593004713" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CorporateStrategyServiceMember" xlink:label="cntg_CorporateStrategyServiceMember_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRelatedPartyTransactionDomain_637843363592994711" xlink:to="cntg_CorporateStrategyServiceMember_637843363593004713" order="2" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RelatedPartyServicesMember" xlink:label="cntg_RelatedPartyServicesMember_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRelatedPartyTransactionDomain_637843363592994711" xlink:to="cntg_RelatedPartyServicesMember_637843363593004713" order="3" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CovidTestingSuppliesPurchasesMember" xlink:label="cntg_CovidTestingSuppliesPurchasesMember_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRelatedPartyTransactionDomain_637843363592994711" xlink:to="cntg_CovidTestingSuppliesPurchasesMember_637843363593004713" order="4" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_CovidTestingServicesMember" xlink:label="cntg_CovidTestingServicesMember_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsRelatedPartyTransactionDomain_637843363592994711" xlink:to="cntg_CovidTestingServicesMember_637843363593004713" order="5" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSubsidiarySaleOfStockAxis" xlink:label="cntg_IfrsSubsidiarySaleOfStockAxis_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="cntg_IfrsSubsidiarySaleOfStockAxis_637843363593004713" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSaleOfStockNameOfTransactionDomain" xlink:label="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSubsidiarySaleOfStockAxis_637843363593004713" xlink:to="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363593004713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FollowOnEquityOfferingMember" xlink:label="cntg_FollowOnEquityOfferingMember_637843363593004713" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsSaleOfStockNameOfTransactionDomain_637843363593004713" xlink:to="cntg_FollowOnEquityOfferingMember_637843363593004713" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_637843363593014919" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="cntg_IfrsAwardTypeAxis_637843363593014919" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_637843363593014919" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsAwardTypeAxis_637843363593014919" xlink:to="cntg_AwardTypeDomain_637843363593014919" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_637843363593014919" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363593014919" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember_637843363593014919" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionsMember" xlink:label="cntg_StockOptionsMember_637843363593014919" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363593014919" xlink:to="cntg_StockOptionsMember_637843363593014919" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_637843363592984925" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363593014919" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_637843363593014919" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PensionCommitments" xlink:label="cntg_PensionCommitments_637843363593014919" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_PensionCommitments_637843363593014919" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363593024698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_637843363593024698" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ServicesReceivedRelatedPartyTransactions" xlink:label="ifrs-full_ServicesReceivedRelatedPartyTransactions_637843363593024698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_ServicesReceivedRelatedPartyTransactions_637843363593024698" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363593024698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_637843363593024698" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363593024698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363593024698" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363593024698" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_637843363593024698" order="7" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_637843363593034691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders_637843363593034691" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfCommonSharesOfferedByPriorShareholders" xlink:label="cntg_NumberOfCommonSharesOfferedByPriorShareholders_637843363593034691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_NumberOfCommonSharesOfferedByPriorShareholders_637843363593034691" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_637843363593034691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_637843363593034691" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_637843363593034691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_637843363593034691" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedPaymentArrangementAcceleratedCost" xlink:label="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost_637843363593034691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_IfrsShareBasedPaymentArrangementAcceleratedCost_637843363593034691" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyManagementPersonnelCompensationSeverancePayout" xlink:label="cntg_KeyManagementPersonnelCompensationSeverancePayout_637843363593045077" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_KeyManagementPersonnelCompensationSeverancePayout_637843363593045077" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_KeyManagementPersonnelCompensationAccruedAmount" xlink:label="cntg_KeyManagementPersonnelCompensationAccruedAmount_637843363593045077" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_KeyManagementPersonnelCompensationAccruedAmount_637843363593045077" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363593045077" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363593045077" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOtherEquityInstrumentsGranted" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted_637843363593045077" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_ValueOfOtherEquityInstrumentsGranted_637843363593045077" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions_637843363593045077" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_AmountsReceivableRelatedPartyTransactions_637843363593045077" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions" xlink:label="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions_637843363593054707" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions_637843363593054707" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues" xlink:label="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_637843363593054707" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues_637843363593054707" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363593054707" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_637843363593014919" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363593054707" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureContingentLiabilitiesDetails" xlink:type="extended" xlink:title="42601 - Disclosure - Contingent Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesTable_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesTable_637843363593064704" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesTable_637843363593064704" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis_637843363593064704" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="ifrs-full_ContingentLiabilitiesMember_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis_637843363593064704" xlink:to="ifrs-full_ContingentLiabilitiesMember_637843363593064704" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ContingentLiabilitiesMember_637843363593064704" xlink:to="ifrs-full_LegalProceedingsContingentLiabilityMember_637843363593064704" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_UniversitairMedischCentrumUtrechtMember" xlink:label="cntg_UniversitairMedischCentrumUtrechtMember_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember_637843363593064704" xlink:to="cntg_UniversitairMedischCentrumUtrechtMember_637843363593064704" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember" xlink:label="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember_637843363593064704" xlink:to="cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_637843363593064704" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesTable_637843363593064704" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363593064704" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_637843363593064704" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_637843363593064704" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_StockOptionPlan2016Member" xlink:label="cntg_StockOptionPlan2016Member_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_637843363593064704" xlink:to="cntg_StockOptionPlan2016Member_637843363593064704" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesLineItems_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesTable_637843363593064704" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesLineItems_637843363593064704" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_DamagesSought" xlink:label="cntg_DamagesSought_637843363593064704" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesLineItems_637843363593064704" xlink:to="cntg_DamagesSought_637843363593064704" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_637843363593074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesLineItems_637843363593064704" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_637843363593074708" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
  </presentationLink>
  <presentationLink xlink:role="http://centogene.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="42701 - Disclosure - Subsequent Events (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363593074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363593074708" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember_637843363593074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_637843363593074708" xlink:to="ifrs-full_NonadjustingEventsMember_637843363593074708" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_GrantOfRestrictedStockUnitsMember" xlink:label="cntg_GrantOfRestrictedStockUnitsMember_637843363593074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_637843363593074708" xlink:to="cntg_GrantOfRestrictedStockUnitsMember_637843363593074708" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="ifrs-full_MajorOrdinaryShareTransactionsMember_637843363593074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_637843363593074708" xlink:to="ifrs-full_MajorOrdinaryShareTransactionsMember_637843363593074708" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_EnteringInToDebtFinancingAgreementMember" xlink:label="cntg_EnteringInToDebtFinancingAgreementMember_637843363593074708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_637843363593074708" xlink:to="cntg_EnteringInToDebtFinancingAgreementMember_637843363593074708" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="srt_StatementScenarioAxis_637843363593085131" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637843363593085131" xlink:to="srt_ScenarioUnspecifiedDomain_637843363593085131" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_VestingInFourTranchesMember" xlink:label="cntg_VestingInFourTranchesMember_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637843363593085131" xlink:to="cntg_VestingInFourTranchesMember_637843363593085131" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsAwardTypeAxis" xlink:label="cntg_IfrsAwardTypeAxis_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="cntg_IfrsAwardTypeAxis_637843363593085131" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_AwardTypeDomain" xlink:label="cntg_AwardTypeDomain_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsAwardTypeAxis_637843363593085131" xlink:to="cntg_AwardTypeDomain_637843363593085131" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsRestrictedStockUnitsRsusMember" xlink:label="cntg_IfrsRestrictedStockUnitsRsusMember_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363593085131" xlink:to="cntg_IfrsRestrictedStockUnitsRsusMember_637843363593085131" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsusDerecognizedMember" xlink:label="cntg_RsusDerecognizedMember_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363593085131" xlink:to="cntg_RsusDerecognizedMember_637843363593085131" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_RsusRecognizedMember" xlink:label="cntg_RsusRecognizedMember_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363593085131" xlink:to="cntg_RsusRecognizedMember_637843363593085131" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_PerformanceBasedRestrictedStockUnitsMember" xlink:label="cntg_PerformanceBasedRestrictedStockUnitsMember_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_AwardTypeDomain_637843363593085131" xlink:to="cntg_PerformanceBasedRestrictedStockUnitsMember_637843363593085131" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingAxis" xlink:label="cntg_IfrsVestingAxis_637843363593085131" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="cntg_IfrsVestingAxis_637843363593085131" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/documentation" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsVestingDomain" xlink:label="cntg_IfrsVestingDomain_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingAxis_637843363593085131" xlink:to="cntg_IfrsVestingDomain_637843363593094720" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingDomain_637843363593094720" xlink:to="cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_637843363593094720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ShareBasedAwardsSubjectToTimeVestingMember" xlink:label="cntg_ShareBasedAwardsSubjectToTimeVestingMember_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_IfrsVestingDomain_637843363593094720" xlink:to="cntg_ShareBasedAwardsSubjectToTimeVestingMember_637843363593094720" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363593094720" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_637843363593094720" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363593094720" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsFormerChiefExecutiveOfficerMember" xlink:label="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363593094720" xlink:to="cntg_IfrsFormerChiefExecutiveOfficerMember_637843363593094720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_FormerChiefFinancialOfficerMember" xlink:label="cntg_FormerChiefFinancialOfficerMember_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363593094720" xlink:to="cntg_FormerChiefFinancialOfficerMember_637843363593094720" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsChiefExecutiveOfficerMember" xlink:label="cntg_IfrsChiefExecutiveOfficerMember_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363593094720" xlink:to="cntg_IfrsChiefExecutiveOfficerMember_637843363593094720" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_MiguelCoegoRiosMember" xlink:label="cntg_MiguelCoegoRiosMember_637843363593094720" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363593094720" xlink:to="cntg_MiguelCoegoRiosMember_637843363593094720" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:label="srt_ManagementMember_637843363593104695" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_637843363593094720" xlink:to="srt_ManagementMember_637843363593104695" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis_637843363593104695" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="ifrs-full_BorrowingsByNameAxis_637843363593104695" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="ifrs-full_BorrowingsByNameMember_637843363593104695" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis_637843363593104695" xlink:to="ifrs-full_BorrowingsByNameMember_637843363593104695" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityMember" xlink:label="cntg_LoanFacilityMember_637843363593104695" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameMember_637843363593104695" xlink:to="cntg_LoanFacilityMember_637843363593104695" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheOneMember" xlink:label="cntg_LoanFacilityTrancheOneMember_637843363593104695" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_LoanFacilityMember_637843363593104695" xlink:to="cntg_LoanFacilityTrancheOneMember_637843363593104695" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_LoanFacilityTrancheTwoMember" xlink:label="cntg_LoanFacilityTrancheTwoMember_637843363593104695" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cntg_LoanFacilityMember_637843363593104695" xlink:to="cntg_LoanFacilityTrancheTwoMember_637843363593104695" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_637843363593104695" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="ifrs-full_RangeAxis_637843363593104695" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_637843363593114809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_637843363593104695" xlink:to="ifrs-full_RangesMember_637843363593114809" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_637843363593114809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_637843363593114809" xlink:to="ifrs-full_TopOfRangeMember_637843363593114809" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_637843363593074708" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363593114809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_637843363593114809" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363593114809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_637843363593114809" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfTranches" xlink:label="cntg_NumberOfTranches_637843363593114809" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_NumberOfTranches_637843363593114809" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsStockIssuedDuringPeriodSharesNewIssues" xlink:label="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363593124705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_IfrsStockIssuedDuringPeriodSharesNewIssues_637843363593124705" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsSharePrice" xlink:label="cntg_IfrsSharePrice_637843363593124705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_IfrsSharePrice_637843363593124705" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_637843363593124705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_637843363593124705" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_637843363593124705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_637843363593124705" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount_637843363593124705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_NotionalAmount_637843363593124705" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363593124705" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_637843363593124705" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue" xlink:label="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_637843363593134856" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue_637843363593134856" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_BorrowingsRevenueAchievementThreshold" xlink:label="cntg_BorrowingsRevenueAchievementThreshold_637843363593134856" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_BorrowingsRevenueAchievementThreshold_637843363593134856" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_637843363593134856" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_637843363593134856" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_637843363593134856" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_637843363593134856" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_637843363593134856" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_637843363593134856" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_ValueOfOtherEquityInstrumentsGranted" xlink:label="cntg_ValueOfOtherEquityInstrumentsGranted_637843363593144927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_ValueOfOtherEquityInstrumentsGranted_637843363593144927" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_637843363593144927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_637843363593144927" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod" xlink:label="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363593144927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod_637843363593144927" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cntg-20211231.xsd#cntg_NumberOfInstallments" xlink:label="cntg_NumberOfInstallments_637843363593144927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_637843363593114809" xlink:to="cntg_NumberOfInstallments_637843363593144927" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256743720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Centogene N.V.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">P7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001757097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Am Strande 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rostock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">18055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares, par value &#8364;0.12 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Units, Units Outstanding</a></td>
<td class="nump">22,567,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young&#160;GmbH Wirtschaftspr&#252;fungsgesellschaft<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Berlin, Germany<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Kim Stratton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Am Strande 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rostock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">18055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">381 80113 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">kim.stratton@centogene.com<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256423544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of comprehensive loss - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Consolidated statements of comprehensive loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">&#8364; 189,923<span></span>
</td>
<td class="nump">&#8364; 128,381<span></span>
</td>
<td class="nump">&#8364; 48,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">161,765<span></span>
</td>
<td class="nump">83,437<span></span>
</td>
<td class="nump">26,005<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">28,158<span></span>
</td>
<td class="nump">44,944<span></span>
</td>
<td class="nump">22,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">19,297<span></span>
</td>
<td class="nump">14,935<span></span>
</td>
<td class="nump">9,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General administrative expenses</a></td>
<td class="nump">46,739<span></span>
</td>
<td class="nump">40,160<span></span>
</td>
<td class="nump">23,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingExpense', window );">Selling expenses</a></td>
<td class="nump">9,860<span></span>
</td>
<td class="nump">8,026<span></span>
</td>
<td class="nump">9,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment of financial assets</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">3,738<span></span>
</td>
<td class="nump">752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other operating income</a></td>
<td class="nump">2,936<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other operating expenses</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RealEstateTransferTaxExpenses', window );">Real estate transfer tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(46,028)<span></span>
</td>
<td class="num">(19,703)<span></span>
</td>
<td class="num">(18,684)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestIncomeOnLoansAndReceivables', window );">Interest and similar income</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest and similar expenses</a></td>
<td class="nump">851<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial costs, net</a></td>
<td class="num">(848)<span></span>
</td>
<td class="num">(1,394)<span></span>
</td>
<td class="num">(2,013)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before taxes</a></td>
<td class="num">(46,876)<span></span>
</td>
<td class="num">(21,097)<span></span>
</td>
<td class="num">(20,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">(46,852)<span></span>
</td>
<td class="num">(21,378)<span></span>
</td>
<td class="num">(20,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent', window );">Other comprehensive income/(loss), all attributable to equity holders of the parent</a></td>
<td class="nump">543<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">(46,309)<span></span>
</td>
<td class="num">(21,426)<span></span>
</td>
<td class="num">(20,839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Equity holders of the parent</a></td>
<td class="num">(46,407)<span></span>
</td>
<td class="num">(21,486)<span></span>
</td>
<td class="num">(20,658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">&#8364; (46,309)<span></span>
</td>
<td class="num">&#8364; (21,426)<span></span>
</td>
<td class="num">&#8364; (20,839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Loss per share - Basic (in EUR)</a></td>
<td class="num">&#8364; (2.06)<span></span>
</td>
<td class="num">&#8364; (1.02)<span></span>
</td>
<td class="num">&#8364; (1.27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Loss per share - Diluted (in EUR)</a></td>
<td class="num">&#8364; (2.06)<span></span>
</td>
<td class="num">&#8364; (1.02)<span></span>
</td>
<td class="num">&#8364; (1.27)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_RealEstateTransferTaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount represents the real estate transfer tax expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_RealEstateTransferTaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeOnLoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income on loans and receivables. [Refer: Interest income; Loans and receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_112_c&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeOnLoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income attributable to owners of the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257191560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of financial position - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">&#8364; 9,194<span></span>
</td>
<td class="nump">&#8364; 12,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">8,147<span></span>
</td>
<td class="nump">16,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">18,904<span></span>
</td>
<td class="nump">22,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">2,972<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">39,217<span></span>
</td>
<td class="nump">53,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">3,869<span></span>
</td>
<td class="nump">11,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentTradeReceivablesAndContractAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">24,337<span></span>
</td>
<td class="nump">29,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other assets</a></td>
<td class="nump">5,453<span></span>
</td>
<td class="nump">8,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">17,818<span></span>
</td>
<td class="nump">48,156<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">51,477<span></span>
</td>
<td class="nump">97,046<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Assets</a></td>
<td class="nump">90,694<span></span>
</td>
<td class="nump">150,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued capital</a></td>
<td class="nump">2,708<span></span>
</td>
<td class="nump">2,654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve</a></td>
<td class="nump">133,897<span></span>
</td>
<td class="nump">125,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Retained earnings and other reserves</a></td>
<td class="num">(109,295)<span></span>
</td>
<td class="num">(62,888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">27,503<span></span>
</td>
<td class="nump">65,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Noncurrent loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">15,588<span></span>
</td>
<td class="nump">17,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liabilities</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentGovernmentGrants', window );">Government grants</a></td>
<td class="nump">8,028<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">23,695<span></span>
</td>
<td class="nump">27,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentGovernmentGrants', window );">Government grants</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Current loans</a></td>
<td class="nump">3,815<span></span>
</td>
<td class="nump">2,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">3,409<span></span>
</td>
<td class="nump">3,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Liabilities from income taxes</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">11,252<span></span>
</td>
<td class="nump">31,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">19,474<span></span>
</td>
<td class="nump">17,962<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">39,496<span></span>
</td>
<td class="nump">57,118<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Equity and liabilities</a></td>
<td class="nump">&#8364; 90,694<span></span>
</td>
<td class="nump">&#8364; 150,130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_CurrentTradeReceivablesAndContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Trade receivables and contract assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_CurrentTradeReceivablesAndContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the capital reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257093720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of cash flows - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before taxes</a></td>
<td class="num">&#8364; (46,876)<span></span>
</td>
<td class="num">&#8364; (21,097)<span></span>
</td>
<td class="num">&#8364; (20,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile earnings to cash flow from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Amortization (including impairments) and depreciation</a></td>
<td class="nump">21,291<span></span>
</td>
<td class="nump">15,128<span></span>
</td>
<td class="nump">6,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestIncome', window );">Interest income</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Inventory write-off</a></td>
<td class="nump">1,795<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestExpense', window );">Interest expense</a></td>
<td class="nump">851<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets', window );">Gain on the disposal of noncurrent assets</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss allowances on trade receivables and contract assets</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">3,738<span></span>
</td>
<td class="nump">752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payment expenses</a></td>
<td class="nump">8,035<span></span>
</td>
<td class="nump">5,658<span></span>
</td>
<td class="nump">6,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RealEstateTransferTaxExpenses', window );">Real estate transfer tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Other non-cash items</a></td>
<td class="num">(862)<span></span>
</td>
<td class="num">(915)<span></span>
</td>
<td class="num">(1,856)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Inventories</a></td>
<td class="nump">5,741<span></span>
</td>
<td class="num">(9,596)<span></span>
</td>
<td class="num">(463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">4,191<span></span>
</td>
<td class="num">(16,344)<span></span>
</td>
<td class="num">(6,444)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">Other assets</a></td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="num">(1,169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Trade payables</a></td>
<td class="num">(20,484)<span></span>
</td>
<td class="nump">23,996<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,632<span></span>
</td>
<td class="nump">6,245<span></span>
</td>
<td class="nump">3,299<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Cash flow (used in)/from operating activities</a></td>
<td class="num">(21,739)<span></span>
</td>
<td class="nump">8,462<span></span>
</td>
<td class="num">(7,775)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Cash paid for investments in intangible assets</a></td>
<td class="num">(2,787)<span></span>
</td>
<td class="num">(6,657)<span></span>
</td>
<td class="num">(7,280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Cash paid for investments in property, plant and equipment</a></td>
<td class="num">(2,915)<span></span>
</td>
<td class="num">(9,890)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Grants received for investment in property, plant and equipment</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="nump">793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment', window );">Grants refunded related to disposed property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(358)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Cash received from disposals of property, plant and equipment</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities', window );">Interest received</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Cash flow (used in)/from investing activities</a></td>
<td class="num">(5,360)<span></span>
</td>
<td class="num">(16,151)<span></span>
</td>
<td class="nump">14,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Cash received from the issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,430<span></span>
</td>
<td class="nump">41,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries', window );">Cash paid for acquisition of non-wholly owned subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Cash received from loans</a></td>
<td class="nump">1,772<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Cash repayments of loans</a></td>
<td class="num">(464)<span></span>
</td>
<td class="num">(2,760)<span></span>
</td>
<td class="num">(12,072)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Cash repayments of lease liabilities</a></td>
<td class="num">(4,244)<span></span>
</td>
<td class="num">(5,018)<span></span>
</td>
<td class="num">(3,046)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid</a></td>
<td class="num">(267)<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="num">(2,029)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Cash flow from financing activities</a></td>
<td class="num">(3,203)<span></span>
</td>
<td class="nump">14,842<span></span>
</td>
<td class="nump">25,473<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Changes in cash and cash equivalents</a></td>
<td class="num">(30,302)<span></span>
</td>
<td class="nump">7,153<span></span>
</td>
<td class="nump">31,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the beginning of the period</a></td>
<td class="nump">48,156<span></span>
</td>
<td class="nump">41,095<span></span>
</td>
<td class="nump">9,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of movements in exchange rates on cash held</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the end of the period</a></td>
<td class="nump">&#8364; 17,818<span></span>
</td>
<td class="nump">&#8364; 48,156<span></span>
</td>
<td class="nump">&#8364; 41,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable and contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from grants received for investment in property, plant and equipment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow relating to grants refunded related to disposal of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_RealEstateTransferTaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount represents the real estate transfer tax expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_RealEstateTransferTaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional allowance for credit losses of financial assets recognised in profit or loss. [Refer: Allowance account for credit losses of financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest income expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest income; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsForNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsForNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for changes in ownership interests in subsidiaries that do not result in a loss of control. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 42A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_42A&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 42B<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_42B&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256884920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of changes in equity - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Total Owners' Capital</div></th>
<th class="th"><div>Issued capital</div></th>
<th class="th"><div>Capital reserve</div></th>
<th class="th"><div>Currency translation reserve</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Non- controlling interests</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at beginning of the period at Dec. 31, 2018</a></td>
<td class="nump">&#8364; 27,281<span></span>
</td>
<td class="nump">&#8364; 1,903<span></span>
</td>
<td class="nump">&#8364; 45,342<span></span>
</td>
<td class="num">&#8364; (16)<span></span>
</td>
<td class="num">&#8364; (19,948)<span></span>
</td>
<td class="num">&#8364; (757)<span></span>
</td>
<td class="nump">&#8364; 26,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">(20,674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,674)<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="num">(20,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">(20,658)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(20,674)<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="num">(20,839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of shares</a></td>
<td class="nump">46,798<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">46,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs</a></td>
<td class="num">(4,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,899)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering', window );">Share-based payments - modification at IPO</a></td>
<td class="nump">10,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,038<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at end of the period at Dec. 31, 2019</a></td>
<td class="nump">59,860<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
<td class="nump">98,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,622)<span></span>
</td>
<td class="num">(938)<span></span>
</td>
<td class="nump">58,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">(21,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,438)<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="num">(21,378)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">(21,486)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(21,438)<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="num">(21,426)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of shares</a></td>
<td class="nump">23,209<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">22,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs</a></td>
<td class="num">(779)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(779)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(779)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">5,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary', window );">Disposal of non-wholly owned subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary', window );">Acquisition of non-wholly owned subsidiary</a></td>
<td class="num">(780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(780)<span></span>
</td>
<td class="nump">705<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at end of the period at Dec. 31, 2020</a></td>
<td class="nump">65,682<span></span>
</td>
<td class="nump">2,654<span></span>
</td>
<td class="nump">125,916<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(62,840)<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">65,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">(46,950)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,950)<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="num">(46,852)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="nump">543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">(46,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="num">(46,950)<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="num">(46,309)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">8,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at end of the period at Dec. 31, 2021</a></td>
<td class="nump">&#8364; 27,310<span></span>
</td>
<td class="nump">&#8364; 2,708<span></span>
</td>
<td class="nump">&#8364; 133,897<span></span>
</td>
<td class="nump">&#8364; 495<span></span>
</td>
<td class="num">&#8364; (109,790)<span></span>
</td>
<td class="nump">&#8364; 193<span></span>
</td>
<td class="nump">&#8364; 27,503<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions or modifications at initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the disposal of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048269145464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General Company Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GeneralInformationAboutFinancialStatementsAbstract', window );"><strong>General Company Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">General Company Information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1 General company information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Centogene N.V. (&#8220;the Company&#8221;) and its subsidiaries focus on rare diseases that transforms real-world clinical and genetic or other data into actionable information for patients, physicians and pharmaceutical companies.  The mission of the Company is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">On November 7, 2019, the Company completed an initial public offering (&#8220;IPO&#8221;) and has since been listed on Nasdaq Global Market under stock code &#8220;CNTG&#8221;.  We have historically conducted our business through Centogene AG (which is now known as Centogene GmbH), and therefore our historical financial statements present the results of operations and financial condition of Centogene AG and its controlled subsidiaries. In connection with our initial public offering, Centogene N.V. became the holding company of Centogene AG on November 12, 2019, and the historical consolidated financial statements of Centogene AG became the historical consolidated financial statements of Centogene N.V. Centogene N.V. is a public company with limited liability incorporated in the Netherlands, with registered office located at Am Strande 7 in 18055 Rostock, Germany and Dutch trade register number 72822872.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On March 5, 2020, the Company resolved that Centogene AG shall be converted into a German limited liability company and renamed Centogene GmbH. Such conversion became effective upon the registration in the German commercial register on June 29, 2020. Unless otherwise stated, &#8220;Centogene GmbH&#8221; also refers to the historical operations of Centogene AG throughout the notes. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In July 2020, the Company completed a follow-on public offering of 3,500,000 common shares of the Company (the &#8220;July 2020 Offering&#8221;), consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of USD 14.00 per common share (i.e. EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR 22 million to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_GeneralInformationAboutFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_GeneralInformationAboutFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048269116680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BasisOfPreparationOfFinancialStatementsAbstract', window );"><strong>Basis of Preparation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of Preparation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2 Basis of preparation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise specified, &#8220;the Company&#8221; refers to Centogene N.V. and Centogene GmbH throughout the remainder of these notes, while &#8220;the Group&#8221; refers to Centogene N.V., Centogene GmbH and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The consolidated financial statements of the Group were prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board (the &#8220;IASB&#8221;).  The accounting policies used in the fiscal year 2021 generally correspond to the policies applied in the prior year, except for certain amendments to the standards which are effective for annual periods beginning on or after January 1, 2021 (see note 3).  In addition, certain prior period information has been reclassified to conform with current year presentation (see note 2). </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">These consolidated financial statements are presented in euro, which is the Group&#8217;s functional currency. Unless otherwise specified, all financial information presented in euro is rounded to the nearest thousand (EUR k) in line with customary commercial practice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.1</b></span><b style="font-weight:bold;">New significant accounting policies and accounting judgments and estimates </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 54pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Revenues from contracts with customer </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group has a diagnostics customer in the Middle Eastern region with a history of significant payment delays. This history has resulted in the recognition of significant subsequent impairment losses by applying the expected credit loss method as the collection of the contractual consideration was historically considered probable upon recognition of revenue. Based on recent developments in its collection experience, recent negotiations with the customer, and past experiences, the Group considered it necessary to reassess its judgments related to the recognition of revenue from contracts with this customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group&#8217;s management concluded, based on the facts and circumstances and management&#8217;s expectations regarding this customer, that this uncertainty in the amount of the contract consideration it expects to collect, and the likelihood of accepting a lower amount or changing payment terms represents an &#8220;implicit price concession&#8221; such that the contract consideration is variable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Therefore, the Group&#8217;s management estimates the amount of the contractual consideration it expects to ultimately collect and for which it is highly probable that related revenue recognized would not be subject to significant future reversals when such uncertainty is resolved. The Group&#8217;s management estimates the implicit price concessions by applying an estimated rate of 18% based primarily upon past collection history. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Despite the uncertainties related to the amount expected to be collected from the customer, based on experience and the facts and circumstances related to the customer, the Group considers it probable that it will collect 82% of the amount of estimated variable transaction price due to newly agreed payment plans established with the customer. Therefore, the Group records the difference between the billed amount and the amount estimated to be collectible as a reduction to revenue. At the end of each reporting period, and if necessary upon receipt of new information, the Group may revise the amount of the variable consideration included in the transaction price. The Group has applied this accounting policy and accounting estimate to arrangements with this customer prospectively with effect from the third quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.2 </b></span><b style="font-weight:bold;">Going Concern</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As an early commercial-stage company, the Group is still in progress towards reaching break-even in its diagnostic and pharma businesses. The Group and Company are subject to a number of risks similar to those of other development and early commercial stage companies. These risks include, among other things, the failure to enter into and successfully execute further collaborations with pharmaceutical partners, the failure to generate revenue from the Company&#8217;s development portfolio and risks associated with research, development, testing and obtaining related regulatory approvals in relation to our product candidates. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group&#180;s ongoing success and ultimately the attainment of profitable operations depends on future uncertain events which include, among other things, obtaining adequate financing to promote our commercial and development activities until the Group can generate sufficient revenues to support its operating cash requirements. The Group has incurred operating losses since inception. For the year ended December 31, 2021 the Group incurred a net loss of EUR 46.9 million of which EUR 46.0 million is related to loss of operations, resulting in an operating cash outflow of EUR 21.7 million driven mainly by the repayment of trade payables of EUR 20.5 million. As of December 31, 2021, the Group had generated an accumulated deficit of EUR 109.3 million, and had an equity position of EUR 27.5 million. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of December 31, 2021 the Group had cash and cash equivalents of EUR 17.8 million with relatively low short term debt obligations of EUR 3.8 million and no financial covenants. In addition, on January 31, 2022 the Company, Centogene GmbH, CentoSafe B.V. and Centogene US, LLC (together, the &#8220;Borrowers&#8221;), entered into a debt financing agreement in the total amount of up to USD 45.0 million (EUR 40.2 million) on January 31, 2022 (the &#8220;Loan Facility&#8221;). Under the terms of the Loan Facility, the Company drew down USD 25.0 million (EUR 22.3 million) on January 31, 2022 and will have access to a second tranche of USD 20.0 million (EUR 17.9 million) upon achievement prior to July 31, 2023, of product revenue from our diagnostics and pharmaceutical services segments of at least USD 50.0 million (EUR 44.7 million) calculated on a trailing twelve month basis as of the last day of any fiscal month. The Loan Facility also includes covenants such that the Group is required to maintain product revenue of at least EUR 30.0 million as of the last day of each fiscal quarter and on a trailing twelve month basis prior to obtaining the second tranche EUR 40.0 million on or after obtaining the second tranche. Both tranches mature on January 29, 2027 with amortized repayments commencing March 1, 2025. The loans extended under the Loan Facility bear monthly interest payments at an interest rate of 7.93% per annum plus the 1-month CME Term SOFR reference rate as published by the CME Group Benchmark Administration Limited (subject to a floor of 0.07%). As security for the Borrowers&#8217; obligations under the Loan Facility, the Borrowers granted the lenders thereunder a first priority security interest on all of each Borrower&#8217;s assets. In addition, pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors on January 31, 2022, the Group also received EUR 15.0 million in exchange for the issuance of an aggregate of 4,479,088 common shares at a price per share of USD 3.73 (EUR 3.35) and warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026. The Group believes that its cash and cash equivalents will be sufficient to fund its planned operating cash requirements for the next twelve months from the date of issuance of these financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The accompanying consolidated financial statements for the year ended December 31, 2021 have been therefore prepared on a going concern basis contingent upon the successful implementation of the plans described above. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The audited consolidated financial statements do not reflect any adjustments relating to the recoverability and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:35.45pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.3</b></span><b style="font-weight:bold;">COVID-19 Pandemic</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The COVID-19 pandemic has spread worldwide and continues to cause many governments to maintain measures to slow the spread of the outbreak through quarantines, travel restrictions, closures of borders and requiring maintenance of physical distance between individuals. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The COVID-19 pandemic resulted in a slowdown in our diagnostics and pharmaceutical businesses. As part of the Company&#8217;s initiative to assist local, national and international authorities as well as other partners in their efforts to facilitate the earliest possible diagnosis of COVID-19 and thereby contribute to allowing society to return to a &#8220;new&#8221; normal, the Company commenced testing for COVID-19 in March 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended December 31, 2021, the Group continued the COVID-19 testing activities started in 2020 with a leading role in providing testing services at airports in Germany. Furthermore, new variants of the virus have emerged since mid-December 2020. How these mutations develop and their impact on the effectiveness of vaccines is not yet fully clear. Furthermore, vaccination campaigns in many countries started during the year ended December 31, 2021, and due to the expected increase in the availability of vaccines the expectation is that governments will further reduce restrictions moving forward. As a result of these developments in the COVID-19 pandemic, the Group has noticed a decrease in COVID-19 test order intakes in the year ended December 31, 2021. How and when these developments would affect the potential prolongation of the need for testing on a broader scale remains uncertain. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Although the Group is taking a number of measures aimed at minimizing disruptions to the business and operations, and while the provision of testing for the COVID-19 virus is anticipated to generate additional revenues for us, the full extent to which the global COVID-19 pandemic may continue to impact the business will depend on future developments, which are highly uncertain and cannot be predicted, such as the duration of the pandemic, the availability and effectiveness of vaccines against new variants, the probability of the occurrence of further outbreaks and the ultimate impact on the financial markets and the global economy, could result in an unforeseen negative impact on the business and future results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.4</b></span><b style="font-weight:bold;">Reclassification of certain Selling and General Administrative expenses</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group made changes to the classification of several items related to its Covid-19 segment, in the statement of comprehensive loss for the financial year 2020 to conform to the changes made in the fiscal year 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The Company has COVID-19 related advertising expenses, credit card fees and other selling expenses which were recognized under cost of sales in the statement of comprehensive loss in the fiscal year 2020 when the COVID-19 business was added to the operations of the Group in the first quarter of 2020. During the year end close process, management identified this as a classification error and corrected it retrospectively. Accordingly, the Group reclassified  EUR </span>2,941k from cost of sales to general administration expenses and selling expenses. The following table shows the reconciliation of the Statement of Comprehensive Loss for fiscal year 2020 prior to and following the revision of the aforementioned costs: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:17.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:18.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:15.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:17.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 (restated)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 (as previously reported)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of Sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 83,437</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 86,378</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,941)</p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Gross profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 44,944</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 42,003</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 2,941</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 40,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 37,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,495</p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,580</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 446</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The changes to the presentation above have no impact to the consolidated statements of financial position (inclusive of December 31, 2020 and January 1, 2020), segment reporting, cash flows or equity and no impact on loss per share.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BasisOfPreparationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BasisOfPreparationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237787528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Effects of new accounting standards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract', window );"><strong>Effects of new accounting standards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations', window );">Effects of new accounting standards</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">3 Effects of new accounting standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></span>New standards adopted by the Group as of January&#160;1, 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following amendments and interpretations apply for the first time in 2021 and had no impact on the consolidated financial statements of the Group:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amendments to IFRS 4 &#8211; Insurance contracts- deferral of IFRS 9</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amendments to IFRS 7, 9, IAS 39 &#8211; Interest rate benchmark reform- Phase 2: Modification of financial assets, financial liabilities and leasing liabilities, requirements regarding accounting and disclosure of hedging relationships </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amendments to IFRS 16 &#8211; Covid-19 related rent concessions</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></span>New standards not yet effective</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Furthermore, certain new and amended standards and interpretations have been published that are not mandatory for December 31, 2021 reporting periods and have not been early adopted by the Group. The Group intends to adopt these new and amended standards and interpretations, if applicable, when they become effective. There are no new or amended standards or interpretations that are issued and become effective for the 2022 annual reporting period, that are expected to have a material impact on the Group. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the initial application of an IFRS. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256711688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of consolidation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BasisOfConsolidationAbstract', window );"><strong>Basis of consolidation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory', window );">Basis of consolidation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">4 Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The basis of consolidation includes the entities over which Centogene N.V. has control within the meaning of IFRS 10 Consolidated Financial Statements. According to IFRS 10, Centogene N.V. has control of an investee when it has direct or indirect power over the investee, exposure, or rights to variable returns from its involvement with the investee and the ability to use its power over the investee to affect those returns. Control is established when it is possible to influence operating and financial policies of the investee, typically with a share in the voting rights or shareholding of more than 50% in the investee. An entity is included in the Group&#8217;s basis of consolidation from the point in time when the Group obtains control of the entity and ceases when the Group loses control of the subsidiary.  Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated financial statements from the date the Group gains control until the date the Group ceases to control the subsidiary.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Profit or loss and each component of other comprehensive income are attributed to the equity holders of the parent of the Group and to the non-controlling interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to transactions between members of the Group are eliminated in full upon consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If the Group loses control over a subsidiary, it derecognizes the related assets, liabilities, non-controlling interest and other components of equity, while any resultant gain or loss is recognized in profit or loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the third quarter of 2020, the Company entered into a collaboration agreement with Dr. Bauer Laboratoriums GmbH, Rostock (hereafter &#8216;Bauer GmbH&#8217;). Bauer GmbH supports Centogene in certain areas of its COVID-19 testing business by providing the medical laboratory services to facilitate Centogene to perform its COVID-19 testing business activities. Bauer GmbH is wholly owned by a long-time employee of Centogene, who from a medical perspective and by observing the Medical Association's professional code of conduct continues to operate as an independent medical physician.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As per the criteria in IFRS 10, Centogene assessed the control it has over Bauer GmbH and concluded to consolidate the activities of Bauer GmbH in the Group from the third quarter of 2020. Centogene does not own any shares in Bauer GmbH. However, based on the analysis of all facts and circumstances surrounding the close collaboration with Bauer GmbH and the employment relationship with the sole shareholder of Bauer GmbH, this shareholder is considered as a de facto agent. Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns. Bauer GmbH </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">has a share in the net result of the respective COVID-19 testing business which has been accounted for under non-controlling interest (see note 23).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BasisOfConsolidationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BasisOfConsolidationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for consolidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfConsolidationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048269213688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract', window );"><strong>Significant accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant accounting policies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">5 Significant accounting policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applied the following accounting policies consistently for all of the periods presented in these consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></span>Foreign currency and currency translation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s consolidated financial statements are presented based on the parent company&#8217;s functional currency. For each entity, the Group determines the functional currency and items included in the financial statements of each entity are measured using that functional currency. The Group uses the direct method of consolidation and on disposal of a foreign operation, the gain or loss that is reclassified to profit or loss reflects the amount that arises from using this method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Transactions in foreign currency are translated into the respective entity&#8217;s functional currency at the spot rate prevailing on the date of the transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The functional currency of each entity is the respective local currency, since the entities carry out their business activities independently from a financial, economic and organizational perspective.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Monetary assets and liabilities denominated in foreign currency are translated to the functional currency using the closing rate at the reporting date. Currency translation differences are recognized immediately through profit or loss. Non-monetary items denominated in a foreign currency that are measured at historical cost are not translated at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On consolidation, the assets and liabilities of foreign operations are translated into euros using the closing rate on the reporting date. Income and expenses of foreign operations are translated using the exchange rate prevailing on the date of the transaction or the annual average exchange rate. Equity is translated using historical rates until the entity is removed from the Group&#8217;s basis of consolidation. Any resulting currency translation differences are recorded in other comprehensive income and recognized under the currency translation reserve in equity if the exchange difference is not allocable to the non-controlling interests. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The exchange rates used are presented in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Closing&#160;rate</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USD (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1304</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1191</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.2271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1234</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AED (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.2091</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.0985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.5045</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.0795</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">INR (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 85.1761</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84.5737</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 78.7980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84.2292</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 89.6605</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 80.1870</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CHF (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RSD (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117.3909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117.2747</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></span>Revenues from contracts with customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The Group provides pharmaceutical solutions and diagnostic tests, as well as COVID-19 tests, enabled by its knowledge and interpretation-based platform. Revenue from contracts with customers is recognized when control of the goods or services are transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those goods or services, usually on delivery of the goods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Pharmaceutical segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">The Group's contracts with customers relate to a variety of solutions provided to the Group's pharmaceutical partners in order to accelerate their development of treatments for rare diseases, including early patient recruitment and identification, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">epidemiological insights, biomarker discovery and patient monitoring. The collaboration agreements are structured on a fee per analysis basis, milestone basis, fixed fee basis, or a combination of these. In addition, some of the Group's contracts with its pharmaceutical partners also include sales of CentoCards for the collection of biological samples from patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The performance obligations in Pharmaceutical segment can either be satisfied over time or at a point in time depending on the structure of the collaborations, which are determined based on nature of the service provided, as detailed below.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring is based on fee per analysis, milestone fees and fixed fees. The revenues from these solutions are recognized over time using an input method based on the work rendered in order to measure progress towards complete satisfaction of the services.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from the licensing of intellectual property for an unlimited period, usually in the structure of an upfront fee, is recognized at a point in time, when the right (or license) to use intellectual property is conveyed.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenues from the licensing of intellectual property for a certain period, being a right to access such intellectual property as defined in IFRS 15, is recognized over time over the licensing period.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from the sale of CentoCards is recognized at a point in time when the control of the CentoCards has transferred to the customer, which typically occurs on delivery.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Diagnostics segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">Revenues from the Group's diagnostics segment are typically generated from genetic sequencing and diagnostics services that the Group provides to clients, who are typically physicians, laboratories or hospitals, either directly or through distributors. Revenues are based on a negotiated price per test or on the basis of agreements to provide certain testing volumes over defined periods. The Group has concluded that the services rendered in the diagnostics segment comprise one performance obligation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The performance obligation in the Diagnostics segment is recognized over time, using an input method to measure progress towards complete satisfaction of the service. In order to measure progress, the Group uses a standardized process which measures progress to completion by stages, consisting of (i) a preparation stage, (ii) a clarification stage, (iii) a sequencing stage, and (iv) an output stage. The percentages attributed to those stages are indicative of the cost incurred in performing the respective stage in relation to total cost. &#160; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>COVID-19 segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">COVID-19 revenues are based on a negotiated price per test, government driven or on the basis of agreements covering tests to be performed over defined periods. Given the short turnaround time for the COVID-19 tests, revenues from COVID-19 tests that are on a price per test basis are recognized at a point in time. Revenues from COVID-19 tests that are on the basis of agreements covering tests to be performed over defined periods are recognized over time over the agreement period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The Group has disaggregated revenue recognized from contracts with customers into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Group has also disclosed information about the relationship between the disclosure of disaggregated revenue and the revenue information disclosed for each reportable segment. See note 7 for the disclosure on disaggregated revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contract balances </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contract assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A contract asset is the right to consideration in exchange for goods or services transferred to the customer. If the Group satisfies a performance obligation by transferring goods or services to a customer before the customer pays consideration or before </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">payment is due, a contract asset is recognized for the earned consideration that is conditional.  Contract assets are subject to impairment assessment, refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A receivable represents the Group&#8217;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Contract liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A contract liability is the obligation to transfer goods or services to a customer for which the Group has received consideration or an amount of consideration is due from the customer (whichever is earlier). If a customer pays consideration before the Group transfers goods or services to the customer, a contract liability is recognized when the payment is made or the payment is due (whichever is earlier). Contract liabilities are recognized as revenue when the Group performs under the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></span>Finance income and finance costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Interest income and expenses are recognized in the period which they relate to through profit or loss using the effective interest rate method. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></span>Current versus non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Expected to be realized or intended to be sold or consumed in the normal operating cycle</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Held primarily for the purpose of trading</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Expected to be realized within twelve months after the reporting period; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All other assets are classified as non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A liability is current when:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is expected to be settled in the normal operating cycle</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is held primarily for the purpose of trading</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is due to be settled within twelve months after the reporting period; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The terms of the liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group classifies all other liabilities as non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are classified as non-current assets and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></span>Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Expenses for research activities are recognized through profit or loss in the period in which they are incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Development expenditures on an individual project are recognized as an intangible asset from the date the Group can demonstrate: </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the product or process is technically and commercially feasible so that the asset will be available for use or sale</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Group has the ability and intention to use or sell the asset</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a future economic benefit is probable </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Group has sufficient resources to complete the development and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the development costs can be measured reliably. </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group&#8217;s research and development activities mainly relate to development of biomarkers and IT driven solutions.  With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#8217;s internal validation test. Before such dates, any development costs are recognized in profit or loss and may not be subsequently capitalized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized development costs are recognized at cost less accumulated amortization and any accumulated impairment losses. They are only amortized as from the date the asset is ready for its intended use, which in the case of biomarkers is normally at the time the patent application for such biomarker is made. Amortization expense commences when the assets are ready to be put in use, and is recorded in cost of sales and research and development expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized development costs which are still under development are tested for impairment annually and when circumstances indicate that the carrying value may be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Other intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other intangible assets purchased by the Group with finite useful lives are recognized at cost less accumulated amortization and any accumulated impairment losses. Subsequent expenditure is only capitalized if it increases the future economic benefits of the respective asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Intangible assets are amortized over their estimated useful life using the straight-line method and assessed for impairment whenever there is an indication that the intangible asset may be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The estimated useful lives are as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Software, patents and trademarks: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 years</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Corona Test Portal: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2 years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Capitalized development costs: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 years</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The useful lives and depreciation methods are reviewed annually to ensure that the methods and periods of depreciation are consistent with the expected economic benefit from the asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(f)</b></span>Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment are carried at cost less any accumulated depreciation and any accumulated impairment losses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The cost of property, plant and equipment comprises its purchase price including customs duties and non-refundable acquisition taxes, and proportionate VAT not deductible from input tax as well as any directly attributable costs of bringing the asset to its working condition and location for its intended use.       </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> Subsequent expenditure is only capitalized if it is probable that the future economic benefits associated with the expenditure will flow to the Group. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Depreciation is calculated over the estimated useful life using the straight-line method. The Group has assessed that none of its property, plant and equipment has a residual value. The estimated useful lives of significant property, plant and equipment are as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Freehold land is not depreciated</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Buildings: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">33 years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Plant and other equipment, furniture and fixtures: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">15 years</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">An item of property, plant and equipment is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of comprehensive loss when the asset is derecognized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The depreciation methods, useful lives and residual values are reviewed, and adjusted prospectively if appropriate, as of each reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Assets under construction are reported at cost and are allocated to property, plant and equipment until they are completed and put into operational use, from which point onwards they are depreciated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(g)</b></span>Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Group as a lessee</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Right-of-use assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group recognizes right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its lease term and the estimated useful lives, as follows:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Buildings: 33 years<span style="white-space:pre-wrap;">  </span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Offices: 4 &#8211; 12 years and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Plant and other equipment, furniture and fixtures: 2-15 years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If ownership of the leased asset transfers to the Group at the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The right-of-use assets are also subject to impairment. Refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">At the commencement date of the lease, the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for leases reasonably certain to be terminated. The variable lease payments that do not depend on an index or a rate are recognized as expenses in the period during which the event or condition that triggers the payment occurs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>Short-term leases and leases of low-value assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption to leases of office equipment that are considered of low value (i.e., below EUR 5k). Lease payments on short-term leases and leases of low-value assets are recognized as expenses on a straight-line basis over the lease term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>Sale and leaseback transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group applies IFRS 15 for determining if the transfer of an asset to the buyer (lessor) is to be accounted for as a sale of assets.  After the sale of assets is concluded, the Group measures the right-of-use assets arising from the leaseback at the proportion of the previous carrying value of the asset that relates to the right of use retained by the Group.  Accordingly, the Group recognizes only the amount of any gain or loss that relates to the rights transferred to the buyer (lessor).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the fair value of the consideration for the sale of an asset does not equal the fair value of the asset, or if the payments for the leases are not at market rates, the Group makes the following adjustments to measure the sale proceeds at fair value: </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">any below-market terms shall be accounted for as a prepayment of lease payments</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">any above-market terms shall be accounted for as additional financing provided by the buyer-lessor to the seller-lessee</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(h)</b></span>Impairment of non-financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment and intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Whenever the carrying amount of an asset exceeds its recoverable amount, an impairment loss is recognized in profit or loss. The recoverable amount is measured as the higher of fair value less costs to sell and value in use. Recoverable amounts are estimated either for individual assets or, if an individual asset does not generate cash flows independently of other assets, for the whole cash-generating unit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></span>Inventories</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inventories are measured at the lower of cost and net realizable value. Inventories are recognized at cost based on the first in first out (FIFO) method. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(j)</b></span>Government grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. Grants that are intended to compensate the Group for expenses incurred are recognized through profit or loss in the period in which expenses are submitted and claimed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants which relate to an asset are initially recognized as deferred income at nominal amounts. They are subsequently released to profit or loss on a systematic basis over the expected useful life of the related asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The release of deferred income related to either type of grant is presented as other operating income (see note 8).<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(k)</b></span>Share-based payments </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Plan recipients (including senior executives and certain member of Supervisory Board) of the Group receive remuneration in the form of share-based payments, whereby the recipients render services as consideration for equity instruments (equity-settled transactions) or settled in cash (cash-settled transactions).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Equity settled transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The cost of equity-settled transactions is determined by the fair value of the granted options when the grant is made, using a Black-Scholes or Monte Carlo simulation model, with further details given in note 20.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The cost is recognized in employee benefits expense (see note 8.4) or other relevant expenses, together with a corresponding increase in equity (capital reserves), over the period in which the service conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest.  The expense or credit in profit or loss for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cash-settled transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A liability is recognized for the fair value of cash-settled transactions. The fair value is measured initially and at each reporting date up to and including the settlement date, with changes in fair value recognized in employee benefits expense (see note 8.4). The fair value per option is determined using the Black-Scholes model, further details of which are given in note 20. The fair value per option is then multiplied by the Group&#8217;s best estimate of the number of awards expected to vest and the portion of the expired vesting period (period in which the service conditions are fulfilled). The cumulative amount of expense recognized will be equal to the cash that is paid on settlement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Service and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">If the terms and conditions of a cash-settled share-based payment transaction are modified with the result that it becomes an equity-settled share-based payment transaction, the transaction is accounted for as such from the date of the modification.  Specifically, the equity-settled share-based payment transaction is measured by reference to the fair value of the equity instruments granted at the modification date and recognized in equity.  The liability for the cash-settled share-based payment transaction as at the modification date is derecognized on that date.  Any difference between the carrying amount of the liability derecognized and the amount of equity recognised on the modification date is recognised immediately in profit or loss.</span><b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(l)</b></span>Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">A provision is recognized when the Group has a present obligation (legal, contractual or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.  When the Group expects some or all of a provision to be reimbursed, for example, under an insurance contract, the reimbursement misrecognized as a separate asset, but only when the reimbursement is virtually certain. The expense relating to a provision is presented in the profit or loss net of any reimbursement.  Provisions are reviewed at each reporting date and adjusted to reflect the current best estimate. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the requirements for recognizing a provision are not satisfied, the corresponding obligations are recorded as contingent liabilities unless the possibility of an outflow of resources embodying economic benefits is remote.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(m)</b></span>Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tax expense comprises current and deferred taxes. Current taxes and deferred taxes are recognized through profit or loss apart from deferred taxes related to items recognized outside profit or loss, in which case it is recognized in correlation to the underlying transaction either directly in equity or in other comprehensive income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Group operates and generates taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred taxes are set up for temporary differences between the carrying amounts of assets and liabilities for group financial reporting purposes at the reporting date and the amounts used for tax purposes. Deferred tax liabilities are recognized for all taxable temporary differences, except:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">temporary differences arising from the initial recognition of assets or liabilities in the course of a business transaction that is not a business combination and does not affect either the accounting profit or the taxable profit or loss</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">temporary differences associated with investments in subsidiaries if the Group controls the timing of the reversal of the temporary differences, and it is probable that the differences will not reverse in the foreseeable future.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and deferred tax liabilities are offset against each other if certain conditions are met.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(n)</b></span>Financial instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">(i) Financial assets </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s financial assets principally consist of those accounted for as receivables, contract assets, cash and cash equivalents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Receivables and contract assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Receivables, including contract assets, are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.  Contract assets and trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are measured at the transaction price determined under IFRS 15.  Refer to the accounting policies in note 5(b) &#8220;Revenues from contracts with customers&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">After initial recognition, receivables and contract assets are subsequently carried at amortized cost using the effective interest rate method less any impairment losses.  Gains and losses are recognized in the profit or loss for the period when the assets are derecognized or impaired.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Derecognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A financial asset or a part of a financial asset is derecognized when the Group no longer has the contractual rights to the asset or the right to receive cash flows from the asset have expired. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group recognizes an allowance for expected credit losses (ECLs). ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies a simplified approach in calculating ECLs. Therefore, the Group does not track changes in credit risk, but instead recognizes a loss allowance based on lifetime ECLs at each reporting date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group considers a financial asset in default when contractual payments are 360 days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Further disclosures relating to impairment of trade receivables, including contract assets, are in note 21.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(ii)&#160;Financial liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s financial liabilities include trade and other payables (include contract liabilities), as well as loans and borrowings including bank overdrafts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Loans and borrowings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Loans and borrowings are initially recognized at fair value and subsequently measured at amortized cost using the effective interest rate method, taking into account any principal repayments and any discount or premium on acquisition and including transaction costs and fees that are an integral part of the effective interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Gains or losses are recognized through profit or loss at the time the liabilities are derecognized or disposed of.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Derecognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A financial liability is derecognized when the obligation underlying the liability is discharged, canceled or expires.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized through profit or loss.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(o) Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Cash and cash equivalents comprise cash on hand and bank balances, including short-term, highly liquid investments that can be quickly converted into cash amounts. These have original maturities of three months or less and are subject to a low risk of fluctuation in value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048236882744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting judgments and estimates<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract', window );"><strong>Accounting judgments and estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Accounting judgments and estimates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">6 Accounting judgments and estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements requires the management board to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures. Actual results could differ from those estimates. Estimates and underlying assumptions are reviewed on an ongoing basis and revisions of estimates are recorded prospectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.1</b></span>Judgments </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Development costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Development costs are recognized in accordance with the accounting policy for certain internally generated assets. The Group&#8217;s research and development activities mainly relate to development of biomarkers and IT driven solutions. With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#8217;s internal validation test. Before such date, any development costs are recognized in profit or loss and may not be subsequently capitalized. As of December&#160;31, 2021, the carrying amount of capitalized development costs was EUR&#160;7,941k (2020: EUR&#160;9,680k). This amount includes investments in the development of biomarkers and IT driven solutions (e.g.,&#160;the Group&#8217;s CentoMetabolome and CentoPortal online platform). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Provision for expected credit losses of trade receivables and contract assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group uses a provision matrix to calculate ECLs for trade receivables and contract assets. The provision rates are based on days past due for groupings of various customer segments that have similar loss patterns (e.g. by segment, geography, customer type and rating).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The provision matrix is initially based on the Group's historical observed default rates. The Group will calibrate the matrix to adjust the historical credit loss experience with forward-looking information. For instance, if forecasted economic conditions (i.e., gross domestic product) are expected to deteriorate over the next year which can lead to an increased number of defaults in the manufacturing sector, the historical default rates are adjusted. At every reporting date, the historical observed default rates are updated and changes in the forward-looking estimates are analyzed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The assessment of the correlation between historical observed default rates, forecasted economic conditions and ECLs is a significant estimate. The amount of ECLs is sensitive to changes in circumstances and of forecasted economic conditions. The Group's historical credit loss experience and forecast of economic conditions may also not be representative of customer's actual default in the future. The information about the ECLs on the Group's trade receivables and contract assets is disclosed in note 21.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Deferred tax asset on loss carryforwards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The tax losses carried forward do not expire. In the light of the Company&#8217;s loss history, the recognition of deferred taxes for tax losses carried forward and deductible temporary differences is limited to the future reversal of existing taxable temporary differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue implicit concession</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group reassessed revenue recognition from contracts linked to a customer with a history of significant payment delays resulting in significant impairment losses through the application of the expected credit loss method. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group concluded, based on the facts and circumstances and management&#8217;s expectations regarding this customer, that this uncertainty in the amount of the contract consideration it expects to collect, and the likelihood of accepting a lower amount or changing payment terms represents an &#8220;implicit price concession&#8221; such that the contract consideration is variable. Therefore, the Group estimates the amount of the contractual consideration it expects to ultimately collect and for which it is highly probable that related revenue recognized would not be subject to significant future reversals when such uncertainty is resolved. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group records the difference between the billed amount and the amount estimated to be collectible as a reduction to revenue. At the end of each reporting period, and if necessary upon receipt of new information, the Group may revise the amount of the variable consideration included in the transaction price. The Group has applied this accounting policy and accounting estimate to arrangements with this customer prospectively with effect from the third quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">6.2         Assumptions and estimation uncertainties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Information concerning assumptions and estimation uncertainty that have a significant risk of causing a material adjustment to the fiscal&#160;year ended on December&#160;31, 2021 are presented in the following disclosures. The Group based its assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising that are beyond the control of the Group. Such changes are reflected in the assumptions when they occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Share-based payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Estimating fair value for share-based payment transactions requires a determination of the most appropriate valuation model, which depends on the terms and conditions of the grant.  For the measurement of the fair value of equity-settled transactions at the grant date (including those issued to replace the cash-settled transactions), the Group uses the Monte Carlo simulation model (previously the Black-Scholes model). The fair value at grant date of equity-settled transactions is not updated at the end of each reporting period. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Valuation of Share Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Black-Scholes option pricing model requires the input of subjective assumptions, including assumptions about the expected life of share-based awards and share price volatility.  The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved.  As a company listed on the NASDAQ stock exchange in 2019, the Group&#8217;s share price only has limited sufficient historical information to be used as a reference, and therefore subjective inputs were included when estimating the fair value of our common shares to be used in both option pricing model. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In addition, our management used different key assumptions in the models to calculate the fair value.  The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in note 20. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group intends to continue to consistently apply this methodology using the same comparable companies until a sufficient amount of historical information regarding the volatility of our own share price as a public company becomes available.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256741064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information and revenue from contracts with customers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Segment Information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">7 Segment information and revenue from contracts with customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">7.1 Segment information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For management purposes, the Group is organized into business units based on its products and services. In line with the management approach, the operating segments were identified on the basis of the Group&#8217;s internal reporting and how the chief operating decision maker (&#8220;CODM&#8221;) assesses the performance of the business. On this basis, the Group has the following three operating segments, which also represent the Group&#8217;s reportable segments:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Pharmaceutical segment:</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">  This segment provides a variety of solutions to our pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring, in order to accelerate their development of treatments for rare diseases; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Diagnostics segment:</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">  This segment provides genetic sequencing and diagnostics services to our clients, who are typically physicians, laboratories or hospitals, either directly or through distributors; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">COVID-19 segment: </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">This segment provides COVID-19 testing services to our clients. Our original COVID-19 test is a molecular diagnostic test performed for the in vitro qualitative detection of RNA from the SAR-CoV-2 in oropharyngeal samples from presymptomatic probands according to the recommended testing by public health authority guidelines. In addition, we also offer COVID-19 antigen testing. </span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The management board is the Chief Operating Decision Maker and monitors the operating results of the segments separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on segment results and is measured with reference to the Adjusted EBITDA. Adjusted EBITDA is a financial measure which is not prescribed by IFRS, which the Group defines as income/loss before finance costs (net), taxes, and depreciation and amortization (including impairments), adjusted to exclude corporate expenses as well as share-based payment expenses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Corporate expenses, interest and similar income and expenses, as well as share-based payment expenses are not allocated to individual segments as the underlying instruments are managed on a group basis. Assets and liabilities are managed on a Group basis and are not allocated to the different segments for internal reporting purposes. Therefore, our CODM does not regularly review this information by segment and accordingly we do not report this information by segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,843</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 20,678</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,247)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (16,702)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 690</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 261</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,480</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,367</p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 386</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,787</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,076</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,539</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,828</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,849</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,291</p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,297</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,297</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19 </b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,194</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,408)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 37,215</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (39,918)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,083</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 602</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,682</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,730</p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,183</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,672</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,802</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,657</p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,670</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,128</p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,935</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:47.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,956</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,306</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (22,949)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,687)</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,362</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,998</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,908</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,268</p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,603</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,280</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,579</p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,590</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,590</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:7.1pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:28.9pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As discussed in note 2, in March 2020 the Group commenced testing for COVID-19 in response to the COVID-19 pandemic and in the third quarter started managing and reporting the COVID-19 business as a separate segment. As such, the Group did not have any activities related to the COVID-19 business prior to 2020 and retrospective presentation in prior year segment reporting is not applicable. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Adjustments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Adjustments include non-cash charges in relation to depreciation, amortization (including impairments), and share-based payments as well as net financial costs, and income taxes. Certain costs, and related income, are not allocated to our reporting segment results and represent the residual operating activities of the Group reported as &#8216;Corporate&#8217;. These include corporate overheads, which are responsible for centralized functions such as communications, information technology, facilities, legal, finance and accounting, insurance (D&amp;O), human resources, business development and strategic initiatives, certain professional and consulting services, procurement, research and development and other supporting activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Corporate expenses also includes expenses incurred in relation to capital raising activities. For the year ended December 31, 2021, no expenses were incurred (2020 July Offering: EUR 278k ; 2019 IPO: EUR 1,092k) (see note 8.2). The corporate expenses for the year ended December 31, 2019 also includes a real estate transfer tax of EUR 1,200k related to an intercompany sale of land and building (see note 13).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Reconciliation of segment Adjusted EBITDA to Group loss for the period</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reportable segment Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 29,545</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 41,001</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 17,262</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Corporate expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (46,247)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (39,918)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (22,949)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (16,702)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,083</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,687)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payment expenses (Note 20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,035)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,658)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,418)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,291)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15,128)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,579)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,028)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (19,703)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (18,684)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financial costs, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (848)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,013)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (281)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (158)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss for the year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,852)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (21,378)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (20,855)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Non-current asset locations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Non-current assets of the Group consist of right-of-use assets (under IFRS 16), property, plant and equipment, as well as intangible assets. All of such assets are located in Germany, which is the country of the business address of the Centogene GmbH, except for property, plant and equipment of EUR&#160;147k (2020: EUR 516k; 2019: EUR 286k) and right-of-use assets of EUR 137k (2020: EUR 709k; 2019: EUR 1,042k), which are located in the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">7.2 Revenue from contracts with customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 146,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 189,159</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 762</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 764</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,131</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 61,910</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 762</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 127,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 128,013</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,425</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 144,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 150,584</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Germany*#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 211</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 140,922</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 141,133</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,616</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 3,622</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,432</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,496</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,763</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 19,309</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,593</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 818</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">                                                          </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,947</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88,587</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 126,642</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 735</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,739</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,947</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,684</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 62,739</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64,638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 65,642</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,605</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,068</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;Germany*#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 186</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 80,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> 81,065</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,572</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> 6,575</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,624</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,265</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,370</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> 19,059</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,851</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,888</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 508</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 536</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 46,347</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,433</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,433</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,417</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,363</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 381</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,447</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Germany*</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 233</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 275</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 508</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> &#8212;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 25</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 25</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,977</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,099</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">&#8212;<i style="font-style:italic;">Saudi Arabia#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> &#8212;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 7,417</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 7,417</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,896</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,276</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 20,896</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 1,882</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 22,778</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 123</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,864</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,987</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 971</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">*&#160;&#160;country of the incorporation of Centogene GmbH</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">**&#160;country of the incorporation of Centogene N.V.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">#&#160;&#160;&#160;&#160;countries contributing more than 10% of the Group's total consolidated revenues for the respective year ended December 31, 2021, 2020 or 2019 </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group collaborated with the majority of our pharmaceutical partners on a worldwide basis in 2021, 2020 and 2019. In addition, in cases where our pharmaceutical partners are developing a new rare disease treatment, it is generally anticipated that the final approved treatment will be made available globally. As a result, we allocate the revenues of our pharmaceutical segment by geographical region by reference to the location where each pharmaceutical partner mainly operates, which is based on the region from which most of their revenues are generated. The allocation of revenues in our diagnostics and COVID-19 segments are based on the location of each customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmaceutical segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the&#160;year ended December&#160;31, 2021, revenues from one pharmaceutical partner represented 5.1% of the Group&#8217;s total revenues (2020: 8.6%; 2019: 24.3%).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December&#160;31, 2021, we entered into collaboration agreements with certain pharmaceutical partners, of which upfront fees of EUR 455k were received in relation to setup fees which will be recognized as revenue over the period of the partnership collaboration. No such payments were received or revenues recognized for the year ended December 31, 2020. During the year ended December 31, 2019, Centogene entered into several collaborations with pharmaceutical partners, of which upfront fees totaling EUR 1,930<span style="white-space:pre-wrap;">k were received.  Such upfront payments were recognized as revenues during the year as they represented the transaction price allocated to the one-off transfer of the Group&#8217;s intellectual property&#8212;provision of epidemiological insights of relevant rare diseases and relevant data. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2021, revenues from two COVID-19 partners represented 6.4% and 9.4%, respectively, of the Group&#8217;s total revenues. (2020: 14.6% and 13.5%, respectively).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To support the expansion of test offerings, the Company acquired laboratory facilities and equipment, developed a Corona Test Portal and leased laboratory space at several locations in Germany. Additionally, COVID-19 testing capacity is provided through our custom-built CentoTruck, a mobile laboratory in a container designed to carry out COVID-19 analysis. Total capitalized investments in COVID-19 testing as of December 31, 2021 amounted to EUR 2.8 million (2020: EUR 10.8 million), of which EUR 2.4 million (2020: EUR 7.7 million) are included in property, plant and equipment and EUR 0.4 million (2020: EUR 1.7 million) is included in intangible assets and relates to the development of the Corona Test Portal. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Contract balances</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Trade receivables (note 15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 25,656</p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Contract assets (note 15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,543</p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Contract liabilities (note 19.2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,479</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contract assets primarily relate to the Group&#8217;s rights to consideration for work completed but not billed at the reporting date on the tests for the diagnostics segment, with the satisfaction of the respective performance obligation measured by reference to stages in a standardized process. The contract assets also include work performed for pharmaceutical partners which are based on milestone fees. In 2021, EUR 483k (2020: EUR 356<span style="white-space:pre-wrap;">k) was recognised as provision for expected credit losses on contract assets (see note 21).  The contract assets are transferred to receivables when the rights become unconditional. This usually occurs when the Group issues an invoice to the customer. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contract liabilities include EUR 2,506k (2020: EUR 2,516k) which relate to the advance consideration, including various contracts with performance obligations, received from pharmaceutical partners for which revenue is recognized over time, and consideration from sales of CentoCards which have not yet been delivered. In addition, EUR 2,336k relates to COVID-19 performance obligations that have not been met as of December 31, 2021 (2020: EUR 1,963k). </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256742184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income and expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseDisclosureAbstract', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock', window );">Other income and expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">8 Other income and expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.1</b></span>Other operating income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,152</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2641</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gain on disposal of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">532</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exchange rate gains</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">314</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income from the reversal of provisions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">89</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 656</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">205</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,936</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,394</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,781</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants contain performance-based grants to subsidize research, development and innovation in the state of Mecklenburg-Western Pomerania from funds granted by the European Regional Development Fund. Furthermore, government grants contain the release of deferred income from investment related grants. Other operating income includes a gain of EUR 387k from the forgiveness of a bank loan granted under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). (2020: EUR Nil). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2019, the Group entered into a sale and leaseback transaction. According to which, the Group sold the Rostock headquarters building to a third party and then leased the building from the third party for a period of 12 years at a fixed rate per month with the option to extend. The sale of the Rostock headquarters in 2019 resulted in a gain of EUR 532k and was recognized in the period of sale. (See note 13)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.2</b></span>Other operating expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Currency losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 192</p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 172</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,092</p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 86</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 182</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,284</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Other operating expenses for the year ended December 31, 2019 included costs incurred related to the IPO charged to profit and loss of EUR 1,092k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended December 31, 2020, the Group disposed of its entire 51% interest in LPC GmbH (&#8220;LPC&#8221;) to the minority shareholders for a consideration of EUR 213k, of which EUR 200k is to be paid over a period of four years and EUR 100k is outstanding as of December 31, 2021 (included in other assets, see note 15). The related non-controlling interest of EUR 268k (accumulated share of loss) was debited to profit or loss, and the sale resulted in a loss of EUR 101k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.3</b></span>Financial costs, net </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest expenses from loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (267)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (173)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,690)</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Currency losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (362)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unwinding of the discount on lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (584)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (865)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (339)</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest income from loans and receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (848)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (1,394)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,013)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.4</b></span>Employee benefits expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Wages and salaries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 43,533</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,854</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Social security contributions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,134</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,212</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,471</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,714</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Termination benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,158</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 63</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 56,296</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 39,271</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 32,843</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Social security contributions include contributions to state pension scheme of EUR&#160;2,706k (2020: EUR 1,851k; 2019: EUR&#160;1,136k) as defined contribution plan expenses. Additionally, the Company recognized compensation expense of EUR 3,252k (2020: EUR 2,775k; 2019: EUR 1,203k) for remuneration of supervisory board members, including share-based payments (see note 25). </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherIncomeExpenseDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherIncomeExpenseDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257114888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">9 Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Taxes recognized through profit or loss:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current tax expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (118)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (74)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (158)</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Current year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (102)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (58)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Adjustments for prior periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (157)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred tax (expense)/income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 142</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (207)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Temporary differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (182)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (514)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Tax losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 514</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total income tax (expenses)/benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (281)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (158)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No income taxes were recognized directly in other comprehensive income for the years ended December 31, 2021, 2020 and 2019. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A reconciliation of the effective tax rate to the Group&#8217;s statutory rate of 31.1%<span style="white-space:pre-wrap;"> for the year ended December 31, 2021, and  </span>31.1% for the years ended December, 31, 2020 and December, 31, 2019, respectively are presented in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss before tax</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,876)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (21,097)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (20,697)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Taxes on the basis of the Company&#8217;s domestic tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,596</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,445</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax rate effect of foreign tax jurisdictions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 412</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non&#8209;deductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,030)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (903)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (441)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current year losses for which no deferred tax assets were recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,211)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,792)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,416)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax income related to prior years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (137)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (157)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other effects</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (196)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (84)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income tax (expenses)/ benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (281)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (158)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The domestic tax rate of 31.1% is composed of the corporate income tax rate of 15%, the solidarity surcharge of 5.5% of this corporate income tax, as well as trade tax of 15.3%. The tax rate effects from foreign tax jurisdictions are primarily attributable to the tax-exempt profit of a Group subsidiary located in Dubai.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tax losses carryforwards for which no deferred tax assets were recognized amount to EUR&#160;85,639k in Germany (2020: EUR&#160;64,464k; 2019: EUR&#160;41,570k) and to EUR&#160;1,083k in other countries (2020: EUR 1,002k; 2019: EUR&#160;505k). Deductable temporary differences, for which no deferred tax asset is recognized, amount to EUR 1,117k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tax losses carried forward in Germany do not expire. Foreign tax losses carried forward may be restricted. In the light of the Group&#8217;s loss history, the recognition of deferred taxes for tax losses carried forward and deductible temporary differences was limited to the future reversal of existing taxable temporary differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For temporary differences associated with investments in the amount of EUR&#160;5,656k (2020:&#160;EUR&#160;4,313k; 2019: EUR&#160;4,360k), no deferred tax liability has been recognized because the Company is able to control the timing of the reversal and it is probable that the difference will not reverse in the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The below table shows a breakdown of deferred taxes in the Group&#8217;s statement of financial position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;liabilities</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,439)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,934)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (133)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,617)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,029)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Measurement of service contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (145)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasing liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,563</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,693</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,903</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unused tax losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 777</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,266</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Sum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,033</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,112)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,034</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (8,241)</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Offset</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,033)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,033</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (8,034)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,034</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred Taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (79)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (207)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256648984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Loss Per Share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">10 Loss Per Share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Basic loss per share is calculated by dividing loss for the period attributable to equity holders of the Group by the weighted average number of shares outstanding during the same period, adjusted for the effect of the corporate reorganization as discussed in Note 1 and applied retrospectively to all prior periods presented. The weighted average number of outstanding shares for the year ended December 31, 2021 was 22,437,301 (2020: 20,909,673; 2019: 16,409,285), adjusted for the effect of the 2019 corporate reorganization).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the periods included in these financial statements, the share options are not included in the diluted loss per share calculation as the Company was loss-making in all these periods. Due to the anti-dilutive nature of the outstanding options, basic and diluted loss per share is equal.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256873512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">11 Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Reconciliation of carrying amounts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Internally</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">generated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Internally</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased&#160;rights,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">/acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">developed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">licenses,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">biomarkers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">databases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">software</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,502</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,010</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,534</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,657</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deconsolidation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (151)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (151)</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 13,922</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 9,219</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,899</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 28,040</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 749</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,652</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 386</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,787</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (297)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 297</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,374</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 11,168</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,285</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 30,827</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated amortization and impairment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,831</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,770</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,788</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,389</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Amortization and impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,917</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 943</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 508</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,368</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deconsolidation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 10,748</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,713</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,172</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,633</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Amortization and impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,149</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,991</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,860</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,829</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,772</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,032</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,633</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,174</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,506</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,727</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,407</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,545</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,396</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,253</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 9,194</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">*&#160;&#160;&#160;&#160;&#160;The net reclassification of EUR 229<span style="white-space:pre-wrap;">k from internally generated biomarkers to internally developed databases represents internal costs incurred in the process of developing internal IT driven solutions on biomarkers.  Reclassification is made to allow more transparent presentation considering this is more in line with each sub-group of intangible assets.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Development costs and amortization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Internally generated intangible assets include capitalized development costs for biomarkers and IT driven solutions such as CentoPortal, CentoMetabolome and CentoMD (see notes&#160;5 and 6 regarding measurement). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The amortization of patents, trademarks and development costs is expensed and recorded under &#8220;cost of sales&#8221; to the extent the related intangible asset are used in generating revenue and recorded in research and development expenses to the extent the related intangible assets are used for R&amp;D purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of December 31, 2021, certain identified biomarkers and internally developed databases amounting to EUR 1.1 million (2020: EUR 4.7 million) were impaired as part of the Company&#8217;s strategy reassessment which occurred in Q4 2021. The impairment is expensed under cost of sales and included in amortization and impairment expense in the Pharma segment.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048269061960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">12 Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Please refer to the following table for the development from January 1, 2020 to December 31, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&#160;fixtures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">As of Jan 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,254</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,730</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,696</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,890</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (612)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (612)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,099</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,099</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,359</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,124</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,590</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 30,073</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,766</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,915</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (379)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (718)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,097)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,364</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,054</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,638</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 33,056</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation and impairment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">As of Jan 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,155</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,773</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,320</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 993</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,913</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,100</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (44)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (44)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 586</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,255</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,642</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 13,483</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,473</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,307</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (157)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (217)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (374)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 493</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 493</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 901</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,110</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 11,898</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,909</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,773</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,869</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,948</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 16,590</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,463</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,944</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,740</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,147</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="white-space:pre-wrap;">*     The disposal relates to the sale of a CentoTruck as part of a contract with a COVID-19 customer</span><span style="font-size:10pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="white-space:pre-wrap;">**   The disposal relates to various obsolete plant and machinery equipment mainly in relation to the ramp down of the COVID-19 business segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">*** The reclass from right-of-use assets represents assets purchased at the end of the lease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Group prospectively adjusted the estimated useful lives of COVID-19 related property, plant and equipment to a remaining estimated useful life of eight months, with effect at the beginning of the third quarter 2021 due to management&#8217;s decision to ramp down the COVID-19 business segment. This prospective change in estimate resulted in accelerated depreciation expense of EUR 4,138k for the year ended December 31, 2021. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257105464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Right-of-use assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.79;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><b style="font-weight:bold;">13 Right-of-use assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group has lease contracts for land and buildings and offices in Germany and the United States, as well as various items of plant, machinery, motor vehicles and other equipment used in its operations.  Leases for land and buildings is related to the sale and leaseback transaction of the Rostock headquarters building with a lease term of </span>12 years, while the lease terms of offices in Berlin and Boston, Massachusetts are 12 years and 4 years respectively. Leases of plant and machinery and other equipment generally have lease terms between 2 and 4 years, while motor vehicles generally have lease terms of 3 years<span style="white-space:pre-wrap;">. The Group&#8217;s obligations under its leases are secured by the lessor&#8217;s title to the leased assets. Generally, the Group is restricted from subleasing the leased assets.  In addition, a bank guarantee of EUR </span>3,000k (which is secured by cash deposit of EUR 2,443<span style="white-space:pre-wrap;">k) is required to be maintained for the leases of Rostock headquarters building and Berlin offices until the expiry or termination of the leases.  Leases of certain plant and machineries were also secured with rental deposits of EUR </span>190k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The lease contract of Rostock headquarters building includes extension options.  These options are negotiated by management to provide flexibility in managing the leased-asset portfolio and align with the Group&#8217;s business needs.  The lease of Rostock headquarters building allows the Group to extend the rental contract </span><span style="-sec-ix-hidden:Hidden_iUFcya4OnkmTbsk8Tv6XcQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twice</span></span>, each for a period of 6 years, after the expiration of agreement in September 2031 with rental payments of EUR 1,400<span style="white-space:pre-wrap;">k per annum.  Such extension option was not included in the right-of-use assets and lease liabilities, as it is not reasonably certain that such extension option will be exercised.   </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group also has certain leases of motor vehicles and premises with lease terms of 12 months or less and leases of office equipment with low value. The Group applies the &#8216;short-term lease&#8217; and &#8216;lease of low-value assets&#8217; recognition exemptions for these leases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below are the carrying amounts of right-of-use assets and movements during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Plant&#160;and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Motor</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">In EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Buildings*</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Offices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Vehicles</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of January 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 13,126</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,407</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,989</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 390</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 20</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 24,932</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,840</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reclass to property, plant &amp; equipment**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,992)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,992)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,121)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (657)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,675)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (187)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,660)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 12,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,176</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,587</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,315</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 37</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,120</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 133</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 179</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,452</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reclass to property, plant &amp; equipment**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (672)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (672)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,121)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (970)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,745)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (138)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (22)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,996)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 10,884</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,339</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,291</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,356</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 34</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 18,904</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.79em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">*&#160;&#160;&#160;As the lease of land and buildings are made through one contract, all the related right-of-use assets are allocated to Buildings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">** Reclass of leased assets to PP&amp;E (note 12) represents purchased assets at the end of lease term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below are the carrying amounts of lease liabilities and the movements during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of January 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 21,205</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 21,704</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,452</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,654</p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 865</p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,244)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,018)</p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December 31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 18,997</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 21,205</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,409</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,528</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Non-current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 15,588</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 17,677</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The maturity analysis of lease liabilities is disclosed in note 21.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following are the amounts recognised in profit or loss:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Depreciation expense of right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,996</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,660</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,807</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Interest expenses on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 339</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rent expenses&#8212;short-term leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,175</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 185</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rent expense&#8212;leases of low-value assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Total amounts recognized in profit or loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 11,803</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,253</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 2,356</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Group had total cash outflows for leases of EUR 11,467k in 2021 (2020: EUR 6,746k; 2019: EUR 3,256k). The future cash outflows relating to non-cancellable short-term leases and leases of low-value assets, are disclosed in note 24.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048236887208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Inventories</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">14 Inventories</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Raw materials, consumables and supplies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,831</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,167</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Finished goods and merchandise</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 238</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Inventories</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,869</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 11,405</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Management assessed inventory obsolescence on all COVID-19 related inventories which resulted in an inventory write-off included within cost of sales in the amount of &#8364; 1,795k (2020: nil).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In the&#160;year ended December&#160;31, 2021, raw materials, consumables and changes in inventories of finished goods recorded as expenses under &#8220;cost of sales&#8221; came to EUR 70,089k (2020: EUR&#160;41,594k; 2019:&#160;EUR&#160;11,285k). </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39__IAS02_g36-39_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257092024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other receivables and other assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables and other assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock', window );">Trade and other receivables and other assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">15 Trade and other receivables and other assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:93.5%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets&#8212;Rental deposits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,922</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,867</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets&#8212;Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,972</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,967</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 25,656</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contract assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,543</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,286</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 29,790</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 37,485</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Total non-current and current trade and other receivables and other assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 32,762</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 39,452</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Other non-current assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The non-current portion of other assets mainly include cash deposit of EUR 2,250k, used to secure a bank guarantee of EUR&#160;3,000k, relating to the leases of Rostock headquarters building, cash deposits of EUR 193k, used to secure a bank guarantee of EUR 257k, relating to the leases of Berlin office, cash deposits of EUR 289<span style="white-space:pre-wrap;">k relating to the leases of other offices and laboratories  located in Germany and EUR </span>190k for the leases of certain plant and machineries. It also includes the non-current part of the consideration receivable for the sale of LPC of EUR 50k (see note 8.2). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Trade receivables</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Trade receivables are non-interest bearing and are generally due in <span style="-sec-ix-hidden:Hidden_01i51NYs8kukTb1nNEXfkg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span> to 90 days. In general, portfolio-based expected credit loss allowances are recognized on trade receivables and contract assets (see note&#160;21.2). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Other current assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other current assets include VAT receivables of EUR&#160;253k (2020: EUR&#160;226k), prepaid expenses of EUR&#160;3,346k (2020:&#160;EUR&#160;4,431k), receivables related to exercised share-based payment grants of EUR 116k (2020; EUR 1,253k), receivables related to COVID-19 bank or credit card transactions of EUR 612k (2020: EUR 1,076k), as well as receivables from grants of EUR&#160;Nil (2020:&#160;EUR&#160;442k).<i style="font-style:italic;"> </i></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for trade receivables and contract assets and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257092152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and short-term deposits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and short-term deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash and short-term deposits</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">16 Cash and short-term deposits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Group has pledged its short-term deposits with carrying amount of EUR 938k (2020: EUR 1,500k) and EUR 2,500k (2020: EUR 2,500k) respectively, to fulfil collateral requirements in respect of existing secured bank loan and overdraft facility up to EUR 2,500k. In addition, the Group has pledged its short-term deposits of EUR&#160;1,000k (2020: EUR 1,000k) related to two other overdraft facilities worth EUR 500k <span style="-sec-ix-hidden:Hidden_SQJSZp5xzU-f4eqciOHicg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The restriction applying to the collateral may be terminated at any time subject to the full amount of the relevant bank loans and the overdrafts being repaid.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256328440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Equity</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">17 Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Issued capital and capital reserve</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in thousands of shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Common shares as of Jan 1, fully paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,118</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,861</p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Issued shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 450</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 256</p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Common shares issued as of Dec 31, fully paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,118</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">as&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">as&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in thousands of shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Authorized common shares of EUR 0.12 each</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Common Shares</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2020, the Company completed a follow-on public offering of 3,500,000 common shares of the Company, consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of USD 14.00 per common share (i.e. EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR 22 million to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31 2021, 22,567,971 common shares of Centogene N.V. with a nominal value of EUR 0.12 were issued and fully paid up (2020: 22,117,643). As of December 31, 2021, the authorized, but unissued common share capital amounted to EUR 6,772k (2020: EUR 6,826k).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The holders of common shares are entitled to the Company's approved dividends and other distributions as may be declared from time to time by the Company, and is entitled to vote per share on all matters to be voted at the Company's annual general meetings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Capital reserve</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, capital reserve included a share premium of EUR 106,665k (2020: EUR 107,498k), being amounts paid in by shareholders at the issuance of shares in excess of the par value of the shares issued, net of any transaction costs incurred for the share issuance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The capital reserve consists of the share premium account and amounts recorded in respect of share-based payments. For additional information on the share-based payments, please refer to note&#160;20.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256328440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract', window );"><strong>Capital management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory', window );">Capital management</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">18 Capital management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group's objectives when managing capital are to safeguard the Company's ability to continue as a going concern and finance all necessary sustainable developments, so that it can continue to provide returns for shareholders and benefits for other stakeholders. In particular, care is taken and an optimal capital structure is strived for to reduce the cost of capital. With the IPO in November 2019, follow-on public offering of July 2020, warrant issuance and aggregate debt financing in February 2022, the Group is focused on achieving a healthy capital base to increase the confidence of investors and the capital market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Group manages its capital structure and makes adjustments in light of changes in economic conditions and the risk characteristics of its activities. To maintain or adjust the capital structure, the Group may adjust the return to shareholders, issue new shares, or pay additional interests to reduce debt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257060840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory', window );">Financial liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">19 Financial liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.1</b></span>Interest-bearing loans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non&#8209;current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 401</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current loans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> -</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 401</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,588</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,677</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,588</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 18,078</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current loans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,815</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,492</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,528</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,224</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current and current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,812</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 2021, short-term cash deposits of EUR&#160;938k (2020: EUR 1,500k) were used to secure the remaining bank loan outstanding (see note 16).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table is based on the original terms and conditions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Conditions and statement of liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The outstanding interest-bearing loans as of December&#160;31, 2021 and 2020 have the following conditions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">interest&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Maturity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Secured bank loan</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2.95%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2017&#8209;22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loan</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">USD</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">1%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2020-22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">4.75%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 498</p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">3.75%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,329</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,329</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 628</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 628</p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">4.50%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 412</p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2.1%-3.5%*, 5.4%-9.1%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2017-31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,205</p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total interest</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">bearing financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,812</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,812</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">*&#160;&#160;&#160;&#160;&#160;represents the incremental borrowing rate of the Group at the commencement of the leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The bank overdrafts of EUR 2,329k as of December 31, 2021 (2020: EUR 628k) were secured by short-term deposits with a carrying amount of EUR 2,500k (2020: EUR 2,500<span style="white-space:pre-wrap;">k) (see note 16).  The other bank overdrafts of EUR </span>981k (2020: EUR 910k) are secured over two short-term deposits with a carrying amount of EUR 500k each as at year end December 31, 2021 (see note 16). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.2</b></span>Trade payables and other liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,736</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants (deferred income)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,292</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contract liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,479</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,483</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Trade payables and other liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 40,122</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 59,990</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,028</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,950</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 32,094</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 51,040</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Government grants mainly include investment-related government grants.  These were received for the purchase of certain items of property, plant and equipment for the research and development facilities in Mecklenburg-Western Pomerania, including the Rostock facility. The grants were issued in the form of investment subsidies as part of the joint federal and state program, &#8220;Verbesserung der regionalen Wirtschaftsstruktur&#8221; (improvement of the regional economic structure) in connection with funds from the European Regional Development Fund. Additional grants received during the year ended December 31, 2021 amounted to EUR </span>168k (2020: EUR 390<span style="white-space:pre-wrap;">k).  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition, other liabilities include a provision for outstanding invoices of EUR 4,978k (2020: EUR 1,245k), personnel-related liabilities for vacation and bonuses totaling EUR 4,812k (2020: EUR 4,032k), a VAT payable of EUR 905k (2020: EUR 4,578k), as well as liabilities for wage and church tax of EUR 1,040k (2020: EUR 1,988k). </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237776952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based payments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">20 Share-based payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021 and 2020, the Group had the following share-based payment arrangements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(i)&#160; Virtual share option program 2016 (cash-settled)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On July&#160;<span style="white-space:pre-wrap;">1, 2016, the Group established a virtual share option program (the &#8220;2016 VSOP&#8221;) under Centogene AG. The completion of IPO in November 2019 was defined as one of the &#8220;exit events&#8221; in the 2016 VSOP program.  Accordingly, all options </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">granted under the 2016 VSOP vested immediately in full upon the completion of the IPO. In addition, holders of vested options are entitled to receive a direct cash payment from the Company according to the calculation as stipulated in the program, which is determined based on the IPO price of the shares of Centogene N.V. and the exercise prices of the vested options The payment to the option holders will be reimbursed by the original shareholders of the Company at the same time as the obligation to pay the options holders arises.  Upon the completion of the July 2020 Offering, the relevant payments of EUR </span>2,768k to the holders of vested options were settled by the proceeds received from such original shareholders from the sale of their shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(ii)&#160; 2019 Equity Incentive Plan (2019 Plan) </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In conjunction with the consummation of the IPO, the Company established a new long&#8209;term incentive plan (the &#8220;2019 Plan&#8221;) with the purpose of advancing the interests of our shareholders and other stakeholders by enhancing our ability to attract, retain and motivate individuals who are expected to make important contributions to us. The 2019 Plan governs issuances of equity and equity&#8209;based incentive awards from and after the consummation of the IPO. Awards under the 2019 Plan may be granted to our employees, the members of our management board and supervisory board, consultants or other advisors. As of January 1, 2022 the maximum number of common shares underlying awards that may be granted pursuant to the 2019 Plan (other than replacement awards) will not exceed 22% of the Company&#8217;s issued share capital. Such maximum number will be increased on January&#160;1 of each calendar year, by an additional number of common shares equal to 3% of the Company&#8217;s issued share capital on such date (or a lower number of common shares as determined by the management board or supervisory board, where appropriate on the basis of a recommendation of the compensation committee (as the case may be, as prescribed by the 2019 Plan and, collectively, the &#8220;Committee&#8221;)). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In the event of a good leaver&#8217;s (as defined in the 2019 Plan) termination of employment or service, all vested awards will be exercised or settled in accordance with their terms within a period specified by the Committee and all unvested awards will be cancelled automatically unless decided otherwise by the Committee. In the event of a bad leaver&#8217;s (as defined in the 2019 Plan) termination of employment or service, all vested and unvested awards will be cancelled automatically without compensation.  Pursuant to an amendment to the 2019 Plan applicable to awards granted in the period between September 11, 2020 and November 25, 2020, unless otherwise determined by the Committee, in the event of a good leaver&#8217;s termination of employment or service, all unvested awards will vest in full and all vested awards that have not yet been exercised or settled must be exercised or settled in accordance with their terms within a period specified by the Committee. If those awards are not exercised or settled within such period, they will be cancelled automatically without compensation. This arrangement is applicable to awards granted in the above-mentioned period only (see note 20(v)). </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the event of a change in control of the Company (as defined in the 2019 Plan), outstanding awards that will be substituted or exchanged for equivalent replacement awards, in connection with the change in control will be cancelled. Outstanding rewards that are not substituted or exchanged for equivalent replacement awards, in connection with the change in control will immediately vest and settle in full, unless otherwise decided by the Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The grants disclosed in the following paragraphs were granted under the 2019 Plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(iii)&#160; Equity share option - Replacement (ESOP/ VSOP 2017)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2017, the Group established another virtual share option program (the &#8220;2017 VSOP&#8221;) that entitled the management board to grant virtual share options to individuals, in regard to services they provide and their continuous commitment to the Group.<b style="font-weight:bold;"> </b> As part of the corporate reorganization, in connection with the IPO (see note 1), a transfer agreement was entered into between the holders of options granted under the 2017 VSOP, Centogene AG and the Company in November 2019, according to which, the 2017 VSOP was terminated, and the option holders were instead granted new share options of the Centogene N.V. under the 2019 Plan (as defined and discussed above), determined based on the IPO price of the shares of Centogene N.V. and the number of options granted under the 2017 VSOP. These share options were issued to the holders of options originally granted under 2017 VSOP as part of the corporate reorganization to replace the cash-settled share-based program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The number of options granted to each holder was based on the number of options granted to them under 2017 VSOP and the IPO price of Centogene N.V. Accordingly, during 2019, 805,308 new share options were granted pursuant to the Centogene N.V. 2019 Plan, with each option representing the right to acquire one common share of Centogene N.V., with an exercise price equal to the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">nominal value of a share of Centogene N.V., which is EUR 0.12<span style="white-space:pre-wrap;">.  The options were considered vested upon the completion of the IPO, but were not exercisable in the first </span>180 days after the IPO (lock-up period). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 549,005</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 805,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cancelled during the year </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (191,565)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (256,303)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 357,440</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 549,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 357,440</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 549,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 357,440</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 549,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During 2020, 256,303 options were exercised. The weighted average share price at the date of exercise was USD 12.13<span style="white-space:pre-wrap;">.  During 2021, </span>191,565 options were exercised. The weighted average share price at the date of exercise was USD 9.76.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contractual term of the share options as of December 31, 2021 is eight years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The share options issued under ESOP 2017 are equity-settled and the fair value of the options were recognized in equity under capital reserve on the date of grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></span><b style="font-weight:bold;">Equity share option 2019 (ESOP 2019) to Flemming Ornskov</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">In 2019, an agreement was entered into between the Company and Flemming Ornskov. According to this agreement, a total of </span><span style="font-size:10pt;">396,522</span><span style="font-size:10pt;"> options, each option representing the right to acquire </span><span style="font-size:10pt;">one</span><span style="font-size:10pt;"> common share, were granted pursuant to the 2019 Plan for his services as chairman of the supervisory board, with an exercise price equaling the IPO price, which is EUR </span><span style="font-size:10pt;">12.58</span><span style="font-size:10pt;"> per share, on the date of the IPO of the Company. The vesting period was </span><span style="font-size:10pt;">three years</span><span style="font-size:10pt;"> commencing on March 31, 2019 as the grant date, during which </span><span style="font-size:10pt;">one</span><span style="font-size:10pt;">-third of the granted options would vest at the end of each year of grant.</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contractual term of the share options as of December 31, 2019 was ten years and the weighted average fair value of options outstanding was EUR 9.08<span style="white-space:pre-wrap;">.  The share options issued under &#8220;ESOP 2019&#8221; will be equity-settled and the fair value of the options were recognized in equity under capital reserve, based on the fair value on the date of grant, and will be charged to profit or loss over the vesting period using the graded approach. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On December 18, 2020, in an extraordinary general meeting of shareholders of Centogene N.V., the shareholders approved the grant of 300,000 restricted stock units (&#8220;RSUs&#8221;) to Flemming Ornskov under the 2019 Plan, which replaced the ESOP 2019 and pursuant to which Flemming Ornskov will forfeit the options awarded to him thereunder in exchange for the RSUs granted to him. The RSUs will expire after ten years, will not be subject to any other performance criteria, will have no exercise price and will be settled in shares. With respect to the RSUs granted: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">33%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> will vest immediately;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the remaining </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">67%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> will vest in two equal annual instalments on each relevant anniversary of October 1 following the date of grant; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">will vest in full upon the occurrence of a change in control (as defined in the 2019 Plan), provided that the holder of the awards is an eligible participant (as defined in the 2019 Plan) on the date of such change in control.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP (EUR)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 396,522</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cancelled during the year </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (396,522)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Replacement awards granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 300,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 300,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 200,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 100,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 200,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 100,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The replacement of the ESOP 2019 and the grant of new RSUs of Centogene N.V. was accounted for as modification under IFRS 2. The incremental fair value of EUR 135k has been recorded in the statement of comprehensive income over the vesting period of the replacement grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(v)&#160;2020 grants to management board and employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On September 11, 2020, the Supervisory Board granted members of the management board the following options and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">RSUs under the 2019 Plan:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:35.45pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.45pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to the Company&#8217;s former CEO Arndt Rolfs: 36,175 Options and 72,350 RSUs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:35.45pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.45pt;padding:0pt;">b.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to the Company&#8217;s former CFO Richard Stoffelen: 16,250 Options and 32,250 RSUs; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:35.3pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.3pt;padding:0pt;">c.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to the Company&#8217;s CIO Volkmar Weckesser: 15,000 Options and 30,000 RSUs.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On September 11, 2020, the management board granted 87,500 options and 75,000 RSUs to other key current and former executive officers under the 2019 Plan. On October 15, 2020, 251,500 RSUs were granted to employees, subject to the terms of the 2019 Plan, the applicable award agreement and the terms specified in the authorization from the Supervisory Board for this purpose. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Apart from one award that immediately vested in full on the grant date and another award that vests in three equal tranches on each anniversary of its date of first employment, all other awards referred to above will vest in three equal tranches from January 1 following the grant date, in accordance with the following vesting schedule:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">i.</span></span><span style="-sec-ix-hidden:Hidden_Di3UQRQ2MUWSk55FplrgzQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> third of the award vests on January 1, 2021;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ii.</span></span><span style="-sec-ix-hidden:Hidden_lq4xIkppPkuJR_e8mjx1ZA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> third of the award vests on January 1, 2022; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">iii.</span></span><span style="-sec-ix-hidden:Hidden_EQTkAO2Ni02-Mndxnfpk_A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> third of the award vests on January 1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All of the foregoing awards vest in full when the participant is considered to be a good leaver within the meaning of the 2019 Plan effective as of grant date, as discussed in note 20(ii). As a result, unrecognized costs related to any unvested part of the award of a good leaver will result in accelerated recognition of these unrecognized costs in the statement of comprehensive income in the period when the employment contract has been terminated. Furthermore, all of the foregoing awards vest upon the occurrence of a change of control as defined by the 2019 Plan, unless the holder is no longer eligible to participate in the 2019 Plan at that time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The options referred to above vest only if the 20 trading day volume-weighted average stock price of the Company&#8217;s shares preceding the vesting date of each tranche exceeds the exercise price of USD 11.60. This hurdle is considered a market condition. Therefore, expenses would not be reversed, if the tranches do not ultimately vest. As the <span style="-sec-ix-hidden:Hidden_2x0a_zAG40CpBOwHDJxpzQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading day volume-weighted average stock price did not exceed the exercise price as of January 1, 2022, the second tranche did not vest on January 1, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(vi)&#160; 2021 grants to management board and employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended December 31, 2021 the following awards were granted under 2019 Plan:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"><tr style="height:1pt;"><td style="vertical-align:top;width:10.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:16.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Award Type (2019 Plan)</b></p></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Market/ Performance Based</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Vesting Conditions</b></p></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Number of Awards</b></p></td><td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Vesting Conditions</b></p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration Date</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 95,499</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Four equal tranches over a four-year period, starting January 1, 2022, April 1, 2022 or on each anniversary of the grant date</p></td><td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_j7I3SlyuWU6KYGVcxzrMkg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 30,000</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Three equal tranches over a three-year period starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_YStt1HXTrUSZGYMRD2aLHg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 15,000</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Three equal tranches of which the first tranche vested immediately and the two remaining annual tranches will vest starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_YVS6AVoIeUKeeejiDsF3JA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 22,936</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Four equal tranches over a four-year period, starting October 1, 2022 on each anniversary of the grant date</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_AdWcPoKHd0iDW7odOEhQgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Options</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Yes</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 15,000</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Three equal tranches over a three-year period starting January 1, 2022</p></td><td style="vertical-align:bottom;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_HW0l6QwPxEehXDxtNMXdTA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 3,891</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Four equal tranches over a four-year period starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_y1wywXdbVUOTeWK6mrdN-A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The grant date fair value of these grants will be recognized in profit or loss over the service period by using the graded approach. 15,000 of the options referred to above vest only if the 20 trading day volume-weighted average stock price of the Company&#8217;s shares preceding the vesting date of each tranche exceeds the exercise price of US$ 12.52. This hurdle is considered a market condition. Therefore, expenses would not be reversed, if the tranches do not ultimately vest. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The RSUs referred to above have no performance-based vesting criteria. Each RSU represents a right to receive a payment in cash or shares equal to the value of the RSU at the exercise date. The Company has a choice to settle either in cash, in shares or a combination thereof. In line with this policy, both types of awards are to be settled in shares and expire on the <span style="-sec-ix-hidden:Hidden_YZDLiCDl6EqhXBUv-LZuNw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10</span></span>th anniversary of the grant date. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(vii)&#160; 2020 grants to Dr. Andrin Oswald</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In 2020, the Company and Mr. Oswald entered into an award agreement under the 2019 Plan pursuant to which Mr. Oswald will receive certain awards in the form of RSUs. According to the award agreement, a total of 324,000 RSUs were granted on December 1, 2020, subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF 1,000k after the grant date, which will vest in four equal annual installments following December 1, 2020, subject to Mr. Oswald&#8217;s continued services with the Company and continued ownership of the a number of shares equal or higher than the number of purchased shares. On September 5, 2021 the Supervisory Board approved an amendment to this agreement. Under the amended award agreement, the RSUs vest in 14 equal quarterly installments following July 30, 2021 with final vesting date on December 1, 2024, subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF 1,000k by June 30, 2022, and Mr. Oswald&#8217;s continued services with the Company. Further, the RSUs will vest pro rata to the number of shares actually purchased up to the full investment amount of CHF 1,000k on each quarterly installment prior to the share purchase deadline and are subject to the continued ownership of a number of shares equal or higher than the pro rata number of shares actually purchased on each applicable vesting date or share purchase deadline. The amendment did not result in incremental fair value of the award. The grant date fair value shall be recognized in the statement of comprehensive loss over the remaining vesting period based on the modified vesting schedule using the graded approach<span style="font-style:italic;font-weight:bold;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The RSUs referred to above have no performance-based vesting criteria. RSUs represent a right to receive a payment equal to the value of the RSU at the exercise date. All the RSUs will vest in four equal annual installments following the grant date, subject to </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mr. Oswald&#8217;s continued service with the Company as of the vesting date and will be charged to profit or loss over the period by using the graded approach.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additionally, a total of 500,000 performance-based vesting RSUs were granted to Mr. Oswald on December 1, 2020, subject to the following conditions:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">1.</span>200,000 RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD 24 in any consecutive three month period prior to January 1, 2023 (for these RSUs, the &#8220;initial vesting date&#8221;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">2.</span>300,000 RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD 33 in any consecutive three month period prior to January 1, 2024 (for these RSUs, the &#8220;initial vesting date&#8221;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.</div><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The hurdle to the performance-vesting RSUs is considered a market condition. Therefore, expenses would not be reversed, if the market condition is not met. All the performance-vesting RSUs will vest in four equal annual installments following the relevant initial vesting date, if the applicable performance hurdles are met, and subject to Mr. Oswald&#8217;s continued service with the Company as of the vesting date and will be charged to profit or loss over the vesting period using the graded approach. If Mr. Oswald&#8217;s service with the Company terminates for any reason, any unvested RSUs will immediately be forfeited. The foregoing awards that have been granted vest in full upon the occurrence of a change in control as defined in the agreement, provided that Mr. Oswald is still eligible to participate in the 2019 Plan and in continuous service with the Company through the date of such change in control (see &#8220;Note 27</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Subsequent Developments&#8221; of our consolidated financial statements as of and for the year ended December 31, 2021).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#0000ff;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contractual term of the RSUs is ten years from the respective grant dates. The RSUs issued are equity-settled. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(viii)&#160; 2021 and 2020 supervisory board grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In connection to the IPO 10,000 Share Options have been granted as an extraordinary incentive to Mr. Berndt Modig as approved in the Annual General Meeting on June 24<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">, </sup>2021. The Options have a strike price of USD 14 and getting vested in four equal installments following the grant date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In 2020, an agreement was entered into between the Company and Peer Schatz, as member of our supervisory board. According to this agreement, a total of 300,000 RSUs were granted pursuant to the 2019 Plan to Mr. Schatz. The RSUs will vest in four equal annual instalments on each relevant anniversary of November 25, 2020. The grant was approved in the Company&#8217;s extraordinary general meeting of shareholders on December 18, 2020. The contractual term of the RSUs is ten years from grant date. The RSUs are not subject to performance criteria and will be settled in shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the same extraordinary general meeting of shareholders on December 18, 2020, shareholders also approved a new incentive compensation scheme for supervisory board members, under which certain members of the supervisory board will annually receive an award of options and RSUs for ordinary shares of the Company under the 2019 Plan with a target value of EUR 80,000 multiplied by the LTI factor. For each award, RSUs will constitute 75% of the value of the award while options will constitute the remaining 25% of the value of the award. The LTI factor will be 100% or less based on the volume-weighted average stock price of the shares over a 60 trading day period preceding December 31 of the relevant financial year. Furthermore, the chairman and vice-chairman of the supervisory board will each annually receive an additional award with a value of EUR 60,000 and EUR 40,000, respectively, multiplied by the LTI factor as of the financial year 2023; the chairman of the audit committee and the chairman of the compensation committee will each annually receive an additional award with a value of EUR 40,000 and EUR 8,000, respectively, multiplied by the LTI factor. The awards will be granted retrospectively for the preceding financial year following the audit of the Company&#8217;s annual accounts over such financial year, with the first annual awards to be granted in 2021 (in respect of the 2020 financial year). The awards will vest in four equal annual instalments on each relevant anniversary of the grant date, will expire on the ten-year anniversary of the grant date and are not subject to any performance criteria. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The options and RSU awards referred above have a service commencement date of December 18, 2020, based on when the understanding was reached between the Company and the holders regarding the required services to contribute to the achievement of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">the long-term incentive targets. However, the grant date criteria for these awards will be met at each future annual grant date, upon the approval of the audited annual accounts, at such time when the terms and value of the awards to be granted become fixed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The foregoing awards are equity-settled and will vest in full upon the occurrence of a change in control as defined in the agreement, unless the holder is no longer eligible to participate in the plan at that time. The awards will be charged to profit or loss over the service period using the graded approach, pursuant to the equal annual vesting instalments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Additionally, in connection to this plan, Mr. Modig was granted 9,427 RSUs and 4,713 Share Options and Mr. Sheldon was granted 878 RSUs and 439 Share Options in 2021. The Options have a strike price of USD 9.92.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The awards will vest in four equal annual instalments on each relevant anniversary of the grant date and will vest in full upon a change in control of the Company (provided that the holder remains an eligible participant on the date of the change in control). The awards will expire on the ten-year anniversary of the grant date, are not subject to any performance criteria and will be settled in shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Valuation of Options</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Virtual share option program 2016 and 2017</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The fair values of the 2016 VSOP upon its exercise and 2017 VSOP upon its cancellation in 2019 were based on the cash payments to which the holders of the virtual options are entitled, which were calculated according to the formulae as stipulated in the respective programs.  The cash payment is with reference to the share price of Centogene N.V. at the date of IPO.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Equity share option 2017 and Equity share option 2019</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The fair values of ESOP 2017 and ESOP 2019 were estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions under which the share options were granted.  The model takes into account historical and expected dividends, and the share price volatility of other public companies in the relevant industries to predict the share performance.  There are no cash settlement alternatives for either the option holders or the Company.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The key assumptions used to derive the option value are set out below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ESOP 2017</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ESOP 2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price (EUR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share price at grant date (EUR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.7)</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Option term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Valuation of 2020 grants </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The fair value of the replacement awards granted to Flemming Ornskov under the 2019 Plan and the awards granted to other participants under the 2019 Plan in 2020 were estimated at the grant date. The fair value of the standard RSUs (i.e., those without performance-based vesting criteria) is based on the observed value of the underlying shares. As no dividend payments are expected over the vesting period, no further adjustment is required. The weighted average fair value of standard RSUs granted under the 2019 Plan during the year ended December 31, 2020 was USD 11.62.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The fair value of the ESOP 2019 replacement was estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions on which the options were granted. The fair value of the options and performance-based RSUs as of the grant date was determined using a Monte Carlo simulation model. The Monte Carlo simulation model utilizes </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">multiple input variables to estimate the probability that market conditions will be achieved. The key assumptions used to derive the option and performance-based RSUs value and the weighted average fair value are set out below: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:37.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 Fair Value assumptions</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ESOP 2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Performance</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Replacement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Based RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">n/a</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price at grant date (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11.05</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12.54</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 88</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0.2-0.3</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0 </p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected contractual life (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">12.08-13.08</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average fair value (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8.23</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Valuation of 2021 grants </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The fair value of the options granted to the Mr. Modig and Mr. Sheldon  was estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions on which the options were granted. In addition to that the fair value of the options granted to the Mr. Kim  was estimated at the date of modification also using the Black-Scholes option pricing model. The awards granted to participants under the 2019 Plan in 2021 were estimated at the grant date. The fair value of the standard RSUs (i.e., those without performance-based vesting criteria) is based on the observed value of the underlying shares. As no dividend payments are expected over the vesting period, no further adjustment is required. The weighted average fair value of standard RSUs granted under the 2019 Plan during the year ended December 31, 2021 was USD </span>10.96. The key assumptions used to derive the option and performance-based RSUs value and the weighted average fair value are set out below: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:43.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021 Fair Value assumptions</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Add. Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Modig and </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Modig</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Kim</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019 Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr.Sheldon</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.92</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.52</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price at grant date (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.54</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.9</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected contractual life (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average fair value (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.36</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The expense recognized for the above share-based payment transactions during the year is shown in the following table: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expenses arising from cash-settled share-based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,714</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- 2016 VSOP</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 596</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- 2017 VSOP (2019: including modification gain)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,118</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expenses arising from equity-settled share-based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,035</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,658</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 704</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- ESOP 2019, including replacement by RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 704</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Grants to management board and employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,217</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Grants to the CEO</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 269</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Supervisory board grant</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total expenses arising from share</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">based payment transactions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 8,035</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 5,658</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,418</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 44<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257094232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - fair values and risk management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Financial instruments-fair values and risk management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial instruments-fair values and risk management</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Financial instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">21 Financial instruments-fair values and risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.1</b></span>Classifications and fair values</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The carrying values of the Group&#8217;s financial assets and financial liabilities approximate their fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.2</b></span>Financial risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group is exposed to the following risks from the use of financial instruments:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Credit risk</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Liquidity risk</i></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Currency risk</i></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss.  The Group is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities, including deposits with banks and financial institutions and foreign exchange transactions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The carrying amount of the financial assets corresponds to the maximum default risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Trade receivables and contract assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group utilizes a receivables management system that closely manages open items of major customers. The Group&#8217;s customers in the pharmaceutical segment are mainly pharmaceutical companies which are usually listed companies, or strongly financed by private equity funds. The Group&#8217;s customers in the diagnostics segment are mainly hospitals, labs and physicians, of which a large part are generating revenues. To avoid default, the Company may request prepayment for new business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to the macroeconomic situation generally, the development of international healthcare markets is a key economic factor in assessing the default risk related to trade receivables and contract assets. These markets are closely monitored by the Group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on&#160;days past due for groupings of various customer segments with similar loss patterns (i.e.&#160;by customers from different segment; customers from different geographical region and customer type). The calculation reflects the probability weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. The maximum exposure to credit risk at the reporting date is the carrying value of each class of financial assets disclosed in note&#160;15. The Group does not hold collateral as security and does not request letters of credit or other forms of credit insurance. The Group evaluates the concentration of risk with respect to trade receivables and contract assets and recorded credit losses reflecting the expected lifetime loss, based on different types of customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Considering the major exposure to the credit risk arising from the diagnostics segment, the Group focused its impairment analysis on the trade receivables due from customers in the diagnostic segment, in particular the MENA and Europe regions as they represent the majority of that segment&#8217;s revenue. In addition to applying the provision matrix, the Group performed an individual customer analysis on major debtors, with reference to the past history (such as sales and collection in the previous periods) and the assessment of their current financial condition and other relevant factors and evaluated if additional specific impairment losses would be necessary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below is the information regarding the credit risk exposure of the Group&#8217;s trade receivables and contract assets using a provision matrix.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;by</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;1&#160;-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;31</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;"> 90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">more&#160;than&#160;90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not&#160;past&#160;due</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">30&#160;days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,013</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,771</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 351</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 259</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 531</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,562</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 203</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 943</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 115</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 30,054</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 17,978</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,475</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 2,596</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 8,004</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 0.9</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 7.7</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 11.7</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 64.1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 5,717</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 167</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 114</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 304</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 5,132</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;by</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;1&#160;-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;31</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;"> 90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">more&#160;than&#160;90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not&#160;past&#160;due</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">30&#160;days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,338</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,306</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,193</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 706</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,870</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 994</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 262</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 178</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 33,967</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 24,185</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 2,228</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,757</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 14.0</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1.6</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3.1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 7.7</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 63.0</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,768</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 70</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 61</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,255</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Overdue trade receivables from the Middle East region mainly relate to major customers from the diagnostics segment. The trade receivables due from the top 10 diagnostics customers in the MENA region as of December&#160;31, 2021 represent over 80% of total overdue balances for this region. These customers are mainly government hospitals administered by the Ministry of Health in the respective countries as well as distributors and, based on our past experience, these customers normally require a longer period to settle outstanding trade receivables. The average turnover period from these customers are 278 days. Therefore, a higher country specific loss rate has been used for the MENA region. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Set out below is the movement in the allowance for expected credit losses of trade receivables and contract assets:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of January 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,768</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,355</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for expected credit losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 956</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,879</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Derecognition of trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,466)</p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,717</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,768</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The addition to the allowance for expected credit losses includes an amount of EUR </span><span style="font-style:normal;font-weight:normal;">949</span><span style="font-style:normal;font-weight:normal;">k which was included in the impairment of financial assets in the profit and loss account. In 2021, trade receivables of EUR </span><span style="font-style:normal;font-weight:normal;">7</span><span style="font-style:normal;font-weight:normal;">k (2020: EUR </span><span style="font-style:normal;font-weight:normal;">1,466</span><span style="font-style:normal;font-weight:normal;">k) were outstanding for more than 365 days and were derecognized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of December 31, 2021, the Group held cash and cash equivalents of EUR 17,818k (2020: EUR 48,156k). This total, therefore, also represents the maximum default risk with regard to these assets. The cash and cash equivalents are deposited principally with financial institutions with investment grade credit ratings. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidity risk </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The liquidity risk is the risk of the Group possibly not being in a position to meet its financial liabilities as contractually agreed by providing cash or other financial assets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group's objective is to maintain a balance between continuity of funding and flexibility through the use of bank overdrafts and lease contracts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Managing liquidity within the Group is intended to ensure that - as far as possible - sufficient cash and cash equivalents are always available to meet payment obligations when these fall due, in both normal and challenging conditions, without incurring unacceptable losses or damaging the Group&#8217;s reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group strives to maintain cash and cash equivalents at a level above that of the expected cash outflows for financial liabilities (apart from trade payables) during the next 60 days. As of December 31, 2021, 30.7% of the Group&#8217;s interest-bearing liabilities mature in less than one year (2020: 25.0%) based on the carrying value of borrowings reflected in the financial statements. As of December 31, 2021, the expected cash inflows from trade and other receivables within two months amounts to EUR 6,418k (2020: EUR 14,857k), which would be EUR&#160;4,834k lower than the amount of trade payables due as of then.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company completed the IPO in November 2019. In July 2020, the Company completed a follow-on public offering of 3,500,000 common shares of the Company, consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of USD 14.00 per common share (i.e. EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR 22 million to the Company. As of December 31, 2021, the Group had cash and cash equivalent of EUR 17,818k (2020: EUR 48,156<span style="white-space:pre-wrap;">k). The cash and cash equivalents are deposited principally with financial institutions with investment grade credit ratings.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to the cash and cash equivalent available as of December 31, 2021, the Group also has access to other sources of funding. As of December 31, 2021, the Group has secured credit lines totaling EUR 3,500k. These bear interest of 3.75% - 4.75% (2020: EUR 3,500k; 3.75% - 4.75%). EUR 3,310k were utilized as of December 31, 2021 (2020: EUR 1,538k).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below presents the remaining contractual terms of the financial liabilities on the reporting date, including estimated interest payments. The figures are undiscounted gross amounts, including estimated interest payments and interest on undrawn loan funds, but without showing the impact of offsetting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractually&#160;agreed&#160;cash&#160;flows</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">More</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Less than</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2 to 12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">1 to 5</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">than</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2&#160;months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">5&#160;years</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 22,050</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 716</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 9,038</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,893</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 34,064</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 37,117</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 15,383</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 3,803</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 9,038</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 8,893</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractually&#160;agreed&#160;cash&#160;flows</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">More</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Less than</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2 to 12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">1 to 5</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">than</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2&#160;months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">5&#160;years</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 394</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 394</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,897</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 716</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,580</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,740</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,525</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,011</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 514</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 55,834</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 59,351</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 33,270</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,072</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 10,269</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 10,740</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Reconciliation of liabilities arising from financing activities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-cash changes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Jan 1, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flows</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">maturity and FX</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;">18,078</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (401)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 865</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,954)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,588</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (401)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,954)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,588</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,802)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,438</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,567</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,223</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (62)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (387)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 267</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,310</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,245)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,171</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,954</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,408</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (3,203)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,303</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (387)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,811</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-cash changes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flows</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">maturity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;">19,647</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (1,993)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,029</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (1,605)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 18,078</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (567)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 401</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Municipal loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (610)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,069</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,383)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,038)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,677</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,323</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,520)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,663</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,554</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,020</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 802</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (865)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,636</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,208)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Municipal loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,635</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,635)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,038</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,528</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 26,970</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,513)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,692</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (51)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Currency risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group is exposed to currency risk in cases where contracts are concluded in foreign currencies. The vast majority of goods delivered and services the Company provided, including those for international customers, are invoiced in euro.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The main functional currencies of group companies are the euro, USD, the Indian rupee and the Arab Emirates Dirham. The following table presents the net foreign currency exposure of the Group as of December&#160;31, 2021 and 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">INR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">AED</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,604</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables and other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net exposure</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 210</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AED</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables and other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,631)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (55)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (17)</p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net exposure</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (2,407)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (37)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (17)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sensitivity analysis relating to changes in exchange rates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Given the exposure to foreign currencies as presented above, the impact to the Group&#8217;s earnings before tax or equity from a 10% change in the US dollar exchange rate would not be material.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048236882280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>List of subsidiaries<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">List of subsidiaries</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">22 List of subsidiaries</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The major subsidiaries of the Group are listed below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity&#160;interests&#160;(%)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Country&#160;in&#160;which</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">primary&#160;activities&#160;are</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">pursued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene GmbH*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene FZ-LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Arab Emirates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene US, LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USA</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene&#160;GmbH</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Austria</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 90</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene India Pvt.&#160;Ltd**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">India</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene Switzerland AG</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Switzerland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centosafe B.V.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Netherlands</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene d.o.o Belgrade</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Serbia</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Bauer Laboratoriums GmbH***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">(*)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Centogene IP GmbH and Centogene Shared Service GmbH were merged with Centogene GmbH on January 1, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">(**)</span></span>The Group acquired the remaining 49% of Centogene India Pvt. Ltd. in 2020, previously accounted for as non-controlling interest.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(***)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Centogene does not own any shares in Dr. Bauer Laboratoriums GmbH. However, Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns (see note 4). </span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257006056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-controlling interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NonControllingInterestsAbstract', window );"><strong>Non-controlling interests.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory', window );">Non-controlling interests</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">23 Non-controlling interests </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below shows information on each subsidiary of the Group with material, non-controlling interests before intercompany eliminations. The Group acquired the remaining 49% of Centogene India Pvt. Ltd in 2020 and disposed of its entire 51% interest in LPC GmbH in 2020. The non-controlling interest in Dr. Bauer Laboratoriums GmbH relates to the share in the net result of Dr. Bauer Laboratoriums GmbH that is included in the results of the Company&#8217;s COVID-19 testing business (see note 4).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Centogene GmbH, Vienna</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dr. Bauer Laboratoriums GmbH</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net assets/(liabilities)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (528)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 245</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Carrying amount of non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">109,015 </p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profit/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 98</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profit/loss allocated to non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 98</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Centogene GmbH, Vienna</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dr. Bauer Laboratoriums GmbH</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net assets/(liabilities)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (522)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 148</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Carrying amount of non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (52)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">55,596 </p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Profit/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Profit/loss allocated to non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NonControllingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NonControllingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257056200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfCommitmentsAbstract', window );"><strong>Commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsExplanatory', window );">Commitments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">24 Commitments<span style="font-style:italic;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Future payments for non-cancellable leases</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Group has various lease contracts in relation to the expansion of the Rostock headquarters and leasing of the Frankfurt laboratory, Berlin Airport, D&#252;sseldorf Airport, Frankfurt Airport and additional laboratory space in Hamburg. The future lease payments and utilities for these non-cancellable lease contracts are EUR </span><span style="font-weight:normal;">107</span><span style="font-weight:normal;">k within one year, EUR </span><span style="font-weight:normal;">2,370</span><span style="font-weight:normal;">k within five years and EUR </span><span style="font-weight:normal;">4,219</span><span style="font-weight:normal;">k thereafter (2020: EUR </span><span style="font-weight:normal;">283</span><span style="font-weight:normal;">k within one year, EUR </span><span style="font-weight:normal;">1,686</span><span style="font-weight:normal;">k within five years and EUR </span><span style="font-weight:normal;">4,855</span><span style="font-weight:normal;">k thereafter).</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Group has various non-cancellable lease contracts of office equipment and storage spaces which had a lease term of less than 12 months or were related to leases of low-value assets, and therefore the short-term lease recognition exemption was applied to these contracts. The future lease payments for these non-cancellable lease contracts are EUR </span><span style="font-weight:normal;">44</span><span style="font-weight:normal;">k within one year (2020: EUR </span><span style="font-weight:normal;">33</span><span style="font-weight:normal;">k) and EUR </span><span style="font-weight:normal;">49</span><span style="font-weight:normal;">k within five years (2020: EUR </span><span style="font-weight:normal;">9</span><span style="font-weight:normal;">k). </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Future payment obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During 2021, the Group concluded agreements with suppliers, for goods and services to be provided in 2022 with a total payment obligation of EUR&#160;6,620k (2020: EUR&#160;4,669k).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256741656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">25 Related parties </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Transaction with shareholders </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July&#160;2020, we completed a follow-on public offering of 3,500,000 common shares of the Company (the &#8220;Follow-on Equity Offering&#8221;), consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of $14.00 per common share (i.e., EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, to the Company were EUR 22 million. We are not aware of any ordinary shares which were issued by the Company and sold in this transaction to related parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on a shareholder agreement from January 2016 the payment to the option holders of the VSOP 2016 will be reimbursed by the original shareholders to the Company at the same time when the obligation to pay the options holders arises. The payables by the Group to the holders of vested options were recorded as a liability with a carrying value of EUR 2,769k as of December 31, 2019 and a corresponding receivable against shareholders was recorded (see note 15). The shareholders agreement had a term until December 31, 2023. Upon completion of the July 2020 Offering, the relevant payables to the holders of vested options were settled mainly by the proceeds received from such original shareholders from the sale of their shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During 2020, the Company entered into a service contract with the former CEO, a major shareholder, to serve as an advisor during the transition period after his departure from the Company until December 31, 2020. For the year ended December 31, 2020, fees totaling EUR 11k were charged to profit or loss related to these services and the Group had payables of EUR 12k outstanding as of December 31, 2020. In 2021, no further service agreement have been entered into. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Remuneration of management in key positions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Key management have been defined as the members of the management board and the Company&#8217;s other key executive officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:75.22%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short&#8209;term employee benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,273</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,313</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Post&#8209;employment pension and medical benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Termination benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 565</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 822</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,822</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,395</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation to key management</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,178</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,683</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,718</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Due to the departure of the former CEO Arndt Rolfs in 2020, share-based payments include additional share-based expenses of EUR 776k for the accelerated vesting of outstanding equity awards and termination benefits include the severance payout of EUR 565k. As of December 31, 2020, the Group had amounts of EUR 1,325k (2019: EUR 769k) accrued for key management compensation. (See &#8220;Note 27 &#8211; Subsequent Developments&#8221; of our consolidated financial statements as of and for the year ended December 31, 2021.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">There are no pension commitments for members of the management board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During 2021, 15,000 share options and 142,764 RSUs were granted under the 2019 Plan to key management personnel which are recognized as share-based payment expenses in profit and loss (see notes 20(vi)).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Group has receivables of EUR Nil (2020: EUR 561k) recognized related to the exercise of options by key management personnel, including the former CEO Arndt Rolfs in 2000 who was a member of key management during the periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Remuneration of members of the Supervisory Board</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The supervisory board received remuneration for its activities of EUR&#160;688k in the reporting year (2020: EUR 603k; 2019: EUR 499<span style="white-space:pre-wrap;">k).  In addition, as disclosed in note 20, certain members of the supervisory board received share-based awards under the 2019 Plan. For the year ended December 31, 2021, share-based payment expenses of EUR&#160;</span>2,564k (2020: EUR 2172k, 2019: EUR 704k) related to these awards were charged to profit and loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Transactions with members of management in key positions and other related parties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company purchased supplies used for COVID-19 testing from an entity related to a member of the supervisory board that joined the board in 2021. Expenses totaling EUR 5 thousand were charged to profit and loss related to the period of service of the board member. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2021, revenues totaling EUR 14 thousand were recognized in profit and loss in relation performance of COVID-19 testing services for entities related to members of the supervisory board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For the year ended December 31, 2021, fees totaling EUR nil (2020: EUR&#160;nil; 2019: EUR&#160;152k) were charged to profit or loss in relation to consulting services provided by a member of the supervisory board. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256742104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract', window );"><strong>Contingent Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory', window );">Contingent Liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">26 Contingent liabilities </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In May 2016, the Company was informed in writing by the Universitair Medisch Centrum Utrecht ("UMCU") that a claim had been initiated against UMCU regarding a prenatal diagnostic test that the Company conducted at their request which failed to identify a specific mutation present in a patient. On October 1, 2018, the UMCU and Neon Underwriting Limited formally filed a legal claim in the local court in Rostock, Germany against the Company alleging that the Company&#8217;s negligence in performing the test resulted in the misdiagnosis of the patient. UMCU is seeking recovery for compensatory damages as a result of the alleged misdiagnosis. By court order of November 8, 2018, the Regional Court of Rostock set the amount in dispute at EUR&#160;880k.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On November 12, 2018, the Company submitted a notice to the Regional Court of Rostock of the intention to defend against the claim. On January 3, 2019, the Company filed a motion to dismiss in which the Company denied the merits of the claim. UMCU and Neon Underwriting Limited responded to this motion on March 15, 2019 with a statement of reply, and the parties made several court filings setting out their arguments since. By order dated June 3, 2019, the Regional Court of Rostock provided a first set of questions to be answered by an expert witness. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2020, the amount in dispute was EUR 1.3 million. The matter was assigned to a new judge, due to the illness of the prior judge, and the decision to appoint the recommended expert witness is still pending. Since then, several potential experts were approached by the court but eventually declined to prepare an expert witness report due to the possibility of bias. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company intends to continue to rigorously defend its position and considers that it is not probable the legal claim towards the Company will be successful and as a result has not recognized a provision for this claim as of December 31, 2021. In addition, in case a settlement would be required, the Company believes that the corresponding liability will be fully covered by the respective existing insurance policies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On August 7, 2021, our partnering laboratory physician and a key executive officer of ours, Prof. Dr. Peter Bauer was informed in writing by the Public Prosecutor's Office in Fulda that a criminal investigation had been initiated against him regarding allegedly falsely billing statements submitted to the Association of Statutory Health Insurance Physicians in Hessen (Kassen&#228;rztliche Vereinigung Hessen). The aggregate amount in question was EUR 42,268.50. The investigation and claims were subsequently dropped in January 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Certain of our original shareholders agreed to reimburse us for the payments that we make to option holders under the 2016 Plan. Upon completion of the Follow-on Equity Offering, the relevant payables to the holders of vested options were settled mainly by the proceeds received from such original shareholders from the sale of their shares in the Follow-on Equity Offering. We have received a demand from one such original shareholder that alleges that it should have paid less to us in connection with the settlement of such payables. While we continue to believe that such demand has little chance of being successfully enforced through legal proceedings, we see the benefit of settling this pending issue. We have therefore agreed to a settlement agreement with the relevant shareholders pursuant to which we will make a one-time-payment in the total amount of EUR 550,000 to be divided up between such shareholders. On November 22, 2021, we signed a settlement agreement with the relevant shareholders. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 86<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_86&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257058584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory', window );">Subsequent Events</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">27 Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 31, 2022, pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors, the Group received EUR 15.0 million in exchange for the issuance of an aggregate of 4,479,088 common shares at a price per share of USD 3.73 (EUR 3.35) and warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026. Based on the fair value per share at the issuance date, the Group expects to recognize USD 3.2 million (EUR 2.8 million) under equity in the first quarter of the financial&#160;year 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition on January 31, 2022, the Company and certain of its subsidiaries entered into the Loan Facility, providing for debt financing agreement in the total amount of up to USD 45.0 million (EUR 40.2 million). Under the terms the Loan Facility, the Group drew down USD 25.0 million (EUR 22.3 million) on January 31, 2022 and will have access to a second tranche of USD 20.0 million (EUR 17.9 million) upon achievement, prior to July 31, 2023, of product revenue from our diagnostics and pharmaceutical services segments of at least USD 50.0 million (EUR 44.7 million) calculated on a trailing twelve month basis as of the last day of any fiscal month. As security for the Borrowers&#8217;s obligations under the Loan Facility, the Borrowers granted the lenders thereunder a first priority security interest on all of each Borrowers&#8217; assets. Refer to note 2.2 Going concern for further details of the Loan Facility.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On February 1, 2022, the Group announced the resignation of Dr. Andrin Oswald as CEO, effective immediately, due to his prolonged medical leave. According to his separation agreement, all unvested RSUs held by Mr. Oswald under the Company&#8217;s LTIP will continue to vest in accordance with their terms through the date of his termination on April 30, 2022, however; the number of RSUs shall not exceed 62,284 RSUs. As a result, unvested RSUs granted to Mr. Oswald shall be forfeited as of January 31, 2022 when Mr. Oswald stopped rendering services for the Group. Total RSUs in the amount of EUR 1,358k that was recognized in the financial statements in the previous periods will be derecognized in 2022 financial year and additional RSUs in the amount of EUR 201k will be recognized in 2022 financial statements to match 62,284 RSUs granted to Mr. Oswald.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On February 1, 2022, Kim Stratton was appointed as the new CEO (the &#8220;New CEO&#8221;). The New CEO and the Company entered into an award agreement pursuant to which the New CEO will receive certain RSUs, which have no exercise price. According to the agreement, the RSUs are awarded in two forms as&#160;&#160;174,394&#160;&#160;&#160;initial performance RSUs subject to time-vesting and performance vesting and 166,667 initial time-vested RSUs subject to only time-vesting. Both awards vest in four equal installments after the grant date and have a grant date of February 1, 2022 and expiration date of February 1, 2032.&#160;However; initial performance RSUs that have not performance-vested by January 1, 2024 expire on January 2, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On February 7, 2022, the Company announced the resignation&#160;of Ren&#233; Just as CFO effective March 31, 2022. According to the separation agreement signed on the same date, all vested RSUs held by the Mr. Just as of March 31, 2022 that have not yet been exercised and settled must be exercised and settled in accordance with their terms within six months following this date and, if such RSUs are not exercised and settled within such period, they will be cancelled automatically upon the expiry of such six-month period without compensation for the loss of such RSUs. All unvested RSUs as of March 31, 2022 will be cancelled automatically without compensation for the loss of such RSUs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 7, 2022, Jose Miguel Coego Rios was appointed as Executive Vice President of Finance &amp; Legal and Interim CFO (&#8220;Interim CFO&#8221;). The Interim CFO was awarded 30,995 RSUs vesting in four equal tranches from January 1 following the grant date of February 2, 2022. The award is not subject to any performance criteria and vested tranches may be exercised at the option of the Interim CFO and will be settled in shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">In February 2022, a number of countries (including the United States, United Kingdom and the European Union) imposed sanctions against certain individuals and entities in Russia and Belarus as a result of the recognition of the so-called Donetsk People and the so-called Republic and Luhansk People Republic by the Russian Federation. Announcements of potential additional sanctions have been made following the war initiated by Russia against Ukraine on February 24, 2022.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;">Due to the war in Ukraine, there has been a significant increase in volatility on the securities and currency markets. It is expected that these events may affect the activities of Russian enterprises in various sectors of the economy. Although neither Centogene&#8217;s operations, performance nor going concern basis has been significantly affected by the conflict, the impact of the conflict and its broader economic implications, such as higher costs of consumer goods, cannot be reliably quantified at this point in time. Therefore, at the date of this report, the Management Board regards these events as non-adjusting events after the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">These consolidated financial statements were approved by management on March 31, 2022. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256821208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract', window );"><strong>Significant accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currency and currency translation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></span>Foreign currency and currency translation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s consolidated financial statements are presented based on the parent company&#8217;s functional currency. For each entity, the Group determines the functional currency and items included in the financial statements of each entity are measured using that functional currency. The Group uses the direct method of consolidation and on disposal of a foreign operation, the gain or loss that is reclassified to profit or loss reflects the amount that arises from using this method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Transactions in foreign currency are translated into the respective entity&#8217;s functional currency at the spot rate prevailing on the date of the transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The functional currency of each entity is the respective local currency, since the entities carry out their business activities independently from a financial, economic and organizational perspective.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Monetary assets and liabilities denominated in foreign currency are translated to the functional currency using the closing rate at the reporting date. Currency translation differences are recognized immediately through profit or loss. Non-monetary items denominated in a foreign currency that are measured at historical cost are not translated at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On consolidation, the assets and liabilities of foreign operations are translated into euros using the closing rate on the reporting date. Income and expenses of foreign operations are translated using the exchange rate prevailing on the date of the transaction or the annual average exchange rate. Equity is translated using historical rates until the entity is removed from the Group&#8217;s basis of consolidation. Any resulting currency translation differences are recorded in other comprehensive income and recognized under the currency translation reserve in equity if the exchange difference is not allocable to the non-controlling interests. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The exchange rates used are presented in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Closing&#160;rate</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USD (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1304</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1191</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.2271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1234</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AED (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.2091</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.0985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.5045</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.0795</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">INR (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 85.1761</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84.5737</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 78.7980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84.2292</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 89.6605</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 80.1870</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CHF (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RSD (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117.3909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117.2747</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenues from contracts with customers</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></span>Revenues from contracts with customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The Group provides pharmaceutical solutions and diagnostic tests, as well as COVID-19 tests, enabled by its knowledge and interpretation-based platform. Revenue from contracts with customers is recognized when control of the goods or services are transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those goods or services, usually on delivery of the goods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Pharmaceutical segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">The Group's contracts with customers relate to a variety of solutions provided to the Group's pharmaceutical partners in order to accelerate their development of treatments for rare diseases, including early patient recruitment and identification, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">epidemiological insights, biomarker discovery and patient monitoring. The collaboration agreements are structured on a fee per analysis basis, milestone basis, fixed fee basis, or a combination of these. In addition, some of the Group's contracts with its pharmaceutical partners also include sales of CentoCards for the collection of biological samples from patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The performance obligations in Pharmaceutical segment can either be satisfied over time or at a point in time depending on the structure of the collaborations, which are determined based on nature of the service provided, as detailed below.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring is based on fee per analysis, milestone fees and fixed fees. The revenues from these solutions are recognized over time using an input method based on the work rendered in order to measure progress towards complete satisfaction of the services.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from the licensing of intellectual property for an unlimited period, usually in the structure of an upfront fee, is recognized at a point in time, when the right (or license) to use intellectual property is conveyed.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenues from the licensing of intellectual property for a certain period, being a right to access such intellectual property as defined in IFRS 15, is recognized over time over the licensing period.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Revenue from the sale of CentoCards is recognized at a point in time when the control of the CentoCards has transferred to the customer, which typically occurs on delivery.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Diagnostics segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">Revenues from the Group's diagnostics segment are typically generated from genetic sequencing and diagnostics services that the Group provides to clients, who are typically physicians, laboratories or hospitals, either directly or through distributors. Revenues are based on a negotiated price per test or on the basis of agreements to provide certain testing volumes over defined periods. The Group has concluded that the services rendered in the diagnostics segment comprise one performance obligation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The performance obligation in the Diagnostics segment is recognized over time, using an input method to measure progress towards complete satisfaction of the service. In order to measure progress, the Group uses a standardized process which measures progress to completion by stages, consisting of (i) a preparation stage, (ii) a clarification stage, (iii) a sequencing stage, and (iv) an output stage. The percentages attributed to those stages are indicative of the cost incurred in performing the respective stage in relation to total cost. &#160; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>COVID-19 segment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">COVID-19 revenues are based on a negotiated price per test, government driven or on the basis of agreements covering tests to be performed over defined periods. Given the short turnaround time for the COVID-19 tests, revenues from COVID-19 tests that are on a price per test basis are recognized at a point in time. Revenues from COVID-19 tests that are on the basis of agreements covering tests to be performed over defined periods are recognized over time over the agreement period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The Group has disaggregated revenue recognized from contracts with customers into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Group has also disclosed information about the relationship between the disclosure of disaggregated revenue and the revenue information disclosed for each reportable segment. See note 7 for the disclosure on disaggregated revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contract balances </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contract assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A contract asset is the right to consideration in exchange for goods or services transferred to the customer. If the Group satisfies a performance obligation by transferring goods or services to a customer before the customer pays consideration or before </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">payment is due, a contract asset is recognized for the earned consideration that is conditional.  Contract assets are subject to impairment assessment, refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A receivable represents the Group&#8217;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Contract liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A contract liability is the obligation to transfer goods or services to a customer for which the Group has received consideration or an amount of consideration is due from the customer (whichever is earlier). If a customer pays consideration before the Group transfers goods or services to the customer, a contract liability is recognized when the payment is made or the payment is due (whichever is earlier). Contract liabilities are recognized as revenue when the Group performs under the contract.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory', window );">Finance income and finance costs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></span>Finance income and finance costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Interest income and expenses are recognized in the period which they relate to through profit or loss using the effective interest rate method. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory', window );">Current versus non-current classification</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></span>Current versus non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Expected to be realized or intended to be sold or consumed in the normal operating cycle</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Held primarily for the purpose of trading</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Expected to be realized within twelve months after the reporting period; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All other assets are classified as non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A liability is current when:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is expected to be settled in the normal operating cycle</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is held primarily for the purpose of trading</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">It is due to be settled within twelve months after the reporting period; or</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The terms of the liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group classifies all other liabilities as non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are classified as non-current assets and liabilities</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></span>Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Expenses for research activities are recognized through profit or loss in the period in which they are incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Development expenditures on an individual project are recognized as an intangible asset from the date the Group can demonstrate: </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the product or process is technically and commercially feasible so that the asset will be available for use or sale</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Group has the ability and intention to use or sell the asset</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">a future economic benefit is probable </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the Group has sufficient resources to complete the development and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">the development costs can be measured reliably. </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group&#8217;s research and development activities mainly relate to development of biomarkers and IT driven solutions.  With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#8217;s internal validation test. Before such dates, any development costs are recognized in profit or loss and may not be subsequently capitalized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized development costs are recognized at cost less accumulated amortization and any accumulated impairment losses. They are only amortized as from the date the asset is ready for its intended use, which in the case of biomarkers is normally at the time the patent application for such biomarker is made. Amortization expense commences when the assets are ready to be put in use, and is recorded in cost of sales and research and development expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized development costs which are still under development are tested for impairment annually and when circumstances indicate that the carrying value may be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Other intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Other intangible assets purchased by the Group with finite useful lives are recognized at cost less accumulated amortization and any accumulated impairment losses. Subsequent expenditure is only capitalized if it increases the future economic benefits of the respective asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Intangible assets are amortized over their estimated useful life using the straight-line method and assessed for impairment whenever there is an indication that the intangible asset may be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The estimated useful lives are as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Software, patents and trademarks: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 years</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Corona Test Portal: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2 years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Capitalized development costs: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 years</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The useful lives and depreciation methods are reviewed annually to ensure that the methods and periods of depreciation are consistent with the expected economic benefit from the asset.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(f)</b></span>Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment are carried at cost less any accumulated depreciation and any accumulated impairment losses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The cost of property, plant and equipment comprises its purchase price including customs duties and non-refundable acquisition taxes, and proportionate VAT not deductible from input tax as well as any directly attributable costs of bringing the asset to its working condition and location for its intended use.       </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> Subsequent expenditure is only capitalized if it is probable that the future economic benefits associated with the expenditure will flow to the Group. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Depreciation is calculated over the estimated useful life using the straight-line method. The Group has assessed that none of its property, plant and equipment has a residual value. The estimated useful lives of significant property, plant and equipment are as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Freehold land is not depreciated</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Buildings: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">33 years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Plant and other equipment, furniture and fixtures: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">15 years</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">An item of property, plant and equipment is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of comprehensive loss when the asset is derecognized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The depreciation methods, useful lives and residual values are reviewed, and adjusted prospectively if appropriate, as of each reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Assets under construction are reported at cost and are allocated to property, plant and equipment until they are completed and put into operational use, from which point onwards they are depreciated.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(g)</b></span>Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Group as a lessee</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</span></span>Right-of-use assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group recognizes right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its lease term and the estimated useful lives, as follows:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Buildings: 33 years<span style="white-space:pre-wrap;">  </span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Offices: 4 &#8211; 12 years and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Plant and other equipment, furniture and fixtures: 2-15 years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If ownership of the leased asset transfers to the Group at the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The right-of-use assets are also subject to impairment. Refer to accounting policies of impairment of financial assets in note 5(n) &#8220;Financial instruments&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</span></span>Lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">At the commencement date of the lease, the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for leases reasonably certain to be terminated. The variable lease payments that do not depend on an index or a rate are recognized as expenses in the period during which the event or condition that triggers the payment occurs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</span></span>Short-term leases and leases of low-value assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption to leases of office equipment that are considered of low value (i.e., below EUR 5k). Lease payments on short-term leases and leases of low-value assets are recognized as expenses on a straight-line basis over the lease term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</span></span>Sale and leaseback transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Group applies IFRS 15 for determining if the transfer of an asset to the buyer (lessor) is to be accounted for as a sale of assets.  After the sale of assets is concluded, the Group measures the right-of-use assets arising from the leaseback at the proportion of the previous carrying value of the asset that relates to the right of use retained by the Group.  Accordingly, the Group recognizes only the amount of any gain or loss that relates to the rights transferred to the buyer (lessor).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the fair value of the consideration for the sale of an asset does not equal the fair value of the asset, or if the payments for the leases are not at market rates, the Group makes the following adjustments to measure the sale proceeds at fair value: </p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">any below-market terms shall be accounted for as a prepayment of lease payments</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">any above-market terms shall be accounted for as additional financing provided by the buyer-lessor to the seller-lessee</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory', window );">Impairment of non-financial assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(h)</b></span>Impairment of non-financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment and intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Whenever the carrying amount of an asset exceeds its recoverable amount, an impairment loss is recognized in profit or loss. The recoverable amount is measured as the higher of fair value less costs to sell and value in use. Recoverable amounts are estimated either for individual assets or, if an individual asset does not generate cash flows independently of other assets, for the whole cash-generating unit.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></span>Inventories</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inventories are measured at the lower of cost and net realizable value. Inventories are recognized at cost based on the first in first out (FIFO) method. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Government grants</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(j)</b></span>Government grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. Grants that are intended to compensate the Group for expenses incurred are recognized through profit or loss in the period in which expenses are submitted and claimed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Government grants which relate to an asset are initially recognized as deferred income at nominal amounts. They are subsequently released to profit or loss on a systematic basis over the expected useful life of the related asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The release of deferred income related to either type of grant is presented as other operating income (see note 8).<b style="font-weight:bold;"> </b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(k)</b></span>Share-based payments </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Plan recipients (including senior executives and certain member of Supervisory Board) of the Group receive remuneration in the form of share-based payments, whereby the recipients render services as consideration for equity instruments (equity-settled transactions) or settled in cash (cash-settled transactions).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Equity settled transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The cost of equity-settled transactions is determined by the fair value of the granted options when the grant is made, using a Black-Scholes or Monte Carlo simulation model, with further details given in note 20.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The cost is recognized in employee benefits expense (see note 8.4) or other relevant expenses, together with a corresponding increase in equity (capital reserves), over the period in which the service conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest.  The expense or credit in profit or loss for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cash-settled transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A liability is recognized for the fair value of cash-settled transactions. The fair value is measured initially and at each reporting date up to and including the settlement date, with changes in fair value recognized in employee benefits expense (see note 8.4). The fair value per option is determined using the Black-Scholes model, further details of which are given in note 20. The fair value per option is then multiplied by the Group&#8217;s best estimate of the number of awards expected to vest and the portion of the expired vesting period (period in which the service conditions are fulfilled). The cumulative amount of expense recognized will be equal to the cash that is paid on settlement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Service and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">If the terms and conditions of a cash-settled share-based payment transaction are modified with the result that it becomes an equity-settled share-based payment transaction, the transaction is accounted for as such from the date of the modification.  Specifically, the equity-settled share-based payment transaction is measured by reference to the fair value of the equity instruments granted at the modification date and recognized in equity.  The liability for the cash-settled share-based payment transaction as at the modification date is derecognized on that date.  Any difference between the carrying amount of the liability derecognized and the amount of equity recognised on the modification date is recognised immediately in profit or loss.</span><b style="font-weight:bold;"> </b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(l)</b></span>Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">A provision is recognized when the Group has a present obligation (legal, contractual or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.  When the Group expects some or all of a provision to be reimbursed, for example, under an insurance contract, the reimbursement misrecognized as a separate asset, but only when the reimbursement is virtually certain. The expense relating to a provision is presented in the profit or loss net of any reimbursement.  Provisions are reviewed at each reporting date and adjusted to reflect the current best estimate. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If the requirements for recognizing a provision are not satisfied, the corresponding obligations are recorded as contingent liabilities unless the possibility of an outflow of resources embodying economic benefits is remote.<b style="font-weight:bold;"> </b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(m)</b></span>Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tax expense comprises current and deferred taxes. Current taxes and deferred taxes are recognized through profit or loss apart from deferred taxes related to items recognized outside profit or loss, in which case it is recognized in correlation to the underlying transaction either directly in equity or in other comprehensive income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Group operates and generates taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred taxes are set up for temporary differences between the carrying amounts of assets and liabilities for group financial reporting purposes at the reporting date and the amounts used for tax purposes. Deferred tax liabilities are recognized for all taxable temporary differences, except:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">temporary differences arising from the initial recognition of assets or liabilities in the course of a business transaction that is not a business combination and does not affect either the accounting profit or the taxable profit or loss</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:36pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">-</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">temporary differences associated with investments in subsidiaries if the Group controls the timing of the reversal of the temporary differences, and it is probable that the differences will not reverse in the foreseeable future.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and deferred tax liabilities are offset against each other if certain conditions are met.<b style="font-weight:bold;"> </b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Financial instruments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(n)</b></span>Financial instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">(i) Financial assets </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s financial assets principally consist of those accounted for as receivables, contract assets, cash and cash equivalents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Receivables and contract assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Receivables, including contract assets, are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.  Contract assets and trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are measured at the transaction price determined under IFRS 15.  Refer to the accounting policies in note 5(b) &#8220;Revenues from contracts with customers&#8221;.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">After initial recognition, receivables and contract assets are subsequently carried at amortized cost using the effective interest rate method less any impairment losses.  Gains and losses are recognized in the profit or loss for the period when the assets are derecognized or impaired.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Derecognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A financial asset or a part of a financial asset is derecognized when the Group no longer has the contractual rights to the asset or the right to receive cash flows from the asset have expired. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group recognizes an allowance for expected credit losses (ECLs). ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group applies a simplified approach in calculating ECLs. Therefore, the Group does not track changes in credit risk, but instead recognizes a loss allowance based on lifetime ECLs at each reporting date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group considers a financial asset in default when contractual payments are 360 days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Further disclosures relating to impairment of trade receivables, including contract assets, are in note 21.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(ii)&#160;Financial liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Group&#8217;s financial liabilities include trade and other payables (include contract liabilities), as well as loans and borrowings including bank overdrafts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Loans and borrowings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Loans and borrowings are initially recognized at fair value and subsequently measured at amortized cost using the effective interest rate method, taking into account any principal repayments and any discount or premium on acquisition and including transaction costs and fees that are an integral part of the effective interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Gains or losses are recognized through profit or loss at the time the liabilities are derecognized or disposed of.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Derecognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A financial liability is derecognized when the obligation underlying the liability is discharged, canceled or expires.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized through profit or loss.<b style="font-weight:bold;"> </b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(o) Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Cash and cash equivalents comprise cash on hand and bank balances, including short-term, highly liquid investments that can be quickly converted into cash amounts. These have original maturities of three months or less and are subject to a low risk of fluctuation in value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The policy of Accounting Policy For Current Versus Noncurrent Classification, Explanatory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for finance income and costs. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 46<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257105640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of preparation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BasisOfPreparationOfFinancialStatementsAbstract', window );"><strong>Basis of Preparation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock', window );">Schedule of reconciliation of the Statement of Comprehensive Income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:17.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:18.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:15.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:17.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 (restated)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 (as previously reported)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of Sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 83,437</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 86,378</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,941)</p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Gross profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 44,944</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 42,003</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 2,941</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 40,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 37,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,495</p></td></tr><tr><td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,580</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 446</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BasisOfPreparationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BasisOfPreparationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reclassification of cost on comprehensive income statement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048429787080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract', window );"><strong>Significant accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfForeignExchangeRatesUsedExplanatory', window );">Schedule of exchange rates used</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Closing&#160;rate</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USD (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1304</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1191</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.2271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.1234</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AED (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.2091</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.0985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.5045</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.0795</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">INR (EUR&#160;1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 85.1761</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84.5737</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 78.7980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84.2292</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 89.6605</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 80.1870</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CHF (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RSD (EUR 1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117.3909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117.2747</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> -</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfForeignExchangeRatesUsedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about foreign exchange rates used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfForeignExchangeRatesUsedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256725416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information and revenue from contracts with customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock', window );">Schedule of segment information and reconciliation of segment adjusted EBITDA to group loss for the period</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,843</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 20,678</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,247)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (16,702)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 690</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 261</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,480</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,367</p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 386</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,787</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,076</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,539</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,828</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,849</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,291</p></td></tr><tr><td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,297</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,297</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19 </b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,194</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,408)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 37,215</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (39,918)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,083</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 602</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,682</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,730</p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,183</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,672</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,802</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,657</p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,670</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,128</p></td></tr><tr><td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,935</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:47.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,956</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,306</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (22,949)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,687)</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital Expenditures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to property, plant and equipment and right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,362</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,998</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,908</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,268</p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions to intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,603</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,280</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other segment information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,579</p></td></tr><tr><td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,590</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,590</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:7.1pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:28.9pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As discussed in note 2, in March 2020 the Group commenced testing for COVID-19 in response to the COVID-19 pandemic and in the third quarter started managing and reporting the COVID-19 business as a separate segment. As such, the Group did not have any activities related to the COVID-19 business prior to 2020 and retrospective presentation in prior year segment reporting is not applicable. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Reconciliation of segment Adjusted EBITDA to Group loss for the period</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reportable segment Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 29,545</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 41,001</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 17,262</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Corporate expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (46,247)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (39,918)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (22,949)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (16,702)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,083</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,687)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payment expenses (Note 20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,035)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,658)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,418)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation and amortization (including impairments)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,291)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15,128)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,579)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,028)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (19,703)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (18,684)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financial costs, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (848)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,013)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (281)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (158)</p></td></tr><tr><td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss for the year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,852)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (21,378)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (20,855)</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Schedule of geographical information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 146,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 189,159</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 762</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 764</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,131</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 61,910</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 762</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 127,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 128,013</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,425</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 144,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 150,584</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Germany*#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 211</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 140,922</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 141,133</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,616</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 3,622</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,432</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,496</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,763</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 19,309</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,593</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 818</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,641</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 146,382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 189,923</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">                                                          </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">COVID-19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,947</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88,587</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 126,642</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 735</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,739</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,947</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,684</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 62,739</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64,638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 65,642</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,605</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,068</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;Germany*#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 186</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 80,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> 81,065</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,572</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> 6,575</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,624</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,265</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,370</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-style:italic;"> 19,059</i></p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,851</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,888</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 508</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 536</p></td></tr><tr><td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 16,951</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,108</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 89,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 128,381</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Pharmaceutical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Diagnostics</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Rendering of services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 46,347</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales of goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,433</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,433</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized over time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,417</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recognized at a point in time</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,363</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Revenues from contracts with external customers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">Geographical information</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 381</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,447</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Germany*</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 233</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 275</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 508</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;Netherlands**</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> &#8212;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 25</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 25</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,977</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,099</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">&#8212;<i style="font-style:italic;">Saudi Arabia#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> &#8212;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 7,417</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 7,417</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,896</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,276</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><i style="font-style:italic;">&#8212;United States#</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">&#160;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 20,896</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 1,882</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><i style="font-style:italic;"> 22,778</i></p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 123</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,864</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,987</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 971</p></td></tr><tr><td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,522</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,258</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 48,780</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">*&#160;&#160;country of the incorporation of Centogene GmbH</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">**&#160;country of the incorporation of Centogene N.V.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">#&#160;&#160;&#160;&#160;countries contributing more than 10% of the Group's total consolidated revenues for the respective year ended December 31, 2021, 2020 or 2019 </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfContractBalancesExplanatory', window );">Schedule of contract balances</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Trade receivables (note 15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 25,656</p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Contract assets (note 15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,543</p></td></tr><tr><td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Contract liabilities (note 19.2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,479</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfContractBalancesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about contract balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfContractBalancesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048231979800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income and expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseDisclosureAbstract', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory', window );">Schedule of other operating income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,152</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2641</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gain on disposal of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">532</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exchange rate gains</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">314</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income from the reversal of provisions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">89</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 656</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">205</p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,936</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,394</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,781</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory', window );">Schedule of other operating expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Currency losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 192</p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 172</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,092</p></td></tr><tr><td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 86</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 182</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,284</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Schedule of finance costs, net</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest expenses from loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (267)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (173)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,690)</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Currency losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (362)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unwinding of the discount on lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (584)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (865)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (339)</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest income from loans and receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16</p></td></tr><tr><td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (848)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (1,394)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,013)</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory', window );">Schedule of employee benefits expense</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Wages and salaries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 43,533</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,854</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Social security contributions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,134</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,212</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,471</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,714</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Termination benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,158</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 63</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 56,296</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 39,271</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 32,843</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherIncomeExpenseDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherIncomeExpenseDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS19_g2-7_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating expense. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256680040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of tax recognized through profit or loss</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current tax expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (118)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (74)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (158)</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Current year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (102)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (58)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Adjustments for prior periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (157)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred tax (expense)/income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 142</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (207)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Temporary differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (182)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (514)</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Tax losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 514</p></td></tr><tr><td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total income tax (expenses)/benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (281)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (158)</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of the effective tax rate to the statutory rate</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss before tax</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (46,876)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (21,097)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (20,697)</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Taxes on the basis of the Company&#8217;s domestic tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,596</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,445</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax rate effect of foreign tax jurisdictions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 412</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non&#8209;deductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,030)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (903)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (441)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current year losses for which no deferred tax assets were recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,211)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,792)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,416)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax income related to prior years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (137)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (157)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other effects</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (196)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (84)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income tax (expenses)/ benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (281)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (158)</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Schedule of breakdown of deferred taxes in the statement of financial position</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">tax&#160;liabilities</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,439)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,934)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (133)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,617)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,029)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Measurement of service contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (145)</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasing liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,563</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,693</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,903</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unused tax losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 777</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,266</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Sum</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,033</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,112)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,034</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (8,241)</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Offset</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,033)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,033</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (8,034)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,034</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deferred Taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (79)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (207)</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048236615288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Summary of reconciliation of carrying amounts of intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Internally</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">generated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Internally</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased&#160;rights,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">/acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">developed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">licenses,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">biomarkers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">databases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">software</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,502</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,010</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,534</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,657</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deconsolidation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (151)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (151)</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 13,922</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 9,219</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,899</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 28,040</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 749</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,652</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 386</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,787</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (297)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 297</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,374</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 11,168</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,285</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 30,827</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated amortization and impairment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,831</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,770</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,788</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,389</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Amortization and impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,917</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 943</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 508</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,368</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deconsolidation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 10,748</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,713</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,172</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,633</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Amortization and impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,149</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,991</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,860</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,000</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,829</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,772</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,032</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,633</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,174</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,506</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,727</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,407</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,545</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,396</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,253</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 9,194</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">*&#160;&#160;&#160;&#160;&#160;The net reclassification of EUR 229<span style="white-space:pre-wrap;">k from internally generated biomarkers to internally developed databases represents internal costs incurred in the process of developing internal IT driven solutions on biomarkers.  Reclassification is made to allow more transparent presentation considering this is more in line with each sub-group of intangible assets.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256331512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of development of property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&#160;fixtures</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">As of Jan 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,254</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,730</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,696</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,890</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (612)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (612)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,099</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,099</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,359</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,124</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,590</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 30,073</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,766</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,915</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (379)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (718)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,097)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,364</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,054</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,638</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 33,056</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation and impairment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">As of Jan 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,155</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,773</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,320</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 993</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,913</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,100</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (44)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (44)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,107</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 586</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,255</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,642</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 13,483</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,473</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,307</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Disposal**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (157)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (217)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (374)</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclass from right-of-use assets***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 493</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 493</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 901</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 12,110</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 11,898</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,909</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,773</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,869</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,948</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 16,590</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,463</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,944</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,740</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,147</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="white-space:pre-wrap;">*     The disposal relates to the sale of a CentoTruck as part of a contract with a COVID-19 customer</span><span style="font-size:10pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="white-space:pre-wrap;">**   The disposal relates to various obsolete plant and machinery equipment mainly in relation to the ramp down of the COVID-19 business segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">*** The reclass from right-of-use assets represents assets purchased at the end of the lease.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256323256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Schedule of carrying amounts of right-of-use assets and movements during the period</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Plant&#160;and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Motor</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">In EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Buildings*</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Offices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Vehicles</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of January 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 13,126</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,407</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,989</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 390</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 20</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 24,932</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,840</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reclass to property, plant &amp; equipment**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,992)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,992)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,121)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (657)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,675)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (187)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,660)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 12,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,176</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,587</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,315</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 37</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 22,120</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 133</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 179</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,452</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reclass to property, plant &amp; equipment**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (672)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (672)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,121)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (970)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,745)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (138)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (22)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,996)</p></td></tr><tr><td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 10,884</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,339</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,291</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,356</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 34</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 18,904</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.79em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">*&#160;&#160;&#160;As the lease of land and buildings are made through one contract, all the related right-of-use assets are allocated to Buildings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">** Reclass of leased assets to PP&amp;E (note 12) represents purchased assets at the end of lease term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory', window );">Schedule of carrying amounts of lease liabilities and the movements during the period</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of January 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 21,205</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 21,704</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,452</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,654</p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 865</p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,244)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,018)</p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">As of December 31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 18,997</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 21,205</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,409</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3,528</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Non-current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 15,588</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 17,677</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory', window );">Schedule of amounts recognised in profit or loss related to leases</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Depreciation expense of right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,996</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,660</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,807</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Interest expenses on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 339</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rent expenses&#8212;short-term leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,175</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 185</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rent expense&#8212;leases of low-value assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Total amounts recognized in profit or loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 11,803</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,253</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 2,356</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about carrying amounts of lease liabilities and their movements during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of additional information about leasing activities of a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 59<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_59&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048269106856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfInventoriesTableTextBlock', window );">Summary of inventories</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Raw materials, consumables and supplies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,831</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,167</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Finished goods and merchandise</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 238</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Inventories</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,869</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 11,405</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfInventoriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfInventoriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048255649560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other receivables and other assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables and other assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Summary of trade receivables and other assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:93.5%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets&#8212;Rental deposits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,922</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,867</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets&#8212;Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,972</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,967</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 25,656</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contract assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,543</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,286</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 29,790</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 37,485</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Total non-current and current trade and other receivables and other assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 32,762</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 39,452</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048255753736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Common shares issued and authorized</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in thousands of shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Common shares as of Jan 1, fully paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,118</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,861</p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Issued shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 450</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 256</p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Common shares issued as of Dec 31, fully paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,118</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">as&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">as&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in thousands of shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Authorized common shares of EUR 0.12 each</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,000</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048269231080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">Schedule of interest-bearing liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non&#8209;current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 401</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current loans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> -</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 401</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,588</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,677</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,588</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 18,078</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current loans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 3,815</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,492</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,528</p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,224</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current and current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,812</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Schedule of outstanding interest-bearing liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominal</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">interest&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Maturity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Secured bank loan</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2.95%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2017&#8209;22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loan</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">USD</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">1%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2020-22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">4.75%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 498</p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">3.75%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,329</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,329</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 628</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 628</p></td></tr><tr><td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">4.50%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">Rollover</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 412</p></td></tr><tr><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">EUR</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2.1%-3.5%*, 5.4%-9.1%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2017-31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,205</p></td></tr><tr><td style="vertical-align:bottom;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total interest</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">bearing financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,812</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,812</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">*&#160;&#160;&#160;&#160;&#160;represents the incremental borrowing rate of the Group at the commencement of the leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">Schedule of trade payables and other liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,736</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Government grants (deferred income)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,292</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contract liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,479</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Others</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,483</p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Trade payables and other liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 40,122</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 59,990</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,028</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 8,950</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 32,094</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 51,040</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256362056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory', window );">Schedule of total expenses arising from sharebased payment transactions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expenses arising from cash-settled share-based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,714</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- 2016 VSOP</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 596</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- 2017 VSOP (2019: including modification gain)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,118</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expenses arising from equity-settled share-based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,035</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,658</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 704</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- ESOP 2019, including replacement by RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 704</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Grants to management board and employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,217</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Grants to the CEO</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 269</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">- Supervisory board grant</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total expenses arising from share</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;">based payment transactions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 8,035</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 5,658</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,418</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017And2019Member', window );">Equity share option 2017 and 2019</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of key assumptions used to derive the option value</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ESOP 2017</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">ESOP 2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price (EUR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share price at grant date (EUR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.7)</p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td></tr><tr><td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Option term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember', window );">Equity share option 2017 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of share option activity</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 549,005</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 805,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cancelled during the year </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (191,565)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (256,303)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.12</p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 357,440</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 549,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 357,440</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 549,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 357,440</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 549,005</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.12</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember', window );">Equity share option 2019 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of share option activity</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP (EUR)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">WAEP</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 396,522</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cancelled during the year </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (396,522)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12.58</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Replacement awards granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 300,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 300,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 200,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 100,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable as of December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 200,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 100,000</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of key assumptions used to derive the option value</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:37.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020 Fair Value assumptions</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ESOP 2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Performance</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Replacement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Based RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">n/a</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price at grant date (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11.05</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12.54</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 88</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0.2-0.3</p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">0 </p></td></tr><tr><td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected contractual life (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">12.08-13.08</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average fair value (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8.23</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:43.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021 Fair Value assumptions</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Add. Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Modig and </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Modig</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr. Kim</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019 Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Mr.Sheldon</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.92</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.52</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price at grant date (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.54</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk&#8209;free interest rate (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.9</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield (%)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0</p></td></tr><tr><td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected contractual life (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average fair value (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.36</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory', window );">Summary of awards granted</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"><tr style="height:1pt;"><td style="vertical-align:top;width:10.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:16.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Award Type (2019 Plan)</b></p></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Market/ Performance Based</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Vesting Conditions</b></p></td><td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Number of Awards</b></p></td><td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Vesting Conditions</b></p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration Date</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 95,499</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Four equal tranches over a four-year period, starting January 1, 2022, April 1, 2022 or on each anniversary of the grant date</p></td><td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_j7I3SlyuWU6KYGVcxzrMkg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 30,000</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Three equal tranches over a three-year period starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_YStt1HXTrUSZGYMRD2aLHg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 15,000</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Three equal tranches of which the first tranche vested immediately and the two remaining annual tranches will vest starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_YVS6AVoIeUKeeejiDsF3JA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 22,936</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Four equal tranches over a four-year period, starting October 1, 2022 on each anniversary of the grant date</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_AdWcPoKHd0iDW7odOEhQgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Options</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Yes</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 15,000</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Three equal tranches over a three-year period starting January 1, 2022</p></td><td style="vertical-align:bottom;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_HW0l6QwPxEehXDxtNMXdTA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">RSUs</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';"> 3,891</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Four equal tranches over a four-year period starting January 1, 2022</p></td><td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_y1wywXdbVUOTeWK6mrdN-A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10th</span></span> anniversary of Grant Date</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about expenses arising from share based payment transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017And2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017And2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048236776472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - fair values and risk management (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Financial instruments-fair values and risk management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureExplanatory', window );">Schedule of information regarding the credit risk exposure of trade receivables and contract assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;by</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;1&#160;-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;31</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;"> 90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">more&#160;than&#160;90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not&#160;past&#160;due</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">30&#160;days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,013</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,771</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 351</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 259</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 531</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,562</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 203</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 943</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 115</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 30,054</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 17,978</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,475</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 2,596</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 8,004</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 19</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 0.9</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 7.7</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 11.7</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 64.1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 5,717</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 167</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 114</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 304</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 5,132</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;by</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;1&#160;-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Past&#160;due&#160;31</b><b style="font-weight:bold;">&#8209;</b><b style="font-weight:bold;"> 90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">more&#160;than&#160;90</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not&#160;past&#160;due</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">30&#160;days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">days</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Middle East</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,338</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,306</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,193</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 706</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">North America</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,870</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 994</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 262</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 178</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 33,967</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 24,185</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 2,228</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 797</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 6,757</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 14.0</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 1.6</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 3.1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 7.7</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 63.0</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">%</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:44.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Expected credit loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,768</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 382</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 70</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 61</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;"> 4,255</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory', window );">Schedule of development of impairment losses relating to trade and other receivables</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of January 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,768</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,355</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for expected credit losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 956</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,879</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Derecognition of trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,466)</p></td></tr><tr><td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,717</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,768</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities', window );">Schedule of residual contractual terms of financial liabilities, including estimated interest payments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractually&#160;agreed&#160;cash&#160;flows</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">More</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Less than</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2 to 12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">1 to 5</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">than</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2&#160;months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">5&#160;years</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 22,050</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 716</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 9,038</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,893</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,252</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 34,064</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 37,117</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 15,383</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 3,803</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 9,038</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;"> 8,893</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractually&#160;agreed&#160;cash&#160;flows</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">More</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Less than</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2 to 12</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">1 to 5</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">than</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2&#160;months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">5&#160;years</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 394</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 394</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,897</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 716</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,580</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,740</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,525</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,011</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 514</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 55,834</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 59,351</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 33,270</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,072</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 10,269</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 10,740</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Schedule of reconciliation of liabilities arising from financing activities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-cash changes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Jan 1, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flows</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">maturity and FX</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;">18,078</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (401)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 865</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,954)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 15,588</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (401)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,954)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,588</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,802)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,438</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,567</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,223</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (62)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 505</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (387)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 267</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,310</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,245)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,171</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,954</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,408</p></td></tr><tr><td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (3,203)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,303</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (387)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 22,811</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-cash changes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Jan 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash flows</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">maturity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;">19,647</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (1,993)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,029</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (1,605)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 18,078</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (567)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 401</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Municipal loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (610)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,069</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,383)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,038)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,677</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 7,323</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,520)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 2,663</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,554</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,020</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of secured bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 802</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (865)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 567</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 387</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bank overdrafts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,636</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,208)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,538</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Municipal loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,635</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,635)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,038</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,528</p></td></tr><tr><td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 26,970</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,513)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,692</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (51)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,098</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMarketRiskExplanatory', window );">Schedule of net foreign currency exposure</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">INR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">AED</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,604</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trade payables and other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net exposure</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 210</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">USD</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INR</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AED</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trade payables and other liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,631)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (55)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (17)</p></td></tr><tr><td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net exposure</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (2,407)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (37)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> (17)</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the allowance relating to impairments of financial assets due to credit losses. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity&#8217;s financial assets and commitments to extend credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMarketRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of market risk. [Refer: Market risk [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMarketRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048258263832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>List of subsidiaries (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory', window );">Schedule of major subsidiaries</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity&#160;interests&#160;(%)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Country&#160;in&#160;which</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">primary&#160;activities&#160;are</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">pursued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene GmbH*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene FZ-LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Arab Emirates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene US, LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">USA</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene&#160;GmbH</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Austria</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 90</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene India Pvt.&#160;Ltd**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">India</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene Switzerland AG</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Switzerland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centosafe B.V.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Netherlands</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Centogene d.o.o Belgrade</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Serbia</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dr. Bauer Laboratoriums GmbH***</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Germany</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;">(*)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Centogene IP GmbH and Centogene Shared Service GmbH were merged with Centogene GmbH on January 1, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">(**)</span></span>The Group acquired the remaining 49% of Centogene India Pvt. Ltd. in 2020, previously accounted for as non-controlling interest.</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(***)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Centogene does not own any shares in Dr. Bauer Laboratoriums GmbH. However, Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns (see note 4). </span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 2<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_2_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256355832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-controlling interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NonControllingInterestsAbstract', window );"><strong>Non-controlling interests.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCompositionOfGroupExplanatory', window );">Schedule of information related to each subsidiary of the Group with material, non-controlling interests before intercompany eliminations</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Dec 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Centogene GmbH, Vienna</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Dr. Bauer Laboratoriums GmbH</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net assets/(liabilities)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (528)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 245</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Carrying amount of non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">109,015 </p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profit/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 98</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profit/loss allocated to non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 98</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Centogene GmbH, Vienna</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dr. Bauer Laboratoriums GmbH</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net assets/(liabilities)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (522)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 148</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Carrying amount of non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (52)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">55,596 </p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Profit/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122</p></td></tr><tr><td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Profit/loss allocated to non&#8209;controlling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NonControllingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NonControllingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCompositionOfGroupExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the composition of the group (the parent and all its subsidiaries). [Refer: Subsidiaries [member]; Parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCompositionOfGroupExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048255859240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Schedule of remuneration of members of key management</a></td>
<td class="text"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:75.22%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in EUR k</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short&#8209;term employee benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,273</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,313</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Post&#8209;employment pension and medical benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Termination benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 565</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share&#8209;based payment transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 822</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,822</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,395</p></td></tr><tr><td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation to key management</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 5,178</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,683</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 6,718</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256364376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General Company Information (Details)<br> &#8364; / shares in Units, &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GeneralInformationAboutFinancialStatementsLineItems', window );"><strong>General Company Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember', window );">Follow-on Equity Offering | Common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GeneralInformationAboutFinancialStatementsLineItems', window );"><strong>General Company Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues', window );">Public offering price (in dollars per share) | (per share)</a></td>
<td class="nump">$ 14.00<span></span>
</td>
<td class="nump">&#8364; 12.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember', window );">Follow-on public offering | Common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GeneralInformationAboutFinancialStatementsLineItems', window );"><strong>General Company Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues', window );">Public offering price (in dollars per share) | (per share)</a></td>
<td class="nump">14.00<span></span>
</td>
<td class="nump">&#8364; 12.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember', window );">Follow-on public offering | Common shares | Major purchases of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GeneralInformationAboutFinancialStatementsLineItems', window );"><strong>General Company Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Number of common shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues', window );">Public offering price (in dollars per share) | (per share)</a></td>
<td class="nump">$ 14.00<span></span>
</td>
<td class="nump">&#8364; 12.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember', window );">Follow-on public offering | Common shares | Selling shareholders | Major purchases of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GeneralInformationAboutFinancialStatementsLineItems', window );"><strong>General Company Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Number of common shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember', window );">Follow-on public offering | Common shares | The Company | Major purchases of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GeneralInformationAboutFinancialStatementsLineItems', window );"><strong>General Company Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Number of common shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_GeneralInformationAboutFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General Information About Financial Statements [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_GeneralInformationAboutFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering price per share of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorPurchasesOfAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorPurchasesOfAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SellingShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SellingShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cntg_CentogeneN.vMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cntg_CentogeneN.vMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232300104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation (Details)<br> &#8364; / shares in Units, $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PercentageOfEstimatedVariableTransactionPrice', window );">Percentage of estimated variable transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (46,852,000)<span></span>
</td>
<td class="num">&#8364; (21,378,000)<span></span>
</td>
<td class="num">&#8364; (20,855,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Loss of operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,028,000)<span></span>
</td>
<td class="num">(19,703,000)<span></span>
</td>
<td class="num">(18,684,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Loss of operations resulting in operating cash outflow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,739,000)<span></span>
</td>
<td class="nump">8,462,000<span></span>
</td>
<td class="num">(7,775,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Repayment of trade payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,484,000<span></span>
</td>
<td class="num">(23,996,000)<span></span>
</td>
<td class="num">(3,125,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,295,000<span></span>
</td>
<td class="nump">62,888,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,503,000<span></span>
</td>
<td class="nump">65,777,000<span></span>
</td>
<td class="nump">58,922,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 26,524,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,818,000<span></span>
</td>
<td class="nump">48,156,000<span></span>
</td>
<td class="nump">41,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 9,222,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Short term debt obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialCovenants', window );">Financial covenants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,812,000<span></span>
</td>
<td class="nump">24,098,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Borrowings drawdowns</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,772,000<span></span>
</td>
<td class="nump">&#8364; 438,000<span></span>
</td>
<td class="nump">&#8364; 721,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember', window );">Entering into debt financing agreement | Loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="nump">&#8364; 40,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsRevenueAchievementThreshold', window );">Borrowings, Revenue achievement threshold</a></td>
<td class="nump">&#8364; 44,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="nump">7.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember', window );">Entering into debt financing agreement | Loan facility | Floor rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjustment to interest rate</a></td>
<td class="nump">0.07%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.07%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember', window );">Entering into debt financing agreement | Loan facility first tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Borrowings drawdowns</a></td>
<td class="nump">&#8364; 22,300,000<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsCovenantMinimumRequiredRevenue', window );">Borrowings covenant, Minimum required revenue</a></td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember', window );">Entering into debt financing agreement | Loan facility second tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue', window );">Borrowings available, Subject to achievement of product revenue</a></td>
<td class="nump">17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsRevenueAchievementThreshold', window );">Borrowings, Revenue achievement threshold</a></td>
<td class="nump">44,700,000<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsCovenantMinimumRequiredRevenue', window );">Borrowings covenant, Minimum required revenue</a></td>
<td class="nump">40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="nump">&#8364; 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsStockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period | shares</a></td>
<td class="nump">4,479,088<span></span>
</td>
<td class="nump">4,479,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSharePrice', window );">Share price | (per share)</a></td>
<td class="nump">&#8364; 3.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, Number of securities called by warrants or rights | shares</a></td>
<td class="nump">1,343,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,343,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Class of warrant or right, Exercise price of warrants or rights | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember', window );">Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_EstimatedRateOfImplicitPriceConcessions', window );">Estimated rate of implicit price concessions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing available subject to achievement of product revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BorrowingsCovenantMinimumRequiredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum revenue to be maintained as per the borrowings covenant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BorrowingsCovenantMinimumRequiredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BorrowingsRevenueAchievementThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue threshold for borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BorrowingsRevenueAchievementThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_EstimatedRateOfImplicitPriceConcessions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated rate of implicit price concessions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_EstimatedRateOfImplicitPriceConcessions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_FinancialCovenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial covenants as at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_FinancialCovenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PercentageOfEstimatedVariableTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of estimated variable transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PercentageOfEstimatedVariableTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAdjustmentToInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=cntg_FloorRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=cntg_FloorRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256836376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation - Reconciliation (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">&#8364; 161,765<span></span>
</td>
<td class="nump">&#8364; 83,437<span></span>
</td>
<td class="nump">&#8364; 26,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">28,158<span></span>
</td>
<td class="nump">44,944<span></span>
</td>
<td class="nump">22,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General administrative expenses</a></td>
<td class="nump">46,739<span></span>
</td>
<td class="nump">40,160<span></span>
</td>
<td class="nump">23,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingExpense', window );">Selling expenses</a></td>
<td class="nump">9,860<span></span>
</td>
<td class="nump">8,026<span></span>
</td>
<td class="nump">&#8364; 9,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingExpense', window );">Selling expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">&#8364; (2,941)<span></span>
</td>
<td class="num">(2,941)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingExpense', window );">Selling expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230469016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Details)<br></strong></div></th>
<th class="th" colspan="13">12 Months Ended</th>
<th class="th" colspan="4"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / &#8364; </div>
<div>&#1583;.&#1573; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / &#8364; </div>
<div>&#8360; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / &#8364; </div>
<div>SFr / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#1076;&#1080;&#1085; / &#8364; </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / &#8364; </div>
<div>D</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / &#8364; </div>
<div>&#1583;.&#1573; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#8360; / &#8364; </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>&#1583;.&#1573; / &#8364; </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>&#8360; / &#8364; </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#1583;.&#1573; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#8360; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>SFr / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#1076;&#1080;&#1085; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#1583;.&#1573; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#8360; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>&#1583;.&#1573; / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>&#8360; / &#8364;</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ForeignExchangeRatesAbstract', window );"><strong>Foreign currency and currency translation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AverageForeignExchangeRate', window );">Average rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1304<span></span>
</td>
<td class="nump">4.1500<span></span>
</td>
<td class="nump">85.1761<span></span>
</td>
<td class="nump">1.0814<span></span>
</td>
<td class="nump">117.3909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1412<span></span>
</td>
<td class="nump">4.2091<span></span>
</td>
<td class="nump">84.5737<span></span>
</td>
<td class="nump">1.1191<span></span>
</td>
<td class="nump">4.0985<span></span>
</td>
<td class="nump">78.7980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing rate</a></td>
<td class="nump">1.1326<span></span>
</td>
<td class="nump">1.1326<span></span>
</td>
<td class="nump">1.1326<span></span>
</td>
<td class="nump">1.1326<span></span>
</td>
<td class="nump">1.1326<span></span>
</td>
<td class="nump">1.1326<span></span>
</td>
<td class="nump">1.1326<span></span>
</td>
<td class="nump">1.2271<span></span>
</td>
<td class="nump">1.2271<span></span>
</td>
<td class="nump">1.2271<span></span>
</td>
<td class="nump">1.1234<span></span>
</td>
<td class="nump">1.1234<span></span>
</td>
<td class="nump">1.1234<span></span>
</td>
<td class="nump">4.1654<span></span>
</td>
<td class="nump">84.2292<span></span>
</td>
<td class="nump">1.0331<span></span>
</td>
<td class="nump">117.2747<span></span>
</td>
<td class="nump">4.5045<span></span>
</td>
<td class="nump">89.6605<span></span>
</td>
<td class="nump">4.0795<span></span>
</td>
<td class="nump">80.1870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialInstrumentsAbstract', window );"><strong>Financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered', window );">Number of days past due, to consider a financial asset as default</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life of property, plant and equipment</a></td>
<td class="text">33 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets', window );">Estimated useful life of right-of-use assets</a></td>
<td class="text">33 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OfficesMember', window );">Offices | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets', window );">Estimated useful life of right-of-use assets</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OfficesMember', window );">Offices | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets', window );">Estimated useful life of right-of-use assets</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Other property, plant and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life of property, plant and equipment</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets', window );">Estimated useful life of right-of-use assets</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Other property, plant and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life of property, plant and equipment</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets', window );">Estimated useful life of right-of-use assets</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_SoftwarePatentsAndTrademarksMember', window );">Software, patents and trademarks | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_SoftwarePatentsAndTrademarksMember', window );">Software, patents and trademarks | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_CoronaTestPortalMember', window );">Corona Test Portal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember', window );">Capitalized development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of days for which the contractual payments is past due, used for considering the financial asset as default.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ForeignExchangeRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ForeignExchangeRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OfficesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OfficesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_SoftwarePatentsAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_SoftwarePatentsAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_CoronaTestPortalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_CoronaTestPortalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230369096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounting judgments and estimates (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Accounting judgments and estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">&#8364; 9,194<span></span>
</td>
<td class="nump">&#8364; 12,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Accounting judgments and estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">30,827<span></span>
</td>
<td class="nump">28,040<span></span>
</td>
<td class="nump">&#8364; 21,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost | Capitalized development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Accounting judgments and estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">&#8364; 7,941<span></span>
</td>
<td class="nump">&#8364; 9,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232630360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information and revenue from contracts with customers - Information by operating segments (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsNumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">&#8364; 189,923<span></span>
</td>
<td class="nump">&#8364; 128,381<span></span>
</td>
<td class="nump">&#8364; 48,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(16,702)<span></span>
</td>
<td class="nump">1,083<span></span>
</td>
<td class="num">(5,687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets', window );">Additions to property, plant and equipment and right-of-use assets</a></td>
<td class="nump">4,367<span></span>
</td>
<td class="nump">12,730<span></span>
</td>
<td class="nump">21,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Additions to intangible assets</a></td>
<td class="nump">2,787<span></span>
</td>
<td class="nump">6,657<span></span>
</td>
<td class="nump">7,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherSegmentInformationAbstract', window );"><strong>Other segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization (including impairments)</a></td>
<td class="nump">21,291<span></span>
</td>
<td class="nump">15,128<span></span>
</td>
<td class="nump">6,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">19,297<span></span>
</td>
<td class="nump">14,935<span></span>
</td>
<td class="nump">9,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember', window );">Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">61,910<span></span>
</td>
<td class="nump">62,739<span></span>
</td>
<td class="nump">44,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember', window );">Recognized at a point in time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">128,013<span></span>
</td>
<td class="nump">65,642<span></span>
</td>
<td class="nump">4,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">15,641<span></span>
</td>
<td class="nump">16,951<span></span>
</td>
<td class="nump">21,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">14,879<span></span>
</td>
<td class="nump">15,947<span></span>
</td>
<td class="nump">17,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Recognized at a point in time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">4,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Pharmaceutical Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">455<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">27,900<span></span>
</td>
<td class="nump">22,108<span></span>
</td>
<td class="nump">27,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">27,900<span></span>
</td>
<td class="nump">22,108<span></span>
</td>
<td class="nump">27,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">146,382<span></span>
</td>
<td class="nump">89,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">19,131<span></span>
</td>
<td class="nump">24,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Recognized at a point in time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">127,251<span></span>
</td>
<td class="nump">64,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segment | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">15,641<span></span>
</td>
<td class="nump">16,951<span></span>
</td>
<td class="nump">21,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">4,843<span></span>
</td>
<td class="nump">6,194<span></span>
</td>
<td class="nump">14,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets', window );">Additions to property, plant and equipment and right-of-use assets</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Additions to intangible assets</a></td>
<td class="nump">2,401<span></span>
</td>
<td class="nump">3,183<span></span>
</td>
<td class="nump">3,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherSegmentInformationAbstract', window );"><strong>Other segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization (including impairments)</a></td>
<td class="nump">2,076<span></span>
</td>
<td class="nump">6,769<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segment | Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">27,900<span></span>
</td>
<td class="nump">22,108<span></span>
</td>
<td class="nump">27,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">4,024<span></span>
</td>
<td class="num">(2,408)<span></span>
</td>
<td class="nump">2,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets', window );">Additions to property, plant and equipment and right-of-use assets</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherSegmentInformationAbstract', window );"><strong>Other segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization (including impairments)</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">2,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segment | COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">146,382<span></span>
</td>
<td class="nump">89,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="nump">20,678<span></span>
</td>
<td class="nump">37,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets', window );">Additions to property, plant and equipment and right-of-use assets</a></td>
<td class="nump">2,480<span></span>
</td>
<td class="nump">9,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Additions to intangible assets</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">1,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherSegmentInformationAbstract', window );"><strong>Other segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization (including impairments)</a></td>
<td class="nump">10,828<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_IfrsCorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(46,247)<span></span>
</td>
<td class="num">(39,918)<span></span>
</td>
<td class="num">(22,949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets', window );">Additions to property, plant and equipment and right-of-use assets</a></td>
<td class="nump">936<span></span>
</td>
<td class="nump">2,682<span></span>
</td>
<td class="nump">17,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Additions to intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,802<span></span>
</td>
<td class="nump">3,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherSegmentInformationAbstract', window );"><strong>Other segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization (including impairments)</a></td>
<td class="nump">5,849<span></span>
</td>
<td class="nump">4,670<span></span>
</td>
<td class="nump">3,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">&#8364; 19,297<span></span>
</td>
<td class="nump">&#8364; 14,935<span></span>
</td>
<td class="nump">&#8364; 9,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additions to property, plant and equipment and right-of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (loss) before adjusting corporate expenses, depreciation and amortization as well as share based payment expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsNumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsNumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherSegmentInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherSegmentInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=cntg_PharmaceuticalPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=cntg_PharmaceuticalPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_Covid19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_Covid19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_IfrsCorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=cntg_IfrsCorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048233207256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation</a></td>
<td class="num">&#8364; (5,471)<span></span>
</td>
<td class="num">&#8364; (3,486)<span></span>
</td>
<td class="num">&#8364; (5,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="num">(21,291)<span></span>
</td>
<td class="num">(15,128)<span></span>
</td>
<td class="num">(6,579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(46,028)<span></span>
</td>
<td class="num">(19,703)<span></span>
</td>
<td class="num">(18,684)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial costs, net</a></td>
<td class="num">(848)<span></span>
</td>
<td class="num">(1,394)<span></span>
</td>
<td class="num">(2,013)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">(46,852)<span></span>
</td>
<td class="num">(21,378)<span></span>
</td>
<td class="num">(20,855)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment', window );">Reportable segment Adjusted EBITDA</a></td>
<td class="nump">29,545<span></span>
</td>
<td class="nump">41,001<span></span>
</td>
<td class="nump">17,262<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment', window );">Reportable segment Adjusted EBITDA after corporate expenses</a></td>
<td class="num">(16,702)<span></span>
</td>
<td class="nump">1,083<span></span>
</td>
<td class="num">(5,687)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(46,028)<span></span>
</td>
<td class="num">(19,703)<span></span>
</td>
<td class="num">(18,684)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial costs, net</a></td>
<td class="num">(848)<span></span>
</td>
<td class="num">(1,394)<span></span>
</td>
<td class="num">(2,013)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">(46,852)<span></span>
</td>
<td class="num">(21,378)<span></span>
</td>
<td class="num">(20,855)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_IfrsCorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Corporate expenses</a></td>
<td class="num">(46,247)<span></span>
</td>
<td class="num">(39,918)<span></span>
</td>
<td class="num">(22,949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="num">(5,849)<span></span>
</td>
<td class="num">(4,670)<span></span>
</td>
<td class="num">(3,239)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_UnallocatedAmountsShareBasedPaymentsMember', window );">Sharebased payment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation</a></td>
<td class="num">(8,035)<span></span>
</td>
<td class="num">(5,658)<span></span>
</td>
<td class="num">(6,418)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_UnallocatedAmountsDepreciationAndAmortizationMember', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="num">&#8364; (21,291)<span></span>
</td>
<td class="num">&#8364; (15,128)<span></span>
</td>
<td class="num">&#8364; (6,579)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (loss) before adjusting depreciation and amortization as well as share based payment expenses but after adjusting corporate expenses, attributable to reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (loss) before adjusting corporate expenses, depreciation and amortization as well as share based payment expenses, attributable to reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity classifies as being administrative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_IfrsCorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=cntg_IfrsCorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_UnallocatedAmountsShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=cntg_UnallocatedAmountsShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=cntg_UnallocatedAmountsDepreciationAndAmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=cntg_UnallocatedAmountsDepreciationAndAmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048231057352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information and revenue from contracts with customers - Geographical information (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Rendering of services</a></td>
<td class="nump">&#8364; 189,159<span></span>
</td>
<td class="nump">&#8364; 126,642<span></span>
</td>
<td class="nump">&#8364; 46,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Sales of goods</a></td>
<td class="nump">764<span></span>
</td>
<td class="nump">1,739<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">189,923<span></span>
</td>
<td class="nump">128,381<span></span>
</td>
<td class="nump">48,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">150,584<span></span>
</td>
<td class="nump">94,068<span></span>
</td>
<td class="nump">7,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">-Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">141,133<span></span>
</td>
<td class="nump">81,065<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_NL', window );">-Netherlands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">3,622<span></span>
</td>
<td class="nump">6,575<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=cntg_IfrsMiddleEastMember', window );">Middle East</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">16,432<span></span>
</td>
<td class="nump">12,624<span></span>
</td>
<td class="nump">14,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_SA', window );">-Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">19,496<span></span>
</td>
<td class="nump">19,265<span></span>
</td>
<td class="nump">23,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">-United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">19,309<span></span>
</td>
<td class="nump">19,059<span></span>
</td>
<td class="nump">22,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember', window );">Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">2,593<span></span>
</td>
<td class="nump">1,888<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">818<span></span>
</td>
<td class="nump">536<span></span>
</td>
<td class="nump">971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember', window );">Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">61,910<span></span>
</td>
<td class="nump">62,739<span></span>
</td>
<td class="nump">44,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember', window );">Recognized at a point in time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">128,013<span></span>
</td>
<td class="nump">65,642<span></span>
</td>
<td class="nump">4,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Rendering of services</a></td>
<td class="nump">14,879<span></span>
</td>
<td class="nump">15,947<span></span>
</td>
<td class="nump">19,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Sales of goods</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">15,641<span></span>
</td>
<td class="nump">16,951<span></span>
</td>
<td class="nump">21,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | -Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Middle East</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">14,940<span></span>
</td>
<td class="nump">16,711<span></span>
</td>
<td class="nump">20,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | -United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">14,940<span></span>
</td>
<td class="nump">16,711<span></span>
</td>
<td class="nump">20,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">14,879<span></span>
</td>
<td class="nump">15,947<span></span>
</td>
<td class="nump">17,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Recognized at a point in time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">4,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Rendering of services</a></td>
<td class="nump">27,900<span></span>
</td>
<td class="nump">22,108<span></span>
</td>
<td class="nump">27,258<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">27,900<span></span>
</td>
<td class="nump">22,108<span></span>
</td>
<td class="nump">27,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">5,425<span></span>
</td>
<td class="nump">5,605<span></span>
</td>
<td class="nump">7,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | -Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | -Netherlands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | Middle East</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">16,315<span></span>
</td>
<td class="nump">12,568<span></span>
</td>
<td class="nump">13,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | -Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">2,950<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">2,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | -United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">2,763<span></span>
</td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">2,499<span></span>
</td>
<td class="nump">1,851<span></span>
</td>
<td class="nump">2,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">27,900<span></span>
</td>
<td class="nump">22,108<span></span>
</td>
<td class="nump">&#8364; 27,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Rendering of services</a></td>
<td class="nump">146,380<span></span>
</td>
<td class="nump">88,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Sales of goods</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">146,382<span></span>
</td>
<td class="nump">89,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">144,669<span></span>
</td>
<td class="nump">88,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | -Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">140,922<span></span>
</td>
<td class="nump">80,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | -Netherlands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">3,616<span></span>
</td>
<td class="nump">6,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | -United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Recognized over time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">19,131<span></span>
</td>
<td class="nump">24,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Recognized at a point in time.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total Revenues from contracts with external customers</a></td>
<td class="nump">&#8364; 127,251<span></span>
</td>
<td class="nump">&#8364; 64,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of services. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_NL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_NL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=cntg_IfrsMiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=cntg_IfrsMiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_SA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_SA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_Covid19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_Covid19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048236570712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment information and revenue from contracts with customers - Contract balances (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">Trade receivables (note 15)</a></td>
<td class="nump">&#8364; 21,065<span></span>
</td>
<td class="nump">&#8364; 25,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentContractAssets', window );">Contract assets (note 15)</a></td>
<td class="nump">3,272<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract liabilities (note 19.2)</a></td>
<td class="nump">&#8364; 4,842<span></span>
</td>
<td class="nump">&#8364; 4,479<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract assets. [Refer: Contract assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from contracts with customers. [Refer: Receivables from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232397080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information and revenue from contracts with customers - Additional information (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>customer</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 779<span></span>
</td>
<td class="nump">&#8364; 4,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RealEstateTransferTaxExpenses', window );">Real estate transfer tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">8,147<span></span>
</td>
<td class="nump">16,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">18,904<span></span>
</td>
<td class="nump">22,120<span></span>
</td>
<td class="nump">24,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">189,923<span></span>
</td>
<td class="nump">128,381<span></span>
</td>
<td class="nump">48,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ProvisionForExpectedCreditLossesOnContractAssets', window );">Provision for expected credit losses on contract assets</a></td>
<td class="nump">483<span></span>
</td>
<td class="nump">356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Revenues recognized for contract liabilities</a></td>
<td class="nump">2,506<span></span>
</td>
<td class="nump">2,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Performance obligations</a></td>
<td class="nump">2,336<span></span>
</td>
<td class="nump">1,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">-United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">709<span></span>
</td>
<td class="nump">1,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">19,309<span></span>
</td>
<td class="nump">19,059<span></span>
</td>
<td class="nump">22,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">-Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">141,133<span></span>
</td>
<td class="nump">81,065<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember', window );">Follow-on Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_IfrsIPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">&#8364; 15,641<span></span>
</td>
<td class="nump">&#8364; 16,951<span></span>
</td>
<td class="nump">&#8364; 21,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | Pharmaceutical Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCustomersInGroup', window );">Number of customer in group | customer</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">8.60%<span></span>
</td>
<td class="nump">24.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">&#8364; 455<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 1,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | -United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">&#8364; 14,940<span></span>
</td>
<td class="nump">16,711<span></span>
</td>
<td class="nump">20,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember', window );">Pharmaceutical | -Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCustomersInGroup', window );">Number of customer in group | customer</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">&#8364; 146,382<span></span>
</td>
<td class="nump">&#8364; 89,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Covid-19 Partner One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">14.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | Covid-19 Partner Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | -United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">&#8364; 1,606<span></span>
</td>
<td class="nump">&#8364; 978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | -Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">140,922<span></span>
</td>
<td class="nump">80,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CapitalizedInvestment', window );">Capitalized investment</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | -Germany | Property Plant And Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CapitalizedInvestment', window );">Capitalized investment</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19 | -Germany | Intangible assets other than goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Segment information and revenue from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CapitalizedInvestment', window );">Capitalized investment</a></td>
<td class="nump">&#8364; 400<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_CapitalizedInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_CapitalizedInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfCustomersInGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents the number of customer in group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfCustomersInGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ProvisionForExpectedCreditLossesOnContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for expected credit losses on contract assets, recognized by the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ProvisionForExpectedCreditLossesOnContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_RealEstateTransferTaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount represents the real estate transfer tax expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_RealEstateTransferTaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMajorCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMajorCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_IfrsIPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSubsidiarySaleOfStockAxis=cntg_IfrsIPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_PharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=cntg_PharmaceuticalPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=cntg_PharmaceuticalPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_Covid19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_Covid19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=cntg_Covid19PartnerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=cntg_Covid19PartnerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=cntg_Covid19PartnerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=cntg_Covid19PartnerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsBalanceSheetLocationAxis=ifrs-full_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsBalanceSheetLocationAxis=ifrs-full_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsBalanceSheetLocationAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsBalanceSheetLocationAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230983960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income and expenses - Other Operating Income (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,263<span></span>
</td>
<td class="nump">&#8364; 2,152<span></span>
</td>
<td class="nump">&#8364; 2,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment', window );">Gain on disposal of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Exchange rate gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReversalsOfProvisions', window );">Income from the reversal of provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Total other operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,936<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Employee benefits expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,296<span></span>
</td>
<td class="nump">39,271<span></span>
</td>
<td class="nump">32,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans', window );">Contributions to state pension scheme (defined contribution plan)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,706<span></span>
</td>
<td class="nump">1,851<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_InfrequentItemsAxis=cntg_Covid19Member', window );">COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GainLossFromForgivenessOfLoan', window );">Gain from forgiveness of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember', window );">Supervisory board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Employee benefits expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,252<span></span>
</td>
<td class="nump">&#8364; 2,775<span></span>
</td>
<td class="nump">&#8364; 1,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember', window );">Rostock headquarters building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease Term</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_GainLossFromForgivenessOfLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized due to forgiveness of loan from bank.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_GainLossFromForgivenessOfLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_LeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for lease term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_LeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherIncomeExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The information about other income expense line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherIncomeExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gain on the disposal of property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReversalsOfProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reversals of provisions that the entity does not separately disclose in the same statement or note. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReversalsOfProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_InfrequentItemsAxis=cntg_Covid19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_InfrequentItemsAxis=cntg_Covid19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232282360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income and expenses - Other Operating Expenses (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Currency losses</a></td>
<td class="nump">&#8364; 86<span></span>
</td>
<td class="nump">&#8364; 10<span></span>
</td>
<td class="nump">&#8364; 192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Total other operating expenses</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Cost incurred related to the IPO</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 779<span></span>
</td>
<td class="nump">4,899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_IfrsIPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Cost incurred related to the IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,092<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherIncomeExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The information about other income expense line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherIncomeExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_IfrsIPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSubsidiarySaleOfStockAxis=cntg_IfrsIPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230374392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income and expenses - LPC GmbH (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="nump">&#8364; 95<span></span>
</td>
<td class="nump">&#8364; 193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember', window );">LPC GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseLineItems', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Consideration for disposal of subsidiary</a></td>
<td class="nump">&#8364; 213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ConsiderationToBePaidOverTime', window );">Consideration to be paid over time</a></td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ConsiderationPaymentDuePeriod', window );">Payment due period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ConsiderationOutstanding', window );">Consideration outstanding</a></td>
<td class="nump">&#8364; 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="num">(268)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Profit/(loss) allocated to non-controlling interest</a></td>
<td class="num">&#8364; (101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ConsiderationOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ConsiderationOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ConsiderationPaymentDuePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration payment due period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ConsiderationPaymentDuePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ConsiderationToBePaidOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration to be paid over time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ConsiderationToBePaidOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherIncomeExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The information about other income expense line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherIncomeExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237417144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income and expenses - Financial costs, net (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseDisclosureAbstract', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBorrowings', window );">Interest expenses from loans</a></td>
<td class="num">&#8364; (267)<span></span>
</td>
<td class="num">&#8364; (173)<span></span>
</td>
<td class="num">&#8364; (1,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrencyLossesFinanceCost', window );">Currency losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Unwinding of the discount on lease liabilities</a></td>
<td class="num">(584)<span></span>
</td>
<td class="num">(865)<span></span>
</td>
<td class="num">(339)<span></span>
</td>
<td class="num">$ (339)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestIncomeOnLoansAndReceivables', window );">Interest income from loans and receivables</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial costs, net</a></td>
<td class="num">&#8364; (848)<span></span>
</td>
<td class="num">&#8364; (1,394)<span></span>
</td>
<td class="num">&#8364; (2,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_CurrencyLossesFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost associated with interest and other financing activities due to currency losses incurred by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_CurrencyLossesFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherIncomeExpenseDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherIncomeExpenseDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeOnLoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income on loans and receivables. [Refer: Interest income; Loans and receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_112_c&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeOnLoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230972440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income and expenses - Employee benefits expense (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherIncomeExpenseDisclosureAbstract', window );"><strong>Other income and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and salaries</a></td>
<td class="nump">&#8364; 43,533<span></span>
</td>
<td class="nump">&#8364; 31,121<span></span>
</td>
<td class="nump">&#8364; 23,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SocialSecurityContributions', window );">Social security contributions</a></td>
<td class="nump">6,134<span></span>
</td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">3,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based payments</a></td>
<td class="nump">5,471<span></span>
</td>
<td class="nump">3,486<span></span>
</td>
<td class="nump">5,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TerminationBenefitsExpense', window );">Termination benefits</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">569<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Total</a></td>
<td class="nump">&#8364; 56,296<span></span>
</td>
<td class="nump">&#8364; 39,271<span></span>
</td>
<td class="nump">&#8364; 32,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherIncomeExpenseDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherIncomeExpenseDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SocialSecurityContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SocialSecurityContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TerminationBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense in relation to termination benefits. Termination benefits are employee benefits provided in exchange for the termination of an employee's employment as a result of either: (a) an entity's decision to terminate an employee's employment before the normal retirement date; or (b) an employee's decision to accept an offer of benefits in exchange for the termination of employment. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 171<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_171&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TerminationBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256343880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Taxes recognized through profit or loss (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods', window );">Current tax expenses</a></td>
<td class="num">&#8364; (118)<span></span>
</td>
<td class="num">&#8364; (74)<span></span>
</td>
<td class="num">&#8364; (158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current year</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod', window );">Adjustments for prior periods</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax (expense)/income</a></td>
<td class="nump">142<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences', window );">Temporary differences</a></td>
<td class="nump">142<span></span>
</td>
<td class="num">(182)<span></span>
</td>
<td class="num">(514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense', window );">Tax losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax (expenses)/ benefit</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Income taxes recognized directly in other comprehensive income</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of benefit/(expense) arising from a previously unrecognised tax loss, tax credit or temporary difference of a prior period that is used to reduce/(increase) deferred tax expense. [Refer: Deferred tax expense (income); Temporary differences [member]; Unused tax losses [member]; Unused tax credits [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments of tax expense (income) recognised in the period for current tax of prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current tax expense (income) and adjustments for the current tax of prior periods. [Refer: Current tax expense (income); Adjustments for current tax of prior periods]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph ab<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_ab&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 90<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_90&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230981656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory rate (as a percent)</a></td>
<td class="nump">31.10%<span></span>
</td>
<td class="nump">31.10%<span></span>
</td>
<td class="nump">31.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss before tax</a></td>
<td class="num">&#8364; (46,876)<span></span>
</td>
<td class="num">&#8364; (21,097)<span></span>
</td>
<td class="num">&#8364; (20,697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Taxes on the basis of the Company's domestic tax rate</a></td>
<td class="nump">14,596<span></span>
</td>
<td class="nump">6,570<span></span>
</td>
<td class="nump">6,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfForeignTaxRates', window );">Tax rate effect of foreign tax jurisdictions</a></td>
<td class="nump">882<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Non-deductible expenses</a></td>
<td class="num">(3,030)<span></span>
</td>
<td class="num">(903)<span></span>
</td>
<td class="num">(441)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Current year losses for which no deferred tax assets were recognized</a></td>
<td class="num">(12,211)<span></span>
</td>
<td class="num">(5,792)<span></span>
</td>
<td class="num">(6,416)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact', window );">Tax income related to prior years</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other effects</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax (expenses)/ benefit</a></td>
<td class="nump">&#8364; 24<span></span>
</td>
<td class="num">&#8364; (281)<span></span>
</td>
<td class="num">&#8364; (158)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember', window );">Domestic tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory rate (as a percent)</a></td>
<td class="nump">31.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CorporateIncomeTaxRate', window );">Corporate income tax rate (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_SolidaritySurchargeRate', window );">Solidarity surcharge (as a percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TradeTaxRate', window );">Trade tax rate (as a percent)</a></td>
<td class="nump">15.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments of tax expense (income) recognised in the period for current tax of prior periods, including deferred tax impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_CorporateIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of corporate income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_CorporateIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_SolidaritySurchargeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of solidarity surcharge on corporate income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_SolidaritySurchargeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TradeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of trade tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TradeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048233505224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Deferred Taxes (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences, for which no deferred tax asset is recognized</a></td>
<td class="nump">&#8364; 1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures', window );">Temporary differences associated with investments for which no deferred tax liability has been recognized</a></td>
<td class="nump">5,656<span></span>
</td>
<td class="nump">&#8364; 4,313<span></span>
</td>
<td class="nump">&#8364; 4,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">7,033<span></span>
</td>
<td class="nump">8,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(7,112)<span></span>
</td>
<td class="num">(8,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DeferredTaxAssetsOffset', window );">Deferred tax assets, Offset</a></td>
<td class="num">(7,033)<span></span>
</td>
<td class="num">(8,034)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DeferredTaxLiabilitiesOffset', window );">Deferred tax liabilities, Offset</a></td>
<td class="nump">7,033<span></span>
</td>
<td class="nump">8,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred Taxes</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DeferredTaxLiabilitiesNet', window );">Deferred Taxes</a></td>
<td class="num">(79)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">-Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Tax losses carryforwards for which no deferred tax assets were recognized</a></td>
<td class="nump">85,639<span></span>
</td>
<td class="nump">64,464<span></span>
</td>
<td class="nump">41,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=cntg_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Tax losses carryforwards for which no deferred tax assets were recognized</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="nump">1,002<span></span>
</td>
<td class="nump">&#8364; 505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember', window );">Intangible assets other than goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(2,439)<span></span>
</td>
<td class="num">(2,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_PropertyPlantAndEquipmentMember', window );">Property Plant And Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(4,617)<span></span>
</td>
<td class="num">(5,029)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=cntg_MeasurementOfServiceContractsMember', window );">Measurement of service contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">4,563<span></span>
</td>
<td class="nump">4,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=cntg_GovernmentGrantsMember', window );">Government grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,693<span></span>
</td>
<td class="nump">1,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Unused tax losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">&#8364; 777<span></span>
</td>
<td class="nump">&#8364; 1,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DeferredTaxAssetsOffset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax asset offset against deferred tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DeferredTaxAssetsOffset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DeferredTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of offsets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DeferredTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DeferredTaxLiabilitiesOffset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities offset against deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DeferredTaxLiabilitiesOffset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements, for which deferred tax liabilities have not been recognised as a result of satisfying both of the following conditions: (a) the parent, investor, joint venturer or joint operator is able to control the timing of the reversal of the temporary difference; and (b) it is probable that the temporary difference will not reverse in the foreseeable future. [Refer: Associates [member]; Subsidiaries [member]; Temporary differences [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=cntg_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=cntg_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=cntg_MeasurementOfServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=cntg_MeasurementOfServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=cntg_GovernmentGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=cntg_GovernmentGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048257444728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of outstanding shares after adjusted for the effect of the corporate reorganization</a></td>
<td class="nump">22,437,301<span></span>
</td>
<td class="nump">20,909,673<span></span>
</td>
<td class="nump">16,409,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230343528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">&#8364; 12,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">9,194<span></span>
</td>
<td class="nump">&#8364; 12,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_BiomarkersAndDatabasesMember', window );">Biomarkers and databases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment expense</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MethodsOfGenerationAxis=ifrs-full_InternallyGeneratedMember', window );">Internally generated /acquired | Biomarkers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">3,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">3,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MethodsOfGenerationAxis=ifrs-full_InternallyGeneratedMember', window );">Internally generated /acquired | Database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">6,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclass</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">6,506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MethodsOfGenerationAxis=ifrs-full_NotInternallyGeneratedMember', window );">Purchased | Rights, licenses, software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">2,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">2,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">28,040<span></span>
</td>
<td class="nump">21,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">2,787<span></span>
</td>
<td class="nump">6,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill', window );">Deconsolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">30,827<span></span>
</td>
<td class="nump">28,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost | Internally generated /acquired | Biomarkers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">13,922<span></span>
</td>
<td class="nump">12,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">749<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclass</a></td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">14,374<span></span>
</td>
<td class="nump">13,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost | Internally generated /acquired | Database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">9,219<span></span>
</td>
<td class="nump">6,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">1,652<span></span>
</td>
<td class="nump">2,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclass</a></td>
<td class="num">(297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">11,168<span></span>
</td>
<td class="nump">9,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost | Purchased | Rights, licenses, software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="nump">4,899<span></span>
</td>
<td class="nump">3,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">2,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill', window );">Deconsolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="nump">5,285<span></span>
</td>
<td class="nump">4,899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="num">(15,633)<span></span>
</td>
<td class="num">(7,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill', window );">Deconsolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization and impairment</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">8,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="num">(21,633)<span></span>
</td>
<td class="num">(15,633)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment | Internally generated /acquired | Biomarkers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="num">(10,748)<span></span>
</td>
<td class="num">(3,831)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill', window );">Deconsolidation</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization and impairment</a></td>
<td class="nump">2,149<span></span>
</td>
<td class="nump">6,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="num">(12,829)<span></span>
</td>
<td class="num">(10,748)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment | Internally generated /acquired | Database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="num">(2,713)<span></span>
</td>
<td class="num">(1,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill', window );">Deconsolidation</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization and impairment</a></td>
<td class="nump">1,991<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="num">(4,772)<span></span>
</td>
<td class="num">(2,713)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment | Purchased | Rights, licenses, software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the beginning of the year</a></td>
<td class="num">(2,172)<span></span>
</td>
<td class="num">(1,788)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill', window );">Deconsolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization and impairment</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, at the end of the year</a></td>
<td class="num">&#8364; (4,032)<span></span>
</td>
<td class="num">&#8364; (2,172)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in intangible assets other than goodwill resulting from deconsolidations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_BiomarkersAndDatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_BiomarkersAndDatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodsOfGenerationAxis=ifrs-full_InternallyGeneratedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodsOfGenerationAxis=ifrs-full_InternallyGeneratedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_BiomarkersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_BiomarkersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_DatabaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cntg_DatabaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodsOfGenerationAxis=ifrs-full_NotInternallyGeneratedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodsOfGenerationAxis=ifrs-full_NotInternallyGeneratedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230794248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,147<span></span>
</td>
<td class="nump">&#8364; 16,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_Covid19Member', window );">COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life of property, plant and equipment</a></td>
<td class="text">8 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">33 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,463<span></span>
</td>
<td class="nump">2,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_PlantMember', window );">Plant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">5,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OtherEquipmentFurnitureAndFixturesMember', window );">Other equipment, furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
<td class="nump">7,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,073<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment', window );">Reclass from (to) right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,165<span></span>
</td>
<td class="nump">3,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
<td class="nump">9,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,097)<span></span>
</td>
<td class="num">(612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,056<span></span>
</td>
<td class="nump">30,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,359<span></span>
</td>
<td class="nump">3,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,364<span></span>
</td>
<td class="nump">3,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost | Plant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,124<span></span>
</td>
<td class="nump">9,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment', window );">Reclass from (to) right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,165<span></span>
</td>
<td class="nump">3,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,054<span></span>
</td>
<td class="nump">14,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost | Other equipment, furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,590<span></span>
</td>
<td class="nump">4,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
<td class="nump">8,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(718)<span></span>
</td>
<td class="num">(612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,638<span></span>
</td>
<td class="nump">12,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,483)<span></span>
</td>
<td class="num">(9,320)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment', window );">Reclass from (to) right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(493)<span></span>
</td>
<td class="num">(1,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,307<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,909)<span></span>
</td>
<td class="num">(13,483)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(586)<span></span>
</td>
<td class="num">(392)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(901)<span></span>
</td>
<td class="num">(586)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment | Plant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,255)<span></span>
</td>
<td class="num">(6,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment', window );">Reclass from (to) right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(493)<span></span>
</td>
<td class="num">(1,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,519<span></span>
</td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,110)<span></span>
</td>
<td class="num">(8,255)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortization and impairment | Other equipment, furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the beginning of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,642)<span></span>
</td>
<td class="num">(2,773)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,473<span></span>
</td>
<td class="nump">1,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance, at the end of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (11,898)<span></span>
</td>
<td class="num">&#8364; (4,642)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers from (to) right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_Covid19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_Covid19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_PlantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_PlantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OtherEquipmentFurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OtherEquipmentFurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232198952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>contract</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember', window );">Rostock headquarters building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTimesLeaseContractCanBeExtended', window );">Number of times the lease contract can be extended | contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseExtensionTerm', window );">Lease contract extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RentalExpense', window );">Rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingAndBerlinOfficesMember', window );">Rostock headquarters building and Berlin offices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BankGuarantee', window );">Bank guarantee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Short term deposits pledged as security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficesInBerlinMember', window );">Offices in Berlin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficesInBostonMember', window );">Offices in Boston</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_PlantAndMachineryMember', window );">Plant and machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RentalDeposits', window );">Rental deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_OtherEquipmentMember', window );">Other equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember', window );">Certain motor vehicles and premises | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BankGuarantee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of guarantee provided by bank.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BankGuarantee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_LeaseExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extension term of the lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_LeaseExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_LeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for lease term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_LeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfTimesLeaseContractCanBeExtended">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of times the lease contract can be extended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfTimesLeaseContractCanBeExtended</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_RentalDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rental deposits to be maintained by the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_RentalDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised on rental activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingAndBerlinOfficesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingAndBerlinOfficesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficesInBerlinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_OfficesInBerlinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficesInBostonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_OfficesInBostonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_PlantAndMachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_PlantAndMachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_OtherEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_OtherEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048233216984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">&#8364; 22,120<span></span>
</td>
<td class="nump">&#8364; 24,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="nump">1,452<span></span>
</td>
<td class="nump">2,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment', window );">Reclass to property, plant &amp; equipment</a></td>
<td class="num">(672)<span></span>
</td>
<td class="num">(1,992)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation expenses</a></td>
<td class="num">(3,996)<span></span>
</td>
<td class="num">(3,660)<span></span>
</td>
<td class="num">$ (1,807)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">18,904<span></span>
</td>
<td class="nump">22,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">12,005<span></span>
</td>
<td class="nump">13,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation expenses</a></td>
<td class="num">(1,121)<span></span>
</td>
<td class="num">(1,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">10,884<span></span>
</td>
<td class="nump">12,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficesMember', window );">Offices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">4,176<span></span>
</td>
<td class="nump">4,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation expenses</a></td>
<td class="num">(970)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">3,339<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_PlantAndEquipmentMember', window );">Plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">4,587<span></span>
</td>
<td class="nump">6,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment', window );">Reclass to property, plant &amp; equipment</a></td>
<td class="num">(672)<span></span>
</td>
<td class="num">(1,992)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation expenses</a></td>
<td class="num">(1,745)<span></span>
</td>
<td class="num">(1,675)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">3,291<span></span>
</td>
<td class="nump">4,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_OtherEquipmentMember', window );">Other equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation expenses</a></td>
<td class="num">(138)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">1,356<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation expenses</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">&#8364; 34<span></span>
</td>
<td class="nump">&#8364; 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of right-of-use assets reclassed to property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_OfficesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_PlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_PlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_OtherEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_OtherEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237382840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets - Carrying amounts of lease liabilities and the movements during the period (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Beginning balance</a></td>
<td class="nump">&#8364; 21,205<span></span>
</td>
<td class="nump">&#8364; 21,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsLeaseLiabilities', window );">Additions</a></td>
<td class="nump">1,452<span></span>
</td>
<td class="nump">3,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expenses</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">865<span></span>
</td>
<td class="nump">&#8364; 339<span></span>
</td>
<td class="nump">$ 339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DecreaseThroughPaymentsLeaseLiabilities', window );">Payments</a></td>
<td class="num">(4,244)<span></span>
</td>
<td class="num">(5,018)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Ending balance</a></td>
<td class="nump">18,997<span></span>
</td>
<td class="nump">21,205<span></span>
</td>
<td class="nump">&#8364; 21,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current lease liabilities.</a></td>
<td class="nump">3,409<span></span>
</td>
<td class="nump">3,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities.</a></td>
<td class="nump">&#8364; 15,588<span></span>
</td>
<td class="nump">&#8364; 17,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DecreaseThroughPaymentsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in lease liabilities, resulting from payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DecreaseThroughPaymentsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IncreaseThroughAdditionsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in lease liabilities, resulting from additions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IncreaseThroughAdditionsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237275624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets - Amounts recognised in profit or loss (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation expense of right-of-use assets</a></td>
<td class="nump">&#8364; 3,996<span></span>
</td>
<td class="nump">&#8364; 3,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expenses on lease liabilities</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">865<span></span>
</td>
<td class="nump">&#8364; 339<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed', window );">Rent expenses - short-term leases</a></td>
<td class="nump">7,175<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Rent expense - leases of low-value assets</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TotalLeaseExpensesRecognisedInProfitOrLoss', window );">Total amounts recognized in profit or loss</a></td>
<td class="nump">11,803<span></span>
</td>
<td class="nump">6,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Total cash outflows for leases</a></td>
<td class="nump">&#8364; 11,467<span></span>
</td>
<td class="nump">&#8364; 6,746<span></span>
</td>
<td class="nump">&#8364; 3,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TotalLeaseExpensesRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of lease expenses recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TotalLeaseExpensesRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048233505960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets - Sale and Leaseback transactions (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RealEstateTransferTaxExpenses', window );">Real estate transfer tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from sale of land and building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Loans repaid using the consideration from sale of land and building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 464<span></span>
</td>
<td class="nump">&#8364; 2,760<span></span>
</td>
<td class="nump">12,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment', window );">Grants refunded related to disposed property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember', window );">Rostock headquarters building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LeaseTerm', window );">Lease term</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_LeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for lease term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_LeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow relating to grants refunded related to disposal of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_RealEstateTransferTaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount represents the real estate transfer tax expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_RealEstateTransferTaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237357416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies', window );">Raw materials, consumables and supplies</a></td>
<td class="nump">&#8364; 3,831<span></span>
</td>
<td class="nump">&#8364; 11,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods and merchandise</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">3,869<span></span>
</td>
<td class="nump">11,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Inventory write-down</a></td>
<td class="nump">1,795<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod', window );">Raw materials, consumables and changes in inventories of finished goods and work in process recorded as expenses</a></td>
<td class="nump">&#8364; 70,089<span></span>
</td>
<td class="nump">&#8364; 41,594<span></span>
</td>
<td class="nump">&#8364; 11,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories recognised as an expense during the period. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of current raw materials and current production supplies. [Refer: Current production supplies; Current raw materials]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232354696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other receivables and other assets (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RentalDepositsNoncurrent', window );">Other assets-Rental deposits</a></td>
<td class="nump">&#8364; 2,922<span></span>
</td>
<td class="nump">&#8364; 1,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other assets-Others</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent', window );">Trade receivables and contract assets and other assets non-current</a></td>
<td class="nump">2,972<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">Trade receivables</a></td>
<td class="nump">21,065<span></span>
</td>
<td class="nump">25,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentContractAssets', window );">Contract assets</a></td>
<td class="nump">3,272<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011', window );">Payables due to holders of vested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders', window );">Other assets</a></td>
<td class="nump">5,453<span></span>
</td>
<td class="nump">8,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent', window );">Trade receivables and contract assets and other assets current</a></td>
<td class="nump">29,790<span></span>
</td>
<td class="nump">37,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent', window );">Total non-current and current trade and other receivables and other assets</a></td>
<td class="nump">&#8364; 32,762<span></span>
</td>
<td class="nump">39,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ReceivablesPaymentTerms', window );">Receivables payment terms</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ReceivablesPaymentTerms', window );">Receivables payment terms</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">Current value added tax receivables</a></td>
<td class="nump">&#8364; 253<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">3,346<span></span>
</td>
<td class="nump">4,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted', window );">Receivables from exercise of share based payments granted</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions', window );">Receivables from COVID 19 bank or credit card transactions</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_GrantsReceivables', window );">Receivables from grants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">&#8364; 442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets | Rostock headquarters building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Cash deposits provided as security for bank loans</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BankGuarantee', window );">Bank guarantee</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets | Berlin Offices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Cash deposits provided as security for bank loans</a></td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BankGuarantee', window );">Bank guarantee</a></td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets | Other property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RentalDepositsNoncurrent', window );">Other assets-Rental deposits</a></td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets | Other office and laboratories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Cash deposits provided as security for bank loans</a></td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets | LPC GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ConsiderationReceivableForSaleOfLpc', window );">Consideration receivable for the sale of LPC</a></td>
<td class="nump">&#8364; 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BankGuarantee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of guarantee provided by bank.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BankGuarantee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ConsiderationReceivableForSaleOfLpc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of consideration receivable for the sale of LPC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ConsiderationReceivableForSaleOfLpc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from COVID 19 bank or credit card transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from exercise of share based payments granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_GrantsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of grants receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_GrantsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets, excluding receivables due from shareholders, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ReceivablesPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of time after invoice when trade receivables are due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ReceivablesPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_RentalDepositsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of rental deposits maintained by the company, classified as non-current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_RentalDepositsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of trade and other receivables and other assets, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of trade receivables and contract assets and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of trade and other receivables and other assets, classified as non-current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract assets. [Refer: Contract assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from contracts with customers. [Refer: Receivables from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities arising from share-based payment transactions. Share-based payment transactions are transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_RostockHeadquartersBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_RostockHeadquartersBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_BerlinOfficesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_BerlinOfficesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OtherOfficeAndLaboratoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cntg_OtherOfficeAndLaboratoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232011816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and short-term deposits (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=cntg_SecuredBankLoanMember', window );">Secured bank loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Borrowings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Short term deposits pledged as security</a></td>
<td class="nump">&#8364; 938<span></span>
</td>
<td class="nump">&#8364; 1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityMember', window );">Overdraft facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Borrowings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Short term deposits pledged as security</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityOneMember', window );">Existing Overdraft facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Borrowings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Short term deposits pledged as security</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">&#8364; 2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityTwoMember', window );">Second Overdraft facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Borrowings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityThreeMember', window );">Third Overdraft facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Borrowings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_SecuredBankLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_SecuredBankLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237283640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Issued capital and capital reserve (Details) - Common shares - &#8364; / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid', window );">Number of shares issued and fully paid, Beginning</a></td>
<td class="nump">22,117,643<span></span>
</td>
<td class="nump">19,861,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Issued shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExerciseOfOptionsShares', window );">Exercise of options</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">256,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid', window );">Number of shares issued and fully paid, Ending</a></td>
<td class="nump">22,567,971<span></span>
</td>
<td class="nump">22,117,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Authorized common shares</a></td>
<td class="nump">79,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euros per share)</a></td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ExerciseOfOptionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ExerciseOfOptionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity, for which full payment has been received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssuedAndFullyPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256929272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Common Shares (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Increase (decrease) in number of ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AuthorizedButUnissuedShareCapital', window );">Authorized but unissued share capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,772<span></span>
</td>
<td class="nump">&#8364; 6,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid', window );">Number of shares issued and fully paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,567,971<span></span>
</td>
<td class="nump">22,117,643<span></span>
</td>
<td class="nump">19,861,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember', window );">Follow-on public offering | Common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders', window );">Total number of shares issued and sold in follow-on public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCommonSharesOfferedByPriorShareholders', window );">Number of shares offered by existing shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues', window );">Public offering price (in dollars per share) | (per share)</a></td>
<td class="nump">$ 14.00<span></span>
</td>
<td class="nump">&#8364; 12.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember', window );">Follow-on public offering | The Company | Common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Increase (decrease) in number of ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AuthorizedButUnissuedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of authorized but unissued share capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AuthorizedButUnissuedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of common shares issued and offered by existing shareholders in conjunction with the follow-on public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfCommonSharesOfferedByPriorShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares offered by existing shareholders in conjunction with the follow-on public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfCommonSharesOfferedByPriorShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering price per share of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity, for which full payment has been received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssuedAndFullyPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cntg_CentogeneN.vMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cntg_CentogeneN.vMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237496168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity - Capital Reserves (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_CapitalReserveMember', window );">Capital reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium included in capital reserve</a></td>
<td class="nump">&#8364; 106,665<span></span>
</td>
<td class="nump">&#8364; 107,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_CapitalReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_CapitalReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256269432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Interest-bearing loans (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NonCurrentFinancialLiabilitiesInterestBearing', window );">Total non-current liabilities</a></td>
<td class="nump">&#8364; 15,588<span></span>
</td>
<td class="nump">&#8364; 18,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentFinancialLiabilitiesInterestBearing', window );">Total current liabilities</a></td>
<td class="nump">7,224<span></span>
</td>
<td class="nump">6,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Total non-current and current liabilities</a></td>
<td class="nump">22,812<span></span>
</td>
<td class="nump">24,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_BorrowingsByNameMember', window );">Total loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NonCurrentFinancialLiabilitiesInterestBearing', window );">Total non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentFinancialLiabilitiesInterestBearing', window );">Total current liabilities</a></td>
<td class="nump">3,815<span></span>
</td>
<td class="nump">2,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_SecuredCreditLinesMember', window );">Secured bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NonCurrentFinancialLiabilitiesInterestBearing', window );">Total non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentFinancialLiabilitiesInterestBearing', window );">Total current liabilities</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Short term deposits pledged as security</a></td>
<td class="nump">938<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_OtherBankLoansMember', window );">Other bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentFinancialLiabilitiesInterestBearing', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Total non-current and current liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_IfrsBankOverdraftsMember', window );">Bank overdrafts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentFinancialLiabilitiesInterestBearing', window );">Total current liabilities</a></td>
<td class="nump">3,310<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NonCurrentFinancialLiabilitiesInterestBearing', window );">Total non-current liabilities</a></td>
<td class="nump">15,588<span></span>
</td>
<td class="nump">17,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_CurrentFinancialLiabilitiesInterestBearing', window );">Total current liabilities</a></td>
<td class="nump">3,409<span></span>
</td>
<td class="nump">3,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Total non-current and current liabilities</a></td>
<td class="nump">&#8364; 18,997<span></span>
</td>
<td class="nump">&#8364; 21,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_CurrentFinancialLiabilitiesInterestBearing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities interest bearing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_CurrentFinancialLiabilitiesInterestBearing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_FinancialLiabilitiesInterestBearing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities interest bearing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_FinancialLiabilitiesInterestBearing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NonCurrentFinancialLiabilitiesInterestBearing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities interest bearing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NonCurrentFinancialLiabilitiesInterestBearing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_BorrowingsByNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_BorrowingsByNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_SecuredCreditLinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_SecuredCreditLinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_OtherBankLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_OtherBankLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_IfrsBankOverdraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_IfrsBankOverdraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230962200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial liabilities - Conditions and statement of liabilities (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="nump">&#8364; 22,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 24,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Carrying amount</a></td>
<td class="nump">34,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Carrying amount</a></td>
<td class="nump">22,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank overdrafts</a></td>
<td class="nump">&#8364; 981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember', window );">Secured bank loans, bearing maturity period of 2017-25, three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Nominal interest rate (as a percent)</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="nump">&#8364; 505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Carrying amount</a></td>
<td class="nump">&#8364; 505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_OtherBankLoansMember', window );">Other bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Nominal interest rate (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Carrying amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsOneMember', window );">Bank overdrafts, one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Nominal interest rate (as a percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="nump">&#8364; 499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Carrying amount</a></td>
<td class="nump">&#8364; 499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsTwoMember', window );">Bank overdrafts, two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Nominal interest rate (as a percent)</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="nump">&#8364; 2,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Carrying amount</a></td>
<td class="nump">&#8364; 2,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsThreeMember', window );">Bank overdrafts, three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Nominal interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="nump">&#8364; 482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Carrying amount</a></td>
<td class="nump">482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="nump">18,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FinancialLiabilitiesInterestBearing', window );">Carrying amount</a></td>
<td class="nump">&#8364; 18,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum | Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Nominal interest rate (as a percent)</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Nominal interest rate at commencement of leases</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum | Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Nominal interest rate (as a percent)</a></td>
<td class="nump">9.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Nominal interest rate at commencement of leases</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityMember', window );">Overdraft facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ShortTermDepositsPledgedAsSecurityForLiabilities', window );">Short-term deposits, pledged as security</a></td>
<td class="nump">&#8364; 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityMember', window );">Overdraft facility | Bank overdrafts, one and three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ShortTermDepositsPledgedAsSecurityForLiabilities', window );">Short-term deposits, pledged as security</a></td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_FinancialLiabilitiesInterestBearing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities interest bearing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_FinancialLiabilitiesInterestBearing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ShortTermDepositsPledgedAsSecurityForLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits pledged as security for liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ShortTermDepositsPledgedAsSecurityForLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankOverdraftsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph C12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_C12_a&amp;doctype=Appendix&amp;subtype=C<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_OtherBankLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_OtherBankLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_OverdraftFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsOneAndThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=cntg_BankOverdraftsOneAndThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237292184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial liabilities - Trade payables and other liabilities (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">&#8364; 11,252<span></span>
</td>
<td class="nump">&#8364; 31,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">Government grants (deferred income)</a></td>
<td class="nump">9,396<span></span>
</td>
<td class="nump">10,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">4,842<span></span>
</td>
<td class="nump">4,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TradeAndOtherPayablesOther', window );">Others</a></td>
<td class="nump">14,632<span></span>
</td>
<td class="nump">13,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade payables and other liabilities</a></td>
<td class="nump">40,122<span></span>
</td>
<td class="nump">59,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentPayables', window );">Non-current</a></td>
<td class="nump">8,028<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Current</a></td>
<td class="nump">32,094<span></span>
</td>
<td class="nump">51,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Grants received for investment in property, plant and equipment</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="nump">&#8364; 793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ProvisionForOutstandingInvoices', window );">Provision for outstanding invoices</a></td>
<td class="nump">4,978<span></span>
</td>
<td class="nump">1,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Personnel related liabilities for vacation and bonuses</a></td>
<td class="nump">4,812<span></span>
</td>
<td class="nump">4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxPayables', window );">VAT payable</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">4,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LiabilitiesForWageAndChurchTax', window );">Liabilities for wage and church tax</a></td>
<td class="nump">&#8364; 1,040<span></span>
</td>
<td class="nump">&#8364; 1,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from grants received for investment in property, plant and equipment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_LiabilitiesForWageAndChurchTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for wage and church tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_LiabilitiesForWageAndChurchTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ProvisionForOutstandingInvoices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for outstanding invoices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ProvisionForOutstandingInvoices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TradeAndOtherPayablesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of trade and other payables, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TradeAndOtherPayablesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax payables. [Refer: Value added tax payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048362017752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jul. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2016CashSettledMember', window );">Virtual share option program 2016 (Cash-settled)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PaymentForSettlementOfStockOptions', window );">Payments for settlement of stock options</a></td>
<td class="nump">&#8364; 2,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PaymentForSettlementOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment for settlement of stock options. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PaymentForSettlementOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2016CashSettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2016CashSettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048255612024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details) - 2019 Plan<br></strong></div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants', window );">Maximum amount of share-based award grants allowed under the plan (as a percent)</a></td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital', window );">Additional share-based award grants allowed under the plan (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional share-based award grants allowed under the plan on January 1 2020 and on January 1 of each calendar year thereafter, expressed as a percentage of issued share capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of share-based award grants allowed under the plan expressed as a percentage of issued share capital immediately following the completion of the initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048232358376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 18, 2020 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>&#8364; / shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>Options </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#8364; / shares </div>
<div>Options </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>Options </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;) </div>
<div>Options </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,822<span></span>
</td>
<td class="nump">&#8364; 3,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember', window );">Equity share option 2017 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted', window );">Number of common shares per option granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price of share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering', window );">Lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at January 1 | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the year | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191,565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(256,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding as of December 31 | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549,005<span></span>
</td>
<td class="nump">805,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement', window );">Vested as of December 31 | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,440<span></span>
</td>
<td class="nump">357,440<span></span>
</td>
<td class="nump">549,005<span></span>
</td>
<td class="nump">549,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable as of December 31 | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,440<span></span>
</td>
<td class="nump">357,440<span></span>
</td>
<td class="nump">549,005<span></span>
</td>
<td class="nump">549,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract', window );"><strong>WAEP</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding as of January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement', window );">Cancelled during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised during the year | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.76<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">$ 12.13<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding as of December 31</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement', window );">Vested as of December 31</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable as of December 31</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price of share options granted</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract', window );"><strong>WAEP</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period subsequent to the completion of the initial public offering in which the options may not be exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfOutstandingShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfOutstandingShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options vested in a share-based payment arrangement."</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of common shares per share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageExercisePriceOfShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options cancelled in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>"The weighted average exercise price of share options vested in a share-based payment arrangement."</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048231325800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Equity Share Option (ESOP 2019) (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th">
<div>Feb. 07, 2022 </div>
<div>tranche</div>
</th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th">
<div>Dec. 18, 2020 </div>
<div>EquityInstruments </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 11, 2020 </div>
<div>Options</div>
</th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>Options </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Options </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember', window );">RSUs | Management | Vesting in four tranches | Grant of RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember', window );">Equity share option 2019 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Incremental fair value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at January 1 | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">396,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement', window );">Cancelled during the year | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(396,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement', window );">Replacement awards granted during the year | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding as of December 31 | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">396,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement', window );">Vested as of December 31 | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable as of December 31 | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract', window );"><strong>WAEP</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding as of January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement', window );">Cancelled during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding as of December 31</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember', window );">Equity share option 2019 (Equity settled) | Member of the supervisory board</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted', window );">Number of common shares per option granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOfShareOptionsOutstanding', window );">Weighted average fair value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 9.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract', window );"><strong>WAEP</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract', window );"><strong>WAEP</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs | Key management personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options | Key management personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Vest immediately | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Vest in two equal annual instalments | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which the right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement each year after grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period subsequent to grant date after which the share-based award expires.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfOutstandingShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfOutstandingShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options cancelled in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of replacement awards granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options vested in a share-based payment arrangement."</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equal tranches in which the granted RSU and options shall vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of common shares per share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageExercisePriceOfShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options cancelled in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageFairValueOfShareOptionsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageFairValueOfShareOptionsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference, for modified share-based payment arrangements, between the fair value of the modified equity instrument and that of the original equity instrument, both estimated as at the date of the modification. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=srt_ManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=srt_ManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cntg_VestingInFourTranchesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cntg_VestingInFourTranchesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_MemberOfSupervisoryBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_MemberOfSupervisoryBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsVestingAxis=cntg_ShareBasedPaymentArrangementTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsVestingAxis=cntg_ShareBasedPaymentArrangementTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsVestingAxis=cntg_ShareBasedPaymentArrangementTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsVestingAxis=cntg_ShareBasedPaymentArrangementTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048228289880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 18, 2020 </div>
<div>EquityInstruments</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 15, 2020 </div>
<div>Options</div>
</th>
<th class="th">
<div>Sep. 11, 2020 </div>
<div>Options </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>tranche</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember', window );">RSUs | Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Awards | item</a></td>
<td class="nump">62,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs | Key management personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs | Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs | Former Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs | Chief Information Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs | Supervisory board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSU Granted One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSU Granted Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSU Granted Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSU Granted Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSU Granted Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ThresholdTradingDays', window );">Trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options | Key management personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options | Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options | Former Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options | Chief Information Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options Granted Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ThresholdTradingDays', window );">Trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Tranche one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Tranche two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Tranche three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement each year after grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period subsequent to grant date after which the share-based award expires.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equal tranches in which the granted RSU and options shall vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold trading days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_FormerChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_FormerChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChiefInformationOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChiefInformationOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_RsuGrantedOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_RsuGrantedOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_RsuGrantedTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_RsuGrantedTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_RsuGrantedThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_RsuGrantedThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_RsuGrantedFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_RsuGrantedFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_RsuGrantedFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_RsuGrantedFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_OptionsGrantedTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_OptionsGrantedTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsVestingAxis=cntg_IfrsShareBasedPaymentArrangementTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsVestingAxis=cntg_IfrsShareBasedPaymentArrangementTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsVestingAxis=cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsVestingAxis=cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsVestingAxis=cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsVestingAxis=cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048226796328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Grants to new CEO and supervisory board grant (Details)<br> &#8364; / shares in Units, &#8364; in Thousands, SFr in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 05, 2021 </div>
<div>CHF (SFr) </div>
<div>installment</div>
</th>
<th class="th">
<div>Jun. 24, 2021 </div>
<div>Options </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 18, 2020 </div>
<div>EquityInstruments </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>installment </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>CHF (SFr) </div>
<div>USD ($) </div>
<div>installment</div>
</th>
<th class="th">
<div>Sep. 11, 2020 </div>
<div>Options</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>EquityInstruments </div>
<div>installment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>installment </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 25, 2021 </div>
<div>installment</div>
</th>
<th class="th">
<div>Nov. 25, 2020 </div>
<div>installment</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of shares | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23,209<span></span>
</td>
<td class="nump">&#8364; 46,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember', window );">Supervisory board members | Options | Mr. Berndt Modig | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfInstallments', window );">Number of Installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionsStrikePrice', window );">Strike price of options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract', window );"><strong>WAEP</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfInstallments', window );">Number of Installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement', window );">Value of equity ordinary shares | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement', window );">Maximum percentage of lost time injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_VolumeWeightedAverageStockPriceComputationTradingDays', window );">Period of tradings days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | Peer Schatz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfInstallments', window );">Number of Installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PercentageOfAwardConstitutesRestrictedStockUnits', window );">Percentage of award constitutes RSU's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | RSUs | Mr. Berndt Modig</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | RSUs | Peer Schatz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfInstallments', window );">Number of Installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | RSUs | Mr. Jonathan G. Sheldon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionsStrikePrice', window );">Strike price of options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PercentageOfAwardConstitutesStockOptions', window );">Percentage of award constitutes stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | Options | Mr. Berndt Modig</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members | Options | Mr. Jonathan G. Sheldon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Former Chief Executive Officer | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="nump">72,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfInstallments', window );">Number of Installments | installment</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments', window );">Value of ordinary shares to be issued as per share based payment arrangement | SFr</a></td>
<td class="nump">SFr 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="nump">72,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Former Chief Executive Officer | Performance Based RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfInstallments', window );">Number of Installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Former Chief Executive Officer | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOutstandingShareOptionsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Former Chief Executive Officer | Volume weighted average stock price equals or exceeds USD 24 prior to January 1st, 2023 | Performance Based RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of units vested during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement', window );">Share hurdle price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Exercised during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Former Chief Executive Officer | Volume weighted average stock price equals or exceeds USD 33 prior to January 1st, 2024. | Performance Based RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of units vested during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement', window );">Share hurdle price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfOtherEquityInstrumentsAbstract', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Exercised during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement', window );">Value of additional equity ordinary shares | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Vice chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement', window );">Value of additional equity ordinary shares | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Chairman of audit committee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement', window );">Value of additional equity ordinary shares | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Chairman of compensation committee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement', window );">Value of additional equity ordinary shares | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average stock price that must be met or exceeded for vesting in the share-based payment arrangement. If this price is not met in the defined period, the shares will be forfeited in their entirety.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period subsequent to grant date after which the share-based award expires.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum percentage of lost time injury will be taken as base under share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of installments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfOtherEquityInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information pertaining to number of other equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfOtherEquityInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfOutstandingShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfOutstandingShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OptionsStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options strike price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OptionsStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PercentageOfAwardConstitutesRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of awards issued represents restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PercentageOfAwardConstitutesRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PercentageOfAwardConstitutesStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of awards issued represents Stock Options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PercentageOfAwardConstitutesStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of additional equity ordinary shares taken as base for issuance of units under share based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity ordinary shares taken as base for issuance of units under share based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of ordinary shares to be issued as per share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_VolumeWeightedAverageStockPriceComputationTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of tradings days will be taken as base for computation volume weighted average stock price under share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_VolumeWeightedAverageStockPriceComputationTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageExercisePriceOfShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageExercisePriceOfShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cntg_MrBerndtModigMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cntg_MrBerndtModigMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSaleOfStockAxis=cntg_IfrsIPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSaleOfStockAxis=cntg_IfrsIPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cntg_PeerSchatzMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cntg_PeerSchatzMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cntg_MrJonathanGSheldonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cntg_MrJonathanGSheldonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ViceChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ViceChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChairmanOfAuditCommitteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChairmanOfAuditCommitteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChairmanOfCompensationCommitteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ChairmanOfCompensationCommitteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048227739736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Valuation of Options (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>Y </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>Y</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted', window );">Share price at grant date (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember', window );">Options | Mr. Modig and Mr. Sheldon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price (USD)</a></td>
<td class="nump">$ 9.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted', window );">Share price at grant date (USD)</a></td>
<td class="nump">10.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="nump">7.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember', window );">Options | Mr, Modig</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price (USD)</a></td>
<td class="nump">14.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted', window );">Share price at grant date (USD)</a></td>
<td class="nump">10.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="nump">7.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember', window );">Options | Mr. Kim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price (USD)</a></td>
<td class="nump">11.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted', window );">Share price at grant date (USD)</a></td>
<td class="nump">10.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="nump">8.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted', window );">Share price at grant date (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based RSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based RSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2017CashSettledMember', window );">Virtual share option program 2017 (Cash settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract', window );"><strong>Expenses arising from share-based payment transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from cash-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2016CashSettledMember', window );">Virtual share option program 2016 (Cash-settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract', window );"><strong>Expenses arising from share-based payment transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from cash-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017And2019Member', window );">Equity share option 2017 and 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract', window );"><strong>Expenses arising from share-based payment transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from cash-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from equity-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,658<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based payment expenses | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,658<span></span>
</td>
<td class="nump">6,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember', window );">Equity share option 2017 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract', window );"><strong>Key assumptions used to derive the option value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price at grant date | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Option term (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember', window );">Equity share option 2019 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract', window );"><strong>Key assumptions used to derive the option value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price at grant date | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Option term (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract', window );"><strong>Expenses arising from share-based payment transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from equity-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,105<span></span>
</td>
<td class="nump">&#8364; 704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted', window );">Share price at grant date (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Management board and employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract', window );"><strong>Expenses arising from share-based payment transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from equity-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | New CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract', window );"><strong>Expenses arising from share-based payment transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from equity-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Supervisory board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract', window );"><strong>Expenses arising from share-based payment transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses arising from equity-settled share-based payment transactions | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExercisePriceOtherEquityInstrumentsGranted', window );">Exercise price (USD)</a></td>
<td class="nump">12.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted', window );">Share price at grant date (USD)</a></td>
<td class="nump">12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted', window );">Riskfree interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_OptionLifeOtherEquityInstrumentsGranted', window );">Expected contractual life (years) | Y</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="nump">7.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract', window );"><strong>Key assumptions used to derive other equity instruments value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted', window );">Weighted average fair value (USD)</a></td>
<td class="nump">$ 10.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ExercisePriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of other equity instruments granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ExercisePriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of other equity instruments granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ExpectedVolatilityOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the other equity instruments granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ExpectedVolatilityOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>N/a</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_OptionLifeOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of other equity instruments granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_OptionLifeOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for other equity instruments granted is expressed, with a remaining term equal to the expected term of the option being valued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value per share used as input to the option pricing model to calculate the fair value of other equity instruments granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of other equity instruments granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from cash-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cntg_MrModigAndMrSheldonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cntg_MrModigAndMrSheldonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cntg_MrBerndtModigMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cntg_MrBerndtModigMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cntg_Mr.KimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cntg_Mr.KimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2017CashSettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2017CashSettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2016CashSettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_VirtualShareOptionProgram2016CashSettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017And2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017And2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ManagementBoardAndEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ManagementBoardAndEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048226653976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - fair values and risk management - Credit risk (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>customer</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">&#8364; 17,818<span></span>
</td>
<td class="nump">&#8364; 48,156<span></span>
</td>
<td class="nump">&#8364; 41,095<span></span>
</td>
<td class="nump">&#8364; 9,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss allowances on trade receivables</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">3,738<span></span>
</td>
<td class="nump">752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment loss on financial assets</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">3,738<span></span>
</td>
<td class="nump">752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember', window );">Credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">17,818<span></span>
</td>
<td class="nump">48,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Specific bad debt allowances | Credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss</a></td>
<td class="nump">5,717<span></span>
</td>
<td class="nump">4,768<span></span>
</td>
<td class="nump">2,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of January 1</a></td>
<td class="nump">4,768<span></span>
</td>
<td class="nump">2,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss allowances on trade receivables</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">3,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets', window );">Derecognition</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(1,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of December 31</a></td>
<td class="nump">5,717<span></span>
</td>
<td class="nump">4,768<span></span>
</td>
<td class="nump">&#8364; 2,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">&#8364; 30,054<span></span>
</td>
<td class="nump">&#8364; 33,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss</a></td>
<td class="nump">&#8364; 5,717<span></span>
</td>
<td class="nump">&#8364; 4,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of January 1</a></td>
<td class="nump">4,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of December 31</a></td>
<td class="nump">5,717<span></span>
</td>
<td class="nump">4,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Middle East | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">13,968<span></span>
</td>
<td class="nump">10,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Europe | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">11,486<span></span>
</td>
<td class="nump">20,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Latin America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | North America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">3,787<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Asia Pacific | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Not past due | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">&#8364; 17,978<span></span>
</td>
<td class="nump">&#8364; 24,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss</a></td>
<td class="nump">&#8364; 167<span></span>
</td>
<td class="nump">&#8364; 382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of January 1</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of December 31</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Not past due | Middle East | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">3,999<span></span>
</td>
<td class="nump">3,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Not past due | Europe | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">10,771<span></span>
</td>
<td class="nump">19,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Not past due | Latin America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">531<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Not past due | North America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">2,562<span></span>
</td>
<td class="nump">1,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Not past due | Asia Pacific | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due 1 to 30 day | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">&#8364; 1,475<span></span>
</td>
<td class="nump">&#8364; 2,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss</a></td>
<td class="nump">&#8364; 114<span></span>
</td>
<td class="nump">&#8364; 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of January 1</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of December 31</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due 1 to 30 day | Middle East | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">1,013<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due 1 to 30 day | Europe | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due 1 to 30 day | Latin America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due 1 to 30 day | North America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due 1 to 30 day | Asia Pacific | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | 1 - 3 months | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">&#8364; 2,596<span></span>
</td>
<td class="nump">&#8364; 797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">11.70%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss</a></td>
<td class="nump">&#8364; 304<span></span>
</td>
<td class="nump">&#8364; 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of January 1</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of December 31</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | 1 - 3 months | Middle East | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">2,056<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | 1 - 3 months | Europe | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | 1 - 3 months | Latin America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | 1 - 3 months | North America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | 1 - 3 months | Asia Pacific | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due more than 90 days | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">&#8364; 8,004<span></span>
</td>
<td class="nump">&#8364; 6,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">64.10%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Expected credit loss</a></td>
<td class="nump">&#8364; 5,132<span></span>
</td>
<td class="nump">&#8364; 4,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of January 1</a></td>
<td class="nump">4,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">As of December 31</a></td>
<td class="nump">5,132<span></span>
</td>
<td class="nump">4,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due more than 90 days | Middle East | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">6,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due more than 90 days | Europe | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due more than 90 days | Latin America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due more than 90 days | North America | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember', window );">Trade receivables and contract assets | Past due more than 90 days | Asia Pacific | Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Trade receivables and contract assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables | Specific bad debt allowances | Credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment loss on financial assets</a></td>
<td class="nump">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables | More than 365 days | Specific bad debt allowances | Credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Development of impairment losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets', window );">Derecognition</a></td>
<td class="num">&#8364; (7)<span></span>
</td>
<td class="num">&#8364; (1,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | Middle East</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_TradeReceivablesAverageTurnoverPeriod', window );">Average turnover period on trade receivables</a></td>
<td class="text">278 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | MENA | Credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables', window );">Number of top diagnostic customers | customer</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember', window );">Diagnostics | MENA | Credit risk | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Credit risk exposure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PercentageOfOverdueBalances', window );">Percentage of overdue balances</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of top diagnostic customers due in trade receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PercentageOfOverdueBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The over due balances as a percentage of total overdue balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PercentageOfOverdueBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_TradeReceivablesAverageTurnoverPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average turnover period on trade receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_TradeReceivablesAverageTurnoverPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional allowance for credit losses of financial assets recognised in profit or loss. [Refer: Allowance account for credit losses of financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProvisionMatrixLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProvisionMatrixLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedCreditLossRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The rate of expected credit losses, calculated as percentage of the gross carrying amount. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph IG20D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG20D&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedCreditLossRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in an allowance account for credit losses of financial assets resulting from the reversal of impairment. [Refer: Allowance account for credit losses of financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeReceivablesAndContractAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsPastDueButNotImpairedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsPastDueButNotImpairedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cntg_IfrsMiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cntg_IfrsMiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=cntg_LaterThanOneDayAndNotLaterThanOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=cntg_LaterThanOneDayAndNotLaterThanOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=cntg_DiagnosticsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230096536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - fair values and risk management - Liquidity risk (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths', window );">Expected cash flows receivables with in two months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSharesIssuedPricePerShare', window );">Common per share | (per share)</a></td>
<td class="nump">$ 14.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,818<span></span>
</td>
<td class="nump">&#8364; 48,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 41,095<span></span>
</td>
<td class="nump">&#8364; 9,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,064<span></span>
</td>
<td class="nump">55,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,117<span></span>
</td>
<td class="nump">59,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,098<span></span>
</td>
<td class="nump">26,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,203)<span></span>
</td>
<td class="num">(7,513)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">4,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(387)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,811<span></span>
</td>
<td class="nump">24,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NonCurrentFinancialLiabilitiesMember', window );">Non-current financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,078<span></span>
</td>
<td class="nump">19,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(401)<span></span>
</td>
<td class="num">(1,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">865<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,954)<span></span>
</td>
<td class="num">(1,605)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,588<span></span>
</td>
<td class="nump">18,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember', window );">Non-current lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,677<span></span>
</td>
<td class="nump">18,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">865<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,954)<span></span>
</td>
<td class="num">(1,038)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,588<span></span>
</td>
<td class="nump">17,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_CurrentFinancialLiabilitiesMember', window );">Current financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,020<span></span>
</td>
<td class="nump">7,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,802)<span></span>
</td>
<td class="num">(5,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">2,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,223<span></span>
</td>
<td class="nump">6,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NoncurrentSecuredBankLoansMember', window );">Non-current portion of secured bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="nump">968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(567)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NonCurrentMunicipalLoansMember', window );">Municipal loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_CurrentSecuredBankLoansMember', window );">Current portion of secured bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="nump">802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_BankLoansMember', window );">Bank Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(387)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_IfrsBankOverdraftsMember', window );">IFRS Bank overdrafts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">2,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,505<span></span>
</td>
<td class="num">(1,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,310<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_FinancingActivitiesMunicipalLoansMember', window );">Municipal loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember', window );">Current lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Reconciliation of liabilities arising from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,528<span></span>
</td>
<td class="nump">3,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,245)<span></span>
</td>
<td class="num">(3,635)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">2,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes in maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,954<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">End of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
<td class="nump">3,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=cntg_NotLaterThanTwoMonthsMember', window );">Less than 2 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,383<span></span>
</td>
<td class="nump">33,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember', window );">2 to 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,803<span></span>
</td>
<td class="nump">5,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 - 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,038<span></span>
</td>
<td class="nump">10,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More than five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,893<span></span>
</td>
<td class="nump">10,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember', window );">Trade and other receivables due with in two months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk', window );">Expected cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,418<span></span>
</td>
<td class="nump">14,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_IfrsBankOverdraftsMember', window );">IFRS Bank overdrafts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,310<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,310<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_IfrsBankOverdraftsMember', window );">IFRS Bank overdrafts | Less than 2 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,310<span></span>
</td>
<td class="nump">&#8364; 1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_IfrsBankOverdraftsMember', window );">IFRS Bank overdrafts | 2 to 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PercentageOfInterestBearingLoansMatureInOneYear', window );">Interest-bearing loans will mature in less than one year (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.70%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember', window );">Secured bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_SecuredCreditLinesUtilized', window );">Utilized amount of secured credit lines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,310<span></span>
</td>
<td class="nump">&#8364; 1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Secured bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 505<span></span>
</td>
<td class="nump">&#8364; 997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember', window );">Secured bank loans | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_SecuredCreditLinesInterestRate', window );">Interest rate on secured credit lines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember', window );">Secured bank loans | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_SecuredCreditLinesInterestRate', window );">Interest rate on secured credit lines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember', window );">Secured bank loans | Less than 2 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 105<span></span>
</td>
<td class="nump">&#8364; 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember', window );">Secured bank loans | 2 to 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember', window );">Secured bank loans | 1 - 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_OtherBankLoansMember', window );">Other bank loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_OtherBankLoansMember', window );">Other bank loans | 2 to 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,997<span></span>
</td>
<td class="nump">21,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,050<span></span>
</td>
<td class="nump">24,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities | Less than 2 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities | 2 to 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">3,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities | 1 - 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,038<span></span>
</td>
<td class="nump">9,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities | More than five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,893<span></span>
</td>
<td class="nump">10,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradePayablesMember', window );">Trade payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,252<span></span>
</td>
<td class="nump">31,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,252<span></span>
</td>
<td class="nump">31,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradePayablesMember', window );">Trade payables | Less than 2 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 11,252<span></span>
</td>
<td class="nump">31,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradePayablesMember', window );">Trade payables | 2 to 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Increase (decrease) in number of ordinary shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common shares | Follow-on public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders', window );">Total number of shares issued and sold in follow-on public offering | shares</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCommonSharesOfferedByPriorShareholders', window );">Number of shares offered by existing shareholders | shares</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cntg_CentogeneN.vMember', window );">The Company | Common shares | Follow-on public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Liquidity risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Increase (decrease) in number of ordinary shares issued | shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected difference between the cash outflows from trade payables and the cash inflow from receivables within two months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from additions. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from changes in maturity. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of common shares issued and offered by existing shareholders in conjunction with the follow-on public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfCommonSharesOfferedByPriorShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares offered by existing shareholders in conjunction with the follow-on public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfCommonSharesOfferedByPriorShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PercentageOfInterestBearingLoansMatureInOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of interest-bearing loans will mature in one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PercentageOfInterestBearingLoansMatureInOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_SecuredCreditLinesInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of interest rate on secured credit lines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_SecuredCreditLinesInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_SecuredCreditLinesUtilized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The utilized amount on secured credit lines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_SecuredCreditLinesUtilized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankBorrowingsUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph B11D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B11D&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph IG31A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG31A&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankBorrowingsUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets held for managing liquidity risk (for example, financial assets that are readily saleable or expected to generate cash inflows to meet cash outflows on financial liabilities). [Refer: Liquidity risk [member]; Financial assets; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph B11E<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B11E&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NonCurrentFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NonCurrentFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_CurrentFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_CurrentFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NoncurrentSecuredBankLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NoncurrentSecuredBankLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NonCurrentMunicipalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_NonCurrentMunicipalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_CurrentSecuredBankLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_CurrentSecuredBankLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_BankLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_BankLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_IfrsBankOverdraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_IfrsBankOverdraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_FinancingActivitiesMunicipalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_FinancingActivitiesMunicipalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=cntg_NotLaterThanTwoMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=cntg_NotLaterThanTwoMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_IfrsBankOverdraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_IfrsBankOverdraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_SecuredCreditLinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_OtherBankLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_OtherBankLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradePayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=cntg_TradePayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSaleOfStockAxis=cntg_FollowOnPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSaleOfStockAxis=cntg_FollowOnPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cntg_CentogeneN.vMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cntg_CentogeneN.vMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048256843176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - fair values and risk management - Currency risk (Details) - Currency risk - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="nump">&#8364; 210<span></span>
</td>
<td class="num">&#8364; (2,407)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD | Trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="nump">2,604<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD | Trade payables and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="num">(2,394)<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_INR', window );">INR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_INR', window );">INR | Trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_INR', window );">INR | Trade payables and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="num">&#8364; (4)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_AED', window );">AED</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_AED', window );">AED | Trade payables and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems', window );"><strong>Currency risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Net exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (17)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph B8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B8_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=cntg_TradePayableAndOtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=cntg_TradePayableAndOtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_INR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_INR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AED">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AED</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048227596088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>List of subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGMember', window );">Centogene GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneFzLlcUnitedArabEmiratesMember', window );">Centogene Fz Llc, United Arab Emirates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneUsLlcBurlingtonUsaMember', window );">Centogene US LLC, Burlington, USA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGmbhViennaMember', window );">Centogene GmbH, Vienna</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneIndiaPvt.LtdMember', window );">Centogene India Pvt. Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Additional percentage ownership in subsidiary acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneSwitzerlandAgMember', window );">Centogene Switzerland AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentosafeB.v.Member', window );">Centosafe B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneD.o.oBelgradeMember', window );">Centogene d.o.o Belgrade</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>List of subsidiaries</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership interest in subsidiary (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneFzLlcUnitedArabEmiratesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneFzLlcUnitedArabEmiratesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneUsLlcBurlingtonUsaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneUsLlcBurlingtonUsaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGmbhViennaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGmbhViennaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneIndiaPvt.LtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneIndiaPvt.LtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneSwitzerlandAgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneSwitzerlandAgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentosafeB.v.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentosafeB.v.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneD.o.oBelgradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneD.o.oBelgradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048230286808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-controlling interests (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Non-controlling interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Carrying amount of noncontrolling interests</a></td>
<td class="num">&#8364; (193)<span></span>
</td>
<td class="num">&#8364; (95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit/(loss)</a></td>
<td class="num">(46,852)<span></span>
</td>
<td class="num">(21,378)<span></span>
</td>
<td class="num">&#8364; (20,855)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGmbhViennaMember', window );">Centogene GmbH, Vienna</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Non-controlling interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets/(liabilities)</a></td>
<td class="num">(528)<span></span>
</td>
<td class="num">(522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Carrying amount of noncontrolling interests</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit/(loss)</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Profit/(loss) allocated to non-controlling interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_Dr.BauerLaboratoriumsGmbhMember', window );">Dr. Bauer Laboratoriums GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Non-controlling interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets/(liabilities)</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">109,015<span></span>
</td>
<td class="nump">55,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit/(loss)</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Profit/(loss) allocated to non-controlling interest</a></td>
<td class="nump">&#8364; 98<span></span>
</td>
<td class="nump">&#8364; 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneIndiaPvt.LtdMember', window );">Centogene India Pvt. Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Non-controlling interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Additional percentage ownership in subsidiary acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember', window );">LPC GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Non-controlling interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal', window );">Proportion of ownership in subsidiary disposed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Carrying amount of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Profit/(loss) allocated to non-controlling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership interest disposed in non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG63<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGmbhViennaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneGmbhViennaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_Dr.BauerLaboratoriumsGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_Dr.BauerLaboratoriumsGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneIndiaPvt.LtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_CentogeneIndiaPvt.LtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=cntg_LpcGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237109592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Lease commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_FuturePaymentObligationToSuppliersForGoodsAndServices', window );">Total payment obligation</a></td>
<td class="nump">&#8364; 6,620<span></span>
</td>
<td class="nump">&#8364; 4,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember', window );">Rostock headquarters building | Not later than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Lease commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UndiscountedLeasePaymentsToBeMade', window );">Future lease payments to be made</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember', window );">Rostock headquarters building | 1 - 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Lease commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UndiscountedLeasePaymentsToBeMade', window );">Future lease payments to be made</a></td>
<td class="nump">2,370<span></span>
</td>
<td class="nump">1,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember', window );">Rostock headquarters building | More than five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Lease commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UndiscountedLeasePaymentsToBeMade', window );">Future lease payments to be made</a></td>
<td class="nump">4,219<span></span>
</td>
<td class="nump">4,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficeEquipmentAndStorageSpacesMember', window );">Office equipment and storage spaces | Not later than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Lease commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UndiscountedLeasePaymentsToBeMade', window );">Future lease payments to be made</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficeEquipmentAndStorageSpacesMember', window );">Office equipment and storage spaces | 1 - 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Lease commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_UndiscountedLeasePaymentsToBeMade', window );">Future lease payments to be made</a></td>
<td class="nump">&#8364; 49<span></span>
</td>
<td class="nump">&#8364; 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_FuturePaymentObligationToSuppliersForGoodsAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of future payment obligation to suppliers for goods and services to be provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_FuturePaymentObligationToSuppliersForGoodsAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_UndiscountedLeasePaymentsToBeMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of undiscounted lease payments to be made by the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_UndiscountedLeasePaymentsToBeMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_RostockHeadquartersBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cntg_OfficeEquipmentAndStorageSpacesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cntg_OfficeEquipmentAndStorageSpacesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048237315368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties - Remuneration of members of key management (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">&#8364; 4,098<span></span>
</td>
<td class="nump">&#8364; 4,273<span></span>
</td>
<td class="nump">&#8364; 3,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment pension and medical benefits</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits', window );">Termination benefits</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payment transactions</a></td>
<td class="nump">822<span></span>
</td>
<td class="nump">1,822<span></span>
</td>
<td class="nump">3,395<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total compensation paid to key management</a></td>
<td class="nump">&#8364; 5,178<span></span>
</td>
<td class="nump">&#8364; 6,683<span></span>
</td>
<td class="nump">&#8364; 6,718<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048227763416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties - Additional information (Details)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 18, 2020 </div>
<div>EquityInstruments </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 11, 2020 </div>
<div>Options</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>USD ($) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;) </div>
<div>Options </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,471<span></span>
</td>
<td class="nump">&#8364; 3,486<span></span>
</td>
<td class="nump">&#8364; 5,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011', window );">Payables due to holders of vested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember', window );">Follow-on Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders', window );">Total number of shares issued and sold in follow-on public offering | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsRelatedPartyTransactionAxis=cntg_CovidTestingSuppliesPurchasesMember', window );">COVID Testing Supplies Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ServicesReceivedRelatedPartyTransactions', window );">Payments for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsRelatedPartyTransactionAxis=cntg_CovidTestingServicesMember', window );">COVID Testing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions', window );">Revenues recognized in profit and loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember', window );">Equity share option 2017 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price of share options granted | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
<td class="nump">&#8364; 0.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price of share options granted | &#8364; / shares</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember', window );">2019 Plan | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | EquityInstruments</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember', window );">Supervisory board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,564<span></span>
</td>
<td class="nump">&#8364; 2,172<span></span>
</td>
<td class="nump">&#8364; 704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember', window );">Supervisory board members | Supervisory board activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ServicesReceivedRelatedPartyTransactions', window );">Payments for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="nump">603<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember', window );">Supervisory board members | Corporate strategy services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ServicesReceivedRelatedPartyTransactions', window );">Payments for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_MemberOfSupervisoryBoardMember', window );">Member of the supervisory board | Corporate strategy services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ServicesReceivedRelatedPartyTransactions', window );">Payments for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyManagementPersonnelCompensationAccruedAmount', window );">Accrued for key management compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">&#8364; 769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsReceivableRelatedPartyTransactions', window );">Receivables of related to the exercise of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel | Equity share option 2017 (Equity settled)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_PensionCommitments', window );">Pension commitments for members of the management board</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel | 2019 Plan | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel | 2019 Plan | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_FormerCeoAndMajorShareholderMember', window );">Former CEO And Major Shareholder [Member] | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ServicesReceivedRelatedPartyTransactions', window );">Payments for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Payable for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember', window );">Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedPaymentArrangementAcceleratedCost', window );">Additional share-based expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_KeyManagementPersonnelCompensationSeverancePayout', window );">Severance payout</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember', window );">Former Chief Executive Officer | 2019 Plan | RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="nump">72,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember', window );">Former Chief Executive Officer | 2019 Plan | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Increase (decrease) in number of ordinary shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common shares | Follow-on Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfCommonSharesOfferedByPriorShareholders', window );">Number of shares offered by existing shareholders | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues', window );">Public offering price (in dollars per share) | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.00<span></span>
</td>
<td class="nump">&#8364; 12.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cntg_CentogeneN.vMember', window );">The Company | Common shares | Follow-on Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Increase (decrease) in number of ordinary shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedPaymentArrangementAcceleratedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedPaymentArrangementAcceleratedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_KeyManagementPersonnelCompensationAccruedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from key management personnel compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_KeyManagementPersonnelCompensationAccruedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_KeyManagementPersonnelCompensationSeverancePayout">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of severance payout.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_KeyManagementPersonnelCompensationSeverancePayout</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of common shares issued and offered by existing shareholders in conjunction with the follow-on public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfCommonSharesOfferedByPriorShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares offered by existing shareholders in conjunction with the follow-on public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfCommonSharesOfferedByPriorShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_PensionCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of pension commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_PensionCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering price per share of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsReceivableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsReceivableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities arising from share-based payment transactions. Share-based payment transactions are transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of services in related party transactions. [Refer: Revenue; Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ServicesReceivedRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of services received in related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ServicesReceivedRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSubsidiarySaleOfStockAxis=cntg_FollowOnEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsRelatedPartyTransactionAxis=cntg_CovidTestingSuppliesPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsRelatedPartyTransactionAxis=cntg_CovidTestingSuppliesPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsRelatedPartyTransactionAxis=cntg_CovidTestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsRelatedPartyTransactionAxis=cntg_CovidTestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2017EquitySettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsRelatedPartyTransactionAxis=cntg_SupervisoryBoardActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsRelatedPartyTransactionAxis=cntg_SupervisoryBoardActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsRelatedPartyTransactionAxis=cntg_CorporateStrategyServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsRelatedPartyTransactionAxis=cntg_CorporateStrategyServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_MemberOfSupervisoryBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_MemberOfSupervisoryBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_FormerCeoAndMajorShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_FormerCeoAndMajorShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsRelatedPartyTransactionAxis=cntg_RelatedPartyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsRelatedPartyTransactionAxis=cntg_RelatedPartyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cntg_CentogeneN.vMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cntg_CentogeneN.vMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048233431096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingent Liabilities (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 07, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 08, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_StockOptionPlan2016Member', window );">Stock Option Plan 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Contingent Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Aggregate amount in question</a></td>
<td class="nump">&#8364; 550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=cntg_UniversitairMedischCentrumUtrechtMember', window );">Universitair Medisch Centrum Utrecht</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Contingent Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_DamagesSought', window );">Amount in dispute</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,300,000<span></span>
</td>
<td class="nump">&#8364; 880,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember', window );">Prof. Dr. Peter Bauer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Contingent Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Aggregate amount in question</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 42,268.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_DamagesSought">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of damages sought.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_DamagesSought</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 86<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_86_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimatedFinancialEffectOfContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_StockOptionPlan2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_StockOptionPlan2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=cntg_UniversitairMedischCentrumUtrechtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=cntg_UniversitairMedischCentrumUtrechtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140048227983752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> &#8364; / shares in Units, $ / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 07, 2022 </div>
<div>item </div>
<div>tranche</div>
</th>
<th class="th">
<div>Feb. 01, 2022 </div>
<div>USD ($) </div>
<div>EquityInstruments </div>
<div>installment </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>item</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,812<span></span>
</td>
<td class="nump">&#8364; 24,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Borrowings drawdowns</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,772<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="nump">&#8364; 721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 189,923<span></span>
</td>
<td class="nump">&#8364; 128,381<span></span>
</td>
<td class="nump">&#8364; 48,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember', window );">RSUs | Former Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Awards | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember', window );">Grant of RSUs | RSUs | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember', window );">Grant of RSUs | RSUs | Subject to time-vesting and performance vesting | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember', window );">Grant of RSUs | RSUs | Subject to time-vesting and performance vesting | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSUs granted | EquityInstruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember', window );">Grant of RSUs | Vesting in four tranches | RSUs | Management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsStockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,479,088<span></span>
</td>
<td class="nump">4,479,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsSharePrice', window );">Share price | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, Number of securities called by warrants or rights | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,343,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,343,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Class of warrant or right, Exercise price of warrants or rights | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfOtherEquityInstrumentsGranted', window );">Value of other equity instruments granted under share based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,800<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions | RSUs | Former Chief Executive Officer | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Awards | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions | RSUs | Former Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod', window );">Contractual life</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions | RSUs derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfOtherEquityInstrumentsGranted', window );">Value of other equity instruments granted under share based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions | RSUs recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_ValueOfOtherEquityInstrumentsGranted', window );">Value of other equity instruments granted under share based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions | Vesting in four tranches | RSUs | Miguel Coego Rios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Awards | item</a></td>
<td class="nump">30,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember', window );">Entering into debt financing agreement | Loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 40,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsRevenueAchievementThreshold', window );">Borrowings, Revenue achievement threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember', window );">Entering into debt financing agreement | Loan facility first tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Borrowings drawdowns</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,300<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember', window );">Entering into debt financing agreement | Loan facility second tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue', window );">Borrowings available, Subject to achievement of product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cntg_BorrowingsRevenueAchievementThreshold', window );">Borrowings, Revenue achievement threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 44,700<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing available subject to achievement of product revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_BorrowingsRevenueAchievementThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue threshold for borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_BorrowingsRevenueAchievementThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period subsequent to grant date after which the share-based award expires.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of installments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equal tranches in which the granted RSU and options shall vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_ValueOfOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of other equity instruments granted under share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_ValueOfOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsFormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_GrantOfRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_IfrsChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsVestingAxis=cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsVestingAxis=cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsVestingAxis=cntg_ShareBasedAwardsSubjectToTimeVestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsVestingAxis=cntg_ShareBasedAwardsSubjectToTimeVestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cntg_VestingInFourTranchesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cntg_VestingInFourTranchesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=srt_ManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=srt_ManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_FormerChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_FormerChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_RsusDerecognizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_RsusDerecognizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cntg_IfrsAwardTypeAxis=cntg_RsusRecognizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cntg_IfrsAwardTypeAxis=cntg_RsusRecognizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_MiguelCoegoRiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_MiguelCoegoRiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_EnteringInToDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=cntg_LoanFacilityTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>cntg-20211231x20f_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cntg="http://centogene.com/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cntg-20211231.xsd" xlink:type="simple"/>
    <context id="Duration_12_18_2020_To_12_18_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_PW37pFbf_ECSJNc8ERvHPg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-18</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_CV9SX4hApkWmqEt_60wM4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="Duration_6_30_2021_To_6_30_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_nqnnCqAqhkms8MmscboYow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IJi6tizcMkqoRBY2BmqqJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:SoftwarePatentsAndTrademarksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_H6sJ9CbA3Uqak-twBHs28g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:SoftwarePatentsAndTrademarksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_QclbJBn7ZU-bkYebSJREIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_CoronaTestPortalMember_LjhxO9L-BkaT6QFPOJAsSQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:CoronaTestPortalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_Nljnlu_Jg0W2A_crlX3lqA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_t0eueDKCHEKgNoS0LdjhcQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Vx47RrdIq0GQ-Ki9-H37zA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_4T1vNzsxNkCbKq5j-Bd34w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_hl6aZ99S1EmWbvQH7J5vNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_ZLDQszdhKEWtIgEyyR7CjA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_h1P9Uyda7EyoO2LPxzrHJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_IfrsIPOMember_d-_7q8doLUSyk01ZAKC7zA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_-kfNLSIGS0CnDBcj9PVDWQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:SupervisoryBoardActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_BvghgdBxEEK2gQ296xhPFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CorporateStrategyServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingSuppliesPurchasesMember_PMe3DYqonU-W4y4ejGN9NQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CovidTestingSuppliesPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_OO2fJYJiZ0i04iwTzazmNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:SupervisoryBoardActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_aVpyI5X7v02azktZKILDIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:RelatedPartyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerCeoAndMajorShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_UKYRDn2W90unJoMzUYsVTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CorporateStrategyServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_cu0LEFW0kkCkn6XxXp6-EA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:SupervisoryBoardActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_hqH7Ao9bKk-C9CGDc25eug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CorporateStrategyServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_JO38uhlHsEqj0m4RCxwbMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_qUqCYL8yF0CdfM0hT5d4hw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_GV4YMZdmTU6rHuLJZRyL-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_hqryZrQyo0u9vk198ZL9tw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_-gQEIJhhKESSr-jRSWvRtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_u8KGLF7B5U-cOI8U7qgNTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_vHwIWQCj6UO2OcggKwqNGA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_NqWV89gKk0OodA4cK3KhyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_PjLMlUODRk2FbEMI9yrkqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_cHFYMEOjEEeAbEoJwPK02w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_hqCpXOTPc0ife4tCRqxAhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AED</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">cntg:TradePayableAndOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_zoJoP5b4TE-XfyAcw6W03g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_mqnnjQQULE6jGbqjlZnJgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_cloQKLoTo0WfQp8u9x2sCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AED</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_DH-VjAVOi0q0q4n9FC79TA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_gr8iddTpHUKdwj10hqL1EA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_Y0wjUE1Kn0Cww5TD7WEkoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_yU8ydiLypEye2GvazPiV4w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_y0Lzs-KudUaAjZAL7q9mYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_WHyj8PIaVEykw5TtSMGt3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_-k8208qQ10SHd_-JTl8E2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_r79EEaTrbE2YzRa5xIlIIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_cMFBX5CjWEKs38l_X26NEw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_aKCHQwKnTkW-WicxuBEYgg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_7LGAWQ8N8EWHfyuzxK-yzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_jzVLa-F6DkiRRjGQ1jjAxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_8GUO8-vudkOK8pX-AcOLCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_C-SoSBT-jUu6aB0HnuOW3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_-5Y_ZC3Cy06jqSRg2rkNWg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_tsk8qBlLdUKKx-fMOsu2-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_Q4DmiPOJc06nX5FPcvcI3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingServicesMember_ybA9VqNfoU6JvMqlmNzzdg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:CovidTestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_3QEbeOJ5BkaO7w7EMQ7ebw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_npNxfNEcOEiHMRcMz1OMNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_PCFksdHhDEW2XtLHDI7Jvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hY1buzymRUmo804bWIJEcw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_-Trx4lnT9EqhKeaem--7cw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_0EhnM-nI9U60TimMN9cS6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_t5U2pU1llkyqTaF2VHf4kQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_r9aWl2b-v0OSqz3If8MAOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_D52k1rmdSkSQ8eJxUeQTMg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_5om3Tuoy6U67GcuWFQxn_w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_8iKdtQU-_Eu7d8Hvzi8aSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sey9N6DwsECg7Y8DnOwQ7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_DOZiypy0h0yBjpMQ3UPvww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_st_41JliCE2l_ojbTOAjxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_Bo1twD2K6U6g1a4dtlQlRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_clx9prwtLE2o24g-cVlXXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_rP9H_6ZxBUiMxdA5czmkLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3ijtgqtaKE687iwfHUfycw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hWWVNS2x5kyprvvsloH-qg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HT11Yq7HqEiuy71IFa5GQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_UQLS1jqBcUaiRdVG9-LbFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_mMrEFk5yCEeTQec-FbsYew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mdFt7GHH9kCbATPAUndvBQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_9xKbq0HvrE23nctfL9kqJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_uhttJnikwUygDyIGsX0K2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_cOG0cWgzz0yXAS58I-gQ_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_khmhDdbQsUmgB98c9HcKgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Ybu5gGcGb0CLhwhCRJoJzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3R-RJj8W30CmqBQ9_P-L6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_wr28CgnaFUihv57zlIv9nw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_HinXUd8jiU-OqKDtmHiBBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_gQTQ8dl_nkqEQsnhaCYVXg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_6jOQBXEji0iws7Kj-GYZLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Ys662UuLNkyBTJCZFPfCxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ythndJ_8XEOkXQ82UmIkkQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_pCwwsigl0U2m5E7-eDM8uA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PF_KqP6LSESi2HEzjtBOPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HrC70U1Yj0u0D_A7_q4GXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_hrmD1qRunUmmMLok8OgVQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Pq1dqziFrECoxJA6IUPO0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_g9Q4KqtnV0uSsn7ARpe8uA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_RO2fs0emCUu9jR98AuIlGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_q9a-MHMvKUK5U_xsAmy2MQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_i4C0ubETiUCzWqGtU1jx2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_6zdpYcOa-ESFJJRwZE-Oag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_l03HHyyeUEi1A6xEJ5Edmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_R_eEBY9qmE-NM3Tvk2KDqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_5aArgCY3JUK83G5Z3yyuaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_zy3jWFs1Ikq8JSLXUCeHJQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ZXy9HwJvXUaEjtHUhuk8ow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_W3F58Jfx80ii3Fx2Pkj0bg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_iS_M28fhFE6M9oKHCruHBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_HkDJI80zTkuUmk--Ej4yXw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_jPRbVhHuNkuHoAHPHl0FHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_HHPssicdQUqnZ5X69XqpQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_dIyWF4ygA0iQzM7wM628QQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_OiigMHAcVkuVDMVMzBsepg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_4JRA7asUB0ioKSQ0gqeV8A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_oREizo1DqkCFGwT7ENil_w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_c1SgMStWuEuH_usbmcBK0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_j0CQFn_gS0GfVtrcdtpKYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_n86T_jTggkKRt30kBqsVZw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mVhL40cYQEePQ61JZHkZ5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ROnDIAnWzk-FwbKaqoEgXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_80vPPmzZsEK-rHwOiITf5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Z8iyfz_ZhEyQVS1VVRoDQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember__5AEW953l0KC20ixoMs7ow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_zA1NYJLwcUaXbGpQUDVDuQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_gNfrmr6fLUixQ62x_Fwrew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_AZFndmgY0UCwCIG8wtdz9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_km5pa8EmQ0OS81LK01_wkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_9Ui5l_nU70uEou7uc-87Jw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RI1XvAcXBkW1sMvmWPyezA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_azRhFhatK0S_v248GkC16A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YTUjyWxrfkmjjtjGT1KC5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_n9XhJgrCrEySPhrU20QprQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RZW3v4iO4kG8NHVW3fjBIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_wJkGwu7MkUC7XJrNmADbTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hgIa0VboT0mS4D8xJQpCCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_DO-kg8eAVE-lWMef-KoDVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Gn5qMK_C4UePkU4n8Ymluw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_FeVjB1MUOEeh9_f7uvi5AA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ZnrF_dp5Y0KfdoqcK2Js3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_7PcrTsViCkCTYuQCigBbTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Oy3dJv22rkSAReGZRjnSUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_tB9oEnXM7EW6ytrbi0USWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_MTbFAzD3FUiK7SEe_WS1Jg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_OeyM4bZnmk-KdBoTF1lVhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_N_D2fMybOEioJzSGBTNgVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_D-7kMsmp8Uer11pu6XnQCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_fKiyneNNIEaYn8UkC13EtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_OP1UzlIcX0OmY9sJACaIww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_1IGbd19w8k2QJL4QJn5QLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_Uoe9zKqJoESD7LidLdm1YA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_tYw_3cgR1Ueq-Gbz16oQHg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_v3fS0Y4zQ0uHtd_W4YK3ng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_WqUWe927Nk6uSgbaCxFjkA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentosafeB.v.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_fxCJFiGsDU2tRIrSA3JTfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneUsLlcBurlingtonUsaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_SSqn3JwlZEKIYquVSRVj4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneSwitzerlandAgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_1RkheOIhVU2eH6psyo77cw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneIndiaPvt.LtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_gdQ7ArXwUU29FpifO1d2Tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_6ilmlbgLQUaozewCaC7r6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneFzLlcUnitedArabEmiratesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_jno_GFKBDk6OafQHIJLx7w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneD.o.oBelgradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_9ANqzl7ZTUajud4xjfwt1Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentosafeB.v.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_UnWKT0VVDEW_wX3NeqiDeA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneUsLlcBurlingtonUsaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_99jSw-B3lEmA9RjJZquI8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneSwitzerlandAgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_tcRN6jVWa0CvEfR4vmQr5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneIndiaPvt.LtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_nM4VKfdToUCleIioxMHAVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_aJjp5Hfn9ECKKXqBeqaLXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneFzLlcUnitedArabEmiratesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_LsRE2steYEuxjfr5k30J1Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneD.o.oBelgradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_gykS6db5-UCUac4tLpVtSg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_cybCz_DIdUCl_xWyu3Pv8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_I8JCso4MK0qgaLEwIyMTbg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_lEC-E1pPPkKKZSA0ZSkDSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_edmJJe7tlEedyQZh-3w6bA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_fuZVkW08oEaKwXZ7YfUYkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_I6xfcf-C2UWRvm-kxsFGQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_kpzFl95A4Eihik8AD-vh0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_imxgf1UU7EmYdPJ5WDOOCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_bR_4j4cSckicZd6QmHkZiw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_pqgYMySFy0mCl4qrOYa00Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_pDjbDgn5b0qPOlPHWmNdPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_yS6hjJywgUWf5TfLOUo9lQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_-qbWr3ldhUuv7EtvkZChEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_2vB3kEQ9kke7ig8iaxIHWg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_-cmNgE1L_UWx4FtHzGHuYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jxm_mplIxEmZEcgIhg-8iQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_eqR6NyQJOkW920BqJk1jTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_PrcgwTEj0kWm_mcSL5ht7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_H9IaZfpHHEeg-x_U6Loa3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_YVVpLHmHuUCyVsz8RIAg9Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rBalwrMaEkicgxSJdYTFzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_9xS0NR0lGEmdKJ-O-1K3zQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_KLZzrB9iaka5B8A46KUKYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_bOr7Q08nUkCJL9UFD5xgEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_MPE_bAH260S1MVcfmAfdbg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_FJL5PQArUkCuYTb_22g-4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_MbQzBIokME2nAKgB5upFAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneIndiaPvt.LtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_XwVB5e8oEUO5d47G1QgffA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_bm2QM3qwUEqolDwi7dS3oQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PGxsbLEs7UOMIWZf7Z03Zg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:PharmaceuticalPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_vD7DKV3Hb0uFeh-tXovtcw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_-u-gDw9Kw02XQH5X4XgSEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:Covid19PartnerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_sgzRGPjWTEKksOKAeqNcwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:PharmaceuticalPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember__CSueLWvfkaKMbg97rwstw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_6_24_2021_To_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_Lggp4PkrtEW3C7ZFnD1fIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-24</startDate>
            <endDate>2021-06-24</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_scfLHvbOHEyhfw0eoqJLjQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrJonathanGSheldonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_NfDBPr_PCU-WeXMIEGto4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_ui7vsg5w4EG0lJsC-MuuLA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Cm6rxbg5V02howDd6-HKiA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_uNK3cJ2KukGhjB1H809MEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_I_CkDW4jyE2fLJmcucRgFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_kVJa9lQw5EeR7IQzDBa0jg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChiefInformationOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_WYFrUDbkkUihIyr9HpBc4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_e7pwRt_d5Ey8miVUeDmHnQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_EZ4EQKl6u0y4U2G9Chnqbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedAwardsSubjectToTimeVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_pLa-1tNWhkaifjyG5-55CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_ECxfpRaeB0icCiSqRrYWNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrJonathanGSheldonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_cKZBZTR-hUKsYvIbDIFtyw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VP9HWW5A2E-7VpFzEFjsVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dLhT7Cmve0CdytDI3taX5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-01</endDate>
        </period>
    </context>
    <context id="Duration_10_15_2020_To_10_15_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_V6gW_1JbeU2rr1ZWiZ89Tw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-15</startDate>
            <endDate>2020-10-15</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DtkVOppjHkWA1R9t0aDNNw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WUAkQyT5QUKI_CA2QFIqng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RzmMZK-ny0O74pah0YcM8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EYVETEm8qkGi1WMdtZbI0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChiefInformationOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_LCJaveMDmkGVp9ON5ZIyPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:PeerSchatzMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MiguelCoegoRiosMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_AnpIXYXhBkuyC6Ni6BiUGA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VestingInFourTranchesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MiguelCoegoRiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-07</startDate>
            <endDate>2022-02-07</endDate>
        </period>
    </context>
    <context id="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_yqUJXsPgDUScDg3m6hyHWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_1_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_9zMVFYEdmk-gHU2SpZ4EMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_mRyO_XlQBEWt7q8iQ7G_8A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_XrpCDWtFQUmPxSAiXPTXUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_vd39B4F3FUO_Erq6z5AVPA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_iozvi2N5fUy5-JmDwCHMOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_FuwgOdOK2EGp4zWT_laRCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_rIlXfTTwmU-ysaRC7xDcSQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_XfZVUuusyE6sKx1xn01SHw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_pbC3EeTlG02DpVQruwf4Tw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_4eI5LpLv_0eo4uPM2ev0NQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_B6gQoQkzLU6SHuMVF2-iZw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_3v-ci-9RIE-ahgs5Q3wFMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_xTVVLa1l40W4cNlLaMYVqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1ld6bOFbL0-jZ3xi0wJJeg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_zZC6MbCQ0E-4cbWihISE2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_CUAJUdk83Um44_JFEP8vXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZZvNtzkppE2H6789cVRd6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_bVwoyln2AUi08pK8bb-Xcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_exG11_HvBUqZzNaMA2BROg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_PUdDMYJxs0uelX1OleXC9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_9Pk-XO-w6kazSFU2ZKTLMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZXCGb0Im-UKu347o-AvPMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_HgkA9kih00i_kzO7PaqJPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_091uV2Fq_0qIxxVqOPG-zw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_QZfp6KzOOkKZiy-H5CT4mw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_iTqtnBHt_kCG66_LrnRX5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_5wg1Zs52TkaxKu1Aw0P4Pw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:NotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_9xKYcirppUaOjw1XbQSfdA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_LIP-LQLQ8UqI_DwDXlei1Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_goSBvtoOwUimSgVTIL8xDA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_loohpHzHaEaNrs2gcMBUCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:Dr.BauerLaboratoriumsGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_N4HdUneZ4E-AHlGZSokgjg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:CentogeneGmbhViennaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_6QowRtO2bEKJIQeTYviHqA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_Nt_CcI-0j0aio14DEtDbsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_tZJnFmxuvESALxdrRN7PBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_IY8Y75xLuUqO-v68GXjtQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_gGgYwThhA0yTgQ_UqSHevA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_wO1nyt_hYEmFefkfmJrSBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_vQpey-VclkGOtoNQ0QvVjg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_TenVHCDHtEWBdBEcmQJ5Ow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_alWkS9-7z0m53IksGJp1Wg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_zxwIfxJDvUW4PlzvkDXuFg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_F94moY9-wE6MiLBgNhWeLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_OLnDAxQ4XESWJVC9_RdH_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_w4OmoUQNEkmOiPw-yYz1gg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_RgosDLxdDkaOOiIDh22DcA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:BankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_eqHyAFkkLECwnDL6Bn6VjQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_NANDNBjf2EaG0Ib3x2YeUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentMunicipalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cArnp-3_30mf8DvP_LdFug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_mWZOLj7bwU68ESmKMOpaew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_d-rj6ZvYbkKxosbQKnX2KQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_s1T9fhanpEauW0zp7hr-Dg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_OrZxBSCrjECX-zhxs899wA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:FinancingActivitiesMunicipalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_DtG1lO2ItU27MlS9ffm2uw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_0I3YNkAwCUaxTut_BdZ8UA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BL1i3OTWXkiZ1SLLgFTjaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_9Fb3pxnGaUSRHrSKjMx4ew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_uYV506SBMkuvBE_EZMSfgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_tFtzIuvOnk6eFcAYgKYnZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_cquxSQFt7EuMikBUJNV8XQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_-D-lKyd0xUG2GJXr65MPdg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5eaVP-7_1UKBsld_2DURNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_6ZxMHT3Ak06Btt3uetZikw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_Fj9Rp4R76k2ZiXVlDvyuMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_4KIQ2EJM10KtGQbtSjZSUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_mCcyce8TbkO8Vgcxe5L8zw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_uGud5JzQG02kaS3Mgza75Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_nHe0IepNs0m-_JVwFYjKRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_t3uvbKfeMUqBA08LcKFV-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Z8byyXazL0CZp8NK1au0EA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Zn-0UMVx3E2y3vqaDMW_5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VBSTmHETgUeIl7NqPr5fzw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_PJiIvVIxGUC41eoN-l986A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_smkCz2ptokGCqin3TdKpUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_3NmcgXK8lEOsvBWBRUv4vA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_pMqKy82tCkCyUZNqkklFgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_BYnxal9n_UyhTA2Zunv0qg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_SRmpcImuLkKr7Mhauf75CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_DVwpaAKq20WetXOFxByNKQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_t6wM7AhQ-EmoLvKXt9OZvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_dYyKiaYqrE-5cSLRxZqoFg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_b6v3zHDw4ki2KCugNSJoWQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_KXY4hB06pEyeR-sh2ouA0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_-0qkA_V1Hk2dqGzpyUy7Dg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_kHvSJAIc5Uy3c7q4gg9Klg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_7xeJVhJvYUmbsnvDHQ8d3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_52eSLkL1IEKzP0P0QbaXNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_zDoz25BuFEmJyAnqcxNW5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_vYQneCL0Uki_zA6xML9L3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_6nXywAwdyk2CprWek0Ldig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_xGvnCbYIxkKMBxggavLiYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_abKhok6QA0qwwg9SxU0qaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentMunicipalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_cNSOgL4hV0ag41MiwnIxFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:FinancingActivitiesMunicipalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_KqENbDNqJkWj590bxS6xEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_h8KVGyeyBUaFAxgh3PnrpA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_FHvvZ20F_UCAedsf03EZGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SellingShareholdersMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_XLF3uUzrWEa3kZA0wFlJcw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SellingShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorPurchasesOfAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_VdrlZSWEREarVoh3zIZywA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorPurchasesOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_LRKY6gLhMEChXFAJqFrQYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_3znQxHgm3kWUN47RhL_tkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_8do-YyNisUSwYP5bueDYNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cntg:CentogeneN.vMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersAndDatabasesMember_z7T7AVbVWEqN5q7cJhF12Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersAndDatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_mgdgQ6ZdVEWu7MZBFuxPcA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_a3Yg9ypl1k2iDGuR8xuRyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_3g8HtBjL_kykX8R0GC1k4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ClpwBom6cUqWd-ufPXZ0UQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_LzHf5lcGX0618OATPQ19RA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_UUEtJvvNV0G4AhFLi2cvzw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradePayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_SpNNQ_JBZUOkx3nQnjLf9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_3oFLP2tExkCs_4EjAnnqvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherOfficeAndLaboratoriesMember_OVbtCKe6kk-CtIPs5TAqeA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherOfficeAndLaboratoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_TE1FCKSJ10Wnq3AFudeGVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:SecuredBankLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_KNPG7ftQ40y3-jayGIuG_w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:SecuredBankLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_M_ofTAJmRkyW0qYhKuCWYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_8WV5gyv1i0GftN0I4C3eiQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeAndOtherReceivablesDueWithInTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_z1xLnpmvrEaXgiuUBqzwfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeAndOtherReceivablesDueWithInTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_vfEsDhfpBk2COGW2LU7q1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nrmK-W5eVkeDWBDFsK1gbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_1I2zB8P7-EGuayPURgq3Xg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_gmTaq6Yn1ECvIEhMtnPX0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_c3WvXYkgjU2w62UITw_QoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_iBTWkttdV062pZ701mLkyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_jAebtKB3PUWEhq3JPxUl8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_YGwYj8iWBkW5FDEsRlrh0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_v7Uhyrox_UqVpbuf1EAC0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_9o0XhkZxGky0b7QNSp7Ieg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_q-OwjmoAGkCq9QP-5ONw2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_VNENwsckGUiWfp5ITIZVqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_-KBY6U1X6EOR-VWQfNcPHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_Z_smm4P60EyfOSuzKxAlhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_AWSNyH90oEO0mlR_BPIyQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_kqTayYwJoEGJgu7xk2O20Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_iNZqJbVbKki0oB6o29DKAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember_8g_ZitjpWU2j9Bs86BqZrw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_XEJ63VPP90SKEPNBmiOU_Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_Nr5CKDFzgEmOhALcEcaUKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_nBhxP_A8lkWu92Je-mOYBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_mTPqfJbCUUm--tsL4sV-ig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_qMKixKGV5UWRZqRsEsGsdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_quezt-h_1EWrq43Pa0YWsg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_im24XRyLI0GqUcsxo8IrZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_VIL6RPyEFkOt1QnphczzYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nnGZ6V0R5Ui7TR-RGngNEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_AHlMhGU4RUO4AYFCEWNB4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_aSbUFoGlt0-vDtnrIjva9Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_YBYcui1xWESYnTn6QF0bXw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_CeCE8jbz0EGNqIacDltO2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_53uzl0nKCEWKL9P-aqzedw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_6HnJiRc8uEOIwyqFZl2paw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_h3ZfOluujEiPQeT9NlQKMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_IGCBy0alu02k3K8HN8HMVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_bV11S-JGL0-qYfeSG-mqaQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_YEwbUrATUE6gX9KIiJ2XJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_alAn4anr30uPH3nv6D0QTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_MAiDhc93mEuXQd1PbNze4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_7zHmJCcCi0iHo0JtjolMqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_Gg9_HCfVqkyGfAYx_drdzw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember__GLD_N50Q0qJTvDIg66vCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_sDI8Zd37_kGSZzcJnjDK3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_oDDkh1PJbE2F8ijvw05Pvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_Q0uVwOjO7ECfq8SqO9fgPg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_2zZ4FqgNmU6u242fuMe22Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_2o28VsnJ302Wcsmk8ET49g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_3_Qlw4YfQ0qJvktlFzldsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_lKSmRPULxECSr0eRnZJv2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_2eYckct7zEO-8jBTYOIllw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_3jNAkLwyqECFEAQq580h_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_gS9HG6od70ei9gUMi0zxBw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DpbCs0wmDU6o6dQo732WVg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ManagementBoardAndEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_aEEdjxkwJUmQ8BYGV087NQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dHEoTjnDeE6r34FsHbGMEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Pv_4vLW3B0ydriIBKiHLXw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ManagementBoardAndEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_Y0FLGBLSsUOi8XOAx5OviQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017And2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_J6cKOx758Uan9G_GzTxF7Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2017CashSettledMember_ddZeCSMPQkigLGIMskIdRw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:VirtualShareOptionProgram2017CashSettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_QBlrGqBAdESpyQFY-rXeBw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:VirtualShareOptionProgram2016CashSettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017And2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_StockOptionPlan2016Member_GI6mBJf-uEaspTZUbL_7cg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:StockOptionPlan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_8_7_2021_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_kqeqzG7A9E-5ZgMWESZGzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">cntg:PartneringLaboratoryPhysicianProfDrPeterBauerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-07</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_S0MC9TMobkCnNHOB62yknw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_X97kRl32r0SL4FxM_6oahw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_OD742rXyRkCCIa1akqAdkw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_yKg2jE127UGpUbOS8qY3Tw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_F1HqNUC0w0yF40_NYU5-pA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_OJOdfR7_SU-Nboe2Mk7i5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_B3S0Y9EU7EC4i2truDPkCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_d0QbT8X_7EC8vnyFCWMmUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_ZdfnsggUIk2dILdWP3oszw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_-iDqdbmCPEajuOsNr85IOA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_k6D4DSCZeEKWLGaxOgVzTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_D3EKD6FKfkq_ZzWKmtMzhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_qttKShlhOUaMLtKd7DFFOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_A_FsM08yS06J9681vM0x0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_s8pyC--PfU2a1cGfakOyRA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_WefR96CjT0i-wI_gc8Tt-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_ep_o1_bT5EeKC78nBN7dbg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_zkuIRUT7fkmPld_mOMD4eA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_1IhyUssZbUOMIOgGzDA_QQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Dsbd-0Y1U0K6IobP1taD7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_ASav9p4dxEO3JQhjgj2p-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_uWLOxsW1eEmoFw2X5N9jYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_FDERhT7zokOtLHTy2PLLsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_gFxC2tLdrUODGcKQ8Sm_rg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6yWOMiPRDECERNx2-xKf8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017And2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_u7fv_dcK-kmlAC640STiRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Ws6ILO8IfUWKpcaFtKnMBQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember__QDyppugek-Sh2NBifnpow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_Wsje2nrQu02pAKwNiLBXBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_yBvnu7QHa0K2BszKcg5KZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember__luwaUE-_Ei_x9Oj9E5zMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_Iz_MtPVKxkKthZpts8RjoA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsDepreciationAndAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_f4ic3iZXSU6dqSWwhtj5RA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsDepreciationAndAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_yMvM3I89g0uOJQ1FgVa7uw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:UnallocatedAmountsDepreciationAndAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_eDNvK1TmeEG14kTMUgQaLg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_G9S6WR6LUkWpOgDW2ba0hg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_QzlZ2gHa9UmZqgp-gMT1xA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_BcIW7LDHy0CnsUV9Pv217w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:MeasurementOfServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_6cqIyIHrEkyiYD7ANN1bDg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_PzgOubk0sUiPtObl6v_YAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_J4CTxkjWd0i7eimj-78dVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_3fVvStyvDkODlS0OB9wu2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:MeasurementOfServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_9Epnx9NGxUyO_NrCcxyv3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_EftQ82OO8kC-o269ZjHJoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_-qIGtGSHJkaH45QX4EJ-vQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_6JeY3hzvoUmiYLFCkMlKPA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_k0i-lMHYs0mveCZGWLchMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_nSTQU73o0Ei4uWEp9Ik9Ww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cntg:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_TVcAOmx4hE6T2TjYZkvryA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2MOgA84ZvUenL2B0HVv5GA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_GU9QgCbQgECYTx4q1I_gFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_jyXlykJnhUCcrgqw5ohJ0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_897mirp3Ske02sLLpjt71A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-tikKSwR3UCPoT5YzJiKAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_PAP0ZlgjQEKQn4Hcd138ig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_7QvO56SloEm_LGEAxTptVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_vbrOgTDfJ0e6FyvtY_qOlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_OdjXVnK2IkSMmsnB2jcPFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_mmip9BVluE-UTcolIDlfkA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_1MoZEasurUyfu0ObaxOLFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_T7-iENiVYUyPsm2u4I6Pqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_ZMDElsu6kkCNvAhR--AP0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_ifrs-full_TypesOfInterestRatesAxis_cntg_FloorRateMember_xBPN5MEG9E6vID66HBPpOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">cntg:FloorRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_UJLB8dmYAkWtWhi5WI1mgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_ad_D9-9ZjU6KAfCtl8pHWQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsRelatedPartyTransactionAxis">cntg:RelatedPartyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerCeoAndMajorShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VMdLXHYHe0mBFblmw8jl9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MkH40joHJkuDjye7-7vt4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_1oxG-ulhZkewdx8UmyncDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_fYFW5_Lv4Eu7pT63KH2LHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">cntg:LaterThanOneDayAndNotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_yaEih7N5-0KOOF5zjhU-TA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_PpfrBDRiYE6X2aaNart3Kw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_mfxVmFR_xEyQeUhCH23gEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_OSY64BhwkUypKBgHktTxdA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_06MXARpagUinzCDOWZ3Lzw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_COIkXqsq3EuSXQ8ccGnOYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jB3v8yGjV0Wzi4l46Yp0Ww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_a9m-Txeoa0yrNuKt2KsrgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_5Ul6LbHt3Uml3dMdzr_SfQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_JJuBkPLnakebKDZ6svlPTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OtherEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_8tdZRFUyHUy1cqWB5uPVCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_dcozlUxUTEm0gw3SLkH3-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5hTATt8HAUSJCLPDnOCGvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_78Nr_Jks_0OKR7JkB9K_fQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_JX-s2F9e10SlNE7SMW4K0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_oIZwdOmoREqE4B_LSTBrPg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_h73Wub4Up0GkkBugURy3GA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:TradeReceivablesAndContractAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsPastDueButNotImpairedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GA3_hAw990K3e4HpR8KZlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_jzWpq6P7GkC8v17Iacya0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_lo0H8n9Nq0O6cFGGChm3OA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusRecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_Gr0aLoEJnkKrHhlW3a8QGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsusRecognizedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusDerecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_vmSzJlkTlU2f0ogmnllTIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsusDerecognizedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_9_5_2021_To_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Wnp1O-SE3EaWTFbyh8ZNrw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-05</startDate>
            <endDate>2021-09-05</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_5BgL8gvkB06Ow57f8rxdoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-01</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ViceChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RRXiYNlkWkq3h07ypEAPTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ViceChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfCompensationCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_serqoK5ea0CVflGxqcVFGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChairmanOfCompensationCommitteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfAuditCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Tb9WXS3-AUy4C6w9hUDAdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChairmanOfAuditCommitteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_vuU72Kbpq0W86SjCUL5Wog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:ChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_VmnidKUOw0WoRlLrj829EQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_x92x8S-RsEqIAad9QHOnPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ha2hcVFm9USAnZurtaYg4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OfficesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_s-Pt6IBZJU6njzi-YxbBHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:OfficesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_9C85cYkhmEagnhCDbgR3AQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_aP3WLzf6M0CLLqABTJdjzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_TgPeSvqouUGI0WVPV6Fpag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_5Ec6abUhxEqrvssO3I3V1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_h_nPcgoxBEe8fAs9VKUdBw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_Lv3jrzK6k02RPZdSdWq4Rw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_sqSmjjzLIUyAz8bHBnf8gw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_pxx5jMplQ023eMujrnK7Mg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_HQ7jbEAacECvHaRSqE6IBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ryAYBZr5MkGcAGRJi9dXVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_K_VUIvDBuUOw0I-5hs6miw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficeEquipmentAndStorageSpacesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_VE4Zb24yM0-210qngfcykg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:IfrsMiddleEastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorPurchasesOfAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneAndThreeMember_1pwVmq3z50WQKX7nCXD94A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsOneAndThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_llexk3x_AUmw6uyZBIrKZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_eAQrHbDIbE2JWeOzUkgTzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_EWLOPAf3s06Yaf102xYwkw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_yHGXCfJRZUmQPTopPKil4w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_LRSLwc9jLEWT_6ss8x1zQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_hvAwpduUMkS_--hMwyClRw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_Chzm4i2edE6J2DMBM3190g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_s1PTQMK510ykabqlfipOvQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndMachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_nN1e1Q0e8kGM1jF00oCH2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_utNz0u9_5EyF6tB0tPCjrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_fT4qcBDw9EGETB6DVY3dyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_4MGHm-fiQ0S-NkUoqSHdJQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_gE_fMmwbY0-dkhMzL5yzoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cntg:LaterThanTwoMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Jxfmi8_7z0KhYrUFcANEng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_HpZLjBEdXU2I8BB2YamhLg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_LUjbd8sTrEGlOUAQswnsuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:VirtualShareOptionProgram2016CashSettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_mLSkDz_SwkeNhCK3FKDtYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_oC-Mfx2jaUiilWSjgsPQBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-24</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_TvyCsMUqekaRcguge2kBDA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_UZb9Ik94skWa-HFbTuSMPg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_q1nYC9yqtEWW20MzQIkwFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ManagementMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_f5-2plb0q0-wYgUIlGZSEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VestingInFourTranchesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-07</startDate>
            <endDate>2022-02-07</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_64L26hAwIkSVEZySJMUuIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cntg:MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_E6OgGNIl3kmP-TkRKZ6LGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:GrantOfRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-01</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6BAEvdBRvEWAG0lUbPv9tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GI6jpuFNvkutlq0qWaVoUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_w5uFjzeAFkaVyynChFMU0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-05</instant>
        </period>
    </context>
    <context id="As_Of_6_25_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_sgqoRzpr6kyNzDY9rq2YQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:IfrsIPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-25</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_1v4SxiTooEOxh0OPstkkmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WQu1wOdXfU6jJWFMBs7BmA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tFCvLv4fB0W8h2vSoBrRIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="As_Of_11_25_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_oVuQnUbma0GfMOyRtTtgqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:PeerSchatzMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-25</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">cntg:PharmaceuticalPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l3DMVfcSck6NtIEREMfo0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSaleOfStockAxis">cntg:FollowOnPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_GTBMEUx2bE2fzTJ4qOUR-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsSubsidiarySaleOfStockAxis">cntg:FollowOnEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2017EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_GQnaSesZO02Ad6SmW22DGQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_mQOuHcBww0qhWOVQnUs6Sg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:PlantAndMachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBostonMember_uzMhEfk4nEWX7K-ikyO7JQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesInBostonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBerlinMember_PZ93SKoOakme1tsNGTWckg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:OfficesInBerlinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2019_To_7_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_5mtjV-dSjU23MM1xhgok7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_T02QWHkiiU6Rq5vnTMYTIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_cIYko65EgkiZ7oKBWF8NyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_PsYZ_Pee1keOQx_1jfic9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:BankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_pxPW_PzRlkKEtKb4tqL2Uw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NoncurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_jBSfbMY2lki0j7PbxL_v1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:BankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_5NYYA4fPLkOwhQf6kwQBhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_lnY-Exnu_Ei1u4vGqsRWWg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:NonCurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_x2UJf7_pxkOnSeiJ7yIVHQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentSecuredBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">cntg:CurrentFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rZ2pIjWt-0-tbNOWGJRkUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_LiVI1zychE6WlZz_18uRbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:PlantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="As_Of_7_31_2020_jjcjEUhSo06U9XQl7FB8sw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_AWKL1ObmqUyfc9ddDXBLhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_E0hk7XwMHkiMLSQWwvqDyw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:FormerChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-07</startDate>
            <endDate>2022-02-07</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VugOHEd-30i25LugBEmvOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_6lvAjzC9w0a-ExtvrVissA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:PeerSchatzMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:SupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-18</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_P4QuY9PyE0m3yFf7W6apMg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-18</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_FG-eKZsRE0Of78EHPSAZ_w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_3_31_2022_To_3_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2MIM2SZhH0CgyvooSRXAiA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_3_31_2021_To_3_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9paPg1JNikGwlMsq-h96ag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_SC_KXEUc3E6xppndc2mfrg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedPaymentArrangementTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-18</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GosQtpqEsUy9vxX2amQi1g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:IfrsRestrictedStockUnitsRsusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:ShareBasedPaymentArrangementTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-18</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Rnqc_kluz0ua1KLQBeraOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:IfrsShareBasedPaymentArrangementTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tp1a3EJuEEC8q9t8edUj6Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:IfrsShareBasedPaymentArrangementTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EbcQzhDBV02EnqEK26rE4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsVestingAxis">cntg:IfrsShareBasedPaymentArrangementTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-11</startDate>
            <endDate>2020-09-11</endDate>
        </period>
    </context>
    <context id="Duration_3_31_2020_To_3_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_7cIHbJ3WAEqZLmNWl9i16Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-31</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:RsuGrantedFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:OptionsGrantedTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_3_31_2019_To_3_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_3U_fG7sutUSP4d2rpl_g0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:MemberOfSupervisoryBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:EquityShareOption2019EquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityTwoMember_z-vR9ah280KWInpHt2Pf-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityThreeMember_MUCauPDoGEOo0vEXc8Cj9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:OverdraftFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_InfrequentItemsAxis_cntg_Covid19Member_jq7vmuWOsU2bxZzrIIp5CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:InfrequentItemsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_InfrequentItemsAxis_cntg_Covid19Member_4cfu7k0uNkCbmNqwluM_rg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:InfrequentItemsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredBankLoansWithMaturityPeriod2017To25ThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_B-4Za9jSeEuOpXOxxvEANg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredBankLoansWithMaturityPeriod2017To25ThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_tH9SKU_4CEueGcGPE4KKrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Bvjg5Ricb0CsHHRkM2oKiw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:BankOverdraftsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrModigAndMrSheldonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:MrBerndtModigMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cntg:Mr.KimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_5GYsZrZiqEGPJtHs8Ny2fw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_xEzYX8OnjUOMl3IAx5vk2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:DatabaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MYgrX_n3jkaDz1IqXgfPzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cntg:BiomarkersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_o6x3iNUNZEKJCglE3V0-6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_nUy4aXz07EqtEkGVtRBxvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:NotInternallyGeneratedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_zf-wHnQpt06jb4tX_HSi1Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">cntg:UniversitairMedischCentrumUtrechtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_11_8_2018_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_0CIYtds9E0mzIEud1TfR8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">cntg:UniversitairMedischCentrumUtrechtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-08</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_D3CrI-gxmka4zS7T_IluDA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:BorrowingsByNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_EVd8k1wgy0qJRv3QcJNjwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_M1EU4d6N9kCphLDz7bVjpw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_5QwdsOAvnkeo5LIcezl3Dw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:BorrowingsByNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:SecuredCreditLinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:OtherBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_l-qjFsXgx02dSZIZxayWmA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cntg:IfrsBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_ByAFGvd16EGpT4q2K6NblA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:LpcGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:LpcGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_laKnVzYd2k-Sn9PzEQVwzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cntg:LpcGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_WmW2dmc1-kKD6NAJoNXQBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xN3cXJlN6kKKfXv-f-akRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_cV4yyZGsZUiiKrDyDu6AAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_hG3SF9wOgkiDoa6rqpCHSg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xItn-kSCNkSjgL0_YwgUQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsBalanceSheetLocationAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_McmJjgE_k0alVLPoqAURaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_SvSryWkeDES4Mz3BiNpI4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cntg:LoanFacilityTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cntg:EnteringInToDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_RostockHeadquartersBuildingMember_qSoBB62nPUyoN1idod-5Jg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:RostockHeadquartersBuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_BerlinOfficesMember_1-SX3GoaW06QetWW2MQe4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cntg:BerlinOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_YXoCaUO5F0KnHQTBrV0F9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cntg:RostockHeadquartersBuildingAndBerlinOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_wBoe6UcpT0q8rlfoh6cZ6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-01</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_QxSd-SnvrUqPZtQeLpmFXg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cntg:IfrsAwardTypeAxis">cntg:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cntg:VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cntg:IfrsFormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-01</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:IfrsCorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:Covid19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:IfrsCorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:PharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cntg:DiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">cntg:IfrsCorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cntg:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001757097</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">
        <measure>cntg:installment</measure>
    </unit>
    <unit id="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">
        <measure>cntg:Options</measure>
    </unit>
    <unit id="Unit_Standard_contract_NQVYhN94Wkqxz3djLmP5NQ">
        <measure>cntg:contract</measure>
    </unit>
    <unit id="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">
        <measure>cntg:tranche</measure>
    </unit>
    <unit id="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">
        <measure>cntg:Y</measure>
    </unit>
    <unit id="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ">
        <divide>
            <unitNumerator>
                <measure>iso4217:AED</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ">
        <divide>
            <unitNumerator>
                <measure>iso4217:INR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Divide_CHF_EUR_09Qkxn-hrkG46Zlsshurbw">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Divide_RSD_EUR_oVrkuRnZ4UOXTq9NNZ3SYA">
        <divide>
            <unitNumerator>
                <measure>iso4217:RSD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_item_-qWnVJTSfkeBJ1EtMUURPA">
        <measure>cntg:item</measure>
    </unit>
    <unit id="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg">
        <measure>cntg:EquityInstruments</measure>
    </unit>
    <unit id="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Standard_D_v74mkiZpokKNiaOyAGgw5A">
        <measure>cntg:D</measure>
    </unit>
    <unit id="Unit_Standard_segment_fj3IE5HhAk64wBBglbJJCQ">
        <measure>cntg:segment</measure>
    </unit>
    <unit id="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng">
        <measure>cntg:customer</measure>
    </unit>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="2"
      id="Hidden_dOEUqG-P8E-R6_hbBKJEgw"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">-2.06</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="2"
      id="Hidden_QF0Wcquba0SW1kQUPxLwJw"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">-1.02</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="2"
      id="Hidden_pREXZ8GJmkKRhYIIX6tiPQ"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">-1.27</ifrs-full:DilutedEarningsLossPerShare>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_3IhO1dtYV0ym0PhbtlF9zA_2_1">0001757097</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_Ep04vdF78Ey2wukykCq3bA_3_1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_PE2_MQC7uEKf3MnvkXA-IA_4_1">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_q6sIDP0YpE2lArUW8PG9LA_5_1">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_lseNrnVwN0K_qa-SRrYIOA_6_1">false</dei:AmendmentFlag>
    <dei:EntityExTransitionPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_6Uj5Qb7n-0CTPEolQRQtSg_7_1">false</dei:EntityExTransitionPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_3_31_2020_To_3_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_7cIHbJ3WAEqZLmNWl9i16Q"
      decimals="4"
      id="Hidden_jSIetAVFSUy9rOmGdWl3DQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.3333</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_3_31_2021_To_3_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9paPg1JNikGwlMsq-h96ag"
      decimals="4"
      id="Hidden_fRre5vnXW0GOsU14ZJw1hA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.3333</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_3_31_2022_To_3_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2MIM2SZhH0CgyvooSRXAiA"
      decimals="4"
      id="Hidden_qjf0jjHjLE63EWQQBJvIIg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.3333</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <cntg:NumberOfTimesLeaseContractCanBeExtended
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q"
      decimals="INF"
      id="Hidden_iUFcya4OnkmTbsk8Tv6XcQ"
      unitRef="Unit_Standard_contract_NQVYhN94Wkqxz3djLmP5NQ">2</cntg:NumberOfTimesLeaseContractCanBeExtended>
    <cntg:ReceivablesPaymentTerms
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_utNz0u9_5EyF6tB0tPCjrA"
      id="Hidden_01i51NYs8kukTb1nNEXfkg">P30D</cntg:ReceivablesPaymentTerms>
    <cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityThreeMember_MUCauPDoGEOo0vEXc8Cj9g"
      decimals="-3"
      id="Hidden_SQJSZp5xzU-f4eqciOHicg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">500000</cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EbcQzhDBV02EnqEK26rE4A"
      decimals="4"
      id="Hidden_Di3UQRQ2MUWSk55FplrgzQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.3333</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Rnqc_kluz0ua1KLQBeraOg"
      decimals="4"
      id="Hidden_lq4xIkppPkuJR_e8mjx1ZA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.3333</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsVestingAxis_cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tp1a3EJuEEC8q9t8edUj6Q"
      decimals="4"
      id="Hidden_EQTkAO2Ni02-Mndxnfpk_A"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.3333</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <cntg:ThresholdTradingDays
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw"
      id="Hidden_2x0a_zAG40CpBOwHDJxpzQ">P20D</cntg:ThresholdTradingDays>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q"
      id="Hidden_j7I3SlyuWU6KYGVcxzrMkg">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg"
      id="Hidden_YStt1HXTrUSZGYMRD2aLHg">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg"
      id="Hidden_YVS6AVoIeUKeeejiDsF3JA">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow"
      id="Hidden_AdWcPoKHd0iDW7odOEhQgg">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      id="Hidden_HW0l6QwPxEehXDxtNMXdTA">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw"
      id="Hidden_y1wywXdbVUOTeWK6mrdN-A">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      id="Hidden_YZDLiCDl6EqhXBUv-LZuNw">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <dei:DocumentType
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_9_lIaYasPUarSdrwrgCkxg">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_H8Us_eAEZUeDH8Ueh2CVhg">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_vBRI8l0zrUmVxK-sJLkndg">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_zvmA6xG5M0OyrB4tkC6gGg">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_t9BqYFbWFUSjz_sgmj0EdQ">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_nlub3AE-90GBLPXPkbW_Ig">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_kZl7UOUqk0S96zZQFiPejQ">001-39124</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_fn2ppT7icE-ncuuMp4Yi2g">Centogene N.V.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_r4wl0NRYhUidn-3j_O6AJA">P7</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_pQCO7-ufhEKUNZCYUmCYWg">Am Strande 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_yZvd_WN7c0qkSVCBlbZBlw">18055</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_ubJcj0ICJUy6qEPNq0UN5w">Rostock</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_lLh2ULlHRkW5vjufhzEQmw">DE</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"
      id="Narr_MLdh2XuKzEmqrkwigOHW0g">Kim Stratton</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"
      id="Narr_miLSBApWLUGb5AR4Jwu7ow">+49</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"
      id="Narr_wNnw4I8qjUe1zglFPqMmHA">381 80113 500</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress
      contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"
      id="Narr_5Hfmwps2TkW7IqPs3TO7Mw">kim.stratton@centogene.com</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"
      id="Narr_JwN3E0ahkUShR515qO2how">Am Strande 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"
      id="Narr_XDZRA_v7a0KotkdQ74akQA">18055</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2021_To_12_31_2021_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_EEsUvRSzfEuY63dA2e0UkA"
      id="Narr_Ix4HujJ9AUO7Hr8JBPZJiQ">Rostock</dei:EntityAddressCityOrTown>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_vkPMRKnvk0ae-4do2q6n-Q_2_0">Common shares, par value &#x20ac;0.12 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_XRVJ3GkJiE-jJ6zjYd3PAg_2_2">CNTG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tc_1n0eD5eTGEGJBVlmg6BQIw_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="INF"
      id="Tc_0If1Fkls4Ey6AUfUr0BRXQ_2_2"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">22567971</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_du3e5d31j0eHKxw104Ud7g">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_ICyBWLZWnU26aCbVjhCJtg">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_TOSrNSW_lE2WPqTZmdYDdQ">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_Di8pKKW05EebT0UZZilgAQ">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_4F6oG0HDAkSqtCMbXMCXww">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_3Qv_dFFMWEObBXBrujsikg">true</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_UXc6G-Qhzk-WDXctWO_zGQ">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_i4QHXF2ySUGRWBXclg-Qug">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_7qjwL9hexUy-J7Lgr8jvdg">false</dei:EntityShellCompany>
    <dei:AuditorFirmId
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_QZuxaj-uZEmiReMbMSsU1A">1251</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_0j-lkqVy6EebMwvnDnSBjw">Ernst&#160;&amp; Young&#160;GmbH Wirtschaftspr&#xfc;fungsgesellschaft</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Narr_VyKI78usGkKl4rIvhrM7rQ">Berlin, Germany</dei:AuditorLocation>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_kI7R-Fys3kyRQuwf934IYg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">189923000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_YI365N1eTkS8_g_gFWG89A_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">128381000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_nn9Y21dDikOXQyqlqvRbLg_3_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48780000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:CostOfSales
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_DT_cbMy180ub_5gJt3x9iQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">161765000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_vt1s6xlTAEC7X5FYynorUg_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">83437000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_EEiG9Tlvv0ugO3ucPNN7TQ_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">26005000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_3MDWeJTekkGKXFCtAnOQGQ_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">28158000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_bQFqeGUrW0-CnffYIhcEfw_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">44944000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_oGV-eRaZqkyZNM0hcQKZ-w_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22775000</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_KSCYpOCv70i7L9LB-FHXAQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19297000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_0YcHF5SVJEeyaIeJ_bBVoA_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14935000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_OqU5a6DFr0CWsPgsIVv3Mg_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9590000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_a2KwvwoXvkuB3qT3gpw8Hg_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">46739000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_7KKEvfFt8kyhKkhxPukGSQ_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40160000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Kuer2Gz69U2RBq8N6sWL9A_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23160000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:SellingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Rh_jyRY0dkm4GaEvTBGKuw_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9860000</ifrs-full:SellingExpense>
    <ifrs-full:SellingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_35_tnJMJ7k6Jm86UhN0E9A_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8026000</ifrs-full:SellingExpense>
    <ifrs-full:SellingExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Sdhqk-lsaEGr8xRgurVa3g_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9254000</ifrs-full:SellingExpense>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_J3f3lNBYyE-pvjgnIfNd9w_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1140000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_X40L-do4v0yCAeJVo0xpaA_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3738000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_u1CqWK4Xt06MmBVR_aUPnQ_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">752000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:OtherIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_kMHNK7h3mkWbwsNCKoo2Yg_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2936000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_perZEneRaU2G-cCcwgC08g_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2394000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_miiGLo1EjES19tyMyDQujQ_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3781000</ifrs-full:OtherIncome>
    <ifrs-full:OtherExpenseByFunction
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_wqpHVb1qnUKQA0wVL3-09g_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">86000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_1DqrdGXF2E2cAocwcnf8rA_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">182000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_5hNAzwAfqUCoBe--yTwf4A_11_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1284000</ifrs-full:OtherExpenseByFunction>
    <cntg:RealEstateTransferTaxExpenses
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_wFHRqsapZ0Kfv1a9D-cK6Q_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1200000</cntg:RealEstateTransferTaxExpenses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_aenT9UG0XEu5eIFc2tQ8-Q_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46028000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_IIdr40QN4ki5OjvFTgJ3rw_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-19703000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_X2k0Vfbq30qFS5mdE2VxXA_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-18684000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:InterestIncomeOnLoansAndReceivables
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ORueScTjoky87SVdYOFlxA_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3000</ifrs-full:InterestIncomeOnLoansAndReceivables>
    <ifrs-full:InterestIncomeOnLoansAndReceivables
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_fzGJdJK1gEGD-OAZ5gU6-A_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6000</ifrs-full:InterestIncomeOnLoansAndReceivables>
    <ifrs-full:InterestIncomeOnLoansAndReceivables
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_4zKnyZk8DU-tm6KUWdIc2A_14_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:InterestIncomeOnLoansAndReceivables>
    <ifrs-full:InterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_SLSgl53eW0qSVRQBFucH6g_15_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">851000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_IMPVC9DK20G8miL-gycXGw_15_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1400000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_x3T5F01BuE6BimST5GbVkg_15_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2029000</ifrs-full:InterestExpense>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_2qnfmZmJI061nfMqq4OhGw_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-848000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_qO-sUsvgqkCBZqEKlY_oIQ_16_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1394000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_rJYq3_NEyUadIeIpHLdWPg_16_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2013000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_FQeteoA8dEqwjI7yHVz2Ug_17_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46876000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Zxjl3mpqdESI1-THUcOFWQ_17_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21097000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_zr1O7YfzSE6jKo6XZUHhew_17_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20697000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_7fQERJ4kXUiHYXovWzB69g_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-24000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc__tahpzJqgEiCTghHsYoKCQ_18_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">281000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_OQ1cg7tBTkqmDQf816JEng_18_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">158000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_gI7gFhZ-JE-H7cRODi5ZUQ_19_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46852000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_26k_Z9JdQU61GdmfT963Zw_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21378000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_7qwxu_r-MEmJeLJL_6ACMQ_19_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20855000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_B3v4FqPAUUK4GZtdWDLkbQ_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">543000</ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_vusIrOxeL0aYgCUwjdQXnQ_20_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-48000</ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_40qgl2vZJUetN5kpoFGfGw_20_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:OtherComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_GlsrxuZS00SyfCh4k6bPCg_21_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46309000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_pjIwZHmZ5UKHYvfVvPZMUw_21_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21426000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Cp5AflAxNky-U4J-g3zvMQ_21_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20839000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ZXWiqgpvh0iOERfIu1YuDQ_23_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46407000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_57gqbvBNVUqXtREAlfekXw_23_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21486000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_dwaKrqFmrE-2pQQQ74RXog_23_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20658000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_iRQGIRitAUW_KYtXLMZqPg_24_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">98000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_urAcgFHmtE-_fuLAdijsgg_24_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">60000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_qSKM4Rs88E6Dn85XQHaR5A_24_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-181000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_v6dwPtGgKE2jn4itu7yTPg_25_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46309000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_4sSK8SjEPE2WZdkQZ5YQyw_25_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21426000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_LqEUjC3Feka1i_CcaePyNA_25_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20839000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="2"
      id="Tc_hV4cTAvZfE2P4_g00iNZTw_26_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">-2.06</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="2"
      id="Tc_m-pkLZTI0Umywozzp_czmw_26_6"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">-1.02</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="2"
      id="Tc_cHA9pDI1YEWEYpyQt0IMYQ_26_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">-1.27</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_qQlqMrk2m0avJKpUdohsmA_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9194000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_L93nupeLOkGrkoQfDvwYmw_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12407000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_XYFJJKBB-UKrwzPhPYQ8cQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8147000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_HGP7-RqT1EudGsSA8leePg_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16590000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_fK6oAlSvPUeEHG_SGzCS5g_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18904000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_wn76efGBNE20QuP259AIkQ_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22120000</ifrs-full:RightofuseAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_vzmAsbSJUEaiMkDfbgJP3w_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2972000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_uqjB8dTOXk-wF5oJRlX3Uw_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1967000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_-i9Y2TCr10Ki7mgvTvxAlg_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">39217000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_8KGNZnJyokOtDynh4gGdIg_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">53084000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Inventories
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_UqIGY5BzAEupfuwATnobLA_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3869000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_j7OKmu71w0ae1hM41fUHOQ_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11405000</ifrs-full:Inventories>
    <cntg:CurrentTradeReceivablesAndContractAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_Orx-m9BdQ0ed13bWarcXOw_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24337000</cntg:CurrentTradeReceivablesAndContractAssets>
    <cntg:CurrentTradeReceivablesAndContractAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_mABCGFJne0CKOncqzXipCA_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">29199000</cntg:CurrentTradeReceivablesAndContractAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_RdCQY1buX02PAyI3g4uMhw_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5453000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_TGHqXp-hsUir_Vj944TpCg_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8286000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_OIrioP3Yzka0nj6SzFS4qQ_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17818000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_BW0XsByQMkGqsX50ZdI3TQ_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48156000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_u33Qk53fC0utwL5l4swl4A_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">51477000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_d45oRkPFq0my7RRh9rjwXw_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">97046000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_gODxXvzfLUaUOL5a8X_o1Q_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">90694000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_OaaTJ0jGDUifKA0ShEFUlA_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">150130000</ifrs-full:Assets>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_0hAwHS0X20aqH5KTdrESQw_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2708000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_R4Ma11M7xECjFn-e2kg-cA_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2654000</ifrs-full:IssuedCapital>
    <ifrs-full:CapitalReserve
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_1CduIpKMwECAwSre01bk_Q_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">133897000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_EBCpuHzvuE-bDPke5IbMgg_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">125916000</ifrs-full:CapitalReserve>
    <ifrs-full:RetainedEarnings
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_71R4pc1mHkiCH3Hcn8L_0g_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-109295000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_S1yJIckRkkeV51DV4eRdkg_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-62888000</ifrs-full:RetainedEarnings>
    <ifrs-full:NoncontrollingInterests
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_SE56LSGob0ioaUwPubRw8A_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">193000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_one_l6aWgkmCTCnf2PtO3w_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">95000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_ehiC7KPiCkGs3A0768Ackg_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27503000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_yxL23TUPy0CZfMwARNqwJA_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">65777000</ifrs-full:Equity>
    <ifrs-full:LongtermBorrowings
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_bm567TG3x0O9ApF2hAj-JQ_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">401000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_LFA_KgoREkGnyGIwjiyKZQ_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15588000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_Vb5LT12150e7_Q9KBx-28Q_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17677000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_v_dpTO7zxUi1QylrQ9D9aw_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">79000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_w6MFp8udaEWhK9KPVZ8eIA_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">207000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_y80Xj1ixp0Cbtfb6jsAP9g_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8028000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_ZmNmMAEO7kOABVmf7SPx_A_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8950000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:NoncurrentLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_igY_cwLLdk2Wr62auzazFw_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23695000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_T4bd-eSLmUebNHYr9dO3Qw_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27235000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:CurrentGovernmentGrants
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc__ixty6V9jEmuhKX-pcccrw_15_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1368000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentGovernmentGrants
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_y0pXOW7S40iMoH7p-fhoXA_15_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1342000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_J0A4UwAHRES101zuSjPAjg_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3815000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_M_0MaxJPEkObmEVlCBB0hA_16_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2492000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_HmlVBKD0jEa75nyw0_lLdA_17_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3409000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_eZx8OcRGFEW5aKYheqctpg_17_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3528000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_NgzNMJAv50Kbx86cJ2NIBQ_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">178000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_xoy0InF8mUCVFKbJhN7FOA_18_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">58000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_ZhSxtenLn0aI0hUnc7Si5w_19_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11252000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_g0EO_tbLGESeSfXUmh6Ygg_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31736000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_AsEg6NY86UyIUpCB9CkXpg_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19474000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_dsmw2mqPIE6PeW1PbfwyqQ_20_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17962000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_XrL2PMIrRkWNCM3vGjxFgQ_21_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">39496000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_rbcVftUbmUKSHbxBF41EyQ_21_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">57118000</ifrs-full:CurrentLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_XjLmmhIObkKkrRZSMhLVVQ_22_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">90694000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_qTligW4WvE-7C-o95b4SBg_22_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">150130000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_AmM04Z9N9EmqZdY59htsKg_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46876000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_WeiIk8IoH0iIMr9ArpKVgQ_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21097000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_tArb5TLgIk2ZXn0jGefvxw_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20697000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_tDL3P_vgcUubIDjj5thA5g_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21291000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_0c-wOJ9KJkO14oNNVHdYng_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15128000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_y21Uuc5V40GlQbR48lNM4w_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6579000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:InventoryWritedown2011
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_gzxTFOW34EuXk2sUxg5pCg_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1795000</ifrs-full:InventoryWritedown2011>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_BxEmvduIrk20g-yBqfnbqw_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_d8hgBc0xAkOXAiRJ5DzSVg_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_R-ILQnRsi0CAFLRzp2yV0A_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_QVwH7-9E-U-0vh51U8LHNw_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">851000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_xqPdfjVj-UWtanytmBJlNw_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1400000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_xVV77f9PgUeG0wEuMlkcEw_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2029000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_teewl5P2XUi8K_Jye6AA3g_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-18000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_fm8P23AQtEOpIlU8ImGYqA_11_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-532000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_TCyxBwcHi0illb6D8DI7QQ_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1140000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_G-RF-zOhLk-ujEzr53cGWg_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3738000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_hKnN1qthd0aUdDNol4_MLQ_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">752000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_5iGZGuWlSUy6wY63uSL71Q_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8035000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_x9ZfrPYqKEmEfgQYUxkdOg_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5658000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_4ZZ7rl9aUkK0hN5LXZO72w_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6418000</ifrs-full:AdjustmentsForSharebasedPayments>
    <cntg:RealEstateTransferTaxExpenses
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_SKWiRdOdsE-Jz6xDXmbpnQ_14_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1200000</cntg:RealEstateTransferTaxExpenses>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_nKwM3Ao0xkqIC9VbS458Qw_15_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-862000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Q3WlGvHRO0--Irt6GtWLCA_15_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-915000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Ovz9ALeV5UWTMf6HPNZl_w_15_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1856000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_a9LkA9SUxEK3tg2IvytdWw_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5741000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_lcgZderpdk6exdSmjpW91A_18_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-9596000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_BfzWFO3a-kqOVC3lXAhRtw_18_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-463000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_kXqUdUPE40iHOt07gMJaoQ_19_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4191000</cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets>
    <cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_TSHpnH4LL0msaZ1ssiRLJQ_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-16344000</cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets>
    <cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_jjUWAeelbUem8osUGXcGOQ_19_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-6444000</cntg:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_kZRpCmfaDEe0Y0VY30QreA_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1828000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_8wC4Z6yJBk-faTUCj1mBug_20_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">255000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_amPmvH_iTkySyfOm1MwQtw_20_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1169000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_2dsTzlpsDESDIoFEwthpTw_21_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20484000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_11GF007iNEeGvgnu5iHfcQ_21_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23996000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_6iQE1Cb5JUWKey6sAhgf7Q_21_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3125000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ZozCo3KYUUyYGO3xLCwdwg_22_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1632000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_ns3xXOeaFkGLqMsRjqae3Q_22_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6245000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_AbRygJkuEkqzr3FQO_5KxQ_22_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3299000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_UL-An_ecmEiUcA_mHeVUww_24_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21739000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_jnGjNFY-rEKrwoinaUj9Sg_24_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8462000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_fGTPCUFDuEm1mbRIS9WwMw_24_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-7775000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_tIiGChd040W-uQQdqsAjQg_28_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2787000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_xb4my2dC1EiwkAjg3SYgIQ_28_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6657000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_jQUDmnJ8ZEikKuRgdaACjQ_28_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7280000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_L_0isg-KF0yF4ZabAu6ivA_29_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2915000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_F_RrfXdo0EWQ5WLXbNpPZA_29_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9890000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_QBEuqKYVNkel-xcvnPdCSA_29_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">296000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Q_qrP-GNo0KjIV46eD--6Q_30_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">168000</cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc__xxVy8PTYUOTiv3-pBmcIQ_30_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">390000</cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_5QRvAGQqcUiDP587y-s0Bw_30_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">793000</cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cntg:PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Iliug9X2CE6CjRMFilC3_g_31_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">358000</cntg:PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_RCvGffQbkEuGAuxeFpRYMA_32_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">171000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_O3bpmlMlR02PDol5GYZDWQ_32_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21300000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_IQ57IgaG_U2fdvpK_kK-iQ_33_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_MtQs5o4G0Eeqv1_WwQuY8w_33_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_8VrO4Jgz30Gku0Waz2geAQ_33_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_fdHqBT-8rUW7eqZ_wDoDuw_35_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-5360000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_icdHsvWsLEiTYeomUXiyNA_35_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-16151000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_mwA1RGW_XU-_7Z9NjH345g_35_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14175000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_deagoZIUTkWNi3t0uWNC4g_38_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22430000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_rfyN1UscfkqI6H-kq-xLPg_38_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">41899000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_VosXx0b5AUumy5zeMar4MA_39_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">75000</ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_cteKEk9kyUu_lDBsyav96g_40_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1772000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_tj0k2kHsFUy1SQtcOYlr0A_40_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">438000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_wILHR51hVEKSk7ulyf03CA_40_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">721000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_PpTkiBEj3k-W9sQ8z9__gQ_41_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">464000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_XO3A9KwVREKE5egiwy_K6g_41_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2760000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Zg26ONDeZEqZJBqZc_zyhQ_41_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12072000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_yN-Xi76UxkGDLPq1W4R4Fw_42_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4244000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Qecqi95kg0WcloE0Np5WFA_42_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5018000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Wto0HBXwAE-s9EbhWib54w_42_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3046000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_HGuM5GwzNUS-uAR9TJZZsQ_43_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">267000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_NBzlHoVim0enN7ZmI65LRg_43_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">173000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_ZB5dqS3KK0-oXEk3UngAfw_43_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2029000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_c3fKc-QfnE6wXtQjnJlxBA_45_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-3203000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_xvodQIiOZE2G-JK2XSXKHg_45_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14842000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_etF7p-o_IkS5cZUU-HJ1yw_45_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">25473000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_huv9AR4F6kGtR4NtQuyFUA_48_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-30302000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Zg5txhFiFk2J5sneE2I0UA_48_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7153000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_9OzQLW23LEW491JUqjLHxQ_48_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31873000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_yXMR5Xw5hEiiWJnjtSpLfg_49_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48156000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Tc_r9ab0mhF90uaunUA1fz_QA_49_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">41095000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2018_mmip9BVluE-UTcolIDlfkA"
      decimals="-3"
      id="Tc_mQ6qLLZADUGTfM0Pmtkxgw_49_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9222000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Wr96Wu-ZCEqgDtugHcI1kw_50_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-36000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_h6TIU3JwEU6cDiNsfeFW3A_50_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-92000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_iY4oG08dgUmOC8l9ukM__A_51_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17818000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_Y_sxXJeINUqG_92wsCnjAQ_51_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48156000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Tc_WUK_RXTg60mQ7YNd3vQtBQ_51_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">41095000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_zkuIRUT7fkmPld_mOMD4eA"
      decimals="-3"
      id="Tc_Hr8YkAMEH0ySnagat8ShBQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1903000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Dsbd-0Y1U0K6IobP1taD7g"
      decimals="-3"
      id="Tc_hco1yEQBkkGuwI2ugSmTUA_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">45342000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_WefR96CjT0i-wI_gc8Tt-w"
      decimals="-3"
      id="Tc_QCRoDoW_6kalBHTgnNtNrg_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-16000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_ASav9p4dxEO3JQhjgj2p-A"
      decimals="-3"
      id="Tc_7hs5QCO0EkeHtDhom4N0Ew_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-19948000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_1IhyUssZbUOMIOgGzDA_QQ"
      decimals="-3"
      id="Tc_J-ruygEKAUiMTpAmv2tg4Q_6_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27281000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_ep_o1_bT5EeKC78nBN7dbg"
      decimals="-3"
      id="Tc_2itMsMFH5E2hsBCobhRtOQ_6_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-757000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2018_mmip9BVluE-UTcolIDlfkA"
      decimals="-3"
      id="Tc_-wwNWav2c0u0CZlMwol8gw_6_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">26524000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_7QvO56SloEm_LGEAxTptVA"
      decimals="-3"
      id="Tc_MzXp-k6Ntk-Ekig8XcMtfg_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20674000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"
      decimals="-3"
      id="Tc_KX1JGGhHBUykuasw7hRl5Q_7_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20674000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_PAP0ZlgjQEKQn4Hcd138ig"
      decimals="-3"
      id="Tc_MwRuJNaj5Eefk2OfB0FZjw_7_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-181000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_395IWrjwEU6P_u0AbebH0g_7_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20855000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-tikKSwR3UCPoT5YzJiKAg"
      decimals="-3"
      id="Tc_GzSOELVogkiHpIG8QZiw8Q_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"
      decimals="-3"
      id="Tc_YNSs5c9Mj0uHdBp_kawGuQ_8_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc__5HIVphVa02juRPaVlKFmQ_8_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-tikKSwR3UCPoT5YzJiKAg"
      decimals="-3"
      id="Tc_Q0LrdS81YEGfozHiYXa5pA_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_7QvO56SloEm_LGEAxTptVA"
      decimals="-3"
      id="Tc_2vNoL6pSakypNSBjvjQHDA_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20674000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"
      decimals="-3"
      id="Tc_9m2EoLR-M0KKZeHfmls7Ww_9_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20658000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_PAP0ZlgjQEKQn4Hcd138ig"
      decimals="-3"
      id="Tc_tzHj3wEj1k-PMKG9zppGCw_9_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-181000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_gpWnoj5OIUKg87A_qSs9Nw_9_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20839000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BL1i3OTWXkiZ1SLLgFTjaw"
      decimals="-3"
      id="Tc_TTWSkv5hbUa475sO8Nm7eg_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">480000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg"
      decimals="-3"
      id="Tc_p19A4o4_AEqVGNl_bay8Ag_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">46318000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"
      decimals="-3"
      id="Tc_-7gVc9pPGEW7uYxZTggEzg_10_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">46798000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_XANsmdfT60mUX-84MZZyqg_10_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">46798000</ifrs-full:IssueOfEquity>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg"
      decimals="-3"
      id="Tc_-GT1UbMF80O-m_AxJcm9sA_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4899000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"
      decimals="-3"
      id="Tc_U-87UZcYQ0S94iIPbtmSbg_11_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4899000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_K7hfullMFk6zUr7HPWWHTQ_11_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4899000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg"
      decimals="-3"
      id="Tc_CBbD55PvYEymgLWs1D0SEw_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1300000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"
      decimals="-3"
      id="Tc_PnhXlRKOiU2HEAQ-m46GkA_12_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1300000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_M10LBl_WhkK2yYC08UZf5Q_12_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1300000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_0Bv6hLkHh0627GSmTJpzjg"
      decimals="-3"
      id="Tc_-T-XLihpokSIVkSjKavteQ_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10038000</cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering>
    <cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_9x_QC_2T2UO8UR8ik76yhg"
      decimals="-3"
      id="Tc_KjIu-XaQ5U2NTwG4IROwgg_13_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10038000</cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering>
    <cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_ylDPkmVO40m1gtj-T1JobQ_13_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10038000</cntg:IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_D3EKD6FKfkq_ZzWKmtMzhQ"
      decimals="-3"
      id="Tc_SKsRYnD_t0ChB2tRk4502Q_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2383000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_A_FsM08yS06J9681vM0x0g"
      decimals="-3"
      id="Tc_WKg1L0fu1U-LhvJ6sliL1w_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">98099000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_s8pyC--PfU2a1cGfakOyRA"
      decimals="-3"
      id="Tc_Dv1OsG1ia06HaNsF-gY44A_14_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-40622000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_qttKShlhOUaMLtKd7DFFOw"
      decimals="-3"
      id="Tc_t105cxVGmEm-nUuDWtUR2A_14_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">59860000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_k6D4DSCZeEKWLGaxOgVzTg"
      decimals="-3"
      id="Tc_y25pPNFrhEafEVqaH6CYSg_14_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-938000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Tc_5FwdPLHYYE-Vhh5w7uJFXw_14_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">58922000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_D3EKD6FKfkq_ZzWKmtMzhQ"
      decimals="-3"
      id="Tc_Dr4rtG6ICEmkCu8MScR7gg_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2383000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_A_FsM08yS06J9681vM0x0g"
      decimals="-3"
      id="Tc_8CwVoBiVJU-os0ISF_1Iwg_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">98099000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_s8pyC--PfU2a1cGfakOyRA"
      decimals="-3"
      id="Tc_sS9zSSYOHUyv_GkyjWuLzA_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-40622000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_qttKShlhOUaMLtKd7DFFOw"
      decimals="-3"
      id="Tc_AMLs-Ov3o0-pAfuDI3KEuw_6_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">59860000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_k6D4DSCZeEKWLGaxOgVzTg"
      decimals="-3"
      id="Tc_Yg37ZERSGEOsfZ5geBdv0w_6_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-938000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Tc_ba0DA9r4Hk-ZFbjizitEaQ_6_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">58922000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ"
      decimals="-3"
      id="Tc_cKzDzlGXDUiygHDBhzLipg_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21438000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"
      decimals="-3"
      id="Tc_rBeeTCg9lE6cL62y-eEY2g_7_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21438000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A"
      decimals="-3"
      id="Tc_Si2rL0g_C0OcJXXeZ0j2BQ_7_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">60000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_lAaJqzVhh0SB9Tms2kVi1w_7_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21378000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_897mirp3Ske02sLLpjt71A"
      decimals="-3"
      id="Tc_X9wq5UaCvEGzaiGk4TfDMQ_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-48000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"
      decimals="-3"
      id="Tc_lPdJEAXlw0ykeejEUyuRfQ_8_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-48000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_dsV4sKroZ06M8GmqDsyvEA_8_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-48000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_897mirp3Ske02sLLpjt71A"
      decimals="-3"
      id="Tc_TrC0XkS52E6-_yazhkwogg_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-48000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ"
      decimals="-3"
      id="Tc_H4nwvWqkUkO9wzzcwrQ27g_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21438000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"
      decimals="-3"
      id="Tc_YMRIeSvyDEukfbOzG20W5Q_9_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21486000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A"
      decimals="-3"
      id="Tc_TQvnrCZ490SZ_YiMY0jdiA_9_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">60000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc__YI-wWwTBkGz8-YKGr-aQA_9_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21426000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_FHvvZ20F_UCAedsf03EZGw"
      decimals="-3"
      id="Tc_KHcMhxzOG02sktUxlxBGKA_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">240000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg"
      decimals="-3"
      id="Tc_LE_1i4R0TU6EKFbDO_L5zA_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22969000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"
      decimals="-3"
      id="Tc_Fieo4nhJPU2_AnURQctdiw_10_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23209000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_uFG7yUIsckeRYtEos9LUqw_10_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23209000</ifrs-full:IssueOfEquity>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg"
      decimals="-3"
      id="Tc_IIkY4vN5EUiHtwiR084rMA_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">779000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"
      decimals="-3"
      id="Tc_uVImODSjYUiK4odT27TMxQ_11_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">779000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_eCM50PTX9EW-e7ZEq4uSsw_11_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">779000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg"
      decimals="-3"
      id="Tc_I8V_zxTDb0Sx-GTD4OEnow_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5658000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"
      decimals="-3"
      id="Tc_mhXDMtAPhkWUnRY9Poc0WA_12_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5658000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_zkSHT5eEP0aW2b9kKHoW9Q_12_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5658000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_FHvvZ20F_UCAedsf03EZGw"
      decimals="-3"
      id="Tc_P-g3T09oU0qxm6-yn4te1Q_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_Yp9XzSXnJkigrQG-mrVxIg"
      decimals="-3"
      id="Tc_G50z5kPr4U6TQyAN9Y_pYg_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-31000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A"
      decimals="-3"
      id="Tc_C6GyxDZKDEybZzR-foOr_g_14_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">268000</ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_XT13ntnL2kS97BgJgX1ZBA_14_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">268000</ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_AHPWZ_boZUay3MOlspTKBQ"
      decimals="-3"
      id="Tc_fwFFtriZJ0SAY07qImyH-Q_15_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-780000</ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_g45qS_lb-EOBQNXX3eMGgA"
      decimals="-3"
      id="Tc__MLDnuRH_0SIs4z7v6E3Dg_15_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-780000</ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_65WGrR1JBUO8EFSEtJaJ5A"
      decimals="-3"
      id="Tc_YJgXoYxtwUiRFHxbAd--Rg_15_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">705000</ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_b_8mD3ZbvUqi-4P5R6Vj4w_15_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-75000</ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_d0QbT8X_7EC8vnyFCWMmUA"
      decimals="-3"
      id="Tc_LGyJEpMeAkKEPqn2fEOL0Q_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2654000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA"
      decimals="-3"
      id="Tc_9G4FZctvvkOOH47LSCtbFA_16_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">125916000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_OJOdfR7_SU-Nboe2Mk7i5A"
      decimals="-3"
      id="Tc_Gcp2vsWNZUOhHEzs-ojl8A_16_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-48000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_-iDqdbmCPEajuOsNr85IOA"
      decimals="-3"
      id="Tc_KLZ5IUzGDEa4yrRt2p-IXg_16_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-62840000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_ZdfnsggUIk2dILdWP3oszw"
      decimals="-3"
      id="Tc_xA7uyI1u8kCbdbCSpiIOeQ_16_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">65682000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_B3S0Y9EU7EC4i2truDPkCg"
      decimals="-3"
      id="Tc_JqhCw1ZAVk6jiphjak4meg_16_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">95000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_nidZ-zQKakOFk_BNYFgD_A_16_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">65777000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_d0QbT8X_7EC8vnyFCWMmUA"
      decimals="-3"
      id="Tc_VY7b4Sk8qkuzp0PSIfemDw_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2654000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA"
      decimals="-3"
      id="Tc__9uwwRxgpUuZKg98RxuKFw_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">125916000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_OJOdfR7_SU-Nboe2Mk7i5A"
      decimals="-3"
      id="Tc_uazZTP1B9UyQsOYmVPdowg_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-48000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_-iDqdbmCPEajuOsNr85IOA"
      decimals="-3"
      id="Tc_YVnbz7mJ4Umv8-pFjNT-WQ_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-62840000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_ZdfnsggUIk2dILdWP3oszw"
      decimals="-3"
      id="Tc_pJ0qp0rJ_Eela17YtQyGag_6_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">65682000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_B3S0Y9EU7EC4i2truDPkCg"
      decimals="-3"
      id="Tc_VbcWh-yfG0GwaNv_9jGD8w_6_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">95000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_FXFjEBaYH0yssVgQkwNEcQ_6_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">65777000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_jyXlykJnhUCcrgqw5ohJ0A"
      decimals="-3"
      id="Tc_6RJ5yH8rKUOZXC5mTzxg8Q_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46950000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w"
      decimals="-3"
      id="Tc_WaO0COkwm0WVcrHfVvsn_g_7_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46950000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_GU9QgCbQgECYTx4q1I_gFA"
      decimals="-3"
      id="Tc_FQRevEEvMU68makFgIv4lw_7_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">98000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_AAAjm3ejmkexKWpidSrU-w_7_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46852000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2MOgA84ZvUenL2B0HVv5GA"
      decimals="-3"
      id="Tc_bLXwpF5LBE2Q-GJwfxpzMw_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">543000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w"
      decimals="-3"
      id="Tc_gdXpkRJn0EWkHGsR1JLLQw_8_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">543000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_wtVnMWkmTEWtQgo0UZJWCw_8_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">543000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2MOgA84ZvUenL2B0HVv5GA"
      decimals="-3"
      id="Tc_K07q23lcIkqeWnD6YTAaYA_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">543000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_jyXlykJnhUCcrgqw5ohJ0A"
      decimals="-3"
      id="Tc_zIVul_d-nUS3tjQmcTxZtQ_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46950000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w"
      decimals="-3"
      id="Tc_Wx66ETZlPESv6nrnKGhfmw_9_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46407000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_GU9QgCbQgECYTx4q1I_gFA"
      decimals="-3"
      id="Tc_Rh3IVTBCyU6GQb-auiBPEA_9_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">98000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ho6rukmJ3k273nLIkUxyYA_9_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46309000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_h8KVGyeyBUaFAxgh3PnrpA"
      decimals="-3"
      id="Tc_o8B9UkDHVEaXtsrW6CxIZQ_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8035000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_BQrRbaXBR062mUOAoSlh6w"
      decimals="-3"
      id="Tc_6r6AEBD-wk2aVdjERnfjFA_10_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8035000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_n5Vwx8fbzEmIiQKz42X_oQ_10_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8035000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_KqENbDNqJkWj590bxS6xEQ"
      decimals="-3"
      id="Tc_2eBLTS8v-EmbRyeVj1LgAw_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">54000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_h8KVGyeyBUaFAxgh3PnrpA"
      decimals="-3"
      id="Tc_wmB2UiuWmkKafNs4FRg-yw_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-54000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_OD742rXyRkCCIa1akqAdkw"
      decimals="-3"
      id="Tc_uVgoMi9p1UK1VOrdl5Mi_Q_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2708000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg"
      decimals="-3"
      id="Tc_ZDgDGUnu8EW3xuDq9mpNZQ_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">133897000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_S0MC9TMobkCnNHOB62yknw"
      decimals="-3"
      id="Tc_Avn8Rwkid06ePyGsQpGsOg_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">495000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember_F1HqNUC0w0yF40_NYU5-pA"
      decimals="-3"
      id="Tc_xCGhCsQuB0ui-irsT0VpnQ_12_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-109790000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_yKg2jE127UGpUbOS8qY3Tw"
      decimals="-3"
      id="Tc_-L1gsFF8_06qkRhU-h4gNQ_12_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27310000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_NoncontrollingInterestsMember_X97kRl32r0SL4FxM_6oahw"
      decimals="-3"
      id="Tc_m0X8yF3bDkmcuL_iZ9xkTQ_12_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">193000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_NAeAhDWuHEKfg3F4tRgmww_12_16"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27503000</ifrs-full:Equity>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_yxewA3ZtuUa4mxbzrLDhPw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;1 General company information&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;Centogene N.V. (&#x201c;the Company&#x201d;) and its subsidiaries focus on rare diseases that transforms real-world clinical and genetic or other data into actionable information for patients, physicians and pharmaceutical companies.  The mission of the Company is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;On November 7, 2019, the Company completed an initial public offering (&#x201c;IPO&#x201d;) and has since been listed on Nasdaq Global Market under stock code &#x201c;CNTG&#x201d;.  We have historically conducted our business through Centogene AG (which is now known as Centogene GmbH), and therefore our historical financial statements present the results of operations and financial condition of Centogene AG and its controlled subsidiaries. In connection with our initial public offering, Centogene N.V. became the holding company of Centogene AG on November 12, 2019, and the historical consolidated financial statements of Centogene AG became the historical consolidated financial statements of Centogene N.V. Centogene N.V. is a public company with limited liability incorporated in the Netherlands, with registered office located at Am Strande 7 in 18055 Rostock, Germany and Dutch trade register number 72822872.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On March 5, 2020, the Company resolved that Centogene AG shall be converted into a German limited liability company and renamed Centogene GmbH. Such conversion became effective upon the registration in the German commercial register on June 29, 2020. Unless otherwise stated, &#x201c;Centogene GmbH&#x201d; also refers to the historical operations of Centogene AG throughout the notes. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;In July 2020, the Company completed a follow-on public offering of 3,500,000 common shares of the Company (the &#x201c;July 2020 Offering&#x201d;), consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of USD 14.00 per common share (i.e. EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR 22 million to the Company.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g"
      decimals="INF"
      id="Narr_Tn1XlrQvTE69Nezz8fZwEg"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">3500000</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_VdrlZSWEREarVoh3zIZywA"
      decimals="INF"
      id="Narr_J1XK7XklVUy5cLYXiBUHLQ"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">2000000</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SellingShareholdersMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_XLF3uUzrWEa3kZA0wFlJcw"
      decimals="INF"
      id="Narr_0kfBukv4fkWnkDAAyIkuOw"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1500000</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g"
      decimals="2"
      id="Narr_rYaXfHCI5E-VEL2qKVsgmA"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">14.00</cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues>
    <cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g"
      decimals="2"
      id="Narr_iha5aPW4FEGHo8-A73BuyA"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.71</cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_VdrlZSWEREarVoh3zIZywA"
      decimals="-6"
      id="Narr_ihMUbPoFVkS-txjNSO_zMQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22000000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_JDRHJX6QGEKarA7N89EHSg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;2 Basis of preparation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Unless otherwise specified, &#x201c;the Company&#x201d; refers to Centogene N.V. and Centogene GmbH throughout the remainder of these notes, while &#x201c;the Group&#x201d; refers to Centogene N.V., Centogene GmbH and its subsidiaries.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The consolidated financial statements of the Group were prepared in accordance with International Financial Reporting Standards (&#x201c;IFRS&#x201d;) as issued by the International Accounting Standards Board (the &#x201c;IASB&#x201d;).  The accounting policies used in the fiscal year 2021 generally correspond to the policies applied in the prior year, except for certain amendments to the standards which are effective for annual periods beginning on or after January 1, 2021 (see note 3).  In addition, certain prior period information has been reclassified to conform with current year presentation (see note 2). &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;These consolidated financial statements are presented in euro, which is the Group&#x2019;s functional currency. Unless otherwise specified, all financial information presented in euro is rounded to the nearest thousand (EUR k) in line with customary commercial practice.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;2.1&lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;New significant accounting policies and accounting judgments and estimates &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 54pt;"&gt;&lt;span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Revenues from contracts with customer &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group has a diagnostics customer in the Middle Eastern region with a history of significant payment delays. This history has resulted in the recognition of significant subsequent impairment losses by applying the expected credit loss method as the collection of the contractual consideration was historically considered probable upon recognition of revenue. Based on recent developments in its collection experience, recent negotiations with the customer, and past experiences, the Group considered it necessary to reassess its judgments related to the recognition of revenue from contracts with this customer.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group&#x2019;s management concluded, based on the facts and circumstances and management&#x2019;s expectations regarding this customer, that this uncertainty in the amount of the contract consideration it expects to collect, and the likelihood of accepting a lower amount or changing payment terms represents an &#x201c;implicit price concession&#x201d; such that the contract consideration is variable. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Therefore, the Group&#x2019;s management estimates the amount of the contractual consideration it expects to ultimately collect and for which it is highly probable that related revenue recognized would not be subject to significant future reversals when such uncertainty is resolved. The Group&#x2019;s management estimates the implicit price concessions by applying an estimated rate of 18% based primarily upon past collection history. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Despite the uncertainties related to the amount expected to be collected from the customer, based on experience and the facts and circumstances related to the customer, the Group considers it probable that it will collect 82% of the amount of estimated variable transaction price due to newly agreed payment plans established with the customer. Therefore, the Group records the difference between the billed amount and the amount estimated to be collectible as a reduction to revenue. At the end of each reporting period, and if necessary upon receipt of new information, the Group may revise the amount of the variable consideration included in the transaction price. The Group has applied this accounting policy and accounting estimate to arrangements with this customer prospectively with effect from the third quarter of 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;2.2 &lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;Going Concern&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;As an early commercial-stage company, the Group is still in progress towards reaching break-even in its diagnostic and pharma businesses. The Group and Company are subject to a number of risks similar to those of other development and early commercial stage companies. These risks include, among other things, the failure to enter into and successfully execute further collaborations with pharmaceutical partners, the failure to generate revenue from the Company&#x2019;s development portfolio and risks associated with research, development, testing and obtaining related regulatory approvals in relation to our product candidates. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group&#xb4;s ongoing success and ultimately the attainment of profitable operations depends on future uncertain events which include, among other things, obtaining adequate financing to promote our commercial and development activities until the Group can generate sufficient revenues to support its operating cash requirements. The Group has incurred operating losses since inception. For the year ended December 31, 2021 the Group incurred a net loss of EUR 46.9 million of which EUR 46.0 million is related to loss of operations, resulting in an operating cash outflow of EUR 21.7 million driven mainly by the repayment of trade payables of EUR 20.5 million. As of December 31, 2021, the Group had generated an accumulated deficit of EUR 109.3 million, and had an equity position of EUR 27.5 million. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;As of December 31, 2021 the Group had cash and cash equivalents of EUR 17.8 million with relatively low short term debt obligations of EUR 3.8 million and no financial covenants. In addition, on January 31, 2022 the Company, Centogene GmbH, CentoSafe B.V. and Centogene US, LLC (together, the &#x201c;Borrowers&#x201d;), entered into a debt financing agreement in the total amount of up to USD 45.0 million (EUR 40.2 million) on January 31, 2022 (the &#x201c;Loan Facility&#x201d;). Under the terms of the Loan Facility, the Company drew down USD 25.0 million (EUR 22.3 million) on January 31, 2022 and will have access to a second tranche of USD 20.0 million (EUR 17.9 million) upon achievement prior to July 31, 2023, of product revenue from our diagnostics and pharmaceutical services segments of at least USD 50.0 million (EUR 44.7 million) calculated on a trailing twelve month basis as of the last day of any fiscal month. The Loan Facility also includes covenants such that the Group is required to maintain product revenue of at least EUR 30.0 million as of the last day of each fiscal quarter and on a trailing twelve month basis prior to obtaining the second tranche EUR 40.0 million on or after obtaining the second tranche. Both tranches mature on January 29, 2027 with amortized repayments commencing March 1, 2025. The loans extended under the Loan Facility bear monthly interest payments at an interest rate of 7.93% per annum plus the 1-month CME Term SOFR reference rate as published by the CME Group Benchmark Administration Limited (subject to a floor of 0.07%). As security for the Borrowers&#x2019; obligations under the Loan Facility, the Borrowers granted the lenders thereunder a first priority security interest on all of each Borrower&#x2019;s assets. In addition, pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors on January 31, 2022, the Group also received EUR 15.0 million in exchange for the issuance of an aggregate of 4,479,088 common shares at a price per share of USD 3.73 (EUR 3.35) and warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026. The Group believes that its cash and cash equivalents will be sufficient to fund its planned operating cash requirements for the next twelve months from the date of issuance of these financial statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The accompanying consolidated financial statements for the year ended December 31, 2021 have been therefore prepared on a going concern basis contingent upon the successful implementation of the plans described above. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The audited consolidated financial statements do not reflect any adjustments relating to the recoverability and &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:35.45pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;2.3&lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;COVID-19 Pandemic&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The COVID-19 pandemic has spread worldwide and continues to cause many governments to maintain measures to slow the spread of the outbreak through quarantines, travel restrictions, closures of borders and requiring maintenance of physical distance between individuals. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The COVID-19 pandemic resulted in a slowdown in our diagnostics and pharmaceutical businesses. As part of the Company&#x2019;s initiative to assist local, national and international authorities as well as other partners in their efforts to facilitate the earliest possible diagnosis of COVID-19 and thereby contribute to allowing society to return to a &#x201c;new&#x201d; normal, the Company commenced testing for COVID-19 in March 2020. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;During the year ended December 31, 2021, the Group continued the COVID-19 testing activities started in 2020 with a leading role in providing testing services at airports in Germany. Furthermore, new variants of the virus have emerged since mid-December 2020. How these mutations develop and their impact on the effectiveness of vaccines is not yet fully clear. Furthermore, vaccination campaigns in many countries started during the year ended December 31, 2021, and due to the expected increase in the availability of vaccines the expectation is that governments will further reduce restrictions moving forward. As a result of these developments in the COVID-19 pandemic, the Group has noticed a decrease in COVID-19 test order intakes in the year ended December 31, 2021. How and when these developments would affect the potential prolongation of the need for testing on a broader scale remains uncertain. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Although the Group is taking a number of measures aimed at minimizing disruptions to the business and operations, and while the provision of testing for the COVID-19 virus is anticipated to generate additional revenues for us, the full extent to which the global COVID-19 pandemic may continue to impact the business will depend on future developments, which are highly uncertain and cannot be predicted, such as the duration of the pandemic, the availability and effectiveness of vaccines against new variants, the probability of the occurrence of further outbreaks and the ultimate impact on the financial markets and the global economy, could result in an unforeseen negative impact on the business and future results of operations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;2.4&lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;Reclassification of certain Selling and General Administrative expenses&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group made changes to the classification of several items related to its Covid-19 segment, in the statement of comprehensive loss for the financial year 2020 to conform to the changes made in the fiscal year 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The Company has COVID-19 related advertising expenses, credit card fees and other selling expenses which were recognized under cost of sales in the statement of comprehensive loss in the fiscal year 2020 when the COVID-19 business was added to the operations of the Group in the first quarter of 2020. During the year end close process, management identified this as a classification error and corrected it retrospectively. Accordingly, the Group reclassified  EUR &lt;/span&gt;2,941k from cost of sales to general administration expenses and selling expenses. The following table shows the reconciliation of the Statement of Comprehensive Loss for fiscal year 2020 prior to and following the revision of the aforementioned costs: &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:18.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020 (restated)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:18.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020 (as previously reported)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Change&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cost of Sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 83,437&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 86,378&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,941)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross profit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 44,944&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 42,003&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,941&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;General administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 40,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 37,665&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,495&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,580&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 446&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;The changes to the presentation above have no impact to the consolidated statements of financial position (inclusive of December 31, 2020 and January 1, 2020), segment reporting, cash flows or equity and no impact on loss per share.&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <cntg:EstimatedRateOfImplicitPriceConcessions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember_5GYsZrZiqEGPJtHs8Ny2fw"
      decimals="2"
      id="Narr_5dGZFaj58kK2ov_8CtkW_A"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.18</cntg:EstimatedRateOfImplicitPriceConcessions>
    <cntg:PercentageOfEstimatedVariableTransactionPrice
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="2"
      id="Narr_84m93eMi2kO1ImK92Jo8Lw"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.82</cntg:PercentageOfEstimatedVariableTransactionPrice>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-5"
      id="Narr_MpO07lU3ikORnmzbd7wvxA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46900000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-5"
      id="Narr_A63Gm3IKvk6dNl2dlWGCBw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46000000.0</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-5"
      id="Narr_95oIYfwehkasMVb15gYj2Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21700000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-5"
      id="Narr_QGHPwJKG2UyBfBlXMem-iQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20500000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:RetainedEarnings
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-5"
      id="Narr_H2aw74aDTky8LgMrnkjN6w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-109300000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-5"
      id="Narr_NzYQN5S3R0KPabTRELrjBg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27500000</ifrs-full:Equity>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-5"
      id="Narr_ulOezOi6FE-8bG8xKTcoOA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17800000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:ShorttermBorrowings
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-5"
      id="Narr_At3qRJ3Af0e_fT_Ov5qh4g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3800000</ifrs-full:ShorttermBorrowings>
    <cntg:FinancialCovenants
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="0"
      id="Narr_3rhvqt-8_kiwbECwQ89Hig"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</cntg:FinancialCovenants>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg"
      decimals="-5"
      id="Narr_Nu6SLiNx4UmI6Ob3xFE6aA"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">45000000.0</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg"
      decimals="-5"
      id="Narr_9HE-Ig303EK8qEf1Spdreg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40200000</ifrs-full:NotionalAmount>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ"
      decimals="-5"
      id="Narr_GrIa9zoFF029SZcYDk1Dig"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">25000000.0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ"
      decimals="-5"
      id="Narr_fhZqxGxvVUOMOiozAvd9kw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22300000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA"
      decimals="-5"
      id="Narr_ocPBo37nZU-6WekR8aYUSw"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">20000000.0</cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue>
    <cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA"
      decimals="-5"
      id="Narr_e4RwcA7IxEmf0lcGHlKWLA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17900000</cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue>
    <cntg:BorrowingsRevenueAchievementThreshold
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw"
      decimals="-5"
      id="Narr_zCngIPi020Sf2sMU79OSSA"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">50000000.0</cntg:BorrowingsRevenueAchievementThreshold>
    <cntg:BorrowingsRevenueAchievementThreshold
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw"
      decimals="-5"
      id="Narr_pE4aIRyJKE-nOrttzzpPfw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">44700000</cntg:BorrowingsRevenueAchievementThreshold>
    <cntg:BorrowingsCovenantMinimumRequiredRevenue
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ"
      decimals="-5"
      id="Narr_R9WmbBvEYEO0seRqPcekBg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">30000000.0</cntg:BorrowingsCovenantMinimumRequiredRevenue>
    <cntg:BorrowingsCovenantMinimumRequiredRevenue
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw"
      decimals="-5"
      id="Narr_DEiR7SenJ0mIdqd66eZsUQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40000000.0</cntg:BorrowingsCovenantMinimumRequiredRevenue>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg"
      decimals="4"
      id="Narr_h-Qox0YeI0KO3tgz67THRw"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0793</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_ifrs-full_TypesOfInterestRatesAxis_cntg_FloorRateMember_xBPN5MEG9E6vID66HBPpOQ"
      decimals="4"
      id="Narr_NFeEPFVrqU67esecxA_Lvg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0007</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg"
      decimals="-5"
      id="Narr_0hUMenMtj0mI6XpC932cXg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15000000.0</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <cntg:IfrsStockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg"
      decimals="INF"
      id="Narr_iQ8Bzzyk4k-oEOtScPohJA"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">4479088</cntg:IfrsStockIssuedDuringPeriodSharesNewIssues>
    <cntg:IfrsSharePrice
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="2"
      id="Narr_p-tWofdHpkGULozNVEGLaw"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">3.73</cntg:IfrsSharePrice>
    <cntg:IfrsSharePrice
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="2"
      id="Narr_Rr9a9buWWkSG39uMCOhZCQ"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">3.35</cntg:IfrsSharePrice>
    <cntg:IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="INF"
      id="Narr_bmxmcuYEPEWvl7LzZHkm3A"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1343727</cntg:IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <cntg:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="2"
      id="Narr_tn1vGUA7h0-N9J6DCcA7HA"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">7.72</cntg:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
    <ifrs-full:CostOfSales
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_TVcAOmx4hE6T2TjYZkvryA"
      decimals="-3"
      id="Narr_1nF_cgmTzkWTbjy_0ni5Og"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2941000</ifrs-full:CostOfSales>
    <cntg:StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_aahy_I2ZpUOsDTLqznnM6A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:18.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020 (restated)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:18.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020 (as previously reported)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Change&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cost of Sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 83,437&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 86,378&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,941)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross profit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 44,944&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 42,003&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,941&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;General administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 40,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 37,665&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,495&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:43.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,580&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 446&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock>
    <ifrs-full:CostOfSales
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_tMU0UZnanUC2lEl3BmpXUQ_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">83437000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA"
      decimals="-3"
      id="Tc_9C15SR1gMUGqUPTiEZl2OA_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">86378000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg"
      decimals="-3"
      id="Tc_8wiHc5sXS0afIVG24If3IQ_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2941000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_2OB2iJbOOU-ESyK7KlsrXQ_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">44944000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA"
      decimals="-3"
      id="Tc__m6tISUzrECv3mPY-h15xg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">42003000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg"
      decimals="-3"
      id="Tc_RCYW5gLePEyfquAe1rR01w_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2941000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_aEipstwprUKqCeZFVOE5Lg_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40160000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA"
      decimals="-3"
      id="Tc_56WruoNcd0Ws9_HYggbF-Q_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">37665000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg"
      decimals="-3"
      id="Tc_ngJt0YVlYEaarQ66kP3bSg_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2495000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:SellingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_8gwRVkfBTkCQumxRz_0f3Q_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8026000</ifrs-full:SellingExpense>
    <ifrs-full:SellingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA"
      decimals="-3"
      id="Tc_aYGnTkKEjEqVQbf0s_KjPQ_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7580000</ifrs-full:SellingExpense>
    <ifrs-full:SellingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_bhdKLGVXVkeTdtYLd1oSUg"
      decimals="-3"
      id="Tc_K2qMK1fD20qf7c2o7pmhJg_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">446000</ifrs-full:SellingExpense>
    <ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_elUZVu29bUKLW77sUU-Tuw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;3 Effects of new accounting standards&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(a)&lt;/b&gt;&lt;/span&gt;New standards adopted by the Group as of January&#160;1, 2021&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The following amendments and interpretations apply for the first time in 2021 and had no impact on the consolidated financial statements of the Group:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:54pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Amendments to IFRS 4 &#x2013; Insurance contracts- deferral of IFRS 9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:54pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Amendments to IFRS 7, 9, IAS 39 &#x2013; Interest rate benchmark reform- Phase 2: Modification of financial assets, financial liabilities and leasing liabilities, requirements regarding accounting and disclosure of hedging relationships &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:54pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Amendments to IFRS 16 &#x2013; Covid-19 related rent concessions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(b)&lt;/b&gt;&lt;/span&gt;New standards not yet effective&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Furthermore, certain new and amended standards and interpretations have been published that are not mandatory for December 31, 2021 reporting periods and have not been early adopted by the Group. The Group intends to adopt these new and amended standards and interpretations, if applicable, when they become effective. There are no new or amended standards or interpretations that are issued and become effective for the 2022 annual reporting period, that are expected to have a material impact on the Group. &lt;/p&gt;</ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations>
    <ifrs-full:DisclosureOfBasisOfConsolidationExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_ILC97jAmu0idta3eBKneKQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;4 Basis of consolidation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The basis of consolidation includes the entities over which Centogene N.V. has control within the meaning of IFRS 10 Consolidated Financial Statements. According to IFRS 10, Centogene N.V. has control of an investee when it has direct or indirect power over the investee, exposure, or rights to variable returns from its involvement with the investee and the ability to use its power over the investee to affect those returns. Control is established when it is possible to influence operating and financial policies of the investee, typically with a share in the voting rights or shareholding of more than 50% in the investee. An entity is included in the Group&#x2019;s basis of consolidation from the point in time when the Group obtains control of the entity and ceases when the Group loses control of the subsidiary.  Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated financial statements from the date the Group gains control until the date the Group ceases to control the subsidiary.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Profit or loss and each component of other comprehensive income are attributed to the equity holders of the parent of the Group and to the non-controlling interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to transactions between members of the Group are eliminated in full upon consolidation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;If the Group loses control over a subsidiary, it derecognizes the related assets, liabilities, non-controlling interest and other components of equity, while any resultant gain or loss is recognized in profit or loss.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In the third quarter of 2020, the Company entered into a collaboration agreement with Dr. Bauer Laboratoriums GmbH, Rostock (hereafter &#x2018;Bauer GmbH&#x2019;). Bauer GmbH supports Centogene in certain areas of its COVID-19 testing business by providing the medical laboratory services to facilitate Centogene to perform its COVID-19 testing business activities. Bauer GmbH is wholly owned by a long-time employee of Centogene, who from a medical perspective and by observing the Medical Association's professional code of conduct continues to operate as an independent medical physician.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;As per the criteria in IFRS 10, Centogene assessed the control it has over Bauer GmbH and concluded to consolidate the activities of Bauer GmbH in the Group from the third quarter of 2020. Centogene does not own any shares in Bauer GmbH. However, based on the analysis of all facts and circumstances surrounding the close collaboration with Bauer GmbH and the employment relationship with the sole shareholder of Bauer GmbH, this shareholder is considered as a de facto agent. Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns. Bauer GmbH &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;has a share in the net result of the respective COVID-19 testing business which has been accounted for under non-controlling interest (see note 23).&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfConsolidationExplanatory>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_gsP_I8VnpEK3lPt1ip6RZg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;5 Significant accounting policies&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group applied the following accounting policies consistently for all of the periods presented in these consolidated financial statements. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(a)&lt;/b&gt;&lt;/span&gt;Foreign currency and currency translation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group&#x2019;s consolidated financial statements are presented based on the parent company&#x2019;s functional currency. For each entity, the Group determines the functional currency and items included in the financial statements of each entity are measured using that functional currency. The Group uses the direct method of consolidation and on disposal of a foreign operation, the gain or loss that is reclassified to profit or loss reflects the amount that arises from using this method.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Transactions in foreign currency are translated into the respective entity&#x2019;s functional currency at the spot rate prevailing on the date of the transaction.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The functional currency of each entity is the respective local currency, since the entities carry out their business activities independently from a financial, economic and organizational perspective.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Monetary assets and liabilities denominated in foreign currency are translated to the functional currency using the closing rate at the reporting date. Currency translation differences are recognized immediately through profit or loss. Non-monetary items denominated in a foreign currency that are measured at historical cost are not translated at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On consolidation, the assets and liabilities of foreign operations are translated into euros using the closing rate on the reporting date. Income and expenses of foreign operations are translated using the exchange rate prevailing on the date of the transaction or the annual average exchange rate. Equity is translated using historical rates until the entity is removed from the Group&#x2019;s basis of consolidation. Any resulting currency translation differences are recorded in other comprehensive income and recognized under the currency translation reserve in equity if the exchange difference is not allocable to the non-controlling interests. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The exchange rates used are presented in the following table:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Closing&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;USD (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1304&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1191&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1326&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.2271&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1234&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;AED (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.1500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.2091&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.0985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.1654&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.5045&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.0795&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;INR (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 85.1761&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84.5737&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 78.7980&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84.2292&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 89.6605&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 80.1870&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;CHF (EUR 1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0814&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0331&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;RSD (EUR 1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 117.3909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 117.2747&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(b)&lt;/b&gt;&lt;/span&gt;Revenues from contracts with customers&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The Group provides pharmaceutical solutions and diagnostic tests, as well as COVID-19 tests, enabled by its knowledge and interpretation-based platform. Revenue from contracts with customers is recognized when control of the goods or services are transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those goods or services, usually on delivery of the goods. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(i)&lt;/span&gt;&lt;/span&gt;Pharmaceutical segment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"&gt;The Group's contracts with customers relate to a variety of solutions provided to the Group's pharmaceutical partners in order to accelerate their development of treatments for rare diseases, including early patient recruitment and identification, &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;epidemiological insights, biomarker discovery and patient monitoring. The collaboration agreements are structured on a fee per analysis basis, milestone basis, fixed fee basis, or a combination of these. In addition, some of the Group's contracts with its pharmaceutical partners also include sales of CentoCards for the collection of biological samples from patients.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The performance obligations in Pharmaceutical segment can either be satisfied over time or at a point in time depending on the structure of the collaborations, which are determined based on nature of the service provided, as detailed below.&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenue from early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring is based on fee per analysis, milestone fees and fixed fees. The revenues from these solutions are recognized over time using an input method based on the work rendered in order to measure progress towards complete satisfaction of the services.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenue from the licensing of intellectual property for an unlimited period, usually in the structure of an upfront fee, is recognized at a point in time, when the right (or license) to use intellectual property is conveyed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenues from the licensing of intellectual property for a certain period, being a right to access such intellectual property as defined in IFRS 15, is recognized over time over the licensing period.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenue from the sale of CentoCards is recognized at a point in time when the control of the CentoCards has transferred to the customer, which typically occurs on delivery.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(ii)&lt;/span&gt;&lt;/span&gt;Diagnostics segment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;Revenues from the Group's diagnostics segment are typically generated from genetic sequencing and diagnostics services that the Group provides to clients, who are typically physicians, laboratories or hospitals, either directly or through distributors. Revenues are based on a negotiated price per test or on the basis of agreements to provide certain testing volumes over defined periods. The Group has concluded that the services rendered in the diagnostics segment comprise one performance obligation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The performance obligation in the Diagnostics segment is recognized over time, using an input method to measure progress towards complete satisfaction of the service. In order to measure progress, the Group uses a standardized process which measures progress to completion by stages, consisting of (i) a preparation stage, (ii) a clarification stage, (iii) a sequencing stage, and (iv) an output stage. The percentages attributed to those stages are indicative of the cost incurred in performing the respective stage in relation to total cost. &#160; &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(iii)&lt;/span&gt;&lt;/span&gt;COVID-19 segment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;COVID-19 revenues are based on a negotiated price per test, government driven or on the basis of agreements covering tests to be performed over defined periods. Given the short turnaround time for the COVID-19 tests, revenues from COVID-19 tests that are on a price per test basis are recognized at a point in time. Revenues from COVID-19 tests that are on the basis of agreements covering tests to be performed over defined periods are recognized over time over the agreement period. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The Group has disaggregated revenue recognized from contracts with customers into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Group has also disclosed information about the relationship between the disclosure of disaggregated revenue and the revenue information disclosed for each reportable segment. See note 7 for the disclosure on disaggregated revenue.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Contract balances &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contract assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;A contract asset is the right to consideration in exchange for goods or services transferred to the customer. If the Group satisfies a performance obligation by transferring goods or services to a customer before the customer pays consideration or before &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;payment is due, a contract asset is recognized for the earned consideration that is conditional.  Contract assets are subject to impairment assessment, refer to accounting policies of impairment of financial assets in note 5(n) &#x201c;Financial instruments&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A receivable represents the Group&#x2019;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies of impairment of financial assets in note 5(n) &#x201c;Financial instruments&#x201d;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Contract liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A contract liability is the obligation to transfer goods or services to a customer for which the Group has received consideration or an amount of consideration is due from the customer (whichever is earlier). If a customer pays consideration before the Group transfers goods or services to the customer, a contract liability is recognized when the payment is made or the payment is due (whichever is earlier). Contract liabilities are recognized as revenue when the Group performs under the contract.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(c)&lt;/b&gt;&lt;/span&gt;Finance income and finance costs&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Interest income and expenses are recognized in the period which they relate to through profit or loss using the effective interest rate method. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(d)&lt;/b&gt;&lt;/span&gt;Current versus non-current classification&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Expected to be realized or intended to be sold or consumed in the normal operating cycle&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Held primarily for the purpose of trading&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Expected to be realized within twelve months after the reporting period; or&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;All other assets are classified as non-current.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A liability is current when:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;It is expected to be settled in the normal operating cycle&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;It is held primarily for the purpose of trading&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;It is due to be settled within twelve months after the reporting period; or&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The terms of the liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group classifies all other liabilities as non-current.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are classified as non-current assets and liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(e)&lt;/b&gt;&lt;/span&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Research and development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Expenses for research activities are recognized through profit or loss in the period in which they are incurred.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Development expenditures on an individual project are recognized as an intangible asset from the date the Group can demonstrate: &lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the product or process is technically and commercially feasible so that the asset will be available for use or sale&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the Group has the ability and intention to use or sell the asset&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;a future economic benefit is probable &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the Group has sufficient resources to complete the development and&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the development costs can be measured reliably. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The Group&#x2019;s research and development activities mainly relate to development of biomarkers and IT driven solutions.  With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#x2019;s internal validation test. Before such dates, any development costs are recognized in profit or loss and may not be subsequently capitalized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Capitalized development costs are recognized at cost less accumulated amortization and any accumulated impairment losses. They are only amortized as from the date the asset is ready for its intended use, which in the case of biomarkers is normally at the time the patent application for such biomarker is made. Amortization expense commences when the assets are ready to be put in use, and is recorded in cost of sales and research and development expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Capitalized development costs which are still under development are tested for impairment annually and when circumstances indicate that the carrying value may be impaired.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Other intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Other intangible assets purchased by the Group with finite useful lives are recognized at cost less accumulated amortization and any accumulated impairment losses. Subsequent expenditure is only capitalized if it increases the future economic benefits of the respective asset.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Intangible assets are amortized over their estimated useful life using the straight-line method and assessed for impairment whenever there is an indication that the intangible asset may be impaired.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The estimated useful lives are as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Software, patents and trademarks: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;-&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Corona Test Portal: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;2 years&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Capitalized development costs: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The useful lives and depreciation methods are reviewed annually to ensure that the methods and periods of depreciation are consistent with the expected economic benefit from the asset.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(f)&lt;/b&gt;&lt;/span&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment are carried at cost less any accumulated depreciation and any accumulated impairment losses. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The cost of property, plant and equipment comprises its purchase price including customs duties and non-refundable acquisition taxes, and proportionate VAT not deductible from input tax as well as any directly attributable costs of bringing the asset to its working condition and location for its intended use.       &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt; Subsequent expenditure is only capitalized if it is probable that the future economic benefits associated with the expenditure will flow to the Group. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Depreciation is calculated over the estimated useful life using the straight-line method. The Group has assessed that none of its property, plant and equipment has a residual value. The estimated useful lives of significant property, plant and equipment are as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Freehold land is not depreciated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Buildings: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;33 years&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Plant and other equipment, furniture and fixtures: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;-&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;An item of property, plant and equipment is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of comprehensive loss when the asset is derecognized.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The depreciation methods, useful lives and residual values are reviewed, and adjusted prospectively if appropriate, as of each reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Assets under construction are reported at cost and are allocated to property, plant and equipment until they are completed and put into operational use, from which point onwards they are depreciated.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(g)&lt;/b&gt;&lt;/span&gt;Leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Group as a lessee&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(i)&lt;/span&gt;&lt;/span&gt;Right-of-use assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group recognizes right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its lease term and the estimated useful lives, as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Buildings: 33 years&lt;span style="white-space:pre-wrap;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Offices: 4 &#x2013; 12 years and&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Plant and other equipment, furniture and fixtures: 2-15 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;If ownership of the leased asset transfers to the Group at the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The right-of-use assets are also subject to impairment. Refer to accounting policies of impairment of financial assets in note 5(n) &#x201c;Financial instruments&#x201d;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(ii)&lt;/span&gt;&lt;/span&gt;Lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;At the commencement date of the lease, the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for leases reasonably certain to be terminated. The variable lease payments that do not depend on an index or a rate are recognized as expenses in the period during which the event or condition that triggers the payment occurs. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(iii)&lt;/span&gt;&lt;/span&gt;Short-term leases and leases of low-value assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption to leases of office equipment that are considered of low value (i.e., below EUR 5k). Lease payments on short-term leases and leases of low-value assets are recognized as expenses on a straight-line basis over the lease term. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(iv)&lt;/span&gt;&lt;/span&gt;Sale and leaseback transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The Group applies IFRS 15 for determining if the transfer of an asset to the buyer (lessor) is to be accounted for as a sale of assets.  After the sale of assets is concluded, the Group measures the right-of-use assets arising from the leaseback at the proportion of the previous carrying value of the asset that relates to the right of use retained by the Group.  Accordingly, the Group recognizes only the amount of any gain or loss that relates to the rights transferred to the buyer (lessor).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;If the fair value of the consideration for the sale of an asset does not equal the fair value of the asset, or if the payments for the leases are not at market rates, the Group makes the following adjustments to measure the sale proceeds at fair value: &lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;&#x2022;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;any below-market terms shall be accounted for as a prepayment of lease payments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;&#x2022;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;any above-market terms shall be accounted for as additional financing provided by the buyer-lessor to the seller-lessee&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(h)&lt;/b&gt;&lt;/span&gt;Impairment of non-financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment and intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Whenever the carrying amount of an asset exceeds its recoverable amount, an impairment loss is recognized in profit or loss. The recoverable amount is measured as the higher of fair value less costs to sell and value in use. Recoverable amounts are estimated either for individual assets or, if an individual asset does not generate cash flows independently of other assets, for the whole cash-generating unit.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(i)&lt;/b&gt;&lt;/span&gt;Inventories&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Inventories are measured at the lower of cost and net realizable value. Inventories are recognized at cost based on the first in first out (FIFO) method. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(j)&lt;/b&gt;&lt;/span&gt;Government grants&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. Grants that are intended to compensate the Group for expenses incurred are recognized through profit or loss in the period in which expenses are submitted and claimed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Government grants which relate to an asset are initially recognized as deferred income at nominal amounts. They are subsequently released to profit or loss on a systematic basis over the expected useful life of the related asset.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The release of deferred income related to either type of grant is presented as other operating income (see note 8).&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(k)&lt;/b&gt;&lt;/span&gt;Share-based payments &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Plan recipients (including senior executives and certain member of Supervisory Board) of the Group receive remuneration in the form of share-based payments, whereby the recipients render services as consideration for equity instruments (equity-settled transactions) or settled in cash (cash-settled transactions).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Equity settled transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The cost of equity-settled transactions is determined by the fair value of the granted options when the grant is made, using a Black-Scholes or Monte Carlo simulation model, with further details given in note 20.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The cost is recognized in employee benefits expense (see note 8.4) or other relevant expenses, together with a corresponding increase in equity (capital reserves), over the period in which the service conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Group&#x2019;s best estimate of the number of equity instruments that will ultimately vest.  The expense or credit in profit or loss for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Cash-settled transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A liability is recognized for the fair value of cash-settled transactions. The fair value is measured initially and at each reporting date up to and including the settlement date, with changes in fair value recognized in employee benefits expense (see note 8.4). The fair value per option is determined using the Black-Scholes model, further details of which are given in note 20. The fair value per option is then multiplied by the Group&#x2019;s best estimate of the number of awards expected to vest and the portion of the expired vesting period (period in which the service conditions are fulfilled). The cumulative amount of expense recognized will be equal to the cash that is paid on settlement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Service and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Group&#x2019;s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;If the terms and conditions of a cash-settled share-based payment transaction are modified with the result that it becomes an equity-settled share-based payment transaction, the transaction is accounted for as such from the date of the modification.  Specifically, the equity-settled share-based payment transaction is measured by reference to the fair value of the equity instruments granted at the modification date and recognized in equity.  The liability for the cash-settled share-based payment transaction as at the modification date is derecognized on that date.  Any difference between the carrying amount of the liability derecognized and the amount of equity recognised on the modification date is recognised immediately in profit or loss.&lt;/span&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(l)&lt;/b&gt;&lt;/span&gt;Provisions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;A provision is recognized when the Group has a present obligation (legal, contractual or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.  When the Group expects some or all of a provision to be reimbursed, for example, under an insurance contract, the reimbursement misrecognized as a separate asset, but only when the reimbursement is virtually certain. The expense relating to a provision is presented in the profit or loss net of any reimbursement.  Provisions are reviewed at each reporting date and adjusted to reflect the current best estimate. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;If the requirements for recognizing a provision are not satisfied, the corresponding obligations are recorded as contingent liabilities unless the possibility of an outflow of resources embodying economic benefits is remote.&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(m)&lt;/b&gt;&lt;/span&gt;Income taxes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Tax expense comprises current and deferred taxes. Current taxes and deferred taxes are recognized through profit or loss apart from deferred taxes related to items recognized outside profit or loss, in which case it is recognized in correlation to the underlying transaction either directly in equity or in other comprehensive income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Group operates and generates taxable income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred taxes are set up for temporary differences between the carrying amounts of assets and liabilities for group financial reporting purposes at the reporting date and the amounts used for tax purposes. Deferred tax liabilities are recognized for all taxable temporary differences, except:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;temporary differences arising from the initial recognition of assets or liabilities in the course of a business transaction that is not a business combination and does not affect either the accounting profit or the taxable profit or loss&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;temporary differences associated with investments in subsidiaries if the Group controls the timing of the reversal of the temporary differences, and it is probable that the differences will not reverse in the foreseeable future.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and deferred tax liabilities are offset against each other if certain conditions are met.&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(n)&lt;/b&gt;&lt;/span&gt;Financial instruments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;(i) Financial assets &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group&#x2019;s financial assets principally consist of those accounted for as receivables, contract assets, cash and cash equivalents.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Receivables and contract assets&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;Receivables, including contract assets, are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.  Contract assets and trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are measured at the transaction price determined under IFRS 15.  Refer to the accounting policies in note 5(b) &#x201c;Revenues from contracts with customers&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;After initial recognition, receivables and contract assets are subsequently carried at amortized cost using the effective interest rate method less any impairment losses.  Gains and losses are recognized in the profit or loss for the period when the assets are derecognized or impaired.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Derecognition&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A financial asset or a part of a financial asset is derecognized when the Group no longer has the contractual rights to the asset or the right to receive cash flows from the asset have expired. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Impairment&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group recognizes an allowance for expected credit losses (ECLs). ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group applies a simplified approach in calculating ECLs. Therefore, the Group does not track changes in credit risk, but instead recognizes a loss allowance based on lifetime ECLs at each reporting date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group considers a financial asset in default when contractual payments are 360 days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Further disclosures relating to impairment of trade receivables, including contract assets, are in note 21.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(ii)&#160;Financial liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group&#x2019;s financial liabilities include trade and other payables (include contract liabilities), as well as loans and borrowings including bank overdrafts.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Loans and borrowings&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Loans and borrowings are initially recognized at fair value and subsequently measured at amortized cost using the effective interest rate method, taking into account any principal repayments and any discount or premium on acquisition and including transaction costs and fees that are an integral part of the effective interest rate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Gains or losses are recognized through profit or loss at the time the liabilities are derecognized or disposed of.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Derecognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A financial liability is derecognized when the obligation underlying the liability is discharged, canceled or expires.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized through profit or loss.&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(o) Cash and cash equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Cash and cash equivalents comprise cash on hand and bank balances, including short-term, highly liquid investments that can be quickly converted into cash amounts. These have original maturities of three months or less and are subject to a low risk of fluctuation in value.&lt;/p&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_z3JAnWXu-U2NXOMDsO3V0Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(a)&lt;/b&gt;&lt;/span&gt;Foreign currency and currency translation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group&#x2019;s consolidated financial statements are presented based on the parent company&#x2019;s functional currency. For each entity, the Group determines the functional currency and items included in the financial statements of each entity are measured using that functional currency. The Group uses the direct method of consolidation and on disposal of a foreign operation, the gain or loss that is reclassified to profit or loss reflects the amount that arises from using this method.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Transactions in foreign currency are translated into the respective entity&#x2019;s functional currency at the spot rate prevailing on the date of the transaction.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The functional currency of each entity is the respective local currency, since the entities carry out their business activities independently from a financial, economic and organizational perspective.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Monetary assets and liabilities denominated in foreign currency are translated to the functional currency using the closing rate at the reporting date. Currency translation differences are recognized immediately through profit or loss. Non-monetary items denominated in a foreign currency that are measured at historical cost are not translated at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On consolidation, the assets and liabilities of foreign operations are translated into euros using the closing rate on the reporting date. Income and expenses of foreign operations are translated using the exchange rate prevailing on the date of the transaction or the annual average exchange rate. Equity is translated using historical rates until the entity is removed from the Group&#x2019;s basis of consolidation. Any resulting currency translation differences are recorded in other comprehensive income and recognized under the currency translation reserve in equity if the exchange difference is not allocable to the non-controlling interests. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The exchange rates used are presented in the following table:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Closing&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;USD (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1304&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1191&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1326&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.2271&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1234&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;AED (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.1500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.2091&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.0985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.1654&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.5045&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.0795&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;INR (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 85.1761&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84.5737&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 78.7980&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84.2292&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 89.6605&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 80.1870&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;CHF (EUR 1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0814&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0331&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;RSD (EUR 1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 117.3909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 117.2747&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <cntg:DisclosureOfForeignExchangeRatesUsedExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_djFnQ_3hY0OGLJsV-pAPNQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Closing&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;USD (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1304&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1191&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1326&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.2271&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.1234&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;AED (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.1500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.2091&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.0985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.1654&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.5045&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4.0795&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;INR (EUR&#160;1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 85.1761&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84.5737&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 78.7980&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84.2292&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 89.6605&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 80.1870&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;CHF (EUR 1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0814&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0331&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;RSD (EUR 1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 117.3909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 117.2747&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:DisclosureOfForeignExchangeRatesUsedExplanatory>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="4"
      id="Tc_fot_rPDa_U65GjIaEzM9Pg_4_2"
      unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ">1.1304</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="4"
      id="Tc_Gjkv91UOekGkXgCKDqeL8g_4_4"
      unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ">1.1412</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="4"
      id="Tc_JTxYuPTmukyQBtGk8AIYVg_4_6"
      unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ">1.1191</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="4"
      id="Tc_dSvSxPgrI0Clujtg_mhkpw_4_8"
      unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ">1.1326</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="4"
      id="Tc_vTfdrj8M1kKC4wStW4TLHw_4_10"
      unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ">1.2271</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="4"
      id="Tc_kK2zyt2vhkOLxumLpc9JLg_4_12"
      unitRef="Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ">1.1234</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="4"
      id="Tc_V0iYyeglJkGiaJoHtYT_iA_5_2"
      unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ">4.1500</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="4"
      id="Tc_PIPQA6WVtkWyvbP_dLpGCA_5_4"
      unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ">4.2091</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="4"
      id="Tc_Zl_6LeiPBUKD0A3nXt5DqA_5_6"
      unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ">4.0985</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="4"
      id="Tc_78kF66dmG0yj-6WSf0DAGQ_5_8"
      unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ">4.1654</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="4"
      id="Tc_lroWQUAyckyjZwLag5lhiw_5_10"
      unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ">4.5045</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="4"
      id="Tc_XyTc1qQn6EiNWMHhuK8edA_5_12"
      unitRef="Unit_Divide_AED_EUR_qW5vSoHK6kyBESlQ61XXjQ">4.0795</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="4"
      id="Tc_h7mnkPabAES8Npm-uQVp2g_6_2"
      unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ">85.1761</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="4"
      id="Tc_RwhI90TvZEu7S8enLG1nCQ_6_4"
      unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ">84.5737</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="4"
      id="Tc_b68Cy5A6UEmIhbWm6JQ8CQ_6_6"
      unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ">78.7980</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="4"
      id="Tc_yOYHDlnEV0WhnUKkCfxjJA_6_8"
      unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ">84.2292</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="4"
      id="Tc_ldlQ9jN6nUa-1VdMmBnGpg_6_10"
      unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ">89.6605</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="4"
      id="Tc_ZBkaMToBsEG3yad5N38vbQ_6_12"
      unitRef="Unit_Divide_INR_EUR_7NE9BeBIqkCfMQ-nOLYzTQ">80.1870</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="4"
      id="Tc_4l2gsdgC6Uev3dr8P0E_HQ_7_2"
      unitRef="Unit_Divide_CHF_EUR_09Qkxn-hrkG46Zlsshurbw">1.0814</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="4"
      id="Tc_-Q804Y3ZX0GP1Kk5MLahwg_7_8"
      unitRef="Unit_Divide_CHF_EUR_09Qkxn-hrkG46Zlsshurbw">1.0331</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="4"
      id="Tc_8f-9X_DYMkeMoI8yUrNIgA_8_2"
      unitRef="Unit_Divide_RSD_EUR_oVrkuRnZ4UOXTq9NNZ3SYA">117.3909</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="4"
      id="Tc_NIVREes-50WN9QMjJcRpbQ_8_8"
      unitRef="Unit_Divide_RSD_EUR_oVrkuRnZ4UOXTq9NNZ3SYA">117.2747</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_jZ2TL6xYhUOwqm0Xr_PmSg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(b)&lt;/b&gt;&lt;/span&gt;Revenues from contracts with customers&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The Group provides pharmaceutical solutions and diagnostic tests, as well as COVID-19 tests, enabled by its knowledge and interpretation-based platform. Revenue from contracts with customers is recognized when control of the goods or services are transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those goods or services, usually on delivery of the goods. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(i)&lt;/span&gt;&lt;/span&gt;Pharmaceutical segment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"&gt;The Group's contracts with customers relate to a variety of solutions provided to the Group's pharmaceutical partners in order to accelerate their development of treatments for rare diseases, including early patient recruitment and identification, &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;epidemiological insights, biomarker discovery and patient monitoring. The collaboration agreements are structured on a fee per analysis basis, milestone basis, fixed fee basis, or a combination of these. In addition, some of the Group's contracts with its pharmaceutical partners also include sales of CentoCards for the collection of biological samples from patients.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The performance obligations in Pharmaceutical segment can either be satisfied over time or at a point in time depending on the structure of the collaborations, which are determined based on nature of the service provided, as detailed below.&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenue from early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring is based on fee per analysis, milestone fees and fixed fees. The revenues from these solutions are recognized over time using an input method based on the work rendered in order to measure progress towards complete satisfaction of the services.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenue from the licensing of intellectual property for an unlimited period, usually in the structure of an upfront fee, is recognized at a point in time, when the right (or license) to use intellectual property is conveyed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenues from the licensing of intellectual property for a certain period, being a right to access such intellectual property as defined in IFRS 15, is recognized over time over the licensing period.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Revenue from the sale of CentoCards is recognized at a point in time when the control of the CentoCards has transferred to the customer, which typically occurs on delivery.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(ii)&lt;/span&gt;&lt;/span&gt;Diagnostics segment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;Revenues from the Group's diagnostics segment are typically generated from genetic sequencing and diagnostics services that the Group provides to clients, who are typically physicians, laboratories or hospitals, either directly or through distributors. Revenues are based on a negotiated price per test or on the basis of agreements to provide certain testing volumes over defined periods. The Group has concluded that the services rendered in the diagnostics segment comprise one performance obligation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The performance obligation in the Diagnostics segment is recognized over time, using an input method to measure progress towards complete satisfaction of the service. In order to measure progress, the Group uses a standardized process which measures progress to completion by stages, consisting of (i) a preparation stage, (ii) a clarification stage, (iii) a sequencing stage, and (iv) an output stage. The percentages attributed to those stages are indicative of the cost incurred in performing the respective stage in relation to total cost. &#160; &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(iii)&lt;/span&gt;&lt;/span&gt;COVID-19 segment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;COVID-19 revenues are based on a negotiated price per test, government driven or on the basis of agreements covering tests to be performed over defined periods. Given the short turnaround time for the COVID-19 tests, revenues from COVID-19 tests that are on a price per test basis are recognized at a point in time. Revenues from COVID-19 tests that are on the basis of agreements covering tests to be performed over defined periods are recognized over time over the agreement period. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"&gt;The Group has disaggregated revenue recognized from contracts with customers into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Group has also disclosed information about the relationship between the disclosure of disaggregated revenue and the revenue information disclosed for each reportable segment. See note 7 for the disclosure on disaggregated revenue.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Contract balances &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contract assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;A contract asset is the right to consideration in exchange for goods or services transferred to the customer. If the Group satisfies a performance obligation by transferring goods or services to a customer before the customer pays consideration or before &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;payment is due, a contract asset is recognized for the earned consideration that is conditional.  Contract assets are subject to impairment assessment, refer to accounting policies of impairment of financial assets in note 5(n) &#x201c;Financial instruments&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A receivable represents the Group&#x2019;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies of impairment of financial assets in note 5(n) &#x201c;Financial instruments&#x201d;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Contract liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A contract liability is the obligation to transfer goods or services to a customer for which the Group has received consideration or an amount of consideration is due from the customer (whichever is earlier). If a customer pays consideration before the Group transfers goods or services to the customer, a contract liability is recognized when the payment is made or the payment is due (whichever is earlier). Contract liabilities are recognized as revenue when the Group performs under the contract.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_nW_qgYlhVk6rP_QX-O0DNQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(c)&lt;/b&gt;&lt;/span&gt;Finance income and finance costs&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Interest income and expenses are recognized in the period which they relate to through profit or loss using the effective interest rate method. &lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory>
    <cntg:AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_iF5inXn_VEiu1IUIuQjXaA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(d)&lt;/b&gt;&lt;/span&gt;Current versus non-current classification&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Expected to be realized or intended to be sold or consumed in the normal operating cycle&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Held primarily for the purpose of trading&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Expected to be realized within twelve months after the reporting period; or&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;All other assets are classified as non-current.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A liability is current when:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;It is expected to be settled in the normal operating cycle&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;It is held primarily for the purpose of trading&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;It is due to be settled within twelve months after the reporting period; or&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The terms of the liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group classifies all other liabilities as non-current.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are classified as non-current assets and liabilities&lt;/p&gt;</cntg:AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_VZU0ms35Nk6mV5-kav4YxA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(e)&lt;/b&gt;&lt;/span&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Research and development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Expenses for research activities are recognized through profit or loss in the period in which they are incurred.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Development expenditures on an individual project are recognized as an intangible asset from the date the Group can demonstrate: &lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the product or process is technically and commercially feasible so that the asset will be available for use or sale&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the Group has the ability and intention to use or sell the asset&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;a future economic benefit is probable &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the Group has sufficient resources to complete the development and&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;the development costs can be measured reliably. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The Group&#x2019;s research and development activities mainly relate to development of biomarkers and IT driven solutions.  With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#x2019;s internal validation test. Before such dates, any development costs are recognized in profit or loss and may not be subsequently capitalized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Capitalized development costs are recognized at cost less accumulated amortization and any accumulated impairment losses. They are only amortized as from the date the asset is ready for its intended use, which in the case of biomarkers is normally at the time the patent application for such biomarker is made. Amortization expense commences when the assets are ready to be put in use, and is recorded in cost of sales and research and development expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Capitalized development costs which are still under development are tested for impairment annually and when circumstances indicate that the carrying value may be impaired.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Other intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Other intangible assets purchased by the Group with finite useful lives are recognized at cost less accumulated amortization and any accumulated impairment losses. Subsequent expenditure is only capitalized if it increases the future economic benefits of the respective asset.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Intangible assets are amortized over their estimated useful life using the straight-line method and assessed for impairment whenever there is an indication that the intangible asset may be impaired.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The estimated useful lives are as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Software, patents and trademarks: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;-&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Corona Test Portal: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;2 years&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Capitalized development costs: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The useful lives and depreciation methods are reviewed annually to ensure that the methods and periods of depreciation are consistent with the expected economic benefit from the asset.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_H6sJ9CbA3Uqak-twBHs28g"
      id="Narr_rFxBEfy6Z06YXICtqmTUuA">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_SoftwarePatentsAndTrademarksMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IJi6tizcMkqoRBY2BmqqJA"
      id="Narr_oIeS_7Gxt0SBsuiJZ8Oo7A">P7Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_CoronaTestPortalMember_LjhxO9L-BkaT6QFPOJAsSQ"
      id="Narr_f-uZndP-jE6YO0SvqX1MUw">P2Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_QclbJBn7ZU-bkYebSJREIA"
      id="Narr_Mq4SykV_qESrN65DoLh3MA">P7Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_I3sebnZ22kKzbMNDxmk9kg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(f)&lt;/b&gt;&lt;/span&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment are carried at cost less any accumulated depreciation and any accumulated impairment losses. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The cost of property, plant and equipment comprises its purchase price including customs duties and non-refundable acquisition taxes, and proportionate VAT not deductible from input tax as well as any directly attributable costs of bringing the asset to its working condition and location for its intended use.       &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt; Subsequent expenditure is only capitalized if it is probable that the future economic benefits associated with the expenditure will flow to the Group. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Depreciation is calculated over the estimated useful life using the straight-line method. The Group has assessed that none of its property, plant and equipment has a residual value. The estimated useful lives of significant property, plant and equipment are as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Freehold land is not depreciated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Buildings: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;33 years&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;-&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Plant and other equipment, furniture and fixtures: &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;-&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;An item of property, plant and equipment is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of comprehensive loss when the asset is derecognized.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The depreciation methods, useful lives and residual values are reviewed, and adjusted prospectively if appropriate, as of each reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Assets under construction are reported at cost and are allocated to property, plant and equipment until they are completed and put into operational use, from which point onwards they are depreciated.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_9C85cYkhmEagnhCDbgR3AQ"
      id="Narr_SR6RyC1ZyUCW1KRCSWmu7A">P33Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_x92x8S-RsEqIAad9QHOnPw"
      id="Narr_97u5u3SPf0SeAumYt1rJZQ">P2Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_VmnidKUOw0WoRlLrj829EQ"
      id="Narr_NFnooShfWkuEyztb1gmVNA">P15Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_ppM0lxXvBEyijrA9pUQPuw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(g)&lt;/b&gt;&lt;/span&gt;Leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Group as a lessee&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(i)&lt;/span&gt;&lt;/span&gt;Right-of-use assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group recognizes right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its lease term and the estimated useful lives, as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Buildings: 33 years&lt;span style="white-space:pre-wrap;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Offices: 4 &#x2013; 12 years and&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;Plant and other equipment, furniture and fixtures: 2-15 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;If ownership of the leased asset transfers to the Group at the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The right-of-use assets are also subject to impairment. Refer to accounting policies of impairment of financial assets in note 5(n) &#x201c;Financial instruments&#x201d;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(ii)&lt;/span&gt;&lt;/span&gt;Lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;At the commencement date of the lease, the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for leases reasonably certain to be terminated. The variable lease payments that do not depend on an index or a rate are recognized as expenses in the period during which the event or condition that triggers the payment occurs. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(iii)&lt;/span&gt;&lt;/span&gt;Short-term leases and leases of low-value assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption to leases of office equipment that are considered of low value (i.e., below EUR 5k). Lease payments on short-term leases and leases of low-value assets are recognized as expenses on a straight-line basis over the lease term. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;(iv)&lt;/span&gt;&lt;/span&gt;Sale and leaseback transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The Group applies IFRS 15 for determining if the transfer of an asset to the buyer (lessor) is to be accounted for as a sale of assets.  After the sale of assets is concluded, the Group measures the right-of-use assets arising from the leaseback at the proportion of the previous carrying value of the asset that relates to the right of use retained by the Group.  Accordingly, the Group recognizes only the amount of any gain or loss that relates to the rights transferred to the buyer (lessor).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;If the fair value of the consideration for the sale of an asset does not equal the fair value of the asset, or if the payments for the leases are not at market rates, the Group makes the following adjustments to measure the sale proceeds at fair value: &lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;&#x2022;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;any below-market terms shall be accounted for as a prepayment of lease payments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;&#x2022;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;any above-market terms shall be accounted for as additional financing provided by the buyer-lessor to the seller-lessee&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_9C85cYkhmEagnhCDbgR3AQ"
      id="Narr_4tFCiN5RKUmlP_To8b26DQ">P33Y</cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets>
    <cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_s-Pt6IBZJU6njzi-YxbBHA"
      id="Narr_qNFrqNx1JEyMnfWsOQ4yhQ">P4Y</cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets>
    <cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OfficesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ha2hcVFm9USAnZurtaYg4g"
      id="Narr_SVnenezYakqS8khy6M8RLQ">P12Y</cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets>
    <cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_x92x8S-RsEqIAad9QHOnPw"
      id="Narr_xFqLBwTyM068JPRg-iIyrA">P2Y</cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets>
    <cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_VmnidKUOw0WoRlLrj829EQ"
      id="Narr_QVy8i3JmgECWEC8s7Cxl3w">P15Y</cntg:UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_M0qaGXsDAUysS45XuUnnrg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(h)&lt;/b&gt;&lt;/span&gt;Impairment of non-financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment and intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Whenever the carrying amount of an asset exceeds its recoverable amount, an impairment loss is recognized in profit or loss. The recoverable amount is measured as the higher of fair value less costs to sell and value in use. Recoverable amounts are estimated either for individual assets or, if an individual asset does not generate cash flows independently of other assets, for the whole cash-generating unit.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_yvVREf9f-k6FFhnn1exAcg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(i)&lt;/b&gt;&lt;/span&gt;Inventories&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Inventories are measured at the lower of cost and net realizable value. Inventories are recognized at cost based on the first in first out (FIFO) method. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_efWKeTl9fU-cUgfu7Q1BAg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(j)&lt;/b&gt;&lt;/span&gt;Government grants&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. Grants that are intended to compensate the Group for expenses incurred are recognized through profit or loss in the period in which expenses are submitted and claimed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Government grants which relate to an asset are initially recognized as deferred income at nominal amounts. They are subsequently released to profit or loss on a systematic basis over the expected useful life of the related asset.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The release of deferred income related to either type of grant is presented as other operating income (see note 8).&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_Z2S-vOxyN0eFJ8F8WfrPJQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(k)&lt;/b&gt;&lt;/span&gt;Share-based payments &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Plan recipients (including senior executives and certain member of Supervisory Board) of the Group receive remuneration in the form of share-based payments, whereby the recipients render services as consideration for equity instruments (equity-settled transactions) or settled in cash (cash-settled transactions).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Equity settled transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The cost of equity-settled transactions is determined by the fair value of the granted options when the grant is made, using a Black-Scholes or Monte Carlo simulation model, with further details given in note 20.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The cost is recognized in employee benefits expense (see note 8.4) or other relevant expenses, together with a corresponding increase in equity (capital reserves), over the period in which the service conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Group&#x2019;s best estimate of the number of equity instruments that will ultimately vest.  The expense or credit in profit or loss for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Cash-settled transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A liability is recognized for the fair value of cash-settled transactions. The fair value is measured initially and at each reporting date up to and including the settlement date, with changes in fair value recognized in employee benefits expense (see note 8.4). The fair value per option is determined using the Black-Scholes model, further details of which are given in note 20. The fair value per option is then multiplied by the Group&#x2019;s best estimate of the number of awards expected to vest and the portion of the expired vesting period (period in which the service conditions are fulfilled). The cumulative amount of expense recognized will be equal to the cash that is paid on settlement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Service and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Group&#x2019;s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;If the terms and conditions of a cash-settled share-based payment transaction are modified with the result that it becomes an equity-settled share-based payment transaction, the transaction is accounted for as such from the date of the modification.  Specifically, the equity-settled share-based payment transaction is measured by reference to the fair value of the equity instruments granted at the modification date and recognized in equity.  The liability for the cash-settled share-based payment transaction as at the modification date is derecognized on that date.  Any difference between the carrying amount of the liability derecognized and the amount of equity recognised on the modification date is recognised immediately in profit or loss.&lt;/span&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_l1rPywNYOE64AEWpmvVKog">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(l)&lt;/b&gt;&lt;/span&gt;Provisions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;A provision is recognized when the Group has a present obligation (legal, contractual or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.  When the Group expects some or all of a provision to be reimbursed, for example, under an insurance contract, the reimbursement misrecognized as a separate asset, but only when the reimbursement is virtually certain. The expense relating to a provision is presented in the profit or loss net of any reimbursement.  Provisions are reviewed at each reporting date and adjusted to reflect the current best estimate. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;If the requirements for recognizing a provision are not satisfied, the corresponding obligations are recorded as contingent liabilities unless the possibility of an outflow of resources embodying economic benefits is remote.&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_orJd1NbdRkewNfJumdCW7Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(m)&lt;/b&gt;&lt;/span&gt;Income taxes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Tax expense comprises current and deferred taxes. Current taxes and deferred taxes are recognized through profit or loss apart from deferred taxes related to items recognized outside profit or loss, in which case it is recognized in correlation to the underlying transaction either directly in equity or in other comprehensive income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Group operates and generates taxable income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred taxes are set up for temporary differences between the carrying amounts of assets and liabilities for group financial reporting purposes at the reporting date and the amounts used for tax purposes. Deferred tax liabilities are recognized for all taxable temporary differences, except:&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;temporary differences arising from the initial recognition of assets or liabilities in the course of a business transaction that is not a business combination and does not affect either the accounting profit or the taxable profit or loss&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:36pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"&gt;temporary differences associated with investments in subsidiaries if the Group controls the timing of the reversal of the temporary differences, and it is probable that the differences will not reverse in the foreseeable future.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and deferred tax liabilities are offset against each other if certain conditions are met.&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_HYYxUgfUBk2g9URowao3tg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(n)&lt;/b&gt;&lt;/span&gt;Financial instruments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;(i) Financial assets &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group&#x2019;s financial assets principally consist of those accounted for as receivables, contract assets, cash and cash equivalents.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Receivables and contract assets&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;Receivables, including contract assets, are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.  Contract assets and trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are measured at the transaction price determined under IFRS 15.  Refer to the accounting policies in note 5(b) &#x201c;Revenues from contracts with customers&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;After initial recognition, receivables and contract assets are subsequently carried at amortized cost using the effective interest rate method less any impairment losses.  Gains and losses are recognized in the profit or loss for the period when the assets are derecognized or impaired.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Derecognition&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A financial asset or a part of a financial asset is derecognized when the Group no longer has the contractual rights to the asset or the right to receive cash flows from the asset have expired. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Impairment&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group recognizes an allowance for expected credit losses (ECLs). ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group applies a simplified approach in calculating ECLs. Therefore, the Group does not track changes in credit risk, but instead recognizes a loss allowance based on lifetime ECLs at each reporting date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group considers a financial asset in default when contractual payments are 360 days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Further disclosures relating to impairment of trade receivables, including contract assets, are in note 21.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(ii)&#160;Financial liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group&#x2019;s financial liabilities include trade and other payables (include contract liabilities), as well as loans and borrowings including bank overdrafts.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Loans and borrowings&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Loans and borrowings are initially recognized at fair value and subsequently measured at amortized cost using the effective interest rate method, taking into account any principal repayments and any discount or premium on acquisition and including transaction costs and fees that are an integral part of the effective interest rate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Gains or losses are recognized through profit or loss at the time the liabilities are derecognized or disposed of.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Derecognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;A financial liability is derecognized when the obligation underlying the liability is discharged, canceled or expires.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized through profit or loss.&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <cntg:FinancialAssetInDefaultNumberOfDaysPastDueConsidered
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="0"
      id="Narr_eEa9Xr7r1kqNfPg30IsJ-g"
      unitRef="Unit_Standard_D_v74mkiZpokKNiaOyAGgw5A">360</cntg:FinancialAssetInDefaultNumberOfDaysPastDueConsidered>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_lF1SxP1oqkeu4yeO0Q_jlA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(o) Cash and cash equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Cash and cash equivalents comprise cash on hand and bank balances, including short-term, highly liquid investments that can be quickly converted into cash amounts. These have original maturities of three months or less and are subject to a low risk of fluctuation in value.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_aBnszJnnWEC0cnGG-9qIjg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;6 Accounting judgments and estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of the consolidated financial statements requires the management board to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures. Actual results could differ from those estimates. Estimates and underlying assumptions are reviewed on an ongoing basis and revisions of estimates are recorded prospectively. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;6.1&lt;/b&gt;&lt;/span&gt;Judgments &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Development costs&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Development costs are recognized in accordance with the accounting policy for certain internally generated assets. The Group&#x2019;s research and development activities mainly relate to development of biomarkers and IT driven solutions. With respect to biomarkers, the development stage is usually considered to be achieved when the target validation process is completed and commercialization is probable. With respect to IT driven solutions, the development stage is considered to be achieved upon the completion of the Group&#x2019;s internal validation test. Before such date, any development costs are recognized in profit or loss and may not be subsequently capitalized. As of December&#160;31, 2021, the carrying amount of capitalized development costs was EUR&#160;7,941k (2020: EUR&#160;9,680k). This amount includes investments in the development of biomarkers and IT driven solutions (e.g.,&#160;the Group&#x2019;s CentoMetabolome and CentoPortal online platform). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Provision for expected credit losses of trade receivables and contract assets&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group uses a provision matrix to calculate ECLs for trade receivables and contract assets. The provision rates are based on days past due for groupings of various customer segments that have similar loss patterns (e.g. by segment, geography, customer type and rating).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The provision matrix is initially based on the Group's historical observed default rates. The Group will calibrate the matrix to adjust the historical credit loss experience with forward-looking information. For instance, if forecasted economic conditions (i.e., gross domestic product) are expected to deteriorate over the next year which can lead to an increased number of defaults in the manufacturing sector, the historical default rates are adjusted. At every reporting date, the historical observed default rates are updated and changes in the forward-looking estimates are analyzed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The assessment of the correlation between historical observed default rates, forecasted economic conditions and ECLs is a significant estimate. The amount of ECLs is sensitive to changes in circumstances and of forecasted economic conditions. The Group's historical credit loss experience and forecast of economic conditions may also not be representative of customer's actual default in the future. The information about the ECLs on the Group's trade receivables and contract assets is disclosed in note 21.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax asset on loss carryforwards&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The tax losses carried forward do not expire. In the light of the Company&#x2019;s loss history, the recognition of deferred taxes for tax losses carried forward and deductible temporary differences is limited to the future reversal of existing taxable temporary differences.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Revenue implicit concession&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group reassessed revenue recognition from contracts linked to a customer with a history of significant payment delays resulting in significant impairment losses through the application of the expected credit loss method. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group concluded, based on the facts and circumstances and management&#x2019;s expectations regarding this customer, that this uncertainty in the amount of the contract consideration it expects to collect, and the likelihood of accepting a lower amount or changing payment terms represents an &#x201c;implicit price concession&#x201d; such that the contract consideration is variable. Therefore, the Group estimates the amount of the contractual consideration it expects to ultimately collect and for which it is highly probable that related revenue recognized would not be subject to significant future reversals when such uncertainty is resolved. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group records the difference between the billed amount and the amount estimated to be collectible as a reduction to revenue. At the end of each reporting period, and if necessary upon receipt of new information, the Group may revise the amount of the variable consideration included in the transaction price. The Group has applied this accounting policy and accounting estimate to arrangements with this customer prospectively with effect from the third quarter of 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;white-space:pre-wrap;"&gt;6.2         Assumptions and estimation uncertainties&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Information concerning assumptions and estimation uncertainty that have a significant risk of causing a material adjustment to the fiscal&#160;year ended on December&#160;31, 2021 are presented in the following disclosures. The Group based its assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising that are beyond the control of the Group. Such changes are reflected in the assumptions when they occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Share-based payments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;Estimating fair value for share-based payment transactions requires a determination of the most appropriate valuation model, which depends on the terms and conditions of the grant.  For the measurement of the fair value of equity-settled transactions at the grant date (including those issued to replace the cash-settled transactions), the Group uses the Monte Carlo simulation model (previously the Black-Scholes model). The fair value at grant date of equity-settled transactions is not updated at the end of each reporting period. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Valuation of Share Options&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The Black-Scholes option pricing model requires the input of subjective assumptions, including assumptions about the expected life of share-based awards and share price volatility.  The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved.  As a company listed on the NASDAQ stock exchange in 2019, the Group&#x2019;s share price only has limited sufficient historical information to be used as a reference, and therefore subjective inputs were included when estimating the fair value of our common shares to be used in both option pricing model. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;In addition, our management used different key assumptions in the models to calculate the fair value.  The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in note 20. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group intends to continue to consistently apply this methodology using the same comparable companies until a sufficient amount of historical information regarding the volatility of our own share price as a public company becomes available.&lt;/p&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_Fj9Rp4R76k2ZiXVlDvyuMQ"
      decimals="-3"
      id="Narr_Krk_7RuDDUWStBP3zAXYLA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7941000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_pMqKy82tCkCyUZNqkklFgA"
      decimals="-3"
      id="Narr_UcEIfV86zE-6Goz-d0ZbSA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9680000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_DNzIVSpV00CdZUlwQk-hiQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;7 Segment information and revenue from contracts with customers&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;7.1 Segment information&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;For management purposes, the Group is organized into business units based on its products and services. In line with the management approach, the operating segments were identified on the basis of the Group&#x2019;s internal reporting and how the chief operating decision maker (&#x201c;CODM&#x201d;) assesses the performance of the business. On this basis, the Group has the following three operating segments, which also represent the Group&#x2019;s reportable segments:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;Pharmaceutical segment:&lt;/b&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;"&gt;  This segment provides a variety of solutions to our pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring, in order to accelerate their development of treatments for rare diseases; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;Diagnostics segment:&lt;/b&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;"&gt;  This segment provides genetic sequencing and diagnostics services to our clients, who are typically physicians, laboratories or hospitals, either directly or through distributors; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;COVID-19 segment: &lt;/b&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;This segment provides COVID-19 testing services to our clients. Our original COVID-19 test is a molecular diagnostic test performed for the in vitro qualitative detection of RNA from the SAR-CoV-2 in oropharyngeal samples from presymptomatic probands according to the recommended testing by public health authority guidelines. In addition, we also offer COVID-19 antigen testing. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The management board is the Chief Operating Decision Maker and monitors the operating results of the segments separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on segment results and is measured with reference to the Adjusted EBITDA. Adjusted EBITDA is a financial measure which is not prescribed by IFRS, which the Group defines as income/loss before finance costs (net), taxes, and depreciation and amortization (including impairments), adjusted to exclude corporate expenses as well as share-based payment expenses. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Corporate expenses, interest and similar income and expenses, as well as share-based payment expenses are not allocated to individual segments as the underlying instruments are managed on a group basis. Assets and liabilities are managed on a Group basis and are not allocated to the different segments for internal reporting purposes. Therefore, our CODM does not regularly review this information by segment and accordingly we do not report this information by segment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Corporate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,843&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 20,678&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,247)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (16,702)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Capital Expenditures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to property, plant and equipment and right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 690&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 261&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,480&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,367&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,401&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 386&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,787&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other segment information&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization (including impairments)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,076&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,539&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,828&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,849&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,291&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,297&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,297&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19 &lt;/b&gt;&lt;sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Corporate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,194&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,408)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37,215&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (39,918)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,083&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Capital Expenditures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to property, plant and equipment and right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 333&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 602&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,682&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,730&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,183&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,672&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,802&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,657&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other segment information&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization (including impairments)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,769&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,289&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,400&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,670&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,128&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,935&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:47.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Corporate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,956&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,306&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (22,949)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,687)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Capital Expenditures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to property, plant and equipment and right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,362&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,998&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,908&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,268&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,603&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,677&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,280&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other segment information&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,308&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,032&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,239&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,579&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,590&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,590&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:7.1pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:28.9pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;As discussed in note 2, in March 2020 the Group commenced testing for COVID-19 in response to the COVID-19 pandemic and in the third quarter started managing and reporting the COVID-19 business as a separate segment. As such, the Group did not have any activities related to the COVID-19 business prior to 2020 and retrospective presentation in prior year segment reporting is not applicable. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Adjustments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Adjustments include non-cash charges in relation to depreciation, amortization (including impairments), and share-based payments as well as net financial costs, and income taxes. Certain costs, and related income, are not allocated to our reporting segment results and represent the residual operating activities of the Group reported as &#x2018;Corporate&#x2019;. These include corporate overheads, which are responsible for centralized functions such as communications, information technology, facilities, legal, finance and accounting, insurance (D&amp;amp;O), human resources, business development and strategic initiatives, certain professional and consulting services, procurement, research and development and other supporting activities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Corporate expenses also includes expenses incurred in relation to capital raising activities. For the year ended December 31, 2021, no expenses were incurred (2020 July Offering: EUR 278k ; 2019 IPO: EUR 1,092k) (see note 8.2). The corporate expenses for the year ended December 31, 2019 also includes a real estate transfer tax of EUR 1,200k related to an intercompany sale of land and building (see note 13).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;"&gt;Reconciliation of segment Adjusted EBITDA to Group loss for the period&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Reportable segment Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 29,545&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 41,001&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 17,262&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Corporate expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (46,247)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (39,918)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (22,949)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (16,702)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,083&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,687)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share&#x2011;based payment expenses (Note 20)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8,035)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,658)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,418)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization (including impairments)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (21,291)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (15,128)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,579)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Operating loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,028)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (19,703)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (18,684)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial costs, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (848)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,394)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,013)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (281)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (158)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss for the year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,852)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (21,378)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (20,855)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Non-current asset locations&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Non-current assets of the Group consist of right-of-use assets (under IFRS 16), property, plant and equipment, as well as intangible assets. All of such assets are located in Germany, which is the country of the business address of the Centogene GmbH, except for property, plant and equipment of EUR&#160;147k (2020: EUR 516k; 2019: EUR 286k) and right-of-use assets of EUR 137k (2020: EUR 709k; 2019: EUR 1,042k), which are located in the United States.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;7.2 Revenue from contracts with customers&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Rendering of services&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 146,380&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 189,159&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Sales of goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 762&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 764&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized over time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,131&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 61,910&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized at a point in time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 762&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 127,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 128,013&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Geographical information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 490&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,425&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 144,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 150,584&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Germany*#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 211&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 140,922&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 141,133&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Netherlands**&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,616&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 3,622&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,432&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,950&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,496&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;United States#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,763&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 19,309&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 94&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,593&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 818&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;white-space:pre-wrap;"&gt;                                                          &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Rendering of services&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 15,947&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,108&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 88,587&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 126,642&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Sales of goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,004&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 735&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,739&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Recognized over time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 15,947&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,108&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 24,684&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 62,739&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Recognized at a point in time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,004&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 64,638&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 65,642&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Geographical information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 149&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,605&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 88,314&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 94,068&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Germany*#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 186&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 80,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 81,065&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Netherlands**&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6,572&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 6,575&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 56&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12,568&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12,624&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 16,711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 978&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19,265&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;United States#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 16,711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,370&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 978&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 19,059&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 35&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,851&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,888&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 508&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 28&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 536&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Rendering of services&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 46,347&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Sales of goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,433&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,433&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized over time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,417&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized at a point in time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,363&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,363&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Geographical information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 381&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,447&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Germany*&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 233&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 275&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 508&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Netherlands**&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; &#x2014;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 25&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 25&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,977&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,099&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&#x2014;&lt;i style="font-style:italic;"&gt;Saudi Arabia#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; &#x2014;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 7,417&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 7,417&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 20,896&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,380&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,276&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;United States#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 20,896&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 1,882&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 22,778&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 123&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,864&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,987&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 971&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 971&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;*&#160;&#160;country of the incorporation of Centogene GmbH&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;**&#160;country of the incorporation of Centogene N.V.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;#&#160;&#160;&#160;&#160;countries contributing more than 10% of the Group's total consolidated revenues for the respective year ended December 31, 2021, 2020 or 2019 &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group collaborated with the majority of our pharmaceutical partners on a worldwide basis in 2021, 2020 and 2019. In addition, in cases where our pharmaceutical partners are developing a new rare disease treatment, it is generally anticipated that the final approved treatment will be made available globally. As a result, we allocate the revenues of our pharmaceutical segment by geographical region by reference to the location where each pharmaceutical partner mainly operates, which is based on the region from which most of their revenues are generated. The allocation of revenues in our diagnostics and COVID-19 segments are based on the location of each customer.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Pharmaceutical segment&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;During the&#160;year ended December&#160;31, 2021, revenues from one pharmaceutical partner represented 5.1% of the Group&#x2019;s total revenues (2020: 8.6%; 2019: 24.3%).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;During the year ended December&#160;31, 2021, we entered into collaboration agreements with certain pharmaceutical partners, of which upfront fees of EUR 455k were received in relation to setup fees which will be recognized as revenue over the period of the partnership collaboration. No such payments were received or revenues recognized for the year ended December 31, 2020. During the year ended December 31, 2019, Centogene entered into several collaborations with pharmaceutical partners, of which upfront fees totaling EUR 1,930&lt;span style="white-space:pre-wrap;"&gt;k were received.  Such upfront payments were recognized as revenues during the year as they represented the transaction price allocated to the one-off transfer of the Group&#x2019;s intellectual property&#x2014;provision of epidemiological insights of relevant rare diseases and relevant data. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;COVID-19 segment&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;During the year ended December 31, 2021, revenues from two COVID-19 partners represented 6.4% and 9.4%, respectively, of the Group&#x2019;s total revenues. (2020: 14.6% and 13.5%, respectively).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;To support the expansion of test offerings, the Company acquired laboratory facilities and equipment, developed a Corona Test Portal and leased laboratory space at several locations in Germany. Additionally, COVID-19 testing capacity is provided through our custom-built CentoTruck, a mobile laboratory in a container designed to carry out COVID-19 analysis. Total capitalized investments in COVID-19 testing as of December 31, 2021 amounted to EUR 2.8 million (2020: EUR 10.8 million), of which EUR 2.4 million (2020: EUR 7.7 million) are included in property, plant and equipment and EUR 0.4 million (2020: EUR 1.7 million) is included in intangible assets and relates to the development of the Corona Test Portal. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;Contract balances&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade receivables (note 15)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,065&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 25,656&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract assets (note 15)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,272&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,543&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract liabilities (note 19.2)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,842&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,479&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The contract assets primarily relate to the Group&#x2019;s rights to consideration for work completed but not billed at the reporting date on the tests for the diagnostics segment, with the satisfaction of the respective performance obligation measured by reference to stages in a standardized process. The contract assets also include work performed for pharmaceutical partners which are based on milestone fees. In 2021, EUR 483k (2020: EUR 356&lt;span style="white-space:pre-wrap;"&gt;k) was recognised as provision for expected credit losses on contract assets (see note 21).  The contract assets are transferred to receivables when the rights become unconditional. This usually occurs when the Group issues an invoice to the customer. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The contract liabilities include EUR 2,506k (2020: EUR 2,516k) which relate to the advance consideration, including various contracts with performance obligations, received from pharmaceutical partners for which revenue is recognized over time, and consideration from sales of CentoCards which have not yet been delivered. In addition, EUR 2,336k relates to COVID-19 performance obligations that have not been met as of December 31, 2021 (2020: EUR 1,963k). &lt;/p&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <cntg:IfrsNumberOfReportableSegments
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="INF"
      id="Narr_Iy3yBWpZSk-8cd1CbE6muA"
      unitRef="Unit_Standard_segment_fj3IE5HhAk64wBBglbJJCQ">3</cntg:IfrsNumberOfReportableSegments>
    <cntg:IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Group_SLzNYBk83k6Si3ccfGKfuA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Corporate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,843&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 20,678&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,247)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (16,702)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Capital Expenditures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to property, plant and equipment and right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 690&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 261&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,480&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,367&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,401&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 386&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,787&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other segment information&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization (including impairments)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,076&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,539&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,828&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,849&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,291&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,297&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,297&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:53.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19 &lt;/b&gt;&lt;sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Corporate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,194&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,408)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37,215&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (39,918)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,083&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Capital Expenditures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to property, plant and equipment and right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 333&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 602&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,682&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,730&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,183&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,672&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,802&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,657&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other segment information&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization (including impairments)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,769&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,289&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,400&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,670&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,128&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,935&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:47.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Corporate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,956&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,306&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (22,949)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,687)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Capital Expenditures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to property, plant and equipment and right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,362&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,998&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,908&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,268&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions to intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,603&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,677&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,280&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other segment information&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,308&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,032&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,239&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,579&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,590&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,590&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:7.1pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:28.9pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;As discussed in note 2, in March 2020 the Group commenced testing for COVID-19 in response to the COVID-19 pandemic and in the third quarter started managing and reporting the COVID-19 business as a separate segment. As such, the Group did not have any activities related to the COVID-19 business prior to 2020 and retrospective presentation in prior year segment reporting is not applicable. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;"&gt;Reconciliation of segment Adjusted EBITDA to Group loss for the period&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Reportable segment Adjusted EBITDA&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 29,545&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 41,001&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 17,262&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Corporate expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (46,247)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (39,918)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (22,949)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (16,702)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,083&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,687)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share&#x2011;based payment expenses (Note 20)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8,035)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,658)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,418)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation and amortization (including impairments)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (21,291)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (15,128)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,579)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Operating loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,028)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (19,703)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (18,684)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial costs, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (848)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,394)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,013)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (281)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (158)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss for the year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,852)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (21,378)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (20,855)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA"
      decimals="-3"
      id="Tc__XJsuzGfQ0y7Jm7nNYJqwA_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15641000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ"
      decimals="-3"
      id="Tc_0RrSOVQKT0-F6eRqLmdtzA_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ"
      decimals="-3"
      id="Tc_xp7qyPN3Z0-uA6oXu6rMjA_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">146382000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_rD_fPknHp0mHBR6S5U2bow_3_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">189923000</ifrs-full:RevenueFromContractsWithCustomers>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA"
      decimals="-3"
      id="Tc_4AHwFwGi20WmWQC1Nnk-Sg_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4843000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ"
      decimals="-3"
      id="Tc_cdX-pGdn6EGby_MYbDmHQA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4024000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ"
      decimals="-3"
      id="Tc_wH1f4G5oX0y8FcIKw4i8SQ_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">20678000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A"
      decimals="-3"
      id="Tc_NHGOgTfaikCLQc4mup1Qiw_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46247000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_UUok8178iEaDyJSjvoCBag_5_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-16702000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA"
      decimals="-3"
      id="Tc_ow5FPpcVwECeKd2rOJlZaA_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">690000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ"
      decimals="-3"
      id="Tc_9F6eSAArHU-7jHXwUVTP5w_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">261000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ"
      decimals="-3"
      id="Tc_BwzNQZLl7EqZQwsb0Z7z1g_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2480000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A"
      decimals="-3"
      id="Tc_UCbzhagSBUOdlXt-uWlLPg_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">936000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_EVGZI9NlCkWjEVJlU9fqNA_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4367000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA"
      decimals="-3"
      id="Tc_AP2K3ufxKES2Lbw3o89ccA_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2401000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ"
      decimals="-3"
      id="Tc_NtarL5e4i0qj6pcKVWdimA_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">386000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Jyd-Y0BHzUyyU9iY1KidSA_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2787000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_gYkceHyg3Uu2LYBIu73ltA"
      decimals="-3"
      id="Tc_BxyNEwev5E2SfrAhgBx19Q_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2076000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_LZ3UDMMB70OEtmeM2XDUcQ"
      decimals="-3"
      id="Tc_4efmSlL9iEqnCadQQnJbZg_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2539000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_NtQCB87UZk-EMIwKO2nRXQ"
      decimals="-3"
      id="Tc_KVpSsuFSoUiAWz3F0zK09w_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10828000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A"
      decimals="-3"
      id="Tc_7MB1rSb2-k-nugaZu38JIg_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5849000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_El8QqdU48EeylSHF934dCg_12_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21291000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A"
      decimals="-3"
      id="Tc_857XTQXm9EOmkOVDlxx8Qg_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19297000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_1g83KVhK5k291d83IAJeVg_13_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19297000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A"
      decimals="-3"
      id="Tc_epU5IxDhC0eW_zgC-QHBDA_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16951000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g"
      decimals="-3"
      id="Tc_i-Gp51oIvkCtEQFRKE9vyA_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22108000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g"
      decimals="-3"
      id="Tc_vN-7Edu_qEGP7sYzn9mKUA_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">89322000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_NyDA1ogoTki5EE_In6o16g_3_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">128381000</ifrs-full:RevenueFromContractsWithCustomers>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A"
      decimals="-3"
      id="Tc_sAcTpLP3wk6dnOPc67UHfA_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6194000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g"
      decimals="-3"
      id="Tc_kcrrKQU8ukibaFE-xphLOw_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2408000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g"
      decimals="-3"
      id="Tc_SDLIShmSzUKnAqp-c0cx3g_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">37215000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw"
      decimals="-3"
      id="Tc_nfwRGDIGxUazNVy6Qk-pUw_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-39918000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_KwIp1Btrrk2wTLE5ofL2SQ_5_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1083000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A"
      decimals="-3"
      id="Tc_D7q703es10uHSAI9cst52w_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">333000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g"
      decimals="-3"
      id="Tc_d3UZSgVYaUOti3s6b7HkFw_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">602000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g"
      decimals="-3"
      id="Tc_wtGyJRnNZEqY7gHmwHkSNg_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9113000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw"
      decimals="-3"
      id="Tc_QACaBAT6AUO8Pk7dh78YKA_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2682000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_GqiNF8sC1kizlAOrxdMHIw_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12730000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A"
      decimals="-3"
      id="Tc_08tLJLmWV02F6toQugtOCQ_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3183000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g"
      decimals="-3"
      id="Tc_WdfqTy07JkmFGos1sRUeBA_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1672000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw"
      decimals="-3"
      id="Tc_tBrgJPSankKF6LR3LOVpHg_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1802000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_PMWuffbankKZljCWaqQ5GQ_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6657000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ktNFiJQnCkWsLbVb8fvk-A"
      decimals="-3"
      id="Tc_BA2nKtqX5k-k32GxzknPDg_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6769000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_MylbYeSSmk6VNcHUKmIl_g"
      decimals="-3"
      id="Tc_V8Ddy_jnCU-PL2K9AmkmWg_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2289000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_sFaMEmE4sUC0HQnCrBoB-g"
      decimals="-3"
      id="Tc__N7vZdoYCE6_OV7nAsXkmQ_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1400000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw"
      decimals="-3"
      id="Tc_I_pMT3AjL0-UxcZYWxQuhg_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4670000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_DbJLxsFsl0yo7fWlXV0JAg_12_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15128000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw"
      decimals="-3"
      id="Tc_ltySzAw4T0i3wk4wXhykMg_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14935000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_iKJ9D8CCmUuVPEABKKOcsw_13_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14935000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw"
      decimals="-3"
      id="Tc_n82iOyhD8kuzYg-qoHiJ9w_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21522000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg"
      decimals="-3"
      id="Tc_vHJz9kCjmk-WE2pCLcHVbg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27258000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_qfNw_Wc7Rk-YS5OUqAHvqw_3_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48780000</ifrs-full:RevenueFromContractsWithCustomers>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw"
      decimals="-3"
      id="Tc_Ip2_2kqqck-K-SI7BSvjDw_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14956000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg"
      decimals="-3"
      id="Tc_OHAe9QQu3EuSW-wwNGv3tg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2306000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA"
      decimals="-3"
      id="Tc_OBTaXfs9J0GNviSEgfA0-g_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-22949000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Zh17cilDXECsjYuLGbmMfw_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-5687000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw"
      decimals="-3"
      id="Tc_TktUgaD9VkuXV7G4mv6e4A_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1362000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg"
      decimals="-3"
      id="Tc_8vHIIPvVAkeUJBQNLB3vPA_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1998000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA"
      decimals="-3"
      id="Tc_2KNQ8WJio0GGB-uWwcfp2Q_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17908000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_XR6qjtetfUuWJwBJQ79YyQ_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21268000</cntg:AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw"
      decimals="-3"
      id="Tc_ijx2LsSWP0K2XvU9VD0D1w_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3603000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA"
      decimals="-3"
      id="Tc_SIRZkSM-pE6a_U26RrNlFg_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3677000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_ZtImMSrWtEeWh2TzOzzxxA_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7280000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_o-NQ_Npdu0q8momKeyReFw"
      decimals="-3"
      id="Tc_sCrgdvRvUEGOnsbJCKGB1g_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1308000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_B9jvKt9tx0-ZhvB8Cx2kMg"
      decimals="-3"
      id="Tc_KrjmzBgCVU28bKhQbFPKTg_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2032000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA"
      decimals="-3"
      id="Tc_ZiJyWA5O80SaQZWOqSwwZw_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3239000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_1-EaA4c5HEKySFXm7MlCmg_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6579000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA"
      decimals="-3"
      id="Tc_waqtHfTlBkOjPeQijltmeA_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9590000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_uVrgoDj7vkiBgvKLApWenQ_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9590000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_gCPdXn3jFkWozmbOkFYa7Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_h1P9Uyda7EyoO2LPxzrHJg"
      decimals="-3"
      id="Narr_rWGOyTRprEiVMm350u67pg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">278000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_IfrsIPOMember_d-_7q8doLUSyk01ZAKC7zA"
      decimals="-3"
      id="Narr_yq1kskiCuUC7y2Vhg4574w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1092000</ifrs-full:ShareIssueRelatedCost>
    <cntg:RealEstateTransferTaxExpenses
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Narr_fvayHq6PW064LGztSv57QA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1200000</cntg:RealEstateTransferTaxExpenses>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw"
      decimals="-3"
      id="Tc_v7UZ_oS2RUi1wSjZcSb1rw_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">29545000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag"
      decimals="-3"
      id="Tc_5TRNCr1PcEW69B-_c2iPlQ_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">41001000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ"
      decimals="-3"
      id="Tc_s7-0A47inEeWhDMevt7D5Q_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17262000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment>
    <ifrs-full:AdministrativeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_dMt53_ifV0effGJfJeH5-A"
      decimals="-3"
      id="Tc_BZXHwepcrUWwjthabQjV0w_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">46247000</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_fp0puVE1VEenFy3WfUuLAw"
      decimals="-3"
      id="Tc_uLw6PZOTG0S_3o0ozQJMHg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">39918000</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_IfrsCorporateMember_t9xDUigREUmGHzvm_BTJfA"
      decimals="-3"
      id="Tc_SCEbno8n_kisSUphBI7otQ_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22949000</ifrs-full:AdministrativeExpense>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw"
      decimals="-3"
      id="Tc_fv-Dok8prU-KkQrEVwgWCQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-16702000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag"
      decimals="-3"
      id="Tc_J3adgAfPsEC7VkDrxif6ZA_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1083000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment>
    <cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ"
      decimals="-3"
      id="Tc_9SIhYrPynUyOtirACmUxzg_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-5687000</cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_2eYckct7zEO-8jBTYOIllw"
      decimals="-3"
      id="Tc_b2FXIQGK3UyQmmVbj9b_Dg_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8035000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_3jNAkLwyqECFEAQq580h_A"
      decimals="-3"
      id="Tc_LgiFsrBpu0mt-rvJKcgTZw_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5658000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsShareBasedPaymentsMember_gS9HG6od70ei9gUMi0zxBw"
      decimals="-3"
      id="Tc_Y-7zgQ_NR0OaIPcSFK9EtA_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6418000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_Iz_MtPVKxkKthZpts8RjoA"
      decimals="-3"
      id="Tc_FSlysEEiLkSV_E70OeDtYg_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21291000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_f4ic3iZXSU6dqSWwhtj5RA"
      decimals="-3"
      id="Tc_u82FPKsN80Ov5drySXVEmw_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15128000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_cntg_UnallocatedAmountsDepreciationAndAmortizationMember_yMvM3I89g0uOJQ1FgVa7uw"
      decimals="-3"
      id="Tc_TfIKTYce30W0T9v_ttOm3g_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6579000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw"
      decimals="-3"
      id="Tc_3B8MCvPqek-sTnh15Pydqg_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46028000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag"
      decimals="-3"
      id="Tc_V8EdBWiMR0CaMSgHRi9c5w_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-19703000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ"
      decimals="-3"
      id="Tc_O05x4K1SHUiCu1VN3Lh2sA_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-18684000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw"
      decimals="-3"
      id="Tc_SjVPy9Eyz0WtdRsNtca7yQ_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-848000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag"
      decimals="-3"
      id="Tc_SvR1Ernmq02EAZ4viwCMhQ_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1394000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ"
      decimals="-3"
      id="Tc_FThgoFCElUuqX3N-oEWP8A_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2013000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw"
      decimals="-3"
      id="Tc_WPFj22i7DkqpFu3CsgEMXA_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-24000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag"
      decimals="-3"
      id="Tc_jKlL6WzE_UqMoh2CKtwLLA_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">281000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ"
      decimals="-3"
      id="Tc_mCQtlnx7CEqIXU4wmhDacQ_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">158000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw"
      decimals="-3"
      id="Tc_yw-Tjtzg40eUZbzoY_DENw_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46852000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_JZHY8QTvbUeo4eQRfKM2Ag"
      decimals="-3"
      id="Tc_V1dodp0zpU6RYeq79N5GDQ_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21378000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_rX0dl9L4DEWhFUYWM4JqOQ"
      decimals="-3"
      id="Tc_ovxlxiTv-ki7UXhZOn36bQ_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20855000</ifrs-full:ProfitLoss>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_kpzFl95A4Eihik8AD-vh0Q"
      decimals="-3"
      id="Narr_U1YSn99VU0uBBS5ULegNQw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">147000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_eqR6NyQJOkW920BqJk1jTQ"
      decimals="-3"
      id="Narr_ZvjiY0qkNE-v1PR-aZWgnA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">516000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_FJL5PQArUkCuYTb_22g-4Q"
      decimals="-3"
      id="Narr_0Ce8ef3U_E6YnYbZKCP5CA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">286000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_kpzFl95A4Eihik8AD-vh0Q"
      decimals="-3"
      id="Narr_8I93HuMDhUWUeX129FrrFg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">137000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_eqR6NyQJOkW920BqJk1jTQ"
      decimals="-3"
      id="Narr_BYmAj3A3ZEGUbqS4A2LSNg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">709000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_FJL5PQArUkCuYTb_22g-4Q"
      decimals="-3"
      id="Narr_c9GRrUxXPEeWMg2y3GEqXg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1042000</ifrs-full:RightofuseAssets>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_8SVUtQypPkKymb0tpY15Jg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Rendering of services&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 146,380&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 189,159&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Sales of goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 762&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 764&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized over time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,131&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 61,910&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized at a point in time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 762&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 127,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 128,013&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Geographical information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 490&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,425&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 144,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 150,584&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Germany*#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 211&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 140,922&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 141,133&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Netherlands**&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,616&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 3,622&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,432&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,950&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,496&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;United States#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,763&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 19,309&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 94&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,593&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 818&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,641&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,900&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 146,382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 189,923&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;white-space:pre-wrap;"&gt;                                                          &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:46.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;COVID-19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Rendering of services&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 15,947&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,108&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 88,587&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 126,642&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Sales of goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,004&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 735&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,739&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Recognized over time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 15,947&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,108&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 24,684&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 62,739&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Recognized at a point in time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,004&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 64,638&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 65,642&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Geographical information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 149&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,605&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 88,314&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 94,068&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Germany*#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 186&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 80,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 81,065&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Netherlands**&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6,572&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 6,575&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 56&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12,568&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12,624&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 16,711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 978&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19,265&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;United States#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 16,711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,370&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 978&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 19,059&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 35&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,851&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,888&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 508&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 28&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 536&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,951&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,108&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 89,322&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 128,381&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Pharmaceutical&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Diagnostics&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Rendering of services&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 46,347&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Sales of goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,433&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,433&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized over time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 27,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,417&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Recognized at a point in time&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,363&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,363&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Revenues from contracts with external customers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Geographical information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 381&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,447&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Germany*&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 233&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 275&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 508&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;Netherlands**&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; &#x2014;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 25&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 25&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,977&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,099&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&#x2014;&lt;i style="font-style:italic;"&gt;Saudi Arabia#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; &#x2014;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 7,417&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 7,417&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 20,896&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,380&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,276&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;&lt;i style="font-style:italic;"&gt;&#x2014;United States#&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 20,896&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 1,882&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-style:italic;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt; 22,778&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 123&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,864&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,987&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 971&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 971&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,522&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 27,258&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 48,780&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;*&#160;&#160;country of the incorporation of Centogene GmbH&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;**&#160;country of the incorporation of Centogene N.V.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;#&#160;&#160;&#160;&#160;countries contributing more than 10% of the Group's total consolidated revenues for the respective year ended December 31, 2021, 2020 or 2019 &lt;/p&gt;</ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA"
      decimals="-3"
      id="Tc_oxpR1Yp8EkG5vb1G99OvVg_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14879000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g"
      decimals="-3"
      id="Tc_vdrEryrgf0iYVrKL6-nySQ_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27900000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"
      decimals="-3"
      id="Tc_PTiu4FrXsUOkBQgyhpnYig_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">146380000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_1QkGkLPYVkOdGhE7Jon4SA_3_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">189159000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA"
      decimals="-3"
      id="Tc_jiimMwq6RU-Wt3ChZl5wXQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">762000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"
      decimals="-3"
      id="Tc_GoDSPayRWUGxOPI2FyC0_A_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_uijL1yjQb0urngRSyE8Fuw_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">764000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA"
      decimals="-3"
      id="Tc_2cGxwXY_pEGGdlRm9-DsRQ_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15641000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g"
      decimals="-3"
      id="Tc_1qt6K85m_0C60a-p2vXtZQ_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"
      decimals="-3"
      id="Tc_ytoUaHhIC0yp0xLQFOoR-w_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">146382000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_eUzNamP2KkyfSE-kwkFqoQ_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">189923000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_rP9H_6ZxBUiMxdA5czmkLw"
      decimals="-3"
      id="Tc_XvbaX9aBx0WRxwwLb7hQTA_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14879000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_UQLS1jqBcUaiRdVG9-LbFQ"
      decimals="-3"
      id="Tc_YOPbt2BSjk2jBBVJVlvRkw_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_mMrEFk5yCEeTQec-FbsYew"
      decimals="-3"
      id="Tc_8KX5wD_sOkGULyG2zOpcwA_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19131000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Ybu5gGcGb0CLhwhCRJoJzQ"
      decimals="-3"
      id="Tc_s7G6_aLf_UKRF_xgHOMa2A_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">61910000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3ijtgqtaKE687iwfHUfycw"
      decimals="-3"
      id="Tc_-3SFV3YHBEGN-ihpMdC8WA_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">762000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mdFt7GHH9kCbATPAUndvBQ"
      decimals="-3"
      id="Tc_DWsyMCJLo02Lp0xQbGOnKw_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">127251000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_3R-RJj8W30CmqBQ9_P-L6w"
      decimals="-3"
      id="Tc_X1M-zwz9akCbExg-raSzLw_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">128013000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA"
      decimals="-3"
      id="Tc_6-UJMD7vAkaCQb_XPCBLcg_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15641000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g"
      decimals="-3"
      id="Tc_RBIsoCMg9EmWMaBoQgecmw_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"
      decimals="-3"
      id="Tc_vQHhseR2gEGpnzcEbInIVw_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">146382000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_aZBboYzmp06DgaDRZRDorQ_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">189923000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_0EhnM-nI9U60TimMN9cS6w"
      decimals="-3"
      id="Tc_m_H12tJANUimXNq77T-_nA_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">490000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_t5U2pU1llkyqTaF2VHf4kQ"
      decimals="-3"
      id="Tc_vsEDVvDg6ku8wqB4ucBqAw_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5425000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_r9aWl2b-v0OSqz3If8MAOw"
      decimals="-3"
      id="Tc_x9fb_UVBG0-zqVLfJE6PjA_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">144669000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_cOG0cWgzz0yXAS58I-gQ_g"
      decimals="-3"
      id="Tc_6BXUKssdsUeWzKah1Bwliw_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">150584000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_clx9prwtLE2o24g-cVlXXQ"
      decimals="-3"
      id="Tc_92pVNsk20kOnUc3UqLkH1w_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">211000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_cV4yyZGsZUiiKrDyDu6AAw"
      decimals="-3"
      id="Tc_NfEwQjVNcEK4kXhwgqQ4mA_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">140922000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_gQTQ8dl_nkqEQsnhaCYVXg"
      decimals="-3"
      id="Tc_8ci5rZjVikuUDCHTimKq4g_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">141133000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_st_41JliCE2l_ojbTOAjxg"
      decimals="-3"
      id="Tc_Du0cpQB1rUivHYg51GmdeQ_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_Bo1twD2K6U6g1a4dtlQlRg"
      decimals="-3"
      id="Tc_iCWci3pbOEuVPvh0iTdecQ_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3616000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_NL_HinXUd8jiU-OqKDtmHiBBA"
      decimals="-3"
      id="Tc_QhLnzDphBEq2AyL7uK-JRg_14_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3622000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hWWVNS2x5kyprvvsloH-qg"
      decimals="-3"
      id="Tc_zO1f_QYW4kG7STRaBrli8A_15_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">117000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HT11Yq7HqEiuy71IFa5GQg"
      decimals="-3"
      id="Tc_ElOv1TrebEq6b67f6B8z5Q_15_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16315000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_6jOQBXEji0iws7Kj-GYZLw"
      decimals="-3"
      id="Tc_3HHfWZD1oUmg_4lv4JDR7g_15_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16432000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_3QEbeOJ5BkaO7w7EMQ7ebw"
      decimals="-3"
      id="Tc_e1Wqu2D5mUS5S4OpJ3AaTg_16_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14940000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_npNxfNEcOEiHMRcMz1OMNQ"
      decimals="-3"
      id="Tc_Zo5QW2IS3kSgjAopDxwoiA_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2950000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_PCFksdHhDEW2XtLHDI7Jvw"
      decimals="-3"
      id="Tc_IG7IBEhoGEO41yWoLiGErw_16_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1606000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_9xKbq0HvrE23nctfL9kqJw"
      decimals="-3"
      id="Tc_FULwdPVKUUuJZRCzcmA1ug_16_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19496000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_8iKdtQU-_Eu7d8Hvzi8aSw"
      decimals="-3"
      id="Tc_vWvI-QE0kkWgQKJPlI71-w_17_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14940000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sey9N6DwsECg7Y8DnOwQ7g"
      decimals="-3"
      id="Tc_ZnvhfT0QiUKxOIacMYE22g_17_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2763000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_DOZiypy0h0yBjpMQ3UPvww"
      decimals="-3"
      id="Tc_OLK-TLEPMUKoVjDFt8J2Mw_17_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1606000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_US_wr28CgnaFUihv57zlIv9nw"
      decimals="-3"
      id="Tc_GDs5IZF28k-xnOzynhNQHw_17_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19309000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hY1buzymRUmo804bWIJEcw"
      decimals="-3"
      id="Tc_jpbxoebsyEW-v2l-LfECtg_18_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">94000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_-Trx4lnT9EqhKeaem--7cw"
      decimals="-3"
      id="Tc_P2TRCrPr_U2GfZF-oyMCjg_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2499000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_uhttJnikwUygDyIGsX0K2w"
      decimals="-3"
      id="Tc_-df86GhYckKjk1RcQ_bKHA_18_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2593000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_D52k1rmdSkSQ8eJxUeQTMg"
      decimals="-3"
      id="Tc_yAbg5r3IfUqAu8zRHKOymw_19_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">711000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_5om3Tuoy6U67GcuWFQxn_w"
      decimals="-3"
      id="Tc_78x44yBJsEiCCT7l5Ydumg_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">107000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_khmhDdbQsUmgB98c9HcKgA"
      decimals="-3"
      id="Tc_PjCE8GTNHkCkcDlPs6sjFQ_19_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">818000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_shDJ8l3oP0uDsinef4hDzA"
      decimals="-3"
      id="Tc_xRJMr3vRDkuKKk97xy650A_20_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15641000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_sl6D0aALMUmq-BIym5Be8g"
      decimals="-3"
      id="Tc_g5Za1l0nBUad7HtrGEsS-g_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"
      decimals="-3"
      id="Tc_jHwYRLRAmECAPl8ROmFRww_20_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">146382000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Jif0mLHN1UmmlFXEmQFuRg_20_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">189923000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ"
      decimals="-3"
      id="Tc_WzEfcy9FAk2mBd6laj28eA_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15947000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA"
      decimals="-3"
      id="Tc_RqwSVSnbekmz2bqjjK-Vzw_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22108000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg"
      decimals="-3"
      id="Tc_16kri3KP80er17SmVnzkww_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">88587000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_ZZWk6TRRX02tasVfWN68ZQ_3_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">126642000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ"
      decimals="-3"
      id="Tc_XjAZYe-l6kam65iemkVrPg_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1004000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg"
      decimals="-3"
      id="Tc_wzsj0i0hs0i83huVlDpp2g_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">735000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_N2nIGdVjc0K7FNqp7yJmCQ_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1739000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ"
      decimals="-3"
      id="Tc_H8NeQFBKPUS0UPXUFrv5yg_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16951000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA"
      decimals="-3"
      id="Tc_b3M8r_P1MEmAOHOVZM3MRw_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22108000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg"
      decimals="-3"
      id="Tc_B9xdDqtFlky-rleRSkBDLg_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">89322000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_upEwo_2wMUqDI-UikvZvUA_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">128381000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_W3F58Jfx80ii3Fx2Pkj0bg"
      decimals="-3"
      id="Tc_FkcED2gI-UC55J4LClZakg_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15947000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_HHPssicdQUqnZ5X69XqpQA"
      decimals="-3"
      id="Tc_y-6caKsGg0KjnkrC6s7_7A_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22108000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_dIyWF4ygA0iQzM7wM628QQ"
      decimals="-3"
      id="Tc_knBqGJvUJkiRVlDMtyfGQQ_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24684000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_n86T_jTggkKRt30kBqsVZw"
      decimals="-3"
      id="Tc_p9ge-8yw1UiB4bDQ14p8cw_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">62739000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_iS_M28fhFE6M9oKHCruHBg"
      decimals="-3"
      id="Tc_81DDU7Fg2kyHyh6OkxNUpQ_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1004000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_OiigMHAcVkuVDMVMzBsepg"
      decimals="-3"
      id="Tc_2swhiELYMUC8cO4eAgylKw_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">64638000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_mVhL40cYQEePQ61JZHkZ5g"
      decimals="-3"
      id="Tc_PzraEugssE2uMAeVNalUiA_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">65642000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ"
      decimals="-3"
      id="Tc_UP3Q2F9H50yW_PicALOQQg_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16951000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA"
      decimals="-3"
      id="Tc_A4c4sRpksE2UdPHjDlRv2A_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22108000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg"
      decimals="-3"
      id="Tc_2HrgsbsDR0CBCq5dOfBHSQ_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">89322000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_NIsul4cvRUiDCYyk1M-K1A_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">128381000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Pq1dqziFrECoxJA6IUPO0A"
      decimals="-3"
      id="Tc_yRsAtrAcZk2Msk1UkPZZbg_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">149000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_g9Q4KqtnV0uSsn7ARpe8uA"
      decimals="-3"
      id="Tc_-Xi7z3g-mku4Yxo6mPUYTg_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5605000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_RO2fs0emCUu9jR98AuIlGw"
      decimals="-3"
      id="Tc_g9Mgba8HX0eroJ7506xGfQ_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">88314000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_c1SgMStWuEuH_usbmcBK0w"
      decimals="-3"
      id="Tc_-YeRz4HSoUGnX8bnsHh0VA_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">94068000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ZXy9HwJvXUaEjtHUhuk8ow"
      decimals="-3"
      id="Tc_08xh4P5zjUOEojHK9Uxp3A_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">186000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_McmJjgE_k0alVLPoqAURaw"
      decimals="-3"
      id="Tc_9N4qoArICEiWb79h5mHLyg_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">80879000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Z8iyfz_ZhEyQVS1VVRoDQQ"
      decimals="-3"
      id="Tc_6leY_yFJ2UyIqRI-V0qhKg_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">81065000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_5aArgCY3JUK83G5Z3yyuaA"
      decimals="-3"
      id="Tc_oLY8H-3CoUywFedSG6pHzw_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_Covid19Member_zy3jWFs1Ikq8JSLXUCeHJQ"
      decimals="-3"
      id="Tc_klsSY23wOE6a93F31Z2Smg_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6572000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_NL_80vPPmzZsEK-rHwOiITf5w"
      decimals="-3"
      id="Tc_f-vWo8BFmEutI1BWoxGwWg_14_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6575000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_HkDJI80zTkuUmk--Ej4yXw"
      decimals="-3"
      id="Tc_NweX7W0EqEOe_TxrHV7aag_15_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">56000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_jPRbVhHuNkuHoAHPHl0FHA"
      decimals="-3"
      id="Tc_gi47sxyQQ02-_igjIUzFvg_15_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12568000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember__5AEW953l0KC20ixoMs7ow"
      decimals="-3"
      id="Tc_okf2xhYoLE-Fk3Wnk_nH3Q_15_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12624000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_Ys662UuLNkyBTJCZFPfCxg"
      decimals="-3"
      id="Tc_VWJLAPPJwUSH4wqNV1Hm3g_16_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16711000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ythndJ_8XEOkXQ82UmIkkQ"
      decimals="-3"
      id="Tc_LBCNfHa8hk-3ZMyas8sSZQ_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1576000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_pCwwsigl0U2m5E7-eDM8uA"
      decimals="-3"
      id="Tc_QaIXYKFa4UuyrlKgVMtQ-Q_16_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">978000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_4JRA7asUB0ioKSQ0gqeV8A"
      decimals="-3"
      id="Tc_tCmrKtEkNkm3hlGbZ2mH5w_16_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19265000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_6zdpYcOa-ESFJJRwZE-Oag"
      decimals="-3"
      id="Tc_P_ETtWDmrUiwlJtJ9SYCnQ_17_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16711000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_l03HHyyeUEi1A6xEJ5Edmg"
      decimals="-3"
      id="Tc_AtG9-LxquUKSqPqbJ4qeSQ_17_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1370000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_Covid19Member_R_eEBY9qmE-NM3Tvk2KDqw"
      decimals="-3"
      id="Tc_PapinNsdGki4zUHeLtDYwA_17_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">978000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_US_ROnDIAnWzk-FwbKaqoEgXQ"
      decimals="-3"
      id="Tc_t3PENPP_NEyLYnet5zJQKg_17_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19059000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PF_KqP6LSESi2HEzjtBOPQ"
      decimals="-3"
      id="Tc_NPAS0k0VBkOMfGcnZ5V0hA_18_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">35000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_HrC70U1Yj0u0D_A7_q4GXQ"
      decimals="-3"
      id="Tc_Sa6474KYOE2zB2inot8iDQ_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1851000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_hrmD1qRunUmmMLok8OgVQQ"
      decimals="-3"
      id="Tc_HZqct216hkWyV1qg3XYAkw_18_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_oREizo1DqkCFGwT7ENil_w"
      decimals="-3"
      id="Tc_BDGNurnjK0iCU6Wbahdu5Q_18_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1888000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_q9a-MHMvKUK5U_xsAmy2MQ"
      decimals="-3"
      id="Tc_JYxKnoCYUUySErq0TJIEqA_19_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">508000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_i4C0ubETiUCzWqGtU1jx2g"
      decimals="-3"
      id="Tc_6DBHW2vvGUq4IfJHmZgRNA_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">28000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_j0CQFn_gS0GfVtrcdtpKYA"
      decimals="-3"
      id="Tc_vvLsyXU6xUCjQQhhla2lug_19_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">536000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YUdjWzdDYUi7gHhVM6TxyQ"
      decimals="-3"
      id="Tc_VWWxczorsEaflaBPtipamA_20_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16951000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_OcHVwMigAkueCVXlbgnyRA"
      decimals="-3"
      id="Tc_VUbkYhioX0i88se4LsUsPA_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22108000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SegmentsAxis_cntg_Covid19Member_-SG9qfGGCEyjBv31nE7bgg"
      decimals="-3"
      id="Tc_fKOz07qWLUmxCykAVwSsNw_20_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">89322000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_jQvYtpx36UCcrm5OeH11iA_20_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">128381000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ"
      decimals="-3"
      id="Tc_tEbVgBUGHEGauNg7CeG1aQ_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19089000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg"
      decimals="-3"
      id="Tc_PP2mOoRDY0aQ4KvOX3FB8Q_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27258000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_FvP2OR7TRUOO3zFLOKJY5g_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">46347000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ"
      decimals="-3"
      id="Tc_7_6NpjMkg0-a-QGlXanbUw_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2433000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_3GgsjFCduEKiaM37cpIQiA_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2433000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ"
      decimals="-3"
      id="Tc_7fKnhPXA_U-oamgVCRi4Dw_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21522000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg"
      decimals="-3"
      id="Tc_dgb5s75L-UW838cCq_q4xg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27258000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_hqXjsxZcwkWSY7WaOSAC6w_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48780000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Gn5qMK_C4UePkU4n8Ymluw"
      decimals="-3"
      id="Tc_mknhD3AMJUmXI_4bgDH2kw_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17159000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_Oy3dJv22rkSAReGZRjnSUA"
      decimals="-3"
      id="Tc_dJ9F-4JqHUmqNE9xBLEqmQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27258000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredOverTimeMember_D-7kMsmp8Uer11pu6XnQCQ"
      decimals="-3"
      id="Tc_AuoMcuCRnkyEfk-_HAFLzw_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">44417000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_FeVjB1MUOEeh9_f7uvi5AA"
      decimals="-3"
      id="Tc_nvGwD466BUmEBtDr0CueeQ_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4363000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_fKiyneNNIEaYn8UkC13EtA"
      decimals="-3"
      id="Tc_tJVeLTCsXUWD-QHpNdw40A_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4363000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ"
      decimals="-3"
      id="Tc_0OgYlSBwD0uJii_i30FXwQ_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21522000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg"
      decimals="-3"
      id="Tc_UDspRZ9Cv0KhljVqRZKcAA_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27258000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_KPhTpHbLLEadKCtTsI29VA_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48780000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_9Ui5l_nU70uEou7uc-87Jw"
      decimals="-3"
      id="Tc_onPiO_yhK0Wa134YYTUaZg_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">381000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RI1XvAcXBkW1sMvmWPyezA"
      decimals="-3"
      id="Tc_jBklO6hv8ky97w7cJL7cnw_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7066000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_EuropeMember_OeyM4bZnmk-KdBoTF1lVhQ"
      decimals="-3"
      id="Tc_KBzkRvyQz0WQunRP0nSiFA_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7447000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_hgIa0VboT0mS4D8xJQpCCg"
      decimals="-3"
      id="Tc_rg6eE_0MB02_u_7tRWy8ZA_13_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">233000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_DO-kg8eAVE-lWMef-KoDVQ"
      decimals="-3"
      id="Tc_VjsXzgcN2k6nNLJlq1OhWA_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">275000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_tYw_3cgR1Ueq-Gbz16oQHg"
      decimals="-3"
      id="Tc_CyXjBwMHK0-A49d6WmwkFA_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">508000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_wJkGwu7MkUC7XJrNmADbTA"
      decimals="-3"
      id="Tc_6DbfIh8aM0e6YbpfFnWUBg_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">25000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_NL_Uoe9zKqJoESD7LidLdm1YA"
      decimals="-3"
      id="Tc_tsxk9zbVFkiIfE0OmIPVlw_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">25000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_ZnrF_dp5Y0KfdoqcK2Js3w"
      decimals="-3"
      id="Tc_SyHJ-UwFUkK0wVHBmWFnEw_15_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">122000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_7PcrTsViCkCTYuQCigBbTw"
      decimals="-3"
      id="Tc_ax96Pwcqv0iw2yjANW65dg_15_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">13977000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_IfrsMiddleEastMember_v3fS0Y4zQ0uHtd_W4YK3ng"
      decimals="-3"
      id="Tc_GBN_GVvF4EWmhfNEoSq57w_15_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14099000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_RZW3v4iO4kG8NHVW3fjBIw"
      decimals="-3"
      id="Tc_bpxlYXfHzUqQrh9B7FGLVw_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7417000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_SA_1IGbd19w8k2QJL4QJn5QLw"
      decimals="-3"
      id="Tc_XnBw-xQ3iUqUDCNyI_2oMw_16_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7417000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_zA1NYJLwcUaXbGpQUDVDuQ"
      decimals="-3"
      id="Tc_fXfaUM9E80CKBKvDQArnBw_17_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">20896000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_gNfrmr6fLUixQ62x_Fwrew"
      decimals="-3"
      id="Tc_T0kcVIvMpk-2cGrYHAiwnw_17_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2380000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_NorthAmericaMember_tB9oEnXM7EW6ytrbi0USWw"
      decimals="-3"
      id="Tc_0zDioZ574kSCDFSsqFhoFg_17_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23276000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_YTUjyWxrfkmjjtjGT1KC5A"
      decimals="-3"
      id="Tc_Tjq5J9WC9USbExOHmhpJfw_18_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">20896000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_n9XhJgrCrEySPhrU20QprQ"
      decimals="-3"
      id="Tc_EnGb4_hDAkyZ3_Ro4tq_pw_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1882000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_country_US_OP1UzlIcX0OmY9sJACaIww"
      decimals="-3"
      id="Tc_gK0DW3aH_UC6MyMPvnXWDg_18_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22778000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_AZFndmgY0UCwCIG8wtdz9g"
      decimals="-3"
      id="Tc_F_AFlfdX8EONPJzAnix9NA_19_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">123000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_km5pa8EmQ0OS81LK01_wkg"
      decimals="-3"
      id="Tc_meLwNgDfqEu94OtW41BNsQ_19_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2864000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_LatinAmericaMember_MTbFAzD3FUiK7SEe_WS1Jg"
      decimals="-3"
      id="Tc_ATaori8rrkSZT_Q7TTyWUg_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2987000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_azRhFhatK0S_v248GkC16A"
      decimals="-3"
      id="Tc_ow3xz6sd90O7-YD5BVWRYA_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">971000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_GeographicalAreasAxis_srt_AsiaPacificMember_N_D2fMybOEioJzSGBTNgVw"
      decimals="-3"
      id="Tc_r3zL7b8rjUaPhWfuj8GQ_Q_20_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">971000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_-PNnr-qH50yiamB8WwgVoQ"
      decimals="-3"
      id="Tc_ocK1NY_R7UCPc_BkWFNN1w_21_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21522000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_N2NY9zxFWEOXszeNTguHvg"
      decimals="-3"
      id="Tc_atm_E8_ZAUqwaJO05dvxGA_21_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">27258000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_K3umCmGaEkKaSIkHqoYJMQ_21_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48780000</ifrs-full:RevenueFromContractsWithCustomers>
    <cntg:NumberOfCustomersInGroup
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q"
      decimals="INF"
      id="Narr_WnIMK273fUWt8SgDFrLyPg"
      unitRef="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng">1</cntg:NumberOfCustomersInGroup>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q"
      decimals="3"
      id="Narr_0GJReRXlV0W3pRxWLTlB3Q"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.051</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PGxsbLEs7UOMIWZf7Z03Zg"
      decimals="3"
      id="Narr_VUsOFwg1WE2sEskrTjwiiA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.086</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_sgzRGPjWTEKksOKAeqNcwg"
      decimals="3"
      id="Narr_alYvYx6ZuEOdCidgO_6DpQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.243</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_rTeL3N4c7kyE8A-TnCYz0Q"
      decimals="-3"
      id="Narr_jD9IhYjtVECbhY3fT_QMyw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">455000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_PGxsbLEs7UOMIWZf7Z03Zg"
      decimals="-3"
      id="Narr_rrXhNLxsLkimX9vKPiJtSA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_MajorCustomersAxis_cntg_PharmaceuticalPartnerMember_ifrs-full_SegmentsAxis_cntg_PharmaceuticalSegmentMember_sgzRGPjWTEKksOKAeqNcwg"
      decimals="-3"
      id="Narr_dd2Hi5MMaUqEtfPhifLD1w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1930000</ifrs-full:RevenueFromContractsWithCustomers>
    <cntg:NumberOfCustomersInGroup
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"
      decimals="0"
      id="Narr_6uIWDsakd0mCqYpw9eyk_g"
      unitRef="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng">2</cntg:NumberOfCustomersInGroup>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_bm2QM3qwUEqolDwi7dS3oQ"
      decimals="3"
      id="Narr_U86HS5PHkUGKAb1hvZTSeA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.064</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_XwVB5e8oEUO5d47G1QgffA"
      decimals="3"
      id="Narr_Uu9m4zMIEUSZE8lNGmHjfw"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.094</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerOneMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_-u-gDw9Kw02XQH5X4XgSEQ"
      decimals="3"
      id="Narr_qX1WmHfk_U25U2MmZ3eqWg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.146</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_MajorCustomersAxis_cntg_Covid19PartnerTwoMember_ifrs-full_SegmentsAxis_cntg_Covid19Member_vD7DKV3Hb0uFeh-tXovtcw"
      decimals="3"
      id="Narr_JkvkzdyF_kKrQu11gqprCA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.135</ifrs-full:PercentageOfEntitysRevenue>
    <cntg:CapitalizedInvestment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_cV4yyZGsZUiiKrDyDu6AAw"
      decimals="-5"
      id="Narr_Fy-LMbyYnUu-Jbrf0I-eyQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2800000</cntg:CapitalizedInvestment>
    <cntg:CapitalizedInvestment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_McmJjgE_k0alVLPoqAURaw"
      decimals="-5"
      id="Narr_Y9VCSSfVkkqBqa8kjL1SyQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10800000</cntg:CapitalizedInvestment>
    <cntg:CapitalizedInvestment
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_WmW2dmc1-kKD6NAJoNXQBA"
      decimals="-5"
      id="Narr_QGpeNDkggEeOVnycy-M8jA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2400000</cntg:CapitalizedInvestment>
    <cntg:CapitalizedInvestment
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_PropertyPlantAndEquipmentMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_hG3SF9wOgkiDoa6rqpCHSg"
      decimals="-5"
      id="Narr_ZrP8pBwpWEmfXMJCV_4_6A"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7700000</cntg:CapitalizedInvestment>
    <cntg:CapitalizedInvestment
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xN3cXJlN6kKKfXv-f-akRg"
      decimals="-5"
      id="Narr_nqmrcG1GHUOmg0JcSH_l4w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">400000</cntg:CapitalizedInvestment>
    <cntg:CapitalizedInvestment
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsBalanceSheetLocationAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ifrs-full_GeographicalAreasAxis_country_DE_ifrs-full_SegmentsAxis_cntg_Covid19Member_xItn-kSCNkSjgL0_YwgUQw"
      decimals="-5"
      id="Narr_duRfdSB8Rk2CWYHVhh7pIw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1700000</cntg:CapitalizedInvestment>
    <cntg:DisclosureOfContractBalancesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_0IYyGA0_SUqAxZSwnVha8Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade receivables (note 15)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,065&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 25,656&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract assets (note 15)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,272&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,543&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract liabilities (note 19.2)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,842&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,479&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:DisclosureOfContractBalancesExplanatory>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_MuxD9rW0jkeSYtHpntMO2g_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21065000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_jhfeL_ySwUCUJkjarQUBHQ_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">25656000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentContractAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_D2NTwhyr9k2wPiSdpclU_A_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3272000</ifrs-full:CurrentContractAssets>
    <ifrs-full:CurrentContractAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_3KbxF-aowUStXlanXGpuWg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3543000</ifrs-full:CurrentContractAssets>
    <ifrs-full:ContractLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_pgsLUB7ByEexZjCtgikR3A_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4842000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_f2-zy2Ioo0ebAxbL9SYZMg_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4479000</ifrs-full:ContractLiabilities>
    <cntg:ProvisionForExpectedCreditLossesOnContractAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_pt18FCBe106oeEApdSPbRA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">483000</cntg:ProvisionForExpectedCreditLossesOnContractAssets>
    <cntg:ProvisionForExpectedCreditLossesOnContractAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_YP6lDqLX_0uin_8AhF-2Jg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">356000</cntg:ProvisionForExpectedCreditLossesOnContractAssets>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_7pv-GgsmDUitIFWZU3JFVA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2506000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_NrQGelycSUyAps5eVXxEFg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2516000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_qlqTrq1LokCZ6m0DO-ruyA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2336000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_Plvod4DR0UKJ5veP8v-7gA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1963000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_xm-qhVC7zEynpX3hKdY93A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;8 Other income and expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;8.1&lt;/b&gt;&lt;/span&gt;Other operating income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Government grants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,263&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,152&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2641&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gain on disposal of property, plant and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;532&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exchange rate gains&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;314&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income from the reversal of provisions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;89&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Others&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 656&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 240&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;205&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other operating income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,936&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,394&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,781&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Government grants contain performance-based grants to subsidize research, development and innovation in the state of Mecklenburg-Western Pomerania from funds granted by the European Regional Development Fund. Furthermore, government grants contain the release of deferred income from investment related grants. Other operating income includes a gain of EUR 387k from the forgiveness of a bank loan granted under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). (2020: EUR Nil). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In July 2019, the Group entered into a sale and leaseback transaction. According to which, the Group sold the Rostock headquarters building to a third party and then leased the building from the third party for a period of 12 years at a fixed rate per month with the option to extend. The sale of the Rostock headquarters in 2019 resulted in a gain of EUR 532k and was recognized in the period of sale. (See note 13)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;8.2&lt;/b&gt;&lt;/span&gt;Other operating expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Currency losses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 192&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 172&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,092&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other operating expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 86&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 182&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,284&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Other operating expenses for the year ended December 31, 2019 included costs incurred related to the IPO charged to profit and loss of EUR 1,092k.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;During the year ended December 31, 2020, the Group disposed of its entire 51% interest in LPC GmbH (&#x201c;LPC&#x201d;) to the minority shareholders for a consideration of EUR 213k, of which EUR 200k is to be paid over a period of four years and EUR 100k is outstanding as of December 31, 2021 (included in other assets, see note 15). The related non-controlling interest of EUR 268k (accumulated share of loss) was debited to profit or loss, and the sale resulted in a loss of EUR 101k.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;8.3&lt;/b&gt;&lt;/span&gt;Financial costs, net &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest expenses from loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (267)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (173)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,690)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Currency losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (362)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unwinding of the discount on lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (584)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (865)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (339)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income from loans and receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (848)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (1,394)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,013)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;8.4&lt;/b&gt;&lt;/span&gt;Employee benefits expense&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Wages and salaries&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 43,533&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,121&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,854&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Social security contributions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,134&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,095&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,212&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share&#x2011;based payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,471&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,714&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Termination benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,158&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 63&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 56,296&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 39,271&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 32,843&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Social security contributions include contributions to state pension scheme of EUR&#160;2,706k (2020: EUR 1,851k; 2019: EUR&#160;1,136k) as defined contribution plan expenses. Additionally, the Company recognized compensation expense of EUR 3,252k (2020: EUR 2,775k; 2019: EUR 1,203k) for remuneration of supervisory board members, including share-based payments (see note 25). &lt;/p&gt;</cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_2FwW3eTMyk6S7q5pWNpjnw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Government grants&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,263&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,152&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2641&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gain on disposal of property, plant and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;532&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exchange rate gains&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;314&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income from the reversal of provisions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;89&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Others&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 656&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 240&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;205&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other operating income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,936&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,394&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,781&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_brwav0xvake-zEnOr704aA_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2263000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_cUuYc1p9TEGLNVihatdYZA_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2152000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_IF-cAIokXE2bBPNzycckIg_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2641000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_R5pfzt1gekaLKdUDGQT28w_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18000</ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_vLG_YDOWNUSF9RDIaJRc0Q_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2000</ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_hoUfFPD_pEugKd1krk8eJw_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">532000</ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:NetForeignExchangeGain
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_kDnHdOjtC0yzd9gDS2nQGw_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">314000</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:OtherReversalsOfProvisions
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_vcCUclbKrEKGfN-JYbjqkQ_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">89000</ifrs-full:OtherReversalsOfProvisions>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_IrJGR4opd0GmnxsiiUZtCA_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">656000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_NEl12jltx0ycVbtE3tBQPQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">240000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_OejMv-Fcjk6RPkXXTGxfqA_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">205000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:OtherIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_3AwBfgN0akqMVfRzrthyoQ_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2936000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_hBOVwDnEZkyDap4e9exrtQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2394000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_wO4kj0ppREK5L5w9PGRyZA_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3781000</ifrs-full:OtherIncome>
    <cntg:GainLossFromForgivenessOfLoan
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_InfrequentItemsAxis_cntg_Covid19Member_jq7vmuWOsU2bxZzrIIp5CA"
      decimals="-3"
      id="Narr_FcrsUCpRjkikSBWy2CWuaQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">387000</cntg:GainLossFromForgivenessOfLoan>
    <cntg:GainLossFromForgivenessOfLoan
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_InfrequentItemsAxis_cntg_Covid19Member_4cfu7k0uNkCbmNqwluM_rg"
      decimals="-3"
      id="Narr_U17oYBhqikCOy-Vp71DSvw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</cntg:GainLossFromForgivenessOfLoan>
    <cntg:LeaseTerm
      contextRef="Duration_7_1_2019_To_7_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_5mtjV-dSjU23MM1xhgok7g"
      id="Narr_r6_V9mA1IEefNGg69raOvA">P12Y</cntg:LeaseTerm>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Narr_f3anBHE6HEaNEpaun0BTyA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">532000</ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_a1BHwSU7HEyn2y1XFWxIoA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Currency losses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 192&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 172&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,092&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other operating expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 86&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 182&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,284&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_nQO9-tlBZ0eC769rR0R24A_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">86000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_qIkc6JP_ukW0KdqkC7p-MQ_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_3qSboAb4hEmtOlSeEqdvgQ_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">192000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_AWVJmlqmW0ykjtWC-Ep0sA_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">172000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_HmfskwjvmU2hqr4JAlAKDw_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1092000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:OtherExpenseByFunction
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc__WQVW2e7IUKuRAQRqpdJ5g_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">86000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_jpWGUCgGCUaBWCRO6BwnhQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">182000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_2Hmu7c2WGUGDxdz-PH9X1Q_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1284000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_IfrsIPOMember_d-_7q8doLUSyk01ZAKC7zA"
      decimals="-3"
      id="Narr_n36eBIbQc0qBMAa1PKLxwg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1092000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg"
      decimals="2"
      id="Narr_EakkEN49IEe4gU5YMSCFrw"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.51</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg"
      decimals="-3"
      id="Narr_RBHxjVnQmE-iKDuzwk2xUA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">213000</ifrs-full:ConsiderationPaidReceived>
    <cntg:ConsiderationToBePaidOverTime
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg"
      decimals="-3"
      id="Narr_SlU7YLuupUyfuixGIGjGhA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">200000</cntg:ConsiderationToBePaidOverTime>
    <cntg:ConsiderationPaymentDuePeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg"
      id="Narr_AMk9_bJTz02RN-gwcyhvQA">P4Y</cntg:ConsiderationPaymentDuePeriod>
    <cntg:ConsiderationOutstanding
      contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_laKnVzYd2k-Sn9PzEQVwzg"
      decimals="-3"
      id="Narr_dEkV8sWRE0mfX5FQXzTIcA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">100000</cntg:ConsiderationOutstanding>
    <ifrs-full:NoncontrollingInterests
      contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_laKnVzYd2k-Sn9PzEQVwzg"
      decimals="-3"
      id="Narr_aLjbD6iW8EShWayocWaqNw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-268000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg"
      decimals="-3"
      id="Narr_lIIbu_M60UCwKmp_EFN9GA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-101000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_8NDe2_gYOkKEsYGSE4ZBKw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest expenses from loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (267)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (173)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,690)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Currency losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (362)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unwinding of the discount on lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (584)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (865)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (339)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income from loans and receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (848)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (1,394)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,013)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_3TD2Glztk0qxYoKJwOGTIg_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">267000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Rm2dK1d8xEelM2vkkg0yYw_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">173000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_5AYwfttHaEy09XwDaKKIsg_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1690000</ifrs-full:InterestExpenseOnBorrowings>
    <cntg:CurrencyLossesFinanceCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_h2W2bf3Q1UWUC9altG27-g_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">362000</cntg:CurrencyLossesFinanceCost>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ixS1HVEH1E6L1vJa5p0CDw_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">584000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_crNgh0ZWzUOYSWBIjeCNkw_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">865000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_9sdxvVvpB0G4bRgAc4EWkQ_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">339000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestIncomeOnLoansAndReceivables
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_7wDmag-3T0-ITZDb_Gybug_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3000</ifrs-full:InterestIncomeOnLoansAndReceivables>
    <ifrs-full:InterestIncomeOnLoansAndReceivables
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_7DiTYTOgi0GCRod7yLzDqA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6000</ifrs-full:InterestIncomeOnLoansAndReceivables>
    <ifrs-full:InterestIncomeOnLoansAndReceivables
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_TFWjUPgOxEy8tBX678HYtQ_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:InterestIncomeOnLoansAndReceivables>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_dUkVdPqrMk6kNKhtHjjhYg_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-848000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_FLA8xo143kysrAAD1u-1wQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1394000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_Bdhx8vlM40aa-Ys2aqSOYg_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2013000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_JhuRiPntzEqP9vFfm81LrQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Wages and salaries&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 43,533&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,121&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,854&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Social security contributions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,134&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,095&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,212&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share&#x2011;based payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,471&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,714&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Termination benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,158&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 63&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 56,296&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 39,271&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 32,843&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_KVH9A5VXA0KHYo07hsRW7Q_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">43533000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Kr0CUPSasUG7FnwOGJwMkQ_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31121000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_E_E8mdpmR0GkfRsWJJyojw_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23854000</ifrs-full:WagesAndSalaries>
    <ifrs-full:SocialSecurityContributions
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_lVNfxbOY_ESGgtgNdZEreg_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6134000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_mlMIumD1RU-0580T_tOOdQ_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4095000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_t1vLfBMpSkKT5YmzuzpG_Q_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3212000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_l-SJuG_1FkWQvEmlclN39Q_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5471000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_2qGsXm4kTk6dzV3h3KCm2A_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3486000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_XEBWvD8au0ei2zkkQoeJ-w_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5714000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:TerminationBenefitsExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Al9FbHw2rUyzF7w0Dk9YZQ_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1158000</ifrs-full:TerminationBenefitsExpense>
    <ifrs-full:TerminationBenefitsExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_w34w8RgfxkCadqmAddrNWg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">569000</ifrs-full:TerminationBenefitsExpense>
    <ifrs-full:TerminationBenefitsExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_sj5hLg9ZZkKCvSZeM5NWJg_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">63000</ifrs-full:TerminationBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc__vFn9yRhGUyOSbhXrHs3yg_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">56296000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_CkojBIRg30q9NNhDHomQfg_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">39271000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_BhZy9Kwas02Ck0pULDWV7A_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">32843000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_lRa3sX5GY0WOtx5dWmUM4Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2706000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_vWyDePzLIUq1yRw36KhWdw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1851000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Narr_7i1XsaHcG0aZM7mzmor91g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1136000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_uWLOxsW1eEmoFw2X5N9jYg"
      decimals="-3"
      id="Narr_5mbRlnmzaUKtbrVQiepjfg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3252000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_FDERhT7zokOtLHTy2PLLsA"
      decimals="-3"
      id="Narr_mJR4gCr0J0GCcigRqsGRBg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2775000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_gFxC2tLdrUODGcKQ8Sm_rg"
      decimals="-3"
      id="Narr_yjUTnMCjdEa8o47wZXWesA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1203000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_5QMH-_ZcDEqF-HzRGN6WXg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;9 Income taxes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Taxes recognized through profit or loss:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current tax expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (118)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (74)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (158)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Current year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (102)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (58)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Adjustments for prior periods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (16)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (16)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (157)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred tax (expense)/income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 142&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (207)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Temporary differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (182)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (514)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Tax losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 514&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total income tax (expenses)/benefit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (281)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (158)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;No income taxes were recognized directly in other comprehensive income for the years ended December 31, 2021, 2020 and 2019. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;A reconciliation of the effective tax rate to the Group&#x2019;s statutory rate of 31.1%&lt;span style="white-space:pre-wrap;"&gt; for the year ended December 31, 2021, and  &lt;/span&gt;31.1% for the years ended December, 31, 2020 and December, 31, 2019, respectively are presented in the table below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss before tax&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,876)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (21,097)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (20,697)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Taxes on the basis of the Company&#x2019;s domestic tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,596&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,570&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,445&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax rate effect of foreign tax jurisdictions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 882&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 412&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non&#x2011;deductible expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,030)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (903)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (441)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current year losses for which no deferred tax assets were recognized&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (12,211)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,792)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,416)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax income related to prior years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (17)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (137)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (157)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other effects&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (196)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (84)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income tax (expenses)/ benefit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (281)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (158)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The domestic tax rate of 31.1% is composed of the corporate income tax rate of 15%, the solidarity surcharge of 5.5% of this corporate income tax, as well as trade tax of 15.3%. The tax rate effects from foreign tax jurisdictions are primarily attributable to the tax-exempt profit of a Group subsidiary located in Dubai.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Tax losses carryforwards for which no deferred tax assets were recognized amount to EUR&#160;85,639k in Germany (2020: EUR&#160;64,464k; 2019: EUR&#160;41,570k) and to EUR&#160;1,083k in other countries (2020: EUR 1,002k; 2019: EUR&#160;505k). Deductable temporary differences, for which no deferred tax asset is recognized, amount to EUR 1,117k.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Tax losses carried forward in Germany do not expire. Foreign tax losses carried forward may be restricted. In the light of the Group&#x2019;s loss history, the recognition of deferred taxes for tax losses carried forward and deductible temporary differences was limited to the future reversal of existing taxable temporary differences.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;For temporary differences associated with investments in the amount of EUR&#160;5,656k (2020:&#160;EUR&#160;4,313k; 2019: EUR&#160;4,360k), no deferred tax liability has been recognized because the Company is able to control the timing of the reversal and it is probable that the difference will not reverse in the foreseeable future.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The below table shows a breakdown of deferred taxes in the Group&#x2019;s statement of financial position.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,439)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,934)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Property, plant and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (133)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,617)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,029)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Measurement of service contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (145)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasing liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,563&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Government grants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,693&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,903&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unused tax losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 777&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,266&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Sum&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,033&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,112)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,034&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (8,241)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Offset&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,033)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,033&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (8,034)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,034&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred Taxes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (79)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (207)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <cntg:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_jjbFVXkzZkW1RB0KBeu52A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current tax expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (118)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (74)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (158)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Current year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (102)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (58)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Adjustments for prior periods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (16)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (16)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (157)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred tax (expense)/income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 142&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (207)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Temporary differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (182)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (514)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Tax losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 514&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total income tax (expenses)/benefit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (281)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (158)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_SxGUz3V2rkynIzyHVbo_lA_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">118000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_BZB0UkmqqUyrQtIfvCrw6A_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">74000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_nYIIW3B_TUy8nYUMXZOD_w_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">158000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_sg8BdQOPqE6tptlijAG_kA_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">102000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_WrcUhE2tIEa5sncVXkATiA_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">58000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_e4D5H1903kizCgEH5a7mVg_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_nuSCIo8OOEa9nwt08SOinQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_CtFNf52RqUuDSHgRVuiqIg_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_dnhUo7hxNECmNdtYspelAA_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">157000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_-0BvXdsMykiBtHaKSG9kgA_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-142000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_4HnqUBH270C2WFty8dtIIg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">207000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_rv0BlH6yQUessgKFy7e-GA_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-142000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_bjdkQwx3GkGbCs_HNF-i-A_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">182000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_6m9jxS_uJEWDkU8Fse5XSA_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">514000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <cntg:TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_RR_c2CKlfEiGcKGoog0rjA_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-25000</cntg:TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense>
    <cntg:TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_E9CarYDcq0yrjiZbOgctag_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">514000</cntg:TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_dtIWfUnob0SvI0oQPJj-3A_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-24000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_vj5Mt8I-VE2F8qkhTRUwow_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">281000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_WM7FaU3JMkugYBp7nk1tzg_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">158000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Narr_YCEhJO9CckmrlC447fjQIQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_yAZZdR4wNUK70-ZV1WRLdw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_asZ1E94wU0ufruGYECS7fA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="3"
      id="Narr_1lSCQx3K0Eu71Ir5tRQ12g"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.311</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="3"
      id="Narr_BuUzrZuIwkuAYyabweqIzQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.311</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="3"
      id="Narr__6c7G70wNkSGWVao_2k3NQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.311</ifrs-full:ApplicableTaxRate>
    <cntg:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_BKoP-nbn2kOmpUjWCJ3ztA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss before tax&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (46,876)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (21,097)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (20,697)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Taxes on the basis of the Company&#x2019;s domestic tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,596&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,570&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,445&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax rate effect of foreign tax jurisdictions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 882&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 412&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non&#x2011;deductible expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,030)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (903)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (441)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current year losses for which no deferred tax assets were recognized&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (12,211)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,792)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,416)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax income related to prior years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (17)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (137)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (157)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other effects&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (196)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (84)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income tax (expenses)/ benefit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (281)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (158)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_vWGeSZ6upk24yS_dcd-l_g_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-46876000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_9mDPCnRhjUuPVQGeKEyL3w_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21097000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_H-Xw7CDLF0KE-g4i-BKCqA_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-20697000</ifrs-full:AccountingProfit>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_UsX8xkjnsUCf-bwqOn2JAQ_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-14596000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_WuEK9TznIUyNoqCrhkCkig_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-6570000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_LJXqrWyqQ0u3q3WVeG4Q0A_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-6445000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxEffectOfForeignTaxRates
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Q-mmvwtCoU2L-pUzecRyAQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-882000</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfForeignTaxRates
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_roubQ7M_CUCSaVj9n5dLXQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-65000</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfForeignTaxRates
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_cqYBLxe8ekWB0Q1TgPUrKg_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-412000</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_WOW6b26A4USiBUPUM9QzuA_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3030000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_imM7oIEgRUa4b-OwpCxmGA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">903000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_CvXyznnWlE2W0WlK2e_RAA_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">441000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Md2uNFQ3OUa2rW5XzsM_Dw_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12211000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Ge06HOelhESGLLh8ummrIw_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5792000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_FAK5KQxVZUKiIE1aux8bLQ_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6416000</ifrs-full:TaxEffectOfTaxLosses>
    <cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ZXL0NXVxN0yI1lIyMYu-fw_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17000</cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact>
    <cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_7r_skojp9U2QYi6lrEwyFw_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">137000</cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact>
    <cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_8RxMSwtVL0a3zordXhY5_A_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">157000</cntg:AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Fjv_R1T_yES9cG4cMlQsZQ_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">196000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_yFR5Dk3xCU-GFj9TdltKNw_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">84000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_mkdARYgt-U-NwBDM1lpOQg_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_jimXim7FLUmQGoWHgP_y9w_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-24000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_FH4QYqnCZ0evMTXzAB4xVQ_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">281000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_pA8br9L4602GwyLtZ8-fRg_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">158000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ"
      decimals="3"
      id="Narr_L6OSm05Z10ebNUdSNibWeQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.311</ifrs-full:ApplicableTaxRate>
    <cntg:CorporateIncomeTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ"
      decimals="2"
      id="Narr_jJ4dMRm7ik2vkwOTV0AZig"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.15</cntg:CorporateIncomeTaxRate>
    <cntg:SolidaritySurchargeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ"
      decimals="3"
      id="Narr_AQpLhg9Lc0uLjg3E7y5jog"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.055</cntg:SolidaritySurchargeRate>
    <cntg:TradeTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_GeographicalAreasAxis_ifrs-full_CountryOfDomicileMember_0jq8-YbtukCNVdyRAobaIQ"
      decimals="3"
      id="Narr_OFbkoWOq3kC8hHSphCUkXg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.153</cntg:TradeTaxRate>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_country_DE_Nljnlu_Jg0W2A_crlX3lqA"
      decimals="-3"
      id="Narr_Pu4qBQiSoUaTZo0Ep8S5hQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">85639000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_country_DE_Vx47RrdIq0GQ-Ki9-H37zA"
      decimals="-3"
      id="Narr_v9gQXE-rrkqQpARDOAWM5Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">64464000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_country_DE_hl6aZ99S1EmWbvQH7J5vNQ"
      decimals="-3"
      id="Narr_Z35OZSeJ_0W8DsX93KnglQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">41570000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_t0eueDKCHEKgNoS0LdjhcQ"
      decimals="-3"
      id="Narr_B7ZierKhRUqJtqnfrtBrwA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1083000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_4T1vNzsxNkCbKq5j-Bd34w"
      decimals="-3"
      id="Narr_gvM6X_dHnEiiZCC1fKAFFQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1002000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2019_ifrs-full_GeographicalAreasAxis_cntg_OtherCountriesMember_ZLDQszdhKEWtIgEyyR7CjA"
      decimals="-3"
      id="Narr_YMj6DtWjM0SrLCFJ1nuu_w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">505000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_8hs8Sp_qc02913n2InDQRQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1117000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_lirgKrv6cEWXhmKtzSmzoQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5656000</ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures>
    <ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_IO6xkyw8fkiYRhcjCl6QaA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4313000</ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures>
    <ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Narr_yljZVbMeBEu307VgYypriw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4360000</ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_8BRIf1cWaEmWEESpTgGFMg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;tax&#160;liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,439)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,934)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Property, plant and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (133)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,617)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,029)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Measurement of service contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (145)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasing liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,563&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Government grants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,693&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,903&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unused tax losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 777&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,266&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Sum&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,033&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,112)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,034&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (8,241)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Offset&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,033)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,033&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (8,034)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,034&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:57.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred Taxes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (79)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (207)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_QzlZ2gHa9UmZqgp-gMT1xA"
      decimals="-3"
      id="Tc_MakMnMkp3EemSLDB_oPCIQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2439000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_J4CTxkjWd0i7eimj-78dVQ"
      decimals="-3"
      id="Tc_rzSUQlnCQkmZf-pU9A1x6A_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2934000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_G9S6WR6LUkWpOgDW2ba0hg"
      decimals="-3"
      id="Tc_GsWTqcNo4kuEPddqp4_a3g_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_PropertyPlantAndEquipmentMember_PzgOubk0sUiPtObl6v_YAQ"
      decimals="-3"
      id="Tc_MFC_gqLjLU6fACWzGtfPDg_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">133000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_eDNvK1TmeEG14kTMUgQaLg"
      decimals="-3"
      id="Tc_T0to9ClbI0i-Wwc52fzpvw_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4617000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_RightofuseAssetsMember_6cqIyIHrEkyiYD7ANN1bDg"
      decimals="-3"
      id="Tc_pbLDW2ip8k-tSyy7Cn6T0A_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5029000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_BcIW7LDHy0CnsUV9Pv217w"
      decimals="-3"
      id="Tc_gRLf00bEX0mtwCH--uS9og_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">42000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_MeasurementOfServiceContractsMember_3fVvStyvDkODlS0OB9wu2g"
      decimals="-3"
      id="Tc_9kE3pYHYW0eMlI7fV2J5vg_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">145000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_EftQ82OO8kC-o269ZjHJoQ"
      decimals="-3"
      id="Tc_uRr0bP5PeE-6surVGkAAjA_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4563000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_LeaseLiabilitiesMember_k0i-lMHYs0mveCZGWLchMQ"
      decimals="-3"
      id="Tc_yy4p_Z_HsE6Pto5AWb_1hg_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4865000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_-qIGtGSHJkaH45QX4EJ-vQ"
      decimals="-3"
      id="Tc_zCFOStjzB0W9cxlddP7Kdg_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1693000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_cntg_GovernmentGrantsMember_nSTQU73o0Ei4uWEp9Ik9Ww"
      decimals="-3"
      id="Tc_BZ1VGOUgMUmmkZ-mqA1v0g_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1903000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_9Epnx9NGxUyO_NrCcxyv3w"
      decimals="-3"
      id="Tc_oqN35zPaMUecic0bIAFMjw_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">777000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_6JeY3hzvoUmiYLFCkMlKPA"
      decimals="-3"
      id="Tc_t77fgSmMKESdotsSQtOApQ_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1266000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_tMpkg4ICakSxrIBCg-ZNHQ_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7033000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_ZvJaXqJv002xpaPhvTNX-g_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7112000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_kbB4ACgQgkWRn3Tclg4OgA_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8034000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_d5W8eBpNGE-YhWUV-Dfk6A_11_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8241000</ifrs-full:DeferredTaxLiabilities>
    <cntg:DeferredTaxAssetsOffset
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_2Jiv8HDyU0-YWlAuI1iVsg_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7033000</cntg:DeferredTaxAssetsOffset>
    <cntg:DeferredTaxLiabilitiesOffset
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_45q7Kxw2KUqj21o2XpxvNQ_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7033000</cntg:DeferredTaxLiabilitiesOffset>
    <cntg:DeferredTaxAssetsOffset
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_anabdRK2HUy3nUnu9H3TTA_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8034000</cntg:DeferredTaxAssetsOffset>
    <cntg:DeferredTaxLiabilitiesOffset
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_c-ChSAqIIUaxZJJDrpusTA_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8034000</cntg:DeferredTaxLiabilitiesOffset>
    <cntg:DeferredTaxLiabilitiesNet
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_nWDo1TN1dkOvoh8NzorbIQ_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-79000</cntg:DeferredTaxLiabilitiesNet>
    <cntg:DeferredTaxLiabilitiesNet
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_r3QCIZxXlUW14m-f0bvtYA_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">207000</cntg:DeferredTaxLiabilitiesNet>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_azlnn4NisUaGL3PknkIOdg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;10 Loss Per Share&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Basic loss per share is calculated by dividing loss for the period attributable to equity holders of the Group by the weighted average number of shares outstanding during the same period, adjusted for the effect of the corporate reorganization as discussed in Note 1 and applied retrospectively to all prior periods presented. The weighted average number of outstanding shares for the year ended December 31, 2021 was 22,437,301 (2020: 20,909,673; 2019: 16,409,285), adjusted for the effect of the 2019 corporate reorganization).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;For the periods included in these financial statements, the share options are not included in the diluted loss per share calculation as the Company was loss-making in all these periods. Due to the anti-dilutive nature of the outstanding options, basic and diluted loss per share is equal.&lt;/p&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="0"
      id="Narr_ZjK6r56f20-k7pUXKthRvQ"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">22437301</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="0"
      id="Narr_IUYm9jcajkOGYF1W-NOedw"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">20909673</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="0"
      id="Narr_cSLhPb8u60G7cq_NGgKkIg"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">16409285</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_AtRVzuIzB0-ojdcaPwqwKA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;11 Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Reconciliation of carrying amounts&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Internally&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;generated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Internally&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Purchased&#160;rights,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;/acquired&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;developed&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;licenses,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;biomarkers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;databases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;software&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Jan 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,502&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,010&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,534&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,717&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,040&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,657&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deconsolidation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (151)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (151)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 13,922&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 9,219&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,899&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 28,040&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 749&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,652&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 386&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,787&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (297)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 297&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,374&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,168&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,285&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 30,827&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated amortization and impairment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Jan 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,831&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,770&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,788&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,389&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Amortization and impairment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,917&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 943&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 508&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,368&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deconsolidation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,748&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,713&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,172&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,633&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Amortization and impairment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,149&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,991&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,860&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (68)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 68&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,829&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,772&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,032&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,633&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amounts&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,174&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,506&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,727&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,407&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,545&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,396&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,253&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 9,194&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;*&#160;&#160;&#160;&#160;&#160;The net reclassification of EUR 229&lt;span style="white-space:pre-wrap;"&gt;k from internally generated biomarkers to internally developed databases represents internal costs incurred in the process of developing internal IT driven solutions on biomarkers.  Reclassification is made to allow more transparent presentation considering this is more in line with each sub-group of intangible assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Development costs and amortization&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Internally generated intangible assets include capitalized development costs for biomarkers and IT driven solutions such as CentoPortal, CentoMetabolome and CentoMD (see notes&#160;5 and 6 regarding measurement). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The amortization of patents, trademarks and development costs is expensed and recorded under &#x201c;cost of sales&#x201d; to the extent the related intangible asset are used in generating revenue and recorded in research and development expenses to the extent the related intangible assets are used for R&amp;amp;D purposes.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;As of December 31, 2021, certain identified biomarkers and internally developed databases amounting to EUR 1.1 million (2020: EUR 4.7 million) were impaired as part of the Company&#x2019;s strategy reassessment which occurred in Q4 2021. The impairment is expensed under cost of sales and included in amortization and impairment expense in the Pharma segment.&lt;/p&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_O07tOhJ-HEWAjyCrm6psgw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Internally&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;generated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Internally&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Purchased&#160;rights,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;/acquired&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;developed&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;licenses,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;biomarkers&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;databases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;software&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Jan 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,502&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,010&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,534&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,717&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,040&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,657&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deconsolidation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (151)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (151)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 13,922&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 9,219&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,899&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 28,040&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 749&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,652&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 386&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,787&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (297)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 297&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,374&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,168&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,285&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 30,827&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated amortization and impairment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Jan 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,831&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,770&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,788&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,389&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Amortization and impairment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,917&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 943&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 508&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,368&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deconsolidation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,748&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,713&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,172&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,633&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Amortization and impairment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,149&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,991&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,860&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (68)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 68&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,829&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,772&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,032&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,633&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amounts&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,174&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,506&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,727&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,407&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,545&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,396&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,253&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 9,194&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;*&#160;&#160;&#160;&#160;&#160;The net reclassification of EUR 229&lt;span style="white-space:pre-wrap;"&gt;k from internally generated biomarkers to internally developed databases represents internal costs incurred in the process of developing internal IT driven solutions on biomarkers.  Reclassification is made to allow more transparent presentation considering this is more in line with each sub-group of intangible assets.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_KXY4hB06pEyeR-sh2ouA0A"
      decimals="-3"
      id="Tc_WCLwihjs20e_WYahst8waw_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12022000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_b6v3zHDw4ki2KCugNSJoWQ"
      decimals="-3"
      id="Tc_c7DJ2MUysU6L_JqghSA1Zw_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6502000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_dYyKiaYqrE-5cSLRxZqoFg"
      decimals="-3"
      id="Tc_SppHi0s1b0-oqTHUuPlcbQ_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3010000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_52eSLkL1IEKzP0P0QbaXNg"
      decimals="-3"
      id="Tc_DI0vHbcZlU2ZVwf-C2TY8w_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21534000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_JX-s2F9e10SlNE7SMW4K0Q"
      decimals="-3"
      id="Tc_z-K3eZzd_kCvG7FFfMBhrg_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1900000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_78Nr_Jks_0OKR7JkB9K_fQ"
      decimals="-3"
      id="Tc_4I0fwiK2m0GlfVvF0ZW_Lg_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2717000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_o6x3iNUNZEKJCglE3V0-6w"
      decimals="-3"
      id="Tc_9hBrCCHd0UKFOnhKGMs20Q_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2040000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g"
      decimals="-3"
      id="Tc_uuoDkseYfUSWS5fP4Qbozg_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6657000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_o6x3iNUNZEKJCglE3V0-6w"
      decimals="-3"
      id="Tc_Oj1blNctVEqs2rHVlRAcHA_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">151000</cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill>
    <cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g"
      decimals="-3"
      id="Tc_ryBVcDVlB0i2zQThCZuBqA_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">151000</cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Zn-0UMVx3E2y3vqaDMW_5w"
      decimals="-3"
      id="Tc_UP9UxDbijEiHojBGzH4Udw_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">13922000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_Z8byyXazL0CZp8NK1au0EA"
      decimals="-3"
      id="Tc_HrNN6Wem_0yUib8XiKlBNA_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9219000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_t3uvbKfeMUqBA08LcKFV-g"
      decimals="-3"
      id="Tc_LdXcudwULU6O5WHxnOgDmA_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4899000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_DVwpaAKq20WetXOFxByNKQ"
      decimals="-3"
      id="Tc_U8aZvKyjsE6qnyvutHZxUQ_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">28040000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5hTATt8HAUSJCLPDnOCGvg"
      decimals="-3"
      id="Tc_3eQx68o9bUWT36gWHdL_kg_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">749000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_dcozlUxUTEm0gw3SLkH3-w"
      decimals="-3"
      id="Tc_yGZ3ipngnke-z1Sk-906Fw_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1652000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_8tdZRFUyHUy1cqWB5uPVCA"
      decimals="-3"
      id="Tc_meV1A7WJMk62pcABhuYkmQ_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">386000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A"
      decimals="-3"
      id="Tc_tYGGWa5Bh0aQ94xJe2bf8Q_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2787000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5hTATt8HAUSJCLPDnOCGvg"
      decimals="-3"
      id="Tc_GLakr7ufn0CLqSO6gutvmA_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">297000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_dcozlUxUTEm0gw3SLkH3-w"
      decimals="-3"
      id="Tc_2TSMHcpON06KNTeWkW8ODg_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-297000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_tFtzIuvOnk6eFcAYgKYnZA"
      decimals="-3"
      id="Tc_MagL1XQcS0K3k4KVY1m63Q_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14374000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_uYV506SBMkuvBE_EZMSfgA"
      decimals="-3"
      id="Tc_Bm3Bc0vk7EeF7OhBcxYhCA_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11168000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_9Fb3pxnGaUSRHrSKjMx4ew"
      decimals="-3"
      id="Tc_sT1qZkyeb0iiLNrNx5jUcA_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5285000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_uGud5JzQG02kaS3Mgza75Q"
      decimals="-3"
      id="Tc_m5EblUlECEGoZrHsfVZSNA_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">30827000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_7xeJVhJvYUmbsnvDHQ8d3g"
      decimals="-3"
      id="Tc_seE_8EuCnU-9e6QQw41YUQ_15_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-3831000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_kHvSJAIc5Uy3c7q4gg9Klg"
      decimals="-3"
      id="Tc_uzfP_0cNbkW8sqkIRbNCpQ_15_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1770000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_-0qkA_V1Hk2dqGzpyUy7Dg"
      decimals="-3"
      id="Tc_n9jDKLEcGU2FN0Xe90RXcA_15_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1788000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_zDoz25BuFEmJyAnqcxNW5Q"
      decimals="-3"
      id="Tc_NehvDJeEzkq-F3E-0jtp-w_15_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-7389000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_1oxG-ulhZkewdx8UmyncDQ"
      decimals="-3"
      id="Tc_NRQJc2zVwk24SsxnV684iQ_16_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6917000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MkH40joHJkuDjye7-7vt4A"
      decimals="-3"
      id="Tc_849eESDRGU-s9E3SGAitXw_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">943000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_nUy4aXz07EqtEkGVtRBxvw"
      decimals="-3"
      id="Tc_qByIgCnClE2xVa04XLfXVA_16_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">508000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ"
      decimals="-3"
      id="Tc_Igb_qNlxMEmHJyucK2Sd8w_16_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8368000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_nUy4aXz07EqtEkGVtRBxvw"
      decimals="-3"
      id="Tc_2WFTaGO8K0uVnaJ7Bj4FQw_17_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">124000</cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill>
    <cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ"
      decimals="-3"
      id="Tc_8VeYMxbIe0GTbhZMOVBZRg_17_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">124000</cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_smkCz2ptokGCqin3TdKpUA"
      decimals="-3"
      id="Tc_3FKP3e6110CQrnbyjQxgVg_18_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-10748000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_PJiIvVIxGUC41eoN-l986A"
      decimals="-3"
      id="Tc_oZwDPBKL00CFBCvHDUmcQA_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2713000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VBSTmHETgUeIl7NqPr5fzw"
      decimals="-3"
      id="Tc__ajVkUUXI0KLv_fCCBXyjg_18_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2172000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_t6wM7AhQ-EmoLvKXt9OZvw"
      decimals="-3"
      id="Tc_1la73vlZt0esO5sqVz6s9Q_18_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-15633000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MYgrX_n3jkaDz1IqXgfPzQ"
      decimals="-3"
      id="Tc_udGnDsOQNUGMAKFOp8RdIQ_19_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2149000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_xEzYX8OnjUOMl3IAx5vk2w"
      decimals="-3"
      id="Tc_PFtFMbkp5U61JP4QyBG6qg_19_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1991000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_VMdLXHYHe0mBFblmw8jl9g"
      decimals="-3"
      id="Tc_I3lEKbEtDUuEIn0bcknYtQ_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1860000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw"
      decimals="-3"
      id="Tc_pxNU40m6ukiHlHAgf4o94g_19_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_MYgrX_n3jkaDz1IqXgfPzQ"
      decimals="-3"
      id="Tc_z2m7nTaYV0-VNI0qdm7vDg_20_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-68000</cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill>
    <cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_xEzYX8OnjUOMl3IAx5vk2w"
      decimals="-3"
      id="Tc_R3z23fXF00C_6ji9fg3XVw_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">68000</cntg:DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_5eaVP-7_1UKBsld_2DURNg"
      decimals="-3"
      id="Tc_30-t3BuHQEW7r1OMS1-V-g_21_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-12829000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_-D-lKyd0xUG2GJXr65MPdg"
      decimals="-3"
      id="Tc_qWYPiULVWUyS6vgMr94egQ_21_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-4772000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_cquxSQFt7EuMikBUJNV8XQ"
      decimals="-3"
      id="Tc_c_o9Q6gHwkiXnOMsHvMqhg_21_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-4032000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_nHe0IepNs0m-_JVwFYjKRg"
      decimals="-3"
      id="Tc_cQPkbcgLxEeTzauz5kP3Kw_21_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-21633000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_SRmpcImuLkKr7Mhauf75CA"
      decimals="-3"
      id="Tc_RastMsBV6kybqKuynxdahA_24_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3174000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_BYnxal9n_UyhTA2Zunv0qg"
      decimals="-3"
      id="Tc_WR48IqQs9UmExnpMb2T0Hw_24_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6506000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_3NmcgXK8lEOsvBWBRUv4vA"
      decimals="-3"
      id="Tc_2O5_4P8DH0W-FTN2Vm1_3A_24_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2727000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_z62Dud7JDEqg0-E4NWE5eQ_24_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12407000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_mCcyce8TbkO8Vgcxe5L8zw"
      decimals="-3"
      id="Tc_gfoeEIqir065bvaF2usHaA_25_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1545000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_4KIQ2EJM10KtGQbtSjZSUw"
      decimals="-3"
      id="Tc_8I5bx3EMZEGWx7lBMfDfDA_25_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6396000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_LicencesAndFranchisesMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_NotInternallyGeneratedMember_6ZxMHT3Ak06Btt3uetZikw"
      decimals="-3"
      id="Tc_iUYLLjDPkUWeU5kDJObJ1Q_25_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1253000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_qDiDC_1kbEWBM2H41QyRGg_25_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9194000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_DatabaseMember_ifrs-full_MethodsOfGenerationAxis_ifrs-full_InternallyGeneratedMember_vYQneCL0Uki_zA6xML9L3Q"
      decimals="-3"
      id="Narr_x6pSX-bON06FLrGP9X3Wnw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">229000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersAndDatabasesMember_z7T7AVbVWEqN5q7cJhF12Q"
      decimals="-5"
      id="Narr_JdodeRLmiEOe-OI-fGbhOQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1100000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_ZGElzQrWUEOol6UVTWtvWw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;12 Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Please refer to the following table for the development from January 1, 2020 to December 31, 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plant&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;and&#160;fixtures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;As of Jan 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,254&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,730&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,696&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,295&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,490&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,890&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (612)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (612)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,099&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,099&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,359&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,124&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,590&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 30,073&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 144&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,766&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,915&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (379)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (718)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,097)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,165&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,165&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,364&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,054&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,638&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 33,056&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation and impairment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;As of Jan 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,155&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,773&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,320&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 993&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,913&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (44)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (44)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,107&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 586&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,255&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,642&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 13,483&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,519&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,473&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,307&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (157)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (217)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (374)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 493&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 493&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 901&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,110&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,898&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,909&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amounts&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,773&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,869&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,948&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,590&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,463&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,944&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,740&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,147&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;*     The disposal relates to the sale of a CentoTruck as part of a contract with a COVID-19 customer&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;**   The disposal relates to various obsolete plant and machinery equipment mainly in relation to the ramp down of the COVID-19 business segment&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;*** The reclass from right-of-use assets represents assets purchased at the end of the lease.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Group prospectively adjusted the estimated useful lives of COVID-19 related property, plant and equipment to a remaining estimated useful life of eight months, with effect at the beginning of the third quarter 2021 due to management&#x2019;s decision to ramp down the COVID-19 business segment. This prospective change in estimate resulted in accelerated depreciation expense of EUR 4,138k for the year ended December 31, 2021. &lt;/p&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_Jgtu3lUEIUWc4gJhwf3ahA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plant&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;and&#160;fixtures&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;As of Jan 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,254&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,730&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,696&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,295&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,490&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,890&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (612)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (612)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,099&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,099&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,359&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,124&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,590&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 30,073&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 144&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,766&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,915&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (379)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (718)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,097)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,165&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,165&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,364&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,054&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,638&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 33,056&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation and impairment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;As of Jan 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,155&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,773&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,320&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 993&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,913&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (44)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (44)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,107&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 586&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,255&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,642&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 13,483&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,519&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,473&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,307&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposal**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (157)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (217)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (374)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclass from right-of-use assets***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 493&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 493&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 901&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,110&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,898&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,909&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amounts&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,773&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,869&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,948&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 16,590&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:47.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,463&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,944&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,740&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,147&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;*     The disposal relates to the sale of a CentoTruck as part of a contract with a COVID-19 customer&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;**   The disposal relates to various obsolete plant and machinery equipment mainly in relation to the ramp down of the COVID-19 business segment&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;*** The reclass from right-of-use assets represents assets purchased at the end of the lease.&lt;/p&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_YVVpLHmHuUCyVsz8RIAg9Q"
      decimals="-3"
      id="Tc_A4opH8uE5ku46dWk2_Oiww_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3254000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rBalwrMaEkicgxSJdYTFzQ"
      decimals="-3"
      id="Tc_qIWGsxnObkiymPik9iECPQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9730000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_9xS0NR0lGEmdKJ-O-1K3zQ"
      decimals="-3"
      id="Tc_oe9jd5HZtUG4S-sctzkDJQ_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4712000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_52eSLkL1IEKzP0P0QbaXNg"
      decimals="-3"
      id="Tc_KQAxuUh-xUeDTXZLHS1Ktg_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17696000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_5Ul6LbHt3Uml3dMdzr_SfQ"
      decimals="-3"
      id="Tc_DW9Wt46YqkmBkgPAiTcC8Q_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">105000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rZ2pIjWt-0-tbNOWGJRkUw"
      decimals="-3"
      id="Tc_3zNnXOn2lkG6J6doJ8UkvQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1295000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_JJuBkPLnakebKDZ6svlPTQ"
      decimals="-3"
      id="Tc_u7SdiEfY-E6LB7iFuuYp_w_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8490000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g"
      decimals="-3"
      id="Tc_iljyShE3kkWceH2mzrAuiw_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9890000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_JJuBkPLnakebKDZ6svlPTQ"
      decimals="-3"
      id="Tc_mhgTYlHNE0K-8nss16rEaQ_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">612000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g"
      decimals="-3"
      id="Tc_rLb2ElMph0C34RPNZv79Fg_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">612000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_rZ2pIjWt-0-tbNOWGJRkUw"
      decimals="-3"
      id="Tc_rIQ-iWfzs0aA-tezLlwKJw_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3099000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_8XNnNkSYmUetZ6xcxtoz0g"
      decimals="-3"
      id="Tc_UEId6O_Eqkq4_uK3w-3ILQ_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3099000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_pqgYMySFy0mCl4qrOYa00Q"
      decimals="-3"
      id="Tc_nIASkJe3B0KKCsoDEdtsHg_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3359000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_pDjbDgn5b0qPOlPHWmNdPQ"
      decimals="-3"
      id="Tc_rOTvqxgVP0e_knkrlME5pQ_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14124000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_yS6hjJywgUWf5TfLOUo9lQ"
      decimals="-3"
      id="Tc_hZMKLf1u_UKP3jRPIUth1w_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12590000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_DVwpaAKq20WetXOFxByNKQ"
      decimals="-3"
      id="Tc_UrvQGSYsqEqWqLcvo5fPFQ_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">30073000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jB3v8yGjV0Wzi4l46Yp0Ww"
      decimals="-3"
      id="Tc_bHEMSf3DmkSg2De0GtXMKQ_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg"
      decimals="-3"
      id="Tc_AGA4Bs0UqkaGsk1rQprwRw_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">144000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_a9m-Txeoa0yrNuKt2KsrgA"
      decimals="-3"
      id="Tc_7yfoU-omNkmnBZW_3n4GeQ_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2766000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A"
      decimals="-3"
      id="Tc_J8_TPGAeKUWDDyxMB0hPEg_11_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2915000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg"
      decimals="-3"
      id="Tc_3NQjF1EBREqYM34TZjEt1A_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">379000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_a9m-Txeoa0yrNuKt2KsrgA"
      decimals="-3"
      id="Tc_9Gvkn3V3O0WGztzODwfXUg_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">718000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A"
      decimals="-3"
      id="Tc_XVg6hfu8CE67YOWYirc69Q_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1097000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_kpRLVUj3dUCplvN3PklXLg"
      decimals="-3"
      id="Tc_kWN3G6EyW0CnwEk5G7s_dQ_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1165000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_woZhM1ci1k6aulEdJ8KD9A"
      decimals="-3"
      id="Tc__70NILmhA0yitYucgyUz4g_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1165000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_gykS6db5-UCUac4tLpVtSg"
      decimals="-3"
      id="Tc_gcIZFMqNxU-Kj9hvOfJHwA_14_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3364000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_cybCz_DIdUCl_xWyu3Pv8g"
      decimals="-3"
      id="Tc_uvOvjEDWJU2XsHKcdIvPTA_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15054000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_I8JCso4MK0qgaLEwIyMTbg"
      decimals="-3"
      id="Tc___mo3q4dP0WD0Wi5ad81Pg_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14638000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_uGud5JzQG02kaS3Mgza75Q"
      decimals="-3"
      id="Tc_ZoG-1jPKn0SzYNEDIAkxnA_14_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">33056000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_KLZzrB9iaka5B8A46KUKYA"
      decimals="-3"
      id="Tc_DwmQGUdw-EGwnA-CHDeV3g_17_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-392000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_bOr7Q08nUkCJL9UFD5xgEg"
      decimals="-3"
      id="Tc_BPPyxzmizEiJMcG5NfJc_A_17_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-6155000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_MPE_bAH260S1MVcfmAfdbg"
      decimals="-3"
      id="Tc_YSULlYwdyk-tpoyEdq3_Mw_17_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2773000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2019_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_zDoz25BuFEmJyAnqcxNW5Q"
      decimals="-3"
      id="Tc_tY7rNbRUF0Sx0Tm32n1rzw_17_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-9320000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_yBvnu7QHa0K2BszKcg5KZA"
      decimals="-3"
      id="Tc_swqeszqP40aTWWX15H0xLQ_18_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">194000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_LiVI1zychE6WlZz_18uRbw"
      decimals="-3"
      id="Tc_6H04yImEuUi59vnSx5DHrA_18_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">993000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember__luwaUE-_Ei_x9Oj9E5zMA"
      decimals="-3"
      id="Tc_3oOdePvIIE-wQdVCgqvTZQ_18_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1913000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ"
      decimals="-3"
      id="Tc_okmPVcJbwka8OHwnFJXn5w_18_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3100000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember__luwaUE-_Ei_x9Oj9E5zMA"
      decimals="-3"
      id="Tc_Rl4G1G_lZUygU-t1Z4LwRw_19_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-44000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ"
      decimals="-3"
      id="Tc_BlyNyKgXp0qw8_Gwa73qXA_19_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-44000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_LiVI1zychE6WlZz_18uRbw"
      decimals="-3"
      id="Tc_24L8DZng8U6bdd1JGtOcfQ_20_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1107000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_xKN7vgBwvEm8_rXx1KOKgQ"
      decimals="-3"
      id="Tc_FaM6KOnJPEGqsHvqGrv2tQ_20_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1107000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_-qbWr3ldhUuv7EtvkZChEQ"
      decimals="-3"
      id="Tc_j5G25t2sdEespmI0meI-og_21_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-586000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_2vB3kEQ9kke7ig8iaxIHWg"
      decimals="-3"
      id="Tc_uCeQZKTEtUG1pTCuNOFMaA_21_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-8255000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_-cmNgE1L_UWx4FtHzGHuYg"
      decimals="-3"
      id="Tc_egLto_vEKUu-oTHSZulTnw_21_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-4642000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_t6wM7AhQ-EmoLvKXt9OZvw"
      decimals="-3"
      id="Tc_0v6WxyxS9kOD9X2jBZmtRA_21_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-13483000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember__QDyppugek-Sh2NBifnpow"
      decimals="-3"
      id="Tc_N_agrjIb2EuJxD1KJZm_5w_22_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">315000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw"
      decimals="-3"
      id="Tc_O6_A5J2iwU-WfgG2xCCmYw_22_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3519000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_Wsje2nrQu02pAKwNiLBXBg"
      decimals="-3"
      id="Tc_9J1L_StY60-P_-gW-7Bmpg_22_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7473000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw"
      decimals="-3"
      id="Tc_NBH_Ptda20aheT3ya16UUg_22_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11307000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw"
      decimals="-3"
      id="Tc_6DekvPpLeEakoofTprwHMQ_23_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-157000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_Wsje2nrQu02pAKwNiLBXBg"
      decimals="-3"
      id="Tc_ZS_RuHPIZ0KDKR6Kni9fVQ_23_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-217000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw"
      decimals="-3"
      id="Tc_3lEoD3iE9UuqMDTpsgGvcA_23_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-374000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_hoLA6ksSqk2QKL0sxmyRIw"
      decimals="-3"
      id="Tc_LOGoXrtZSUG2WOtnXBByjQ_24_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-493000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_mHT6ZdRMvUWe678QvmWYNw"
      decimals="-3"
      id="Tc_0GV29zkdAkyv-UDBo_YJqA_24_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-493000</cntg:IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_lEC-E1pPPkKKZSA0ZSkDSw"
      decimals="-3"
      id="Tc_7yTQi-EoNEWXwOxQCIvMNA_25_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-901000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_edmJJe7tlEedyQZh-3w6bA"
      decimals="-3"
      id="Tc_DMGbzlKx9UWgY2BxyYoRMg_25_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-12110000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_fuZVkW08oEaKwXZ7YfUYkg"
      decimals="-3"
      id="Tc_E5HDknBXl0mOOdls3OSGxQ_25_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-11898000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_nHe0IepNs0m-_JVwFYjKRg"
      decimals="-3"
      id="Tc_FPCUfjA8EEKNtWOlhwlp6A_25_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-24909000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_jxm_mplIxEmZEcgIhg-8iQ"
      decimals="-3"
      id="Tc_s85zntYqL02W4gHcznFBUQ_28_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2773000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_PrcgwTEj0kWm_mcSL5ht7g"
      decimals="-3"
      id="Tc_-jykLyXQhEW2IBZ2gpmNjA_28_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5869000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_H9IaZfpHHEeg-x_U6Loa3Q"
      decimals="-3"
      id="Tc_-AGJI8xAgkGojTVOMfYBcQ_28_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7948000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_RwWmN_4E9kCwDtgdFaDTPw_28_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">16590000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_I6xfcf-C2UWRvm-kxsFGQg"
      decimals="-3"
      id="Tc_fp4kfCO-DU6OEWSfC8rwWQ_29_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2463000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_PlantMember_imxgf1UU7EmYdPJ5WDOOCQ"
      decimals="-3"
      id="Tc_u2REgqopHkW33Y_w-UOM7w_29_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2944000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherEquipmentFurnitureAndFixturesMember_bR_4j4cSckicZd6QmHkZiw"
      decimals="-3"
      id="Tc_qvCdYq7spUWdmtw3sQV7Bg_29_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2740000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_rQG6P-4TJU-Ae_dVavKcrg_29_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8147000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_6_30_2021_To_6_30_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_nqnnCqAqhkms8MmscboYow"
      id="Narr_k2_Fjk4HLEWp1W3ig99UNw">P8M</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_XKxkjhf3VUqUECgVbRF31w"
      decimals="-3"
      id="Narr_j8G0Cri8KUmh1EaLZTftOQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4138000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfLeasesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_KPfJ9M5OvE2CiAgY4ggk1w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.79;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;13 Right-of-use assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The Group has lease contracts for land and buildings and offices in Germany and the United States, as well as various items of plant, machinery, motor vehicles and other equipment used in its operations.  Leases for land and buildings is related to the sale and leaseback transaction of the Rostock headquarters building with a lease term of &lt;/span&gt;12 years, while the lease terms of offices in Berlin and Boston, Massachusetts are 12 years and 4 years respectively. Leases of plant and machinery and other equipment generally have lease terms between 2 and 4 years, while motor vehicles generally have lease terms of 3 years&lt;span style="white-space:pre-wrap;"&gt;. The Group&#x2019;s obligations under its leases are secured by the lessor&#x2019;s title to the leased assets. Generally, the Group is restricted from subleasing the leased assets.  In addition, a bank guarantee of EUR &lt;/span&gt;3,000k (which is secured by cash deposit of EUR 2,443&lt;span style="white-space:pre-wrap;"&gt;k) is required to be maintained for the leases of Rostock headquarters building and Berlin offices until the expiry or termination of the leases.  Leases of certain plant and machineries were also secured with rental deposits of EUR &lt;/span&gt;190k.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The lease contract of Rostock headquarters building includes extension options.  These options are negotiated by management to provide flexibility in managing the leased-asset portfolio and align with the Group&#x2019;s business needs.  The lease of Rostock headquarters building allows the Group to extend the rental contract &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_iUFcya4OnkmTbsk8Tv6XcQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;twice&lt;/span&gt;&lt;/span&gt;, each for a period of 6 years, after the expiration of agreement in September 2031 with rental payments of EUR 1,400&lt;span style="white-space:pre-wrap;"&gt;k per annum.  Such extension option was not included in the right-of-use assets and lease liabilities, as it is not reasonably certain that such extension option will be exercised.   &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group also has certain leases of motor vehicles and premises with lease terms of 12 months or less and leases of office equipment with low value. The Group applies the &#x2018;short-term lease&#x2019; and &#x2018;lease of low-value assets&#x2019; recognition exemptions for these leases. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Set out below are the carrying amounts of right-of-use assets and movements during the period:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plant&#160;and&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Motor&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings*&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Offices&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vehicles&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of January 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 13,126&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,407&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,989&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 390&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 20&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,932&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,112&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 37&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,840&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Reclass to property, plant &amp;amp; equipment**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,992)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,992)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,121)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (657)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,675)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (187)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (20)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,660)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,176&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,587&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,315&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,120&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 133&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,121&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,452&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Reclass to property, plant &amp;amp; equipment**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (672)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (672)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,121)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (970)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,745)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (138)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (22)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,996)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,884&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,339&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,291&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,356&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 34&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,904&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.79em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;*&#160;&#160;&#160;As the lease of land and buildings are made through one contract, all the related right-of-use assets are allocated to Buildings.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;** Reclass of leased assets to PP&amp;amp;E (note 12) represents purchased assets at the end of lease term. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Set out below are the carrying amounts of lease liabilities and the movements during the period:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of January 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,205&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,704&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,452&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,654&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,244)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,018)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,997&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,205&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,409&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,528&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 17,677&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The maturity analysis of lease liabilities is disclosed in note 21.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The following are the amounts recognised in profit or loss:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Depreciation expense of right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,996&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,660&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,807&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Interest expenses on lease liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 339&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Rent expenses&#x2014;short-term leases&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7,175&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Rent expense&#x2014;leases of low-value assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 33&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 25&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total amounts recognized in profit or loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,803&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,253&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,356&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Group had total cash outflows for leases of EUR 11,467k in 2021 (2020: EUR 6,746k; 2019: EUR 3,256k). The future cash outflows relating to non-cancellable short-term leases and leases of low-value assets, are disclosed in note 24.&lt;/p&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
    <cntg:LeaseTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q"
      id="Narr_DVul-qwNoU-IX9jISccCog">P12Y</cntg:LeaseTerm>
    <cntg:LeaseTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBerlinMember_PZ93SKoOakme1tsNGTWckg"
      id="Narr_5iITBTkSK0Soqx2elp0CzQ">P12Y</cntg:LeaseTerm>
    <cntg:LeaseTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesInBostonMember_uzMhEfk4nEWX7K-ikyO7JQ"
      id="Narr_14mI8B5sOEeHre5HQ10L0Q">P4Y</cntg:LeaseTerm>
    <cntg:LeaseTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_mQOuHcBww0qhWOVQnUs6Sg"
      id="Narr_8j_Uy10XH0Sr5dv2Ca956g">P2Y</cntg:LeaseTerm>
    <cntg:LeaseTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w"
      id="Narr_Tkdf_DYUeU29eeCd1TkVzA">P4Y</cntg:LeaseTerm>
    <cntg:LeaseTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ"
      id="Narr_9X7FroP1hUGjDT99X03Law">P3Y</cntg:LeaseTerm>
    <cntg:BankGuarantee
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_YXoCaUO5F0KnHQTBrV0F9A"
      decimals="-3"
      id="Narr_qQ6BYGnFpUOzHOR5AMAkgA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3000000</cntg:BankGuarantee>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingAndBerlinOfficesMember_YXoCaUO5F0KnHQTBrV0F9A"
      decimals="-3"
      id="Narr_agoz2Sxx5ESqPYHqVGtgJw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2443000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <cntg:RentalDeposits
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndMachineryMember_s1PTQMK510ykabqlfipOvQ"
      decimals="-3"
      id="Narr_3JMwUNWbME-J-e24dfj1rw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">190000</cntg:RentalDeposits>
    <cntg:LeaseExtensionTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q"
      id="Narr_f7b1TlMoxUGhEkgUQhtqBQ">P6Y</cntg:LeaseExtensionTerm>
    <ifrs-full:RentalExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q"
      decimals="-3"
      id="Narr_2ZpcXkHzjU2y7AK2ya-jwQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1400000</ifrs-full:RentalExpense>
    <cntg:LeaseTerm
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_GQnaSesZO02Ad6SmW22DGQ"
      id="Narr_uANWOZQDik-a8w2--V8TXA">P12M</cntg:LeaseTerm>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_n_ZGNv-qq0Oa4-1jGmR49Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plant&#160;and&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Motor&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings*&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Offices&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vehicles&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of January 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 13,126&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,407&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,989&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 390&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 20&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,932&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,112&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 37&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,840&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Reclass to property, plant &amp;amp; equipment**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,992)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,992)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,121)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (657)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,675)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (187)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (20)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,660)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 12,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,176&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,587&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,315&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,120&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 133&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,121&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,452&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Reclass to property, plant &amp;amp; equipment**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (672)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (672)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,121)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (970)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,745)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (138)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (22)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,996)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,884&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,339&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,291&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,356&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 34&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,904&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.79em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;*&#160;&#160;&#160;As the lease of land and buildings are made through one contract, all the related right-of-use assets are allocated to Buildings.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;** Reclass of leased assets to PP&amp;amp;E (note 12) represents purchased assets at the end of lease term. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_jzVLa-F6DkiRRjGQ1jjAxg"
      decimals="-3"
      id="Tc_TOD0VYIUOkSDqJgAhtrMQA_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">13126000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_-5Y_ZC3Cy06jqSRg2rkNWg"
      decimals="-3"
      id="Tc_-h2yv1fUskm4ujKkhQW6jg_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4407000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_8GUO8-vudkOK8pX-AcOLCA"
      decimals="-3"
      id="Tc_lB6MF5JEtUam1E_QVet6MQ_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6989000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_C-SoSBT-jUu6aB0HnuOW3g"
      decimals="-3"
      id="Tc_TMiAc3VwTESnCLL6uyPkVA_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">390000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_7LGAWQ8N8EWHfyuzxK-yzg"
      decimals="-3"
      id="Tc_UlsQFWellEehx36Fz2_HWw_4_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">20000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Tc_AoP6j5nOxUm5hblpIrL04A_4_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24932000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_COIkXqsq3EuSXQ8ccGnOYw"
      decimals="-3"
      id="Tc_4FePoV6JX0yASTitMDNzpg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">426000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow"
      decimals="-3"
      id="Tc_IkR9yLIEe0yXV5m3AEf9OA_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1265000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_06MXARpagUinzCDOWZ3Lzw"
      decimals="-3"
      id="Tc_spj7Du2TR02R95CjIOratg_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1112000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_OSY64BhwkUypKBgHktTxdA"
      decimals="-3"
      id="Tc__q7xwZETg0Kwx159zUZ8NA_5_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">37000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Jv-WfhEofE6qszWXSLBk-A_5_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2840000</ifrs-full:AdditionsToRightofuseAssets>
    <cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow"
      decimals="-3"
      id="Tc_pQAV6F2AJUyoSV3qWIeHqg_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1992000</cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment>
    <cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_uDWfmBMpQEG-_T0rx9HhNw_6_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1992000</cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Ws6ILO8IfUWKpcaFtKnMBQ"
      decimals="-3"
      id="Tc_cnFSIizzY06cpS7W6-TiTA_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1121000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_COIkXqsq3EuSXQ8ccGnOYw"
      decimals="-3"
      id="Tc_XGeWolCl_0-Th_b3bS-ReQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">657000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_pNtsEKk6MkiZLT1fVk2bow"
      decimals="-3"
      id="Tc_GjADpXGwm0mLkTQGA0uieg_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1675000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_06MXARpagUinzCDOWZ3Lzw"
      decimals="-3"
      id="Tc_mPBljKCmQ0qQFHaI53n03A_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">187000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_OSY64BhwkUypKBgHktTxdA"
      decimals="-3"
      id="Tc_VzN3G-Id0U6IB-NC0e4weQ_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">20000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Y4JZVzu5R0mKIlgJWijzlA_7_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3660000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_-k8208qQ10SHd_-JTl8E2Q"
      decimals="-3"
      id="Tc_kNNhtOH-iUqjzVF1WnXWsw_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12005000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_aKCHQwKnTkW-WicxuBEYgg"
      decimals="-3"
      id="Tc_EJgujLEgE0uPkmF6qeK-aQ_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4176000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_r79EEaTrbE2YzRa5xIlIIw"
      decimals="-3"
      id="Tc_cjIf6PG_30KCbGnhW79szA_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4587000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_cMFBX5CjWEKs38l_X26NEw"
      decimals="-3"
      id="Tc_KpjLJTKRQkedrQTwbKqqvQ_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1315000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_WHyj8PIaVEykw5TtSMGt3Q"
      decimals="-3"
      id="Tc_me1Hxnr9lUOtlAEHVJv_dg_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">37000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_31f8ZPCWekyiARFE5Vv0KA_8_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22120000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_mfxVmFR_xEyQeUhCH23gEQ"
      decimals="-3"
      id="Tc_CtGJy-nq8EmGnmFus7-Pkw_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">133000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw"
      decimals="-3"
      id="Tc_9UQd0CTawEKQ5P3K8NsFtw_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1121000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w"
      decimals="-3"
      id="Tc__QWuzJb_tEe3xlu_uvu3xw_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">179000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ"
      decimals="-3"
      id="Tc_TaBZADcJRUu0DjfBcweKLA_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_O3zIRmm9-kiwrJ2zczZF1Q_9_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1452000</ifrs-full:AdditionsToRightofuseAssets>
    <cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw"
      decimals="-3"
      id="Tc_kUCvT2nVC0OXwfo3SowPSw_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">672000</cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment>
    <cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_uV0HyL3Wb0aRrhU0NCgkhQ_10_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">672000</cntg:ReclassRightOfUseAssetsToPropertyPlantEquipment>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_u7fv_dcK-kmlAC640STiRQ"
      decimals="-3"
      id="Tc_38c4K7GNlEGlRnKcgAvB2g_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1121000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_mfxVmFR_xEyQeUhCH23gEQ"
      decimals="-3"
      id="Tc_jk49Sm9OpkiO1nw7Pii7NQ_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">970000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_dCN4wygPskWleQ9VdmjFPw"
      decimals="-3"
      id="Tc_gVcUhAdK6Eu3y3fOnQOZkQ_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1745000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_56lW2xNLGUSbRS1Az1Do8w"
      decimals="-3"
      id="Tc_DALg24qPSkCNhlojKywoxw_11_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">138000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_Ga7WQ0Mb80maSKQO2k2KOQ"
      decimals="-3"
      id="Tc_x2v73PqrGkuvJrMX6lSP9Q_11_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ZElEkkRjNE6MFeRjf0Fu_A_11_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3996000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_gr8iddTpHUKdwj10hqL1EA"
      decimals="-3"
      id="Tc_bjbvjqoQ20CfkqVeqCjxvA_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10884000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficesMember_y0Lzs-KudUaAjZAL7q9mYg"
      decimals="-3"
      id="Tc_Q3quzy0y80OBMHIeDER0XA_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3339000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_PlantAndEquipmentMember_Y0wjUE1Kn0Cww5TD7WEkoQ"
      decimals="-3"
      id="Tc_x8Z_H1I8lkSTpC2gGtziHw_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3291000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OtherEquipmentMember_yU8ydiLypEye2GvazPiV4w"
      decimals="-3"
      id="Tc_C3DT4saejUWcL_B9vlQMeQ_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1356000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_MotorVehiclesMember_DH-VjAVOi0q0q4n9FC79TA"
      decimals="-3"
      id="Tc_9saIT23wJEy3RGSq9S0Mxw_12_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">34000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_IM2zTj2yoEa6p2-04wFtjw_12_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18904000</ifrs-full:RightofuseAssets>
    <cntg:DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_4FQyH7Gvqka8HZrbMkT7ZQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of January 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,205&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,704&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,452&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,654&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,244)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,018)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,997&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 21,205&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,409&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,528&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 17,677&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory>
    <ifrs-full:LeaseLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc__6PMn3pGcUaQhkPSTcIPTg_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21205000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Tc_JacIAf1T5kKDJ-j4Muy1Bg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21704000</ifrs-full:LeaseLiabilities>
    <cntg:IncreaseThroughAdditionsLeaseLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_m-w-1rULJk2Xzhm1nY_4Tg_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1452000</cntg:IncreaseThroughAdditionsLeaseLiabilities>
    <cntg:IncreaseThroughAdditionsLeaseLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_aVFqKxPd_0mH66osK3BrBQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3654000</cntg:IncreaseThroughAdditionsLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_6-eLcSCsQU-yesW_ZQGhkw_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">584000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_cMg4tOk-dU-RqJ4qL2pVQA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">865000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <cntg:DecreaseThroughPaymentsLeaseLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_1K73IkC3O0eQevFuzwj78w_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4244000</cntg:DecreaseThroughPaymentsLeaseLiabilities>
    <cntg:DecreaseThroughPaymentsLeaseLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_D5WNBV8LlEutseZXecoeHQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5018000</cntg:DecreaseThroughPaymentsLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_TZ4ZZOwVzUy2vhHrizc-_w_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18997000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_sD0tFAcbZUalsecoSByv7A_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21205000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_S5JtMxDlC0CRFh9VtIyOsQ_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3409000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_YxgT12517kGrXWEmQNt-lQ_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3528000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_gl7d-JOGNUyJO7OVBBHNpg_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15588000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_B2ti329oPEid_Bgr4q1GjA_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17677000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_2LaOICDf-UWYGRvu2j0rFA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Depreciation expense of right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,996&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,660&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,807&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Interest expenses on lease liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 339&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Rent expenses&#x2014;short-term leases&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7,175&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Rent expense&#x2014;leases of low-value assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 33&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 25&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total amounts recognized in profit or loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,803&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,253&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,356&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_o5AyOhSDNEaqRbL6Hl2cOg_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3996000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_DsKCuwl6V02-5YzblpZ5Gw_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3660000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_ws9hnnGbKEqgAD5AUfq0hg_2_6"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">1807000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_PmHBy3Js70iXQqcdpFZDMw_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">584000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_wBFPwTkSYk-E_xrbdzUOkQ_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">865000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_IJgYZMp270KfpDNEfDmAig_3_6"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">339000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Bjr_Hbk7uE23rHmVpAZQBQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7175000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_i3UrikjR20-oUhfjVhTvEQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1695000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_SiX3BBeBNk6BsADAK5H6kQ_4_6"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">185000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_vN1NwbID2k-J5uMO2n9PeQ_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_ux-f9Z3G7UyjfQFMP882pA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">33000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_6uSjvmTYZkOKCn_PLHtT-A_5_6"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">25000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <cntg:TotalLeaseExpensesRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_mBwHgKo62068XCGLbII6Xw_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11803000</cntg:TotalLeaseExpensesRecognisedInProfitOrLoss>
    <cntg:TotalLeaseExpensesRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_rYu5B6DT3kKRA8z22QP0Pg_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6253000</cntg:TotalLeaseExpensesRecognisedInProfitOrLoss>
    <cntg:TotalLeaseExpensesRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_4xSu2RwkdUONxNRkbkNxHQ_6_6"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">2356000</cntg:TotalLeaseExpensesRecognisedInProfitOrLoss>
    <ifrs-full:CashOutflowForLeases
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_8Y5k8cAPq0W1Riru2hEv5Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11467000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_lVIHp779qUaKXqVBfX-plg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6746000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Narr_Bp8IDy_Ql0WhkEqr0PL43Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3256000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:DisclosureOfInventoriesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_jQKH3VTkI0-7a222FNUCqQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;14 Inventories&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Raw materials, consumables and supplies&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,831&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,167&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Finished goods and merchandise&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 238&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Inventories&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,869&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,405&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Management assessed inventory obsolescence on all COVID-19 related inventories which resulted in an inventory write-off included within cost of sales in the amount of &#x20ac; 1,795k (2020: nil).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;In the&#160;year ended December&#160;31, 2021, raw materials, consumables and changes in inventories of finished goods recorded as expenses under &#x201c;cost of sales&#x201d; came to EUR 70,089k (2020: EUR&#160;41,594k; 2019:&#160;EUR&#160;11,285k). &lt;/p&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
    <cntg:DisclosureOfInventoriesTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_a6AwE_1lrUiV8cG4iJvk5g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Raw materials, consumables and supplies&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,831&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,167&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Finished goods and merchandise&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 238&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Inventories&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,869&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11,405&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:DisclosureOfInventoriesTableTextBlock>
    <ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_PxUz52lFIUGZK2BNDaO3aQ_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3831000</ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies>
    <ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_mgZMJU8YF0SaY0Hbk9XLMA_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11167000</ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies>
    <ifrs-full:FinishedGoods
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_vpvcRPbcyk6qSd_s6Q29Sw_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">38000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_QxTIRyJhK0it3cD1iO6BxQ_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">238000</ifrs-full:FinishedGoods>
    <ifrs-full:Inventories
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_mWYmJRkmXUmZkh-G9X76QQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3869000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_vMnmpnNeQ0SzkbfO4dc-HQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11405000</ifrs-full:Inventories>
    <ifrs-full:InventoryWritedown2011
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_DIpD1aSnj0KjEbWoe__hsw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1795000</ifrs-full:InventoryWritedown2011>
    <ifrs-full:InventoryWritedown2011
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_nHibbpQwLU-HByekTll-Ew"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:InventoryWritedown2011>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_8Jo7f6VT3k6sHlJuB6X_vA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">70089000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_hSjMnFTq10WTU2iqTkUIFA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">41594000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Narr_k9Ds69_fFUaYNbFCjFsiDA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11285000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_GYPjuLeXWEGQAaILfhmBtQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;15 Trade and other receivables and other assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:93.5%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other assets&#x2014;Rental deposits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,922&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,867&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other assets&#x2014;Others&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,972&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,967&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 21,065&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 25,656&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,272&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,543&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,453&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,286&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 29,790&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37,485&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-size:11pt;font-weight:bold;"&gt;Total non-current and current trade and other receivables and other assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 32,762&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 39,452&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;"&gt;Other non-current assets&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The non-current portion of other assets mainly include cash deposit of EUR 2,250k, used to secure a bank guarantee of EUR&#160;3,000k, relating to the leases of Rostock headquarters building, cash deposits of EUR 193k, used to secure a bank guarantee of EUR 257k, relating to the leases of Berlin office, cash deposits of EUR 289&lt;span style="white-space:pre-wrap;"&gt;k relating to the leases of other offices and laboratories  located in Germany and EUR &lt;/span&gt;190k for the leases of certain plant and machineries. It also includes the non-current part of the consideration receivable for the sale of LPC of EUR 50k (see note 8.2). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;"&gt;Trade receivables&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Trade receivables are non-interest bearing and are generally due in &lt;span style="-sec-ix-hidden:Hidden_01i51NYs8kukTb1nNEXfkg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;30&lt;/span&gt;&lt;/span&gt; to 90 days. In general, portfolio-based expected credit loss allowances are recognized on trade receivables and contract assets (see note&#160;21.2). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Other current assets include VAT receivables of EUR&#160;253k (2020: EUR&#160;226k), prepaid expenses of EUR&#160;3,346k (2020:&#160;EUR&#160;4,431k), receivables related to exercised share-based payment grants of EUR 116k (2020; EUR 1,253k), receivables related to COVID-19 bank or credit card transactions of EUR 612k (2020: EUR 1,076k), as well as receivables from grants of EUR&#160;Nil (2020:&#160;EUR&#160;442k).&lt;i style="font-style:italic;"&gt; &lt;/i&gt;&lt;/p&gt;</cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_NxAHQLYKqUmoxzc024D-fQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:93.5%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other assets&#x2014;Rental deposits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,922&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,867&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other assets&#x2014;Others&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,972&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,967&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 21,065&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 25,656&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,272&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,543&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,453&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,286&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 29,790&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37,485&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-size:11pt;font-weight:bold;"&gt;Total non-current and current trade and other receivables and other assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 32,762&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 39,452&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <cntg:RentalDepositsNoncurrent
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_K8g4VQ-Uf0C_Y2tuitDFjw_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2922000</cntg:RentalDepositsNoncurrent>
    <cntg:RentalDepositsNoncurrent
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_Ai8g4HNpMEWYMlGn6-1BRA_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1867000</cntg:RentalDepositsNoncurrent>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_FzYkcSs43UeEHlyXwytPxw_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">50000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_juC6uvuZZk-yTX2CFLFLPg_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">100000</ifrs-full:OtherNoncurrentReceivables>
    <cntg:TradeAndOtherReceivablesAndOtherAssetsNoncurrent
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_jrw75RVplEanskSkTqlwew_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2972000</cntg:TradeAndOtherReceivablesAndOtherAssetsNoncurrent>
    <cntg:TradeAndOtherReceivablesAndOtherAssetsNoncurrent
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_zhjnQWHz9U-zNzVWngKpkA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1967000</cntg:TradeAndOtherReceivablesAndOtherAssetsNoncurrent>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_tttgsHDPWkCPbgUJsAGCgg_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21065000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_f9AxArUVekCvdvLRDD1gKQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">25656000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentContractAssets
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_Roxqwk9_o0iYLX_6sft3bw_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3272000</ifrs-full:CurrentContractAssets>
    <ifrs-full:CurrentContractAssets
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_BqAEJWKmHUinh5TlO3f2SQ_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3543000</ifrs-full:CurrentContractAssets>
    <cntg:OtherCurrentAssetsExcludingReceivablesDueFromShareholders
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_ZuzpDYdJA0WTXI8jFby0xA_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5453000</cntg:OtherCurrentAssetsExcludingReceivablesDueFromShareholders>
    <cntg:OtherCurrentAssetsExcludingReceivablesDueFromShareholders
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_4cqQIsJ3xEWJ6qadrlbqnQ_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8286000</cntg:OtherCurrentAssetsExcludingReceivablesDueFromShareholders>
    <cntg:TradeAndOtherReceivablesAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_fCN7p8QZjE2KavQ0XVgLzQ_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">29790000</cntg:TradeAndOtherReceivablesAndOtherAssetsCurrent>
    <cntg:TradeAndOtherReceivablesAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_oYGLnOB92EC796XSq9FiwA_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">37485000</cntg:TradeAndOtherReceivablesAndOtherAssetsCurrent>
    <cntg:TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_KgdvaJerE0GfOnTbiQ7RtQ_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">32762000</cntg:TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent>
    <cntg:TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_vivOn8R-pEG_IyXJCx__vg_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">39452000</cntg:TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_RostockHeadquartersBuildingMember_qSoBB62nPUyoN1idod-5Jg"
      decimals="-3"
      id="Narr_AY8VjJeOk0aQnIhPd8c3Ew"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2250000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <cntg:BankGuarantee
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_RostockHeadquartersBuildingMember_qSoBB62nPUyoN1idod-5Jg"
      decimals="-3"
      id="Narr_B5cYDpQ_WECqTIxGfUjfUw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3000000</cntg:BankGuarantee>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_BerlinOfficesMember_1-SX3GoaW06QetWW2MQe4Q"
      decimals="-3"
      id="Narr_NUuOBHzdYkGzQx02Gs6piA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">193000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <cntg:BankGuarantee
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_BerlinOfficesMember_1-SX3GoaW06QetWW2MQe4Q"
      decimals="-3"
      id="Narr_SsaLgMlGB0GrioxhM4yQJQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">257000</cntg:BankGuarantee>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_cntg_OtherOfficeAndLaboratoriesMember_OVbtCKe6kk-CtIPs5TAqeA"
      decimals="-3"
      id="Narr_LJig_czkYE2MFhHlrMPc_g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">289000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <cntg:RentalDepositsNoncurrent
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OtherPropertyPlantAndEquipmentMember_Chzm4i2edE6J2DMBM3190g"
      decimals="-3"
      id="Narr_phu7mduXZkaTVY8JouUd3A"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">190000</cntg:RentalDepositsNoncurrent>
    <cntg:ConsiderationReceivableForSaleOfLpc
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_ByAFGvd16EGpT4q2K6NblA"
      decimals="-3"
      id="Narr_BJaDW_H3UUm4yPPOfM3qVA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">50000</cntg:ConsiderationReceivableForSaleOfLpc>
    <cntg:ReceivablesPaymentTerms
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_nN1e1Q0e8kGM1jF00oCH2w"
      id="Narr_4548dG-J2ESKpOi2Yh4iQg">P90D</cntg:ReceivablesPaymentTerms>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q"
      decimals="-3"
      id="Narr_M2q5TWt2CUitjWilSK13sg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">253000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw"
      decimals="-3"
      id="Narr_XtWVDDLngEqiiWTDU7dw-g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">226000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q"
      decimals="-3"
      id="Narr_MIwom-loXkKMcUHftlU0Xw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3346000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw"
      decimals="-3"
      id="Narr_r6XGprE460OmckrPJnAD5Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4431000</ifrs-full:CurrentPrepaidExpenses>
    <cntg:CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q"
      decimals="-3"
      id="Narr_WQIN2K3qekCXYT2b_nxBcw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">116000</cntg:CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted>
    <cntg:CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw"
      decimals="-3"
      id="Narr_HF9yqAe9IEiqszYY_yjMPA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1253000</cntg:CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted>
    <cntg:CurrentReceivablesFromCovid19BankOrCreditCardTransactions
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q"
      decimals="-3"
      id="Narr_0P3ntA_dnkqMT76JFIIq9Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">612000</cntg:CurrentReceivablesFromCovid19BankOrCreditCardTransactions>
    <cntg:CurrentReceivablesFromCovid19BankOrCreditCardTransactions
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw"
      decimals="-3"
      id="Narr_ecKb2umnFkmsRvRzurq0uA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1076000</cntg:CurrentReceivablesFromCovid19BankOrCreditCardTransactions>
    <cntg:GrantsReceivables
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_FJSa844dWEqllSz6Yen56Q"
      decimals="-3"
      id="Narr_vLiR8ZW69U-m5d7I6TU20g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</cntg:GrantsReceivables>
    <cntg:GrantsReceivables
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OtherAssetsMember_WUR-aFJFI0u5LQoAFKkoLw"
      decimals="-3"
      id="Narr_ys6FIXFyLkOuiIzh4sb_DQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">442000</cntg:GrantsReceivables>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_qWa_yKiGzku6QVBOaepZeA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;16 Cash and short-term deposits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2021, the Group has pledged its short-term deposits with carrying amount of EUR 938k (2020: EUR 1,500k) and EUR 2,500k (2020: EUR 2,500k) respectively, to fulfil collateral requirements in respect of existing secured bank loan and overdraft facility up to EUR 2,500k. In addition, the Group has pledged its short-term deposits of EUR&#160;1,000k (2020: EUR 1,000k) related to two other overdraft facilities worth EUR 500k &lt;span style="-sec-ix-hidden:Hidden_SQJSZp5xzU-f4eqciOHicg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;each&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The restriction applying to the collateral may be terminated at any time subject to the full amount of the relevant bank loans and the overdrafts being repaid.&lt;/p&gt;</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_TE1FCKSJ10Wnq3AFudeGVQ"
      decimals="-3"
      id="Narr_V_IgYhoORkOKgvzZbxp5dg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">938000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_KNPG7ftQ40y3-jayGIuG_w"
      decimals="-3"
      id="Narr_UHCsIEclWEutIQA5A6DOYg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1500000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA"
      decimals="-3"
      id="Narr_Wi4g3sYqFki41PmpP44cRQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2500000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_M_ofTAJmRkyW0qYhKuCWYA"
      decimals="-3"
      id="Narr_G3uHKhH3x0idZDXlmed8Iw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2500000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA"
      decimals="-3"
      id="Narr_5Azu9p7vXES1CG9vqffEug"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2500000</cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity>
    <cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityOneMember_TFYrR_2rskuaSE4xcgV7KA"
      decimals="-3"
      id="Narr_eqkdEqx9_Uql7uLisBQO6g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2500000</cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_llexk3x_AUmw6uyZBIrKZg"
      decimals="-3"
      id="Narr_qVh9CaDi002jY7X1hLF1sA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1000000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_eAQrHbDIbE2JWeOzUkgTzQ"
      decimals="-3"
      id="Narr_GpHVpfEEu0mJS7WD1f7mBQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1000000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityTwoMember_z-vR9ah280KWInpHt2Pf-A"
      decimals="-3"
      id="Narr_NLuZhdgnfUGUSgaAHbB2dg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">500000</cntg:IfrsLineOfCreditFacilityMaximumBorrowingCapacity>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_e8GNH3iUCEeYvcRMOAyo_w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Equity and liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;17 Equity&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;Issued capital and capital reserve&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in thousands of shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Common shares as of Jan 1, fully paid&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,118&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19,861&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Issued shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Exercise of options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 450&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 256&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Common shares issued as of Dec 31, fully paid&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,568&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,118&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;as&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;as&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in thousands of shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Authorized common shares of EUR 0.12 each&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 79,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 79,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Common Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In July 2020, the Company completed a follow-on public offering of 3,500,000 common shares of the Company, consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of USD 14.00 per common share (i.e. EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR 22 million to the Company.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31 2021, 22,567,971 common shares of Centogene N.V. with a nominal value of EUR 0.12 were issued and fully paid up (2020: 22,117,643). As of December 31, 2021, the authorized, but unissued common share capital amounted to EUR 6,772k (2020: EUR 6,826k).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The holders of common shares are entitled to the Company's approved dividends and other distributions as may be declared from time to time by the Company, and is entitled to vote per share on all matters to be voted at the Company's annual general meetings.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Capital reserve&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2021, capital reserve included a share premium of EUR 106,665k (2020: EUR 107,498k), being amounts paid in by shareholders at the issuance of shares in excess of the par value of the shares issued, net of any transaction costs incurred for the share issuance.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The capital reserve consists of the share premium account and amounts recorded in respect of share-based payments. For additional information on the share-based payments, please refer to note&#160;20.&lt;/p&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_w1O19ysKPkixGezFlWnJ3g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in thousands of shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Common shares as of Jan 1, fully paid&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,118&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19,861&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Issued shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Exercise of options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 450&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 256&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Common shares issued as of Dec 31, fully paid&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,568&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 22,118&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;as&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;as&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in thousands of shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"&gt;Authorized common shares of EUR 0.12 each&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 79,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 79,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA"
      decimals="-3"
      id="Tc_v7A7NetO0UeU6yGdJOMY6w_2_2"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">22118000</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember__CSueLWvfkaKMbg97rwstw"
      decimals="-3"
      id="Tc_lbcnowgHU0G2IE348WK21w_2_4"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">19861000</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw"
      decimals="-3"
      id="Tc_W4v9z1sS6EOitCkdHfL1Bg_3_4"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">2000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <cntg:ExerciseOfOptionsShares
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ"
      decimals="-3"
      id="Tc_UqWB2AGw8UWQ2x6k91tZBg_4_2"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">450000</cntg:ExerciseOfOptionsShares>
    <cntg:ExerciseOfOptionsShares
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw"
      decimals="-3"
      id="Tc_i8vJW8YKwUyBeYcOA9PcAw_4_4"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">256000</cntg:ExerciseOfOptionsShares>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw"
      decimals="-3"
      id="Tc_QcE2hCHsiU6UobMvWavEQg_5_2"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">22568000</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA"
      decimals="-3"
      id="Tc_tTUxzRoHH0m82cuSmtRnkA_5_4"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">22118000</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA"
      decimals="2"
      id="Narr_nExfVi5yM06p0ttKKgQ84g"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw"
      decimals="2"
      id="Narr_O3iMfclVXkeJWwz2V1N_kg"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw"
      decimals="-3"
      id="Tc_vc2VmiAVw0uFVNbNFBNOAg_3_2"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">79000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA"
      decimals="-3"
      id="Tc_ACP5dWAcW06OslLl53Rvqg_3_4"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">79000000</ifrs-full:NumberOfSharesAuthorised>
    <cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA"
      decimals="INF"
      id="Narr_GC4pkn-rOUGvoCTv022lmg"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">3500000</cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_LRKY6gLhMEChXFAJqFrQYw"
      decimals="INF"
      id="Narr_3PJGmHN1C0eKXHdnp72rAQ"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">2000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <cntg:NumberOfCommonSharesOfferedByPriorShareholders
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA"
      decimals="INF"
      id="Narr_ErGmpvj3fkCaK9MeuNQJkg"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1500000</cntg:NumberOfCommonSharesOfferedByPriorShareholders>
    <cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA"
      decimals="2"
      id="Narr_LIl247JxjUGI--JvosdQxA"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">14.00</cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues>
    <cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA"
      decimals="2"
      id="Narr_LI-Lf14Bfk29YPEcUl2HqA"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.71</cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jVgw9A21PkCE2w-_tSjSGA"
      decimals="-6"
      id="Narr_Yo-DMXNOEkqp3f-wlRkAEg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22000000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw"
      decimals="INF"
      id="Narr_nS8nGZ3WpEWHLKcxJekD7A"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">22567971</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_AI56m3ztu024BcHUGojjfw"
      decimals="INF"
      id="Narr_JQcXhg5ewUGvactMzDngHw"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA"
      decimals="INF"
      id="Narr_Ctm8QfY6ZUaR7887v8kZww"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">22117643</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <cntg:AuthorizedButUnissuedShareCapital
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ"
      decimals="-3"
      id="Narr_rZg-vbCF7061UyWd0dygEw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6772000</cntg:AuthorizedButUnissuedShareCapital>
    <cntg:AuthorizedButUnissuedShareCapital
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_-cKQANlj3UKrbu-TKwCEjw"
      decimals="-3"
      id="Narr_aWQRXn3tFkWy2T24htl54g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6826000</cntg:AuthorizedButUnissuedShareCapital>
    <ifrs-full:SharePremium
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg"
      decimals="-3"
      id="Narr_7dHa0K-F-E686NK_1a9C3Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">106665000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_IIhLDRKibkmZBEcUkZh_LA"
      decimals="-3"
      id="Narr_m-V5GGJSiEaUhK7SH4_osw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">107498000</ifrs-full:SharePremium>
    <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_57KnDNeWO0iA3t_hyCLBCA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;18 Capital management&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group's objectives when managing capital are to safeguard the Company's ability to continue as a going concern and finance all necessary sustainable developments, so that it can continue to provide returns for shareholders and benefits for other stakeholders. In particular, care is taken and an optimal capital structure is strived for to reduce the cost of capital. With the IPO in November 2019, follow-on public offering of July 2020, warrant issuance and aggregate debt financing in February 2022, the Group is focused on achieving a healthy capital base to increase the confidence of investors and the capital market.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Group manages its capital structure and makes adjustments in light of changes in economic conditions and the risk characteristics of its activities. To maintain or adjust the capital structure, the Group may adjust the return to shareholders, issue new shares, or pay additional interests to reduce debt.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory>
    <ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_81DAHHNTVki3s4dSmdibrQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;19 Financial liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;19.1&lt;/b&gt;&lt;/span&gt;Interest-bearing loans&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non&#x2011;current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current loans&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; -&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 401&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,588&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,677&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,078&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total current loans&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,815&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,492&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,409&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,528&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,224&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current and current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,812&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 2021, short-term cash deposits of EUR&#160;938k (2020: EUR 1,500k) were used to secure the remaining bank loan outstanding (see note 16).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The following table is based on the original terms and conditions:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Conditions and statement of liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The outstanding interest-bearing loans as of December&#160;31, 2021 and 2020 have the following conditions:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nominal&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nominal&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nominal&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;interest&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Maturity&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Secured bank loan&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2.95%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2017&#x2011;22&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other bank loan&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;1%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2020-22&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;4.75%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;Rollover&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 498&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 498&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;3.75%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;Rollover&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,329&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,329&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 628&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 628&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;4.50%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;Rollover&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 482&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 482&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 412&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2.1%-3.5%*, 5.4%-9.1%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2017-31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,205&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total interest&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;bearing financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,812&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,812&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;*&#160;&#160;&#160;&#160;&#160;represents the incremental borrowing rate of the Group at the commencement of the leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The bank overdrafts of EUR 2,329k as of December 31, 2021 (2020: EUR 628k) were secured by short-term deposits with a carrying amount of EUR 2,500k (2020: EUR 2,500&lt;span style="white-space:pre-wrap;"&gt;k) (see note 16).  The other bank overdrafts of EUR &lt;/span&gt;981k (2020: EUR 910k) are secured over two short-term deposits with a carrying amount of EUR 500k each as at year end December 31, 2021 (see note 16). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;19.2&lt;/b&gt;&lt;/span&gt;Trade payables and other liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Government grants (deferred income)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,396&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,292&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,842&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,479&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Others&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,632&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,483&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Trade payables and other liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 40,122&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 59,990&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,028&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,950&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 32,094&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 51,040&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;Government grants mainly include investment-related government grants.  These were received for the purchase of certain items of property, plant and equipment for the research and development facilities in Mecklenburg-Western Pomerania, including the Rostock facility. The grants were issued in the form of investment subsidies as part of the joint federal and state program, &#x201c;Verbesserung der regionalen Wirtschaftsstruktur&#x201d; (improvement of the regional economic structure) in connection with funds from the European Regional Development Fund. Additional grants received during the year ended December 31, 2021 amounted to EUR &lt;/span&gt;168k (2020: EUR 390&lt;span style="white-space:pre-wrap;"&gt;k).  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;In addition, other liabilities include a provision for outstanding invoices of EUR 4,978k (2020: EUR 1,245k), personnel-related liabilities for vacation and bonuses totaling EUR 4,812k (2020: EUR 4,032k), a VAT payable of EUR 905k (2020: EUR 4,578k), as well as liabilities for wage and church tax of EUR 1,040k (2020: EUR 1,988k). &lt;/p&gt;</ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory>
    <ifrs-full:DisclosureOfBorrowingsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_Rclh6jKCw0u8d0Zd50ZQFg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non&#x2011;current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current loans&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; -&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 401&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,588&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,677&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,078&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total current loans&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,815&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,492&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,409&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,528&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,224&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current and current liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,812&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfBorrowingsExplanatory>
    <cntg:NonCurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g"
      decimals="-3"
      id="Tc_SNErCC6INU-VvmcR47jVOg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">401000</cntg:NonCurrentFinancialLiabilitiesInterestBearing>
    <cntg:NonCurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_5QwdsOAvnkeo5LIcezl3Dw"
      decimals="-3"
      id="Tc_ErqcLyLmHEuWjPJfdMZIvw_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">401000</cntg:NonCurrentFinancialLiabilitiesInterestBearing>
    <cntg:NonCurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw"
      decimals="-3"
      id="Tc_p4r9x3XWk0-nW2hutpT1gg_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15588000</cntg:NonCurrentFinancialLiabilitiesInterestBearing>
    <cntg:NonCurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ"
      decimals="-3"
      id="Tc_Xftml7P9zk2dwEq8-CZOXg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17677000</cntg:NonCurrentFinancialLiabilitiesInterestBearing>
    <cntg:NonCurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_vNPLT9UNs065TCdzsgfptw_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15588000</cntg:NonCurrentFinancialLiabilitiesInterestBearing>
    <cntg:NonCurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_9xuNGh_DxUW7gSYGQ2jzJw_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18078000</cntg:NonCurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_EVd8k1wgy0qJRv3QcJNjwg"
      decimals="-3"
      id="Tc_cDbrdNtf-0GrLTsZIRtlcQ_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">505000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g"
      decimals="-3"
      id="Tc_GUuxUf0ZfESeLHJf_dIE2A_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">567000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg"
      decimals="-3"
      id="Tc_Vx0h4SIOS0GdX8qdvb10RA_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">387000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_M1EU4d6N9kCphLDz7bVjpw"
      decimals="-3"
      id="Tc_6BJp_gKYl0i4wRY4lJ5VPw_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3310000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_IfrsBankOverdraftsMember_l-qjFsXgx02dSZIZxayWmA"
      decimals="-3"
      id="Tc_WrE-Mw6cHUSpo9QEh7QVdQ_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1538000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_D3CrI-gxmka4zS7T_IluDA"
      decimals="-3"
      id="Tc_b_jwtvKk5UGyX0qKoeeZaQ_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3815000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_BorrowingsByNameMember_5QwdsOAvnkeo5LIcezl3Dw"
      decimals="-3"
      id="Tc_sXhlxS2eOkyD_HDdWFBqEA_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2492000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw"
      decimals="-3"
      id="Tc_eDy5ku6jSkycUgTy_gPK7w_13_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3409000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ"
      decimals="-3"
      id="Tc_F8_330c4DUqUgs2csF704w_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3528000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_otc_S8aYYkS5mH0m5zGnRg_14_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7224000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:CurrentFinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_jK6dRf3hW0aDawEjADBrYg_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6020000</cntg:CurrentFinancialLiabilitiesInterestBearing>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_3rTw41ZQvUaBhE0RgSYMxg_16_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22812000</cntg:FinancialLiabilitiesInterestBearing>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_dufkgawG4U6-nEjZIauNEg_16_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24098000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_EVd8k1wgy0qJRv3QcJNjwg"
      decimals="-3"
      id="Narr_tuRneWNBrUWxJnoTYn7gfg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">938000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredCreditLinesMember_yzh0vCGDaUGw77DJSpv__g"
      decimals="-3"
      id="Narr_jiL92RAQTkqZYyYUTyoq6w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1500000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
    <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_LzMBW9gaz028Y5vBMkMS9A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nominal&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nominal&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nominal&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;interest&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Maturity&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Secured bank loan&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2.95%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2017&#x2011;22&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other bank loan&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;1%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2020-22&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;4.75%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;Rollover&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 498&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 498&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;3.75%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;Rollover&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,329&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,329&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 628&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 628&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;4.50%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;Rollover&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 482&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 482&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 412&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:20.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2.1%-3.5%*, 5.4%-9.1%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2017-31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,205&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:20.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total interest&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;bearing financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,812&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,812&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;*&#160;&#160;&#160;&#160;&#160;represents the incremental borrowing rate of the Group at the commencement of the leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg"
      decimals="4"
      id="Tc_IXE4rpUyvUiPPLB14HNk5g_4_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0295</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg"
      decimals="-3"
      id="Tc_rXm3DvGM8UiYyX6I9sKG5g_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">505000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_Psx5qU5_9k2yEHTNaD2Qrg"
      decimals="-3"
      id="Tc_-9PtfuZveE2APzH1aTl08g_4_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">505000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_B-4Za9jSeEuOpXOxxvEANg"
      decimals="-3"
      id="Tc_R3r1C_zoPUKav8kjMPlMJw_4_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">968000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember_B-4Za9jSeEuOpXOxxvEANg"
      decimals="-3"
      id="Tc_DDSHXiGqg0CcQCScFyT2KA_4_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">968000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_ZMDElsu6kkCNvAhR--AP0A"
      decimals="2"
      id="Tc_CpSvbO_z8k-NjSgQRfepvw_5_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.01</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg"
      decimals="-3"
      id="Tc_batS-sYagE-QDWp7TZ56Xw_5_12"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">387000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_OtherBankLoansMember_-qiUfAorrEetesEim7CdIg"
      decimals="-3"
      id="Tc_EmeDgqfzdkOaT-hjWhcmAA_5_14"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">387000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg"
      decimals="4"
      id="Tc_1RZx2UNrakKiw2XAP0SvyQ_6_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0475</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg"
      decimals="-3"
      id="Tc_FOpZtyxtE0qOTWIWz6ob1A_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">499000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Q9M2TPVmVUmht0v_gWPBXg"
      decimals="-3"
      id="Tc_hboJDQCbrEKkHYQUZV3Uow_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">499000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Bvjg5Ricb0CsHHRkM2oKiw"
      decimals="-3"
      id="Tc_UMmh-fVlJUaXgyo_FhTfvQ_6_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">498000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneMember_Bvjg5Ricb0CsHHRkM2oKiw"
      decimals="-3"
      id="Tc_11CaYxC55Eqli1Yj-Nwcrg_6_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">498000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw"
      decimals="4"
      id="Tc__YeMhL5bSkqLNnyoezwu_Q_7_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0375</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw"
      decimals="-3"
      id="Tc_kUkfI0jcKUaJ2oj3RiePDg_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2329000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw"
      decimals="-3"
      id="Tc_juEMvYRhw0uo6ZrieADZGw_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2329000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ"
      decimals="-3"
      id="Tc_PliM0JjAKkmUwZ2G-hrauQ_7_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">628000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ"
      decimals="-3"
      id="Tc_u3rOoyv3M0SpFAESNRELqw_7_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">628000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg"
      decimals="4"
      id="Tc_Espk9Rka1k-pARgLNkFZKQ_8_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0450</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg"
      decimals="-3"
      id="Tc_wHeCdmK4aE6S50Hl6XUBog_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">482000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_hARy7_TrfUCfciemFtKbhg"
      decimals="-3"
      id="Tc_FaPQ6blrsE6Vetk2AIEMbQ_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">482000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_tH9SKU_4CEueGcGPE4KKrA"
      decimals="-3"
      id="Tc_ieRBZnrvn0-1sihICW1_Og_8_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">412000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsThreeMember_tH9SKU_4CEueGcGPE4KKrA"
      decimals="-3"
      id="Tc_V4sGxEN0dUip11QR8MMY6Q_8_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">412000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_T7-iENiVYUyPsm2u4I6Pqw"
      decimals="3"
      id="Narr_v-cawZbRg0CKBl15LVoJrg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.021</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_1MoZEasurUyfu0ObaxOLFw"
      decimals="3"
      id="Narr_8plfUY1E8UqXa1RiIsmfdA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.035</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_T7-iENiVYUyPsm2u4I6Pqw"
      decimals="4"
      id="Narr_zMjPpdA_90m93DGYRANnZQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.054</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_1MoZEasurUyfu0ObaxOLFw"
      decimals="4"
      id="Narr_4iSjJVMcQEq197yCT4phKA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.091</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw"
      decimals="-3"
      id="Tc_6tjd6J6-50qX91bWKC21Iw_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18997000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_6r79SgpLM0WgGcVAcvoMYw"
      decimals="-3"
      id="Tc_4okpTuGiiUKz5deaOhahQQ_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18997000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ"
      decimals="-3"
      id="Tc_B9wwck9zp0e9_SOSUB7ntQ_9_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21205000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ifrs-full_LeaseLiabilitiesMember_vjcnao6lTU24r3Dg_n_fcQ"
      decimals="-3"
      id="Tc_yCU1kmokekmqliHJG1wugw_9_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21205000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_1UnOSBWM9E2epK4n800W-A_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22812000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_-Idw3JiLXUi2fL8FxvMkeA_10_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22812000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_IKcw2_7uvEm1b6LMo8yteg_10_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24098000</ifrs-full:NotionalAmount>
    <cntg:FinancialLiabilitiesInterestBearing
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_UW5OZHQ_yUGLise6LHigDQ_10_14"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24098000</cntg:FinancialLiabilitiesInterestBearing>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_bwllefsfY0G-rnQWLJ9HLw"
      decimals="-3"
      id="Narr_byYMEH6z5EyIdIGsGEovyw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2329000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsTwoMember_cSapgtAVKESDjJgiMUtmIQ"
      decimals="-3"
      id="Narr_m0ukmlUR1kyvQ4ZXljcZYw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">628000</ifrs-full:NotionalAmount>
    <cntg:ShortTermDepositsPledgedAsSecurityForLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_llexk3x_AUmw6uyZBIrKZg"
      decimals="-3"
      id="Narr_TMvURLSNZ0CXntRaZFK64w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2500000</cntg:ShortTermDepositsPledgedAsSecurityForLiabilities>
    <cntg:ShortTermDepositsPledgedAsSecurityForLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_eAQrHbDIbE2JWeOzUkgTzQ"
      decimals="-3"
      id="Narr_Qh1Vce5U_Em42sWAEgGAWw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2500000</cntg:ShortTermDepositsPledgedAsSecurityForLiabilities>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_DSJZa96GuEC5_0WXZ4BVag"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">981000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_Q1DbtLOZH0OX5G216yU_7A"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">910000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <cntg:ShortTermDepositsPledgedAsSecurityForLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_OverdraftFacilityMember_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cntg_BankOverdraftsOneAndThreeMember_1pwVmq3z50WQKX7nCXD94A"
      decimals="-3"
      id="Narr_NE0GII52302Zzk0_xWojOQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">500000</cntg:ShortTermDepositsPledgedAsSecurityForLiabilities>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_B9-X4_hQ30yoq6e1PKrQ0w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Government grants (deferred income)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,396&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,292&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contract liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,842&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,479&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Others&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,632&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,483&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Trade payables and other liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 40,122&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 59,990&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,028&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,950&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 32,094&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 51,040&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_r-CHEK_QPkWNFftEdWX5Jg_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11252000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_l9_q4upCWkWrMDKoNfkrxw_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31736000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:GovernmentGrants
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_b_Fy_aQzPk-x5h-T-IsQlw_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9396000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_DiCsJnkbbU6BeboOID5fEQ_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10292000</ifrs-full:GovernmentGrants>
    <ifrs-full:ContractLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_v4mfea3M_EGsI8nJaTeGGw_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4842000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_hYPQyHIBEUKGXkMpnsRl2A_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4479000</ifrs-full:ContractLiabilities>
    <cntg:TradeAndOtherPayablesOther
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_jXtmBRdiYEifjoUpoOe5zg_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14632000</cntg:TradeAndOtherPayablesOther>
    <cntg:TradeAndOtherPayablesOther
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_H1exWaB9OUWs-hvb6nwVtg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">13483000</cntg:TradeAndOtherPayablesOther>
    <ifrs-full:TradeAndOtherPayables
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_Y674ToFL6kG_B2Q38bxn_w_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40122000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_Wzk6zqe99UuFwgJjBxFOWg_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">59990000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:NoncurrentPayables
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_ABcJ1boxBUiCtGqOFAiz-A_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8028000</ifrs-full:NoncurrentPayables>
    <ifrs-full:NoncurrentPayables
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_4pgxwZBLb0SDu4nCeIGQIw_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8950000</ifrs-full:NoncurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_MS7rNAi-ukW7kslCFM99wQ_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">32094000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_5cIpFW0b6UeW-WLDhGDbQg_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">51040000</ifrs-full:TradeAndOtherCurrentPayables>
    <cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_HownMObnFEGjeTBeqXgvMg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">168000</cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_xKyztGeqck6141zz0AIeuQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">390000</cntg:IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cntg:ProvisionForOutstandingInvoices
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_wGZMYneIaUaHN9QUB0qPow"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4978000</cntg:ProvisionForOutstandingInvoices>
    <cntg:ProvisionForOutstandingInvoices
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_8Vk1MKi5eUasGBi7Jl21Dw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1245000</cntg:ProvisionForOutstandingInvoices>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_4OnQv4YpZEGujXHQFeV2Cw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4812000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_JZbEC-V61Uu22sFWgA-Zog"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4032000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:CurrentValueAddedTaxPayables
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_FwDNC3IfVUSthlNOdI3VDA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">905000</ifrs-full:CurrentValueAddedTaxPayables>
    <ifrs-full:CurrentValueAddedTaxPayables
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_aSLOpv7nd0yIeGkFKxFHQw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4578000</ifrs-full:CurrentValueAddedTaxPayables>
    <cntg:LiabilitiesForWageAndChurchTax
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_ez_gN1ZXhkuNYqcapve3dA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1040000</cntg:LiabilitiesForWageAndChurchTax>
    <cntg:LiabilitiesForWageAndChurchTax
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_IdzxW1q4CkCOzEOxT9EOAw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1988000</cntg:LiabilitiesForWageAndChurchTax>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_TQrIWtB550iFByrQD7hiTA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;20 Share-based payments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2021 and 2020, the Group had the following share-based payment arrangements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(i)&#160; Virtual share option program 2016 (cash-settled)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;On July&#160;&lt;span style="white-space:pre-wrap;"&gt;1, 2016, the Group established a virtual share option program (the &#x201c;2016 VSOP&#x201d;) under Centogene AG. The completion of IPO in November 2019 was defined as one of the &#x201c;exit events&#x201d; in the 2016 VSOP program.  Accordingly, all options &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;granted under the 2016 VSOP vested immediately in full upon the completion of the IPO. In addition, holders of vested options are entitled to receive a direct cash payment from the Company according to the calculation as stipulated in the program, which is determined based on the IPO price of the shares of Centogene N.V. and the exercise prices of the vested options The payment to the option holders will be reimbursed by the original shareholders of the Company at the same time as the obligation to pay the options holders arises.  Upon the completion of the July 2020 Offering, the relevant payments of EUR &lt;/span&gt;2,768k to the holders of vested options were settled by the proceeds received from such original shareholders from the sale of their shares.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(ii)&#160; 2019 Equity Incentive Plan (2019 Plan) &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In conjunction with the consummation of the IPO, the Company established a new long&#x2011;term incentive plan (the &#x201c;2019 Plan&#x201d;) with the purpose of advancing the interests of our shareholders and other stakeholders by enhancing our ability to attract, retain and motivate individuals who are expected to make important contributions to us. The 2019 Plan governs issuances of equity and equity&#x2011;based incentive awards from and after the consummation of the IPO. Awards under the 2019 Plan may be granted to our employees, the members of our management board and supervisory board, consultants or other advisors. As of January 1, 2022 the maximum number of common shares underlying awards that may be granted pursuant to the 2019 Plan (other than replacement awards) will not exceed 22% of the Company&#x2019;s issued share capital. Such maximum number will be increased on January&#160;1 of each calendar year, by an additional number of common shares equal to 3% of the Company&#x2019;s issued share capital on such date (or a lower number of common shares as determined by the management board or supervisory board, where appropriate on the basis of a recommendation of the compensation committee (as the case may be, as prescribed by the 2019 Plan and, collectively, the &#x201c;Committee&#x201d;)). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;In the event of a good leaver&#x2019;s (as defined in the 2019 Plan) termination of employment or service, all vested awards will be exercised or settled in accordance with their terms within a period specified by the Committee and all unvested awards will be cancelled automatically unless decided otherwise by the Committee. In the event of a bad leaver&#x2019;s (as defined in the 2019 Plan) termination of employment or service, all vested and unvested awards will be cancelled automatically without compensation.  Pursuant to an amendment to the 2019 Plan applicable to awards granted in the period between September 11, 2020 and November 25, 2020, unless otherwise determined by the Committee, in the event of a good leaver&#x2019;s termination of employment or service, all unvested awards will vest in full and all vested awards that have not yet been exercised or settled must be exercised or settled in accordance with their terms within a period specified by the Committee. If those awards are not exercised or settled within such period, they will be cancelled automatically without compensation. This arrangement is applicable to awards granted in the above-mentioned period only (see note 20(v)). &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In the event of a change in control of the Company (as defined in the 2019 Plan), outstanding awards that will be substituted or exchanged for equivalent replacement awards, in connection with the change in control will be cancelled. Outstanding rewards that are not substituted or exchanged for equivalent replacement awards, in connection with the change in control will immediately vest and settle in full, unless otherwise decided by the Committee.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The grants disclosed in the following paragraphs were granted under the 2019 Plan. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(iii)&#160; Equity share option - Replacement (ESOP/ VSOP 2017)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2017, the Group established another virtual share option program (the &#x201c;2017 VSOP&#x201d;) that entitled the management board to grant virtual share options to individuals, in regard to services they provide and their continuous commitment to the Group.&lt;b style="font-weight:bold;"&gt; &lt;/b&gt; As part of the corporate reorganization, in connection with the IPO (see note 1), a transfer agreement was entered into between the holders of options granted under the 2017 VSOP, Centogene AG and the Company in November 2019, according to which, the 2017 VSOP was terminated, and the option holders were instead granted new share options of the Centogene N.V. under the 2019 Plan (as defined and discussed above), determined based on the IPO price of the shares of Centogene N.V. and the number of options granted under the 2017 VSOP. These share options were issued to the holders of options originally granted under 2017 VSOP as part of the corporate reorganization to replace the cash-settled share-based program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The number of options granted to each holder was based on the number of options granted to them under 2017 VSOP and the IPO price of Centogene N.V. Accordingly, during 2019, 805,308 new share options were granted pursuant to the Centogene N.V. 2019 Plan, with each option representing the right to acquire one common share of Centogene N.V., with an exercise price equal to the &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;nominal value of a share of Centogene N.V., which is EUR 0.12&lt;span style="white-space:pre-wrap;"&gt;.  The options were considered vested upon the completion of the IPO, but were not exercisable in the first &lt;/span&gt;180 days after the IPO (lock-up period). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of January&#160;1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 549,005&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 805,308&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cancelled during the year &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (191,565)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (256,303)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 357,440&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 549,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 357,440&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 549,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercisable as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 357,440&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 549,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;During 2020, 256,303 options were exercised. The weighted average share price at the date of exercise was USD 12.13&lt;span style="white-space:pre-wrap;"&gt;.  During 2021, &lt;/span&gt;191,565 options were exercised. The weighted average share price at the date of exercise was USD 9.76.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The contractual term of the share options as of December 31, 2021 is eight years.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The share options issued under ESOP 2017 are equity-settled and the fair value of the options were recognized in equity under capital reserve on the date of grant.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;(iv)&lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;Equity share option 2019 (ESOP 2019) to Flemming Ornskov&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;In 2019, an agreement was entered into between the Company and Flemming Ornskov. According to this agreement, a total of &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;396,522&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; options, each option representing the right to acquire &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;one&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; common share, were granted pursuant to the 2019 Plan for his services as chairman of the supervisory board, with an exercise price equaling the IPO price, which is EUR &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;12.58&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; per share, on the date of the IPO of the Company. The vesting period was &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;three years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; commencing on March 31, 2019 as the grant date, during which &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;one&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;-third of the granted options would vest at the end of each year of grant.&lt;/span&gt; &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The contractual term of the share options as of December 31, 2019 was ten years and the weighted average fair value of options outstanding was EUR 9.08&lt;span style="white-space:pre-wrap;"&gt;.  The share options issued under &#x201c;ESOP 2019&#x201d; will be equity-settled and the fair value of the options were recognized in equity under capital reserve, based on the fair value on the date of grant, and will be charged to profit or loss over the vesting period using the graded approach. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On December 18, 2020, in an extraordinary general meeting of shareholders of Centogene N.V., the shareholders approved the grant of 300,000 restricted stock units (&#x201c;RSUs&#x201d;) to Flemming Ornskov under the 2019 Plan, which replaced the ESOP 2019 and pursuant to which Flemming Ornskov will forfeit the options awarded to him thereunder in exchange for the RSUs granted to him. The RSUs will expire after ten years, will not be subject to any other performance criteria, will have no exercise price and will be settled in shares. With respect to the RSUs granted: &lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;1.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;33%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; will vest immediately;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;2.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;the remaining &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;67%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; will vest in two equal annual instalments on each relevant anniversary of October 1 following the date of grant; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;3.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;will vest in full upon the occurrence of a change in control (as defined in the 2019 Plan), provided that the holder of the awards is an eligible participant (as defined in the 2019 Plan) on the date of such change in control.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP (EUR)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of January&#160;1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 396,522&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cancelled during the year &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (396,522)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Replacement awards granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 300,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 300,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 200,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 100,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercisable as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 200,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 100,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The replacement of the ESOP 2019 and the grant of new RSUs of Centogene N.V. was accounted for as modification under IFRS 2. The incremental fair value of EUR 135k has been recorded in the statement of comprehensive income over the vesting period of the replacement grant.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(v)&#160;2020 grants to management board and employees&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;On September 11, 2020, the Supervisory Board granted members of the management board the following options and&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;RSUs under the 2019 Plan:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:35.45pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.45pt;padding:0pt;"&gt;a.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;to the Company&#x2019;s former CEO Arndt Rolfs: 36,175 Options and 72,350 RSUs;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:35.45pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.45pt;padding:0pt;"&gt;b.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;to the Company&#x2019;s former CFO Richard Stoffelen: 16,250 Options and 32,250 RSUs; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:35.3pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:35.3pt;padding:0pt;"&gt;c.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;to the Company&#x2019;s CIO Volkmar Weckesser: 15,000 Options and 30,000 RSUs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On September 11, 2020, the management board granted 87,500 options and 75,000 RSUs to other key current and former executive officers under the 2019 Plan. On October 15, 2020, 251,500 RSUs were granted to employees, subject to the terms of the 2019 Plan, the applicable award agreement and the terms specified in the authorization from the Supervisory Board for this purpose. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Apart from one award that immediately vested in full on the grant date and another award that vests in three equal tranches on each anniversary of its date of first employment, all other awards referred to above will vest in three equal tranches from January 1 following the grant date, in accordance with the following vesting schedule:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_Di3UQRQ2MUWSk55FplrgzQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;one&lt;/span&gt;&lt;/span&gt; third of the award vests on January 1, 2021;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;ii.&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_lq4xIkppPkuJR_e8mjx1ZA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;one&lt;/span&gt;&lt;/span&gt; third of the award vests on January 1, 2022; and&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;iii.&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_EQTkAO2Ni02-Mndxnfpk_A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;one&lt;/span&gt;&lt;/span&gt; third of the award vests on January 1, 2023.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;All of the foregoing awards vest in full when the participant is considered to be a good leaver within the meaning of the 2019 Plan effective as of grant date, as discussed in note 20(ii). As a result, unrecognized costs related to any unvested part of the award of a good leaver will result in accelerated recognition of these unrecognized costs in the statement of comprehensive income in the period when the employment contract has been terminated. Furthermore, all of the foregoing awards vest upon the occurrence of a change of control as defined by the 2019 Plan, unless the holder is no longer eligible to participate in the 2019 Plan at that time.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The options referred to above vest only if the 20 trading day volume-weighted average stock price of the Company&#x2019;s shares preceding the vesting date of each tranche exceeds the exercise price of USD 11.60. This hurdle is considered a market condition. Therefore, expenses would not be reversed, if the tranches do not ultimately vest. As the &lt;span style="-sec-ix-hidden:Hidden_2x0a_zAG40CpBOwHDJxpzQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;20&lt;/span&gt;&lt;/span&gt; trading day volume-weighted average stock price did not exceed the exercise price as of January 1, 2022, the second tranche did not vest on January 1, 2022. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(vi)&#160; 2021 grants to management board and employees&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;During the year ended December 31, 2021 the following awards were granted under 2019 Plan:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Award Type (2019 Plan)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:16.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Market/ Performance Based&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&lt;br/&gt;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;Vesting Conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number of Awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting Conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expiration Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 95,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Four equal tranches over a four-year period, starting January 1, 2022, April 1, 2022 or on each anniversary of the grant date&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_j7I3SlyuWU6KYGVcxzrMkg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 30,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Three equal tranches over a three-year period starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_YStt1HXTrUSZGYMRD2aLHg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Three equal tranches of which the first tranche vested immediately and the two remaining annual tranches will vest starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_YVS6AVoIeUKeeejiDsF3JA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 22,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Four equal tranches over a four-year period, starting October 1, 2022 on each anniversary of the grant date&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_AdWcPoKHd0iDW7odOEhQgg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;Yes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Three equal tranches over a three-year period starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_HW0l6QwPxEehXDxtNMXdTA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 3,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Four equal tranches over a four-year period starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_y1wywXdbVUOTeWK6mrdN-A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The grant date fair value of these grants will be recognized in profit or loss over the service period by using the graded approach. 15,000 of the options referred to above vest only if the 20 trading day volume-weighted average stock price of the Company&#x2019;s shares preceding the vesting date of each tranche exceeds the exercise price of US$ 12.52. This hurdle is considered a market condition. Therefore, expenses would not be reversed, if the tranches do not ultimately vest. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The RSUs referred to above have no performance-based vesting criteria. Each RSU represents a right to receive a payment in cash or shares equal to the value of the RSU at the exercise date. The Company has a choice to settle either in cash, in shares or a combination thereof. In line with this policy, both types of awards are to be settled in shares and expire on the &lt;span style="-sec-ix-hidden:Hidden_YZDLiCDl6EqhXBUv-LZuNw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10&lt;/span&gt;&lt;/span&gt;th anniversary of the grant date. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(vii)&#160; 2020 grants to Dr. Andrin Oswald&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;In 2020, the Company and Mr. Oswald entered into an award agreement under the 2019 Plan pursuant to which Mr. Oswald will receive certain awards in the form of RSUs. According to the award agreement, a total of 324,000 RSUs were granted on December 1, 2020, subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF 1,000k after the grant date, which will vest in four equal annual installments following December 1, 2020, subject to Mr. Oswald&#x2019;s continued services with the Company and continued ownership of the a number of shares equal or higher than the number of purchased shares. On September 5, 2021 the Supervisory Board approved an amendment to this agreement. Under the amended award agreement, the RSUs vest in 14 equal quarterly installments following July 30, 2021 with final vesting date on December 1, 2024, subject to the purchase of ordinary shares of the Company on the open market in the amount of CHF 1,000k by June 30, 2022, and Mr. Oswald&#x2019;s continued services with the Company. Further, the RSUs will vest pro rata to the number of shares actually purchased up to the full investment amount of CHF 1,000k on each quarterly installment prior to the share purchase deadline and are subject to the continued ownership of a number of shares equal or higher than the pro rata number of shares actually purchased on each applicable vesting date or share purchase deadline. The amendment did not result in incremental fair value of the award. The grant date fair value shall be recognized in the statement of comprehensive loss over the remaining vesting period based on the modified vesting schedule using the graded approach&lt;span style="font-style:italic;font-weight:bold;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The RSUs referred to above have no performance-based vesting criteria. RSUs represent a right to receive a payment equal to the value of the RSU at the exercise date. All the RSUs will vest in four equal annual installments following the grant date, subject to &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Mr. Oswald&#x2019;s continued service with the Company as of the vesting date and will be charged to profit or loss over the period by using the graded approach.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Additionally, a total of 500,000 performance-based vesting RSUs were granted to Mr. Oswald on December 1, 2020, subject to the following conditions:&lt;/p&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"&gt;&lt;span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;"&gt;1.&lt;/span&gt;200,000 RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD 24 in any consecutive three month period prior to January 1, 2023 (for these RSUs, the &#x201c;initial vesting date&#x201d;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.&lt;/div&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"&gt;&lt;span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;"&gt;2.&lt;/span&gt;300,000 RSUs will vest if the applicable volume-weighted average stock price of the Company equals or exceeds USD 33 in any consecutive three month period prior to January 1, 2024 (for these RSUs, the &#x201c;initial vesting date&#x201d;). To the extent that this hurdle will not be met, these RSUs will be forfeited in their entirety.&lt;/div&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;The hurdle to the performance-vesting RSUs is considered a market condition. Therefore, expenses would not be reversed, if the market condition is not met. All the performance-vesting RSUs will vest in four equal annual installments following the relevant initial vesting date, if the applicable performance hurdles are met, and subject to Mr. Oswald&#x2019;s continued service with the Company as of the vesting date and will be charged to profit or loss over the vesting period using the graded approach. If Mr. Oswald&#x2019;s service with the Company terminates for any reason, any unvested RSUs will immediately be forfeited. The foregoing awards that have been granted vest in full upon the occurrence of a change in control as defined in the agreement, provided that Mr. Oswald is still eligible to participate in the 2019 Plan and in continuous service with the Company through the date of such change in control (see &#x201c;Note 27&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Subsequent Developments&#x201d; of our consolidated financial statements as of and for the year ended December 31, 2021).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#0000ff;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The contractual term of the RSUs is ten years from the respective grant dates. The RSUs issued are equity-settled. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;(viii)&#160; 2021 and 2020 supervisory board grants&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In connection to the IPO 10,000 Share Options have been granted as an extraordinary incentive to Mr. Berndt Modig as approved in the Annual General Meeting on June 24&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;, &lt;/sup&gt;2021. The Options have a strike price of USD 14 and getting vested in four equal installments following the grant date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2020, an agreement was entered into between the Company and Peer Schatz, as member of our supervisory board. According to this agreement, a total of 300,000 RSUs were granted pursuant to the 2019 Plan to Mr. Schatz. The RSUs will vest in four equal annual instalments on each relevant anniversary of November 25, 2020. The grant was approved in the Company&#x2019;s extraordinary general meeting of shareholders on December 18, 2020. The contractual term of the RSUs is ten years from grant date. The RSUs are not subject to performance criteria and will be settled in shares. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In the same extraordinary general meeting of shareholders on December 18, 2020, shareholders also approved a new incentive compensation scheme for supervisory board members, under which certain members of the supervisory board will annually receive an award of options and RSUs for ordinary shares of the Company under the 2019 Plan with a target value of EUR 80,000 multiplied by the LTI factor. For each award, RSUs will constitute 75% of the value of the award while options will constitute the remaining 25% of the value of the award. The LTI factor will be 100% or less based on the volume-weighted average stock price of the shares over a 60 trading day period preceding December 31 of the relevant financial year. Furthermore, the chairman and vice-chairman of the supervisory board will each annually receive an additional award with a value of EUR 60,000 and EUR 40,000, respectively, multiplied by the LTI factor as of the financial year 2023; the chairman of the audit committee and the chairman of the compensation committee will each annually receive an additional award with a value of EUR 40,000 and EUR 8,000, respectively, multiplied by the LTI factor. The awards will be granted retrospectively for the preceding financial year following the audit of the Company&#x2019;s annual accounts over such financial year, with the first annual awards to be granted in 2021 (in respect of the 2020 financial year). The awards will vest in four equal annual instalments on each relevant anniversary of the grant date, will expire on the ten-year anniversary of the grant date and are not subject to any performance criteria. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The options and RSU awards referred above have a service commencement date of December 18, 2020, based on when the understanding was reached between the Company and the holders regarding the required services to contribute to the achievement of &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;the long-term incentive targets. However, the grant date criteria for these awards will be met at each future annual grant date, upon the approval of the audited annual accounts, at such time when the terms and value of the awards to be granted become fixed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The foregoing awards are equity-settled and will vest in full upon the occurrence of a change in control as defined in the agreement, unless the holder is no longer eligible to participate in the plan at that time. The awards will be charged to profit or loss over the service period using the graded approach, pursuant to the equal annual vesting instalments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Additionally, in connection to this plan, Mr. Modig was granted 9,427 RSUs and 4,713 Share Options and Mr. Sheldon was granted 878 RSUs and 439 Share Options in 2021. The Options have a strike price of USD 9.92.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The awards will vest in four equal annual instalments on each relevant anniversary of the grant date and will vest in full upon a change in control of the Company (provided that the holder remains an eligible participant on the date of the change in control). The awards will expire on the ten-year anniversary of the grant date, are not subject to any performance criteria and will be settled in shares.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Valuation of Options&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Virtual share option program 2016 and 2017&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The fair values of the 2016 VSOP upon its exercise and 2017 VSOP upon its cancellation in 2019 were based on the cash payments to which the holders of the virtual options are entitled, which were calculated according to the formulae as stipulated in the respective programs.  The cash payment is with reference to the share price of Centogene N.V. at the date of IPO.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Equity share option 2017 and Equity share option 2019&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The fair values of ESOP 2017 and ESOP 2019 were estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions under which the share options were granted.  The model takes into account historical and expected dividends, and the share price volatility of other public companies in the relevant industries to predict the share performance.  There are no cash settlement alternatives for either the option holders or the Company.  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The key assumptions used to derive the option value are set out below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;ESOP 2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;ESOP 2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercise price (EUR)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share price at grant date (EUR)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Volatility (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk&#x2011;free interest rate (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.7)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.7)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Dividend yield (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Option term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Valuation of 2020 grants &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The fair value of the replacement awards granted to Flemming Ornskov under the 2019 Plan and the awards granted to other participants under the 2019 Plan in 2020 were estimated at the grant date. The fair value of the standard RSUs (i.e., those without performance-based vesting criteria) is based on the observed value of the underlying shares. As no dividend payments are expected over the vesting period, no further adjustment is required. The weighted average fair value of standard RSUs granted under the 2019 Plan during the year ended December 31, 2020 was USD 11.62.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The fair value of the ESOP 2019 replacement was estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions on which the options were granted. The fair value of the options and performance-based RSUs as of the grant date was determined using a Monte Carlo simulation model. The Monte Carlo simulation model utilizes &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;multiple input variables to estimate the probability that market conditions will be achieved. The key assumptions used to derive the option and performance-based RSUs value and the weighted average fair value are set out below: &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:37.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020 Fair Value assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;ESOP 2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Performance&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Replacement&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Based RSUs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11.60&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;n/a&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price at grant date (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12.02&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11.05&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12.54&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 88&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk&#x2011;free interest rate (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 0.8&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0.2-0.3&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected contractual life (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8.9&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;12.08-13.08&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Weighted average fair value (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12.02&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 6.20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8.23&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Valuation of 2021 grants &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;The fair value of the options granted to the Mr. Modig and Mr. Sheldon  was estimated at the date of grant using the Black-Scholes option pricing model, taking into account the terms and conditions on which the options were granted. In addition to that the fair value of the options granted to the Mr. Kim  was estimated at the date of modification also using the Black-Scholes option pricing model. The awards granted to participants under the 2019 Plan in 2021 were estimated at the grant date. The fair value of the standard RSUs (i.e., those without performance-based vesting criteria) is based on the observed value of the underlying shares. As no dividend payments are expected over the vesting period, no further adjustment is required. The weighted average fair value of standard RSUs granted under the 2019 Plan during the year ended December 31, 2021 was USD &lt;/span&gt;10.96. The key assumptions used to derive the option and performance-based RSUs value and the weighted average fair value are set out below: &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:43.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021 Fair Value assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Add. Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr. Modig and &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr. Modig&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr. Kim&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019 Plan&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr.Sheldon&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9.92&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 14.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.60&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price at grant date (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.01&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.01&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12.54&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk&#x2011;free interest rate (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.9&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected contractual life (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Weighted average fair value (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.45&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 8.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.36&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The expense recognized for the above share-based payment transactions during the year is shown in the following table: &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expenses arising from cash-settled share-based payment transactions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,714&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- 2016 VSOP&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 596&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- 2017 VSOP (2019: including modification gain)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,118&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expenses arising from equity-settled share-based payment transactions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 8,035&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,658&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 704&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- ESOP 2019, including replacement by RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 704&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- Grants to management board and employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,217&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- Grants to the CEO&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 269&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- Supervisory board grant&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 67&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total expenses arising from share&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;based payment transactions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,035&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,658&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,418&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <cntg:PaymentForSettlementOfStockOptions
      contextRef="Duration_7_1_2020_To_7_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_LUjbd8sTrEGlOUAQswnsuw"
      decimals="-3"
      id="Narr_ZhlVc0Rm70yhYqJIpzeGEw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2768000</cntg:PaymentForSettlementOfStockOptions>
    <cntg:SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants
      contextRef="Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw"
      decimals="2"
      id="Narr_QCC3g2vuA0OFV-PR2D-tag"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.22</cntg:SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants>
    <cntg:AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital
      contextRef="Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw"
      decimals="2"
      id="Narr_zJ2LPHQJxUea7Y--vcgYuA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.03</cntg:AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg"
      decimals="INF"
      id="Narr_Am_wCa6iC0GIiYv0shNH_Q"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">805308</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <cntg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg"
      decimals="INF"
      id="Narr_wHBophN4DU6aL5iB7WDUxg"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1</cntg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg"
      decimals="2"
      id="Narr_-8F_QYhOEU6YD7GUD5UCgg"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <cntg:LockUpPeriodSubsequentToCompletionOfInitialPublicOffering
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg"
      id="Narr_iRVofv-Nu0qeW-9XpZPvHQ">P180D</cntg:LockUpPeriodSubsequentToCompletionOfInitialPublicOffering>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      id="Tb_YaH8ceRrm0Ky7RFQZIiPRQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of January&#160;1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 549,005&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 805,308&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cancelled during the year &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (191,565)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (256,303)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 357,440&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 549,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 357,440&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 549,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercisable as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 357,440&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 549,005&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="INF"
      id="Tc_dNove82cp0CGLO5zNIEobg_3_2"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">549005</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="2"
      id="Tc_HjTaXMhYVkWTESmYsg1jdw_3_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_e7pwRt_d5Ey8miVUeDmHnQ"
      decimals="INF"
      id="Tc_52YFiGkVW0OqCg5mLIk-Tw_3_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">805308</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_e7pwRt_d5Ey8miVUeDmHnQ"
      decimals="2"
      id="Tc_vI5GvOCbIku3X4rLfHMkDg_3_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="2"
      id="Tc_T8SDgiOnzEq9JeF6-UzXZA_4_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA"
      decimals="2"
      id="Tc_fWsidVZhO0O1il74nkggRA_4_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"
      decimals="2"
      id="Tc_M8dcnfT7VECcCMsKUzV-pA_5_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="2"
      id="Tc_pdKFf6IpqEeY48_NQAarHA_5_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="INF"
      id="Tc_AT7kn4qSika81IVFngucww_6_2"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">191565</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="2"
      id="Tc_3qv-Zp_KBEi1aKHoZ68CNQ_6_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA"
      decimals="INF"
      id="Tc_OyHO9Uptq0O1qKhtiKvWWw_6_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">256303</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA"
      decimals="2"
      id="Tc_gng_PIY2UEOvr8uygM5NuQ_6_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"
      decimals="INF"
      id="Tc_h-hfQBkQaEapb-AlAKGZIQ_7_2"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">357440</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"
      decimals="2"
      id="Tc_VRfUUfxaL0WcMf7YrKvRJQ_7_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="INF"
      id="Tc_iFfhi9fFQ0OCy2kA1SG84w_7_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">549005</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="2"
      id="Tc_LAgfXVhttEi4IGuAgS9swQ_7_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"
      decimals="INF"
      id="Tc_hxYxBLj63EKNy1GjLeNLFw_8_2"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">357440</cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement>
    <cntg:WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"
      decimals="2"
      id="Tc_aUOO-aLlQUWTWDikE4QmyA_8_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</cntg:WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement>
    <cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="INF"
      id="Tc_EbuCrHe-M0-D38q0JuKdIA_8_6"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">549005</cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement>
    <cntg:WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="2"
      id="Tc_BhYBFXklBEqBhACF6d5_IA_8_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</cntg:WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"
      decimals="INF"
      id="Tc_Fqjp7_2Ij0GmKbqq7cXJzg_9_2"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">357440</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_gv9vtWbSHUa0_Wn38yQuGg"
      decimals="2"
      id="Tc_KhnQ5agUdk6K8uMdGoy0Rw_9_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="INF"
      id="Tc_odEs-CmFTEGkj5y9cY98Vw_9_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">549005</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_CclGTMzBIkO6K33i9_ot3A"
      decimals="2"
      id="Tc_h5iPqH9wNk-JXqOBZCrNTA_9_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA"
      decimals="INF"
      id="Narr_Nj16-3xlpUO_AZk5lBdQ6g"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">256303</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_fYTjWvCsb0awI8-g8qs2IA"
      decimals="2"
      id="Narr_XKwfJHQbMEuZl7VHV1VIbg"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">12.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="INF"
      id="Narr_SZWhPt5cME-6nFQl4-buZw"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">191565</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="2"
      id="Narr_-3PrERXhskq6YdKykpJSXg"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">9.76</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      id="Narr_TMom24coW0KS2dif2ckpSQ">P8Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ"
      decimals="INF"
      id="Narr_27tVEIT76kyaZ6QvlR45JA"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">396522</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <cntg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ"
      decimals="INF"
      id="Narr_DWhCQF0eQECWNRwG1YEHBA"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1</cntg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ"
      decimals="2"
      id="Narr_0DigrR_K4kqQpyFewhkgZg"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.58</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod
      contextRef="Duration_3_31_2019_To_3_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_3U_fG7sutUSP4d2rpl_g0w"
      id="Narr_wG9QEV5iFEK5qFu07NNzpw">P3Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_yHp9HDkOAUqv9rIC7hMWnQ"
      id="Narr_Zb8h6tWrckatccS4tRQypw">P10Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <cntg:WeightedAverageFairValueOfShareOptionsOutstanding
      contextRef="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_lo0H8n9Nq0O6cFGGChm3OA"
      decimals="2"
      id="Narr_TRjUSoJDxkeqOp5WlbO1_Q"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">9.08</cntg:WeightedAverageFairValueOfShareOptionsOutstanding>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_P4QuY9PyE0m3yFf7W6apMg"
      decimals="INF"
      id="Narr_zdWC3YBbNkGIoPzx90vfig"
      unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg">300000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_P4QuY9PyE0m3yFf7W6apMg"
      id="Narr_2QDODHxjjEKsl6SyJy1IYA">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_12_18_2020_To_12_18_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_PW37pFbf_ECSJNc8ERvHPg"
      decimals="INF"
      id="Narr_kLA14L8WQkyOyM4aFn3sMg"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GosQtpqEsUy9vxX2amQi1g"
      decimals="2"
      id="Narr_fBd1SX8v1UiVQvW7LMTQZA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.33</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedPaymentArrangementTrancheTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_SC_KXEUc3E6xppndc2mfrg"
      decimals="2"
      id="Narr_6n386dL_kkKgFWdT5qjGQA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.67</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      id="Tb_fTSBOfsvm065oMaYOItquQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP (EUR)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;WAEP&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of January&#160;1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 396,522&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cancelled during the year &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (396,522)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Replacement awards granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 300,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 300,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 200,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 100,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercisable as of December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 200,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 100,000&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA"
      decimals="INF"
      id="Tc_wMwUCttlRkaa7oWL-AqNWA_3_2"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">300000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_WYFrUDbkkUihIyr9HpBc4g"
      decimals="INF"
      id="Tc_fGJiOawZ_k2c-9ZMtY0o7Q_3_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">396522</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_WYFrUDbkkUihIyr9HpBc4g"
      decimals="2"
      id="Tc_WeLrkEw_702WqgZDDZuv8g_3_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.58</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <cntg:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ"
      decimals="INF"
      id="Tc_-6eXns3x6ECH-RuI8ka1uQ_4_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">396522</cntg:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA"
      decimals="2"
      id="Tc_KR4m-TlPGkSDepQAVKvgxA_4_8"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.58</cntg:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <cntg:NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ"
      decimals="INF"
      id="Tc_Hl90vTmhpkKqtGjdSZOxYg_5_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">300000</cntg:NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw"
      decimals="INF"
      id="Tc_cnPD8qHnh0adpD-n8-9PsA_8_2"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">300000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA"
      decimals="INF"
      id="Tc_bP4nkeiyRUaEZJ5BOerC_Q_8_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">300000</ifrs-full:NumberOfOutstandingShareOptions>
    <cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw"
      decimals="INF"
      id="Tc_bNu6uYT5zkiZMAFpmfT9ig_9_2"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">200000</cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement>
    <cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA"
      decimals="INF"
      id="Tc_bZ-e8gw9ZkOeAzUgZjB1Wg_9_6"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">100000</cntg:NumberOfShareOptionsVestedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_-4TfBxv9r06C5SPaLfkvQw"
      decimals="INF"
      id="Tc_Kpei5KgED0GlOlvzmehdkQ_10_2"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">200000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_2kTMSwxvd0WWfn9Rs1PYxA"
      decimals="INF"
      id="Tc_xTY6tS2b7Uql2O4Y6Cfs2Q_10_6"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">100000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="-3"
      id="Narr_rB54wt7ApU-4pIo0uScntw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">135000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_uNK3cJ2KukGhjB1H809MEg"
      decimals="INF"
      id="Narr_KQxIN9OyjUKLzTN8FXVh5Q"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">36175</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WUAkQyT5QUKI_CA2QFIqng"
      decimals="INF"
      id="Narr_a2bGsKk2U0WxjARcU-Xi7A"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">72350</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_I_CkDW4jyE2fLJmcucRgFA"
      decimals="INF"
      id="Narr_bZBGh6S6_ke6UYJqTTZl4Q"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">16250</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RzmMZK-ny0O74pah0YcM8w"
      decimals="INF"
      id="Narr_-ej1Fj0KAUiokCQmiSAq-Q"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">32250</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_kVJa9lQw5EeR7IQzDBa0jg"
      decimals="INF"
      id="Narr_SGpVE3SW-Uawtq2MJ64BKg"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">15000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChiefInformationOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_EYVETEm8qkGi1WMdtZbI0w"
      decimals="INF"
      id="Narr_avRlBuBJZUusgvsMyA9GaA"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">30000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Cm6rxbg5V02howDd6-HKiA"
      decimals="INF"
      id="Narr_I5ietvi4M0KvubF4xTNGhw"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">87500</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DtkVOppjHkWA1R9t0aDNNw"
      decimals="INF"
      id="Narr_DpJgpG76zkigVptANTm6lA"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">75000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_10_15_2020_To_10_15_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_V6gW_1JbeU2rr1ZWiZ89Tw"
      decimals="INF"
      id="Narr_4nMhsJovQ0yPqZtbe9LYRQ"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">251500</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:ThresholdTradingDays
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw"
      id="Narr_4EfkezdPzEyhUV5UpaxFgQ">P20D</cntg:ThresholdTradingDays>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_drUZawS6I0mIAbfReWeahw"
      decimals="2"
      id="Narr_Idpskh2iI0y4Esw4p7SX5g"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">11.60</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6yWOMiPRDECERNx2-xKf8w"
      id="Tb_HrK_vOvd5Ei-vWOLiq8dZQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Award Type (2019 Plan)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:16.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Market/ Performance Based&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&lt;br/&gt;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;Vesting Conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number of Awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting Conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expiration Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 95,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Four equal tranches over a four-year period, starting January 1, 2022, April 1, 2022 or on each anniversary of the grant date&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_j7I3SlyuWU6KYGVcxzrMkg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 30,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Three equal tranches over a three-year period starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_YStt1HXTrUSZGYMRD2aLHg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Three equal tranches of which the first tranche vested immediately and the two remaining annual tranches will vest starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_YVS6AVoIeUKeeejiDsF3JA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 22,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Four equal tranches over a four-year period, starting October 1, 2022 on each anniversary of the grant date&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_AdWcPoKHd0iDW7odOEhQgg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:16.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;Yes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:34.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Three equal tranches over a three-year period starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_HW0l6QwPxEehXDxtNMXdTA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;No&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt; 3,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:34.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Four equal tranches over a four-year period starting January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:1.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:23.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_y1wywXdbVUOTeWK6mrdN-A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;10th&lt;/span&gt;&lt;/span&gt; anniversary of Grant Date&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q"
      decimals="INF"
      id="Tc_UX-48ti_3USQLBTVUjWqUA_2_4"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">95499</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:NumberOfTranches
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q"
      decimals="0"
      id="Narr_3rVgj-GzYU2rCp9r19bN4A"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">4</cntg:NumberOfTranches>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedOneMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BVaskKW4yEyLJcy_JnED_Q"
      id="Narr_JT5I4ZtgKEOG9ew79wgmDw">P4Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg"
      decimals="INF"
      id="Tc_m7PoOqw3vUuW4wbIEFjONQ_3_4"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">30000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:NumberOfTranches
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg"
      decimals="0"
      id="Narr_9LqGBvbi9UqaCsgr69gKVA"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">3</cntg:NumberOfTranches>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Q3Au7p9MV0W0Q63X77iccg"
      id="Narr_hKFi-yAJTU-h22lkh4bf4A">P3Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg"
      decimals="INF"
      id="Tc__R_eHsuWKUavy9wnMKZYYA_4_4"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">15000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:NumberOfTranches
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedThreeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_J-F-KXMjYES-3Cai3_K5Pg"
      decimals="0"
      id="Narr_xFWf4stNDEK_UAxuwVcWcQ"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">3</cntg:NumberOfTranches>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow"
      decimals="INF"
      id="Tc_TRCScpLXX0ueIRx6JPt4Iw_5_4"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">22936</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:NumberOfTranches
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow"
      decimals="0"
      id="Narr_tyspVN7iqUOwH7JG0TpWSg"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">4</cntg:NumberOfTranches>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFourMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_YRw8gbD7iUiVFsru1oQcow"
      id="Narr__TZVmeg1lUKtzJPL5gsXHw">P4Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA"
      decimals="INF"
      id="Tc_p7m2lvwPqUqNTeESUzOJZA_6_4"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">15000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <cntg:NumberOfTranches
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA"
      decimals="0"
      id="Narr_33fwTOZB-EO0yLiBWy1xPA"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">3</cntg:NumberOfTranches>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA"
      id="Narr_bluO8PnwMEy6V3t-TT3Mfw">P3Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw"
      decimals="INF"
      id="Tc_gpgSHoPgDUWAbAx4UPa2eQ_7_4"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">3891</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:NumberOfTranches
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw"
      decimals="0"
      id="Narr_Wpe4WcN-y0CUpFLK0pN5tQ"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">4</cntg:NumberOfTranches>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_RsuGrantedFiveMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_TilwyhC4m0e6ps5QKJJBaw"
      id="Narr_JyHkg5U1xEiORD_NaXE8fg">P4Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA"
      decimals="0"
      id="Narr_vLjL-EvSzEC2RNYzgXU1MA"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">15000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <cntg:ThresholdTradingDays
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA"
      id="Narr_feUrPfWYgkq0h13SsJEHLg">P20D</cntg:ThresholdTradingDays>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_OptionsGrantedTwoMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DxxpVfXb2UyosiwtX1RCjA"
      decimals="2"
      id="Narr_vk7r6doJzEOyCID7egq2xA"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">12.52</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_5BgL8gvkB06Ow57f8rxdoQ"
      decimals="INF"
      id="Narr_rtpFNzyC6EebEKpQ0yPZVg"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">324000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments
      contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_5BgL8gvkB06Ow57f8rxdoQ"
      decimals="-3"
      id="Narr_SaoY48j9vUqHnUKSU8cExA"
      unitRef="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w">1000000</cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments>
    <cntg:NumberOfInstallments
      contextRef="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_tFCvLv4fB0W8h2vSoBrRIw"
      decimals="INF"
      id="Narr_vGWKh0IeDkupy3NcpCSeJg"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <cntg:NumberOfInstallments
      contextRef="As_Of_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_w5uFjzeAFkaVyynChFMU0g"
      decimals="INF"
      id="Narr_Se9FBfbMEkadVGUYXiclfw"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">14</cntg:NumberOfInstallments>
    <cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments
      contextRef="Duration_9_5_2021_To_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Wnp1O-SE3EaWTFbyh8ZNrw"
      decimals="-3"
      id="Narr_vghz6NonG06ixhQVrxKyMg"
      unitRef="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w">1000000</cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments>
    <cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments
      contextRef="Duration_9_5_2021_To_9_5_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Wnp1O-SE3EaWTFbyh8ZNrw"
      decimals="-3"
      id="Narr_AdOPaBywW0-1us04VPhjDg"
      unitRef="Unit_Standard_CHF_ySsAkuG64UavcWO9-bgV7w">1000000</cntg:ValueOfOrdinarySharesToBeIssuedShareBasedPayments>
    <cntg:NumberOfInstallments
      contextRef="As_Of_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_1v4SxiTooEOxh0OPstkkmg"
      decimals="INF"
      id="Narr_K-xxB-gLZkyxMosLWWF6wQ"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dLhT7Cmve0CdytDI3taX5Q"
      decimals="INF"
      id="Narr_Kp6EzzZOaUmkGU5DPuQAcQ"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">500000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_QxSd-SnvrUqPZtQeLpmFXg"
      decimals="INF"
      id="Narr_Yz_CSruBVUeNZXDdfkibtg"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">200000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <cntg:AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement
      contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member_QxSd-SnvrUqPZtQeLpmFXg"
      decimals="0"
      id="Narr_7cOLSgMle0Wbhw17TCGw_A"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">24</cntg:AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_wBoe6UcpT0q8rlfoh6cZ6w"
      decimals="INF"
      id="Narr_sahBKr3cmk6S-oyxIxfHjA"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">300000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <cntg:AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement
      contextRef="Duration_12_1_2020_To_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_StatementScenarioAxis_cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member_wBoe6UcpT0q8rlfoh6cZ6w"
      decimals="0"
      id="Narr_YxOAMr09bEOT-0bDc7rTGQ"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">33</cntg:AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement>
    <cntg:NumberOfInstallments
      contextRef="As_Of_12_1_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_WQu1wOdXfU6jJWFMBs7BmA"
      decimals="INF"
      id="Narr_tL4HBehor06rR-hC6A8AZw"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_FG-eKZsRE0Of78EHPSAZ_w"
      id="Narr_R1FYrr8HKkugkYFGO2ak-Q">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_6_24_2021_To_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_Lggp4PkrtEW3C7ZFnD1fIQ"
      decimals="INF"
      id="Narr_BdaZ4MMxkU2rksIQbB_V1w"
      unitRef="Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w">10000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <cntg:OptionsStrikePrice
      contextRef="As_Of_6_24_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_oC-Mfx2jaUiilWSjgsPQBA"
      decimals="0"
      id="Narr_CvaPxEK_DEaJmIP0wuR1wA"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">14</cntg:OptionsStrikePrice>
    <cntg:NumberOfInstallments
      contextRef="As_Of_6_25_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_sgqoRzpr6kyNzDY9rq2YQA"
      decimals="INF"
      id="Narr_FTEkK3kHdE-kNkbv7Wg3Mg"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_LCJaveMDmkGVp9ON5ZIyPw"
      decimals="INF"
      id="Narr_QVyVGH2hAUeyxq1GV664mA"
      unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg">300000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:NumberOfInstallments
      contextRef="As_Of_11_25_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_oVuQnUbma0GfMOyRtTtgqg"
      decimals="INF"
      id="Narr_Y41wyVT6k0KOHEVitb1AxQ"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_12_18_2020_To_12_18_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_PeerSchatzMember_6lvAjzC9w0a-ExtvrVissA"
      id="Narr_58TwUE7ZxU2trEQmBoi1BA">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g"
      decimals="-3"
      id="Narr_rHKg6VgVB0mSXWOGUyhWSw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">80000000</cntg:ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement>
    <cntg:PercentageOfAwardConstitutesRestrictedStockUnits
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VugOHEd-30i25LugBEmvOw"
      decimals="2"
      id="Narr_9LbULMP4SEmMXrxN_YbTPQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.75</cntg:PercentageOfAwardConstitutesRestrictedStockUnits>
    <cntg:PercentageOfAwardConstitutesStockOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Jxfmi8_7z0KhYrUFcANEng"
      decimals="2"
      id="Narr_h86hj6mXVEOkT6YQsDhb4A"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.25</cntg:PercentageOfAwardConstitutesStockOptions>
    <cntg:MaximumLostTimeInjuryFactorShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g"
      decimals="INF"
      id="Narr_QYbkUqUGI0GGGMYpW3QVdA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</cntg:MaximumLostTimeInjuryFactorShareBasedPaymentArrangement>
    <cntg:VolumeWeightedAverageStockPriceComputationTradingDays
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g"
      id="Narr_BGoT1fAS-UmK7p6LgvajGg">P60D</cntg:VolumeWeightedAverageStockPriceComputationTradingDays>
    <cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_vuU72Kbpq0W86SjCUL5Wog"
      decimals="-3"
      id="Narr_6LWbmVPPNUuuvpFWQgzO5A"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">60000000</cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement>
    <cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ViceChairmanMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RRXiYNlkWkq3h07ypEAPTQ"
      decimals="-3"
      id="Narr_2t6p9n1sbkeZf4i0nD6r2A"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40000000</cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement>
    <cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfAuditCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Tb9WXS3-AUy4C6w9hUDAdw"
      decimals="-3"
      id="Narr_A5uSV1t_z0OJWWSHOsZB0g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40000000</cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement>
    <cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ChairmanOfCompensationCommitteeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_serqoK5ea0CVflGxqcVFGg"
      decimals="-3"
      id="Narr_C_jzIXVOs0WliQ-rbKf1ig"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8000000</cntg:ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement>
    <cntg:NumberOfInstallments
      contextRef="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6BAEvdBRvEWAG0lUbPv9tg"
      decimals="INF"
      id="Narr_j0iMczECHkKgPAk6KU-80A"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VugOHEd-30i25LugBEmvOw"
      id="Narr_LSySPZozWEO6G_sDkgluzA">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_cKZBZTR-hUKsYvIbDIFtyw"
      decimals="INF"
      id="Narr_tU8k9q-Zz0q4OHpspGebow"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">9427</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_NfDBPr_PCU-WeXMIEGto4Q"
      decimals="INF"
      id="Narr_xQmaksRLu0iM1UHlJl16pw"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">4713</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_ECxfpRaeB0icCiSqRrYWNQ"
      decimals="INF"
      id="Narr_vikfvIdvFk-4TLPTkR9y1w"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">878</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_srt_TitleOfIndividualAxis_cntg_MrJonathanGSheldonMember_scfLHvbOHEyhfw0eoqJLjQ"
      decimals="INF"
      id="Narr_S4tRSFJKoEqDK_ZNJtn7CA"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">439</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <cntg:OptionsStrikePrice
      contextRef="As_Of_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_mLSkDz_SwkeNhCK3FKDtYA"
      decimals="2"
      id="Narr_bF1ZNaRc_0yI3p7XrQcG6Q"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">9.92</cntg:OptionsStrikePrice>
    <cntg:NumberOfInstallments
      contextRef="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GI6jpuFNvkutlq0qWaVoUA"
      decimals="0"
      id="Narr_AdkMNyabo0qE55vkMnjAoQ"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g"
      id="Narr_3rO9ic9Oz0KMBhGQGmr0fw">P10Y</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ"
      id="Tb_jbMKzGSr-E2jhnsvtDsC3Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;ESOP 2017&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;ESOP 2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercise price (EUR)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share price at grant date (EUR)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12.58&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Volatility (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk&#x2011;free interest rate (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.7)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.7)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Dividend yield (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Option term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="2"
      id="Tc_WYwsuiDyMkGhW3r_INt0lg_3_2"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0.12</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="2"
      id="Tc_dnyDvbPD7UOpb7DZn5ZfUw_3_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.58</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="2"
      id="Tc_wAGpjVb-fE-aJv8qH_IhWA_4_2"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.58</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="2"
      id="Tc_vVheOBSkGk2X3QF1S06ATw_4_4"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.58</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="2"
      id="Tc_asOGfFS59kuR1IOldCaicA_5_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.70</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="2"
      id="Tc_0g5sVJHNbk-LHPDVVeU2VQ_5_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.70</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="3"
      id="Tc_Nhiy4zShskqMF5d6fvRMrw_6_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.007</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="3"
      id="Tc_gkLuAF6p5EGPHz2diVJZ9Q_6_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.007</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="2"
      id="Tc_NdDf16HekkOvfAz5iyLd7g_7_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="2"
      id="Tc_NXIg35pG60WOhsKdSsmNCQ_7_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_tEi4My1tuEyG2_PC1wDnAg"
      decimals="INF"
      id="Tc_KBYFPfyBv0qG7WjP7snUjw_8_2"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">10</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="INF"
      id="Tc_MLSv-kSNcUylj8JuRkGf1A_8_4"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">10</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_jzWpq6P7GkC8v17Iacya0g"
      decimals="2"
      id="Narr_aUbZiy5LP0OSlkqSuDbRxA"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">11.62</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_6yWOMiPRDECERNx2-xKf8w"
      id="Group_4dqvl66igkm_qZoArtz2YA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:37.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020 Fair Value assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;ESOP 2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Performance&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Replacement&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Based RSUs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11.60&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;n/a&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price at grant date (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12.02&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11.05&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12.54&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 88&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk&#x2011;free interest rate (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 0.8&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0.2-0.3&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:60.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected contractual life (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8.9&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;12.08-13.08&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Weighted average fair value (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12.02&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 6.20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8.23&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:43.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021 Fair Value assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Add. Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr. Modig and &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:11.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr. Modig&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr. Kim&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019 Plan&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Mr.Sheldon&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9.92&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 14.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11.60&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Share price at grant date (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.01&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.01&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 12.54&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Volatility (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 75&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk&#x2011;free interest rate (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1.9&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dividend yield (%)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:54.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected contractual life (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Weighted average fair value (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.45&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 8.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7.36&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <cntg:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"
      decimals="2"
      id="Tc_7qmxFQMMQk2EUq4uUCQkTQ_4_2"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">14.00</cntg:ExercisePriceOtherEquityInstrumentsGranted>
    <cntg:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"
      decimals="2"
      id="Tc_jT52EJGwX0-QIKnQfeUQfQ_4_4"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">11.60</cntg:ExercisePriceOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"
      decimals="2"
      id="Tc_ywLl3WKYtEmocJHHaFWK3g_5_2"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">12.02</cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"
      decimals="2"
      id="Tc_BJajiBQUFkOhD3JYfweeBQ_5_4"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">11.05</cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ"
      decimals="2"
      id="Tc_nos_TJSHVUKBP2otr9cgTA_5_6"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">12.54</cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted>
    <cntg:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"
      decimals="2"
      id="Tc_K4zcQjcj-0G1zL4W-Hx3dw_6_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.75</cntg:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <cntg:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"
      decimals="2"
      id="Tc_U0EYoUo7kEmaf39mw73npw_6_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.75</cntg:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <cntg:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ"
      decimals="2"
      id="Tc_U3dL2UW8w0astct0HgHDXQ_6_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.88</cntg:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"
      decimals="3"
      id="Tc_M1fiIOYIW0KcYb2my31JwA_7_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.010</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"
      decimals="3"
      id="Tc_IHVUSL9A_kaMuU23dVnXmg_7_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.008</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_q1nYC9yqtEWW20MzQIkwFQ"
      decimals="3"
      id="Narr_DjQNc5v5LU6PrY_o5Zn4MA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.002</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_UZb9Ik94skWa-HFbTuSMPg"
      decimals="3"
      id="Narr_LTSG_eQOiEKu1efS1JIc1w"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.003</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"
      decimals="2"
      id="Tc_aym4bDgTdUGRKwi3KSlRGA_8_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted>
    <cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"
      decimals="2"
      id="Tc_eJNdcHtb-EWTyNPmBDHQkA_8_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted>
    <cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ"
      decimals="2"
      id="Tc_rRQNye40_0K0B6_LgC_qSg_8_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"
      decimals="INF"
      id="Tc_j7WDesr-QEqqGk39DcRJWQ_9_2"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">8.9</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"
      decimals="0"
      id="Tc_6uiDOv2FwE-WW-IDUs_P_g_9_4"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">10</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_q1nYC9yqtEWW20MzQIkwFQ"
      decimals="2"
      id="Narr_LJx_bv0HR0CfPp2elHi04g"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">12.08</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_UZb9Ik94skWa-HFbTuSMPg"
      decimals="2"
      id="Narr_i0jFySjFxUCbUKj_SoZgag"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">13.08</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DTtZ89KsCEuDMkyldlxzqQ"
      decimals="2"
      id="Tc_UvqGtu9jFE-maNSZKxMTdw_10_2"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">12.02</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw"
      decimals="2"
      id="Tc_AlCRK2GcoUK6WPX8HlPA4Q_10_4"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">6.20</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_idJOtchqtUaFH_dU-54KiQ"
      decimals="2"
      id="Tc_qfZG3vLNEEmWS2Lm_dE5yg_10_6"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">8.23</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_GA3_hAw990K3e4HpR8KZlg"
      decimals="2"
      id="Narr_fKUrEmy53UabchIhp8siJA"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">10.96</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"
      decimals="2"
      id="Tc_YewQlsdnLk652Zw4RewnZA_5_2"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">9.92</cntg:ExercisePriceOtherEquityInstrumentsGranted>
    <cntg:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"
      decimals="2"
      id="Tc_6GuQ8IJBjESXSttS7aSO3w_5_4"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">14.00</cntg:ExercisePriceOtherEquityInstrumentsGranted>
    <cntg:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"
      decimals="2"
      id="Tc_ApA6I9dG5EiTiCY0sbN10A_5_6"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">11.60</cntg:ExercisePriceOtherEquityInstrumentsGranted>
    <cntg:ExercisePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      decimals="2"
      id="Tc_gtschjwo6EiWOOsJE69qVQ_5_8"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">12.52</cntg:ExercisePriceOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"
      decimals="2"
      id="Tc_bFmnaoMk4k6jMoE2cRy9bA_6_2"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">10.01</cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"
      decimals="2"
      id="Tc_J0ggkk5fOUOMOdwxnkLDDw_6_4"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">10.01</cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"
      decimals="2"
      id="Tc_unI_p9Zr_0-7trtiuWGEnA_6_6"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">10.80</cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      decimals="2"
      id="Tc_tbQohHSGb0O6IPfEwf7ANg_6_8"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">12.54</cntg:WeightedAverageSharePriceOtherEquityInstrumentsGranted>
    <cntg:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"
      decimals="2"
      id="Tc_EDYw8de1e0Sf0NzTMkXQ5g_7_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.75</cntg:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <cntg:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"
      decimals="2"
      id="Tc_C87tVGi3-ESgX0mP4Cp5_w_7_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.75</cntg:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <cntg:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"
      decimals="2"
      id="Tc_gB_F5P9klkuY4B0yLpCfyQ_7_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.75</cntg:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <cntg:ExpectedVolatilityOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      decimals="2"
      id="Tc_gMD60fJtKUGVCCczmSprlw_7_8"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.75</cntg:ExpectedVolatilityOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"
      decimals="3"
      id="Tc_WjT2dQQ76EqYakaj_DgIyA_8_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.017</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"
      decimals="3"
      id="Tc_fW9J3OCCzkmzMJQcaCDwFg_8_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.017</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"
      decimals="3"
      id="Tc_JjM4FP0boku3hyVhvE-FYQ_8_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.017</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      decimals="3"
      id="Tc_i0XMq9GiS0ysXlkEes9AmQ_8_8"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.019</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_TvyCsMUqekaRcguge2kBDA"
      decimals="4"
      id="Narr_wskYj88WnU2CXEGI_AM_Tg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.019</cntg:RiskFreeInterestRateOtherEquityInstrumentsGranted>
    <cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"
      decimals="2"
      id="Tc_VAuWMZgmIUmPXfBWXcyeKw_9_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted>
    <cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"
      decimals="2"
      id="Tc_2ciOVKnWm0WQ2jjTQg_C6g_9_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted>
    <cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"
      decimals="2"
      id="Tc_LyWTajzXuUGh7FDTADP7tQ_9_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted>
    <cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      decimals="2"
      id="Tc_2tKexMT_s0iL6ZdT6awZDw_9_8"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0</cntg:ExpectedDividendAsPercentageOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"
      decimals="1"
      id="Tc_24sSvyMV5ECMYimkQoAhow_10_2"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">10.0</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"
      decimals="0"
      id="Tc_6hMk-JNwrEKy2qSqxUcuqg_10_4"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">10</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"
      decimals="0"
      id="Tc_WDf-Fj4EQ0Oq4hcrdsBXoA_10_6"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">9</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      decimals="0"
      id="Tc_yZFTXhQ3j0iRyr_uZEzsMQ_10_8"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">10</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:OptionLifeOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_PerformanceBasedRestrictedStockUnitsMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_TvyCsMUqekaRcguge2kBDA"
      decimals="2"
      id="Narr_I1rCAsrPQkmEDDsnjwdoEg"
      unitRef="Unit_Standard_Y_MtPmc_xo8ka0OpO-RuTfjA">10</cntg:OptionLifeOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrModigAndMrSheldonMember_PNQApkTU2kmsZHY0WhXNeQ"
      decimals="2"
      id="Tc_LHMSasOI_UKrRC5MWGqOBg_11_2"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">7.86</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_COZweI_01E2bhhJUYvzcvQ"
      decimals="2"
      id="Tc_5qMOlS6S00W-fNeD4aIUTg_11_4"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">7.45</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_srt_TitleOfIndividualAxis_cntg_Mr.KimMember_OLgTnup_rUuickqDhdIJ5Q"
      decimals="2"
      id="Tc_KifMm3YDI0SvYnypKuGl1Q_11_6"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">8.21</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_BSqvOANkRkSQsmUqztSOLA"
      decimals="2"
      id="Tc_icPGmVFojU2VLviNHBm4HA_11_8"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">7.36</cntg:WeightedAverageFairValueOtherEquityInstrumentsGranted>
    <cntg:DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_RaeoBkxFsk2bshEhtxofzA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expenses arising from cash-settled share-based payment transactions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,714&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- 2016 VSOP&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 596&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- 2017 VSOP (2019: including modification gain)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,118&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expenses arising from equity-settled share-based payment transactions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 8,035&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5,658&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 704&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- ESOP 2019, including replacement by RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 7,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 704&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- Grants to management board and employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,217&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- Grants to the CEO&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 269&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;- Supervisory board grant&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 67&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total expenses arising from share&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;based payment transactions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,035&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,658&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,418&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cntg:DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory>
    <ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg"
      decimals="-3"
      id="Tc_f5HI1KD04EmB7usSkHFfrQ_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5714000</ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_QBlrGqBAdESpyQFY-rXeBw"
      decimals="-3"
      id="Tc_fQ8u-8x8vEu4Nk2m0JC67A_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">596000</ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2017CashSettledMember_ddZeCSMPQkigLGIMskIdRw"
      decimals="-3"
      id="Tc_h_ALBLMaQkmHouZfpqAjIQ_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5118000</ifrs-full:ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ"
      decimals="-3"
      id="Tc_FdwDE7Iil0yD0UfM6qPnfA_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8035000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_Y0FLGBLSsUOi8XOAx5OviQ"
      decimals="-3"
      id="Tc_6C-RoTp7u0myNRwtRsUZiw_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5658000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg"
      decimals="-3"
      id="Tc_jYUqoxf5w0aSVW5kiFp4kQ_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">704000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ"
      decimals="-3"
      id="Tc_KnBtKjQfNUiN6nVy9SE1jg_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_9d_Mqf82V06Mmf4qU7VDHQ"
      decimals="-3"
      id="Tc_EO7NXiyF70S2OlhMfL7rDQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2105000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_J6cKOx758Uan9G_GzTxF7Q"
      decimals="-3"
      id="Tc_q3aCf5BIr0KJdoHwgbswng_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">704000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_DpbCs0wmDU6o6dQo732WVg"
      decimals="-3"
      id="Tc_v8iCuTJmqU2hDuofjXYWww_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">985000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_ManagementBoardAndEmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_Pv_4vLW3B0ydriIBKiHLXw"
      decimals="-3"
      id="Tc_YrKQ4B_s20mqqdf8SmB6iw_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3217000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ChiefExecutiveOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_aEEdjxkwJUmQ8BYGV087NQ"
      decimals="-3"
      id="Tc_pG9TT6POq0ug5Z7RsXlpWQ_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">269000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_39gElOVO_E2M7b7YfC682g"
      decimals="-3"
      id="Tc_K1oTeO_vXUid_7vKJtffcA_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">50000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_dHEoTjnDeE6r34FsHbGMEA"
      decimals="-3"
      id="Tc_THB15o9o50W6zgbEa6v-LA_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">67000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_2zcISlAFmESb0DOtcF3ORQ"
      decimals="-3"
      id="Tc_IK_Ext4ibE2I4UjdvOg95A_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8035000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_Y0FLGBLSsUOi8XOAx5OviQ"
      decimals="-3"
      id="Tc_ehwQhZZ-IkKIzaNInUjONQ_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5658000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017And2019Member_dnnMiCUEPkCPvz3Pngwtcg"
      decimals="-3"
      id="Tc_f7m7zamK8EiyOIBjoUd0vg_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6418000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_FcqkeGXwfEGiYyANVgJytA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Financial instruments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;21 Financial instruments-fair values and risk management&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;21.1&lt;/b&gt;&lt;/span&gt;Classifications and fair values&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The carrying values of the Group&#x2019;s financial assets and financial liabilities approximate their fair value.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;21.2&lt;/b&gt;&lt;/span&gt;Financial risk management&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group is exposed to the following risks from the use of financial instruments:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;"&gt;Credit risk&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;"&gt;Liquidity risk&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;"&gt;Currency risk&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Credit risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss.  The Group is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities, including deposits with banks and financial institutions and foreign exchange transactions.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The carrying amount of the financial assets corresponds to the maximum default risk.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Trade receivables and contract assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group utilizes a receivables management system that closely manages open items of major customers. The Group&#x2019;s customers in the pharmaceutical segment are mainly pharmaceutical companies which are usually listed companies, or strongly financed by private equity funds. The Group&#x2019;s customers in the diagnostics segment are mainly hospitals, labs and physicians, of which a large part are generating revenues. To avoid default, the Company may request prepayment for new business.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In addition to the macroeconomic situation generally, the development of international healthcare markets is a key economic factor in assessing the default risk related to trade receivables and contract assets. These markets are closely monitored by the Group.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on&#160;days past due for groupings of various customer segments with similar loss patterns (i.e.&#160;by customers from different segment; customers from different geographical region and customer type). The calculation reflects the probability weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. The maximum exposure to credit risk at the reporting date is the carrying value of each class of financial assets disclosed in note&#160;15. The Group does not hold collateral as security and does not request letters of credit or other forms of credit insurance. The Group evaluates the concentration of risk with respect to trade receivables and contract assets and recorded credit losses reflecting the expected lifetime loss, based on different types of customers.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Considering the major exposure to the credit risk arising from the diagnostics segment, the Group focused its impairment analysis on the trade receivables due from customers in the diagnostic segment, in particular the MENA and Europe regions as they represent the majority of that segment&#x2019;s revenue. In addition to applying the provision matrix, the Group performed an individual customer analysis on major debtors, with reference to the past history (such as sales and collection in the previous periods) and the assessment of their current financial condition and other relevant factors and evaluated if additional specific impairment losses would be necessary.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Set out below is the information regarding the credit risk exposure of the Group&#x2019;s trade receivables and contract assets using a provision matrix.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;by&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;1&#160;-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;31&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt; 90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;more&#160;than&#160;90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Not&#160;past&#160;due&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;30&#160;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 13,968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,999&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,013&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,056&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10,771&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 351&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 259&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 531&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 23&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 72&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,787&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,562&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 79&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 203&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 943&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 130&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 115&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 30,054&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 17,978&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,475&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,596&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,004&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.9&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7.7&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11.7&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 64.1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,717&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 167&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 114&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 304&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,132&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;by&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;1&#160;-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;31&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt; 90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;more&#160;than&#160;90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Not&#160;past&#160;due&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;30&#160;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10,515&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,338&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 385&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6,306&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 20,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19,193&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 706&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 313&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 37&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,870&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 994&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 262&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 409&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 178&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 136&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 33,967&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,185&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,228&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 797&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,757&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14.0&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1.6&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3.1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7.7&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 63.0&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,768&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 70&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 61&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,255&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Overdue trade receivables from the Middle East region mainly relate to major customers from the diagnostics segment. The trade receivables due from the top 10 diagnostics customers in the MENA region as of December&#160;31, 2021 represent over 80% of total overdue balances for this region. These customers are mainly government hospitals administered by the Ministry of Health in the respective countries as well as distributors and, based on our past experience, these customers normally require a longer period to settle outstanding trade receivables. The average turnover period from these customers are 278 days. Therefore, a higher country specific loss rate has been used for the MENA region. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Set out below is the movement in the allowance for expected credit losses of trade receivables and contract assets:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of January 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,768&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,355&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Provision for expected credit losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 956&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,879&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Derecognition of trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,466)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,717&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,768&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:normal;font-weight:normal;"&gt;The addition to the allowance for expected credit losses includes an amount of EUR &lt;/span&gt;&lt;span style="font-style:normal;font-weight:normal;"&gt;949&lt;/span&gt;&lt;span style="font-style:normal;font-weight:normal;"&gt;k which was included in the impairment of financial assets in the profit and loss account. In 2021, trade receivables of EUR &lt;/span&gt;&lt;span style="font-style:normal;font-weight:normal;"&gt;7&lt;/span&gt;&lt;span style="font-style:normal;font-weight:normal;"&gt;k (2020: EUR &lt;/span&gt;&lt;span style="font-style:normal;font-weight:normal;"&gt;1,466&lt;/span&gt;&lt;span style="font-style:normal;font-weight:normal;"&gt;k) were outstanding for more than 365 days and were derecognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;As of December 31, 2021, the Group held cash and cash equivalents of EUR 17,818k (2020: EUR 48,156k). This total, therefore, also represents the maximum default risk with regard to these assets. The cash and cash equivalents are deposited principally with financial institutions with investment grade credit ratings. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Liquidity risk &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The liquidity risk is the risk of the Group possibly not being in a position to meet its financial liabilities as contractually agreed by providing cash or other financial assets. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group's objective is to maintain a balance between continuity of funding and flexibility through the use of bank overdrafts and lease contracts.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Managing liquidity within the Group is intended to ensure that - as far as possible - sufficient cash and cash equivalents are always available to meet payment obligations when these fall due, in both normal and challenging conditions, without incurring unacceptable losses or damaging the Group&#x2019;s reputation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group strives to maintain cash and cash equivalents at a level above that of the expected cash outflows for financial liabilities (apart from trade payables) during the next 60 days. As of December 31, 2021, 30.7% of the Group&#x2019;s interest-bearing liabilities mature in less than one year (2020: 25.0%) based on the carrying value of borrowings reflected in the financial statements. As of December 31, 2021, the expected cash inflows from trade and other receivables within two months amounts to EUR 6,418k (2020: EUR 14,857k), which would be EUR&#160;4,834k lower than the amount of trade payables due as of then.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company completed the IPO in November 2019. In July 2020, the Company completed a follow-on public offering of 3,500,000 common shares of the Company, consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of USD 14.00 per common share (i.e. EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, were EUR 22 million to the Company. As of December 31, 2021, the Group had cash and cash equivalent of EUR 17,818k (2020: EUR 48,156&lt;span style="white-space:pre-wrap;"&gt;k). The cash and cash equivalents are deposited principally with financial institutions with investment grade credit ratings.  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In addition to the cash and cash equivalent available as of December 31, 2021, the Group also has access to other sources of funding. As of December 31, 2021, the Group has secured credit lines totaling EUR 3,500k. These bear interest of 3.75% - 4.75% (2020: EUR 3,500k; 3.75% - 4.75%). EUR 3,310k were utilized as of December 31, 2021 (2020: EUR 1,538k).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The table below presents the remaining contractual terms of the financial liabilities on the reporting date, including estimated interest payments. The figures are undiscounted gross amounts, including estimated interest payments and interest on undrawn loan funds, but without showing the impact of offsetting.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractually&#160;agreed&#160;cash&#160;flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;More&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Less than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2 to 12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;1 to 5&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2&#160;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;5&#160;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 400&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 22,050&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 716&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 9,038&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,893&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 34,064&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37,117&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,383&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,803&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 9,038&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,893&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractually&#160;agreed&#160;cash&#160;flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;More&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Less than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2 to 12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;1 to 5&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2&#160;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;5&#160;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 408&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 394&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 394&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,897&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 716&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,580&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,861&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,740&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,736&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,525&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,011&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 514&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 55,834&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 59,351&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 33,270&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,072&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,269&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,740&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Reconciliation of liabilities arising from financing activities&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-cash changes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Changes in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Jan 1, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Additions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;maturity and FX&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;18,078&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (401)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 865&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,954)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (401)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,677&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,954)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,588&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,802)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,438&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,567&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,223&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (62)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (387)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 267&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,528&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,245)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,171&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,954&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,408&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (3,203)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,303&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (387)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,811&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-cash changes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Changes&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Jan 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Additions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;maturity&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;19,647&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (1,993)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,029&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (1,605)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,078&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (567)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Municipal loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 610&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (610)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,069&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,383)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,038)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,677&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,323&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,520)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,663&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,554&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 802&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (865)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 63&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (51)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,636&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,208)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Municipal loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,635&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,635)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,490&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,038&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,528&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 26,970&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,513)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,692&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (51)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Currency risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group is exposed to currency risk in cases where contracts are concluded in foreign currencies. The vast majority of goods delivered and services the Company provided, including those for international customers, are invoiced in euro.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The main functional currencies of group companies are the euro, USD, the Indian rupee and the Arab Emirates Dirham. The following table presents the net foreign currency exposure of the Group as of December&#160;31, 2021 and 2020.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;USD&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;INR&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;AED&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,604&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade payables and other liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,394)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net exposure&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 210&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;USD&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;INR&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;AED&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trade payables and other liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,631)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (55)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (17)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net exposure&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,407)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (37)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (17)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Sensitivity analysis relating to changes in exchange rates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Given the exposure to foreign currencies as presented above, the impact to the Group&#x2019;s earnings before tax or equity from a 10% change in the US dollar exchange rate would not be material.&lt;/p&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfCreditRiskExposureExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_H0rM1e-FoEWXaRCRAPAGfQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;by&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;1&#160;-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;31&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt; 90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;more&#160;than&#160;90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Not&#160;past&#160;due&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;30&#160;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 13,968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,999&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,013&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,056&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6,900&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 11,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10,771&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 351&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 259&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 531&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 23&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 72&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,787&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,562&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 79&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 203&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 943&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 130&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 115&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 30,054&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 17,978&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,475&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,596&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,004&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 19&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 0.9&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7.7&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 11.7&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 64.1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,717&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 167&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 114&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 304&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,132&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="11" style="vertical-align:bottom;width:98.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;by&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;1&#160;-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Past&#160;due&#160;31&lt;/b&gt;&lt;b style="font-weight:bold;"&gt;&#x2011;&lt;/b&gt;&lt;b style="font-weight:bold;"&gt; 90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;more&#160;than&#160;90&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Not&#160;past&#160;due&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;30&#160;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;days&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Middle East&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 10,515&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,338&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 385&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 6,306&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Europe&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 20,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 19,193&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 706&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Latin America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 313&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 37&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;North America&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2,870&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 994&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 262&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 409&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Asia Pacific&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 178&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 136&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 33,967&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,185&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,228&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 797&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,757&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14.0&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1.6&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3.1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7.7&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 63.0&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:44.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Expected credit loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,768&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 382&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 70&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 61&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,255&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfCreditRiskExposureExplanatory>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_im24XRyLI0GqUcsxo8IrZA"
      decimals="-3"
      id="Tc_9JjtUgLAbE2wOiSGuQUa8w_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">13968000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_AWSNyH90oEO0mlR_BPIyQw"
      decimals="-3"
      id="Tc_nTkZL5fzbU-GZiY4-BzJoA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3999000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_Nr5CKDFzgEmOhALcEcaUKA"
      decimals="-3"
      id="Tc_jZrctc6-8k60SCTcgwA0DA_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1013000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_9o0XhkZxGky0b7QNSp7Ieg"
      decimals="-3"
      id="Tc_uHF5eSLlfEq9BBegSXj4nQ_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2056000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_c3WvXYkgjU2w62UITw_QoQ"
      decimals="-3"
      id="Tc_1aidK71z30mTBFdfhWlxow_5_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6900000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_qMKixKGV5UWRZqRsEsGsdw"
      decimals="-3"
      id="Tc_m6VrfdCIM0e0wyxBKHb6aQ_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11486000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_-KBY6U1X6EOR-VWQfNcPHA"
      decimals="-3"
      id="Tc_cg6g4Gqj0US64SnKYf3K6A_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10771000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember_8g_ZitjpWU2j9Bs86BqZrw"
      decimals="-3"
      id="Tc_VFMTY9LeFkW3POw2-56-6g_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">351000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_YGwYj8iWBkW5FDEsRlrh0w"
      decimals="-3"
      id="Tc_9qYelMj6pkGtIOcIoDW-hw_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">259000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_1I2zB8P7-EGuayPURgq3Xg"
      decimals="-3"
      id="Tc_xUDF6u8EY0ujk92yWdMFlQ_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">105000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_mTPqfJbCUUm--tsL4sV-ig"
      decimals="-3"
      id="Tc_GbE__KHYVE2wdTmhvACTfw_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">683000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_VNENwsckGUiWfp5ITIZVqw"
      decimals="-3"
      id="Tc_OwlHrNDUrUGq7iCuB_0k4Q_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">531000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_iNZqJbVbKki0oB6o29DKAw"
      decimals="-3"
      id="Tc_KW-MoPllyE6VY5ToEVUxhQ_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_jAebtKB3PUWEhq3JPxUl8w"
      decimals="-3"
      id="Tc_N6c5UPV0B0qgRbfl39VVQQ_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">72000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nrmK-W5eVkeDWBDFsK1gbQ"
      decimals="-3"
      id="Tc_myiwVN3fzkyEfUPRmC4Apw_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">57000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_nBhxP_A8lkWu92Je-mOYBA"
      decimals="-3"
      id="Tc_KhiOGSvyhkKGqvXFeEp_6A_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3787000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_q-OwjmoAGkCq9QP-5ONw2Q"
      decimals="-3"
      id="Tc_T-7t_gEWlk2DEeJshQgNEw_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2562000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_kqTayYwJoEGJgu7xk2O20Q"
      decimals="-3"
      id="Tc_aS9RTFX2IUSx5emw2WvBPA_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">79000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_iBTWkttdV062pZ701mLkyA"
      decimals="-3"
      id="Tc_xgUe2M9TXUSceLIa4SSfig_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">203000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_vfEsDhfpBk2COGW2LU7q1A"
      decimals="-3"
      id="Tc_xJdFfxYYo06MklfZFS1wag_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">943000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_quezt-h_1EWrq43Pa0YWsg"
      decimals="-3"
      id="Tc_r62w91iZc0KKStEDoSEqBQ_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">130000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_Z_smm4P60EyfOSuzKxAlhQ"
      decimals="-3"
      id="Tc_4rf9u7cwKEuGdfKVj0kLow_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">115000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_XEJ63VPP90SKEPNBmiOU_Q"
      decimals="-3"
      id="Tc_rFCZEY6Qq02lqRmwWpcbHA_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_v7Uhyrox_UqVpbuf1EAC0Q"
      decimals="-3"
      id="Tc_dPQitgfgG0CQ5c21QCLBsg_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_gmTaq6Yn1ECvIEhMtnPX0w"
      decimals="-3"
      id="Tc_hD-lq1hKdU-FfbxI72PMLA_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA"
      decimals="-3"
      id="Tc_7SyEmzNi9kO8uN3NICcsRQ_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">30054000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A"
      decimals="-3"
      id="Tc_VKwo4ltU0Eu-PsFinYDHPw_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17978000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg"
      decimals="-3"
      id="Tc_1XhI2NxhtkyG9BnYVdZUTQ_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1475000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w"
      decimals="-3"
      id="Tc_iw8OPryKP0eyAGWxp6s09g_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2596000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg"
      decimals="-3"
      id="Tc_T0RPq1FNd0OLmlR80VkInA_10_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8004000</ifrs-full:FinancialAssets>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA"
      decimals="2"
      id="Tc_2E800b-WzUqJ2F8D3lcZjw_11_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.19</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A"
      decimals="3"
      id="Tc_Ph04-bIgaUqJHKor4wuvyQ_11_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.009</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg"
      decimals="3"
      id="Tc_2AAEmSUFGEWq_yEwotPSLg_11_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.077</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w"
      decimals="3"
      id="Tc_0ebZJVXAi0KSN937uEDnhQ_11_8"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.117</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg"
      decimals="3"
      id="Tc_fslTFiPS1Eu3QrRL9quSpw_11_10"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.641</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_c89TpkaIN0Wjj6cRhxS-VA"
      decimals="-3"
      id="Tc_vkSEFITnzUmXDI5SzMZ-GQ_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5717000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_UJ6w3c2J0UC1AQcLLDv0_A"
      decimals="-3"
      id="Tc_AHBqq1lctUmLRuf2X2rymQ_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">167000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_iilL6bs4rkyGWthw9wR6jg"
      decimals="-3"
      id="Tc_iMJK-s33vE-yy4-HiqyAjw_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">114000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_EkN1YyiIfEGssw7Ivayu3w"
      decimals="-3"
      id="Tc_wa3K-iwIOUaMZCQ8b0FHtw_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">304000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_diEvsWGgKEq9IwkZsYAodg"
      decimals="-3"
      id="Tc_ZIbC2vKf3k28skyQdmJifQ_12_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5132000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_lKSmRPULxECSr0eRnZJv2g"
      decimals="-3"
      id="Tc_ZHxr2DPjskqhXqtiiyM9lg_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10515000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_MAiDhc93mEuXQd1PbNze4Q"
      decimals="-3"
      id="Tc_YTyQNN2nVUaTnyJ0ls0InQ_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3338000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_oDDkh1PJbE2F8ijvw05Pvg"
      decimals="-3"
      id="Tc_u6m_Yed7SEqxutCUGRDesw_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">486000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_h3ZfOluujEiPQeT9NlQKMA"
      decimals="-3"
      id="Tc_pnhAYwMsf0Olk6dImpxqyg_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">385000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_aSbUFoGlt0-vDtnrIjva9Q"
      decimals="-3"
      id="Tc_3VvzXc0jukOd6JsHBJf4Zg_5_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6306000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_EuropeMember_2o28VsnJ302Wcsmk8ET49g"
      decimals="-3"
      id="Tc_wfH976ejkUm--3QpMW30jw_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">20017000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_EuropeMember_YEwbUrATUE6gX9KIiJ2XJg"
      decimals="-3"
      id="Tc_x9sJRzwJYUGcx1LLY0gyng_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19193000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_EuropeMember__GLD_N50Q0qJTvDIg66vCg"
      decimals="-3"
      id="Tc_ErgisO8R-kCWreWA-zfb2w_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">706000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_53uzl0nKCEWKL9P-aqzedw"
      decimals="-3"
      id="Tc_P8e3nH29S0amwFBPstGnpg_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">113000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_EuropeMember_AHlMhGU4RUO4AYFCEWNB4Q"
      decimals="-3"
      id="Tc_feAody0TM0C7Xe0bNLfB2w_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_2zZ4FqgNmU6u242fuMe22Q"
      decimals="-3"
      id="Tc_bp6Mlu13m0W7bNWESgqKbg_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">387000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_bV11S-JGL0-qYfeSG-mqaQ"
      decimals="-3"
      id="Tc_tVj0kRf5O0m7e5ExvpgFdQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">313000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_Gg9_HCfVqkyGfAYx_drdzw"
      decimals="-3"
      id="Tc_o7CFssGmpkGz92oNDAGr7A_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_CeCE8jbz0EGNqIacDltO2Q"
      decimals="-3"
      id="Tc_gIJpI3cdQUSjke84yIFkqA_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">13000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_LatinAmericaMember_nnGZ6V0R5Ui7TR-RGngNEQ"
      decimals="-3"
      id="Tc_wSpQAEr3LkW6MbyqQeZJMA_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">37000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_Q0uVwOjO7ECfq8SqO9fgPg"
      decimals="-3"
      id="Tc_ZrBi_nuLP0WkHTLdXABXBw_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2870000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_IGCBy0alu02k3K8HN8HMVQ"
      decimals="-3"
      id="Tc_g_DfF030IUi-mkV7T2IISQ_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1205000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_7zHmJCcCi0iHo0JtjolMqw"
      decimals="-3"
      id="Tc_EfRFR9JlnECpK9ReMuecSA_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">994000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_YBYcui1xWESYnTn6QF0bXw"
      decimals="-3"
      id="Tc_FXxcs8jgYE--eOnALsn4Qw_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">262000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_NorthAmericaMember_VIL6RPyEFkOt1QnphczzYg"
      decimals="-3"
      id="Tc_VHdxlT-nF0iPbHX2Uxq2Bw_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">409000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_3_Qlw4YfQ0qJvktlFzldsA"
      decimals="-3"
      id="Tc_ygi-4VfQmk6Xibc3cHVYaQ_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">178000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_alAn4anr30uPH3nv6D0QTA"
      decimals="-3"
      id="Tc_amuKvSwNjE-X-wEQ62HIbg_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">136000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_sDI8Zd37_kGSZzcJnjDK3g"
      decimals="-3"
      id="Tc_SkewiIzrxE6cGlvbR9ggWg_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_srt_StatementGeographicalAxis_srt_AsiaPacificMember_6HnJiRc8uEOIwyqFZl2paw"
      decimals="-3"
      id="Tc_EPEblYu3K029Cxzhlahuzw_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg"
      decimals="-3"
      id="Tc_JkMHBuxVHE21CWqUtVYhWA_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">33967000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA"
      decimals="-3"
      id="Tc_rKrWrsLwqEWN_yIQiWtyxw_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24185000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg"
      decimals="-3"
      id="Tc_JbBTJlzGA0-0J8jOQ8y6Pw_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2228000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ"
      decimals="-3"
      id="Tc_b4L1eSmwBEOngGH3XLCJJQ_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">797000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ"
      decimals="-3"
      id="Tc_wLsBLyI82ECAAZ4YaZ9_Og_10_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6757000</ifrs-full:FinancialAssets>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg"
      decimals="3"
      id="Tc_-0IxtnnFyky2sT9-QkDDvg_11_2"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.140</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA"
      decimals="3"
      id="Tc_KGqRiZoVbEipvam_d01O8A_11_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.016</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg"
      decimals="3"
      id="Tc_iXln2W9AkEyrDP6ak4-WYg_11_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.031</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ"
      decimals="3"
      id="Tc_j4NF056ALkqTD4U6rselfA_11_8"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.077</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ"
      decimals="3"
      id="Tc_nTBvxjYG3UiRxR-7XgMtJw_11_10"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.630</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_WrcXS4pDrk-7DiUMG_RgOg"
      decimals="-3"
      id="Tc_nRXdp9fEtkCp3Em7I3NR5A_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4768000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_CurrentMember_ZY9b6_aNJk6Q5iWuABwtLA"
      decimals="-3"
      id="Tc_DXmMrbJrOkK0-r60akJ__w_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">382000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_cntg_LaterThanOneDayAndNotLaterThanOneMonthMember_2zrN6seLBUuoduupsdbkwg"
      decimals="-3"
      id="Tc_90oXq7goVUqdcKePv0zfvw_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">70000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_Bvtf8mn-RkanQRE_74lqiQ"
      decimals="-3"
      id="Tc_xsj5ew1MuUq69PcaL-RHAA_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">61000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanThreeMonthsMember_ztSFsEZEPUOMAymXadEBTQ"
      decimals="-3"
      id="Tc_GH-53fgKPEuoGpxKLhl4rw_12_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4255000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <cntg:NumberOfTopDiagnosticCustomersDueInTradeReceivables
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_64L26hAwIkSVEZySJMUuIA"
      decimals="INF"
      id="Narr_4pdriHhBJE2GHXniQqabPg"
      unitRef="Unit_Standard_customer_5AR5rC7mfUa4LSGHj9m9Ng">10</cntg:NumberOfTopDiagnosticCustomersDueInTradeReceivables>
    <cntg:PercentageOfOverdueBalances
      contextRef="As_Of_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_srt_StatementGeographicalAxis_cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember_fT4qcBDw9EGETB6DVY3dyQ"
      decimals="2"
      id="Narr_hZlXvB2DU0uiBnVuqCW7pg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.80</cntg:PercentageOfOverdueBalances>
    <cntg:TradeReceivablesAverageTurnoverPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentsAxis_cntg_DiagnosticsSegmentMember_srt_StatementGeographicalAxis_cntg_IfrsMiddleEastMember_VE4Zb24yM0-210qngfcykg"
      id="Narr_XKniojgU_06DwCkuYt0u2A">P278D</cntg:TradeReceivablesAverageTurnoverPeriod>
    <ifrs-full:DisclosureOfAllowanceForCreditLossesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_gAy1sDsf7EuuQT-My0HvSg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of January 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,768&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,355&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Provision for expected credit losses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 956&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,879&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Derecognition of trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,466)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,717&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,768&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfAllowanceForCreditLossesExplanatory>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_yaEih7N5-0KOOF5zjhU-TA"
      decimals="-3"
      id="Tc_NJsrNGkH7UGNuEyfBdBf4g_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4768000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2019_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_PpfrBDRiYE6X2aaNart3Kw"
      decimals="-3"
      id="Tc_pKMT6IDEZUmLXlAXd5i8FA_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2355000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_oIZwdOmoREqE4B_LSTBrPg"
      decimals="-3"
      id="Tc_NnOo77CfVUyYRjhnEYUfwg_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">956000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_h73Wub4Up0GkkBugURy3GA"
      decimals="-3"
      id="Tc_ydkYHXjxFUGHTYyzO5EcBg_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3879000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_oIZwdOmoREqE4B_LSTBrPg"
      decimals="-3"
      id="Tc_Z7BmirTh-kGC2Rg4i9BhTg_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7000</ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_h73Wub4Up0GkkBugURy3GA"
      decimals="-3"
      id="Tc_1ECxqVgeu0WO1Ll6hs11ug_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1466000</ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_fYFW5_Lv4Eu7pT63KH2LHA"
      decimals="-3"
      id="Tc_bt31yd1qdUiy0oyz5o-UfQ_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5717000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeReceivablesAndContractAssetsMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_yaEih7N5-0KOOF5zjhU-TA"
      decimals="-3"
      id="Tc_y0ozVQImk0StaPLNxVjBoA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4768000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_mgdgQ6ZdVEWu7MZBFuxPcA"
      decimals="-3"
      id="Narr_LB8Qd-kc4UufC4gkgcsn5g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">949000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_tsk8qBlLdUKKx-fMOsu2-g"
      decimals="-3"
      id="Narr_SYRJ6FanMEKOjhz5t8-R1g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7000</ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_TradeReceivablesMember_ifrs-full_ImpairmentOfFinancialAssetsAxis_ifrs-full_FinancialAssetsPastDueButNotImpairedMember_ifrs-full_PastDueStatusAxis_ifrs-full_LaterThanOneYearMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_Q4DmiPOJc06nX5FPcvcI3A"
      decimals="-3"
      id="Narr_YDsTZ6wR4E6OaOEkyWpZEA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1466000</ifrs-full:ReversalAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_vbrOgTDfJ0e6FyvtY_qOlg"
      decimals="-3"
      id="Narr_KMxbgwJ2aEydRHBrrkwOhA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17818000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_OdjXVnK2IkSMmsnB2jcPFQ"
      decimals="-3"
      id="Narr_k56-tlvah0yfKohCGjZHOA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48156000</ifrs-full:CashAndCashEquivalents>
    <cntg:PercentageOfInterestBearingLoansMatureInOneYear
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_4MGHm-fiQ0S-NkUoqSHdJQ"
      decimals="3"
      id="Narr_qqs8Jct6pkuPMkbFouUtPg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.307</cntg:PercentageOfInterestBearingLoansMatureInOneYear>
    <cntg:PercentageOfInterestBearingLoansMatureInOneYear
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_gE_fMmwbY0-dkhMzL5yzoQ"
      decimals="3"
      id="Narr_GHvcINjqOk2eGfcVEVGfkQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.250</cntg:PercentageOfInterestBearingLoansMatureInOneYear>
    <ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_8WV5gyv1i0GftN0I4C3eiQ"
      decimals="-3"
      id="Narr_BnwEwUxSDEK1eT5u4J2XUw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6418000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
    <ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember_z1xLnpmvrEaXgiuUBqzwfw"
      decimals="-3"
      id="Narr_gXS7QOUTD0SrwkbJsGyBxQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14857000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
    <cntg:ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_XAwKuSPnr0CfJZw74ZEzjw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4834000</cntg:ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths>
    <cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l3DMVfcSck6NtIEREMfo0w"
      decimals="INF"
      id="Narr_FY6EWW5ahUiwgKEajlAVSg"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">3500000</cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_3znQxHgm3kWUN47RhL_tkg"
      decimals="INF"
      id="Narr_QfxbOF9lNkGc8V4jEpK63g"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">2000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <cntg:NumberOfCommonSharesOfferedByPriorShareholders
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l3DMVfcSck6NtIEREMfo0w"
      decimals="INF"
      id="Narr_raRIGTlYa02NVj0tT5d3PA"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1500000</cntg:NumberOfCommonSharesOfferedByPriorShareholders>
    <cntg:IfrsSharesIssuedPricePerShare
      contextRef="As_Of_7_31_2020_jjcjEUhSo06U9XQl7FB8sw"
      decimals="INF"
      id="Narr_7xDhfdUcoEekQECsfcRduw"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">14.00</cntg:IfrsSharesIssuedPricePerShare>
    <cntg:IfrsSharesIssuedPricePerShare
      contextRef="As_Of_7_31_2020_jjcjEUhSo06U9XQl7FB8sw"
      decimals="INF"
      id="Narr_dbk8jxJctESltv2lrOG0sQ"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.71</cntg:IfrsSharesIssuedPricePerShare>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-6"
      id="Narr_u1oRH-U820CdaIuG7lDGdw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22000000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Narr_D1drPQr1q0q737HT0qzUKQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17818000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Narr_JCW74FIF-k239gwzf4Ojqw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">48156000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA"
      decimals="-3"
      id="Narr_jwW4X_aZCESSgOMtJk3SgA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3500000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <cntg:SecuredCreditLinesInterestRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_yHGXCfJRZUmQPTopPKil4w"
      decimals="4"
      id="Narr_ZfXE9A8lZEKe-aBCDhstBA"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0375</cntg:SecuredCreditLinesInterestRate>
    <cntg:SecuredCreditLinesInterestRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_EWLOPAf3s06Yaf102xYwkw"
      decimals="4"
      id="Narr_3bDrVDb3EUWx5v0FUiWq4Q"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0475</cntg:SecuredCreditLinesInterestRate>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg"
      decimals="-3"
      id="Narr_mR6eN6qM5ke5iTRSfC5Flw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3500000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <cntg:SecuredCreditLinesInterestRate
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_hvAwpduUMkS_--hMwyClRw"
      decimals="4"
      id="Narr_eZhJ8AzJ60OUg24cF8e87Q"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0375</cntg:SecuredCreditLinesInterestRate>
    <cntg:SecuredCreditLinesInterestRate
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_LRSLwc9jLEWT_6ss8x1zQw"
      decimals="4"
      id="Narr_U4U3eIZNCkm1kYztWqwjyQ"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.0475</cntg:SecuredCreditLinesInterestRate>
    <cntg:SecuredCreditLinesUtilized
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA"
      decimals="-3"
      id="Narr_Chiox0C2VEuBnpGA-pNRrA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3310000</cntg:SecuredCreditLinesUtilized>
    <cntg:SecuredCreditLinesUtilized
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg"
      decimals="-3"
      id="Narr_9xq-thEZ_Uivgn_uxG2erA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1538000</cntg:SecuredCreditLinesUtilized>
    <ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_ypN6cf5jwUqIXmv-sMO4pg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractually&#160;agreed&#160;cash&#160;flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;More&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Less than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2 to 12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;1 to 5&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2&#160;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;5&#160;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 400&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 22,050&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 716&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 9,038&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,893&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,252&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 34,064&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 37,117&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,383&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3,803&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 9,038&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8,893&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:43.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractually&#160;agreed&#160;cash&#160;flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;More&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Less than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2 to 12&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;1 to 5&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;than&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2&#160;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;5&#160;years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 408&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 394&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 394&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,897&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 716&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,580&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,861&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,740&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,736&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,525&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,011&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 514&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 55,834&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 59,351&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 33,270&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,072&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,269&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 10,740&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ClpwBom6cUqWd-ufPXZ0UQ"
      decimals="-3"
      id="Tc_ClzUacjHeEmEVobSapvTZQ_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3310000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ClpwBom6cUqWd-ufPXZ0UQ"
      decimals="-3"
      id="Tc_7-FlBEX6cEOZXQOzrmBSBw_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3310000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_pbC3EeTlG02DpVQruwf4Tw"
      decimals="-3"
      id="Tc_6Kaecxn1uEqlY68azOX6zA_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3310000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA"
      decimals="-3"
      id="Tc_QpH5Ilre3kqzF-W0QaEVCg_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">505000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_JC_E95z0UUuBrejEw9wHjA"
      decimals="-3"
      id="Tc_oduN0WNssUmJL4DTLxeT7Q_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">505000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_rIlXfTTwmU-ysaRC7xDcSQ"
      decimals="-3"
      id="Tc_Yi_wE8GMcUGlr3GX5esrow_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">105000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_XfZVUuusyE6sKx1xn01SHw"
      decimals="-3"
      id="Tc_tXsYmauIHEWcVMAwQrTASg_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">400000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_a3Yg9ypl1k2iDGuR8xuRyQ"
      decimals="-3"
      id="Tc_QEYKoZF4AUSJbFbJGXBvZA_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18997000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_a3Yg9ypl1k2iDGuR8xuRyQ"
      decimals="-3"
      id="Tc_ThrwxFUg1keLDS4l96NQuQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22050000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_vd39B4F3FUO_Erq6z5AVPA"
      decimals="-3"
      id="Tc_WF-o3pC-5UyStSSYofy5rg_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">716000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_iozvi2N5fUy5-JmDwCHMOg"
      decimals="-3"
      id="Tc_ZfFkURx2TUSzHzw-T8C-Uw_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3403000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_mRyO_XlQBEWt7q8iQ7G_8A"
      decimals="-3"
      id="Tc_yg1c-rbY1k25G9WNpSCNMQ_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9038000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_XrpCDWtFQUmPxSAiXPTXUw"
      decimals="-3"
      id="Tc_PJqcfrNwcU-OsQKJeNHA_A_7_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8893000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_3g8HtBjL_kykX8R0GC1k4g"
      decimals="-3"
      id="Tc_XaUSHGjOgUORizkIpl512Q_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11252000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_3g8HtBjL_kykX8R0GC1k4g"
      decimals="-3"
      id="Tc_ROX7PKM7bUyuOpHrYEixZQ_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11252000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_FuwgOdOK2EGp4zWT_laRCg"
      decimals="-3"
      id="Tc_zrA-ltqzV0ygAiygKaM6hw_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11252000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_1hiBXJfI_EKgD4yyz3Pq0g_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">34064000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_Ujg80_ymDEu1MuT6xY1rRg_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">37117000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_3v-ci-9RIE-ahgs5Q3wFMA"
      decimals="-3"
      id="Tc_6kVhSFkzTkeXwHO-qlLXvw_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15383000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_xTVVLa1l40W4cNlLaMYVqg"
      decimals="-3"
      id="Tc_ItwGncdPpked97QNaVZH6w_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3803000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_4eI5LpLv_0eo4uPM2ev0NQ"
      decimals="-3"
      id="Tc_iLRmzlufb0aJbTjOhWg6Xg_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9038000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_B6gQoQkzLU6SHuMVF2-iZw"
      decimals="-3"
      id="Tc_WHto9fIKO0aYJ6Ox6ntHWA_9_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8893000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_3oFLP2tExkCs_4EjAnnqvw"
      decimals="-3"
      id="Tc_bknb7zv_GEirVzDl9Ehr2g_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1538000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_3oFLP2tExkCs_4EjAnnqvw"
      decimals="-3"
      id="Tc__OUuDcXs5Uy7EpzKkSukIg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1538000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_IfrsBankOverdraftsMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_091uV2Fq_0qIxxVqOPG-zw"
      decimals="-3"
      id="Tc_ZbR-MKl-706zjab8L5sStw_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1538000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg"
      decimals="-3"
      id="Tc_cyd52sbaY02A1-_pjd1iRQ_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">968000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_r3sNq7m5jEm2WnGMcJ6bxg"
      decimals="-3"
      id="Tc_rfw5EaOIZEO9ikfpHEIUGg_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">997000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_9Pk-XO-w6kazSFU2ZKTLMQ"
      decimals="-3"
      id="Tc_tU1eMxIwb0qn7faplyNpAQ_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZXCGb0Im-UKu347o-AvPMA"
      decimals="-3"
      id="Tc_Vc4IJOcuzkSPCPSqfQd1OQ_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">584000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_SecuredCreditLinesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_PUdDMYJxs0uelX1OleXC9A"
      decimals="-3"
      id="Tc_5jxYa_Wi7Uq-Doq3LiVGoA_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">408000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_SpNNQ_JBZUOkx3nQnjLf9g"
      decimals="-3"
      id="Tc_PwexXvLEy0-u1e9yqquCcw_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">387000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_SpNNQ_JBZUOkx3nQnjLf9g"
      decimals="-3"
      id="Tc_a4NZNuWSGUqaX7iq5S9mug_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">394000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_OtherBankLoansMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_HgkA9kih00i_kzO7PaqJPQ"
      decimals="-3"
      id="Tc_NWutEw8r30-67642BhnPRw_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">394000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_LzHf5lcGX0618OATPQ19RA"
      decimals="-3"
      id="Tc_o8MEQ-zT20iaZUWedNozbw_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">21205000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_LzHf5lcGX0618OATPQ19RA"
      decimals="-3"
      id="Tc_u6LlJvcDmEKJhyUfGnB45g_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24897000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_CUAJUdk83Um44_JFEP8vXQ"
      decimals="-3"
      id="Tc_gKUPTlZPk0K7nA7Ms_Q1JA_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">716000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_ZZvNtzkppE2H6789cVRd6w"
      decimals="-3"
      id="Tc_tb-oOSRE-UygOBpUDCliEg_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3580000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1ld6bOFbL0-jZ3xi0wJJeg"
      decimals="-3"
      id="Tc_pTIvRj8OSE-UOPmqIAkiQg_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9861000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_ifrs-full_LeaseLiabilitiesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_zZC6MbCQ0E-4cbWihISE2w"
      decimals="-3"
      id="Tc_H1pH8qajbU6YQPSDymYbXg_8_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10740000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_UUEtJvvNV0G4AhFLi2cvzw"
      decimals="-3"
      id="Tc_eupuvdqWJ0GOaVOSZTuuxQ_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31736000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_UUEtJvvNV0G4AhFLi2cvzw"
      decimals="-3"
      id="Tc_Bqvc2xAmu0arn6AZJRZo1g_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31525000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_bVwoyln2AUi08pK8bb-Xcg"
      decimals="-3"
      id="Tc_4ybqaNcYikKMqufttMavTg_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">31011000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfFinancialInstrumentsAxis_cntg_TradePayablesMember_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_exG11_HvBUqZzNaMA2BROg"
      decimals="-3"
      id="Tc_fWXrbpjrnkm0OAdeqy9Etw_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">514000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_mBD111ZqN0SbmSka4TmvrQ_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">55834000</ifrs-full:FinancialLiabilities>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_Gg1wTDQqDEum8by69-39OA_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">59351000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_NotLaterThanTwoMonthsMember_5wg1Zs52TkaxKu1Aw0P4Pw"
      decimals="-3"
      id="Tc_4YqJ5Nr1akSy-WLNCvdy7Q_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">33270000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember_9xKYcirppUaOjw1XbQSfdA"
      decimals="-3"
      id="Tc_9eNT1tXanU-fp7HhEybDrw_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5072000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_QZfp6KzOOkKZiy-H5CT4mw"
      decimals="-3"
      id="Tc_hwQAkC1L80CO_ga8C4JceQ_10_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10269000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_iTqtnBHt_kCG66_LrnRX5Q"
      decimals="-3"
      id="Tc_4azmXKmbwEm_4uvkYqEnug_10_12"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10740000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_qbAkh0qoUkOq6hEK27Bkzg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-cash changes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Changes in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Jan 1, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Additions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;maturity and FX&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;18,078&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (401)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 865&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,954)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 15,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (401)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,677&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,954)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,588&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,802)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,438&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,567&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,223&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (62)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 505&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (387)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 267&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,310&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,528&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,245)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,171&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,954&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,408&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (3,203)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,303&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (387)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 22,811&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-cash changes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Changes&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Jan 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash flows&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Additions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;maturity&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;19,647&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (1,993)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,029&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (1,605)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 18,078&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (567)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Municipal loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 610&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (610)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,069&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,383)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,038)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,677&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 7,323&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,520)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 2,663&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,554&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of secured bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 802&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (865)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 63&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 567&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (51)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 387&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bank overdrafts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,636&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,208)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Municipal loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,635&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,635)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,490&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,038&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,528&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:52.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 26,970&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,513)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,692&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (51)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 24,098&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_TenVHCDHtEWBdBEcmQJ5Ow"
      decimals="-3"
      id="Tc_4eqjIXPypEOFJkQ7Z3j2TQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18078000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA"
      decimals="-3"
      id="Tc_QS63WKzCGkeFVE5tbwp_Tw_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-401000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA"
      decimals="-3"
      id="Tc_3DV6lOw0Ck6YDwghfx2eYw_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">865000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_77G0fYvzJ0eJWxHmU4B1pA"
      decimals="-3"
      id="Tc_r2eNHxsPz0Wj_JUZWZqyFA_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2954000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_6QowRtO2bEKJIQeTYviHqA"
      decimals="-3"
      id="Tc_v23W3KY60kKLF3GcRks2oA_4_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15588000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_vQpey-VclkGOtoNQ0QvVjg"
      decimals="-3"
      id="Tc_kOxFRdQngU6eev45ml9o7g_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">401000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_6nXywAwdyk2CprWek0Ldig"
      decimals="-3"
      id="Tc_XQiOYQUlekqGCGXTjhbVyw_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-401000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_alWkS9-7z0m53IksGJp1Wg"
      decimals="-3"
      id="Tc_MAHx5DwU9U-Am9iLOWBADA_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17677000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_5NYYA4fPLkOwhQf6kwQBhQ"
      decimals="-3"
      id="Tc_qJ2ptkQhp0yqozY0gsE5sA_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">865000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_5NYYA4fPLkOwhQf6kwQBhQ"
      decimals="-3"
      id="Tc_EbK6rsYsKEWdwrpFpwHCmA_6_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2954000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_Nt_CcI-0j0aio14DEtDbsA"
      decimals="-3"
      id="Tc_I4VkJB5zKUG82Ap4dF9dCw_6_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15588000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_w4OmoUQNEkmOiPw-yYz1gg"
      decimals="-3"
      id="Tc_DMu3fZPZdUijpwijBhanHA_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6020000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ"
      decimals="-3"
      id="Tc_1iKApBV_VUeolfj8yZHnbA_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2802000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ"
      decimals="-3"
      id="Tc_t0cjufIzb0W-QuZBo4poKw_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1438000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_oaN_dnD1yEmb_dwYoB8NAQ"
      decimals="-3"
      id="Tc_F-iEy5uUEEGB5GwuijW5jw_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2567000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_wO1nyt_hYEmFefkfmJrSBA"
      decimals="-3"
      id="Tc_L6RTMYZ39UqBtr7ZSxhwAQ_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7223000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_OLnDAxQ4XESWJVC9_RdH_A"
      decimals="-3"
      id="Tc_2JoEci9nMUmvav9QmZxhdA_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">567000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_xGvnCbYIxkKMBxggavLiYw"
      decimals="-3"
      id="Tc_yAqUllaC7UG4sHpIoiCwIA_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-62000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_gGgYwThhA0yTgQ_UqSHevA"
      decimals="-3"
      id="Tc_66kQ9wJsEE-ZCctMw2SRBA_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">505000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_RgosDLxdDkaOOiIDh22DcA"
      decimals="-3"
      id="Tc_FeVhcC0Y2EWLdRgziSaN0Q_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">387000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_PsYZ_Pee1keOQx_1jfic9g"
      decimals="-3"
      id="Tc_1xktjJObpEuEU0gh6zlQiA_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-387000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_F94moY9-wE6MiLBgNhWeLw"
      decimals="-3"
      id="Tc_B3TXdMGtxUGWZAQPEtonfw_10_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1538000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_lnY-Exnu_Ei1u4vGqsRWWg"
      decimals="-3"
      id="Tc_Ucr7N3ZBsEOhDy8kYrtwTg_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1505000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_lnY-Exnu_Ei1u4vGqsRWWg"
      decimals="-3"
      id="Tc_44bLbsx7g0WcmqBU1aWP0Q_10_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">267000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_IY8Y75xLuUqO-v68GXjtQQ"
      decimals="-3"
      id="Tc_83ed-IaC90ePfQrAtUnHQA_10_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3310000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_zxwIfxJDvUW4PlzvkDXuFg"
      decimals="-3"
      id="Tc_njMdyopzR0GzNJaJmmINSw_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3528000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA"
      decimals="-3"
      id="Tc_cRNrW39x40efl2w8qN3UeA_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-4245000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA"
      decimals="-3"
      id="Tc_QM4I3hzjWU2BHqdp9vbmhw_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1171000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_7SsZB-10MEuQVW_oap7LQA"
      decimals="-3"
      id="Tc_PT49kS_2TkOdcjflN9QDSQ_11_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2954000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2021_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_tZJnFmxuvESALxdrRN7PBA"
      decimals="-3"
      id="Tc_tDgQc3KZmkagyHW0Wz1Cig_11_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3408000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_nhhmYMldF0CUWqhi36Qfrw_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24098000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_Q8mBgLyZRUufMp-biczt5A_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-3203000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_2s0W5H4zUE23o4U5dDKpbw_12_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2303000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_ws8g8p225UO0lU0mxApvrw_12_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-387000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw"
      decimals="-3"
      id="Tc_ua1vFCt-7UGHonFxeMO3wQ_12_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22811000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cArnp-3_30mf8DvP_LdFug"
      decimals="-3"
      id="Tc_AJIviUGrFkaZbmMKR2r3RQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">19647000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw"
      decimals="-3"
      id="Tc_ulKON3ArBESlzhu6QE921g_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1993000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw"
      decimals="-3"
      id="Tc_rf2UP7nTWE-CZevEAlpbxg_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2029000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_cvZViiYpdEidBQB4ggpMOw"
      decimals="-3"
      id="Tc_MZXS74HX802UNatMxkbHsw_4_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1605000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentFinancialLiabilitiesMember_TenVHCDHtEWBdBEcmQJ5Ow"
      decimals="-3"
      id="Tc_1TdWGs4Xg0K3ZHKQSBt9LQ_4_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18078000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_eqHyAFkkLECwnDL6Bn6VjQ"
      decimals="-3"
      id="Tc_9xzA89FgLU-DeuxCYZxn7A_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">968000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_pxPW_PzRlkKEtKb4tqL2Uw"
      decimals="-3"
      id="Tc_8eKTbnR3HEG17h1BEKQrDQ_5_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-567000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NoncurrentSecuredBankLoansMember_vQpey-VclkGOtoNQ0QvVjg"
      decimals="-3"
      id="Tc_Tdre_HO1ZE2miGUd3I4eUg_5_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">401000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_NANDNBjf2EaG0Ib3x2YeUw"
      decimals="-3"
      id="Tc_sfXyrDGmjEyoB3Dj1DfN1w_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">610000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_NonCurrentMunicipalLoansMember_abKhok6QA0qwwg9SxU0qaA"
      decimals="-3"
      id="Tc_739X0Aoq2USfgPjcfG2a7A_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-610000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_mWZOLj7bwU68ESmKMOpaew"
      decimals="-3"
      id="Tc_kfrx77ICeUi3BE-B_cTxAA_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18069000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg"
      decimals="-3"
      id="Tc_ilJH2SLZy0KHSnoFaQ2P4w_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1383000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg"
      decimals="-3"
      id="Tc_XvymHspzUUqC1owAytzzlQ_7_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2029000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_AjUrJhteeE-PoEeZL54Svg"
      decimals="-3"
      id="Tc_rQsW8U1s6E2hgefoJf4QRQ_7_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1038000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember_alWkS9-7z0m53IksGJp1Wg"
      decimals="-3"
      id="Tc_Y3cXh99f8UK7yix38ngMxA_7_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17677000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_0I3YNkAwCUaxTut_BdZ8UA"
      decimals="-3"
      id="Tc_vqzUop8bLkaizFLi5gFLRQ_8_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">7323000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg"
      decimals="-3"
      id="Tc_WXXGiAZiAEWlH0Czns801w_8_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-5520000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg"
      decimals="-3"
      id="Tc_f6ULlssHEUmmjTOkDHnkng_8_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2663000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_GYWp1WliWU2lKS3vulATAg"
      decimals="-3"
      id="Tc_e8_P7E1DiEqSEsHqLAJ7PQ_8_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1554000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentFinancialLiabilitiesMember_w4OmoUQNEkmOiPw-yYz1gg"
      decimals="-3"
      id="Tc_rFW16WQ4xUyrbct4uUb1WQ_8_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6020000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_DtG1lO2ItU27MlS9ffm2uw"
      decimals="-3"
      id="Tc_60pq9NcdWkmUWREn6M5rDA_9_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">802000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ"
      decimals="-3"
      id="Tc_hdYR85AR1kGfxJPtO-VLWA_9_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-865000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ"
      decimals="-3"
      id="Tc_fYsDKOhFNkybQGg1b38TDQ_9_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">63000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_X5hYAZgNREaY5fgILI9SEQ"
      decimals="-3"
      id="Tc_-b5PjdfPDk-Pk7zCC45nxQ_9_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">567000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_CurrentSecuredBankLoansMember_OLnDAxQ4XESWJVC9_RdH_A"
      decimals="-3"
      id="Tc_lqAeVrhdd0GU9Mjeh920MA_9_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">567000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_jBSfbMY2lki0j7PbxL_v1A"
      decimals="-3"
      id="Tc_Ik_jVGhIqk2fHUGyuhDEdg_10_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">438000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_jBSfbMY2lki0j7PbxL_v1A"
      decimals="-3"
      id="Tc_Lbx0mDWFaEqydoAUbitM9g_10_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-51000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_BankLoansMember_RgosDLxdDkaOOiIDh22DcA"
      decimals="-3"
      id="Tc_mj8KFaMAckSBR9f2jRuBng_10_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">387000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_s1T9fhanpEauW0zp7hr-Dg"
      decimals="-3"
      id="Tc_abNv3NrBaEGxrUMwk3Zi5w_11_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2636000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_x2UJf7_pxkOnSeiJ7yIVHQ"
      decimals="-3"
      id="Tc_3XqMquP6RkKy9ROSzfPL8w_11_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1208000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_x2UJf7_pxkOnSeiJ7yIVHQ"
      decimals="-3"
      id="Tc_HFiOdZ-Y4kyBlsipBiqfig_11_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">110000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_IfrsBankOverdraftsMember_F94moY9-wE6MiLBgNhWeLw"
      decimals="-3"
      id="Tc_0g0ElfNkVEeN-j-MC4yhTA_11_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1538000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_OrZxBSCrjECX-zhxs899wA"
      decimals="-3"
      id="Tc_jrcQF3W98kqNhgh8MZKzvg_12_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">250000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_FinancingActivitiesMunicipalLoansMember_cNSOgL4hV0ag41MiwnIxFw"
      decimals="-3"
      id="Tc_lh3tzwT700e4kKuoDfAFoA_12_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-250000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_d-rj6ZvYbkKxosbQKnX2KQ"
      decimals="-3"
      id="Tc_ogqp7WhmgEOM0Xmy6JBnWg_13_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3635000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g"
      decimals="-3"
      id="Tc_BHYx8uF8eE2LNChZCOm7uw_13_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-3635000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g"
      decimals="-3"
      id="Tc_1JWtm7LJN0WprstxLyniFg_13_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2490000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_89P28jQcdkCapfYu9EJb6g"
      decimals="-3"
      id="Tc_0i8E4ucgD0-2XnuMdGZfAA_13_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1038000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember_zxwIfxJDvUW4PlzvkDXuFg"
      decimals="-3"
      id="Tc_9DRzWLPV2kKhUslw8RkUbg_13_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3528000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Tc_JH4HT5voa0u8oHnbmcr-oA_14_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">26970000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_zJ926KDgOkOvAYPlZqSjMQ_14_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-7513000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_0oecJmP9Q0C65pyFE0DM1Q_14_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4692000</cntg:IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc__C4uXEVBPk6TH-s69zxaNA_14_8"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-51000</cntg:IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw"
      decimals="-3"
      id="Tc_5D3u_9f_g0KFJcOGmUjhtw_14_10"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">24098000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:DisclosureOfMarketRiskExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_UB1q1bVu6UaMz10KGZlzOQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;USD&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;INR&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;AED&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,604&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade payables and other liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,394)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net exposure&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 210&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;USD&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;INR&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;AED&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trade payables and other liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,631)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (55)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (17)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net exposure&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,407)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (37)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (17)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfMarketRiskExplanatory>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_JO38uhlHsEqj0m4RCxwbMA"
      decimals="-3"
      id="Tc_PR-vy-OBLEq6RpL3QZTsAQ_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2604000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_qUqCYL8yF0CdfM0hT5d4hw"
      decimals="-3"
      id="Tc_HVVZ9wAmh0ewd5Im8bMr3g_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">8000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_GV4YMZdmTU6rHuLJZRyL-Q"
      decimals="-3"
      id="Tc_o2MU-mHcF0OnnMbONy4B1Q_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2394000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2021_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_hqryZrQyo0u9vk198ZL9tw"
      decimals="-3"
      id="Tc_SQXq54jQAU-yWEuCSgjjBQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-4000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_-gQEIJhhKESSr-jRSWvRtA"
      decimals="-3"
      id="Tc_dSGfnPgM-EymHajaLn9rDg_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">210000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_u8KGLF7B5U-cOI8U7qgNTg"
      decimals="-3"
      id="Tc_k7okwAoBJkalzAC7KLgHdg_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_vHwIWQCj6UO2OcggKwqNGA"
      decimals="-3"
      id="Tc_266ZtC7CZ0us19U2UHV-2w_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1224000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_ifrs-full_TradeReceivablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_NqWV89gKk0OodA4cK3KhyQ"
      decimals="-3"
      id="Tc_TvLBtzBNB02oOsKUHvp7OQ_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">18000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_PjLMlUODRk2FbEMI9yrkqw"
      decimals="-3"
      id="Tc_QAL5F6kshkKrLWu930_zYw_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-3631000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_cHFYMEOjEEeAbEoJwPK02w"
      decimals="-3"
      id="Tc_lX8qTMWsMEi-43zppyJrzg_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-55000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_AssetsAndLiabilitiesAxis_cntg_TradePayableAndOtherLiabilitiesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_hqCpXOTPc0ife4tCRqxAhg"
      decimals="-3"
      id="Tc_mOyNcon8C0-_3dpcd7yNjw_4_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-17000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_zoJoP5b4TE-XfyAcw6W03g"
      decimals="-3"
      id="Tc_hL3Gb0rkQk2mFv6qOHHbcw_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-2407000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_INR_mqnnjQQULE6jGbqjlZnJgA"
      decimals="-3"
      id="Tc_aPIXchJQrkaovZPPdDvxaQ_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-37000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_AED_cloQKLoTo0WfQp8u9x2sCA"
      decimals="-3"
      id="Tc_wMH-_ZleYU2n3mUhmiZ6Gw_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-17000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_BiJuVZ4RGUaRIt50TDldTQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;22 List of subsidiaries&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The major subsidiaries of the Group are listed below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Equity&#160;interests&#160;(%)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Country&#160;in&#160;which&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;primary&#160;activities&#160;are&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Name&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;pursued&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene GmbH*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Germany&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene FZ-LLC&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;United Arab Emirates&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene US, LLC&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;USA&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene&#160;GmbH&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Austria&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 90&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene India Pvt.&#160;Ltd**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;India&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene Switzerland AG&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Switzerland&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centosafe B.V.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Netherlands&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene d.o.o Belgrade&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Serbia&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dr. Bauer Laboratoriums GmbH***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Germany&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;(*)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Centogene IP GmbH and Centogene Shared Service GmbH were merged with Centogene GmbH on January 1, 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"&gt;(**)&lt;/span&gt;&lt;/span&gt;The Group acquired the remaining 49% of Centogene India Pvt. Ltd. in 2020, previously accounted for as non-controlling interest.&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"&gt;&lt;span style="font-size:8pt;"&gt;(***)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"&gt;&lt;span style="font-size:8pt;"&gt;Centogene does not own any shares in Dr. Bauer Laboratoriums GmbH. However, Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns (see note 4). &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_lxcl3rnzGUOO9pON5c8Qdw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Equity&#160;interests&#160;(%)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Country&#160;in&#160;which&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;primary&#160;activities&#160;are&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Name&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;pursued&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene GmbH*&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Germany&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene FZ-LLC&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;United Arab Emirates&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene US, LLC&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;USA&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene&#160;GmbH&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Austria&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 90&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene India Pvt.&#160;Ltd**&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;India&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene Switzerland AG&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Switzerland&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centosafe B.V.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Netherlands&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Centogene d.o.o Belgrade&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Serbia&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 100&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:58.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Dr. Bauer Laboratoriums GmbH***&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Germany&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;(*)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Centogene IP GmbH and Centogene Shared Service GmbH were merged with Centogene GmbH on January 1, 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"&gt;(**)&lt;/span&gt;&lt;/span&gt;The Group acquired the remaining 49% of Centogene India Pvt. Ltd. in 2020, previously accounted for as non-controlling interest.&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"&gt;&lt;span style="font-size:8pt;"&gt;(***)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"&gt;&lt;span style="font-size:8pt;"&gt;Centogene does not own any shares in Dr. Bauer Laboratoriums GmbH. However, Centogene meets the criteria of the control model under IFRS 10 as it has exposure to variable returns and the ability to use power to affect returns (see note 4). &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_gdQ7ArXwUU29FpifO1d2Tg"
      decimals="2"
      id="Tc_G8nEM-VVPU2hafKaph0I7Q_5_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_nM4VKfdToUCleIioxMHAVA"
      decimals="2"
      id="Tc_HWTpwnGTK0SC6clbUadoEQ_5_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_6ilmlbgLQUaozewCaC7r6g"
      decimals="2"
      id="Tc_ZuDB41W95UmG0qIx-dcIIQ_6_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneFzLlcUnitedArabEmiratesMember_aJjp5Hfn9ECKKXqBeqaLXQ"
      decimals="2"
      id="Tc_UY5q5qJHYUSK6Opz08AiTA_6_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_fxCJFiGsDU2tRIrSA3JTfw"
      decimals="2"
      id="Tc_AN0WMpBl3kmdkbawKi8LSA_7_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneUsLlcBurlingtonUsaMember_UnWKT0VVDEW_wX3NeqiDeA"
      decimals="2"
      id="Tc_EiehPPcljEaUl9VtZIGXIQ_7_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A"
      decimals="2"
      id="Tc__RVynQHV-0GFfD7Wxt8mow_8_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.90</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ"
      decimals="2"
      id="Tc_iMJS3h6DEkmyZ2QlkZkBcA_8_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.90</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_1RkheOIhVU2eH6psyo77cw"
      decimals="2"
      id="Tc_9VqieLtNfUupz5kLjzqblQ_9_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_tcRN6jVWa0CvEfR4vmQr5g"
      decimals="2"
      id="Tc_4Sw5d8VocE2wr2mGpa89zA_9_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_SSqn3JwlZEKIYquVSRVj4A"
      decimals="2"
      id="Tc_vkMr0jwQj0maLPHrsfw2ZQ_10_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneSwitzerlandAgMember_99jSw-B3lEmA9RjJZquI8g"
      decimals="2"
      id="Tc_AOhqy_UXp0meQKqRuTQffw_10_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_WqUWe927Nk6uSgbaCxFjkA"
      decimals="2"
      id="Tc_YCeC3eNu-EeTx4uHpuEpqw_11_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentosafeB.v.Member_9ANqzl7ZTUajud4xjfwt1Q"
      decimals="2"
      id="Tc_-udDoKVDV0ion86V43IGQw_11_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_jno_GFKBDk6OafQHIJLx7w"
      decimals="2"
      id="Tc_oLyqhUkN60mC3FK4S8288Q_12_4"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneD.o.oBelgradeMember_LsRE2steYEuxjfr5k30J1Q"
      decimals="2"
      id="Tc_mHftXLOAhkW2pwOUh2cynQ_12_6"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_MbQzBIokME2nAKgB5upFAA"
      decimals="2"
      id="Narr_WneCGMFxw0WaYUvBA0Voqg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.49</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_bdJ2MveWp0Wb3cklyIDN2w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;23 Non-controlling interests &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The table below shows information on each subsidiary of the Group with material, non-controlling interests before intercompany eliminations. The Group acquired the remaining 49% of Centogene India Pvt. Ltd in 2020 and disposed of its entire 51% interest in LPC GmbH in 2020. The non-controlling interest in Dr. Bauer Laboratoriums GmbH relates to the share in the net result of Dr. Bauer Laboratoriums GmbH that is included in the results of the Company&#x2019;s COVID-19 testing business (see note 4).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Centogene GmbH, Vienna&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dr. Bauer Laboratoriums GmbH&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net assets/(liabilities)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (528)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 245&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Carrying amount of non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;109,015 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Profit/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (6)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Profit/loss allocated to non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Centogene GmbH, Vienna&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dr. Bauer Laboratoriums GmbH&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net assets/(liabilities)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (522)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 148&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Carrying amount of non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (52)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;55,596 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Profit/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Profit/loss allocated to non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneIndiaPvt.LtdMember_MbQzBIokME2nAKgB5upFAA"
      decimals="2"
      id="Narr_lopWH0tNrEiIAFDieA5kZg"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.49</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <cntg:ProportionOfOwnershipInterestInNonControllingInterestDisposal
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg"
      decimals="2"
      id="Narr_ROI6v__qmUuEgbgVjmoA2Q"
      unitRef="Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw">0.51</cntg:ProportionOfOwnershipInterestInNonControllingInterestDisposal>
    <ifrs-full:DisclosureOfCompositionOfGroupExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_EMcANNxHcE-Oy7QPsW-zXQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Centogene GmbH, Vienna&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dr. Bauer Laboratoriums GmbH&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net assets/(liabilities)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (528)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 245&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Carrying amount of non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;109,015 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Profit/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (6)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Profit/loss allocated to non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dec 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Centogene GmbH, Vienna&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Dr. Bauer Laboratoriums GmbH&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net assets/(liabilities)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (522)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 148&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Carrying amount of non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (52)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;55,596 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Profit/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Profit/loss allocated to non&#x2011;controlling interests&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfCompositionOfGroupExplanatory>
    <ifrs-full:NetAssetsLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_goSBvtoOwUimSgVTIL8xDA"
      decimals="-3"
      id="Tc_v9iAxHXr50uMI9eXNxSO4A_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-528000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_LIP-LQLQ8UqI_DwDXlei1Q"
      decimals="-3"
      id="Tc_PTcVR-BDKUCy-TmXTib-4w_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">245000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NoncontrollingInterests
      contextRef="As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_goSBvtoOwUimSgVTIL8xDA"
      decimals="-3"
      id="Tc__REgU0rrLES4hIhNUeNRHw_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">53000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg"
      decimals="-3"
      id="Tc_tiVI4Ca3A0ujGu8nxtirVA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">109015000</ifrs-full:Revenue>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A"
      decimals="-3"
      id="Tc_3w8hQiQkGkSWlrHdh0P2EA_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-6000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg"
      decimals="-3"
      id="Tc_UHyP2bUQJUO0AX5z7dBTNg_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">98000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_WBzeTSm5hken_52_uX2Q0A"
      decimals="-3"
      id="Tc_TR6Ioej2TUWC9ZtqhJcBzw_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_-pKMHpORVkGgR4F4KBBjgg"
      decimals="-3"
      id="Tc_tT5GddUzHkKBkOpkSyHEkQ_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">98000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:NetAssetsLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_N4HdUneZ4E-AHlGZSokgjg"
      decimals="-3"
      id="Tc_hFxjeS8FzEOVORCzwQQ6bQ_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-522000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_loohpHzHaEaNrs2gcMBUCQ"
      decimals="-3"
      id="Tc_PxjjbsvS4USz6ZtfdZ2jNQ_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">148000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NoncontrollingInterests
      contextRef="As_Of_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_N4HdUneZ4E-AHlGZSokgjg"
      decimals="-3"
      id="Tc_8RBEJLjKL0W6chS1tQ0q6g_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">52000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA"
      decimals="-3"
      id="Tc_no40aXQfcUiTh-rgQr2e1A_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">55596000</ifrs-full:Revenue>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ"
      decimals="-3"
      id="Tc_2H98c9So_U6BEUu5UUb7Gw_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">-1000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA"
      decimals="-3"
      id="Tc_G2fx8-BQxEm2ef7tCGdR8g_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">122000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_xdKv6_caQEq_m58jcisnBQ"
      decimals="-3"
      id="Tc_Rg36bPI0ekmxWwrd6VzhRg_7_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_Dr.BauerLaboratoriumsGmbhMember_d9SgDA0nYky79zvo5TZROA"
      decimals="-3"
      id="Tc_V8Sb_z2vFE2XYXvuJYojnw_7_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">122000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:DisclosureOfCommitmentsExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_vjlAyeyEM0ebQpm6_1TKGg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;24 Commitments&lt;span style="font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;"&gt;Future payments for non-cancellable leases&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:normal;"&gt;The Group has various lease contracts in relation to the expansion of the Rostock headquarters and leasing of the Frankfurt laboratory, Berlin Airport, D&#xfc;sseldorf Airport, Frankfurt Airport and additional laboratory space in Hamburg. The future lease payments and utilities for these non-cancellable lease contracts are EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;107&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k within one year, EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;2,370&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k within five years and EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;4,219&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k thereafter (2020: EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;283&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k within one year, EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;1,686&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k within five years and EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;4,855&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k thereafter).&lt;/span&gt; &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:normal;"&gt;The Group has various non-cancellable lease contracts of office equipment and storage spaces which had a lease term of less than 12 months or were related to leases of low-value assets, and therefore the short-term lease recognition exemption was applied to these contracts. The future lease payments for these non-cancellable lease contracts are EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;44&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k within one year (2020: EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;33&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k) and EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;49&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k within five years (2020: EUR &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;9&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;k). &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Future payment obligations&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;During 2021, the Group concluded agreements with suppliers, for goods and services to be provided in 2022 with a total payment obligation of EUR&#160;6,620k (2020: EUR&#160;4,669k).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_aP3WLzf6M0CLLqABTJdjzQ"
      decimals="-3"
      id="Narr_RwctMCgMfUqZgnHA0rn5eg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">107000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_TgPeSvqouUGI0WVPV6Fpag"
      decimals="-3"
      id="Narr_-UCv7e8yekKwM8vGMNMzqA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2370000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_5Ec6abUhxEqrvssO3I3V1A"
      decimals="-3"
      id="Narr_FzFLTHZmrE-JUgHbkZABvw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4219000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_sqSmjjzLIUyAz8bHBnf8gw"
      decimals="-3"
      id="Narr_DLOvALFr0kqMITYoKAYNrg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">283000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_pxx5jMplQ023eMujrnK7Mg"
      decimals="-3"
      id="Narr_1BNUDDirG0udlLoX8M473w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1686000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_HQ7jbEAacECvHaRSqE6IBg"
      decimals="-3"
      id="Narr_lG3u2aJ-ZEmF60wLRqXyYA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4855000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_h_nPcgoxBEe8fAs9VKUdBw"
      decimals="-3"
      id="Narr_NQIztkmHHEOoGB6SECyqiw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">44000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ryAYBZr5MkGcAGRJi9dXVQ"
      decimals="-3"
      id="Narr_VWt7AeeDFUenC6PhIo32hA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">33000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_Lv3jrzK6k02RPZdSdWq4Rw"
      decimals="-3"
      id="Narr_CvUkCaEkYECd30gNV47i4w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">49000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:UndiscountedLeasePaymentsToBeMade
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_cntg_OfficeEquipmentAndStorageSpacesMember_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_K_VUIvDBuUOw0I-5hs6miw"
      decimals="-3"
      id="Narr_75wX3Cd-XkGtxs6HIBWmFw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">9000</cntg:UndiscountedLeasePaymentsToBeMade>
    <cntg:FuturePaymentObligationToSuppliersForGoodsAndServices
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Narr_739Kzt-dNESkM4dq5WqElg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6620000</cntg:FuturePaymentObligationToSuppliersForGoodsAndServices>
    <cntg:FuturePaymentObligationToSuppliersForGoodsAndServices
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Narr_1S1nUlJdWk2KrAU_Mg4JWg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4669000</cntg:FuturePaymentObligationToSuppliersForGoodsAndServices>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_ILeAe7x0x0eYefBdnXErew">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;25 Related parties &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Transaction with shareholders &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In July&#160;2020, we completed a follow-on public offering of 3,500,000 common shares of the Company (the &#x201c;Follow-on Equity Offering&#x201d;), consisting of 2,000,000 common shares offered by the Company and 1,500,000 common shares offered by selling shareholders at a price to the public of $14.00 per common share (i.e., EUR 12.71 per share). Aggregate offering proceeds, net of underwriting discounts, commissions and transaction costs, to the Company were EUR 22 million. We are not aware of any ordinary shares which were issued by the Company and sold in this transaction to related parties.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Based on a shareholder agreement from January 2016 the payment to the option holders of the VSOP 2016 will be reimbursed by the original shareholders to the Company at the same time when the obligation to pay the options holders arises. The payables by the Group to the holders of vested options were recorded as a liability with a carrying value of EUR 2,769k as of December 31, 2019 and a corresponding receivable against shareholders was recorded (see note 15). The shareholders agreement had a term until December 31, 2023. Upon completion of the July 2020 Offering, the relevant payables to the holders of vested options were settled mainly by the proceeds received from such original shareholders from the sale of their shares.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;During 2020, the Company entered into a service contract with the former CEO, a major shareholder, to serve as an advisor during the transition period after his departure from the Company until December 31, 2020. For the year ended December 31, 2020, fees totaling EUR 11k were charged to profit or loss related to these services and the Group had payables of EUR 12k outstanding as of December 31, 2020. In 2021, no further service agreement have been entered into. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Remuneration of management in key positions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Key management have been defined as the members of the management board and the Company&#x2019;s other key executive officers.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:75.22%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Short&#x2011;term employee benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,273&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,313&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Post&#x2011;employment pension and medical benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Termination benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 235&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 565&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share&#x2011;based payment transactions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 822&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,822&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,395&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total compensation to key management&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,178&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,683&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,718&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Due to the departure of the former CEO Arndt Rolfs in 2020, share-based payments include additional share-based expenses of EUR 776k for the accelerated vesting of outstanding equity awards and termination benefits include the severance payout of EUR 565k. As of December 31, 2020, the Group had amounts of EUR 1,325k (2019: EUR 769k) accrued for key management compensation. (See &#x201c;Note 27 &#x2013; Subsequent Developments&#x201d; of our consolidated financial statements as of and for the year ended December 31, 2021.)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;There are no pension commitments for members of the management board.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;During 2021, 15,000 share options and 142,764 RSUs were granted under the 2019 Plan to key management personnel which are recognized as share-based payment expenses in profit and loss (see notes 20(vi)).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2021, the Group has receivables of EUR Nil (2020: EUR 561k) recognized related to the exercise of options by key management personnel, including the former CEO Arndt Rolfs in 2000 who was a member of key management during the periods.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Remuneration of members of the Supervisory Board&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The supervisory board received remuneration for its activities of EUR&#160;688k in the reporting year (2020: EUR 603k; 2019: EUR 499&lt;span style="white-space:pre-wrap;"&gt;k).  In addition, as disclosed in note 20, certain members of the supervisory board received share-based awards under the 2019 Plan. For the year ended December 31, 2021, share-based payment expenses of EUR&#160;&lt;/span&gt;2,564k (2020: EUR 2172k, 2019: EUR 704k) related to these awards were charged to profit and loss.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Transactions with members of management in key positions and other related parties&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company purchased supplies used for COVID-19 testing from an entity related to a member of the supervisory board that joined the board in 2021. Expenses totaling EUR 5 thousand were charged to profit and loss related to the period of service of the board member. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;For the year ended December 31, 2021, revenues totaling EUR 14 thousand were recognized in profit and loss in relation performance of COVID-19 testing services for entities related to members of the supervisory board. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;For the year ended December 31, 2021, fees totaling EUR nil (2020: EUR&#160;nil; 2019: EUR&#160;152k) were charged to profit or loss in relation to consulting services provided by a member of the supervisory board. &lt;/p&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_GTBMEUx2bE2fzTJ4qOUR-Q"
      decimals="0"
      id="Narr_E3b57ggAI0uxi9OopMF-xw"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">3500000</cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_dei_LegalEntityAxis_cntg_CentogeneN.vMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_8do-YyNisUSwYP5bueDYNA"
      decimals="0"
      id="Narr_bSpsNumra0GN4elpA7-elA"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">2000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <cntg:NumberOfCommonSharesOfferedByPriorShareholders
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw"
      decimals="0"
      id="Narr_bMoqabtO3UmacNgCA2g5Nw"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1500000</cntg:NumberOfCommonSharesOfferedByPriorShareholders>
    <cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw"
      decimals="2"
      id="Narr_s2hMoGUk_USN72EFMqnmDQ"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">14.00</cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues>
    <cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw"
      decimals="2"
      id="Narr_YdeR0vJvC0-7G98IJMXAQw"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">12.71</cntg:StockIssuedDuringPeriodOfferingPricePerShareNewIssues>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_13BSSqaMrk-TyOO1Po2CTw"
      decimals="-5"
      id="Narr_hfwJZjPdJkaOC_0kWqYy3Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22000000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011
      contextRef="As_Of_12_31_2019_sWZj64-X7kK7sf17lrrNaQ"
      decimals="-3"
      id="Narr_kgRGLkYQlkeIrrZMDDLOOA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2769000</ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_aVpyI5X7v02azktZKILDIQ"
      decimals="-3"
      id="Narr_yLLVkt4tu0CNsxgneohp7A"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">11000</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="As_Of_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_RelatedPartyServicesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerCeoAndMajorShareholderMember_ad_D9-9ZjU6KAfCtl8pHWQ"
      decimals="-3"
      id="Narr_SaOWnS-0-0qWf7k31OENDQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">12000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_TzGt5k02KU24muzvFzlSKg">&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:75.22%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in EUR k&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2019&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Short&#x2011;term employee benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,273&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,313&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Post&#x2011;employment pension and medical benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Termination benefits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 235&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 565&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Share&#x2011;based payment transactions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 822&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,822&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,395&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total compensation to key management&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 5,178&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,683&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 6,718&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_PASyBMbq_kOKFJb4KDKuvA_2_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4098000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_t7-I26YIbEmNBhzN-uePsA_2_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">4273000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_bDvczoc11k-2eDF-Udn0RQ_2_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3313000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_q6mnXcDSO0aPvVeKi3lnNw_3_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_Yo99T2TvvEufczfK9aMdJA_3_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">23000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_3GccoFHI60i9i8bzC7ihDw_3_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">10000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_tDMFeMAbGUSSrb-eh3olMQ_4_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">235000</ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_qoaVyxoLvkWI0Z88L8dHVQ_4_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">565000</ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_TR5tXJJHR0GAnbITgZZaFA_5_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">822000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_jAg1gti6FkSAEridGE5AYA_5_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1822000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_h7RMIc2i90GI5UWKLeBnDg_5_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">3395000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      decimals="-3"
      id="Tc_OCzoIwdcBEKRtdFJFcJmkg_6_2"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5178000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg"
      decimals="-3"
      id="Tc_w-6GO53SxUCFTK0vm_vOUQ_6_4"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6683000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw"
      decimals="-3"
      id="Tc_rWe-d70qOU-DMi2yGf9Prw_6_6"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">6718000</ifrs-full:KeyManagementPersonnelCompensation>
    <cntg:IfrsShareBasedPaymentArrangementAcceleratedCost
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_AWKL1ObmqUyfc9ddDXBLhg"
      decimals="-3"
      id="Narr_QhVEBNK-z0Gto2VvnHrg9w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">776000</cntg:IfrsShareBasedPaymentArrangementAcceleratedCost>
    <cntg:KeyManagementPersonnelCompensationSeverancePayout
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_AWKL1ObmqUyfc9ddDXBLhg"
      decimals="-3"
      id="Narr_LxokMPAk6k2yL1d6fAR3ZQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">565000</cntg:KeyManagementPersonnelCompensationSeverancePayout>
    <cntg:KeyManagementPersonnelCompensationAccruedAmount
      contextRef="As_Of_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_T02QWHkiiU6Rq5vnTMYTIA"
      decimals="-3"
      id="Narr_LGQ0Io8d7UWYcOttEe5Hzg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1325000</cntg:KeyManagementPersonnelCompensationAccruedAmount>
    <cntg:KeyManagementPersonnelCompensationAccruedAmount
      contextRef="As_Of_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_cIYko65EgkiZ7oKBWF8NyQ"
      decimals="-3"
      id="Narr_3cUWnnB9UEaWdSZQsG1gig"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">769000</cntg:KeyManagementPersonnelCompensationAccruedAmount>
    <cntg:PensionCommitments
      contextRef="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember_HpZLjBEdXU2I8BB2YamhLg"
      decimals="-3"
      id="Narr_MnkCMN1KFkSzy2BNR6ZJlQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</cntg:PensionCommitments>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_ui7vsg5w4EG0lJsC-MuuLA"
      decimals="INF"
      id="Narr_jKHUAGS16k6SrFfcXj077Q"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">15000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_VP9HWW5A2E-7VpFzEFjsVA"
      decimals="INF"
      id="Narr_-ZPgOU3NwkSHRu3DYC37og"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">142764</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="As_Of_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_UJLB8dmYAkWtWhi5WI1mgA"
      decimals="-3"
      id="Narr_3pk6uwz0gUe4TTdLiVvRvw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="As_Of_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_T02QWHkiiU6Rq5vnTMYTIA"
      decimals="-3"
      id="Narr_XR_5j4sszkKVgohoqPhLnw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">561000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_-kfNLSIGS0CnDBcj9PVDWQ"
      decimals="-3"
      id="Narr_pnWpMsBUkUqxs5V-B7VoBg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">688000</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_OO2fJYJiZ0i04iwTzazmNQ"
      decimals="-3"
      id="Narr_trdBhrzcTUueXnB-lduZGw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">603000</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_SupervisoryBoardActivitiesMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_cu0LEFW0kkCkn6XxXp6-EA"
      decimals="-3"
      id="Narr_upyS1Lvwe0Kgbe9SlLiSnw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">499000</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_uWLOxsW1eEmoFw2X5N9jYg"
      decimals="-3"
      id="Narr_CcbVNbo83EO3EpdW4BGz_Q"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2564000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_FDERhT7zokOtLHTy2PLLsA"
      decimals="-3"
      id="Narr_JEVQ6ELaTkSpdEEFUWvZ8w"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2172000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2019_To_12_31_2019_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_gFxC2tLdrUODGcKQ8Sm_rg"
      decimals="-3"
      id="Narr_Kdf0KMf7k0KvgpOr2Cp6bw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">704000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingSuppliesPurchasesMember_PMe3DYqonU-W4y4ejGN9NQ"
      decimals="-3"
      id="Narr_LQ1JGeWKGkeWMhUml2YwXA"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">5000</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:RevenueFromRenderingOfServicesRelatedPartyTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CovidTestingServicesMember_ybA9VqNfoU6JvMqlmNzzdg"
      decimals="-3"
      id="Narr_jHPd97YNA0GBf6YnGoLd8g"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">14000</ifrs-full:RevenueFromRenderingOfServicesRelatedPartyTransactions>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_BvghgdBxEEK2gQ296xhPFA"
      decimals="-3"
      id="Narr_w0qiCrZhrESL4aoN7aUqYQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MemberOfSupervisoryBoardMember_UKYRDn2W90unJoMzUYsVTQ"
      decimals="-3"
      id="Narr_KN-rBH9g5kmABipvW0R0lQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">0</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:ServicesReceivedRelatedPartyTransactions
      contextRef="Duration_1_1_2019_To_12_31_2019_cntg_IfrsRelatedPartyTransactionAxis_cntg_CorporateStrategyServiceMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_hqH7Ao9bKk-C9CGDc25eug"
      decimals="-3"
      id="Narr_XrgE1jM06kC6TESMnrlDBg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">152000</ifrs-full:ServicesReceivedRelatedPartyTransactions>
    <ifrs-full:DisclosureOfContingentLiabilitiesExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_5g3mR-oXF0ieCs5Nz-dkKg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;26 Contingent liabilities &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In May 2016, the Company was informed in writing by the Universitair Medisch Centrum Utrecht ("UMCU") that a claim had been initiated against UMCU regarding a prenatal diagnostic test that the Company conducted at their request which failed to identify a specific mutation present in a patient. On October 1, 2018, the UMCU and Neon Underwriting Limited formally filed a legal claim in the local court in Rostock, Germany against the Company alleging that the Company&#x2019;s negligence in performing the test resulted in the misdiagnosis of the patient. UMCU is seeking recovery for compensatory damages as a result of the alleged misdiagnosis. By court order of November 8, 2018, the Regional Court of Rostock set the amount in dispute at EUR&#160;880k.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On November 12, 2018, the Company submitted a notice to the Regional Court of Rostock of the intention to defend against the claim. On January 3, 2019, the Company filed a motion to dismiss in which the Company denied the merits of the claim. UMCU and Neon Underwriting Limited responded to this motion on March 15, 2019 with a statement of reply, and the parties made several court filings setting out their arguments since. By order dated June 3, 2019, the Regional Court of Rostock provided a first set of questions to be answered by an expert witness. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2020, the amount in dispute was EUR 1.3 million. The matter was assigned to a new judge, due to the illness of the prior judge, and the decision to appoint the recommended expert witness is still pending. Since then, several potential experts were approached by the court but eventually declined to prepare an expert witness report due to the possibility of bias. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;The Company intends to continue to rigorously defend its position and considers that it is not probable the legal claim towards the Company will be successful and as a result has not recognized a provision for this claim as of December 31, 2021. In addition, in case a settlement would be required, the Company believes that the corresponding liability will be fully covered by the respective existing insurance policies.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;On August 7, 2021, our partnering laboratory physician and a key executive officer of ours, Prof. Dr. Peter Bauer was informed in writing by the Public Prosecutor's Office in Fulda that a criminal investigation had been initiated against him regarding allegedly falsely billing statements submitted to the Association of Statutory Health Insurance Physicians in Hessen (Kassen&#xe4;rztliche Vereinigung Hessen). The aggregate amount in question was EUR 42,268.50. The investigation and claims were subsequently dropped in January 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;Certain of our original shareholders agreed to reimburse us for the payments that we make to option holders under the 2016 Plan. Upon completion of the Follow-on Equity Offering, the relevant payables to the holders of vested options were settled mainly by the proceeds received from such original shareholders from the sale of their shares in the Follow-on Equity Offering. We have received a demand from one such original shareholder that alleges that it should have paid less to us in connection with the settlement of such payables. While we continue to believe that such demand has little chance of being successfully enforced through legal proceedings, we see the benefit of settling this pending issue. We have therefore agreed to a settlement agreement with the relevant shareholders pursuant to which we will make a one-time-payment in the total amount of EUR 550,000 to be divided up between such shareholders. On November 22, 2021, we signed a settlement agreement with the relevant shareholders. &lt;/p&gt;</ifrs-full:DisclosureOfContingentLiabilitiesExplanatory>
    <cntg:DamagesSought
      contextRef="As_Of_11_8_2018_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_0CIYtds9E0mzIEud1TfR8g"
      decimals="-3"
      id="Narr_IgQu2xrI9kGtCgB8CbRNQw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">880000</cntg:DamagesSought>
    <cntg:DamagesSought
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_UniversitairMedischCentrumUtrechtMember_zf-wHnQpt06jb4tX_HSi1Q"
      decimals="-5"
      id="Narr_F-pRJTDvhUmIQF6GJBdcsg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1300000</cntg:DamagesSought>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="As_Of_8_7_2021_ifrs-full_ClassesOfContingentLiabilitiesAxis_cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember_kqeqzG7A9E-5ZgMWESZGzA"
      decimals="2"
      id="Narr_DrNaBcerSEWcWX1rbnwHhw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">42268.50</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_StockOptionPlan2016Member_GI6mBJf-uEaspTZUbL_7cg"
      decimals="0"
      id="Narr_jAwQWBXpvUKUY6dSmJZPxQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">550000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory
      contextRef="Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q"
      id="Tb_ej5azOKb_UWRaq8VKnGDmg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;27 Subsequent Events&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On January 31, 2022, pursuant to a securities purchase agreement and a warrant agreement, each signed with certain investors, the Group received EUR 15.0 million in exchange for the issuance of an aggregate of 4,479,088 common shares at a price per share of USD 3.73 (EUR 3.35) and warrants initially exercisable for the purchase of up to an aggregate of 1,343,727 additional common shares at an initial exercise price per common share of USD 7.72. The warrants are exercisable immediately as of the date of issuance and will expire on December 31, 2026. Based on the fair value per share at the issuance date, the Group expects to recognize USD 3.2 million (EUR 2.8 million) under equity in the first quarter of the financial&#160;year 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;In addition on January 31, 2022, the Company and certain of its subsidiaries entered into the Loan Facility, providing for debt financing agreement in the total amount of up to USD 45.0 million (EUR 40.2 million). Under the terms the Loan Facility, the Group drew down USD 25.0 million (EUR 22.3 million) on January 31, 2022 and will have access to a second tranche of USD 20.0 million (EUR 17.9 million) upon achievement, prior to July 31, 2023, of product revenue from our diagnostics and pharmaceutical services segments of at least USD 50.0 million (EUR 44.7 million) calculated on a trailing twelve month basis as of the last day of any fiscal month. As security for the Borrowers&#x2019;s obligations under the Loan Facility, the Borrowers granted the lenders thereunder a first priority security interest on all of each Borrowers&#x2019; assets. Refer to note 2.2 Going concern for further details of the Loan Facility.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;On February 1, 2022, the Group announced the resignation of Dr. Andrin Oswald as CEO, effective immediately, due to his prolonged medical leave. According to his separation agreement, all unvested RSUs held by Mr. Oswald under the Company&#x2019;s LTIP will continue to vest in accordance with their terms through the date of his termination on April 30, 2022, however; the number of RSUs shall not exceed 62,284 RSUs. As a result, unvested RSUs granted to Mr. Oswald shall be forfeited as of January 31, 2022 when Mr. Oswald stopped rendering services for the Group. Total RSUs in the amount of EUR 1,358k that was recognized in the financial statements in the previous periods will be derecognized in 2022 financial year and additional RSUs in the amount of EUR 201k will be recognized in 2022 financial statements to match 62,284 RSUs granted to Mr. Oswald.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;On February 1, 2022, Kim Stratton was appointed as the new CEO (the &#x201c;New CEO&#x201d;). The New CEO and the Company entered into an award agreement pursuant to which the New CEO will receive certain RSUs, which have no exercise price. According to the agreement, the RSUs are awarded in two forms as&#160;&#160;174,394&#160;&#160;&#160;initial performance RSUs subject to time-vesting and performance vesting and 166,667 initial time-vested RSUs subject to only time-vesting. Both awards vest in four equal installments after the grant date and have a grant date of February 1, 2022 and expiration date of February 1, 2032.&#160;However; initial performance RSUs that have not performance-vested by January 1, 2024 expire on January 2, 2024.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;On February 7, 2022, the Company announced the resignation&#160;of Ren&#xe9; Just as CFO effective March 31, 2022. According to the separation agreement signed on the same date, all vested RSUs held by the Mr. Just as of March 31, 2022 that have not yet been exercised and settled must be exercised and settled in accordance with their terms within six months following this date and, if such RSUs are not exercised and settled within such period, they will be cancelled automatically upon the expiry of such six-month period without compensation for the loss of such RSUs. All unvested RSUs as of March 31, 2022 will be cancelled automatically without compensation for the loss of such RSUs.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;On February 7, 2022, Jose Miguel Coego Rios was appointed as Executive Vice President of Finance &amp;amp; Legal and Interim CFO (&#x201c;Interim CFO&#x201d;). The Interim CFO was awarded 30,995 RSUs vesting in four equal tranches from January 1 following the grant date of February 2, 2022. The award is not subject to any performance criteria and vested tranches may be exercised at the option of the Interim CFO and will be settled in shares.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;In February 2022, a number of countries (including the United States, United Kingdom and the European Union) imposed sanctions against certain individuals and entities in Russia and Belarus as a result of the recognition of the so-called Donetsk People and the so-called Republic and Luhansk People Republic by the Russian Federation. Announcements of potential additional sanctions have been made following the war initiated by Russia against Ukraine on February 24, 2022.  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"&gt;Due to the war in Ukraine, there has been a significant increase in volatility on the securities and currency markets. It is expected that these events may affect the activities of Russian enterprises in various sectors of the economy. Although neither Centogene&#x2019;s operations, performance nor going concern basis has been significantly affected by the conflict, the impact of the conflict and its broader economic implications, such as higher costs of consumer goods, cannot be reliably quantified at this point in time. Therefore, at the date of this report, the Management Board regards these events as non-adjusting events after the reporting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"&gt;These consolidated financial statements were approved by management on March 31, 2022. &lt;/p&gt;</ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg"
      decimals="-5"
      id="Narr_j0PDncpUlEae0gbZhafoqQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">15000000.0</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <cntg:IfrsStockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_PfbiCPD-B0GrffKTWQRTmg"
      decimals="INF"
      id="Narr_aRhRL31qK0GesOzHiEACsQ"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">4479088</cntg:IfrsStockIssuedDuringPeriodSharesNewIssues>
    <cntg:IfrsSharePrice
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="2"
      id="Narr_h6WGsLpXJ0-LsyKqcdn7Sg"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">3.73</cntg:IfrsSharePrice>
    <cntg:IfrsSharePrice
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="2"
      id="Narr_nvGGHpbgz0mwQJQjcRvBaw"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">3.35</cntg:IfrsSharePrice>
    <cntg:IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="INF"
      id="Narr_e1IXOCGGp0ic-mNPRjXvpQ"
      unitRef="Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw">1343727</cntg:IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <cntg:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
      contextRef="As_Of_1_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_sG9lkTNKwUu9Sp-x1iCRnw"
      decimals="2"
      id="Narr_8sH7FwG3a06h2j8tuXvsAg"
      unitRef="Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA">7.72</cntg:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
    <cntg:ValueOfOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ"
      decimals="-5"
      id="Narr_UIUadL-fLkSFLVnlMPSgBg"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">3200000</cntg:ValueOfOtherEquityInstrumentsGranted>
    <cntg:ValueOfOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ"
      decimals="-5"
      id="Narr_L2U7mXVoSkyrvHOgagDcAA"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">3200000</cntg:ValueOfOtherEquityInstrumentsGranted>
    <cntg:ValueOfOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_2V5JfV2zC0C1FkG3QafygQ"
      decimals="-5"
      id="Narr_mfGNMdWL1E6fxWRpcgQjkg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">2800000</cntg:ValueOfOtherEquityInstrumentsGranted>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg"
      decimals="-5"
      id="Narr_BrnQ6w1yZkifNfMVgjUwTg"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">45000000.0</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_dVdtJBuj00W7LV_3lttMkg"
      decimals="-5"
      id="Narr_GPVPqlybA06fzIvF7DCMqg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">40200000</ifrs-full:NotionalAmount>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ"
      decimals="-5"
      id="Narr_-jX5-4e5PUK7RzZV7gi8pw"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">25000000.0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheOneMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_Dr637SVq-UuuaKVp1oZ-WQ"
      decimals="-5"
      id="Narr__rE_aoSvq0GxXdsVtdoVdw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">22300000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA"
      decimals="-5"
      id="Narr_bSjTM6DdQU-k8ITbjL2BDg"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">20000000.0</cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue>
    <cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue
      contextRef="As_Of_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_0aq9JFS3j06X_i3Fu9KoxA"
      decimals="-5"
      id="Narr_WoIxTMj36UKZmZ46upRYUw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">17900000</cntg:BorrowingsAvailableSubjectToAchievementOfProductRevenue>
    <cntg:BorrowingsRevenueAchievementThreshold
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityTrancheTwoMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_toNpqLxkdUiCYTSACudSBw"
      decimals="-5"
      id="Narr_NwD8VWRJ6UG_9hP2yIrrLQ"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">50000000.0</cntg:BorrowingsRevenueAchievementThreshold>
    <cntg:BorrowingsRevenueAchievementThreshold
      contextRef="Duration_1_1_2022_To_1_31_2022_ifrs-full_BorrowingsByNameAxis_cntg_LoanFacilityMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_EnteringInToDebtFinancingAgreementMember_SvSryWkeDES4Mz3BiNpI4g"
      decimals="-5"
      id="Narr_OY98Irvs9UOmlM9ACY_kJw"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">44700000</cntg:BorrowingsRevenueAchievementThreshold>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_yqUJXsPgDUScDg3m6hyHWw"
      decimals="0"
      id="Narr_SAeuWp0xa0acQU_psQaNTQ"
      unitRef="Unit_Standard_USD_-Y7LjOdYNUa1AhNYBA21jA">62284</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <cntg:ValueOfOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusDerecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_vmSzJlkTlU2f0ogmnllTIQ"
      decimals="-3"
      id="Narr_8hmA3-5L4EqExDdvI1pVEg"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">1358000</cntg:ValueOfOtherEquityInstrumentsGranted>
    <cntg:ValueOfOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_cntg_IfrsAwardTypeAxis_cntg_RsusRecognizedMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_Gr0aLoEJnkKrHhlW3a8QGg"
      decimals="-3"
      id="Narr_vpEC0L9XN0KXo9rGE3GcgQ"
      unitRef="Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ">201000</cntg:ValueOfOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_1_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_9zMVFYEdmk-gHU2SpZ4EMQ"
      decimals="0"
      id="Narr_D4Ba5x7RHUqYgG2e4Sf-Nw"
      unitRef="Unit_Standard_item_-qWnVJTSfkeBJ1EtMUURPA">62284</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_CV9SX4hApkWmqEt_60wM4g"
      decimals="INF"
      id="Narr_a1XsZWYI5kyzlDByLjZ1gQ"
      unitRef="Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q">0</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_pLa-1tNWhkaifjyG5-55CA"
      decimals="INF"
      id="Narr_oRex0nq_FEmBfBA9A8C_Mg"
      unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg">174394</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_cntg_IfrsVestingAxis_cntg_ShareBasedAwardsSubjectToTimeVestingMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_EZ4EQKl6u0y4U2G9Chnqbw"
      decimals="INF"
      id="Narr_ib51hwuN_EilaWo0ZpYgpg"
      unitRef="Unit_Standard_EquityInstruments_eqSrU2PzhE6xXU8VKlm_Zg">166667</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <cntg:NumberOfInstallments
      contextRef="As_Of_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_E6OgGNIl3kmP-TkRKZ6LGg"
      decimals="INF"
      id="Narr_p6gHpr-Omk2zjb5wJ0Bteg"
      unitRef="Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ">4</cntg:NumberOfInstallments>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_E0hk7XwMHkiMLSQWwvqDyw"
      id="Narr_EoTvK5j-b06NE_wudxnEFA">P6M</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
      contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_E0hk7XwMHkiMLSQWwvqDyw"
      id="Narr_fAfhR8pG5kikKMC7LnPHZw">P6M</cntg:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_MiguelCoegoRiosMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorOrdinaryShareTransactionsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_AnpIXYXhBkuyC6Ni6BiUGA"
      decimals="0"
      id="Narr_jpZWlIskAUql68qJ8FKl0Q"
      unitRef="Unit_Standard_item_-qWnVJTSfkeBJ1EtMUURPA">30995</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <cntg:NumberOfTranches
      contextRef="Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ManagementMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_f5-2plb0q0-wYgUIlGZSEQ"
      decimals="0"
      id="Narr_lcMJ_X_KtUaAk4moGwDWTw"
      unitRef="Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw">4</cntg:NumberOfTranches>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>133
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M[(W"M\?QL"I@W_B2\2>]<DVJJMQ+^5#=7*2'O: BXCE/3"7!X.>1G_ \KY2
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M<S9M=31<8,)RS3&4%;,-\8E<*F5!,IW *+KC3*&-Y9';V@KI5H2V$G5HM,L
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M36 &.!H5+ IRN*GWE,LVO<RRW_*&-FMNXZ04T[ <17X2X<2E!*#B/'96V0I
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MW9?JD1__8%U #<$E+V7S"8XM-M-/7.ZEXE5GK.^KHFZ_Z7.7B!,#&'L,4&>
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M)=&8E0.6)EGFF2;0T H0O'A2+@OZ5)1ZFS"N]5O?)T-X6,E-:5Y=<UJ[2K)
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MIM>I, #]_YIS]7ICCF3[(_CY?U!+ P04    " #X<']4=0>]$>T'   %(@
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M-(D*R4^B,WWJU4)"1R&F5PCQ93C;WEXHM;>-L8UH99M'R'A+&LHF(2GUDP8
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MH@2HYRO.Y8^;\K7:^=WQ[7]02P,$%     @ ^'!_5!6+G">W!0  5@T  !@
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6RM5]MNVS@0_96!%UBD@"O;2K))
MVR1 +MVT!9H&2=,^T]+8(D*1+DG%S=_W#"4KMC?IP^Z^V+H,SYR9.3.DCI;.
MWX>*.=+/VMAP/*AB7+P=C4)1<:U"YA9L\6;F?*TB;OU\%!:>59D6U6:4C\=_
MC6JE[>#D*#V[]B='KHE&6[[V%)JZ5O[QC(U;'@\F@]6#&SVOHCP8G1PMU)QO
M.=XMKCWN1CU*J6NV03M+GF?'@]/)V[,]L4\&WS0OP]HU2213Y^[EYF-Y/!@+
M(39<1$%0^'O@<S9&@$#C1X<YZ%W*PO7K%?K?*7;$,E6!SYWYKLM8'0\.!U3R
M3#4FWKCE!^[BV1>\PIF0?FG9VN8P+IH07=TM!H-:V_9?_>SRL+;@</S"@KQ;
MD"?>K:/$\D)%=7+DW9*\6 --+E*H:37(:2M%N8T>;S76Q9-+MNR5H7-7+Y1]
MI(^V+30R=C2*<"!FHZ(#.VO!\A? )CE]=C96@=[;DLM-@!&8]?3R%;VS_+>(
M%UQDM#L94C[.)[_!V^W#W4UXN_\UW WTO1Y]+Z'O_3_)_#W8A%9P10>GG^#H
MG&UT<QC05?8MHYT__SC,\_&[6/'*>WHR>?>*E"U)QX"^FP9=:N4U!YHYB(ND
ML91G*G5@2#M0K%2DZ)4-XBJ@[91YC;XR)14@J O0$3SQ''5!SI.#3T\EQ >"
MT:4^<U9-#6\0QA4M< G>84B+ZC'H0L-/@EM4"G8%-S%Y: ,&S8R^(J!:AS0#
MW(S6XB,-NHZF7MLYHDA.C8Z/\C""=\3HB&C00LOBUD^B5V DP)X36,D/&$R+
M9 M\BS'B/.A8*GTS#S1]I":(!]=XNK=N:;B<\XK*W+@I^*[G$,WI[SD.$7QA
MFE*6\D*77&MGW+Q/8)_-E+A4(FO=@Y(915/M$HI' KY8NG(/7$^1Y /I@\F;
MX48:)%F&(Y=  8B.&JB+9FJD/+,9I_RL]/'Q^LN&+BH%78 I?#);,CH($')]
MI4*I?M!E&^#G%!,UZ&H,].B*>[@MF3K4\ZNOEQUL1M\9J BB I;S$J,1DK9L
MBH2-/$XEI1Q$;MXU\VI-S:>7M+.L=%%)>9'NE',,[[!F<UE//[P:M@6%]AC2
MXH3[Y))FVBI;2"I"1*VEOH&P;04IM*0/EQC<02J)':[53RN2IZ7"6L=.>AL<
M5ST%B^B=@2@VVBM#Z\L[V^T]2QVKQ/"%^@RW^WG*A:I;A5;.)!6MIL V%;<F
MD$F^4DB7G/64@$]P1D-P7#Z?GVWH=1;_&B?%LW6+VJI5#E9QI1P976N!-5I-
M=>IFB!,-Z7SRIFTB<\52=X,8,4K2.L]SD:X7@<UF&GHVKDA+,,].:[J5F0;!
M'@C$Y'"\OT\W+@EYB#&+V0,"DK*+)D)Z,"ZYQR3;M-V70^&'!WGJ270$#/?3
MQC3>;$@HRYD'+MMANI'04*$;D%;)X0/[-B092AV)9^)?I4?8>;:H1[G5"AG=
M-N#20J9!V=6-H:YTZ*%FX6RG>HFI5?LJFYUK.*K9IU+VD</H4P,W^9LVT(SN
MK)'&34-_B8G7EKT<]J-@@UHW%$B9X.0(!WYI/&\*:JW_MA78#0B<)M,BZV+7
M7)\:3)5_YGYM&&+',3AROD8,V],07G:'^^/Q<#P>I[AA@]*@<-M[S([<=*'U
M+NE+![0:I</4$PBH \\%^%GP69(H-I5U)U+:R8M\^B4XRAIQD-[(5)!L0F'H
M)"^*[Q+;!TMWMQ<TV<N B01OX-*.SCBC]W<W&!G9P209I#>O,CJ=SR$ V2#[
MA"V\*YBEV[#M"W3:"99>IXBQ\Q6N2?NZ.&EWZV[#E:-$>R+ NR F2\23/.<Y
M=G:$)-)TZPG)4L;'N^^>.Y*-ULZZT.L\G>AE$(- >^SMG_8?#:?M6?G)O/WB
M0 _/-8@:GF'I.#O8'Y!O3_'M372+='*>NHAS>+JL\.'#7@SP?N:@Q^Y&'/2?
M4B>_ %!+ P04    " #X<']4Y<QI)0(3  !@,P  &    'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;*5;:Y/;-K+]*ZBYE5MV%:W12)J'-[:K/./8\5:RZ_+$
MN9\A$I(0DP0#D",KOWY/-QX$-0^G]GZQ1Q31Z&YTGSYH0*_VQGYU.Z5Z\:VI
M6_?Z9-?WW3].3UVY4XUT,].I%M]LC&UDCX]V>^HZJV3%@YKZ=#&?7YPV4K<G
M;U[QLT_VS2LS]+5NU2<KW- TTAZN56WVKT_.3N*#SWJ[Z^G!Z9M7G=RJ6]5_
MZ3Y9?#I-4BK=J-9ITPJK-J]/WI[]XWI%[_,+OVNU=]G?@BQ9&_.5/GRL7I_,
M22%5J[(G"1+_W:D;5=<D"&K\&62>I"EI8/YWE/Z>;8<M:^G4C:G_3U?][O7)
MU8FHU$8.=?_9[']6P9YSDE>:VO&_8N_?76#&<G"]:<)@?&YTZ_^7WX(?L@%7
M\T<&+,* !>OM)V(MW\E>OGEES5Y8>AO2Z \VE4=#.=W2HMSV%M]JC.O?7$NG
MG3 ;\<FJ3EI)KGIUVD,R?7]:!BG77LKB$2EG"_&K:?N=$S^UE:JF DZA4M)K
M$?6Z7CPI\9TJ9V)Y5HC%?''VA+QELG/)\I;_M9T3L:LD=L5B5_]/]STM92&2
MG&Z4([ZTM7)XVN^4W6NGA.M4J3=:587XW_^Y6BSF/^(K<6.:3K8'?G+V(V6*
MLD[T1MRHMC=;U2KQK]GO,R';*GOTH5G_+/J=-<-VAV05),DJ2N-*6=($#S!E
M:WKE"K'?Z5KEDW[ P.Y[4Q;'\Y$*NG> @+73E996*S<3OT%>:5IG:EW)7E5B
MHUO9EEK6PO5X  SH75#)3RSVRJK@*[RO*;M+8RN,4DB@?B<^MKVR+?L18MXG
M@9]59VROVZVX[:&-M)43SX)=']]_O@TF/1?2">W< .GK T\\E?@6\PWMD:!K
M@__$,WH[BGQ[>QU%>D/E.+"#P24\( ;GC:"!&^U*R#\H:3GV!7G/RKH^P$?6
M*M<9.!&NII>3!-EUM1Z%=%8;RS(*H;Z5JNL%\%N4RO:2G 6/5MZK09!+-F"E
MRYV 6X7:;!1C)H^5;3M KTY!-%Y;JZUN6[("@4I?;^ =\4^)E^Q!A+P5SYSR
M(226,/\C9JXJ31XLDBY>52\6ZOLR0]&_DS2+(N@O:^D<!S[IBU"AM_PZEP-\
MTO;>7P@(AP]^_#CWPKO>_9THDSZN2(QWIQJL*8)7D**3V#^[_-&)S="6(2B\
M,N5A]F3J8BVSN7.3[TU,,V(RPM2X4BT,58[RU0R.\NG93U\^BZ_/:0CA2G0+
M50Y:BM(TC;(\56>I!I9JQM$Y7_XH%K,S\2]43J>W+;0K)3SY4(#2/-GS/X9J
M&]R%+Z"-A@%X+8K]K.Y4.^#!QIJ&G-[3S"Y7#<$2W_XM934MN13 A6UK(+1T
MX\LAL'_5504@^DDZ2D:$QI;\QG*EV&F\#).!%+E!G3R0LJC5M3PPW,"K\5V:
M$OY$#1^S!P%G,)R7Y$@6 9?Z<R!Q&JBK+4NNC7.P%D!!>7@@%Y$<]0V+3G)+
M@)3VKXE&8>4J@I>>8:^._"3@6_06)1N%JP8<^^C8RZ@V=/%XX+_&#)TU:[F&
M9X:.R=+$ .N78T95!N_Z%[Q'[L#*.K^4,)Z@.=.(] =" U.+.*)56]-KUB<L
M)^L<5JG@>.BP.-E85(\1MS.5-4G#UXZB%,$-2DE>=*S%&&$6J]:/X?^P:0\&
M6D_K'%6;W0^WE,&-;,$_>24AHJR'BM)T'9W%J,QBR;I2VW)H""_+D!CC\"31
MKWQP$X(4R.J#(M.(W")[_PP0XN&P/\0@E UEVW%4'(6$[L-4S@,C+YU?!1I5
MZZ^JUCN#>(,<)# * >DA$8JHH&D.5(:=;+><\B%9D%X-J1X@B2R--0V!3[#0
M$W27K!JM(M2)=, -Y2X:][CJ3MRA_E/0,CJ#0QBKB@< -EN>$6H>=]']Q)EZ
M":G.,CB!V&'L+ZIQ >5[P0"QW>&5E%AL3PS&&'8A&O_"H[T9ZHKJ#8H6P<0?
M)!C3Y>BQ&?K!*AYMG:RIV**^L;LF$<"09.H[5<V>#M>I/QY=F"DT827C.%B"
M?\F#9U<_A(C'8!0.#=L92SB;,U (P#GFTSM0$MTKUF"T@JK&4>J&Y4JHB,?K
MA(!4CRF'IW"2<G"$DQ3<CZ7DT:QYNAVC$&'-T0KCP5[7=0J-J\4/,<#&<!O=
M%T-8(/1:)\M0QLG]%>(#.K1J#U?*K57DVY!=78VW20S&:FS>JOM8^G!2<,01
M3:,GE09#L^R4M>KWQ)7H\1KZ0V)0-[HK>C^I/G&_)ANX^@*:!V\&8W*H'&]]
M+H,VLOT2$6L3D_;DS<..WF2H'HN1TAW[#;[(^4YN5R,/-!M1I?NIG;Q\E-<!
MJR-DWEN#V3&W""R9,?>8YQR.64YT%3E"6LC>!HYXO[I0$!'#([:,U>87/'T>
MHQH#L#GX$_RX]QLL8L@Y%5N(#X;FO:&\M6WZYBV#+VA?G;.Y%PB>+7F$-W^Y
M*Z$7-*^)6I)>B#Q'P+=G>F]I[6B6-?[Z^H+6-U;^D7?Y,KZ36">Q'AQ8)57F
MW)N\E_13,V7. $^*=FC6WD2KW5=HHQM=@YYS1AK'>,/,."<@GDH>&2ER(^->
M$0*\W+#^!44+;4189$_6!<ZQD;HFP,7$1*N)19*"F B82T&Z&8A'J6^J'+#.
MF\&R",H)N38VISG>&Z4:>B)?2&3;8UMV?QZ_6^O5E)D<;=,9QG/;*9,V"$*O
MG+<.;,C !WT$!RK$TI:[(A^)^2E,&=61FFO"7OHT%JKM@+^(Z2+XK;FCJJ-;
M_WU(<C-P_%+:"Y2IBK='[D'"='8UA^9P-@=J<")/G555SM^>-&';N*EA-KKG
M##:=BGZM5 <\(7&Q,*;R(<AY?=R,/KG.H\VR C,GUX?-%1$N0W,WM DD*[/
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MH6[O%+4>W$,(F9=\3FC>==Y!!H-?#KG$+K]QOTLEI]-)#Y\=,69 G2TU[7P
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M\K'NMWLI3+"<OHG&IP UJ@>OI0<9OU5#842L;OT7M99K C["ED #6VHJD0[
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M%!$=>@'?;PRX4OA $Z0?U;SY#U!+ P04    " #X<']4#?<SJ<<#  #+"
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M]V/^J["H7H=VJ* Z/C[[F)#M1V>_\::-XRHW'L,O+FO\VV ;!'!?&>-?-L'
M\/]E]0]02P,$%     @ ^'!_5$[=QOJX!@  <Q   !@   !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6RE6%&3VS8._BL<W]Q=.^/87N^F39O=G<ENFF9GFEXF
MN>:>:0FR.*%(A:3LN+^^'T!)EG?6N8>^9"T* ($/P <HUWL?/L>:**FOC77Q
M9E:GU/Z\7,:BID;'A6_)X4WE0Z,3'L-V&=M NA2EQB[7J]4/RT8;-[N]EK/W
MX?;:=\D:1^^#BEW3Z'"X(^OW-[.+V7#PP6SKQ ?+V^M6;^DCI3_:]P%/R]%*
M:1IRT7BG E4WLU<7/]]=L;P(?#*TCY/?BB/9>/^9'Q[*F]F*'2)+16(+&G]V
M=$_6LB&X\:6W.1NO9,7I[\'Z&XD=L6QTI'MO_V?*5-_,7LQ4297N;/K@]V^I
MC^<YVRN\C?*OVF?9]>5,%5U,ONF5X4%C7/ZKO_8X3!1>K,XHK'N%M?B=+Q(O
M7^ND;Z^#WZO TK#&/R14T89SQG%2/J: MP9ZZ?9.1Q.5KU3A7?36E)K!NEXF
MV&:)9=';N<MVUF?L7*S5.^]2'=4OKJ3RU, 23HV>K0?/[M;?M/B:BH6ZO)BK
M]6I]\0U[EV.DEV+O\F]$>F+X:C1\)8:O_C:$W[9SI9ZVI/Y;$U?>4Z^,*VQ7
M4E0),N22208/?D=![6M3U.H>AWY+CM3OBT\+5>O(%E*00DNU<:+9D';&;=G^
MPYL/']7%2MV/]U"IWABG76&T51\3#M"48 +UJBA\*%DO^4%O_JT;85ZSSSN*
MB0@>$IZ2B)0FH$^5#WC=_V[]'F%(+.SCH#97]+7UL0OX!?' ;1?9@YT.1F\L
M@2M2%UQ45? -[$=6]78G;DO4)_;@4BD'>F.L20<VU442Q3,NL(BN*G8RU3Z.
M-RX8-8D4N8(DO#%HS7*,U+#)& U["1O&5;8C5Y "R09D%%"R-]4(=XL4%)+2
MZA$(Z=":0EM[R!%I%6L=6$#D=EZ,]>  )GE;>UOV:6X\A%.-=#Q?_7/0&JPC
MM2Y7TX%=[HNL',1^#;YK__6/%^N+'U_&<Y4IX+-TZPU@9U60>49B-*+\)F%P
MG%3(6,D'P:(@<&Y\K&<]'S[2BMTFFM)@MB" &"G%N;(FIQ48SCD0W^2$HX8P
M63*P>J*),?&E0_V5#%II(M+%ORM5=D$J'?<<2 >5P3X%IICVS#&)<>R9(RHL
M,XEG>X)"A_#M4V(]&"B=0?1QW.^#KXST$2"*.50-'D#@K7?< (C%0RO($6J"
M!^R.1FP0EDXIF$W'0> FR0<P03ZX?BB,Q=A".!L\>BC-E)6<=\]Z-RU#AS*@
M@/I"(FC'_<!Z*!V<883& <2S:N")G70(3UUT14+I64#,Y6HMRP7];)N]D.R+
M,R<%D.,8"F%^K *I-!UK56%+89=L[D8.)6@7M>P0*'9*>X+O#36;"1)][,".
MK,&4E@) /%4'QSH ?]H<"_50G2]F9IMI2<Z9.8 [%7[KS)\]V8N+N$4_5>CG
M,)0XC]F7@I @!F P-"PWR*'/BD9^N3;'@I)\]8Y(B.U)P2T4\\+J\J5ZR-E$
MAD.IOG0Z)&;2BJ<YA@2_NH<'?!.)<VR,:16.6:LW/F0:T=M $^)^'1:8DAU,
M_99E?#!=$]6OS>;M7'WPV)>*S^H[!$BZXAN%IGYXF758JN>M[P<[? :PV]8'
M0'$<7@BMH,#LQ'G5@A*/A/O_?'IX_>SB)Y6 )V.[Z2(&.:#9'!B,G2D'GFBH
M9(I6=G#UH"*%G2ER"U>ZX(1QAQ^OQ3E& 2_;_^<V66<EW2>1&*9*SV/![QU
MA5,:F7';9T*_U+36'S#!$,UX*:?=9VK2H]/P(K8D.[-4#0SYC;C?1_>N%P33
M>M <9^O?4<H![N$!KPI?4C\9R@[#DDO2N"Z'GT<>C,>\%)2$7BPYTZ,+]2&B
MS[5C.F>',LD&@\0:S1EZ8NG@?HC,V3TAYW&<EPQIK0E8TO5^(/',J@.!YY5@
M!)G#F,(\'48CJ3]9[(N)<Z6')><3)T>Z3,:R4-_1^$*]Q=H!5^?RO8&&S9=I
M0'KH9RT&/]=/SW&%"06Z(#$91A1S@%MN+,."^>516TDS/4)"B%[J0_HM<R
MJ4U[W)H #QV7B1SET<X\,_KTO1%F Y5)CW.RP67B.YH=H*0I/@TQ;9]DN6?8
M(9,-2HH'))L>5E48[1,\;(9/KH-G]KR\XQTWNG&7F\!3B]\G&Y:CU'/DX"*>
MAH8YW[9Y*V=[&YXC&BLTICVO"V#0'-99\OXN$H]'U.;Z\OO%4U\NR\F'8$-A
M*Y^[G #<D;\)Q]/QB_I5_I \BN?/\7<Z;'DGL51!=;7X\?DLKY/#0_*M?%9N
M?,)'JORL22, %L#[RL/3_H$O&/^?X?8O4$L#!!0    ( /AP?U0K %BV3R4
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M+2W<^V3L -A$DY3JZO<(DL3 #!1V5)[  FW-Z:V,I/P\9"]C3B*K%4/G(*$
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M/+V ,_A)4NKD !CV0>P:$=TR0BC>1S,N#SD4]9N3Q+IOQRS'HLQP<":8#+?
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M_%]*0?% 35?3R1%_OX,,^TD%N;#&-HH%\+//0#&$P3*(BP[93QP*2GYV-F(
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MXXNRI@9XORIA$_T##3#^EM#S_P!02P,$%     @ ^'!_5*C*$- @!P  TA
M !D   !X;"]W;W)K<VAE971S+W-H965T,3,N>&ULM5AK<]NZ$?TK.^JT(\\P
MDDB*>L2/&<?QS76GZ?782?,9(B$)(Y)0 -"V^NM[%A IV;[VA[;Y0O&Q6.R>
MW7, Z.Q1FXU=2^GHJ2IK>]Y;.[?].!S:?"TK80=Z*VM\66I3"8='LQK:K9&B
M\(.J<IB,1I-A)53=NSCS[V[-Q9EN7*EJ>6O(-E4ES.Z3+/7C>2_NM2_NU&KM
M^,7PXFPK5O)>NN_;6X.G8>>E4)6LK=(U&;D\[UW&'S^-V=X;_$O)1WMT3YS)
M0NL-/]P4Y[T1!R1+F3OV(/#S(*]D6;(CA/%S[[/73<D#C^];[[_YW)'+0EAY
MI<L?JG#K\]ZL1X5<BJ9T=_KQ=[G/)V-_N2ZMO])CL$TF/<H;ZW2U'XP(*E6'
M7_&TQ^%HP&STQH!D/R#Q<8>)?)2?A1,79T8_DF%K>.,;GZH?C>!4S46Y=P9?
M%<:YBS_<6AI2=:XK2:(N2#ZAWE;:LZ&#>S8:YGM7GX*KY U7<4)?=>W6EJ[K
M0A;/'0P15Q=<T@;W*7G7XV>9#RB-(TI&2?R.O[1+-O7^TO\MV6>^QYWOL?<]
M_G\ ^:XKYN%'NQ6Y/.^!:%::!]F[F-&;,]!L$-/?_C)+1NGI?_VK:KK^?D<;
MCS5?1KC$<_JB'Z2I04-'*R-J9RF)DDF*:YPEE$S&,7T!]PD,*Y3=:BM*TDO:
M&NB&<;N(MB5&A7A_-FKK/;63QK/N-NGNLC2AZZ=\+>J5)".<I!4FL/Y[G)QV
MOVD\IIN QM+HB@ /9 +1'D)X4"P>KX?.Y@%-2Y-L0LF8<\WHFW8\TL/,T0NG
MZE4+>!+-4YA&Z7Q,:32='1!_C5 .&C F\.%EL\[E!Y:.HC5P&BJXL*I0_^:8
MK10F7T=0DP>H9("( 5-UK1^$5R]XX_RL8SR0W%>9;TI9+QJS^O!#6H<(Z!9Q
MPK\2 8]E4Q<VS(B9%SOOX+KAPHB:[N0*?I'OYZ-)?\.0 :Z&,:BTD1&MWLPN
MX%U*),8100JE,;)H ?,QJ/H!P?G1,!6N@V"P;^=7...G; HTM?!E9\_<E^EL
MNCF4&:BN(.:UM)8-!(2YWE"ID5>;+S*!>S:^T@:)/BC36+I418342R67D8?X
M&MGH2N5T+_/&*+>CR]Q1_^KR[OJ>;T\&U&<R?/11_%.5>'%3T]^;<N?Y$?DI
MOAC=; E9R@  ZBL(;1AXZB%:B'Q##L%9X=>C ;SGVA2<.LP?UXH[X.#,ZK+P
MCW<:BP#&KK'D_FR$<=RVBT:5[5 !,V4*VN+;SD^(8768-;CHK#L CT< 3/A
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MIV%GLQ4[7N8M9=%X&L-L#&'+HBDV:=^PEU!U8.4"B_:2-0#39S/*)G/"9C+
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MVN&L[Q\+B>;%T 2,[[1V_0LM,/RNN?XO4$L#!!0    ( /AP?U2"J%/E2@,
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MQJK* *$9/P9,9]S2*$Z_M^@?+7?DLJ2*G8GJ;U[H]9&3.E"PDG:5OA2;/]G
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M/]=X(632+,#Y4@B]'9@-QBOF\;]02P,$%     @ ^'!_5$!([UNN!P  I!4
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MA&&R8C\* +<ZT&<+>5\K:47./EMNA?&P$MLC']SSGFNI:DRRHC00P7:0;CU
M+=M 7WW J[)8]%YL9%:(=BD(U4Q\J^4.B6H9U,_=NA(:@C<T=YEGSMDO3OL7
ME98&Z5UPIYE5I*?AA:!!9/:29UL&NRO#FU2&>F[4G4)ZH&L#,OI6<VV%-KU8
MY)'=,-XZ#EVEFW8^N/6'O\S#8'8!19>%7#>:LAKXU:1^T:C,-;016:VAW/)
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MV@U _TI!T;;A%N@O9J__!5!+ P04    " #X<']4$I=AA P#  "Y!@  &0
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MUK-EGBW[OV(=!+ON.C,-RW$14/L8U,\8+.,,!J3P^=,DB=+97S^YA.O'>]@
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MM#/1>THFXPWE]Z>N" ?CA%[[V@]-0VE1O;K)TEO[N7S>C:-W]VZHWS*]YM*
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M'2;6TA#/O[ L^8.#UB?P>6$,[0+?H/^$S7\!4$L#!!0    ( /AP?U0&MR7
M\@0  /\+   9    >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;)56;6_;-A#^
M*P</V%I E27Y-5T2($E3+ 4Z%,W:?::ELTV$(E62BN/]^MU1+[;<)FB_6!9Y
M]]QSK[KSG;$/;HOHX:E4VEV,MMY7;\=CEV^Q%"XV%6JZ61M;"D^O=C-VE451
M!*52C;,DF8]+(?7H\CR<?;*7YZ;V2FK\9,'592GL_AJ5V5V,TE%W\%ENMIX/
MQI?GE=C@/?HOU2=+;^,>I9 E:B>-!HOKB]%5^O9ZRO)!X*O$G3OZ#^S)RI@'
M?KDK+D8)$T*%N6<$08]'O$&E&(AH?&LQ1[U)5CS^WZ&_#[Z3+ROA\,:H?V7A
MMQ>CY0@*7(M:^<]F]Q>V_LP8+S?*A5_8-;+I9 1Y[;PI6V5B4$K=/,53&X<C
MA67RC$+6*F2!=V,HL'PGO+@\MV8'EJ4)C?\$5X,VD9.:DW+O+=U*TO.7M]]J
MZ??G8T]8?#+.6[WK1B][1B_-X*/1?NO@5A=8# '&1*)GDG5,KK,7$=]A'L,D
MC2!+LO0%O$GOV23@35[T+'X!:=HC30/2])=C]#-Z('0!2HJ55-)+=) NH+VY
M<Z[& G)122]4$.S^6W1H'Q%^_VV9)9,_?_HI-?BMJ1UA.3!K<%M!4"&F_)/
MC2E+ZH;V7 2A#T(#!7Y=*[6'2L@"LBQ*TV6/FIY%RWG:\6UU^3+-#J:S*$D2
MN'U"FTN'C&LJ[CS72TQGR4%Z-C_A(AOTAA)50RB&(:?9_,#IA.*O/ALSS>\S
M0>LXA.!U>D>'"5S5I&?E?YS$@2\$<OOE,R0Q]0F*? N+LQ"=#N7DM0W$?:-\
MI^%#35ZSB8B8(=]70N_92*70<Y1@;11-U#>D5M4K)7.RN48K]8:-3Z)9D@03
MW_$ZPHOHEL:K\ZU6R. /M0B9C*[V S9<K^FSAGH5&L&*#82;K5$%6BH\3RY4
M5N8(W@34W@OX<O\.TFE,F!7: 2Z\DC'&(;1I%B_2(!!N7L=PM=E8W B/ATA4
MUN2(A8M T_>-H&L:5G9G9?"XD"XWM?8N"D:H_D*ULEO>"NU$\^'(C6.1'?D3
M+&<9#6)RB:Y:ZFU B$)7NUBNB-DD]!P7"Y?N(CHCQM_EXP:U-QO4"'_'7V,:
M_WY+H=&&ACW-@4>A:AR44^#1]0I1/>J0NH)77#1OF^981//IY/4/6$4M+>8N
M^A*.8%5[BE"+/8A[/Z)*#AC=DN?,:!XM%ME#9[4Y66;S![+Z#X%WV2;S0[\9
MD_R67C581U'\@VXK2MPCW13R41;(7<F>&I*RG#5O)5%MDN7H:[B'%=*G.%>"
M2VYM30F>-H< S,]AW48!3+H!@4=#==-7$_"^H!1!>\_\28 LL$S!E7O"5NN:
M0L,IM/0LZ5-,U>5BN#F9Y<_FX73H2YVKN@A=WM"A?:N4==G509K,H_E\-HA[
MFBRBZ=GRX36E$;FZFU2YIC)HPG$GGG0@^\'9%CK'H[E'POB4H^O'127LH1#Y
M8#"Q^^;BF?!=X[ SM0UY,?:@W-MM"N4T NU<<@.#?1A$'OHVY+%STV)N+,=,
M\K+H*MKZ>I?>\-Y6D!M[6B=IAP5:Z$ 4A62:9%7J9KMETMS5G<$3O0AH^-()
M+Z.4/RH*S563)3]<,L9'2UF)=A-63P>!>;.?]:?]=GO5+'4'\68U_BCL1E*Q
M*UR3:A(O9B.PS;K9O'A3A15O93PMC.'OEC9TM"Q ]VM#1-L7-M#O_)?_ U!+
M P04    " #X<']44E@$LK0#  #^!P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R,RYX;6RE54USVS80_2L[[$Q[446)<AHGE343.TWKSB3U)&ES!LFEB @$
M6&!I1?^^#Z!$RY/&A_8B$<"^MV\_L%COG=^%EEGH2V=LN,I:D?YEGH>JY4Z%
MN>O9XJ1QOE."I=_FH?>LZ@3J3%XL%C_EG=(VVZS3WIW?K-T@1EN^\Q2&KE/^
M<,W&[:^R97;:>*^WK<2-?+/NU98_L/S9WWFL\HFEUAW;H)TES\U5]FKY\OHB
MVB>#OS3OP]DWQ4A*YW9Q<5M?98LHB U7$AD4_N[YAHV)1)#Q]Y$SFUQ&X/GW
MB?U-BAVQE"KPC3.?="WM57:94<V-&HR\=_O?^!C/L\A7.1/2+^U'V^6+C*HA
MB.N.8"CHM!W_U9=C'LX EXMO (HCH$BZ1T=)Y6LE:K/V;D\^6H,M?J10$QKB
MM(U%^2 >IQHXV=RH7HLRH+2H ;(MZUS &T_SZLAQ/7(4W^!8%O3666D#_6)K
MKA\3Y! TJ2I.JJZ+)QE?<S6GU7)&Q:)8/L&WFJ)<);[5?XSR$>G%1'J12"_^
M5^J>YEA>TM<T]+%E^M6[H?\AD"L_<^K<0/N6[6BF[9:J(TYY)G$45,/;0?F:
M!.@;U_7*'H!7I39:#M&D0I&T'9@4MFGK$HNS%7O<#EM3HZW"BI0Q9+GB$'!-
M<5V#X'*KTC#:_1[7N(\BPXR"@R\EI 5B[ ,]7/7>W>N:<6UE\#80I@>%%E);
M9VKV(?DKV7*C93QUD T;4;N3S9QN+?7*BZX&H_P,3A"J#A1M1L7PZGK1'=)P
M2D<0/U1PFBRQ0.;JY "J/-<#XHL)JEP0<LT)-J=/6MIT<GOW!VE+[]P]=R4D
M%8OEBQD8#.;7CY@C_5 :70';L(\9!,GO@SG$5EW,:*^\5RBA#F$8DQEE;K>>
MMTIB DLYYCEBX><-EWZ(>0:^F"4%J?11?N,P 2 _3:]6\WW$*&I9&6D/4\AQ
M*L7PM*TPE\,I0-N@ E$"%&J+!A)W3'PZG]K.[UCF#SUW;,1 L3)?9S7B.Q0
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M/0#L4<T=Q@*8.>0)WZNYQZW"RW1P%\:0>P8L<-SX:*$;39RC,XIB@8HCUW1
MKU&HL1&J@(3K-6;;K=29L:3DRK$?;> Y>>Z%_4:-N>[F!>R%$E!IM(R1C9$
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M>3%3,9G.HI.38=A30+HO&NL\HNFYQT&/:6\>OC$BCQA1KS)D=0MK6 QVE&_
M60,2!/VJ!8F%3L>RR"5$0&A$$I79Y\LW8C0>C"8@3VY40*T<8,THD$(RBX$?
M/XCGPH\]<6D05IH5[:D.FH0MM0?+&O+<V"6.R) Y,W%FJS17,6AUJR^JI@)
M9_,J4W^Q3=4A&.[>.,BHVXH;ZZD:HI#B1%MZTVU*26,>F#F>':(.>YM*L"E
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MN'L)--%YWX,-/^4-QT'QZPE]C3PKAAA^'SMX2"Y<(TH:F-%@;6;G:IB9=U&
M20(UW^NY5^ [+/LD7/;\H:O6KGEX9MU8CT("JG$]6>#A.*5!J1"M,W5Z4@;:
MGNAR/,V:!*O"/B.O)(5R<*:AAI^Y/V&5,>8XH..87,IL*T0 @H1='[87_WT,
M7RLZZE5Z:]D%D\-YI_W)-A/Z:5@>5(A=UB<L>=#JM55%Y 4<8@M[]2D3AC0&
MYG88'*N!;&D):>;@6$:!U)%)+Q#"[\9F\:E9Y^#1T1\OH >KM7?=6&<7NE>
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M'GDT6W!19IV!Q><8,*NJ':<E$@;;K"N%&;6>!W"?B!M8*N2F&JTS, "U,,5
M#DH8T0,F+C-H!\*L&]9%05;2,]49A%S?*\[P /B-^D+T;F36]I@>^(3<C:Q/
MHQ-!F#0V-?:#AJ4FE[*S0N!1D3V"A PZ+'K)REL1P9B1G>H>\%7WHR5:JS-
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M 6+G]S=P$=JQ(LL>^8O3<6]GZA].\C.'96>(P1;3L3@>S:<GJ3GW[K0'AKK
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;)U6VV[;.!#]E8$*%%M
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M#"D-Z&4$\>7^&,9 JFYT'H_1ZJE)KX#OIU.DGSV9^D/31[*7.Y]QX^<^[_/
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M=MF5V#35JQ3*',WMA0LL6(D-ZXWS:3ZTU3Y 7J<2:75/>UBAO!-[;HN!G*8
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MDQEO ]5X$5TKGRLV+D;7R,^*L)!Z/H#G6X=-I[]@ ^/WJXO_ E!+ P04
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M,& 7RJCMY;.L#PNT[::=@<8M=FYZ\>K;1J<3F[Q!KMIRAT5S<*/NPT!T^-/
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M1Q2S)&P78-E7@.N@@MD+F_(;2FCM+L#6%4K/-2IEI"K061K25S)5%"5OS*!
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M='K%&*CT$LH^0\A9XJ57V5GV$_G660RO\?Q4Q<I?2R"O"W?+-!5=1@KN]_Z
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MV6)1L.2;@LYXF"GM76'23\:W 2"7I%\SZ;RV8-0[&5U)*>7R;!+LB,=@QWX
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M?FE9-=JJ-N\-7E8M,-5\G0N8H]$#T']50>V^H1<87B1]]A=02P,$%     @
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M"XJ<;C;F0;3(:1(%&4UN/8-@LI0/\J2T0]J7NMD*]>AO*3^QK,);L4Z67ZO
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MD3*6R!M.@CTFNE).J+4'=Z^Q'QR1X;">QD&:+&;'Y(L$P75M\*%GW&/ MK7
M^Q.J8O"EE5M_FP>MB8H/"Q/L,O_.>Z%7+UK[)%C/V&F0\3WJQ^Z)8@SV/0C;
MFA%(%LR]+($AJ3HCRB<.XCUKGN('X!W:2K5^4B[DERP9]=*@0+885C_K>S#*
M'[4V0NV5DB.S)0>SXP&2R-^DGQ2FV5%%SR5YGH]2'L19-JYNVH;E2$@)?G<#
MSC&3 E?8P440$S-]6*VP6B2,J)"]JM<95$<\=?0[5B)?[)6%OJ[/44&X]VQL
MP*S]X]ABE5OENA?DN#N^OU]WS\ZOZMWC_;TP:XE,7,,*3:.7.7ZO3/<@[A9.
M;_TC=*D=/FG]=(/_(<"0 LI76KMA00>,_TK._P102P,$%     @ ^'!_5&^8
MTC!8!   00L  !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULK59M;]LV
M$/XK!PT8DH*+)%*OK6/ 25HL PH$2;I]IB7:(B*)+DG5S7[]CI(MN:WC!D._
M2#KJ[N%S+SS>;*OTDZF$L/"UJ5MSZ576;M[ZOBDJT7!SH3:BQ3\KI1MN4=1K
MWVRTX&5OU-0^#8+$;[ALO?FL7[O3\YGJ;"U;<:?!=$W#]?.5J-7VT@N]_<*]
M7%?6+?CSV8:OQ8.PGS9W&B5_1"EE(UHC50M:K"Z]1?CV*G+ZO<+?4FS-P3<X
M3Y9*/3GAMKST D=(U**P#H'CZXNX%G7M@)#&YQVF-V[I# ^_]^@?>M_1ER4W
MXEK5_\C25I=>YD$I5KRK[;W:_BEV_L0.KU"UZ9^P'723U(.B,U8U.V-DT,AV
M>/.ONS@<&&3!"P9T9T![WL-&/<L;;OE\IM46M--&-/?1N]I;(SG9NJ0\6(U_
M)=K9^6UK>;N6RUH -T98 V>/'"5S/O,MXCLMO]AA70U8] 6LD,)'U=K*P/NV
M%.6W #X2&]G1/;LK>A+Q1A07P$("-*#A"3PV>LMZ//9:;T]@1B-FU&-&+V ^
M#.4,:H5%6JBVD+7D?<7A2L&U?I;M&GBCNA:CBVOR-(DA+J?W_/VWC ;L'?SJ
M-\9'Z);7]?.K3=:B%9I;49X"N>MT4>'9*4&[4V+(3V%]7GSNI#Z +<47;"&;
M@Y5:%M@=Q!$TV<+[3_?P-"XLI<(D/0EM)CP\+NX\3RM&K>R6:S$N/"K+:[A6
MQL*B3]U?O(6A&@,(*0DHA83$ 1TM& G" &A(8A;!HBRE*X1IAY#D03!*E*1A
M>B %T?0O(4F<PHTK**-J60X5Y?Z&]-WX/@OC\'SW'!BBQ?[ ($5&<J28$QKF
M$)$LSX%F_383M33*D5824V!9XBAE*=R+HL;2?#.R.:-Y>CXQS=-O(KYG="C_
MP":$,"(LC2 ,29AD$!.:Q< "DM'TU<7VL_>B*+JFJ_MRQ!.GK?QW"!QO2Y#-
MADN-%\JQ;#*2,:1(TC1PSRR#E+ LA\4)E(3DF+\\8A '&62$H5O',G8J3F.$
M0QJ=?R<=RVA TBCK*X?A,TPIA#%)&#M)%!4QRP=%F#M7LR1 %P(LR!_SG603
M&?3J_V2;8F9=U:7(,2(!H^Y8.*:_*MG7W_?6(_%B&**H/Z-];6.I(:\H2(\R
M)G$4HR[+$_RF,<.#$^81O(''2D"+ Y(>XB17LA@[O.LS%!U]@I56C6ON^^8W
M=<:#[F/5H<K4TZ9NI 5.5T8XA_::4& +<F+1:=<2L;U9I+31JA"F=V0'Y*(Q
M&MT^0JEQY&FQL=7=<-J1\T3F8I_XR2%I<+@HA:.)!/$BQ*I"2?/6;+ S8BWM
MR WJKM9E*;3;UU9H[.R=!3)T=Q8.,[8"P8L*I[[E'VNMNLW1*_#BV$7L'XPU
MC=#K?G@SN"EF>YAPQM5Q/EP,8]&D/@R7'[E>2_2_%BLT#2[2V!NNHKU@U:8?
MDI;*XLC5?U8XXPKM%/#_2BF[%]P&X]0\_P]02P,$%     @ ^'!_5'UAPY%O
M!   00P  !D   !X;"]W;W)K<VAE971S+W-H965T-# N>&ULM5?;;MLX$/V5
M@1=8) 83BZ*NK6,@EQ;;!8H&2=I]IB7:$B*)*DG%\=_O4)(5)762(ME]D31#
MSN&<N9CC^4:J6YT)8>"^+"I],LF,J3_,9CK)1,GUL:Q%A2LKJ4IN4%3KF:Z5
MX&EK5!8SUW&"6<GS:K*8M[I+M9C+QA1Y)2X5Z*8LN=J>B4)N3B9TLE-<Y>O,
M6,5L,:_Y6EP+\[V^5"C-!I0T+T6E<UF!$JN3R2G]<.;9_>V&'[G8Z-$W6"9+
M*6^M\"4]F3C6(5&(Q%@$CJ\[<2Z*P@*A&S][S,EPI#4<?^_0/[?<D<N2:W$N
MBW_RU&0GDV@"J5CQIC!7<O.7Z/GX%B^1A6Z?L.GV^N$$DD8;6?;&Z$&95]V;
MW_=Q&!E$SC,&;F_@MGYW![5>7G##%W,E-Z#L;D2S'RW5UAJ=RRN;E&NC<#5'
M.[.X5)A?9;8$ZH)7!GB5@OC9Y#4&WL#!#5\60A_.9P;/LA:SI,<]ZW#=9W"I
M"U]E93(-GZI4I(\!9NCDX*F[\_3,?1'Q0B3'P"@!UW'I"WAL8,Y://86YB_@
M>P.^U^)[S^!?8_^D32% KK!,[K#\NYBB6/_^T5UD7C[ISS\BUV$?X?]^?S.9
M4&^V'@B2=SNR:E25FT:)7U;R"CY]OX+;07'6Y$6:5VL]:"[;D.\D&_I5?F_!
M'K;<2,,+.)?:P*FV"?N;5]!5G@.,N+X',0F9 QX)L=!I2((X@-,TS>TOS0,.
M=7PT<V,?(N+%#AI%^+S(=2TU+Z;M/NI^'-X' 74/^^>52 JN-:R4+$'9WY8C
MN3IJM #4"J.GT^DC]CL<*S/BQ/$KJQTQ;*I=3UEFS(^!>H2Z'E"7^.@L<X@3
MLA$W9.1YX)(P"/ 94_^!SP.A Q;&2"2D$3XIGA>^C1 E-/"?)=*M_D*$6B(!
M,O")@YE"/@&+@"%M/_C/>N$T29JR*;@1*78WWH=)SKMK!@LJ+VN>J[;;]]1/
M[$) J._;(&)H8\)0>S'&& C&WO =QVQ$/*9LE$_J/*VJ?>%Z*A]XWN%CX3TU
MA\EPPE=6]]2<'P78'"Y& ]/D82\QXD7L<3@8%ADC/HTA)!Y&C%+"$.U)W>VE
M2/UPQ-&E8XF%[Z3LC5*R;VU/9<8.M9U%J6-91'$$KD=B)_[MNGOM?<Z5VN+O
M'?!2-I71^V+>U9U/HL!&-/8BH$';['L<=HD7,-OH7=-[#F:+>B%,X283D/8I
MP/',MH(&(P$O"4!5>^]Q.,<FD#>J26XQH%!S93I]@L.!PI$,QQV3V7W??GRY
M.,(4=S,/WC/','W^D#NN<MF@NTLM"V'$Z"(M>9+A!:FVHSG&3J?%UMX.+88M
MJMY3Q<L:4KFIK%M6,3BR;#3"8&EHL6Y!IKT_ZI62P0U8O%K8Z/>:NE%)AK-C
M"MRTIPATM#^P$+APO&_@F(W&.HS(NAU>-88.$]M->(-VF(]/N['P87LW7'_E
M:IWCKW<A5FCJ'(?^I'-])QA9MT/B4AH,?_N9X8POE-V ZRLIS4ZP!PS_&A;_
M E!+ P04    " #X<']405]+GO,$  #E#@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6S-5VUOVS80_BL'#RB20+$EZKU- B1-BG5 5R-]V6=:HFVA
ME.B25-SLU^](R1*3.EZS8L,^V.*)=P^/Q[OGQ+.MD%_4FC$-WVK>J//)6NO-
MR]E,%6M64S45&];@S%+(FFH4Y6JF-I+1TAK5?$9\/YG5M&HF%V?VW5Q>G(E6
M\ZIA<PFJK6LJ[Z\8%]OS23#9O;BM5FMM7LPNSC9TQ3XP_6DSERC-!I2RJEFC
M*M& 9,OSR67P\BHQ^E;A<\6VRAF#V<E"B"]&>%N>3WSC$..LT :!XN..O6:<
M&R!TXVN/.1F6-(;N>(?^QNX=][*@BKT6_(^JU.OS23:!DBUIR_6MV/[*^OW$
M!J\07-E_V/:Z_@2*5FE1]\;H05TUW9-^Z^/P(P:D-R#6[VXAZ^4UU?3B3(HM
M2*.-:&9@MVJMT;FJ,8?R04N<K=!.7]A3.!7+TU8QH$HQK>#H(UUPIH[/9AI7
M,'JSHD>[ZM#($V@!@7>BT6L%-TW)RH< ,W1M\(_L_+LB!Q&O63&%,/" ^"0X
M@!<.^PTM7OCC^YT>@(T&V,C"1D_ ?L!B*5O.0"RAH%+>5\T*:"W:!N.)[^2>
M,-.FA%K<,4QQE,I6&AN]9K!ALA+EON@?=N+%+QGQPU?P?WW..6VTW?;NS7O<
MKARD=T(+^9W5VP9N/MW"%[AJ*UYBC-0)O%\NJX(I8%_;:F/BYXP^LW558/K"
M1Z$I_\\V=VG/^3?:M,AMT"6L#T'H!22!R(O\%!(OSW((<Q_G@$1>'A*X+,O*
MT).R0 %Y!1'J!QY)8OP/L*#"%(B713[<LH)CZH 6L)'(RE+?>["Q,7U!Z\VK
M,08G)P_<,ZA/R4>!E^?D^-GZUPQ[0%%12ZWL&_8(A2''V8 $QW"4Q.FQD9(T
M-L_,2,3'O]!+$GQVT<+B9O4",R <XD4\WX\Q7D%JHA9G*48A#&(;!8+@_J.(
M[?,Q",-Q;!P:I30?Q\[0BV+R+\4W29\37:N]/[;."=@8#W*>^L?N;!K%KAQF
MCD0<9_ L\CQYZBR<H/E>ED6#&'IAF#L2R1U5+XR3<6XT"C(O]R,X,8L9BN,,
M.ZE9EALZ,+_%KKJ!2H8=KF2H*$6[6H-H&!385B2V< \HYQ9",DXU*_=3*T*@
MGBBL!A[HP!U3P,/;G;19WSA2[NQ0<SZWAWT#1XW0#!/R&%?"\U"6I3>M+-:N
M!=76&88[V*&!9K*>[K9^H+G$0W.)?ZJY=*ORBBXJCJ7!NM9BW'IF>SGLQG,9
ML=H1M\TF6][_D$R!("$B+>RF44PQFT8FZ IXS,DDCK!OX#DPI<<*BITLSI!?
MY_2^"\Y1Y)$H<BHC]OP@VU,9-H_SU'7$]>OOGJ];*4V+"K$=N"44DPQ^%\UI
MT<\',3)?YK 6\FAZ()&2(9&2'TZD7?X@TXA54YF4Q@-#XEM6&K -<Z'44&-8
M%S;)U+ZL.;SFS_;5 UE$?.3P?63YU!>7)3PW39(1+/ R;-'?)PVB?E]?CS-I
M@$1FO+6?([UY3_!J+:0^-;S0QQ%2['"QLWB2.U(6/T#I07I+4_!B>WI'>3ML
M+,H<%\;XQ/TWT*.S_G/O60<F J-QXI'8@3+$OB\#9\[5HV9R92]8"ND:%^QN
M(</;X0YWV5U=1O7N OB.RE6%Q<S9$DW]:8IT)+M+52=HL;$7F870>"VRPS7>
M0YDT"CB_%,C8O6 6&&ZV%W\!4$L#!!0    ( /AP?U3CFQ:B. (  /T$   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;(V4;6_:,!#'O\HIDZ9-0N2)
M4M8%I-('K2\J(5BWUR:Y$ O'SFS3=-]^9P>R3!IL+R ^^_X_W]EWSEJE]Z9"
MM/!6"VGF065M<Q.&)J^P9F:L&I2T4BI=,TNFWH6FT<@*+ZI%F$31-*P9E\$B
M\W,KO<C4P0HN<:7!'.J:Z9]+%*J=!W%PFECS767=1+C(&K;##=J79J7)"GM*
MP6N4ABL)&LMY<!O?+"?.WSM\X]B:P1A<)ENE]LYX*N9!Y )"@;EU!$:?5[Q#
M(1R(POAQ9 ;]EDXX')_HCSYWRF7+#-XI\9T7MIH'LP *+-E!V+5JO^ QGRO'
MRY4P_A_:SC=) \@/QJKZ**8(:BZ[+WL[GL- ,(O.")*C(/%Q=QOY*.^998M,
MJQ:T\R::&_A4O9J"X])=RL9J6N6DLXLG^8K2*LW1P(>O;"O0?,Q"2V2W'N9'
MRK*C)&<H<0+/2MK*P(,LL/@3$%)(?5S)*:YE<I%XC_D8TG@$293$%WAIGV?J
M>>F_\[Q F_2TB:=-SM V70F#*H&? W=97N:\?S=+HO0S_.^72WAX6<,>Z'CZ
MTQD:$:Q92_5A47,FS AR):G?_+T"DP4U7],(=]GI:);&$,>C>'H-CUQRJJ$"
M=DH5G6.-.J]HP U".H.$?L-:(?GTDY-/HJN_'6@X*$E"[7SC&0KG(&U7G?UL
MW]NW74G_=N\>AF>F=UP:$%B2-!I?7P6@NV;K#*L:7^!;9:E=_+"B]PFU<Z#U
M4BE[,MP&_8NW^ 502P,$%     @ ^'!_5&O.ME&: @  1@8  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#,N>&ULK57;;MLP#/T5P@.&#?!J6[9S:9, 3=IA
M>^A6I.GVK-A,;-26,DEINK\?)<=.BK5!!^PE(BGR')(6F=%.J@==(!IXJBNA
MQUYAS.8\"'168,WUF=R@H)N55#4WI*IUH#<*>>Z"ZBI@8=@+:EX*;S)RMELU
M&<FMJ4J!MPKTMJZY^CW%2N[&7N2UAGFY+HPU!)/1AJ_Q#LW]YE:1%G0H>5FC
MT*44H' U]BZC\VEB_9W#CQ)W^D@&6\E2R@>K?,W'7F@3P@HS8Q$X'8\XPZJR
M0)3&KSVFUU':P&.Y1?_L:J=:EESC3%8_R]P48V_@08XKOJW,7.Z^X+Z>U.)E
MLM+N%W:-;YIXD&VUD?4^F#*H2]&<_&G?AZ. 0?A* -L',)=W0^2RO.*&3T9*
M[D!9;T*S@BO515-RI; ?Y<XHNBTISDP6BN<(7.0@38&*^IQA^<B7%>HC*]<:
MC88/"W?Q<108HK8 0;:GF38T[!6:B,&-%*;0<"URS)\#!)1SESAK$Y^RDXA7
MF)U!'/G 0A:=P(N[1L0.+_X/C3A!EW1TB:-+7J&[:X8 Y J,8WX[7].=T_#O
MWPU8&%_ 6\]2P/7]'!Z VMIU]5@)X1O-D',?7M##5 J%@>]'2=J[B%W,R<XK
M&HR-U"6]&>8/&8/('_3Z+[D[D^[R2,-.C,*#3"!]"S(DD-F>>_%7VUCDA[T4
M6.KWTA[,Z+TI&OKV\<8^(XS83Y/X62*0^DD:P\!G@]Z!<.CWAR'$?3\9I+"0
MMB0AQ:>V</N%6MG\RPBU!#'S^SUV4(>4!'OI705'LUVC6KL-IB&36V&:,>^L
MW9*\;';#P;W9L#=<K4NAH<(5A89G_=0#U6RM1C%RXS;%4AK:.TXL:-&CL@YT
MOY+2M(HEZ/XZ)G\ 4$L#!!0    ( /AP?U09&5=7@P(  !@&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;)65;6_:,!#'O\HIDZ9-0L0Q#Z4=()66
M:9U4J6K7[;5)#F+5L5/;&>T^_6SG :@*VE[@Q[O?_>\<F^E6Z2>3(UIX*80T
MLRBWMKR(8Y/F6##35R5*M[-6NF#63?4F-J5&E@6G0L24D'%<,"ZC^32LW>GY
M5%56<(EW&DQ5%$R_+E"H[2Q*HG;AGF]RZQ?B^;1D&WQ ^UC>:3>+.TK&"Y2&
M*PD:U[/H,KE8#+U],/C)<6OVQN S62GUY"<WV2PB7A *3*TG,-?]QBL4PH.<
MC.>&&74AO>/^N*5_#;F[7%;,X)42OWAF\UDTB2##-:N$O5?;;]CD,_*\5 D3
M6MC6MH-Q!&EEK"H:9Z>@X++NV4M3ASV'"3GB0!L'&G37@8+*:V;9?*K5%K2W
M=C0_"*D&;R>.2W\H#U:[7>[\['SY7''["I]^L)5 \WD:6P?U6W': !8U@!X!
M)!1NE;2Y@:7,,#L$Q$Y-)XFVDA;T)/$:TSX,DAY00I,3O$&7XB#P!B=3[)\@
M#3O2,)"&1TA7JBC<EV1RIM$ -Z;"#)ATO\KF2O,_;_.OTST-_?AA0LG@"_QK
MSR6X8)5Q<0VH=:O&%\LW! Y5LF#TG4EP%5U70KQ"R7@&E/:29-)1D_/>9)S
M39U3X^LW$[H+37N$$%B^H$ZY0<]5I;];IK,8CLC.>C2&]RL6)+EC#J=\J&DT
MWFEZ(_%_^SI,W1XI6JLA%*_UVULD<-F=+*0'N3C(\O$>2-]= &1I#F?GH3HM
MI9Z^]]'%>[>U0+T);Y)Q^$K:^N)VJ]VS=UG?]IUY_6;>,KWAKOP"U\Z5],]&
M$>CZ':HG5I7A[J^4=2])&.;NZ4;M#=S^6BG;3GR [L]@_A=02P,$%     @
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MK; R'91"*6I/@7JV$T=' LSO LP_.<#P]U(I%*QCZZW!=ES*6X/M_];OQ?S
MXNLW_EW@?P;O^M3]2R;EH[;[JP1=8MH/M>2QE[KJNP3)%.]6KYG:RDP]D;%"
M;-';WC2=/X]AHPL=Q_Y91TH=$C;N36D=XMCB(#+M6:AW7/?SJVY,^F#4&2',
M4$+0O4X(0TE!J^6-PYY:MR+/-0%X<=RTR+0A5G>8M=/*=FG<? /,$KH]AVEI
M-5P[]L:^<P36BVC=2-U>)ODA4#HF9R-W[)]]L,$?>V>C>$SV;V/D/GDQYOHX
M#MN.$IOBY31=G9XZ]VES5)L2EH-E3B>HR53]A-5V'[#TQ'*WPNQ6 3H RD@D
MQ[)4RUL(B4E,"S#^BHE)4WR38KL!ILPD$042)X:C)3!YNQ-_)#4&76H,3DZ-
M2K*4PX8]FA+.9&=A'/>5M'A<PG]0@]SM*TKP(GVJMT,W@&_:NTICM)5DVO;O
ML-;F4D<PWH H^'N(;3<.@#@VU;]'K#HEUOB#%^S9D4=[,R^,ZVA&L9X=N!0(
M_CDC][E.@\;#(L8F.CW$Z(?#I106)1A6Z*>^T_VW78K^Y(%/;,=SANY\TJOB
M"RY7YJU2H0-A]JH+^FZU>PY]KE\!3^3U6^J:R56&]4/.E\CJ8$:P0-;ODWJB
MQ,:\"19"X0O##-?XI.-2$^#^4@C53K2 [I$X^Q=02P,$%     @ ^'!_5*J?
M&OI'!P  .1X  !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&ULO5E[;Z,X
M$/\J5DYW2B5*, 0">VVEOO9>VFO5[G9U?[K@)%8!YVRGV7S[&QO"(PTD[79/
MVPWX,;^9\3P\V"<K+I[DG%*%OF5I+D\'<Z46'T8C&<]I1J3-%S2'D2D7&5'0
M%+.17 A*$D.4I2/7<8)11E@^.#LQ?;?B[(0O5<IR>BN07&89$>L+FO+5Z0 /
M-AUW;#97NF-T=K(@,WI/U9?%K8#6J$))6$9SR7B.!)V>#L[QAPL\T01FQ@.C
M*]EX1UJ51\Z?=../Y'3@:(EH2F.E(0@\GNDE35.-!'+\6X(.*IZ:L/F^0?]H
ME =E'HFDESS]RA(U/QV$ Y30*5FFZHZO?J>E0K[&BWDJS2]:%7,G[@#%2ZEX
M5A*#!!G+BR?Y5BY$@R!T.@C<DL U<A>,C)171)&S$\%72.C9@*9?C*J&&H1C
MN;;*O1(PRH!.G=W/B:#'6J\$+<@:UEM)-/Q,'E,JCTY&"ECHB:.XA+LHX-P.
M..RB3SQ7<XFN\X0F;8 1R%8)Z&X$O'![$:]H;",/6\AU7-R#YU4*>P;/>X7"
M/;#C"G9L8,==L! NR3*EB$^1XHJDB'Z#R)%4(B*89/D,307/D-3L6]R1$B27
MQ#BIW+7B_8Q_^2ET'>]7]-8GR]'UESOT5'7H==8_#OS@"%WO5",F<GXLJ5(I
M*")?+FE+J19/[-9/WYK@,3K6C +T<']SNW/FKK8?!07=I* ;:ED_@#)QNDRT
ME!E/V)3%Q(3^#++3T>'8%L9AA][TWR53Z]=K'EJ.YP-RX(=HXFB=K[786FJK
M(;6@BY3$U. \KM'=_9<:8F(YCE-;R<*.7X\9R-^ ,T2OXI @<DBI!0PG(D$D
M3Q#-%BE?4UI#1F$-X5DN+.;VFC1!U9RBR^N;SG5S@V@'_?UR0<4SDURL2UEF
M&K%>[5JGX"7_S_M"J:"(?D6O-$)@C7'8$_=^%?=^;_A=&X<H9>$+XV[&+?6*
M:_/V\ @J'L%[IJQ)!3LY.&4]T34B$K;F1;%D2\T+;)Y0 9NF,7VIW#-)EW17
MFNIG]M;T9'+0=N<F=B9U%$&\4A$S2=%"L)BB(22U.N0=&S:F30.[-CB 6=1R
M,E&E4R9$;9,6L]NM!YY"8DFUX8<_'T'TZ;\[)I]*9YP*2B&J%154*B0,*,P;
M.O9D\WO%GEE"P4?6C*:)&7;@WTVQR$"9H>&:$B&/$';@K\?>867O\&VN.MR,
M%%GMJ(=75/&*WM-EL5.7*\[!3MO2Q)1WH,7.FJ4?\WNWT/T^O-E1-SU_+[-'
M*M#7\^O;UOO-4DD%F4/G."*UCG^2? G5,L+('T>P _AM7PX=W_*<L.@TJ1H6
M/%D*#:"#5KM0E4Q;E*W.2Y+'4!AWT.Y*]CNQ6H.;@.S&'.((6W[@=\3IT/4#
M4,[;&GZY1E B4K.&'D:>/['&8Z>-U%JZ!XA)$.HMI*5*NCA^"WU? #3J=?R6
M*(Y>$\78K;FY[QK'=16.O1\0Q_V8_TL<-QJ[X[G8/@Z-:L]QJKI.AY 7!9;O
MNN5&\_JXW&X/2\#M#>VN46F2%91ELM@"OX-54Y7F^+ZTU/7<GT#V2=35WI-"
MMDVRU>Y,(.[61+S5[D\?>ZC[HJ[^2,7]'XLF4=RF).]#JTM?[+]K<JCK71S\
MGY7I'F[OF!X<])$P@1ZT)"VINRK8J*SXZAFW5)BS-@C\%U3-H.V2XL*8PWPY
M;I?$7^ZO&FE@;#=B%6,[J%OYB/35QVT<UW;<)D[CLU2GFO&+:MG7?U4!$QY0
M. ,H;*!U%>[8[K%C>UU%=#7-?,3'.EACGL,G8:R6\#69LBFMBNO0CG2!W=0F
M/,8>_**OYD1/1_HS%? YC:;:ML;+>M<@L!L[0VB[WH_=D [TN&T_.T\2N^K<
M'MQN;YZ?A(T^\83-S.?MRU[]]A?+VE]O.M_L0KJ?@]'XRZ%]SUZWCNRHX8T]
M/JY]TSW<RQW;P=VML(V[Q^?;KX>X_\3\KUBTWJ/]8?":@-"Z-2,B:NCYBI"8
MV&'0:(P;$6\WJJB)[05]6T9]EH'W'&84MPIZQVB7,SLWA!]S5M'U/-<"H<_K
M!2W.*4U$U$OUB8@GJD:MS%]D<5UIZ!KEDD.MTH[(LKX$=<\+=3<#/31@?":*
M$]$K[5NMX\6_>6URWQI'M=T_\J70!Y_@*?I8#?9FJ%W _HB@*0P=FY)L =LQ
M3RP$=94P_*L2UYS<NQ8ZARA+-TW$0?8<41+/(97DL),+69I/[^B-.*R]3\T[
M)?;:E>?GN0ZDW2(K/=:4N5/DPUAC_P#64[2:,U!5ZS9E0JK-&'HNBDF6931A
MH&^Z-JE53U0KC@35-VNF3LWS%N:*I:FA_D[YP321%WRGL6]BQ;4[5M9]O6FW
MMYQ_&N?4!ZWQCS&O9X41?LOJ',9W5^X;-6[S,BIFYLY20L9>YJJXV*MZJWO1
M\^(VL)Y>7*I":IDQ6-243H'4L2=0T(OBGK)H*+XP=X./7"F>F=<Y)5!;ZPDP
M/N5<;1J:075;?/8?4$L#!!0    ( /AP?U0>?3:4A @  &(@   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;.5:6V_;R!G]*P,5+62 L>;"ZZYMP':2
M=HLX->*D[>N8'$F$>5&'E!W_^YX94B1M291<;';1]L&DAIS+=SW?F:'/GDK]
M4"V5JLGW/"NJ\\FRKE<_S695O%2YK$[+E2KP9E[J7-9HZL6L6FDE$SLHSV:<
M4G^6R[287)S99[?ZXJQ<UUE:J%M-JG6>2_U\I;+RZ7S")IL'7]+%LC8/9A=G
M*[E0=ZK^MKK5:,VZ69(T5T65E@71:GX^N60_786FO^WP]U0]58/?Q&AR7Y8/
MIO%+<CZA1B"5J;@V,TC<'M6URC(S$<3X5SOGI%O2#!S^WLS^T>H.7>YEI:[+
M[!]I4B_/)^&$)&HNUUG]I7SZBVKU\<Q\<9E5]DJ>VKYT0N)U59=Y.Q@2Y&G1
MW.7WU@['#.#M &[E;A:R4KZ7M;PXT^43T:8W9C,_K*IV-(1+"^.4NUKC;8IQ
M]<7'M)!%G,J,I$55ZS7L75?D'9G+5)-'F:U51621$)U6#UBW@*-,%S+]*N\S
M59V<S6I(8>::Q>V*5\V*?,^*C).;LJB7%?E0)"IY.<$,XG<Z\(T.5WQTQO<J
M/B6".813SD;F$YU-A)U/O,4F[PY89&1=MUO7M>NZ>]:]0\8EZTR1<HZ5FX1K
M8G\A=9(6"U(O%8FU2M*Z65Y]7Y756ML1M9:)0M]8I8_6-U;*&*;6"'TBJTK5
MU2YWC0OUIS^$G(J?R8^^7U9&";A2Y?=*=^X\>ORMK&J2K!6Y?]YZ][6LX<P_
MZ[*J#H]GB/ZMAZ(5)/J91+1[G9<P?;V4A7F8%N3#MR_DH7LK\W*-3-DT/Y<U
M66WFVSP4E"3RN9=JNW&3)@E"XH,9R803^2'!-8H(<R@3A#O4\XGO1+07Z\-:
M [0)8XX;^H11)P@8$1XCW,,PZG4=/R&^"G*9*YW&DOBA(!X4Y8($G'C!0')=
M+[MNP@G" .MZ/B=!!"<)$KEBX,=4PFYQ.D]C"$PAAD<BXI,I.WGE$$$AO$M8
MX$1!"'W<P#/S1CX)'4K=7I_O*V"X2C:AGQD_:EE#Q8C\D=!3<PU. UP9LS??
M/66X[1SH.0$+"/-[_1AS(8N+-TSP'Q[HQP4^/7K\_T7@4\=#& E'B)"8H!:A
MAZ 7U'\=]!PQ9=P;.2Q"'*,#0Y;L"WF!2!8FBQ"%@HA](<^=,$ @.QRY$T4N
MX0A]ET9[8M[$LL"ZH9G6=&'\M4>$260DD>NPT,0\YR%R*8!*P2#O1N+>/:4F
MVD]]7(6-]2;^?6%?[!SI.H$!CQ!I2XG/T.9>9YB1\N5UY<L[NGPEZA%\;V6I
M@JEF^0K5T[:,**A-6F7&$RAI95NY3+4J4>#TL(;MJE?C4KPU_;:B]T75L9G8
M9.A?9;$&;26L-21W!,QWJ\O'U#)4U&M3C[?L#F4C0+1 #$5(<RA7+HK4%O:=
M57NS]#3H\7(*</3]DVVL:-',2C3B0K]SH7^T"[6JTF2-8-U0"/.[5CJW,LP[
MCI2E\C[-H)"J'%@SSM:6JJBJ3L%?8(NTP"@T 0+/EDKM<NJX7+\U)A^Z7_<F
MR9Z)7&AE?"ZK)9ECE[,?:_?=;PR>PJW;M.=::OUL[+EOZ">%U+90W,6LR2G6
M%S)FVCT"VKZ',+N!J7[&O&'L/?Z_:#XKJ5%8V_N5+!Y(^:ATHN4<FPF@-J,O
MKD,=AN"XKWVG8I#<!-LOS)R5LL!B@&+S-Z0S+CT\]2>%+=PP9H'3H%/ 8L.D
M* E87U*$X]*>V$0.1?'9M$(G1'WY:K,7<=VD+A@7]_BKVUN5[59W'>J#F 0.
M,P7-<P3X&5#$\"TK2B/"[YT*OW5J]"[^'TB-3@['$^&+ZZ^0(F:K8"*[U\\+
M>U+MTNU%_F;+[V"*+A;#GI6(R-TKS=B[_1G(&V8%-A1"W)<9Z(6]PR,G]'MD
M-/L:E[Y.041) /*%F\<]<Z.L'^*QP^)U?3TG%-@31([9.8&P<; FSZ'8&F%E
M[D>M "-5-^BJ;O"&JHMR&\,R<L,0AI:2V/6;B)_K,M^48#3MT9;ML:NTCB_^
M>^'$Y[)X9V$A1M(MU-N!X2 0M?.FQ=:KK10'MR/;E7<+LRZ3Q!*W0;;+>JW3
M^MFRUX__[)Z_J.56U;76AO[NY$U]3&/C&_1Y.77I8-,<^GTF3[D3>6[_#N7!
M"\,7*ZVPA6E#J-H&!\S\:OJQA##WX=S9=A4-'#\(MB;9)7,KZ_6H17S'0#V&
MA)2?F+,!$=HS!^ #=DNB&SVNI>D_]?EA)0V5N!K'O4. ,47G[87&$7_0&O 8
M[N]?M2%0UWO] ,3$7G**O9WK#<+#8<%@4V/\8-E-V%8S0"^-, PH1\6)V=J
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MO^&Q_M;V?^S>0G74?!Z?CM$-+WA>YK"!A-%6PA9$UIW/JO]P"U1K/]KC6G#
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MC+QDP&G"RH&A,^ TMG*]OM45IZCE%"URNE=B;PIW@40T"IS$P^S2L5'LN.&
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M'8.%()-%!"(Z(6F0Y^ZF5V=UNR'?!\\$<UM4X-HS!6B-RSG!@EBAD(9"KPL
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ME$5=2@B,>I2%'4X(S/>"".?D-YS\04Z_K4&:^O,E2<WVQ4CXQ\.ZOMVM;HK
M:!383H<$!@O]L*<S0<,B&&3Q.<FY42N>FD6FM/I$<M 8E^!X]-#M,D% U(G<
M#A$$9?:L@_,(&Q[A((_;W&P2()H_ ]J+\&A0UJEK>@PY8V%GQ<T0$/5"O/:H
MJ3T:K/U _E^ 2XQ A"VFT&,=$@B,42?H[@@,9H>>AQ.A=NN=]HF;HC:] 26D
M>XY,WT6+*6LK8(.\[F%M!(L_IM#GYJ@#L^-5%WFNU^D9 G.I;7>7'@*C ?-9
M3\]:HZ/.?^1&^$*#-#,L#9)K(/!<^!&^T^K1#K>(']C=E8K@J!UV50_+YOEA
MT$.Z=5<Z;*^OJW>=X%7YQG"8?J.X?@&GK;?287,]5<(I8H/'&HZA$!''8/TJ
M3EM3I<.N^IJ.TV,;/!)R!(,H.8;JE7+:^BD=-M23Q)PB'HBI.8;#Y!S%#>AY
MZZITV%:GNRT_I**MS]'H772<M?[$AOUI>I*$U4DZ[6%NT&D/AG.BB';;@^$8
MB]R>7Z"L-49&W_9W=9WO4$[#O4)J8@C,-1K>Y87 '.;TT6K=E@V[;?GM4WWZ
MK/E+N63P=AWF;QV/O<^W'6OMA[W=UQU#C".TG>ZO" SF^=[16D1@ODM[=(^U
M+L3>[!/O<(36&IC_/EUKM9T-:_N_WV[!\=<T]AV+X; /60R'?,E:>Z=?AORR
M/$549FXVN:[.<YJGS4GE57D^UWE^32]FU7ECFZ8Z_OS"Y3+)%4EA85+:YX%9
M';(Z4:QNM%B79VR/0IL.E)<KX#'( F#>+X30NYMB@.9<=_(/4$L#!!0    (
M /AP?U1_8JAEG0H  -%-   9    >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM
M;+U<:V_;.!;]*T(66,P VYKOQVP:H(V[,P-L9XMF9O:S:C.Q,+:5E>2DL]@?
MOY3MF!1Y12N I2^M[1P^+H]X>'G)J^OGLOJC7AG39-\VZVW][FK5-(\_S&;U
M8F4V>?VV?#1;^Y?[LMKDC?U:/<SJQ\KDRWVAS7I&$!*S35YLKVZN][]]KFZN
MRUVS+K;F<Y75N\TFK_[\8-;E\[LK?/7RPY?B8=6T/\QNKA_S!W-GFM\>/U?V
MV^Q4R[+8F&U=E-NL,O?OKM[C'^:8LK;$'O)[89YK[W/6VO*U+/]HO_R\?'>%
MVBZ9M5DT;1VY_>_)W)KUNJW*=N0_QUJO3HVV!?W/+[7_8V^]M>9K7IO;<OWO
M8MFLWEVIJVQI[O/=NOE2/O]DCA;QMKY%N:[W_V;/1RRZRA:[NBDWQ\*V!YMB
M>_@__W8<":\ %CT%R+$ "0NPG@+T6( .+<".!?9#/3N8LA^'>=[D-]=5^9Q5
M+=K6UG[8#^:^M#6_V+;$WS65_6MARS4W=^;!TMADQ?;P$.VYV"XMIT]FNS/9
M?55NLD6Y;2K+4&T[UZR.W3)5G;W)?C3E0Y4_KHI%ONY4\MW<-'FQKK^WH(^_
M?<F^^^M?%!7L[]]GQP\6G?VZ*G>U;:Z^GC76F+9+L\6QXQ\.'2<]'<<D^V2[
MM:JSC]NE678KF-E1. T%>1F*#R19X]PLWF84_RTCB&"@0[?#BR.@^'QP<:P3
MUM 3L71?'^VKKZ@7Z[+>528K[S,K%)7E9?N0U0?"ZT03[-0$VS?!>IKX8NS(
M5VVEMH7:5$_%PH!,'JH1^VI:)7JZP4IC;LU\\L<7@!$A&.G"YC&,"<KD"=6Q
MA9]LX4E;[O*UJ5L['LH2?AP/Y;G7K!0LL"#&8$D#,^<QB#!*X>Z+4_=%LON_
MEHV=?U\.D[8&9ZWYUIAJ:U&GZ0M9*6(+E-:$!H8",**HPH&I,8PIJ1!LJSS9
M*I.V?MQ5]G%./+_J5)$::XKH4Q-Z&EYT/. <<14^@#%,,R140$N,DJQO F'D
M5A*4M/7-C\:*__;/Q+!A;UG"8W&#B6N$3,/.L9T./0QC&DX; *<P$CS@!X!Q
MI'KX<0L"IFE^?C'-RE3K>+WM5NCD'[/1.'*ZC-/"?#F.8MVE@I"0H1@EN(P(
M C2<]_#C)!RG-?Q3L5RN3?8QKYO4R#F9Q'(T>IR$8C41/2J>0H+1B!\ 1@1A
M(4$ C"&M>SAR<H[3>O[F+M\MB^Q]E7\M\I3/Z523H+%8(DY-"9Z$I?FQG>[2
M@7N6#N*$F*2%^)>RLEUX;UNU^XB4Q4[LR&CN+W$"2-(.\,4>_F,[G<=5,RV"
MAQ^$D6CY &"$$BEZ6')23-)2_.:W;=&897;7Y$WHZ'>K=)I'Q&@T.2$D:8?Q
M<C1)8/PI"O<Q( R%VYTY "-$RIYUGCA))FE)_F<[A$,FDU,]HL=BB3HAI&GW
M\6(L'=OI+LXZ=,4 %%8J])2ANK3JT3OJ])BF]?A]7>39YWQ1W!>+U. Y :5D
M-(:\B$+:@;P<0Q1P@U5(4 SB5(3\Q" M<0\]3M?IN<#&HGS8%O^U6E<^F2IK
MBHUYFQI")Z&4C\:3$U4Z43" QOMW@35&(5, C,1Q#P#&6*_S0)V\T[2\>VSE
M399GCV6Q#VB>I\U)*ATM4D"=RM*)8@44"!80A7 D@3%.\#C>!L 8%3T!*^;T
MGJ7U_O,JKS;YPNR:-G:<"D<Z666C!0V8DUJ6]E6'1SVAH("24=03@''MA6..
M44\ II'JV=$P)^HL+>KG Y\LUE@IPGT9 ,((A=LR -4?^V1>''HB/YP!#K:=
M$3@T%H )S</H)P CF'LAAZZY;A%A:3^\.W.R_V5G(Z+,K1UL-(><.<5F$SGD
M+':AF0Z7)P"$6;@X 2 _G-TUU*T;+.V*1TP-B)$RMV"PT=QR[F2:3^.6SSG@
M2O=-?>XDGZ<]Z6B$AT71N)-[/IIGS9T(\XD\:P[(, Z6DEL Q$/'&JJH3[FX
M$VJ>%NJ(K:&!'^Z=XXWF87.GDGPB#YL#!VE,LU#"()B0.%QP !BQ+D)/X(<[
MO>9IO8YE;&@DB#NIY*.YV-PI)I_(Q>: BPWQ!L @WF)8@C?AM%N\QL6VO T-
M#0FGOV(TEULX#183G=.)V(G6X1$J@*%AA!7 8-*SE@FW"HCT*A#1]=HXA'!"
M+$8[NA-.BL5$1W<"N%<![*0@&+"3@F#2OXW2-=>[@I%>%%+TO2XP(9PRB]'.
M^(239C'1&9^(3^7BG20  G:2 *H_*"'< B'2"\2\R!^V96T93 V== HL1SO=
MDTZ#9=H''AR1D/'I'9$:A:L6!",8A;%QL#;">\XOI%-[.9':RUBE07,!&&0N
M5%N_N4[U95KUO4=NR%9>.HV7HVF\=!HO)])X&:LR9X2'7 $H@<+E&4!))'K<
M*>D$7J8%OLO4@*V\]*ZTC:;CTNFXG$C'92R^)'1J;P$05N$V$ZI)]MRDD4[%
MY6 5;XD:=N]).5%7HXFZ<J*NIKFR\4'%,AW>*P @P5G!'(#TW7A23NE56NF[
M/ V+W"@GK&JT*R#*B:R:*/2LH)@RQ:$ 0C#"HQN>$(QJV7/6IIS<J[3<!S-K
MX&THY216C19^5DYLU33AY[F*@\;]MZ&4=RTYK=/=01X:(E-.'M5H<6/M1%)/
M=)U#0U<P>.C$ 2C,9;C<0'71OOOHVFFU3FMU,"N&!L>T$TH]6A!:.[W4$P6A
M-7#*)P4-&0,BS%2BD#$ I51/(%H[V=9IV>XR-C0LIIU.ZM&BT-J)I9XH"JV!
MN#'387@%0&$5'7I"=2DO4:9KJ]-LG=;L+F$#[T]I)[EZO%00+Q=DJF00(($C
M\K\!$(\VM0"H]_X41GXJ2%K]NW2]-HZ)D9<G@L9+%$%>I@B:*E4$#8M*@#@@
M+/&"$YWZ>N,2&'GY(BB](-S^Z_>?YV^2V8@8>=DB:+QT$>3EBZ"TBSHX&O92
M43>L+'Q_X(6*&*@4[[L&BI&7\H'2$G[^]LU+#9WG(.I@C)&T+R$%>1DD:**+
M&B\-16,=FQ(#E:9]1\]V/GC&I-WJE\=Y2)0-(R\E!(WF3F,_N^Y,>MWEN,"
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M9_&$Y5I _3[E7&Z_Z %VK^J=_P]02P,$%     @ ^'!_5,F&XC1D!   "A
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M&-<,-("\X*:VR:,&E#Y.@IH/=^NRR4',[2TOD6VZXE"N5JN'Q)V]/VOK _W
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MZ59EA[G^^@!A 'I_Q;G:3\P![??,["]02P,$%     @ ^'!_5$?B F=@ P
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MODEA2DT^BP**8X(0/79&XW>C]_$@8P;Y#1G3WT@<Q=0C:'4Y//+ LXOA]';
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M80'].Y5& -ZOA-"[![- ]Q^!^;]02P,$%     @ ^'!_5$4UE_0*!0  B!8
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MT-_7G*OGA_QNL;Y\7OP+4$L#!!0    ( /AP?U1:9!,>9@(  -T%   9
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M($BWN\^*1-M"=;@2W;2+_?%+R8IHB4?L5'Y)9'DX',YP/@W'6CZ6U==ZP[D
M/_*LJ"]F&R&V[Q:+.M[P/*K?EEM>R&]6995'0GZLUHMZ6_$H:0?EV0)Y'EOD
M45K,+I?MO;OJ<EGN1)86_*X"]2[/H^KG-<_*QXL9G#W=N$_7&]'<6%PNM]&:
M?^;BR_:NDI\6O98DS7E1IV4!*KZZF%W!=S<L; :T$G^G_+$^N ;-4A[*\FOS
MX6-R,?,:BWC&8]&HB.2_[_R&9UFC2=KQK5,ZZ^=L!AY>/VG_LUV\7,Q#5/.;
M,OLG3<3F8A;,0,)7T2X3]^7C!]XMB#;ZXC*KV[_@L9/U9B#>U:+,N\'2@CPM
M]O^C'YTC#@9 9AF N@%H/(!8!N!N &X7NK>L7=9M)*++954^@JJ1EMJ:B]8W
M[6BYFK1HPOA95/+;5(X3EQ\+$17K]"'C(*IK+FKPZI:+*,WJUV .WG^Y!Z]^
M_RW C/SQ&G07("W 7YMR5T=%4B\70EK1Z%K$W8S7^QF194:(P*>R$)L:O"\2
MG@P5+*3Y_1K0TQJND5/C+8_? @S? .0A:##HYOCAGL,<W+L4M_KPL2YUZ"2]
M3M+J)!:=UU$6%3%_ R(!Q(:#![Y.BR(MUJ!<M3=^\J@RQ6*OEK5JFY3^+OU/
M/'^Y^&ZPAO;6T).LX47RG!U[A?3 CA"&I#=C'R=ZBK&L-Y:YC4U+":BOO*J!
MW+ @D5G2Y+TK*GZOVI\LTD&O,W":^S'?1FDE02D _R%A77.3.P/-G1!ZGME1
M83]SZ)ZY$+PJHBS["=:\X%4D> (64?QMEU;RZC^@/.E8)_04>;S)O </> ;/
MDRF=WD.?8N@3LT\A4O:@J7.ETSB(+B5TE"P&*8>]"EX0_]HNN.T2R!4MA35(
MIML#"D_P-#X=OP=T3#'J,8M/%8&@&T'W/,[D\HPS,FU&A$++A(I+T)]\T_GZ
MTG'(QIO.(&5WD&(>=$/O;E?%&[FGFOW55I+U&Y"E<4,_>567*_$85<X=IR '
MP\EV'%(L0]YY=ERG=Q!_'UD>>4A1$)U&P2,V -+Y!Q'%HPU@D'+8JRB)W)2\
M*6OA"H3"%YJN^$(*4^A,Y5>G=^"NP"/>V*L&,4BQ!>9(@1"Y07B5)&ES6C*B
M!^FP0W[@CTTS()%16\ 5$I$;B;+HEF:562KK,6F@L6K7T3B'%%IF5FQ$D[,1
MZ=3#7H T5^EBPV /+59T1&XZ-LDAP3A-?884*=%TI,2*E/A,I,0Z*2$.$1H%
MP20F#W;(' 2LB(K=1'6F$M:IZ)-P;)D!L*&M:,<*G=B-3D=Q@?42$866U,4'
MQUMWA?B"!.HT#I9.L#\^_YG$!B$>6JSPC=WX/C:!CBAML6(OIM.EC^(F?N8T
M^^+TT6D:(JCM45U*UG>V "CF8C=SW<FC8Q,RJN6U :X^M&UFQ5;L9JLK>_1#
M]MR>/@JKV'W,?DGZA(;C/F3!V$6ZV"#$P\Z3(C9Q$[O+GE^NT8EB+8'3== 4
M*,EI)_'C>V@Z1DD0CE/'((4]:,$[4;0E;MHZ4X?HP,3!^,QF$$+6JH0<="3=
M4#VB@B-Z66NOX(@B*YF\_4CT*I:B8-Q2,4@- CVT5S&;N)E]%<>[?)>UCYN$
M;RL>IZW+Y +RLA+IO]'^%PVYC+3O_KFVO.(NF:Y!210SB9N9+T\D U$A97A\
MR#3)^3BP!4*AE[C1>\R6U1DZA\AR$*.*H=3-T*MC ]UUR_4BEGG>^-1HD KP
MP5-A:*NB+YV\=T#UTG:.H!Y8D]QP PQM5FRG;K:_*,4F.U-117,Z77N"*A33
M,[4GJ G0GD_&E85)#@?80G)Z\#N2F^3/)^0U-?0?;%M<$9D^0^03T]'0I(7:
M^<X@Q4);A4H5P^GD_0JJU\H28@'2+#;)#<(_M%D](:C["7&V=#SBA$;5XX!.
MU^!@"O7L3 T.IN-\+H\X8X::Q*#O6^HYIK#/W-@_(A>9 =^V9&2*W>P9=I^6
MC,SPZU@8PK&7=*F06!XS3.&;3=[Z8'KU/2>^/S[>FL0&P1]:K!X-S/UH>&DF
M_O)ICZF' )NN4<(.?O4_4Z.$&=K.".H!,W6G_<"6#0KWS(W[(VI49L2[I49E
M"MKL&6B?F(>&=Q "-JY1#5+4LSE)D9M-WD/I-+)!'GI8"ZM!;!#]O<6+@S>N
M<EZMVQ?1:A"7NT+L7USJ[_8ONUVUKWB-[E_#=S?[5]:4FOT;=)^B2N[8&F1\
M)55Z;WWIPVK_4MK^@RBW[7M=#Z409=Y>;GB4\*H1D-^ORE(\?6@FZ%\-O/P?
M4$L#!!0    ( /AP?U3\)#RT/P<  /LK   9    >&PO=V]R:W-H965T<R]S
M:&5E=#<Q+GAM;,V:;6_;-A" _PKA 4,+Q+7X*JE+#+1QAW7 T"!=NP_#/B@V
M'0O5BRO123OLQX^255,27VRKT; OB6P?3\<[WG-'2I>/>?&IW' NP)<TR<JK
MR4:([<O9K%QN>!J5+_(MS^0OZ[Q((R$_%O>S<EOP:%4/2I,9\CPV2Z,XF\PO
MZ^]NBOEEOA-)G/&; I2[-(V*KZ]YDC]>3>#DVQ>W\?U&5%_,YI?;Z)Z_Y^+#
M]J:0GV8'+:LXY5D9YQDH^/IJ\@J^7/BX&E!+?(SY8]FZ!M54[O+\4_7A[>IJ
MXE46\80O1:4BDO\>^#5/DDJ3M.-SHW1RN&<UL'W]3?O/]>3E9.ZBDE_GR1_Q
M2FRN)L$$K/@ZVB7B-G_\A3<3HI6^99Z4]5_PV,AZ$[#<E2)/F\'2@C3.]O^C
M+XTC6@,@L0Q S0!TZ@#<#,"G#B#- %)[9C^5V@^+2$3SRR)_!$4E+;55%[4S
MZ]%R^G%6Q?V]*.2OL1PGYC>%7$*%^'H!MDF4"1!E*\ _[^*MC*T SQ9<1'%2
M/@=3\.;#+7CVXP\!9N2GYZ"Y '$&?M_DNU*.*R]G0EI4Z9TMF[N_WM\=6>[^
MZRY[ ;!W 9"'H&'XM7OX@B_E<&@=OCA]N-<=/I-N//@2'7R):GUXB"\=^O%!
M/Z[U$XO^UY%4N^07(!) ;#BXX_=QEL79/<C7]1=?>528O+A7RVJU%0@>YI#1
M4$[YP6 -.5A#SK*&R]D>L6.OD+;L""#Q#V;L8T;.,98>C*5.8Z_??7R[F,+0
M$05V4,6<45[$Y3+)RUW!J^FNZ@3A*YD(>PC7,+N3A 5;9VK]6>D%L>!I^9?#
M*O]@E>^<X)M2Q/+NTI!=R=>[!"3QNC;0:84I8]WW"4":9V)3.DP.#B8'HZ1+
M>- ?.DU=<%D)EW$=$M-J#+6%1B .S.L,>HJGGCLM=G&RDCGI\A!LT1G^CQ8;
M5*2#Z+]9;M=';H1Q31.G-Q4_(1YEQ4'%1'@>%$]&--2QAWP?6U:CPAYT<V\
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MK7A1"<C?UWDNOGVH7N<\O.\[_Q=02P,$%     @ ^'!_5*7<60D1!   MQ
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M$/=7E/*/D_(![7\+%O\#4$L#!!0    ( /AP?U3<ZMAX2@,  )(*   9
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M=;YP9@ZDF+&FT'=B]QMVAB:&+Q&%LO^PZ^9Z#B2-TJ+LP*2@Y%7[9,]=( X
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M,K.F%HAPC'*J[OCF&E<-C0U?R*DL?L&FK/5'%@ASJ7A:@;6"E+#RBK:5$2T
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MSTW=;Y74OW(=IR:?>4[S*:<I2#F]YRE7G!7@([@6><)-90I \P04BBJFRZV
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MJQP7++'OZ\;HQ<:.YP.WAE+8"\(1Y/,]@_UI9*@/@G.:0Z)RHB%/W3:@<N-
M$E(W<I">C>"E&G'#MU0YW#^>-BG7'ZG#^'RMX>E[[<?-TZFB6-F"X1WAAGVT
MH5 0=O)PB7:^U/#TK?9O+YY':+I-+).LE$F&-'FV(H?#B[A[*AMFBU2\Z#,[
MG2ZRH')GNG&%$E%R77=8[6S;\=^8/K<W?UM]"9CN]&RF_HSX3.2.<85RN@63
M[O4<P&3=F=<#+?:F5]T(#9VO><S@:X;*2@#>;X70IT&U0/M]M/X?4$L#!!0
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MW%@"NIG"QB!5^<[?*+)SY)>%?;A0.P=[OE6*CH9+T#V%Z1]02P,$%     @
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M9<K?",,K AB19Z^RJD.:BH_MD&]P#.)H2;1%;48?%&W!>,)0;Q^0>?L@#S7
M/,:I":T>P,@\@,_\)D;U0$;_U]?GC4)N'C2X)_);SUPT^)&-!JK''3*/._OA
M?:.03'XXC<-6>5K_%V:K2$0G)DNAXW;[HA98>0!>WG":%>>O+Y1SFA27:X(7
MA$D!\7Y)*=_=R"/=ZM\0XW\!4$L#!!0    ( /AP?U1)>J8'TP8  &8C   9
M    >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;*V:;7.;.!" _XK&]S+-3&LC
M"?S22S+3)D[J9GK-))?VLV++,7. 7"'B9N9^_$E $+'%@E/W0VV,=K6[6CV[
M@AQOA/PW77&NT,\X2M*3WDJI]?O!()VO>,S2OECS1-]9"ADSI2_EPR!=2\X6
MN5 <#8CG#0<Q"Y/>Z7'^V[4\/1:9BL*$7TN49G',Y--''HG-20_WGG^X"1]6
MROPP.#U>LP=^R]7=^EKJJT&E91'&/$E#D2#)ER>]#_C]53 R OF(;R'?I+7O
MR+AR+\2_YF*V..EYQB(>\;DR*IC^>.1G/(J,)FW'CU)IKYK3"-:_/VN_R)W7
MSMRSE)^)Z'NX4*N3WKB'%GS)LDC=B,TG7CH4&'US$:7Y_VA3CO5Z:)ZE2L2E
ML+8@#I/BD_TL U$3P'Z# "D%R)8 P0T"M!2@76?P2P%_2\!OFB$H!8*N)@U+
M@6%7DT:EP*BKP+@4&'?U85(*3+8$Z*AIX;SGE?,ZBU2+721=D25YBITSQ4Z/
MI=@@:<9K?>9+GJ>YO,ZL,#%;ZE9)?3?4<NKT=L4D?V>2<H'6[$EO%I6B=VCZ
M(PO5$\KOHJ_K//O?3&^_7B/BX<D1>G/.%0NC] C]^=N8#OV_T "E9G"*P@3=
M):%*WU:W]"__K$26LF21'@^4MMK,/9B7%GXL+"0-%GYALH\H?JMG)L0A?@:+
M7_#[/O)&A;B2+-%0<F@Y[VX$=HA/8?%S/N\C/,[%O2*VLR15,LOCO1U"A_X+
M6/\M7VO]A7E>L5PN+9?=G?0<XI\ZB^.)0WS6(4;/(9[>W: W95R.2H?N;L_1
MF]^/&F/TN;O^YQAM1[Y1]U5GW7BRA^Z!WJW5EB75EB7Y9'[#9#>W=RGZ#WUA
MB:YY)H'TQ3>>JC!Y,%MM*3*)RD0WXR[U5X7$$ADY8'I:34_SZ>D>Q #4^I5:
M'_3J[RR^Y]+86;.]>;^>%=J"7)OI&QY/_>/!H\. H#(@  THD9<O$Q(%\LQR
M:NZ5=[A2$5\< <X.J[F&AXSAJ%([ EV8)7.99P2+T)*%$CVR*.,ZCF4NNC9E
MH7%8BR.F@3N2X\J,,>A=L92 /Y-*T03TYVNF4J6KALELIM!GEF2Z[4-8>]0,
MN=ED)S.H9_Y53A6T< R;# -38ER^8\\65 \T^DRGK.X0]<HN,FDL5RN.GCB3
MH-6?2ZUU>]Z!!M4J/(9YP=<1FQ>D8!LF%REZ,$S8VT+<%MB7!EJ>81AH+Y8Y
M-0C0/.4Y#FC+6I>:6Q>[X[@KUSAH$2PT,05]-(#6 7>YUUAT9J7.NC7$Z=WN
M. RMC&4RAJ$\_<GE/$S9?<3W7IE=0+MMWQT'VFYQC@.00M\_3*\!!F'+:CS<
M,STK$#FW2:%M5'>(](-Q@S^6[1B&>R-7G$84NC#N:(5%.QZ_?J\Z&Z?Q7N&P
MI0'#M:%SN3:M$J]Z"QVS-%MS^1BF0J_@O= \A'HRBWWB';*D$XMO N/;-D:%
MEY;>T/Z[(@Y: R0CM>X3IO6ENW8X;2#[K#VQ,"4P3&U(YB*.]<*71\^U^;%(
M!1NCYIZ>.+#98)HE)H&)^=R(:U/FIA%[<#6O'UN44-JG] _7*?6U@I>O$'P9
M <M= O?1W_.G6*;6/7*I_4>Z)65A8H(R%XGNZ.<JT_UI%"YYGM0UH-0WLWO%
MX*FQEZ<BN.\L]@F,_1T_:AUU;3/6['=:O%L-)GVO:0?88D#@8E!+LU L'!-_
M:E% VR-E:P+YQ7Z?6*H3F.H-<&E!W7ZM/+5,IS#36UH(:AE.88;OP<Q24T=F
M4HMM"F,[KXW7$4L@AVK/  [Z$(!:?E(81-TC-2TUU8^N#4TCM?"BO]0T4DL/
M"M-C'S^&G?VP?*#P]JY66^^<MN<^=I]3>)_ON^AVUU-XU^=/M&S%WGE ZHQ:
MZS'_Y6,HN^G]EO/[5I%R3=ZBHD,=\BT[?)@=VTNI/Z[X$XKMXS]=!%*1)#R"
MYK.@\,E!G^]99OAPUU9?9=<C;G^W'1L%.P?&F6,8]LEHV/#XSZ\]@(314P^T
ML]J\U&N9XL-,V3>@EC$^S)@.F3IK4=$E4RUT_.[0*0/XRF2U2/(/BB3?(LF'
MD=1XZG)F[BZ+QB9UMS-W=Q@.&HD56&(%<)O2VG\%%C;!H1J5BV#W@.ERVC$,
M<MIB*NC8SY1O/U 8QWP1,L6CI_:B%UAJ!0?M= *+F^  )\5IBQ)];O,\Z-P6
MU%Y_P(>GW8 F2&T$XC\,7UB2F(]0%V46%6^)VX-L218<]'U(8)$4=#XG04&&
ME0Q'34$>U%Z\F[] ^<+D@PX1BOA2:_+Z(QUR6?Q11W&AQ#I_%W\OE!)Q_G7%
MV8)+,T#?7PJAGB_,Z_WJ3VM._P=02P,$%     @ ^'!_5&GEF5#.!P  \S8
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M3[,5MC-R '[.@ I%%]CHFI]2=H6@VV8A8Z'M*8[C@8<NCK.^(>BV=\BJ6P*
M01>'F)[)&@%]B>("!%T<@@;YH%$PR <7B.GB):0R'^)[#,ENXX:,.Z!\ #2Z
M.!JU^="!PB"DBE $&KHXRWJG0WL#K4H'0*"+(] @'7 !@W0 7+IXK6B2#KB"
M03IX@$D/QV0S'3IOD^_J @8].IPL\(",'@ZV;WDTE:$PC9XZGW'0F#.KPW*W
M*\!%3\?%]4,I9)G'$RZF'WV^X+16"YLE$]U3+%<>X-##<6@0CAH%DW $>'KF
MYXJ;)WM>= O-:]S8'M!)HP?@]$S!F=7S@!SS>FUJ!K[;NI_6<1E2=GL 6,^\
MQ@2OO?B.F@<P]094>_H 5=]T7V[@.[]C4^Y1W^UVB@\$]LV/)A5.Z7.KR@?&
M^@,ZL_2!MS[.VWY.:1]@4D]YW\H'W/KFU2<XY26WKGQ@JC^@@M0'[OJF>W43
M?[2K4X1<?N,!(O,#RXT_S XM?:"C/Z!#2Q_8Z>-E9)_Y/_?;)YBT_<#&I?:R
MW4>K *@!#E1-V7:F,=>7;0%@-= ]<-2G;+NHU7;*-K;G,L6, &0#O!+MNZ^J
MY0Q.N@(@:H 35;^OT@CHCWX#(&M@3M9OZWD@&7H7+@""!@,B:  $#7""-N9_
M(AH0Y7$7.C4BMKUGVW]@_0&8!N8PW;B@1"$:-)ZN'!!$ X!H@$/4T 6XB-8%
M(8 R--_.;UV@N=L0 OO" 6WJ0V!A:'S<B3A!(Z)VPKCQDQ;Y<[ O47X7BZ$F
M?":4K#U9?N7K7UBMWY39LOJ5RVU6EMFB>CGGT93G\@+Q_2S+RLT;^<.9[>_<
M#O\'4$L#!!0    ( /AP?U0#=@)*[PD  ,$]   9    >&PO=V]R:W-H965T
M<R]S:&5E=#DQ+GAM;+6;ZW.;2!+ _Y4IW=Y=MFHC\7[LV:[:^*EDO7'%Y^QG
M+$82%P0*#'YL[1]_,PC1(P'-2";Y$$N(;GIZ>G[T-,W)<YI]RY>4,O*RBI/\
M=+1D;/WK9)+/EG05Y.-T31/^RSS-5@'C7[/%)%]G- A+H54\,33-F:R"*!F=
MG93'[K*SD[1@<930NXSDQ6H59*\?:)P^GX[TT?; EVBQ9.+ Y.QD'2SH/64/
MZ[N,?YO46L)H19,\2A.2T?GIZ#?]UUM=UX1$><K7B#[GTF<BQO*8IM_$EVEX
M.M*$232F,R9T!/S/$SVG<2Q4<4.^5UI']46%H/QYJ_VJ'#T?S6.0T_,T_C,*
MV?)TY(U(2.=!$;,OZ?,-K49D"WVS-,[+_\ES=:XV(K,B9^FJ$N86K*)D\S=X
MJ3PA"9A6AX!1"1C[ GJ'@%D)F'L"5I> 50E8^U>P.P3L2L!6O8)3"3A[ D:7
M@%L)N/L"7H> 5PEX^R;Y'0)^)>"KFL0CL9HY3=5/>CW9^[-M=(ILIUO?G^]N
MD>V$Z^6,3S:Q6 ;R1<""LY,L?2:9.)_K$Q_*U5#*\_B-$K%R[UG&?XVX'#N[
M7P89?2]"/R3KX)6O29:3]^0Z"\0'EI*$K[WSR\\D2$*^O-<T>XKR-'LECVF0
MA60ASB/O+B@+HCC_F?SK'Y[I6/\A$Y(+Q3F)$O*01"S_I?Z)'_GO,BURKI ?
MO;_*=HZ<3!@?E;!M,JM&\&$S J-K!'0])IK]"S$T0S^_N2+ON,Z?HR1G01R+
M\;2H/,=5?BR2,3&LC<K/:T&8_*=Z3"WZ+G!]%W0V)KI7ZM,NOQ<1>YUR^[*B
M=/>^SUKT7RKHU_2-?FGDJ,U7!^BLW?IP?T'>_=3CW6N%"=,KS95W6[3<*-AG
M;K3HEP]?R+O*CUL;6U1.U55J.RH;<X8[X*/R=71_YSHMNCX=X ;5J?]=)?SM
MALX63;>XIC_2IUJ3UJEIPIE5@\NHP664JDT%<)VG*Y[)Y($()42U6:LV2]56
MA^IIGA=!,J,DG6\Q]O<67VU1M='FE-I$IO1T9IB&YI],GN28:)YE.:[OU6?M
MF&K5IEJHJ?<-(J_HZI%FPN)J:?%/M]F8?*!9$C)RFX;1@A^:WGU&/&77E[>'
MG@2G5NV@(_NC$.,04S"%N!&#P0/R]XU66W9SNXO=VA!7T9"T<FAYT^,CKEW<
M=H=Q&W;H&O_7;HM7V^+AT\VRZ!LEZRS:1&=:3S&ZWL\W6CW9F ZO^+4E/CKS
M&Z\@\ZQKD(%HZ*"N*W>&118E"\*6E+S2(,/=6^E4]*\NI4,Z:HQ ,KF+ RR$
M=6"4CD/JS]\N[S!%0"0=1U*WCQ2RAPN]R9XN1P%X=)P\M:.X#5_N'W)LF( 3
M?7">Z  4'2>*L%):NXU[>JOGFC@Q-23. "HZ3I7S-&$9W[4604SB:$Y;+XZK
MT+4R!E#/ UAT[XWK&<B@^T?&JIK+_8-<;@!G#)PS<L2VDF57+R##T(<.6D/*
M<HRWQLE-CPJ%.#$ 1 8.(MF)G<D'=B4 C&$-[E8 C6'_B.SB4Z56(;TP@$L&
MSB6E*<95J$PQH,G N?(UB(LRNZ#E<B5I%D9)P.=8(1>^J73+MQH/6;S )P//
M?&Z#EVA5K B/N!F?FV!16ABG.2,L6E$^;_\KLM=6BW#%/&L8:]H_,<\!^0R<
M?'<TB])0&,8GE#MMD9,P>&W=W/9H<K06R=W-#'#/5.<>ME^XHWQ%W,^6 ?L+
MNRYPT1R<BR9PT<2A=L3-?%JI5+VSF-)^T7S;S=,$ZIEX6O6VF^>TTJX\1 "F
MB0-3-8AZ4D$3J&@Z@T</(,Y4W=,=AG^SN:OKP+\)9#-Q *G@OT>% OY-@)C9
M"S&)L,&SF-\9SY58Q K&\<]G^-^M2.O1Z]H]G+6 :-8P1"LAT2Q_8#8 W:S!
MZ68!W2QUNK6YVFJ2S+<,MZ.6!!RSWL@Q2ZI+'<6QUL$TF84,!HAE#4<LY;N?
M!?RR!N>7!?RR?@B_;BUE?EG +^O-_+KH4:' +POX9>&<.0(.'],D8$LN<3TF
M]TL:A^@TV< I6QLZ!FP D(U7JOH848G+<^VY'>5F&\ADXQ6M7D380!O[J)I6
MZUC, \8"C++52U@*A71LT%+!?/ *EPW,L?%MX)'EX4^56E\F\-@W.OP+E+)Q
M2O5E$CE+9]^V1K9..Z[?Z,LH;("8C1/HP% X+*FP@5TV7E4_YGD*T,C!LZ;.
M!QEMKG>:]77+U<WVD'  6@Z>-?7BPP$2.7B.=  ^G&:ZA P& .8,4 MK!,UA
M-QL':.8,7B]S %N.:KU,)79:BF2FW^%MZ7D@GE#UAPZ R<'!<4CHM&1,G6,!
MW#CJN!']9]RUY\N(SLGE"YT5HI6-?)[/.<6S_BVU W1Q!J>+"W1Q<;KTI"-7
M;A,HIF')E8E-[TC+>:YAVAT%#!?(X^+ITI$I\P>WF49)STXWW3DMY^R=<M5_
MRA0]97?4 $D7AV1=R]TOXK*4/%(2Y7G!@R'(15UU\Q/9Z04C0<:G=$'+SW^+
M;JU6'VV,T(V]I['[/N@[;7>0P&$7Y[#"#F3:HT)A!^("B5V<Q+VD<H&[+LY=
M=5)=N4WJMB^PYGG8 @,^NWCR>1#3>&I8=AV++IL/9<#U4,Z5VC7<P2D'X'9Q
M</=2SFLXUT;JKRZPV\5WM4?BZ])M/DUMH D[9;=-!>X&'K[S[5T"'H#;P\%]
MP!+PF@3%O.\!1CT<HP?%=O]VT0.T>7A%[HA@]H!3'K[_/:ZSZ=IK><;@Z*[=
MX61@G8=OC?MC!ECDX2PZIJ7HVFOI]4#&!4#R>K:IAP3/US0N5I0\ER\<B%OS
M$\W$!GJS5][L[.EW?J?+^2V=T)<9I6%.1,NK88F?^4%^:_\8)(6XV>LY*WLO
MS6.0ZTE=:7CSR#%1"N3S5,E7B$9R\D3SO:E=EX]=6X'01)N! ,$'OOEXMEN.
MF"R++(RW]9:>(LMEI5%NPC.ZFO  COX;]],^,,['&<>C,9M%N1II_>:.^CWJ
M62">K[ZI_H&KQ32[5XLU/F:Y^,!=?_"=N@\4]55WZH<O%[\EA<0F%7CL]Q0F
MCU@N3F.YF!T5&Q]0[..Y8?]R >;Y>"9XV')IIH7O4<]*;;CJ3SO.ET$D(A;M
MRI7;<@=_>J%K4J.MAN=U]=8T",-(Z.6[MV,ZCK;7D5N.'*1%4Y.Z=S7UM.^K
M"-J9BH>EIEYM\.Q.UZ0.70W/[X;S<#/CLS /2_V^FOI#VFWXEA87W&(R2U>K
MB#%*48=(#<#:X,]D=4UJZ=44&^?>[.^6HB/F;ZG+5U,O/,K^GDG>4'2[U ^L
M#5YWU.77!WK>'QC,[=5U]GL7][P^D5ZV%"\WWP;9@F_"24SG7$P;B_I*MGE=
M>/.%I>OR_<O'E+%T57Y<TB"DF3B!_SY/4[;](E[IK-_:/OL_4$L#!!0    (
M /AP?U2;@I'SL@D   -!   9    >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM
M;,6<;6_C-A+'OPKA:P]98&.3U',O"= X#NY0[#5(FBWNI6+3L;!Z<"4YV0#]
M\$?)M$>VQ:'LV)N\2/P@_C7DD#]2PV$N7K/\6S$3HB3?DS@M+GNSLIS_,A@4
MXYE(PJ*?S44JOYEF>1*6\FW^/"CFN0@G=:$D'G!*W4$21FGOZJ+^["Z_NL@6
M91REXBXGQ2))POSM6L39ZV6/]58?W$?/L[+Z8'!U,0^?Q8,H'^=WN7PW6*M,
MHD2D192E)!?3R]ZO[)=;QNH2]25?(_%:-%Z3JBY/6?:M>O.?R66/5B:)6(S+
M2B.4?U[$4,1Q)24-^4NI]M8WK0HV7Z_4;^O:R]H\A8489O&?T:2<7?;\'IF(
M:;B(R_OL]=]"U<BI],997-2_R:NZEO;(>%&46:(*2PN2*%W^#;^KEF@4X+:F
M %<%^%8!BVL*6*J U?4.MBI@;Q?0W<%1!9SM DQ3P%4%W+KMEXU5M_1-6(97
M%WGV2O+J:JE6O:C=59>6#1RE5==Z*'/Y;23+E5</LS 7YY5O)F0>OLE.4Q;D
MG'P-XT58NSZ;DM_GU:N"G-V(,HSBXA/YYS]\R[7_10:DJ,H7)$K)8QJ5Q>?U
M5_*3/V;9H@C327$Q**6IU0T'8V76]=(LKC&+<?(E2\M904;I1$PV!0:RCNN*
M\E5%KSFJ>"/&?6*QSX13SGY:6]YBVG /H='C/3E35?[TO^UF:1&_Z2Y.42M'
M>PAM6MDB=MM9C 4;8HACK'4/M&IQ6R.N>A>B9*^5[%K)TBC])MY(6$A(JOZZ
MJ#IUF4G0Y))>)"MG(B?BKT54OLGN693Y8MG=7V1G%\C]G?7]';0FH^\B'T>%
M(/,\&@MR]OAP\ZFM"RQ5@EJE0O_+%6-]]V+PTG)O=WUO%[UW/8[5C<.2/.=A
M6I))6")F+ 49V[2#.NV&>&M#/-20KUDLP1%7;7SV<]M]1WAYS^E3^C/B#7]M
MB(\*W4?%MVDNA'1U*>08*DE>-T>[4;@6[?NH3<':I@#5N8E>HHE()^0M$O%$
M9PNN00WMPRB@GQKZZUS.[W*,C"5J<SG'+\*8Q-%4-M*;"'/)^;])&RU&2M=I
M]AS:WFU88R)BJ#5_UHL :4WX(G*YJB'3,,J78U/?AY7F1B=V^UQC"P=;>!<F
MR?I_R?MR)II$ST1.9/6[AYET799B'@#T,>M#B,4 F<P^!K.NE4P36D$_T#4T
M$)/AR-P?6]=*<9-;<E PC2U 4(8CU$BNH4' B"X&$&4X!?>"U] @QOH>;A8@
ME>$<[,2OH4'$"#"@*<-1>"C ADJW"\ XX)3C.#T$8-=*<Z,W>WU?LQK@0%..
MT[1)L,]+@F&+:" CYQ]"+ [,Y/AZL2NQE,R&CVU-LP(N.8[+ WBE%+ORB@,[
M.<Y.,Z\, D9><6 GQ]&W'Z\,8B9><< HQ\G7C5<&$1.O.."3X^0[F%=*MQ.O
M@)X<I^=AO K:>&5K'AHL@*>%PW-SQ?5;E&!/ED!!BWT(K2S@I86O)+O22LEL
M/XUIY@&K\7"-T_( 8"G%;6#Y&E. G1;.3C.O# )&7EG 3@M'WWZ\,HB9>&4!
M1BV<?-UX91 Q\<H"?%HX^0[FE=)M\BK0=!^ IX7#\R!<*<V-ONSW.:.-'\U$
M; %(+1RD=R*O8_RI'&/7=23U_N$1#6@!%FWZ(0"S :$VOI \(+!DMSR4,]YW
M-*LO&V!JXS UQY8, KYO&!LV@-7&P=HME&,0,0U5NQ'ZQ-EX4/3$;EF:RM%A
M:?P$=+5Q(+8/B&INC](H66!SNPVLM-V/&1J 1_N8#^D&,=8/MKN"ZD*FU2G'
MNQ  UC[1ZM1&5Z>J%BT@EDR@FE6%#?"U#X%OU=?"[X:^Y@"&G8_!L ,8=G ,
M[Q?--HC1OH7V&0>([)B6MP>&D)VV]:ZE[0\.<-G!D?HURFLCZHTSDM4.D]-7
M)B>NI-J_\LC9,"QFI!!E&8L)MH/E 'T=?.>I:H:T$ 4)\ZB(TF<RS;-D:<+F
MWBJ1C906X=BTY>4T]IQ,FTYMMQ[+*IZK*AKMD#Y2^WEM6X/J_F[#40YC.C\!
MOAU#M-7@)W?II_,N?@)B.]X/]A/0U3'3];1^VJ6P$VB>'QW JV,(L2ZAMN&E
M>A15VR'5=C#2."[PU<7Y>G2_N !6%V?AR?VB[K_A%T\7B72!O*Z9O+MV+^>@
MXU@^5!8T1[Y/+6=K9F^YRG$=?_.J6W55LQ4\JFL$@+W;(;JQ53^Q:AB\;E:G
MNNW&D-OJMGN5:^L(Z<*DXAJVYG1#[VSUC1F-+LPCKO.>)8Y<X:QL,"UJW$;.
M CX'; 7'_M[)*VKUW%+3:[0V[3/-3J0+4X.+KZ/US[D=S?)VS*J>>76] .8-
M%Y\WS%$S@X!G>LAT83)P\<F@6H2>=W_B,:B=T2INAO5>#R80#P\?=PN<&41,
M#>7!I.)UV7TCLHT2T\.3MSL]Z$+['DP.GF%R:$='L \Z/*"P]ZXLACW0X0$<
MO;WR%KJ-4:79<8QZP$[OT"R&CG8Y>]D%?/7>F]%@$#"RPVNDA9F#)7NPPZ#6
M@1U 6.\820T&$6-# 60]'(O[L*-[&H,/*/5_\%K<!VSZAZS%C[JF518TUWT>
MI=O1JI:K.*-;J\/;5BW-FM8'=OLXNVM.W\4AEF'F YO]C\DP\X'4_E$RS&Z4
M3)=\#1_([!\[O^S&;\LOXWVJ66'Z0&/_G30>&03,J;% 8_^(H>N108R9S&JD
M[!X!Q2.#B G%/J#8/TU^V4CI,FMC8T6S!1H FH/C9YC=!"T99DA_#H#6 4[K
M-:CJ8'LJ[:E9_)2%^:0.#XED'F=O8GO-LWD[X&* 9YX=?5X* **!*>7LY/-2
ML!M#"/SM<$2P&[2P./,TC@1"!SBAFX[\KW@EP]'O6+,!? ,\I'!\CP%K U-D
MX=0>&RD+FA[CKFZ( Y@#G*5-7SPLYB)_B8HL?U.C*A')D\C1)@+6!OX/]D[C
M%(29JZ<>3\%N5')[E==RC:L93(PV3U7@E&ZZT'RXB='&"0GZ,>ELC#9.1M#C
M)+2M=':R0'1G!FCCU 0]>E+;2K)K4@JCC2,4]+V);28%\\D!VCA208^9VV92
M:\E+V+*L<<""'B.]S:1B/@#5.&9!3Y3AMA+N= :*-@Y8T!-DN:U$M[)R+<WN
M'Z.-$Q841W439H:L-M8\><8^)J&";9PW._Z!L^N5Z,;I3=IO;+0N5]VMU[&^
MNTV_0>/H=B+RY_J0?2&[XR(MEX>;UY^N3_+_6A]?W_K\NCKA7Q\)!YGEOP?X
M$N;/L@U)+*92DO:K:&.^/'"_?%-F\_J ^%-6EEE2OYR)4+JBND!^/\VR<O6F
MNL'Z_QY<_1]02P,$%     @ ^'!_5*M",%"2"P  4%4  !D   !X;"]W;W)K
M<VAE971S+W-H965T.3,N>&ULO5QM;]LX$OXK0@YWV 6N,8>D1*F7!DB3+'8/
MUR)H=^\^*S:3"+4EKR0G76!__%'R"RGQ15)"[9?6=H9C<H9\^ RMAQ<O1?FM
M>N*\#KYOUGGUX>RIKK?O%XMJ^<0W:75>;'DN_O)0E)NT%F_+QT6U+7FZ:AMM
MU@N,4+38I%E^=GG1?G977EX4NWJ=Y?RN#*K=9I.6?WSDZ^+EPQF<'3_XDCT^
MU<T'B\N+;?K(O_+ZM^U=*=XM3EY6V8;G55;D0<D?/IQ=P?M;H''3HC7Y;\9?
M*N5UT(SEOBB^-6]^67TX0TV7^)HOZ\9'*OY[YM=\O6Y<B8[\?O!Z=OK2IJ'Z
M^NC]IW;T8C3W:<6OB_7_LE7]].$L/@M6_"'=K>LOQ<O/_#"BL/&W+-95^V_P
M<K!%9\%R5]7%YM!8]&"3Y?O_T^^'2"@-<&)I@ \-<+\!6!J00P,RM@$]-*!C
M&X2'!NW0%_NQMX&[2>OT\J(L7H*RL1;>FA=M]-O6(EY9WLR4KW4I_IJ)=O7E
M3UF>YLLL70=97M7E3DR"N@K>!0]I5@;/Z7K'JR#-5T&95=_$]^9B]C0FPN*Z
MY*NLWO_AAQM>I]FZ^C'XQ]]B$M%_"6_!KT_%KA)MJXM%+7K:?-]B>>C5QWVO
ML*57@(-/15X_5<%MON*KKH.%&.)IG/@XSH_8Z?&&+\\# O\,,,)P^]N7X(=#
M3W_<!YF7AEY>C_>).CX-OFY&^X)DR-?M>%^QPU<GD.0T84CKG%B<JVGGW[=%
MM2NYPRT]N:6M6VISFU9/[41;-B_X[[M,3+YF+IHFS]Y5U+IJH/#Y$E@,\<7B
M64V>;D5C"*.NU8W!"E 2=JUN=:L$8WPRZ@PY/ TY=$;RAC\+H-ZVRZEX"++-
M5JRY]MVZJ"I>.:(:G;XB<D;U]OM6 #(74=UGK7$<I&NQ/8A%+U:V0.JZ3%=<
M8/Z2BXC?K_M?NP_X_EM"->! 42_>NA%AI)>4&]V(A98XLM,@F7.0OW0#UPSJ
MX81JJ8BD>1*Q,6/2C0QCTHVL8XI/8XK=RT&N,L<T2$[>$I]K%I#</)"_57OP
M%0XL6X-9=]UV^ZIL=.#LZZ_]B;[ON-AF2L%6#A,E^#/X*I9,]I M!?]8"<IQ
M7ZL+YL]@7&8 RVYAK[F1. UD\MHWIH5H\0X9L'Y6="O*HOY*,%AA$H:6U,F]
M >A<2 D2C2%TQNNJ:GS_.\UW@C$'8 Q5."((UP8K1Q DE,-?@^6@0W#2WQ6O
M#48D9HEE#!*IP0W5-UQTKGC,LZ9(,'9.Q])WVE0TV "-;  A(1?<F+N? ((\
M\<T]+P6!,G8P'K5:="O3:HDU5N&8*!+L(?$"=-=%5;N8M=P%,/()85A"-O8
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MZ;@Y8=IQLVZ&*<26;9Q*A*5NA)U43 SX0N>)N988: ?GD;.4H!)[Z?13#.-
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M*GT;T+Z](3^Z."%&&H4SF44LM)0LH"K=P W0DXJ6(6<1U7\B.0Y@H"49$(^
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MQ//*=?W4-4BV[IH#>]'$>-&(AGS4LV:F%&/6,9#NM4N=VOU6M5F!Z92:.L4
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MR4GX_1#8E=4?FO#1G#Q#A*1+GEH44W@G;KQ/9  QR7U.4C:>FS$QX"&S:*D
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M07_#:A5!8_=*?'+P8JS(&']G@%2,'<_HAVH[ R(>941LH3^)@F?BAB<)VBJ
M"=9+%#$3-S$G6R]1 $S< +1:+T%PEACQ/X@4"V-;0)Z"7N*&'@3G >L'AM-P
MBE.)>WMONN$48!(W8.R&,V&1AH8GC4A!2&SGS(EB2N)QO:I:;,?M,G\0?A,J
M("1N_VNZ";6X2[<[93>AZ4(E26KT/21:)XRI;> JH"0>H-390O0QL%6[$O4@
M%GJQ$=YXZ&&8I^)%Z@ZIG&S@5/$B=>^<(9'=:"0ILH=&C3!>1 IHPBQK[U01
M*'43Z,"U=ZH@DIXH4#Y5'$D]<8G^4.'4]&>0A1<B95]XI0I*Z7="*9VT'$2D
M'%HI)J5N)F$M'/P1'.1BI I4Z8E E2I0I=\)JETY[C&K*>4PJQ88[N:4Q:R3
M_0X(]7#O$\$)0BU^.W3CZ7W9BEHT[?FMG*6Z4=7O%DB^%L76:1<=9HM]-ZG*
M[806O,K[I)"Y7)MB62 WO@='X44<_@5;2/M*$G81CDN.WE^+#0_=Y/M\R&F7
M7'!H%9^(?!!J(=FAFWU?6KDT_Z]4=\L^_;AN+O_)VZ K@4>XAF9V$#).,#'[
M0(%0B]4./:M!/[>?JW ?K&!2UL@!"+5X[=#-2%]?>%826^V%IB$]8B,UM8#O
MT+TLM)+PN2#WF ])X$EM\=6A%@0>N@EMFD^2\&->YNO-VMG_M1CN,#W1H-+3
M:,!S\+!#8%!GK9" FSZD/!5'%S'#"7=XP=';Z0DZ;EKBK9)]\[6*GE^S2WXY
M0:MH_/0DQAS1*NZ*J;U5#BXX>CL-Y)[D&K15#G+&0$^3 ?<I[P$-I-'2D]YB
MQ]"NX& *,3&$2%GV0D'/A@$W'%'#3G?'])P7.-$V&NA)*IXL%8=1L9@Z8])!
MI%AB"<$$+4$%/!DJJ%FG[1"!EFX"Y$2;:Z!EAX G/<1FTQD@*1_4=EH)6L8'
M>%(^_M7O64QS*;4T#_#D>1Q@'8T-GL0-OULV R0APWK@#UH^!G@2,APM@SA/
MJ;4?:WCP)&.,6^8@.&BI%4!.!0<M$P(\J1 .<R'[YU9S:=D-X$EO^'# H2-H
M.0W@26J8;AXM20$\60I3%AA(^@$DNO>[,R@B1R0C;1-4I.?[NME@)SR2?D#D
M(PW&8W(TL7KP6IX">!(5C.8^V"G14@\@.I53HN4*@"=9P&%=)$\ N&%;M]1(
M+XT[GD0!S++3P:.E"( G1^  JVK@\03].ZR*@(<B&>J(&$ML:V$MVA\\X?Z8
M72>Z)5IX/]!3X4J+V@=/V+[=J$C$/G)ZA8HEW)94KX7V@R>V'S/J@6=:0/5[
M!D[EUFAQ_. )Y'=8UW1FD(,M3,QQL@5:G#]X OVW9UOWV5-_G.5\7PTP]$0[
M[J"%[ ,]^E:6YRJ&$2:$C>/2,;D(8EO<(FA!_>")ZG<T-1)]@.J&X D8L<WV
M6D _>"+ZAVU]\'2J!>@#.Q6CM!A\\ 3AVTV[*\A]ID7B\R,(P7KUAT8I3XR^
M8=KI\ZD6;@_L5'!B^K4EWP>GV7/!P:8(V!QY+<0>/#'VNUN\L(O91G5JR&&G
M0HX6' ^>Z/CWY;SNIY]7"[']ZX?N *K<K&_EPJU:!E6]R,NL?MK?*-@T&[&0
MS6^]=&X&2)1\=TN7]:(NT$+EP1,K/["L5.-=5135XWEW9=KFMLCG^RO)7 ;2
MHN2!G^H44(N0!^[>).X[I&;DH6V[,(RF*A9=0RQMK^=J@>OGYX\/0^PMH(76
M@R>V_I]CM7N5NLVJIT!\RYO^HK?^IY5\"5$W'E6Q*'RGJAJS/$'VOZU$(#O,
M?58^225.TW4TEO%3L4P+@0=/#/S_8<!> Q(3CP_82^VZT[6H[_J;;)N@O]-O
M>V?G_MO]=;D_]W?$CKZ_@9]FVSMO537;.W@_9O5=7C9!(9:RRO"B"T2MM[?:
M;C^TU7U_J>IMU;;5NO]S)>3<5'<"\O=E5;7/'[H'["\7?O,_4$L#!!0    (
M /AP?U2<=O5 2P,  )T-   9    >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM
M;*V776_:,!2&_XJ525,KC29V/H .D%K::;U85=%VNS;!@%4G9K8#K;0?/]M)
MD]! V@UNP([/>W+\Q'[C##9</,DE(0H\)RR50V>IU.K<=66\) F69WQ%4CTR
MYR+!2G?%PI4K0?#,BA+F(L^+W 33U!D-[+4[,1KP3#&:DCL!9)8D6+Q<$L8W
M0P<ZKQ<F=+%4YH([&JSP@MP3];BZ$[KGEEEF-"&II#P%@LR'S@4\'Z/0"&S$
M3THVLM8&9BI3SI],YV8V=#Q3$6$D5B8%UG]K,B:,F4RZCM]%4J>\IQ'6VZ_9
MO]G)Z\E,L21CSG[1F5H.G9X#9F2.,Z8F?/.=%!.R!<:<2?L+-D6LYX XDXHG
MA5A7D- T_\?/!8B:  9[!*@0H(\*_$+@VXGFE=EI76&%1P/!-T"8:)W--"P;
MJ]:SH:EYC/=*Z%&J=6KTC:8XC2EF@*92B4P_(25!!\PQ%6"-648DP.D,""J?
M]'U3_6A-B(X89T*0-'[)ATZNB,*4R=/&2 =</T[ R>=//3\*OIZ"HJ'O!QZ6
M/),ZNQRX2L_%5.3&1=V7>=UH3]U7)#X#/OP"D(?@#OGXXW)O6^YJ@B5&5&)$
M-E^P)]_C_55+%K_,XMLL_IXL6^!:\@5EOJ"UJEMM ^1YQ64FR"[$N3JR:K/?
MUR,$-8UUG6,SIH,"KUM&;146EH6%[^$"?\"#P#.BO2 F=(VGC,B6*4=EYN@H
M"+MEONY!"'-U6$<8><$;ALT@B%"P&V&O+*SW880K_&+YV9W*U9((P"B>4D85
M;:7:+V_6/PI5Z%6VXQW$M9"'6^O.[[\ENRO,CWRXFRVLN2)L+>_F=M(VS<H6
M(#H.N,HBH'\8.+]!I &M&=+Q]^QH6'D-;#<;C>P?]S2L[ *&Q\%8V02,#L,8
M-1CUWF)LAL#>'HJ5W<!VOZE3_.]M#2L3@;WC@*V< O8/ ]MOOE :"[3?7*!A
MN!LMJBP'M5O.Q77;.QI5WH#@49BAVN&A_?3P#K-Q(=_B ?=L6%0Y"6IW$LWC
M\*6&*G] P7&P5:Z VD\1[V(+FTNM@<VMG9W-A\L/+!;Z* P8F6N5=];5243^
M+9!W%%_9X_24*WTXM\VE_GXBP@3H\3GGZK5C3NCE%]GH+U!+ P04    " #X
M<']4S7^8=7P#  !R$0  &0   'AL+W=O<FMS:&5E=',O<VAE970Y-BYX;6RU
M6-MNXC 4_!4KTDI=J4IB<VLK0 )Z6XEJ45&[SR8Y@-7$IK8I;;]^G01BJ(JA
M"%X@=CSC,QF8Y*2Y$/)%30$T>D\3KEK>5.O951"H: HI5;Z8 3=GQD*F5)NA
MG 1J)H'&.2A- A*&]2"EC'OM9CXWD.VFF.N$<1A(I.9I2N5'%Q*Q:'G86TT\
MLLE49Q-!NSFC$QB"?IH-I!D%)4O,4N"*"8XDC%M>!U_U2",#Y"N>&2S4VC'*
MI(R$>,D&?^*6%V8500*1SBBH^7J#'B1)QF3J>%V2>N6>&7#]>,5^FXLW8D94
M04\D_UBLIRWOPD,QC.D\T8]B<0]+0;6,+Q*)RC_1HEA;JWDHFBLMTB785) R
M7GS3]^6%6 /@^A8 60+(5T!U"Z"R!%1RH45EN:QKJFF[*<4"R6RU8<L.\FN3
MHXT:QC,;AUJ:L\S@=+O/E$9B;&P<*18S*ADH='8-FK)$_6X&VNR1K0RB)5^W
MX"-;^#!!#X+KJ4(W/(9XDR PQ945DE6%7>)DO(;(1Q5\CDA(\#<%]?:'AXYR
M*N4%J^1\U2U\/>!:3( #NDM']P[":DE8S0DK/W# 05LK:6O..O\N.$@U93/$
MN 8)9A/&[28?Z,P,9R CH^=;G]WT. S],/SUG1\' #<4UDN%]3V=N/U$_20Z
M1T^<:8A11](1NDF9I-IY*1OE1HUC.G11TEZ<UB$WO<.A X ;"B]+A9=[.O0T
M1/U^[QQUY](LFFC!C5O#CF,/'-H$"X]I#UZ+1GQ:@W;P.QPZ!+FIDEB5Y >!
M=H[,G9)SZJ*V48DK1W7&1B:NGM@9-__E=F-^#MS4:/,;NX/2^O*'&U%H\*9]
MU->N6RJVT8GK1W7&1B5NG-@9-[_K/W, <E.E36[LCLA.'+/L*90F*RWFD1>)
M->WKDFGT.F?RZ\/0LFCW1M7+737;+,;[AO%PP?0GR(1R<Z^\<SVBV0PF1\U@
M8C.8G#B#=_ [?D^'(#=5V@PF>V2PHF- 7?_9=U':["5'S5YBLY><.'MW\+L<
M.0"YJ=*F+]DW?6-?^ *9AG<B:0PN<IN^Y*CI2VSZDA.G[PY^ES<'IV^PUKVF
M("=Y4Z]0).9<%VUB.5N^..CD[?*7^2Z^ZA7MOZ4IWD8\4#EA7*$$QH8R]!O&
M?%DT^,5 BUG>(X^$-AUW?C@%8[?,%ICS8R'T:I!M4+YF:?\'4$L#!!0    (
M /AP?U0 "FZA*00  "(1   9    >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM
M;+U8VV[;.!#]%<*+721 8XG4Q5;6-A#;[;9 6ACIMOM,2[1-5")5DK*;OU_J
M$LG1A4FZZ;XDHC1SYLR0/.1X=N+BFSP0HL"/)&9R/CHHE5Y;E@P/),%RS%/"
M])<=%PE6>BCVEDP%P5'AE,06LFW?2C!EH\6L>+<1BQG/5$P9V0@@LR3!XGY)
M8GZ:C^#HX<4=W1]4_L):S%*\)Y^)^I)NA!Y9-4I$$\(DY0P(LIN/;N#U&GFY
M0V'QE9*3/'L&>2I;SK_E@P_1?&3GC$A,0I5#8/WO2%8DCG,DS>-[!3JJ8^:.
MY\\/Z.^*Y'4R6RS)BL?_T$@=YJ/I"$1DA[-8W?'3>U(E5! ,>2R+O^!4VOHZ
M8IA)Q9/*68\3RLK_^$=5B#,'Z \XH,H!M1W< 0>G<G">Z^!6#FY1F3*5H@YK
MK/!B)O@)B-Q:H^4/13$+;YT^9?F\?U9"?Z7:3RT^<785<J8$C_6G/:!,$4&D
MDN!B312FL;P$5^#MESMP\<=O4\=W_[P$U8.V!7\?>"8QB^3,4II-CFF%5>1E
M&1D-1(8(?-2!#Q*\91&)'@-8.HTZ%_20RQ(9$=<D' ,'O@'(1K"'T.KY[G:/
M^_K9[C P9./4,^,4>,Y+9\: [=;8;H'M#F"OL!#W.2A.>,84X#O .'M&M'(:
M2G"_ ,^%Y;BX@H$SLX[GQ>XQ"KS:YA%MKZ;M&6EO!-]195W$7,K+/F*ENW<>
MT_6G'FI1ZS%#T)E,'YNMO6X&R)YZ TGX=1*^N?:$*;XGC("_DNW[-T!+&6/8
M,*F3&GCRZ@MF6F-/C:0_Z1,(2TF4U-6G>$MCJBCIGX1IM[H>:M5VU6N$^BL;
MU"2#7[FJ@QY*[47=9S/ &MJ-!-O_;5E7_H_"^BUF?39P@-G9X0"?SPS@..8A
M5B0"BN>5[5UMO?RAB5O%OVMC#]!'#7UDI+\68[#$&1'@%F^YP(H+FB6RV'B&
M30$;B8:OK]&P$6EH5NF7;+H*ZKQ\R/7:->X:07<Z4.5&E*%9E>_(D;",]++J
M*BVT QMVB'7M/,\+_ %JC=1"L]8^O;/\3N"@+54]-G!(JF CUG#ROVRM2>>0
MZB;0M1E.H#D1H/E(:,ZQ#RRB&&R.:@QNE>DB!QLEA\&K;RS4""XR"^Y-%-&\
MZ\ Q2(D(=2*ZQ0'\Q(B0!YKF%UN9;275:8E[W9I\SZAHWU"K&Z4YD!N,;?MW
M$^=&BI%9BF\WJZ=T"S7"B-#KE[=11>0\M;13+HJV3A_!0V6-J$RY'"BK.8 '
MGRIKH['H5]Z$5ZA[RT7^@**B1E'1"^ZY/ZT-*]1S@85V^U)@G36/"1'[H@F7
M(,S+4?9>]=NZT;\IVMO6^R6\7I?M>@-3_GKP$8L]91+$9*<A[?%$$Q-E0UX.
M%$^+%G7+E6YXB\<#P1$1N8'^ON-</0SR /7/(HM_ 5!+ P04    " #X<']4
M^SA5%%D#  !O#   &0   'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6RM5VUO
MVS80_BL'#1A:8(U$R9;MSC;0."TVH-F"]&6?:>EL$9%(A:3B!NB/+TDIDN,7
M+6CUQ2*IN^?N'I*/SO.=D'<J0]3PK<BY6GB9UN5;WU=)A@55%Z)$;MYLA"RH
M-E.Y]54ID:;.J<C], ABOZ",>\NY6[N1R[FH=,XXWDA055%0^7B)N=@M/.(]
M+=RR;:;M@K^<EW2+GU!_*6^DF?DM2LH*Y(H)#A(W"^\=>;LB,^O@++XRW*F]
M,=A2UD+<V<G?Z<(+;$:88Z(M!#6/!UQAGELDD\=] ^JU,:WC_O@)_8,KWA2S
MI@I7(O^/I3I;>%,/4MS0*M>W8O<7-@6-+5XB<N5^85?;QJ$'2:6T*!IGDT'!
M>/VDWQHB]AQ(?,8A;!S"0X?1&8>H<8A<H75FKJPKJNER+L4.I+4V:';@N''>
MIAK&[39^TM*\9<9/+U>B*)@V^Z(5O+I"35FN7L,;>/_E%E[]_MLTBD=_OH9F
M (S#YTQ4BO)4S7UMXEL4/VEB7=:QPC.Q2 C7@NM,P7N>8OH<P#>)M]F'3]E?
MAKV(5YA<0$3^@# (R8F$5B]W#WK2B5HR(X<7G<'[B.9 0=)1VH,Y:C%'#G-T
M!O.ST#2'DCY:0!#KG&VIO0"GZ*^18H=D[^_#,HYM80_[E!P;C>)XUAH]2W+<
M)CGN3?)6F(.:W$%FA.2^HE*C5+"N6)XROH7O\(_0D%.S"CJC' 1'>$0J>^B)
MV\CQ8)1/6LQ);S4?*EU)A-Q!-\PKT +6:*Y>BJ>HKQ''>ZR28'+ _+%-.(U.
M$S]M4YW^$O'$7.6QX[J/F%D;;388V23H%"@8G.X&\AF7T>3PJ)^P(O$T/DTY
MV9-,\DND7PM3CCOH&_.)^E_V2=@%#H?COQ,M$@W/?W3$["@DLT/^3UA-Q^,S
M_'>*2/HE\=_-AB4(>%^QTJFB^1R!V1)I^@Y0)4U0_93FD$[NR'BXC>BDC,3#
M;T1\3/'H<!N.;:(SND,ZC23](OFR37B9_I!.[LAT..([62.SX8F?'7]'C\[_
ML<WAA];?:]T*E%O7T2I38<5UW0>UJVW7_,[UB@?KE[:;=BUA!U.WXM=4;AE7
MIKR-@0PN)N8@R+J[K2=:E*Y!7 MMVDTWM-*&TAJ8]QLA]-/$!FC_8RQ_ %!+
M P04    " #X<']4N"/P2 4#  #O"   &0   'AL+W=O<FMS:&5E=',O<VAE
M970Y.2YX;6R-5EUOVC 4_2M6)DVM-)HO"&D'2 4V;0^5$&VW9Y-<B-78SFQ3
MVG\_VPDI34+:%["=>X[/N;[QS>3 Q9/, !1ZH3F34R=3JKAQ79ED0+&\X@4P
M_63+!<5*3\7.E84 G%H0S=W \R*78L*<V<2NK<1LPO<J)PQ6 LD]I5B\SB'G
MAZGC.\>%-=EERBRXLTF!=W /ZK%8"3US:Y:44&"2<(8$;*?.K7^SC$V\#?A#
MX"!/QL@XV7#^9":_TZGC&4&00Z(, ]9_S[" /#=$6L:_BM.IMS3 T_&1_:?U
MKKULL(0%S_^25&53)W90"EN\S]6:'WY!Y6=D^!*>2_N+#E6LYZ!D+Q6G%5@K
MH(25__BERL,)P(_. ((*$#0!PS. L *$GP4,*\#09J:T8O.PQ K/)H(?D##1
MFLT,;#(M6MLGS!S[O1+Z*=$X-5M#CA6DJ,!"$9!H@-9 ]PP$ML?"MX@"W8"0
M9O@$KWIOILM!'[Q"%TM0F.3R4J-^/*[1Q=<O<1@-OU^B:H (0P\9WTO,4CEQ
ME=9K=G632MN\U!:<T>8'Z(XSE4GT@Z60OB=PM=':;7!T.P]Z&9>07*'0_X8"
M+_ [!"T^#_<ZX,M/P_WK'C=A?7:AY0L_=W8]C,.:<6@9AV<8[S,NU$"!H AH
MD?-7 +0!!ENB.L^O9(LLF[E@GF=#[SJ>N,^G.>T("L;A^Z!E.R@,_;>@=VY&
MM9M1KYL5EVI0^K#U6E2WE:Y&7=4I27#>ZZYD'YUH"AJR%Q^'+-LAOM?M*ZI]
M1;V^'O3Y$%:^H'WZHPYQHX:!=LPH&G7+&]?RQA\4$18P,)>Q*<TR]4I@)K&]
MZCNECELRXB!H2&W'^*V@93LH#*_/&(IK0W%_OKG2E9)P:@JH3'N!28H4;]R(
M7<[B5F&/_''S%6D'15'<+*2.H+$?-ZRY)ZV @MC9EBJU^#U3Y3U9K]9=^]8V
MJ\;Z7'?SLOF^T92? G=8[ B3*(>MIO2NQCK;HFROY43QPC:<#5>Z?=EAIK](
M0)@ _7S+N3I.S ;U-\[L/U!+ P04    " #X<']4"_9N2(((  "I*P  &@
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MZP/J_H8Q^;S18WOX(Y#] 5!+ P04    " #X<']47/Y6D;T'  #E)0  &@
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M[CS04^Z8,(1=Q;1A=S".Q#&&0"^Z>S2*D-6)X.O>'^PN"<,X=B. N16$(8;
MW8@CF +0@"%A:-Z#.^^C8/V>"IK_<0[_ %!+ P04    " #X<']4EXJ[',
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M>&UL+G)E;'/-V\UNVD 81N%;0;Z V/,_4X6LNLFVR@T@8B *8(1=-;G[(K*
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M\34_6?[/>?,34$L! A0#%     @ ^'!_5 =!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #X<']4YG"B
M.NX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " #X<']4F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( /AP?U3+>N-SEP8  /,=
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " #X<']4<99T!N(%  "B&   &               @(':#@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ ^'!_5 9PEI%V
M!0  CA<  !@              ("!\A0  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( /AP?U1U![T1[0<   4B   8              "
M@9X:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #X<']4
M+J5*F3P&  !''@  &               @('!(@  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ ^'!_5!6+G">W!0  5@T  !@
M     ("!,RD  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M /AP?U3ES&DE A,  & S   8              " @2 O  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " #X<']4#?<SJ<<#  #+"   &
M            @(%80@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ ^'!_5$[=QOJX!@  <Q   !@              ("!548  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( /AP?U0K %BV3R4  /%^
M   9              " @4--  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ ^'!_5.6^P\"]"P  @A\  !D              ("!R7(
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #X<']4I!^"
MYIL4  !72   &0              @(&]?@  >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( /AP?U2HRA#0( <  -(0   9
M  " @8^3  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
M^'!_5,ZJJ&_@!@  NA$  !D              ("!YIH  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " #X<']4@JA3Y4H#  !P!P  &0
M            @(']H0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( /AP?U1^J2.!M@4  .@.   9              " @7ZE  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ ^'!_5',;RB)(!0
M;@X  !D              ("!:ZL  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " #X<']40$CO6ZX'  "D%0  &0              @('J
ML   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( /AP?U02
MEV&$# ,  +D&   9              " @<^X  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ ^'!_5/08.ZL !   )PH  !D
M     ("!$KP  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /AP?U0BY\IW%!P  )5L   9              "
M@:C3  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ ^'!_
M5)(N65$H$P  -CX  !D              ("!\^\  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " #X<']4$/>4[J,#  #N"   &0
M        @(%2 P$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( /AP?U1=M'$ B ,  '4)   9              " @2P' 0!X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ ^'!_5%$#=\?& P  U@@
M !D              ("!ZPH! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " #X<']43()Q7HP(  !4%@  &0              @('H#@$
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( /AP?U1;9_$%
M,0@  ,L2   9              " @:L7 0!X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ ^'!_5-$NW):3"@  6!H  !D
M ("!$R ! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #X
M<']42BI /)4F  !_A@  &0              @('=*@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( /AP?U0]Y;".G@(  ,4%   9
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M970S."YX;6Q02P$"% ,4    " #X<']4;YC2,%@$  !!"P  &0
M    @('M:@$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M /AP?U1]8<.1;P0  $$,   9              " @7QO 0!X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ ^'!_5$%?2Y[S!   Y0X  !D
M             ("!(G0! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " #X<']4XYL6HC@"  #]!   &0              @(%,>0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( /AP?U1KSK91F@(
M $8&   9              " @;M[ 0!X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ ^'!_5!D95U># @  & 8  !D              ("!
MC'X! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #X<']4
M(>/GBX($   P#@  &0              @(%&@0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( /AP?U2JGQKZ1P<  #D>   9
M      " @?^% 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ ^'!_5!Y]-I2$"   8B   !D              ("!?8T! 'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #X<']40G_/0YD#  "S"
M&0              @($XE@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( /AP?U3?.RJ&X@(  -,'   9              " @0B: 0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ ^'!_5+>/"7N;
M @  R04  !D              ("!(9T! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    " #X<']43M8"].\#  !#$0  &0
M@('SGP$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( /AP
M?U13-5;RK@<  # B   9              " @1FD 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ ^'!_5$P\YJNV P  W0T  !D
M         ("!_JL! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
M    " #X<']4JYRQ"I$&  #K)   &0              @('KKP$ >&PO=V]R
M:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( /AP?U2(8+Z+E (   H(
M   9              " @;.V 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL
M4$L! A0#%     @ ^'!_5'/\<9A("   %30  !D              ("!?KD!
M 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " #X<']4Z%:H
MM]P$  #C%0  &0              @(']P0$ >&PO=V]R:W-H965T<R]S:&5E
M=#4W+GAM;%!+ 0(4 Q0    ( /AP?U1_8JAEG0H  -%-   9
M  " @1#' 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
M^'!_5'$JK35B @  *@8  !D              ("!Y-$! 'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    " #X<']4(H]UZ#<'  "V)P  &0
M            @(%]U $ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4
M Q0    ( /AP?U3)AN(T9 0   H0   9              " @>O; 0!X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ ^'!_5#F4!I/A @
M%PD  !D              ("!AN ! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6Q02P$"% ,4    " #X<']4*\V+8BL#  "T"0  &0              @(&>
MXP$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( /AP?U3;
MBCBG%0,  (()   9              " @0#G 0!X;"]W;W)K<VAE971S+W-H
M965T-C0N>&UL4$L! A0#%     @ ^'!_5&4UK0#_ @  VP@  !D
M     ("!3.H! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /AP?U32!IS$R 8  "8H   9              "
M@:#] 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ ^'!_
M5/PD/+0_!P  ^RL  !D              ("!GP0" 'AL+W=O<FMS:&5E=',O
M<VAE970W,2YX;6Q02P$"% ,4    " #X<']4I=Q9"1$$  "W$   &0
M        @($5# ( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0
M   ( /AP?U2-07;O)P4  #D8   9              " @5T0 @!X;"]W;W)K
M<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ ^'!_5-SJV'A* P  D@H
M !D              ("!NQ4" 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q0
M2P$"% ,4    " #X<']48_84QEP#  #+"@  &0              @($\&0(
M>&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( /AP?U04.XVC
M40,  .@)   9              " @<\< @!X;"]W;W)K<VAE971S+W-H965T
M-S8N>&UL4$L! A0#%     @ ^'!_5&Y<,ACN @  @P@  !D
M ("!5R " 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " #X
M<']4F^!(HL4%  !*&0  &0              @(%\(P( >&PO=V]R:W-H965T
M<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( /AP?U3Z@'M5VP(  &P*   9
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M970X,RYX;6Q02P$"% ,4    " #X<']4B>E N3P%  !R'   &0
M    @(&?.@( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    (
M /AP?U1#B7]S\@,  "L-   9              " @1)  @!X;"]W;W)K<VAE
M971S+W-H965T.#4N>&UL4$L! A0#%     @ ^'!_5/W;*U([ @  %@4  !D
M             ("!.T0" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"
M% ,4    " #X<']4U,[/4A@"  #U!   &0              @(&M1@( >&PO
M=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( /AP?U09D^(#)04
M )(8   9              " @?Q( @!X;"]W;W)K<VAE971S+W-H965T.#@N
M>&UL4$L! A0#%     @ ^'!_5$EZI@?3!@  9B,  !D              ("!
M6$X" 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " #X<']4
M:>694,X'  #S-@  &0              @(%B50( >&PO=V]R:W-H965T<R]S
M:&5E=#DP+GAM;%!+ 0(4 Q0    ( /AP?U0#=@)*[PD  ,$]   9
M      " @6== @!X;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%
M  @ ^'!_5)N"D?.R"0   T$  !D              ("!C6<" 'AL+W=O<FMS
M:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4    " #X<']4JT(P4)(+  !050
M&0              @(%V<0( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+
M 0(4 Q0    ( /AP?U3G$!P7\PT  &A8   9              " @3]] @!X
M;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ ^'!_5)QV]4!+
M P  G0T  !D              ("!:8L" 'AL+W=O<FMS:&5E=',O<VAE970Y
M-2YX;6Q02P$"% ,4    " #X<']4S7^8=7P#  !R$0  &0
M@('KC@( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( /AP
M?U0 "FZA*00  "(1   9              " @9Z2 @!X;"]W;W)K<VAE971S
M+W-H965T.3<N>&UL4$L! A0#%     @ ^'!_5/LX5119 P  ;PP  !D
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M965T,3 R+GAM;%!+ 0(4 Q0    ( /AP?U2R"1O@5@,  / 4   -
M      "  5FQ @!X;"]S='EL97,N>&UL4$L! A0#%     @ ^'!_5)>*NQS
M    $P(   L              ( !VK0" %]R96QS+RYR96QS4$L! A0#%
M  @ ^'!_5&BDEC ^!P  MT(   \              ( !P[4" 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( /AP?U3M2,2UY (  /$[   :
M  "  2Z] @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M /AP?U31-?Q97P(  -<Y   3              "  4K  @!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@    !N &X /!X  -K" @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>746</ContextCount>
  <ElementCount>466</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>217</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>22</UnitCount>
  <MyReports>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - Consolidated statements of comprehensive loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated statements of comprehensive loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00200 - Statement - Consolidated statements of financial position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition</Role>
      <ShortName>Consolidated statements of financial position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00300 - Statement - Consolidated statements of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated statements of cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00400 - Statement - Consolidated statements of changes in equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>Consolidated statements of changes in equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>10101 - Disclosure - General Company Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureGeneralCompanyInformation</Role>
      <ShortName>General Company Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Basis of Preparation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureBasisOfPreparation</Role>
      <ShortName>Basis of Preparation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Effects of new accounting standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureEffectsOfNewAccountingStandards</Role>
      <ShortName>Effects of new accounting standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Basis of consolidation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureBasisOfConsolidation</Role>
      <ShortName>Basis of consolidation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSignificantAccountingPolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Accounting judgments and estimates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimates</Role>
      <ShortName>Accounting judgments and estimates</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10701 - Disclosure - Segment information and revenue from contracts with customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomers</Role>
      <ShortName>Segment information and revenue from contracts with customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10801 - Disclosure - Other income and expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureOtherIncomeAndExpenses</Role>
      <ShortName>Other income and expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10901 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>11001 - Disclosure - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureLossPerShare</Role>
      <ShortName>Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>11101 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>11201 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosurePropertyPlantAndEquipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>11301 - Disclosure - Right-of-use assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRightOfUseAssets</Role>
      <ShortName>Right-of-use assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>11401 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureInventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>11501 - Disclosure - Trade and other receivables and other assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssets</Role>
      <ShortName>Trade and other receivables and other assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>11601 - Disclosure - Cash and short-term deposits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureCashAndShortTermDeposits</Role>
      <ShortName>Cash and short-term deposits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>11701 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureEquity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>11801 - Disclosure - Capital management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureCapitalManagement</Role>
      <ShortName>Capital management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>11901 - Disclosure - Financial liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialLiabilities</Role>
      <ShortName>Financial liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>12001 - Disclosure - Share-based payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPayments</Role>
      <ShortName>Share-based payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>12101 - Disclosure - Financial instruments - fair values and risk management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagement</Role>
      <ShortName>Financial instruments - fair values and risk management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>12201 - Disclosure - List of subsidiaries</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureListOfSubsidiaries</Role>
      <ShortName>List of subsidiaries</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>12301 - Disclosure - Non-controlling interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureNonControllingInterests</Role>
      <ShortName>Non-controlling interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>12401 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureCommitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>12501 - Disclosure - Related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRelatedParties</Role>
      <ShortName>Related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>12601 - Disclosure - Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureContingentLiabilities</Role>
      <ShortName>Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>12701 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>20502 - Disclosure - Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimates</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>30203 - Disclosure - Basis of preparation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureBasisOfPreparationTables</Role>
      <ShortName>Basis of preparation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSignificantAccountingPoliciesTables</Role>
      <ShortName>Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureSignificantAccountingPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>30703 - Disclosure - Segment information and revenue from contracts with customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables</Role>
      <ShortName>Segment information and revenue from contracts with customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomers</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>30803 - Disclosure - Other income and expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables</Role>
      <ShortName>Other income and expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureOtherIncomeAndExpenses</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>30903 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>31103 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureIntangibleAssets</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>31203 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosurePropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosurePropertyPlantAndEquipment</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>31303 - Disclosure - Right-of-use assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRightOfUseAssetsTables</Role>
      <ShortName>Right-of-use assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureRightOfUseAssets</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>31403 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureInventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureInventories</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>31503 - Disclosure - Trade and other receivables and other assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsTables</Role>
      <ShortName>Trade and other receivables and other assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssets</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>31703 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureEquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureEquity</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>31903 - Disclosure - Financial liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialLiabilitiesTables</Role>
      <ShortName>Financial liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureFinancialLiabilities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>32003 - Disclosure - Share-based payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPaymentsTables</Role>
      <ShortName>Share-based payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureShareBasedPayments</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>32103 - Disclosure - Financial instruments - fair values and risk management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables</Role>
      <ShortName>Financial instruments - fair values and risk management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagement</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>32203 - Disclosure - List of subsidiaries (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureListOfSubsidiariesTables</Role>
      <ShortName>List of subsidiaries (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureListOfSubsidiaries</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>32303 - Disclosure - Non-controlling interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureNonControllingInterestsTables</Role>
      <ShortName>Non-controlling interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureNonControllingInterests</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>32503 - Disclosure - Related parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRelatedPartiesTables</Role>
      <ShortName>Related parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureRelatedParties</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>40101 - Disclosure - General Company Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureGeneralCompanyInformationDetails</Role>
      <ShortName>General Company Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureGeneralCompanyInformation</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Basis of Preparation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureBasisOfPreparationDetails</Role>
      <ShortName>Basis of Preparation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureBasisOfPreparation</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>40202 - Disclosure - Basis of Preparation - Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails</Role>
      <ShortName>Basis of Preparation - Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Significant accounting policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant accounting policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureSignificantAccountingPoliciesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Accounting judgments and estimates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails</Role>
      <ShortName>Accounting judgments and estimates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Segment information and revenue from contracts with customers - Information by operating segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails</Role>
      <ShortName>Segment information and revenue from contracts with customers - Information by operating segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>40702 - Disclosure - Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails</Role>
      <ShortName>Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>40703 - Disclosure - Segment information and revenue from contracts with customers - Geographical information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails</Role>
      <ShortName>Segment information and revenue from contracts with customers - Geographical information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>40704 - Disclosure - Segment information and revenue from contracts with customers - Contract balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails</Role>
      <ShortName>Segment information and revenue from contracts with customers - Contract balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>40705 - Disclosure - Segment information and revenue from contracts with customers - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails</Role>
      <ShortName>Segment information and revenue from contracts with customers - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Other income and expenses - Other Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails</Role>
      <ShortName>Other income and expenses - Other Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>40802 - Disclosure - Other income and expenses - Other Operating Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails</Role>
      <ShortName>Other income and expenses - Other Operating Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>40803 - Disclosure - Other income and expenses - LPC GmbH (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails</Role>
      <ShortName>Other income and expenses - LPC GmbH (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>40804 - Disclosure - Other income and expenses - Financial costs, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails</Role>
      <ShortName>Other income and expenses - Financial costs, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>40805 - Disclosure - Other income and expenses - Employee benefits expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails</Role>
      <ShortName>Other income and expenses - Employee benefits expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Income taxes - Taxes recognized through profit or loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails</Role>
      <ShortName>Income taxes - Taxes recognized through profit or loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>40902 - Disclosure - Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails</Role>
      <ShortName>Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>40903 - Disclosure - Income taxes - Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails</Role>
      <ShortName>Income taxes - Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>41001 - Disclosure - Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureLossPerShareDetails</Role>
      <ShortName>Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureLossPerShare</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureIntangibleAssetsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>41201 - Disclosure - Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosurePropertyPlantAndEquipmentTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>41301 - Disclosure - Right-of-use assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRightOfUseAssetsDetails</Role>
      <ShortName>Right-of-use assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureRightOfUseAssetsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>41302 - Disclosure - Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails</Role>
      <ShortName>Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>41303 - Disclosure - Right-of-use assets - Carrying amounts of lease liabilities and the movements during the period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails</Role>
      <ShortName>Right-of-use assets - Carrying amounts of lease liabilities and the movements during the period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>41304 - Disclosure - Right-of-use assets - Amounts recognised in profit or loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails</Role>
      <ShortName>Right-of-use assets - Amounts recognised in profit or loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>41305 - Disclosure - Right-of-use assets - Sale and Leaseback transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails</Role>
      <ShortName>Right-of-use assets - Sale and Leaseback transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>41401 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureInventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureInventoriesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>41501 - Disclosure - Trade and other receivables and other assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails</Role>
      <ShortName>Trade and other receivables and other assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>41601 - Disclosure - Cash and short-term deposits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails</Role>
      <ShortName>Cash and short-term deposits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureCashAndShortTermDeposits</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>41701 - Disclosure - Equity - Issued capital and capital reserve (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails</Role>
      <ShortName>Equity - Issued capital and capital reserve (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>41702 - Disclosure - Equity - Common Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureEquityCommonSharesDetails</Role>
      <ShortName>Equity - Common Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>41703 - Disclosure - Equity - Capital Reserves (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureEquityCapitalReservesDetails</Role>
      <ShortName>Equity - Capital Reserves (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>41901 - Disclosure - Financial liabilities - Interest-bearing loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails</Role>
      <ShortName>Financial liabilities - Interest-bearing loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>41902 - Disclosure - Financial liabilities - Conditions and statement of liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails</Role>
      <ShortName>Financial liabilities - Conditions and statement of liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>41903 - Disclosure - Financial liabilities - Trade payables and other liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails</Role>
      <ShortName>Financial liabilities - Trade payables and other liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>42001 - Disclosure - Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails</Role>
      <ShortName>Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>42002 - Disclosure - Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails</Role>
      <ShortName>Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>42003 - Disclosure - Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details</Role>
      <ShortName>Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>42004 - Disclosure - Share-based payments - Equity Share Option (ESOP 2019) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details</Role>
      <ShortName>Share-based payments - Equity Share Option (ESOP 2019) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>42005 - Disclosure - Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails</Role>
      <ShortName>Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>42006 - Disclosure - Share-based payments - Grants to new CEO and supervisory board grant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails</Role>
      <ShortName>Share-based payments - Grants to new CEO and supervisory board grant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>42007 - Disclosure - Share-based payments - Valuation of Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails</Role>
      <ShortName>Share-based payments - Valuation of Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>42101 - Disclosure - Financial instruments - fair values and risk management - Credit risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails</Role>
      <ShortName>Financial instruments - fair values and risk management - Credit risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>42102 - Disclosure - Financial instruments - fair values and risk management - Liquidity risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails</Role>
      <ShortName>Financial instruments - fair values and risk management - Liquidity risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>42103 - Disclosure - Financial instruments - fair values and risk management - Currency risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails</Role>
      <ShortName>Financial instruments - fair values and risk management - Currency risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>42201 - Disclosure - List of subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureListOfSubsidiariesDetails</Role>
      <ShortName>List of subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureListOfSubsidiariesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>42301 - Disclosure - Non-controlling interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureNonControllingInterestsDetails</Role>
      <ShortName>Non-controlling interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureNonControllingInterestsTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>42401 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureCommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureCommitments</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>42501 - Disclosure - Related parties - Remuneration of members of key management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails</Role>
      <ShortName>Related parties - Remuneration of members of key management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>42502 - Disclosure - Related parties - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails</Role>
      <ShortName>Related parties - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>42601 - Disclosure - Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureContingentLiabilitiesDetails</Role>
      <ShortName>Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureContingentLiabilities</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="cntg-20211231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>42701 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://centogene.com/role/DisclosureSubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://centogene.com/role/DisclosureSubsequentEvents</ParentRole>
      <Position>102</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" original="cntg-20211231x20f.htm">cntg-20211231x20f.htm</File>
    <File>cntg-20211231.xsd</File>
    <File>cntg-20211231_cal.xml</File>
    <File>cntg-20211231_def.xml</File>
    <File>cntg-20211231_lab.xml</File>
    <File>cntg-20211231_pre.xml</File>
    <File>cntg-20211231xex12d1.htm</File>
    <File>cntg-20211231xex12d2.htm</File>
    <File>cntg-20211231xex13d1.htm</File>
    <File>cntg-20211231xex13d2.htm</File>
    <File>cntg-20211231xex15d1.htm</File>
    <File>cntg-20211231xex4d12.htm</File>
    <File>cntg-20211231xex4d14.htm</File>
    <File>cntg-20211231xex8d1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cntg-20211231x20f004.jpg</File>
    <File>cntg-20211231x20f005.jpg</File>
    <File>cntg-20211231x20f007.jpg</File>
    <File>cntg-20211231x20f008.jpg</File>
    <File>cntg-20211231x20f009.jpg</File>
    <File>cntg-20211231x20f010.jpg</File>
    <File>cntg-20211231x20f011.jpg</File>
    <File>cntg-20211231x20f012.jpg</File>
    <File>cntg-20211231x20f014.jpg</File>
    <File>cntg-20211231x20f015.jpg</File>
    <File>cntg-20211231x20f016.jpg</File>
    <File>cntg-20211231x20f018.jpg</File>
    <File>cntg-20211231x20f019.jpg</File>
    <File>cntg-20211231x20f021.jpg</File>
    <File>cntg-20211231x20f022.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1483">http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full</BaseTaxonomy>
    <BaseTaxonomy items="42">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>139
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cntg-20211231x20f.htm": {
   "axisCustom": 7,
   "axisStandard": 36,
   "contextCount": 746,
   "dts": {
    "calculationLink": {
     "local": [
      "cntg-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cntg-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cntg-20211231x20f.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cntg-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cntg-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cntg-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 864,
   "entityCount": 1,
   "hidden": {
    "http://centogene.com/20211231": 17,
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 3,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 26
   },
   "keyCustom": 138,
   "keyStandard": 328,
   "memberCustom": 139,
   "memberStandard": 58,
   "nsprefix": "cntg",
   "nsuri": "http://centogene.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://centogene.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10501 - Disclosure - Significant accounting policies",
     "role": "http://centogene.com/role/DisclosureSignificantAccountingPolicies",
     "shortName": "Significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42502 - Disclosure - Related parties - Additional information (Details)",
     "role": "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
     "shortName": "Related parties - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnEquityOfferingMember_GTBMEUx2bE2fzTJ4qOUR-Q",
      "decimals": "0",
      "lang": null,
      "name": "cntg:NumberOfCommonSharesIssuedAndOfferedByPriorShareholders",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_StockOptionPlan2016Member_GI6mBJf-uEaspTZUbL_7cg",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:EstimatedFinancialEffectOfContingentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42601 - Disclosure - Contingent Liabilities (Details)",
     "role": "http://centogene.com/role/DisclosureContingentLiabilitiesDetails",
     "shortName": "Contingent Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_StockOptionPlan2016Member_GI6mBJf-uEaspTZUbL_7cg",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:EstimatedFinancialEffectOfContingentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProceedsFromIssueOfOrdinaryShares",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42701 - Disclosure - Subsequent Events (Details)",
     "role": "http://centogene.com/role/DisclosureSubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_2_1_2022_To_2_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsChiefExecutiveOfficerMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_CV9SX4hApkWmqEt_60wM4g",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_EUR_shares_k-8d0CMmekuAivI8Ro5T9Q",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10601 - Disclosure - Accounting judgments and estimates",
     "role": "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimates",
     "shortName": "Accounting judgments and estimates",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10701 - Disclosure - Segment information and revenue from contracts with customers",
     "role": "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomers",
     "shortName": "Segment information and revenue from contracts with customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10801 - Disclosure - Other income and expenses",
     "role": "http://centogene.com/role/DisclosureOtherIncomeAndExpenses",
     "shortName": "Other income and expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10901 - Disclosure - Income taxes",
     "role": "http://centogene.com/role/DisclosureIncomeTaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11001 - Disclosure - Loss Per Share",
     "role": "http://centogene.com/role/DisclosureLossPerShare",
     "shortName": "Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11101 - Disclosure - Intangible assets",
     "role": "http://centogene.com/role/DisclosureIntangibleAssets",
     "shortName": "Intangible assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11201 - Disclosure - Property, plant and equipment",
     "role": "http://centogene.com/role/DisclosurePropertyPlantAndEquipment",
     "shortName": "Property, plant and equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11301 - Disclosure - Right-of-use assets",
     "role": "http://centogene.com/role/DisclosureRightOfUseAssets",
     "shortName": "Right-of-use assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11401 - Disclosure - Inventories",
     "role": "http://centogene.com/role/DisclosureInventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00100 - Statement - Consolidated statements of comprehensive loss",
     "role": "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "Consolidated statements of comprehensive loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11501 - Disclosure - Trade and other receivables and other assets",
     "role": "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssets",
     "shortName": "Trade and other receivables and other assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11601 - Disclosure - Cash and short-term deposits",
     "role": "http://centogene.com/role/DisclosureCashAndShortTermDeposits",
     "shortName": "Cash and short-term deposits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11701 - Disclosure - Equity",
     "role": "http://centogene.com/role/DisclosureEquity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11801 - Disclosure - Capital management",
     "role": "http://centogene.com/role/DisclosureCapitalManagement",
     "shortName": "Capital management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11901 - Disclosure - Financial liabilities",
     "role": "http://centogene.com/role/DisclosureFinancialLiabilities",
     "shortName": "Financial liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12001 - Disclosure - Share-based payments",
     "role": "http://centogene.com/role/DisclosureShareBasedPayments",
     "shortName": "Share-based payments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12101 - Disclosure - Financial instruments - fair values and risk management",
     "role": "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagement",
     "shortName": "Financial instruments - fair values and risk management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12201 - Disclosure - List of subsidiaries",
     "role": "http://centogene.com/role/DisclosureListOfSubsidiaries",
     "shortName": "List of subsidiaries",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12301 - Disclosure - Non-controlling interests",
     "role": "http://centogene.com/role/DisclosureNonControllingInterests",
     "shortName": "Non-controlling interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12401 - Disclosure - Commitments",
     "role": "http://centogene.com/role/DisclosureCommitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00200 - Statement - Consolidated statements of financial position",
     "role": "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition",
     "shortName": "Consolidated statements of financial position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:OtherNoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12501 - Disclosure - Related parties",
     "role": "http://centogene.com/role/DisclosureRelatedParties",
     "shortName": "Related parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12601 - Disclosure - Contingent Liabilities",
     "role": "http://centogene.com/role/DisclosureContingentLiabilities",
     "shortName": "Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12701 - Disclosure - Subsequent Events",
     "role": "http://centogene.com/role/DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "20502 - Disclosure - Significant accounting policies (Policies)",
     "role": "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies",
     "shortName": "Significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30203 - Disclosure - Basis of preparation (Tables)",
     "role": "http://centogene.com/role/DisclosureBasisOfPreparationTables",
     "shortName": "Basis of preparation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfForeignExchangeRatesUsedExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30503 - Disclosure - Significant accounting policies (Tables)",
     "role": "http://centogene.com/role/DisclosureSignificantAccountingPoliciesTables",
     "shortName": "Significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfForeignExchangeRatesUsedExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30703 - Disclosure - Segment information and revenue from contracts with customers (Tables)",
     "role": "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables",
     "shortName": "Segment information and revenue from contracts with customers (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30803 - Disclosure - Other income and expenses (Tables)",
     "role": "http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables",
     "shortName": "Other income and expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30903 - Disclosure - Income taxes (Tables)",
     "role": "http://centogene.com/role/DisclosureIncomeTaxesTables",
     "shortName": "Income taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31103 - Disclosure - Intangible assets (Tables)",
     "role": "http://centogene.com/role/DisclosureIntangibleAssetsTables",
     "shortName": "Intangible assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossBeforeTax",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00300 - Statement - Consolidated statements of cash flows",
     "role": "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated statements of cash flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31203 - Disclosure - Property, plant and equipment (Tables)",
     "role": "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentTables",
     "shortName": "Property, plant and equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31303 - Disclosure - Right-of-use assets (Tables)",
     "role": "http://centogene.com/role/DisclosureRightOfUseAssetsTables",
     "shortName": "Right-of-use assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfInventoriesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31403 - Disclosure - Inventories (Tables)",
     "role": "http://centogene.com/role/DisclosureInventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfInventoriesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31503 - Disclosure - Trade and other receivables and other assets (Tables)",
     "role": "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsTables",
     "shortName": "Trade and other receivables and other assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31703 - Disclosure - Equity (Tables)",
     "role": "http://centogene.com/role/DisclosureEquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31903 - Disclosure - Financial liabilities (Tables)",
     "role": "http://centogene.com/role/DisclosureFinancialLiabilitiesTables",
     "shortName": "Financial liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "32003 - Disclosure - Share-based payments (Tables)",
     "role": "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
     "shortName": "Share-based payments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCreditRiskExposureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "32103 - Disclosure - Financial instruments - fair values and risk management (Tables)",
     "role": "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables",
     "shortName": "Financial instruments - fair values and risk management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCreditRiskExposureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "32203 - Disclosure - List of subsidiaries (Tables)",
     "role": "http://centogene.com/role/DisclosureListOfSubsidiariesTables",
     "shortName": "List of subsidiaries (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCompositionOfGroupExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "32303 - Disclosure - Non-controlling interests (Tables)",
     "role": "http://centogene.com/role/DisclosureNonControllingInterestsTables",
     "shortName": "Non-controlling interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCompositionOfGroupExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_1IhyUssZbUOMIOgGzDA_QQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00400 - Statement - Consolidated statements of changes in equity",
     "role": "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity",
     "shortName": "Consolidated statements of changes in equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2018_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_1IhyUssZbUOMIOgGzDA_QQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "32503 - Disclosure - Related parties (Tables)",
     "role": "http://centogene.com/role/DisclosureRelatedPartiesTables",
     "shortName": "Related parties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProceedsFromIssueOfOrdinaryShares",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40101 - Disclosure - General Company Information (Details)",
     "role": "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
     "shortName": "General Company Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_7_1_2020_To_7_31_2020_cntg_IfrsSubsidiarySaleOfStockAxis_cntg_FollowOnPublicOfferingMember_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_MajorPurchasesOfAssetsMember_xbFqw04HbU2A4f3d19Z_-g",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cntg:PercentageOfEstimatedVariableTransactionPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40201 - Disclosure - Basis of Preparation (Details)",
     "role": "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
     "shortName": "Basis of Preparation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cntg:PercentageOfEstimatedVariableTransactionPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40202 - Disclosure - Basis of Preparation - Reconciliation (Details)",
     "role": "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails",
     "shortName": "Basis of Preparation - Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cntg:StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_z1oMzZi-ZUm5khME3yuDyA",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cntg:DisclosureOfForeignExchangeRatesUsedExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AverageForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40501 - Disclosure - Significant accounting policies (Details)",
     "role": "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
     "shortName": "Significant accounting policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cntg:DisclosureOfForeignExchangeRatesUsedExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AverageForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_USD_EUR_3pfV49c8qEOVCZomdpsTyQ",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40601 - Disclosure - Accounting judgments and estimates (Details)",
     "role": "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
     "shortName": "Accounting judgments and estimates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full_CapitalisedDevelopmentExpenditureMember_Fj9Rp4R76k2ZiXVlDvyuMQ",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cntg:IfrsNumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_segment_fj3IE5HhAk64wBBglbJJCQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40701 - Disclosure - Segment information and revenue from contracts with customers - Information by operating segments (Details)",
     "role": "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
     "shortName": "Segment information and revenue from contracts with customers - Information by operating segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cntg:IfrsNumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_segment_fj3IE5HhAk64wBBglbJJCQ",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40702 - Disclosure - Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)",
     "role": "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails",
     "shortName": "Segment information and revenue from contracts with customers - Reconciliation of segment Adjusted EBITDA to Group Loss for the Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_SegmentConsolidationItemsAxis_ifrs-full_OperatingSegmentsMember_Z-lfge1Nx0acHpjrSH-1Pw",
      "decimals": "-3",
      "lang": null,
      "name": "cntg:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromRenderingOfServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40703 - Disclosure - Segment information and revenue from contracts with customers - Geographical information (Details)",
     "role": "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
     "shortName": "Segment information and revenue from contracts with customers - Geographical information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromRenderingOfServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cntg:DisclosureOfContractBalancesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentReceivablesFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40704 - Disclosure - Segment information and revenue from contracts with customers - Contract balances (Details)",
     "role": "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails",
     "shortName": "Segment information and revenue from contracts with customers - Contract balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10101 - Disclosure - General Company Information",
     "role": "http://centogene.com/role/DisclosureGeneralCompanyInformation",
     "shortName": "General Company Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShareIssueRelatedCost",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40705 - Disclosure - Segment information and revenue from contracts with customers - Additional information (Details)",
     "role": "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
     "shortName": "Segment information and revenue from contracts with customers - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "lang": null,
      "name": "cntg:ProvisionForExpectedCreditLossesOnContractAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40801 - Disclosure - Other income and expenses - Other Operating Income (Details)",
     "role": "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
     "shortName": "Other income and expenses - Other Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NetForeignExchangeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40802 - Disclosure - Other income and expenses - Other Operating Expenses (Details)",
     "role": "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
     "shortName": "Other income and expenses - Other Operating Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NetForeignExchangeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NoncontrollingInterests",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40803 - Disclosure - Other income and expenses - LPC GmbH (Details)",
     "role": "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails",
     "shortName": "Other income and expenses - LPC GmbH (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_LpcGmbhMember_NZ2HmatyC0yGDlaYQHgwZg",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40804 - Disclosure - Other income and expenses - Financial costs, net (Details)",
     "role": "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails",
     "shortName": "Other income and expenses - Financial costs, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40805 - Disclosure - Other income and expenses - Employee benefits expense (Details)",
     "role": "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails",
     "shortName": "Other income and expenses - Employee benefits expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "cntg:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40901 - Disclosure - Income taxes - Taxes recognized through profit or loss (Details)",
     "role": "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails",
     "shortName": "Income taxes - Taxes recognized through profit or loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "cntg:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40902 - Disclosure - Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)",
     "role": "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails",
     "shortName": "Income taxes - Reconciliation of the effective tax rate to the statutory rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40903 - Disclosure - Income taxes - Deferred Taxes (Details)",
     "role": "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails",
     "shortName": "Income taxes - Deferred Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdjustedWeightedAverageShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41001 - Disclosure - Loss Per Share (Details)",
     "role": "http://centogene.com/role/DisclosureLossPerShareDetails",
     "shortName": "Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdjustedWeightedAverageShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10201 - Disclosure - Basis of Preparation",
     "role": "http://centogene.com/role/DisclosureBasisOfPreparation",
     "shortName": "Basis of Preparation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41101 - Disclosure - Intangible assets (Details)",
     "role": "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
     "shortName": "Intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_cntg_BiomarkersAndDatabasesMember_z7T7AVbVWEqN5q7cJhF12Q",
      "decimals": "-5",
      "lang": null,
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41201 - Disclosure - Property, plant and equipment (Details)",
     "role": "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
     "shortName": "Property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_6_30_2021_To_6_30_2021_ifrs-full_SegmentsAxis_cntg_Covid19Member_nqnnCqAqhkms8MmscboYow",
      "decimals": null,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "cntg:DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_7_1_2019_To_7_31_2019_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_5mtjV-dSjU23MM1xhgok7g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cntg:LeaseTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41301 - Disclosure - Right-of-use assets (Details)",
     "role": "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
     "shortName": "Right-of-use assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_cntg_RostockHeadquartersBuildingMember_wUQMlEMObUO7qh9vMmBS2Q",
      "decimals": null,
      "lang": "en-US",
      "name": "cntg:LeaseExtensionTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41302 - Disclosure - Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)",
     "role": "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
     "shortName": "Right-of-use assets - Carrying amounts of right-of-use assets and movements during the period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "cntg:DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2020_G3uP9Hojg06aBjcC-4PTLw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41303 - Disclosure - Right-of-use assets - Carrying amounts of lease liabilities and the movements during the period (Details)",
     "role": "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails",
     "shortName": "Right-of-use assets - Carrying amounts of lease liabilities and the movements during the period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cntg:DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "lang": null,
      "name": "cntg:IncreaseThroughAdditionsLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationRightofuseAssets",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41304 - Disclosure - Right-of-use assets - Amounts recognised in profit or loss (Details)",
     "role": "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails",
     "shortName": "Right-of-use assets - Amounts recognised in profit or loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2019_To_12_31_2019_nshF4PQdSEWIDjk8BsiWDw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:RealEstateTransferTaxExpenses",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41305 - Disclosure - Right-of-use assets - Sale and Leaseback transactions (Details)",
     "role": "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
     "shortName": "Right-of-use assets - Sale and Leaseback transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cntg:DisclosureOfInventoriesTableTextBlock",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41401 - Disclosure - Inventories (Details)",
     "role": "http://centogene.com/role/DisclosureInventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cntg:DisclosureOfInventoriesTableTextBlock",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:RentalDepositsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41501 - Disclosure - Trade and other receivables and other assets (Details)",
     "role": "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails",
     "shortName": "Trade and other receivables and other assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "cntg:DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:RentalDepositsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_TE1FCKSJ10Wnq3AFudeGVQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41601 - Disclosure - Cash and short-term deposits (Details)",
     "role": "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails",
     "shortName": "Cash and short-term deposits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_BorrowingsByNameAxis_cntg_SecuredBankLoanMember_TE1FCKSJ10Wnq3AFudeGVQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10301 - Disclosure - Effects of new accounting standards",
     "role": "http://centogene.com/role/DisclosureEffectsOfNewAccountingStandards",
     "shortName": "Effects of new accounting standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_jL4DwBv26UeCO3uIFycTGA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssuedAndFullyPaid",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41701 - Disclosure - Equity - Issued capital and capital reserve (Details)",
     "role": "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails",
     "shortName": "Equity - Issued capital and capital reserve (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ",
      "decimals": "-3",
      "lang": null,
      "name": "cntg:ExerciseOfOptionsShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProceedsFromIssueOfOrdinaryShares",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41702 - Disclosure - Equity - Common Shares (Details)",
     "role": "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
     "shortName": "Equity - Common Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_l61_J8NdJUSB75T7bkjrnQ",
      "decimals": "-3",
      "lang": null,
      "name": "cntg:AuthorizedButUnissuedShareCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:SharePremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41703 - Disclosure - Equity - Capital Reserves (Details)",
     "role": "http://centogene.com/role/DisclosureEquityCapitalReservesDetails",
     "shortName": "Equity - Capital Reserves (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_CapitalReserveMember_pceNtQlcu0ai8Z8stznIYg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:SharePremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:NonCurrentFinancialLiabilitiesInterestBearing",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41901 - Disclosure - Financial liabilities - Interest-bearing loans (Details)",
     "role": "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails",
     "shortName": "Financial liabilities - Interest-bearing loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:NonCurrentFinancialLiabilitiesInterestBearing",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NotionalAmount",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41902 - Disclosure - Financial liabilities - Conditions and statement of liabilities (Details)",
     "role": "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
     "shortName": "Financial liabilities - Conditions and statement of liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:BankOverdraftsClassifiedAsCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41903 - Disclosure - Financial liabilities - Trade payables and other liabilities (Details)",
     "role": "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails",
     "shortName": "Financial liabilities - Trade payables and other liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:GovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_7_1_2020_To_7_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_LUjbd8sTrEGlOUAQswnsuw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:PaymentForSettlementOfStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42001 - Disclosure - Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)",
     "role": "http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails",
     "shortName": "Share-based payments - Virtual share option program 2016 (Cash-settled) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_7_1_2020_To_7_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_VirtualShareOptionProgram2016CashSettledMember_LUjbd8sTrEGlOUAQswnsuw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:PaymentForSettlementOfStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cntg:SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42002 - Disclosure - Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details)",
     "role": "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails",
     "shortName": "Share-based Payments - 2019 Equity Incentive Plan (2019 Plan) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_1_1_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_viz3Hu6t8UeaOOUIM3hpCw",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cntg:SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42003 - Disclosure - Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)",
     "role": "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
     "shortName": "Share-based payments - Equity share option - Replacement (ESOP VSOP 2017) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2019_To_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2017EquitySettledMember__z9yeAFBpUyKV7EsRs6tNg",
      "decimals": "INF",
      "lang": null,
      "name": "cntg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_iu9FEHW3Ek6roFW54mtfJw",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_2_7_2022_To_2_7_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_srt_ManagementMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_cntg_GrantOfRestrictedStockUnitsMember_srt_StatementScenarioAxis_cntg_VestingInFourTranchesMember_f5-2plb0q0-wYgUIlGZSEQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cntg:NumberOfTranches",
      "reportCount": 1,
      "unitRef": "Unit_Standard_tranche_PoL9U-UWIUKcaq1H7PE8Jw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42004 - Disclosure - Share-based payments - Equity Share Option (ESOP 2019) (Details)",
     "role": "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
     "shortName": "Share-based payments - Equity Share Option (ESOP 2019) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_EquityShareOption2019EquitySettledMember_UMmZv4njDEiol_dnb0_6bQ",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10401 - Disclosure - Basis of consolidation",
     "role": "http://centogene.com/role/DisclosureBasisOfConsolidation",
     "shortName": "Basis of consolidation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_1_1_2022_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_IfrsFormerChiefExecutiveOfficerMember_9zMVFYEdmk-gHU2SpZ4EMQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unitRef": "Unit_Standard_item_-qWnVJTSfkeBJ1EtMUURPA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42005 - Disclosure - Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)",
     "role": "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
     "shortName": "Share-based payments - Management board and employees Options and RSUs grants awarded and exercises (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_9_11_2020_To_9_11_2020_cntg_IfrsAwardTypeAxis_cntg_IfrsRestrictedStockUnitsRsusMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_FormerChiefFinancialOfficerMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cntg_LongTermIncentivePlanMember_RzmMZK-ny0O74pah0YcM8w",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_Options_oDwjAiUwR0qCRsUS52f03w",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_ytJyAnHc00KJbWznv8Eytg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IssueOfEquity",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42006 - Disclosure - Share-based payments - Grants to new CEO and supervisory board grant (Details)",
     "role": "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
     "shortName": "Share-based payments - Grants to new CEO and supervisory board grant (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_6_25_2021_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_cntg_IfrsSaleOfStockAxis_cntg_IfrsIPOMember_ifrs-full_CategoriesOfRelatedPartiesAxis_cntg_SupervisoryBoardMember_srt_TitleOfIndividualAxis_cntg_MrBerndtModigMember_sgqoRzpr6kyNzDY9rq2YQA",
      "decimals": "INF",
      "lang": null,
      "name": "cntg:NumberOfInstallments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_installment_jmSpYN5730-8_NgPaunshQ",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cntg:ExercisePriceOtherEquityInstrumentsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42007 - Disclosure - Share-based payments - Valuation of Options (Details)",
     "role": "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
     "shortName": "Share-based payments - Valuation of Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_cntg_IfrsAwardTypeAxis_cntg_StockOptionsMember_ELnVfmA0EE-lIrDFAvFqGw",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cntg:ExercisePriceOtherEquityInstrumentsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_USD_shares_AqbZCG7GHUWn8JoskANbkA",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42101 - Disclosure - Financial instruments - fair values and risk management - Credit risk (Details)",
     "role": "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
     "shortName": "Financial instruments - fair values and risk management - Credit risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_vbrOgTDfJ0e6FyvtY_qOlg",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42102 - Disclosure - Financial instruments - fair values and risk management - Liquidity risk (Details)",
     "role": "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
     "shortName": "Financial instruments - fair values and risk management - Liquidity risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMarketRiskExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_-gQEIJhhKESSr-jRSWvRtA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42103 - Disclosure - Financial instruments - fair values and risk management - Currency risk (Details)",
     "role": "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails",
     "shortName": "Financial instruments - fair values and risk management - Currency risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMarketRiskExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_srt_CurrencyAxis_currency_USD_-gQEIJhhKESSr-jRSWvRtA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_gdQ7ArXwUU29FpifO1d2Tg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42201 - Disclosure - List of subsidiaries (Details)",
     "role": "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
     "shortName": "List of subsidiaries (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGMember_gdQ7ArXwUU29FpifO1d2Tg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_qzdigaEMKUeuzUVfFaWxOw",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_RYExOuWQfE693x_rjNNxIw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NoncontrollingInterests",
      "reportCount": 1,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42301 - Disclosure - Non-controlling interests (Details)",
     "role": "http://centogene.com/role/DisclosureNonControllingInterestsDetails",
     "shortName": "Non-controlling interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCompositionOfGroupExplanatory",
       "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "As_Of_12_31_2021_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_cntg_CentogeneGmbhViennaMember_goSBvtoOwUimSgVTIL8xDA",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:NetAssetsLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:FuturePaymentObligationToSuppliersForGoodsAndServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42401 - Disclosure - Commitments (Details)",
     "role": "http://centogene.com/role/DisclosureCommitmentsDetails",
     "shortName": "Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cntg:FuturePaymentObligationToSuppliersForGoodsAndServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42501 - Disclosure - Related parties - Remuneration of members of key management (Details)",
     "role": "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails",
     "shortName": "Related parties - Remuneration of members of key management (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cntg-20211231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ZzReUxv-ckSKII26w9GF6Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_EUR_fIwXpDqp0kyuMCCARnXZvQ",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 217,
   "tag": {
    "cntg_AccountingAndMeasurementPrinciplesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Significant accounting policies"
       }
      }
     },
     "localname": "AccountingAndMeasurementPrinciplesDisclosureAbstract",
     "nsuri": "http://centogene.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cntg_AccountingAndMeasurementPrinciplesDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Accounting And Measurement Principles, Disclosure [Line Items]",
        "terseLabel": "Significant accounting policies"
       }
      }
     },
     "localname": "AccountingAndMeasurementPrinciplesDisclosureLineItems",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_AccountingAndMeasurementPrinciplesDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information pertaining to accounting and measurement principles.",
        "label": "Accounting And Measurement Principles, Disclosure [Table]"
       }
      }
     },
     "localname": "AccountingAndMeasurementPrinciplesDisclosureTable",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The policy of Accounting Policy For Current Versus Noncurrent Classification, Explanatory",
        "label": "Accounting Policy For Current Versus Noncurrent Classification, Explanatory",
        "terseLabel": "Current versus non-current classification"
       }
      }
     },
     "localname": "AccountingPolicyForCurrentVersusNoncurrentClassificationExplanatory",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of additional share-based award grants allowed under the plan on January 1 2020 and on January 1 of each calendar year thereafter, expressed as a percentage of issued share capital.",
        "label": "Additional Subsequent Shares Authorized Annually As Percentage Of Issued Share Capital",
        "terseLabel": "Additional share-based award grants allowed under the plan (as a percent)"
       }
      }
     },
     "localname": "AdditionalSubsequentSharesAuthorizedAnnuallyAsPercentageOfIssuedShareCapital",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additions to property, plant and equipment and right-of use assets.",
        "label": "Additions to Property, plant and Equipment and Right-of Use Assets",
        "verboseLabel": "Additions to property, plant and equipment and right-of-use assets"
       }
      }
     },
     "localname": "AdditionsToPropertyPlantAndEquipmentAndRightOfUseAssets",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of operating income (loss) before adjusting corporate expenses, depreciation and amortization as well as share based payment expenses.",
        "label": "Adjusted Earnings Before Interest Taxes Depreciation And Amortization",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of operating income (loss) before adjusting depreciation and amortization as well as share based payment expenses but after adjusting corporate expenses, attributable to reportable segment.",
        "label": "Adjusted Earnings Before Interest Taxes Depreciation And Amortization After Corporate Expenses, Attributable To Reportable Segment",
        "totalLabel": "Reportable segment Adjusted EBITDA after corporate expenses"
       }
      }
     },
     "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 1.0,
       "parentTag": "cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of operating income (loss) before adjusting corporate expenses, depreciation and amortization as well as share based payment expenses, attributable to reportable segment.",
        "label": "Adjusted Earnings Before Interest Taxes Depreciation And Amortization, Attributable To Reportable Segment",
        "terseLabel": "Reportable segment Adjusted EBITDA"
       }
      }
     },
     "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToReportableSegment",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments of tax expense (income) recognised in the period for current tax of prior periods, including deferred tax impact.",
        "label": "Adjustments For Current Tax Of Prior Period Including Deferred Tax Impact",
        "negatedLabel": "Tax income related to prior years"
       }
      }
     },
     "localname": "AdjustmentsForCurrentTaxOfPriorPeriodIncludingDeferredTaxImpact",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable and contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]",
        "label": "Adjustments for Decrease (Increase) in Trade Accounts Receivable and Contract Assets",
        "terseLabel": "Trade receivables and contract assets"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndContractAssets",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_AuthorizedButUnissuedShareCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of authorized but unissued share capital.",
        "label": "Authorized But Unissued Share Capital",
        "terseLabel": "Authorized but unissued share capital"
       }
      }
     },
     "localname": "AuthorizedButUnissuedShareCapital",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average stock price that must be met or exceeded for vesting in the share-based payment arrangement. If this price is not met in the defined period, the shares will be forfeited in their entirety.",
        "label": "Average Stock Price Hurdle Price For Vesting Sharebased Payment Arrangement",
        "terseLabel": "Share hurdle price"
       }
      }
     },
     "localname": "AverageStockPriceHurdlePriceForVestingSharebasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_AwardTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "AwardTypeDomain",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BankGuarantee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of guarantee provided by bank.",
        "label": "Bank Guarantee",
        "terseLabel": "Bank guarantee"
       }
      }
     },
     "localname": "BankGuarantee",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_BankLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Bank loans.",
        "label": "Bank Loans"
       }
      }
     },
     "localname": "BankLoansMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BankOverdraftsOneAndThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for both the categories of bank overdrafts, namely, one and three together.",
        "label": "Bank overdrafts, one and three"
       }
      }
     },
     "localname": "BankOverdraftsOneAndThreeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BankOverdraftsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for bank overdrafts, one.",
        "label": "Bank overdrafts, one"
       }
      }
     },
     "localname": "BankOverdraftsOneMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BankOverdraftsThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for bank overdrafts, three.",
        "label": "Bank overdrafts, three"
       }
      }
     },
     "localname": "BankOverdraftsThreeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BankOverdraftsTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for bank overdrafts, two.",
        "label": "Bank overdrafts, two"
       }
      }
     },
     "localname": "BankOverdraftsTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BasisOfConsolidationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Basis of consolidation"
       }
      }
     },
     "localname": "BasisOfConsolidationAbstract",
     "nsuri": "http://centogene.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cntg_BasisOfPreparationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Basis of Preparation"
       }
      }
     },
     "localname": "BasisOfPreparationOfFinancialStatementsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cntg_BerlinOfficesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the Berlin Offices member.",
        "label": "Berlin Offices"
       }
      }
     },
     "localname": "BerlinOfficesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BiomarkersAndDatabasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for biomarkers and databases.",
        "label": "Biomarkers and databases"
       }
      }
     },
     "localname": "BiomarkersAndDatabasesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BiomarkersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for biomarkers.",
        "label": "Biomarkers"
       }
      }
     },
     "localname": "BiomarkersMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_BorrowingsAvailableSubjectToAchievementOfProductRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing available subject to achievement of product revenue.",
        "label": "Borrowings Available, Subject to Achievement of Product Revenue",
        "terseLabel": "Borrowings available, Subject to achievement of product revenue"
       }
      }
     },
     "localname": "BorrowingsAvailableSubjectToAchievementOfProductRevenue",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_BorrowingsCovenantMinimumRequiredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum revenue to be maintained as per the borrowings covenant.",
        "label": "Borrowings Covenant, Minimum Required Revenue",
        "terseLabel": "Borrowings covenant, Minimum required revenue"
       }
      }
     },
     "localname": "BorrowingsCovenantMinimumRequiredRevenue",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_BorrowingsRevenueAchievementThreshold": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue threshold for borrowings.",
        "label": "Borrowings, Revenue Achievement Threshold",
        "terseLabel": "Borrowings, Revenue achievement threshold"
       }
      }
     },
     "localname": "BorrowingsRevenueAchievementThreshold",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_CapitalizedInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capitalized investment.",
        "label": "Capitalized Investment",
        "terseLabel": "Capitalized investment"
       }
      }
     },
     "localname": "CapitalizedInvestment",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_CentogeneD.o.oBelgradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the information pertaining to Centogene d.o.o Belgrade.",
        "label": "Centogene d.o.o Belgrade"
       }
      }
     },
     "localname": "CentogeneD.o.oBelgradeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneFzLlcUnitedArabEmiratesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Centogene Fzllc, United arab emirates.",
        "label": "Centogene Fz Llc, United Arab Emirates"
       }
      }
     },
     "localname": "CentogeneFzLlcUnitedArabEmiratesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Centogene AG.",
        "label": "Centogene GmbH"
       }
      }
     },
     "localname": "CentogeneGMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneGmbhViennaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Centogene GmbH, Vienna.",
        "label": "Centogene GmbH, Vienna"
       }
      }
     },
     "localname": "CentogeneGmbhViennaMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneIndiaPvt.LtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Centogene India Pvt. Ltd.",
        "label": "Centogene India Pvt. Ltd"
       }
      }
     },
     "localname": "CentogeneIndiaPvt.LtdMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Centogene N.V., Centogene GmbH and its subsidiaries.",
        "label": "Group"
       }
      }
     },
     "localname": "CentogeneN.v.CentogeneGmbhAndItsSubsidiariesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneN.vMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Centogene N.V.",
        "label": "The Company"
       }
      }
     },
     "localname": "CentogeneN.vMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneSwitzerlandAgMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the information pertaining to the Centogene Switzerland AG.",
        "label": "Centogene Switzerland AG"
       }
      }
     },
     "localname": "CentogeneSwitzerlandAgMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentogeneUsLlcBurlingtonUsaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Centogene US LLC, Burlington, USA.",
        "label": "Centogene US LLC, Burlington, USA"
       }
      }
     },
     "localname": "CentogeneUsLlcBurlingtonUsaMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CentosafeB.v.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the information the pertaining to the Centosafe B.V.",
        "label": "Centosafe B.V."
       }
      }
     },
     "localname": "CentosafeB.v.Member",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for certain motor vehicles and premises with lease terms less than 12 months.",
        "label": "Certain motor vehicles and premises"
       }
      }
     },
     "localname": "CertainMotorVehiclesAndPremisesWithLeaseTermsLessThanTwelveMonthsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ChairmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to chairman.",
        "label": "Chairman"
       }
      }
     },
     "localname": "ChairmanMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ChairmanOfAuditCommitteeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to chairman of the audit committee.",
        "label": "Chairman of audit committee"
       }
      }
     },
     "localname": "ChairmanOfAuditCommitteeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ChairmanOfCompensationCommitteeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to chairman of the compensation committee.",
        "label": "Chairman of compensation committee"
       }
      }
     },
     "localname": "ChairmanOfCompensationCommitteeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ChiefInformationOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chief information officer.",
        "label": "Chief Information Officer"
       }
      }
     },
     "localname": "ChiefInformationOfficerMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ConsiderationOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration outstanding.",
        "label": "Consideration Outstanding",
        "terseLabel": "Consideration outstanding"
       }
      }
     },
     "localname": "ConsiderationOutstanding",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ConsiderationPaymentDuePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration payment due period.",
        "label": "Consideration Payment Due Period",
        "terseLabel": "Payment due period (in years)"
       }
      }
     },
     "localname": "ConsiderationPaymentDuePeriod",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_ConsiderationReceivableForSaleOfLpc": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of consideration receivable for the sale of LPC.",
        "label": "Consideration Receivable For The Sale of LPC",
        "verboseLabel": "Consideration receivable for the sale of LPC"
       }
      }
     },
     "localname": "ConsiderationReceivableForSaleOfLpc",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ConsiderationToBePaidOverTime": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of consideration to be paid over time.",
        "label": "Consideration To Be Paid Over Time",
        "terseLabel": "Consideration to be paid over time"
       }
      }
     },
     "localname": "ConsiderationToBePaidOverTime",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_CoronaTestPortalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the Corona Test Portal.",
        "label": "Corona Test Portal"
       }
      }
     },
     "localname": "CoronaTestPortalMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CorporateIncomeTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of corporate income tax rate.",
        "label": "Corporate Income Tax Rate",
        "terseLabel": "Corporate income tax rate (as a percent)"
       }
      }
     },
     "localname": "CorporateIncomeTaxRate",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_CorporateStrategyServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to corporate strategy services provided.",
        "label": "Corporate strategy services"
       }
      }
     },
     "localname": "CorporateStrategyServiceMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_Covid19Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for covid-19 segment.",
        "label": "COVID-19"
       }
      }
     },
     "localname": "Covid19Member",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_Covid19PartnerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the first Covid-19 partner.",
        "label": "Covid-19 Partner One"
       }
      }
     },
     "localname": "Covid19PartnerOneMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_Covid19PartnerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the second Covid-19 partner.",
        "label": "Covid-19 Partner Two"
       }
      }
     },
     "localname": "Covid19PartnerTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CovidTestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for COVID testing services.",
        "label": "COVID Testing Services"
       }
      }
     },
     "localname": "CovidTestingServicesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CovidTestingSuppliesPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for COVID testing supplies purchased.",
        "label": "COVID Testing Supplies Purchases"
       }
      }
     },
     "localname": "CovidTestingSuppliesPurchasesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CurrencyLossesFinanceCost": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cost associated with interest and other financing activities due to currency losses incurred by the entity.",
        "label": "Currency Losses Finance Cost",
        "negatedLabel": "Currency losses"
       }
      }
     },
     "localname": "CurrencyLossesFinanceCost",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_CurrentFinancialLiabilitiesInterestBearing": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails": {
       "order": 1.0,
       "parentTag": "cntg_FinancialLiabilitiesInterestBearing",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current financial liabilities interest bearing.",
        "label": "Current Financial Liabilities Interest Bearing",
        "terseLabel": "Total current liabilities"
       }
      }
     },
     "localname": "CurrentFinancialLiabilitiesInterestBearing",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_CurrentFinancialLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for current financial liabilities.",
        "label": "Current financial liabilities"
       }
      }
     },
     "localname": "CurrentFinancialLiabilitiesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CurrentReceivablesFromCovid19BankOrCreditCardTransactions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current receivables from COVID 19 bank or credit card transactions.",
        "label": "Current Receivables from COVID 19 Bank or Credit Card Transactions",
        "terseLabel": "Receivables from COVID 19 bank or credit card transactions"
       }
      }
     },
     "localname": "CurrentReceivablesFromCovid19BankOrCreditCardTransactions",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current receivables from exercise of share based payments granted.",
        "label": "Current Receivables from Exercise of Share Based Payments Granted",
        "terseLabel": "Receivables from exercise of share based payments granted"
       }
      }
     },
     "localname": "CurrentReceivablesFromExerciseOfShareBasedPaymentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_CurrentSecuredBankLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for current secured bank loans.",
        "label": "Current portion of secured bank loans"
       }
      }
     },
     "localname": "CurrentSecuredBankLoansMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_CurrentTradeReceivablesAndContractAssets": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Trade receivables and contract assets.",
        "label": "Current Trade Receivables and Contract Assets",
        "terseLabel": "Trade receivables and contract assets"
       }
      }
     },
     "localname": "CurrentTradeReceivablesAndContractAssets",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_DamagesSought": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of damages sought.",
        "label": "Damages Sought",
        "verboseLabel": "Amount in dispute"
       }
      }
     },
     "localname": "DamagesSought",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_DatabaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for database.",
        "label": "Database"
       }
      }
     },
     "localname": "DatabaseMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The decrease (increase) in intangible assets other than goodwill resulting from deconsolidations.",
        "label": "Decrease Increase Through Deconsolidation Intangible Assets Other Than Goodwill",
        "negatedLabel": "Deconsolidation"
       }
      }
     },
     "localname": "DecreaseIncreaseThroughDeconsolidationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_DecreaseThroughPaymentsLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The decrease in lease liabilities, resulting from payments.",
        "label": "Decrease Through Payments, Lease Liabilities",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "DecreaseThroughPaymentsLeaseLiabilities",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_DeferredTaxAssetsOffset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred tax asset offset against deferred tax liabilities.",
        "label": "Deferred Tax Assets, Offset",
        "negatedLabel": "Deferred tax assets, Offset"
       }
      }
     },
     "localname": "DeferredTaxAssetsOffset",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_DeferredTaxLiabilitiesNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred tax liabilities net of offsets.",
        "label": "Deferred Tax Liabilities Net",
        "terseLabel": "Deferred Taxes"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNet",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_DeferredTaxLiabilitiesOffset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred tax liabilities offset against deferred tax assets.",
        "label": "Deferred Tax Liabilities, Offset",
        "terseLabel": "Deferred tax liabilities, Offset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOffset",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_DiagnosticsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for diagnostics segment.",
        "label": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsSegmentMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about carrying amounts of lease liabilities and their movements during the period.",
        "label": "Disclosure Of Carrying Amounts Of Lease Liabilities And Their Movements During The Period, Explanatory",
        "terseLabel": "Schedule of carrying amounts of lease liabilities and the movements during the period"
       }
      }
     },
     "localname": "DisclosureOfCarryingAmountsOfLeaseLiabilitiesAndTheirMovementsDuringPeriodExplanatory",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_DisclosureOfCommitmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Commitments"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cntg_DisclosureOfContractBalancesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about contract balances.",
        "label": "Disclosure Of Contract Balances, Explanatory",
        "verboseLabel": "Schedule of contract balances"
       }
      }
     },
     "localname": "DisclosureOfContractBalancesExplanatory",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about expenses arising from share based payment transactions.",
        "label": "Disclosure Of Expenses Arising From Share-based Payment Transactions, Explanatory",
        "terseLabel": "Schedule of total expenses arising from sharebased payment transactions"
       }
      }
     },
     "localname": "DisclosureOfExpensesArisingFromShareBasedPaymentTransactionsExplanatory",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_DisclosureOfForeignExchangeRatesUsedExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about foreign exchange rates used.",
        "label": "Disclosure Of Foreign Exchange Rates Used, Explanatory",
        "terseLabel": "Schedule of exchange rates used"
       }
      }
     },
     "localname": "DisclosureOfForeignExchangeRatesUsedExplanatory",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_DisclosureOfInventoriesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of inventories.",
        "label": "Disclosure Of Inventories [Table Text Block]",
        "terseLabel": "Summary of inventories"
       }
      }
     },
     "localname": "DisclosureOfInventoriesTableTextBlock",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureInventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income (expense).",
        "label": "Disclosure of Other Income And Expenses Explanatory [Text Block]",
        "terseLabel": "Other income and expenses"
       }
      }
     },
     "localname": "DisclosureOfOtherIncomeAndExpensesExplanatoryTextBlock",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for trade receivables and contract assets and other assets.",
        "label": "Disclosure Of Trade And Other Receivables And Other Assets Explanatory [Text Block]",
        "terseLabel": "Trade and other receivables and other assets"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesAndOtherAssetsExplanatoryTextBlock",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_Dr.BauerLaboratoriumsGmbhMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the information pertaining to the Dr. Bauer Laboratoriums GmbH.",
        "label": "Dr. Bauer Laboratoriums GmbH"
       }
      }
     },
     "localname": "Dr.BauerLaboratoriumsGmbhMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to employees.",
        "label": "Employees"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_EnteringInToDebtFinancingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for entering into debt financing agreement.",
        "label": "Entering into debt financing agreement"
       }
      }
     },
     "localname": "EnteringInToDebtFinancingAgreementMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_EquityShareOption2017And2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for equity share option 2017 and 2019 .",
        "label": "Equity share option 2017 and 2019"
       }
      }
     },
     "localname": "EquityShareOption2017And2019Member",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_EquityShareOption2017EquitySettledMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for equity share option 2017 (equity settled).",
        "label": "Equity share option 2017 (Equity settled)"
       }
      }
     },
     "localname": "EquityShareOption2017EquitySettledMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_EquityShareOption2019EquitySettledMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for equity share option 2019 (equity settled).",
        "label": "Equity share option 2019 (Equity settled)"
       }
      }
     },
     "localname": "EquityShareOption2019EquitySettledMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_EstimatedRateOfImplicitPriceConcessions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated rate of implicit price concessions.",
        "label": "Estimated Rate of Implicit Price Concessions",
        "terseLabel": "Estimated rate of implicit price concessions"
       }
      }
     },
     "localname": "EstimatedRateOfImplicitPriceConcessions",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_ExerciseOfOptionsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares exercise of stock options.",
        "label": "Exercise Of Options Shares",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "ExerciseOfOptionsShares",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cntg_ExercisePriceOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exercise price of other equity instruments granted.",
        "label": "Exercise Price, Other Equity Instruments Granted",
        "terseLabel": "Exercise price (USD)"
       }
      }
     },
     "localname": "ExercisePriceOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected difference between the cash outflows from trade payables and the cash inflow from receivables within two months.",
        "label": "Expected Difference Between Cash Outflow From Trade Payables And Cash Inflow From Receivables With in Two Months",
        "terseLabel": "Expected cash flows receivables with in two months"
       }
      }
     },
     "localname": "ExpectedDifferenceBetweenCashOutflowFromTradePayablesAndCashInflowFromReceivablesWithInTwoMonths",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of other equity instruments granted.",
        "label": "Expected Dividend As Percentage, Other Equity Instruments Granted",
        "terseLabel": "Dividend yield (%)"
       }
      }
     },
     "localname": "ExpectedDividendAsPercentageOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_ExpectedVolatilityOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the other equity instruments granted.",
        "label": "Expected Volatility, Other Equity Instruments Granted",
        "terseLabel": "Volatility (%)"
       }
      }
     },
     "localname": "ExpectedVolatilityOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_FinancialAssetInDefaultNumberOfDaysPastDueConsidered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of days for which the contractual payments is past due, used for considering the financial asset as default.",
        "label": "Financial Asset In Default, Number Of Days Past Due Considered",
        "terseLabel": "Number of days past due, to consider a financial asset as default"
       }
      }
     },
     "localname": "FinancialAssetInDefaultNumberOfDaysPastDueConsidered",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cntg_FinancialCovenants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial covenants as at the end of the reporting period.",
        "label": "Financial Covenants",
        "terseLabel": "Financial covenants"
       }
      }
     },
     "localname": "FinancialCovenants",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_FinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Financial Instruments [Abstract]",
        "terseLabel": "Financial instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_FinancialLiabilitiesInterestBearing": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial liabilities interest bearing.",
        "label": "Financial Liabilities Interest Bearing",
        "totalLabel": "Total non-current and current liabilities",
        "verboseLabel": "Carrying amount"
       }
      }
     },
     "localname": "FinancialLiabilitiesInterestBearing",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_FinancingActivitiesMunicipalLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities related to municipal loans.",
        "label": "Municipal loans"
       }
      }
     },
     "localname": "FinancingActivitiesMunicipalLoansMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_FloorRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for floor rate.",
        "label": "Floor rate"
       }
      }
     },
     "localname": "FloorRateMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_FollowOnEquityOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a follow-on offering.",
        "label": "Follow-on Equity Offering"
       }
      }
     },
     "localname": "FollowOnEquityOfferingMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_FollowOnPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for follow-on public offering.",
        "label": "Follow-on public offering"
       }
      }
     },
     "localname": "FollowOnPublicOfferingMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_FormerCeoAndMajorShareholderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for former CEO and major shareholder.",
        "label": "Former CEO And Major Shareholder [Member]"
       }
      }
     },
     "localname": "FormerCeoAndMajorShareholderMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_FormerChiefFinancialOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of former chief financial officer.",
        "label": "Former Chief Financial Officer [Member]",
        "terseLabel": "Former Chief Financial Officer"
       }
      }
     },
     "localname": "FormerChiefFinancialOfficerMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_FuturePaymentObligationToSuppliersForGoodsAndServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of future payment obligation to suppliers for goods and services to be provided.",
        "label": "Future Payment Obligation To Suppliers For Goods and Services",
        "terseLabel": "Total payment obligation"
       }
      }
     },
     "localname": "FuturePaymentObligationToSuppliersForGoodsAndServices",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_GainLossFromForgivenessOfLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized due to forgiveness of loan from bank.",
        "label": "Gain (Loss) from Forgiveness of Loan",
        "terseLabel": "Gain from forgiveness of loan"
       }
      }
     },
     "localname": "GainLossFromForgivenessOfLoan",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_GeneralInformationAboutFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "General Company Information"
       }
      }
     },
     "localname": "GeneralInformationAboutFinancialStatementsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cntg_GeneralInformationAboutFinancialStatementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General Information About Financial Statements [Line Items]",
        "label": "General Information About Financial Statements [Line Items]",
        "terseLabel": "General Company Information"
       }
      }
     },
     "localname": "GeneralInformationAboutFinancialStatementsLineItems",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_GeneralInformationAboutFinancialStatementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to general information about financial statements.",
        "label": "General Information About Financial Statements [Table]"
       }
      }
     },
     "localname": "GeneralInformationAboutFinancialStatementsTable",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_GovernmentGrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tis member stands for grant received from governments.",
        "label": "Government grants"
       }
      }
     },
     "localname": "GovernmentGrantsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_GrantOfRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the grant of restricted stock units.",
        "label": "Grant of RSUs"
       }
      }
     },
     "localname": "GrantOfRestrictedStockUnitsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_GrantsReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of grants receivable.",
        "label": "Grants Receivables",
        "terseLabel": "Receivables from grants"
       }
      }
     },
     "localname": "GrantsReceivables",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IfrsAwardTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Ifrs Award Type [Axis]"
       }
      }
     },
     "localname": "IfrsAwardTypeAxis",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsBalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Ifrs Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "IfrsBalanceSheetLocationAxis",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsBalanceSheetLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Ifrs Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "IfrsBalanceSheetLocationDomain",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsBankOverdraftsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for bank overdrafts.",
        "label": "IFRS Bank overdrafts",
        "terseLabel": "Bank overdrafts"
       }
      }
     },
     "localname": "IfrsBankOverdraftsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsChiefExecutiveOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chief executive officer.",
        "label": "Chief Executive Officer"
       }
      }
     },
     "localname": "IfrsChiefExecutiveOfficerMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Ifrs Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Class of warrant or right, Exercise price of warrants or rights"
       }
      }
     },
     "localname": "IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Ifrs Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Class of warrant or right, Number of securities called by warrants or rights"
       }
      }
     },
     "localname": "IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cntg_IfrsCorporateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for corporate segment.",
        "label": "Corporate"
       }
      }
     },
     "localname": "IfrsCorporateMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsFormerChiefExecutiveOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with former designation of chief executive officer.",
        "label": "Former Chief Executive Officer"
       }
      }
     },
     "localname": "IfrsFormerChiefExecutiveOfficerMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from grants received for investment in property, plant and equipment, classified as investing activities.",
        "label": "ifrs Grants Received for Investment In Property, Plant And Equipment, Classified As Investing Activities",
        "verboseLabel": "Grants received for investment in property, plant and equipment"
       }
      }
     },
     "localname": "IfrsGrantsReceivedForInvestmentInPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IfrsIPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO"
       }
      }
     },
     "localname": "IfrsIPOMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "ifrs Increase Decrease in Operating Assets and Liabilities [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IfrsIncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Leases [abstract]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "IfrsLeasesAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsLineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Ifrs Line Of Credit Facility Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "IfrsLineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IfrsMiddleEastMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for middle east member.",
        "label": "Middle East"
       }
      }
     },
     "localname": "IfrsMiddleEastMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsNumberOfReportableSegments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Ifrs Number Of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "IfrsNumberOfReportableSegments",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cntg_IfrsRelatedPartyTransactionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Ifrs Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "IfrsRelatedPartyTransactionAxis",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsRelatedPartyTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction type between related parties.",
        "label": "Ifrs Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "IfrsRelatedPartyTransactionDomain",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsRestrictedStockUnitsRsusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "RSUs"
       }
      }
     },
     "localname": "IfrsRestrictedStockUnitsRsusMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsSaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "IFRS Sale of Stock [Axis]"
       }
      }
     },
     "localname": "IfrsSaleOfStockAxis",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsSaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Ifrs Sale Of Stock Name Of Transaction [Domain]"
       }
      }
     },
     "localname": "IfrsSaleOfStockNameOfTransactionDomain",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense.",
        "label": "Ifrs Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "verboseLabel": "Schedule of tax recognized through profit or loss"
       }
      }
     },
     "localname": "IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Ifrs Schedule Of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the effective tax rate to the statutory rate"
       }
      }
     },
     "localname": "IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Ifrs Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of segment information and reconciliation of segment adjusted EBITDA to group loss for the period"
       }
      }
     },
     "localname": "IfrsScheduleOfSegmentReportingInformationBySegmentTableTextBlock",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which the right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Ifrs Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "IFRS Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period 1.",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement each year after grant.",
        "label": "Ifrs Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period subsequent to grant date after which the share-based award expires.",
        "label": "Ifrs Share based Compensation Arrangement By Share based Payment Award Expiration Period",
        "terseLabel": "Contractual life",
        "verboseLabel": "Expiration Date"
       }
      }
     },
     "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_IfrsShareBasedPaymentArrangementAcceleratedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
        "label": "Ifrs Share-based Payment Arrangement, Accelerated Cost",
        "terseLabel": "Additional share-based expenses"
       }
      }
     },
     "localname": "IfrsShareBasedPaymentArrangementAcceleratedCost",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IfrsShareBasedPaymentArrangementTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Tranche one"
       }
      }
     },
     "localname": "IfrsShareBasedPaymentArrangementTrancheOneMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsShareBasedPaymentArrangementTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Tranche three"
       }
      }
     },
     "localname": "IfrsShareBasedPaymentArrangementTrancheThreeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsShareBasedPaymentArrangementTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Tranche two"
       }
      }
     },
     "localname": "IfrsShareBasedPaymentArrangementTrancheTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IfrsSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Ifrs Share Price",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "IfrsSharePrice",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_IfrsSharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Ifrs Shares Issued, Price Per Share",
        "terseLabel": "Common per share"
       }
      }
     },
     "localname": "IfrsSharesIssuedPricePerShare",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_IfrsStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Ifrs Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Number of common shares issued (in shares)",
        "verboseLabel": "Shares issued during period"
       }
      }
     },
     "localname": "IfrsStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cntg_IfrsSubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Ifrs Subsidiary Sale Of Stock [Axis]"
       }
      }
     },
     "localname": "IfrsSubsidiarySaleOfStockAxis",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsVestingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ifrs Vesting [Axis]",
        "label": "Ifrs Vesting [Axis]"
       }
      }
     },
     "localname": "IfrsVestingAxis",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IfrsVestingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ifrs Vesting [Domain]",
        "label": "Ifrs Vesting [Domain]"
       }
      }
     },
     "localname": "IfrsVestingDomain",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_IncomeTaxDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureLineItems",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IncomeTaxDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to income tax disclosures.",
        "label": "Income Tax Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTable",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions or modifications at initial public offering.",
        "label": "Increase Decrease Through Sharebased Payment Transactions At Initial Public Offering",
        "verboseLabel": "Share-based payments - modification at IPO"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactionsAtInitialPublicOffering",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from (to) right-of-use assets.",
        "label": "Increase (Decrease) Through Transfers From (To) Right-of-use Assets, Property, Plant And Equipment",
        "terseLabel": "Reclass from (to) right-of-use assets"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersFromToRightOfUseAssetsPropertyPlantAndEquipment",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from additions. [Refer: Liabilities arising from financing activities]",
        "label": "Increase Through Additions Financing Cash Flows Liabilities Arising From Financing Activities",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "IncreaseThroughAdditionsFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IncreaseThroughAdditionsLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in lease liabilities, resulting from additions.",
        "label": "Increase Through Additions, Lease Liabilities",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "IncreaseThroughAdditionsLeaseLiabilities",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from changes in maturity. [Refer: Liabilities arising from financing activities]",
        "label": "Increase Through Changes In Maturity Financing Cash Flows Liabilities Arising From Financing Activities",
        "terseLabel": "Changes in maturity"
       }
      }
     },
     "localname": "IncreaseThroughChangesInMaturityFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_InfrequentItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents axis for infrequent items.",
        "label": "Infrequent Items [Axis]"
       }
      }
     },
     "localname": "InfrequentItemsAxis",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_InfrequentItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents domain for infrequent items",
        "label": "Infrequent Items [Domain]"
       }
      }
     },
     "localname": "InfrequentItemsDomain",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_KeyAssumptionsUsedToDeriveOptionValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Key Assumptions Used To Derive Option Value [Abstract]",
        "terseLabel": "Key assumptions used to derive the option value"
       }
      }
     },
     "localname": "KeyAssumptionsUsedToDeriveOptionValueAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "N/a",
        "label": "Key Assumptions Used to Derive Other Equity Instruments [Abstract]",
        "terseLabel": "Key assumptions used to derive other equity instruments value"
       }
      }
     },
     "localname": "KeyAssumptionsUsedToDeriveOtherEquityInstrumentsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_KeyManagementPersonnelCompensationAccruedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amounts payable resulting from key management personnel compensation.",
        "label": "Key Management Personnel Compensation, Accrued Amount",
        "terseLabel": "Accrued for key management compensation"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationAccruedAmount",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_KeyManagementPersonnelCompensationSeverancePayout": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of severance payout.",
        "label": "Key Management Personnel Compensation, Severance Payout",
        "terseLabel": "Severance payout"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationSeverancePayout",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_LaterThanOneDayAndNotLaterThanOneMonthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a time band of later than one day and not later than one month.",
        "label": "Past due 1 to 30 day"
       }
      }
     },
     "localname": "LaterThanOneDayAndNotLaterThanOneMonthMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LaterThanTwoMonthsAndNotLaterThanOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a time band of later than two months and not later than one year.",
        "label": "2 to 12 months"
       }
      }
     },
     "localname": "LaterThanTwoMonthsAndNotLaterThanOneYearMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LeaseExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension term of the lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Lease Extension Term",
        "terseLabel": "Lease contract extension term"
       }
      }
     },
     "localname": "LeaseExtensionTerm",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_LeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for lease term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lease Term",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LeaseTerm",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities related to current portion of lease liabilities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]",
        "label": "Current lease liabilities"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesCurrentLeaseLiabilitiesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities related to non-current portion of lease liabilities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]",
        "label": "Non-current lease liabilities"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesNonCurrentLeaseLiabilitiesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LiabilitiesForWageAndChurchTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liabilities for wage and church tax.",
        "label": "Liabilities For Wage And Church Tax",
        "verboseLabel": "Liabilities for wage and church tax"
       }
      }
     },
     "localname": "LiabilitiesForWageAndChurchTax",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_LoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represents the debt financing agreement secured on January 31, 2022 (the \"Loan Facility\").",
        "label": "Loan facility"
       }
      }
     },
     "localname": "LoanFacilityMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LoanFacilityTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represents the first tranche of the debt financing agreement secured on January 31, 2022 (the \"Loan Facility\").",
        "label": "Loan facility tranche one [Member]",
        "terseLabel": "Loan facility first tranche"
       }
      }
     },
     "localname": "LoanFacilityTrancheOneMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LoanFacilityTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represents the second tranche of the debt financing agreement secured on January 31, 2022 (the \"Loan Facility\").",
        "label": "Loan facility tranche two [Member]",
        "terseLabel": "Loan facility second tranche"
       }
      }
     },
     "localname": "LoanFacilityTrancheTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LockUpPeriodSubsequentToCompletionOfInitialPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period subsequent to the completion of the initial public offering in which the options may not be exercised.",
        "label": "Lock Up Period Subsequent To Completion Of Initial Public Offering",
        "terseLabel": "Lock-up period"
       }
      }
     },
     "localname": "LockUpPeriodSubsequentToCompletionOfInitialPublicOffering",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_LongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Long-Term Incentive Plan (LTIP).",
        "label": "2019 Plan"
       }
      }
     },
     "localname": "LongTermIncentivePlanMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_LpcGmbhMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for LPC GmbH.",
        "label": "LPC GmbH"
       }
      }
     },
     "localname": "LpcGmbhMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ManagementBoardAndEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to management board and employees.",
        "label": "Management board and employees"
       }
      }
     },
     "localname": "ManagementBoardAndEmployeesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_MaximumLostTimeInjuryFactorShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum percentage of lost time injury will be taken as base under share based payment arrangement.",
        "label": "Maximum Lost Time Injury Factor, Share Based Payment Arrangement",
        "terseLabel": "Maximum percentage of lost time injury"
       }
      }
     },
     "localname": "MaximumLostTimeInjuryFactorShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_MeasurementOfServiceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for measurement of service contracts.",
        "label": "Measurement of service contracts"
       }
      }
     },
     "localname": "MeasurementOfServiceContractsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_MemberOfSupervisoryBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for member of the supervisory board.",
        "label": "Member of the supervisory board"
       }
      }
     },
     "localname": "MemberOfSupervisoryBoardMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Middle East, Europe, North America, Asia Pacific Regions.",
        "label": "MENA"
       }
      }
     },
     "localname": "MiddleEastEuropeNorthAmericaAsiaPacificRegionsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_MiguelCoegoRiosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Miguel Coego Rios.",
        "label": "Miguel Coego Rios [Member]"
       }
      }
     },
     "localname": "MiguelCoegoRiosMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_Mr.KimMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mr. Kim.",
        "label": "Mr. Kim"
       }
      }
     },
     "localname": "Mr.KimMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_MrBerndtModigMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mr. Berndt Modig.",
        "label": "Mr. Berndt Modig",
        "terseLabel": "Mr, Modig"
       }
      }
     },
     "localname": "MrBerndtModigMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_MrJonathanGSheldonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mr. Jonathan G. Sheldon.",
        "label": "Mr. Jonathan G. Sheldon"
       }
      }
     },
     "localname": "MrJonathanGSheldonMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_MrModigAndMrSheldonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mr. Modig and Mr. Sheldon.",
        "label": "Mr. Modig and Mr. Sheldon"
       }
      }
     },
     "localname": "MrModigAndMrSheldonMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_NonControllingInterestsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Non-controlling interests."
       }
      }
     },
     "localname": "NonControllingInterestsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cntg_NonCurrentFinancialLiabilitiesInterestBearing": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails": {
       "order": 2.0,
       "parentTag": "cntg_FinancialLiabilitiesInterestBearing",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-current financial liabilities interest bearing.",
        "label": "Non current Financial Liabilities Interest Bearing",
        "terseLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "NonCurrentFinancialLiabilitiesInterestBearing",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_NonCurrentFinancialLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for non-current financial liabilities.",
        "label": "Non-current financial liabilities"
       }
      }
     },
     "localname": "NonCurrentFinancialLiabilitiesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_NonCurrentMunicipalLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It stands for Non current municipal loans.",
        "label": "Municipal loan"
       }
      }
     },
     "localname": "NonCurrentMunicipalLoansMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_NoncurrentSecuredBankLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for noncurrent secured bank loans.",
        "label": "Non-current portion of secured bank loans"
       }
      }
     },
     "localname": "NoncurrentSecuredBankLoansMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_NotLaterThanTwoMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a time band of not later than two months.",
        "label": "Less than 2 months"
       }
      }
     },
     "localname": "NotLaterThanTwoMonthsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_NumberOfCommonSharesIssuedAndOfferedByPriorShareholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of common shares issued and offered by existing shareholders in conjunction with the follow-on public offering.",
        "label": "Number Of Common Shares Issued And Offered By Prior Shareholders",
        "terseLabel": "Total number of shares issued and sold in follow-on public offering"
       }
      }
     },
     "localname": "NumberOfCommonSharesIssuedAndOfferedByPriorShareholders",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cntg_NumberOfCommonSharesOfferedByPriorShareholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares offered by existing shareholders in conjunction with the follow-on public offering.",
        "label": "Number Of Common Shares Offered By Prior Shareholders",
        "terseLabel": "Number of shares offered by existing shareholders"
       }
      }
     },
     "localname": "NumberOfCommonSharesOfferedByPriorShareholders",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cntg_NumberOfCustomersInGroup": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the number of customer in group.",
        "label": "Number Of Customers In Group",
        "terseLabel": "Number of customer in group"
       }
      }
     },
     "localname": "NumberOfCustomersInGroup",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cntg_NumberOfInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of installments.",
        "label": "Number of Installments",
        "terseLabel": "Number of installments"
       }
      }
     },
     "localname": "NumberOfInstallments",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cntg_NumberOfOtherEquityInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to number of other equity instruments.",
        "label": "Number"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_NumberOfOutstandingShareOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Number Of Outstanding Share Options [Abstract]",
        "terseLabel": "Number",
        "verboseLabel": "Number"
       }
      }
     },
     "localname": "NumberOfOutstandingShareOptionsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of share options cancelled in share based payment arrangement.",
        "label": "Number Of Share Options Cancelled In Share Based Payment Arrangement",
        "negatedLabel": "Cancelled during the year"
       }
      }
     },
     "localname": "NumberOfShareOptionsCancelledInShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details"
     ],
     "xbrltype": "decimalItemType"
    },
    "cntg_NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of replacement awards granted in a share-based payment arrangement.",
        "label": "Number Of Share Options Replacement Awards Granted In Share Based Payment Arrangement",
        "terseLabel": "Replacement awards granted during the year"
       }
      }
     },
     "localname": "NumberOfShareOptionsReplacementAwardsGrantedInShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details"
     ],
     "xbrltype": "decimalItemType"
    },
    "cntg_NumberOfShareOptionsVestedInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of share options vested in a share-based payment arrangement.\"",
        "label": "Number Of Share Options Vested In Share-based Payment Arrangement",
        "verboseLabel": "Vested as of December 31"
       }
      }
     },
     "localname": "NumberOfShareOptionsVestedInShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cntg_NumberOfTimesLeaseContractCanBeExtended": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of times the lease contract can be extended.",
        "label": "Number Of Times Lease Contract Can Be Extended",
        "terseLabel": "Number of times the lease contract can be extended"
       }
      }
     },
     "localname": "NumberOfTimesLeaseContractCanBeExtended",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cntg_NumberOfTopDiagnosticCustomersDueInTradeReceivables": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of top diagnostic customers due in trade receivables.",
        "label": "Number of Top Diagnostic Customers Due in Trade Receivables",
        "verboseLabel": "Number of top diagnostic customers"
       }
      }
     },
     "localname": "NumberOfTopDiagnosticCustomersDueInTradeReceivables",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cntg_NumberOfTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equal tranches in which the granted RSU and options shall vest.",
        "label": "Number of Tranches",
        "terseLabel": "Number of tranches"
       }
      }
     },
     "localname": "NumberOfTranches",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cntg_OfficeEquipmentAndStorageSpacesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for office equipment and storage spaces.",
        "label": "Office equipment and storage spaces"
       }
      }
     },
     "localname": "OfficeEquipmentAndStorageSpacesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OfficesInBerlinMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for offices in Berlin.",
        "label": "Offices in Berlin"
       }
      }
     },
     "localname": "OfficesInBerlinMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OfficesInBostonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for offices in Boston.",
        "label": "Offices in Boston"
       }
      }
     },
     "localname": "OfficesInBostonMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OfficesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for offices.",
        "label": "Offices"
       }
      }
     },
     "localname": "OfficesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OptionLifeOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The option life of other equity instruments granted.",
        "label": "Option Life, Other Equity Instruments Granted",
        "terseLabel": "Expected contractual life (years)"
       }
      }
     },
     "localname": "OptionLifeOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "cntg_OptionsGrantedTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Options granted two.",
        "label": "Options Granted Two"
       }
      }
     },
     "localname": "OptionsGrantedTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OptionsStrikePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options strike price.",
        "label": "Options Strike Price",
        "terseLabel": "Strike price of options"
       }
      }
     },
     "localname": "OptionsStrikePrice",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_OtherBankLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities related to other bank loans.",
        "label": "Other bank loans"
       }
      }
     },
     "localname": "OtherBankLoansMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for other countries.",
        "label": "Other countries"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OtherCurrentAssetsExcludingReceivablesDueFromShareholders": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current assets, excluding receivables due from shareholders, that the entity does not separately disclose in the same statement or note.",
        "label": "Other Current Assets Excluding Receivables Due From Shareholders",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsExcludingReceivablesDueFromShareholders",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_OtherEquipmentFurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for other equipment furniture and fixtures.",
        "label": "Other equipment, furniture and fixtures"
       }
      }
     },
     "localname": "OtherEquipmentFurnitureAndFixturesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OtherEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for other equipment.",
        "label": "Other equipment"
       }
      }
     },
     "localname": "OtherEquipmentMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OtherIncomeExpenseDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Other income and expenses"
       }
      }
     },
     "localname": "OtherIncomeExpenseDisclosureAbstract",
     "nsuri": "http://centogene.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cntg_OtherIncomeExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The information about other income expense line items.",
        "label": "Other Income Expense Line Items",
        "terseLabel": "Other income and expenses"
       }
      }
     },
     "localname": "OtherIncomeExpenseLineItems",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_OtherIncomeExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "na",
        "label": "Other Income Expense [Table]"
       }
      }
     },
     "localname": "OtherIncomeExpenseTable",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_OtherOfficeAndLaboratoriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for other office and laboratories.",
        "label": "Other office and laboratories"
       }
      }
     },
     "localname": "OtherOfficeAndLaboratoriesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OtherSegmentInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Other Segment Information [Abstract]",
        "terseLabel": "Other segment information"
       }
      }
     },
     "localname": "OtherSegmentInformationAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_OverdraftFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for an overdraft facility.",
        "label": "Overdraft facility"
       }
      }
     },
     "localname": "OverdraftFacilityMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OverdraftFacilityOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the first overdraft facility.",
        "label": "Existing Overdraft facility"
       }
      }
     },
     "localname": "OverdraftFacilityOneMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OverdraftFacilityThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the third overdraft facility.",
        "label": "Third Overdraft facility"
       }
      }
     },
     "localname": "OverdraftFacilityThreeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_OverdraftFacilityTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the second overdraft facility.",
        "label": "Second Overdraft facility"
       }
      }
     },
     "localname": "OverdraftFacilityTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PartneringLaboratoryPhysicianProfDrPeterBauerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for our partnering laboratory physician Prof. Dr. Peter Bauer.",
        "label": "Prof. Dr. Peter Bauer"
       }
      }
     },
     "localname": "PartneringLaboratoryPhysicianProfDrPeterBauerMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PaymentForSettlementOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for payment for settlement of stock options. [Refer: Property, plant and equipment]",
        "label": "Payment for Settlement of Stock Options",
        "terseLabel": "Payments for settlement of stock options"
       }
      }
     },
     "localname": "PaymentForSettlementOfStockOptions",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow relating to grants refunded related to disposal of property, plant and equipment.",
        "label": "Payments of Grants Refunded on Disposal of Property, Plant and Equipment",
        "negatedLabel": "Grants refunded related to disposed property, plant and equipment",
        "verboseLabel": "Grants refunded related to disposed property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsOfGrantsRefundedOnDisposalOfPropertyPlantAndEquipment",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_PeerSchatzMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the member of supervisory board, namely, Peer Schatz.",
        "label": "Peer Schatz"
       }
      }
     },
     "localname": "PeerSchatzMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PensionCommitments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of pension commitments.",
        "label": "Pension Commitments",
        "terseLabel": "Pension commitments for members of the management board"
       }
      }
     },
     "localname": "PensionCommitments",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_PercentageOfAwardConstitutesRestrictedStockUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of awards issued represents restricted stock units.",
        "label": "Percentage of Award Constitutes Restricted Stock Units",
        "terseLabel": "Percentage of award constitutes RSU's"
       }
      }
     },
     "localname": "PercentageOfAwardConstitutesRestrictedStockUnits",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_PercentageOfAwardConstitutesStockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of awards issued represents Stock Options.",
        "label": "Percentage of Award Constitutes Stock Options",
        "terseLabel": "Percentage of award constitutes stock options"
       }
      }
     },
     "localname": "PercentageOfAwardConstitutesStockOptions",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_PercentageOfEstimatedVariableTransactionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of estimated variable transaction price.",
        "label": "Percentage of estimated Variable Transaction Price",
        "terseLabel": "Percentage of estimated variable transaction price"
       }
      }
     },
     "localname": "PercentageOfEstimatedVariableTransactionPrice",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_PercentageOfInterestBearingLoansMatureInOneYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of interest-bearing loans will mature in one year.",
        "label": "Percentage of Interest-Bearing Loans Mature in One Year",
        "verboseLabel": "Interest-bearing loans will mature in less than one year (in percent)"
       }
      }
     },
     "localname": "PercentageOfInterestBearingLoansMatureInOneYear",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_PercentageOfOverdueBalances": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The over due balances as a percentage of total overdue balances.",
        "label": "Percentage of Overdue Balances",
        "verboseLabel": "Percentage of overdue balances"
       }
      }
     },
     "localname": "PercentageOfOverdueBalances",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_PerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to performance based restricted stock units.",
        "label": "Performance Based RSUs"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PharmaceuticalPartnerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for pharmaceutical partner.",
        "label": "Pharmaceutical Partner"
       }
      }
     },
     "localname": "PharmaceuticalPartnerMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for pharmaceutical segment.",
        "label": "Pharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalSegmentMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for plant and equipment.",
        "label": "Plant and equipment"
       }
      }
     },
     "localname": "PlantAndEquipmentMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PlantAndMachineryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for plant and machinery.",
        "label": "Plant and machinery"
       }
      }
     },
     "localname": "PlantAndMachineryMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_PlantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for plant.",
        "label": "Plant"
       }
      }
     },
     "localname": "PlantMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ProportionOfOwnershipInterestInNonControllingInterestDisposal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership interest disposed in non-controlling interest.",
        "label": "Proportion Of Ownership Interest In Non-controlling Interest Disposal",
        "terseLabel": "Proportion of ownership in subsidiary disposed"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInNonControllingInterestDisposal",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_ProvisionForExpectedCreditLossesOnContractAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of provision for expected credit losses on contract assets, recognized by the company.",
        "label": "Provision For Expected Credit Losses On Contract Assets",
        "verboseLabel": "Provision for expected credit losses on contract assets"
       }
      }
     },
     "localname": "ProvisionForExpectedCreditLossesOnContractAssets",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ProvisionForOutstandingInvoices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of provision for outstanding invoices.",
        "label": "Provision for Outstanding Invoices",
        "terseLabel": "Provision for outstanding invoices"
       }
      }
     },
     "localname": "ProvisionForOutstandingInvoices",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_RealEstateTransferTaxExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents the real estate transfer tax expenses.",
        "label": "Real Estate Transfer Tax Expenses",
        "terseLabel": "Real estate transfer tax expenses",
        "verboseLabel": "Real estate transfer tax expenses"
       }
      }
     },
     "localname": "RealEstateTransferTaxExpenses",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ReceivablesPaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after invoice when trade receivables are due.",
        "label": "Receivables Payment Terms",
        "terseLabel": "Receivables payment terms"
       }
      }
     },
     "localname": "ReceivablesPaymentTerms",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_ReclassRightOfUseAssetsToPropertyPlantEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of right-of-use assets reclassed to property, plant and equipment.",
        "label": "Reclass Right of use Assets To Property Plant Equipment",
        "negatedLabel": "Reclass to property, plant &amp; equipment"
       }
      }
     },
     "localname": "ReclassRightOfUseAssetsToPropertyPlantEquipment",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_RelatedPartyServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to services provided by a related party.",
        "label": "Services"
       }
      }
     },
     "localname": "RelatedPartyServicesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RentalDeposits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rental deposits to be maintained by the company.",
        "label": "Rental deposits",
        "terseLabel": "Rental deposits"
       }
      }
     },
     "localname": "RentalDeposits",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_RentalDepositsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of rental deposits maintained by the company, classified as non-current.",
        "label": "Rental Deposits, Noncurrent",
        "terseLabel": "Other assets-Rental deposits"
       }
      }
     },
     "localname": "RentalDepositsNoncurrent",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_RetainedEarningsExcludingCurrencyTranslationReserveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit, excluding the currency translation reserve.",
        "label": "Retained earnings excluding currency translation reserve [member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsExcludingCurrencyTranslationReserveMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RiskFreeInterestRateOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for other equity instruments granted is expressed, with a remaining term equal to the expected term of the option being valued.",
        "label": "Risk Free Interest Rate, Other Equity Instruments Granted",
        "terseLabel": "Riskfree interest rate (%)"
       }
      }
     },
     "localname": "RiskFreeInterestRateOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_RostockHeadquartersBuildingAndBerlinOfficesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for the Rostock headquarters building and the Berlin offices.",
        "label": "Rostock headquarters building and Berlin offices"
       }
      }
     },
     "localname": "RostockHeadquartersBuildingAndBerlinOfficesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RostockHeadquartersBuildingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for Rostock Headquarters Building.",
        "label": "Rostock headquarters building"
       }
      }
     },
     "localname": "RostockHeadquartersBuildingMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RsuGrantedFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to RSU granted five.",
        "label": "RSU Granted Five"
       }
      }
     },
     "localname": "RsuGrantedFiveMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RsuGrantedFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to RSU granted four.",
        "label": "RSU Granted Four"
       }
      }
     },
     "localname": "RsuGrantedFourMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RsuGrantedOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to RSU granted one.",
        "label": "RSU Granted One"
       }
      }
     },
     "localname": "RsuGrantedOneMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RsuGrantedThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to RSU granted one.",
        "label": "RSU Granted Three"
       }
      }
     },
     "localname": "RsuGrantedThreeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RsuGrantedTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to RSU granted two.",
        "label": "RSU Granted Two"
       }
      }
     },
     "localname": "RsuGrantedTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RsusDerecognizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units that have been derecognized.",
        "label": "RSUs Derecognized [Member]",
        "terseLabel": "RSUs derecognized"
       }
      }
     },
     "localname": "RsusDerecognizedMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_RsusRecognizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units that have been recognized.",
        "label": "RSUs Recognized [Member]",
        "terseLabel": "RSUs recognized"
       }
      }
     },
     "localname": "RsusRecognizedMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SaleOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockDomain",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SecuredBankLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a secured bank loan.",
        "label": "Secured bank loan"
       }
      }
     },
     "localname": "SecuredBankLoanMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SecuredBankLoansWithMaturityPeriod2017To25ThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for secured bank loans, bearing a maturity period of 2017-25, three.",
        "label": "Secured bank loans, bearing maturity period of 2017-25, three"
       }
      }
     },
     "localname": "SecuredBankLoansWithMaturityPeriod2017To25ThreeMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SecuredCreditLinesInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of interest rate on secured credit lines.",
        "label": "Secured Credit Lines, Interest Rate",
        "verboseLabel": "Interest rate on secured credit lines"
       }
      }
     },
     "localname": "SecuredCreditLinesInterestRate",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_SecuredCreditLinesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for secured credit lines.",
        "label": "Secured bank loans"
       }
      }
     },
     "localname": "SecuredCreditLinesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SecuredCreditLinesUtilized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The utilized amount on secured credit lines.",
        "label": "Secured Credit Lines, Utilized",
        "verboseLabel": "Utilized amount of secured credit lines"
       }
      }
     },
     "localname": "SecuredCreditLinesUtilized",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_SellingShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for selling shareholders.",
        "label": "Selling shareholders"
       }
      }
     },
     "localname": "SellingShareholdersMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based awards subject to time-vesting and performance vesting.",
        "label": "Share based awards subject to time-vesting and performance vesting [Member]",
        "terseLabel": "Subject to time-vesting and performance vesting"
       }
      }
     },
     "localname": "ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ShareBasedAwardsSubjectToTimeVestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based awards subject to time-vesting.",
        "label": "Share based awards subject to time-vesting [Member]",
        "terseLabel": "Subject to time-vesting and performance vesting"
       }
      }
     },
     "localname": "ShareBasedAwardsSubjectToTimeVestingMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of common shares per share options granted in a share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Number Of Common Shares Per Option Granted",
        "terseLabel": "Number of common shares per option granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesPerOptionGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cntg_ShareBasedPaymentArrangementTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Vest immediately"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementTrancheOneMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ShareBasedPaymentArrangementTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Vest in two equal annual instalments"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementTrancheTwoMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of share-based award grants allowed under the plan expressed as a percentage of issued share capital immediately following the completion of the initial public offering.",
        "label": "Shares Threshold Maximum As Percentage Of Issued Share Capital Allowed For Grants",
        "terseLabel": "Maximum amount of share-based award grants allowed under the plan (as a percent)"
       }
      }
     },
     "localname": "SharesThresholdMaximumAsPercentageOfIssuedShareCapitalAllowedForGrants",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_ShortTermDepositsPledgedAsSecurityForLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of short-term deposits pledged as security for liabilities.",
        "label": "Short Term Deposits Pledged as Security for Liabilities",
        "terseLabel": "Short-term deposits, pledged as security"
       }
      }
     },
     "localname": "ShortTermDepositsPledgedAsSecurityForLiabilities",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_SoftwarePatentsAndTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for software, patents and trademarks.",
        "label": "Software, patents and trademarks"
       }
      }
     },
     "localname": "SoftwarePatentsAndTrademarksMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SolidaritySurchargeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of solidarity surcharge on corporate income tax rate.",
        "label": "Solidarity Surcharge Rate",
        "terseLabel": "Solidarity surcharge (as a percent)"
       }
      }
     },
     "localname": "SolidaritySurchargeRate",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of reclassification of cost on comprehensive income statement",
        "label": "Statement of Effect of Reclassification of cost on Comprehensive Income Statement [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the Statement of Comprehensive Income"
       }
      }
     },
     "localname": "StatementOfEffectOfReclassificationOfCostOnComprehensiveIncomeStatementTableTextBlock",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cntg_StockIssuedDuringPeriodOfferingPricePerShareNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering price per share of new stock issued during the period.",
        "label": "Stock Issued During Period, Offering Price Per Share, New Issues",
        "terseLabel": "Public offering price (in dollars per share)",
        "verboseLabel": "Public offering price (in dollars per share)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodOfferingPricePerShareNewIssues",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_StockOptionPlan2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to stock option plan 2016.",
        "label": "Stock Option Plan 2016 [Member]",
        "terseLabel": "Stock Option Plan 2016"
       }
      }
     },
     "localname": "StockOptionPlan2016Member",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_StockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for stock options.",
        "label": "Options"
       }
      }
     },
     "localname": "StockOptionsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SupervisoryBoardActivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to supervisory board activities.",
        "label": "Supervisory board activities"
       }
      }
     },
     "localname": "SupervisoryBoardActivitiesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_SupervisoryBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for supervisory board.",
        "label": "Supervisory board members"
       }
      }
     },
     "localname": "SupervisoryBoardMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of benefit/(expense) arising from a previously unrecognised tax loss, tax credit or temporary difference of a prior period that is used to reduce/(increase) deferred tax expense. [Refer: Deferred tax expense (income); Temporary differences [member]; Unused tax losses [member]; Unused tax credits [member]]",
        "label": "Tax Benefit Expense Arising From Previously Unrecognised Tax Loss Tax Credit Or Temporary Difference Of Prior Period Used To Increase Decrease Deferred Tax Expense",
        "terseLabel": "Tax losses"
       }
      }
     },
     "localname": "TaxBenefitExpenseArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToIncreaseDecreaseDeferredTaxExpense",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold trading days.",
        "label": "Threshold Trading Days",
        "terseLabel": "Trading days"
       }
      }
     },
     "localname": "ThresholdTradingDays",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_TotalLeaseExpensesRecognisedInProfitOrLoss": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of lease expenses recognised in profit or loss.",
        "label": "Total Lease Expenses Recognised In Profit Or Loss",
        "totalLabel": "Total amounts recognized in profit or loss"
       }
      }
     },
     "localname": "TotalLeaseExpensesRecognisedInProfitOrLoss",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_TradeAndOtherPayablesOther": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of trade and other payables, classified as other.",
        "label": "Trade And Other Payables, Other",
        "verboseLabel": "Others"
       }
      }
     },
     "localname": "TradeAndOtherPayablesOther",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of trade and other receivables and other assets, classified as current.",
        "label": "Trade And Other Receivables And Other Assets Current",
        "totalLabel": "Trade receivables and contract assets and other assets current"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAndOtherAssetsCurrent",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of trade receivables and contract assets and other assets.",
        "label": "Trade And Other Receivables And Other Assets, Current And Noncurrent",
        "totalLabel": "Total non-current and current trade and other receivables and other assets"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of trade and other receivables and other assets, classified as non-current",
        "label": "Trade And Other Receivables And Other Assets Noncurrent",
        "totalLabel": "Trade receivables and contract assets and other assets non-current"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAndOtherAssetsNoncurrent",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_TradeAndOtherReceivablesDueWithInTwoMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for trade and other receivables due with in two months.",
        "label": "Trade and other receivables due with in two months"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesDueWithInTwoMonthsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_TradePayableAndOtherLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for trade payables and other liabilities.",
        "label": "Trade payables and other liabilities"
       }
      }
     },
     "localname": "TradePayableAndOtherLiabilitiesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_TradePayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for trade payables.",
        "label": "Trade payables"
       }
      }
     },
     "localname": "TradePayablesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_TradeReceivablesAndContractAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for trade receivables and contract assets.",
        "label": "Trade receivables and contract assets"
       }
      }
     },
     "localname": "TradeReceivablesAndContractAssetsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_TradeReceivablesAverageTurnoverPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average turnover period on trade receivables.",
        "label": "Trade Receivables Average Turnover Period",
        "terseLabel": "Average turnover period on trade receivables"
       }
      }
     },
     "localname": "TradeReceivablesAverageTurnoverPeriod",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_TradeTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of trade tax rate.",
        "label": "Trade Tax Rate",
        "terseLabel": "Trade tax rate (as a percent)"
       }
      }
     },
     "localname": "TradeTaxRate",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cntg_UnallocatedAmountsDepreciationAndAmortizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for unallocated amounts depreciation and amortization.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "UnallocatedAmountsDepreciationAndAmortizationMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_UnallocatedAmountsShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for unallocated amounts share based payments.",
        "label": "Sharebased payment expenses"
       }
      }
     },
     "localname": "UnallocatedAmountsShareBasedPaymentsMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_UndiscountedLeasePaymentsToBeMade": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of undiscounted lease payments to be made by the company.",
        "label": "Undiscounted Lease Payments To Be Made",
        "terseLabel": "Future lease payments to be made"
       }
      }
     },
     "localname": "UndiscountedLeasePaymentsToBeMade",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_UniversitairMedischCentrumUtrechtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for Universitair Medisch Centrum Utrecht.",
        "label": "Universitair Medisch Centrum Utrecht"
       }
      }
     },
     "localname": "UniversitairMedischCentrumUtrechtMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for right-of-use assets.",
        "label": "Useful Life Measured As Period Of Time, Right-of-use Assets",
        "terseLabel": "Estimated useful life of right-of-use assets"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeRightOfUseAssets",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of additional equity ordinary shares taken as base for issuance of units under share based payment arrangements.",
        "label": "Value of Additional Equity, Base For Issuance of Units Under Share Based Payment Arrangement",
        "terseLabel": "Value of additional equity ordinary shares"
       }
      }
     },
     "localname": "ValueOfAdditionalEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity ordinary shares taken as base for issuance of units under share based payment arrangements.",
        "label": "Value of Equity, Base For Issuance of Units Under Share Based Payment Arrangement",
        "terseLabel": "Value of equity ordinary shares"
       }
      }
     },
     "localname": "ValueOfEquityBaseForIssuanceOfUnitsUnderShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ValueOfOrdinarySharesToBeIssuedShareBasedPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of ordinary shares to be issued as per share based payment arrangement.",
        "label": "Value of Ordinary Shares To be Issued, Share Based Payments",
        "terseLabel": "Value of ordinary shares to be issued as per share based payment arrangement"
       }
      }
     },
     "localname": "ValueOfOrdinarySharesToBeIssuedShareBasedPayments",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_ValueOfOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of other equity instruments granted under share based payment arrangement.",
        "label": "Value of Other Equity Instruments Granted",
        "terseLabel": "Value of other equity instruments granted under share based payment arrangement"
       }
      }
     },
     "localname": "ValueOfOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cntg_VestingInFourTranchesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Vesting in four tranches.",
        "label": "Vesting in four tranches"
       }
      }
     },
     "localname": "VestingInFourTranchesMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_ViceChairmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to vice chairman.",
        "label": "Vice chairman"
       }
      }
     },
     "localname": "ViceChairmanMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_VirtualShareOptionProgram2016CashSettledMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for virtual share option program 2016 (cash settled).",
        "label": "Virtual share option program 2016 (Cash-settled)"
       }
      }
     },
     "localname": "VirtualShareOptionProgram2016CashSettledMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_VirtualShareOptionProgram2017CashSettledMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for virtual share option program 2017 (cash settled).",
        "label": "Virtual share option program 2017 (Cash settled)"
       }
      }
     },
     "localname": "VirtualShareOptionProgram2017CashSettledMember",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_VirtualShareOptionPrograms2016And2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for virtual share option programs 2016 and 2017.",
        "label": "Virtual share option programs 2016 and 2017"
       }
      }
     },
     "localname": "VirtualShareOptionPrograms2016And2017Member",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_VolumeWeightedAverageStockPriceComputationTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of tradings days will be taken as base for computation volume weighted average stock price under share based payment arrangement.",
        "label": "Volume Weighted Average Stock Price Computation Trading Days",
        "terseLabel": "Period of tradings days"
       }
      }
     },
     "localname": "VolumeWeightedAverageStockPriceComputationTradingDays",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to when the volume weighted average stock price equals or exceeds USD 24 prior to January 1st, 2023.",
        "label": "Volume weighted average stock price equals or exceeds USD 24 prior to January 1st, 2023"
       }
      }
     },
     "localname": "VolumeWeightedAverageStockPriceEqualsOrExceedsUsd24PriorToJanuary12023Member",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to when the volume weighted average stock price equals or exceeds USD 33 prior to January 1st, 2024.",
        "label": "Volume weighted average stock price equals or exceeds USD 33 prior to January 1st, 2024."
       }
      }
     },
     "localname": "VolumeWeightedAverageStockPriceEqualsOrExceedsUsd33PriorToJanuary12024Member",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "WAEP"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_WeightedAverageExercisePriceOfShareOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Weighted Average Exercise Price Of Share Options [Abstract]",
        "terseLabel": "WAEP"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsAbstract",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cntg_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average exercise price of share options cancelled in share based payment arrangement.",
        "label": "Weighted Average Exercise Price Of Share Options Cancelled In Share Based Payment Arrangement",
        "verboseLabel": "Cancelled during the year"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details"
     ],
     "xbrltype": "decimalItemType"
    },
    "cntg_WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"The weighted average exercise price of share options vested in a share-based payment arrangement.\"",
        "label": "Weighted Average Exercise Price Of Share Options Vested In Share-based Payment Arrangement",
        "terseLabel": "Vested as of December 31"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsVestedInShareBasedPaymentArrangement",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_WeightedAverageFairValueOfShareOptionsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value of share options outstanding.",
        "label": "Weighted Average Fair Value Of Share Options Outstanding",
        "terseLabel": "Weighted average fair value of options outstanding"
       }
      }
     },
     "localname": "WeightedAverageFairValueOfShareOptionsOutstanding",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_WeightedAverageFairValueOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value per share used as input to the option pricing model to calculate the fair value of other equity instruments granted.",
        "label": "Weighted Average Fair Value Other Equity Instruments Granted",
        "terseLabel": "Weighted average fair value (USD)"
       }
      }
     },
     "localname": "WeightedAverageFairValueOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cntg_WeightedAverageSharePriceOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of other equity instruments granted.",
        "label": "Weighted Average Share Price, Other Equity Instruments Granted",
        "terseLabel": "Share price at grant date (USD)"
       }
      }
     },
     "localname": "WeightedAverageSharePriceOtherEquityInstrumentsGranted",
     "nsuri": "http://centogene.com/20211231",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "-Germany"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_NL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "-Netherlands"
       }
      }
     },
     "localname": "NL",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_SA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "-Saudi Arabia"
       }
      }
     },
     "localname": "SA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "-United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AED": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AED"
       }
      }
     },
     "localname": "AED",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_INR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INR"
       }
      }
     },
     "localname": "INR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "USD"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document and Entity Information"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Units, Units Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://centogene.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ifrs-full_AccountingProfit": {
     "auth_ref": [
      "r70",
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accounting profit",
        "verboseLabel": "Loss before tax"
       }
      }
     },
     "localname": "AccountingProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": {
     "auth_ref": [
      "r81",
      "r88",
      "r138",
      "r149",
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated depreciation, amortization and impairment"
       }
      }
     },
     "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additional allowance for credit losses of financial assets recognised in profit or loss. [Refer: Allowance account for credit losses of financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additional allowance recognised in profit or loss, allowance account for credit losses of financial assets",
        "terseLabel": "Expected credit loss allowances on trade receivables and contract assets",
        "verboseLabel": "Expected credit loss allowances on trade receivables"
       }
      }
     },
     "localname": "AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "verboseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions to right-of-use assets",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsToRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "verboseLabel": "Weighted average number of outstanding shares after adjusted for the effect of the corporate reorganization"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments of tax expense (income) recognised in the period for current tax of prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for current tax of prior periods",
        "negatedTerseLabel": "Adjustments for prior periods"
       }
      }
     },
     "localname": "AdjustmentsForCurrentTaxOfPriorPeriod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r163"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation and amortisation expense",
        "verboseLabel": "Amortization (including impairments) and depreciation"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in other liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r163"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade and other payables",
        "negatedLabel": "Repayment of trade payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForInterestExpense": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for interest expense",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "AdjustmentsForInterestExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForInterestIncome": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for interest income expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest income; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for interest income",
        "negatedLabel": "Interest income"
       }
      }
     },
     "localname": "AdjustmentsForInterestIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for losses (gains) on disposal of non-current assets",
        "verboseLabel": "Gain on the disposal of noncurrent assets"
       }
      }
     },
     "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments to reconcile earnings to cash flow from operating activities"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "verboseLabel": "Share-based payment expenses"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdministrativeExpense": {
     "auth_ref": [
      "r2",
      "r59",
      "r119"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 2.0,
       "parentTag": "cntg_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAfterCorporateExpensesAttributableToReportableSegment",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity classifies as being administrative."
       }
      },
      "en-us": {
       "role": {
        "label": "Administrative expenses",
        "negatedTerseLabel": "Corporate expenses"
       }
      }
     },
     "localname": "AdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r30",
      "r92",
      "r219",
      "r233",
      "r234",
      "r262",
      "r283",
      "r288",
      "r311",
      "r312",
      "r314",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Allowance account for credit losses of financial assets",
        "periodEndLabel": "As of December 31",
        "periodStartLabel": "As of January 1",
        "verboseLabel": "Expected credit loss"
       }
      }
     },
     "localname": "AllowanceAccountForCreditLossesOfFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation, intangible assets other than goodwill",
        "verboseLabel": "Amortization and impairment"
       }
      }
     },
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "auth_ref": [
      "r112",
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts payable, related party transactions",
        "terseLabel": "Payable for services"
       }
      }
     },
     "localname": "AmountsPayableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "auth_ref": [
      "r112",
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts receivable, related party transactions",
        "terseLabel": "Receivables of related to the exercise of options"
       }
      }
     },
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "verboseLabel": "Statutory rate (as a percent)"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r26",
      "r205",
      "r206",
      "r207",
      "r298",
      "r301"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssetsAndLiabilitiesAxis": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets and liabilities [axis]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssetsAndLiabilitiesMember": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets and liabilities. It also represents the standard value for the 'Assets and liabilities' axis if no other member is used. [Refer: Assets; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Assets and liabilities [member]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AverageForeignExchangeRate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies."
       }
      },
      "en-us": {
       "role": {
        "label": "Average foreign exchange rate",
        "terseLabel": "Average rate"
       }
      }
     },
     "localname": "AverageForeignExchangeRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_BankBorrowingsUndiscountedCashFlows": {
     "auth_ref": [
      "r284",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Bank borrowings, undiscounted cash flows",
        "verboseLabel": "Secured bank loans"
       }
      }
     },
     "localname": "BankBorrowingsUndiscountedCashFlows",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BankOverdraftsClassifiedAsCashEquivalents": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Bank overdrafts"
       }
      }
     },
     "localname": "BankOverdraftsClassifiedAsCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Loss per share - Basic (in EUR)",
        "verboseLabel": "Loss per share - Basic (in EUR)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BorrowingsAdjustmentToInterestRateBasis": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings, adjustment to interest rate basis",
        "terseLabel": "Adjustment to interest rate"
       }
      }
     },
     "localname": "BorrowingsAdjustmentToInterestRateBasis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      }
     },
     "localname": "BorrowingsByNameAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Total loans"
       }
      }
     },
     "localname": "BorrowingsByNameMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BorrowingsInterestRate": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings, interest rate",
        "terseLabel": "Interest rate",
        "verboseLabel": "Nominal interest rate (as a percent)"
       }
      }
     },
     "localname": "BorrowingsInterestRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r247",
      "r280",
      "r314"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Minimum"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CapitalReserve": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the capital reserves."
       }
      },
      "en-us": {
       "role": {
        "label": "Capital reserve.",
        "verboseLabel": "Capital reserve"
       }
      }
     },
     "localname": "CapitalReserve",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CapitalReserveMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing capital reserves."
       }
      },
      "en-us": {
       "role": {
        "label": "Capital reserve"
       }
      }
     },
     "localname": "CapitalReserveMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCapitalReservesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CapitalisedDevelopmentExpenditureMember": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets arising from development expenditure capitalised before the start of commercial production or use. An intangible asset shall only be recognised if the entity can demonstrate all of the following: (a) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (b) its intention to complete the intangible asset and use or sell it; (c) its ability to use or sell the intangible asset; (d) how the intangible asset will generate probable future economic benefits. Among other things, the entity can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (e) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (f) its ability to measure reliably the expenditure attributable to the intangible asset during its development."
       }
      },
      "en-us": {
       "role": {
        "label": "Capitalized development costs"
       }
      }
     },
     "localname": "CapitalisedDevelopmentExpenditureMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "auth_ref": [
      "r81",
      "r85",
      "r138",
      "r142",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r258",
      "r268",
      "r269",
      "r329",
      "r333"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      }
     },
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountMember": {
     "auth_ref": [
      "r85",
      "r142",
      "r148",
      "r150",
      "r151",
      "r258",
      "r268",
      "r269",
      "r329",
      "r332"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      }
     },
     "localname": "CarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r21",
      "r175",
      "r200"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at the end of the period",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the period",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and short-term deposits"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r153",
      "r177"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Cash flow from financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r153",
      "r177"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Cash flow (used in)/from investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r153",
      "r177"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "terseLabel": "Loss of operations resulting in operating cash outflow",
        "totalLabel": "Cash flow (used in)/from operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashOutflowForLeases": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash outflow for leases",
        "verboseLabel": "Total cash outflows for leases"
       }
      }
     },
     "localname": "CashOutflowForLeases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in liabilities arising from financing activities [abstract]",
        "terseLabel": "Reconciliation of liabilities arising from financing activities"
       }
      }
     },
     "localname": "ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r131",
      "r133",
      "r208",
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r131",
      "r208",
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "auth_ref": [
      "r135",
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "auth_ref": [
      "r268",
      "r270",
      "r272",
      "r274"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsMember": {
     "auth_ref": [
      "r268",
      "r270",
      "r272",
      "r274"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments, class [member]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "auth_ref": [
      "r278",
      "r279",
      "r310",
      "r323"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories"
       }
      }
     },
     "localname": "ClassesOfInventoriesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share capital [member]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      },
      "en-us": {
       "role": {
        "label": "Closing foreign exchange rate",
        "terseLabel": "Closing rate"
       }
      }
     },
     "localname": "ClosingForeignExchangeRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCapitalReservesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r4",
      "r47",
      "r182",
      "r184",
      "r192",
      "r197"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLossCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Total comprehensive loss",
        "verboseLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r4",
      "r49"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLossCalc2": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to non-controlling interests",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r4",
      "r50"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLossCalc2": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "terseLabel": "Equity holders of the parent"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ConsiderationPaidReceived": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration paid (received)",
        "terseLabel": "Consideration for disposal of subsidiary"
       }
      }
     },
     "localname": "ConsiderationPaidReceived",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContingentLiabilitiesMember": {
     "auth_ref": [
      "r136",
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent liabilities [member]"
       }
      }
     },
     "localname": "ContingentLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContractLiabilities": {
     "auth_ref": [
      "r212",
      "r216"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer."
       }
      },
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "terseLabel": "Contract liabilities",
        "verboseLabel": "Contract liabilities (note 19.2)"
       }
      }
     },
     "localname": "ContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of inventories recognised as an expense during the period. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of inventories recognised as expense during period",
        "verboseLabel": "Raw materials, consumables and changes in inventories of finished goods and work in process recorded as expenses"
       }
      }
     },
     "localname": "CostOfInventoriesRecognisedAsExpenseDuringPeriod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r2",
      "r59"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CountryOfDomicileMember": {
     "auth_ref": [
      "r305",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the country in which the entity is registered and where it has its legal address or registered office."
       }
      },
      "en-us": {
       "role": {
        "label": "Domestic tax rate"
       }
      }
     },
     "localname": "CountryOfDomicileMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CreditRiskMember": {
     "auth_ref": [
      "r264",
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Credit risk"
       }
      }
     },
     "localname": "CreditRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrencyRiskMember": {
     "auth_ref": [
      "r292",
      "r315",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Currency risk"
       }
      }
     },
     "localname": "CurrencyRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r31",
      "r192",
      "r193"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current borrowings and current portion of non-current borrowings",
        "terseLabel": "Current loans"
       }
      }
     },
     "localname": "CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentContractAssets": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current contract assets. [Refer: Contract assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current contract assets",
        "terseLabel": "Contract assets (note 15)",
        "verboseLabel": "Contract assets"
       }
      }
     },
     "localname": "CurrentContractAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentGovernmentGrants": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current government grants",
        "verboseLabel": "Government grants"
       }
      }
     },
     "localname": "CurrentGovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities.",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r33",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentMember": {
     "auth_ref": [
      "r273",
      "r290",
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a current time band."
       }
      },
      "en-us": {
       "role": {
        "label": "Not past due"
       }
      }
     },
     "localname": "CurrentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "verboseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureInventoriesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of current raw materials and current production supplies. [Refer: Current production supplies; Current raw materials]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current raw materials and current production supplies",
        "verboseLabel": "Raw materials, consumables and supplies"
       }
      }
     },
     "localname": "CurrentRawMaterialsAndCurrentProductionSupplies",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentReceivablesFromContractsWithCustomers": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current receivables from contracts with customers. [Refer: Receivables from contracts with customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current receivables from contracts with customers",
        "terseLabel": "Trade receivables",
        "verboseLabel": "Trade receivables (note 15)"
       }
      }
     },
     "localname": "CurrentReceivablesFromContractsWithCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersContractBalancesDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax expense (income)",
        "negatedLabel": "Current year"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current tax expense (income) and adjustments for the current tax of prior periods. [Refer: Current tax expense (income); Adjustments for current tax of prior periods]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax expense (income) and adjustments for current tax of prior periods",
        "negatedTotalLabel": "Current tax expenses"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax liabilities, current",
        "verboseLabel": "Liabilities from income taxes"
       }
      }
     },
     "localname": "CurrentTaxLiabilitiesCurrent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentValueAddedTaxPayables": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current value added tax payables. [Refer: Value added tax payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current value added tax payables",
        "terseLabel": "VAT payable"
       }
      }
     },
     "localname": "CurrentValueAddedTaxPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current value added tax receivables"
       }
      }
     },
     "localname": "CurrentValueAddedTaxReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deductible temporary differences for which no deferred tax asset is recognised",
        "verboseLabel": "Deductible temporary differences, for which no deferred tax asset is recognized"
       }
      }
     },
     "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r24",
      "r27",
      "r74"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income) recognised in profit or loss",
        "negatedTotalLabel": "Deferred tax (expense)/income"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income) relating to origination and reversal of temporary differences",
        "negatedLabel": "Temporary differences"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r24",
      "r27",
      "r74"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "negatedLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liability (asset)",
        "negatedTotalLabel": "Deferred Taxes",
        "verboseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r1",
      "r3",
      "r59",
      "r201",
      "r296",
      "r302"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation and amortisation expense",
        "negatedTerseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization (including impairments)"
       }
      }
     },
     "localname": "DepreciationAndAmortisationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r84",
      "r87"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails": {
       "order": 1.0,
       "parentTag": "cntg_TotalLeaseExpensesRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, right-of-use assets",
        "negatedLabel": "Depreciation expenses",
        "terseLabel": "Depreciation expense of right-of-use assets"
       }
      }
     },
     "localname": "DepreciationRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for finance income and costs. [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for finance income and costs [text block]",
        "terseLabel": "Finance income and finance costs"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for financial instruments [text block]",
        "terseLabel": "Financial instruments"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for foreign currency translation."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for foreign currency translation [text block]",
        "terseLabel": "Foreign currency and currency translation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for government grants [text block]",
        "terseLabel": "Government grants"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of non-financial assets [text block]",
        "terseLabel": "Impairment of non-financial assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for income tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for leases [text block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "verboseLabel": "Revenues from contracts with customers"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for share-based payment transactions [text block]",
        "verboseLabel": "Share-based payments"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected volatility, share options granted",
        "verboseLabel": "Volatility (%)"
       }
      }
     },
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the initial application of an IFRS. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of initial application of standards or interpretations [text block]",
        "terseLabel": "Effects of new accounting standards"
       }
      }
     },
     "localname": "DescriptionOfInitialApplicationOfStandardsOrInterpretations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEffectsOfNewAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Option life, share options granted",
        "terseLabel": "Option term (years)"
       }
      }
     },
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk free interest rate, share options granted",
        "negatedLabel": "Risk-free interest rate (%)"
       }
      }
     },
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Loss per share - Diluted (in EUR)"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "terseLabel": "Accounting judgments and estimates"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimates"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of additional information about leasing activities of a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of additional information about leasing activities for lessee [text block]",
        "verboseLabel": "Schedule of amounts recognised in profit or loss related to leases"
       }
      }
     },
     "localname": "DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the allowance relating to impairments of financial assets due to credit losses. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of allowance for credit losses [text block]",
        "verboseLabel": "Schedule of development of impairment losses relating to trade and other receivables"
       }
      }
     },
     "localname": "DisclosureOfAllowanceForCreditLossesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for consolidation."
       }
      },
      "en-us": {
       "role": {
        "label": "Description Of Accounting Policy For Basis Of Consolidation [Policy Text Block]",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfConsolidationExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfConsolidation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "verboseLabel": "Basis of Preparation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBorrowingsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of borrowings [text block]",
        "terseLabel": "Schedule of interest-bearing liabilities"
       }
      }
     },
     "localname": "DisclosureOfBorrowingsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cash and cash equivalents [text block]",
        "verboseLabel": "Cash and short-term deposits"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDeposits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting judgments and estimates"
       }
      }
     },
     "localname": "DisclosureOfChangesInAccountingEstimatesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of changes in accounting estimates [line items]",
        "terseLabel": "Accounting judgments and estimates"
       }
      }
     },
     "localname": "DisclosureOfChangesInAccountingEstimatesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesTable": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the changes in accounting estimates."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of changes in accounting estimates [table]"
       }
      }
     },
     "localname": "DisclosureOfChangesInAccountingEstimatesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [text block]",
        "terseLabel": "Common shares issued and authorized"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of commitments [text block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCompositionOfGroupExplanatory": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the composition of the group (the parent and all its subsidiaries). [Refer: Subsidiaries [member]; Parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of composition of group [text block]",
        "terseLabel": "Schedule of information related to each subsidiary of the Group with material, non-controlling interests before intercompany eliminations"
       }
      }
     },
     "localname": "DisclosureOfCompositionOfGroupExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Liabilities"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [text block]",
        "terseLabel": "Contingent Liabilities"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [line items]",
        "terseLabel": "Contingent Liabilities"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesTable": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to contingent liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [table]"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCreditRiskExposureExplanatory": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity\u2019s financial assets and commitments to extend credit."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of credit risk exposure [text block]",
        "terseLabel": "Schedule of information regarding the credit risk exposure of trade receivables and contract assets"
       }
      }
     },
     "localname": "DisclosureOfCreditRiskExposureExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of deferred taxes [text block]",
        "verboseLabel": "Schedule of breakdown of deferred taxes in the statement of financial position"
       }
      }
     },
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [text block]",
        "terseLabel": "Schedule of outstanding interest-bearing liabilities"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [line items]",
        "terseLabel": "Borrowings",
        "verboseLabel": "Trade and other receivables and other assets"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [text block]",
        "verboseLabel": "Summary of reconciliation of carrying amounts of intangible assets"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "verboseLabel": "Schedule of development of property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [text block]",
        "verboseLabel": "Loss Per Share"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of employee benefits [text block]",
        "terseLabel": "Schedule of employee benefits expense"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of Financial Income and Costs [Text Block]",
        "verboseLabel": "Schedule of finance costs, net"
       }
      }
     },
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments-fair values and risk management"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments [text block]",
        "verboseLabel": "Financial instruments-fair values and risk management"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [text block]",
        "verboseLabel": "Financial liabilities"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [line items]",
        "terseLabel": "Financial liabilities"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesTable": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "General Company Information"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureGeneralCompanyInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [text block]",
        "terseLabel": "Schedule of geographical information"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]",
        "terseLabel": "Schedule of key assumptions used to derive the option value"
       }
      }
     },
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about key management personnel [text block]",
        "terseLabel": "Schedule of remuneration of members of key management"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of new accounting standards"
       }
      }
     },
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets [text block]",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of interests in subsidiaries",
        "terseLabel": "Schedule of major subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfInterestsInSubsidiariesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of inventories [text block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "DisclosureOfInventoriesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureInventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "auth_ref": [
      "r236",
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of leases [text block]",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "DisclosureOfLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMajorCustomersLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of major customers [line items]",
        "verboseLabel": "Segment information and revenue from contracts with customers"
       }
      }
     },
     "localname": "DisclosureOfMajorCustomersLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMajorCustomersTable": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the entity's major customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of major customers [table]"
       }
      }
     },
     "localname": "DisclosureOfMajorCustomersTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMarketRiskExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of market risk. [Refer: Market risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of market risk [text block]",
        "verboseLabel": "Schedule of net foreign currency exposure"
       }
      }
     },
     "localname": "DisclosureOfMarketRiskExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for financial assets held for managing liquidity risk [line items]",
        "terseLabel": "Liquidity risk"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis for financial assets held for managing liquidity risk."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for financial assets held for managing liquidity risk [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [line items]",
        "verboseLabel": "Lease commitments"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]",
        "terseLabel": "Currency risk"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": {
     "auth_ref": [
      "r265",
      "r266"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [text block]",
        "verboseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-controlling interests [text block]",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "DisclosureOfNoncontrollingInterestsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]",
        "terseLabel": "Schedule of share option activity"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital management"
       }
      }
     },
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of objectives, policies and processes for managing capital [text block]",
        "terseLabel": "Capital management"
       }
      }
     },
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCapitalManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment information and revenue from contracts with customers"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "DisclosureOfOperatingSegmentsExplanatory",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments",
        "verboseLabel": "Segment information and revenue from contracts with customers"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other operating expense. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other operating expense [text block]",
        "terseLabel": "Schedule of other operating expenses"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other operating income [text block]",
        "terseLabel": "Schedule of other operating income"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfProvisionMatrixLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of provision matrix [line items]",
        "terseLabel": "Credit risk exposure"
       }
      }
     },
     "localname": "DisclosureOfProvisionMatrixLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfProvisionMatrixTable": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the provision matrix."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of provision matrix [table]"
       }
      }
     },
     "localname": "DisclosureOfProvisionMatrixTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Schedule of carrying amounts of right-of-use assets and movements during the period"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [line items]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]",
        "verboseLabel": "Schedule of reconciliation of liabilities arising from financing activities"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "Related parties"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share-based payment arrangements [text block]",
        "terseLabel": "Share-based payments"
       }
      }
     },
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPayments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "List of subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r123",
      "r125",
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "List of subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiaries"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [line items]",
        "terseLabel": "List of subsidiaries",
        "verboseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "auth_ref": [
      "r123",
      "r125",
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Significant accounting policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [text block]",
        "terseLabel": "Summary of awards granted"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]",
        "terseLabel": "Share-based Compensation",
        "verboseLabel": "Share-based payments"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other payables [text block]",
        "verboseLabel": "Schedule of trade payables and other liabilities"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other receivables [text block]",
        "terseLabel": "Summary of trade receivables and other assets"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [line items]",
        "terseLabel": "Related parties"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, property, plant and equipment",
        "negatedTerseLabel": "Disposal",
        "terseLabel": "Disposal of property"
       }
      }
     },
     "localname": "DisposalsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r166",
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Effect of movements in exchange rates on cash held"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "auth_ref": [
      "r1",
      "r3",
      "r59"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Employee benefits expense",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EmployeeBenefitsExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Impairment of financial assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for impairment of financial assets [member]"
       }
      }
     },
     "localname": "EntitysTotalForImpairmentOfFinancialAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for segment consolidation items [member]"
       }
      }
     },
     "localname": "EntitysTotalForSegmentConsolidationItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSubsidiariesMember": {
     "auth_ref": [
      "r123",
      "r125",
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for subsidiaries [member]"
       }
      }
     },
     "localname": "EntitysTotalForSubsidiariesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r26",
      "r37",
      "r181",
      "r183",
      "r205",
      "r206",
      "r207"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance at end of the period",
        "periodStartLabel": "Balance at beginning of the period",
        "totalLabel": "Equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity.",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities [abstract]",
        "verboseLabel": "Equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Total Owners' Capital"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCapitalReservesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentLiabilities": {
     "auth_ref": [
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimated financial effect of contingent liabilities",
        "terseLabel": "Aggregate amount in question"
       }
      }
     },
     "localname": "EstimatedFinancialEffectOfContingentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price, share options granted",
        "terseLabel": "Exercise price"
       }
      }
     },
     "localname": "ExercisePriceShareOptionsGranted2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExpectedCreditLossRate": {
     "auth_ref": [
      "r273",
      "r290"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The rate of expected credit losses, calculated as percentage of the gross carrying amount. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected credit loss rate",
        "verboseLabel": "Expected credit loss rate"
       }
      }
     },
     "localname": "ExpectedCreditLossRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected dividend as percentage, share options granted",
        "terseLabel": "Dividend yield (%)"
       }
      }
     },
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from cash-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from cash-settled share-based payment transactions",
        "terseLabel": "Expenses arising from cash-settled share-based payment transactions"
       }
      }
     },
     "localname": "ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from equity-settled share-based payment transactions",
        "terseLabel": "Expenses arising from equity-settled share-based payment transactions"
       }
      }
     },
     "localname": "ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions",
        "terseLabel": "Share-based payment expenses"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions [abstract]",
        "terseLabel": "Expenses arising from share-based payment transactions"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      },
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "negatedLabel": "Share-based compensation",
        "verboseLabel": "Share-based payments"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails": {
       "order": 2.0,
       "parentTag": "cntg_TotalLeaseExpensesRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense relating to leases of low-value assets for which recognition exemption has been used",
        "terseLabel": "Rent expense - leases of low-value assets"
       }
      }
     },
     "localname": "ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails": {
       "order": 3.0,
       "parentTag": "cntg_TotalLeaseExpensesRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense relating to short-term leases for which recognition exemption has been used",
        "terseLabel": "Rent expenses - short-term leases"
       }
      }
     },
     "localname": "ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeCost": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "terseLabel": "Financial costs, net",
        "totalLabel": "Financial costs, net"
       }
      }
     },
     "localname": "FinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r263",
      "r268",
      "r269",
      "r272",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets",
        "verboseLabel": "Trade receivables and contract assets"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets held for managing liquidity risk (for example, financial assets that are readily saleable or expected to generate cash inflows to meet cash outflows on financial liabilities). [Refer: Liquidity risk [member]; Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets held for managing liquidity risk",
        "verboseLabel": "Expected cash flows"
       }
      }
     },
     "localname": "FinancialAssetsHeldForManagingLiquidityRisk",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsPastDueButNotImpairedMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for financial assets that are past due but not impaired. A financial asset is past due when a counterparty has failed to make a payment when contractually due. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Specific bad debt allowances"
       }
      }
     },
     "localname": "FinancialAssetsPastDueButNotImpairedMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets pledged as collateral for liabilities or contingent liabilities",
        "terseLabel": "Short term deposits pledged as security",
        "verboseLabel": "Cash deposits provided as security for bank loans"
       }
      }
     },
     "localname": "FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCashAndShortTermDepositsDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities.",
        "terseLabel": "Carrying amount"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesMember": {
     "auth_ref": [
      "r278",
      "r279",
      "r310",
      "r323"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, class [member]"
       }
      }
     },
     "localname": "FinancialLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinishedGoods": {
     "auth_ref": [
      "r36",
      "r101"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureInventoriesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current finished goods",
        "verboseLabel": "Finished goods and merchandise"
       }
      }
     },
     "localname": "FinishedGoods",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ForeignExchangeRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward foreign exchange contracts held for trading",
        "terseLabel": "Foreign currency and currency translation"
       }
      }
     },
     "localname": "ForeignExchangeRatesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gain on the disposal of property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains on disposals of property, plant and equipment",
        "terseLabel": "Gain on disposal of property, plant and equipment"
       }
      }
     },
     "localname": "GainsOnDisposalsOfPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "verboseLabel": "General administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r90",
      "r220",
      "r307",
      "r321"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails",
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r90",
      "r220",
      "r307",
      "r321"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails",
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goods or services transferred to customers at a point in time. [Refer: Performance obligations satisfied at point in time [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Recognized at a point in time."
       }
      }
     },
     "localname": "GoodsOrServicesTransferredAtPointInTimeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GoodsOrServicesTransferredOverTimeMember": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goods or services transferred to customers over time. [Refer: Performance obligations satisfied over time [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Recognized over time."
       }
      }
     },
     "localname": "GoodsOrServicesTransferredOverTimeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GovernmentGrants": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Government grants.",
        "verboseLabel": "Government grants (deferred income)"
       }
      }
     },
     "localname": "GovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r81",
      "r138",
      "r149",
      "r152",
      "r258",
      "r269",
      "r272",
      "r273",
      "r329",
      "r333"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cost"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossOnFinancialAssets": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 6.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss on financial assets",
        "terseLabel": "Impairment of financial assets"
       }
      }
     },
     "localname": "ImpairmentLossOnFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill",
        "terseLabel": "Impairment expense"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentOfFinancialAssetsAxis": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment of financial assets [axis]"
       }
      }
     },
     "localname": "ImpairmentOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated statements of comprehensive loss"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r52",
      "r64",
      "r70",
      "r71",
      "r121",
      "r203",
      "r297"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "negatedTerseLabel": "Income taxes",
        "negatedTotalLabel": "Income tax (expenses)/ benefit",
        "verboseLabel": "Income taxes expenses"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails",
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome": {
     "auth_ref": [
      "r54",
      "r69"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to components of other comprehensive income",
        "verboseLabel": "Income taxes recognized directly in other comprehensive income"
       }
      }
     },
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesTaxesRecognizedThroughProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "totalLabel": "Changes in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of ordinary shares issued",
        "terseLabel": "Issued shares"
       }
      }
     },
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of shares outstanding",
        "terseLabel": "Number of common shares issued (in shares)"
       }
      }
     },
     "localname": "IncreaseDecreaseInNumberOfSharesOutstanding",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through acquisition of subsidiary, equity",
        "verboseLabel": "Acquisition of non-wholly owned subsidiary"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughAcquisitionOfSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the disposal of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through disposal of subsidiary, equity",
        "terseLabel": "Disposal of non-wholly owned subsidiary"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughDisposalOfSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through financing cash flows, liabilities arising from financing activities",
        "terseLabel": "Cash flows"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "verboseLabel": "Share-based payments"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers, intangible assets other than goodwill",
        "terseLabel": "Reclass"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The difference, for modified share-based payment arrangements, between the fair value of the modified equity instrument and that of the original equity instrument, both estimated as at the date of the modification. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Incremental fair value granted, modified share-based payment arrangements",
        "terseLabel": "Incremental fair value"
       }
      }
     },
     "localname": "IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r19",
      "r142"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill",
        "periodEndLabel": "Balance, at the end of the year",
        "periodStartLabel": "Balance, at the beginning of the year",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [abstract]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r132",
      "r143",
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureAccountingJudgmentsAndEstimatesDetails",
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails",
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestExpense": {
     "auth_ref": [
      "r202",
      "r295",
      "r302"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense",
        "verboseLabel": "Interest and similar expenses"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnBorrowings": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on borrowings",
        "negatedLabel": "Interest expenses from loans"
       }
      }
     },
     "localname": "InterestExpenseOnBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      },
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails": {
       "order": 4.0,
       "parentTag": "cntg_TotalLeaseExpensesRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "negatedLabel": "Unwinding of the discount on lease liabilities",
        "terseLabel": "Interest expenses",
        "verboseLabel": "Interest expenses on lease liabilities"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsAmountsRecognisedInProfitOrLossDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestIncomeOnLoansAndReceivables": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest income on loans and receivables. [Refer: Interest income; Loans and receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest income on loans and receivables",
        "terseLabel": "Interest income from loans and receivables",
        "verboseLabel": "Interest and similar income"
       }
      }
     },
     "localname": "InterestIncomeOnLoansAndReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesFinancialCostsNetDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as financing activities",
        "negatedLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRateTypesMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate types [member]"
       }
      }
     },
     "localname": "InterestRateTypesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as investing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest received, classified as investing activities",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestReceivedClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InternallyGeneratedMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items that have been internally generated by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Internally generated /acquired"
       }
      }
     },
     "localname": "InternallyGeneratedMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Inventories": {
     "auth_ref": [
      "r20",
      "r32",
      "r98"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current inventories",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "Inventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureInventoriesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoryWritedown2011": {
     "auth_ref": [
      "r56",
      "r100"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventory write-down",
        "terseLabel": "Inventory write-off"
       }
      }
     },
     "localname": "InventoryWritedown2011",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureInventoriesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfEquity": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "verboseLabel": "Issuance of shares"
       }
      }
     },
     "localname": "IssueOfEquity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital.",
        "verboseLabel": "Issued capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Total compensation paid to key management"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, post-employment benefits",
        "terseLabel": "Post-employment pension and medical benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, share-based payment",
        "terseLabel": "Share-based payment transactions"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, short-term employee benefits",
        "terseLabel": "Short-term employee benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, termination benefits",
        "terseLabel": "Termination benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationTerminationBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesRemunerationOfMembersOfKeyManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel"
       }
      }
     },
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "auth_ref": [
      "r233",
      "r234",
      "r283",
      "r287",
      "r291",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "More than five years"
       }
      }
     },
     "localname": "LaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember": {
     "auth_ref": [
      "r281",
      "r286",
      "r291"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one month and not later than three months."
       }
      },
      "en-us": {
       "role": {
        "label": "1 - 3 months"
       }
      }
     },
     "localname": "LaterThanOneMonthAndNotLaterThanThreeMonthsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r282",
      "r291"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "1 - 5 years"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearMember": {
     "auth_ref": [
      "r29",
      "r328",
      "r331"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "More than 365 days"
       }
      }
     },
     "localname": "LaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeMonthsMember": {
     "auth_ref": [
      "r273",
      "r290",
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months."
       }
      },
      "en-us": {
       "role": {
        "label": "Past due more than 90 days"
       }
      }
     },
     "localname": "LaterThanThreeMonthsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities.",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "auth_ref": [
      "r173",
      "r178"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesInterestBearingLoansDetails",
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LegalProceedingsContingentLiabilityMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a contingent liability for legal proceedings. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Legal proceedings contingent liability"
       }
      }
     },
     "localname": "LegalProceedingsContingentLiabilityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities",
        "periodEndLabel": "End of year",
        "periodStartLabel": "Beginning of year"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [member]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011": {
     "auth_ref": [
      "r254"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 4.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities arising from share-based payment transactions. Share-based payment transactions are transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities from share-based payment transactions",
        "terseLabel": "Payables due to holders of vested options"
       }
      }
     },
     "localname": "LiabilitiesFromSharebasedPaymentTransactions2011",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LicencesAndFranchisesMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity and the right to operate a business using the name, merchandise, services, methodologies, promotional support, marketing and supplies granted by another entity. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Rights, licenses, software"
       }
      }
     },
     "localname": "LicencesAndFranchisesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LongtermBorrowings": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current portion of non-current borrowings",
        "verboseLabel": "Noncurrent loans"
       }
      }
     },
     "localname": "LongtermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes"
       }
      }
     },
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Major customers [axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersMember": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Customers [member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MajorOrdinaryShareTransactionsMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for major ordinary share transactions. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Major ordinary share transactions"
       }
      }
     },
     "localname": "MajorOrdinaryShareTransactionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MajorPurchasesOfAssetsMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for major purchases of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Major purchases of assets"
       }
      }
     },
     "localname": "MajorPurchasesOfAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for material adjustments used to reconcile items in the entity's financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Material reconciling items [member]"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [text block]",
        "terseLabel": "Schedule of residual contractual terms of financial liabilities, including estimated interest payments"
       }
      }
     },
     "localname": "MaturityAnalysisForNonderivativeFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r30",
      "r92",
      "r219",
      "r233",
      "r234",
      "r262",
      "r277",
      "r283",
      "r311",
      "r312",
      "r314",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MethodsOfGenerationAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Methods of generation [axis]"
       }
      }
     },
     "localname": "MethodsOfGenerationAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MethodsOfGenerationMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all methods of generation. It also represents the standard value for the 'Methods of generation' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Methods of generation [member]"
       }
      }
     },
     "localname": "MethodsOfGenerationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherExpenseByFunction",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating expense",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MiscellaneousOtherOperatingIncome": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating income",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MotorVehiclesMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Motor vehicles"
       }
      }
     },
     "localname": "MotorVehiclesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NetAssetsLiabilities": {
     "auth_ref": [
      "r11",
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets (liabilities)",
        "terseLabel": "Net assets/(liabilities)"
       }
      }
     },
     "localname": "NetAssetsLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetForeignExchangeGain": {
     "auth_ref": [
      "r16",
      "r105"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net foreign exchange gain",
        "terseLabel": "Exchange rate gains"
       }
      }
     },
     "localname": "NetForeignExchangeGain",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "auth_ref": [
      "r16",
      "r105"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherExpenseByFunction",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net foreign exchange loss",
        "terseLabel": "Currency losses"
       }
      }
     },
     "localname": "NetForeignExchangeLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "NonadjustingEventsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncontrollingInterests": {
     "auth_ref": [
      "r25",
      "r186",
      "r189"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "negatedTerseLabel": "Carrying amount of noncontrolling interests",
        "terseLabel": "Noncontrolling interests",
        "verboseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Non- controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r31",
      "r192",
      "r194"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Assets [Abstract]",
        "verboseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentGovernmentGrants": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current government grants",
        "terseLabel": "Government grants"
       }
      }
     },
     "localname": "NoncurrentGovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities.",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfLeaseLiabilitiesAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r33",
      "r192",
      "r196"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "verboseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentPayables": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other non-current payables",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other non-current receivables [abstract]",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentReceivablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-derivative financial liabilities, undiscounted cash flows",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotInternallyGeneratedMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items that have not been internally generated by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Purchased"
       }
      }
     },
     "localname": "NotInternallyGeneratedMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r28",
      "r233",
      "r234",
      "r283",
      "r291",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than one year"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotionalAmount": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      },
      "en-us": {
       "role": {
        "label": "Notional amount",
        "terseLabel": "Nominal amount"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r239",
      "r255"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of instruments granted in share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of instruments granted in share-based payment arrangement",
        "terseLabel": "Number of Awards"
       }
      }
     },
     "localname": "NumberOfInstrumentsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "auth_ref": [
      "r248",
      "r251"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "RSUs granted",
        "verboseLabel": "Granted during the year"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement",
        "negatedLabel": "Exercised during the year",
        "terseLabel": "No of RSUs exercised during the period",
        "verboseLabel": "Number of units vested during the period"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "auth_ref": [
      "r240",
      "r243",
      "r247"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Outstanding as of December 31",
        "periodStartLabel": "Outstanding at January 1"
       }
      }
     },
     "localname": "NumberOfOutstandingShareOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercisable in share-based payment arrangement",
        "verboseLabel": "Exercisable as of December 31"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "negatedLabel": "Exercised during the year"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options granted in share-based payment arrangement",
        "terseLabel": "Number of options granted",
        "verboseLabel": "Granted during the year"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares authorised",
        "verboseLabel": "Authorized common shares"
       }
      }
     },
     "localname": "NumberOfSharesAuthorised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesIssuedAndFullyPaid": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity, for which full payment has been received."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued and fully paid",
        "periodEndLabel": "Number of shares issued and fully paid, Ending",
        "periodStartLabel": "Number of shares issued and fully paid, Beginning"
       }
      }
     },
     "localname": "NumberOfSharesIssuedAndFullyPaid",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OperatingSegmentsMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Operating segment"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OrdinarySharesMember": {
     "auth_ref": [
      "r43",
      "r127"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Common shares"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherAdjustmentsForNoncashItems": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other adjustments to reconcile profit (loss)",
        "verboseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherAdjustmentsForNoncashItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherAssetsMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r6",
      "r46",
      "r55",
      "r199"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income attributable to owners of the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, attributable to owners of parent",
        "terseLabel": "Other comprehensive income/(loss), all attributable to equity holders of the parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentAssets": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherCurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 6.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherExpenseByFunction": {
     "auth_ref": [
      "r2",
      "r59",
      "r120"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 8.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses."
       }
      },
      "en-us": {
       "role": {
        "label": "Ifrs Other operating expense",
        "totalLabel": "Total other operating expenses",
        "verboseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "OtherExpenseByFunction",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIncome": {
     "auth_ref": [
      "r1",
      "r2",
      "r118"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 7.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Ifrs Other operating income",
        "totalLabel": "Total other operating income",
        "verboseLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current assets.",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentReceivables": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "cntg_TradeAndOtherReceivablesAndOtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current receivables",
        "terseLabel": "Other assets-Others"
       }
      }
     },
     "localname": "OtherNoncurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherPropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other property, plant and equipment"
       }
      }
     },
     "localname": "OtherPropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherReversalsOfProvisions": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of reversals of provisions that the entity does not separately disclose in the same statement or note. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other reversals of provisions",
        "terseLabel": "Income from the reversal of provisions"
       }
      }
     },
     "localname": "OtherReversalsOfProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)",
        "negatedLabel": "Other effects"
       }
      }
     },
     "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Par value per share (in euros per share)"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureEquityIssuedCapitalAndCapitalReserveDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PastDueStatusAxis": {
     "auth_ref": [
      "r273",
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Past due status [axis]"
       }
      }
     },
     "localname": "PastDueStatusAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PastDueStatusMember": {
     "auth_ref": [
      "r273",
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Past due status [member]"
       }
      }
     },
     "localname": "PastDueStatusMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries": {
     "auth_ref": [
      "r170",
      "r171"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for changes in ownership interests in subsidiaries that do not result in a loss of control. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments from changes in ownership interests in subsidiaries that do not result in loss of control",
        "negatedLabel": "Cash paid for acquisition of non-wholly owned subsidiary"
       }
      }
     },
     "localname": "PaymentsFromChangesInOwnershipInterestsInSubsidiaries",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Cash repayments of lease liabilities"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of entity's revenue",
        "verboseLabel": "Percentage of revenue"
       }
      }
     },
     "localname": "PercentageOfEntitysRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of voting equity interests acquired",
        "terseLabel": "Additional percentage ownership in subsidiary acquired"
       }
      }
     },
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Post-employment benefit expense, defined contribution plans",
        "terseLabel": "Contributions to state pension scheme (defined contribution plan)"
       }
      }
     },
     "localname": "PostemploymentBenefitExpenseDefinedContributionPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets."
       }
      }
     },
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r158"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from borrowings, classified as financing activities",
        "terseLabel": "Borrowings drawdowns",
        "verboseLabel": "Cash received from loans"
       }
      }
     },
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issue of ordinary shares",
        "verboseLabel": "Net offering proceeds, after deducting underwriting discounts, commissions and transaction costs"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureEquityCommonSharesDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureGeneralCompanyInformationDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares or units",
        "terseLabel": "Cash received from the issuance of shares"
       }
      }
     },
     "localname": "ProceedsFromIssuingShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sales of property, plant and equipment, classified as investing activities",
        "terseLabel": "Cash received from disposals of property, plant and equipment",
        "verboseLabel": "Proceeds from sale of land and building"
       }
      }
     },
     "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r45",
      "r162",
      "r182",
      "r184",
      "r192",
      "r298",
      "r300",
      "r313",
      "r324"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Profit/(loss)",
        "totalLabel": "Loss for the year",
        "verboseLabel": "Loss for the year"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to [abstract]",
        "verboseLabel": "Attributable to:"
       }
      }
     },
     "localname": "ProfitLossAttributableToAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r48",
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to non-controlling interests",
        "terseLabel": "Profit/(loss) allocated to non-controlling interest"
       }
      }
     },
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r1",
      "r2",
      "r259",
      "r298",
      "r300"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "totalLabel": "Loss before taxes",
        "verboseLabel": "Loss before taxes"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r53",
      "r126"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit Loss from operations",
        "terseLabel": "Operating loss",
        "totalLabel": "Operating loss",
        "verboseLabel": "Loss of operations"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r18",
      "r85"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment.",
        "periodEndLabel": "Balance, at the end of the year",
        "periodStartLabel": "Balance, at the beginning of the year",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [abstract]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r86",
      "r132",
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r122",
      "r124",
      "r190"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "Ownership interest in subsidiary (in percent)"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of intangible assets, classified as investing activities",
        "negatedLabel": "Cash paid for investments in intangible assets",
        "terseLabel": "Additions to intangible assets"
       }
      }
     },
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets",
        "negatedLabel": "Cash paid for investments in property, plant and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r247",
      "r280",
      "r314"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r247",
      "r280",
      "r314"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [Member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in allowance account for credit losses of financial assets [abstract]",
        "terseLabel": "Development of impairment losses"
       }
      }
     },
     "localname": "ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in intangible assets other than goodwill [abstract]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in property, plant and equipment [abstract]",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RentalExpense": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense recognised on rental activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Rental expense"
       }
      }
     },
     "localname": "RentalExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of borrowings, classified as financing activities",
        "negatedLabel": "Cash repayments of loans",
        "verboseLabel": "Loans repaid using the consideration from sale of land and building"
       }
      }
     },
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsSaleAndLeasebackTransactionsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "auth_ref": [
      "r10",
      "r106"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Currency translation reserve"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarnings": {
     "auth_ref": [
      "r37",
      "r60"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings.",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Retained earnings and other reserves"
       }
      }
     },
     "localname": "RetainedEarnings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r9",
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r1",
      "r2",
      "r51",
      "r192",
      "r198",
      "r259",
      "r294",
      "r299",
      "r304",
      "r305",
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers",
        "terseLabel": "Total Revenues from contracts with external customers",
        "totalLabel": "Total Revenues from contracts with external customers",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractsWithCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromGovernmentGrants": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income from government grants",
        "terseLabel": "Government grants"
       }
      }
     },
     "localname": "RevenueFromGovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromRenderingOfServices": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_RevenueFromContractsWithCustomers",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from rendering of services",
        "terseLabel": "Rendering of services"
       }
      }
     },
     "localname": "RevenueFromRenderingOfServices",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the rendering of services in related party transactions. [Refer: Revenue; Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from rendering of services, related party transactions",
        "terseLabel": "Revenues recognized in profit and loss"
       }
      }
     },
     "localname": "RevenueFromRenderingOfServicesRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromSaleOfGoods": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_RevenueFromContractsWithCustomers",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from sale of goods",
        "terseLabel": "Sales of goods"
       }
      }
     },
     "localname": "RevenueFromSaleOfGoods",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue that was included in contract liability balance at beginning of period",
        "verboseLabel": "Revenues recognized for contract liabilities"
       }
      }
     },
     "localname": "RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in an allowance account for credit losses of financial assets resulting from the reversal of impairment. [Refer: Allowance account for credit losses of financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reversal, allowance account for credit losses of financial assets",
        "negatedNetLabel": "Derecognition"
       }
      }
     },
     "localname": "ReversalAllowanceAccountForCreditLossesOfFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r230"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRightOfUseAssetsCarryingAmountsOfRightOfUseAssetsAndMovementsDuringPeriodDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssetsMember": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use asset"
       }
      }
     },
     "localname": "RightofuseAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk exposure associated with instruments sharing characteristic",
        "terseLabel": "Net exposure"
       }
      }
     },
     "localname": "RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]"
       }
      }
     },
     "localname": "SegmentConsolidationItemsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsAxis": {
     "auth_ref": [
      "r91",
      "r133",
      "r215",
      "r298",
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      }
     },
     "localname": "SegmentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsMember": {
     "auth_ref": [
      "r91",
      "r133",
      "r215",
      "r303",
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [member]"
       }
      }
     },
     "localname": "SegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SellingExpense": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 5.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling expense",
        "verboseLabel": "Selling expenses"
       }
      }
     },
     "localname": "SellingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ServicesReceivedRelatedPartyTransactions": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of services received in related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Services received, related party transactions",
        "terseLabel": "Payments for services"
       }
      }
     },
     "localname": "ServicesReceivedRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Share issue related cost",
        "negatedTerseLabel": "Transaction costs",
        "terseLabel": "Cost incurred related to the IPO"
       }
      }
     },
     "localname": "ShareIssueRelatedCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesOtherOperatingExpensesDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremium": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium",
        "terseLabel": "Share premium included in capital reserve"
       }
      }
     },
     "localname": "SharePremium",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCapitalReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShorttermBorrowings": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current borrowings",
        "terseLabel": "Short term debt obligation"
       }
      }
     },
     "localname": "ShorttermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term employee benefits accruals",
        "terseLabel": "Personnel related liabilities for vacation and bonuses"
       }
      }
     },
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "auth_ref": [
      "r123",
      "r125",
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureListOfSubsidiariesDetails",
      "http://centogene.com/role/DisclosureNonControllingInterestsDetails",
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesLpcGmbhDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SocialSecurityContributions": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Social security contributions"
       }
      }
     },
     "localname": "SocialSecurityContributions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated statements of cash flows"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated statements of changes in equity"
       }
      }
     },
     "localname": "StatementOfChangesInEquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCapitalReservesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureEquityCapitalReservesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated statements of financial position"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)",
        "negatedLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfForeignTaxRates": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of foreign tax rates",
        "negatedLabel": "Tax rate effect of foreign tax jurisdictions"
       }
      }
     },
     "localname": "TaxEffectOfForeignTaxRates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of tax losses",
        "negatedLabel": "Current year losses for which no deferred tax assets were recognized"
       }
      }
     },
     "localname": "TaxEffectOfTaxLosses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income) at applicable tax rate",
        "negatedLabel": "Taxes on the basis of the Company's domestic tax rate"
       }
      }
     },
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRateToStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [member]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount of temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements, for which deferred tax liabilities have not been recognised as a result of satisfying both of the following conditions: (a) the parent, investor, joint venturer or joint operator is able to control the timing of the reversal of the temporary difference; and (b) it is probable that the temporary difference will not reverse in the foreseeable future. [Refer: Associates [member]; Subsidiaries [member]; Temporary differences [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised",
        "verboseLabel": "Temporary differences associated with investments for which no deferred tax liability has been recognized"
       }
      }
     },
     "localname": "TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TerminationBenefitsExpense": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense in relation to termination benefits. Termination benefits are employee benefits provided in exchange for the termination of an employee's employment as a result of either: (a) an entity's decision to terminate an employee's employment before the normal retirement date; or (b) an employee's decision to accept an offer of benefits in exchange for the termination of employment. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Termination benefits expense",
        "terseLabel": "Termination benefits"
       }
      }
     },
     "localname": "TerminationBenefitsExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesAxis": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodsOrServicesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesMember": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all timings of the transfer of goods or services in contracts with customers. It also represents the standard value for the 'Timing of transfer of goods or services' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [member]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodsOrServicesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersInformationByOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r247",
      "r280",
      "r314"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Maximum"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementLiquidityRiskDetails",
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails",
      "http://centogene.com/role/DisclosureRightOfUseAssetsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails",
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "auth_ref": [
      "r34",
      "r38"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0
      },
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade And Other Current Payables To Trade Suppliers",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails",
      "http://centogene.com/role/StatementConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and Other Receivables",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureTradeAndOtherReceivablesAndOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherPayables": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other payables",
        "totalLabel": "Trade payables and other liabilities"
       }
      }
     },
     "localname": "TradeAndOtherPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesTradePayablesAndOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables and other assets"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeReceivablesMember": {
     "auth_ref": [
      "r11",
      "r267",
      "r271",
      "r273"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables"
       }
      }
     },
     "localname": "TradeReceivablesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Transaction price allocated to remaining performance obligations",
        "verboseLabel": "Performance obligations"
       }
      }
     },
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]"
       }
      }
     },
     "localname": "TypesOfInterestRatesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksAxis": {
     "auth_ref": [
      "r261",
      "r265",
      "r266",
      "r315",
      "r316",
      "r317",
      "r319"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      }
     },
     "localname": "TypesOfRisksAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksMember": {
     "auth_ref": [
      "r261",
      "r265",
      "r266",
      "r315",
      "r316",
      "r317",
      "r319"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Risks [member]"
       }
      }
     },
     "localname": "TypesOfRisksMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureContingentLiabilitiesDetails",
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPayments2019EquityIncentivePlan2019PlanDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsTables",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsVirtualShareOptionProgram2016CashSettledDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_UnallocatedAmountsMember": {
     "auth_ref": [
      "r303",
      "r309"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items that have not been allocated to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Unallocated amounts"
       }
      }
     },
     "localname": "UnallocatedAmountsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersReconciliationOfSegmentAdjustedEbitdaToGroupLossForPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses for which no deferred tax asset recognised",
        "verboseLabel": "Tax losses carryforwards for which no deferred tax assets were recognized"
       }
      }
     },
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses"
       }
      }
     },
     "localname": "UnusedTaxLossesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureIncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, intangible assets other than goodwill",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful Lives, Property Plant And Equipment",
        "terseLabel": "Estimated useful life of property, plant and equipment"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://centogene.com/role/DisclosureSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WagesAndSalaries": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wages and salaries"
       }
      }
     },
     "localname": "WagesAndSalaries",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureOtherIncomeAndExpensesEmployeeBenefitsExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Granted during the year",
        "verboseLabel": "Exercise price"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement",
        "terseLabel": "Exercisable as of December 31"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement",
        "terseLabel": "Exercised during the year"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement",
        "terseLabel": "Granted during the year",
        "verboseLabel": "Exercise price of share options granted"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureRelatedPartiesAdditionalInformationDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r240",
      "r243"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Outstanding as of December 31",
        "periodStartLabel": "Outstanding as of January 1"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16",
        "verboseLabel": "Nominal interest rate at commencement of leases"
       }
      }
     },
     "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialLiabilitiesConditionsAndStatementOfLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding share options",
        "terseLabel": "Weighted average remaining contractual life"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionReplacementEsopVsop2017Details"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageSharePrice2019": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price",
        "terseLabel": "Exercise price"
       }
      }
     },
     "localname": "WeightedAverageSharePrice2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price, share options granted",
        "terseLabel": "Share price at grant date"
       }
      }
     },
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEO"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCurrencyRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LatinAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latin America"
       }
      }
     },
     "localname": "LatinAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ManagementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management"
       }
      }
     },
     "localname": "ManagementMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails",
      "http://centogene.com/role/DisclosureSegmentInformationAndRevenueFromContractsWithCustomersGeographicalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureBasisOfPreparationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureFinancialInstrumentsFairValuesAndRiskManagementCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsEquityShareOptionEsop2019Details",
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsManagementBoardAndEmployeesOptionsAndRsusGrantsAwardedAndExercisesDetails",
      "http://centogene.com/role/DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://centogene.com/role/DisclosureShareBasedPaymentsGrantsToNewCeoAndSupervisoryBoardGrantDetails",
      "http://centogene.com/role/DisclosureShareBasedPaymentsValuationOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 22
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r1": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r10": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r100": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r101": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r102": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI",
   "URIDate": "2021-03-24"
  },
  "r103": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r104": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r105": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r106": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r107": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r108": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r109": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r11": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r110": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r111": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r112": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r113": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r114": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r115": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r116": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "21",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_21_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r117": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2021-03-24"
  },
  "r118": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r119": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r12": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r120": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r121": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r122": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r123": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r124": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r125": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r126": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r127": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r128": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r129": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r13": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r130": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2021-03-24"
  },
  "r131": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r132": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r133": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r134": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r135": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r136": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "88",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r137": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r138": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r139": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r14": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "125",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r140": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r141": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r142": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r143": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r144": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r145": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r146": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r147": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2021-03-24"
  },
  "r148": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r149": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r15": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "134",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_134&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r150": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r151": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r152": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r153": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r154": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r155": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r156": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r157": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r158": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r159": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r16": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r160": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r161": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r162": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r163": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r164": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r165": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r166": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r167": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r168": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r169": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r17": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r170": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "42A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r171": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "42B",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42B&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r172": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r173": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r174": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r175": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r176": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "46",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r177": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r178": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C__IAS07_IE_C_TI",
   "URIDate": "2021-03-24"
  },
  "r179": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r18": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r180": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r181": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r182": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r183": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r184": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r185": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "IG63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r186": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "10",
   "Paragraph": "22",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r187": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "10",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_10_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r188": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r189": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r19": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r190": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r191": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "2",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_2_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r192": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r193": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r194": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r195": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r196": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r197": {
   "Clause": "ix",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r198": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r199": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r2": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r20": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r200": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r201": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r202": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r203": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r204": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r205": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r206": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r207": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r208": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r209": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r21": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r210": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r211": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r212": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "105",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r213": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r214": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "114",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r215": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "115",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r216": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r217": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r218": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r219": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r22": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r220": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r221": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r222": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r223": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r224": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r225": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r226": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r227": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r228": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r229": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r23": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r230": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r231": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r232": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "59",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_59&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r233": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r234": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r235": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "C12",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C",
   "URIDate": "2021-03-24"
  },
  "r236": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2021-03-24"
  },
  "r237": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Presentation",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2021-03-24"
  },
  "r238": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "44",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r239": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r24": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r240": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r241": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r242": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r243": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r244": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r245": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r246": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r247": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r248": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r249": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r25": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r250": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r251": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r252": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_c_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r253": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r254": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "51",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_51_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r255": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "IG23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_IG23&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r256": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r257": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r258": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r259": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r26": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r260": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r261": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "21C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r262": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r263": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r264": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r265": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r266": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r267": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r268": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r269": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r27": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r270": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35K",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r271": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r272": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r273": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r274": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "36",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r275": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r276": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r277": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r278": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r279": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r28": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r280": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r281": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r282": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r283": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r284": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11D&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r285": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11E",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11E&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r286": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r287": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r288": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r289": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B8",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r29": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r290": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG20D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r291": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r292": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Defined terms",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2021-03-24"
  },
  "r293": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Scope",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2021-03-24"
  },
  "r294": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r295": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r296": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r297": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r298": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r299": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r3": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r30": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r300": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r301": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r302": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r303": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r304": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r305": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r306": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r307": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r308": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r309": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "IG4",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_IG4&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r31": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r310": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r311": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r312": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r313": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r314": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r315": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "124",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r316": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "125",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r317": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r318": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r319": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r32": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r320": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r321": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r322": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r323": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "9",
   "Paragraph": "7.2.42",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r324": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r325": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_112_c&doctype=Standard&forcepdf=true",
   "URIDate": "2021-03-24"
  },
  "r326": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r327": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r328": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r329": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r33": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r330": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r331": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r332": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r333": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r334": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r335": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r336": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r337": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r338": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r339": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r34": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "70",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r340": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r341": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r342": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r343": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r344": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r35": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r36": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r37": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r38": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r39": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r4": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r40": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r41": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r42": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r43": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r44": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r45": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r46": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r47": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r48": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r49": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r5": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r50": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r51": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r52": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r53": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r54": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "90",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_90&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r55": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r56": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r57": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r58": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r59": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r6": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r60": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r61": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r62": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "22",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r63": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "22",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r64": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r65": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r66": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r67": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r68": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r69": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "ab",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_ab&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r7": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r70": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r71": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r72": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r73": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r74": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r75": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r76": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r77": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2021-03-24"
  },
  "r78": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r79": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r8": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r80": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r81": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r82": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r83": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r84": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r85": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r86": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r87": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r88": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r89": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2021-03-24"
  },
  "r9": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r90": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r91": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r92": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r93": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "171",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_171&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r94": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r95": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "9",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r96": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Section": "Scope",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI",
   "URIDate": "2021-03-24"
  },
  "r97": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r98": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r99": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_d&doctype=Standard",
   "URIDate": "2021-03-24"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>140
<FILENAME>0001558370-22-004868-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-22-004868-xbrl.zip
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M"(LQ\\,":>>.04,WALA,S-IQ8$8''P<AL;)XEQGF)B$8'*UAYG,KG)V5!@/
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M:5[@:67ZT73*.0#>S55E-#\S!1=?)^/Z4 (YJD=!1?P7AME;-_+[QW_]G6[
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M,";D6<)"7$"K9/4!=)-$M:A=OL:P'0(LVOSYL9ZIQ EG0.H3>V0KJB]:9%$
MYP3D2G4Y*,Y]^H,[X%&[QZ/$\(*N.>C4)>=,[:NSNS,FCOD$,P!#:W*5K_[1
MV=XKZ6C, 8=$OY%NU[SK?2^;>+H;&+<(Q[N>&16/2X%&?7:85-<1<\6R-[B[
MZ9$S>RJEX30(U/M.K30/@'?8"GODL/2F>Z$^1K[/+5.5!WN.%BD:J+F%.Z2&
MN^R^IR2\E)@R0&61 =NY,)Q+.Y,=R%WR^N>)J!QI#:_F\DF77F3Q4>>UY<&
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M>=8%Y29Q99:D/:Z)IQ7"3:+J<3B% E@[4NR&<Y/ <RIB:/>6QUQ\I4OFZQB
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M9=FITQ_<%9].ND_C/D3"L'+AHJ7L30V@7A%AY=<_]O,_,(CR- JN8XGY)%G
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MQ3B5OWE7#4YRGVZH'HLCPDQ\%NC%SALDH7V5;"^IVTY1D 4LIP 2"GTYW8K
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MI@3)SOAK$+P"X//[< D]HK4.4=W"UDYS7;1!!-^-+MI:TPE)R,<N0OD#!C?
M#LD7Y]DCD,DWA>UE4;>0^49C6B+*\$5R\>;>G@VW2_P.0@UM=PU3U.#!Z=R^
M$A*GK2I9TO2&E[UN.P1%!*>V)^I2.+F(BS$_*=Q:MI<CU/9BP9WU:#!:K3S7
M8FFD(A$OY7]%W?:)0QW ->\'//S".F78RYZ]O-K->;6U;(X;YS$&RBV#4^#C
M*/$UNU1>9&]SNX8J\SDU1#8RH8W:J*2*<[621X4[J"68]$V.G$..LNBN_.+M
MXG,5,+6<FE/:Y\3YB4$DGZ,E7=?BHHU4*97<&^P>HV3]=:#3(> -DW5)GO)>
MC<W>JN'Z#45\%84 P,#TV(F<^"2#8/22=&UUYNHF@R=C W3"F.TE,[:XDCKS
MMB9'BS/;"T'5UK_(Z;,)XV%4HW?>P=<7TPLY:+*P_+5PK04G(T5W^P:6#.;_
MFO@: )\&-%0=[FBHFY9)VSL01UMGXPYMGA80!=3Q%1&I<<&LUWZ6Z/WA^>6@
M51+9(%6T=4&^U]%F_<6G'E[53CZ\T-?TG(:<I3O,.]>0M*6>JR$UN!(!3I51
M93Y^H[G@%\ N3W>=*:7./"NE_\XU?!4(M+4^^>;^U'Q],(G*<$V/GH_B3XF>
M89M=T'\*J2NS1#XEV]%2#)K J);#889,FP:9\72Q20*$^%%D]LIIW[-=[<NZ
M87D#($LD@#8]I9YR!T3#G@4AA)R'Y.$/Z%O1CUQ/PQZM-7-60F@ 38#8M*'.
M7&V(HYM3!DU00EO5SR!NP(EDABFNHJ605'"V,"1)G (?<Z)J2D9F>C=@!;%;
MI0V*RK:;H?+0#^R_:>+SM?<7*PM\,+SL#M7G>8.:OHP,VOKOQCN:JL9E3#*-
MZ"Q%N6,O6PO4)HC<EZ&IRR09XGC&,."W;SR,.P7E)MRD0UI S]Z5C/T::[&$
M'( P<II'H4R4G +QI*C8W,PMW6))J8-<SG.O4'J)E.>Y,M%:O]OK%4J);$-'
M(4"-$*72^?^^%W8F:;Q3X!CU"*8,R5+ON>=H3+KN"WJK<I)=;A*(>YNF$R_6
MBG>?<EREBR7>*R,:A2+S+R-W,06+0W?S2ZNB3#9V?B62W:+J* 1![FQ=#2 &
M2%NG5(848T$NEU7*DF<XO.IKQ6]I:&IM,.1I\7AO^AJ8](90EG]9;HLA)W%=
MD=*..^L\1[T9'NVNX4T& 91YZR>A:@WF_0]JCE.\MCJ3398O6]<$U ;[,0Y?
M\E78C\52#;2 R_OC55_/"EK+PCIWYT1/,X;R;Q/Y$/>BBMYQ7'H1L'[FDA <
M;8WCV$,D$O&84U9SWHHB4F"G+@;"?E1NRV5*:\FD.IBTC4(N6Y+-('O+0\!*
M-M1D&LF2[VQX<?[Q23\;6L(*054K+)F%Y%/7*J(:: J6H<_/A4^<![!\)B@F
MSC_ ^L'TS3F@GR(I0ZN?$S_'NR0F%>(F5KI;FG)L&75,__P76!O+I&_U[*P,
M:1[)H*'O V\,ES12G0$JG#0B5571$M5C34YT;%]AL ?^PC95U"'BDI!5*$V3
M05M[L)H0CQ 3!E :T"(-"%A^@\<E71(TT#9J2&2.;>TR[J6VMMHZ+H$2@Z^M
MP5Q-@)R;E_:0IIS6CDN>1 G0H&']Y33B%OF'"O+?_A]02P,$%     @ ^'!_
M5*S5S4^[?   H;H( !4   !C;G1G+3(P,C$Q,C,Q7V1E9BYX;6SLO5MSY#BR
M)OB^9OL?8FM>SIB-,E-9M\ZVTSL6NF7KM%*AD2*K9O:EC"(1$:QB$%$@*67T
MKU^ C N#Q)4D"*>*#]VEE #0/W>' W XW/_S?WY;1Y,71)(0Q__X[OS=A^\F
M*/9Q$,;+?WR7)6=>XH?A=__S__V__Z___'_.SO[WQ>/=),!^MD9Q.O$)\E(4
M3%[#=#69X\W&BR=?$"%A%$TN2!@LT63RZ=U/[_[VX8>/[[[_Z6_G'R9G9[N1
M+KR$]L3Q)!_RX[OSPU\N=Z/B^.^3[]]_?_[^XX>/'R??__W\X]]_^&GR\.70
M\ NE<A$J6T9A_,??V?\]TT].*-PX^?NW)/S'=ZLTW?S]_?O7U]=WK]^_PV1)
M^W\X?_^_O]P]^2NT]L[".$F]V$??36C[OR?Y+^^P[Z4YKTK=OSV3:#_ ]^\/
MWQ*V8/\ZVS<[8[\Z._]X]OWYNV])\-V.1/9GC8_LFW^KM=]A.O_TZ=/[_*^'
MIG2@4#)T"?:A?9 >.I0;__B^^.-WE-&3R7\2'*%'M)CDG_M[NMV@?WR7A.M-
MQ,;*?[<B:/&/[_PX75+8'\_//Q:@_]O53J?V_YW&P76<ANGV-EY@LLY9_MV$
MC?_U\?9 BD];XB6*T3L?K]^SO[[7&R@'IL7=]VV1/:54FQDEESA.<!0&3+D/
MOTQFB\N5%R]1<AM?_YE1.K50F@_:(^*K,/$CG&0$/:T\@O*9_N!M<\KFWG.$
M$CU):@SC!-5G2B;QHDN\I@:OK%=7*/7"R!2=>C@G*"F_0ZI(#P1M/-("GF0<
M(+@>D8]C/XS"3E$*1G4S#\-E3)=*WZ/VT/=Q1@UBO'R@=L,/4=(,L-Z03M >
MZ?FO+%CF]H*M DD:TGG5%*_NH&[DBW**2K:#TO:(7E"<H1N"UW252(GGI\FO
M=*=VF24I7M,=7ZGYQ7:V04QOX^5NK*9J89.2 ?'V=/;/%KM1IL'OM 4*KI_#
M-/#F^#/!V>8.)\D-)@^(A#CHD^WMB1R01#XCO"3>9D5-5M1ZS;9#PH"X.0V"
MD+5UQDLY 4XX.4M7B-S2P_,:L:7AVP;%"4KRWQYL6O'G9HQJ,#Y8/NQ_:X\3
MM2\ XL7=QO^\?EYU";XZI!.T!55S[QNJK2W7BP7RT_"%_?61[ICFF!U7LQ23
M+?MG,U9T\#W7?+I""T0("G;_:,D%_FB.,*9>O SI.7V:)*CI?E(XBA-,#P13
M\Y)N'R*O\"S]F86;W-O4")QZ."<H'\/E*ITMOB:M)"<<!02F2X^0+5TEIFMV
MJJ,G]VH#*HXO^*5PIUUEA!UN6^S/N_\\""X^>1%;@^X0_="SY_\Q)UZ<T*T:
MM< =:8W6%YSP@E(2,-+RY9BN/BA\R9V2^U^UF3N&8SO!?^DE*TK/TPJ3=([(
M^@IM<!(V1:P<S0G&PGE^FR09"BZ]39AZ$25R]],C2A!Y:;AS,1K9(?9+O%[C
M.'? -Y2L9!R7N$XXW0Z:8"@GZ&["V*/;8"^Z"[UGNAM.0W8)E"+*]O0">6PA
MN<->4^ML/#H8'ESBN/ 7,!MZN"B;+4I-NF.)R<> W,O]$I(T\Z+\#[,-HYUN
M3I?$6W_\</X3,\Y/*$TCU-0]V?Y[0/A$R?NTL]TQ@TP/F&SWSG[-_ML5>W0_
M X0K!:DE83ZB3>3YN=I?)WCS"_T?I?WGKMAC_#VH?+HN"/UDC3&U#P#AQ!<O
M]I:YO"ZP1P)V^*5#XBU"24$X,YV/299\IAM^>AQZI8U0WNP;(G[8V'-HE1(@
MO"T(G>-[]'J),%N"L@W=FH0))ML<8]Z@*_X9?@T(CW[QHFSG*=Q)N;.533RR
MV]W0;9RD)(^)2FZ\D# Z\Q/E8YC\<9P$EP31O0O[7<O]4.//#8%+=R$UM)3P
M;6^,XG]Q"+RZS A!L=\?J[@?=,*INS"AV_ZG[#FAHJ/'HZ:KEF0<)[CN<9S?
MRN(HRN\<BQ-@0W"JP=QXM_!Z':8M F%X [CQV:*(!8<^>(2=.SN\MS<9V)$,
M\WBMW'BV/.7+AW*SIZ'6 /V9L1//2XMX+=$HQIARLCWB[['M?BQ3PD9!R=I[
MAS*"-^P_>?CX>Y2@Q?M=^_>O88#(6>P1@E\1^4[)(QZ%$2&'\=@'SW;_H+P\
M_]O9^?G9QX*;U6^5H>QQF+$S]>*@.$44D2K3;V%RA==>2.?"PLNB-#&0L/Y@
MI^PQU#(&+-D']B^\Y#GG89:<+3UOP]Y4G+]']%OL-VS()*?W[,/Y[L'"?T,H
M6-?5KC90(0W:]OWUMQ3%";O4O8[I:E[$R[(USI+>'48(X_1]$*X/NN%%43,%
M*SU]8,\W?LSYD(_6 57T9\8>')\%N; [)+$^=!?TYD.=K='ZN>F$Y1-[.FX'
ME*XH4<3/GM'9@1$=TLL=O5M]**:]'878C[VCF/X[C,-B9L9_[$9G]+2>X27:
M$6L7H.#PVS!E'SAVGY3Z3PK;-_F2*T1C6Z$&UI6)EV+\].G3AP^3L\EQ9/J/
M_> 3.OJD&'["QM]#/WPAQ[-'%&'_Y(L1>Z.&"5<E<@Z%"Y+D;$J];SC&Z^W[
MPJ1_?_;QA_>++(I^8RV./YWYF/QV;))K3O[[O,5EY"4L_&Z1.T/VMYF4ZCT!
MD?>,HG]\I]'CM_,*ES3[O ?/CR\GUE&/(T4?4YX<>YURY:CW4W+*'VIH]I]8
M$+PVE10V("E+Z/?PIC@I[$?8&;HVEK#@S!'BW[4@3.9XHDTZ)G2S^(_OFFO;
M88^5(/_=$K^\#U"8*]J?/[ ?SXH?"[.,PM_NT-*+BK>+G,G$:5%3%$&;?L@O
MOGEULH,IT5[^,Y?P:H/&RBSG%.9_K3<]Y5+']))'5=\JN*,I" AB,V/WPYQ^
M0Z"1\@X2.<NZ](.U]&&ATM;:<!%Q6[527VVV8@D%O:JTBN*]AG,I;:WFEM9U
MO-[@N'A?75RTRC<YW.:RU5S8 10;"M(4^YER(PGD:K,N=BPJMF,9 2[V)P*"
M3S<G54*!SA$VD?<[J.?2M>B4$):0H'@W*YLUN@-(E,ID"%#,DU*LF' :?24L
MT^S=P?1L(%_<@%('\U@?V>G,UD34:L+7W<SL-[_=4B(.MXI;%FM/Z4^Q_P=G
MBJH[U/1+KTO'<(X?N/?6],?2BP'NOLZ@IP2@5M_&T\>(]]B8KMXFBPX.-CD,
MZ0>Z%I929-S&+R@I;H-OX_(]OG0MU!U 9M@-A@#%O.( D<QQZD4WF)3I56T]
M53UE^U&=OAVL@@TDBXWI=+ &ZN.J[&YU\ "=YI=>BI:8D3I;5&(BI,=#:3?9
M,5'9$11[*J(]I=AL*O/ZZD]F4>\NSIRZLI1-8A%]+HZD"CS2R2O" 73ZWE.V
MY@EO6,Z(/ 9FNDC9J\L-)NGAW:UT*NL/(=%6LT& LU QKT4=C-C3Z0QN)$*L
M2Z"#*6P"Z'0ZRX  G<./[+PLG:*'%A(5.VD##Y]J4I4;J5!V.WEXS,6R;SJ8
M#R4:3]6]2EMW=VSR4#KVFVHDW>[7OY66T&TYX\'%MOP7CL*;#U#3E&9#P. 5
MU\$C;JB%O0/W32NI8!59O4VF)C#87).3#W1)V2>?E#MH2HUD3IA*,Y! 5?<+
M)\TTP';K+^$S&LL_[,(!<D)HQ=%?(Q"H[M.]8?Z$(_;1[#D*EU[Q#%8V$\1=
M)*HB[S0 EBCFC*R3,5LZG4]:XL(F1#F8:S(0IS-/13S0>5C.%SLER)-/06YK
MB9H)V\/F@6+."=J;\*'3F::2"M8DQ<'\$I!^.K4D) .=55^\WS$YYA&63:EZ
M4XD>\1L#AJZ82;S&VO [G4-2,6 =(AS,'A[1IU-'1"S8>9-F1!7T6&XD59;3
M9J" 3I=+@I;LJ#JG@K_PXD U580])"R0]NEDTG E@;5I<#)GRC2?SA8IK;:"
MHRZ\B&T:GU8(I?O*7[+8*%%[<>20K(=]+/*(*'$/,SQ=1D!I<!AKD]-_X).8
M_).X)SG90!>((DE"QM(:QP%[UEC\&P6[G/PJ'X)F?VD$O?8(0#EW)%3U8%#8
M18L_O$Z=!-^;BA#KT^<D-E\33^4EH12'K<6JJ -PR#>JLUY)NHA-O*)3+Z#D
M"Y>TDS&P+I<O/89C$Z+Z7\2D($[6,27Q0)>RG:O^6%V3$GU+,6A=!_%[J:],
MQ/U \:8:JRDBWC!,5SZ,0<RN>J#N+J24HI9&[:HI=7>#)4(FC]M5(P(ZX>F9
MDJW6Q?N"!2*SQ6>,@V1&(9&7T%?$\FKUEKU8T^T_+)XI+(!F_S9\Z_;IFJ&4
M<4-27;Q=TX-V.OD-( &=]8>,'[NB.UHY:XYM92<M?FO(Z'4SU)1;ZW/ 3E8:
MKBSX^6BJ9+C,1%,F6Y"#IDJNA;#$A*2E,#OZKVJ('?V5,+3VY&\U-:C]U0'1
M7'VN_%5,> ?Z*F(1YGZF-WVLD,7TCT,.=(O-RPFM9[]%/75LF:SO</BD:^G%
M?9ORRLXJH"%1_IH@)]'E"B&&)%@OY%" SN8'+TFOLMP_E"GB"ZLM9?%SO+9P
M<:N"".MM=;%W&S(HD0#6(,%%@&"=Y$I<()]4H+/E,->%=6/U%D!I=QW+KAP
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M>5K:*[0AR ^+E\QKEB0]*7Z.@]OUQ@M)'GT4!Y\)3I+**%)C8NF#,K-C\9.
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M]2:]\OS[+GA>IAX OV]C>@!GS\'9=_.',I<L60797N) K/J*7KU*Y8<NI*(
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M893*[$CTNJ"'(/]I?OV01_/>8%(/PZ=+3H!V+'KPMM)@ST9CP:C&V9%F-.+
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M+XI0<+'=M4MV#863J/6P_4K58DQ1)]QPIPHGA30/?VPF?^58_0K=CN^H)0O
MY.1Z1#Z.V3N+1AFZ/FIEZ#J;G'YE3-EE/677H6[%PDN><_0)27/@[U&4)NQ?
M9P7&\[.=@:"_^NV1;MQWB><X#U>X+=Y$9BXNLNZ*AS06 K>2B*"-XY<F$O7A
M<+B3FB(M>/Q$S:1';3 U4R\ASI)H6R1?0 'W#8I>%Y=O4J2*LQ> &H([G7\)
MF9*QM8FNC,6QA*X:NQL8OTB1>7 S"(74<!R7;Q.T)-<0%U!GR_C,Z(T_,[(8
MQH63E!ZFO$@6,%UN\P:>'0F0#<&M^IG@)"G"^(7B.FGS!MX8"9 -0EQ%6NII
M'$R#-65_DK(CW NZ_K:AFT#Q>4;9[TT].%*B'8*H=W675)*M-GM3[XNJX!QY
M99["99QOXNBQZ8#A ;-GI2@Q<\G\6$^:7AI]XAV&GVQVX]MWQ@A\D4>H=")]
M01XCEVU Z 8W]L,-7>*.,'C>E*:#0)F A^*RMW%*-3BDQ!4E=V;I"I$YU>K/
M& >O8:19PEIS&/?^FG;2%Y1'UD0/U!@KJ5>G']'K#R8=23/MKR4IT4-MI7X-
M7J2O[!:/KC,L@6<<Y _/UA[Y0U;"4:,7F-0F)BIY+$FC@=#Z/=<E)G2T.4K2
M!TQ$E>.E+6$<&YL*081J"!O379GU,$'!%7I!$=ZP=2'?HP5A2I<#A2W4[@_C
MJ-E Q VP0I7U?A6@AV2Z?TBW#Q';!,<!>XVV$5Q#F7=W7V#!RIY'@1JHS(54
M*^:ULA^\O8V65M>"Z^0H@4KU(@LC5CE0E2BOU@[&;D=3*2L!L%4L-K8RLP4]
MN\M*6U0:P-BX&/"3!P*HDN=K<U/[I=<9QJ:DT730 PA4M-"KT7UO;S\Q%J,;
MB]&-Q>C$Q ,5RAQO]"12;PACCZ 61YUR&SLL$S-:NU!J>AEQYS(@I3WLP\:M
MP1KTEL)1;C!!X3*^_N;GMY!%5NUG=B'LBP,>Y)V<I^=OK1BZ2(?@C9R^(.(M
M$0>(4+RR+C 60AVMK23=DV :@A@OJ;I2A381HZP+C 747(PR3$,0H_JR4&5[
M#49P>13OVA ;P!Z"'GQ-$/WO7;A .[8$TZ2(B9XMYO2(IH0KU(\.1H9AXXVG
MRJG"=,"'(2B2V$.O,B0:/5T&/79M0#3@#D'>*K46PFQL,"0CPC 4VE/ S$!(
M</?RS/F.98,6G<6$K5R&MW9X*N=!L\YUE4;D;Y]G"]JL6#)X,C$?PWG%0+&R
M'<1ACJJ_Q*VW,24ZR].IRR:+O+W+T@,=3ALYR/YDDFO!;7R%%EX6'3)(7'G;
MY,%+TJN,U1E*0LH,Q,T*V&P<YQ-)1R7KHC+"Z"C _ZB=_Y4%R_4N+O+P2L$L
MQ/^G>HC_<?S)[_L/3+PXF*#])\:4"]93+MB*AB1DR\Q:GJ"8TINMLXC5J[I"
M&X+\(J$&_2-)PZ3X.0YNUQLO)/D6+@[R-VB54:0Q==8^Z/[E04N=JL9>VF(4
MT+/3*:G**%Q>8S"W\K:GE4Q5@-\K<Y I9"WI >.(*T/#>;$[*'']=9Z1M7Y<
M/[XC&]^1-;H<@6X"WN2+F2Y?IC7 "E368^J<,76.K<6A^;( )2*B(R7IY'+3
M3JJ(0M-NXP4FZ_W!9%<]@>7COJ2:R?QER:]ANKK,DA2O$4E*S2^VAS*JN[$,
MW4\_<S),% --PN-G<N\3*>B:,"E-_#UEDU=*VL3?TT;[E\B;/&\G>$_@9#>O
MWHSWJL9Z?9>5J"L4X[(CBSE;<10&N3#S&28]=2AZ0?48R>58S3$CA0ATFW%-
M[66Z3>:8[I5N,!&"4.PL38<!<ZS04N=*,51#K$ E7]-MU;,V47L8AX5FBEQY
MV":""%2$7^@6AX1>=,BZ'2]U)JNJ&XPM7A<"52&UEGH?DPVFJL0_D(N;P9A*
M>FIUFAR_BF0(,6+[6:ZS<W&W4=$Z S78J,#>EV@N2GVM14WW%9)M1*=KC, 6
M/:P\>M[R49:&OA?MOBBV2=+F,&P37R\.MDB*P'I<SU7H+6.<T&\G2EZ+V\)8
M?A6,%I/?0\ZOES X_R1+]772 $:F!04_*S0#M<I?O-\Q.7B;I.LFKZG[= KM
M5T\>KD%(2WDHX#4&LYZ*-4\FGO[6U@>/I#$BNFMKI3F,M56F+X(5MH(#Z$28
MAVLZN6>+.?'B9,'"1IE_/YG10R5Y8>F(I)9,L[<#XZ:5_]S$N&E"':J85?DS
M=/N#L8I&BFTH:N!SND+M'@9!P>P%$?;80A7,ICT #.MLJ-V5<#=ML(,3]S1]
MP"&[*6TE<^XH,$YBE@3/10Q4^M+U[,XH D;6'4K8BQJB.-9%M-SW'^ B\8_O
M7^\45>D8@7MJ1:YR60\8T]1<@%K@AN!(5\:E"&>F1D\8[ILVTU,#I'6G65$R
M$ 77'HE9)ML+M,"$)7= !"7IW/O&7J>57D3$0?$HXM_Y/WFSLNV(\"I%&<S:
MMN![D'>0LS298_&[_SC0>:K=>"AX):2,)-P0]1 ,]D-&_)67H'HT_>6NT"A[
MN7X;O[!WI?%RZJ?A2U[27FC(6XSH\DUY-P:^!7CKAB /:>5$DTI2 "B[]"JQ
MGSN>V$IT0YC W,6E>,"H*O2GT]5YB@!-K:T<@S20#4&XCRA!E&4KBJ'Z=$4B
M5T4OY]E&&XE4 6I0P?F'<*J\QVRQ&^6PE7P.T\";X\\$9YL[G"0W^_+?IG'[
M'[N.VS^E?((7^X#]R9[XR?7%[?QJ.DGQ)*=_P@!,Z-<F5.J3 L88W#\&]X_!
M_6-P_QC</P;WC\']&M$[8W#_&-P/,K@?Z(SY2JG)/XF"(J.+:JZ(.\"X=.AB
MEH@Q6DD-6OO:T\HCZ()NY8,';RM>BHQ[PYA-*I4[9@8U@&8_@6N-&,EEA8FX
M-(:!L?ZTD)L&QB$XF<:0BK<34M'N-G*:IB1\SO*X@SFNQ2!T?_>K_" ,&^'D
M:EC)FR'8EFFPIF)C?MTT?$$JQ[6@-8PM6!L;(@ &/-9CNJ#M#EO^'=5)_T:B
M&1E_X:B2AAP;@D'9@6%W*_FV^;FT;<Y#6CT_C]5@]RW7ZTV$MT@2J]!PM*&&
ML[0&/@0->4L7XE9B5-[*Y?@#P8LPS>]'*7<.7- )45+W'&I@BQ'((4BYJ/I
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M8WIHIB>Q4\H5]DZK+QSKIZ6KE1*;.@AMF,6G;,-2N228;"^P1P*Q+12UA&$
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M9^+@)@^-"=4/CZ1]8(30-1"A)CZ[]HA^<J]%6K:)UQY&#%A[.\7#!G06R79
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M8VWIZHI-C@*;A?D1S2*</]8CG/<C_X_)AHT]\>)@@O:COY5H9R'[],.>54-
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M*^.8E1&(*H[92OI4/A )32"\J1C3+HYI%\?LLV\Q?:-EUO42$-(80_Y_.Q_
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M+F+(5G::QX^(#ZJ<1E".J@+U.6XWZZ3WXG>Y?9C)CZFE!LY/I$(E.-''$L5
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MTFO#;W&YM\/W[U[$#XIXK5QNXT6B/O@<> 0#W<H<LHWE^:4OO4V8<E_X:_6
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MRM)TN'[UQY6#KSV?AJ!2AY(6^H\/5#6SV@S9KVJY]QBVX=40U$L;EE";#$:
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M=H'QOJN)2)30;(E@IPOF@M#H".-95E-Q:  $ND[M"BOELYI=(@2[VYHI(:S
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MO]8._WBCT C&,4=F7UOG2H$CH%.( M?L7.AV+XPETTFM,0S76467NIPY 37
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M(L"6JU0T</"6V^$1LIYD$:==(C![:L_&&,*'_K!XEJ\F"1VI1 =]0AA;,,N
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MZ#J$*6#4J #V]_-:C&E=-_K'?U!+ P04    " #X<']4.."1$[;8   =UPT
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M&T[C"YW3;$R0GRJ8_B[D-(JCQY=4V&^XU5COW+=ZN.'SN49N;VR"FY#/-ZO
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M/!3XJ:@M'NFT:NI\F'A.:M$8II=H[./"=.A%1&/C:*J@NBSLD:G3#\ZW8;+
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M&XED0XV_,:%)O)]4$670._OR\89)HKK9)ENXR(WGKI%2.PVDZ-E+)>IXJ87
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MY3'9S;;\:DMQ\)^JOORR0-=(;:"!T$/D6,I5QWI#C((:6D<3=AC8/7^/N?+
M4#E?99OQ57YK!%]$B4+)563NI6*\\/O9B?Z@V19#)SQ5]5P40&K%5R->8[?%
M0)B>^Z%"01A#;AOAPY=Q-% &C( +SX-?RG8!<4]11 /W)=\_PPL'ZS1PC-?!
M_>F11Z/,B2QB+2,RBP(*<\7H\D3::"P&0CJ(,E2F1CH@O.X5EX;$L$\_@3;*
MV')P?H=D%(T2\  *W# *8R;#N$]1>#IV/N=KH; H&#%2A^:<3]=],>!A)L5
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M>WY7N2[ZW\II>W-Q3@VEN_IE3>$*%M:!&U'.\@<J_UT'\@FU- TGWIP2L0_
MHQ[EA-2-!E( [J62:F31@0#J0,-&#OLK>G(,\LI+1WL-E9#2QPFSY$0>CQ1C
MSG5S?TJU?,GE=\N90(3%\8EZY!7+_O)ZR&UBN VT%B.4'\#*LJG%&XK\3T+:
M+_19M&R,T&P)(86(_LHIMIYMJ&"/T_H)9>LB&7GY1BDLS;-'ZZ!*X;.\%Y@Y
M3/IP'5P<E&OXJ7>Q9U&1O-XGAR5R7"('OL@O%1$Q-OQ9/J)]0?CXLL_$->AF
M5-1M[5:H-"E 62_T?2>*"_,Z ]Q!E**I]+E0M<P;WMY&H4NI%T,Y9:&,S;::
MIZN<Y4UZ(IVG+,2O!K"MW5"'K>;<6_M#.H(LB"VF%IAMPG041;KVV  QI0:^
MT*0,!W*XBW2?W*/>R17[Y"=X7>(Y8N(7C\5N>.++[ L1S'*UB;<0X<Y]4KIQ
M[H8QYO<<KO;PPF&\#E:ND ;.'])W*1IK5=E308\N5FK1%/]L(X$:=>PD&:@(
MJ!P/%LQ./F+^7 H\@&!=AVD\I[H#GK4Y"^46Z)WA3)RJH><?HS;B<RYM#510
M0ID)(#AK.PZM-5J&]6F/.\LM\-O@4,>9DACY^AGC0?W[,$G"PV8KF&PQR.:V
MZ.U2(V+5/!L:HK92';_69^\L8(?38:3;4V_R7SX='O>KP%LG<;F:O]GM*F,J
M2$VSIUH:;V>9D<"^>]M#HE%O=UV4?N?<_)M8,+(DKCP0,>,=L(ET)6K5#P@-
MUU#%GB\3UL%#^($^)L5C8[N(BN-P-2!TZ(L9!KJJ('=^TX[87;ZS' ,[.DW'
MAR<50N)Q#LJORV4\3.S;DRGEVDAZ7"&K2 ^L["66BD4:Y9BV=T8*&79*:,@Y
M;>F).NSM)$"_'-3J;GIYBQC9[O#[,(K"9^ZT\?L7**&JW=-2-$9O\SHAZRNY
M\Y:H;5K+L*T-%T2AXG@ E74Q;H;596_=A5 T7YS]ZO<BFMHNRH:'BMO$[60_
M=.PP5['TN.'T/CKPVG#RHEYD-+9":F<M8N4+A_,FV)<(&H[[5#M)UP(1/7*N
M19(XI&2I8F 24_<448^$ ?EW)SA!5/#SNPO"3>LG\@IZ_@!\DHS1'UY/O&88
M04M"H&U*<R3G@]C-W=--T(S[)NV7XI J41M=L]YX24ZJY'UX=]VR*$Y$8,X'
MS-YC^"Y\>' E5KRY4%E E4=3$^183BAQQ53&1;.'Y[ 3FI7;+PS-SD35H5G>
M>(%H=L[[\&C&\2E,4]&^4S@;3HO-<)8\A\C@;"R)J[:":TG_P >-BS?;[R #
M3+LEI>F % _-A:TN[%6M42_M6YFVAD(@+%_.E:1))+,%$>Y3E:47?+=L5*G;
MHS?I%E'K5TT;&Z,VZ#:>[:^0ELQ8//(X2A&]CWX81L"[YI6DLR9(K4XG4/$6
M4O5S[.&CBMVA7SR"882I3?W$T<#R?<P%P07YI@GU-XH:,?TH(778 =1C=P'C
M!DFQ&/W48B_-1!<Q?*B$PF:HA#*GC@KBY/>3MY-%82"++U?,D'EM*4T/()*'
MS8>CSUR6B)NQ5^!8\MI9$[*:=T6*#C8**)+:S/IAG_Z[BF&=O96-(\--6$:E
M0Z77H]UBL*DSV"97P5VJ@FRHM)A :; 9]H,P6L* 0'=+N;:X(^RX;#D+?W$B
M!G?]2EE90MXF_70E@!GTK)210U^GWM@!T$X8ZZOP^6A@^#1WA:=TP,K5;N$.
M$X,A#G5D U;>5A=#S@",.%2BMA!<Z]#[?1@E7*&'(L=*&5LWMT4*G$8B5E>+
M#0U1KP=U_%H_9G.*(C@ ?,Q)SK62&T,Z09, 47GT&3[Z;&==MU*UA9J5WKP*
MGRC_,6E<CC6V0NI++6(5>ZEG3;"'$QJ.^YS!.P?8$H 989N7C'6S$8C#_TO$
M^3L-O.PHOEY^?>I]U^$5453+S6G.$ Z,*IBK$FSNYR# WAU_)<Q0B;!GS9#"
M3YM@]0<?RFU03^ *5NT?=Y#D4OB9:^(>7*H#4PO58YXNXHK5D\-\B-;O3X^_
M4S=Y"%?NGM$GD0NUV=Y&(93\NH/G,DZ-FPWVI)"ZW! *RL,"2SK88X>^8ED?
M..3!11ZD$R?C .H&  LD"8E3, &MCY(-'FD(/B8.,.;25NFJ6C[P!;DOM+2J
M:BD=GJ3CSQ"Q(-"4TZ@IO3V-@LRI;"6Q'WC/&-ZQTZM.WW$9J&L@? /&:GHM
M!U%-A.B/GZGE\O572EODOA1;'[-!Y)CB%Z-<9"!7P<!\I%FA;VH-E+$M46E@
M$$C+UJ%I/:P[^O<3BZAG%%VV]ET&L)FIH ';]!V7 V^&<O1'N(,<H$"ZD#Q2
M<G 89Y,%U(.]**AN#CM0!>[E^QJS >#("BJ%.ME(%R0=BV2#H0@!IU.$>Z:(
M*%-$CPAOBN(.Y91KY:Z$LCE2R#055%7<H=P6]298"\M#3/*5*R!S;8N-).=Z
M=-F,BO*/)%VV^5?Y!LDK.$&!>0N.WI&]R5%:O8MW=D7H&I:5\MZ)C4HHM?5?
M$' 9J4*%9-K."X$V,QF&P#HG'PF"O:K?/,)H\^/?N,I8J14PX'INS>52/%<D
M'R'1/AW7J3=2/[=40[ZJ,^^*?5UG(8GU?)B_F(CN\;<)M0!#$=VS;W+ F1]Y
MF\4LNCZD.7:$.+4F[BN"ISXA_6%H](>1E.GG9RW0H_B9.%6DSC]>!!J?<VN=
MX"LN.7#/<DC,;0E.6+/W-YWR [Z.3^7Y*]AY+#]VY?O8<P#Q< J08"MDGBNE
M>V")I##6R=@:3+CRG3C>;/_J1)$3))OHCNWV2?Y^,M3480FC\97C^]1[_Y*V
MB].&RE"Q/UGLZ#.0XBJ0U9/F$G!N*!'[QQUQ/I@L^/Z\9^Y>!*,N\ A-GN7H
M!.[CP_#DX+S :02W#QY )-1[0SY"V?QOSN$(F0>/IX0$84)\=F!PI2()+\@_
M_?CCQ8\__IC1BL]HR-'?02/14(8],R#PW%^-@.VK3/=_+70OZ//0./_J"F:(
MY 9J.F?\Y#WFBJ#GUN.5RGS+*BQ9OYNK\+FDPJA1A6/,-M??:.2R6$Z5^8=V
M4TP[K47.*X8J:I],6@@M=@8QE<OZ3G%*__Q1^TC\<@I84G*YD@>1\)2(,C4\
M%,<"ZF-KJPW)<VWF2Q7<X#VVOC2(73.\1A.S/4Z*L_.DK1,_"K[B*!%'26^I
MG\3PVZ4\-7IWF2(Y_]/?[BBWYT0D'C74,6QN@11U->( EC9\C/#T1L>EK47>
MT2<&!1)D?C'CIB8WO\C759]BA/TM[D,(J4!Z#>1MEF%U59$:[$XVP&]Y-3Z'
MMSTYP-36=^_2P.$,W$:<L? 4^R]WXN8C]1HK#AIV06R;I@)GIMK6'JGE&K-M
MOQ&;$289Y<F!4[H2W+S@CB3]Z(Z*#0ZV9:X(M(OC9Z4]V])!;.2]5%. M 41
MI.[03Q;KT%=4O!MPFZ$H;K<*N",[4%@/^.5"!2X[^C0N"NX]P/E'TTK A@A2
M6^^GE'Q'H3,%[%L)]@)9'^*X>^J=?%F1+-B&T<&1-79H!*GM(A4B+->IA)*,
MAX(S6 *FK$V\D3"]KDHE*OF0I#0F*0:](*5JGU_%P,C*I(N%?5HMGBN"<0Y7
M_ ])O$GV-'K@V/<I#+UGYOO:%P$ZDT&*17T54\VW[$8#X:S;6Y1>^TWY6P/I
M@,01(Y(0AB0)'Y/LTD&Q/D&@5U7[DP2&_=%[4T=5G#U98-(9M?]TE:''U043
M;QG^D8/[<)L\0SJ)DT"U9CXG/D2.1P].]$?STQOFO9!:=T>Q\T"UO0OVR+2#
M! ._H1"G(U^0HQQ;A*!)/OK$8><$BKAOD7A %[X*HS!P'FB<W(8\X&^>GO0M
M,;NJ7KS</9N;87?)%JX'=D/(09(C$AB2R#$G=KZ11#Z7"U=4>>4<&6>*Q=3[
M0)^H'Q[!,*Z_'6G@L80O-%NB2O/^2)W96A6UQ9E99]1195<9K'TB'><?D/]?
M#$3<,,96IS%?J-Y&(>Q;O=QRF1,^,U___<2.BI0 B^[XG:.3(A0;%]J^N%VC
MFP@#;%0<TX%XI 9#R?=JLL%0;E H5=,RA;3W0^\=AJ)7W:*E$VI_,.7=_BA9
MTB=B +$G?ET8O^*-WYG+"IR8#TF/;4^#GK=#;]X*T6KE *J-4)NOBE?KZ_T9
MO0'7SYOMEKF*AV8;&R U([4P^2*Y\BGVM7$SLWUJT9^OB$,YQL1+X&$E2ZGA
M FFQ46X;J!AV1NJ'=DJH8KQ)3]3 WTD :\L79R3: !Z75SR$Q\WV#A*36CR@
MH2%Z:U<)5[7L>BO45JQDUM9B/_/EY.%TF"DM[4;Q@G(O0DCMLK]RK%+4;I \
MGSQHFMJY4+;V?Y,_BPRO_'#!Y':D^!;ANK3KGSQQ<YDX)(&\JS>$!VXQ+=K
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MJ\C9"UQ0D06V7SD?%V;7".?"L/G5>!US-8D-[E.FT"=LNY#J3,ZV.,BD)WJ
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MM8UW8-_6V$N7T/DR*,P&(7$Z"OF:('RS)=4!+ 5#GWDBNA*7TK7+E;9>Z-W
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ML0?<9LSWJ1)1O*WC5LPV"<DCE;X*MY%)P@><^I6P486O>NE#2-Y3 @,0&('
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M?MHXE'A#7(!.8:7EZB9L!*2IXVU7R"_2$TT(1BINRP3S$Y\K8E(U9X!D2 ?
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MT4&;Z."R2:^KO*[\7UFR7P=/-*T,L [N3X\Q\Y@#*_CWD1.X>Q$9YSW@EW7
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MR3ECX:?D)+[7Q?A(P=69*NM;5DN#H][IVI;1/+I/GN;$&2-P=)T *^]$M)^
M=!FM\ ;LP#5(S@]A.4-D0Q/R#'%Y^V3L.%Q\*H7PHN(\D+P[52=R5)3:6JYO
MH[=7&NRS0T3KX#B4S/PPTHIB.Z!R$(UY(:8=46T"9X:6T9H$T=L[P51^?3Q/
M!)U6Q54@Y3BJUJ[%O?-3E-(@"XB6")Y)R042Q;'7?KJ,;Z.D<?O<JS=2 #-4
M0[&)UN^*?1]M((GQ5AI(52)0Y%:Z<"+B@FY6C9E3AI?U :<]\EYZ=*7DCR0R
M5934R$U()#VRC E0=(.;0F TZI!SI)@2?S9-"5P.)KS?7^[3-4=M2!@@4%RY
M!"D:(\5*/2'K+EM32]2.5RO#@Y(Z1')4F3.D<6MD13RM;!=.I)0FNZK(FK0(
M.[&9[F-(?/! W^X@NX=/ \AUF7W*@<S;KV"A?-SO=D%;*$7_<? ;MYEJCNR^
MWR"X(<%0%F.TD".3F+Z1;4Y11-VNLF]V!5&29%0GQ)*1U?-05<L9/+M,]ELH
MFB=UI%+(Y#G6_&3#O ]1Y+5F2JNU0H\5C6*=9"TKFZ"V\V9.AUKQ.AN5O,"P
MDR:XLBC==4TJ66*$Q:L-_X=O]LK4X5H?)>ER?1.^\I\CBOWJIF619!N9RWWL
MAR_W(OQ+C73]!T)OP:;*.5KN>XZ"&@>,A3&&"DX0SD'\DF3U$(0FQ;F@)\@2
M&:8XX9(_MH8ZUGS G1=93*RJ0Z[2]2E.O47Q[]DIP@J2[H.F8Z^F9V3.0S5+
M]25+J1_ <4L]0_5Y%,?1&]=XCV+9^F.AA[$!*E*GC=<<"#68#9''3FIX+Z/:
MD!;^N2 \I.ZU.\,3Y9[D-5!'/:6FENB-1BE>W21.FJ&>\&IN3:>S+/IE_?)-
ML_+Z_&JKZU1/GV%]=!<EO6_2XP1A60GOO#RJS*,R=B9_!Y+6Y;)=A5(.NQ!/
MDJ*82O^OHR)E>Q_,!J8K<KU294L'[*:GS;_EG$6R@J4LP"SV#D&%]!3U+%WJ
M8-DF+"Z_K)]3>]NKSE:_\9#"A#55#=D<W<ZNDI:)3*-ND@)<);/&U%<YYG3G
M7E/)_A133V*R7)%BMF+^:WG^%0W<H;A#ZH\<H[+[P9+GQ7,B,J4J]=S5"SWJ
M:HE=Q];6+J@15(]S6W,_C,)W^3UXU0Z^T(RB&V34P@>WFOA82NZLZ$LI09,/
MVM(6J4EJB:@H"5,VQ+X_ZN3;4J:XHU(QRB(Q9T1D!O/7OKQ6J=CLI/5C+&HF
M2ZN<CWQ&RK$GKRIC4<SJV><["\5F')_5-P)P^U&QJ@M20.LC<,,Q?F-[U-Z%
M!MO#)K?"H9AJ?^5<WLR8Q1]6'Q.!H[8(/3%PU?_)/I)W,NT.AL$82.UTD$K*
MYT4]!\#NJ!C+8\>!27OLHUM\F)'?((VN,Z$E/CR1@%&A6?DT2X+KVNUI?X\T
MC6J.ITU1^25[_GH\E=KFSK1.4TV!%YTG%B>+E7Y_I#!MK(JZ;Z79&;6CU5>&
MX0<Z)_ RW<G-6,)?8$2!2C*D:VX5CQL:,V#7RS(;<>6$"16O.)*?__+^O5*+
M!@.AQP53Y1PEINTY"FJD,!;&.+%MI<2Z2*V6 ,EW@F:>9@V<NX+J5)NWT37#
MQY5^B+=GD)1C$P4>9Q.<W5>60*'!:&<[XV(5(Z6'=?5U%>PA.6\%,B_WK%!!
MQI4RK,%P,*3884=)]> =DY&P;P:'"V9G5Y@?_N3[/I9S47/TP<!*[,DX.2/I
MAJ;BZ)N/X*<'XD4,_/V4)&Q'8YJR@'\FKXU%VDAHFM M@S"CE G@BN ,*F53
MQ!--HGWI]N7OX[)]9$&\MMWDY G0)U4&)CA?GUI9]C/_:.V<+X:>U%U\0\=T
M%X/.Z"Z^I0.Z8V&F/YV;YG9Q9&WU.9=3;#31',K954KO$SG[<12]Q.8?VK@(
M48SVS6!MHYK,@+<VU#>%PLV2#8+DEY=8Y-8^ >>^=H89CRWKK0<XGY7.+_]F
M!C<H;C0FTD55;]^K*6[Z. -V2[7F9/(C&Q:?O!SH:(H9?SL$K)98;6J''3F[
MV!X"BS+K@@!#GV_@Z9KO&2'?0 0/9MXV+&P"R1B2-HR]MW>EA2JH90,3,?(D
M(6_N92R.EIMD'( R%U&8^!Z+90'#@N!U%#_2@"W7M[M5D\AZW3"C3P_!"R32
MZ(,=E?J(8#YO:^^(*\>;5>(5<!(O'.5Q9"#>(-W>7XR,4V/HI4:CXI813H4
MK#^6XH]]_SR1$MKG *Z[Z<SU_"P2LGL>\Y[H5YW8WNY^2'&RM^B-B3=5G5#?
M*^OR/C0E7Y9-'R@0/DG;HGY13/[[F.VH[^4YM[OT=]I\+E-=(6CC##]J.X>)
MK6)YZ'S>R7'=EN7NDPO6MJ#W'0(.<<5/8KW@"N_J*XM7?L)77W&9=UX)X4@^
MQ#1,3VK_#!X,J8W:45+IS)N.A-[%'RR8W6"&ZB&$"%M@&2O02(0PD%KX5$)>
M)#]C;P$FTUN.G@_'FKJJ:$J0)X)^4=^29!Q,<.@QG;9.M*0[GYQC]47TZGOO
M?SVGX>_+^")FGI]>T-BKAMKIJU)OL/EA=0\E=6"UQDCSQ.H^@CG&ZHOEYYM+
M\OY7;E+A[Q ?MA+LD!7GIQ;GB@*LQU"<$JP+59UGJI(,$." 5%E @]9CJ$NM
MIJX991&NQ=*3J ]KE(TPPZM2J (V3UI@AT,UPT-@CL^L^ #QG"7>"8\@J<#=
MR/!E7U YHO,G3.TP8U^L$_B0OYQ%;'AD?/%C'H#@;41#=:I.54/,&-$J7($3
MC:VP8T4[TY;3;U*22')RU0HXP9$1PXVXC\=2V7R<\\IB+Z;K])JNX"72H24+
MKK(I9N/J$+!\-M/<#KN!=;%MV\1"$N44R3HC.?9+%$<B+T\$<VEGRY#U,+5J
MZUE9VXF8:H,KFL[.YDXYMVQV<.6^]F,H^X/.^NP)?_753T2U^'$M\>DMZF&)
MU=:SLL03,=666#2=G26><N[ $KF7&4%(,3I3M"?]HQ1Q9$/DS?LLBO7V\S+&
M4U%;S+%L/#^#;.#=@4FF&S]&:9%VQ8\=F^3-.A9IR)=K>=!<>-CTJ[_=;XM<
MY1=TQ[])#TTZ,!@#L^F:JJ0PY[X#8#=Q8WE,YWTV<%G8@*RRH<D^])@$@.Q^
M(K<)\N:G&ZB&4(]FCM9\!WNH7*0E:>S+BPP2A=5 :)&G817M X\\LXPT9$>)
M*XV*9Z'! 2K8"T@"]DJN)H*AT7\B($B (EFN\QNUG"C)?[^"+,GI3G#XC6CV
MXHH=K=:JN("W\BS)XD.X*OR4!OIU0EN[(\5Z4T6H"]ZH^Z*./>TI@JE9U,O9
MK"2A,C9H)6GA+//9J:+;7A6D.H>8O\F<**2GV=S.KC24IABNS2=P7 "J=QDD
MQWJY^F./;F7]N(?M7R9Q<I,D>^8M0N^:?W>XI_YQ9'BOCNBA05?XH^)&';U0
MPX V\Z:37!(HK#TAOJ A\AP !P<"KQ^<V+M\TWXE"DKB5\$9N1([,H>J>$QI
MG,Y$&>?LQ0_#!GU,BX\W(=^\<T$NF?S_39AK;!GS7X_&AZKFE&KN/0QZ[#13
M3!U)^XV!&E<-13$^T\C(D>^]C. /D) S+(PMRJC6K6ZJ5,)C:T="C!3=X@ET
M^39E*1,12ZZ;CG+439%:MHZ Q;&QHAWVT^$NMH>$"(?'ZUSM35$:K7[/LU>/
M?-[J2NCB9=ER3;*1Y0NS*<*&G0L)D&J>?'RL_=MBGVZBF/.KNV^K=4"*3/K"
MMNW3RM:H_8A.IJWYX;08>\(:LZZDS8;ZDT%:Q^TV"@<X ^Z,]Y[&(C_(/8N%
M!I1Z:FB(WEA5PM6-]+@5:N-4,FN<"X+&60*7'82-P)A3N>ACR$:^YWL4MH^C
MI/SL!XO^>0XG%\+DCXXTENLU@^</A_O8C^*N4A[F0R$U3!L**OQ_PW&P[P^&
MBC5D_Y#*#++%*EU;MJJ'9I'D ZI4LSPFN5K& \X!^#SXYSX4L2,BV$3&>T1!
M$+V]XQ_M]L^!OY(C\>XC;TBFTG+F 4$0B-2M)$VRTP*1V#C3[?F!"/I3E^J8
M;$(>3<;369AP2C#3E)/*,:P/1_-O"L0'8O>W!=F.D?K$++Y)1)X B.> ON[5
MHC^O+$)LN5\^WZ>?0@GTU2B()OWH=,(,I-I"%]C9V0,[7.H+8"<K$"W/89[W
M*=EG%.N10".CG7L=5$Z?. F2T\@2L&54)@"T4257_]ZX#N&$_/<QV_K[K?)T
MY*@14E1K%ZI^\%9M@?K0K9%1XZ>#8A[NY&A3';6YDXA[FE#)D8FM61YG"9GT
MX]>3@T4\8<K7?DC#E0^AED7%8?V _K;>Z.VTEQK4<<G*KJ@MNY\$=J*1USD=
M$E3J<*.,Y"^BD9MTL^ ; J5B=7JB-PUM\8\RJG=U0VT2^MP;)Y\LP_$5MD Y
M&62FT*2-QK?XFEW03_YN@>NS7MT>]7378-MTGE\W3>ZLTB[Y(A_J&\WR]B2
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M6XXC.@KJ'&%.TU=/'<J)W=Y]+E->4PJKQB#'-C('A6-V%Y^S./12*._ZHO;
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M;ICF8.0*T5KWLZA-5\7K\$?1S8\BK8CTRN+GJ,L8;4LVPS>@>9$6"1FW49)
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M$#8TGH41=O$^QD)8+A ><$)R5J9:!%WH0R7CO"__;WL%:?8=$2E*6%37L$"
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M$:*G",8I]"492%D!=#"BPTB:R,8?# TM46PBKO4<CG4S(%K$7 +IM2Q6*Q9
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M:'*?BZ>L0C!"3,C8LN+:PW<>;=_VROG3.012<!NBD)[7';>SR^>C*8;;:X\
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M]&H[-=25$Y3IJ9\/!<E'(%)>G%PH.'*77I!MP+RA*KI4]&L[8734$Y0.ZMC
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M8%F46&A7JMG*2X#J',D$ 6\E+"(L!5JU\T@F*$@$+[B3OZ.JGUUPZAS_:RD
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M"&81^GM-*E>2Q3SW*,1^,S#@U'"M2KH92C0Q>M:A_.J"(PZLAK 0E(5!C)Y
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M(20M8?5Z!4#3H=2#WOU887OPTRI+K8Z0.2J6$-R0L)<7=[!4ZW*ATG@\VVU
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M//4SP-"6  /P6@2M]TKF3='JT^>U:A'T^X/+?N/G9,TCRAS-)&W1:C;4KD4
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M;GSWUV"0E86B#%ZE*G:/?]SDBY_O/[_Q7>A^J_*KG@^&_89&2"D;[GA'277
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M0FX>U/.W3R(5(K.'?7E-G];SR>/:O$0K+NU9YJU<O,D+@.(UJMY8_@ BMS=
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M@/J6(PW&<C4[\!U**VDW?]9\KF8'L%%2U,*EOT:0+2LP#@3^D],4#*[JH.P
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MNKSQ['D0QHGGQ)NZL)VVL-(")H-3P<J1@)1QX!T 7/LVGH?&C.&$Z\:X+B=
MMK5UK6K&FXBCT)(T:CIA@;P Y:'&JK0^6NO#\<K51=GBE*A]<QB4SABSU2B[
M2Q?,VC52Q;O])@" 'P6JQM4Y@Z$F[R7W2D:#]Q?S9,?)S1J]8#K6_%%^+R5
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M[GC5N?KV<L/B!O\)#!?2X%)X8=D#@H?[QV<6#_A/O>*!98]&O\8-^JY;9GO
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M(K[.)SN_<&('5=( Y$H-VLK^KY"=!Z+C[N\'W_D6>'BJ?1G9WV^77H2GW;P
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M8MCE#[S$(;O%O"ZTE*A<T9$U&4WZVVW66ZXI0HG2F1N#UVVEV7UG)0D83B6
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MB)_C290'O)-2$PQ[]M,4F6X=ZPBBQ]O=$2^B%TIB,T]35D-PNBZFFOT;5@:
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MW$XB#=3V_;2%\FXH%=,-3S7"*.3D&SY8H89O_/>7C#TOBWGX__X/4$L#!!0
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MY2:(E"E(V5P)FTYRA;TK1?_Y=^9'THTD;'F_9<M7__?7S/<7O__Y1XZD9JO
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M2FA@U>WF1AAY_5Z2@?_8WC $P#^=\H+$O9$#M$%7!JBND[J5'ZZ'BSQ")SD
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M0LVAM2 L8$Q%RE4[*5I37_L/'8V3@+N!HRUT&CPV=\JR(&E=I5\M(8U)!>*
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M"I@A_M!>^C"_>?BAEOA[ .5WEG@D0%1J56)7*#[LU'+#[%#E87Y ^:&6> A
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MWU#U?ETJ&9U5C@;= M/94&4)G:<KZYF&^J&^4B.]OI%^6N3Y-4N)^T+X3Y4
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MH[BF(#;]+P+@Y,03IGKT:@Q@V/9L4=O4)%IJN1ZNRLVR0*8, .="\'T8G&:
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MC%(Q_^ 12'+8) U/4N+XL=C%,W5R@R]\6Z^2CF9E>@J[@+DM1TH=:6!S1?*
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M!YX?W8M>QA@@ICYPNV 1IY(MM;T5X9MK-J6Y[;8#5YY)V]L_I1!WUQXV*IE
MV+@#6LKH8P)=58RZ#!T?;CWF#S7Z[%5_H-*+[*Y^B(7=($Z"X:+[NV]1M,\
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M;'=T36U4F::G,TH7XE7WB]#ZFC12@/TAP/+O =8I&V[5*1,*S2_"3F6$N$,
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M0=YBYX38V4?&6_#<4?"<## ]7-(<N.*X,-D$TW/0]31L%6C>BC7081= '?!
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M+9*I2JL3*B[\H/\^BX$#TWM#X)0*2%9R\L?8'(=HF_FHQ7@^HU7:_ES[IZ@
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MX\=8'BB(CPN2;%\X-5[/=:9"1=7K])@.)[I%II$PJBB[(N_4>.13X_WD7/P
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M:YK-*<N"XAZ9-DG4<S$%6QBLVIP5@F:^*&O"EV0:^99I/^3.RR5&O%QFX\5
MG:Y6ZD=$6<B18WCD3^& )-NZ'P^3:?NB[!'/2.M&P!J @"B9/*<$YH S @!*
M#B%PP*+U"(??@F.#P/$& C=W[@+:HZ3#LK\ O4R_\(B'Q42-D[-,I(15YD8B
M;,E)LI_Y;/J>FGT*\,M$H!#^=\!YK<=9Q:^F0DBT5(C3^&+I>GY2(Q:5&+?3
MO5::98:+KME7AQ@MU-ZF\?O.>Z@1:!67F9RK+VY6)4_3)&^)=D"BX8A9Q<P
M*$I25^%:SS\)-4VQ>Z$X':2P3*)8_:C*O58W]_;WWW?>1:@Q6;I8=.+JU7BY
M_76YYF-O_U;Y<4K8.7:LL^$(G&9: 0.,;<EIEP7M<,D,F [70XGBLCW\T>'[
MWP^<&[7<E-R9W>J[0WMDX<AF$_-D8'SE5E@;LRRPS)<.B(:N+H%Q_'[W903
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M\Q;Q,W.+&ZU*-X1A5 R[(;<8#O(ZN<5XY.<$9_%0"HB<K5AF2G*J%FI"W#
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M@=YGSY2' XMW2EV%9?G%]OR E*FS%%\41=VUPGE4:A4EVM\X":K&^PNJ[JO
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M3Y*,_ULM\KJ,LKC\POYH/A-W#;'=N@ O7 2>P=TAE,K"\4S";*_>Q9TORV?
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MJYS1Q\C]8H3-R'(FM;2)?^<SDE[=(+,(>!F>/:,K6>^ZU/DO_6M;,*%/IG"
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M?M^;^7U[S?S8-/,'-:T+=*OQ.$\7Z&J EC9\1J$ERD6M*$UDVGE&/Z3(P8M
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M)S4(*KTY&/[ [\DF]Z:RUUNMGJF.<=,&-Z_/:=H>P8.C>,%FICAL-])5GBT
MBJ)WU7KY\XO-5&%F;")H+7'V/7WEINZ:HF8B#=9W(27["-2FPY%ZA:EM-H5@
MMVK,Z>! *>0[?/I'#9^/>1H$!D71)R:L_K-6_+%D"6MKC=S+N@)E+WIYJB>K
M@[T#J_K$/B52B2D:9NU$01+/?!]*59U/';V4GB4(YA%%<:XYR_0=).%.AXIJ
ML16_"Q9/Z>;<.8.)JU6TIK04+0&RK&2QA<--BCR*"==?J$JF$SJMO+3R$2*P
M,S RV;;FF#TBFQ/,G%4_C$]7+JJV*8O^L<7I\L^N("KEW.D/BR2&BY"0GX^.
MQL_,@^]MO+TCSACX)M-M#T^08'Q&@00[*6J('L@EP$VHRY)FF:?YM48UMK&,
MV(>2T]"FTJ&$M=-TMLPF#_XWKT$"Q27!\(=IR71["/J(N:[9"*ML%MNA/T0(
M2FVM:2IS?$PMR;HD)$-)&3S/,DPYOV=_:J)08)%<CSW8M;A#))RZ(7<0O//>
MM.OU\EO9IZR-#$4NTYGN6./^6G[7')V[LM6X&SKMD5N\*+D_O$H*3T\7 8LA
M/R5OCU:MH 0]7F'-3K]>A$& U$G\)+&"$YE,C#!$Y+9S$T5$G<1L2BMDB%,I
M%:'1E77?G"6GAETW5>NIE_G9M,'4T&PNCX6-3#+6Z/*V[A\K<+SA][#PR5(_
MP&#?)TW,Q 0TYY9S]4(PF*_E4+UWS A*UH\N'OB#L#?N\5$WJZNVNFB]%OM>
MPBF)A B8(D/K5C 1$>P;^_=-'BP,>4#MH+!D:I9HS@^:7D0P;!Z,Z%V/?X0M
MY_IO**8229A 3(Z.$U&T4-7=FF;_^O:+EO9;68:+A@T;C08G-S^[OM%/*H?/
M1?^%U?R-I3&[(M_]/0O>8J\K-MR.CD9#-OH_6_[Y'W/LBB)9KU<X_+7$<H+\
ME !2(#110]!6:91Q-K@@U2ZL'19ARCP%5([D9EN?4H;T#79'HA3!A2H.GYT[
M@.]?T#Q;C=\'^U/RB"V0-FP,3IV;Y)EZBOBNH%2(LL%8V5X@ 96*L3N^S">Z
M(V@DV-GQZ?&SX/3XB#K,2BK)\;UQG>BR\)<1/:IEOF:SY1PTNKP9_KSA)N$H
M@.U+Q?)%;/0RA0R,B&U#EMB($RGP:[PK&/ 4E*FCB7')$>VFOX%^K%EN[+)&
MVX?^JL#)]5LSHP4G,W5GG7B*N@'#O@TF7S)SUW!S\=65,'BIUVI2U%BQ!OGB
MQ[_&1<MRM!I:S2!<WG22OBP&8/QC6._@77D=I61-7[QZIX>SPS*F.41_<8#9
M'X1QI H5#S:03TKI)^<KPYKGH-ZT!_L_R9+5=H5^#EWT*Z@:SY$[&1QO/\([
MZI8#ZQL\Z_L&^[[!F_L&]W_@NDSFKP3?!=T<I66.!@MC>O)$9?9=TWR1AB0_
M-EJ1XG0"EK:W1$SS[%+9Y#:-+"5R-((AET:?#X+7;!E#K?N<N^-UUHE*T:<V
M-W(S")P=QNBBJ@H.:)SIUQ7:-;SA=5Y<,ELOF5]J6*/XX 5G *2+H]24+[@X
M&G1B,K_E)2R#255@O[6QKQQH=:R<Q61W/(*E2T+P:^:^H^X=M)P@L:5.P!7&
M..+I(K_FU] ?QRB,Q^AT/B:'8@Q=HN #5 C<4!8H*"$VBB$\860B'%34,SH0
MT\_IC%#1LST)_U-6INV%ZQ(<"B+%0\QU# P'"6Y(-0N,P2QQDPP)"O6$(!]J
MR0A&="'XL!"B2,_#L,N"7Z+W=28^2NJFU=##.9^.>%@*F^THEU:Z/S?[#$5O
MY=M_TW34[:..FX+1!M;=N,%EC6,1:):?S"BW^4HC[8MDY4B\D(93\F,#EY"#
MIF\>)2>T^/9A)7[PE);S'H69.^1*8?=T8DAGJ@3NV&DQ*"G>(%ORV,0TJ3;6
M-Q4JA<V]#,C3)!M.H-?N'0^9SPF"KXRC G/9LDXJQ?EJ;Y!R^RL./$GR40T)
M%.Y3#6E"VK,.$=TTH(@L58.MTO))83R-B@D/2:QT_Z15B>9!0=TRDH^N3A4O
MAM8[9%GX;7@FI[(1!M$RQ^H[04199[I$A-PQ8A#U<(W- R5TTD[3%6HCYN'N
M0T$8\YO$YNK4"8 'G(L/B6Y'S;&D85#YF]JGG)"3B^OP*0VY%O41HH'=QC.6
M6PV"B6(FBG>7/"8R)1$+(A)S9E():*&UZ[5D>OD+3L5C&_?HTP9[?<@Y ]QS
MG2?!0\0GC-[7X9'4(U"IA8[64*!#)!)L8Z=YL<H+$TK#GJ9NAY]7^I_D=>71
MIF+F0 IF= \$$Y0H'VL_L1XL\UB<*SW"1G2!=AWU<N(=5W6EQ8NN:NYA+R\Y
M<ZQ]H9FV#B-Z1CLL1JO8X?:RD)R1/QLM5?!GS3!\>O@I+ H^FZ=\MHF2 \YG
MB;J)1&(_=1?A%[!)<SR%VK2E:A"\@I,@?B:I79ZWYI"%1W%NQCC[>LCM(=MR
M@DB#$N9\)X-LT#&[V/]=C?=7++[=HDAP=T[:%STV17_O_O7FY=/A18!V3RVI
MYNS++=>G=T_3?PMWI/DF8!->JJG.6P\OV+B9=[M*BII(];"X9BI0X/KCOHRP
M5%% H$2?HI\,GX4@E 66M^C4_%XOHBP,7BS@C)(!^IF4SNAH=,1W^AT[E(-_
MJ"@%,_"NF(-1^[<A!@9C)EE-\T"@9BEW!19;K[L$X_H3FK9Z 4]9@K& R)-,
M)CV#3"%;FZX@RP^B\0%XN]\&'P;\?+_]CVW__BVTPRE<=T%08M-(MP7HA&\,
M$?*B].8,P DF?1DR:"];>VW5X X$5]BA3;,O:![&'<G%S_AHMLO5PWE(9/E;
MEN!+?F"3B>_]DRKPE4)!6RZ1*2AV7A_GVE?4ZD0*BU'GVE242EW2]B1$Y@BN
M"/I-6''%M +OANPG)M%DN]WG\JY(!L\=NXH/B#EZ)#2%QTM##16!FRT($"(^
M,E8(J @A1M-::D6CFW"CL"D)7&3XK[ PZG;[2XC="9Q23A=YGI9N#QK89XUF
M1@N$\&?%AD-.DY"Z@P3CK!SXQ4 .5=-UX_JSTX2\A 6N"8YSK5M6,,U019<*
M!YBA./ CZG[_" 0E1H$KHYF:U])\7W5DM?P4B55D)3UMY4. $CV1E.PD+<A3
M/'U/%SGX"SA,=[J6(X+-_P4\KKH$L6"+B)ZXO9WZA$.#Z(?\O@TB*X=VP4$>
M:)8?3)APVH=./Z$OJ2</G!8XKG1T40UIQORN7PXE[*BM$T@^E5YMC-L68"_@
M!4S9/H0EJBS^P=179$XP^A8LI7 7<QW)&Z%WAZ8ZO;MSWVW94)<2;M9->W$8
M6@;S-)\0S(&C0$U#; K7@L)@^2'MIE)U13MY1605+H'8(D+?U12[M0G-@I]>
M_L("B# I6#LS<=DX?4T=)=K(Z&]/7SD)N2Q'8:ZYG&F(/WA.#&IT#KB(HCL-
M)E%V609/^&'Y=DY^JV1/$5X<Y%G"2]([R9]U$J.K+*7![QLI1%TQY)^6J*5*
M*C7"JV!T*5@*1R&;RJ/C SJE1VW%+).'+)BRT)'V5M(U(;ZJ"U(S7+O@0P!"
MG%,)E)SQ4F<BV[(">\42X=S1?UE]-SXD<!CF<R3:10)^SKQJS8^*_QN= TS3
M+!((Q:\@1B)I)2TZ0:9L)%!!1I,\39&AF@\IT[&X@'#0'&99B'@EI+RW0%XB
M4E^?+,4OJ_ZOE3[SR&1P:B\5[%/'XW&*\&30(*;$?/ 2D6'T:5P+.,!9QV:3
MP\>(2$66F<P9QAJE V!:2UCL![$.J<$3 0/8\=7F=]]SK,D89E*Z>F,&P3]R
MGMQ^O5 ";[MV8U:\W2JOI-=;%+!==W3>,*:;22!&&1 TDEJSX.GK>)U]"N(]
M3%1W%M>-CG0I^-P-=K'!_KIKF%*GY#3 2PA1T A  \($V;G2/1NVI.$^B+4>
M =I=I_UB,V@J;. W.Y('82#5'C=6.T3<P'F/&^AQ ]\*-^#IC4;*[4TF416Z
M_&0OUJV#[2:[RTKJUSCGVXRE8(ZPLEE'QF)I$T]EU T5!)@R5^H9JU5*M'>H
M,>Q#85!>XJ!QCC%*K<_\&/<)N8+7I!0C3Q4AEP>VLMFDH%1+N=M+Y^-I0@9.
M0(J_-S%D.Q/18BIE_\G>^UJ1KX3!C11CC!MRS2WEC=2I'PDS78H?S9DI!XUL
MBG'KB!T38TJ_O*S! _3*[@S8-&F5@/C2RP@^5:';K(O9QL>OQ0.U^6_I#7&*
M+29+C(O9#+Z8P0@!<14'7XAIHUHT#^#1'7Z;:COH35" 7[EA'Z6W3>:!@/:2
MA8+KP+:2MV3RX+"ZF-H1:F-*GM6X_$]-M*<#$K>$1$F!JRA)'<89VU)9(=;"
M$@-:5P@7U/'(;9HL,S45J2*H#$QOSMF"#A$+*<;CO=7!*O6E.B4^#<'?;(9E
M>79H<PR>ISQP0-?"*FE&<#)K=L%TLF*99,DR^3>W\5@B[":S-;VVT3^A.(OH
MW9./@A..2]\-ERQ#RU%!O(;!I,9>[MU%[W/NG1,8M>WQ30J( A=1.I-\PBB4
MWE^0<;#C$K+Q5N O)&[J/GQ=V>2O<UI" _"H&MD/6CYY*'Z7ILQJT0SU4D^<
M7]+1F4KG(0F&!C;K V4/![9?$6K9J@=>TV84J;_@!9UK/?O%-S*$DS(3D$R3
MKKU%)U&Y+.M=INWO6\?5;3)*N>"06-X[C4O38)7MC6CU?Z/NM5:)'/]JH9RX
M@WU7E3&FR088K.F;S3U,(B&)6$I^CIZYS3I^<KG0\#4YZF2.5XR;EV)J&6$N
MM&QE*Q/1$PU$!?6!<+(77[?S03JA91@@BPH&+6YD&C61.>@Z6192"I:KBX1*
M\",?>YC\+ ]WQ^O/R#'94*S4G-84VIM7+'694__:(=2F!!FJ++I=TR59ZQSX
M_L/OX?$-!<D=:H0VB/KA/V;T/RZJZ?2A.)+<V*,%G_]E%2GZ<R M*(4K9E_(
M4T5^:<L^R9(FN%;^15L0&5+BG%BG6MBBJ+/+T.6M:HV_A-M3F<6Q[M3RP' &
M&8;)2 S=*H?)ZY@H$_2C3J,5Z_Q$?8WFH]L5-QO[T-8]M/I5GE]Z99*MK@?O
MP^[NA\U*3Y@>!/YF(Y365FO8!$<-<.-/L+5^9I?+@YB0S!D0@E\PES19+6ET
MMD4ALX>=.\P^7^SOO[/3[IN0[4>R_#+1SH%3C[$T/'#O*+U\ZHB'^SNZ8SXA
MSPPSYIS2\ MLNNJ#"4WK*S,]H$'3M-[=;,:\ ,ER7@AKD EG^HDR$F&KS9(0
MU6>]KE/$@F#K$/;)8$^730]I9A8P1CP 2X$F9,YA_!6=+O,PI9IK!WQC00HW
MNS)S[4P"M_6&$0FJ*=Z/N25HB.%,K9D-I3%J%)Z/CTW[54BE2O(*S>^/SYWV
M+/05S>WT\KO;Y-DR*FOIO<%,GCP!WD6N/SZQ=P\276S7N)HJRN8TG%*&+M@*
MN@G#W4@)PYQ7;W]]]].KMZ],D?(%X1""7_'I?L%EWVO7ZRU4CF<_.HW#[SH0
M8?4M"K+;-'#AC8#V5!;+2074&?K3&@7IJ9V%2LF,H&S,8#4]C_VIWDM=6]$D
M#2\=.XU7^<4W[=96TT& <"&94K.BP?TUY3.@-"#M[:4M-6PLLX98[)K2 <4Z
MHJW=Z>@E97%>VG9*"+D2V#]J6R /7Z!7Y)U8O>RB$5-Z5*(B(MJ("%/9%OC5
M/F%4K_=5$4*KM 60/GG&V%)/N:L"X27^$2'I^'P0?&!@9KJVFMC72&+]:4]:
M)\^H.NTE834),\ .&D6IV%1IN')!CXE;(6^!3I9S; ?!R]H811W_&&>/IT*X
M^]9A-[WLF1MSXKMS'"@3Y^'M(GA> 7LZ<!CW4QSWV^/?*I5Y P.P*M0L:;$C
MI5"-$'F#]G[U0L+-\*-XJ3_J>&[S*;I#%M,2KM9/D"\V4Q8\[UR!L S:E\<*
MT],TH19>4F)A6U8%R:3OA8<421\"_%K)O**-BP0UIE7^S7K2VP0^8V+>P<8E
M""O0NX9SCY)B6B\)16+LNGX<"^R@SA"=HW5:E34)!=QXD5]S-([14;IFN\-:
MNO")!PBU$;LNPO5"24Y-N5]R7RKEC*]U"2@J831W$('IE@(F:P%G21,LS*7)
MI6+8 3R%$KIG6X&*4DEZ7A&)BCD?\BRXJ<UU=6>C.;^/&_IQM4D_#C!)SYG?
M2DZ[!JK*F*#XC[JL;A0%"AA;XN"##C1]=$@9\,JWPR$3VCS-9T\13>U8UK:]
M]8$7\SGFV<%_F49%P1O>-.?!>7AR?&$MNE2WM=;I>*T9)7LH; )'(JL6I4#I
M)%H7S,5$@57-V'7=#LJ!_7<65D0?)<HTN^M4IH8]IY2U(SIHB'1DU*ZXOLZ[
M'8?#\7FK4QV?9:W 1^=FJ);3!7K#9 -QWRUS"]6^[:!>_*>8!53'HK&F.1B#
M?[.)W_BL"#7LV%/.:K7WZ.SXU+Z&CAZWOL,AEC@O^A)G7^*\B];H&\* WRF=
M7K)Q9$/;':,;B^.V4Y&/FDQJ-QV@\?U"7$$H&'2 =#>2UQGEW:9TF35+,#]1
MPDD?RTPSY:#4>O/.'04 UWIRYZ*P)F (.>TXL^ER_OJ 0YH/F(WBQPR=.\LM
M-J4P)& .Z6[E I3Q)2<_.$RH#)-J2.^>9.SS_$!2\\T)"RD/OV?&0A*TGK%P
M1TTB-2M;6)A0&H%$8R:H,X9E"BKUV3WBN^S%YQZ(CX782L_ @GM3HAJ\J8*#
M% I/@Z+&\@YU_6<Q!_U-_=5+5R]=GG0Y"8\2+.<4NR((<2L8XRC&.D.) /+X
M&:BM>R0_1[WXW*WX8&<V)U2X?=21'@P:5Q@QYKIN9.$*]($_ZV1ZB9&I_KC#
MG [!-P2KBGE8MFBL[IB#U(J)=O;"VK<+#X1PHF'$'V'+L/BM-B=I*_-SZ0L2
MY!SW,&_P-IE'H)$&_)QJZ;53;*-!Y%DF[H=))FZ,!1I@1D8N"4S*I@0P,^,R
MPK0+LML#CCQKIAN0V8_VVGUE=TC'=8%GB++4)<H>"@\_@D^?6AH\-C: 24TX
M8?)!W<(5WK0&+B0<A):[3[PTLVZH,JTDMZ/,##=PU_IH$QU/WC@?[04HG$F1
M@%#_0Z57"I40"GB4E4]%RK_[^[<MA]\WT- .< J= &G[+#\X?:FRZ0[ID R8
M<-//<Y5;L M_@\/()H2&XU-7,OZ6=+[O<Q2J+?O;H;4[*X#!W_Z:?"T1(&O6
M<==;+")" ML08CR'[ HC6S6&_'59(=L$Z3.DC2@8:T&+OPNT;@,_PSM_"!6G
M"G)+"4(YX:<\69'@W(FN&I'7(R4NAX*ZK"=_T!OD8"N*:O%GC45)A$*AT2L7
M6"XF!E,PB&A3EW5&V0R\NXP.(1A#Y7]ZEN9Y#/]=@))'Y<]AIO3:?:JP]PJ'
MIPBZV_8H:IY-M4HH1H4?T5-CK7)55WROPE[+K!F!N#7HQ ?0DN)+DR6!U3N_
M@*D1:7$TE2O=:AH*!;CS:1F5@DJ>]A>AHP+,9XPKX2/*" RMQ@#0_"5AN-<=
M67591T)K3IFM0? SJ/*<TE8;[HDBGM<E? F++$T"$C11*9&T$2^'L:5.A29L
MEF>L6!B!LNPG#N[=>;1*(-.QKCGHTDDN,-X&H!YL/EU;8>\8&3CJ37M?EV42
M!=$RHGIDBLQHILZ)*",BG(&XD0]K0&QI>OH5HWTL_9X 8'^[1'RY>BK79B?;
M, H8@EA^3/D06.8(<_[R7?(O-#"*\X=OX5Z+X'F5$MHY^!4A!VN/CX':\=\^
M__4=81)TO<^;=J3?1EX#%NM5A*&,;I9TM?,_8>=JN'ADDX$_(C;?1$ :>X]E
M,-YGPG#RE:+,:9BP_+>ZX*N'UL/OYMC$5\E",$0.5T/#OV5%G(0D&B8.Y@T&
MC)IE;3LH-=6'3%PH*H;[[!L)R<FZW4(2TA+Z@VGU>] =--A#T,RE A\291].
M$+R=YH]JX9K%S64PYRS%87Y^2XBX1FG$;I95R^:+^/EFXRZ?4NOFN?P\F]MJ
MVLP]_B%&;5C3W=FI(X>+D\8>$L6<S;")2/&/=.B?:5 .\R):EAO8A&['RA+L
MVTYS6(I5X&2VOKWI/E#"G :!H6$EVDP7U\4&9UC/Z/11;9"5<IM,CCIZ-2$:
M=?3>$2",Y@AHFC]O]AOW;90Z;-4^DG-0S#)U,NEM??_M9'J_N)1LA.3 D<KJ
M$U\:7OTI8D#JI=2?P)O+JT0WHL7YM&:LW^^"\&#8#9I3>*D9T9Q?.?@-8=AS
M>.":C2MNUX_T_][8HF5H$EO(<\+_:*P@1Z;LK%HZN;!)R@9.6#Y'&J\I=QA0
MEYZ$F,AI427:5,*B+[6_:3'Q,]WOPIPWSKN&IH^D^:#J*DIKO[?&@%?P5]1C
MI&*'TM/AEVM1XY4TP4A/]?,9<N,< G83U7.O1(X'K\(#*02TK#UI-YPTBG=/
MJJ-HKC]B/C-\^'IZ28PV^%+Y!'->IYM1ZX&0WV(^01(G/C%MH1RSZS=<NOQ+
M5+TTNAQ$>6)2K"PX['AM4B:.??= (\(B&#OWLOLC9]@<J;M3+EWZX@:UNJ5]
MXT;-&E)X.%$T1PMEI-*C!#0>KWV :85O4Y,U&(MMB>-&.K:1K-U''GBOV(EM
M=9AMV>0/ZR48U_\BTSX\;PPRV)J@_G9/OX6!%M7'#"Q&25F_:^K@-E2;%DOK
MX;L]G>/TO@H8&./<4J:4$A,NSK'81#+) #&=#'8O3#+PS*[C9Y17>CD],#DM
M0$XR'D_NREQ2:@\H%$N4"']FPQD25:=3+<Y 8=WVM\I7!J3,U$_RT98/TI3T
M<I,L'A@F;WC4@_)Z4-[-H+Q>Q3Y(%;N%\5GHV7=B#7=(P#VK[;)NKT"8\%]:
M+?MM#WE=81N#Y9]HE8B<C@F^Z<:@A4AF0K>E84U^<#YA<F62;S 9%%42QSFU
MJF :D8>[44,?-D%G"5.00A#!W0XNL[]' @\1B/%]PL:SNC=PF#W(>^<&"Q-7
MFB'LMHU&1[?P8:2SP(RO*3<PN  B7EQ8[BZW_':<$G2X\'OWZ3&=;2-*G!:1
M?Z!W1*0WE24R38D &H^H)>+;-&V$$MI1QIX2M[-QP$W^UYI9Y3NB6!O 8R,0
M]CR:8VG&Z$J:!KPW! 40*T$OL8](8F^R1I3'*$L0K9*\>)L>Z1S>X0S===/9
ML<(^K<+.6C)CF4SJKO-Z@PVR^,WS2'[W$F-[ML\!X6*5]-+JA:M+&2EY12;>
MH:YHE3XU.PJN:,X)@MWSD/Z@",W,TLR>BPUSN*6]:1/;)B#A$Y,V:ES2&7+3
MR!^[WD:DVYD[PT)R#YR7T1G;V]9&;IG$<Z>P^"28NO!>(S#NWDR&^%$1X32#
MV[:'V;/&BI9"K\ZA!A(^0$23&KX@+W?9G*TDMUKK&Y6FIV93,>7N,K_8QF-$
MTSQXY#)".ZGKUOLTJA%-WW0;\ZJ0'[D46X02]"Y,?:$3^ QUY?,\)D2?-F\4
MI54^)[]Z$+S*D-1$YM!K@J5=GI:G_K3))%TGWN)7NJY(22%XNSB)N5(O%'F,
MA#&RR(49J==8RV#Y]'A$SO;1-QS]I(S%Z*C7M*504%96L<0%F1P:S66*,Q'"
MH:9T%7#LB1Z=NJ %P4%<R0;: WIZF4@AQQ$D,-7RDOHE;EAZ)+71*%**JO3O
MF_R&3LQ".!ZF,/2PKF(J_U!34U?#?(+K%=)HZGR%D-B%Y?TJ[>GWV&-HE^H)
M4F$X7Q3>!.=+WL4<KQ760(RYS!'0$9FCA)ME/3T.R,E<8XC;E"_<<AYA)85,
MXUX;/@)8PH(ZP.G>,O&I,>^)0"VE<KZ$9X&'@=/3!S3)JE X(1.W :U!64$$
MK+QA67Y'NHS>G"J&E&.I4G/V^0O'F)H./=,U)22T^!WXN5!KJK14C,[&IR'N
M>6(-IV=G9'J%65OM785NZZ%#>@HKK<_/#KO4V YZ3?WH75;"ZM<LECE:H0^+
MN=XPMJKNG%O%UW&.G0QMHI1 >8]'-NTPB_(*U.*2NSI)9HT7W)PB*$V;T[0N
M9=A*U[RTN[.PS2%M94GOI6, ,_S=S/"S9*EV75R[Z;^_+!2]-\'X7/>/."WY
M(I+)<6;5$=_+I@%SVG3A; L:J2"@O*Y2FS>HT*_<W>#XL/5G7YJFJNE3Z0Q-
MDP41& F9+&L>FF/46"*<H]"6*+064;D4=M(8Q_TB-5 KB>5+G>; P].%0ZP8
M,9"N=0N-<)BF-![2<1OA ,.VT"^(R5:3FB(=)"<($>&"CV_?B1IQ(JLI.1O'
M]*>&D(\0>.YH@>"#PW]$CJK[:V)AH9?N?E$CAKH+*'(WGN"ZR,/AV46\I%D_
MDBFZ5+D02&.#WH<ITS1T>85!'UEL'4<+3(.7<PK!'(3DEB^WE6#4F  :+2"O
M3NX&NXFP=R"6^,V2J._,66JTN0OYM3Z)--:A<0R7B$5I((3MO$%G05:+=0G"
M%F5V%'2^2LA(X10/9J6[CBR-AQV]/',?QJ?(([EAL<$25HS&R'Z<F$Y6#H:Q
M>=T%C6MV0;;=$F E6%C"B5%8WMX:0TU9U?2ZG'='5437C="!9BI$V'3$R.KS
M3>=V\[[BYACF)3\J(P:M.#%DZX@D9FP/7E)F<I2V)Q*VYBE/G&M<2&)PA0>T
M*KV)M4:+."_EQ^;*0P]Y%_:($G14. B>!VDTO:2=$^+7!F-]]_'OM'CL)>C^
M"(M'+:/44#7Q>-_6M?@"IJB\*3DA ^>G>CR-GM()5[G-.%4S@&5[+./G8M!N
MH0/G@&PU<<6\R*^K18.CZ:NY.+=C";5'8:-8HZ:J>#R2,1 ^5(#PZ3?GNQVS
MJ1W-$J_"1.\YJ0P*HP3Q/0A^N?&:SE1>_Y1:L4E ]F.(TID;*4$*HM+ATC(:
MA')'B8E)W1'%QC7!H7QL$1N05KTV6F:<J<ANH.M>=*MNIP%U32] /R$6"XA>
MT.?2(]6!\:5W=0I]Y1843>"C&&;WYE28SYTN:SL"= ^B]+&H^"#IE8;#'LK1
M0SF^%;_2EX:EG"RA+A?"^[9FLOB,1BZ_(&?7-%;+R6;L$/O<C=7Z7;#1=IP]
M&J2HR(B9]885D 6XY0NW&>MM_/<F,P1S98-ACOMK+3\Q7(GG_Y*:SU>@8J]:
MZ&SK7HB%,<2$H6;A%'_Q='#QE^#)^&@P^@N.#!7GVV%1Y3WGB8O#T> 4/GT\
M'!S?\.F&R%"SN.%QY*27S+XA>V1ZSMUYZV%3XK"9*C/^W#+Z8WL-2MMTMBJ.
M27'FVU=YY4P@"6W79*%6,H-&+Z&!(,)*_)5 *N8J7B+*D$/(1!!W(7#" %&%
M4:1'\T/*!?;"7N^R)K2;O@Q^T9+0Z(?.C!M8I;(4]Y([$QQ4#(5]9N P/!UU
M,SK &$QX2A=J3#&O\&E3S"J/0SD/F9Y"\T-!^O.:/^*]XJW>BP-9"4%\CF#I
M1O \+AYGCZO@A"XM?XWWK[."N/.#$5NF)+;113/)'>)OO<H+OJMICKG5Q?7#
M$X^K8+&:ZKEF72#1ANY V3K);XNC=JT=M?9 C;L+0]PA:=N91WV=&HJS[31%
M\IK]"OYQ'#6[)V7"<_!/UOZHI82L$.YP,AB"@AR-;E2G.BCU] ]\$U3[#\$Y
MJ=G1^4U7^9X$6 @2Z>AL?Q,Z'FY^1VR!M)@9C;/![!GRQ%\M^2#$&$RVJ(^-
MW(J2W"GH+0J9&KV];LS+K;79!K:16XEE(R_3P/SQX9)7:AX/?NJ0TV?+/";%
MH?$&^$W-LVV6Q.H#_PK-PN_&23=Z 2=K.IQTYTHM8>TE[[@B%G>,W/28./T5
M6.:Z];:2--K<].GFUI 1@A[;5%XM&S7OB%D@+ACA//:28T_NB'.F:#%VA4S6
MFNT"S=4PN$?25S,'+KD1DAK;NBGUL*LYC:C>(,^-+&LR8PA;Q,/+:Y[28U,*
M3CCM7J6[ANP5(PJ(V#W,!QL ?L'-3;8[]4AOU:5[[Y_>O7@C(P@ICY)I/@$S
M,$JS@@AF214T3Y$8M&3I4^IGFRNKEW:T9"A^H9"R:URQY$5*PO5B[FU)TT%H
M$(F<A>V *^<>VG&Q;;DMBXE)0-(6*6Z=8Y_Q7GH$$&<8N2Q19PTC+F@!D]R_
M!:W2+57><U#A!9YJ+'W46:J%#8GV4WS.&)$.I:Z].A@LV>$)0<)(V7(:2O=;
MD[7PO2CI.:;F8=*IR5)3$$@QSIU!9?PWBJ?*:J>DGD[DVV7P!@+1M'=^/E-,
M_\9AYC[JOX]S%MG=:+.?/%J.J;=(-N2YU2+<L 85#6KE 8MDDI :3X7ZG.RT
MP>YC6C6RR4_J*A-XQ8'@7Y]Q7PE^W!J\O%;8I@O$3PH1SE)A2B4,?D[B&#0B
M\MC@S0QZ15@%0TLKJ#/-<3 \&HS_$H(+?/87>HVS"_JWFS\(-WC/6WCZFQX_
M>VG4;[_$ZIR#YK13;@D[18X;NC[NQ$PV_68M.)*O):C:P09QW%PS/BA6,VZ*
M 2-4$B, !HD9@0LJ-5UD.9(K:![F!&T63[JPGJFRT:69T.-#\)R260>R9A#\
MQ((C;JI^5XKS"S-(?D(U_H@F( 4\]];P^)05' [Z$043&8^LQ#U8(2<5#_^%
M(ST(7B8R>J7[2&8$4ZV(K@?'7NC/.**MW]')SLP5TM:L%L) ,=?RVSD,VDGG
M),IY2W)O>'4:]91ND >&7\A=1!6N3/2KD1-+@DG%:.0 L_3(1/4Q37";II@G
MJFA\T1QG2ULF-$)FW8:<<1,IG% %F;5TA@ZSKR!:H-HP0C3Q2498_+'XX$85
M2YY!C#CAO&C@OYRT&-)13E$CR,'02RU4>E1]7="H/A!N]EGT)&<$G=1)&GLJ
M3T^PPMR3[C3SX@+C2L*CT9K 2H*D.C-%M"LH 1X>/#OHZB:XN Q4<>,^/@/J
M$Z'T256"VXBADR 2\)YD)ZFFCAUNJX(\4<M7QIK1Q#,(SM"#I3V!\%@]NFD#
MOQ$UTT8638<93CLBJBCR(D$(5Y*GK&RM.U-GV). "$\$P7@,6SYQW )ML4P^
M:O]64[3I,7A(XV6_$+(((,XV*8EG#7XD!%["6<XS;@G9R'SXTL&"VX*@$$$T
MV.#'X3?A#^+Y[&!8[=BGNC1 5/<+G<G9&SR5+0Z8^ 5JFB"?+*$.D??*'SUO
MLR9;R,U:*GNZGJ:J^1(4*B*ECW<'7E>-BV!,L9 R,>J$65#<G749+9GL#[?A
M.B_2V&LK];['@'K9-(<",T9^/$Q9$<W*%FOM8& HB)796UW(%)__^,>UF7!*
M%MDCQ:17+2(\_?C7@RQLC_K"=E_8_E:%[<V1G3,+D<"YVN,@M!8WE]M1L_I?
MZ(@A)O,R25.9QTP8+VZ0T@8X[-+?! A$5\VX-NB2+^'=2QH)Q^2N;D_C!G"P
M!O@X.8^-WL4K[4>[0Y/1,4[!("#:"8?822ZRGJ2@D.K*F0>8J0IIQ(UVTK1A
MWB!A"^0LUV +EX:Y%SX=\E1!8=*<$%6=8HYR_SKT.?IZJ0.LS15&IV3*OO?.
MZX$9%!J%YS'*PT)7QD"230F;1D2>S;":8OL!9>_R*2>_27?_KH-1K!3'N7;;
ME$,!S#,K3;3O,0MS'$BI'.OE0#@#&I%6A>E%)8D8";#+](28JZS(NZ7\*F71
M7!>8=A)#Q-U6+-SL!#IAW5>MX^VG8X*G,E"SJFXGWEA<T8V.NE%6#IPW>GF6
M=YGQ^] OH;DMVYR6,HE"5%J:@/@S(I_2X_*R)#'6>9$9W_ 0^8NHB,UH= A:
MJO5*L"\E,4WB%]-\:BH3X%]="]^(MWR$X'T/ZY9/+T,];MA5(_CI%]%R4B1$
M%_ES5):@-N!D5)4A,%MC*L"*/-?*4&NNK4\G!2$AQ>NB6R^EG:'#G;<'D!WV
MTHTR:-@9+VSHCRW2#-^AU8)PFEUG,)?QH;!NL"2*ZTQPPKG<83;"7("^GV.&
M1!D][/"6ZR4(@TD4&]9S@Z'5+[\A)' EGVJ)C09QZA!8$L%RI>:%#@,$<6R1
MQF[O-Q*$X\!UN0J%_T(>#CN=:78)VZU.:4)M86YCW1IU>Z:M3#!U(EH8 ?@9
MM\-(IM*96.R$V?B)%XLDB_CMFI_%7W_(:S<[R2&VX7.W7)D)2A;#102/(BWR
M0E**:R-C5C<"GC5H'K_"#[&VZ2CN@V$-!>]*)PZK?4XB0?-#4[@)9J>D@I?.
M4#34FFD>L ;/3@$W&2^OEY#/.AT>9SVM8'0R/NM^>CL%Q9H2:73TC!;5FC@Y
MAB55V1,FQ9Q;"H>[Q:QSOO./O!"4/XFRK"_/C"&EQ! F>+6K)))>W((/=6HE
MWVA,,NNTNM;O*HR)QTR.AQ/OKCL+/1+B.^*$)]JR?K07U><[XJ'0[0^X_23:
M&0V-TN34I@+=21.?Y[@(BZ48PY!A2II3B0Q-!-ZQ6^7$"X@0,#<2#TW:5.&Z
M;TZ%]%PY,RZPV[F*3'L%&4HTL]*&1A[]#,\_)4;L;Z9IE"P]?GGUB?KXQ/EB
M:-P=R;L7'+I,.;#W3XDK!X)!D_8GSFALJ.'<L$V<; AF^'6QS4LR;<$,UH3U
M8WL)9:% ]K%5"<&+UY3IS-$?5QY>H/MV#IT%:'O)*PNW,K%05CZF!'&O16QC
M1./PN1^21' #F!)K$% $F[W^MX"]0!'O>F_I0M$WMXUF3G,[8Z_T&36,30WB
M:%L/F$G7H:5HH69.S+"A#7GM9IZO70IH1\HCW@8-9!8D@+/RHA*:';<R>P##
MYLJ ,_ZL\5?VL5PN#=V=N-1@6H'*L4LA-G 0!!^4PMG;H]'1LS<0I'&Y[AC=
M [N8[S("G@G^CM*=HV<_#H(?M35Z=X5:3UW+K_X)&Y\&O_"P$V0]IQL,N9;;
MNMDY+)V!'#BWE8L]Y^'TX"S$D;&B=I#6.S+^VR[0>IJ!?AS1110K^P-W[*DA
M1P>]61D.!B%P2=5+5%9<,&34,#R!4T^@$ %#5D1LA%+WLBMZK8P#)R$404D0
M?S;%U*DY^<U,,DU\>7Y[!=FF17'4;1PM<390P,4@XAN12*=!(^NF66;@''[;
MN6"=(PK8W)JZ>\?[V_2!ANLR98Y.7&BGR<>^:.=K)J]*Z2S)7]S>//%8N-OO
MVJ3 44F5N3/B%;DL5M!_$>Z'7G6E\SX>S;U]\\)P130\14XOD:.H/SO-!3_6
M0&S[9%M1Y_NDT759)]H0LUPU4?WH%U')7CNU.Q!;H7EK5]P=X)C?GKG;%1DP
MZ8$E97",/S'&:PKMJNC=%]^*$UK(@I/$XE-'1"-H4@Q&\P?78+NF"[3\V1S-
MZ[4#-:!!2&112NQSJ2GFTG92UW*8NT'<*Q_R  NF)#3=##AU^!RD'_KN.I*T
M+MY26R*SKXE6;B"9VX#;<H,4W?Z@[]SM<KE%_DF2DY=8M/B)Y%'#&SJ>!P'-
MLM_DW&57>2HT0KIGR>7OX)!(4_JX;#G4T:Z/9)->CI:B_7U&V)24W]>.#8%^
MT%$QW%%4.]018:&P+T3?$%9C$F67G&>_=EC"F$< _U"$7U93DXN\(_GZ-3>-
M;83,X<FLM/L%AFAV(,RV-+*3TR%< ]$-3)DWRATMZ"5:*:SE-1!"J3]H<"35
MJTLYCRHV.H*S$$N<B<6MA9:7"U,E*>GWSHK_7+/:^0/^3"N/2?:(H0;]0OD]
M[3Y3WT^>H=!(YH8>6R10GH_2@2PFZ".E5V;H'*5VDB*V;+_7BLO/S@^-_9?P
MGO-W,B;6W**=<@MEVC HRR;T7W]),^LP68L6=3+2R._ ]].W7RHE@_J<QB0-
M 4:ODH9-F">;8/B?JBNLX/M3WNUH]\/LTA[WQ>R^F/VMBMFWT=@M!<1L-:AJ
M;&*>4KPQ02JY7T,GO+632%EPGD^64@Q*\3I96S\UP@07T[6CZDSN&!1"Q94%
MG?$V2$0*0XUML2!!^TQ\6RF_DNXBL_$'N/QE+-6\T.:T.87&"CN2BKPQ%B_?
M/I?R;P)N^U4^I0H8%_"I L6?IW"RBJBTS3H6W0!.R,I]D.DZPR85#C8Y>T,!
M9YZMEYA.'000M"?,Z<>FAGP%R17%>88M3_0L'$E$.JN _:_@_NH G]"?% :0
MDZ\?D YHDP/$YZ>1C\ %G 9<[K]K6E&]8T;MX^IA=&1!VKH.83QLM*YQ$5US
M-&3<\&:['@M!SKT#I8.'8)I$G @*KCYUGT371)7E):P@7-+4*09.6Q<("RO-
MP#)$C)H):U3JU?-\91:?]JR$8HMS3W0>$ 90ZJ%C4ITR918\&C&9.^F2Y+0[
MVW9>L&LB5L(F&B9N9++'E*)BQUV,ZKA.J4&.H^A90M%XZ07%VSG?0C<B]%%H
M$JFJC IX3)!(CG3!89#D.S8'0I8V5&8HF!KDAI"H5;ERPR+MD'?&1]2Y+2)$
MZ7-QVFD+^*P;66H0''$.1TE[<P:FTH0/-N?Q5;+E7QK1.EL"SZXQ1$[IQ:F-
MN] :I)? [(,/DT&GRLQ.,O@1]M4X71%WLDQ/5)O[ZLY:KM]UPR"]R*YQ$OS!
M9EC8I<*:I)T[EY#%S32G%K7N4/ K=E.&G+>>IGWI#N1":'KZ,!RBDA=-1'9A
MIUW7V8AP@-\]K^<U:(71T?"<NQ,=#F=Y9C=("J7QP<&M.^@J_ZG-L:/G([='
MB-]R,VL8OXPL?%;2IDS2AFB*F@<\$[A-Z@\,N?=;-8Q"]I%64G7H5"(<3><F
M.^"%]BT0@0EHM);P>:@KRXBQ"YB #"SR=\@AM<D^L[^MET$/R'3X['@/N&Z4
M%!M80G2:\IT/C:,V!KL5^C SN15?5,Z"LZL0<FE4"S579T^7$:6'#,+%YF6N
M$3TQ2]"*@E=;+<#>7B($+LWS&&$OR .,:QDVX<BY9DY6E8&KZ)\),"645B,"
MTRS]O2+G;R=(I&[ <>7FYME$AM.PT45T+U@FB' 2$V+L"HOO&E$ G?-F>FDB
M_(V /?2OY% [F*@/QL/IN/:U7%J ,DBSS.:"SQRX%#A7GDD]N2R+@LT#DCW=
M8()^[Q[$JNST+9G+-+A1"D7E0.EQED!@9O,'&R=!U>6=)< \3S-O'T]*A9@C
M>DU>95/?;7PO@MB:8^T0 G*#W*9*%BTE:Q-2)CCX!ZQ%94D!S+D*&]\-=3NW
M<"C2I;@[2HH';70NN#TX)IB.,V**L.]0*NTK,$(5%OY,QR'3&3FYJW63;P&'
M#F'T(P$17UT',> P45^;+L)3&LE624QEV"XY]SC)P!,G?4CSB3#5-@A>72FC
M:2':@%\@;=>5;!@1/XB$HGON/ST'$A0""MY;JT":!DY?-'0&M[!PA!>RJ?(N
M*V.I!K;":9PG]#*&''"X&KGE0:S;J%XRA1MXBW:V='8.F\WR^2[]3>ANPR&I
M^_7(E$D^EL)NKE#3LSDW-"G(NZK'+)*46I.G45&XY=N9\=%-I8/ H(*K=+9$
M:Q4+\6S6TP6)U:X-4_53ZVO*$%/3%#B9V.AO1@9M>([<EPP79*H_:Y] WU+7
M@-S":[3$E$'ILHA2,O]**PY3ZV0\?*AEWTDF3&3Q4*8H5W2-8B0Y)WVS4#A@
M]=M;$-S$@\T0 @\!.4SOZR#1D*&5D^/W)6HD3D7+E\&E<.OB.(K6=$V0XLS6
MUA'3O0&Z=\$YVE[_]IW5+.4-R0'N?#<N#::JX7;J%R+_SFD.A$\NW>*F56NN
MMXN_^3')7T85CLBY9'M."/=?$":K2^]/T?QA2"K>I'Q.\VC]BCX,?R%L1W?V
M;9Q,!3^VD"\Z]2[,NG"EP;4%M$5%'L43Z5K/]&26!@>+1R?5NAV%P+H'I8JX
M;<G)M"IFHL9<6YG/*J)9U^O+'BEKYH@?!KSN;.XSM0BH63PA'1]B<0=ME+/R
MC<YF?9<%?(T@?XMZ2?P.IB#OL=D@8%]3(1''&%Y0=UHW$T(F*U5 M%,@DUBA
MO 9F;C7=?J1 <ZWP3O#N5Q&Z..09Z1?T9*K3EH8R:2(BW!?%0IQ80P=J>DDO
MH!G"S8A4(?"WL"!Y"(C<DS2U'6D.C72XV;6TD"NX-^E@\IM(7\I$ <(AFCA7
M ^>C&/S$A'BTB-C5@6ZUI@9)VQ>X\UCN4JBRJ(7I.D<B\S*I9#@KR[B(%0]K
MBDQ 2FE4AA]+%YGD0V,ZI[19L"9P8M ?L'TF&?)UO :IO)R!C\[>#FVEC$O(
M0<UK42:D7,%I9>=$Z:%$_HF4Q^6^;Q\?WP2B^4U<FOB$]^\PRYK'?5FS+VO>
MP[+FNQO]( KDKNHT4X9V31Q=08\YJMP8&JO(=<>K[MY"IQ1A'SFXCFR?F!X'
M=66K:XPS=P[1'_:S"3)7LG5)*_;R(%>.3]SQB8E*>5"5@QJE$0+2S0?AO^7+
MB%6Y0M5K>WBE"Y<@LG" GX*:7H*%YM=T)X]24VW!2VF>"((T?UD-WP(:=>HG
MSD'I!GS.D\Q;.HS5:G9PQ,=XLD0E4*CO>2W+!&0GLL'&E3*Z>Q"\UJUT#7\/
M66]HW( \]TT>LB%ST%VV34],+ZJ$,[:XUL2<"N3+=-+B2#^UD&R*F?^'P'\*
M;%:8J"FT\>:K<\_+BJ:H&(@9(?1<>3"-@];^KZ(UDT_89C)_JD2T6BD0N]!Z
M5AHQZ?)2P&IA6H5< ^=U=G(E.-X"C\N6_WUW00:M-2+6)@!7.CX84B;>9K;V
M0MY6][@+38@DP]^,J7494[!?VJ%N MSA/E.X@,1*FKR+3E_NY[4<P3))&M 9
M#7HS@R%F+\1_#5V+V""CE"3?&.CDAGRYD [4Q@H["1P)JG8AR/T:$>"71KV$
M)Z0)Q&V&?'2%00/RE-T6A##"Z$F9#X4V_=].>-G$H9LZF#12@))4-7,DDR4Z
MS<Q$13G01&=%:-1G)D2C^BGO+K#6AH*.%&?[B=$&1[#QA"^[ '#W&KN$.<EB
MBA"V:CJ-5MJ/H%=;:SW&VE*K@!)[>3+ZIYN6=8?@;<PZMCN/K!A@(=+NZ9LT
MQ0QV%'K-B9WW)B7O<+!QD.K-RW,V7 ".3FZ(VDN2JJ[<U+XPYW-\J1_+#'Z*
MEC17E/$Z&F[)>>=9,\F\[89B91SY<V6?\2NUH7?3$X %YN&1KI)@;EOXYW[X
MHJ.7;<EAHKR0-X)5IX$0ADZ!$H92=I!>8M.@X61O[90VO+RM*E/2"MN:.\XJ
MJU5)>CJ//-TPUVNS*:-4*]QRP9,RO4F,N9>%8=_$6]&NV:(=O+MA=Z=%J%,8
M4ON]-[K7CI H7.6&#1BPZDME^/O(0<R2W$/A5"I:&@B3-QT;.=YQ-RR1#D/G
M<:JMZ?G9.KKU#B$JFB[8(=6@@X[\/["56$$#'X$XZ,A=X^*/GAR'JHL7KMR^
M<HS*0U 8.(:UD*9I^.:5,M/V3$I7+7%LAE*EF4"I6:TK&;'AIL'=:I.3^>2,
ML1UPN*F!0PJ[U\HC@#;%*"\YY$H1>$A@.J8"M#%%XYU69)M<. I)E)#9AI;N
M ><>[VE)FF1'\SLSSXS,)4PM8W,6#'1--,D&M\-'=$JL!.E:SH;EHA266>+V
MA]#B,334\CHCM:5P84=:L9KE\6&8V\]G\$\>TXD):*LZ&"5+0[#Y%=.US^O)
MCV<\,,;!NG2BN20(-Y2?]-0 TS#(A>1+<'X6N< ]ZB++KUSB49HNB@^A0RQS
ME)JC8",]?=1_+5U"=@X [4#W*X 9JZM-+^)<(B_F428871<DT\VQ8L;TFLF5
M9KH# JGOK _MW3:8 Z@7$&Z94=/M7]B"4/.%VT:D0<4FV6T]IE-2P$QAU.WQ
MZ6M2K9HNZ6B)C5=K0*Z%8XB;HRL"2.A1$;C1Z'YV$,1A;12K!LE,\:VFRJ4!
M9[I,! OK'CM"-7L71O\0(D6BYS<P%.%PXR1#<L65<]D.+/^@<ZESU(6:%C47
M4SLY[EJ+@84#\P9F42G"]+0NY^:QN&%O$=I5;JACDF F71L$[_D+QDE#J%#&
M6&+W#JA7.N>PZH+-5K@-]T#0;44B[XT/]L9K22-K6W94_O$WB( 7CQ\-A6E[
M4Y\<M]1"(ASVJM =B."XK@(*TARM!!JX#X1F,LQES?AZ''&# 1*1-;<KP&;)
MC)9V.)PZYM6XS-Y>0R">OI=$?.T067N_U]#UTJNGTK(Y&>4?: 4EP)/J"54Z
MGM)HFE6I?M!_L260[^ ;!?Q_;'A7*!%/JR:U#.%'_MM?J]C](.@#VF2I]-":
M5_GJF4O<DN5$VR+)_?/V-?=9VM!U+=S=9TY-I8-<QKO;A_42#LM_P6?^SW\,
MS\?/7)J&QCO?V=,O41]1QD)S,QIL'3$A<V7X6EMHTV!J*)0H42DD#BBT^.&0
M5?=T[7X#@O[HD_P:#W_!:HR=?H_9,!2'AE0=?\$!1GE0NB>V[.']G"H\PA(C
MB6/I=PDM15E',Y=7FY?65!,!,S*-O_V]4Z/WVT$Q.WM%N6L<8)7H2HM@#SF)
MZ_'@:PK'I"QK\GQI96^XS#,K17_%<_97.IZ'5Z4]Z:NT?97VYBIM;WP>HO'1
M,#^;2G81MUH#FKDV3IK?>,"=W&PW<[;!K;"(SG5=<:\VJ=1>]AZB[#G9$%,*
MYCR3;AU 4@ZG3Y5A_"Z<O!>BQRY$+K+$L(.X: R,MR@%7G-RFO'IW-;>B\IC
M$I561;&*X >2N3) %!P.!7OA)!1[*7E,4F*J*CH=VA0;,]4C=.O0H8G 1: 4
M0G2F&MO5:Z%>OOA6.$F1V?":^9QF:Y7!^X4!>CLK^ALG:XR0?3*)$LQ=L%,^
MP8YKR[YA\S.-3@8[/RML$KQS2D224-1+T$OIXY)2+(R8+@1W, /FZRC9C06#
MSIF74LUR"DV][#PJV1$-A^3!J)0TC*-@^@_JFM$L5EKMD I3NE*J";+*A# P
M;9871I5;RLQ5D<!C)-P2+I0JO= ])J%SR)NX=J:K(U14-QS6S-XIEI<+I [J
M#KNZ")XE V&9$(>K(-OG\!HN!$:"(_97X@@9[+7&:0PTV)(XJ(-9BE:X#S >
MGZ1V]]&[<#1W:!!7FPD?80%J/+S%!UB;WY*;2+.>A>R<V@52X=NGRWGDZ*2,
MT4U<)).DVC#MVIVOP7/#X]T&5/>R_9ADNV,$FH,8\9 AWO0SCT7*F9NV%$1L
M:S)S7E=49&2:3V)O"H-)OI["TV$K4HW0N50GDRL<:AXZ]6*#QG"+WC26HQ?7
M1R2N;JU+0Y^8"T8F1//L-00R,-34MAV8T3MN*Y9P+-!40 *,6FBE5\2P6&?;
M4CY#JA4T!8(Y6M4T248C=OW1::_%N7B14_]"\ MB$(F=_SGX.4_P"[OM#)'%
MRM:\?O'+\YV_-=3?^I[YI9;84R]T:_1H'N[$R4$@>7F>7^KT![*>EMS,6-H.
M.[(B5?)T DN&W?SV]X,-!_2;H\N>,\45(^G] 8E^JX>A2A&P9[(!GD?:R:%[
M1'Y[0LQ@5U*%6&(&)#)$EU>O:P@'H><U]?%4!8FW%T*63"!G!!7ELRT(-Y1+
M0>MK)J'_Q][;-L=M)%FC?Z5C]NZ&'0%R)'O\MIX[$;(DVYJUQWHL>2?NIQOH
M!IJ$U0UP@09I^M<_E2=?*JL -"G9(TIK?I@8J]D-% I56?ER\IR;?S2%Q0DC
MCX?8*7L_#*9F"W:>(8O2"XP\NG(841)WHM@0EET$X54O/G(0S=6;N]Z3C<AV
M$2D(O4)*_NB:&ICD3-E_<(XU.$C8%S(AV 0B>K3^73C<MB"V#:"I A>#.[&2
M!YE@.N?4)H3R+Z/:\-P^V;1[D0-PZ+H$)2#6ZW D)3U< N,?I8_6-<43YH=M
M&V]].IU'[@DD +5V91ZZ(ED6(0*COCQB, D&<B>])4E7<'@1Y<Z2\ZD<;U3H
MG)>+V@T=4R;^;C.04H5.:;:<I>?O#&[;W!4-87QX:9[@<<7%QJ>?;;K2H?-F
M6X#3X&6!\[N,F/SX=@CV>G7>[7Y7.LW?AIY6\V)[4GOIJ8/#*2T9E=T2?5UJ
M31Q;/1UMF^:BY,P5\Q,4:F-(EE=:P*6K7M*HET!"7G3RG825-H-%L,,!5#\_
M0L16&%M[>1!4_%M:A=*TI$2$;H]8P]'\1"?B\+2V6.=F]ITH0RF3[I#F*V%>
M7Y'Z7&)G?.,343^(*1'2;\=_T3#=JN_04( \8IV(<EH8N_# F\JU<MQMNR/-
M!0@HT-H"QR ^ON/@CS<6G?$0TM>MT%]SE[(=G<1K"8[)7[BKO[QH#F+=*A X
MX9!NF:.7S$)=._2M _4>UWL2<;?;OIJL"0:M3UTK(+34K&=%"'<-IW7F)TVW
M)Q-FIHHX'9XQMJ4=EYZ:8WDJO7U;4.P,D^%H;,U3C$96?,9B]5YR.WUZCQJ^
M1PV_+6ZGY=-ZV?3>'[]')^[[<BY^U3YPU8XW:0/A%51V4$@)X,=3055-+E>:
M6:YJ5_H#SP\X7;F=^P*JW!K6WF[N[,@FFL&SZY0-6%]TJAM_E&3A6##MC#AK
M0Y8M!3#E@#K/=3=&S>*$0I//"3H.9\]*GNDT>@B3Y ]WS)1;JNOPM-OF]^W*
M_6V>\E%\=]4QIV]4B-:7[51V0HCG&I$]+S-GSHZ&T.\>HP.KEWM!))!!;6KS
M?JCI5/T-2R'>)&&BQ&Q<UCE1ML]%Z8(X0Z"2<_;Q%E$+<IA*SDU1HKFN7J)0
MG\'Q:)%UK+G*NN@?%48[>T$/M6>EYY*<U<$(DEZUW=6NKJBI'WWO2 ?I<[([
MRWQ 5.]?UY9,(+;0Q+HD.NB6E3(NYVQSTV_!<4?$^Y0D0^#0$?G >;G;WD;K
M5.=-^\2OFUIT%'2>HL#Y+2X3!:.B'4#+=,+,]#HO4_CJF=0ZH=(?:F#Q.<5F
MXDO<MIX(P$(&6E<F"X(G^=ULQW9]5([5_5[5T)M6ACLCM@?-D'??4<7D;;*Y
M%LX\59D"?7]8,X,(:EW5SI[PQMI9/HZ(AS6K=E<'KL64F?4SDX?%JP\K;9"8
MQD8B']75K.I]F"*@L"JFICS4<6//Z@5X!=],1 $46#:KBAH,]AJ\AN >#LL!
M:C]RCHO\6Z3+DHB3UWL,]=2N1T(&),E@1M)T=Z1QR:^IA_LX9"W2&H;SD7!Q
MSI CV(&FVP3'A&N.9@,V%/E=N$KDOJ:TKQ+\:L2\3W2O:<\H183?($0VV ,\
MPHX3&+!<0SPS\0DO'VZA&4?*>;>.5ET?(_)?DX:) X?0+^QVE&$ETY5[M]-Y
MH__TKX.%7Q#?AZ?&VS&;PI26)9%,]V11#U=UG5RS']N<LEEXR#@YVD,#H]R-
MI6."V'*A;/ZU*G<VON8<]O ;:^;0ATL]=H&48;Q;%E2Q+/SLK70:' A-U,'[
M*#^_M/SDQZ>KI[>R=.;]+)@ZW-.2AXEY0UYB'U9Q.'7R^SC;QD\1M2+EWZH8
MR-R36SX)8\:+F:3(,M@0E#1+,KQ)<4:2O.H__^MX'E_#?GX;SN3PGDT!-!(#
M[9F?DQ6-0-48G 7D"@26169W5P) K42V[C(P(-?["P(YSU]3._0=8CKS'4JF
MW2LY$Q4]D)_'ZDQ%]DS'V)>]&B;.)QUDL=+J*4 4K?5T7IKIPZ$<^;B(F-/Q
MD>JWN(=^&L#0+MN39\-GMT)\;2 Q_D@'E$99M#2:/F_/UQ-#9)R,[DD6$GU;
MG5>E'"7QC1 )19^/6-KY@'$2%,L;S8GEN!!#U(O20JR,V14LW'2K7^HX]92<
M1LF71>^4;BD:D[NR 5=T W-+_DGA65K3,H=E KD(IVX4E?.2-_&O#W9^*[MJ
MZKV@@N3JVX(;,W:PW21 #XLOT6O#@5IO1I%FFW"VW!T%JCLCY;&:K(*5%M[#
M-D]G041'PZESJ/$\./]Y#3JR+O@D&?NQ]X\(2ITT;]Q"-N)&48C"D1BQQ&O,
MM=CBG_52;1/W<<<125J)C"_R,PNQN[F@T(<]-$,XJFQ<BKH=:'G0!$H ZS+_
M;KG)#',S%2JXR*AX%E-/7QAV/[2"DWIE0EV4=R&K7$A2@!(;(9!UHXMG0NY-
M\$/Z.ZOKAC=&?$92Z%&#EJM!F:J%QYH,Z:*6N?\V^(N(6,A>1<R!;$LMP0-1
M\-XL^MNL^8SB[8V7?AYX)8N>$\=QR<^]@+>X^!T=.^?)WWCU%^J@*#>Q<TYF
MR24X&*L/L]IK'I.A+!23L#%U3=^W4MIG]Z6T^U+:VRJE_2;?#\C"%.&6L%YG
MA7/R>K/\QK(.LJ34MR,%_QX;5R\S:S.W.]E<R@1GE.EW<PC31;-\?CH_TV#K
M9(UJF8,&IC)S$0\H8!;4OY((L$IG;.*]+7X3<SMIKCL^QQX?P[( $C6W'=?%
M2JMX+,=M6FETN@ >=4*(%3M';Z$56E@.BP2#Y=JZM-(G1M%2:?6_J@FOK)69
M](N&-9HG=;^J<UR-SZ%L1ZH+N5#_GL+Q?V\?@32B)DF@)7"7W]WU11,<P";*
M5$:5OS#V\!UEY'4D-Q'O%=R@E:H#W;=9_9'6F^:]/26_E_KRM003OKA?(G^D
M)1)L10=<IUL7F&)$472L)1T%NJ*&#1C]QHGL*9=5P_G850DA> Y=E8O?K[H_
MY*I3ONR2Z1\7:F/A7]8M!*7@NG[%N?C8:=$+F ;U1$D5Q*9^[Q)?C#TQW^!/
M,_F%=Z9A[#6#)Z4%IUZ,8K+-5,O%G/PM*W50W;0<LB#BD!93@$KCN_H7LU!*
M@81%N4&GK7-/ %_7%C-J/RI\4XU#*#!FG2L^)<=#[J:FP>:7S2V62O@<A<N^
MWM0A/F:0S=?$>T0S]:0?SU:/7&HQ#/@#:7;\^LDC:6#\L%@]'2F!5E(CY7[?
M#-:'9Y]_3_!XRBVM'IV!Q4$O\_1[=QEF'%E]75>0/7[6JN07C5\N$3Y_[E_U
M]Z*<_*3FW. '?VUF,@X2H__I;U\1)&E0^875]C_^[:-//OJR7SWJ?VUK D =
M:L*V\G5_;5J\X%>'^J]_;O[V89'U:);CX;SK@7 5L!KB9GI"]U'<=BQ,X3*1
MDMI+>+)7DIW3ZE?R1Z '(NRD2 /;B;("55Q8[$-%P?ND_M;7Z(U=7R<[7L:/
M*S"_-YCWNZH1Q38!;X;(.\Q]"!7/:QQZ6&1U:Z%CGHI K3W?NY"1C$\ (O6M
M74+6I7L096?ON$'*-?EIV"HWN*/$Q:/!C>&(92KL&;4A$P4]'_L&VQ6V.8,Z
MFC8-?LRJ2_6I9CE2UWSS*.U0-!\7+9:$#%Z557 O4.M>*@G?,FMP+'\TV\O[
MOU6V[9^"+%,HI=/" G;>3F+WRHY@?UV.3S-0KB)5-016<;WQ\?I<DB%?4UXQ
MS7E5]:BT+N,<S6)%N*-^A$32W17D?L]9A5KR0O:+B?H4XAIU+X<]+65?[Z)4
M*U5SCD -%NM@-. "/R]8HE$X#>JLCV^Q UMZF;4>)FM$M[B##*SJMAO/SG,Y
M'JIO$@*9RU]W" "7@F=<PQI )26\PSE;2@% -J3-T9\Q\G:FK4WFP;BDT"0/
M7)I[?U)<2Z!LG N2;&E<5^(D9GA/<;820@DN-;+LEUP _OLM8,7(\G/'A@+@
MA;[2G?81Q10FO))-.8$F*:RY 5XJJK[Z!':ZEEV#^2!_(=!L/7#_[F4M2+M!
M--E2S'RLA<<:&Z_^*+JN*5ZO'::#B3,=-;EPN_"XXT ]S]CQAX8038\S02^X
M1U&!L1E4^NLFI3$^0N!_Q=L2NT'\ZGILJ#N_I170; PT9OMKV?:F4)VI&FK^
M0U6>%83A<KZ??A+5MI3%PG%,Q4;.<(%M<S 5[!]&5VI/@09X3<2(.F3L$E6%
MGB*T:S7:S$4[SLE&QL)_'BOI.U<PI6F01<9?WJ,JM5@G7!%1"M!9BN@D>'G/
MS#HLV 7KT@^+)$[3,;A56(34.0%%^6[/\#1!+KR]=N]G6[^IRZP!FVT,3/O8
MTH-.>,22]8/#17@F7'/)SV.(CRON%$Y82*3]2(3EX'"4W+-S..]QM @,.SFY
M6-.1?#KJ-= Z&_Y?Z5#:7?AN2N>3V$5F&+2L6\/$)&6(+0<QC-A#17*)PIE4
M/?!R.Q"C$GI0DA9G+YK-@GG441]O?HQ=GPP.!_G5K,%Q7=8<R_4]T:1(GTX8
M0GG9<3P9OK<G+A71PU,N(NY6Y\X<=OSF!N3@Z=QGY,2L=50).TQVEP@5,80M
M<]QP5%ZLGHR'S7F1,2B%IWXOP2*?WX-%[L$B[T#?-9Q=D$'Q_KVXX+ZR,0.*
M"PK0G8\9R]KIZIEQ(\0OS3DHFO-4$J%H$ MOP4S6=GK<.&=%3YN$YX&'P5_.
MGL-8O/X5;1"_&93C6B;%+5F&E]!<:?NF4F8=8;!9FE(G.SR9W3L,S%YK)O3Y
MSI#,] YD7"@2+G7]!?5-5919]IE ?78*U0"&(3Q)$:],+>J P2;0 /9^NUY\
M74YTCU/$ITZ\[ZE?GG9;U.;/O-ZZ<,XH 1!J]&9$GI)[-=(_0 4O"STV77O9
M,)PK&$8I6<QD5&E9LANOW(#:4>K*/ZF]%4;!IG<Q35F1?E-)7'S@S[2%3%].
MBM;W=>4_TJI$;WZ##"EWW1SMQ4\@Z[+$SJ\'D5Z7^E+#_%SDLG"8DB[/>S+@
M/^(:,_H@"EG=4>L%Y2[*ZZ[W149\7SY%;;+9K\=^8 #I@?Q?#IG%Z;)P>''U
MQI0N>D.LFU22&\A-<B&JM%_=EKCWX6<Z^>F&2D5>RNL9!QE5'63<VNUN1!DC
M;JLWN']5;YC3EV<-TRTEHJSM\1U ;^2L&WA',2,C56+I2;'#[T"M- .]\#3=
M,0Z9N2$8RWHGU'&HGB-MBYPU]\=4HK'#947VW811P?.<D"M+>5+*7VFWCI#"
M(F$<3!47S\.7?NZH<6DGY:.8-L?+/H#OG\Y>HK%AH(?(KO1"QBZ$B.N^*ZG;
MMTN83UTYZ;E[-*J!R'7UF708E -W-?[2CS;M'Z _" ; ARG$EMPHN[%7#1<H
M+6-JC)3 %O8P:II\1Q>ZY'SZ50@VS^&WN%=S1Y&-;X=F\A;*0G(ON>W!U=G8
M4(F\Y?368=I"G=82D6>M71K/MYY[8C5A3"3*&)J)X5QN/+N85"P"N7[8U.6%
MX9AH-=()YU@]A*58'JDPN) EI_R:A.D+Y?EEQJ]W):QW<_.JKB]6P&XB 8K5
M75XT%5@W9$5;R<DGP96 VS5>C^%YUV$"Z\-=1NE.?V$GE1EWVDY(D].RW2+!
M#7/'H9>%&K&)N0.X(P+CA!/TNB[E=.VE,+\FGI-V#/<E!6$$'QN^Z;X^G'?5
M0(::RW^$LP\^XB6QT7,1E\]E)9(038M4"P!#[W9&OF&R?PD3!\BSW -*:&2.
M0UJ>XN+%80HFC(@B3B/8BC@OW=GMNT*I_29LF##=X9U*GAX+*^.N87KT0K,0
M81P[F83>SX*@ 'LFK$>XEG-'-=132M4=<RBF"]CR^4G]3!G78F4V9BJRF'5F
MN]A=7K>O*$$(<??4<#B)A50&#4E-7I"H]."3^I9I/5@E.V.'368<P GG <C*
MY!D1G,<2S((W^YK\J=KV^FIL=YB^6E< S.5X 30WVH)),"!,D7AC6Q(KY9 [
MCB-G9HL$*KHGL:;S^!Y;X(9%CC2PY_!*V(FXE%MY6! Y'\F<N>T TLE;B!/Q
M:D*>KN^N)-U,>!1RX!Q973Q,)'6W3",Y9181'-E(\^N.JCNG(0-:&*#0UBQM
M,]BI"Z^!EP13$X6)&3H<XUOZ^1)(B=8XDZ8Z3K(E**$2]FQX15! PR15M,V8
MJ2K\/ %OYLR;:2="$^*FRQI55XJR<#S$9[37'?8/^8EI[;=/,0AS3S>VJE_$
M>%='X(G&R6$DA)<03/N+1U:<<*X,=89\PO/!J"T\I)"2W0)E)8V0W1 Y)]7B
M)'3;A75)7@#'W<>X5,QBL1R@NFR*'<(Q &:VB#BKP8A$)K[:'R[BJ-+<Y/O?
M2!<\ 6_235MD6S-\#@+*U^5X-8/I"(LXO*ZK=\8;S/IY$X2R&L>("D/U_S8&
M\.V!01X-#LDFA()@N8AX8H7=),057JDN:TD"B@I\A>17!.=VCN)FS4D..Z3Z
M2/>GK!AR8CB$JDCT[(SM([8UAU^<]>5>,7H'S5A<[,H#6B<<8A'PF_J<B ,O
M:W,2<1/FNY3F33%\[%!Q!Y8(02U2C$24&F;-EU<I9QA\WRKI_.(S7&V0P##3
M%$-$PT58&8>)F"PBJPL_XE=W$S/OZCE1A #T:=_#5<2^K<D, >LQAO<%GC7S
M4)7%Q#U3,B!,T )*+WA@P5E-2\GO)<SCBWN8QSW,X^YA'M;&6;"?9DEH8DL
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MYHQ;9FPG9&YL0\A$=-#A5;8Y*8@2<):VMIC4?B2^KRUG1+B50QUL=_X;9.U
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MR@;23AY%]A1CXGMJF^%5+#'FL$DYWFUO:S_77"["G: W'K_B='%3*?T":N6
ME)'8!B.%'E'5IO(LH\A!4(:#/<:$)UN9%&Q.N9T% ;SO6DW\=DZ>3!X[7NC6
M1)N%0*S=43W?%D>[E24'!*)1W,C*R76.3DBUV+\TV5G3TCYJNG*6V&*5\&(+
MLTLD,HN(ZG\]U>?K S7S&KMRH_J%:47"V7A4_2RW:&<V/8KZ4D*)NAMTL2=:
MCV*/Z*_-3))7:J=_^MLW1)PBY;-79\%H'7[]ZY^;OWV8>%+A2T^^23KD")5?
M[ZP%X:HGT$ZKRP:E^[:C](\^X1!<(L M?/NPU4\,3=2U]A@OM495,HM+3WW4
M3=@++8,>F$,>!:#X>^^T-\"J?3%GXF6ZGGQ3Q'?!1#I\4S[J\0UKL1V,CC!*
MA#D&L=EESHI=52/*-(02,"NM)3%)N\FKI-<:(IRR4@)LOCC9RN"FHP=;1!LJ
MN9P)+1#A/!"'4AKDPP(#(B-+.%K:D7"WG:$'[/SMU9@SSC+./9,1+\2;TZ4O
M[R=7;TI##IYFN-,^-$M+]\6-M?L"%4%K3,ENP@:0RYM+4@@3$^_W.ULL$NC%
M[Z#$D'0L:YQ0*""&/#I::I,J;FRJ\%AAT:UA:YSVA&?4@]-N9JV)>CI[.Y&0
MC5B'G5Y?1B=0LA.6'LN/*)I+FO^18ZMC1!F24I3T)W-ILJR6\TK<,Y=G2;I9
MLH_LTY!*D"0Y%5\^^S94%P4=HW08IV\[(VD7&T7ZCM+V$CZ9&1'2G'[4[+?H
M>$LN$>L4&G&ZHPEY+^NZG][7=>_KNG=?UQ7&J5FFG4*Z47:21D6!9SP0&LN!
MW&:U@]@^Y%UI3"4#/*OZP[,J\H[(\'V P-4DD$(>C;FP,:S2()X,ZEUU65+M
MX9I9D#_ZA%I3'WY>9*)R'YJJW(35("- T)I@Y$!X%)YQ)Y?_#)?_5,N!J>YG
M&TXV:(L(XEJ2O[3$G%"H"BE[43Z0\^#N0B41?.*$X9[Y]NA;B?OM=?&N&.=K
M9 SBJE(4S(G! 6HN75FY JGRZ[N,8=>*.%A33Q!][(YIX#UF=55WD=X1D84
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M8 6WV"5=S'3:>,:!8,T4$0)K-_>Z\Z8TP5MR><;3!?PSNDE6Q;F&M"T6&(1
M6O$V"@DP2P2;V6)T_E^D%SC.13I#MNB4';0#Z#;4NMY!6\H6)C!'Q2R^(=21
MN9H4:+E4*.9T)-:$)*C\%YO6LHB9 S67=4SKS[?+-)+GD]?\V=RGYL"U$(M+
M+@Y8V.#68&M51D_DXVO\4N;1['A6Z.$U@8(#'PM-\ C##!X2[K'7&EVVDED,
MTE1O9BOB1+5##!29P$+TB^,"^R"NJ)3+X4-2_1[;\(JHR)GN=J0D\+G)'[)
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MSX9PR0'EWVO#;VN#SRAF:_N6L3LYP[H%/3+],Q@L6,6![C*M&!(4)9?<IK_
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M\F:X!@EO<_:BONY\2[$RAMP!$TAJ)0S'*^ECTF]1(6Y@ 8HIO;]P"P54!F1
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M&PJP@BV*3)A^(L?"")^,>^+D6-)!\](L#86U4Q<K[(#>N>!\F:8EJ 5<7-+
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M<0IGE/&\ ZHK/:^($+QHX*NJE80UK69E2 R@56297KD!LP'H/U/,__D!\W_
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M^1(O&%9W(8,FF;2B6?0KR HL\G;_'R(T4NGB;2H9]$&(")MN[JX/BI0\;R!
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MM (#CE31OI&3*?X[EJPMAHTAJ##(C93"<;ZHXT=^4":-@\7!4V2 ]HXB2BX
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M<(^^JA?4\5422@). !QH 'O93,B2:DI;9@J!<\'&E /@A?AVO+Q4-;01DA%
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M6*2@1G_DT?'?$TI68X9@P15XRF'H(VW#/D'DH[+!^$%JU1(&B@2PP+2<H6Q
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MHFI##05C@*4 O:4F#-?,\3*G3A,8/5VFZ[0IBY04[JH412GAC\^Q:@ +#=!
M)?Q#H8VB"Z_@H]?K.L^N<_.YO(0&A"I+ETW^)J^L#,<\ATX0]R]W;*\0YF3X
MRD@H6D!:SS%7]PB&<$<"-2G>9;!;LTAFA2,,<K8YO*#W#H(,6%#VZH?A1^3<
MD]Z) '*H0*,M(O\0@LOGSY\FY%CC#@Z>H'@AD<4QPL_,JXB@"(2$+M(VMST"
M@C'"T@"5'+!:BV= I8?@'?#:'/A=?DRVW,[OHW8+[94'XJ%+)Q>Z3XRO/(\X
M\_$1T?Z^^XTRN&;+>L*I)N^:FHDPV&F X$2J?X^X^/>I)&4_=F1X2T2_A?!G
M^40FWL.,V;E,LX0(-#FF!Y YYD62,' 7'IR1^%UB7AN[_^(E$("O/B^+_(J!
M6G&/^U3N($[2<% 1IG1ND*N]E)#\FL%L6T<1W[4WRB\1!*@..\=,PL/9.R!5
M;[QL@WP(AH'XS!'?*[B!K;B%AVYRKDBO<VRDMQV&6*E=0P7*H'7KY>@J$:>3
MF9:V+G.L9.G0C.#H^[L55C)^C^UFW&4J.W>L);G/5FW=++O;$@JT;A_ &E*E
M>BFP^BS'TK>N)'0KXD)%^F0&XAP^"7?$C[ ?W"=*I(8C%!;C5^&64 #SJ^?/
MOIU=].PWM_W%!?([,4.JXL%@V,4;O/"YSP3PBCDBZ-UQ)NO-=R(?EV !.2RS
MAH!:"%;<P@^DVLM$H'+ZLUC!08RCMNZYX5F\,WC(9H,3% (V$":QS(Z1!%0>
M_#7:"7<DRV)QB1YXP7?6<"."!R*C>F(Z#7$:[1]-W@?$R+'OM&^%'B/A'2"$
M@]@P!/P+B@^EM03(E%?]0G!<RP5_\?0MDB_6OGL2,C8$XR-J*"!7!,EQ9Y>=
M28//7_DW M!.1QZ'G#J/U@QPA(FB: 1NMY:^'K>1ETO"UM!6]W-*_'E'5X92
M0M[FDCLV* &&S\#6U"5* P..@L7-]3Z@V]888=ZGQH5'O%J>61OF*3*\1 UV
M)1#K'H:2L")B-?BK!/,QC@\'G(@*,4_A.KN2P!G[@]S:"OR=S/8AB-[_L<EY
M:Y)THP1#P6]^+,IH* J9^)FM,=PM27 _4)?QZ*U NN.8P#B9!9DQ29\J]'=W
MCC\T_9CX9&!N8*+,YWX7(XVYA8&E%MCK4@51^-&*JY)I>.917>\UM7@ICS[+
MCR%XC=E1L%<M'BI$-\J5C,MQC79./B#&#_K+\.]WB( E%">)WLL[$A80NJXA
MYB]0S(^(]VDX?'XP36;R69]E:?SQH31^*(W??FG<Y(T3-$B>FQC*Y-1SO*BI
MVW1W(--H?T,0YQX- ]T[B3_F)=M!=_<ZYY0@F15EEH);6F]\3.@AA]>_$*E+
M\20D/L!*^SO"7/?8#YA6@0O !#",[322DQ)WB^F^B3:B9VL>9;).@B9@3O (
MX0AZ$FWXJUX=SY)Z6NXO%E4PPC\!M(G<42B*WB!TFO9JPA!,8;@\K:JB2NS'
ML"$@99]GVCKU^X#[XWT]=9BG<CE_^,MKFQ8SG8A*T?P6E%Q);!7S8%>JF#OD
M083OP^YRSB0%7;ZI(BM*S$92NIHO.&EG&0KG?'C4[,WRR>BP7DGNLPH:;R*$
MI96$T=Y=UFZ"O'X:91E]>@]3U7!$T\'L4BFYQIB"JIAA+HPZU\I0_3(LA&,@
M.-^00TB_+>WRP[74#:QP%?2,N/(%RFOPMYK7D']O!_8?'H&:;7*4I#]Y7F<;
M5O]+3=ODCL<-B/G)!8,3KH)1"=/'_:UWT?#Y/<R//DB\C)1O38MEB&&OHB8>
MQB_\.2)9QE8#KTE%]DCPN-0+5I A4MY B;W,+(Y,>MBVA08+(K! E8OLX*0N
MT:[35@N+HO03T!7WJ5JCEZI&17=6UK<=-A"SRK9;_'(#31A83FV!MO:" L,<
M];R5>!(:'>KKZ@*8'L=@T=U6V/1 \^86C1&FX?8AP09M<XHXJ*="XW29NDSI
M($E?\D83G<ZA"[6G!IH)M+LTD70D7\2/("VU"ON*1+(5C9G\A,IA!5Q3?OEH
M \<+_)YK.CZHU@Y+ZF546AKYP6OQH9#-RO> 2-2W;;G$VX&/@K)*[/6$8Z?7
M^GTT#M^KY/,J;(64T8.RLM=31@J91=HT&S<5A//P[ /@E0E>*]>+B#-7MU3B
MB=\*%%7_/?5FD$?@_/B/K[Y73&A8>>;W2;1-S+^C-! F7%\).-H?+>2X</+Y
MF4DTOR3G$U!-0.AT].=BVMC^X2]__],?S^\]>-*XP;>+2Q<OMUW>0WV[S;M_
M)W_^JOB++1/\_77WG;X*##KBK4^C<?V"1W7/H7R77^?-/+<#@-]/[ #<9\P0
MQ'.))=00U)(:JA[?%T?9D\1*;3A'(YY=>,^$L'.T*ZO:5WS1N=#4S2UM1A+.
MC*M9E!8;.5F@"N!;S>>H3D1-I" 74,FFB\B.W>&C]J]!1R#;,LE3(P@8*Y.:
MN K98E-UC;2,*]^)98 H*[PN6/U:$I=3YH+I(G@BL!V6SQ\46(P;+AVYSN-"
M-"LJ:+->N"5'A-]7OR_3<;NI8H(5]M,B"@%&RB83K)()-9,:'&-%# D-$%CZ
M>4/)ZSQ0B.Z$3*')J4>X*[J>T7Z0%EOC)/ '!#=;DHBV-HS>$6IB+PY"2762
M?L? +F!LP+UO@N<M:]!7N)MD#42]R5?Z):!6F15<WSR"-7F=0G2EX7ZETSGO
M"]H:J)\^]F NW^&FE4UCW^;H-6"_\V,"\N75\=]+N%/+P+;\%7LTY3/M[!E^
MQMN:GXQ^"WR-/C^3SQ_3YPE41>& +#E7>G&CX_UV#;'S/"9(H/EU4[O,"XR$
M 5?)@%<%QO!!(40O62'I^C/?9)S+Q(*IVQ_^B1Z-HCC(:,_KJ<Z7E2"+ZEX,
M(MS_*UP+900H$DT I8V2:,A20BTO* 4]0:95(&3)>N551P+=[A)K%/+3M,>=
MCT02JO@SX:I07[G;*F/#I5HD$=-"X5<[_O7K4"?HEN[^O'_^Y++IJXOV(I_#
M;0V O/_*F])YSU?N(TUZ03=5R()#L'-%QX\.@@3F$'SIAP+7#X+KO5RZHB7P
MRN.JV#)5@@;/RL(R9-GLHJYY-\#V)=ZN#JI '7NHT%GOWL#Y$C)3L-L Q$FP
MJ[Q;6/-PF4_M..DAX.U)U4(TVJ;L0N5PG>1PI9+)"8HV%1<[,TA)>SV,C)V
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MK7$7)2)/#++82] (O/CA_?]IJT=(AM? :>:Y5_9<]T?9DEX2W".I,1D9E<8
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M^3LLO-;#NB%'$:'0BC\D.HY;"DA_F3ZRMHL7XD;UE.J;BPUILG/28" FW9V
M"P]0'(PF?.0[FA1,AJ.3DC?HLG$?*ODB64_5DG'-KATO&:A5NX'XW4I9;HR]
M.:TB^D=U)!&$'#RA7PA(7E'E,ZT^+;!D&&$HS&XAM1\YCD 64\\]HRL??[-[
MW;\0,@TN.]5H 1- O6@$HE,^9I):]70^;:ZH>]^%&RD[#6^)A/#]ZIZ[N4DB
MD28*%,TL?#+5\Y^$]587;LHLUD+M%MH.DE_"6"T VL\+1O;TXM/C!^>Y[AMP
M[-.KFCL.L-4?6ZH3TJ:"'UPV/;$]S0C;WT'C#:OQ$/<-R-.N:E:W4CX6(U%G
M>X$1]QOM]=NZ+/\1D^6)WKRH+ *9CY!/(\.![%J<*HB,^7]S.P<"H\$-IZ@5
MZI7!B?74X,*#QH8#@<"8E4B,].6^VP+LX!;U]'1&*L5PKA YPNTI5E&,ND:%
M]=K<?Z.+.&JQI/^+R\U?XYHBO[N&*1A20(A2INLV_UK^P\<:SH?M&O=_F7R%
M/%Y<1PX:1-OKJRZS'P3&.1<3EAQ2X2YPL<(3=VUV^;%SLQ?@FU\WZ5KBAD?#
M9W[(&$("2-AO3TSP,I6HE%][O5DY>_&_4)WL[%$H3A:]\ZV-/C5,W6A8WOEF
M<Z%\#29ZV#R1.O-%U*Q> AC,$X#TU7\</IS=).&\<K8.+G%(#C!'0G==DVIW
M&_#L72'P;P&M*T%599"KPTL%F HBFH$G?H6^@CW\%6[]PPDXG(#M#JQLTZQH
MX3K9FVOC]]W-LR,NN':7.C3JB5 >9![F\.V4:QDO.8R#G&<8C ^A%#C&:\GL
MMCW<684;Z!WD8#P<IR_J.-D^**K6LAO$^K8!#U_E-<AW^$9)<,;F""?TX$%[
MG,A3PF*>"+3@3O<ZN@,W2%/I5L5V]%HZF=C-MZOT @$3(FQ\:1_>ACS49QIB
M?(=A,'X&4)\8:WW[[+MG24S87GN16Z5]7V/7NO-,\Y5<\6X2G8>LL+:!G6LH
MND"R2L'A7Q$W/_H%\1?<*+23F9FPL'3(20!JI%/ *2OQ<MDAST:7EGCDZ6GX
M$^9Y(<0]]I69&7<3$5<*DC4TI_6 X&3B&HFB)OW#G61\9ZY<S 8;_J*XXB:U
M2 "XJ*YJ1%;X6-WP#1"ITMFCTUD&^DFX')"OT0YXN_"($WCXA*I8D@U9\B]D
MVP;8ZTI1-DB'L+2(AKPLYKGA;;;%35E&/NO<RDJL8+J?S6"/"'&[H+0.(P;+
MFHC]2L1'PF.A/DA;+R=6 Y.RHF[H\=?R\NM;7-2$-RS5!>E0()>4?Q--D]'H
M/!K(#%&,6'0:.,4>32AGRGA-R!["-"@&C39*?++0>]'3160>T!@>RG6E;*/Q
M80)<BT>@PC6088 @&\D,>3C<0XX\(;802Y R97U&./<6GR6-R!=I<(AC:]ME
M7THZ?%Y\K-Y89W%_<">[)OW%T1VS_R628%BC)W=1UR44T>KE<G!TS^_ST245
MC2#UUXN\8=%X,TUI-F>D6\BA&:H+;ZN'AE<EPXW(!UGMP6<3\1M)L0<?BG?"
MU"T 1$ID)^%0M6L\B(W$BX'9O(&]1'T[R(" ^X ;W[OQ;,"GDBQ9GI8(?Z3U
M0MYR<DV@.D(3G<Y40VK)Y\%*I:-V1I83$KJJ =]+3@3P=O&2@TWP:DAHTA"D
MLD#2SS#4L :5 >2<Z"/HC/@O, P<D"$2=<=DZ48JTG[;\L=*X^X)Q;[M19Y^
ML F3T>5D%;UM2[I']!2N(RTB]T-(JNP]5I'EG1@N[V=O/).YQR2,WWH7Q,M-
M5P#+(EB@1PCN *Z>)@?C)<S\QZOT#<(I0$Z.T^MJ(@5-08SWUCT+XL"[ S#6
MN$$U3"[DB U,SG7:^JO>R'-HQP!YD]=U\^;SE(J^?W[ 7ARP%[?/APTTQPL7
MR!P1R*YN8F1=1/^/8D+B21@HG5'G<I?H'>S66H5=S<[K;'*3B@(WW=0%I1$
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MY\Y5?3/812$F<_ZA41LCEQK+C#X]H6G"S??7HL44 \I!0!=FO99H/)C7CV2
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M-H<HZ=S&?XG821=?*/\U8]OH$\S19O1WK1! .@=="#Q,<+&4A;M^H"1 !%S
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M\!;UK)P($6Y;HN"62E20R,A[$1/)[I]RKIH0_)?E-)R,$K2#N? H>-,,PBO
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M/6#IY1C11*4* G.!AW,2!86-VN0MQAZ!2/C4YD==6M<O=^T4#?1G'8\?*G'
M*&;V[<-[\4/NR0:X=,H<@]=T5@7'O7+4IG*]PW@]VB?^:KTN+"$36'!J7FK(
M0R0VW0G_4HM:SNM9DZ_"G'%/F!F7<*YMEAM!F*4F5!>S,]VC(=/>W06I7=]A
MEC]L[I/FRC]LO1D3INOOF\PJ/=AGE?99I0]DE99A=O0EG]P?'TD[V.?N8D!3
M*]4$>""LC_&'-COB3V]G'QN+%7.C$%Z &P/U+,Z8'P:G)7L?I-K,=/D+99,
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M&-H.4UKT+#L+GM"4,A85Q_G.I.WZE604$#,%!VL3!?A4<A75Y^@<[ .C?\?
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M!T9!P-=)0:-G,8"^9FJ*'VB-Z:-()-+MUU&-HZG_4:#1GIM8.0=[0 #:UA:
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M'!=JE1R3WK\<+C <#]'4Q-GEC*G%@2A6\YPMPZF&G&"G"J2OXZM-EC^38\K
M@?3Z?R5JI]=48GE5KS8,O[HE!,]+4(BY2>^+=7=RDPS;Z=06?1J2"F)&1E9W
ML ,2A.)^%)XB><9Y<Z2-&MIPQ52J<[)=RH:0]TT+-K$DN?WW-(.GJ?8/() _
MV*=K#68:(W<>5W&&_0)0A)8!X<$56OK0 S^"J0H/R1GV&'U300\9<JDP]5*[
MC!\*JX:$PTHV]D/Y8T+R4=M6L!<5?+9IS6F8,%QI)O-QAS7=$K+34O^+;:P*
M:%VW5JX[JP8P=Q?7/$=>4:RKM.X!+N'_16TQ6WA,U&6#X>R.N\PR?U<,R\A)
M::!UM6&[Z(44_:*>,36(5,4L]T]"6<@J$OT-.IK4?X!/M>A!N:B"5E#>;,<>
M,.^35I9-LR=1;]:5>UB?\NLU8@DGB"_U_4TX:NOJ=JR7Q3*TH(F*C@5NKA'\
M42!OA/E:R=8KS%V/L8*#H3)[@B.;;<),D#&=*K,?+;L>_)\ZDO)+Z']#'U0C
M(UK2-[AIV/S<IL7*BX,5;0$G!DN-(W[MH(51@B:G;3BK80P:4RGU"?OTFHDX
M!.NC3Y-*R-EB85WTKK.L ;DW55;76H>/LS/8PZ&X[-OIG/I+.(A>.;:1KW9/
MOID'1^B'M\$H3O-;JC@\K[(_Y]6&:@W'AT>G_38H6K'*_<!F#Z,F6WLE&L%E
M,(.,>)='Z;2N/49Y?)O]%E;.&I"3VNRLBNX.]%HG]%KA)[BO<77FX6!;E$I*
MC5"4&4P9L<D>3CSD_$'<B?T7P0-OZR6PCS7P.U%*:V>5JU/#ZF9QZ J_;F@>
MLW9;3<-M"A;ZE/ICM&Y<:3 ,E=),HNY)'?'NV>T<6I9M*[(X+960"TX$A9U)
M0L/9.KR%/HS:09[JC'#'IEJ%)KAPPTIP9^*HD!>I;YY!6L'"D&G.A9HCKRH*
MIT#HL:#Z=L3SB_$X.,]9%6O+T&XU.C!^"85NTH86B02,V?26BJ=.A&C$I*%'
M#P?V"#!81DXZM%_XT2,W;["<:KO[YXMXIN%^OYX]!7"*3A VS;VWPNV!%7';
M</W''Z(#Z/,^WBGMAQ&%F@A;<U6Q=<:9*.RGXCU1UX/55YMC9'6GW3'A&;38
MJ+Y]NIQU(K[44?*)$4ED0C<+V,]'0VO#]64B./K@*N$-0M/V%Z(=)KP(E^4%
MF8/NH6!1UE)4T+*?A2'C[&<"GP#51QV:YV1B)2!;L!&6I PI5+7B[<+B1?T@
M(T8.3X,6=*1.D'99;_U VPT)%0^-PYSYEOB95YMF57.FQ<54-A_<' ]@OLZ,
M)#IXU1+5[P7IS2'#0)M#,0U,Y7O;J*$_;ZIB1RMQGO;F2N+_[V^S.WGVK&A(
MVV$B9Z22 W"O+Y^G=_V!*9>IW;LW3XU#?9XN"8"7Y_5DNPXO+>RL!/2Z3EJY
M^$@<KGO<>?7Z[-F+L[?/'V?"$R.@V[NW9Y235\\33D:/H%!DTIXQ^/9%WM()
M_(;G)SM+=YPX*V%N7V !ADN=R(H3W""!M!(2+$8,=$@6U,F0U:\':8>=-TX^
M(X,7GU00YA/WIUT2V7SP"L +SD<ZET&?+<]_-<@-?TU1-U]2*T#M[=!9W/-7
MY6G<\4.OZ1^D8$D)DN")3<NU HO[.3$ZVMME#I$6[I_US6J"K[@HB\64E<XW
MDWI"?5H$=IJBHF=8*)LYW6("8M(I'.M8=104?3%I0">B#*N+0%$8PKDO!I85
M:R8$AZPI>8>'5U(L(3/3V@#*5V\>ZUVE[3)A@H,AN"#$UODBAYY](<<(?T0*
MH10ZKMJR2)SK'F*P:_FB-(IT> J%!$]VSQ?2)!Z^/.7\$N>I5ZN%>TN P'Z+
ME;L'A_O*W;YR]Z4J=_^:IVO]V&1,T"TBM+]2#I.&5A\$6TN$0ZT'2ZQH=_B.
M$77YLF<P!#_09O&P@7MJ(R#'B7:'\SI)'F3-757&?VR4 4E6P7I;5('$:VI:
M%(,$(TR2X,#5*JTVZW@OBNL( >TT4=)C X=%Q_)_9.@]]:I]$E5K6"H:3$JB
M:3&W0UEK;ER)-,$6%^X:GC=K\X58<N9);6./D$(DX!CYE^/O3-&/K'D\E!S1
MQ-$$[RQ\H-[9\/FLIW>,7M.;:2P17V48+$#V(C)E5 51S+8SV_'\?1*/7*I0
MB[I-1YIME*W+MMW01DC[>F396YDC8J6E)!8K-'30VAH9J0?)[1!U#8@.%5^*
ML \EU8LJ"*V4)SRVF^V')%W>7:,I.M1VC K:T8FZ(%%NVP[4:["40I=(U^+?
M^B"\)^1%""5&.O.]$LZS)\Y'$&:GK]7_?5)0F(G& )%2CYX3?_9EG=Z! .A-
M6#$: 0VGI(3@N$L,Q2]9GE#?E#0K=IQ?3DU&FFV"H+U^_9?C6$3<*3N<^H/P
M^J2="NL+,E^/2?-&]8=XQVO:"6/<F6J2;!>5O(V$E!_ CW:2AXB:"![ $Q ]
MY,':-_:%=8O\T]S*#SYOP@*!XJX; MY$7#!\<*5X]''V#+5?)K"(KG/G5QS3
ME])K0]TG=IVRNJ0\P*PSYK*:E^<E9  ']^/.5S=BA@*41FNM9O/T6G-Q[*.U
M2&4Z4.CFD5@K4.E? -C#.KJIC 5@Y2FR+*1.*-B]\')H <RD_-=I%RBJ)JQQ
M?30]YEP+]%JJYRG-@<;KG'&F:/ BGY1HK.B]@5TD8+M/\&3;)0ET37C:&>VA
M_/%9Y%&IMP^$#@+F$'$XR:V+19=^@>@ #/4P0.Q.V"0G=2N$DR_R[8XTBL]]
M>+/!$J6TS*-2:%[Y_/_Q*%';M3P@IZ:2U7?RR)D-\;W2FHX6*E+:F5+1UG$I
MA".PK35#V%_@,6Q/G%T)JRXN$%9]]Z?/D$G\M,?3JXMP8>GD>EY-QG8VZ0>W
M?#9=FPV_]ECB!QA1JKC= %I"/Q'KL^1L'@1%8+I=B=H\2IV*%V_>G$4?SY5Q
ME)* OC \OC \W2TXC/22;U[^W5(F87G^'BR4'L"/?(8V::A5DGO/,,A/Z3>]
MY9'^6B$Y_V:-PF;XPJM-<.OJ[#6I_;)I(765]7S;A'T2GFJY7=3EE#@0IR'
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M\)Q$-3R[ ]8XN+?_Q$-JH$Q.418WUQN%N0-;>RGU,PF6&J\9,S\[&%:AE]F
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M5X$8'(D @"M"]8+_O'(K*-544>6OJRT,GJ;&C;P+:(M683@H]<P8P5IKD7X
MW?E>D1SR'[>1E*& S_8L=;:XIEO; &#,57Y)U7+=0' +J?H$=:!T;EN;AACI
M =E.J:=M,*S+HH)E(TB:>>FZ4%PS@W9 "9]G:* ;-ME%.#B)T7,N.QPE3[SB
M4@BZYJA9\:.V?:9QU!>!BW[#TJ5/[MVF2V_3I=>P5_+JR--+%$&_0IS6*#1V
M:L LB[*60&90GQTC.<XML#P$=8TT*? F$8'2Q*E/J:&OJC4TO3486GWG(EN:
M/\ 8=89_FX8T>'EF/79Y]>MJ81HF:+S*2^TI5\U.*UPS"Z1O0?7$DO!CZ:V:
M*C&-P<9GF:VL?42GOPZ;EXJ_8HB;RBL3*').\)#T[INQ+%&@SOFS@'F:ZXWH
M\7EC_4>67PNB71;/#SFN9^PD< VR)MNL4"F Y4$N6NZ8A-Y ,**QH$VPO>CY
M4ZH(7B'W,%?^E"GH8.J4R(4%!&;UT :3QA<V:J3&$U5+T7J+%C1K+ !2C?$#
MC?E*L]/T\F[X)$_MID_3W<]]CT"0O#7$40O6 ?\_($Q<X^!58S_LOS1N[W"=
M,"BI$2OU:Y:\-1]N<)/T_,"L=86:.#XVQ"RF?(RP4\,J #%"=;5A@JY;Q-<Y
M#?</YT"_8+0N[*P!C;X-9[+#$'W@Y0-23$)^,[[!Z.:68Z+Y%1CKVN6[#.BL
MM''<.F'"TC?QI5A,<#6BHY_U_0Z+/&-/B9LFZ'#XQ)0YH\/Q:;LJ7:S6MX4(
MSG!!K@X?4'W^DK-^+:)Y(H8A#,C&T/\5$U?/IW:OJPP.#N0H.72UE9)S2I.7
M:P%%1LX[6>]FYH=?6/6!<PZX5V23@V ]1J1JRMP NR.$8B]!59ZY/4-\%H@[
M//4]C\*#*R.I!VM>=67$>N$5FDZJ(;0]U+,BVB<DX4L%,TV3US\=[IWEOR3H
M0O6J8*@TX4BL-3)%4\+>(,S+28(/1JQRKA6MKCK4GP-2 CPS)%P0>)#;A63A
M^SQ?*A2?ASVHRPN'A8VD(7 3^%\Y0C,<5?"!.(>J[Z=U+:4+4N0YVXQY&)D$
MB0"[?'=>O#L\NTLVT3)'N_$7%C)^V%$1FH5Y,E$/GS&^\(9L0,P66\"^[*(P
M'D>42]T+<6'1QLPI=T;9UH-DN1_H[$X1*RN%T=-8BA-58J-X?6P_GI%,$N(L
MERGP W Q#)?<#T*BCFW IN;!(@8Q ?] C$]1HX*>*[CK(#68!M@EKMZO9C.M
M0(!*+C YT0+QD7-<VU&#W7EY^-P75JAD"9+^TGCV)8]^=&0B!XO!/R7#^>UY
M,:53 #RH)P?W8D"H&QD*GJ/A>G<J_B6KF[C7%YW?88(B1--ER-_.$KM0D8 2
M^+ZHE4#$1Y7(1"79*I)8[-L@/J4E]*2J!2E!R=:4-8R117SQ96IO'P)\I]Z"
M#WVG07XE;+Q1FQ.68\AZ%S&) ))'ANUQB%G3R',T).@_BQ5[@%(L["<.I%/L
M]@@%C\4'X#[VIMR) 11]PR_Q&77M1C3IR<^ADX-.?6^*LW8G&\G([N):.*9/
M 49H2P(P]Q ]\#W0T1V MOANHRC!*FT707P7EH(KRI+'($&?!R'669E_*-!+
MRJ_&PDO"B#'01$#Y.0CRB>V)CPXCMEK4;B<GK?J ?Y3\>2-++&@(;K6*5AI.
M9-J*A""E!ZAHM7EH- #.*J @7,_XAKV^TQ9E;=GOS,"#;+'2 +-!_<N->^;V
MXD\HDJ,8(J *0P&WA[]LDG 0?;^%">(''T-^G1>+<=^TT/P[)BL,1A*FDYGK
M!QZQP;.(9.(P$UT>3MP(TSE:MKB"T!N^ (]9%OP=9RN@-7ZBH25V^*UKU7[)
M<L1,\HQ/.=D.E7;2%T#T$:@$U%@RK<M*Y<:4C!R21FC<0C9/)V2AM_79!-'_
M&M(6^8,@Q*\2CDW 5Y6KT>;Z(;1(G0O5(B\(AU(P9($,F*$_5YC @&:O^0RN
MJC(ZDTC02_D%RBP<*JE-=I&M0+8X]FCV- )NJ32LJ=T<F6- E@9LL&-V@M'"
MSIA!#J+?-!B/O<PNH6YX3N/<;])T^RY%"%OHI2N:Z1Z+."Y,77$!A>9511TA
MR,6"2XON5=Y[IY)+W'AM$5H4@V+%KS2 N(E47L_)SC!?DCZE-WL. #_"K._.
M4;0UE9 :.Q?VHO.Z7;(8P-=#B%<';4-?OZM'!FTHJ+['R:RY4'WF#RHC>\!8
MYRFAOC^1X.-FA &L.U-UJG(72A*+GNW_AWS^'Q::%9K-AE'Z>C5=WE9@WSGK
MA"4D7O3<%MWY0EL7KPWZ>S=?K=\YJ3('K4.&:6V?S[.W:[MN(N>*L8O<TL"D
M(Z2EM>&2]J]QZ0('E^PZ+A'4/"G7)G".4N([0CL,- $GACVC!/-1Y(HDI0X7
M28Y<0^NPS\\]<Z,SU0TH1(/"0]1 2]!NO[8NE^LK(0O!S^%*!<3/.\?SI-Y@
M(W134O^DM1 W,J^Z?YM7O<VK?JV\ZG8MW<2&G30R<N*#Q#C^I.WI<U:;E2.K
M!I6$:5TN7>=+*?6Q"%C)-0T:XL0>U(33D/+'075Y@"C5'$/JF!04,S02QR^S
M!&(>[0!_''X0,=:D,;5-FIS5/?^3*67@==I3\/<]L-3PAU _Z&0SD#N91KHV
M!U'$Z/ K2G&9!"F6:ZO-U&@Z!SYHY2,*B"A8MWB*:O-K&U:"6_K2T2SMR+I4
M!!"/0FA@P;I1 ^XF5^GC^@,$%*W)#;I*,5\#YJI^R5MQ\/#-]U;@9[DA::D<
M:Y >Y7D#8!(7Q>&Q< IEG8' XJ_(-7D$5N'%D[."QXDN\9F!#3#M\G*&: ?
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M)X-?WMZ:VUL3._CW_MR!80YWQ7= 8=M<U_+M9;B]#.XR?)Z-=1,OPVME6PJ
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M)\64C<$Y<E[6Z8'$"YP+F'7.OA28W'(56E814I([>8(5K.9'5>-&V%OY8M;
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M-@_^]XD?-=1,W>H]AU^DD'6<ME5KCHE#?%H7-1MM<D<O0F@("I^!?Y1\]:Y
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ME[6<[>U@#UK(E>R@Q9),I_/Z,@>"@G!*2"T.1N E12 /A@:/8R*(K6?1LZI
MD"G:,B)$=/UX7)I=7AY?NK9?LO?5U@*TP[IJ^PT3].->=.K+,[?I1\='(S\8
M%[#;'",343R9Y#0R'Y)$*#)X1(M*+"R';%T-"A>7.7%?/;*7!+KJF8"V!_K7
MM:P?_?CLU'K6]2BPE_CLU">6P2S %5;]4LH$V/?1TCL!GV#7K?3A_SV4>2T
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M. '%$< *P&PWF#&3JVO0'%[T]54!W ,/(./E!+_78<3Z<ED US0U.08:GYS
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M!3>W;R:DQP1D(M?_<+!''+-H7(F39]+AG^3R [Q-.DU%ZT;Q'%JP1>*I$&@
MQ6),SA",-*M&V4Z)P'D-^&;GSA/41%F&N&"%TG<9HN1X^3Q)69=X<9LWII@)
MQE$5\0(AIAP\JU"?D/U#YDI?7T6'6&#G(#:1A-5!W=TT6>/+TM-@<D@>Q:FD
MKEADG1N;)S$*1C=*?O;@4@(LQWA9O/'D@C<%V1=2XN_\=:TK$]>3CF.^"K0Q
M6IP^D,B!!H/+Y^'2U6G</DEKT5;$*=QL@1#CY7]ORV_(*:FT6#M'$S#70/GD
M,TQ'I@W.3.L.C0>G A?S'@]P)0<F8J;P+7\%T/.:'<J-$)[^XSF+T$0?E$6E
M9CH 7AUFL:3'.0[BP@H-#_W;<(>\&)W13X,*JI@/,?@%';T.T!OL3ZP]J1W*
MMJUB+/^ (CT4] LTN#"YVX@B02'<)YT=J' _A]PGA\,:;*Y,LHO-%OF,B^)6
M+B;A+X955@;W ['$^-QO%T>^1M/7^S>BXASSC+\1O'QK:_[IR\<_+68KZT>;
MT%JI2$9(#7!L2S3M,JF+0)YVJ13XOY?VG97[4)]'IVC&(>-.^+<:V=,>?;9N
MD-(V6U6:)0[0),H"O"E<=](XFQE%;&L;R<L\O,@[W;I=08L6ZJ!DE4,V<1S/
M$A"V('JH-HVEN9"C1I>!(1(&]4RJLNSR/\=9.Q*O1JOV0'?BNWQ3%QD=-U)U
M$ (;H1A@\!!7&*%1@4NNLRKS<5E?YBXZ0,M\=7';+WV1=-F""]F"O*P6< V'
M+1%DQD1W*8,*AUF\9FR[!-?9$OB8::4L]X)WB(X6H^[03SCQG^E%C6\$'$2U
MG^2L(_>SSG"W;K;PQ'[+DKBFDK6]!*1BYH1A8)'S;*3)T2>#QOEY5LZ&)R3D
MY"O9S@C8_%@PY^2V5IU2GF A-/J_X0'CE>$(BX27!90E<X@N&ZD %<<8HC0,
M^' !S+EBI@*>8L'TSMPU7+ALO6V\O"!XL(D(D3==5ZJ1]([3(PPC)C\L6H!=
M,2&2))YAI:C!.-VX].@-4#<E3%DON0=_Z1MX!<L#.G["A(HN\=#257:IPWC8
M9.&7'-F+2_OCIH)_W]]/]Y_L\XO^_> @O?_HOD2A." ?++I5O V?!04%WK+I
MOV@@6LU25#,5PQ&"Z,[-I-1YR2$0+4UF(DQD_HQI0B8KZSE_?7#DUC>192L0
M=2S'(9TD07Q2+%"AL<WT+5+T['D5-AJ?#D*$S$XD]*\2#=<E?'/J0&Y?JSO#
ME?&P25B(?&4JV&P+Q3*'5:5@37#1K>DY+V=[YH:Y'FPISZ -<,@:?"3T)_3@
MYCT'H5(?TS;':QE,/(WY4\G R)?Z 0STP(%V7Y(*LBR(5+:.?]#;L0$,M__8
M!<4']'M7&Y?\+8=2S#G@VH64RY5RT@I^% MFWC8ZFUQ]FII;INA!9D?1>M'O
MSXLE,O<-")REXB!#N"NO6JU)"_QC7J@T$*X!UYRKSW/='+; (HP0IQ42K=".
MQ/72?FK'_48+O-9TZ783'1)B%_ JY-4<,E<J]9S3(6G."PD-![]VUHWM:S12
M%?HSR&X1]?^^?^]>>N_>/2^"Q2,(5H45$%X\9-?S%@SV2^V2[6:)$T(JV]R1
M<,2QX8FX<I4&S1L^! "N/:\LN&I Y_D0TUP"C;$L;V9&]^EM1O<VH[O[C*Y'
MBH*TC(G!MYB0L'WE_FLYLJO!_]0PW57.</)]P4WSWK:Y6GP$I1UFC6^21IIT
M]8*.KE6I'FYHT0_3N @=LAP-0/TA=;@Z3\#QK6^?>6Y5YLK#XLBCP")PQXQT
M8L2)9U!?,$ZM/&VSCG4J_MJ8:D>N%O2T81]/<C88,*FFW=CLA]Q@] %A:C(N
M[M^[DO\H,N*Q)4[-TLEP]6!6\ZJEO!IJZSGMCH,NDQ?.(9F[A*T7R[)>:6P,
M!@"BAMX\0A.$+IS],HW0-R.6V6YHL&@EFQ0ZVE8L@ZVPAYH/)NY$T%8G0\@O
MQ%,EW6&LK+I<OM=->%WW-(1GG5X2]N9T!9L.2N*2>;82-]D!'Y0G)'&6CJ&4
M"*CC.2#!!))',ROF'_/[+_$'W\7B6QI"6B.!\O%1)@\<+8ENF0O?=VZ2TIB.
MI33Z4I,=-7BTF*:L<=D8S;C$T6 N%8&-R4%P$:-++?1VR#U6&V*_OU1:"=?>
MCU=7?@$W["9GB3PI$[8@^@E$7)"&\4[EU:<D),:T\*989&P*#K(U 72;1PH8
MUECVR-]\X_MF9SG4#0>'U _P5$(X4SFOX/61<*\0O(N%QFO?)Q9RKNRH7W'0
M23S$O-WHO:YG^,/\3IA]0?B7ON9@MZ8%798V"Z%S<X]D?9FU'>J/?J4[S-$/
M_ $_'!?UX,]1:DSQP-,0 US;IZ5ZE4X6:5BNTBWKFC0M!$E8P"/]ZAWZ,TC>
M&:0=*&!0Q=-W+8 SR+]C>A<66$8PTTADC%/<H58/BVL"3-J-3 J<0<+:Y(Z)
M!K,TT6NOY5>ZJVIIVDN&@54J.0O_T:+GP9(/'[N[KD046KR:3/JE ?R>>31*
M+?(X#+*)W)B2Q25'(3=&4,(?GCSNU@2"EF%=#M(YHEQ)U*VW]7MB3\UI2*F(
M@<MYUU2:$+F4"Z_CJD&I*?ZPE%HO=GSYN)'WV%2"<%K/F=ELO#*UJ>J=I[N0
M?EBV^OP35,Q5)-E*CNH5D_?PQ.G;K)&63#>@<"@ JQ(T@)WNK=GI/A)W:B5@
M9WW%/)<Y0O^>=U3#33$4%E,V-+T'XVS]Y=:Z;)4:"K_0!O"$%GN)4.^D+,.,
MX]1;QJI?CLZ+<DKFBS,I]#">5(:%Z<G!@?1O[ EA+ U6?]6K_66(9TR^&I9$
M!J ;KCS.\V%QS=U,EX"943EU/<5I"HP_6" <J>&M/Z_;)6NG6+'ZX)?4.KG
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M@?5/[;;LZ'S\*;R8;><#ZO ;8 =&X"V_?>PCOXG6J1G\Q?1/B.TXVG^:+S;
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MZ'KYKW/]^?H7EJSN_46X<8TK^/<O[U]I.DD".%.8<\7\C43 N,]\<]J2MY$
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M7F/%)[^ET6>0K4<!QQ*XKRICS6)0:2RZ/7O!!ER&-4M6X<+@X3MAFU+.!C>
MN8F$U8<<8'OKTC13584)N ='I*2'Q7P2"<;.._X0HHIQQ7HW/5-V01&]:/#
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MN%$C,85+]H.*ZJF*8![R#J,;-Q Q"3/?A#<6F<5T=ZKN^D0:"?]W9GB:HMQ
M*XK1:A7$!0%91SQO61I'ZD9 MZR5D54RA[(PI33/,DM(@RK>919)&&-N&66V
M3WY>#&QO>;>D!\(.,%6T+)<R/5IFEY3GS^TP$14^XFKL!",$[(K#K]/J,$*J
MJ'64U:%?L+J)*$THC$F7J[I[2#>K%?><"FE1[Z^Z#,,$?8&DZ A6"E(&N;@+
MFK ACN)GRG/(L@4_!7/, /_!N))J]=5E]"K-*\M \_B\Q/YOT4NQ?G-*:0O
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MA'2KXO-,Q2EFK=K_'4>0$6_ H()))7=(6=JQPO8+RO2,CS!!N2D+EKB>#RL
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M*XGB^2 82T"\8AY<)4@.7"##"=8>@XEL5ZFVZ0"$0#O[1I8Y/OGPL_+R-'%
M7X]/EZ?\L@X_!W6VG@Q[]LL\/Y<4!;S+-L"LPTI9]X89F] +.)9[KNG9D<=I
M0U@AC2+."14&,]*C CS[U+T>#P@3&P8=V;CKN@VK-! \O6&\'5D&#IKOBF@-
M>J+C6P51$,#?ZDVW?&]JX_OWY7X?$^J% &-,!CWK9?'I(P',<9XEOLE6@J/M
MZBJIG0^\]R*R)<S5B^A[K4F=.<;N#!5MZJC7HKLA3?=O)+/LNQ7+OFET(,Q/
M$J2S680'QC=WL[8Z1V>R,]9!IU8.[[K?F[Z4;2_E+F?^6IZ5AF-D\</.MV+G
M 2);;C6:P:,Q5&6'SOG*#6Z8:AJGE@M?W:"=$!#WD*F%73SC)$KG21JAQXKO
MC/G*R,3@#!2SY#K=E-I]9B.G@9?@C]=K+R%8=>\[^ICPKA5S%V+4>9AN?-FY
MDU#YP[L WDO.9\G($9./&<QS8:Q<?RG?3SO)'6=?H.K/Y\P7ULT"R37WN%>+
MPN"NP;?R_LT_8-\W+(@%H+M\I22D&\-">0N@.^;[G)YJ/S)YBE=IHN,:MQKJ
M?-A!G0NZ=%#G!_0%LZS>\!'3 77+^@"%_S=W/4NC&\-W9R3K:;")PJ4G/&+9
M<P)^"B[N+^&M:/!PYT8+"AU2GT[0>U(!+O+GA!1['M#3NK(&= G(OT-?2+R(
M+6'PA/0L[)BWAD5F"H<Z::XIW,DU.SSMS3T6S.])(RI]1V=_[QQMNH\P&G^*
M0E#SO]+FGA5$'G0Y'B/W4M?.L7&I.G>4.7KUOA#ZK&XC3@?T#'Z[>*4YQ-SV
MOZ$E\@GH,4!K8(XLK0<P1GL&>=.5'T;*4(BWQ!FFIF6-<P-9T]ZPPJ\0O'",
M,ZVZF@VFD_PK"G,58\-4;SUX:H]=\K?P#GX8F?G=D79K,;Y\F$&%-HMT)AW3
M&=JY^4[ST\UWV*EJC6[#FOOY;84OG<%^?TW&]";F>#C-#3!P*C=MGPU'(3ML
M\R6[%%0V3X<U>+'HQQNOO&52-G[PFW0F+;00^Y_GKCVR" RG"]=Z:G=TO]X:
MF>/)R,A<^FSA]L2TAB=T9RHX\8.!.1T,#AI&[986\*+;(+Y*6$ \C[P9VF(S
M$/N>\9.^/,%]N57"4&4ZT^R<88F&]&:*>U=]93V60VZ5T?PN=C?XH%/@"TBB
M&V$#YP!IFO4N_B!.N;,>#?R4YTVB;X";4$ J>HYH4];;+:N#66?7 WL#7LKM
MS3L0E^@Y<N:&(J-Q;]0U%-$<@8NA]CL]>]P1H@&$L.S>9-I1H@&4Z$2B(83H
M1.*R/47VGM+M0O!]'&W0KCVH <5XVNL_[H:THJ=()QN=;&R3C19#ZC]&3Y%.
M5,XA*HWJ+"$LMQ8+0HU-13K2MX[T#6TKTFG2SNAHH4'^J&U%A$Q<NF+Y-_=&
M) /$KN]&GOQ'./?HFGJ>1L 2ZG:B-CFX]+IKJ]26YT:C86H.*L<WR72H5]UU
M9&X:F8?F</)@N+9+'.@_NV";N4D8W1MQNMGX4E5A^E.ZIOM$RHYLYU%=-Z.V
MC"N=?NVJIR/?.<&)QM:T)J5RZ2/CT[=<7D:].N72B^O.PR+K#LR!72.^=4?F
M9I)Y:-K]!\.G7<+L>7]0_4AW:K;PU'3,:;_?F3WM):!E3L=EN[6=9L]G;#O4
M&3I'G(!/#(O/-D?#&O%A.S9H)QL,AF5KN 5FT@&0C'M3[]MR;WI)=+[*:](G
MA\\W->WIN&.'CAU$2U)SZ@P[M,;=]5>5Q4Q5R#X#TQD5,-$(V,>>]NP\M ^)
MX8/K 3GY'@B2)7!/M)K:#9C+88! 9A0B-(U/WZYEA;:^?H[Y(1 1U1E$P).+
MT C"Q/A7"IR[O*<Y*6P4\N]-;0-W TE0H2B:\ (B@A"WJ+Y4WH[ #!'R$JCC
MXNT)QUF$#WUVXXHUT"A ?A8%]%& U9VN#((^,NK5,=7?',K3>+O NO8XB2@+
MOL%5?P)[U'#S$WY0S5]7\G>>DC]G=[.(KI;C;.5-7753$^A@#7I#IZ-$ RC1
M240SZ( 2T9T1-5+BV'C3GB.Z79FUCZ(+VK4%#T\N=NS>^''OD]I1[==)1B<9
ME9+1XCJ71ZGUZP3ET06E6>5>W(MIL1C46NGWS"A?ZC#5-LKS0K\XW905R*A*
M@?A>P!1D*OH"""Z+KRIL'GP,+[BR7H%:23=-+"7L%'5GT;3-UG_<0L+S2T2Y
M:- L50Q24QP6K;W@$3)5VYOGN"]X>H;K< 3,/CK3T3%'HT&;55BM)+QT^_!3
M2#@U1\/Q@U.[G"V-B<]*RZ\K-V)TIDS?\/:!&_>^D,I5#XM>>J5U*YZF%7*<
MPL@3L^^4*U@[.N>\FR= YR$HK(>7[)S?.OH9$VI,PTT77I)5*/N\)4-G!;78
M"AJ:_4&9(Y\K!=MH!#GF=/QP](-&&$'?(O>6^3YU4)V'T0;!$1CUO$H#D=W'
M\_EN.\/H>1A&ENE,1IUA].0-(]N<3&M28N=&5E"MJV3*<7>,MM$0<LRA56NM
M8*LIV$9#R#8'_7(\KY6&T"?PKB(WF%,3L;67KCLCYPD;.0-SX-2*U_+4Z/Q$
MC!SPM?OE(Z;Y1LX7-H]2+WF4:/3E[GS/<J_=5FO(,ONCNE72,R!U&\TFR[3'
M-6FE2Q\Z9P26>FI'[!,QI2QS.BBC-G9T?FJFE&V.QS7=_)^5EC5"4K4ZOG#9
M/.7'X<FQ.1K6BGW7:@I?-A_Y<2@\,H=63=?WESY4#@"7VH/P4&>B?J-WXU&*
M-/:!KC4-<*@H+L=##@U&YMB9=EQ3K^7VY+FF;\(^[@"JTHK&3U]'+Z.MW$KM
M$UE8 FI0%9STK"E;5Y2QYVO3]8IV13N$B FCUY) JGS^>\5P].K>B,G#PQ[V
M^O)@!18)F-INPTV3T.@;?7RO7GY>2ZE #J&&\'1T@)WK,L+.E?5J6]'3:?_]
MPN*$@*@06 C+A1!5*V)+G\T3 AKRUL \"<(3X;\B-O?=./:6,F\$/I^#T+E>
M(("A"$\+_\2O;L)P$:-YLL!A]V$;49D 3U11'_:,JZ^,(?@5,^S> (=!F"1,
ME$.CAT_="]R UQ3@6M8$NN7&. %9 6J44)$,'=LK646L&E/)R)#"U*_LOC5%
MN"T_Q2>9'[,[<#\8(G<EB #V-@A2F,P7M@FCY%6=\$N'E-HXFR/A%#1IFONP
M!:@V5P6Q=?"5CP$0L;58QAYD.D[H.:L_*J) _.=_'*0,M'4)O6"3]-VP:XZ>
MX2[AU:]=_\Z]C\4Z)Y.>/5!*06E\W ECV)M,7AK9GYERT&:#4%3:EN5DG?\J
MCT<E/ML#X:$I3]OJC1Z)+-II0R>.=MBX!@C+\B\O_O3M\[M*)L2_08E&:]?/
MU7R)C\ .)GPOD,YW(0%UQ8HGW4/X,K^K5=MU)GC#;%-^VJ/9JL -P>L93X4Y
M<X"7E - -*Q1;Y!#0.1FX(G0A0481&X<G J#:!J;"-;K;5S?OS<6*<-9PO+D
M'J":+"$B\K-#@B+"#V8,3P'7V(#5Y<UA(!^VE6&&-)Q' 2\:$RE"VFF!6M]%
MZ,345T<6?.<&L3BK\(-9&GL!BV/$:V2Y:6FSP%$/F :?<8R/YM$44;)%]I(O
MLKSG<]!,22$+\P:Q? +*2< E><$M',AA)"8!IYQ:&X(R@G5+NQHNES%+D)E<
M(_91NHP%R]:Q\."<AE%BU/G6^ W?K24<VBS[S"LE0_2,3X&:N,E/?[4[L"0_
M#H41(/=76R6?.3][80J?OE'O+3@ .>2GF[@&5_ 2(A(W?Y]%H [9&.MXKGD%
M#^X]?)V_?<#9"/:EJH_3)4%GU6Q0VW3&X\*@!)H)?!!QEA5/4C'"R1BB]:.T
M:DKY4/S,3+%]%>;8>0$SM\UBISZUS(DSJ *+M7O3G*J<FA.IW8Y1O+N(:!04
MJ<:*]NAT17J'5N4QVC33%6& A?Q@3D>W(/4Y!7D'NXG_FU!:>/:5&)QTIAOC
M?J/"Y ^!R">1-^<:B9:(C[W[_,]/[Z_!&(9=7( .F3>-?3^!='H195C 6C(_
M 5P8EER(F;4YY5!=B[,[D-^(1Y0(6(.^D7&_PB#FAY@Z(G2U-IQ.--QDS0IP
MP*"8' 2I;.@(R"SF/J-8HA_&N$#M9.<GR#4N,HXE:81OR;Q; B"6Q5# ?>![
MBOUP(X^X4GB8_$M@9R]9&?,43LTUR $_)3-1(6Y>+EGFPE8Q;3.XE6ZQC,_*
MJOD4P/'"C!^,*ZE^7UV&9?G$,G/+XQ.KTL+#025@M]T;Y72P;4Z=4Q5CP5J%
MDWDZ>$QC%?@RO D\&>ZXB1#GFF^!J>M3U[C!,$@F7,ZD:#$HS0D31 AH-$/)
MCC)F;O '" N\FL:'"8,7R_@JWH41F%BW7I3&QEL/=O0+\SVV-$E*/H DA,#%
MQE>)I_ 6>/WJW=LO'[[BG[7&'Q[ ,SO/[NFH@FF&=F^<8YI)31QC3>Q:^05^
M#1XNVJ+SE1O<,+"_0>-$#&SKN#'*Y1/:WG"*$]-\]6 &L-3&:)C<[&(Q.Z%F
MY+&E,XQ3(&#&),5O3N21DZVV"XE;Y09FIEW%%@X'TPJA<XJM%29#JR:I,P?]
M>H,*^,LTN(,-$L;JPHO)QP;K%[QN5-^^YU(<5+: EJ)*O1:"^;VP3R[=L""C
MX\\P'^-'AO,TOKG?-<1_!/V\#&^]+0=5EB[%%X"QXGGDS8!N[BR\A?,0@_.X
MI\:,KR')K6$ORQAW<)!F(:W)N'0P;''/A^9X7,7/%I@>R- YB\$R^Z=T"ZE5
MMA_HEM^0Y?QV\7M*\:@//W[Z]O[MV1H]? 8J;YD#4=!%DOM^>!>_[II/G*7Y
MQ'C4LW9V4NN0Q<^$\6[W!E9'B 808MH;=H1H B$ZB6@((:9=@Z(ZZ7!DANK>
M([I=<*R/HPO:M0</AZ2UK=[@<2L96]%^HI.-3C:VR4:+\=<?HP%%)RKG$)5&
M-2+@GDR+Y:#&#A3/CO)M)WQ5E4$#VD-T:K2S.%IHC3]J@P@A$XTN -MR[?"Z
MUN/EXCMP=I@586(T"L/@(AOQC!G@*=&_!=; KRLW6@,=4II5.T_SVK -]EW6
MG*&J]A2$P<F@1G#3EM.O=>0;F=;TP<BF#;&9WGON31#&,,TZ8'":<0C6K%R:
M=;B=IF_Z=HVMM9X>E9M&Y$,)>X4@RY-7;;1B9#E%=_Y=-D3[&/K&[INC<8UM
M;%I.X"='7V=LVM:#^T,TQ )ZMJ&"L\$E;36C6B06QT,EV5-S.!@^K?#B.5GF
M^7',P#+[?6L'N%8'!E0'&-"X P/JP(#V@ 'IV'(6PN;5S*R[RG7LK("J4")#
MQ4A8*;7)A8"-6-QMZ450&&)\ )A)5=&_93K%HCY1I5THE*( V<F%D,8W!$-3
M[\=%;2(/=@FVVW"3)/)F*:^V$;5\.H1-A,T(4Z:!353O5:X".X]8$R@8NMCU
M%9@,02$$.D2!OC']D5871H6E*T98 UZ0PJ=Y,"&DH 03@LG?,C_<T(@)<]=G
MK0,]@-4668"PFL_Z]JFDW@J:,\(./$:>QT9CR60!N^%P/^)IZC1U.G(.9S<U
MB]WL5BKQ%]RV2"-"?I)O).PB53P+_XN=>JF^T<7R-H1/$M6-D;O8"V'1-)Y0
M4!@5#,%]_[HUS\@<.N,\1PP&!:TCW-)C7WV(QWN:;N)5_3''=\SPPPC2DN"[
M:.\4K>,D2N=)&K$\KIE %,,1@!>NTTT)D"0;.0V\Q*0.K5["$2Z_PW_Q72OF
M+L2H\S#=^/ Q :"0_@SO G@OZ28U:,)B@=DA7@WS7!@KUU_*]^../@)PSQ$,
M^A'A;]*($".\8(FF >\U,@O3Q%B%=Z#A#5#Z\Q119(JI'R8] 7()%$U13 GM
M+(T(N".8@^6KH$KC+36K@BYK/"\XI!?1_M/'+U^--7 ($%/NUD]@4FY,&(GT
MEFWWW_P=L4G']"_+?J/J8G,+@1D)';,;OH:&M-[(T^50F--#X:DNI( ^BJEA
M?7X:Z\<GKRJG-:B&GP>7BP-WZ_AK!X (:%3[J';S<_;BS[>(EP5;((B)E0[&
MAUT3>*=-0'M:OE+24P'9(4!,BN<*0<1&!!%[$+828AK /J[A']<?C:N/'O#G
MW\,>GPZXF]?.U+('KX!+<CKAZX=W^,NWH-U\_JPUO"@O_-FK<!!$!?R+O_YO
MZD;@?($2?N\F[I]_\"ZDD;X11@\>\:2V>4VX .5">160QVG@@D69%TZ".D2*
M,G>^@L]CM%;_Q=>E* TLYR$T,F)7S%&Z.1YB-MZ_U$;H>D2P$5D?!G>A4,NE
M$5DM+FDUKA>2E9N0U@2V]A!(* "&BF,WNJ<YP S!_,T4B=1N^LMB4*N!,JMR
MGZ?^PIBAN>,NN)T=_)X&A Z7<9Y<R0$ZC+0C!PA#H&<RY".&9MIF R)!\$&[
M499[!D(29)LF]0J()@ZI5N_1AM*>H^6)H'!I0MI= 16)G_9J10,0CCJY^X@H
M+C_@SCY]<F;  &?0F^Y,=7VZU: \BM3K#ZMO2[3?'1L].Z9(ER^Q9W<TN# -
M1KU)1X1+$Z'?FXXZ(ER8"./>Y)EBR#2("/W>I*/!Q07!ZHZ$2Q/!ZHVZ(^'2
M1!CUQM.."!>7A&>*V],@&HPZ3^WB-.B\Y<O3H#L0&D"$3A N3X-1;]HY:I<F
M @A"YR-<F@BCWJB3A,<CPN'E&%O;.N^[ZSGSOLA\W.'(F5O\6G;!YB&_A;_&
MQE6OJ?L)_E7ZFM\8TY7BR0 QDU,!8ARG9]NE.B#JQWRQ!/82ADS%[I\)G&N/
MHWIF-CN5.\8G<T>_YPR>'G=4(WC5=M'\3)3/P\WZ9HO/P3>M;1./CUX4)X;(
M3#IVR?Q>LVU+?F0^X/>,;=N4KSQU]F1&F+1OR8_.!U8+]<&WE1>=S ;\4JMM
M2W[T<P%CBFW;E(\AIJR?S@CG!4QJ I5;*.P/.ORM-JZXD_7:S_Z.#[:%S]NV
M*0\\^^WN[*\.'K=M4[:=_0] -[?&=<*;=U&7YQ%UR=AGN"]JR<7-Z4UVWIA=
M0IJN5-V3:7P*C __^&+HB.8/"SQ>%&RGO-8OO RTEF"[W;C5G1^$2\04&P7[
M:#AT@&W?F:V(M -S.NK7MSDB^MBLS6D TX@ 9+/VY52F&5KF9&S5R323QNU-
M(WC&>CJ*QNF;UG14W^:(L&:S-J<!3".B'<W:EU.99F";DWJ9IG& S<W@F:>C
M9RS;M/IEA-G6V;R-9YDGI&:FYACAQ#N6>626F3;/S#O9G!F93LUJYC+F3--X
M9/1T>&3<-^VA_5"P\P;$5=_E4"W_'*?Y5](@8\(ZQ6"J@C_%%&@$BJ5@='Z%
M\#%&X2QL0)%N:E.ZSTU8&I?<5E^(H6^.AS7JUWUH'\_B!&Y@%ER=KN+0J;$U
MVAY0C&?"+XW+EJO/@!N8TV&-,<Q]V!'/@F$:F&I3'\,XYM"N.Q;U[/GER>J7
ML=FW:FQD=1;SMO'<\G2UR\@<U-G8M6.71N;[U<8N-E@O_5JME]U5[4_3?6Y<
M'F!]WM#0[(\?W&>OF?E,.XM'?XJP5<8F"I=>8E 5Z8YH5>GW%PY?-6VC=4XK
M[567:W483VZ]J!R8=K^N+G\M3+NZ#$.U)@_K>(::FHXSJ8V?FG<-TTQV:F"*
MUC$GYM;^X .,O[^J#:6C=<E:ESKO6I)6<9)Z&O?K1'UIV"XUDYV:IYWJX2;P
M;R;CVKBI>;O43&YZLLK),>WQJ&.G,[-32_+!3O#M+'/0']3'3UUJ6(M2PXYG
M%WMH6N-QVS'/OK"8N=%\)5K89LV)V?<-"V(6M^5>HVE\O[M95(.#T*;C="E<
MCQ&_:B<W](==?M8C1)_:R R..;&[Y*O'<,_:R UC<.9KS97I,JOV-(]I+B_8
MYFA:;V)#QPNM50R.:=5>F/?LF6%W$Y'F,L/ '-=;"_Y<4Y[:27S'+FN")Y'/
M]!,+6.3ZAKM8>X$7)Q'O%"^C)DVNMVO83G984 ^2,<LVA]/: S8-VYP&,$UK
M<I .8AK+' YJ!1!K7I2_$3S3P$2C!_!,O_[:NX9M3@.8IC47]H<JFCH#R.W+
M(>I2AHZ.*TZF==?@-6QK&L$Q3TC+ ,O47%?5N*UI!,NT)/7G$):9FL/Z2_$Z
MS[HMZ3X'V2[5*,OMR_'YRGP?7MB*X-1SDY>VI@G9IC4HHZ1U:4+/,TT(N,'N
MTH2Z-"'!#+9=JP/7I0FU.AO &8V[-*$N38@T@U,O&%>7&=)>Q6";8WO0,4.7
M)D2^MNDX-=Y'=FE"[2+^:% ^%IY$FM"G]<;U(BJH"I?&T@O<8.YAVE <LZ2V
MVJJ&+;K+Z'E8:+K+YNFR>8YAF.&D2^7I4GF.89A^C:';+H^G13?LN_=E*ZZ4
M,W[5Y?!T.3Q'6/36N&[?OF%;TPB.::"&.?U,JM?_;]S&-()AGE &#^B80:T7
M"UT&SU/+X)E:909I7_K.YV3%(B/<,*PQ"VX,+YB':]:6D'G3V+NM"3?.J,:;
MLR[=IM7I-A8'/NS2;;IT&V2&OM6A\G2WZN)6?5)WM=6S9X66ZH7IH-Y.UQTG
MM%8IU%\=]>Q9H:V)-J-QO=!,79I-P_A_^QV.5;[#>1(Y-L7X2-W(Q0U;;H.R
M:YYF&SZGQINKK?DWS=ZZ!C#=U@R=9N_<R7Y;E\%SJ0R>I\E0UUV&S\7NWY\F
M1PUKO:#O<H".R %ZF@QE=: MG8ZJV7:O-R.DXZ@CDHB>)D?5BU[7Y1CMRC%J
M-@>=&'>;UA5VNRB3;.^/]N*OGU7HS0_CN,Z&C,]-+BZ=G'0,W;<R_, <.?VZ
MFE W/5.IM"W/)'6I%DX9FZ/)H#Y.:?2]S*48Y=)I3;4PBFV9SF!4;V/[9FW*
MY5GE\ND-M;"*99O.:%(?JS0Z ^I2G/(4=,K$M(8U\DGCMJ0)?/(T-$K?M/JU
MF2D=IS0RGZHFSV<\J)-1NN2J1H0)C^<$QW3Z3D5K^!\2=^:SO_YYX=T^?"6]
MC'XR9$:?P#\E?G//FK+UFTT8>XD7PFJ93VW*)(<AO/.+W&RRH-SU//3#Z+4,
MO,D1-]\KAB.(Z-Z(R8"5/>S!R#R:!P0.F-IAPTV3T.@;?7SO#_!B^=\'4W:2
M<<NUSY;):V<D2>T%P*[)ZVOZI,#P$T7F*^O5?__)&O7?U/7?#]_G#$9?AI&1
MK!C\;QHE*^-?J1LE+#*\P+#[X-<8[\*8P*%BUV>Q:=SL:2SG!B!<14#OE0N/
MS!@+C(C%B9NPA0';'+&ES^8)O=U; Y/2>_!?$9O[;AQ[2Y!-)"5^[BY(6&-]
M8-.81VSA)<;<C1;&DHGWAY1Q5YK%,@K7QEQ?#L[BE 7UC*NOC!E!F###[@UP
M&-@]&#N@<# M, /3HA4CQA8,%N.[W[,Y6\]@B@[L+^XRO03^Z-,?DB+)*H*7
MW#,WB@T&/+(H_]#,?F7WK2G67OHI/LG\F-W!+C D9++R8N-M$*0PF2]L$T;)
MJQY)?CWZJJ1V"CQLV=4J>^'%&]^]?^T%!.H^\\/Y'SF)P-^($/.H2M4]:,(T
M$$A_M';]\A)>_/7''E>0=';\[/TK]8#1[FFKW[D;+Z&]C('L<Y'*>?;-_ P"
M<>NQNQK?KN]^01WA"Y''W7@%\@G;$4F>!B;;1,!YWL;U_7MBW[LP^@,%9BYV
M"G=-_DU"!'N9@BX@P?9]DIY9"K+-8A)KSL="Y-P@!AW )1'T1!3>BC<+L?-=
M4.5N$D;P;G>.-H"'8R1LO@K@D+BYA^&6D0NBG<[QK300O!P$:[ZB?RS8+?/#
M#>'@@1KR;FF(GO$I #&.P3X@*419L^GY&;L/@X5IW.%88$# RA.45S?A>J!J
MI2"'^%V$VP6<S]R8J24;=QYL BPZHH])4<&6PD9N@$SA@A0'O P43.(%*<.5
MJZ=IU&VK84L@1P)+^1NHMC!"6\>_-^DW:Q>FQ!D8R> K%E_!RTA9XU,QF\/T
M%X8? AE,8YT&M%R??V!P X*.2.V8GOLP&[2F5@4#P,E$6I[NM=M,<U@WBR3G
MV@-I.BJYL?H3;=KTW__\CX.L#&U=PN"PZ5B_ >T%Q/CCVEW"JU^[_IU['XMU
M3B8]>Z"L#75%B#MA#'N3R4LC^S.S.K39K-WOU]J6Y8P(_BOY$5F+\K.2%?2B
M,"K1!4TCV^J-'HDL!>7E9$3XLVO \;;\RXL_??O\KLK)VZJ?Q4<O_OH-C55D
MW7?P+2H$9>B[?SV +_.[6K5=C[('F@)'8;T!;18%)*M+8#A4>; B)<^@[6XB
M=PV2AP_#O^:,+80I@^())DN"-L8FG?G>''ZZA#D$-Z2Z_B<%;8SV@<EUQWKC
M,S*]P+;X&/I^>'<-IM4'$'L0^L_BET(YSAGLP<((6*+&5&^'N2";@YY9@$+%
M;V#B++J+//H'*+<YR$["%3:\=NW%I,!-7!GX9,YH\ 84*>RF#Q_SJ;I@G$0T
M6YMF*]6."V^9)=*8PNG=@%%$VW6%[IW=?_,S*"+C(U?\]_29]>85-WM04=+Q
ML\8)X>O_\?6],0#S7[Z=1L$)#?H]-:57-',4*F0)^+UXQAJJGX%M%J8W*P.6
MEL+,B UQJ?!5O'(C83?>N5$$!T1<I[6UXX@N&0C ()D9"H<'7Q!-+5/WKC@1
MZ0S23Y@9&H]+/V6P/CCSX$GCUHT\!K]!L%@X*,,H=U8C0[K<"<??ZV-Q*QL.
M2;(?EL![&A.+VAC.(M7G9\[DX,)0=AO>??[GI_?78 :#%EBP-<I#H&T ;-0?
M3+ E/G[CAS-\"\PS7-_WC,L1Z8\@O M@?B!5.-&,-@&7=LT0X*8'S3^ EQC)
M'?/!70'&2U;<%ENP>!YY,R09F %W* E"4O!_+/O-QYX!JC/UP:)Y#[+JAS%N
ML-"C$>PG^@F?09_<<*+TA% 9OZ$3YWM@7G R2J(NJDE)SW#+#_Y ^MV"TX6*
M 1XBB^J:H1654<@+T$@3-#Y0,P)WW3!R^.X\\%]Q8W(:(6=[>L'OX'&21SE+
MP/Z!J7-'U^;L#RP?ITMP.SU\+? MOKFP,"('6'IPEL1(2;GWM ?X>O3_<*JZ
M;H#/T;"K\ DOY(EMH?79?(EOJ)SI .=<ND'"DE%/_G_L+5*NL]0L03C6L13U
M;"=]CZL<CVUUKW/^1)QX:^)9#\U$^"=HBWM.">,;C7Q#]CJ*$K(=/\S@>; (
MP5+G1TE\X)#<9Y&? MO!B)$+LH[6,S$7C#1+$^+=$/XW7H5W.&9>N<$1'+,$
M3]<SG20G1E<Y0:45S;/EP(+VW4W,7LL_]&G@6X4EC0;9G!MRTFD@$Q<C<O(#
M;N#2)SDS6 O%BF?*?D82R8FI6"$M\[ <M^&@MS.C13,RM>%1@^%9)S=-_IL"
ML:^YRP"N\F*OM:[%3]6C[BP._30I1DOK-EHK;V#X@_#EH6%W+93ZL!"\W>OO
M#,%WA#@3(<:]T<Z;PHX0YY.(G=?8'2'.1(A1;S+N"-$ 0G02T1!"=!+1$$)T
M$M$00G02T1!"=!+1$$)T$E$O(8XLWML7V#C?HB=5 <RSI/7MBRD\ASW@[GRA
MPG7S_7+UK?EK_(;N&C]%NET[1>5WN];Q6L=KS=RUCM<Z7NMXK<F[]JQYK?-Q
M.A_G$:XL:RGRV2<2NY!JOF&V(J_.J:E*;U^8ZSF0?5^$Z=*J\(RG;,<(C9;_
M'UERQUC -8#5*8)G37^GHWQ[*'_&(Z S?COC]RD:OUJN=W?RM4W_/93X/[,X
MYE1/5F[0T?^YT=\-%AW1GQO1.<4[TC]#TO\21BS3]Q501)V!VR@#=U+:@OV"
M7?YO31)^\5R5!YNZ;KSB.T*5T&U1?(UB@HM?@#V4"41\#^N@.P9XC@S@9 S0
MJ8!GR0'#C@.>.0?PW=C.!YTMW#Q;N 5[\.C!WE;F3)TG,M"V76GZW5C'*\W9
ME8Y7.E[I>*7CE8Y7'CMAXZ)=.#$5R0W^,+"J=A&YRR2NS2Z_]+JD^UE7$+I9
M_7>='-#Q82V)3<>JL7.ZJ.9X*E06 8:.RDVD\D5:H#X)=A!(L!U#= S1,43'
M$$<P1/,#TE\%=/P,+5CJ4M'.H'+-EFK+^&_8'[;-Z7Y,"[2CWK,X-RY(YHNL
MNB-M4R7XD0S"CM3M(74KXY8_4T\TK2G$DXE<GI^;GTJ(T[;-_K"+?G6^K>"'
M@6E9TXX=.G80SHHYL)V.'3IVD%<E(ZMV[[5CA[:RP\2<3,O:H05AT%48)=0T
MC?=[#.^,6]=/&?6MJ]$L;F=4K94QT0H^;),[_KQ#HH-!JXG7Q5(.HW+M?D5'
MY>91N0N./GM2MS(X^BUR%PR;TV*?5MZ<=I-&\Q6&3,-"$^"G$#)]_&3/!@$P
MU\'MEF7:0_NI.;^/GPW:L4$+V*!!,9 GQB]=]F#',!W#= S3$C/\O#RQ%_"_
M/N2/L^,>[(>VJ!7RJT%,NWWE6^^5QJ:--3AU$?OL 8.S$;MQ@8+CB6U-3=OI
MB/T\B#TT!V.[H_6SH+7(#NAH_0QH+:[^9T5[\X<$XZ>U+L$+P$%(7CNC.ER*
M<\RKE&=K>,'<3Q<RO\"@?MML820A_\20^/ZQL0PCP\?@,_[_+/5\Y(O8-,+E
MTIMC7#HV[ICOX__>NI$7IC!XPM:QL0X3^.DM6WES&;\.DQ6+#/:OU-NL8:8&
MT'*^,MR(&>Y\#AX13@'?A_^*\#TXH4\?OWPUK)%)(ZQA=E0PYB8&#&8 !\0X
M$L^6")=B^AOW'E\0$R@"/<@_YQD6_*?S< W/S!G-9 '+QY^K1^.><3;RM(=M
M7#\.%>]H/2 ,!,DU"!\7ON;LY(4!D@]WE'V'><?X@=CB+V&<A/,_C!5S%_]*
MW0CHPCD$]Q[I#L^%:61\C-S@CV4:)<""X"2[P%'W)GWSUHLVF#/S(XM\+S#5
MO]__]Y_LH?TFCIF_"*,E#2J_RT9+6)S@:SBR2 QS J9 /@S"I,"+]RSI&=]@
MSLLT <XK,AB.GR9R?_ 'L+X8!PJNYRZPE^^C_BF)%;X,R.J,!F^L_AA^!(*#
M8]UYR0IV, R8@0B#IGS(-IUQO_38TKOES_&)B&<'X+M,LV=1Z)B[A(4:5^\9
M,/P,_G(LT[#[=O^U>L'$V3\+RQQ-1@?/8C(<5LVB5R,#MT*.?F/&PEL0;ZU<
MV*I%&I%N0_T%PX6+6.HQMN!J[@X>"ND'\S2*X O_GGZ*W]ZCZKV>N3YREQ&O
M&$/6!=:^(54&JAE4\8(MO0 X&*B#KXE2J8(C=I-RX8RE,%(-KI!O>.+#]_D*
M!S/>@8+T8A3;.BG65%58,C0TXP3_W[*5=?(+'!:1!UKO&^QZ#.*L[F'/LD6[
MK,)?(^\6C[)??5><;$!D)"3HWJ\K4#J<QK\1PR09?NG3INWN>7T.C/]Q SB%
M[J56M$V40#H;2(;@&'-U,?E5WL._O8D8W^8KE"1<@-U_L_-)>L9Z\XJ4)]<!
MXAE0GX&[9D)5@N3J8WX*;N',"J-8_9YL,DG)+3,I?5M^NQJXAY.-4WQ<'-N[
M5RR4>GD&M'DN_HL,RABM0S&B>IEQY>$*X#%X[D887P-PS:=F?S(AVPPX-A8<
M"R\##0GF)NI+_BD^_X^O[PVG-W:XSKSR8,@[P=A -)BXZX/>9-]9-/=B.H7%
M^:PE4BR-=(.S*\[%,IV!8X[ML8&>$$HX6CFE:07R1?(U3)NH_KB<[[@WMJM(
MI.AJ<@M8S>4F"F,\'\(Y["?I;'D6#WM] ^3!1P5-%HH<BHP+?=D>6+H+#T:#
M[7"5WI<V+^CXE,X2?J3[N):-AU,.C**],&K4X?W#PKO]ZY_A/_)WX&FX$7J[
M*S&XO%-Q\"7<U[7Z_9>/XM/F8>KL0>;1BG/#ZD^U:=-___,_].EG5T/7\] /
MH]?R DA;UXKK>YN<]!MV/0.KZH]K,JQ>N_Z=>Q^+=4XF/7L@\;9?JTLDW EC
MV)M,7AK9G[@?I<U<N]^OM2T3(8%KGRV3U_Q7\B/RYN5G84SB\IH[ ;<,Q\Z-
M2G1)PLUKV^J-'HDLA</;T4(+KK&*V/(O+_[T[?.[ MOQ0?#OUT$8K5T_9Q6(
MCU[\]1L)%1VL0'$Z1@5/NH?P97Y7J[;K'*?>M],5/+DQ+AQ0\Q24^1H/SH@)
M"U:8EJ1*^._(+XK"-8T%IL@&35@Y=G8@X"?9>',_)#\0WL2U;\Q5G/Q<J+ *
M<V=.%O,"E5?Q5,_IW7=BI/?P>ZE[&Z7<SL4$BB3HVXMC>U.7)>#" 7@CXC[H
M*V+D*,$0PH*M V]Y7V "XI,YBXB[<H&'R.-T3\FBA1-R!G,@_^9N%:(T1OCW
MQ@7G/N0^CQ>XR ON_%YRRQXF%4_)_1!,+IVH,,8!X@V;HY3RC1(Q)FY3+%W/
M3R-6' 96"[8 G.EKP\.'L\Q-;N>!LG^&+O$'=[Z2.Y61WXO1T ,:WDO&$[M(
M&07C-S%8)AZ/W'QA-_!7Q,-,7U _QSK?+2B<^??PEELOEHT:P)H:5V#^@(T-
MTP)/6],&.X=31O,5!D3D=-$AQYF H35/\6VN\7N("XXX89'PX-Q':BF:PGE5
M-K;W+ A,:HH=" $EKE&2,O>B>;J.$[3B8AQPZ8%(N.CL9V/"UPF75WB ?R-B
MH\#6KJ\8-\YD?<7\A3&[-^(4J*7(9,*_9[^#'.! <@KL^YQMB*U-/22,3X0A
M" !J:9RI>'R3@AS,,9+!,!9"PD=OR=[^[&1B=\_5$#T44%A"%=]GS%&S$]^.
MO3H@#ZG"K]]K 9BZUC&-=_#V\(:!U/^TGOU-_/NKNV3&C[U_]H@>V2/_^&H:
M/__\#MX!_T85D-,P/X91%-ZQ2'/T<@$&?)2(_-&=TQYS%_WS=S@Z%L9'.,W0
M1:/QQ8C\JUP\  ?AA^V2?H".J1> QDQ2$?*+\*V>9I0!$4@%X?^BZO6X!BE/
MYPI<$I^??CYL#=C0C PM=)YCN<J?4;46@A1\GB:*/YZ <Q<(A0/"KW!(#*;!
M-,&7 =6$OB\\Q'P>N>?3X&."@Q]P'2%',.5;W]YH6KIG_$,JX?P*S-QH68!B
M[?X!RO(6CF^RZ\7B%;V4SJ++(\(HQ*7D @:@Z&&S-[B,-=X=9'&%_QIH;GI.
M<RY!AR/[X<AW\$XP0^8K?J&VA&T)[^+7<%R]DN:,SJV@8FDB,KR[>R+_96M3
MR$G -US16]JE',6N9O1:BC MY2E!#_]H_ )'"QP#P.]76IQYQF#"K^!82CR?
M7_FXD>_!+^']HSX<Q_>Q?@^!(_]/ZBO!=(Y;$092[/ZN1?VH+XK[%AKW9M$O
M;0=RTDJ?XZ=QQE9H+.OFFS@O)4,)DNI[Q94VV(0:V?'R"HP?C]VJ^.PF"A<I
M?!O!9T$J)1,?7'CN31""_,Y% =#*!1]TSE*ZW(?#,KJE2]B8W0A;=(EA*;QL
M2FB7AOHNP4_F*;_H1>HBRX%@X$T$'-=@6X"M#ML"AK47:V$B'\<" M+88- N
MO1C?S1^^(H'4UE/>18UELKU\&\N3_EX%Y7(:$JR]W&:GNV0ZD]4;-.9Y"#63
M=)AR!&L@:PQ?J-[LD0*.E<M0FH$;QRRAJ^"ZC[=6G++(\6LWX9NE7Y%GXH$V
MNSQE[2D)\]CD\@7R"L?)O]&=E+>EXLX=>>X7%_Q(@XO_$,7>'F!F@.0L$%+Y
M*RYYVBMGH%QXZ%60+Q)3&_>FSDL*O;I!D*Z-C9^2VC&L:\ZN[W[YP ?Z^OGC
M%WZ$80H 'P!8GLS2>,7(ZB6M"S_X*0I!E_\(#ZY@=_XPWB[67I#9U3][:P]9
M[DH3<A?OPD/2?B" XY=PV'-_E>0.KTK1O8R%+P-/.4))/CNC]VU"2H7,#W[L
MR:O1_(&7%_,UJ".P](!#Z!Q6!P/>F(*NH0M]^!Q\$,&P\/\!!@_01Z)3-SM6
MY$TJG7;HM<SG4<IXODL:;%QO4=(3&2_F3G2E>9<>G'+P0J2H5"7<%[P#44K@
M&Y@HWA((6X/L%V7 ";XG?2M62?]>,B8D!'YV]?V5X2UA(Q84IX>A<\XFUW@@
M!7#>13$*IPQ+Y';5Z?5?RF]*!^V,\8UBN >F<76?O3&S"@YZD3%+DZI9@B(.
M*;-HSS3M@Z?)S9=_O^)6\)T7PZ\M^/6SDZMO)?M=Q+-B+<KJ+H%\:PH[P]=@
M?+B4/Q"@Y97[C+85K1-N8H#5YZ9^8HI4(!ZHU1]%88F\N0QSN5LB@1&F@D6L
M(-QX9PCOCY?W='1+/T:^P52C5YS7?/>)O_!N?HE!$DQ-X@SG12BNL0=F501^
M#K\WU*(2^3B*>@T9I&)DP86YV<(N@*T&YB[J _X/[=(0232# R( O80^WPUX
M.OC2-8MN9-J3.X>-X!<!\ PY) L\8;Q9YK=Q-P4-$@/#-3$=LA@/%5*A:1<\
M6X0&$4806%PJ0$DQF?5&,X-CG=3S,/47>(C"L58T<!=L[KM%@AUGK@G?6)@(
M0M<J!8N; 7J.1XEG^9O+1<J5M"B)-_GQ3J'KS<8'@QB]-VWCN7X0R8TBF3"G
M4%$1X3(#FK3(FXGGL.NH_F>P(\U.?&G;]2<6U'37G]WUYWFN/X](Z*)X7\3/
MO'=X7'S$\$O=R65\9[T$Q&5>GMT.]5 ]72_.\FG_CY(O/^"UADK9X 4"(L!B
MD>;$A,^S6B":14],@]XT^ON@^C&\H64-J\P<D1 )PX)&AV/S]654<%Y_XN8?
MVD90K%2H-%[92W'.3<Q>RS_TF>%$A%I#Z9ASJ<HK'*TF0ZB;LD9/(OE6,9K%
MEW58M>UXU+-V5FUJ\JR-CPGV2$&Y)?+?%(1_S;7S'6S"7L4H=II>+!]U9W'H
MIPE[9!U9I+WVX.%DUTZU!U<:#:R.$ T@Q+0W[ C1!$)T$M$00G0242\ACD3$
MV'M&GV_5EVS*O5L9M&L/P"#$#__RPGEQZGY8O<'P43=DLLO1/R!WY6,HG!$P
M\/D?Y*_P/\EIJ2IF[F2CDXV:9.."^$H/E9V2-]^)2DM$97)4?A\G:_F_-0$\
M<,.MQ7* ,:S:D#PZRK>+\OU*=5?P-/I;[/#<23)4)TEAF9T>;:HTM=/D:+!
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M?BMCJ2N'>)0.Q0!#JF>$N3(C9"T)XB+X;>(-5WZ6*+_9%:1\1TBXO?:\@*Y
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M@VCNTT'<0R7G9CCPU7^WA79]4Z(VJ/S05'Y3)C)H_- T?F.HW<IP;]+X=0)
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M^7N;TS&(>!(&H1='@1?$KNWY2'!IQ<QUDS!EMB><'H-IY)JV;XHH-CW7C-U
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MVRE.@ALSM4?'L/ZX;"IB12;_+S=B*OD+6VA8:[%=T3PI.[@I/QFF_L&I_*8
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M00[[DJ=.(Q>\RM0J##;O;AN)5*7<(>BDJ)/AP79<,70@Q.ITX-KGI9JE?8&
MJK&%@M4 Z?),TI^NT3;1M1P>2#O/?MO.TU')VW:>5V_7+5K/9 ')K^@0G6MO
M[>G2*?>G%4:Q3[^I[%H0IF#!;'\*(V3:^_-5['\BCX;3WMC]"%W%NJ$,]\.P
MN8'PE:I:(NS:$20W;OK$0BU%J6.:.&&[IL&(>SUNR=#2?D[MJKB[V!HV=6DX
MN96\MO47<:VAMR<:5BH* XXI/1O?1'#$P#'_$*:(14!,#T<03[&TD4)2XO9F
M9!4N\R18Z5+[P[5FE21UE9*Y-OT9K<0*T>S+PD1GVVZ=&+^-0^9!4I3MP#6\
M<XH:#K^.HD:/B*(>CIOEV+&:&Q5Z99OBI4UFS[4M1U;W5OH<!VLZCDX#<;F=
M2ODP4M+0Z12H'6*A^11*THT,4&LIN3HVZ\#X>L(*N@?:PMH\2;L Y&%[KA9N
M/6F"BI1;:-"I8YB':8KSP45HZNZ\+_U4N][>B;;T^ALYM":,2>H_]T[R>0K/
M(WF^U.=Z%6]H?X6$33O@6_=Y/7M43J\3IY\T-QU]$Z&.B:>!YPTF"%66\D[
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MB_,LI2%\K'NL.F)F(56':4;4Y#H].F4;$([;>CQ^Z5KW@TKYY69/,- 0.GA
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M3;TEK /^643ZN6!/I*O-! 3OE#YCB Y2DG=P8-M'4>"XZQVN5B;L7M1D0XV
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M]T#38,>=WGC2&8WKW43:4WP\IS@8=^LU'QZN8EP_P!\?N\Y[!.KL.9@G.2+
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MD9S)VK/0@8]')>P"CN-$'B2X87YCC\()9N#?([7FR)<.M$=@!1BH"P>0>C(
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MFBZ?PU@Z^T3,RW;/#L^<\^EZOQ,VMC[[COV4PE\QK:M/H.6>JW!%4@!^8P_
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MSHY=Q2H38(^#'3M'6^X\_H36/SIU0KK5<EG%BD%F16[4BR76Z"/7%[D["UZ
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MB:BMFG(SQXXT@#T2C,*MME2JAZIK\[E)SO<R3/0_/ZI/.E#WQJ :BOMY1+Y
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MS;=.CLANO/(>S-+55X@*'>\X->S%R&</$H \ZC>2\>IG,!XLUX&C>I>PFXQ
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M@^K?/3GZE"+9P$>C_+6FCXWN+]J8SHIG\=56.H"/OU,46%J56';)6(NW>,O
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M3*K Z(GC'AKW 4YC>*8^D%Q'3+7)!)Z8(=/!._J8&",,NXW>J2XJQP'E!]7
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MRV$'4+4>\ $T>_.8D27Q-L*0=/6]*CDA,0+IY&:IG%>MP00X;[O"%2<G+%=
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M+M(E<3C2=%V[2M=5Z;HGF*Y[I=2'K;:T4&:YN&^^R21+\2<37RAV[!I8G T
M4!MC1!(,&CE.$EW4E$KE\&P*<&[Y8$1T94IS@U6_56AT8Z68J6VY HWX;W3?
M,-S(;U@;5]4&!8:]=#W#0H0EG$K$G7=',3RL/IK";^JR7N,K1I6O@T)!D>5:
M9EB8="J3HCHW]:+3$'QJU2-IXZ1NR/=ATN)LUHE&2N+V<%.KE_LRQ[^,%58S
M:<&::L\CQ'D5$HSBTF 89IR7XF"GKI"&L2E/61*?7.%VL5.G_"@X?5>E+]E\
M%O80M*^5.KDF/'!BH^EED?13G?SANBJT:ZC ?BFA9B2*\^D&N5CW1Y:B)99+
MW+E*7><E?\,P<P1&%&(KO,!&O9=D>BLQ=G7=JJIKLGEO"'I7R=2*_(A0QY>F
MMEZOG(_!#*2"0-NF4"MZ$CAUY3.NKD;5U><'<GX_.B%#RO$AJ"PG_33#)_NR
MRJ=:BJ"1!/*2ZB+,Y4]57E;E91W$RSH?)[IH28699JHW5]AN-Y; G-C5^)<;
M$B^:"=, O>J!N#/<6D>?&&U\6JJ.N:UG)N '<LR<LHL:8["H-% >%+'P%NJI
MQ52&KMXP'82H'9.$UH?W')8OMV\,G".<A%F^>CPQ0D(BY89BEE)6F53X:5C\
M;V(T^OOJ5-M\+(J&HV_T28 EQL.?KRCE+BU;5ZH"V? PU9*HODS@U<+M[^>J
M*[<D/5+)M/*4&_5[8?CPX9K3*U*XY+O$V +35* F*PT*8$X(WUH/S9=W3S]9
M49HH+D)58]8@0L+(V=/#AA&>0/..VUED%EJ=0]U#]1CFR.'PM%896R=.S\GI
M#LVN?(F\8Q# ^9Z*U$:P3>V[K?A3&;6EJ#O!X$_O'-/Y_H9;G;J(E8:H+6U^
M@2 I71HN2,<674/IJKX?]@F=5IY-F<@0/JB3*<8+SY?ZV]A^KGO;O&(L?9%Q
M'00&T!U)R/<!8F6'R-((L2!\ITMX0@ARCH)WGVVP+]W=8F!-K>7RK3YD4I0/
ME!$L2P.?$ZI/%1[A_>$3\#;P-[=G@7J,,=P@8]W5HK.;*KNET].8WE*IZ9-
MIB*<)D5K"F^=+,V5/F*] L887,IC[24Y$Q.FUUHAB]A"S!R'E\M+$!4849P5
M 2&^('>#-?)<D81XTVRV0%@5RPE!["OS;=8)'D[R=;;^@Q\%]K>-)2;&#<M@
MC@!WT&AR2Z S+]R].*$>IMQG=>50K]'B[\P4EKD?9800@8=EHD#$L>=U5:K:
MB5#HCV)[+/;+;YCY:TI0>ES,A!6\02BQS?"*I@C7H_=6PBV9Z,?" 9^D*F85
M$L7$?]#AG]Z=UHP.7*5K73(#R>R/)%Q\N.#R1@.8KEUBPU9=.U2YJPTF5=7$
M&3B'U$:;@6%<5&D'3+2Z\8=;56'DV@/Z ]LH?Z/SU=]+>Y:<3(M*H%CE3<E4
M%B!F+H]=R!D$=%FP@6]0$G@SR^SJPI&-"3!@Q9<H?!.ILVKROVB(Y75Q6=0&
M'ZPRGR)U,I\<NEA5;%_JA#AD4W:1W!JB8A5B!M:Y:E>C[C\\DX97I58V4]5R
MYD(0D$WZ:)*N!)RL<E73I&)EX&7$?LCNVE09KK X]G&T&/2HY5<X/D\XSROA
M9<,;3&"L@4); I=I28'9B.8WZ+"\IF$82YR7_H6>+KLQ"QMB.KJ,7:?*V%49
MNR>8L;NPX5T3<<D[!B>Y*RS7' O&&^A.7YX^Q&&ATTZVM,)A4]1*-58!Q>B0
M^M!2^H2IIZF U/Q>PUMIEQX=FW#NM*]I\^O>3VJ:HB&W/.@VBK\8(\!T*E%D
M-8XFD@#W!&EIX8,_13>?ZE>P=U\B9KH*CCT,G2Q".AUX#EQ,$E'KRE*CR^F=
M'"J>6KO]!0<*@U'OORS,1"/A_7C!D\+Z'*@*>U*(TUDX\:U'7M-%P#GOL;AX
M7+N:N,6K*K:HVW67>F>=.CX"G<J+CB)RLM;$DPG O7#JS0^+EN-([HJT.O92
M4M1:&8PE>=0"C9NQN-4G XVFI8HKRQL>B\V,JQH@'?V<JB@NS%$W%[/9[+"G
M>D0VIN$N\G$YK'%0!<P64-4THVX>&_H$FBZC\%*798"N"TZH<51M:=0,9IE[
M@KXH%*B:P<)$W5_'RG0[O&3E6KDWC<[BEVZS.=6F8,">&K?AS8_.L)$!T_]S
MF=&?-]:]O M3"^>B0@A2=UH5><^XT2+';N@.DR[]2-V9:'D(U4&G5I7.E)ZY
M 6KC=3%!J[('ZY2(Z8+,.3ZN#K'^8]=D(VUJIPB.XI(%S*/YF8HD$CBS5I+&
M'U0^LD7D5=T$JG>J$$HNK6@XH=!L>8F"@A8-U)EU*G?RJ2F8U+#[<]U[OC3
M30YK2:.98& 9./%3ZNEV5N" _!IF&>Q:4QD##;0T0N/D],UWW>(G)09G2V)
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MI-;4PLK<LT4S4+>NF(?RS12Z%[F-2]I0#S\M2<'BR',K.HC#E,C(-7K7T8S
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MN9JFV=!KWVP6EG]I[C###WX:X6_ /.UA5<YD@HW?NFHUY5YFOJZ5-4>FJ*U
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MGL>45E\*_[KLX-"A0;)39HGBW!T-"ST 6EM%S&XIZ(4W!1N36.NT&)'EK=1
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MB&V[3_(*O&VJ;_[(K9I.B<:K,)[M$5,W+)8I!1%7NFGIQ12O<*82FZEPTBP
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M5%IP;@#AD5JS'%+?1/ HR' K&*.>S"R>W%UNK9VEQL7,DGS&1&/9;DR:L/N
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M2CA;R;\J$GZG1TYHVVHW-UHT<RL:,>@:6\MF"J4AUQ:IV _-IC$6^N<@L)/
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M26[I]C['S_4RK1>FXTR%SY1HN=/,&^18B!@*>_!VGZC= YV < $\ &?_V +
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M?(J53>=5UW"VDMMKFI^Z]IKN.C-GLTH;4144GPPD5QXVX]S#X#2>2.,XO$P
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MW*2Q$, XSEI!G#C)?+(SA(XJ62G5\R5?!8<%MJ>I+JC9=7F6"RWD>UO(\'
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MX1J1 6\PGE%$9DB;5=K34-IRW8;TIP'E'X*KRTH39#XML$@@!;; H=I6;',
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M19/7\TUIZC,Z,\XN&XU"N=>:HJ/&48%U);7D;7:"WLM5QC7:VLII!YVKB]!
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M>05+L:MF?VWKL&&[+J1=PIO+B9TL.;>^HWX;!:/OW[M[?#P%\_CJ>/RZFD[
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MX-=P553J9^J3&/5$#I,/;/FOE)@[T%[\OSY?."N6\&> %F 6C$?[F.%'0-M
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ML\+FC*1[I5*HICEBP#7H57W@JB8+A"WU\YR@ 1?TD; E_M)^RC\3G-!]F]3
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M%C4+%2!.#.#&'[K+,.?*FSYDHY^M]PHKDNB?80.8@" O%E:!-\.38T#2IA)
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MC$Q0P@N8%Z86O 3R+]4Y&'+TRY -./@R!Z\E=&;VX*.-[1LSF%2!]9+ RUS
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M'TFI!M> ,BX@'/>#9: X/,P6L$'0 EP0M'YI"@\]''9Y@FV%(+[2E)-(_I"
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MA35_?9Z*PGPZ'_14.**J)LDD5\^N.(7J+6>.#%1%BOSY_)G.O\_JA--C09"
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MKUZR8=W<T)SDU]R(XTE7[J[:4UF'V?WDB^KFO+BA8LQ0W@[5A:ABYC7I/1K
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MNQX(FL-#\.%]1,A@!JZ8&]YH#<-$"'HT ;CO'X1^R_G.1=6$0*91Y[=C<R]
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M_HST7)@K9:1U5D*?YJ[SQLW5QO!0/VTN!O=^72\XY_D"E*98JGM^!<?D;@+
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MB*V^9K7-^]W"X+C9;G7;K;-6DZCF\/;XZKV;Q45C[ZHVZV0GU<K\[O)P2SN
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MX<(6*M-Z6"93ADI5K:]^[*-4X?IKSAJ<R&'N3A6NOXL.+HA&@2$YRXZ$\40
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M+7%"(HC99WO$2G\J$[LO>EP2;E=H-_?P5M$87?2[!+D4F3-2?_A'- L.-Q.
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M>?:&Q^&->@@-Q56XJ*,7 JDV>@0&:Z,91[RXJW;?A@!ER3Y:*4%3SEV)HM&
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M/@^<ZY!P-869&8&_(,-3F3"%B05]/%%#+=P30-P X0[=AB?G?D(Y3!W*^/-
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M4@+ !(!WG&5P+@CAE;K(]LJ&@Q8*&23HK=7) A<!A.#5E4R:0Q,,)1B*9S+
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M^*KO#R$<WPI'G2^G+$'CSUSJ"1KOW&)]-P1#WY&4XK241<,%NJF*^8;30M8
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MP69H[F$K</(@!9Z8.X_@Y&YET;RC?__O_WD^_Q]^(D1U+,?]=@#ILX5-=YC
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M>";O&4JJJ:C&Q% ?QEUSA2JSES=&8HM-RG,L8QS#"R.3W/QKW9(=:RZ(X3$
M9<]>]/R)-;+D%*16K*TJ4H62Y(W'ST.\=FUMJCS85&PG.Y"DL"VX2[13+@E+
M8-9'UV=3)^_.?L H5)QN\4W0>$DTOC1H##*+!B.A8TC9;6]9\"5LML&O'0JF
M<YEB#U^M"M*2+$W*Q?E0;]4C"$*#YK-$IQ((/A($9VA6S-NRWD8+DZ[OJF-_
M41E<.XERM:IZ85^B-U)V)HK3J:7@5J!#8 &SB"+>RLN_@XC4FQ>J=QQ?L5Y>
M%GY7[H^WUG:PDLZSN+VE] +_!,#_V E&EA9# ?#FWMQ..OQF&9PTGO6VX]Q
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M=18SVH&%Y3]F87>1\.P8EK-,$4!&X+EO>2>8I#RO=T,'*](#H$4X^\U\YXY
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M50?^#'($PJ.QAP(>5U!\U.IUN<$F9Z-RNCA;_E%[68 26/!\P!:=#F=O1!?
M&2#NW);AU \X2$3D+'[Y )"Q$54CJ"T*JJ%E73<V$<EH.#\@H%V%!X!MD5=4
M49^[EI1F1-L!3Y#JP=$!G"YSX9GA FSX[/".X0P2^ .4"ZN9@)P'HA0,+$B5
M#VY: 5]Y!/^U(-(TPQ(?4M*;;Q>>2:HB>#'X1((834V0#\XM97T#'B[X=DBG
MO1?!8RJ>]6P_8L!.<4']$/SE+Y@V )G]V+J^L,2U"QZ^[HB:36QE._P'TMC(
M EIL!WRS[&I=V&@NT[5I;+Z=[:QZW<R1Q*_-X8#'WG#B!NPAJ!@ <1M1%VV[
MNV@9W-%Y>,"?7>$MFR;-P4J1E6&)\3&2<;D^,'F\$,-I_G28O'C^<2AB+C7G
M="6E@KL\(09@00S)=DG# E#9R)9KIPA9> #@465Q$3+64T"NAB;SJ:'(NQ:P
MSA3!.ZF_@=RI(?SC]\<O'''P&3UF^85;4!"WHY!SK;/V5+?-6N\%,6E;Y*$N
M(>N&+>J_J4@:+1C3TG(M*V373X_- EH>;KQO_W9D]4B1>Q;TB_NZNIYJN*H?
M$"H_'$PT"1J/ ]L'KHT+1A8$X B\ \P_A7-5PL=_!+#@@<R@U8/+@UD&AS]F
M@_4Z^.O L!T#?'<I<L+:Y2P'#E28N[*Z_RH'+I,M(9BVX <W=."DE>"NX4\\
M7?V$_,-O0#9I#KIIV1"@&7R$;[%PL-H7GA;[IU6:)54NF)BS""?E/*,M>IO:
MP<N4HJ>+$)C3G-4X+0Q7-)9IM]'M4C*4@G2,.<&UXC#7@J\] H[[ %56GAT7
M-0*M4^*B4Y7R18OK;B"]/A:29[]>Z>',++!^R%L@OZ"($P@GI0$Y+)^G81EF
M8+I _D X(EPQ1L&,K)#T_$W%R7H &[C>N:H3@.6B3OZJ:X<#92TRG%ZJ4?D:
MQ74HDW-UI#2"$RKB*H>5 .X'\Y%VH42A^)\!#94"_.]P/_L(S7Q/^%B/MP;X
M(_8.'^L+)MNO9&2-"(7C*%DYM%3SAG2A1ODZYJ.3"K.M&T1"R7I:2E8<.04?
M:_XQGTGXOV+ <O"]C^/DE'QY<$1*HI=KTPO^B"<\AE>HE\1>KE,OB;U<IUX2
M>[E.O23V<E5\K&%XG/"Q?LAGW#F_(C3,>^)7/"$?:X*+>\+%Z?A8$US<$2Y^
MEX\U6DNOJ[R9="U+U'D_I1KPI"1U,MA?V7N>L(P;_YHB]:MJ63A[)>9Q%SH\
MP8TIM='[W6+:44LS1"0+^:(U0 98-F)BQ<_4LI/@^][Q??:BR@_C>UU7^'RC
MQ[H*@S2%M4(6S'2['S*PHF=JPTGP?>?X_@H6D3?PG5D/YP8QSRXIS>FJ0Y%:
M"QNI'U*OHL53LG3][*CO0AW4M["QN+@YWE(+W$FY*1)%WJV3_=*^WJ@\)<;A
M$LRXH:EKC4%\9>4P9)HR$9L(R4#1PIGH0!.8WRW,O[1G]VV8U[2%K7BKC49C
MR[65;1 JT2Q'[)_H W*&R.+*(N9?Z.1]+JX[8?[SEL1RC@SHSQK^DSZN+^_X
MC;Q(R:^X>O :,?Z$9?IC!A,+=;KI#HC^8&T*C9S$9M_,,R4FE)C0-9C09?J#
M/V)"*Y.ITJ14)6FNQ)"#;K[DZ<L^,"$8>>)Q"W)B0XD-78$-7:B=^",VA-4T
MM\!CP)"JY:VP2_=JQ0G:#TEWT0<,_UF[?=)9_/%'?:OW)&A5@[T]L&LK)8*O
M"ZFRR =]8ZD,^A"V5D7-LP( ENW CBO>#5IR][VWCA'\1KW73?%+<-OP(],R
M%G+8<0Q/9+^H&RMLU03H'(:=T9SE#P$0NXLA;"5[;J.#EX 7B%KFA#1;6.."
MT:*'OH*@,Z))%G:?;[Y]MHHAD(M8MVU7'(1"(X$H8[NU]$Q>+-7G?1Y9E]H$
MA_::K:TGO;734QXOAJ$;@CL 1=#*^2ZP,>2P.S0<(28&[6TR #GX8=D2/XI6
MT[5$=KT39(FCVDU:='?T>%'AF&W7^UQ(\]SP.02+B;P JZ/NU)_:W>VZ_H1C
M63SH FV9?%6;+R/X=F; N7*.3R)^M:QRTWY-\F8O B/L4^B%_8:&!9^[N^AZ
MNFC92]FL!\VYMG/P2/X3HM/8 :0I3E&H3K98I\2L1.>F[2%9L;QO_^:.R2/^
M@KV^P<_"KL-6CTR!UZJE_H9 PI!_P ?!G]!_ON^]CB;K1M ?;D,36X)5%':%
MABVX0/+@P<10Y!?J^?\JC7[2(9&'HNEQLC  UB%O1"'6*0U*M>UJK/<U*BTW
MR^[.4[ M37S[%T./Q\,J#U#20?OU'R_OH('ZA:A'1DF$XNZ"V!>ZN%AQ#U6Z
M,&VYKDG["U?>5NO5574)Q8T<'Y,K*3E@_IB+*1/\;@H6C'^Z^_Q+9/G!_O-7
M2/7AG<NNV M>\$!H1%LILO/&:(=@@TY:\GA_N>D#H2T,UWJK*QT239P>HH3-
M=A>GEZ/*-?7Q;BI@2GJH%WL[JC_V=J? 9-=U;/B.8,V,A:- *6/<9@84HBTF
MN4I_LAO5>=CM_Q8<C><?3'%!Y/=Z[453?S]%E;!3/XA/N8#:X"%E/_65Y[Z'
M+ #[2!/<*>C M0Q5#=E=HL7B/+[]NA5Y4*)@Z =2V2_,L$8!/"7XM5BM<JW5
MO)R7&9P:+AG.-WB&6W<\."7V>'ZDDOJ;XWE7<T,U!$LME#D,[+\'= &".)>=
M%X$_6('A/S_L"31"*H>7- V7VQA<]SKQ(M0"PH,5)H3C6/+<#3:X(^.75*S6
MZW.7;><1FO2:FLE2E4ZQ&ACN<>3UI^XD[HAM(G/ -E&1=4[G94X--^T/*5UT
M4E] -1$^AQCRR[W#-(%WRB+&2M.NTJ3L:75(96>EII<P35PGTP2:3SH;8\#R
M]9W >**7Z]/+NY..$J4DQI+H)3&6JU9*8BS7J1?\L9CHY9HX)F!@G'!,?,AG
MW'7/^!''_6TWC)^28"(!Q;V XH3L$G\N*,(E_)YP\?OL$L$J>EU5CON,^T'I
M%*3^AM3VIQDD"TW@RM[Y9*U&\=,"O[(H\^A=4W_?>OW_'J%1DKVKEPS+,CP@
MUMAFY5$9JZH[1T'6VZG1;'C=ZJ@NA6036/YXR,/W!.0)R+^^0O]S(!]HF-!$
M!7Q+B6H;VRB*A/A3+V*<*!R7+B4@_V"T\H?C_/Q5])_#>8Z8>@O'J7&4CQ0G
M7IEK-NNV%#%//.2+QV4ZWW\W/+LBIJ];V(%\+GOUT7S5^1+M-T]&D:CSSGWP
MN6*-L#PR\C"MP,%$-2QQ+1MP;"C&8/-%IH_2#$T6.=6I8H6T%+)09/+'+1NG
M"S+^+(#_[*SC*ES67>0Z:!T$&D'Q;C1X2Y!M'CR=DS*B*6@I5>8"A<LG7'ZO
M3 K)QO"FLQ_!V+K6,TQC/+>\':*U,55#J7P+W32XG(F092\D0LC%])\FV\,$
MZM>8 _D U'FK(RV1&;.CN],A4ZJO1+*C>"%A 9[/)5!/,B&WD@GY -J+MK#=
MC#=F":EFYP.)X+,4HT34 IE,\;ZR(?7GAMGG"=G!N530>6,%?9VP%OT^$B4G
M7:L2\KLO"-'"7A!@R!"CA!YU'@<(C;'E@E?6."F=&2'I^FA6GK-5?^Y*; X&
M:<<9_ 3B"<2O(#3[),3+\F@ZZDHR4B4'AE#P6[ORF@ 0!\'9N7C_[P7B7UX^
M<W4HOUQ(]CF4CRK,BNY)W2WEXTYIDB_@M:G3!RB'AU3OP?PN<FH_YS ]:3'=
M+;W]R6LL;XP@[G/2NOU4W8N6X.A0);Z)'7@-@5;&0F]MM96\TFDNG=IJM9Q*
M;#X@*\T>,Q5\3\PH,:-K,*.SQYJ?,J-*B\"W!IK-*+YM$409==.HUP=F!"NA
M'C+%V&1W8DAG3!,FMG1%$>VG;*DD++?X1FUG$8Y+3VV,6P^[P9($ EGL 8FA
M1/M^G\REKQ\][)P[Z _D59&SH(DL_WEYEPQ\CG,T"+[9R(!E][!^PG0EC15>
M]_W]S_][T=_X9+:0N<.P?NQM\^#%HKY*+#!324R'[9/< MS[!Z=ZG&_O/0$>
MLC<'=O_CR;ZA*%*Y1QS_*_7\1RB0(VE"4I #F;T@_0B_]9+V(_KL)SV<D6(<
MP_R!H8\!5,!?]]VBV<?LF33URMMDGO7R7RZUM* ;^-]1EXSMZX1_CF/"B3X"
M&ZJ >\58I$@C(%&QGV#+G9R%] 7:7K,!O7I+:%T?\:@=PQ'M/<,E9+&$V8R
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MW9&-_DD&>?Y@*H3?,$(?>0B^&-M4QYW%=MZ=LM2P*CE21YA1E@A+;$!<E7]
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M8SZ<0V-(.G!&\ <T>'UX0!)]-_(9E]YM/8F6)8$?DPQ8SMU=#&#[/#SHLN"
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ME.93+%U)8_CKZ5+_\_]>3-%Z*A^ (V(-Z\<^+WOP8M'T+BQ(T4IB.AS2Q2W
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MH02!9PS#&+6)P(WO?0I6B0D8O^;YL"0H;%SPW' &GP5_V4P1>+8"U@)%UQ*
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M&.*8.V\7I;!AJ4,1< CSXQ=UAQ/X#7/(.0T+1!271Q1)4FM5S2I1XBOK!M[
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M'=LF#VLL>"86/W.+D5U;3U-=W3&V"9.:O346MH$C_S&V?QXM!XK= J:%&P8
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M,*JWZNE>#*R'KPKN'V\6#-&"\&H'A_X['OL$YJ9Q+XY:7+FH8;WU>(H:?9X
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M!6M-V.;J%3;;YJPV\O^P 951166T@<B4EJN@DRR"F.D\YATW&)-<ZU6#L8V
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M8NY?[5KZ[7#.>R'!MA_J!](5GFY!HV<7WA'.'N(YX+;]H,^)5>Y'J=[OC^/
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M.JMWC2*N7(BGKE*8P"^ML#LB#<IN^ I[9LN_MC_LSPQ.9'.@"$]WQ.!,[O
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MBGO!$.671%(X6%Z*LKV+]L\$Z\6>AQ\<%!/8!07\]E&O'7X((=?RI>&FPWD
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MR\^PVNMGEHE5<PK3B2,%&HF%2"Q<D"O>/\Z+I$)$_S#1/RU8U@K,+V* LS'
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MDF> !\ W[9@SEF/J2[YA;+C-D(I9@B/'S)$_(@>V:183'/\7T9R"P:+_C>T
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M&?<K.S+7V\H4\N6QEZ7@'@>!!GCN=,N]Z"EF/1MH0]SC7#9&C'7X9#<?P3&
M.9<MW5RYGX;<_:@V#NRC8""^$WB3:!&$B>L?J'!0Y8'?<34KRGT?MY2GSI2
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M>WCE*SYXVJ.OBWGXZ#+M""9,-$(&;1;=,K8.0HB9<%N5$TJBUU 5DC+\*\3
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M%M0^<!J2?UV;:W!5 F0Q:\=?SZ,WJ.B=:-P/4A9X1&5PO0HL"Q,S<GQ@";E
MUN7^&["QO0?%,7=Q(&K"AX^$H*8[]@XQ0$NS&= +$'XCX@F:QP'41^U3>>QX
M0VO=M_KJA6_ANS<R!O8" (WH ,-V/4:1H*]HZ]F.A[S@AP?P+: /V<0&YB'_
M;6]@[OO!>A26Z*.-R\5'I-UU6-&2X$NQ?K0"D(&A8Q]%ZJECV9?'>(B/B.<A
M0\';(^+7KO9VY+W>@S$3=Y^-^=GJ-[&I*\E6,"Z%7#SO01MN##$BC+X!'X.4
M5?>8.DJ5WDZCH\B_YBY'O6+:]R&Y\Q(ZKI<$;)NZNN\3.DG\H9VTP"!>^5>
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M3_\#U^S"G^P89X%>:-Z:K?F;3CVET]BLLDU_:[[QY9[]?:TF$Y&G2.I4A]&
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MH4O(JCLH\;ABY56#,\U1XR62"$>7JL$RH\Q0B:M9H9407Z^[(G3WG<0"F(
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M8KS>)ZL=2I G%*\8G=:/7_@MN,F0M:_[7A$[=K% MBP'<B=H'T(<H#M,DT"
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M_[_+CFF_4]SXO%GM<R5I)@2]LJ:95:Z<3P)Q1BT1"5-/<>H69[5_FN@[TRC
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MD.<4'J8[ =MV^C@[8PRP&&!7 + OV9[/ S!43MF#:KDY59%ZN5T8#$0&&W0
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M]J-)U0[T]/#E=45ZE0">3Z5JN7&Q+?FY%;HLI8?S=MHVF#G,8@W/@B-T*L>
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M/+$]P>UXITJAL?)@(^(#7*9;6DJ76EV:-BSY5"FT:ADII!RS1-)N/V4YV=%
M0WWJ5"FT66V9IROU#$?7JF2-T<N3C6Q")_)1/Q?=%95<#/0NW1M.#=U:XLL9
MN5\T[;E@7!>KN9N!O6(P(S^KMI7.PL4Z;/:X95E&:DYZ9LLJ9ANCH3.MM^I=
M"K0\>CN1'2VZ@\ZDQB"5;'Z^3 ^\\DIFD^CQ0[GA/+]QETN'X=+,+.G*120/
M%NF$@-:D;FZ8)_,31AF3G>*PT$\7R)/5\AIHSZY*ZWF-J>F96J9L]>9B]Z2
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M7"9]4I0WU2+JIU9U'<QGML.-L^,L:YX497)L4ZEL9^+3>B?%9'36Z-=9[Z2
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M%KV.9@M&7253V,0CNJ)G3*BP^&OV,1O)-?10*[YB3'ZE>A,C,&($YD3+$)P
MA]NOY%L33ZRP:)+&IK-9E1FO-OSJ M@C2VXG4ZGFYG1OU'.<7IKKM7!O6T:6
M>$0CN;H>ZH<Q^&+P?07X'FN*OFW;JLM]PUVP%N,JO+HLS(1*-74!U%$+BJQD
MA5**5OI*?HS:TV82W56<!5O3?:'N-@RU&(>?PV$4EVISO>6J1375KMKKV#JS
MW#B]5IWZ>KS*CLW/YIY)TLJPU;*K-)E=#F"Q]4Q8(?HU%?4&CC*"E=H:O9RS
M=['^S";PM6SO]QID<(>L<@W&[=D*S4^+NL&9#950R7G#I#&^ZV>G5%A>.HD^
MHLGH+-UK@=X7:M8QT&['ACT;Q*JH+*MJ2FHQK49+\-:&6B\4MM6J(X385YQW
MQ!"[=XA%8ZF>#5NN46$7V8G%HDC: =+B#DNT084UJP&V,A%:K;&)&FT8UQVB
M[<KMT;.ATIEVS%FY5YJB+;+2EFA/2E--&:!R:YL29[=-+^VX'9CPIBZ$W)F*
M35[' >WY*IW<_L'JYVM\W8'=N:MM]2SO'R[]11?&7D80DR+:D]#FIM]01YV4
M'-:@3Z?N]V#U;%BZ_4.:ZX=2Q*>CGP91/I-V!B4%1^B>/$+U-I%?I%@OK&L?
M%8BN[H T/A*]$[1%=1SZ:9C).;:8:F=5377'1 [UZXN\Y'< S,@89O&)YY7!
M[,JMRW/ L5$@4:GJU)C2()_G-WIO86EPU\N\ <<;./#L*K8:H"K[KV2)(LS'
M+EJB[22LX-#SC$;E;6J]MW94>7$ZB-!<Q-^+>2C412#-E:TP=X$L?QCUPWD?
M$SJ=-$DOQYS*S=F"7/%A*79X1/F8OI,#RC.;AS%.+FH+?BU"I&&VBK?R^8VJ
M;QK5#L_E"UX15E,G(D3(9<\7XQ/%6X32APR]K\50==X@BFUT:JHN/O,'LQ6-
M%,<=@"$RQM W.B>\.(8N8\5]+=84=-189DM*#_7MD:;2HIVE=(@U8,==T_)$
M6GB[O_+S=H-9BBK7Y657%C$U5SA8%.+K%B4HS>/9ZGB>R0P-!LN/Z%*%I1IL
M'Y9Z?LR>H+\[.\$M[$IB^0HPAN)3W%L]Q;TF_KCR0]R=R%,V(#JX:W#RQ[E\
M0+G#QD36*XS>'DFYX8CWQ9K'9J%U'E'T57R:&T/JZ@YSSP(FC%=:@YHQU-%A
M!YO/^QV9S9,R !,1&9B^YW%3C+KKLO4O [>Z/^QS\\W(94JS=+'0IPKMM-,!
M<"-CN'VWT]TKA]N-'.Z>9Q=T:N*ZT6=M5*F3$Z%/<MZD %7*S.NPO(%3WMT\
M!:("1P!(,Z$IDICX"Q8XMN-3WAL]Y1VS#:>M\^S:S*@<VEJTD*[;E^8W>Q,U
M^5[DASVJ Q'^Z"T!C+![*[\Q2-'YQEC1U8Y)S4R/3:*[NZ?QR>Y]'$==)S;^
MQ"I$HT<%.6NH2+7I673-QY:]Y9KAW:4,41%<%XW/H6+P7 %X/F3<?0%JA@4)
M*<X)NH.VEL2,MP0[-S(IB!I@RITZO8A!<\^'MQ<!S65,M"\ ES\I]D>S#CY'
ME:YOL>Z$WMB-#@37^\]KHU^1"Q_6OMM4_L-U"$YH*TDK3]E6NZ/J=*%@&W-/
M,&GY-WK!&>SDW_'"E9S9[BXL)[CPQG)"@C4U5T%-S6^1*3GYD:J[=W_T>PLI
M *[A_/?%/7]8B#:H0_O1?:%>;O0XNU5AF9K5S:<:P]*RE0.F2C*XRON8(>_W
M^#<^L;I7_'UE3JD_1EYJV6AI/;*'HD-$:HH%@JLP_0!Y\/[O(Q%?38R1=W/(
M^Y)44W\,N9HB-71\7*B@O=78\!<UMZ0E.Q!RY(]?&: .?Q/(74+YO('CXUM
MX)6?(9\+J0K?+NF#HCEGL$%]I33+.9TH4Q"I\)KP(_Z:6AJ8QO\XW%030PL:
M+H=BN%S8[DKVLS,*MV* MS@_<?)EO_HS,2&N%Z)ABPE+Y$W9 %\4X%(FP'HD
MN*FY$A.!+".!!"46H0@E'+ P=CBQ=D)P+0#*X!OP?#NAV. [IF<D%"/XHV1J
MFND%3>"<_TP$XPN7IPD6VE+X#R%BLNF*S'J%\&JO5JE@I)<M%<G.@9@5%)O7
M3-NUP$9$AP.T*0M,O"$7+5,/,)';PT1_;SR@/1!]SC$M?RMN4[;+B69.71=M
M%9O:,WKFK$UI Q @ L%<@)<"@17/2TB_7;,#60H_>2KSA;V?K(.EV#UF6RV,
M!PO%+6SQY^Z'_9[!CLS"W-4ZMT:"!3-V?4,T47)^<JYC[OX04&GXERUKAVWV
M:'S;!OXEW (RZ'_A !UKUZ_M^Y+AP-\7\4%F'M%7"RP#M>3$\X&D6Q(0T]VD
M[7Y'X!;U<VJ)G(IX8)K^79BV N7DIR7"' <K\<4SMVL1O'C7E)O:IN8Z3S4/
MT7"@7[B-?V 7!V-Y^O=3.SKVF"3CA;B"A<@\$J_&V\0+$2/B>RU$C(@K68@8
M$5>R$#$BSKL0'XQ3WFJM%RX@?S@IKY6+!Z8=S703ZIF*Q;]% ]^A3D^(P M+
MP%L)Z5^3"6B<WXH\?$S:P^C>XW_/--I[6'DT7OGON?+)[.%<_.'&=_$2[*&3
M,,&%7L*$9)EZ@N?L&6*+CJ.)PIM^T+,)_Z7GXNM/7[<PN.JS'SCH)':.*Q[7
ML<IGN[$2+UZ\>-<0#P[L$5:J>*-%8;E 5=]MY/-4UQA-8!C/*\=+R>S^\1+X
M[4]/4,/3RZ!Q>"0+GI:F# $^='N0*AA&0\DS=%O-MU<;O&W(GL/+^P>IR'N2
M=#WU\.=VVX)G6GFP5VVWJJ,.[Q]O58SA3.%G)=,4[);5$ZV5PHMV5^1%8)4+
M!45HFD['!2LC^473ZH:G@O";E$W9X 7VTVDL_IR;,E6N)&L%E*#U7-JU>VJY
M*%D=%H-A$ZF'=/*,M8#>/-XY-]IVDI@@@^<C";">9&+0:[5O0=N]GMW]B@CE
MW+M!O'[Q^L7K=W<;^D"Q8.J&O1V];9FRQ>EP!X#;;2_<;K>;>R>G6:5ECA+H
MWL+O%,>(-1)SWAUL[IV,BV36F17M$DT5T]%JGDQ3+!YL[MDW ZT^=0?I&KP#
MIQ2 =*  )/Z"\O4SH1B\YL(N)'134"0POD"L94XQSG$[Z3I,CM@K\!T,RWB5
MXU7^KJM\!VI)^E@M$82)F.\UVAU5D>NE2L-6*T+W#M22&4O5<_4&UU'ULNE.
MI,62FE<Z+!'Z')+)S W[''Y[("$&/J:O/Y+X%NST;:CH**(^0I<GMN$K/8TJ
MZG1OBA9:#E_$6]W.>>@G?/VE"*@H> 4Z75$TU"^@C-0@EVU#HM@4O!B=>4#Q
M2.YG7@".9SYK^#XH0P]0AD:)LC%:K)=R]9[-M)3,J$6M4ZV5<A<H(_-(U^PO
MTBZJ^\VNYW1M9J)X &4$W.;)U&O;?(RR^T?9O1S?719E\S&S--=2RD.YWF"8
M4I7B@E [ &6P!C)Z_N.[ZW+HT="7!]?Y8<^59XD+#8 KT*FG?J+;8^((G]C^
MOU*E.[O]XX'ESS3TR8HPY@5:,35 7E.4):=WH134C)Q3FW>D)J,T26/@9WMT
M<BZS9)"3Z %%(\F@&D/WVT(W2DW^)'2S MM82AEL@)(-72*63'I0*-\%=.E6
MNCE2_&(:[6$M;=:0ZFFKT '0!?H\]I!$([2:8^A^/^A&:AZ<A&Z5Y&NM=3J5
M83@C6V)+F_ZZF+X+Z"YQ+B^E<A4+K54%L^S)4]LSX*X;D9%P08L@2#QC)QPS
M 1[$R5LKP 2"F #RF!#UA6;ZHA@[V&.GQ =U_3SGB+)I*9!ZNO N+(0OF$MQ
MCVL:3S*7@R)'&0*]$[@(LSP5%M.\C7IZ@2%-4NB8:1P;#N["N['**'FW7]67
M##8KN*8T'XV'GL>FH;F0S=R+GSY&]>7,@.M%=7O%$JOZ$,^AOF IE5Q-*=='
M9SK^ORRJQU:M0^18&T/UY5*0,CT]1RH0U<"2P!^P9#K&];W@^BC^ZAZ\SL\Z
M)DR2EZ=;L:%[UX9N'$3X'5;Y6E40F)DY/U-$B5Z+O N5A)8D@4W8BE#WX&A:
MF*]5K\KHG4QN7!J@F73S+EPABU*VWR?;K27JRJE)NFN/M,6PPV8"+R8922VJ
M&/37"_HSZ2<75$9Z[@("PS8M?^OGDJ%Z$FO,-Y+'Y<JVJ<_YO_:$,3"5(]RB
M\*Q,:ZU!BZ6Q1GJ:'DMY,H/=A=.KEC3[8HM=C1A%8-.K6M61))YBL]#IE8KP
M@#Q&^K="^N=\8E^(=*%,F_VY41!ITL*)HEV>EAHT=0]([Y=SR929-5/HD-S(
M4YHC5T@=(ATHHV3L!?LV2+\'+]F_;^2;ZYL.I^UJ5KRX'!7<A@J2T;V>T0_(
M2?;?-]N]=JOJC)D.+S[;UV/0'4(-!U 33!=6J;@^K+TJ.;<<2/J%M[>^?)^L
MU%AZ[1#*E,8J!#,75BTYFPKJA[]R8^N.H!Y]TK@8P9>/)_W"FV%?CF!QYG5F
MDPE246N5#=>L&,R\U0R*E+]R&RQ&<(S@FPHK_<);9U^?3"JMIS><7LO0BM^J
MY.8F(Z K&2*8!,;J W$R;<-1>NG]XGW/1>2NM33$M588#*M5[!7AX#61LR!W
MS+8/?^(!^)(HJG#\-O4X1NP=4H1#+"($_K+6QO_]/P=%1)[X#):R,ZV?.]+:
M&]BV> D6\)<L(F&-$DX"[_[):1[GVSN*S#QBQ,[^__E$?' J$JG'3.:_B><?
MX80<S2:LDK<W9P=5\,)O'=;!V_[MC4(IVX5QS,5/+/D85 <$O^Y*LA"/1$0K
M]>+L"-_C82XQLR!'_J??RI\$#/P9X!00E'906V/[)V#5!\4(32F1-X.J@O:3
MF'*_SET,\T#:]DLMGA@E+*CXGMT&$*'X%,D#L!ZXB*##,R$I!F?P"J>!;X,_
M!.R?X&PXU@(@4DCP"3SYD("&7!!:#O7!X(<W'13_FUJ)?WZ]V6Q7S-,!BQ06
MZ+03(ABQ<-R!A^>W'^;U?Y4H#J7\E/A&5>KS>4O;K_=9W$WY7B'94S4]B_Q2
M%4LC3Z)+RMBGF@.YZCO;XKR JT6!<EYIQ\)FR8@J@!XMX^_E\FFT">5YN&?$
MS >Z B3X9&_ NQ4KL8)E?NU N"S%5O<N5ERFMP<\)2@V$!#_IV)HB@$V!<WD
MU2-R",4<)T_QP:<Z_%N"W!792#YN"^L$K)C7.-M^2C,93NG>%']-]>"7TPE+
M"?.<9?G0';M=:T!RD'E*8$M>!,[I]+_V'B-R@9(8=O_ICYK"!:J+ F5EL;#,
M-5!B'4A?(ACA\S ?8ZEY6VJP/:EYAF9T\/N@O 2" <M%BVNP;X =:;N#/A>,
MAEVU0^\^_,"U RU!.L4R/S]:UOASFM!!S>4]I2R8!M@)!$B&Z3H_)64M"OLJ
MV4ZC# 7B\'CF4%A>V/B?ZO4+!T&P4J"_OW<1)#-')O[_]Y\LF89')X?]>N$'
M4,XMXHH#^LR?UASSEB@H3B GP- Z92/&$O&])**N+%T%R(1_54*!QC)Q299P
M+4LT^%=%XK2-'8#YR;H_H[KQVTX'N_<'-M(#!KS$3GZ@$NT+RL(2@SJPAYV$
M^SW<RX.?G1GG)#A@<KG0'%]P%H"MIVA:PC"=A"Z*3D(!&J(Y!=*X579=T"<+
M?.64#I  IB[OV@!OH FTSZ +\2$!C-4@HQ/0+O:_!^Q%^S&1^)TBPN]U.5!
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MR**Q8Q)+7(D&,)=!AP!!K4Q%V$G\0W@S,!@?7 6P?X$1B+8#!B3N(I.@?\\
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MP3_E@0:E%&9\%M=I=]01DNUI<R,2G4AY8-SW.\TF9@P8KF_X552ST8K1 3Q
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MEZX"NLXE-!/('/@J^(XI0+8&BH4#&-UT'1O*/=C C^DX9&D.C!>L2,)Q+2.
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MN*#/:RQ)8RO1G3:;J\KG]RX6B>Q.7A0,38OD8:3OY[;J/@A/<UM5J!A)CYC
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MN6E=--?F@&K#I3QBXE_1CC_H.AU(0J=<FG*ZP+6-C5F96P2"\B(5NTZ1!Y1
M[R0^F2+@NR'@9 =<FQMD6[5&=BRL VY>=H>LL1H!C. I1E*,7!(C?^L>+0:A
MSBE<#65+<WS3[XJ6U,XG EL;EX$L?['IP6N=,=9Z36J0DS#"%GEGV+J:I^66
M0)CFSZ043BF<I"(SWS:#ZK"PU)5JBU]](RY94>EX:. E_V,1_RM.$*E%B03
MN_MU=C6S/6177-#G-9:DL97H3IO-5>4K;L(/^A&0B9$;5+6*R-;T KY>;[#6
M M9%.JY)@S_ )'Y$CSMAC;$4)2E*KHB2D]E#PE2G8'$]*[ !T@BZY&J(N&V
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MN:M<5FU?=6]KDU*^2?DFN7QSLDWZY)[(C@4^C$,[?[D_Y"-]W5L?U.?W[[U
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MT"D\Q+]6;,6(V-\-YJH:[Q'XD'&E<8:=&9$>$'VS8+@3:;;=9LVQHD,XWB(
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M,NL*I%L.ZM51>UV'OG(_\DO'U9NIZ0[:$*!962["G&TWQEQSC><07MQ>G'S
MZ$.M]!2EAB[C?DG^N91"^]:@#331R<)=CUQ^[< !O301FAK5:?]JFNB;T.[P
M@P6!3WE&@-9]-LAW].DT!Z -NF2GL#ZSNIE@6)]-]TR8N_1=+:VI^D_)XB<-
M5-[2)IQ#54VO6YWF_#NE,@KI/%NI3B8UMM-QH6F[TU^V_<1X1I5.2;-;>@-B
MU[.R-)7J-NT6=)&(=="C3=U.& -,X9K"-4EP!0IF0-5*]6(V1PB0S%4H(;O0
MF]VOU/\X*5S-K&.&C).KFI*U8?+96ETO*P"N1_7*%*QG]6'>$UB?M- W[^NF
M-]V^=-.-@D]TS>V;7J=*6'[[][UWD#!"9!^)%!%)( 3ZB'[3&Q\)(T2*B(00
M(D5$0@B1(N+JM\\NFC20C.MF%PW')/!^V74[0_PIJ?T3%\K@+Z>S7_^JW<<7
M?OH;9+<+A*\<-S?,^Z>\%?:^"I12/WG4/^5-KY3ZMT;]4]S>NG8D_GS7M:X=
M!_G/>[<13\6\"<S6OM0E##BAES! (L&R'%;Z?'Y*"AS*R;I>"Q?-4F(2"5"2
M'/GY;'X$!QY""ZA0[D%HN+UBA3R@Z)FN6*%7OUYP5,(F(14NQ7(RL0RR#)J+
M?H^B]9H)<X["X'(-JTW65\M0?XWE[K*>\S>Y9@Y&'<ZK">7E/,OQVPM5R)EN
M5*5 OF$@GR*']=(>PLM=F+JT_^/4^F!RTZDO<"WB0Z?(U6\\M:;UAB5PA;:)
M%L=LHT*O77.1O&L1/%,GBJ3I3<R:6^\'- :+FV&XO?$$FJL?;<=Q'VZ(:YT;
M*7@3#5Z@#,KEXK#!<E.659DQZU3#5@U&DP=>:T MNHV^UV -",<V\_FZZF[T
M[9TF@DB1FR+W6R&780OB9)&?#[AN2X8-3<7]?'NQ8B972Q9_$[DS;MV,]IK*
MPY"(*7-9R:Z;4W#LDI$]EWT/N;?I_+W"Y;,$.(8OVFOO.)63G!'_QQ3X"TJT
M4ZK^&Z?JM(@QWF6A@;9FY)#LPUCR9-"DCI7&L&OR)CHK+LD%5RZ/Y7!WT>P!
MAX^*H1-&(5-TINB\,#J!;C];V/:4YX4Z2TY+X\74&ME5_6I!FS?1*;4J WE2
MY5U3<I:C5DLI+%<2O[U7AJ703*%Y9] $RKML.7RM[G0=N*_Q<RJ@5ZB73QXT
MPT89$D>6.A10&YL)DYDQ(DO@X'Q3>7_S"M]Y6FZ^;3[?<#_-CFJ#3.TE:#$I
MV9*U]@POL\WO!AT1G8R\[5\<]X-<;7_)Q$T4+]88LF0L57O;Z''?>#&:UV'7
M3-"!<=>\$33''#M+==L0TIA%$LH'7WKJUA@'<K+_\3*JY-K12KW,6 5/S/C2
M*N.X&741@!W17&>6D3((_,]N'\ V@(<(G4AP69;DOMR43.@$EI*Q'3]Z7B;"
M4[1<R=HV?01,"=!OV(&T"R?&F>;/$NAE*YH.$*Z3_0W,O: $.W&.#/HWPX(H
M_CORM6.5(H1G7^?)_]__\^("P)/ !]=0'??G7JH_6]CNX@$:"WA=A;;W"R0M
M>O=/R0JEM;>_2$IM#\WXQ/CY=#* K<@0CQ3U3^;WCV!##G83W'!]MF<O;K!N
MO_7R#NONLS]<<M@1QG?F/U'D,6;6Z-?]=0K\$3\3I5Y!&/M-E_^1,A,7G"?_
MU>7R1S,#8V%A P%OO1 6NX]^_.K&%XD=+9/?W@CVGL26=$K1=<AM;[<Q?BVH
MWO=U.*"KZP[@$<AB#R(XE#+:MN>S9$7?CCZ(CZ97K5HS!UU:XQ_B\^6]E_[/
MV,W\^]<?AX&6NV!:?D0D-;..@!!)'1OT_CV8P,/OMZ,P0O\^X=X5%"^Y_(!]
MG[,G\DAL-_.5+-HW@RW*"U,M#4*-+1G#-=/LZ=6USXA@*/[CF A+R,DJQ0L0
M58H@85H:BPBEHB*ND*0XSLJX*(\57")1245([,>6J:6]VH$URX:9JU8LEJRP
MU56!LEO8+!01$7\],M2]?)VGQR8,%?U233&Z9K'/B"BP[%^.'([DYK!=,*-G
M-IT22^1S1C'/;'/$7HZL#H06-()T1(""P@I9EU *K8!8 _QZ9,$81#JFC@W8
MH$9*@S8]<BUY5T3QY<C96F<K!6R#L#-V!HNL#N&2MZO)]G+DIKEBT"6:ZYLS
M/A?MLMNEN!&S]9>^',FVN[Y>X5M9@?1$FFT5<JV  O4X#N:96XAM'0MG$WA1
MS:XJ[FKC:\RNT,ZKMYM\U<J;&LER[*2V:ND.9G1XD3Q\9J=0:XGEVHAA^TQ5
MH[QBJ1S28.3!,PF\T"O-ZHPHU*C::( W"[V)R8C9PV>VD4B%7;8I"NZC5$_5
MNK,6/0,C#YZI^TI'DM'6P@S:57?@+$MM0=!%ZO"9_DQ>+%UQ1 @=WT&L886H
M]M=@Y,$S&9UOSM7<A(,[C97!E-H.$A1"D3Y\IE3>#!9<OV4+7"X/SUTTVYWD
M^&CDP3/Y&A,4_)6A"!Q2&/0KN>JJ/8DX&3Y\J%P@)VB5J5K"PNTORC5TJ7>&
M.AAZ\-1:&9UW8(90S-I,%-AZP*]J"",BR.%3/9LA"DJC7#+[H846?0T:("@/
MAAX\U=,I=#!4\A4AS^N#6D/IAY,) VRA@Z=6BST2Q\AF35#SD171E11+]W0P
M]."IJHZQL!!Z-<%821;3:/2QH1-- #M\JN-DJTRV 4U8%)WU+4HTNV(^'GKP
M5'K(M3M5*:\(:HL?5A%D+*S:.AAZ *A@S"@^4ZYAIKH:AGG2J9:7D?R,ANX1
M==G6WYWHJ#6TR'"W_8J]5#T_/O\J=B<8>X9B1!::ZAUK"IXSJD%OA+=+@M2N
M^ 3<+5A*]UQ-P0_.S+>5 !3-U"-#$IS>WK,E7+A'_30ZT9^__E4?^,B*L*))
M1@?\6+6<\!HMWRM N8K(_0%26RO9PEQ[4Q(XCIYS34*F>"6\0/_W]P_^^RJ*
MLS<%OE85AZ >J6_:G#=A%^V11YQ*"9$$0I"/*)%2(@F42"&1$$+ CPB64B()
ME$@AD1!"P(]HJCB=D!*?3)?[H^)ZV0ORU\EV_9,T^!9[\"=U[4J7W:Z]+7?%
M&D]5E;"_KJJ$/%+T35>78./X\3:GQM@[8[:__O<_QU(74F&:+,1\KI;4F3MG
MGU]L?I7?\TY@^^X3PV__&ZU'GIQJ"[X7P?]DPZ7GY+=@@O>MEIMF@O342R#_
MW\(>)/XLG+M&-'AW%H)LU65\06_W^\DN8Z7,D)Z3*6NDI^<G3L^;J<W;E&:I
MF#SYF7G#_I1YX'J!JJ0\<>JC\X9YXEGE<B1EC%,?G/?!&%\K:;\_-J]\;S,?
M;8"CJ[::*<W&Y?__9'Q^[74EH 3-_F2\\DZ45#?ZSCJE[.G/MT37D_S@A>)(
M^U'%Q48Q=(EMU 0UV @]K2CU5USXXU.YQ+]O$7\D,_QW[:$G"53:W3C6%3[+
MN(-0$%"Z.#<T#E'0E]UCT4]=*6ZYSMQQP=0YC0MMU?4FQGR?Q?QL5NNGB\,0
M^G1SN$39; /J]5H".I&TFC2?P)7L[E(_ A_K[9S"[-3:PK>&&?P"9O#I8&8W
M\%Y-4[J.D+?4BN&L&F6FQUP)9N5^=Q[:I6X-[N1)V1H+DN*P_.Z"_KLPNP%?
M_V\=JSB"ZO7\;1H3)ZN(>Z%$G1>3!V!4E0SC2N,,.S-^%QGXQF2XN'_[VJ+T
MY!I+<5.WY"UK <[:,]9.P)*&-;/&>IT7)&>CAGDIGW7):^DQHZ"0PY$^30BS
M$KRHK"!%KE3 -==SZS$W"XX+>_BO#8Z3ZQGO@T.J3N=$6;-I-E^K#18Y=2'5
M!_R5P"$,B06QJ):'0J=&<O,-3#%&EXG <2;MX]JZ_6^%1.@\9$ZID5Q[9:=6
M4JZ]'J'#I+1)W2^74&8$+Y+7N<"UHEWS'5OPI)VHUE;Y:M$H>04!]=L5M\-@
MU:X67DE4,TVXWYCG+,R<*>98"FL&5>^ TAKW[H\YM6KSO=%S<FWG3?0(=K_6
MA7N] ML7PP'65!=&0;V6FX4UU/_7WG<V)XZL"W^_5?<_J/:\]]3,+>,C! C8
MO355!)%SM/V%4F@)(2$)!=*O?SM(0A@YC6T<AE-[=@TH=/>3\[S7$_4%QX_U
M_,2]JU=OH!60_5YN%D(J*)[UIULQ'^!I*7B.:ZO\GW[R%^?*J_W42V$^48%A
M!)QT6MR#T7"9F6O F&68F7?#].F/XJ2SP61G]&N3!%VMR.7L=.OFEN9FED-Z
M2/[B3KFX4]X\;'.?'+92<\W.1+[/K6;+3&XAJHY1_"@/BMIN#%-SMLQIR]T=
MT]>U.ZTH%B YL$^0PU=WH-0->"94;^U>$V)IN=+_?I\LFN_F3L'0ND#GXE Y
MAP*#D0UQ!L@3?)Z='&AST*W/)V,&U%C+V9G9K/A1KI3\9*6"EMN1QYZUSVBM
MQ7XEZ*C[Y\65<G&E?*"F$T,WKCCHL(O)E*=+:TX>I-?+OIWYJ%!J>KC)2+F)
M*7+,QF:658O/Y?<%2#??RHE"#3>JNP>VCCJ&%ZI?TX#YG7[?7\_E$H'4!4P7
M_\R9U)L(UA44GT\/ARLCU=CH=URS?KOR)L/!9)'^*!?-6FO;]&+37]!+OM6K
MV8Z\8>[ZJ!'YM\IY^1#BN7ASWIYX\OG%<),HIG1N6<@/%HV[E5?/?9224^C.
M5[O9^,:BEZ#?7 V\45^6<</_[YP3X_ RH(K7D^MO8^M\F ;TT1OO #3$&A'8
MVR7Z?O2>/DQ/^K,MW#=5G1"+*5ZOKX.@UFH\!7DFV]%8;Z@(?&E;66@?I3'=
MED I!3I>@@.C;=JK61YGK39HR,IW=PE]F!+U9U/6F^I5]R@K7^BL]GKV;C3F
M%YZ4WB[DC9O\J/A8PI/*9G-2GM#P_AP[2:?JU3ZFK._E-)*NS6N3*@)=L7D)
M7 RJ3^PT K;P5=-T+OZB+Z;T(-Y01JPAX P^CUX8YJQ::1;+&MOEY7ZMWFAM
MLQ\5#S-;N]5\K'58>EE*59KI88[)Y?KH#"[^HHN_Z&/]17'$TW(&'..XX);S
MH')C9[04W?@P!6=9D]V;5K<PUZ:,M>F.YXRX,S#Q?%-_4=F^IHJ\!VRJQ0NF
MC0;?J=[2(6UT+BE G]8O]-W:X?Q924!(-B69-]GNMX/>YW<GG$ /L_[_X*F:
M1T.-?G]!UX<C#OK+1;YQ38M\C,PMOT[FP3)FS-+Q[*3HQ*7PC-'L3]/^.VA;
M%XYWVL8\#K_ZF@6!&&,RUW30"0\)1A">&X7F?U(T1:/W1L<CO5WSNX?&I/[X
MWY\/-9[_O7]'$F5[6#3B ?21)),Y;P.)@L;H6A5)#SIJ Q4.:@EL!?ZP4=TY
M==RCCH+Z6H,W/*B(4'Z'QNNW&=+[Y/$<J<Z2ZE@ZO_M;-735  E!-T7-ART>
M[AO70NDW%T4^H>= 3('B2S]JW^A_A:#WOS]#K1W_9W28'"RN/!4=-1HF;(,E
MKQJ0$[RY(EQP9EWYO;/!VD)_7ZR;6IMCC$)3*68\JU)XC<\<V*@/)*^ KCPQ
M77@N9,1...FXX!_>B>+;X6U[-C5 J=JN;#?TE+\=KXL%>F*NE+]^I?,G2N__
MH''.<<GC%-S=-:4:N*_D%6798*V:GJ/O(.!$-/\$0@[NB.(="CX/SQ&V31T5
M&U+!"*#K%TPH]MD.YC"/:MZ8'"#K>ECP8%Q_1T'Y"!=_M,$I)H<(/9Q*V$^Y
MZ(@KU00(V"YE;@S(-7>4@WBE@Y#D,=OCFJJ9&P#!>!5!M"4 KH-)7[0A'&V(
M=?Y<<1^3J*4I 1V2/T0+JEX9#*DDC9!-=:DY_ _86GCZ-P4%TQI2*D8R&[B>
M;3B8HZ-'\<21@*[Q'$!9<!DV^L#+,A#=\/(?#@!H7X!*_[RFXKN/!RK!?XY&
MFY]^_B3ND7.,AW]DTN(QSKUDGCF/N=@,Y.5L/D>+,YIAP"R=2DNS?#*9GR6E
M7"8O\WF0S0A(%^&#.Z#!7ZSUM=M]D[6XG;)(J3>EQ%QL%V;)&7W_RN5*Z.Z[
M3$Z@EZ6UFBT+-\W!1$&.DOM7]BTI[U@S;SEN;H6<(8W7=W(979F^?V6F:FRM
M=G=LT>K&3$Z6=P.MU=O,F-.WVP.KD3)NLB(]7:EJ_W8[3A9G_5GJ],H*5Q*M
MICO>:5Y/3G0!UV+X@C)+GUXI]VXYPY3E ;<LVB.AW'8S5F(#KSQ9YX)UJL8Z
MR:3&">ON1F"FMTVII,PRI\\LY^R465T!;UQEI7)NIM)L'J K3TZIHGC)DE5U
MUEIU-^[7ZS?SCK!"W6I.UZEQ^U5+K;&TU^/OY$EUQVHCU"SA^,J9S#*") K2
M3$[F4[.TG,K.\JE\;D:G1"&?SN8%GF'O/WM^VVPL^F*N/09]9[5Q$\RJ65?B
MX)_*S>T)%#TCFNG-C#YH+M)>.A;^[6)UT!1R8EO;C6Z7-4GD[5XR%OZ]"BWT
ML_E=25N5=\RM7E<X(5^(@W]KI.4:?=E*:5XWL]CJ2:>P'&WBX#_LY57A9K>9
M<=V!71LD,WQOZ?7CX)^?E$MY+MGICM5ZUS%55:Z:3BS\)\"1&^9JGN*JI6QM
MGN@FZH5^+/R3/68J<-QL-T[T.;J_9,N.A#L@GIR28'M)^=:I56E5M]I"N=7:
M+;9*'/S70^5FR8QR+-=-,_FAXK6V?4A/!_@?L=,7A0/N]@,PWJX3HC9LUNL,
MN\E7*VS_5+<JJXZH8]G1E3NF$5%<0NV*VT(]VD!";.>[$X69(#68]AI,+7HJ
MI$1-W]7+'0;JF@ J8!9\@6M[X,UD=E29QMU-(Q8L^C_BJ+X)RZ2HS@/ZET.=
M318@M9XH>@+0S0W4#,P-4@R(SHOT>/@/X,4YY81.VT#@$W, VU7P6J0*Z%</
MZI0.? %\*"!?B.;20HH(T%5H0.,7.=?4Q<8X@XVAF]:T1KL=FU/KA4I9!86,
M=O<;-D9@8F"E#5FPI@/A!6]0(:SA/7 %7R8XTK)$5!3M ZQSQ]0@,'8E>E<M
MZ_QMOZ9L[EZ</8L>_%0@!#* TBD;*^/#1$^*@]^@6V?7L]EJ.?8X15 FBZ59
M8/I__<HD8^ 74!\"5JM7(EX/'W"$WAZBUZ>, PJ[HR G@FHY(E)L4J";T <#
M("7=\707(<2CCW'G/'P78CFB[DE "AY!;G<"7E,B# .[_;+_.%2I.ZF7$\D\
M!9> 2( 2/$<U@'//*,!\]+RB":W4=]EU9<S-XJ02UQ8+G<ZV)G*)[B[;[SG3
MQ!XU+7P7J?0"<^#W#8#GN0LB*T,+\?V<2WZ+D1 N,#!!=""[?R/W9? %]@B3
M;WQSFUP3\4;[UZ!OB$<A1SRNKAVL*_2KXHW_MHL\RUS3^<?"T!$?;^25)GR-
M#*5L<([!YP1Z]-^"#7@ML8$G%^/SO><W/O@$PDMYP3%US[WO;3[?+)CD\W$E
MZHI^;>PEQUX <49 D#TQU\GTY=@O^/_G 2+ ?_K1'+[+L;_LV)^?N//;(OG,
MLR'?9>S;X[3^G<:^/4_,?/@,M^-X\A5%VFI=X/W;\'Z<K7XXO!\S95\UP\]G
M7U]F]"VTTKGQ@-+>%-6_\##'A[)67G@^4;;W@:?Q1<>)?S .?5)V^M$G\C5F
MCP<,^.-KS2G><8#K_.>'KI(\"!4X/]^./KY-FJK/)3]5FBI*3?WQS*@'E)\S
MN;ZYL<HKB]9V7KM4*@R,F[MU_]$@U7OT0U;,87'MFMW-6%T.E<FHWLIMRT<A
MJD3J13$JB,8%C,6M P[_13EPN?!185PC=6BPDU<+V]J-G:&]=CT/;CK;83==
MF*50R#K#Y$XB&Q=ZB*,'^M,GW7]6TH!Z/5;KC[3Z2$BP5>\E6OU6/S=>U6?E
M3?E&!^IQ@=3;$,A]NNB-Q,D@42PWQZ5=8K2\&:E"(HU23M)__6+2F;<KA7I_
M]TE,K3=OVSL4N^.7*"\5A?K@7K \S_\3FT/P-8WJMQ9Y%_GV\?(M/O\HAH)G
M TX9T[;=XH;I>7W>&8/.H(82O)!D2[VC8/NR*/[.+J"WJ33Z<H;% *R!X;U-
M'XWOIC=]/COB/8L5OQOT/KW6^\;R\KW::SRE R>L9KMF=0<3K:H,TI5TLUA<
M*,HKA*C/DF*$IJM.ZND2GRK0WJ+JY8RMJ]J3PBQ#VF?DK^CDJ>I+?2G=MV>;
MLNK^YX=N.F_HW/FR-/P-U=K/.-7JA01*D+0%4?0QWTUJDYOWU;Y6U893W:Y)
M<[K'<*B(!&JX[$7!_?0*[A?!^[.+IR/LOX_TX]JNQPCC?F/<I0LWF7U6*HXZ
MJ'(&#6T[]5=^=>O!%U=(6E&\KILBC\J(7?-L#IN//H#O;6Y<Y-\3'*#@NK8J
M>#C'?60^[/UY4$B.!FS=! MF-)Z6\G?N:MX0B_O-+(N$Y&GAQB6\\24-O8LH
M?3-".K$(1YFJ)(WW-:U9U+J6-MS5.*U/AK6_@[S][FT4/SBS\#R;_ QFY06V
M[P7;<UA1;[/+HSXDGV1AEVJ]/Z):@R@GUW3FX(R^%"]=X'*IY?M$4+A0Q^>$
MRY]>Z7<6*'R]PK^88WEF'2#]1>O"GHT(?TQ9X MQX%M5"7Y";/C@HL&7<H0_
MI8;PA>?RIY44OO!X_K *PT_$9CXMAGT-SOS1!_0YL.P+QOU/#^=[5R>>[O=[
M1_U/]_O>M1UOT&#S).K?2=>DL0'NTERB4-.K=T-34Q:O"5:^M'9Q7MDNP#!7
MV7/=27=0VF_Z?5;H![6+S'<-[K\OM7S66/\1M7Q68GDJOJ^;YMRJ[6L\QW=L
MAU'$=G%<.D<UXW:Q$)SU,#T>[MD[5Y;NF$6G3ZH9D^FO',4_)88_HKCQ_27F
M13Q^.O'X[)R=W*#(-5J+9HN>LN)\F'3[](I5_-+']Y2+WX4 /D6B^!$!?(=B
MR%.8?:O:R#_.BGD&EE[@^97U['?.JGVK(0)/:=U2?JB4"[1QJ^VR^?W:S(SN
M!MW7I*<_7#]IF&F:O^G+XE@=S1.VTK<9D/3K)S.9JTS^M"[K"Y5/GE+$5Z^F
MO.C1GY.D'U:KMU)SS<Y$OL^M9LM,;B&JCE%\C0G]O%I+II;/B?FA.1NS16[L
M9<9C(5O=D%K+]RPC^2ZD\/DTZB]""6<7;H]67U89>9M+%/M;;LD .>N6JM(@
MYU=?)F-<KM_,7OFSJS'_. /G(C_/4F(V4%*LT*O30%MNIQM;8B?[^4 A)9KT
M)8KS7:W+BP1^-XJ:Y(;";,^L*QQS<WNS]AJWYL+8D*+-9XCIAT8W?]D9R1^^
MD5<L':=L1Q+311WP-N(!\WL'DD+O?8_,] ?S>)CTH0K;)^I* H43CQ/.__N_
MCA+K0[:$ZMY,^^\@'2FR,3^AG\%\2@$)DK?/R_#=?_/ZAM\Y0>5:[IH)\^G^
M#E.:T%%0F>M<[G^HPY_H0$Y.$Y741<[LJ&2.W'5<-.=_]T3Q@ \8-"^>25YC
MU( ?@S*%]'7ZG2!U3[RD#G#Y/YZ:VXA+_FO4+<52&?H;$@GD4OI1PI7_U5^_
M1KAR$0TF)26(3HBF_*^W'IM[A&U1.HO9962T[Z-YG!TS,C43,E*<#(<5>%DU
M>$-4>1W>#;_ TH#B\0C,,A QEP]'"N&IJ^'X59P#^MA+_T^PJ?_\>O(R*!WP
MLEP()$#M("&@4:YH*N?) JX.;V?H9/Z0A?HHHSC&\CCT/?NPSJ5*Y&[<E,[U
M0B_LP(YKTT#H6TMVEAPUJ\HGF!V=IB(K?XB*5!?BKXA5G @G/_MBGUQ>Q7,A
M,"B+WQ&41UB(Q])":@"ZCND=(I$#G#/LXQ%I^O3&3GA5.-!Z#NEX#34ZTW/(
M7C!J(\4'C;XEPW21\NGS!;"%CW;P^&TR_W9@.JXI:M0<\-+*XVW(D!Q,?.AA
MR,CWKX.ZE*')GNU2>J G[JZH(K"AKD855!M-([ZBRO_^%Y-A_G$<H$NF+1]^
M.-SN?X7?@40/6AWD3(>G4ECE1XNO\4O!LQ4R3U@FP"1[#$&*GN*Y?F80Y;,9
M!\2#.7(T:*8P*@H( /_DB9^O-W5)1YFP3E<FF4\'1=T'52T"J:*GZDAZ^ZKZ
MX2%M'IX6U+WPW8>OH8QHH8GJHSEO= UP"SFH?RO?2TU;>YEMTZ56:U4HCAK2
M8O]RNQD/IQX;$F2%*#L)2"UT\#T?7".S"-J\=!)9(O.G-Z+;+BEM>;RZ4XQ:
M@;:-#%!07\YLC$+_3+!I>(R\BJ;-$[ES]2>"_3[,"X84Q80*%)'H:\=_WDCI
M@>%Z97KC:IV>3GH3M@+5U'/B0F)<6F=!;@>TYJ:=6U?;G?9^58#RZ2J5/769
MO!P;9+AC7PU!'.1/1HG[P,]P(LL+X_F66]EKQ^FFZJE)\N7F_BN 7]E76J/:
MW=+F$HVQ4A.TNT)QO?GK5_J*0?K@[P,?B@9H:"$KB_J!E,R_/Q/@Z0\7 <YJ
MN%PL]JWZ>%?8YX1:T9!SRN:<D"^WNNM"JV+3VJI=']V:S<)MQX8B@,F=#C3X
M)B+@7&!_H0BPMMO,HFWI?9I)@;:WL(UFMGU6$9 L=L;ELFI7:4_26^9-KIW.
MIB 72%ZQN=,LD^\D LZ.$O>!7^MG%P)7X$6NM*[Q@^&*8^O%LP)?KZ8\AF\D
M[KAEA:4WK<'J9G=;0"(@EXD;3O0;(N#GM7\;]<6MOJ=,'6C F;*L0I,*K#S5
M0H>/,1[BC\TK@)A;#K69J^(</AA:9?XCX"$MT=TZ<!QX<'!Q289:PN?.X4-M
M:@-/DMB7)$9,+&E\@[E)K'G= WY-WQ5^'SYZB#0 VY/.'!J!"?P*\C8;B*9B
M8',06JE@:>&_-G"CO&7I*GD',>["O3UF&7YO6["+(<H% (7<?$C .<30?+TR
M,)\9/5$QMT4.Y.#;\Y/F6"J>51GH].M[5UO6:ES7K!;9(5?:K52D!J;?4!?X
MJHK@N\/?WA5NBW=VIJU5Q4)UT%#STLWDK/Z R=3-%@ H5\; *+&]>=U,,7,H
M U*OT05_?C9A?TYJ?Z$.V%JG%O:^R6HT,^C=24-INDH/SLH"2NNQ5N(Y[98K
M22E:Z4S2636-6,"KS,!3!?#/9@(O1(OF;#*NK\M%;]S=T/5$9NZP2_6L:)'-
M;&Y2)2EQHU7=K</6ZL7IL@+1XC58\?/Z8X,9Q[$*RA1T5<&>>^>M8X\/1O3+
M$#D,Q0_"N:&N";%4U#T4J^,5&_C10T1#E.-AS<R&"A[2MA33E(@Q!=^^5D42
MC13@IFQSK:('0*J#3V?(W3S\U>7UF"TC'1+2C9\P=-[6YP\%^WX'NPE,?93N
MAML;F</@X"JF746GADC7/[-XC$_EFWLW(76XH=9.2ZO,=,7IRE^_V"N6.?6'
M:A&&=I9#O)^*M',;NX)1$VFZV1"F>V.=XW;N;QJ0;W>(R6'2&.L-::HQ3;LP
MGK65=&.J(*.294]9AX8,Q#-1WA=*"GIU@V@> V16T[5\/I7+I^G<C/Z+)%GX
M/S%Y6F(D5IIEDMG4+)U*2;,<CRZ3I7PZF67Y3)(_OD/(2[(L232\569FZ9R0
MG^5%B(?IK)"6,TE)2.7SQW?03%:&OX(92^?$61KDL[.<E)5GDD +DB2C?U+'
M=Z33:89GV-0L!40!O@. 63Z79F9T3I#$=%IB@ 2.[\B"E"#FX3NR= JN1>+I
M62[)@!F32K)I@4^F648ZOB,II,64+.9F&5[*S]*RP,)]T.D9#_A<2LZP?(I/
M']_!RA*?R68S,RF9A^\ .7Z69_+BC$W*+),4T[ED7KRW\PS<J, *LUP^!69H
M'3.X%WH&WYB3,E!O8'+W=IZAI8R09K,SD&1D> ZT.,O)=':69@"=3Z?R\+?C
M=XS$60VX;5"2\FUZF,OF!:.=T)/[ N06]/TK*R7:D-,[VM%XK5#O%1O+;4W:
M(+YR_\J\DMF51J4$SU6+_*:B] =[L8:N3-^_4MW/2X51+J&-E^.AT$Y8X_*&
M[L,KV>.=I9@,A&D^/TO1$))IA "Y+)^:T7E6I'DVGP89X?ZS1]744)38Q&"\
MVBI\1=[.S:*VF3'WL3@IIW,RD\S-4EDY!_$%(DU>R#(05QE) !E18C*9^\_.
M]-QRN[Z1':U:<O+B#11$:@5-Y;[W[#R;9)+))#T390%"/24P<-T0I'Q.DI.R
M(#&,E+W_[-9PELXL^[,&5[V=U.AT_:;.KM&\X!.(Y.?]>:)"&S2M+J4>G199
M=\"C*^^='I!9(9O*T/ 8TW"'0AI278K-S&2!R3(R"ZD"G#R[VQUL1 N "@=R
MK:99**;%U:(_R]S?(2L+Z4PV V:RQ,!G2W1R)M!)<08!QN0 ^E%F[S\[5]YF
MLZ5$B==8>N,Z4NTNV=CT9VSX[/.F  V(:ZS'V^XN+@>HW@(%D-W26QJJUW)1
M,FXX&VR(H%4-#T@%]Y'K9NBRY/DSAE"24(;R]P9U-QLG7GR,I/Q]V?CV2WTB
M<>_Q5*68C+F1S1N.KZT197O.VV .?T0).N^[ER<<U76#:GCZCFB62-^[HC;(
MG[JT=("0@H>:G8Y\P'#IE@<U-A$YH('M9Q,]4Q?%^X5FJI>O<+5IBM-8VZQ,
M,^FE*S<V#ZBCV8@ZF@VU46PKUR&-AOGONR%4#KOR$$50#N9T!:^Z:R"#VMUU
M_27[5F]U5&QSXRTC<(R\'S72J^YXD#BR"^CG:K20 <$GDAQ!TQCB?=8=!U&\
M(>'7 JFXZ]FJ:0\C0 ]U6CJBTW(I(9-5E$*=]K9JOFM:[4IB"TWAU%6&IJ]H
M^M0X0(""KR7XY 3I77 M$*%VU _T 1$,0_]3":%(3H0*C@3_GOSGYQ5.,U4=
M]TM#5@+JK 447N<@W_6=(\=%1IWK]8DO)73*8!"5> N1\CW'2M>65 .M"6_8
M?T1.,A.WNX[JC(>;VUY&\$#YME-X*2(=1$[=$&WD.2D#\M^Z$>#7\>L)AL4B
MD3"T''B3S=/53AKH5B&; #K.MJ&?BT08:2EA=X1,.(/X2^+$&\ YF2H.ARN^
M;6N)T:[;3?9,IC3:O!G#>"&?$-KFBA?<;FJ\Y,6.4BHP2J:#H^G/YA,AB!U
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M&ZR!X7U--#P>5;L3"OG)JB.;8[:Q;J_T96>_EUXC7 ;D:)!P&:#S0^ZHKGS
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MI^+A]8BHO(QP,NRD(KU_0KT"Y5ZA]P7'"5<X5^'.-N!(Y_+U"_)2?(._:J0
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MG%JVLJFF>)J=,XN<Z]VLG0)JZ'D=4[=+_( A'2,P12E872Z!A%S3D++Y,+-
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M^X4JB6=+)I>'C2VNJ?83\,27O8>36:(-LOCC^!6;^I[3\M=!MD 5"0-LPWQ
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M0U3C(7=,V]K:D+"E*T. OQ2F-K8$>%R][J"I!QLRJ4Q7;<4=TRTQ6^$REE[
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M1$>/^@<2[V<@I.7I:[9,/?UR1\.GH"DAU_X+EOC)AMU<],Y#_FV!SO;6CF?
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M%ZBZ]&,%QT_*6'5#O66GVPOY&I&C#>;.F]FE1SOR)_)PPXDN:/)@-K),LTG
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M)*1Y>9=#.FRG :UW34TN7"S97_$<:?VK:=4#G#E?UFMF>X48Q@%-217E]0F
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MJ-'&EJ=>9;PTE%SD]T19]B(,D6=#&P!2]>DU:S@A+UB554XE";X>-C1;C&<
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M-+/_'SP%0/_27SI,,DK23-+;GB& SK]AB^A72SV>:,K3A6+SJ:/]V='<J/F
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M?T[WO:>[[SVW^]U7U>^]>G/7J%I5:^TUQS?G'-_ZQAQK[^?9YU7@S4<):0D
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MU5+1,F%/(-]8%=XKH=$9-O8,.!>6!H8!FU ^/ :>I>YBIQ)9%P<'F^DSCUB
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MO:#64ARWUMA&E#V349":;F--#9>-VTZZ2I4"(GWNC;;RF&$LHTM=RI831<6
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M9G-CB[9,.-+/FJQ^E:2YQ=K^?,JO7XA\Z-T'4G1N#U71#;54RKP(JM3$,UM
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M^ZWHH5'J993VL=4X,;O'L,1>BP4%$W#W]BA&N%T6@HHQ0;"2"J@.J=_1$4,
M#SRM[ED[.]SHK/AC+<S9!<OYY=@K&DSL1"I)FO<Z<+U+!R,0P%E[@FNQ_F)(
MTL6)*".WEC5=$A/'QO/U>BGCQ<J-&";TH:RV:NQ;8O0Q2J;!8N[EY7J#_-N=
M>U@_V;[&QZ4-P3Q 8$0IH]06:O].)=-=RV7670'IUJ<7SDENXK* @TCD:9C=
MU.L#$.?^V9&5OZ)$\'7>NO;7"?&HWZVWKI6V\22++O3/P ^L$EMAZK&J8OJZ
M&1QUM3.M7K^]W!96WT_R.T($Y3>13(P,FS75<9;'G%5OBF$2E",W+Y GSF%+
MYJT@C(M)R:X0Z\^AVX .:X,Y7" _/SVW4>T8!_0#IR%1V2QJ.M,B:K]*$'4Y
MJ6\BW3YGS$&DM0-'QJ*?>9QNS0E6['L)\-8"]TCVGM!K/G'JV61%'N>?<N1N
M&=NP"X(ME1.G(]5Z-<VQU;SAM.W!JICM P^*F8+OW1^*837?RHVV5#O[2'ZP
M:@Q*N'&VOS-KZ80LX E^G*JGN*G\-'?]9X [_G&Q)WK:_X/%?_!FRWD+Q@W5
MN<HI_-"B&_9I%Q42:MP2/XO*^LWGE;,911+Q\)?GAEZX,PNI0$[]0>.0'A+3
M\0>M+OAZHW*IW*:0YFN$UA$[5&OHK\38'1FZ]GX[Q\B%<S,^?;1#G$?3Q>,+
M0'7V 3E'\OIGRC.P'/] 9SUDMXVW:?$5&4R+7*4$:Y(\R-5^WK/I:*TW#64:
M[.;@)7<,B)8@+Q4D%GPM5[*B++4UJP&%,Q=?DT5C2G66?;IE?!C2_28] 7D&
M)F>UR2XU$OP^UHO+Q'M5NJ_M2:Z%Z5.0*OP$ 'YX1K!*&CR6O,*4#7N!]\)]
MK^WHQ3DNK.^7P@?ZB,DGNCW7A;CV9>U:(MR'\+OS.P5$/Y7C:EO!3Q'-T,WW
M-$_W_GY,U>MW99WZ;ZQ,BG08T_47:PCDUWNRINLMS9+<F!FBR3-+>JC\^;U4
M;R!Y"]C1LK5)I]^D"3;E9^)O7Z]7RX?\(9UT8W![-\SV\&'#\AGXTS!#+0X(
M2)ND2L2IF[MR,_109$%8_ZZ_8'JW<-\_2$(TN4A9'R?&BU1^]^+0]&SQ/Z*:
MJF6Q-BQ>GD5T[%=[F)_(^#$+GE/F!+[_;%'Z]HCSW_TI^Y7@US?0T;*\GI4Z
MD*#X,W P$Z7>^,!2?2\8:+L8@;?I(:C;<L]H*^RU$YXEG_S*#NJ7M>O*KBCN
MF@7^VQX7..85@0.%0UA2?=8;]^&9COG N2%K]I*Q4$XRP"".]Y&VFTFNM[_:
MRMEX1'&.8,54_QA?H+]EF:/;KWWT]S.0[3/R>%'U#\?5OOT^4?K03]3G3^8.
MA$8<K=P[[)'VR#J4'>)X*>"B7A4[!4]_S]557]6T-:@GR9N]8P\49LR27_RE
MPMP X>DEQ"HXU=7<E">V$(N+]Y<$:8C<1$C,IWYP7Y4=J3/>1>X]8UVPE!B&
MAU(2*U7;-\;K"MZ=%HB,^+O^6A[3H$/%+A=C6SZ'Q\XD2H,6(4DLYKG50<F^
MZ!<14L0KV=<MH"_'M9Z7XT^7P2;/F7,QNT!0/NZ$>?PR9>6I<4<XF=-2/UTD
M#/TU.=$[W; XP#"A>1;(^2L^!7GI8A+&4H?03ND^N#BV/BZL'\3)^1WN,[$:
M"Y03/GM)6&B^D(BI!AI8DHJ%6W3$6)R$S>1H@_G.]/2H6PZBZ11#GZW'BN[Y
MC8$MOMW$JT=6KF(5!3@S))GN;8H57#("B_XO,\0)A2@.C0T286=O= /]-:*X
M+_/'A+!,)VS,J[#CYK2E;7A$3FF%GP&8;CH+QK7J(,/:8*X<Q2"I2;KH;"Q*
M,(SB!81'9LSS"AOBS",W6NCP#,!V6]I=+""?!9_USV_^Z,?+45^XZ%V'* IA
ME5;=T^\FT3?R>H6,;BE9)+8*M(85F^<LM%FZ6?-]'K%WX!W88C?(1L35(49C
MT7)6@+?6%>CO>>)G@$*?%%H:0I7]I4$!$Q1/9FGV>9;3D?3:&EKMXQ%2QD$J
M+3.@U%IQ0,S6=I"EW2"D"T,9'TR@4+;4"HU \511MDS"P9%VX4^LJL5X[-.C
M--?_0?[NQ:$WS7E5P:*437*F,":+_L>@;(&ZOOPJ%K[8WK$?[N?E81&E[ES\
MA2_)/+_#6EGU<HK9/=ITK.Z6C%!E0R"2TNU>*Z2QV.*8D;(FP8Q;X:?QZ.2D
M CP7([XLART'.'@#9&WJ1N_O3H$QX^]PH&8:3#NEIA$G5(*+J/!94O2O4<88
M@>-4J.+$D&20>]_W+ECY$B&G<J*DZH+6U-S>YNMF"0L=Z/9URE84:\"22J.M
M0@]!M ZZ<EO^*#SSH0\;-,OF:;CJ7LUIYQ:Y1?#8F#WI2@E5;OW.5>DPAR;1
M+_"]TVU\WP/=Y5\53XY-J:MC%]T>JR.NO@OB"V#_G_Q'!?T2DZKVZ Q!41_\
M9=7I\OPBY<.G=G $+WV,7#=)NU/;3I[K.=/N=]770%]S=>KZ^*0'QF-UX(^Z
MV5=?HE,"^-%UO-8+]LRLO6YL8X_>QTG%M?=[5X6 JKY$U2^LI*?.-4\QL,\.
M)M?&+!0<DP?HF!6>JDO7+*9Z8RYS[6[:R,]DC?OS[N?[%,U:AOZY.L-%U,]H
MI3XIPYOR)3^X"S$)<ZD,>0900*C/@(_+0[E.;J4,7[!TK@=1E POIORZ!6B6
M0S^L0;; 9&(UZ4QNT,\U*V7GHI1:^29R'572,?? $N\)%P?QG&^&4AR09C];
M_#@^0M]'[F)N)/T@*_EO5[YAC*C/<2SO!^["7-34Z-H"VK!,WNP3.O-+_BC]
M> $])C]PY.O(%%0ON-3V=+WU%18'JW-?"/\;;VP!,!0 JZP/2_9L)*?0[XJ>
M]ZUA*SI.=]M__$Y*,UWDP997=?U5;6F[W(+]?V((45[O=T#FSA[$U364].P?
M6A1RPNAS;_W_5FBFNDE^R<W8!2_WL^[>JI?,)#Q(!VORR6!(+7V;4T]4\@LM
MMB+!V]SY>*.?RE5$IU^IXS?RRN_XB^1<J>#.UY;KMM*%+)+^>^+\DX$G\<(7
MXH:V7( +H?:E)1R/(NL>\[(\,BV5#>4C,0O@8G1Q;M(GQ.F<&ZMHDN =M(A\
MJ,WG#I+VQ$;[/-2&$G6K.%$O;I]F7Z6PIOL3Z\"R[I'Z@98EPUTE6?E#3JW.
M.(]X#!>P0B=!DIDXC(2G2=:VU59-H3-SW(ABA8PEI=)HE?)MT>S^*[HZP6\;
MFFI_\/^\)#K<=N.:TT>\X9K:%+&X,*+WJP8;!UH.\_I+^Z[7ZGUPM#:0K1YP
MT#4;"J8T"$34?,!6E6^^KMT83L H8DMK6-Y T_@T5C]9 _"ZKI;*Z^S,E^Y[
M0F+&+T%$@TY-;QJ;%(9!#S\S)3[>F17WY"R6!;-#V:OT?&KCFS:AO$C4A%YJ
MP1"CF09^:,E_*>8J@^+LEO00" /! @&"NP^#!1N<)#!,</<07 8&AP!!$A+"
M1W /[A)<!R=(T "!H .#^R#!-;!\]V[=VMI:^6KK;MT?_?-4G??MT^?IIT\_
MC45IN/AZ'(G-9ID"R/Y=Y\>1[VYN6< [Y$R'L$K<L(C^FF9K#UFY!4QHS< '
MO47>I=J$24ZGQ\S4U#\7M^N[M K.7!+ARRQ4A9>8H94T>EVBOP!\:,F#,X>+
M1#_ZMM&$C%%;*%_Y&-E9]:/*&J,*<TG/?]S/FT0@<F)V/([$KYYU/*+VRKV_
ME!Y)/-KP4(#855,L-(5 >;VIYG"O=%5IGBU>B.P<]2Q:YJ4/&^&KG_RUU,29
M!2AC-FUCE"M[[9@0VP*?D!)0ZN@='J1(^#?Q3=>5ZF*P6OV5<G<_CO)5"U<7
M-Q6]O^M"/L"4)OTNQ[0X_?J<;*8 BFP48@VG"[J2)SK7:0KX4BTTVT_ZAT*I
M-]XNQ^X %+)2=%/W=/9I(XP?#=YUM&RHLU.H:XX-WY"%7,@!D??2BS;UO27\
MW^L=0<E'GX/+:3F3/\NYB&-ZR;'8 I@R=HR_6;^J-E5]C")T4ZW28E'2LT'Y
M.+H 3LK HM<.E$/,H5V\B%%E:L@T9MS*\W+R9?[29L$$2WMD9\^14]-L,M^X
MN2Z,1V=77%9PA.Y@R\A7-W.Z]+V9=6T]^R>J,FT'PAMLS@5RK#C&/_CSJE-^
M>[R9D6?[ ^2?N\$3J5/-MY#Z883-F^ZDA*#<Q 0C9#!C@)\;P9*P1^,?1GHT
M:]^_4ACH,#"6/8&XEG2W1=3GX._Q1:OL>2L6V&._:5@]Z66I/T9S[XA(]B.Y
MWRF]"I,)<$:' &63LQZ4+$->HCWO5P)AM@_XWNRG%8N3U#!ZR^[:TBV7;OO^
M3@_Y[.])6&FJ;/](Z0=;EVNO9?C*86DJ_X/\]YI&'%&Y(W0J]]#*#X6<@.$1
M+<@VN.W+GV9:/YQWRKKA(MU@FAH7(:C;?8 "9847<K+JI7WG/$&U'C7.;++
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MH"KEA4P0@RUYO[NV\26]CD_+&QV=-&;CWXE<B8.()WJ^*A++/OC@X0]!?!A
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MR&]S :8#X5"7X'6S X9QK",GBM'SU XC9 B'I>OC5/O,V'7!!-:%'U<T&UR
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M;#_Y'E+?,5 ?)U]_.C]6RHQ:XD0 JW8-65&ZGM@E*PA@J^]N VX%0@#/TL/
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MYT4YT8(0=1-AY;[Z_><=PPL"7]YQ<#6SS+5SA#]M"[_K'S8_49.5EC ]AM2
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MWL3>7I42_]]2/:_*LEVO>3B6I2VXIS+[@[#1>*=H6P1[G@$<ER,E31M\D22
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M5DB.A 8?&O$8?'@?<$5W7E@K&,K5W)@N./1Y4@PDX>R7<[AD!,JPY;PL2QS
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M&_HMV*;V6U6(_."R&1BS<7W"V\V#K.=\R,W!#!-_2>:M^G<$J6_= =+\2%%
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M.GHQ.G-AN/8O([=_P\D8T@S[1,V\WTR8^6I)"ENOUX7F:J4G^FTX?$D# *T
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M,!M&5Y&$ YTI942<13V9]<0-D &=5610IIQ#2B0&')=\O+9/J$DTHTY/[SL
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MG;Q$M,8&'A;HY-'\W-J7)Z? *L,68+("(QMNN556&/GH4$H%/$79C2C&:BK
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M3<.=K7FNBQ"Z>(!/\[TD=AS@13N\,57*$#Y*S:QPHW!7%'_ =]S_?5L- T&
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MV*/@HVH/<*X<@>H6=EQEA/.T"%0;E9V[?^7*O,6:29#TI6U@:BD.0(/]?^W
M$JLQZ/N>K]<,EC0HZOG CC-TL&DZEVEJ_>:B]0BAX</\#:@P1'%(HQ9[?F#7
M8.?)_$[,R.Y>"M)>0-@VX&L5%/MC8OP"".H-CC]YZ>!.B"6XS$37;\-+XOF!
M5F\.8]&S4#6K Q(;>6( U,U#+<N>\B'(DX/*][8X3!92M](NH:#*"?@<H]5.
ML*7>"!VK'A6U[>BY553*Y=4<#.GF[6TOQ[E?$.Y2T@P3]DDPCP,-<XM=+Z !
M\]RCV^1^2BF1XRFIG#,O#YAGYA15*=2-X#<LQ'%U4F I-*0?!0?=D[0@D645
MCJ^TU9\>P36N/-YJ5P<@,H%38$#VA.+GY:JR1/UVC,03-[/-/-&#@]=>U/_\
MH%0P_2<8?'0LWV,<?7S-]OE4D3T4MR)UU5U4,U@8F#WD-39FS(AXTC]00=<=
M# <(# \V"IAS53BVY;$HW38X/).K.FT ')!!RJ,:.UVH:PHM_B4.S$\;;CYI
MM2#83I6KZY6HF)AX/\)./KUQB]UPKJIIUJQO\[+_IJ<,AQ%#+D.["9/]%>RC
M4#)JE+Y#?^J/Q9QP9D=0XAS \ F1K3T.@MGN73?0UE-_%]C'@4=N\QIN/J#N
M ]#I$&NQEKX7^ZYGX>0!1B]_%BKJPI)DGDE$85!DQ,JJ7J$-U]V.@-#;5&\&
M\R3 @.OO44,>!-H^G.J:A^V<I,?EZ-71M H^^"U"A(,^7:DI2S1:\OL8^%!Q
M'JO_I,@I)?N:%*S:_TB7XDFPR69AYPT#:N&]RDV$.E6<.,==1[]2N5^+_>!J
M:>MOK>UN0?@F:UV"4LBJ'H7%4@C^,H^6BIN->E3Q/TP/_UO4@)3P ]]S.G*C
M>S$JD_DJ'%AZ.B7\3)@YD:6_;B8_^OVBTLD4G[;J.W%KG22'G/T\;,9*8#A]
M4U6GE2ACPMG'4!'"^!:,(:%_^XMT%I\Z(<_LI2GHEW"<&7M$N:6A[YI6H/M(
MXKAN&H3D?N\4\$69EF,P%<W"II[MPYI)EE5=\E+__56#1+7'NP$M1:"8O6FN
M^[<"K+D5=Y3F9\BN'"0CYHX\^L0_5W1]RW*AOPU@W+^'.Y.V42H:7-Y6'<Q:
MD7'RSQX6>R4O>'1U)=_R*\#D_,T6@2H*Q,YT$&%*)Z8"DB&GD[7^NVN%\L[]
MIGWY*&6%G/M8$H!+</#\$$50&0FD1 >):F4X.ZV;(N>(?>]=&\6GV[P-$.4S
MA/;+>PY3!6>5(GEP>!!?)WK@M2X!.H,,=&*)1\UG?PY)&4]&J#W=$HBWJ#S]
M"L!)6X;;Z6>AU1)$$K6ZWMO6?JY@]X/>ZJ;J535GORF/^#!&%,2ED7K' BAL
MP\X':DT[Y18OE !"6:=B789'9!!*A<8%#GV262]35"Q72XQ,+SC=>IL!=_D*
M"&PM$2VUUPOP9/RV?T+U^_/PQ3 ![N4=!6_C%=ZY_!?*S5.#/^2(.(<6#,76
M7-_-P_O!FT=$"0)[I7YRZ9^);WTA1D;;W*E62$///=[,NS4-JIL?<1=]EM.2
M;,.=;K1 IDF3T8\B#!P5:AMU[S3DW+IL!>FU/M, /$*BXT\;1E?I:/:?= *U
M!#WL-Q1Y&!7I$W&*469]QXZ"5>UMNR,"8X'M0W-KX_WS=J >YU=D+;L">D-T
M7FDH3 :0Y\D7J*NAT=P4WT,)[0XB5V-B4QA41S8G8X2G<1R6?LQ*M&U!M3CB
M7J0SX\MPR4'$SMRFI^;3NX-G'(! %!#]_O[-\65\/:J!/6A9IVS](](US#2I
M$O]NHS:T_,OB]'2_&DG(-81;JBFGR@\62O;V1C4ESP2_^\GSI4)=>GAI]-%&
MY5%#2#O'=%5[5V3!!Y.:*23]>"47#M4Y;R(+64AY3CDL/72,A=(;O;[DP#_E
M[ZM00 [UI]K(8N=E9C+I@,=$4XOQQ"/VE!T37QZ+MWCI7!:=#NMNLD&QC$QT
MO.JN8Z[0*S@SK%!2?X9\45;EJ\SY%/@Q7G/%W[D/^R?5MZ!3(;NM&,LR3DW-
MZ\LQ]7V*O>$1.&G'$'[/FZ)?<O+L%N)@:RKU28@%*%L;J)J4^(H]1CI6CHF)
MT>8';^%_SH"I3X'%P([GBYTA:]7@5!]J@+N>AYIM4DRH)@!A7+Q34\AHM2IN
M3EV]6M/39=S>!6/%)W1L0WB\II;1QX:!1,)@W8"C%K,U>&K2/)EI=K'YX^20
M"=^M8;%V74!/$-ZR4@%)1%?=4*)BW[[O],H=9B]%'\G6G4"&8U0VY(8/DPH(
M#UUSQ]4.(DYW@_62DFA>1J6'/%AJ>=@G'2?H,TB*^E]BGWJ^V$4N6V>'B9!_
M#7&IQCGD<@?;,O#NZ>Q?1Z-@WT,6=K1 #\[=!EQ-JK*QE9_B"1.M^J7H'SR+
M6E9F<;<I_A!0Y$0A@$<(=;4I(9B;"T.'=!T/?YZ]1JO]\:[9'/]%F+\WE8]Q
MIEISDL5-3^_\L3[5)E+?0/30:,J@!\TXE"HU/S8)L0@3S67J*Y/S_) HG<7X
M"E!.WOG)L&NVOQ<CAX*4B939E[RLD[7)=%IL/F[*L*/ 1Y%DUPM22F)LO0-E
MU@/@M#_&!4UY/H&7IB>[?HA(/9;H'QNOC7QMT-R$B:YK#L;>48'U2I>T;)<>
M\IWT:;5%SKS+^J/UETUMW9X\H#=$(?E9DTDEOAOG=0D_W/\:G[HEG*4JI3K#
M^ WT22FKX,=5FL?BM/4;#Z"XVS3LMJSH0J90;''L*!D_'CYER(BNJVD+NGY6
MY$W)4\5%$'7\8>KS$!>JF77HCH:[CWWK_98#1BMHCF#:I='&R_CWB]#VX.Y)
MSQQNB.SE/I.6=1P9[R(U;1.F6*PCT;DLI?3L<WQ() %D4#W\\&2%NZAWNTBX
M9.U%,Y@K55;6W&WEB_GK-,KX3\^4?*A]M6&QE032)47+YWJ!$Q(?<P&^3#-P
MP@W%>M+BJL%'XP,^>(*T<L<N-3$PO]4YF7UC.0B2AV)+10GVAX%,>E\YKCHQ
M57Q8 &I><OW;!^[_^4\P_3KY#U!+ P04    " #X<']4(/LV]"J)  "7EP
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M_R&$,8M]3^.)U@E=XO,M4C'A0Q Y>".$YG62CO*"KD<\Z6U.RB<6RB_*HB&
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M#;EVO> GA&O/<X9S6D%"J9VO^'A!BUG?Y7)M,5JCS_6Z]+BBD)*<X/J\F9Z
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MF9%),]T;HJ'SJC8%_W$3B\YXZ0EPO?=CBN.NNS%KJ6M+XR9F92G['I.$)2H
MGB&4E9S)D+6VIR4\(_CR9X?HE@)NK79#]L.V=J/+YS*VWGO[G/4&A*VX@O'_
MR>F1?PZNYA3"P%GKY*+-!;A;7"GK L-@B\?1ML'MZ"!ZBHRIS603<AVV_%+R
MF9=U9 P;::%[NG8(BEXD4K4!T55)Q =2HHDZ4^1L[I\2#S?C,-/S8ZGGB2SC
M'[#E;+"NS.3J-;P@QESIJ2PC/77MRM7-X;08TI_)+A^8!6;Y'>LWL\?"[<>9
M%87R@P)159#X#VQK/'7R+5T(\'%E#Y@3OK>>=R:\PV7XTQ2,M;&*B^S:3UZN
M*\5>,Z+D3N_N'&N>?T[T^0SWP"=.R0\JK[9HC5KR)B4M-Q77L,)$,3^FO<-G
MPW7>YUS/DX0@H::LER@@@/A3*'&8D_+GZ;O7E]RWPZ9Y4I(%N'N\K!AO-ONR
MOZAQ_F$0_M*!Z+A@W3AKX_%ZV[&#]FSDDFO?!]U6-TO'!.WHQ?:$M)@P<G4Y
M=X5)GLMT.6.'E"2^4Q$L_[W!-EH.QM1.7LDP0TG< L-VG)D:A8+##1A+N%5M
MA%0>/4]FH@X#V<#<]R8'BU,O86'?!7T.S?Q'0/I1X@7R;#XT58@;=&*Q=J+L
M!DU(>@]"O*#ECG2V2E-<:CPS<*3',NQ;478L=)D)^LZ^^]NVG,ED0O7FU&%Q
MJ^A@G?AX5TT2KJ,#//Y6TC%-BIZ280^YTI:AM\FTTE4E,IYQZ$LI$Q.#.6L0
MM2C#?:E] [-MDV9X-FMF6ZS__ 4]U+!FTO%X*X[;7T_/T0ZV>QUF5.:7:;W[
MB%;;U/!R98CNJ,^48HN)%GD<_L<U-)$T0ZW/96$A%=>OU.]:^:QXW@\F\K?E
MAOK]D71VF*C,9>"C1HV6@?\U=U[!G,FI.EZI)FO&,5_AHX3^4K3[]-:B^*<L
MK61$\$;%A[S:*?VFN$L:*:F0<%4JAW5R7V0^J%QHA5U!U@])?)6WI?;?U[?>
M7(=(JBT^ ?W/<3::K;/\;TM]27QMZ[5_YH#)?)Z "L?2HJGL!U-?19Z_#7Q@
M@"0^!B.QYG0Y@Y%W( >C50[Z@DBIM2G9;-U@38@OK)D>N,-:TA;'.#5X_<=,
M%O]:"T&;5BE0EV7['-I8_@3@9A'T?Q/-M"=IG,C0=&IJSQOM2F7)TG-8T,\P
M>BF::=Z]AFX2=(@.4O-4B5H_H5+;JXFV%,]DJ5Q39O^BFV+&)IKHD.9#IA8)
MWAF=@=+49;X.YNCG"M%%6>4MN9V1B_/BM+0T:Y(ZA@%#(B[$8<;[JG/<^JY6
MWCH?'"V/<=IQ9'YD<5O  Q 8I9[,;ZKR$>8QILH)4!@(6WR'28]9L"/Z1O/8
M1) YO'[9F]]E#'&110T^0WH.F?]RO=!CIG./1^J*Z.K; '6L/#%_W^\IOD-#
MGN@U4F$UA(_<M*WPN.]D$2CMUFE:K>7V^C,CPEB.E^;_WN7X9W:".>G4HLZS
MB A#Q*27PCRE-U#N GXQJV%ZCG$M_0Y]2!#*P1CT(;%O9DGP H3Q!2D@7Z!K
MRZU5?K_YPP;-S=<MOS5A)VPQ4;0C$S\>D&^A)^#D'7&>R<Z&.SE+;-&D:_S%
MF)R2'(SI39 XN*(G+8"!3-Q?:(G<:C&3EYBF'_\2A2HJ:%J+H"\2L?'&K./,
M3IHE"E@0YO6@A#IJ44:L11CB1_ICO- XA[-[T=)_3@,MN.8(3O/FY#D[^Z4>
MR']Q7T&H%KR4SW0*";K8IKA7!VV2"IUXSY+IK?^X&O)Y0ZT03$/[30.[&>4)
ML+H[U;_R-KN.:)QSY,[:.7EEQ7*/.>_@/%N389!FM5^HJ:[(,1KF5+-H[:&E
M4OF3"D_QC3 R)5C95;82FGE4CO J5*HAV,2XS2;4SBA^;C_FH\+L/8ZXI4/2
M::)&Z-L<O FQM>9P!ZJ.F:K/;3\UB.>II. ,  YI9.%]V6^:KED)^)L6; [!
M'%AL>28_>&(KD92FXG\<[BY46/>"TQT,@]C%Y.'\;>HZ>O/[RAF;.?DT==^B
MB+3 YQSW\A/N*S>!4LP"X/E5T&JONZYH*SDCMI<N<#>YK'+(HB9DJO^%C>H!
M<G^[Z**V"BO#>29P(1@1$(@H2LML@\1P,9,QIWS5NB5I$3/XSPJ0Y(_[7\]@
M%#34^]QT >_1_+P?.!]AUV5'^Z'+7$Y][;*<&4R6-]DVNP>F3>!!ND:C\<,;
M'==L[]F,-^7\MK.;UZ8M'#1]$5]S-:4 \M)I5?T,&@[F=9>@( AD?/("7^M+
MXZ9;:B?(82'#&Q?N 1->[JA/<^9^(713D'">'ZW,Q0PXD;T0=M9LXC#4KXXV
M0[RR8]&F:X;1-A/?[_[I?Y%$*E%BB.[(U9,K--)I%D<$%U-<-=D2[P+9D<,)
MX0&GH= TAE '<H.YB#15_1%E54;<,=MC^YGM.45Z^%8;.:.N=M6?HSM#^HQ_
M1(\(JQ9IX%HJ=W[D8J)B=<T72;2B[ /;7,!>R:UY5++%GKQ.UF=3'S8E)NLC
MHX:H :$!7.PU#T";NO1/I4]AK'4->ZUZK7P.-. (A0Q-,9HYM HQNN%6TMS!
MO\C3CIAN3'*@ JIX;'<4UT<HNH '=RW04USK";IV 'K=20B#DP;?%,3Q5U)N
MO4N=][^B^*ZNSVA+U,*K%'2(R$.((0,_KL%@.WS-DZ@O#;&_B6F4!L^"/#R<
M<@@_FV5_UJA7U2-"Y)&9M$KCQ^=XV\U(AJ.4YR^4W*MG<*O4/F37(\EQ UF/
MY5L,RNIX M"FQZM(MCI!S><FJ[_K(.-DCPA?".;W;UGTMC)FCSQ@'*:?+:W[
M1)G.GNV-6]N5Q#<>##6%Z&_Z\.-7M]N5S$RQK>-[N=I)>ID/!&18YDT14GVZ
M\&0^$7$M,3+_R)FH:C0^ :?GK^ZZTI;4_NC.3D@2+'P*^/<30?\&9(HGX*]<
M2?WVWPES68,WKHO@+E5Y27B PYI1/.<R!^$O;2Y/,S\L7$GD2?MI[6]NAN(B
MY7TW(^"FS?DSE63)X1P)!89 T8-W.YNP$3^]W3/E"LY$,1J+]5^G,@T )]))
MH]7V"(VTC;$V%?F6R8T<.9+^-%"Q9LB)%<A0>5MVG=2UQ?YP(3C51%LL'#99
M\0);(DT25VZ2A:G@?6&AIQV+Z=+Y#9JS8@=J>D1,1\WWO#W'$DFF$=Q^+@R<
M*YY-(?C^+Y>E!G/!/Y=^"7:6Z$G236>G'/8[+P+:\H:01?7^-#E%JKP(QKC_
M2E7,_X3*P]RL"VHL=),1$OO>;6=]F^F/Y-M VF(.#UM X: 0<5+"=A!%.VA8
M%O!55K"U]>I1TJ%,P:U -@7/: UUE[Y*NE9S-*.J<,:$Q'1_7U?E:YR)WE5Z
MJW27<EUJB;G35 MV%" &((&OQPO<Z$L/C[6YVC9KOK\=H9%V9-ITZ3^^OM7R
MO>RIL7$);0:O;W4/=CN,"P*HHZ)HTJF5U.H.<>WFWS^MZ&/'_ZF6Z9<;:1IS
MLR?JGO]95]/>$=HW<51L)Q4$BO@M9+BN0]A[ )I<GMS#5<V27!]?M:C<2RM(
M*Y<T-W<DKHMY<%'J)?ZS#E\IO#_DOEC*YJXKT4>#\^40SV*R3 !>C]\V]Q,+
M3;FHGU'=G*,=]#XE%>7CI<(.ZM=M_H\2QPMMCDA_@K2^36TUQ.U\_>UXV;Q,
M2[A-"O9+]CZWV1<B!B7QNLH+.9+73P1L57=M4(@^N'/$RUPZZ^@QD2V5;3M<
M.34+<1 BZD*^6JA/XTT':6Y-]7C\#+7N[D)_1_).4P>+[WA7>R8(HQ3!.TCU
MP_LIW1$24Q]J]*S40X-K2])@3QEY/GF.%:'>%1E_@$%3DT\(2WE?*U-SW<PY
MT3A06-)4TM,'9,UA4$3F@&),*MU$]EA__6U:CT>5O+:&" O\\^.S2\I/109!
M:QR54@M#PH8G<GM<")B;?8*6O*_+9\:^%C2*C<MSMI*56&.Q9T# 60T-]N[D
MT\Q,SFW1T*B@':M6']3>?EF\9PK=*:<7X?,5NOZ&%D VGKZ#T[A_$%_TIFN5
M\D)][8E=2J:"%$TO'J_Q2O,K(5AG0W<.Z"M34KZCSRU(5PW/_;1<6&]!I T1
M>!"8,#8D.'1@<VR?G&,E*4]<Q#<R\Z".^=A501?=^NTJ9CC^[BSS\"9-GG#9
M)M_AQ7U.U.^PDC%NDWCO9)1R [-3U-]6D1RA1QV2VNJEXJ][4]EH:,,2@$'?
MTUGHQ#L/T@BSE_6-=?%"QQQR8ACS<*13\#50DD(66Q9%4M]9(FY\@? 8G*5N
MID-2/97@4N.+[31;-9)GKU5BU K>]NC<&W0:W*^/46*R 1A*S%H#7R^< =(?
MBAWGIDY+<6;?8T41*TLA4XTSYTY[%.GKC[FC-LMG!M>HDE(Q 7S;W_Q(9);;
M!V@2-<VB[G_H4T69X1QJK$ZVX)03BVC((2DB;$QIO8_]#*X0_4DU.9V&B*]N
M.,ME:1JB&F?U JG-PJ5:O[V3[!5&6<ZM61KN,5:ID#)Z3>?R8/Q!=P1+/C.I
MC :SW.)@@+\PDWQ*U.QHT+$I\^6AN,"1O*2T(WVF(UFP$01V(;PGA\:X\K-^
M(,6C(G5;F,CS";B<6?35NAUX/\>Z)9U!1 L<$G<N.,=]J4\8H+E36C1RLA#D
M$/1.:QXXB+)1"U)2F!J_9'2L/'X?*$[Q/C:L'^73X1$V09/!7-CBP+=/6%BF
M"Z1SUK3WS(657]ORQ]+J:M'R*Z3,)]G\]VC91/*S=[7+T%MRFNKC])/043YF
MQH@)[\:!]70;2W "SYI%])CB=-:%F?.FZN]\="8UH\)_(EV[R/L\B*+EYLS+
MX#*7_E"K.8CV%>_3>7!ZR^Q15XS.JK@_L^VAC^FFBT0N 8C_(-YP80!SA;^0
MRM5P XS0W ER_\[NJ*HJ;^/WT&F&]VT1]__6P%.>-L-E7:GHU3%"_Z3%(7SF
MXBI&DICJ7AY"(TCJ]>8UU2DA3Z5HNRQ\U;H6:_U%T]>^*66GYO[CC5_]Q4]
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MZ N,!BQ)%Q%J<=L$3[M2KYHDN?2\:)VLY7C,U4I'&Y;T&/(*QL'6P6)N2Y^
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M<,TE[8R:WQCMF \4>PB.B.5U.4+JB)GTY4FE.5(0?OK&XJ-D"D:@C-G>>VJ
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MVW7^O)"E01U$MP"Y8V,BU+5_72)0OME+S!4O'MX!Q;'8/YO&;I!-AOD*C(_
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M/]OY(^DI:)!0GE!7[N-H+1%<YTY+_8V=DYM3$V[!8P1[;^]"-'A5:D][F3*
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MA%%55'[.OK9^RUI>!D_7H:IXB?&*X^R3NQBF=?4#M;D#)1M4%BT&:KL(E%S
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MA\0Q35O][%(.-YK_%%2-J%L37ZN*+<BXP/A7"510;KK_*$)Q1V*.&( "S+^
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M@JQ"RW(TJSIHGK5>E^IVJ%S2NOX J=5>KF5K="/Q3I[>!?Q<U=E;KJMU]S-
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MZX8"-U:C_P8E*/Z-,:!"O^DBNB43?+X+?:_55%:A0U142'U9&DH'7B#.T'1
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MS[/0P.>@(.IUJI%4_U,1+IWWL?M?S!(@;5K4$#3^G4PTGD:#,M7OG<W]U_=
MTMJF,;0P?&"(':9LGK#/^GT&9WC9NT%91D2*?.LK8M[$1II*HPQMJGK4CZ=7
M&E@2C$/U/&B5\UP.MPIVLH6Z\@YT71W!.C3'&>TMF9]FB@L6+#7YI&AXRVQ,
M#(I[.-K27<YWE)*N[MI>N874F=\#V+=\ER3W@+E=]>53@XMY$_>6$X3T4G<Q
MYY)V!K)@7\Y8+1X=-M#X1DOH 4V=F3GG@N@A@QT60M\:LY*JP&J%_HXFG]E?
MKUXDWD,\$;6TR-P;_ PWCD:":+$9,;+A%)J/P6,NV*\".;L'4"YGUP^7/%/V
M\T,99%_8/NE-.'!IL<R XGTE<PF<W,JTG,F%ZTH5%@O7U"@Q))F%<C.JXB8&
MB8O(._V:/FL++]1ML<-.ESE:IP'129!04W91E/A6SH<8?13/5$?1I86B2[_U
M9G),O35C7BBU.SD[O7DKY780=-,4U)4FPN\NJ=%O^T%Y&!YA>@Q0K:GM\(^U
M<))?1&Q*O1,T\3$W=TKWS'PU-7=J\'+3TBQUF,%='-^67%30U)EAJ7S CF"3
MF]7J3N_3VZ@(P:>6(H,;NNS,@K";I!N!_AREVZ]YBX9Z<DFNQ#:FK*AX7H4P
M$H%M,;5XW2NQ*XW-W&+*-]67>%17YI1:9^#-VGQ(L'GH>J1.#O@H3G2GDY3*
M7RR#K;5%LY+VL535]\!')1PHCUX^2IA<JZ^'],/O@5@ZC<GW38&*#8G]"_H&
MSY\0T-5_LNT2*9DBE!8VR!AF^0=HP'BW=-1^^\C>=\7B'G@$MRA:]QYN+_]-
MS:+RH.[:+VG"_N$$,4C+;QKI=*I?3\6^->LRKGMW[:G? UN3OL=V=S*K[7_.
MCOXS(*F8#A.@LK^:$KL\^U?QBFB=TIVW]#U _Z ?H_[C6N?&7N#^WTK_WTK_
M?U#IDT/T7^'=3Z/#>3$5Y*#@:JHE)C+)8BA M3IR#QB&G0( K1^7QY@B4[[9
M@7EH^=.)S0@"9]UG%CEAN>F,?UK?^)\2%C2]T,,ZL&"W;7[0X[K))</EIN1Y
MQ0VQ[](05$C)EXD<P;1W=O&>KYXY]S+V8]!$F#=N6_(ZZ:HI)W%SVMJ=8? P
M?0BQC:!!@&?CE6*@VG\YYDY<*^#,/#,^.#@$?[5=:WFI67\]18JGW?@VV&P!
M=R!&"A67=(37:N8UI/[QL]15"_"P49@6B@GTK3UW%*PF[,TH.*::U-Q:,V;@
M7--A(YB!(<(TXB3  :YF9@=G<CZ$%=J]>\?-8V"X+/RDO,&S5 BWEL3)SSS6
MGA@&\-V>:?&DI1S8/2@<"UE&F7O %RR,R!<Y_"@&0,8R+Q;3K7D9C?Q-E2Y3
MP#1=:3/W1X(? (H (9%0AV6.?Q.2BA,_EN=I.*&+V4BC$#0"1 "D5$NAA93)
M@A^F[5^/EP?K) DTR+_\#UB!:/=S_P]02P,$%     @ ^'!_5,82KG%GQ@
M"M<  !@   !C;G1G+3(P,C$Q,C,Q>#(P9C Q,"YJ<&>\NP=45,O6+KH0$$$4
M09!,DY0@B.1,DZ/D#"I*#B)1HM $R1D$ 8$F!Q$0)",YYRA(SCE);*#3;??9
M[KW_<?[SO_O>>/<VH\98W6O.FG-6U9KS^VH5Z!_H)>".LKR2/(!U#0"P,'\
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MG$M&L"9!+BTP:28IN\@*#229G/7:LC]A*G\(Z<XU.6Q&]6OJ8)(071RD"0W
M,87CQIZ*X%4M>!>*&ICH00.3+/#VRW%,"M;'0[J@@>G4%- 5QG$/B(BI\6TH
M2N(^)DDUIW/67(VC5C')[T$\Y.+B _(<Y5J]N*L.CT$#F:DB@1<2LKJLF!H@
MB 9*BQ&IV44*",]FY!N3M0F&?E/VV2GPFL&X;_$OV8Y_I._BD'8N&8+%CH+=
M*YI.4LVGFQZ:<J2 3C=*3 'I!KZZ46AKAG&<"=4 0N)HR_9GW5*U1U4U[[Z'
M7N$7VOZ7W.H(;>NQM0&O3BZB\!"=,MI*&+UJ-/ 3O,'Z3.J@N302^H]L>1+%
MA)(1@)Q-VXWN-N#__-HQV!P&DN'5LYGH7*/$>[J'8/=YW&>/E5QNWWWXINB1
M@_V^P.5AC9M3*[@/ZN!$-O'<G+..-W*5;"1^LW&(G,V;N<[UP#GN^0Z+>G6U
MS<9)XDJMIU.__%"M]D422*Z8Q$XD<F2. E'K]ECX80(%21!]Y,GQVD8-YQDU
M=>VRQP,%PP@.<Z+&FD+$8]L>@UDG++6#7*Q!0_\0@3*A"=.JR,^AF_V6NJTX
M7<:.FP78)Y^JC08WISE7/;-?F(7X]+-UF!>34&>HZ4 6=<?MHXQ%=>Z(K%8I
M-/U0Q(3_P%P^EI7FS@V<*W=2K(CK66_X JSTL))^V.,$;5AIM>\ X">ZQ<_4
M//EVB_-O',M'KLQC$;ZS6I= Z)5J6PL_=0I4U8MQV0?N_#"+-$<#SRNQAHUV
MR+D*TX9J",;D,[OK-'QWY,&%H#P.H_F)V.QOL;+KH?%ZTIJ*&I(48IOB/L5N
MAO;[]/'Z['%=>7/^(UY+FH[GD]7#S*WWF'$_KI^>9Q):?#_#JZJM>]Q)ZI3K
MH8<3.U2H)-%?B]+5AEM>S2D2C_F,]>E)WQZO?$#JTN4,8=]N[UH.J=.N-6,Y
MVI7O"9VN>MSX12B3T(:?4]9X3NT>CFPM-_VK36M3_$T:N%YC[J+UU^"7T'1L
M9^X)+[=L3_N52,KP?2M=('*M'/#-U<DLO8'CU$U;B&6=2XC?PL17"?Q:??]-
MPTKX37:IJM\,GSFB@6^01#/]^R:A9X[-;5)RI'I6DO]!]:]&%YP+1;J@0'TY
MXK>4P%>;"'"B1,".@ARI%L4_Q?Y*;GV>F*?)"76)DO;G?J\IATV H1TV; J:
M9YEXJJ@F=5C,2;XVYIDU88%W7XZSFAKC_I7><HHP@,0$A'FH1VKP7V$L:#PN
M8L2D!>@!OX*6'!K@!,_9WLGH</W5:1P:^"YW"L;H@) Z)C*(K;M;OQ2XCTX3
MD.V(3IX_$;PV*PG!6Q]F-( )G?M)0?>8.HSHA)3>#%,WKIN,EY][SYT>0[)*
M'?DH0/607W"SY!G=?TV!;#K39"'Z:2B3N$=;O*@B-(#)2U42FC@N(C?F]DUY
MFT>0[+4[[,;0"_A'5+W@R>>RK._V"OA9!O.RJL%=OA#UMB1-'.?WQ'4MH.X=
MK%/8I\VLHM+FU>6F"$Q*">?*K--% V7TVE@OQ K65C'VSXK,CTD4U#F')ID.
MKT!YLM!=<N0R8AN3AKL[F@]K3OA,I&:U7HS,J>V-UG+6#8%^0)4CWH).>O_E
MU]^Y+BM[15._W+J2IV/(S&G]4R'U%2KQWA9X,P&#3"%(6PR)BL&0DR70P(2.
M ,%#K8D2@DX"3X> !A3&G>5]U7=2'+V445T;V*(8/#PQC=H#G?5 >.7*$+XR
MJ(L"'SF'-^5&UL\T*#ZN/R6"SD'5O=P/2(36B9M4Z 2OS&87BF\'Y#E<G$8@
M89BT;//T-9LA"4.P=^)U03JSDY#MA-/\;CY6]QL?[RO"43ET&:=)T*-+(OA*
M%BTN^6U=MXC;] :K#IPH1_5%&-/X3/I=Z:->4-(28 Y'MD@LG-$T[W"B@7D'
MY(TQJ4F3J[7%OO0SLL:1>3S$\;]FT%ADPIXK^'29ZFY?FE7FC!U>H_TNY)C#
MIEGW5\+5 35PR;!_^LXVV[SETFP!17E2:=HYJN$\496!>F4,H('\SF'(EAV9
MY="T,/./Q8IA#*F,V5;FM!)G---@$U40_]29A084:=  A@=N78__BN_R6RQ*
M]=PF*EF3DN,^"]VL K]VC5'J[&'O,*(<@L09UR.M*W&2Z <CCOGYJRK;Y!_P
MX"6M@G49/UDMY$>@Q \\4608]X((IO!=#-3_[.Y^Y:)E#9UASR*B4V>X4548
M^;T&?(SAEY:V9/XGS^Z=?O3\H/_5C!)0KN/?>K-)I8 (YD #NQ53.5.O[RY;
M1:0NSL@C(Y'JJB+^$20XTQG30TXH,@&H]:L2V?NPMQV;=%4*3R<VQR/I%&6:
MW=P)3[LOOJ?3'1OO8O%ER;QF6J>@T>MMG^&K$;:@:FH5_)G"N=P?1\K=Z1A7
M-CW/S"1,0OJ#PI?6-R ME7^/.^2=;.G;%K/Y(.I$>7D =;BK&M.AKYX_J_@R
M8E^=)XP\/9M'?X/V2B2FJ%B?CEZ*^:=T<BKCC?N)[V.X-4[%WFS9:;^W.K_I
MD^JL+':X#ABDD<D]*?AB6@ V>CE22G=-4(Y.-CG(I4I&S/[KEAMFZ!NU6C_/
M576V->:6=KF'WXC-[%$KB5\<II7#5$]\PEND\=WV+LR:V:)"NM@;P*?(#'5P
MB!<PT#16RE1ERFD6V[NQ5ZU[GXGC$Q9="#WT@KBX)/<I;70_Z9+$*F'N/KA!
M;GB"#)Q2M#JEFVN>-&3M=AEN.,U==UUQZ%!M,]Q<! W,O.;,J:ET)U$^4G0O
MZ]&5\3I^K* ,E @$N8M_GPM:T>305DBDF&^@=@:&*0Y4#28K4ZKP\66#Y3P(
M)570 $>O\)PXABAA2&6-IK93L"$QEF>N+B#?,"U%GP:M][+RO]"-L-=]_1H1
M\[6?PH'7K/RI1-?,_&T%<5Y)TM>5WF',)/)F-CB'C!_66$T+8A7$15],<&4^
M5=K(XLZ7"62/IWLV1+TAT0()>BK!4'-7]4:P0CS/X\*>V>-E<*-_+ZW3D_JI
M:8Y\:XYUN^35Q!3\IPI?(Q/2B*%JWT:P'_$)"/:-M#NLA03%UAA(/V9FA:$L
M,ZM_KO7?E1,-N"G7&&@V2  /$\).0-KI[>I%C[T)6DD<CK=TEQ3(OIT;#Y'J
M_:2R A;MN7?NK#CVI+!_@X6@;^"V2\SR=@:8'4B=>A(_91B_PAS&.:W8K3T"
MX%%B1Z=TVDW*HABJ:FHS*)EBDS6A:^SK ;$W6H3QXEISZR;SM(K(TK(Z8C_G
M]:T\/L9M;5U;VHQ<#0=^9'_9.&)D2Q7B3#7,,:>6#0OXO,P;ZR@1@K#MW^E\
M8"WW+5[M*6-;@]10RR9SFN,MP&;4D-ONYR"'J:C-P"NSZS*5N%PP*<KAYT1Y
M2A)?:<A=9I/OFQ%:2DL]_=+EJZ%F'*.&T+B>2)8HT4# ;<"Y40L6(+209-#A
M%F9V>R%115._;+-D[$'3-O9)Z>$+K/=<?KQIJ[3E@\"K48/V#NZJ^H%J?>,G
M)M;T0;BFJ"/*JZ.I0-D%!H.-.)*N%<E\.4("H/.Z<;%KYR]Y#-B+FTE9X _7
M)RAXW\K\;D%^;K/ -V6E[,<"YUEANKXU<Z2#'E(G3O*>-8;M]$Z!O[>CCE"Z
M4<8B_\:ILL,?\F;^)Y[T-U_24D?5H0&B=<V,W[4=*O4&PR#8"/\IQZZA8QS5
M#TV#=;_4_*NZCR2_CD%Y0N$[4:-H8)@7@["U6?,<OR!_?],ZB 'O#"//-$?E
MVCK&*KT#*8:>O@8+%O$-_B71.P:&X9T5;E?C6RL'"\3I]XO%2IS=9&0*)CXN
M8-K(;T?5@V$A)_D9!;MRG?8*?YI+$_M*+9CD0>]S^!0-!,EI<5V%@1=,=J6I
MI7\+5#!N$I_A^.R$AS^Z)UOA:</$&OE3$3XQ_]NNYE_<"J?RO@.G+E&2[TMH
MXX'":69/D([GVT=.)UI*, S<<+E*C8X(8S29OS3^]A56#FLL:LA! QE6J*L\
M-/#A%[#1I<563./A>-(F46"UL!\YX?V/^Y +T&GAUBLEDAB.KOWU#&[$\TI\
M8I?0JTA0:AQD0NG,9%=SU+%ZK7C]O=OQ<'_,RAG?7PYJ%5RE0)8PD";3ADK@
MOFK5P??N _6WY_Q]T0'U44)Q#EX*FD2G_(,185_ 7F@@7?59G(?=R=""21S%
M/_!'SOY=R+ ^8L>P]$$'R^#;Y%:Q,V'^I"01$_Y1G5-^_BG$6\%1R"FQ^MW!
M<WT),ZL!S30X/P?Y7;X"UU)?^1W(--]>]?4%9/@VJAR"063I8,1;%10<PBM5
M!\6#E8U/YM?7)C]3QHF\OKJ0E$3DG1P]B\3 ""<T<'I7XWM!;;(4/DDMBYN:
MSU:T9^1=*'?%M57H>='T*W)O-& <]]?.8TJA[?>JCJX7A*52M[H@T_PD<ZIQ
M\"G$MLT+_89[D 8\I#-H8-0.#8!BT4 3&XS\[LT4R<2?M'Z4V[UYJ2L6W,0/
M8^:+EF %>9W%>@>ZM+C*:."OW<(*==8:O\NHA 8Q^$C-76I#HM3+V[6;TT6&
MMZK/4 W$,Y#N-?!A^#M7,MN;85]9#DU"?T1[KT38K-L5ML:%LF3Q[;V;5:T0
MADP8HX'ZQ2OBW,#/S6>]S8D<[KQ)D91/(Z-1I]NO']SMP2F]OD'KLS7N"*M^
M"/L',?R\F[)N7"09YW?;$0M6HFKS_L)!S487>M]+X+8;U$R?[*"G*^>UZR)T
MR[E*'(KP;4?!3OG&SEL@11]0J!C4@P).!QOWXTXFTE;*]RYQJ,/&%TDUHN:S
MJ@:YS:X^[)T%B+=$,! :D.1;,[8,EC_.0_YX+C8ZI 9N4*(Y/Q(XPGGGI\ 3
MO11S !])_$QBGQ__\+RHI D!/>O\-4/J*?99*3G$RD[1;T>WB& ^VS^KZKOY
M B@E=&9C^"#DH/DL3FFM;VYL$Z.0[L9A.(;T9A$(&D.&*2&'6VA@Q=:0:@&?
MQ4^&@?*'TGLW!YA/H2+SPB2[#F9*/V$H6ZD)G%=[SIC923"1;0'#;4MH7L0A
M%VT][3SM^RG,Z11UL0=IUA*0,R1XG.G-)4%CX#5>#.=_EM1(]PVF; VNVCOO
MI)>P74K!0B5NZ<Z^NS!<V2B#Q9W2UP7/V#=;*\Y2SC:3;C$%LYZW%!9EA(V5
MBZD6/#?YZ%#186*YO_B88HA[:EL/ ;813TIBJ)..=S"+#&R5^%Z1<!YEO.&L
MG*I#>GFVIY9JF:&FA7-?DVGI5->^#XP]B)_S(X?WADN#&#DS8"  #-/XV:6.
M[Q_N9^N'LTW*U> S&)M1LPPUU&\.O'K=NA_C-<*DDT0I5O1ZDB_:,BA%TIWI
M=<LT7<-/H9XN.^WD'Q^>5*8(5)J_W5#MZ50TFUCS&HN2&'WI(4O Y-/PWE54
M$ONX!5',*-HH?4O9IHPPS('2N8_)4BN9VFW9*0V>,&%:LN/\+&\]1VI3S),Z
M.TIQ>$"8,T"(<FEU5_)>[OAG*P4B IXZ4\\=XT#%>MULW#:!]83!6QL"^S^P
MA8<SL<GBS%/3-"MYVG:REXWHBQ-97_-T?AVM3EO-%Z;9O,>9]ZW2M;8Q?CG'
M-<$K<6CRA%0>P*YEV94DARJ5NS]IN[ZX3"C)Y+9'G"&O)#:Q;8/S.CK.K[?9
MYG3.>3'E,U+1A#H?SOKF.O.SK1SZE.M[=U%#M@D/RDE4U@==U\)&W7&%VF,X
MHD56P4; 9(1">5@-A]@Y;MC-D^M+5M&2?.JY!G-6 R&']^:K^@[F8?ZM:U1]
M<?S>$/'LI)VG?/T4+XCZF/KHTMV=KG0V5'9W*PJG-(Q20F^M[]EG:(AW22ZF
M E-VUL^E]ZF26,V882;*Q<A$\]A0MR\:K1]XJG7\NVY[K/)_L'E4<17TI?:$
MV*W+@%34@/3RQ-]O]NM$=&"XL;^WP"?!B&RSE#[Z&)B46#Z!2R2)TMFN)%6@
M8OFCX;5-WX.;\==7DUJ&KJOS75;.&D?$.3&;]Q!D4/@IIY5*+BU-"GXLEOT1
M91DO8W?\8+"8.A1^5-7D\#; *9+@+9-6JGDXVR')R& @1[G_@T6.>&&:6[.>
MW:6LV'*N]N+8F1&'I7,.KTEIEERZ;A.1,:=:?"X.EI^/G6V/G;Y9(SSDY63
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M(1*<M=$XXN8I"XB9<MS@90_>G?#/:$HI/I_RRFM57Y M_\S%X$+G'MO!NEH
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M6%]L]34<35Q3==8/1!99"^&/B>Z5LYW/ND,>&W<3-G3[8+\+>Q7A*(*( ^T
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M=?-2_O(GR<#9F_% XRY[[>&:9_*>N3[Q.$_I<\,]=WX?W+28<BB@'TXL,_M
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M'P?J#'%I(T4%E13?=KMZPG0A2<QDC9BX^^C94Y>A8<TKA%-,[H#_I&;M/>U
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MT(+#BS4_T;&PURPILDQUI9P'60JC&G(F"E0;0OZ?XMXSK*EH71>- B(6$$%
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M%Q$ @=>D/UU4LC4PT!OUBT/?W(&@1G-ZW8D2K"U449'Q2EY(5!QW&"]*BID
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M$%\'#HIRM%)!F00=@DM!'0?<_96Y7SX^_&WJ2@Z>R,J:C&5 7D*D?WXC"]8
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MD5)B(4N29Y;(;\9JRDR_QPM38E6?[")(W$WIAAZGBA1==Y\*<NC_X9>,#2S
MO?Y, "CR<X_7 EZ[%)"/?OOA]RDY"*5>->R#FU3]#6QAUU&>D2FLKI",V30N
MA6RY$64XAQ,!@&^?(0 4U) ')]O4"J?N(>)]_K3]LHL4AK_KES6\[W3.=^6;
MJO75H7VZ$?8!]@=%+H%0IZE2^F]](6GFQ&GFBU?YK(.I YW @$@G$S":%$H
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MC) .7-<%VB*/C&ZDKSS)[U/;/7C(A.+"*(,D3V14.((2@OW9_JQ@QXHIM?7
MY]V0N ><J"=4#?$US*X[#G)K_6269"\O 0482"$#;*GB.X+)KQ?<J(9OE9NG
M+F"WU6,V\*,^Z'PM(DYBIE:_%: DUH&BSX?"86A/S?N#RM?)A>IDX3YKR&P_
M\]]EQ]V[P8B[XF\"153#;@19S =9?90M@-,TH_77ES#0)$J-%$S[TN4$-Z3\
M B5IN/;2=M4'BR*92@'*[P%+OTH1(EF7]$U9Z]#*\-5MW!K^SI+Q >;!Z3-K
MW*W 1;#7^7,(59-L8F)@#E)*D *I-5*__@(CCA/_C#\'K2K/M6^W@%!$K'WM
M8_AFDPRO[#H111, ^1<%#Y2Q7'2+T=".&4P/EN>:[F2@0]-UV?49R!'N(MO;
MXB(=F\RL.>F2OT>Z*42T$6DR.2GKVHX]!Z_;Y4\WQU/(&A9LX*U+#1X_E\]@
M1?1PXD[RT4+@D7XP]&%^2!<?O5IL">> 16HN1^!)H>PP"+8)O2@*I;5P.ZN\
M "O,F;6L]&FFWRCQF?VFX1/,OF9S;8-KRD>%+[=>%Y3-!XRQ?IQD*IQ!V6=;
MR6+\KMV^[5)P:P FMH6@-F&'^X7[;*G%&Z-/D0_%)@@ UQRT0/VP0F;!O>+6
MVM*?CM6DP8(-F((R;OOZ1K&DLW!SZFI$EJRUD71$]/[HLD%ZP*%GS=K= E<?
MSK3^&9,@19O:!LR=GPB.OG<$ !$GUSY+J@=:AOC>M@^ _ ;/Y7U<7C<QW>3V
MC?) 0.#\5.YO7+)U;S37]W5/;-64YD.G^C=1]2;XD%U7T&D+>5\\H&MX C?U
M(XBF/DW&C^Y=YO,!-[6U6L,7CT"UV>Z/-+-[XFO6#DI-#G-%>LJ?VGQ5O"S6
M9\M>ZT@&+]?/:FGWX'_>@;=/W8$@Z(E*OSP5?"QBR',1'7;?'WZ.3B:J9E&]
M]$54$?8J46DI)C^.1M^8 \_8XKT-7?-GVQOBLPF )'LLSW(L9/\'GS<R&9BI
M5+7#1(]*-B,_$I7]I%DK[C9P\G#"-5=DD%&$06SBYG#N)01+P9WKLS=+\8G.
MHP3 7>)DJ;=\T*'^I#%NMP_S>*&1\XRJ_(YA=WIMNZ\_L<%E\)'!^>U<]-RW
M0&N:G63AP"KJ#9[^-<<G.D59BU/'M9\Q&E2U70E3(2&NH)Y>H$7"J&5-\HLX
MJD=7Z*F_I(OS<;!^AS1'7EEY6_3GDQ+O6US"V]Y3%"<].<LKNQOD%::0WZ7L
M7PV!/)K'B%V<\*31K[9;%HHWQMK<$PZ&QU#QTPTX*:U4^]2(A7VZ"1OT0+?.
M!^CDA[,9#T^;(RS?Y+YE39QPTR<ZP:Z^2S.0WN<WK0O,2][FSFN)..V(W%T_
M,.>9G\W@@S,VP3G/K^<[(A4*YQ=[3W=O/*>&@R5>M\!F1H']J8[Y(V13&8C6
MIBX8KYO((\$2$6BMI(PD"O-P5;9'%NE!?7TC([9.V]T#/6[F.%.:.W?)48(7
M9G-UY*YEN+*%Z,81OQ=68''B\#33@RKJ>#/FMQB4EWJSZ DG>^0Y(VIY:I71
M+&KT++B@WS6/&E=&TVS9+58N4?ZV=&MO)&UX8TC2#7?Y L?<^C^0E]>W&3LM
M1U+!1/]>&_5OZF_WWUT0S_0NRGG]\\Q%H2UEHNZ($@Y_9!A# (AIHXF@'#66
M,Q2/]P/ACAT3=%]7<48MY:2(5#))04Y#Y?7E#/@6/K#;RWE@GZ83Z2Q1)*&0
M!$"I1F*.SS,O@_1O_]BCX"(NVHV(4T X+!$2Z54<8*X[$]F,+KA5A8Z9:AFD
M?3!9MT\_S][I0OE."HGCJ=B233B_[J-:!T1O05%#3)87V=L7\0%>>@W[FR_2
M1!_EJF6[F#>.+-T!)K0CIT 6AWD0>/G?#,[P\/1%7:T!/=W;ZT$GDA@"()0F
M_C3,%Q38GJE$Y%':TMFFZIC"-C2>9O<D)]LI]8IV45'BW7TMB<[@HAYK#:0R
M]B@"CP:MZ3'W.2.Z<VY3-5!]^T;B8A_+F?W7'S#Y2;"NGX,CZ'"-029484,5
MUXTM-@OG?S[XJ+WER6]8!>H;16LM^P(5]M@=LYGWEH+V/L"R!C$PLBQ*-PO^
M6T>:!.MD+\RG\\7X:;.V%NC+N<Z'X]L4U]4_%EXRZKL^L2%*GTR//0&BAC2O
M:]CB5I/MID<X,?G?+IPTV*Y[E]R_<>PS]E[Y.:L(>S+2SSV 7!!(!KBH> [[
M7_/*=QW8R'C8U:T&.PA7%7:=&'E#>=H]2F4)UV[DM7G$;)+1PQB$/&L^DK.J
M.]"(+1AN*9")$C42<?$IB0M"U@]\!3&^B4DZ>.X%DD1 Q=[)3G9VNJBZ-4+%
MF!$Y!9?#K)G8<;T$P'.L=O#DZ 'CDKI6#TRZV)\JCR^<\4EOI(IT>\M0S8E,
MM1P_/PX<R[UPVEBY\6D>ZH5= O%HQ+K,)2;#F),M%+3>!* _V"W4-MB@_?Q.
M\MEY%MIN*," GNR5)U=2[\G^44;G9M TN&QGG/O0-IL6I%1^DU)?_RCKLH\W
MD!BLMJEDDO0-.?<A>;Q!THM)Q<T=*!]A,J:\V4Y5%)]^I>Q]KP?I&B4C !A?
M187(,:P.#UJ_?3T'G"X1$WS.T\B3PU-PUP*YJQXU-+IRC!M=*R< [A  7]-\
MZ(5([DN@V79'AN8^CYR'7ZN@]%' ^J*;/WPXM\O_]41*A9,3I[*-9 [*0>2]
MTH(GK!RL]0'WP2=%+R1"Z_7JZM$&P*T&M)8?=[D,T"N0=VRM?Q[*[!5ZE/+S
M )KI>]84[X!FW29B1GTL+_-3H["%Y+K%_0WTK3%]7+'V@3P!$*2/Y<(80!:#
M\=B"L^=BGPM\?5CS[BE/Y__'09U'$/;UX'+LD?9ACEQ+,]D*R*UAA;C4@I8W
MOUVDTYBT-#70UP.TN2X;_:0,U%0X;8:@SY+Q&"+<U9!HU'U03/]I^PT]RGF
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M1^\Q":B"X$TR(1W_G_:)_U=?2\'S$P&1C 8"P!BT:($C-3"<$OMLMQ_',0S
MX(-I(;-BYG%@J)?D[=L]>FKS&;5W)@F 5W-^JD1L,_;/-Z!<D8+_GX[([5_5
M_GX4FU$.*0 XT)^H1N"0;=7_N$!,DF1RZH"NF?;IS>1<"&H)^,_;^E-$_[W
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M=7616Q#OE*<XE@NUJ&O$D.ULT/R9-9IY\CBQ9R>Y(>[$D^(XR_?UHL?Z>*?
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MC];NJ%L#I;4X54RWEV PWQY1,5BW_$'9V\$"S(B?@@?>"C1HCV]1R>BX<7K
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M"YT("A@Q   1@#%3^Y?S2K^3O3K]S\?3KA@<Z.KYB$>2+B6G.CBC\J9RB*Z
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MM##1 ^;_48W(YE>JJ@X+J1Q=6,K>U,^N=CB)?!!^)R>N13C1-S(RF<W40IB
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MU*?HFU3$[?B6P(1<X:O\TA(#0_&7; .ZU"BR#^^4D"BPQ!&SL^*(]Q1;GJ;
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MV3<XB2A:[+B9JS;H:4 O4JZG7&<?3C/QGY>2HA!ZXB?S772XIF[@27J]_G'
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M_=CA<AXO-"QA4(Q6U,KG>1='W>Z**XV75+_K7J_WDWX!O/>B-8$)%/HELC-
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MVU],#7MT2YD<O3U&P9.\D+@@83'.D /[LIN7APEPN,#IP/%]!) 2@P!FVQ
M%:C*$@&P7Q,68PE9\:+J<:X/L##'<5ROCW@F.%_'=F3,)YC'F15 IJJ%\@W(
M_%O P/Y=Z[ 3$)Y1@[;:$8!%49?4WZ%(W!\V&[PE4%"I< $7YT4 YZ<(8.)W
M()CW_,Y)D(%++A(]1>8V!?JR_"-N_C&@^>X9O?*22M^PL;7[T$#Z=3(FD?FP
M?<6P*O6XY(/D\6#V8AJW+07E8?[$>RMSSUM\UUZ9RCO9+]-XP4>R-":LV\A6
MAU\N"<E7'",IR)QJWU/?W&U*W[DZV_,"9IT:2-H)&4F#;T:G]EJ#K]&?1E6
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M_S(E=/,G["_]"I$^@!]X]7KA$-'?^0P_!90EO8@L=]L2Z^CF+.5G?FN1;R(
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MP+@?]]YRR\]YYE[I"1G:>B4*>1UOXBM8V*C>3,=4O7MR;!=;2/VFJ_!I@H*
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M4EV*78.?9;ZO*+N^:?3'Z%"&^FN]2$:EA"*-U<#R%!@JC0065JSO.SA;#^Q
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M--&4(5*3S-)/92*@J[.W=8B+V<,+,ABM(U4\2_J1'ZG@$LCY P.</1T]ZG9
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M,K@(9N46<Z37OVP5M@\[HFP%Y&O!#2 DE'OGD'O9# =E[1RFG8+ET5@&)!"
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M&L**\IRQUI/MYQ^$/1Q@MXYX9A(R+A' 7#BNJ='^-7]XS2^K%_)51CN173'
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M@+ IP:P;Y^AY!.%^_CEXY\CPWDJNEHX&#%-YW9K:?4PI5N-5C4YDBN_Y701
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M8Y,(F0$BK&W6(V2;5E .EREVD"0"B/9\@ !*Y""'*'KDJ6G(%ANSP6.91N=
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MWEWYLU?8>6$]K0AVX6,PHRL'<IJ2N9\T1F?T@_&N3%5DD:;X3X4"TYGS*<_
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M?UP>=!K^$,E]T/A! 5,E&W_HVOOFYW"ISV+"+@NGU()I5RCKX8^$C(-,'N8
M,)Q:+("4T08#8]C,#:U?#R@T:,[\YBAJAB @>E]#]:>44%)'O\2NM><W\=FQ
MB\<;U0(D6-WRBE!"L%KSILF)"3<R8 3&:MKPLXV2Y@)K-3=*5:?^YS\'.A3*
M]C6:(@4E&OSP/%/BU-U";YB=IHUMK;&W9MB;)3,TT,IUDD\DFF$%14J55DDZ
M^MNI.D2\J EPC!K]?I]<59N:634<-V:;JS-_Y'#?/IP"]Y#<"%R]3.>2?&>8
M>I4G\*F=E#UI4'<T%/!N=1Z0XJU[; ,DD*(\)=2&5B^AZ\9_:635T/J<J:%-
M%='NG-$X?PXD)"#[ 5F96[,\)-5Y$(HN:VMG?P8D(U=FP%X+[6O8^&3?I/
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ME(TW.N0SGR4QH$#"MXS%U%5]ROO=@6-UA#*05#OP0HSP:8LM:,Q=2LY46\7
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MK;["8&WJ,"(Z$UO.FF:/Y7V<XO\7U5MFR;]J\Q1J\BM$<48[VLHDRJ%%NOD
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M%SLM^JJ/(&UJ+&;LZH^R@0%(6,'S6XV'UU$HGBP7#O9PV5R1FF.J1"0P.5V
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M9)$^D!VTT&.PA9Z>^ S0 W2.5^!EF>?%& B^/TA]!DPN[;)7L/&,$T.Q"V5
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M1^JCN2H]]HKN'^J<28R92Q3*+LT=^]DT![)7; 5))KAW94MUH7G\IN-D)\0
ME+"(RV?DUW,HPGA;R;)6*?&W#8AQA[*.R"U[IT_/MQ")$]N@[Y& 4OE#"531
MUJD&(F]^?E*G7T[07/%56<&!.R*Y[0,-6P_D\OR/#6:5M5$*$#9@/_\:HV2<
M-=DYC!Y92- _(-RMF._.S#UYME,$*>1+=W]JI2")X?UCF!;1HW'6';0BMF)?
MONKV15C6#[:GG$2L1Q-7>7*<EQX(HICVM+"& P0ZCZ'6AF%'LEF/J;2LF$G[
M\]$B;O;1TG@")P<S(=T$"@=5Z_M&=8U-2BG'[ 9LY\%J-5^#<3)WJTQL6Y4E
MM(FY':E-&ZO:A8J[-5P]_U-KD/^ON0YI@^G7,DAV7B!-DD7 "PV:)$%J?X/,
M[B.GRWM?1+3\C$W/?SJ%!\:P_ILZO*S64;YT@%4:&J2%;88N*M 0#&BR @$B
M?LIV.G[724[LN<WA3_M(O8F\94#DL0YUK&>9OYM;+Q>NYQDJE.AGEKL+6FWY
M8=RX)U=W 1_+PVATGA<([U^ ;+=A\TFZ),F$@45?.\X*':>\M/G5[Z\'?^Q,
M[C&63:/,FII#UBFSCN37AD96O3(ZOZ;C8?6C1J.+_(F5SU;E[3G:JJ??<FD*
MZJKK)!-$)>M\FX 2 =N(2#G<>1KG(U(ECG7T<OQ6@EABYWI3I3[YTTY*^9,\
M LBZCKA@WTI1URZD$9\.@:0[ RY!J=5W[S,@O(B^/%_Q'UIA=.]:N/()Z]%Q
MIO"R[R?X@M'&D(^YZ^Q*Y1'.P=)YZ(MQ?8*4DF@P9  +I<?)D8M>Q3>KLP*O
MY8]_9;I#7K4ZRE/?6:4OE#?ZZ+W,E%EJ9+,A,?&8U:$)%=@"E/MXE)'>T;>W
MG1IY3PZ+.!XCY3M3@"'8]KANJ #3E^X-,22(/TWZE %08_6:\[:HYIC+M_-7
MV;BCTIIM30VQ78YE#I0;G987H:XZ$N4>FX6N0C-!!^@5N6D#_PZ)S_6/U4G[
MR+06_[ITWTF&TP=NE9'W3N# G=>(6J[0X2W0X_)2')P[QE9\G2KBR(ZCO8V0
MK:O9T'1X.PR;+JNU:0ONK"*8C67/NUA67,[.6"/O4*728YD&8R&0'U@0$!!]
M9(Z.*A<18@LX7_%-KJE;^*1YWQ\GORO8+Z5PHLMC@B\:A8A9.#YF\+4<DC#^
MJ/X3B^YS3@S:%1WNF6;_^K!\.7*>O@F%.H0XWGGIIXX'A\#]TL7B0@"E2\GR
M_ )/H[/^8NU@X^=9,W,P<&RC^;J/18B*X)/)OI \PM"I3I7N;+3!83T<K[3+
MF[)KDS>'(:"VG]!/]G*IG_%'XX<<9Y=(B.,(Y#%5KTT<3=S:HKGEPC1C5U\_
M,25BUS6]D@-V=4D;P*)W\(9?GJ:Z5I^2)%-:M OEBX<V<$&!$2HV-75&.3JD
M3%^865Z]6'[N77=(#>^L IR_I+*M>P9@'7*6^B5=G\_(X%;0L3:[LQIB,LNA
M1V,!@0>:7;D&!KTB:K?A\1+5A*T"VLL#C.D/_70[ 51\V6\4#/_T2!J3]&<Q
M14F(G"]M5EA);NBVA(D-HR-Z*MRO[7O=6]XWF3@["^[M&>B2?^0GM^ 3LZ\I
M%Q9I)JC<9OE]CB4J'*FELP#B.\<VV-_QENE?P!D:AB_R>:AQ1O\B1D%KV:J>
M3[%28O%42 6^ZEU-)@-/A%]D%6CXN>>G]FN$<YWYA>PKT$8K=WY+(M C_&7J
M")X5NRIRR?[%,RSBJ<MW41Y##:=-H3AK,DN(_)S7X/<G0DX)+5S)B6]#CS95
M8 :*037B[K'DLI^7564 "+KHP5BVAI.1RM/&@2^&8U/ ='#B=8G%<9$LVZBK
M?FPG5[;/M^0+&]J&T(=>OS0O(_PTP<VF!UM?2IS#%DI$^-*P ZN<?YKC+YK6
MP"8".8&MMX"BHN]'Z@3 2OUI2TV&T_(^*1S.?T=9/=+45PVUWD]O/TBS814[
M)A7[H2L^/0@+7;Y?2GBFP'H.J@1QX1U>-C(V^E@:Q7H/0\ "@[6I>GRMZO_G
MCIOE4>Q^KL:::LJ*R!4*.F<VNJAS))Y/9):3XFQN8D1D>2KBY*\/NI57N$+N
MZ4[V*7=Y$,9M_ E3/YUO8.ID=F3DVX0!3H;OBI.C[;WY-O'ECJ9*+D]-Z(R8
MJ'''OAO5B[JS>4B&]F> @MIU%!/<S*F6?RTJD*P&] P@$#<XJ+@\H% @5[(3
MH/'8G^@CSAKZT:*2_M-Q$<=L)U(A-'GW[0-, M01.I:'D54R_[/,A8%-8]V"
ML*^\R!M=]LWQS=5FA<VPZ,5X<>X!QMP_E>O9#[SX(K&X-?2(5*!B7VVQ\S$T
M](Y(,8UZZ#E?=?W:[-_B)R?*C(F\W&NKO>8;WPZHB2?*R/8 N4B IO,G"TN*
M[:"OM[RIH($^/T:85#!=\^,O!_(;XNAK$' ^W"AK+ZWH;Z25[69A;^7D)PRD
M<&*;V (#LSX)%"/[D#Q:2C;:)(JEWP  G\!#&U14I4GZ%+?FA>ZA!:;<X7JG
MY@(,KE;Y!0S!P3$?K3OEJ%R[EDFV<F8-KP9",@I_UPQ1%F]"=1)"J=)(  :
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MIPSJ<;-'(5O'OA;I#;HI2\S(WCN'^I D1HZ]U3-_>2A$NN_R=R;J_VQ**:;
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M1Q+ AA!EV<>*W4S+<!P]/5978O8Q/+U85Q_SRCTB>4A+\!84O?W7A^A=5EW
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MV]"N6-PNY47>D,T[5@CZU)?44VW(GNAZ[I1L=,U]<L+;9[ QS@C0#"/@0.L
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M3YASQ,K&!'O J7]5NO7_\?\D<!Z6_QU02P,$%     @ ^'!_5"[2)H&?JP
M0;X  !@   !C;G1G+3(P,C$Q,C,Q>#(P9C Q-2YJ<&?DNW=<$VVW+CP( @*"
M-"D"04%I @J$#@$5:2)->HD*4@64WD-1$:17Z;TW04*'2)$JO43IO;=00PC)
MR;/W?O=^WGWV^_W.]_WYG>&WAB0S]SVSUKK76M>U)L'_QB\ -]2>JCX%B*X
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MQ?3A?@^95(Z],]K'( @SPA63 Q$_N5@X4,#MLW=#^EH_?VLRN92?0UG$@C/
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M:TG_P6/Y(;_F8A3[&1G)%T.5H7&*@%MCG@Y1G\' HH?E5%O4*N:X(F%@Y^M
M4#C,?=WID)%>T?,]+F@&-K8-^^A-EGXS82_\,>,""1YH5_97X+8T?O04QM]"
M'5JB2:'6>K>)HH-+?!@/H,"NW=ZPU1_'W4QY,+7D>^,Y$=JN&Z>!@:EI>$#-
M,AD/'$1MS1^+FL$6Q*!8#1=AM\K^]\Z)3%,1O\1WM%=O'@3&($&"'MHS=H+\
M98FT.?1'#S(E0<\,;F=[QIKX;+=P"'#)#KC<#DT(8,M<&@!TPK8[G?]<ECLY
MX08A43U?0)CKQE"T"I?*6L-XI45@SSGV<R,(?=V55K.DVU&LNRI\)I[[&>C,
M<,B?X":]B1-;)<2IZ^2<Z6^S@7I&KG$=E@3&V8G)4)'9&;\<%>&4VT+#3?'$
M00K++6Z-9-A 03RP ,705H@,X13.YD_I89>DWX7\N<UMF*X7*!6V\2N&RTB1
M[-U"E'L1+ %+0L->N*E?_O'.J/K7*\1;^?9VC4$,K'UA'++!Z$ 8QAJ%-F4-
MN;Q2CMA?UB++]<S%*4U7HLEPG^!)B\+G5PF+UVP(%P3O(OBAIQE) '%&0IDD
MJA # ^X(A,1Q17\[]) B"=>4>7G5GF#M9N''"?^V]VY(5^^6UD\M&GC]JK4A
MY0H)XDV="#^=:)#?._N"2G)4($)Z,/=FAN.S4;M8('&U3F)O+)Q:0\\[DK91
M;J>43)-1KZN@ER,*#U#>>H8'LAR_$W"T,M:&H$M$ 6Q8PHC &+EPX.5<%50R
M"+58@0?FBV'M,365+)QWR]R&R717U7^Z^%D5.OTX@U4]@ TB#KA^XX%%"]O,
MX^N3L -R/! !.JBJ&<*0;D/0)+"N9N:ME,^2$F<$_(^TP@.LFKMFRCC8'F+_
M"!:AB>2VQU5HX9*/A1*6(P3T)[C&8F7Z[9-?U*B[$47YDZJ 0L"CR ]H#J\*
M,!Z@:C[L);#'[(;?5=WQK?"]B3^/<M,<A](&WKUKG] *T</ ,5>=60VPD>NX
MI@%L2B/F*%W3,$YAP@DLF6-D?FV>O!O8>XV8S$'\I-%M[_35.I%['G8H_%\^
MTB:8)%B+8!*]NDNLW:9TE%E.\Y>_Q_G??1L@Y][<;8('8N,1)T=.V-BBOQ\L
M_6-/9X_CJ1Y?#7WMM?>ZCZ_GE@ITTZQ>.-(\?*T3*S!^$L:;4Q\9]]-?C% /
M"F'(2MR@_8# *.Z?WG9WPA@S\RSQP)[8)41W _H1#QQJ'N.!LWP\,!)A;H!2
MQRE?[)_=(;RS-R\^0.!4<9FX8P0! ??A^& ]!,B"6X%B!.T+$!?-_M"8I3?0
M0PE"W7&";:HLEV[N4^"!GNP<&/(#B'#.&BO&IQUQR&N3>;)(AOMBG,;4.5"?
MBQ:[A*[8(P67Y\^)%/$ 5(!@'+@;N-_S#*>@!4/VX8$-0?,N)O2(/ ?BX$_5
M N*<H0RV6X@+MYNK9/V.CO'*,KZ7?#.3I)CTW<X*??T>#F[Q]Y1+\.D787T]
MX2#YD(H1<Z5_,C_D;U74Z*;WKM8D >(3$2(.68; 7*M\^/?0$X&&)4V%"UMB
M'!H%^[ZJD[T-F+$^*8GJ#&$?F?1DPBG$P9#]L T!,SD7CJL$%LH]?W(XCZ%
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M-T*MN*+1JB OU[,!'"J#M"LND5S<CL9@6-&3!W&,**LC4]R>>VH7%9;%[\]
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MOB6=D0Y%RQ;%/KSN=9O"WE[JCG/TYA1?Q65MHTR^,;X#=B7A'CX"G6\ +X^
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M,=>3^(39/.?(]-/[ 2LDE)NB%.E)C &NMW6F!6_?Y0V<W1">/C"L^;R;4C.
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M:M?UP4G6.5N'>M.OF0-Y_,7B9N-FD^O^"\Y VN/O1_E+H'*+(L$(P83VN^4
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M@06YNA;_)6@/1?7C,OAL9K?BW&#__=1/2!7-\$#S29D Y9AMEE]85JFMOE_
M.X<JL6BFJ9>O,#1U$L)J*E2B!=-5MLHD/XR5S[YV[Y'*U%.77YX-]Z>/&]W3
M3-%55H'<ZS]1E^7]VQ(64,@O???@TAOS.1SL#=<C2=W%(S=SFISA&0\YH2><
MKRY=?)78=D=%)/M]J:81LNY:/<"7W8-O%TA3]= E[?I5ZY"?G&5Z;] ]D:$:
MMQF#(8L$^WYI?C)RZA!R,=B<5CACU!=Z-^*QXY+ND'0OG1^];;HK8Y.E+21F
M9^E'/")GD(K+O62S:<=@_WC;3?!B.*,8&G+F>[1?0W99V(F)@@3Y^:&J.50;
M>T/_3( J),B"@6+(R=,R'4ZN>ZQM?@\/.2N3F+62U*,HXP=^>7I"OMX/\),^
M3Y;X:73%_'<:E ,\QUVB@CJ2R.[6Q+CNG=9,.=CA>I;$9[ZXL4P/\Z1B.Z*:
MEV'P<%OWI&JWA0<L/Q/U0L<Y1]\R#:U%K#(6O$=/0*W00%EDWHD?8ZWM>*W@
M#C^;U[H 2_G]71$-1W> O'1KSHP[KH8HT:A,Y[1BQ#C7H*$Y96NAYU0"C =@
M..2:QWU:A'83CT!K^UU[Q08T>ZE:HI)E]; 0.P&W3^T_9T('O&OL>H;X I(/
MA^\'_Y3D&UNJ_6&KGC7(FI0_S%*]=+;RN(XE7=7S )RR!#Q_5N]P&12""U*E
M,)RF+B5W1%;M[U?-R,'*DX@Z?6EMS1I]N0T"VU(<9E@J&11$NN=U!&8-9F7<
M[2@Z&\-9> M=7$7NYIJ1@H%+,-+-9$A;0SC'S(ZI,XL[*;0,.<K'\ZZ%%;R2
MG%4DO;;93/[[E,.6OQ9#-F V89\7?/U&Z)U7#]S?W<<Z\JC3#G(TN8@6K\6O
M"5&S/E(L0RD*N7K[^8+,)JJ@0)E FJI'T4PBZWK,8C0U8I;7_'U))-@O?8X%
M*H5:[E4V-$P>1U97V[UN-K53=C.LB$BG>OS1DP*V<F.$2\"*'RHJP?:A].3W
M;Q $\O)3V3ISW]0"GUFZHDAW%;!48F\J*5YN^XXJ*F&N<FR]!28SLUFFO)0P
M (?</_EN_]33;(9IWSGN<T(KHS_ CV)R\C")7W/?DV)+5-M<Y3(1/DO^OW[0
M[O__[TI&R6:R6X.57=4CL^_ 3^DT),7IV8TM8+2Z]P>P':63*Y7Q,PU*Z1,)
MDBUPFRS I\/SO6>!ZKNFJN1Y=2QOEN;%A-=%X/HHXHSLWD2CYB^OW$)J/[DZ
M%9FEI."#4*O%Y)%A;T]A; KS428)7>7A_9\FY 8V24[%R =*G?*+'E"!0P)8
MD[^S"3D,YB.$2[BQ*]+UHTI^A7QV_TV(&B3/HA<9\I8(I7MV%XC@:L&P9=Y]
MA@Y8#J86S<(^CH#L5JFN=*8_KM.HV$;I2;Q2_'EN4F^.EBW;6&\:\S^+&<;U
MZKY#2[@M'!Z6=#!>.G]J.6;R%T>\S?W>W\_<TXU."^7_3?P P)(.H-B=!-YV
MT:,6F)N8&&'L^!H&X8+H;Y\,W]M$  5I71[4H,[V(9C-U=]$X9LM)%5[9CDI
M#A4&&>>V3D>'NTV@(Y@Z<J/CDEF*C8]UAOLF21IO!-NI]MY%AM?VYM\_S[01
M^*B0@?A+K)Z9!HPNC$:/(3-H7-MMM'(C"B$TMO>6\Y;@]GN-)\Q9TM%)#!,?
ML^N^&>@/BN@XT5(AFE1O.K+QAT7D59C*)F3/2RQ6?3(2]71X&>%@CMNRS_76
MHJSG2C!UA%,FFZ<U'J!R@V_( 35NV@[SP[Y<[*WMA[Z8K%?6VX:#7[N='8D9
MM@O9O<"N7(.IIB=L7_>_S0(0C5._+>>54T#ZJIKF:/!@8T;9)^RAE:CXZ/"+
M>I6@7N%?0Y,];X(N<Z(@M#\2*9WF!,;=OC[M>!R9I]?Z,2@[+F(%4;O9_-C8
M1L-0)1,-/M <XUSE:4(,E2<RE_UBYD3[)4P8[G@9A88Z5!$;B#Q5ZZ<?Z']$
MAR%[;4Y43*$O_$6?;Z%J'V=M=TPY(SM:.M %?_/3?^A.GTF [@!1X8?[$%IE
M(V*%\D01._Z21Y[,<^7+-:\YTN_?HK-L4D5\CC62L8$[<O[:UJ>.\!?WOQN;
M(\+,D$!F2ZO/,G21D%SZ\%;^,]>K0N(W[#TDNTKF>)MT%XR-7]DJ<QA)3MOM
M0K.J Q0YR'D^J:>K$C3OO%6R:I;HH'?>M&%?$X.M"X$,*9Z6%14LJ+P03#JK
M>=CY*Y2\;S=#C81<WZ;>%5LA:PFQ=68QWGE(D]#G*R6NOM]T#55NKS\[,(9E
MS+5VK_F)>+UU8WLON:=ZYZ-W=3M/^GSJ"?21T2/E"H_Y,96? 2LWU+,#U HE
MI%I7^ UL18W69A#ZVSK.L_GN,N3;0[4["41,M1;H@&*N(&<?SE+L5-5*_O.I
MJ:/:5>R"=WJ31#%=%ED^>;EP\*G[&$2"%-&Y=$E)\[K<FI*TA^5AB++9=>'-
MZ6XPB/\X>TMN;F_HN\7[6&.)E9=<DW&85=,;31<3PJYX #IUNSK)27]&?XI)
MI,YVJO=)\,>M29[].9M=VJXD5]<S U^E(=O(AL;"#1W?VB''^TYA>7VF3]_:
MS&RB6KZ=G_03EQ3:E[VPRZ\+^98?^]0RNJ5/H0?+P00DYL:R\GDD>V=Q7'XS
MF&EEFEF[O^'F9^)GWQ$4UN2\+'&G;PFZ?PH5O1UW(,\YRD%2R"I0H#KR-7Y'
MTTC#9H&;&TT %FWJ?[PK[ Q\T+(J-=FR,XL'\!@)R#LYW)AKF)GMH/O=(]CX
M\;GY^TWIQ='8>JO)2)"E!I\O+<1I'=7,'"!Y/U=4LNC#12JM4:U'9IJ^7A>I
MV5/IGE96R81PT_N?\]%Q[1H>JN?K#?4.Z&\O-"L_CUF],#-,*X#1^0K#M"N1
MN/""OM%I:TK*4=YX[GL53]B](@+&$(GTQ$J59(\X)2>'%.-+^NWN=&U(+NK<
MCT]128_G.<G,HRXH<<BOT?FYG[B);+JF%/0+49WL<./[M_G*&MT:T6]DAIG.
MF!9FMS56N@=B89ME3!B5D"@[/*"*>2RBOE7]Q8".H B0^24F<P5J@\ R!K-E
M1OF^-Z\(5F?O2O91'Y@2Z7@C:<+Q6S4NO]*=ISK#2F.M9BB?XA=TNX.1!R60
M)LI;7;R [ 9S\^4-I8DX<Z<GQOI".)-DVET5*F=:0KQ"ID_P "8C(379 2$[
MB5JNEUV"+$BWJ-RSC>3=M9 W%8>PP"SD5NCN0^(5>^;XGD^['PGTZ?<!!9-1
M854):RME'MM[.(@[K6_/YCLU-/GB$BDX!TVF%QT5K+I;O?9$S>0>*G#1IZYW
M2'0R+,@X9''(YGNN1?+/FJ9)/(#<#BWA]^$(=HWD_FR;7<FV5V/O<E+=5\5Z
MMV/GX_=O?-:<@L9@-,LYR&OZUCC^ZBH^F4*CN6Z.2-6APXQ!0\I?A^5B"MWT
M(MW@JAVV7.N8A:H+Z\EPC^DYQQ_/OVY,E"<KJS"_^9&V\7,,RKD>=]![]T[$
M@L9-E3OA.D<4;_K(M"DR&JN;9[8V8>5N8<_+@KK_=>>2.7W^'V'9-)F*VFI5
MK6]!S6N"A6![BM3JF"W*VW9<=[]"*Z[[T$64O73T+#/M8"1=/J0*Y>)W']/_
MG?55ABW%(SYKU=2JK6W8RQ?^Z_G2X3B8-D25CUGI1Z_[QCOFA#G_!L_NR8JS
M>$1+S_Y%.M=#E]TQY12_-!0>$.@:HEHN=,_Q Q2+"N^U%L^;'<$#'%,M'6J4
M(C8O3-]V6"%<"0$JJ/-V@)M<AS![;:MXNCR4WS99NAES:^*#RK1=LU0MB$\R
MQ3EUQ+G,FO*C,OUDD?FU=FWSM_:D2I0T:JWIO"(T.[K[J6=0;UMT'%>:2?!J
M7EI]2DY*()/Z^MEY[7D+;3 GF6)-9>(H/5>?F'7+9'OBGVD>\VHO(;2^D]#\
MJ38Z5/+GO$;>N[EQ;PI+)4*%)63%," 0AF@&-V=W)FZYQV!S[H$'> OGS%$=
MV/FZ/@EY-<HY,DG/WO4TEOG:IQK9>S3;(=<2-@J4ZNXU4IYM.5SGZ;S*-1%)
MSEY\ 1"^6H3804@@XQ$VDT)7GRX\"5YC-+E(92!J$EW0'RW;6Z^M'M_-#P3H
MOV5.>VL*,$M\O.BT\\II\V&D[J'QX9.@#M%[I?T"S:'Y'>Q',/I<FXY-J1+=
M>O/@W,*:,T'X*[YXLE^PRHN(*';JTSF&MXW?3@VHXKO7=PT^<?ZDF8LXZ18I
M@@IP$&/<:G\V5=<&*-YCX2TI9"Y3$,[ZN!O"JH\=;5E^N8EX^S-V8*L:8IXP
M$"NSRM5M.A&V<ATS9O;[)%2V-DZIW,F>!V#K(JEV A;&LMFY0MG12A].Q<0"
M;@WDTTR<D>BTK1SFAAB-<G$QU81HER=:Z[HXY;7S"9\"Z&+DZQF;=1<.7R 0
M!GHS3ZOR&G60S]PZ[US7[NUMI;NO*"#@7.\>6:D"^D7E]8**G0OZ[3G75K6)
MG$+TO41FNL-.%ZWE,7TRG30%9538X [LS_WX@?9&S/*)M5"(RS<SFB@5?7*G
M5#.*.*:FFW4+U&@CK&[>C+X\Y(R-<S]V[>F1SY#6RVLTC/.7'*)%??>88=<T
M^,L?I,[%6C(76TW.7SNT#'F&Q P[V!6"B9539/C$/U '-*RSK%H"DY2,&(U%
MY3_[2!?JS5@G:LA#E6_S]7(G+KBOBUB8S)X8]]7LBI-]=)VQ,S6&6TQRV?&=
MF;]\P=,%.K33C#C4-D?;QVX*>3E-&)DG:=MIT$Q>P10P7U&*.P;PS;J6>CZK
M"BO?O+0D8<G2]QE6;G*=:-$UGZ/1Y^XD;H *&24OS_<=J0C>2!=Y\3J4+C/U
M7>C-I4!/X5UK%V-Z=+0:G'9D*,#)CB$=-:IH9N;KSX;XM-]J-_-1@F_(6N#@
MVO99,E>+3_TGQ'Q>X4PW<>:GUPL<@4J?A;N(YG"^[$F!>^)RB-3$JT,>_"7A
ME@9U]I56I=_UBHAKW@^$L'P$056VV5CV[;<6UY1<V0JQ!]-@A'M3I2Z7/E;J
MD'?KXMG/0NMZ$VO1SWV(#+:%P;N*C[I4 ><&42"&TRSW93R S!B\8[=T"52U
MI6>0"S-U&UY_TYO6)OB52 :.* ,AL2I+]QY)X<:ZS^Q&9SUQ\A<#5,(S#=$M
M<-8\>5\D;@MVJN@"(YVUGDPNX9LW(':-\W1HU Z]X1PW-@E+A+8L14&L S[:
ML=14QU;!"@9+<-6\58RA[GL,89.4%[ZI7I^+4H>+^,ZE.RAX@L$A:]L>JRZ%
M^Z[&5,J',JHU->E]_!FJBHD3^3%94\ZU/S2#GLD Y*F)#;P*.L[M71KL.%3A
M3RO&3*LICPP4/\25^C]4CEBQ3>M>9YB//V^\.K+M)7&64*ILRI5F5?WZV^M\
MO6"/56SNZG$4UB5W1?U@57BR3=8[45=#/_^2NZ!?&1NA(*Y.$L)TF)AU_SM5
M!F7!:G;7 >:<^BNQO6G4QAK 6R>J9!E"Y>'> ==%-"?D5Q:/W,JM=N?)-''W
M#$H\=Q2AHSO4*9-DF &_M3V#ZY;UEQA=%KUE1KQ[]Y&G=^Y"*P8-,L;<+1**
M.'C:\%2\J'D@@%2+-#A:V&=_@S7UCD\59<;:NG+)IS@--Z^2A11MJ]T+UY8E
M9YEVT<[UFIRJB9VMT=KX[/Z"'GU6PVNI0@,%+($DXMZ3E\[-I,AB#_W1K7O3
M#;4-WX;YF]5"%?$ <ZK/%",ZR!;V]=EC'LEA1/^TCP0!^(O_^66Y\QS%L#X0
MR?33LC1?HB]EW*\,;*!L80#W^T*4;8_=KHE'>3/F[7P.7ZKD6'R&'$@.=2>[
MS.8HOWG7(360RCU?'GPZK)^2!EWWFK;@3:=75$'L2YQ-HJJWC(Q<><75#T4/
MY.#V_"ER8^JE.<:"!N/?&U'LM[5(HT1//]QIQ(E/<F=TJ&]>^*:HE,[T8;B,
M_"/'BF:!G]Y'OTEN @:<4I^^%5#A^/53#VPD0^<^P*DCFY;@U,C!&)_>=)@\
M>$@4?/JV47=)X<5!%< NLY:D^-SO?>39*I5P-VL$0^9R'D;;#0^ JBPB>=4C
M-.I5]Q9<J>HK=JI2_%+N&8?21B;&E3[+*S"H_EDPUVU5/O/S5JZUD)WX:L!1
MS=:8@-],IR3S6*/\S<AE#DYAB;7&. -ED^%*<HU./2$PD8/-:[2EW;.0PNF%
M[20J(12*V)D3*17!8KCWY*/C38,(U)Y.)1YPW8BKK+ZL"J9</"][K>W#H'WY
M"^F ZXL,JK<WYI.U7>K(TJ^.KM6 H[TY#"J:4)L?X0QLA_E5R(L# X63?@[F
M:R9Z8.T,=HSR,Y+^V;OI$_Q)R1'I#,C7R:=-D;MPT<C"0*EC>[UIJOO=C@--
MBD.ZB/I^DINRUHO7EA1AM%8#&G+VE!(AZV[OW%9/6.%5&B&M29#I>OJT^7HX
M<)IJQ/#7^CB7:02@_)T0O>1A[WH2R\5.EBW%YP;U"B752=6SJB0LF2"FRX]=
MJ)E%A;=#V=:(-+R79:V#_[VS_Y6U'[>'KZ84^\@U'U7&%,CG(236,\XV4C03
M/LG$WK61XYTF.BD+!A)=9V!CM!\^.ZK  XKQ /5X<QQJ$/5S)L]SX4LC=_'F
M15F*P[V\O;F\LM3J?E>'O*?(F)I$D="9VW 86&(+A) UOI@MY6W328Y,3*_'
MU"\TMTQ$*R'E?A9Y!+6?7>074%1^G.6CGIQ[*R7ER$N=_I'$QY1B1%=B\;M
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M/,N:'_6\.9Y[-'N\IB+VR<+WA4^\:LYC+?"7(^FT]=::V!0M:K2_)PNSOW\
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M$X]2?E@'XQ18=F=8MA"L#(1-<=L7^%Q^'TQJ;-(=G4_8 ?H&PY-KX[VV_4X
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M^D4I#V/SI,W J%W:^W @V*K< [8E2GY./MS?8^O(HS>%"7\C7@HST*(M^_>
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M02JL'F1MT$1!G0NGKU&T2.#M>R7CF8.1A,"G(<0.-."J:9950=A_="C+36?
M-GB>EYPJCNJ7?<K,XS.R($*#?]TL>,\SLLZLMY7^^+9E#?W'M,YX:4YU3665
M_M.!#P;&>_A*; \M(S S/Q]X+]MLY+T,<9/HK%;)1X(2.R=Z:">+:+MY/_"B
M;-]"#$((0MKZYJ8T%%Y\]O.XCCF\ R1_[X$.;8L5"N^ ]P&A7>50>JZ&UVO^
M!@L;;.+8.)*\E"*T?)Z=2.LL#ZH7J3_&"MSI/ >BR)X_QL3MM[$UQ[OX_.BO
M=VZ]_TMS#;=R?^Z S--SFKBZ2-8J1!U<0FAVO?IBA67/&IE+O)%E_107\_A<
ME2(D,T5/OJIQ(L8H #I%[>F5@62GK1ITJ\%>?^0+CXQ%2R=(9=,X?ER:6L=Q
MVQ+T/V)]/_Y['.X;F/YRU$;RE,B8LEA]FSJ("?ZCI*-X:YI"?NKAE8$CT!?%
MHNLLX4SH-XK5P)'K6Y[!W3^G$&1WCJ_/I<P'$W-+QT?%TMRPU?X4N)I=#YVZ
MG?*QN#KLXJM^(;*.T2, S('IWU37"Y,W>.0^3M_4S]*Q@#>%I,IF;ZDXG^.\
MJ>;O]1*/P)KO85A/MSQ"NXPVV\W@&B*51.H&.BQM)XT8MS(':L!],%WFGWA,
ME13H]R>:FB'G>M<XDMX4ZKLO/QX"7G/M2J?'O)=&W '&GD2++O%ITQ!0KI!N
MN+F6/1[YGR,%F*1'2$C=!$0DW\3.DYQ+=^\2.1^^^*JJV+^^VT>"OXMG^_+=
M0EZ)G5#HQF'58]%]AY.V8=7WZ!'Q*WZT?,S\LDY>KDGBE?,2#9$J@_J JF)W
M@+T).$LYZCD)Y90M0,2@3A7\"V_;Q2#Q3XY2DG&:(H4+]Z"1PM S8$=5Z 6(
M"W?]7=ZW2;4SXQ3?Y,V,[TS.$T8#5WEHW]"LQ>EZ%H-9:\9K?N.9&DF\G$(J
M4-I$D,ETS(<,&1<GVJ6ZG[F:R@;9,Y?Z$/&]R:.@=6U;]B"MO<P(7^B8FS,S
M4A&W>$'C6L)W(P4B1;.+[CUDJ6")R;W)9Y)/W%#4R1WNY'*IKYS1?B)4YN-1
MNNT+'C!2Y3I[MSG[@)V+4#UT*(+R]+H0P_<?P<$/#-/U^(U\U(V0\SD;S-&H
MO02_$Q &HH>QM9P6'AE4,$":,#?W>NKWQBOFAHRVWI[/(;,?O&G 5")<&!;[
M'@+:B*6B4KNC$M=\UUHDP<:GP@.D07+X<&_+&$^,R\B^)M]K>>S 99RB#F?^
M%V=RE[.+R(!X->_G"T,_?*I>P$?.<X>5I"?6J?8CEFWRLB%F?,W_L%B,J2F*
MDZ:KR.4Y@XNIJ'7Y0S4NN6F&/6:U!4S\[KG&XYM?5@>GDTD#7#!=39Q/XI4/
MHZ#LZVLDGX^_N9(F,T!=O9SY?X[]-3*#]BH:+V];Y('JGTF:HO&S-><-CV*T
M6,[->/GT>6C" ;@>U.<"055$'[EG/FYS[V!/UJPXB;F4F:(VJVDN@M<_86"L
MHUJH0^#%_V3P0?891.KU34;U#'57KUP>.O$]K%_F8U$B.!(&'I\3*J$VEVVT
M7E5FJH:7I2Z.4VI]#?.T=MQSZV6%X%FD'_EMC\G$-43K^/S#N]U/X;7?_=V+
M?/^^T!>YBK<[>!D06TN\..3!B)L-5TFX+H&:A1+18D\,.6I3Z'K6C>&6[WY%
MQ-+.L4BMO40(H*&TND@7'T]#%;EK#>V4UYD<F!31O <^O,/&X1XES&\F$:-6
M=!C*U?W&7(V>3Q:+R7!*[>NFF.H1ZWEDU&/CF*#(<UCZFBR"-Y0WK WC%X>R
MWWMN!GWNKQ!*/3&+.)G"OKXVNA,T5,*L8<?!B$ZJV'O--??*QF)@AN0@][1'
ME=.V].OX]QOBFC\RRFZ8OX6(^!-"(HZO%21&RMP5E":^%%@4(&&(U7=OC?N&
M QU!J*E2P28")DT!WB_/1F!=\EJ,.#AUI&AMMD)Z7JF"$3DTONX40Z[EEQ]2
MP"C^_79Y.C/_W=E&6DZ_'L^#H17E%!CEPMK[?GXV9J5$Z9X"&MWQ+5]?TYOO
M#F"Y1:7C3LY6)O/KF9'7<.^G#>%?$=&@=PY63.K]SJXB+T_0!LHSK21CF2;*
MRQB$G U*9I$U%OU]%LVA)\,N<\WO!-@]P/E(<J^)[D8FH1F+B&!TH;"%P*,;
MSI;&B9WO6!I^-DZNCY,?OZJHVTI4$_+,,]<"X^GC\H2&$2?P"%V:^ZKC,'I8
M,QVZ3"0I3VS6U%43@>V=;[6E8&(+VHSH;CVJDD_R7L)"Q 4)_E0W.=6)BTU>
M=/135U*]XVOW-;_4<_$JF#4K+MO(:^[_VA^50XAVUEM +:;YC;WV0XR_#Z/Y
MS2(V]I*JR&HP*(9 "&E&_B?"PIZT:HXZJ)JQD),:-P1+0<J;YLJS- FKXII!
M8_L7Z6^'[0&W.X ;N18HA*HHG-M"-J,Q1(#RDI_%6:5@*^@ +=C8:OZ$'%CC
M)R?-5W;ZAF53]_+CH&<RS[B7'[ QG&)5^/N6TW[ /3W[U2/)I_RX?1A9CC@2
M=AG?O[<4N"U?Q5R]?VZ)J/WTYEB>LE^7M\XS\)"2-=-W+[SF(=,X%W%D&IT]
M)E42!H;+?@_-I.96JO]9(E+9 LQ<8TD:OJH9 \&FH*15 0QT'GS5!K+,T48U
MQX&_CE]8W'_+.++R3KN54[&X;;*Y T8)7*>.9\P,_[P>49IQW,U3LHH6[)"F
ME-U,H>^ *I@UJ5$->4Y/N6P_"1CZE <3^YC*RN8L92[=TRIP9>1>4Q.!Y.MZ
M&F>AN:"(@2& UK'EF209YJ]VDTE_Z7#N94Y*SW\DC]/"'^^FN?40^ZO75Q_#
M8?C(N]R\LHPTKH]Y/ .L^]3F6^DAO1AE7J3J.,G(>=NA95H%E5C6L[*A@0OG
M\,YJR51/OG-SWDEG'GN+SB?51+M#HK8"5PI&.KJ/C5)2_]38;+[A.R#"B.@F
M=(G5,\G=4G\_A3Z\L/Z^HW%3!F^ UV*4<+-"'8<X5Y;FEG,T-UFVR1!(I#S5
MY2K)[/MX;<_?F=J#K&DVG6P.3U/PJS'PP9P'Z6EM0BDM)-QJ8KU %:^S@T'O
MK2-&5KD/ZF$B*C_3GZ$Q8AWC<N$:G[[\4;_ 4RHD*K@P?1T&/O6#(=X%*L[
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M3RI$%,Y@[2E])!<O-IQN][_$?;FV4Y@6.)W,5#VV]$/T1T:+F/2OH^.UB=!
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M>-$<^+W+?OGDFQ^!S+":X&H+POX+G@.I&T0[I/M!*!MZ8:;Z>)-<OOY(H5(
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M.5]QDS/Q?DSN7X8*DXLI]9JC2?#P:KPWS%AOR/K^\X5-Q$UL[LR08PDUF[C
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M \QFA4OBM"'XWX!$\(^5I:"O3'V- K^Q@T:N\KVKCQ-?N)AM+EB/C@F.^TH
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M_C3#ZP ?%3">V5RE?1=C;'2,%'&K$H7$/6N3SR=M'MYX%[!98,#%\O'#C9)
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M=>DON7/)QMQ$6BP6309]\&Y\)#^V,XWN64JB<Z*S_9T-==3T[P$:?F?T%9?
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M D/#-N[Q8J:>_;LXMV\N[HVE&^BJ?.&-R(EG9&0Z?;B;E!=X2QP6K%<:X*X
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M$(=E\>H!8C\*^QV1X.CH&MO$*# U0\!?4?X7"M$O0I]>@>M.F6<XJIW_F*.
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M.G5L^2L* M><NJMR2<J5&9D^=K[[^()L.0/GC-$;[PIBV=M$+35.UGNMYQ7
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M"_BE\SSS]&G[$NI=WF'(]"?;$P,=!8FB@9M0NYVY"'S0'_8B3@_W'$&N\AY
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MFYJXV#D12I.QC:JED194X?8:>@I"CZYH&M])QL1Q]-2&$]UC?6LOIW> G8Q
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M#<4_'. VE4"_AEOF]SB@RM]/EH[B9Z/EUUW8:C.ULMJ7=8&JY;1P3!.4.WH
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M 63<F$C2CV<5D#@^$'BNE/6UEQ/TKV0XITRWAWTMCQ50DB2Q3J0.H")KRG7
MF <Y)6*#H]^&B-?LH$>LA@$SV95;IR#C,CB\FGZ+Q@]2+1\F8G+/!#P?2A3N
M[D@%X1/M^ER^BBO_/7X3!\8BK*?Y%$7,CJ02JB?5NV;D.6@< ^%]<N._.RQK
M+8^(XXJ'28AEI1J[C@2L)[1-#:NMRS'AANLW6*6J(#G^PF,^VPEN^P));SXD
M+G82),R80=W)OGJ=]_PM3+].S'@&*N%'BP7GF4<CV@MOS,9I?*KC=C"'4$N;
M) "F)"6UJQ=",D#+7^_6>^N_^F/ )]+QIWYI]S. 4RJD,V"?4%5B3J$.6U(E
ME%QJ7S*+ X,5.5FX'Z<+306Y*TE&U'-?E7J#5CPS>LOW')*0TV*%B7B-SEK9
M/-Z!4URCR;)0IZBBAUT5CTF<-%Z!#4BGU@7T,U1OTE 824U_!D6_!?< FK^S
MF$L6="585RAACFRNHXR_#&E")G&1*J'9,7Q5F[^UF=4\\^FS6(MXTY1/7^V^
M.^7HZG4FU/2HRD*38-G6ISU,2[EJAS]*$J^O#O)G7<1Z6I#0/!GQ;(OISNL_
MKM5L?!"<*JBNTA=5'\;F7G@:C,KWYU$,G4+F5]\,S*SY5=2G .;XMO;=Y]!F
M6?"0#GTF<WTHH?64]"%L[5N*NNXT2NHOS-OFW]5O'[<? F^4$'_8VCUFKMIY
MF;LDYY\E"2F] >, & 70-JYUO5CK9>SZJ8DG:WN/>B\(HM!HZ^!O4&P,R+XK
MXE#%"G;NDX-0C2^Y;C7M.;4*F!31Y4[SFVZFX&W>@79F9KGM@H^P?+M_CE8P
M*'BQ6 (15/D"<69C=?XTAW52E45VPID^:N\*DX6>9,]O1BLWJP9;J-$LI&SS
MZSO.^C).@U )/Z9J1G68-!]_:]!()"-OEBUJ3>9*[',)T*NX0BLK61IQL2V0
M!SGW:VN9-F6A2YQ<R!J?G!YG GT.5+3DRU3DDS6"A+HURP-\T;=F4@_RUGN)
M7B$G-%?J>5]''/\$6I&BGUK\.$F/*OBA+<^Q5"),I=Y/!0I(N\A"%SR-:+<_
M'3E"\_/>BNX*NT3'FA-'#V9/Q<0J&0#)2)&DP>B]2UX3,-6965"--/8DVA@&
MR2#WNDRV<1E6MK=/L[>_8\?0_7D+6X_\ D]2'LP"#SQXS:OY<.8.,#+2UM-M
MLY<7;G@G\M/"P=JBHI(^9BE3I\] <,6#_/H"=\;Z:_4S]ZYMDF.>(=?RP6>@
MJP'_SB+=$K>;\U0GH+&!+P0'IL.S^6R=D4IA8A!H";04\+RHT#R!2+])S(0K
M5,\._38;5"[4;8 ?K3'+?M8 HCN]_]&^3?;S2\OC.S:2F8[^Z+-&^,_U8<#R
M/X4W!.:>6:C)\:W-(<2AOQZ7V^B)^*QE\:SR+X6HT/-YRB&ZTD1K^5\L@[X#
M759_3RZYYSA^> :X'N]U@)TE>X*(KG>H 0N8]2)7VQ"M NQD/,)K2R&GJOU]
M??3Y"K^=V_9CZ,25[<KMD\/]52W,5SQGKE0P7&#:K=U*A9=-)Z6,EAC/2M"6
M;L!*F\-CRO637^K38QFY1=LSD+G]#+3;"A-@Z2Q*8VI&&72ZYZ )\5H'JZ$4
MP?W4X=2\MDM[<AO_[^O$:NL92'4@1I[&M6EK"J4[/":D*N MVTHLB!Y'G DF
MD/_'R,;M*I Z?_YC9.KLN@FP[C5>W5Z5.Q<%?J;R._A$=7]47&H\>^2OZ-MO
MG_SNKVCQ/$R?##-?>@/4&Z>H0UK'2I:13G^]XKW7T$]N@^SQ*.2X;3'D<NX0
MT/%>E?55-B6XMVU\N& I$WL,\\D-'WV$.I9L,='%Z4M#XKS0##'F]1!T)<_S
M5K:* ZZCV&+WZ$3X*SQ08G8&4<WIN#<=Z? FM&H_,:&P^[GFRC22I:D-%"Q*
MM*B<^E]%*+N-2\N6,#X6,U\] \>!2BLRU=;GATN_KN%4!7L\G@&ABF? =R9F
M3I$R/O%((N)Q"PG!CPA2]]XS\(F_K'W,9J>D<*9TI_D+J"&D?JJ_GZ#4\,!.
M[.ES].-%^X;P\+S]VT RUR(R+WON$?'''^8O[3GZK9A4+-Z8K)\[0!D:#N'0
MTSP>; H>**K\QAG\5CJ?V(&Q!NT=<IMO DZMZO**RK;>5J!:J\7!>[6XF#Y2
M>"NN@ WW1:@*=H3SQH,U,S\NQU($YY=E*9.@ZX(DBGZA=,!LM[FN9^1/0S*P
MAS[4D&>GIB'XNK6J&3N /P(&T;M"<+OV&:BJ0[^]$KJ>? 8B >7L"C]3&_+S
M [_CO&> 2.@_/W.9U?DZH<?:&UY%4#3FC.]TYZ3#T@@!Q: B*,W=_4[V87/A
M3]VLH8[6DP(<*OBGGX&Y9O]G(,GT&?C,?#,.3W3 _F_Z6K(^T?0=A#W6V KN
M?KZ27#4D7'7WX@L<X)]!R0IH'H(97^S:U\P[+/7!_YQ3@A_\%%+=.]$<+$%
M<8VS1PO++#;.</$:_+86U:>/:7B'9NXSO(VR.*@LF^[?]3%>80;LM)\>ZLT=
M#7@$#\+'R[W]+DO0Y+'.5I?Z$T^@R EJPM$QW9RR9"QI3I/-8>\A+B\#OS:<
M9[0[ P>?C^[W+LT_[%6$V#%1MN/'ALQ)<U1+$&PPE,^/[>BK4U'^Y*+EYB$D
M_0.;D2K;_K/%>R G#,_:SC]"\ !DKP5QFCX22A#+_^-0@$0%^84,7RZS"/Z:
M"/OC]7Q)8;8_&Q-%G,[)?0\E :@Q^JCA)".'(QTA\GU=LVK!0B>;3BL]17R5
MB80 -RE];K8_BZIL(W[H^_DZUW-[\-/?7\$E!;O0_#A[DR_$X(AQT5+]$RJW
MB+>'Y^CQFM+B@/-U!GESQNE16-=[[9?[D!\G>;H%"JWJ(>Q@/&\>R"2Q Y,+
M**Q<*[8!-F.[&846-B-)IBUJZ\A$:M.X\'6"Z,UBAK;8*#?_SDD9J0%4MN4M
MB:.8( F;Y'LJ"B^ROO&9(!R84::DPDB.)!1]>XB5,5C63IWBD#G:5$7:O$C\
MZL9N+6BCC;JA9;5;RVC3---F)=O_ \4D<YGKB.CRLIIVGJ.)SQ6 ]IDM\*)T
MH):OXF(A&4*O]7/PA^RP^=M)X5M[7B?]!+A7'R3$ 2</ED7/:-7$#_5#6]!7
M_$T^/4O;],"P@/O,5:R177ZB9678_+SHEAF3XL:NCK((#HH&[00,SUL).IG_
M;:/4]^-6\G6^V^3#BVKC'5M\DG-ED9/V'FR8YD':SJ>+!-LG[#8Q>6M&E2NC
MPFZ@7:>,IEM?/O09D&L6.F%00DB/_O79EP;M\%.! !>V+M8#5:*PUF+Y&6]<
MKVU09E]*W [V(O:>.8>,(MZ>RID]]8NY#/87H'0(YCICH(7F54OB& /L<T]$
M(@ZTD U#?]R=PI=O:Y7!33>U[9"A7#2#=3N_O=D*>].H(F!@<QQ1L=AJQDM^
M'O5JJQHD*=+BUR9NNX:.:HMRG72WU*W:W]V,Z8]>9VS-U4 4N?>Z*:*(:$V$
MQ*3:1\3K9!];$FZ,Q/1&;54),5?7DZM#R>GJ/K3^\0 [;&]FHZMR]P3:P[CH
M_J=1*;>0XK.\S_YC#A=WANIAXZQI5MU17?Z\]A!J-5PC/4[KTZ'P8A?I.=1?
M@&Y6](3/P;VV%TU686[45L@@LPO/*?K <S5JFV.QNMN+7$R=7]+8(]>J9ME
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M;HGEP:V-JLS##_"FJ $B4$7$<I:;W\EUC:N_4G638DVQ9&(+WU%?[UP09B%
MK<ZT94K>K.&%;<U0!E()=;5,)@I@4DV5,?)OTSMPIW'RQO14W4WZ.>C*.\_,
M[/)'4&+5%OIGOX?[(BVX1,<QNQXU^#Z"2S4KX%VB>0CP(]@9O!\E1=@#Z$^5
M$BM*9Y]'Q+*74;YJ?-\(D? ^LRE-(8A90J]MSIT,G4)A(PEL%'B*?Q0\DHW4
M58X8^(F#2=!G1("M$P^3:5[ CZ^BO[A('/Y-.* ^""6GDEQ5YS_>_W];4J@H
MPH ;J.8"?]]C_9.;=BY3@(=)IKO,"&ML?VS PXBF"J+>.%R5,7)G7M.G0[(O
M.1JD =FFB0^TKW3?MX:"8DC(&>-]^=5H(BQBWW<KP6DB4OZP'!;QMN0 +08J
MG0MC7AJ'[?MP;7BO(%-/:U3EACL&OFW_&G4YR,RJFD\Q[$<'+)YJU-X=/L97
MH[)VP,),@;9+__ N6&'+>Q,ANHF&H1=M<(SE@&=S!'!@;E 2W2D_9)2]P&\'
MO)LO K*=>*_CN;#LK*7VI]H<O3Q?>Q"?QO.UTWVM_3+)X=A) ,F]$)+!DJ\:
M['CH1"*/QH'9%?PP7?;VA'@!*E<-2R3ZP2OXT\[M+ 1:"(ZW).3@CY-ES/\U
MW.5(<(63Z"_.M -W*DS6M)H:\J:&+T%<:7B>>Q7E_'5R4&^.$^?!+:0*\;2,
MJFS +IN=I:L2.Y#I2.JBQV7"0**\Y?IPC'L_#+B,QAMD:,4V-5'[,G-:9-\-
M03_#%0IFSJHYP<MQU-HL#5#\M(&[\P0Z39XIM3M8#Q.7,F,@4D'N_8"XIBW9
MW5PU,0IAXIPG.8I4>S-_R0XS?@,3<],[:&W^46K W=((6*]W,\3=K?)1\-ZU
M7+)$S?1ZV^*.Z-#;V@$[E_DK-VQ^V[$P-P7XP_$,8);GK2?7<7,-(-%OWK9)
M&23GV_K2_W8[%*4?R,/DIZ]FP8<15ZF:M#]Z1P^?6Q,[38=7WB)[8UMFR,H^
M+FE-[(<S$CWIS_TE3F_8/%'TJ(_Z^V;*'>RJG#Q9M&.N:_K".8I0G@O7,OQD
M*QU%4\N\'P;5(7(+ LL>RT/)[R=R_5VOJ%2.F5B;<1UZ)"76PZ4H:?)TP/U_
M&B3CS%-IFW@NFNOA4DT3N>' *"K&MB8VQ&];H?72W'P[:5@7TOL]6 #&":5<
M%F:C1.5%WU!4K'#2>)O"%Y*HM4 W#4/]\D7@</"]9R;J[U4#X[^GMQ<0'E/T
M&FH>)]GST$0V-W5/DB-(_2(F(0Q<(#IV[/:XNBHAP"^'"@RM_.)/J&\.PN%4
M4([+6HC2C-:Q^QGI&*/8H#!YN,T"-HXGA$L[(PX($DS[NZW7Q<G*(]*\:&&=
M6,O>[J&P;%(C%O-DWB?F YIP!VF)QOKR]OE'R/+',/ID2EIAYT$T 4=D\B##
M;'^>)O9TC3,H@7U0KI]E@]5X[\&R*>Y"7 QG]&@:>[K"\N1>[R*T%E]X6].$
MB+'KS=G&]G&4N*N:$J+@'6[?U;LBDVBR_:1WE-(=!(!EM$V2YF2% Q/46QI"
M=66*,80+2M+HE106C8WM'[&;$";)]25M$X*B4M8UX&/021+)C 4C"K%A"(FH
M+O[QP#;DV->:T^.?H!O &74BAHD(ACH+5/[#IW-8FVR4<>D?A&6%!9(Z>Q63
MZWK 4PI^X"H:,+-3G+=$F'@;F9?\V^CMJWH<5$ZI44_^>TUC<<!\5\=U1I,+
M2Z;_8VQWUOM1E"*$NO]#3#M!J=/1^#N:2#=O/)5")AVIQXDG\T?T7:VWCFQA
MUPZ1/S&]AZ3XI2T)K>TT!YM1>%AVWK:_4ES]7/*K3P90[^@1IUGA,-;(=ALB
M B*]5!?\W_\2_ "3:YZ%,NF<_X.G#]<I1_]K7%CA/=O99O2@/S'!;8T\#RL6
M[W9^I*3]=( Z+ \5A:6U@-4K78XNOAJ8@%[O"1;J;U[!A'W)Y_GX/Z$QRT.$
ME+CBA&O)(L;"R(SG"5'O8H+"@PAV99(XCX*HD^.Q!Y 4R64*3VLCM*.TSJ1S
MSPBNLY#+[96"HL8'JZ)T?5G[9J,2-)D?-VY_!]6Z']^I%16TD#@HIP#YN M%
M8]-3,X@"++<SF[RBNG)X:SD6?9*C$[<:VW'9?V9GB^P$L^H/#@!*2I$[LFF8
M7L:TLG'TT3KV=)+EH9J!C+6QI:C%B"=^S>)GP,1'Z.1 O.((LJ>^5WX[-HY&
MEY%WBM*GT/#^APZ(6$+SDXB?#K#MZ@=;7@6^TJHXS/I.PJXB-"K@V<<QJ^V)
M_2O%;4^D:)_9B7;4U#!!0D"J'-'P%'46'[EH02%F#]N%2K<>J526U%*ILAD\
M*7PF\Z'7N#5SU%_ 3^_WQ6L[ZJWQLLV@4I#>8B\G6KN'0&>IVNDT_NM"1;#7
MI'R$;F_@5M],*]2V)3R4A+^B;E0;%B/WD8Y&B#= F'3Z;BO5D^[C.\FVIK3;
MK 9Q4OIE7P(H1X$_>\<?Y=SHX<[K3<V1)Z23MK[P5G6'@MZR*S>C:_1Y4U(_
MP83+10Q).P<23%JM#:5B1"/:5S+_4U$6_W/*8:RM/ZOKR1>T-PNY<'#Z8W.)
M V.P?$:?%D1M1N[%N?9M38/N=3BWO:.^K]/$]-JW#:5;S7&_DF0:0VD)]&W:
M5X>XLH<>=$[4$9EJ1M/M]@ZWYW_#?DK>C/\-#[J0^N1SY'<<^\3^N:E]9W3G
MZ99\XQ_A0?]5;N+J!;=G\F7>;_I%_B,*Z3\+2OZK]C^BD/ZK'/G_/[K13J3=
M"5U/@.U=+:%'_8)N<[N_3M-%7/9J75]6,FAG<C'1:MH\Z^I:YWJL@>OA=O$9
M6*%ZL":Z=DZPI?^"#H=#\E0+<[I>=97_RL.U(KM5^F1,>#;7.^03TP%3*N2$
M JK8O(.[D_0,(/"+O<ZLE"7]Y7Z.;^K'"YR[O!_H0K&.E=3 G7\&?J6>)KI<
MT;8?_\D30G@P?08$E?U67LPD^_F/H&DWJC)+S=S,0 ,6BNC*GF? 3UQ"\/7-
MT)//CV>@/=N?_P![S]IV0K+3CP"MGN6EFDI!9P5>5#WFWQ;(7+#8HS EI M"
M!DQ88=%ZV]X)!2XS:!)4A_I!SQ%QQZU?1E;^D<$!*L9" G:*@#T> 3RA"RVP
M_7<6Y5I_=/)S:&7YWN?13*#13V&O98;9&3X2R]83*Z))#91'W[.MD^@X+W06
M+("^4S1CY/MS?V9><\_OI_YMOU857:0R;P.5=4"XL;)7>QIO,MR(V;3<57/P
M)7N0^!D_0/FJ+R+Y7/T96%.]Z:@8,<H[_;+LN>W_@5]SW7661@R^E'.=OY"E
MG%5@/[,)J\^(&FLMN?+#XJS=,X#BT:O]#$3_G:M\\I<Y 656B<<] _+B 'A
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MWI1&;U&PZ 1_#J#$YB!,65M;NU03Y,Y:WJ\EKGYZT II_K3WZ6QA=R"0@0%
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M\1#;"A*EW/)=LO56<9<_!^Z$+U#?Y86T"E.SG(H8KR:4L5?=JU(\LNQ @0P
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MP:M)PMNX2R,3PPK$$>>1W-D=6LG/ST/6'!=F&,/O+\>HU+\Q2N[C>,IT^IV
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MVUNAF3*>8J;ZU0!ZC5]J?6/]RB"2MF/'V#KE)^4:F@V2P&QN[G135%,0U[=
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MBOKR513-QTT[-NJK# P!F:JI*@][C=IXR;@S<^*H)O\[+D_-5RJ \*<U93,
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M<#$)RR0+]@[G_WQOXE<51I;C1D^C01/X;D?P0JJ?<"]X2%J%W!<7KM=T@7O
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M3$[%1$-.P4!)3$S+1<?PDH6=G9V,AD> FY6?B8V=]7X0N(</'Z*CH1,\>D3
M^HSX&>M_^;IK ;!1X/+A-N#A*( 'V'#PV'!W'0 9;)Z(<+\NX!\7W -X!$0D
M9)2'J&BP&ZJP@ =P\/ /$. 1$1$08-]ZPKX'$+ 1'S]C$4%Z(J^/3&&+P^H3
MF8E"^:JL%5=A])"*[;V=[T-4/'P"PJ?4SVEHZ5ZP<W!R<?/POGXC*B8N(?E6
M44E9155-7</ T,C8Q-3,W-[!T<G9Q=7-[Z-_P*?/@4%1T3&Q<?$)B4E9V5]R
M<O/R"[Z65U1658-K:NO:VCLZN[I[>OO&(.,3DU/?IV>65U;7UC<VMWYL'QW_
M/#D].[^XO+KW"PZ A_OG]2_]PH;Y]0 ! 1X!^=XON ?.]S=@(R ^8T%Z+"*/
MK&_[A(+5!P7G561F6>M#2C:%0]SW=J.H>%3LR]1']Z[]\NP_YYCO_Y%G?SKV
M;W[- .CP<+#-@\<&A(#S*]HL;U3:K[S5I4999@?N(*YXU!2'WO=N +*"Z8-3
MW$')52DI1;1M7NN\O-F!5H65;5SLM9->%6H0%GT. G9D3\:#('H\2 >9^9%Q
M9N9MO,WT,TF/ S:^<[BN.=NI26_._*P@@/9_L7RSI,GT(L^\77Q2Y^F<E_W'
MK'NVXW9((%2@6127^/B2\U@J=!:KFBUDR=B;*JN\@:LH'<O%:TJ)\PXPX8(+
MCVWVFF,A^< &$>";+ 9PY-7<P(%+8U7NVLR[7&!G9Y;*R)SRS"7'ZP$!6GB[
MH/;R(^G8R?PZH\[&>?^?)1?+#2%T$:!R$7*HH]?,]IGVJ^V')QN^,PRN7$A&
M^ERE?3Q:[B.(,[_6Y9_VE<4"[XG%DQ\LPW57*!U1HF4!$]RM0R_=PD[@W()R
M\K1UYEWO $M(4K^AO\% /TU"8_+ZCQ,.I[^,\!=[X3]9E3=M[I3DV-G57]]P
MB;UKT$SB"@]_5'@"R(OB_&]-%7,5M'"1UWHVQK1%>C0?<\)0#UL/-NU._8OT
M]L79LP\H)8^*]XJRW#6]V<JZ\T_8 9<^@KQ#X_)H0$E#8E5H09FA.1^W_<>Q
M.6]N\;(VW[7*V<R,%8F.$3@QHFG,$Q-A"?VTTV$F+7+%TZO%+/[GC[@X.RPF
MPRH35RKY<:#OP>8VJ(O'DM&*WRIGH=O5 C<G-?,;%AO92RYK%N^7_;V4^:>$
MTCFU\A]SOBCW+3,Y,A/U9CP2@Y)PO:M4U2?I#S1Q:D7\@FP+D.E,!%EO'(*#
M^-4=:.+VI2Q00F1Y^A\[^:.[KU)N(UKK^(=WTI5NN<7Z2=FE&]6 ZXR5HPEF
M6F,ER=I]Q3!4D3<(AZO&(/(35<FI-DJ0!48=W"KE*@9T2Q:_GQCISN@N/+H'
MJ%I'^[K?"F]*]PW9)/-I C*;RL<]Q 4;<(U?6#&]8V5II?N6.YAA@J"<S)+O
MXM<-KC[G#<LV,8^3DYF,&#JR<A+M.[2KH=HDD=:$E%8%2S/-O@M6&4V5;QHF
MV4E$3Q8#G@MD.- ',/K%[D0FGK1:V:Q*W1J=\DF2-P;QF;9%D;GY(T2&(/+K
M;2+;K>9GIPFT?U>&JIZS.7<\HL[[6"7FJXXG86E$1V[?@$W8.C\E>-I>O []
M='B,B47R%OI3L2Z0,D2:C]]4:PDK]2'@R$,UY5K0P5&*H:LYW4_D63*IEA41
M71FGD+$)$>@V[[5YB#8,IWGA=*6L;N"//QA,15]*'K)*>:5,6 FIX-D3T[QE
M[1H[$*L_HM[/0<N;>98VMM;]H;GSN,Y*U](@W&T4TC2Q$HYCT6PV;F.U>W(I
M6H2E(3-J/Z0=E"9+<K%1995Q9#.]MV=2,P8Q1HBW:)*D@J]Y!2#<2@LG891^
M<?DD/\YN4AXW*T\AJ5?G_)K8[R+F:XI?=#<.R@KSJ8#.<'L:O>Y>\(_GE>/9
M 70# R2J3B]?N@Q_>$E?>A'N[FSPQ2S<S)&COBGO,=OK9Z_ZE(\Q>,.0<8=^
M")*E=W *LHR5,,EI-V40#!1^7'@H(,"GLM"\?(!S$373A5; GJ PN4RCCQ/%
ME2!.V"L2]G!UL1A0A4Y8673R-JC&:S3@X6&>F>I#LE+V02O.+C$IFQF"S:F<
M#4<&+F[0L3GSJ.+&8P9G:>O1.2ES^]1,;^H 9.YACK%'\$IC'J*>7TW+-7H1
MH4]7)G], Q&@I^6%7I0DT(2X@W='C/-!/1SN+LRK*6\CVT+(:876D\D:6JZ@
M,7#1N6@6>\8$)^F/=01J0^/.91MKXH>ZN WG7A<@%R!?3IKX,*Q+">'(OH<0
M;97D2>E!:E_-RLSWR4SR=%,].=!&VWI:7;CBR:8R\2BTW&PYB#J[HL$_0-#8
M2 O3TNUJ7$/7_U2;:5,#[+NQ0$\BYDH3ML)#( NGWX430DSLG(%.Q),3+5L=
M9(.][:8;"/;M+9"D:-M+4Z+T\+>%X&Y-)3=7T"R&+DB9D+ %K54)8;HD:QX>
MF[I]O%(/?D'5B+Y'CTCNBY4/%\;#5Y^TDS8+I1XT#Y'=#S$?LI,EZ&6'V]1Y
M/&IM(TC<Z8E7EM]J1QE;/$DW31EL\!)>;[E<3,;37!M?=]QDG)^M6&NNSXK#
M5&?(!9S.(%/TJD;'NTQGX=3Y[>%!,'LIZAV@URD89?!BBPFMMXY\+:YE-F#[
M@R2)9T$3+627G^]P0X"%B<W6V,#]=7<"Q*9'KVD-O"0-F+K8;>RH'JG4YU>-
M=\OZBAA9H41<&I8N6CK0<&_.C3\%W\2&8]X!4RF+O87V;5>2HQY<1H9WP$XL
MUX![(M&&)90*JIQ:O.56"66$5#5R[<HPDKN$.+/6&5:#ZO(FO>D\WJ+AI6<O
MT/3;(^7AQZSF#]D)B5PJ<3J#*RR\./VKXBK"YEJ>I=DW,OJHS"E+MMSR=)H)
M?:J2-M$H;YK*K=1TQ_M)7E$YUV>X.S  QWW2?3I(M @_;XZYDA.W39L],8,,
MII5\8=#;'H+QL/N5*3R^ZD3V6&4RB;C89%5A_<<TCBA-_Y39.?CSIHOO M5)
M<_XE#5*KGN_'-*_KK82D)%8EK$Q,@^M]G5ET9&#)D]>H.L7/M3+H+%H%,8P6
M]^6S"_$ 1USFN!!2"\KOLJGD5M9 /*S<G;,7S7)7CN=)][OVC5]Q'E(ABNQB
M6F].>K\D/5<LKSI:0U9I2IAF>+ @GK ?0C+/,K)*2$G8J3Z1,5X9#LRZA#':
MRT?+ASY+DV5=#K$FSI]=OYU[U%[M\O6*,Q&T@G/482'0$*73($_=MO9JJ!Z,
MR!^%)#PL4%@X></C6N A!&T)D,#;Z?$5V.]X+I?)[Y/BD5<%F,QJSU^4=DZ=
MA3H[FN6:E8DF%.>PL)=+U/:SIBSI';+,%*+-.TM/<BQB3&OWN[-^]RQOD_)]
M^H8'5:GL>MYE.,<\',.<5Z=NIBF<NK!QX"'N>E4[*V6Y-^Y$K"1RN*RN1A@F
MJKF]UG9=SD9NA/E4&</+7E.,64,$+#C^E @V2',Q\%ZMS^B33-ABAUML6 ,A
M^ME5411"S!WP]*--S$^(C7F\)$1/-[BN\KU4\;<9<8IH9SJJFT_HSD:?KFDH
M9RHY=#$N/G7P6J4E%_3G=N.P4O8[HM7W7;OGOW@0?<IA)PVO6'74,7/J4Q%%
ME/^8<#5U6OV#.+VWR+*XEAPR'?[G4PL;5',OY;5B5_L5Y&^^9FJU_A+((2?P
MR/#5%@4UA]#B/"E]VVQS</QC<8KB.=4I1@IILB-BXCV;=^_S19?X OEY"GZ<
M<\F+VW/F7OD7C1I]-(&W%H%/0Q'2@'@*=3X-.:-S=S4SLH(/I.%DK8U:)6OO
M"_WJ'F8*_[KST5?F@-*PH(?C#S#I@2?C)H0'8.[S$EGI6.IZR!.9(Y+;IMR0
M9HORB2\1B?$7WN)09NGFL7I&Z[8=^;%<<%ES5-?:4C>_Y^==SU#[J_A/IP=8
MO;GB7ZN3;1ZEMFGQ5Y<<4(4TQMN%>M_*VKP%>B&G8D>XDP7.(/?B5M0Y=CQ;
MLY$YJU#5BV"Q+VQDKU/<'+Z6[0A2U%6-.M#W'C!LUC?'X=>;)A%^\7U9A-*#
M\)B,L/OPUB*G?(0C'-,<?R^K,682/RH1.NQ(F1GP>KQ V3+<FA>U>(6$=:^X
M,GEG[WW;(^/)W<:*NH1EJ_GWVS(OD05,'U07V#AG7:RVJYQ=56>=J=I)-STL
M4>]2%E>0D5C[8!]B._G5A;7KO$.%M[ASO_ZK'\E:A#!EO>/QD5\:II +.BEW
M3E.TTK@@E8L=?5ZY*V/#]%,B3J9G"LVN"3Y3!%W((CO:-'[\0L[+\[Q7"_L2
MVIN-4<OO&"106X61R>U;,S ,VG5G!"D.'2>K0,7F%-OL#A\UA]XK?6]X7-C^
MV&V3 [$YF..1.:3=25%KOH4I,\I]>C?3.7:") (1Y2$A?2]I%<1%LQV_CLR/
MB=T]T6IA19;K$1&+;(*>G;!0CO$/*-)XY3SSZZ29_6F.5.9!!4D#]-'Z"BL:
M((RHA"_=0!AWO6&\B(/^HO+2L: RL?)'^D!C@",GY 4+D6$$_)" 6U*QC45^
M>D#Z801GXU?.K C"T:;Q5D Q-,>-"S[*E6I*ER/]LR.1Q7<;:LC><MR,A('O
M@^$X(W(V'GC #?'KD8OUD2 )&2:AWK7NM ;)<GA\S6836WB;-X^ &-7XC?I2
M86W:DF"FU:94]89H*RUF;\"ET!)WJ8(H2I!W%(Z>-55Z1YJT+=CKR;BOB\;&
MX.[,N9BW*,7 ?EGO\8O#5]'CI/,[9<$#+S,3R.--%[#610Y\W>7@M_YE_?!O
M]H*F&AS38^A+PTH3MQY!TC_<YRE.$^X6%X24K(E555Q_L&CSQ#5PO4F.I/<?
M7SV=G#\_  <V=!POTF*L;:X+9D=W-TJ+TC_[*56+IC';='MVQ)60IKD.-Y=R
MDS=NYW*>66RUZ'7MDCP@RWCLO2_CI;C-P^\^/BYO2#RV3PZK"5M(@)RL($-_
M''EA+!$3"PNJ,<W9UT\&9M=-1^@B&]7"\N;&3^2%$7'^8BKQTF5IQWR]1<5K
M=2% =,-;;6$>@(60.%K%%%90T?YA7W5^:#CE@/<F\<":7@?IJ$V"B;C604 8
MFHN5OIK5<AA!_/X7<USQ$=2H(%H@ZV^67\*84>^?6>O+DV5=0(&D>/$T+@@H
M-,HUN_J@;V!@94YT@$*A-#SUH%A>%%9 _3=,@0U18> #(ML>-LC]A!V.&I=L
MA@)ZOF5Z_49WX?81("G*0:)E)"/*^Y<:Z(LQ:D["$BJ@\4*H4O3V8&3T['-S
MX]53("HH_(]13O7Z"&5$,A#_[M3_E.5*DH?:V4\1*^X,"[+< 3V99G> [H\[
M(&LM V-#\Z-+G_>T8%5?AY%FH?M!Y1Q[M/D3S09C%9:81Q3>3S*Z6NR0W#8:
M0*U)H;G1*_U$.S\\"DT;!@\JJ]F(X%H03BD:F:&/AQ&*9Q=$\V-J^1(U^U*^
MUA(P8(5F7*48CB#EYE9T?NUU?R%%'2-&):B2224FZ"JH<;CH\B0:,IDEE9Q*
M 35JK#-X4N-D:$;#W9^&;S9=@^%'CM+;,VA"ANM"(?D^2?NM)+5PHK%D2T2I
MF".\!7;8EZ=)/[N\4)L^=PMF.,4OO!7E??Q]-N6K'R0\#P=N;G:.HO-VR171
M%4'Y\X8Z$4":N-'D>>%79#8SV6ACFRM##0X;?4]%^1S%A+L5O@RW]- >*G;=
M?'4(NB4D =P]_Q&SZ%'*P40^FV,9<<NDK!F<LL6NG[J&+WWN@-EN**2$IL7Y
MI?H%1#9MVV7)GW]P[.VRDC$G/-71^ ARZ0]GU5PK0<W@ZC2!5]\'UQ,FWDC[
MZ^'XI.A_WJ3Q&>1<5*F)U[!_61?6/VQA6MV1ILC=<YEPLQ:%\?+!">'SKZ*.
MF>H![KI/--@#GXA:5BR\Z;7.(W/ D!69$F!1N"UM!UD]N0/:Q"W6'WHL6YWU
M-#2S72\TNG;9IMD*8T(<I?K=_:LF\L)HC(GG&LP[8I=539 9H_B6[,=557';
MJ/0E+,/?KMDPW;"YM(8UFV S=,DR'3,O(,U&S%9T]S6^%..F:,CNCG^IXP*1
M2YMTV?2_:2Q_LQRSPH&,8#LNASP:V5>^:<KO!MGI;7IX!PS80^?O@+,<M\%?
MJ8%+',U@Y8OY[DA!%7$51 IJ8RY^;7";?);..F^\N+G;I1[ 4GD'.)]F8+1M
M+[&C*W ZZ;P*>3#GL+924=D_S5R\%J7&_TE2@U/Z^IO2:@E]XF%\N- R[811
M&73PFBL>+AF4WLQM1- U>GLP5D=OF@M9B6>Y+.:8UL,Z4;'."VNG.<Q +2Z>
MZVS<A#34A#;$8T4R:?OJ+4_9],B(VT^EF7=%%^86$,P$-SQ0SP*Q\B.1XWH\
M:EE:#>L^^B3CIR1U2=-47?'\G1^#LTRGDN>$$HLW<JF ZPDND1E7?^%K>]PA
MN6^NR8,.O;W#/:Q%J'OR-3>9[DG CZAU7!RL.72ELAXJK9#3;HYUC?1.W=T]
ME>/N:Z*!:_8#C#N@RL!IDI)[NOOM[@WVBNS%6W;UTJ;>,QNFY<SI#9LA7!E[
M'YA'WKP:OWHE#W--YP#D=S_E;PMN\;P91^5>LTFL8?&:!&6ZES*F3G0(34]5
MY)0S1$NCA'REZ]W28EDB]1Y!JL)5D)890LE+6EDA>.;?QE[>Y^,JUYYR=/Y)
MBZS%5[)*6G &)2_M:I(VMSN6<N!K:5JR)#\4!\XZ*/.V2H\#N2QJ@[8$_D66
M)$5!3 1F#UOTN%*>PC?-P.*9L^_2J*Y174;:HZ7G"2;D,(^K1$U2W<6!Z$(U
M/:$XT)CB)^B!3M,$0UUL#GCFZ89+\:IWOBMU+*Z8F+B7$+$<8MV+F+JNQ =M
M$'/.R, [8#P^53P1NB\KY"\1/U+6,+>@,2/8J]V#*BCJL0E!YX6!8H6HL>:%
MW]L:"&,5)GA6W,;6.Y2J3]#@1L"VQH&B6##'@&1[6F"O;OY;7XN1_#/2_I01
MQ"1ZUN&.IXXW]!Q5'0JO#./8*/K\E7+M9 ='?")##D6X<?4YI 4E]JFDKE6D
M[ .GC14HA/:(CRY&8)-#DYJ5NG@WZ2PWUX'!U4YNFV)"2-KAY2CPO\5_W,UT
M@CM@30X6R:4G=\"HG6KF5)J'P1T0^0H";8;< :*]PJ3/1''DX.Y-Y]-?P<5U
MW8VL=?B2:!]6JK7> 2>&#G![)_\8UY7KW]"E]'FI^L7T'?!2Z-KE#IAQ7!O_
M9T\,;D<(X0[8X+D#K.^ :X5&XX;DI?2;;J&]Q3O 7+5HY(^'/CL*ASU4]NI0
M]I:0VMW3Y5.7T"71GM!.J]")80S<9LP_7=F[ Y"%UN3J8:Z<PURQG?JL"KXA
MOG?E -H,&U&T6YCT$VQ$1*G2T^S;&=_*_ S4N.8=V>NJ(0LWY<ZA J]5Z7$F
M/!<#B32TSB!RL=V#U^1S/"3*A259WCR)#!PH-EYS9[Y'V76/$R)CI3901NJL
MR0U9O[52^H((BBNO=QX^WOI!L29%W'\FL19^2^;A7Q9'CB72;B# C5171PN?
M&"U:<RUPH2G1$46DRVP!W^%N!\>_A&6;-!0O/)Z@HUF^*.7C=%CFKH_&'K3D
M(/]<!FIG&SGNH]V( ^?CGG50UV#*L/)]1K_J\[(XCR4S)')/.2P99.,6GVY@
MX8-3)A15DIR.%4,%F]*3N;#3<7EAXH""/'-5SN<X$*8W"JVT4IJ:HZC=]&S$
M/:\?M?AR$P*;OA@6]N)5:;-[ 0XSAK&$=B(]6%UY>77?;NAE@H"5Q;<37H-Y
M9!4ZF> *3@51>$T6[I;YZY'^LK+=.70_E<RQ@V)'*<?JJEH)GT^#49)9472X
M\DH5#[@" 0)$,6YD_J3M_ P,#2LNN22\C^IU"1N-SX)SB:4V<"A3[@ L8A^_
MM#F((XG [A(7T@PV F=<:VRJO&287*>=##+)P]6TJHE180)!_'II$0Z^K0QL
M48&-M?9"ZP>TXRF9+UR1,X4T%OX=44G_=UE0^KJ4_Z+[#J#PS[L%Y4&#H[SY
M7_U3IC5B+FW>A)Z#3I?N@"M6WI]])T)^Z<=<,":8\KL#MGJVX&?_*6*/;4+3
M?\+? >#PVSP=:9V*HPJH'NCLZ ZHW.G-_Z<Z@9_T^HU+7+E:A2[#0+/-T/%2
M]3\>V?!ZE>PF]"S]="G]BO7MV=419@CHF&L&-.4+VNJEA1_^TX]9* :H)],9
MYL8!S(W54JQ2FPN>>S<6;T'-T. P;P$,V'B8I!>EQ>9USD%6F67C!XSO+:C>
M1\CT?#FP38&?\KE4A<WFH>QGT); 5]"28?JJ3O01<^O5P6=^<1OGG.^7A]19
M78.;%,M^M5V$/ENBMNF'13>Z=X!P^$UB\!T0G($1ORQ6]75;D*XVX%JQH2[0
M,M57EH_7KQ'I@ZR.[*9.]&T9E1=EO&P2.UZ.G"CM-A5Y:O$I?+AMV$J-;$ :
MYI2'T I?<*-"=X_/WE,.&QXB!FV,ET6RPA8CN6,4-7&7N9%!VE\L_ EH%;GU
M/.U$2#_*(4E=!)Q?<\L$6E-9/*\A%"/G_I =<K*9"WI:13)4=G99.=4 2=KL
M?4+5:WZM9-WZB"PQS9UDH4$)=!B\#U$9TRQ[SC!8R/(IH!^),>3:@/2TU"CW
MNUE^KX&1E7F)71M*+)S@!0Z<E$@-;*&\()ZVIEOKL0IHQB&^!"%1AI8G)[BE
MR@X[0M_4J<&)&U;&?&5A1;*R7<5_H-]_UG1<88 EBB9[=0?(WN)3NY&X;L(0
M"X=1:.=6Z$0K!F[E3_#= L$ R^8>L)!A@!4YE:::^0NPF@Z@#61W@)BX,.GB
M/T9%CO:PO ,2R&X;0'N\Q^:GZ7\-Q3\K$]**0UFH0?H9+%RJZ"<M_J6L62&[
M1WR;>\2'@>]HE"IXZO,OQ&^"0!M@8DQ,4IC4]4]?%F&(+XK6#/,%=(M/XN+O
M#H)!/@X3#/)O89"OY0"WY0 ;]/TVE''DA*BR:OR@(3"-A:(T9B^6*F1=A$2D
MZ ZX4">%#9L!ADKUWP$=4W!'[E"Q?MVKHWLX_X [R#L6DB0^KG?\3L -N_#Y
M_E3\)9FX&2GCR.D.N K"W' 9Q4;)'+/CCX"^[DTB4?SUR.:CT#&G-F@J^#X[
M=T8<W>T%"P2C&[+,TQ3W2:KA-\BNURG)#E],IJ1D.[E,Q^$1:$#['LWTV^=G
MU=0'>&I*-M3%+: %DEK0J_A:8R<:B3E:8Q*MZ;D(\"H'IY+.J<_,<*9F?^\[
M1YSL%;1PC\(G>(_MNDE)?K+E;OJ!Q C7)W=.4\/%Z38.KSILI(\JB.YUD9&8
M1&@-P<D/O[2$KU#<,!*.Q7>FJV%'V8_K-,/G$>&4N 7Z37CXHS SJ.#SLFK1
MMC8L9E-Y'\SNF7C*<)!U/ A0OC$RN0.:S&QM\ONM&*<EV6]?G:F^N*&J5S5\
M.[V-\NJ[@ PM?$E6S0%%VWZ+FHAYM8XV=#1OT<KTBRV6#?.:L5R-7HOA,29)
MH45[&\&>=?%RM:8-Q7*VBT&TA^FLTC(&<G\/=TLKC8_PTY/_1$7X_T01\(Q2
M.=:9[NTNUS;$.KTR5G8(KV=1090%CEW@::K<_GHG&Z1*LY@QQT(1\R"Z/T+J
MP5M"^Q3]5A+A#(R F?W!JGX?$X.\9%N*7D=;!M0CAK> 9U#+'GKGYV[^?(*O
M3^UGVTV*MIW.OI4%KFHZU(0:J4W,G>F)<,NQ>DJKRCXV9RG*+]0O5T'?<MBQ
M^^+C[;3;L@UB>Q>N70M.D#:/>+6'':9''AIE6>L10P\.\4;B1F41)B&VR.EW
M=M:;I,"O\;<FZJ]21]!?4ED.G$LF"803'XRH&K#0\*ASRCKJM:[>NC0=-5;_
M4$M_'A,AH^2WC_D@(UF^(6W;HH#)B.V=L\1R6<T:-F3$QV<6?BPUW]Q9HVA'
M8#:;MV2TG$,828H4!Z[WO>2^-.#F_!<&*7U^07,'L Q?PUAA)G:'_8]7BW]+
M8)W%WT43X+K^S];%W_+7<>5_D4TCR)FC,&DVX!+>DJ0;>(IR8&/2$/;F\QL$
MI@R]Q^X%FQL<X7< ZB?A.R!]4!8*A=%JA_(PODL=C#0FWE=5!4RONB!\["N2
MD7JYVSZB@GS#D&H ]2P2.IB] XZ4,5(TZ\6-^-MQ95Y@)4N2Z'[B?YAS82 7
M==;GWDOE$O+FW;;80^3R,"]Y[6=!G+'4IB,]WOYVV2\P6.'V4C![5,F6R?!U
M=ZZ*JL%RLU1F<!$$L3X]1B3?KY+F&Z>\>IWYT7(7M8KKZ <9'K#F8[CCH[N1
M>D]0196_+-3(,;,?=S;ZX7!-MV=8E32V(.5*4-%QY!O2L4_E^U+&]6K"8<3!
M9>]+M?3S3JNU9VG48.$B\5=B+\W?3)Q,,QE4:UX;V%)\DO"86.@3$YE-.<GK
MSO_>[S)INZ#9V.>K@1LKY8V!H<JS\ZXGBE[3W5W?"AU;W!II]#$Y*G(N,BYB
M273N]V\6 H)C\P&N ;BOAW7\FI#7I7D[_5Z-M=KC]GWIA;]\3+_K_,&;F)2'
MO7R[^L/VH9D-__M]ER2ED)I>5''+S32)U0O-,6]&E.PGA!]-J8U0=4WGE Q]
MTF5D-^4%_%/B= VBQI"K9O![3%O?8<RZO4](*DEE8),FN2WLA.L8JJ!3&[X6
MY_?B4+L(EKP6C:$#V3QK-%;3X(D(H%SD_]E-N.'-\(A&&N]YA]F9[\C/-5?Z
M]3M@D;M3ULK"QN1!JP6"W*MF)^Z(%^$9Q,HV>ZD"[_TW&\!@-H/W4KP/)*F
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M0 X_047Y2J^@O_K[]5;H3E&J_(]?2ERI5GH\@WDBLP-M3K\'>@VYBV$^@3O
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MDM"D@A/QN/6=G0B5X>.NW$;M3>Q-F&,=;1@>&_!1O\H[YDBGK]IU2X<%3.]
MZ<SV&KO2B(:65D]9.UK]M[Y\8C!D,CB9+YG'H[#052^:</H%KE!D=NS,&6:1
MPL;:ANJ>HSVDZ3=R)/-_&IN6P&%3+4-AYI%.AT+]I>MF3[ZW2UQD3K4D&UE4
M/^5E3P\Y5#S'2?X"^XBP7Y:(S]5+0H,VJXJ_Y6^XV9C;8++B(%OH4H<(B=^S
M(8FB9ZQ=:#GP>LDS7&6DSD6"J4E=@.I28E9/+S#$)]-8#@Z,.F[=I!"ALGLM
M%+,M;KG'@QSNQ4U1J=J)W="VL2KS6+N=OV*6=["*TL3JNU'K'+P=#ZX?^Q/-
MMZ.R3[HI;M<=6W&I&_WGYP+X+,R,(]!W1:G+=GF3UK1F*7?R3LV8S>CHG9O2
M$_-RMP^WXA4$"K7[2G% +^82(M--&4B$^_/??V#EOAI_ZE4K$'JM76G&ULO:
M3X\=8,FY"S^;0IJJY*;B,2)M12_*+TL<?!X[A: 4=X;O;$>P5YR3),Q6AA/7
M_6W;]+P:Z7"NQ"ZJ8L=.6P-6WLLJ1!U8!C?*@]QI$C;-_?LYD22[)%O6IDI^
MST$=CM^]V!%"<Y3BP\08MK#EG$UD5H_#51@2>0/L 2F&I&X?+-[2_=QVK1TH
MN!4;GS'?GDF+%\51U3_*_.]H-:WXSPWR!LMJ&_72>*Y4KA[5L>^QZ6L1CC?C
MMER!*4TMY,Z#2YP]T,XE3+G%LGF469&HO6 I_NS/8SDM-K5REFKWE%%1/(E[
M-GR^;@!S'*MY\DO\BJI_I;]^MIDTY;?>8STUK.AM-VA @V_0^MFQ8.8AE+#O
M1[V3@/5_\8\%&GS^_3^M9K?!,^52'3983GV6F]S/6AN XP/T#$EAN46./#WL
M.X!BP>!IVA'&<<SW'/?5WXPSFJ=LFA&5W4CET5:U0-Q\K@MV7NC[F/!$['-_
MP<26X74%>5%',H9[H6K[] X(M6R@BBRN]N/^.7T630 6IP])2]SG<RZJMPFZ
M8LHDBRPR8^TH^B",QNLI\P'T6J6)!I9<]-!9T&[L9A7CVRNVW"?M^1IR5N<;
MX&5CYR<W<H=GT81^K\=(19%#/U<?I><1WM)67Y1F;6-?/NV*9GC;C0!4Y(UO
M(I]PM(^^'6M:=W_'Q=B8W.QE QW?I[G(7-Y[SH;TZ0M_$"81MM6JD S;E;S5
MD:[H..4Q1^ASM=@P%#@3V8(AS"V+3UG!;Z\_5;;;S4[7GV_ N$]6::1!-G<;
M:66J[8I-DJ1I?O]KW!'Z)MF>DU"[MAT>;4[+HS!A'N#68AA* !I0A7Z_ W9/
MMSA,-Z*#O;;+8=K:5TSJ6QOT_;YTGMW>?.2<0?-8#:/S"FYI '50WY1PHK,8
ME7(TWDYE%"O. W?2#-4,U;]1J/I$=(AUN#A]^^LGGY6VK8P=7GK('BZ48OEI
MC"V\= ND4%\EF[H#2/)+O!A^<**0CYZ8D7((=:@@W #(EZC';^G3=QZ7G=!_
M.IR;J@<;?">_2%]NU'F&5)73H'?Z^$U%EU IE$]>ZT9]S!)+)'MKC-\<]+GH
MX06 >8R[%B-_&JB&C[E<6^ILW?U-Y$BHW:WAU2,+*9?6;:I DQ"0[HU3W2/D
MCH@=O $/H6SNBC!=VMYG$I3(0 I<W);XX=3PZ9X0"FA-L0Y&)YOW(G\RYFLM
M']OPP'$2MSE3$=$\R2V.O#;RD#_.WPX8_U?L QE,@BC>2Y"U7Z]K0;_G8*JN
M3^JER?6ZD&)G?@&YKT7!&)K+ER15;K55A8'N[QA5^NRI;Z6Z*\)EZRWRNW00
M_8/SS[4,'7';#0Y25L!&O'0KA.^@PJ$W>[/\C7E.NZL$I\/FWQR*WTCR&[?M
M#("U(<Q1TY\->/3#D 1,O_&(6O?%+M[<0U;Y#K1!][XBTT*$Z438(EC>+P+^
M/:=.C%V,=B:!:L=/!')AHO7GS\/[TFOXMP38TH555!NXL)JC^>SMSYD_9<,)
M<P#93]C'U4+7 FZ/7,_;,2^#[H!9LMNT1J1_]$=M@A>/.6&8.A5TWR"=L>AL
M8@;U3%O $OF7:"^RN$&NB 0U,8M]@&6J+9GE'W7N[_LT%:Q:>?,;\FK"U _1
M_YSZ\;[G/XK4TEL0#30XJOYJ21 VR3S8)'5[[\50T?8-^D&_T"+=59IBIL8V
M_M2>11[R3^K0.+$W#"I"*_SV$$ATBG-)JEY]RJ*&EIE;]A>Y62K.('0N5@HV
MN&<]--;.AE9Z#W7$YJ;01&WIU*[=*DDD=<XN7:]2*_FRC[KRA.+/ A.?X_45
MJ7K4B\F]Y)F#(U_:%,"0R!=M&:V2F"A^5LXF#.:2Z]O56!!=$'Q7[1S+@SI;
M:YL6VUMYS%$GK'DN,;#=Y/\-5A-VBZ_+0S:?Z3,?"<9=-SG]G/6JYL7$^5%L
M8ONH-_)S^C.LSC)E):;Y3S1V>MY$(7O\*G= &]DE$5/S3N>ONK-%%003H&+]
MI5=']R<(E$@V0E@./[3(,"[TG"719M6'^]WO*O_U"NBFK7D/#.W5<=?Q/Q*"
MZNN>S=X!AB5\KQRTS4>IP &.<4HA184U@-H#6PCWZ; &,)15S2Z9&?8FS*@B
MD%1.PSW?HZ6/)48'!3EE,SP_=[9\QIS+]A)+F+^=(&I;B$.OE09!WX>&8,O]
MUA3^>=!VM=D>R-.0T1>9>F(,T?&['%;+Y@NVGT#MT*M)C#PSZM15RK9OA4:1
M>"+/\:D<$7Y&B)PC>?/9_)>#L\N+L9,JC;Z*CNC;-:H=3OHJK(9L;)_JI298
M@417A_R<>:%;(7L'\!O> 4W29,;I4!=8?'@DK:Q[AE><G30G>JXI*37_^;'@
MH-#-433TDMVNJ77O!XCUNJ=PQNN>Q_)@/*;[1RE)=,U^!_SLDKU>FZKPH!(/
M;XL7F8BYK;V@)&LEL1(1M.\9VFY3$\NF.A5W_Z46?/Y;:N$W*%K\=?9'E$_W
M"GK?C3!173+Q4H=>RHX?F=-FU6"._"I"8=+[MP,^WB5WP#+F36B\[NG*K\;;
M6'Q7&#KD=B@O<X]=7M0Y/?V7F/;\2TP\(/P"3N-9L2H7:QTM2\&RHV^^@.7P
MR])KJSN@7#5M!+%?0&&_DY \\A4>9M6J*MPG,3B?UG-B"$2EYN,&HT\BYV C
MG@C+G*8]$L*3X1]*M!D/UQMKDU8D%YQ9>T2<D E;$1Q.6F[\&==/.V_:- -4
M]#A#\_-9HMQHX0MHCKZ>R"%G>KR\ Q)*;\ON@.F=$8OAIK\0XS].;,3=2,+@
M)6@1V@C#Q-=NIR^.%P.%CEDT8:&1!?/;1IC8\<]637R[S26^M=#.7O,)0BEC
MJ<(%S ^*O>Y;3S#4.P;N^W^[;?3;KCB?MM\H@J]E QBCO>9TZ(;8;C#EY;GP
M(J>\"U'5$F2L>]G:MXJ9=].O8!5]&.AT"PJ+O-P[X *&FSJU B'79/JW%3Y0
M4"O,NV11,Q L<"&@&WL8L(J?R=YRP0!#Z.K$G? ,<R\%\R<4\R9DYN]*JT3J
MF@::? >LIM^Z[7OAJ=TF=YPS;U@/)J-;=1_E:-%)2W*&O?.R^%@8D/*,K[I>
MZ%C Z<_6!Z;@;SL]E>D!2YX$U=MJV$;0#YO^>49SY*\[PK&YB"ZT07\'6(+.
MW$Z>_@'0_5Y4L%EUPIS4@<5A9J-;[.^OJ#,PW*6DS#16Z/8&PO1BLZW6$.B)
M.#_P'B.#ABHK4UDG-V4#UZHD^2=C)"G?JHC.U))J^/V$2@\3.Q;1NW^JCNGQ
MD61I '%ETRE>/5%E= QDU ]$K*J,$I;T-<.)#^8_\H5K73,D?@I(,UH97;]A
MFTVD>MFW!=6'0^T:X":1$=ZVW5-EOQ;@/9?!3O',]QA2XHD^\/$67$:4 ;;5
MPB:2F!30HJDK710?AGS:C LW(&WZ$BD:EVFK3U')\))$JX"8DZWU($P:>&V+
M'O>S0:&3BBDO88W Z.JD5.:OL16[$>_\?']IP$ "JBP7F$*KC KTTF202+OI
M_B4@,S"Z_CL]IWNK6?R,$9_DV)1N0]'O>N8?O7MT,V8UT\XG)L-#4EA>(M61
MM'?PR6J]IGRT>-0HY5F:.O"3P-?92D?V];B?,*F-:_:VAM>CO9CJ;3=V/U1/
M0>O$LR'/K^R0DK5( ZSFA+DB=TD[@5>8">$>JC#-RZPHW>^9.SW7U8[P:A#[
M)FP)]-;=XU70T//@-X<W>)EA*V.Q(C6G?'+VET' !C.[IY1L:V-YW+RL6(2^
M;-X@1'!ZN$HLR7$NBN$]_D^BV' S)O%\D9_8!T';C$W4VV:U-I6S? G?]3ZK
M9PE%SF'^D+7Y+*_>,6J:1N8[SC*GH9#/19IGC@%B$2;NW @O,+O@JE:8+=@:
M0Z<[N:PSF>4Y@X47PCOV5&MUF\?*S);*E&K]$FOED1\)+3^X=@EL:]H$NB59
M:^YQ#FUP$E#@F8:O.<-?J73YK-@6Z/3J9YBJ3!KH)RXX8X>L/7#*2DD!YV=@
M3"XH\C^D%Z42#7"2#&W?\35_&S;WCESDPVCE]\L!<V7),X3HJ_&87VW>S44L
M["J+?C1I[N+!#D&39!QUIW=[74NUW:\G:S0;V12_18B[&E%AN"$3S'GBG!B<
M#+IA!GK(YU^8TU*4CUI9*3AY!J@BY[(ZT1"O@7 -9CVDZUP&>$LBK1R??%B0
MPEV][>H12BC.)M2X ?,729N_*/Q8R-U_J.%&W/!4)].6*QJW@GU^54Y]:CN;
MVBOO0=3!N_%=*NP%=4GX-)\N+C)1 8);-NTWS8^?3L)996[%348PS_T,!T U
M"?#0JYSJBV2'HP1';8J9[>?+#7'TW=>A$2 6Y7[&RW<"361+5^W-[J7'9?VM
M.=OX3UQ9--FD%S@04[V^LJIN?Z!C.AF4:1,A68^)X-DB-K ]41P-AW",2QT]
M*];#FR$-M#)[<#O,?8A\'>@M=/ 5M@-@6<)/RF.,)5G61+WO&T UT\@_<>SZ
MO>3.+D!^.QBW^\U]'5"X!FBOE1A?@K'9^G&U"+K1&O=\BL^Y6YCF@T:ZAX8J
M+Y0BH_((2>=4B9:'L0:+&3M+_+YHJ&G,6FTX=W&9$(0B"7VZGI@FUPLB]OV^
MYN,M.U86=ZUV^F&0]^W8QL]]1AQY!6O<#1UV<+SV$2K(L'3VG=,*YS'&4A%A
M&!H&SC%OI$XL+1+^([($U)0\,BXPO_V!%OYG?OW"+<5V XLOT],%GWD#-0?:
MHL0X<X$?VZ;P <DRC>"::_[)\FX6;NPZK,$3$HES8J6X&<%,ESV2XHIA\NW(
MF^^"(>*HH 6*.A<HA>?7N5D+-V)\.?#BL1H6: FS&RKP+GU%]#BK,^>'2EQ$
M*2KU^PNR_9(1(39AXH89Q[W&[NF-JCB>P);0D0";C&WQFI4OU:.G:-VF>U9I
MKLA*X1NM)^^Y%:%'N)#NHR=[*ANSFB-+=?Y-=T!4B]\= '@)'6W#B.0Q<RP>
M(_/;RDI_%WEZ_)8[P-')YS()6-^ E%KM"PYS%)4-R"!8?V3S1%80Z,9=N,"[
M96!/M)PAS*NSR%K0>MAL^B*;8='1C93 3[WLYLVU<FWUY DW4Z9-\]HW\CN@
MA2S\QJU.%W-'(Z#>U!!2Q%#$D!7?=[L:;PE@HF3 M4)/ 4?V_^-_M53C.CLF
M>8\4=+PUW]#S \?N6Q@W3NCU.$F>$!>5"17<F#=7?HDQ)>O\K#F9>:W9\W'C
M:I<D8Y:$=HD,A.ML(K@>PIUHN6WG)[/FQQ+MBM?B,QF:^H2VEJ,LPB)"]E1Q
MR,Z#*>^]>?M6F^Y9JQ[&6KJP6B)#0(ID8C(X?P!\;JGOK&HL%K6TRN2BG6>\
MQ(,6@<?)0UBT&%B76F?FI.+^*9&A_P6GV%B]FMMUN+F9]O>@:+G@:%6P@7=U
M7=*0/CLZGC#W^XS5'VF?%L"B$+6=I+T6J<8F@TQW]3>6B3'$^ZW=\]TR%P=:
MX_T"92*V"!'QUTWF./,GPQIQC\3.Z$MYT1(55A3$$Z*PAF1I4M8FT_HT4YC9
MLG+Z5NFOV,3EXE9EIHPCF:BC]'VI4Y BC$0V>2Z]N8>KS%H]K!I$"]O7RR2M
MJ9A:S[Y^C1\Z"D_\X'5 V%+B=.S>DQU&]-WP<R*IL+&8BI.EX=KI=59A8DZ:
MU<#L6FQ@/W$\37K'Z&Y.#?]04#Q]2.G6H)5YQXP,L2L%)S4NY9!</C&G<+]>
M2&2$)$?CX2Q4C#[\ZL3F]A%]5%.ZG.)C<S(SA<)JZEKTEP+XSC8Y#H+ >+$E
MQW1.0QJW@86*,H-M+9BNY92?%#F'1CK';CE!(5949I!KGMWM]%^T?-536^_?
M2:9Z*,'TB.P?>N3SV#I6/R4.F"C>-&V#DLJ6>)/:J5JRBY>T:L;C711?82K3
MS,*;N&7^^5&QUA3/H?:DY>6ZAC$:AYD120K]E9J/'OTIQV$O7;OEM2N3UB0N
MB?M214-B952M.,!14#"OIA71X-27^F!9+KQ"!HD"'+YL8T<%+9^()PC?D"?$
MB_5^[+C;Y-\&Z@?21+;QSLU2QIQ2\:;6$#[/N%9>G\R-?Q82[^^7.T%(;1O"
M7(U,D*496)3&'8(TI@__9D7BK#Z ABJ $/D1^(=2/:>]) \U=^N79.=3:'VR
M$YC7*UM@5\A8Z7'\BU[3!!1\U#F]3 3KMO"$%.<B*X4A*?I)<7]]E7X*AJQW
M3!+7+6EV*()+)U\/"0>:M&NC!VS;GO%88KEA-*SDCN^7TM3I[N&:;J)YAZ-\
M]HF2[?>9BW+9-BNDL8CD'LIA,D'>L<(X6-:]Z6S>"X<.ZP3K:!]N*I5#0)7^
M\VU=8ZXZ&G;:1\U\2G9N87Z-;KXO'50(V]%#?#'7W%2I;4+3%6-ROWUH3M_H
MS JBIQQ%/0X/7#QFO1?@2?<"7*=41_;H84#VBDM41W">E"AZA->1S\*-OIV]
MQJB9K&+_X#+=<JU>R7XUS^TSJR\1;\XHCE?$ <IZ"@H,]4 %C/MCGQ:O92O'
M]C?39NB-XCC,)-,D^_HKD$WBO$.[X6G6!=Q5M'.S;Q/ >.7?6RG[?<C3!U3A
M(>M&W#1@#W?E9&D%>XINLYQ927ZJ2CA*YRCBG\>A'=48$O/U2'5?KN8N^Y1F
MS)FX/%69FN-/JY-#RZ3XK)CWP"K!CDVKO=^'^JM>K456ALF(ZW#_T*!\.S:[
MQ_EBNM97546/N,^I-PQYCKP4<&00-Q\(5W[J$&K)D.6@2'3)93XM^<!;#1!9
MV_3KEN'.55O<IKA<J\;DWR-/DIC@8O^4]O_U:NW14*]K^">V>^1.##)TP2BW
M<<TEF3#;,.PCD0AI$!-AE,NH2(F1L1A-RF4:<6J49IB2FEPG$6,HY))QB:G<
M<FF:/<;6?WMWSCKGK'/6.G^\WW_?>K]O/>^SGN?]WJ_\W.5"]A7^Z-DL8A4'
MPWVX-E*'F-2 +&CO.XE7\^V.ES7;2%;Y%"R+G0Y\LN7X.S8!EF)3J_?3\XNE
M;Z1'7JGX=@)Y%W_;JQ[JY62[Y<WMWSXX0W.GG"Z5(3PS..EJ,JWB)/=6;$IW
M91YY;%P"X8OP[AB^1STHOF7OS3\?^F^<)?44ZT$5 []ZBW;G$+G[*!5&H86D
M_IV#]6!79I@SZHSQ:XLG\TB-=C<#4\S CYK/9L[+IMPPBYSR:# ?.>[YT=.R
M40R&]P.#>0VSL0OIZ^:+1^]#L?(H@F_3MYT.918]\5_=S^1VI[F#B0#Q&YPZ
MH&<Z>CB)L"*5]QX*H<?&W]5YQGPR^:C)<]*"%=-=A^J-PT.Z:\60."D9O%DK
M<$?\PX7^K78WL/7#J@A[$UB2<UPB"170\EB6!'Q+D*PW@19B_=KN* 3$=7AC
MMFQNW.%2AP8$G8!Z\P!WG')?L>9.BY6^"-/)Z3/3DK0_?Q5D*CUG>\!DE"I9
M/&:6EMQILRZ(IJ!ED^,4;M,@QH:Y^!CP1/K?"I6U5<.+9I?:ZVG1HL?!GF&J
M!KEA!G&%8\G6]CC#AS+SO-(^\C4DM?K68M>6'7U)Y1$79 ,Z"%JL.AOH1G8%
MS-KQ>#[9G\#DRY5D)8#4U6*/9<)C;SHTA9?^GFY9KY*?K8]+$RKD[.,,>3Z+
M7+;(A"85T,$2$@QUFW:C(5[TEV+?$5[ NYF%R172%:.]F,R7^K>'1#6ST^_E
M]B4'H]O <$72::35!X)0JN>8P!,C#@F#XU#^I;?26UDD+9W:(^P&&E:!BR'D
MG^*DZ9F:NH"?=4!(HKI:$ZI[]O0O4U*\Y'D1ZVRCD@2055>1B\GGO<T:7V#6
MEE8"O7'M+564(VP"&7&;0-;NR757GWLG;!&1 @J?Z#=Y<IM,<5X5LR?,1\WA
M)3[*H_/?8'.7:UG]H(SGVG1P$W ";36OP-0F(.W(45WZM@$D, 2B^8*]HF6#
MJ7XO=A[V='0VE1I>[S2\BLR9VH/ZGH\<V!_01>45H,])T@=IY"))S;M9+C5\
M$O90-.VGO-4+]G:<^]&1L08L6K.66U#OT)0U$+Y^'P&E'K'@#B;:D"P(T<'+
MC3::^5>))VXKT)>$N I;B? =S#5I<:^IG)BRMNLI):XOGI.-JYW&] U!7F\U
M^4J!ET9:]?9UCRM=DJK\NHPVR+6;7I&2HHOAW,!XT\NE/AN$U@@=0HNWY6!)
M*#3TM;REFP@.D33U"P(35N#*B6$H!AE[.5K1_.9_%$G;$]XU,K=/$RL_]TFI
M/,E9%NM='BZTKAH6N-&?9@9^?N_S.G,[^U#%P :246%)U]=6W>&\M="?FG6<
M0G$>74^(DI,*&9J+/V"&D!.AH%*M./>O@HD0>3AJVOM32X^#LX8$62VK0>#,
M;EM927&-'64L_?I<[43#@.#W8)G(LZZRFI@NLZM@C9X#.596+LTC0:'BDA6O
M(#@W=;$-(Z.?<,O_&;+LZ81V]_WGQX@#?EX_%XG.TO7D%&&&;;!0A"E45H[L
M^GF6<1#30449&"?,;X^Q8GZ$#0*Z -Y\YN'!?!_Y^D3'O^S&MD XBWR B^5)
MZ/!\/??4W/;O0=;;Q+]8?\IT7I;W& A5%>JRE>]A%*Z1^$7V^:V6H-FVDI@*
M*%\.7P!S^-RS;2\?QI@TJFUBV5N=BEIA9*_.2CM)%B.+(_0!"9"[KA]V.-4B
MI%>@Y[<)1*T(>]<=ZYP_HD<8M4EAD1)V=;T/58YFK0M^!1G#LYY7,M*#>;N-
M=7:L4F"[T)/;=WE@XM2)CC6^KP3FR/%4]ROOE=#EW'W*80M-$WKY=Z.%>G1M
M>9GKR3/9+3<0[1K3.#M)3(MR44QS'>O2#]C,_;#45&,T!-+?6AQ+=S'MMEA5
MV&!/A%_LE+YP^H/R";6190FX(@>->OB#V;W__+XL%+$_&CH]9YL ;5#HFJ'1
M@?VZVY(Z;B>#:U1(FX D/9LQ)TK>!":TL)PC_\#GJ;Z=/GDH0;S7#'K@7>5C
M[)^9:.AF?[ RH*=P9(Z?:K[KM3OHL=&^-3$Y0\\WAO_)G_E_$0I/8-_A<=^.
M8*-F!'GPWQH8:@%!;Y^/M1F$G;^;V:ZN]2 LK'AZ[<RY^0RCFLH,,UH?QJ$B
M,2TQ?#W4K3(K%'\XPDX&G^X#<TB5.\>,(NV^A5&]2);$+R?*!"9DJSYN(\>7
M'PC][O,4R5)ZV9Z0X/T+1*^-V^A93X+.YCE$B)7637\];U]X%/6G0^$XXW:1
MX3@EBQPR7M?)Q.G5EM1X4=Q=@?@N.?*Y,RM=Y" *_XU*ZWGV(56G/"$%^BP$
M0)CGWKE'Q,/>3M$;B2"SF5,O&D>[M&[<#,F%72N[V5)L9Z<HGC(E0:[,L'E)
M>.<S,C8TUU\$99S^W;QK1W).G:'_HN[E0KR4PS"76O7^%LB$W5=B[BQ]V&W.
MHUJ'3?GKS$HE4:,VY%%QH)UO8CSI6YPX$H^PK1/-G:WF^L>YI.T,&*LMNM#?
M;&??:7%#:L]X%MQDT(C9U0R^R/3@5I?+G?!?<_NRBV8;U%TPZFX\&!Q1#'JM
M#8M3#1JDAA3<R0;%6\Y>";QF<=-GK-*_:D4_+^?C@9,%9\^Z33S24OKNE_>_
M/9;^GT-D<_@/4$L#!!0    ( /AP?U0P^^2=9SD  +]'   8    8VYT9RTR
M,#(Q,3(S,7@R,&8P,C$N:G!G[7MU5%S)UN_!78,%#18(&MPE(7AP=Q((U@&"
MNP^2QB% @@=W@CL$M^#>N+N[=3\R,_?>F7?OMSY9=WWS_GBGU_ZCJJOJU*[]
MVU95!S8-6P)PY:1DI0 X> " >_@!L%E  D!%1D9!1D)%04%!0T-%QR3 PL3
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MJZVVO)(HG -UC5:U13MWSQRAIO R2J[G1A,C#2/<0X#H2X"N6J#-H<$BB"]
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MN[.M@I44F%6;OQC?2B2]DD+]0LO@X*^$XHOE9MNZ>$UJX[,[#0,$]\^]1&&
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M2B5=-RJIN+0#X@.Z@P%&H*4I&$ F67?V@/.A#SRSHPS*9Q !D6WA_",]M6'
M7V_RN_W&?<OY60:M?O4.PG_D?9$';Q=<O!#5&TH\5$2HQY8>%'[*PU_^X'X]
M:'*8-LZ<PWCY@CE2+W>!\5NG[K1V^/.Q!4&X*PN]Z*MWQC..YWM-V+4>'QA9
MOA@Y4/ABLQLJJ]X69:2HXZ R?]#3(P;!786BZ2#E/D/KO<I'Q*ET-<3UXYO:
M"*ZKG?MZG\Q8>U=],X4!HKZ*1GUFM<O:U.EMAI1\T@NBF/:#LLP<,)U:3'.]
M\\1KZ*$.7&VHM_*ZN]86WR"^JW\,7I;$[7K2=_'T(\]?%><'US42CW98##A
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MODU\7NBA<G'-4F_#HK96[\5M@P@K2D+J0>%"O76?N6V/CATA1->$?^GN_:[
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MNE4?"3Q#QX*1L5014^_W6GO@5$*4$%@\X_E7SZ4Z;H872B%HKEE0_;'=[,\
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MFP &.)3QO'X,2V=" _N(,-]"\D4#1O?=+F"\IH#1?3T!@Y&89^"2Z-U+%VQ
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M;G1G+3(P,C$Q,C,Q>&5X,3)D,BYH=&WM6VUOVS@2_BN\%+=M <OR2]MTY32
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M18S*9.)NIDTY-#*17$O27GJ2ZU)I3LN4AHBG<QOC6*K+-<H(:&.1V&A2P2G
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M[RO21ZE(NQG8+  J 3F./=*]0BP% %(1G&5E.!/\BAB+9[>.LSA>[CX(65Q
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MXG!QTU2]7NO0'OHOC[AOHQS_ 5!+ P04    " #X<']4@ V>F<\$   !%0
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M>!1RQ2D._ !>)X>>7;O4)BM?<+[&I,Y+SFCUG%)%_UPP1<WR4AG/GR$Z(L>
M:?).C[+C?X"@Z4+A\$0-\1-N!0+WF18-[]P_"8&([)7"[3;A,H&U-2=U#%C"
MFJ""#$]WL"!,(1BEHI4)NV/(!!<T%$,GL!Z14"(.5:<M4H&KGCE'A5F].M1Q
M(M>"-ZC)DJK:9K5!JJUX^W7 V&D[/VN3&2+< =P0E1:;I[W[4L5C,%ILK-0]
M/*.I;'(8++ 3*2,<[E&L5'*I@G=N_8<ZG,K9:4#H_N(_4?RL(V-5R<DZ8*(.
M9\IE^AC*)54YEZM-0O^]TF[-I3\6E>F)6T<6)Y7>/?^^EPR_"EV#MC3=%1MV
MJ[@99.&J8)I:54E2&@CS\/&PV;9]WS[OUEBWY0:;LMLNSV\&V&;-&-W:W,WO
MA[9@%Q=O4&]#??:&\QO.;SB_X?QSX?QBTWQ["K^<U:A@-,=5&-=BDU(8YSG#
MGR"U \U-5_-:J(TW4Y(^SI3$!.X5U-9]U2ZA-=[=<\;=W+ILWY2U1SL79?N7
M<"698185)8\6R7'A#<A2LJQ-XX<S^^3#^W J%198>VE6%[O37.[5MX47?P-0
M2P,$%     @ ^'!_5#P#T:+.!    A4  !@   !C;G1G+3(P,C$Q,C,Q>&5X
M,3-D,BYH=&WM6.MOXC@0_U=\7>VVE<B[#S9AD6@(*J<6JI+>W7XTB4-\-7;.
M<:#<7W_C)&R!V]U/I[8GM5)Y>-Z_F<P,[OUB&!'/,4](BJ[CVQN4BJ1:$JY0
M(@E6<+JF*D>Q* K,T2V1DC*&KB1-%P2ASZ;CF+;9/3>,?@]4A:V,X#[R+,^Q
M7-MUD>WYCN>?N>CN%IT\Q.%IS3V<AO'7NZBQ>O=P=3,.T9%A6;][H64-XV%#
M.#-M!\42\Y(J*CAFEA5-CM!1KE3A6]9ZO3;7GBGDPHKOK5PMV9G%A"B)F:KT
MJ-_3)_!*<-KO+8G"*,FQ+(GZ<O00CXPN<"BJ&.GWK.U[PSL7Z:;?2^D*E6K#
MR)>C)98+R@TE"M^S"Q6 I 7D YXG8TU3E?N.;7\,"IRFE"\,1C+E TZ7%\]G
MDB[RYT/1!.=+PK"B*Z*U[^A-&,'2GPN5!X<FOB=9;.4RP961X25E&_\XQ(S.
M)3WN'%\3MB**)A@^EP"L41))L^.@9B_IWP3\@@@9Y<3(2>.HZ78#19Z4 5H6
M8$Z?!@TF?@O'?,_LNA&<"Y8",7K*Z9PJY'BFV[/F@%WQ(GXF4,A$'CBJY7_H
M:YMG %N)I=\%B14MP7=&U<;/:9H2#CH^?>BZMA?T+"W_NM'\#/8PNH_'HW$X
MB,?3";KZBN+K"(77XVB$1N/)8!*.!S=H.@*.Z!X>P?O9PV 2HWCZZBGZ65!.
M%SV8,S,TT2P*Z\ <[]SNH,$,#8;3NS@:_F]"V0;PV;Z --39F0WNKP:3:&9,
M_[B)OJ)!&&N*:]MOZ[EY<X_)LZM(_W>;=_!AS%$B.">)[I/-,%,Y00/.*\S0
M/2F$5#"OT$C()>!LC)#(4 CQBP7A!$W,WTQTHB5T,*X=A&()DW!3?W."4Y0)
M62O,:)F P@VT:D1X"D-P2!*RG!.)/*<#FEUG3T]C>:NF@\8=< 8,_EJ5JH,2
M(A7--JBH9%EAP%T)M%/X;31-X>,2X504>N[NLF^9='%!2-KT#,LYYJ0TID^,
M;- @49JBBZL#= QV04XSSDE9DY8;],C%FA&8]CYZG00Z9NU2FZFL8FP#&5T6
MC)+R.9^2_%512?3F4FK/GR$ZP:<(<N2<GZ2GWX @225A<H*&Z E6 @[+3(N&
M\]D["Q#FZ2N%ZS;A4@Z%M<1U#%"_"H."%$[WL,!4 AB%)*4.NZ/)&+8S$ ,G
MH!B!4  .9:>M4 Y[GCX'A6F]-]1Q E?%&M1$061ML]PBU9:[^3I@[/6<M]IA
MA@"WCVZQ3/+MH^Z^5/%HC*JME;J!IR0130[]"MJ0U,+! <5(!!/2_V#7?Z##
M*BW=?3Y]<#TOJ%L0!%#])ZJ?=:2T+!C>^)37 <V92!X#L2(R8V*]3>F_-]J=
ML?0G. 9=<>?(8+A4^^<_]I+"5ZYJV%:ZOT*_;A4W<RQ8YU01HRQP0GRN'S\6
MM,LV+.J7-=IMP:%MX>T6Z'<#;/.FC>XL[OKG0UNR5?\=ZAVHO8MWG-]Q?L?Y
M'>>WA?.+S?/].?QR=L.<D@R-OBV)TRRC\#.D=J"YZFI><[GU9HZ3QX44D,*#
MDMJYL-HGM,;= V?L[;7+[E59>[1W4W9X"U?@!>11$OQHX R67A^O!$W;1%Y>
MF&>7'X.YD%!B[:U97>Y6<[M77Q?V_P%02P,$%     @ ^'!_5")CX\AH P
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MJOY(FG2P^H!-+8NZ72QSX\4TXV+:_WG(,Z;);VQ";F5&\Y\;K@3^:Z9X_//
MUM;\3P9=P_ ,NS<>%3R!SE'6@1M_'^Z1^K?5<_,P6GKBA-FQC:2(X.;-?<I'
MW( :6^V+Y@@FK=B6B%^0"&L^*%2E2:L5[&?,-8@HN)GV4QY%+(<>?GK6:P>=
MP4436^](Z"].8YX(KE-R5V;0P_319G)U\G8U-^?+D N!?YA:D6NT\2%7BE,!
M7;YA8LP,#REV#VSA+3YC>3+OF!KSD)&K1#&&5+<^G2,:?DZ4+//("Z60JO\L
MMC^#[<WS3\]:I\%@>].W"5EG#RR'_W7RCBZ'*==D;<+(<<H4XSF-04U$L1C,
M K"^D81J8E)&$"/M8(:11U;=-XS/"MH:/"<P3 LZ& ;/82 CJJT=L\,Q+(]@
MH'1"540B:^&N"C"$I'W>(&#B6F3$S(2QO/^8C+%1E3/][W*I+F"MMSVLO0:=
MDCL#TTMD3%[2,84F#?(+4R#2M $X*Q33J*6(C*96,56EO&KV/HX1';%4Y VC
M OP6FD?DM901N:,Q,U/GS( 1AHXTH8;<) G+%2NA,T5^9PDYZ33(>2OH]LB-
M$C2'NS,)R/%CP?H:BA0-#;@&Y IDD0K4N"UH/PU(_I7U^(:)! P]C3E<6-:M
MT^VMZVO0AX2%Q,@OV>@-.7Y, U&O)*FVM7P:!((&F15( #P/I2JDLA: YX2&
M<!UA\.2(!4<FZ$0C?^'GUPS,!A7DEA7E2/ 0RVLR<4P$I)9P[>S. BU=9<!H
M$/1$C)PUP$,,NEU0H38R_#RC(W_O06GH2# R@BEBZL51<$1")D05 LVN=4'#
M^KKVOFP+]+P$+33KUQ^VX7UY$$@9F?472C"FLS$/BNL).I6EZ<?\GD6#A6#+
M"57/C5'P&]4"NVJ!?U(%AB9:O+L!>"L+;PW(8Z80E*)B-$MN(.9@DG+#/)PR
MUL_E1-&B%O'4AQ5;QY>5E"U_593E^]^R[)9EM]V 1 !,L3Z:!6[&J O]N'+T
M'Q8:\HX:]""KY5(O7N>/H^1-G.>F5<R.,/X-D["DP.]#VYTMTO9P02/@4)7H
M AOZ&20#]YAI5 J&I&8B229AK.@F:T.<];650IE')6CYP_6MO:>M9W9W=7OG
M7<M/7ALIE-$PK?4_\^82"0L@MY%&!.RH>&@LIWXL"D#+!XK9CAP=/G3O7.%K
M8$MX'J>[I\7=0N:)D6K;/^U^3U;M=-=HM;V_M!K*P@9/59RLOR>3?G<7MKL]
M+KS*9)X N4D;)TI@OH1BYE4WE@P7L)M.J1!SLK2W9V1I&0TY"]2D; >HK$WL
MB94*)<<</$!=8EC+L6V13C5\!-EL#78/_4 IM)!YS@02JLM7S+ORR7"3A$X"
M)]\F 4 T2LZ\B$ZQ>S)A[#/F1+A[L.LCHSPW%)]I6U(D'<.=@4#7.,LD)DM(
M1&&:P=/]H^3*9FTT@24'O$^5G1R>68<:LRZ,E 5^Z :!?6[]? TK=/\=WJV;
M\\ZCF7-0),QKQDTU\RQ/:()8&X6S2AHOK9\&%0K%H1DM$)40TE0)F(V9BS7(
ML:P0<JI)NT5>W;LH$%'T2OE@\TM0[ULZPJ@*6I>9KBKH%6'V7_U/S#3O7;S3
MV5O#_'YN,5:#G2I3<0AWOO=&QZ)*4/;6V4 OFGK,_H@R8@U"T1NH? &3 KYT
MXQ!T_#\Q6[OG!U\;=?QM*FL'_OEZD,'_BLNVB8@'Z:PJ6B<T\!UBO(>I3R0T
M&]V#3T#G+BH!P_]'":UB#B[&S$=M@,=7,*@@!"94,4F0@XN!OK!-B8X4HY]!
M;P06FW:NJ+*Y5BB0&CR4 I8C."#H&8!8Y)CYB4^8 )5"AR&ZE#'@4%A/=+[Y
ML3R7%1K.%W2\Q+U/#>]=O[L[O'?\DPUXWW/ +\=P#T5M$-WASC3 7<"X7:QD
M4+=+.'S24.OLDEJ[&ZEUW[%F W^](3LP)[:*]@P&TPTR9A!."P:?D!4A(@<P
M/C] KH;<B=_:'>1._-X&R(WW&W%ABD<=$&Y"AG6<@CEX;'8 4@VDTZ]/1O]]
M(+4WY9[W'$>:F;*H'<+*+"Y "AT\<.7:)R25)=C+L@".P[P@U#Z@;&XA=^B,
M=3<Y8^,]-Y T3#D;L]H5BTN,)68Y=0@.P%DSY0QO,8"M0IP[L4B5XIC$1'_-
M0;7&Z &%-0I;N_33SC;Y:>,?RD]S 2Z "DH-!K1C1G#'H[ HQ8WO^3:-#0MP
MXR-/".Y]H+"'$&$6EO=V2("=8#,!_E#8RZ7A,9\Y;M6&G&*Z%,;NQN'U+ GC
MPM*T.B!;;=KP0XRZ3Q:8W_] \(NHH37J5E 6\QR%=B!,V0;4S<APWK*!:3R%
M64/, [)[S 0"G;I\(26ZY Z0 !:(= G<!!ZE3HR:?65N3VT*3F&:)FR$.Y>"
M;S#RZ^QS2 K6T<X./8#V)@]@SQ<!GFE6-A7M@%8? ZZ@AF@1=&(!KEA2"L?/
M#]/L'F\<'?:)?H@=\).]W0&_95F95P':8</[:S>\S[:WX?VKW7K3/%HXB;9R
MELT=0$/CBC=T=:;0'6ZS16M?QVL\?"BH.C-6T.GJ8Z@]70;6'<^7A20&GB3V
M;-JQVW'';O"D6ZZ9?FY/@ZWOO5CSCZ?,8N:^_U5E RK9-S2(2E7?A<NL'O[Z
M=QTSGF,J(06IS-H9*JB WQNW1ZCF\W([8_OZ&X15/=NA.^=6N3S68(!UP&\6
MXK$Y$G&%)ZXBAE+A*><%W104)A.L3GT=2@4AYY@K$'#A6/7Q];S<&\)SO$],
M 9GE)0S8(UCRZ?GAG/3!%#VF*>KNK2D:XG)'IVPX7V$'D_35QZRW>P;KRUR,
M9XJ9?5<)D.+*5[!M4H-J-!5<N1K_ I>#= )7849X:Q+.-07R4Y+3S*(U8>UV
M%U<4O5R<0/?:#_<W53/:6'MC0&!_!@NO[UB^D3K=M>&Q@N?,JZZ#I1=4N%>$
M5"6+;PU9?1\)BNO9LS.>S7'WZ5CRFD-Z/;]]4K-(]0:1P)*%>\^)?7'*Y7\!
M4$L#!!0    ( /AP?U3,@#0Y<@@  )0Z   8    8VYT9RTR,#(Q,3(S,7AE
M>#1D,30N:'1M[5M[<]HZ%O\J9]/9/F9B8TQ("*2926G:WMV;MI/0[NR?PCY@
M;83D*\D0]M/OD6P32.CT[BUYM62&@&4]SO-W=(ZMH[\%P:G,F$PPA0^#L]\A
M54DQ06DAT<@LM<ZXS6"@\IQ).$.MN1#P1O-TC "'8;,91F&G'03'1S15OQJC
M9!=:C5:S$4=Q#%&KVVQUXT/X? 8OOPSZKWSOMY_Z@W]_/BU7_?SES>^_]6$G
M:#3^U>HW&F\';\L;>V'4A(%FTG#+E62BT3C]N ,[F;5YM]&8S6;AK!4J/6X,
MSAN9G8B]AE#*8)C:=.?XR+70?V3I\=$$+8,D8]J@?;WS9? NZ% /RZW XZ-&
M_5WV':IT?GR4\BD8.Q?X>F?"])C+P*J\VXIRVZ.1#;I]H\]5,..IS;K-*/I[
M+V=IRN4X$#BR79+3P?YUF^;C[+I1E<QU-0IF^13=[$OS)@*9[@Z5S7HWEU@W
M,J_'C92TP8A-N)AW7_29X$/-7^R^^(!BBI8GC'X;$FQ@4//1BY[O;OA_D>@B
M#@67&&18$AK&G9[%*QO0+&-:SK7V2IET21S@/AWZ-#NE;(8K-,S*689*I'3S
M]"KC0VY)M<V]H\:0!)EO@NC#=32O(_%@'8GUBB>:,_&]]6[P(\>"FPPNB@DM
M-]\@2[?U0$RU\[62KXS2#5Y9MYJH''=+/E-N2!>"VWDWXVF*DN9X_JP31ZW>
M4<.-OU/M+%E40I"#>HFQC:KHG683G"E]"6RL$3V^*0DVP[LVP'MC,4<]4GKB
MD!S4"!(E1YPNK=JH13XLCREG8ZD,=39 S,+%R?E%T%=?@_A.G>[/\'C+[^JE
M!WR"!C[B#,X5:8>6]2UN^77"K>(,@;U5DZY#TX=UT26D:;4JN*D1])L\?T^U
M.\>#C!LX6?CBRPPU<LE&)%C0.*)M!NTBK )FG)."XS>.%OQNS* N4$\Y.<R"
M$F]'/\"7)[39>P7$GC<38H-+8F2(=H8HNYM5V7I;_8YE_FJV%C??7L'[R?##
M;KF7=09%VS"-Q@"S\$^R/"%0&ZO9\V=QW.HAQ,UH%SK-3MR&,VIKQSV99"AW
MX3TZB)W#R[NRR'YA2!FH-V6(6WO[ZW'K!\3/9+J5_+U[>I^TJ,8HT;O['3KI
MZ<?!I_>G'T\WY:6[0)FIFN0.6KA,E,Z5]HDTE\ 2ND[]OFX!7X+-C-OEN=_O
M,$7-!)QC7@P%3UQ[#5-^ *.(.N:F#$9+P'<R@0O"/)DB'.Q2YA:UV[1'(?A)
M+A= %_X45FS94" ,28RH7^]$.Y"@$%4JOK@V.4OJZVKY<D20*"%8;K!;_^AM
M4@#-PQN,1=>LNG*#N_0,!(+-56&[(WZ%:6^I"E"26<O/:OJD-0MEMRC<JVH6
M-EV^N\9<;[CN+>N?HG8<B@HX/882F;U9QBT&3HC8E6JF65Z3N!_NTT25N"LJ
MF^%-4E;O_XBOKM+NIR&*R)S%;6YNJ6(I)KBZC=LC%L/_8&+AC%FW.ZV\KD\S
M:9:4&T;/2L,)ON$U]6"N\@-R6I;*KQ(NJKV6VZP[G4X8P6U2*58M5/T&-5$$
M%R@)DB$MT"<F8)&04\/,U1$4H'&:=V4@ E10E(V[SM1(3J$+ZD(=H-QE&(?J
MU:0T,F%:SX$<&XP*R+&$0VEI.<4Q>/Y'H6POX99$4\YARJ80!D19SL@7*;LL
M'"667>(-2HB9DA).1#K>W%+D9'ZU,EJ(.0RY7_-S_[Q<P?6TF3+?)-^EWD@N
MPAVJTOQ&25.%*3<YT>#$=H[C0I1+EZ46EQ"Y(JO/^'Q*Y*>M2\P4I)@NDSY(
MN78NER*M-Z&\L)RE5$?.B#@GG.J:EE623;DNS%)! %[VK]N# :T3?$5-%,J"
M2 S M7Q]]1C"VT/[[#8X/K;@&#^AX)@0P#A/K"HIYG'&PVT1;EW\.YDH.29<
M5P2C%.TH'(P]TII=6&0XX!(J?]^#-*?P(-C092>*HI8+0)+N,8V$WR:GL3XH
MN CAL5HK)[D2O)?&,<G$W+BPJUS 30L"^^OXLUK:A9DK#C(#BW!M,HJ2+GS<
M6I)=^@"4:47YC9FQ(;$BE$M^7,G8169'U75,)*H6G#IU-@]Z!F8X!,J_+.54
M1!XIX]*/K),H,&R2"S2/(79L4Z.?#_U;3P?]/UU#QHHK/<X@\/,F1='F8L*R
M2KE,1)'B+C 7**HP83,R1;/[",#OH?7ZRT-GW FC]E\$S_\;*^,H/&S? DO^
M/;#<I-5\$R^KIC^!F#>>TJ_=$KD]T,+.5IFKU'.X)/05A-V:9#MLWY])ML*]
M-2;YU&PR1<&)][DS2+]G]MM=,DT49K$#KC:]/@O@93GG>I^\8JU;@UPQR+VP
M>7\&N1=VUAGD4[-(J2P?T6)UCD9Y7B&L-T9?B%S4'*6O%U;/O3)D@E)4-1JY
M0D19[S0>9LO7)*>X!ENWUOK8K'7ZQ(S5%+E#09\ U14*7RNIWZ0NS5CC'P77
MOOB]8INN^NZ*%DF&R:6!X;PVYV^;Z9/:;V^WUS]-96+OZ50FSG%2R*K*MZU&
M/-EJA'O(Z2/^I2L\,U>;%:)^*90EB7N3I7K<N%2U==5H7WE.RY=(%[ \TEB^
M')T1M1C"B5E4JM=E8G6]>+F>#.X8QN+!:UF)YG*JW%NDU)=K,-63$#\\4:Z@
M;9 &,(MB3B2H"2!+LJJ<LGBEIT)]-P *R>WV@>I3];!MX'IL@:O]= +7@/S3
M(\?@VE&W >Q> ]A&8A9IL8+36V<,W)N>])WX<Y+P#]JG0+R_"W$4-[WF\2HG
MM#;NYAG3%"E:37\W7I9">?BP_)_I!82PY'*L52%3!R-*=Y]%_J^W=(1P]48E
M@OB&2*):/\N'%ZNFE;.+-\]%YFR,P5 CNPS\:8XNH]A8X\?!?KAW4"-(=8XQ
M\D!1GK?T!SB/_P=02P,$%     @ ^'!_5-9B.Q@2!@  O34  !<   !C;G1G
M+3(P,C$Q,C,Q>&5X.&0Q+FAT;>U;;5/;.!#^*[HP+>T,?DG"2W#2S)1 2V_2
M'E/"W=Q]DZ--K#G%\LA*#/WU)UEVL .!0!/@J)G!B?6Z>G:?7=E9=7ZSK),P
MP.$0"#H=?.TCPH?3"802#05@J4H3*@,TX%&$0_05A*",H2-!R1@0.K3K==NU
M6WN6U>VHH7I9'QYZJ.DTZT[#;320V_3J3:_90&=?T;N+0>]]VOKXC][@[[,3
M,^O9Q5'_2P_5+,?YJ]ESG./!L:G8M=TZ&@@<QE12'F+F."??:J@62!EYCI,D
MB9TT;2[&SN"[$\@)VW48YS'81)):MZ-+U!4PZ78F(#$:!EC$(#_4+@:?K)9J
M(:EDT.TX^:=IZW-RU>T0.D.QO&+PH3;!8DQ#2_+(:[J1;*N>CJI>:'-I)93(
MP*N[[IMVA FAX=AB,)*>PNE@_[I,T'%P7<C-XCP!#$LZ SUZ8=PA RP\G\N@
MO3C%;3VCO-^(A](:X0EE5]YV#S/J"[J]LWT*; :2#K'Z'BM@K1@$'6VWT^8Q
M_0%*+K5"1D.P C""VHU66\*EM-0H8S6=+FT;3#P%!]+_+?.I1?!+(B1F$)\S
MHBI/+@/J4]7<KG<<7\$8;4[DI1+V:2P1'Z%XZL>44"PHQ*DDJ4XE]AGD(OE<
M$!#6D#.&HQB\_$MQ\GTU:#:OUM!0U2@*9=,; \!3R?,"H_VTI*#,&DK!5?I6
M?4%HVQ2Y$/FB#+R2Y.4S$!H6ENE%V8CDDW824 E6'.$A>"%/!(ZR>7;W[?KN
MFP(LN4&F$.W9NQE0Z;<%*RR(P-6T(\83+Z"$0#B_M_14GJ^<P+]6HF"[U[*-
MO$:0O"GV8\ZF$DK0K,-$6@^RD([NF,]9[N8>J/IW]?<=1[<Q%FR<07:5Y"=T
MM&<?'/RJ*GH@BTLZ*HRB*F<T5EZ&47F5(U#KOMUJ-=QF>S-JVVTINZCT]EQZ
M<Z2XS5_NS1VF<MM*:\J[-FMSB/#PW['@TY!H[\Z%MT4.H3YJM!^H^A3'U16_
M$;CKA\7X;")(4:9[@O)Y(0[JN"@#0-]AK**DVGK)>9Q>#>HGBDV;PK&,V@U3
M+0*WQ.2MC'RM!QCTD\:,"KK'^^W7A]VJA%Z7O\R8GFVL,Z'KT252T8D2M.6F
M?WF]>7RZKFT!/B3^*@K+5_ T&KOSF2=4CY=7*,03*/O2]8-K7,%2;%='[TG-
M_2[PWF[5]]WVS>NFD<P\PXIFFCW1KXZTMLZ7!O7O4T%C0H=ZMZBW 5R,<4A_
M8'W_E)N ^\SW;M>0U>IW-2_?;_345HV/(03T>>*?KFTOL"*"C\8H,]FUQ-X5
M95W&L,<MY9GH]QG$!(=7+S?XOF:&??K'ZO=[SQ]]-T.^IXI[KY"5%R'5/UM\
M%-A')Q,JL,Q>!U>Q;C-,O#C?04NH^#]B7$6L^S1^# PG6,".TOC'*NB]I&UE
M%?)^:69^G,924%Q%N0U2[TM(*$9G,VFCOB15L'OEE$K5706YYV#:>4+E#Q ,
MAVH7_[D*=Q4W%TRE8"!5R-L,$6,\ G1D_VE7@>Z5D^D;R,!PZ1%O2:IP]_/A
MCMC<YN@(V%A@ E6XJQBZ&.Y ^-7#W:. 79Z'<0/R6O=8V.@(3T&@/E;KP)(+
M.IW$V4L7DV<13\N2F614NZ'%7L!;89"GEJI>Z\L,J@+IRZ3I[;\&.FG^>9[>
M:)+1S;(^U-P:&@)CF?3S>PUG?K]2WOJZLSQS?;ES!J4JT+?I BR&K_A4>B-Z
M":28-VG$S.F6NJFY 67-6K=:UZW+6$CW7J27SI#4'%N>RMDJFT;.QO+4Y08W
M<[4>FYUN[O1 2BIE&:Q=S-'(BNXZEZ$];'FCP"%&(9>()R%2EH;B  M51,/,
M;6E'9:-3GH#":@==]YP R#C- QT*!9:@.,\+U:<;!&=HP@DPI**S&N;+I^_G
MJ.XBK(:6*% ?<!GQ>"H 28YF6'775BQ 3D48(_V8KH?")D5-MYG&@"(EAM W
M>#2"H<R;SQ/6;C#D]@,ZN;T4<X33:R"6;RVR;)["69MR189X8X$";NF01W:@
MIW3,HUPV/T 4X3%8)I\;CQ2^'IYQFC/C8-_>O7:%ILQ-UV0.)J4GG;K_ 5!+
M 0(4 Q0    ( /AP?U2&A93_L2H  #'X 0 1              "  0    !C
M;G1G+3(P,C$Q,C,Q+GAS9%!+ 0(4 Q0    ( /AP?U0^(X2 4A<  "!F 0 5
M              "  > J  !C;G1G+3(P,C$Q,C,Q7V-A;"YX;6Q02P$"% ,4
M    " #X<']4K-7-3[M\  "AN@@ %0              @ %E0@  8VYT9RTR
M,#(Q,3(S,5]D968N>&UL4$L! A0#%     @ ^'!_5#C@D1.VV   '=<- !4
M             ( !4[\  &-N=&<M,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( /AP?U14K0I2VJP  .BO#  5              "  3R8 0!C;G1G+3(P
M,C$Q,C,Q7W!R92YX;6Q02P$"% ,4    " #X<']4K<XA-4Q/"  D64\ %0
M            @ %)10( 8VYT9RTR,#(Q,3(S,7@R,&8N:'1M4$L! A0#%
M  @ ^'!_5+_%G-*F9P  ,G<  !@              ( !R)0* &-N=&<M,C R
M,3$R,S%X,C!F,# T+FIP9U!+ 0(4 Q0    ( /AP?U2LB7DM&%@  ")C   8
M              "  :3\"@!C;G1G+3(P,C$Q,C,Q>#(P9C P-2YJ<&=02P$"
M% ,4    " #X<']44>Z@,X#-  #(Y0  &               @ 'R5 L 8VYT
M9RTR,#(Q,3(S,7@R,&8P,#<N:G!G4$L! A0#%     @ ^'!_5"#[-O0JB0
MEY<  !@              ( !J"(, &-N=&<M,C R,3$R,S%X,C!F,# X+FIP
M9U!+ 0(4 Q0    ( /AP?U0*"$#PSGX  +:4   8              "  0BL
M# !C;G1G+3(P,C$Q,C,Q>#(P9C P.2YJ<&=02P$"% ,4    " #X<']4QA*N
M<6?&   *UP  &               @ $,*PT 8VYT9RTR,#(Q,3(S,7@R,&8P
M,3 N:G!G4$L! A0#%     @ ^'!_5*.R)GPNF0   [T  !@
M ( !J?$- &-N=&<M,C R,3$R,S%X,C!F,#$Q+FIP9U!+ 0(4 Q0    ( /AP
M?U3)1*1<2ED  $IR   8              "  0V+#@!C;G1G+3(P,C$Q,C,Q
M>#(P9C Q,BYJ<&=02P$"% ,4    " #X<']4LG'KO#FN  !EO0  &
M        @ &-Y X 8VYT9RTR,#(Q,3(S,7@R,&8P,30N:G!G4$L! A0#%
M  @ ^'!_5"[2)H&?JP  0;X  !@              ( !_)(/ &-N=&<M,C R
M,3$R,S%X,C!F,#$U+FIP9U!+ 0(4 Q0    ( /AP?U1+_%C5:W\  (R)   8
M              "  =$^$ !C;G1G+3(P,C$Q,C,Q>#(P9C Q-BYJ<&=02P$"
M% ,4    " #X<']4$O$YLFE#  !M4@  &               @ %ROA  8VYT
M9RTR,#(Q,3(S,7@R,&8P,3@N:G!G4$L! A0#%     @ ^'!_5!%^,Y+K2@
M4U@  !@              ( !$0(1 &-N=&<M,C R,3$R,S%X,C!F,#$Y+FIP
M9U!+ 0(4 Q0    ( /AP?U0P^^2=9SD  +]'   8              "  3)-
M$0!C;G1G+3(P,C$Q,C,Q>#(P9C R,2YJ<&=02P$"% ,4    " #X<']4B9F5
MQK@P  !,.@  &               @ '/AA$ 8VYT9RTR,#(Q,3(S,7@R,&8P
M,C(N:G!G4$L! A0#%     @ ^'!_5,V;-BON"   63,  !@
M ( !O;<1 &-N=&<M,C R,3$R,S%X97@Q,F0Q+FAT;5!+ 0(4 Q0    ( /AP
M?U3!.;^9\P@  &$S   8              "  >' $0!C;G1G+3(P,C$Q,C,Q
M>&5X,3)D,BYH=&U02P$"% ,4    " #X<']4@ V>F<\$   !%0  &
M        @ $*RA$ 8VYT9RTR,#(Q,3(S,7AE>#$S9#$N:'1M4$L! A0#%
M  @ ^'!_5#P#T:+.!    A4  !@              ( !#\\1 &-N=&<M,C R
M,3$R,S%X97@Q,V0R+FAT;5!+ 0(4 Q0    ( /AP?U0B8^/(: ,   @)   8
M              "  1/4$0!C;G1G+3(P,C$Q,C,Q>&5X,35D,2YH=&U02P$"
M% ,4    " #X<']47O'C1B4*   ,1@  &               @ &QUQ$ 8VYT
M9RTR,#(Q,3(S,7AE>#1D,3(N:'1M4$L! A0#%     @ ^'!_5,R -#ER"
ME#H  !@              ( !#.(1 &-N=&<M,C R,3$R,S%X97@T9#$T+FAT
M;5!+ 0(4 Q0    ( /AP?U368CL8$@8  +TU   7              "  ;3J
M$0!C;G1G+3(P,C$Q,C,Q>&5X.&0Q+FAT;5!+!08     '0 = -<'  #[\!$
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
